1,1,41,ASIC1,acid sensing ion channel subunit 1,13,ligand-gated sodium channel activity|acid-sensing ion channel activity,brain ischemia,ppi
2,2,5999,RGS4,regulator of G-protein signaling 4,14,calmodulin binding,alcohol dependence|alcohol abuse|bipolar disorder|endometriosis of uterus|endometriosis|schizophrenia,ppi
3,3,8490,RGS5,regulator of G-protein signaling 5,7,GTPase activator activity,hypertension|essential hypertension|schizophrenia,ppi
4,4,9628,RGS6,regulator of G-protein signaling 6,14,GTPase activator activity,mood disorder,ppi
5,5,6000,RGS7,regulator of G-protein signaling 7,19,GTPase activator activity,intellectual disability|learning disability,ppi
6,6,8787,RGS9,regulator of G-protein signaling 9,10,,drug psychosis|schizophrenia|blindness|asthenopia|bradyopsia,ppi
7,7,6005,RHAG,Rh-associated glycoprotein,5,ammonium transmembrane transporter activity|leak channel activity|carbon dioxide transmembrane transporter activity,hemolytic anemia|Rh deficiency syndrome,ppi
8,8,9028,RHBDL1,rhomboid like 1,5,,,ppi
9,10,6007,RHD,Rh blood group D antigen,2,ammonium transmembrane transporter activity,favism|hereditary elliptocytosis|hemoglobinopathy|congenital hemolytic anemia|schizophrenia|Rh deficiency syndrome,ppi
10,11,604,BCL6,B-cell CLL/lymphoma 6,123,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|DNA-binding transcription factor activity|sequence-specific DNA binding|DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific,lymphosarcoma|lymphoma|central nervous system lymphoma|Langerhans-cell histiocytosis|reticulosarcoma|non-Hodgkin lymphoma|B-cell lymphoma,ppi
11,12,6009,RHEB,Ras homolog enriched in brain,47,magnesium ion binding|GTPase activity|GTP binding|GDP binding,lung cancer|non-small cell lung carcinoma,ppi
12,13,6010,RHO,rhodopsin,17,G-protein coupled receptor activity|11-cis retinal binding|G-protein coupled photoreceptor activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|retinal degeneration|cone-rod dystrophy,ppi
13,14,6011,GRK1,G protein-coupled receptor kinase 1,9,protein kinase activity|rhodopsin kinase activity,night blindness|congenital stationary night blindness|hereditary night blindness,ppi
14,15,6014,RIT2,Ras like without CAAX 2,17,GTPase activity|calmodulin binding|GTP binding|identical protein binding,,ppi
15,16,6015,RING1,ring finger protein 1,82,,,ppi
16,17,8737,RIPK1,receptor interacting serine/threonine kinase 1,108,protein kinase activity|protein serine/threonine kinase activity|protein-containing complex binding|JUN kinase kinase kinase activity,,ppi
17,18,255877,BCL6B,B-cell CLL/lymphoma 6B,18,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
18,19,8767,RIPK2,receptor interacting serine/threonine kinase 2,84,protein serine/threonine kinase activity|protein homodimerization activity|CARD domain binding|JUN kinase kinase kinase activity,inflammatory bowel disease|ulcerative colitis,ppi
19,20,11035,RIPK3,receptor interacting serine/threonine kinase 3,108,transcription coactivator activity|protein kinase activity|protein serine/threonine kinase activity|protein-containing complex binding,calcium metabolism disease|nephrocalcinosis|calcinosis|heart valve disease,ppi
20,21,6016,RIT1,Ras like without CAAX 1,22,GTPase activity|calmodulin binding|GTP binding,sick sinus syndrome|ptosis|congenital ptosis|blood coagulation disease|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cryptorchidism|enophthalmos|orbital disease|exophthalmos|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9,ppi
21,22,6017,RLBP1,retinaldehyde binding protein 1,3,,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|retinitis pigmentosa 30|age related macular degeneration|macular degeneration|intellectual disability|learning disability|night blindness|congenital stationary night blindness,ppi
22,23,6018,RLF,rearranged L-myc fusion,17,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|zinc ion binding,,ppi
23,24,6013,RLN1,relaxin 1,1,,,ppi
24,25,6019,RLN2,relaxin 2,2,,prostate cancer|prostate carcinoma,ppi
25,26,605,BCL7A,BCL tumor suppressor 7A,52,,,ppi
26,27,6035,RNASE1,ribonuclease A family member 1; pancreatic,6,ribonuclease activity,,ppi
27,28,6036,RNASE2,ribonuclease A family member 2,3,ribonuclease activity|lipopolysaccharide binding,,ppi
28,29,6037,RNASE3,ribonuclease A family member 3,13,lipopolysaccharide binding|ribonuclease activity,asthma|intrinsic asthma|allergic asthma,ppi
29,30,6038,RNASE4,ribonuclease A family member 4,1,ribonuclease A activity|ribonuclease activity,prostate cancer|prostate carcinoma,ppi
30,31,6039,RNASE6,ribonuclease A family member k6,1,ribonuclease activity,gallbladder disease|liver disease|toxic encephalopathy,ppi
31,32,9275,BCL7B,BCL tumor suppressor 7B,30,actin binding,,ppi
32,33,6041,RNASEL,ribonuclease L,14,RNA binding|endoribonuclease activity,prostate cancer|prostate carcinoma,ppi
33,34,9921,RNF10,ring finger protein 10,62,ubiquitin-protein transferase activity|transcription regulatory region DNA binding,,ppi
34,35,26994,RNF11,ring finger protein 11,110,DNA binding|ubiquitin-protein transferase activity|zinc ion binding,,ppi
35,36,11342,RNF13,ring finger protein 13,37,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
36,37,9604,RNF14,ring finger protein 14,30,transcription coactivator activity|ubiquitin-like protein transferase activity|ubiquitin conjugating enzyme binding|ubiquitin protein ligase activity,,ppi
37,38,10475,TRIM38,tripartite motif containing 38,27,,,ppi
38,39,9274,BCL7C,BCL tumor suppressor 7C,65,,malignant glioma|benign ependymoma|myxopapillary ependymoma|cellular ependymoma|tanycytic ependymoma|papillary ependymoma,ppi
39,40,56163,RNF17,ring finger protein 17,3,,,ppi
40,41,6045,RNF2,ring finger protein 2,722,chromatin binding|zinc ion binding|ubiquitin-protein transferase activity,,ppi
41,42,56254,RNF20,ring finger protein 20,120,p53 binding|transcription coactivator activity|mRNA 3'-UTR binding|ubiquitin-protein transferase activity|histone binding,,ppi
42,43,53840,TRIM34,tripartite motif containing 34,7,,,ppi
43,44,10612,TRIM3,tripartite motif containing 3,20,protein C-terminus binding|ubiquitin protein ligase activity,,ppi
44,45,56658,TRIM39,tripartite motif containing 39,82,,,ppi
45,46,10336,PCGF3,polycomb group ring finger 3,40,DNA-binding transcription factor activity|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
46,47,6047,RNF4,ring finger protein 4,57,DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|ubiquitin-protein transferase activity|zinc ion binding|nucleosome binding|SUMO polymer binding|androgen receptor binding|ubiquitin protein ligase activity|transcription factor binding,,ppi
47,48,6048,RNF5,ring finger protein 5,55,ubiquitin-protein transferase activity|zinc ion binding|ubiquitin protein ligase activity|ubiquitin-like protein conjugating enzyme binding,,ppi
48,49,6049,RNF6,ring finger protein 6,9,ubiquitin-protein transferase activity,tongue squamous cell carcinoma|squamous cell carcinoma|esophageal cancer|esophageal carcinoma|squamous cell neoplasm,ppi
49,50,9616,RNF7,ring finger protein 7,61,copper ion binding|NEDD8 transferase activity|cullin family protein binding|ubiquitin protein ligase activity,,ppi
50,51,9025,RNF8,ring finger protein 8,62,chromatin binding|ubiquitin-protein transferase activity|zinc ion binding|histone binding|protein homodimerization activity,autistic disorder,ppi
51,52,10107,TRIM10,tripartite motif containing 10,25,,,ppi
52,53,8732,RNGTT,RNA guanylyltransferase and 5'-phosphatase,44,mRNA guanylyltransferase activity|polynucleotide 5'-phosphatase activity|RNA guanylyltransferase activity|triphosphatase activity,,ppi
53,54,6050,RNH1,ribonuclease/angiogenin inhibitor 1,50,ribonuclease inhibitor activity,,ppi
54,55,8731,RNMT,RNA guanine-7 methyltransferase,21,RNA binding|mRNA (guanine-N7-)-methyltransferase activity,,ppi
55,56,6051,RNPEP,arginyl aminopeptidase,9,aminopeptidase activity|epoxide hydrolase activity|metalloexopeptidase activity|zinc ion binding,,ppi
56,57,57140,RNPEPL1,arginyl aminopeptidase like 1,2,metalloaminopeptidase activity,,ppi
57,58,607,BCL9,B-cell CLL/lymphoma 9,8,,bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|ovarian cancer|major depressive disorder|mental depression,ppi
58,59,10921,RNPS1,RNA binding protein with serine rich domain 1,220,RNA binding|mRNA 3'-UTR binding,mood disorder,ppi
59,60,9311,ASIC3,acid sensing ion channel subunit 3,8,cation channel activity|sodium channel activity|acid-sensing ion channel activity,,ppi
60,62,613,BCR,BCR; RhoGEF and GTPase activating protein,96,protein tyrosine kinase activity|GTPase activator activity|kinase activity,bipolar disorder|enophthalmos|orbital disease|exophthalmos|placental insufficiency|clubfoot|communication disorder|language disorder|acute lymphocytic leukemia|chronic myeloid leukemia|intellectual disability|learning disability|myeloproliferative neoplasm|bone marrow cancer|thrombocytopenia|neurotic disorder|endogenous depression|melancholia|thrombocytosis|major depressive disorder,ppi
61,63,26507,CNNM1,cyclin and CBS domain divalent metal cation transport mediator 1,23,,melanoma|skin melanoma,ppi
62,64,617,BCS1L,BCS1 homolog; ubiquinol-cytochrome c reductase complex chaperone,25,,lactic acidosis|alopecia|hypohidrosis|anhidrosis|ptosis|congenital ptosis|blood coagulation disease|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis|cholestasis|sensorineural hearing loss|neurotic disorder|major depressive disorder,ppi
63,65,51808,PHAX,phosphorylated adaptor for RNA export,48,,,ppi
64,66,6091,ROBO1,roundabout guidance receptor 1,19,axon guidance receptor activity|identical protein binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|autistic disorder|lung benign neoplasm,ppi
65,67,6092,ROBO2,roundabout guidance receptor 2,23,axon guidance receptor activity|identical protein binding,autistic disorder|vesicoureteral reflux|bile duct carcinoma|bile duct adenocarcinoma|intrahepatic cholangiocarcinoma|cholangiocarcinoma,ppi
66,68,6093,ROCK1,Rho associated coiled-coil containing protein kinase 1,63,protein kinase activity|protein serine/threonine kinase activity,,ppi
67,69,9475,ROCK2,Rho associated coiled-coil containing protein kinase 2,33,RNA binding|protein serine/threonine kinase activity|structural molecule activity|Rho-dependent protein serine/threonine kinase activity,,ppi
68,70,9991,PTBP3,polypyrimidine tract binding protein 3,292,RNA binding,,ppi
69,71,6094,ROM1,retinal outer segment membrane protein 1,3,,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
70,72,4919,ROR1,receptor tyrosine kinase like orphan receptor 1,23,transmembrane receptor protein tyrosine kinase activity|Wnt-activated receptor activity|coreceptor activity involved in Wnt signaling pathway; planar cell polarity pathway|Wnt-protein binding|protein tyrosine kinase activity|transmembrane signaling receptor activity,bipolar disorder,ppi
71,73,4920,ROR2,receptor tyrosine kinase like orphan receptor 2,49,coreceptor activity involved in Wnt signaling pathway; planar cell polarity pathway|Wnt-protein binding|protein tyrosine kinase activity|transmembrane signaling receptor activity|transmembrane receptor protein tyrosine kinase activity,cryptorchidism|sensorineural hearing loss|enophthalmos|orbital disease|exophthalmos|gingival overgrowth|gingival hypertrophy|ventricular septal defect|inguinal hernia|umbilical hernia|omphalocele|hydronephrosis|intellectual disability|learning disability|syndactyly|ankyloglossia|cavernous hemangioma|capillary hemangioma|Klippel-Feil syndrome|spondylolisthesis,ppi
72,74,6095,RORA,RAR related orphan receptor A,29,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|oxysterol binding|sequence-specific DNA binding|transcription factor activity; direct ligand regulated sequence-specific DNA binding|transcription coactivator binding,autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|stomach cancer,ppi
73,75,6096,RORB,RAR related orphan receptor B,22,,endometriosis of uterus|endometriosis,ppi
74,76,6097,RORC,RAR related orphan receptor C,43,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|oxysterol binding|transcription factor activity; direct ligand regulated sequence-specific DNA binding|transcription coactivator binding,,ppi
75,77,6098,ROS1,ROS proto-oncogene 1; receptor tyrosine kinase,8,protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,lung cancer|non-small cell lung carcinoma|malignant glioma|gliosarcoma|mixed glioma|melanoma|skin melanoma|lung adenocarcinoma,ppi
76,78,6101,RP1,RP1; axonemal microtubule associated,1,microtubule binding,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|familial hypertriglyceridemia|hyperlipoproteinemia type IV|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy,ppi
77,79,622,BDH1,3-hydroxybutyrate dehydrogenase 1,20,3-hydroxybutyrate dehydrogenase activity,,ppi
78,80,6102,RP2,retinitis pigmentosa 2 (X-linked recessive),42,GTPase activator activity|unfolded protein binding,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|myopia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|polycystic ovary syndrome,ppi
79,81,6100,RP9,retinitis pigmentosa 9 (autosomal dominant),10,RNA binding,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
80,82,6117,RPA1,replication protein A1,482,damaged DNA binding|single-stranded DNA binding|G-rich strand telomeric DNA binding|sequence-specific DNA binding|single-stranded telomeric DNA binding,,ppi
81,83,623,BDKRB1,bradykinin receptor B1,3,,complex partial epilepsy|temporal lobe epilepsy,ppi
82,84,6118,RPA2,replication protein A2,456,damaged DNA binding|single-stranded DNA binding|G-rich strand telomeric DNA binding|double-stranded DNA binding|protein binding|sequence-specific DNA binding,,ppi
83,85,6119,RPA3,replication protein A3,391,damaged DNA binding|single-stranded DNA binding,,ppi
84,86,6120,RPE,ribulose-5-phosphate-3-epimerase,48,ribulose-phosphate 3-epimerase activity|metal ion binding,,ppi
85,87,6121,RPE65,RPE65; retinoid isomerohydrolase,7,phosphatidylserine binding|retinal isomerase activity|isomerase activity|phosphatidylcholine binding|all-trans-retinyl-palmitate hydrolase; 11-cis retinol forming activity|all-trans-retinyl-ester hydrolase; 11-cis retinol forming activity|cardiolipin binding|carotenoid dioxygenase activity|beta-carotene 15;15'-monooxygenase activity,epilepsy|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|retinal degeneration,ppi
86,88,6103,RPGR,retinitis pigmentosa GTPase regulator,48,RNA binding,Kartagener syndrome|primary ciliary dyskinesia|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|alternating exotropia|exotropia|monocular exotropia|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hyperopia|hypogonadism|primary ciliary dyskinesia 1|corneal disease|keratoconus,ppi
87,89,9501,RPH3AL,rabphilin 3A-like (without C2 domains),14,cytoskeletal protein binding,,ppi
88,90,22934,RPIA,ribose 5-phosphate isomerase A,32,ribose-5-phosphate isomerase activity,cerebellar disease|epilepsy|optic atrophy|polyneuropathy|peripheral nervous system disease|neuropathy|visual epilepsy|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy,ppi
89,91,6134,RPL10,ribosomal protein L10,356,RNA binding|structural constituent of ribosome|translation regulator activity,autistic disorder|cryptorchidism|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|sensorineural hearing loss|prostate cancer|prostate carcinoma|visual epilepsy|acute T cell leukemia,ppi
90,92,4736,RPL10A,ribosomal protein L10a,187,RNA binding|structural constituent of ribosome,,ppi
91,93,54805,CNNM2,cyclin and CBS domain divalent metal cation transport mediator 2,6,,sick sinus syndrome|epilepsy|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|intellectual disability|learning disability|schizophrenia|visual epilepsy|hypoparathyroidism|pseudohypoparathyroidism|central nervous system origin vertigo|renal hypomagnesemia 6,ppi
92,94,624,BDKRB2,bradykinin receptor B2,21,phosphatidylinositol phospholipase C activity|bradykinin receptor activity,rheumatoid arthritis|bipolar disorder|complex partial epilepsy|temporal lobe epilepsy|hypertension|essential hypertension|neurotic disorder|endogenous depression|melancholia|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|major depressive disorder|mental depression,ppi
93,95,6135,RPL11,ribosomal protein L11,219,RNA binding|structural constituent of ribosome|5S rRNA binding|ubiquitin ligase inhibitor activity,anemia|macrocytic anemia|sick sinus syndrome|isolated cleft palate|cleft palate|migraine|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|polydactyly|Diamond-Blackfan anemia|congenital hypoplastic anemia,ppi
94,96,6136,RPL12,ribosomal protein L12,175,RNA binding|structural constituent of ribosome|rRNA binding,prostate cancer|prostate carcinoma,ppi
95,97,6137,RPL13,ribosomal protein L13,250,RNA binding|structural constituent of ribosome,stomach cancer,ppi
96,98,23521,RPL13A,ribosomal protein L13a,135,RNA binding|structural constituent of ribosome|mRNA binding,,ppi
97,99,9045,RPL14,ribosomal protein L14,248,RNA binding|structural constituent of ribosome|cadherin binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|Parkinson's disease,ppi
98,100,6138,RPL15,ribosomal protein L15,194,RNA binding|structural constituent of ribosome|cadherin binding,anemia|macrocytic anemia|sick sinus syndrome|isolated cleft palate|cleft palate|ventricular septal defect|stomach cancer|migraine|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|polydactyly|Diamond-Blackfan anemia|congenital hypoplastic anemia,ppi
99,101,6139,RPL17,ribosomal protein L17,162,RNA binding|structural constituent of ribosome,coronary artery disease,ppi
100,102,6141,RPL18,ribosomal protein L18,261,RNA binding|structural constituent of ribosome,stomach cancer,ppi
101,103,6142,RPL18A,ribosomal protein L18a,233,RNA binding|structural constituent of ribosome,,ppi
102,104,6143,RPL19,ribosomal protein L19,179,RNA binding|structural constituent of ribosome,,ppi
103,105,6144,RPL21,ribosomal protein L21,164,RNA binding|structural constituent of ribosome,alopecia|hypotrichosis,ppi
104,106,6146,RPL22,ribosomal protein L22,181,RNA binding|structural constituent of ribosome,,ppi
105,107,9349,RPL23,ribosomal protein L23,257,RNA binding|structural constituent of ribosome|ubiquitin ligase inhibitor activity|large ribosomal subunit rRNA binding,,ppi
106,108,6147,RPL23A,ribosomal protein L23a,235,RNA binding|structural constituent of ribosome|cadherin binding,Parkinson's disease|breast cancer,ppi
107,109,6150,MRPL23,mitochondrial ribosomal protein L23,61,RNA binding|structural constituent of ribosome,,ppi
108,110,6152,RPL24,ribosomal protein L24,198,RNA binding|structural constituent of ribosome|cadherin binding,,ppi
109,111,6154,RPL26,ribosomal protein L26,127,RNA binding|structural constituent of ribosome|mRNA 5'-UTR binding,anemia|macrocytic anemia|sick sinus syndrome|isolated cleft palate|cleft palate|aortic valve stenosis|migraine|Potter's syndrome|Diamond-Blackfan anemia|congenital hypoplastic anemia,ppi
110,112,6155,RPL27,ribosomal protein L27,156,RNA binding|structural constituent of ribosome,,ppi
111,113,6157,RPL27A,ribosomal protein L27a,162,RNA binding|structural constituent of ribosome,cerebellar disease|pancytopenia,ppi
112,114,627,BDNF,brain derived neurotrophic factor,18,growth factor activity,alcohol dependence|alcohol abuse|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|anorexia nervosa|autistic disorder|bipolar disorder,ppi
113,115,6158,RPL28,ribosomal protein L28,153,RNA binding|structural constituent of ribosome,,ppi
114,116,6159,RPL29,ribosomal protein L29,101,RNA binding|structural constituent of ribosome|cadherin binding,,ppi
115,117,6122,RPL3,ribosomal protein L3,208,RNA binding|structural constituent of ribosome,,ppi
116,118,6156,RPL30,ribosomal protein L30,217,RNA binding|structural constituent of ribosome,,ppi
117,119,6160,RPL31,ribosomal protein L31,272,RNA binding|structural constituent of ribosome,breast cancer,ppi
118,120,6161,RPL32,ribosomal protein L32,126,RNA binding|structural constituent of ribosome,,ppi
119,121,8678,BECN1,beclin 1,123,,colon cancer|colonic benign neoplasm|lung benign neoplasm|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|schizophrenia|status epilepticus|Lewy body dementia,ppi
120,122,6164,RPL34,ribosomal protein L34,95,RNA binding|structural constituent of ribosome|cadherin binding,,ppi
121,123,11224,RPL35,ribosomal protein L35,164,RNA binding|mRNA binding|structural constituent of ribosome,,ppi
122,124,6165,RPL35A,ribosomal protein L35a,106,RNA binding|structural constituent of ribosome,anemia|macrocytic anemia|sick sinus syndrome|isolated cleft palate|cleft palate|ventricular septal defect|leukopenia|migraine|aplastic anemia|Diamond-Blackfan anemia|congenital hypoplastic anemia,ppi
123,125,6166,RPL36AL,ribosomal protein L36a like,60,,,ppi
124,126,6167,RPL37,ribosomal protein L37,42,RNA binding|structural constituent of ribosome,,ppi
125,127,6168,RPL37A,ribosomal protein L37a,247,RNA binding|structural constituent of ribosome,polycystic ovary syndrome,ppi
126,128,6169,RPL38,ribosomal protein L38,168,RNA binding|structural constituent of ribosome,,ppi
127,129,6170,RPL39,ribosomal protein L39,31,RNA binding|structural constituent of ribosome,,ppi
128,130,6123,RPL3L,ribosomal protein L3 like,41,RNA binding|structural constituent of ribosome,,ppi
129,131,6124,RPL4,ribosomal protein L4,228,RNA binding|structural constituent of ribosome,,ppi
130,132,6171,RPL41,ribosomal protein L41,8,RNA binding|mRNA 3'-UTR binding|structural constituent of ribosome|mRNA 5'-UTR binding,,ppi
131,133,6173,RPL36A,ribosomal protein L36a,46,RNA binding|structural constituent of ribosome,,ppi
132,134,55859,BEX1,brain expressed X-linked 1,17,,,ppi
133,135,6125,RPL5,ribosomal protein L5,247,RNA binding|mRNA 3'-UTR binding|structural constituent of ribosome|5S rRNA binding|mRNA 5'-UTR binding|ubiquitin ligase inhibitor activity,anemia|macrocytic anemia|sick sinus syndrome|cleft lip|isolated cleft palate|cleft palate|migraine|Diamond-Blackfan anemia|congenital hypoplastic anemia|acute T cell leukemia,ppi
134,136,6128,RPL6,ribosomal protein L6,327,DNA binding|RNA binding|structural constituent of ribosome|cadherin binding,Parkinson's disease,ppi
135,137,6129,RPL7,ribosomal protein L7,235,DNA binding|RNA binding|mRNA binding|structural constituent of ribosome,,ppi
136,138,6130,RPL7A,ribosomal protein L7a,194,RNA binding|structural constituent of ribosome|cadherin binding,,ppi
137,139,6132,RPL8,ribosomal protein L8,220,RNA binding|structural constituent of ribosome,,ppi
138,140,6133,RPL9,ribosomal protein L9,182,RNA binding|structural constituent of ribosome,,ppi
139,141,629,CFB,complement factor B,13,complement binding|serine-type endopeptidase activity,systemic lupus erythematosus|myasthenia gravis|pneumonia|age related macular degeneration|macular degeneration|degeneration of macula and posterior pole|age related macular degeneration 1|hemolytic-uremic syndrome,ppi
140,142,6175,RPLP0,ribosomal protein lateral stalk subunit P0,224,RNA binding|structural constituent of ribosome|large ribosomal subunit rRNA binding,,ppi
141,143,6176,RPLP1,ribosomal protein lateral stalk subunit P1,148,structural constituent of ribosome|protein kinase activator activity|ribonucleoprotein complex binding,,ppi
142,144,6181,RPLP2,ribosomal protein lateral stalk subunit P2,166,structural constituent of ribosome,,ppi
143,145,6182,MRPL12,mitochondrial ribosomal protein L12,155,RNA binding,,ppi
144,146,11222,MRPL3,mitochondrial ribosomal protein L3,52,RNA binding,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|liver disease|combined oxidative phosphorylation deficiency,ppi
145,147,6183,MRPS12,mitochondrial ribosomal protein S12,14,RNA binding|structural constituent of ribosome,,ppi
146,148,6184,RPN1,ribophorin I,178,RNA binding|dolichyl-diphosphooligosaccharide-protein glycotransferase activity,,ppi
147,149,6185,RPN2,ribophorin II,106,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,prostate cancer|prostate carcinoma,ppi
148,150,6204,RPS10,ribosomal protein S10,189,RNA binding|structural constituent of ribosome,anemia|macrocytic anemia|sick sinus syndrome|isolated cleft palate|cleft palate|migraine|Diamond-Blackfan anemia|congenital hypoplastic anemia,ppi
149,151,6205,RPS11,ribosomal protein S11,222,RNA binding|structural constituent of ribosome,,ppi
150,152,6206,RPS12,ribosomal protein S12,129,RNA binding|structural constituent of ribosome,,ppi
151,153,6207,RPS13,ribosomal protein S13,218,RNA binding|mRNA binding|mRNA 5'-UTR binding|structural constituent of ribosome|small ribosomal subunit rRNA binding,,ppi
152,154,6208,RPS14,ribosomal protein S14,287,RNA binding|translation regulator activity|mRNA 5'-UTR binding|small ribosomal subunit rRNA binding|structural constituent of ribosome,aplastic anemia|essential thrombocythemia|myelodysplastic syndrome,ppi
153,155,6209,RPS15,ribosomal protein S15,163,DNA binding|RNA binding|structural constituent of ribosome,chronic lymphocytic leukemia|Richter's syndrome|stomach cancer,ppi
154,156,6210,RPS15A,ribosomal protein S15a,191,RNA binding|structural constituent of ribosome,,ppi
155,157,6217,RPS16,ribosomal protein S16,234,RNA binding|structural constituent of ribosome,,ppi
156,158,6218,RPS17,ribosomal protein S17,141,RNA binding|structural constituent of ribosome,anemia|macrocytic anemia|sick sinus syndrome|isolated cleft palate|cleft palate|migraine|aplastic anemia|Diamond-Blackfan anemia|congenital hypoplastic anemia,ppi
157,159,26505,CNNM3,cyclin and CBS domain divalent metal cation transport mediator 3,31,,,ppi
158,160,631,BFSP1,beaded filament structural protein 1,8,structural constituent of cytoskeleton,,ppi
159,161,6222,RPS18,ribosomal protein S18,208,RNA binding,,ppi
160,162,6223,RPS19,ribosomal protein S19,206,RNA binding|structural constituent of ribosome|protein homodimerization activity,congenital dyserythropoietic anemia|anemia|macrocytic anemia|sick sinus syndrome|colon cancer|colonic benign neoplasm|large intestine cancer|cleft lip|isolated cleft palate|cleft palate|placental insufficiency|congestive heart failure|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8,ppi
161,163,6187,RPS2,ribosomal protein S2,312,RNA binding|mRNA binding|structural constituent of ribosome|cadherin binding,,ppi
162,164,6224,RPS20,ribosomal protein S20,176,RNA binding|structural constituent of ribosome,,ppi
163,166,8419,BFSP2,beaded filament structural protein 2,18,structural constituent of cytoskeleton,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
164,167,6228,RPS23,ribosomal protein S23,190,RNA binding|structural constituent of ribosome,,ppi
165,168,6229,RPS24,ribosomal protein S24,182,RNA binding|structural constituent of ribosome|translation initiation factor binding,anemia|macrocytic anemia|sick sinus syndrome|isolated cleft palate|cleft palate|migraine|Diamond-Blackfan anemia|congenital hypoplastic anemia,ppi
166,169,6230,RPS25,ribosomal protein S25,229,RNA binding,,ppi
167,170,6231,RPS26,ribosomal protein S26,159,RNA binding|mRNA binding|cadherin binding|structural constituent of ribosome,anemia|macrocytic anemia|sick sinus syndrome|isolated cleft palate|cleft palate|stomach cancer|migraine|Diamond-Blackfan anemia|congenital hypoplastic anemia,ppi
168,171,6232,RPS27,ribosomal protein S27,179,DNA binding|RNA binding|zinc ion binding|structural constituent of ribosome,,ppi
169,172,6233,RPS27A,ribosomal protein S27a,173,RNA binding|structural constituent of ribosome|ubiquitin protein ligase binding|protein tag,,ppi
170,173,6234,RPS28,ribosomal protein S28,122,RNA binding|structural constituent of ribosome,anemia|macrocytic anemia|sick sinus syndrome|isolated cleft palate|cleft palate|migraine|congenital diaphragmatic hernia|Diamond-Blackfan anemia|congenital hypoplastic anemia,ppi
171,174,6235,RPS29,ribosomal protein S29,96,structural constituent of ribosome|zinc ion binding,anemia|macrocytic anemia|sick sinus syndrome|isolated cleft palate|cleft palate|normocytic anemia|migraine|Diamond-Blackfan anemia|congenital hypoplastic anemia,ppi
172,175,6188,RPS3,ribosomal protein S3,302,DNA binding|damaged DNA binding|RNA binding|mRNA binding|structural constituent of ribosome|DNA-(apurinic or apyrimidinic site) endonuclease activity|endodeoxyribonuclease activity|microtubule binding|tubulin binding|Hsp70 protein binding|oxidized purine DNA binding|oxidized pyrimidine DNA binding|protein-containing complex binding|iron-sulfur cluster binding|Hsp90 protein binding|small ribosomal subunit rRNA binding|supercoiled DNA binding|DNA N-glycosylase activity|RNA polymerase II regulatory region sequence-specific DNA binding|oxidized purine nucleobase lesion DNA N-glycosylase activity,melanoma|skin melanoma,ppi
173,176,6189,RPS3A,ribosomal protein S3A,285,RNA binding|mRNA 5'-UTR binding,,ppi
174,177,6191,RPS4X,ribosomal protein S4; X-linked,249,RNA binding|structural constituent of ribosome,breast cancer,ppi
175,178,6192,RPS4Y1,ribosomal protein S4; Y-linked 1,13,RNA binding|structural constituent of ribosome,,ppi
176,179,6193,RPS5,ribosomal protein S5,202,RNA binding|mRNA binding|structural constituent of ribosome|rRNA binding,,ppi
177,180,6194,RPS6,ribosomal protein S6,249,RNA binding,stomach cancer|breast cancer|liver cancer|hepatocellular carcinoma,ppi
178,181,632,BGLAP,bone gamma-carboxyglutamate protein,6,structural molecule activity|structural constituent of bone|hydroxyapatite binding|calcium ion binding,asthma|intrinsic asthma|allergic asthma|calcium metabolism disease|nephrocalcinosis|calcinosis|heart valve disease|prostate cancer|prostate carcinoma,ppi
179,182,6195,RPS6KA1,ribosomal protein S6 kinase A1,236,protein serine/threonine kinase activity|protein serine/threonine/tyrosine kinase activity|kinase activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|ribosomal protein S6 kinase activity,Sezary's disease,ppi
180,183,6196,RPS6KA2,ribosomal protein S6 kinase A2,38,protein serine/threonine kinase activity|protein serine/threonine/tyrosine kinase activity|kinase activity|ribosomal protein S6 kinase activity,,ppi
181,184,6197,RPS6KA3,ribosomal protein S6 kinase A3,72,protein kinase activity|protein serine/threonine kinase activity|kinase activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|ribosomal protein S6 kinase activity,Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|epilepsy|clubfoot|sensorineural hearing loss|inguinal hernia|tooth agenesis|anodontia|intellectual disability|learning disability|mitral valve insufficiency|mitral valve prolapse|rectal prolapse|visual epilepsy|speech disorder|Coffin-Lowry syndrome|non-syndromic X-linked intellectual disability,ppi
182,185,8986,RPS6KA4,ribosomal protein S6 kinase A4,21,protein serine/threonine kinase activity|ribosomal protein S6 kinase activity|ATP binding,,ppi
183,186,9252,RPS6KA5,ribosomal protein S6 kinase A5,68,protein kinase activity|protein serine/threonine kinase activity|ATP binding,cocaine abuse|cocaine dependence,ppi
184,187,27330,RPS6KA6,ribosomal protein S6 kinase A6,37,protein kinase activity|kinase activity|ribosomal protein S6 kinase activity,,ppi
185,188,6198,RPS6KB1,ribosomal protein S6 kinase B1,81,protein kinase activity|protein serine/threonine/tyrosine kinase activity|kinase activity|protein serine/threonine kinase activity|ribosomal protein S6 kinase activity,hypertension|essential hypertension|neuronal ceroid lipofuscinosis 1,ppi
186,189,6199,RPS6KB2,ribosomal protein S6 kinase B2,198,protein kinase activity|protein serine/threonine kinase activity|ribosomal protein S6 kinase activity,breast cancer,ppi
187,190,26750,RPS6KC1,ribosomal protein S6 kinase C1,9,,,ppi
188,191,633,BGN,biglycan,21,extracellular matrix structural constituent|extracellular matrix structural constituent conferring compression resistance,rheumatoid arthritis,ppi
189,192,6201,RPS7,ribosomal protein S7,203,RNA binding|mRNA 3'-UTR binding|mRNA 5'-UTR binding|ubiquitin ligase inhibitor activity,anemia|macrocytic anemia|sick sinus syndrome|isolated cleft palate|cleft palate|migraine|Diamond-Blackfan anemia|congenital hypoplastic anemia|breast cancer,ppi
190,193,6202,RPS8,ribosomal protein S8,314,RNA binding|structural constituent of ribosome,Parkinson's disease|breast cancer,ppi
191,194,6203,RPS9,ribosomal protein S9,213,RNA binding|translation regulator activity|rRNA binding|structural constituent of ribosome,,ppi
192,195,9125,CNOT9,CCR4-NOT transcription complex subunit 9,45,protein homodimerization activity,,ppi
193,196,6236,RRAD,RRAD; Ras related glycolysis inhibitor and calcium channel regulator,16,GTP binding,lung cancer|non-small cell lung carcinoma|breast cancer,ppi
194,197,6237,RRAS,related RAS viral (r-ras) oncogene homolog,40,GTPase activity|GDP binding|protein-containing complex binding,prostate cancer|prostate carcinoma|juvenile myelomonocytic leukemia,ppi
195,198,6238,RRBP1,ribosome binding protein 1,56,RNA binding|signaling receptor activity,,ppi
196,199,6239,RREB1,ras responsive element binding protein 1,17,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,ptosis|congenital ptosis|isolated cleft palate|cleft palate|constipation|dental caries|DiGeorge syndrome|velocardiofacial syndrome|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect,ppi
197,200,10692,RRH,retinal pigment epithelium-derived rhodopsin homolog,1,G-protein coupled receptor activity|G-protein coupled photoreceptor activity,,ppi
198,201,6240,RRM1,ribonucleotide reductase catalytic subunit M1,46,ribonucleoside-diphosphate reductase activity; thioredoxin disulfide as acceptor,lung cancer|non-small cell lung carcinoma|adrenal cortex cancer|adrenocortical carcinoma|adrenal carcinoma|liver cancer|hepatocellular carcinoma,ppi
199,202,6241,RRM2,ribonucleotide reductase regulatory subunit M2,41,ribonucleoside-diphosphate reductase activity; thioredoxin disulfide as acceptor,large intestine cancer|colorectal cancer|polycystic ovary syndrome|liver cancer|hepatocellular carcinoma,ppi
200,203,6247,RS1,retinoschisin 1,5,phosphatidylserine binding,glaucoma|hyperopia|retinal degeneration|retinal detachment|cataract|retinoschisis|peripheral retinal degeneration|X-linked juvenile retinoschisis 1,ppi
201,204,6248,RSC1A1,regulator of solute carriers 1,3,sodium channel inhibitor activity,,ppi
202,205,8553,BHLHE40,basic helix-loop-helix family member e40,78,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II activating transcription factor binding|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription corepressor activity|protein homodimerization activity|MRF binding|E-box binding|RNA polymerase II regulatory region sequence-specific DNA binding|transcription factor binding|sequence-specific DNA binding|sequence-specific double-stranded DNA binding,bipolar disorder|glioblastoma multiforme|giant cell glioblastoma|schizophrenia|coronary artery disease,ppi
203,206,6249,CLIP1,CAP-Gly domain containing linker protein 1,39,microtubule binding|zinc ion binding|tubulin binding|protein homodimerization activity|metal ion binding|microtubule plus-end binding,,ppi
204,207,6251,RSU1,Ras suppressor protein 1,32,,osteoporosis,ppi
205,208,6242,RTKN,rhotekin,15,GTPase inhibitor activity|GTP-Rho binding,,ppi
206,209,6252,RTN1,reticulon 1,29,,coronary artery disease,ppi
207,210,6253,RTN2,reticulon 2,17,,paraplegia|hereditary spastic paraplegia 12,ppi
208,211,10313,RTN3,reticulon 3,29,,,ppi
209,212,635,BHMT,betaine--homocysteine S-methyltransferase,10,zinc ion binding|betaine-homocysteine S-methyltransferase activity,alcohol dependence|alcohol abuse|diabetes mellitus|type 2 diabetes mellitus|iron metabolism disease|hemochromatosis|Wilson disease|Langerhans-cell histiocytosis|lymphosarcoma|lymphoma|reticulosarcoma|non-Hodgkin lymphoma|B-cell lymphoma,ppi
210,213,861,RUNX1,runt related transcription factor 1,84,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|transcription regulatory region DNA binding,rheumatoid arthritis|glioblastoma multiforme|giant cell glioblastoma|acute monocytic leukemia|acute myeloid leukemia|chronic myeloid leukemia|lymphosarcoma|lymphoma|central nervous system lymphoma|myeloproliferative neoplasm|bone marrow cancer|neuroblastoma|prostate cancer|prostate carcinoma|thrombocytopenia|juvenile myelomonocytic leukemia|thrombocytosis|acute lymphocytic leukemia|essential thrombocythemia|myelodysplastic syndrome,ppi
211,214,860,RUNX2,runt related transcription factor 2,58,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,psoriatic arthritis|rheumatoid arthritis|isolated cleft palate|cleft palate|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|sensorineural hearing loss|dental caries|dental enamel hypoplasia|arthropathy|arthritis|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|osteoporosis|osteosarcoma|bone osteosarcoma|osteopetrosis|osteosclerosis,ppi
212,215,864,RUNX3,runt related transcription factor 3,30,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|ATP binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|celiac disease|esophageal cancer|glioblastoma multiforme|giant cell glioblastoma|acute myeloid leukemia|lung benign neoplasm|polycystic ovary syndrome|pustulosis of palm and sole|psoriasis|parapsoriasis|ankylosing spondylitis|stomach cancer,ppi
213,216,8607,RUVBL1,RuvB like AAA ATPase 1,270,DNA helicase activity|transcription coactivator activity|ATPase activity|TBP-class protein binding|cadherin binding|ATP-dependent DNA helicase activity,,ppi
214,217,10856,RUVBL2,RuvB like AAA ATPase 2,291,RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA helicase activity|transcription corepressor activity|ATP-dependent DNA helicase activity|beta-catenin binding|TBP-class protein binding|chromatin DNA binding|identical protein binding|unfolded protein binding|ATPase activity,,ppi
215,218,6256,RXRA,retinoid X receptor alpha,132,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|retinoic acid binding|DNA binding|double-stranded DNA binding|DNA-binding transcription factor activity|retinoic acid receptor activity|transcription coactivator activity|nuclear receptor activity|zinc ion binding|peptide binding|sequence-specific DNA binding|retinoic acid-responsive element binding|protein heterodimerization activity|DBD domain binding|LBD domain binding|transcription regulatory region DNA binding|vitamin D response element binding,prostate cancer|prostate carcinoma|thyroid cancer|thyroid adenoma|thyroid carcinoma|sciatic neuropathy|lesion of sciatic nerve|malignant mesothelioma|benign mesothelioma|amyotrophic lateral sclerosis type 1,ppi
216,219,6257,RXRB,retinoid X receptor beta,71,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|nuclear receptor activity|9-cis retinoic acid receptor activity,stomach cancer|breast cancer,ppi
217,220,6258,RXRG,retinoid X receptor gamma,35,DNA-binding transcription factor activity; RNA polymerase II-specific,coronary artery disease,ppi
218,221,23743,BHMT2,betaine--homocysteine S-methyltransferase 2,4,zinc ion binding|S-methylmethionine-homocysteine S-methyltransferase activity|betaine-homocysteine S-methyltransferase activity,cleft lip|isolated cleft palate|cleft palate,ppi
219,222,23429,RYBP,RING1 and YY1 binding protein,63,,,ppi
220,223,6259,RYK,receptor-like tyrosine kinase,85,transmembrane signaling receptor activity|frizzled binding|Wnt-protein binding|Wnt-activated receptor activity|coreceptor activity involved in Wnt signaling pathway; planar cell polarity pathway|protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity,isolated cleft palate|cleft palate,ppi
221,224,6261,RYR1,ryanodine receptor 1,20,ryanodine-sensitive calcium-release channel activity|voltage-gated calcium channel activity|calcium channel activity|calcium ion binding|calmodulin binding|ATP binding|calcium-release channel activity|calcium-induced calcium release activity,ptosis|congenital ptosis|blood coagulation disease|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E,ppi
222,225,6262,RYR2,ryanodine receptor 2,28,ryanodine-sensitive calcium-release channel activity|calcium channel activity|calmodulin binding|calcium-release channel activity|protein kinase A catalytic subunit binding|protein kinase A regulatory subunit binding|suramin binding|ion channel binding|calcium-induced calcium release activity|calcium ion binding,epilepsy|visual epilepsy|catecholaminergic polymorphic ventricular tachycardia|catecholaminergic polymorphic ventricular tachycardia 1|catecholaminergic polymorphic ventricular tachycardia 2|catecholaminergic polymorphic ventricular tachycardia 3|catecholaminergic polymorphic ventricular tachycardia 4|catecholaminergic polymorphic ventricular tachycardia 5|central nervous system origin vertigo|coronary artery disease|malignant mesothelioma|benign mesothelioma|heart aneurysm|autistic disorder|arrhythmogenic right ventricular dysplasia 2,ppi
223,226,6263,RYR3,ryanodine receptor 3,6,ryanodine-sensitive calcium-release channel activity|calcium-release channel activity|calcium ion binding|calcium-induced calcium release activity,,ppi
224,227,6271,S100A1,S100 calcium binding protein A1,27,protein homodimerization activity,intracranial vasospasm,ppi
225,228,6281,S100A10,S100 calcium binding protein A10,51,protein homodimerization activity|lipid binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|acute myeloid leukemia|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|mood disorder,ppi
226,229,6282,S100A11,S100 calcium binding protein A11,29,protein homodimerization activity|calcium-dependent protein binding|cadherin binding involved in cell-cell adhesion,,ppi
227,230,6283,S100A12,S100 calcium binding protein A12,2,copper ion binding|calcium ion binding|zinc ion binding|RAGE receptor binding,mouth disease,ppi
228,231,636,BICD1,BICD cargo adaptor 1,23,structural constituent of cytoskeleton|cytoskeletal adaptor activity|proteinase activated receptor binding|dynactin binding|dynein intermediate chain binding|dynein complex binding,,ppi
229,232,6284,S100A13,S100 calcium binding protein A13,20,copper ion binding|calcium ion binding|zinc ion binding,,ppi
230,233,6273,S100A2,S100 calcium binding protein A2,20,calcium ion binding,,ppi
231,234,6274,S100A3,S100 calcium binding protein A3,15,,,ppi
232,235,6275,S100A4,S100 calcium binding protein A4,67,RNA binding,colon cancer|colonic benign neoplasm|ischemia|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|arthropathy|arthritis|adult respiratory distress syndrome|newborn respiratory distress syndrome|intracranial vasospasm,ppi
233,236,6276,S100A5,S100 calcium binding protein A5,1,copper ion binding|calcium ion binding|zinc ion binding,middle cerebral artery infarction,ppi
234,237,6277,S100A6,S100 calcium binding protein A6,34,calcium ion binding|tropomyosin binding|protein homodimerization activity|calcium-dependent protein binding,diabetes mellitus|type 2 diabetes mellitus|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|intracranial vasospasm,ppi
235,238,6278,S100A7,S100 calcium binding protein A7,60,calcium ion binding|zinc ion binding,pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
236,239,6279,S100A8,S100 calcium binding protein A8,76,calcium ion binding|microtubule binding|zinc ion binding|Toll-like receptor 4 binding|arachidonic acid binding|RAGE receptor binding,atopic dermatitis|contact dermatitis|occupational dermatitis|acute myeloid leukemia,ppi
237,240,6280,S100A9,S100 calcium binding protein A9,113,calcium ion binding|microtubule binding|zinc ion binding|Toll-like receptor 4 binding|arachidonic acid binding|RAGE receptor binding,colon cancer|colonic benign neoplasm|adult respiratory distress syndrome|newborn respiratory distress syndrome|schizophrenia,ppi
238,241,26504,CNNM4,cyclin and CBS domain divalent metal cation transport mediator 4,10,,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia|blue color blindness|color blindness,ppi
239,242,637,BID,BH3 interacting domain death agonist,60,death receptor binding,bipolar disorder|schizophrenia|stomach cancer|liver cancer|hepatocellular carcinoma,ppi
240,243,6285,S100B,S100 calcium binding protein B,38,calcium ion binding|zinc ion binding|protein homodimerization activity|tau protein binding|calcium-dependent protein binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|Down syndrome|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|schizophreniform disorder|schizoaffective disorder|schizophrenia|mood disorder|intracranial vasospasm|brain edema,ppi
241,244,6286,S100P,S100 calcium binding protein P,26,magnesium ion binding|protein homodimerization activity|cadherin binding,polycystic ovary syndrome,ppi
242,245,638,BIK,BCL2 interacting killer,16,,schizophrenia,ppi
243,248,6291,SAA4,serum amyloid A4; constitutive,2,chemoattractant activity,,ppi
244,249,6293,VPS52,VPS52; GARP complex subunit,68,syntaxin binding|Rab GTPase binding,prostate cancer|prostate carcinoma,ppi
245,250,26278,SACS,sacsin molecular chaperone,17,chaperone binding,intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|Unverricht-Lundborg syndrome|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy|Charlevoix-Saguenay spastic ataxia,ppi
246,251,274,BIN1,bridging integrator 1,77,clathrin binding|actin filament binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|ptosis|congenital ptosis|pseudosarcomatous fibromatosis|ophthalmoplegia|Bell's palsy,ppi
247,252,6294,SAFB,scaffold attachment factor B,99,RNA polymerase II proximal promoter sequence-specific DNA binding|chromatin binding|double-stranded DNA binding|RNA binding|sequence-specific DNA binding,,ppi
248,253,6295,SAG,S-antigen visual arrestin,5,protein phosphatase inhibitor activity,glaucoma|sensorineural hearing loss|night blindness|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
249,254,6296,ACSM3,acyl-CoA synthetase medium-chain family member 3,2,acyl-CoA ligase activity|fatty-acyl-CoA synthase activity|fatty acid ligase activity,prostate cancer|prostate carcinoma,ppi
250,255,6299,SALL1,spalt like transcription factor 1,22,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|beta-catenin binding|histone deacetylase activity,tuberous sclerosis|Marfan syndrome|situs inversus|imperforate anus|constipation|cryptorchidism|sensorineural hearing loss|clubfoot|esophagitis|peptic esophagitis|gastroesophageal reflux disease|ventricular septal defect|umbilical hernia|omphalocele|congenital hypothyroidism|myxedema|hypothyroidism|intellectual disability|learning disability|kidney failure,ppi
251,256,6297,SALL2,spalt like transcription factor 2,34,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific,coloboma|blindness,ppi
252,257,27164,SALL3,spalt like transcription factor 3,4,DNA-binding transcription factor activity; RNA polymerase II-specific,Burkitt lymphoma,ppi
253,258,64092,SAMSN1,SAM domain; SH3 domain and nuclear localization signals 1,12,phosphotyrosine residue binding|RNA binding,,ppi
254,259,51411,BIN2,bridging integrator 2,7,phospholipid binding,,ppi
255,260,10284,SAP18,Sin3A associated protein 18,122,transcription corepressor activity|RNA binding|histone deacetylase activity,,ppi
256,261,8819,SAP30,Sin3A associated protein 30,60,transcription corepressor activity|histone deacetylase activity,,ppi
257,262,56681,SAR1A,secretion associated Ras related GTPase 1A,29,GTPase activity,,ppi
258,263,51128,SAR1B,secretion associated Ras related GTPase 1B,19,GTPase activity,microphthalmia|eye disease|hematopoietic system disease|hypobetalipoproteinemia|intellectual disability|learning disability|retinitis|retinal disease|steatorrhea|liver disease|marasmus|kwashiorkor|protein-energy malnutrition|nutrition disease|chylomicron retention disease|Fabry disease|lipid storage disease|familial lipoprotein lipase deficiency,ppi
259,264,1757,SARDH,sarcosine dehydrogenase,2,sarcosine dehydrogenase activity|oxidoreductase activity,,ppi
260,265,6301,SARS,seryl-tRNA synthetase,65,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA binding|serine-tRNA ligase activity|selenocysteine-tRNA ligase activity,,ppi
261,266,9092,SART1,squamous cell carcinoma antigen recognized by T-cells 1,125,RNA binding,,ppi
262,267,6302,TSPAN31,tetraspanin 31,1,,,ppi
263,268,55909,BIN3,bridging integrator 3,21,cytoskeletal adaptor activity,,ppi
264,269,6303,SAT1,spermidine/spermine N1-acetyltransferase 1,78,diamine N-acetyltransferase activity|spermidine binding|N-acetyltransferase activity,alcohol dependence|alcohol abuse|bipolar disorder|blepharitis|conjunctivitis|corneal dystrophy|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|ectropion|keratitis|keratoconjunctivitis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|obesity|schizophreniform disorder|schizoaffective disorder,ppi
265,270,6304,SATB1,SATB homeobox 1,53,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|double-stranded DNA binding|sequence-specific DNA binding,,ppi
266,271,6305,SBF1,SET binding factor 1,43,protein tyrosine/serine/threonine phosphatase activity|Rab guanyl-nucleotide exchange factor activity,clubfoot|Charcot-Marie-Tooth disease type 4B3,ppi
267,272,6307,MSMO1,methylsterol monooxygenase 1,14,C-4 methylsterol oxidase activity,,ppi
268,273,6309,SC5D,sterol-C5-desaturase,12,C-5 sterol desaturase activity,congenital heart disease|ptosis|congenital ptosis|intrahepatic cholestasis|sensorineural hearing loss|epilepsy|placental insufficiency|gingival overgrowth|gingival hypertrophy|gallbladder disease|liver disease|myelomeningocele|meningocele|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|visual epilepsy|thrombocytopenia|cataract,ppi
269,274,6310,ATXN1,ataxin 1,264,poly(U) RNA binding|poly(G) binding|protein self-association,syndromic X-linked intellectual disability type 10|choreatic disease|basal ganglia disease|focal hand dystonia|blepharospasm|olivopontocerebellar atrophy|optic atrophy|autosomal dominant cerebellar ataxia|spinocerebellar ataxia type 1|progressive bulbar palsy,ppi
270,275,25814,ATXN10,ataxin 10,48,,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|basal ganglia disease|focal hand dystonia|blepharospasm|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|agnosia|spinocerebellar ataxia type 10,ppi
271,276,10904,BLCAP,bladder cancer associated protein,4,,,ppi
272,277,6311,ATXN2,ataxin 2,79,RNA binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|olivopontocerebellar atrophy|ophthalmoplegia|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|schizophrenia,ppi
273,278,6314,ATXN7,ataxin 7,83,thiol-dependent ubiquitinyl hydrolase activity,syndromic X-linked intellectual disability type 10|choreatic disease|basal ganglia disease|focal hand dystonia|blepharospasm|retinitis pigmentosa 30|age related macular degeneration|macular degeneration|movement disease|lingual-facial-buccal dyskinesia|olivopontocerebellar atrophy|seborrheic keratosis|skin disease|actinic keratosis|autosomal dominant cerebellar ataxia|spinocerebellar ataxia type 7,ppi
274,279,9522,SCAMP1,secretory carrier membrane protein 1,32,,,ppi
275,280,10066,SCAMP2,secretory carrier membrane protein 2,24,,,ppi
276,281,10067,SCAMP3,secretory carrier membrane protein 3,47,,,ppi
277,282,51282,SCAND1,SCAN domain containing 1,26,DNA-binding transcription factor activity|identical protein binding|DNA binding,,ppi
278,283,6317,SERPINB3,serpin family B member 3,46,virus receptor activity|serine-type endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity,tongue squamous cell carcinoma|squamous cell carcinoma|contact dermatitis|occupational dermatitis|esophageal cancer|esophagus squamous cell carcinoma,ppi
279,284,640,BLK,BLK proto-oncogene; Src family tyrosine kinase,59,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|signaling receptor binding,rheumatoid arthritis|diabetes mellitus|type 2 diabetes mellitus|systemic lupus erythematosus|Kawasaki disease|obesity|maturity-onset diabetes of the young,ppi
280,285,6318,SERPINB4,serpin family B member 4,58,serine-type endopeptidase inhibitor activity,contact dermatitis|occupational dermatitis,ppi
281,286,6319,SCD,stearoyl-CoA desaturase,22,stearoyl-CoA 9-desaturase activity|iron ion binding|oxidoreductase activity,chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease|liver cancer|endocrine exophthalmos|hepatocellular carcinoma,ppi
282,287,8796,SCEL,sciellin,14,,,ppi
283,288,7857,SCG2,secretogranin II,10,cytokine activity|chemoattractant activity,,ppi
284,289,6320,CLEC11A,C-type lectin domain family 11 member A,38,growth factor activity|carbohydrate binding,malignant mesothelioma|benign mesothelioma,ppi
285,290,11075,STMN2,stathmin 2,30,tubulin binding,,ppi
286,291,641,BLM,Bloom syndrome RecQ like helicase,91,four-way junction DNA binding|Y-form DNA binding|bubble DNA binding|DNA binding|DNA helicase activity|single-stranded DNA binding|ATP-dependent DNA helicase activity|helicase activity|ATP binding|ATP-dependent helicase activity|DNA-dependent ATPase activity|zinc ion binding|four-way junction helicase activity|ATPase activity|annealing helicase activity|protein homodimerization activity|G-quadruplex DNA binding|forked DNA-dependent helicase activity|telomeric D-loop binding|telomeric G-quadruplex DNA binding,azoospermia|Bloom syndrome|bronchiectasis|tongue squamous cell carcinoma|squamous cell carcinoma|cryptorchidism|diabetes mellitus|type 2 diabetes mellitus|placental insufficiency|hypertrichosis|leukemia|lymphosarcoma|lymphoma|central nervous system lymphoma|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|sinusitis|syndactyly,ppi
287,292,6322,SCML1,sex comb on midleg-like 1 (Drosophila),21,DNA binding|DNA-binding transcription factor activity,,ppi
288,293,10389,SCML2,sex comb on midleg-like 2 (Drosophila),11,DNA binding|DNA-binding transcription factor activity,medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
289,294,6336,SCN10A,sodium voltage-gated channel alpha subunit 10,2,voltage-gated sodium channel activity,atrial fibrillation|constipation|epilepsy|erythromelalgia|atrioventricular block|hereditary sensory neuropathy|sensory peripheral neuropathy|visual epilepsy|Brugada syndrome|Brugada syndrome 1,ppi
290,296,6323,SCN1A,sodium voltage-gated channel alpha subunit 1,5,voltage-gated sodium channel activity,cerebellar disease|epilepsy|idiopathic generalized epilepsy|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|childhood absence epilepsy|hemiplegia|intellectual disability|learning disability|movement disease|lingual-facial-buccal dyskinesia|focal hand dystonia|blepharospasm|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|antisocial personality disorder|avoidant personality disorder|narcissistic personality disorder,ppi
291,297,6324,SCN1B,sodium voltage-gated channel beta subunit 1,4,voltage-gated sodium channel activity|sodium channel regulator activity|sodium channel inhibitor activity|voltage-gated sodium channel activity involved in cardiac muscle cell action potential|voltage-gated sodium channel activity involved in Purkinje myocyte action potential|ion channel binding,sick sinus syndrome|cerebellar disease|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|childhood absence epilepsy|sudden infant death syndrome|atrial fibrillation|photosensitivity disease|photosensitive epilepsy|visual epilepsy|infantile epileptic encephalopathy|Dravet syndrome|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy|partial motor epilepsy|Brugada syndrome|Brugada syndrome 1|familial atrial fibrillation|generalized epilepsy with febrile seizures plus|atrioventricular block,ppi
292,298,6326,SCN2A,sodium voltage-gated channel alpha subunit 2,5,voltage-gated sodium channel activity,cerebellar disease|dystonia|enophthalmos|orbital disease|exophthalmos|epilepsy|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|focal hand dystonia|blepharospasm|visual epilepsy|infantile epileptic encephalopathy|status epilepticus|basal ganglia disease|benign familial infantile epilepsy|benign neonatal seizures|benign familial neonatal epilepsy|photosensitivity disease|photosensitive epilepsy|locked-in syndrome,ppi
293,299,6327,SCN2B,sodium voltage-gated channel beta subunit 2,86,sodium channel regulator activity|voltage-gated sodium channel activity involved in cardiac muscle cell action potential,familial atrial fibrillation,ppi
294,300,642,BLMH,bleomycin hydrolase,47,aminopeptidase activity|carboxypeptidase activity|cysteine-type peptidase activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
295,301,6328,SCN3A,sodium voltage-gated channel alpha subunit 3,6,voltage-gated sodium channel activity,complex partial epilepsy|temporal lobe epilepsy,ppi
296,302,6329,SCN4A,sodium voltage-gated channel alpha subunit 4,10,voltage-gated sodium channel activity,ptosis|congenital ptosis|spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|hypokalemia|familial periodic paralysis|myopathy|congenital myopathy|myotonia congenita|ophthalmoplegia|chronic progressive external ophthalmoplegia|myotonic dystrophy type 2|myotonic disease|fibromyalgia|myositis|obsolete Timothy syndrome|hyperkalemic periodic paralysis,ppi
297,303,6330,SCN4B,sodium voltage-gated channel beta subunit 4,1,voltage-gated sodium channel activity|sodium channel regulator activity|voltage-gated sodium channel activity involved in cardiac muscle cell action potential,atrioventricular block|long QT syndrome|long QT syndrome 1|familial atrial fibrillation|long QT syndrome 10,ppi
298,304,6331,SCN5A,sodium voltage-gated channel alpha subunit 5,27,voltage-gated sodium channel activity|ankyrin binding|voltage-gated sodium channel activity involved in cardiac muscle cell action potential|voltage-gated sodium channel activity involved in AV node cell action potential|voltage-gated sodium channel activity involved in bundle of His cell action potential|voltage-gated sodium channel activity involved in Purkinje myocyte action potential|voltage-gated sodium channel activity involved in SA node cell action potential,sick sinus syndrome|atrial fibrillation|atrioventricular block|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B,ppi
299,306,6334,SCN8A,sodium voltage-gated channel alpha subunit 8,6,voltage-gated sodium channel activity,autistic disorder|bipolar disorder|cerebellar disease|dystonia|enophthalmos|orbital disease|exophthalmos|epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|central nervous system disease|nervous system disease|autonomic neuropathy|visual epilepsy|infantile epileptic encephalopathy|status epilepticus,ppi
300,308,6337,SCNN1A,sodium channel epithelial 1 alpha subunit,24,ligand-gated sodium channel activity,bronchiectasis|bronchitis|cystic fibrosis|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypertension|essential hypertension|lung disease|germ cell cancer|germ cell and embryonal cancer|embryonal cancer|polycystic ovary syndrome|pre-eclampsia|proteinuria|autosomal recessive pseudohypoaldosteronism type 1|autosomal dominant pseudohypoaldosteronism type 1|pseudohypoaldosteronism|lactic acidosis,ppi
301,309,643,CXCR5,C-X-C motif chemokine receptor 5,14,G-protein coupled receptor activity|C-C chemokine receptor activity|C-C chemokine binding|chemokine binding,primary biliary cirrhosis,ppi
302,310,6338,SCNN1B,sodium channel epithelial 1 beta subunit,22,ligand-gated sodium channel activity,sick sinus syndrome|bronchiectasis|brain ischemia|bronchitis|constipation|cystic fibrosis|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypertension|essential hypertension|hypokalemia|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|lung disease|autosomal recessive pseudohypoaldosteronism type 1,ppi
303,311,6339,SCNN1D,sodium channel epithelial 1 delta subunit,23,,,ppi
304,312,6340,SCNN1G,sodium channel epithelial 1 gamma subunit,16,ion channel activity|sodium channel activity|ligand-gated sodium channel activity,sick sinus syndrome|bronchiectasis|brain ischemia|bronchitis|constipation|cystic fibrosis|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypertension|essential hypertension|hypokalemia|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|autosomal recessive pseudohypoaldosteronism type 1|autosomal dominant pseudohypoaldosteronism type 1,ppi
305,313,6341,SCO1,SCO1; cytochrome c oxidase assembly protein,17,,lactic acidosis|anemia|macrocytic anemia|ptosis|congenital ptosis|brain disease|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|heart disease|cardiovascular system disease|gallbladder disease|liver disease|intellectual disability|learning disability|optic atrophy|proteinuria,ppi
306,314,9997,SCO2,SCO2; cytochrome c oxidase assembly protein,56,copper ion binding|protein disulfide oxidoreductase activity,lactic acidosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|influenza|Leigh disease|myopia|mitochondrial encephalomyopathy|cytochrome-c oxidase deficiency disease|fatal infantile encephalocardiomyopathy,ppi
307,315,6342,SCP2,sterol carrier protein 2,45,fatty-acyl-CoA binding|cholesterol binding|long-chain fatty acyl-CoA binding|propionyl-CoA C2-trimethyltridecanoyltransferase activity|oleic acid binding,azoospermia|dystonia|polyneuropathy|peripheral nervous system disease|neuropathy|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy|focal hand dystonia|blepharospasm|hypogonadism,ppi
308,316,6343,SCT,secretin,4,hormone activity|signaling receptor binding,autistic disorder|choledochal cyst|polycystic ovary syndrome,ppi
309,317,6344,SCTR,secretin receptor,9,secretin receptor activity|G-protein coupled peptide receptor activity|peptide hormone binding,,ppi
310,318,6346,CCL1,C-C motif chemokine ligand 1,3,chemokine activity|CCR chemokine receptor binding,nephritis|glomerulonephritis|kidney disease|primary pulmonary hypertension|pulmonary hypertension|interstitial nephritis|pyelonephritis|pyelitis,ppi
311,319,6356,CCL11,C-C motif chemokine ligand 11,9,chemokine activity|CCR3 chemokine receptor binding|protein dimerization activity|receptor ligand activity|CCR chemokine receptor binding,asthma|intrinsic asthma|allergic asthma|brain ischemia|atopic dermatitis|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|allergic hypersensitivity disease|pneumonia|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis,ppi
312,320,6357,CCL13,C-C motif chemokine ligand 13,10,signaling receptor binding|chemokine activity|CCR chemokine receptor binding,,ppi
313,321,6358,CCL14,C-C motif chemokine ligand 14,13,chemokine activity|CCR chemokine receptor binding,,ppi
314,322,6359,CCL15,C-C motif chemokine ligand 15,2,signaling receptor binding|chemoattractant activity|CCR chemokine receptor binding|chemokine activity,,ppi
315,323,6360,CCL16,C-C motif chemokine ligand 16,6,chemoattractant activity|chemokine activity|CCR chemokine receptor binding,,ppi
316,324,6361,CCL17,C-C motif chemokine ligand 17,4,signaling receptor binding|CCR chemokine receptor binding|chemokine activity,atopic dermatitis|allergic hypersensitivity disease|pneumonia,ppi
317,325,6362,CCL18,C-C motif chemokine ligand 18,8,chemokine activity|CCR chemokine receptor binding,lung benign neoplasm,ppi
318,326,6363,CCL19,C-C motif chemokine ligand 19,7,chemokine activity|CCR7 chemokine receptor binding|CCR10 chemokine receptor binding|chemokine receptor binding|CCR chemokine receptor binding,allergic hypersensitivity disease|pneumonia|allergic contact dermatitis,ppi
319,327,6347,CCL2,C-C motif chemokine ligand 2,22,protein kinase activity|signaling receptor binding|CCR2 chemokine receptor binding|CCR chemokine receptor binding|chemokine activity,asthma|intrinsic asthma|allergic asthma|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|bipolar disorder|calcium metabolism disease|nephrocalcinosis|calcinosis|tongue squamous cell carcinoma|squamous cell carcinoma|heart disease|cardiovascular system disease|carotid artery disease|brain ischemia|inflammatory bowel disease|ulcerative colitis,ppi
320,328,6364,CCL20,C-C motif chemokine ligand 20,5,CCR6 chemokine receptor binding|chemokine activity|CCR chemokine receptor binding,inflammatory bowel disease|ulcerative colitis|colon cancer|colonic benign neoplasm|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18,ppi
321,329,644,BLVRA,biliverdin reductase A,25,biliverdin reductase activity,cholecystolithiasis|choledocholithiasis|cholestasis|liver disease,ppi
322,330,6366,CCL21,C-C motif chemokine ligand 21,17,chemokine activity|CCR7 chemokine receptor binding|chemokine receptor binding|CCR chemokine receptor binding,rheumatoid arthritis,ppi
323,331,6367,CCL22,C-C motif chemokine ligand 22,34,CCR chemokine receptor binding|chemokine activity,atopic dermatitis,ppi
324,332,6368,CCL23,C-C motif chemokine ligand 23,3,chemokine activity|CCR chemokine receptor binding,malignant mesothelioma|benign mesothelioma,ppi
325,333,6369,CCL24,C-C motif chemokine ligand 24,1,chemokine activity|CCR3 chemokine receptor binding|receptor ligand activity|CCR chemokine receptor binding,atopic dermatitis|allergic hypersensitivity disease|pneumonia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
326,334,6370,CCL25,C-C motif chemokine ligand 25,5,hormone activity|chemokine activity|CCR10 chemokine receptor binding|chemokine receptor binding|CCR chemokine receptor binding,,ppi
327,335,10344,CCL26,C-C motif chemokine ligand 26,3,chemokine activity|CCR3 chemokine receptor binding|receptor ligand activity|CCR chemokine receptor binding,eosinophilic esophagitis,ppi
328,336,10850,CCL27,C-C motif chemokine ligand 27,3,,contact dermatitis|occupational dermatitis|malignant mesothelioma|benign mesothelioma,ppi
329,337,6348,CCL3,C-C motif chemokine ligand 3,12,protein kinase activity|calcium-dependent protein kinase C activity|chemokine activity|phospholipase activator activity|kinase activity|chemoattractant activity|CCR chemokine receptor binding,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|brain ischemia|nephritis|glomerulonephritis|kidney disease|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|allergic hypersensitivity disease|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|status epilepticus|malignant mesothelioma|benign mesothelioma|liver cancer|hepatocellular carcinoma,ppi
330,339,645,BLVRB,biliverdin reductase B,16,biliverdin reductase activity|riboflavin reductase (NADPH) activity,stomach cancer|esophagus squamous cell carcinoma,ppi
331,341,388372,CCL4L1,C-C motif chemokine ligand 4 like 1,13,,,ppi
332,342,6352,CCL5,C-C motif chemokine ligand 5,44,phosphatidylinositol phospholipase C activity|protein kinase activity|chemokine activity|phospholipase activator activity|receptor signaling protein tyrosine kinase activator activity|CCR1 chemokine receptor binding|CCR4 chemokine receptor binding|chemoattractant activity|protein homodimerization activity|protein self-association|chemokine receptor antagonist activity|CCR chemokine receptor binding,asthma|intrinsic asthma|allergic asthma|atopic dermatitis|nephritis|glomerulonephritis|kidney disease|alcoholic hepatitis|primary hyperoxaluria|primary biliary cirrhosis|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|autoimmune hepatitis|malignant mesothelioma|benign mesothelioma,ppi
333,343,6354,CCL7,C-C motif chemokine ligand 7,19,chemokine activity|CCR chemokine receptor binding,cholestasis|nephritis|glomerulonephritis|kidney disease|allergic hypersensitivity disease|interstitial nephritis|pyelonephritis|pyelitis|pneumonia|malignant mesothelioma|benign mesothelioma|middle cerebral artery infarction,ppi
334,344,6355,CCL8,C-C motif chemokine ligand 8,9,protein kinase activity|phospholipase activator activity|chemokine activity|CCR chemokine receptor binding,rheumatoid arthritis|allergic hypersensitivity disease|influenza|pneumonia,ppi
335,345,3627,CXCL10,C-X-C motif chemokine ligand 10,6,signaling receptor binding|chemokine activity|heparin binding|cAMP-dependent protein kinase regulator activity|CXCR3 chemokine receptor binding,alopecia areata|brain ischemia|colon cancer|colonic benign neoplasm|atopic dermatitis|influenza|primary biliary cirrhosis|thyroid cancer|thyroid adenoma|thyroid carcinoma|neurotic disorder|endogenous depression|melancholia|coronary artery disease|interstitial cystitis|chronic interstitial cystitis|major depressive disorder|mental depression,ppi
336,346,6373,CXCL11,C-X-C motif chemokine ligand 11,7,chemokine activity|heparin binding|CXCR3 chemokine receptor binding,interstitial cystitis|chronic interstitial cystitis,ppi
337,347,10563,CXCL13,C-X-C motif chemokine ligand 13,10,chemokine activity|heparin binding|fibroblast growth factor binding|CXCR5 chemokine receptor binding|CCR10 chemokine receptor binding|protein heterodimerization activity|receptor ligand activity,malignant mesothelioma|benign mesothelioma,ppi
338,348,9547,CXCL14,C-X-C motif chemokine ligand 14,4,,asthma|intrinsic asthma|allergic asthma|contact dermatitis|occupational dermatitis|endometriosis of uterus|endometriosis|lung benign neoplasm|substance abuse|substance-related disorder,ppi
339,349,6374,CXCL5,C-X-C motif chemokine ligand 5,5,identical protein binding|chemokine activity,allergic hypersensitivity disease|pneumonia,ppi
340,350,6372,CXCL6,C-X-C motif chemokine ligand 6,4,chemokine activity,rheumatoid arthritis|arthropathy|arthritis,ppi
341,351,6375,XCL1,X-C motif chemokine ligand 1,10,chemokine activity|chemokine receptor binding|protein homodimerization activity|CCR chemokine receptor binding,,ppi
342,352,6846,XCL2,X-C motif chemokine ligand 2,3,CCR chemokine receptor binding|chemokine activity,,ppi
343,354,9255,AIMP1,aminoacyl tRNA synthetase complex interacting multifunctional protein 1,66,tRNA binding|cytokine activity|protein homodimerization activity,Balo concentric sclerosis|adrenoleukodystrophy|Alpers syndrome|narcolepsy|central nervous system disease|epilepsy|leukodystrophy|visual epilepsy|blindness|Pelizaeus-Merzbacher disease|hypomyelinating leukodystrophy 3,ppi
344,355,8548,BLZF1,basic leucine zipper nuclear factor 1,57,DNA binding|DNA-binding transcription factor activity,,ppi
345,356,6382,SDC1,syndecan 1,60,,malignant mesothelioma|benign mesothelioma,ppi
346,357,6383,SDC2,syndecan 2,97,,,ppi
347,358,648,BMI1,BMI1 proto-oncogene; polycomb ring finger,401,zinc ion binding|promoter-specific chromatin binding,glioblastoma multiforme|giant cell glioblastoma|malignant glioma|gliosarcoma|mixed glioma|osteosarcoma|bone osteosarcoma|essential thrombocythemia|myelodysplastic syndrome,ppi
348,359,9672,SDC3,syndecan 3,21,,obesity,ppi
349,360,6385,SDC4,syndecan 4,27,thrombospondin receptor activity,lung cancer|non-small cell lung carcinoma,ppi
350,361,6386,SDCBP,syndecan binding protein,231,interleukin-5 receptor binding|phosphatidylinositol-4;5-bisphosphate binding|cytoskeletal adaptor activity|syndecan binding,arthropathy|arthritis,ppi
351,362,9147,NEMF,nuclear export mediator factor,27,ribosomal large subunit binding|tRNA binding,,ppi
352,363,10283,CWC27,CWC27 spliceosome associated protein homolog,21,peptidyl-prolyl cis-trans isomerase activity|cyclosporin A binding,,ppi
353,364,10813,UTP14A,UTP14A small subunit processome component,111,RNA binding,,ppi
354,365,10809,STARD10,StAR related lipid transfer domain containing 10,3,,prostate cancer|prostate carcinoma,ppi
355,366,10807,SDCCAG3,serologically defined colon cancer antigen 3,54,,,ppi
356,367,10811,NOXA1,NADPH oxidase activator 1,17,superoxide-generating NADPH oxidase activator activity,,ppi
357,368,10194,TSHZ1,teashirt zinc finger homeobox 1,4,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|chromatin binding,bipolar disorder,ppi
358,369,649,BMP1,bone morphogenetic protein 1,51,metalloendopeptidase activity|serine-type endopeptidase activity|peptidase activity|metallopeptidase activity,osteogenesis imperfecta type 3|muscular atrophy|osteogenesis imperfecta type 13,ppi
359,370,10806,SDCCAG8,serologically defined colon cancer antigen 8,15,,asthma|intrinsic asthma|allergic asthma|obstructive jaundice|biliary tract disease|bronchiolitis|cerebellar disease|diabetic ketoacidosis|diabetes mellitus|hypertrichosis|hypertension|essential hypertension|tooth agenesis|anodontia|hypogonadism|cystic kidney disease|premature menopause|androgen insensitivity syndrome|intellectual disability|learning disability,ppi
360,371,6387,CXCL12,C-X-C motif chemokine ligand 12,14,signaling receptor binding|integrin binding|chemokine activity|chemokine receptor binding|CXCR chemokine receptor binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|ischemia|prostate cancer|prostate carcinoma|periodontitis|malignant mesothelioma|benign mesothelioma|breast cancer|coronary artery disease|liver cancer|hepatocellular carcinoma,ppi
361,372,6388,SDF2,stromal cell derived factor 2,13,dolichyl-phosphate-mannose-protein mannosyltransferase activity,,ppi
362,373,23753,SDF2L1,stromal cell derived factor 2 like 1,38,,prostate cancer|prostate carcinoma,ppi
363,374,9210,BMP15,bone morphogenetic protein 15,7,cytokine activity|transforming growth factor beta receptor binding,gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|hypertrichosis|premature menopause|androgen insensitivity syndrome|polycystic ovary syndrome|premature ovarian failure|46 XX gonadal dysgenesis|hermaphroditism|hypogonadism,ppi
364,375,6389,SDHA,succinate dehydrogenase complex flavoprotein subunit A,120,succinate dehydrogenase (ubiquinone) activity|succinate dehydrogenase activity|electron transfer activity,lactic acidosis|ptosis|congenital ptosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B,ppi
365,376,6390,SDHB,succinate dehydrogenase complex iron sulfur subunit B,119,ubiquinone binding|2 iron; 2 sulfur cluster binding|3 iron; 4 sulfur cluster binding|4 iron; 4 sulfur cluster binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|paraganglioma|cerebellar disease|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42,ppi
366,377,6391,SDHC,succinate dehydrogenase complex subunit C,16,heme binding|succinate dehydrogenase (ubiquinone) activity|ubiquinone binding|electron transfer activity,paraganglioma|cerebellar disease|constipation|sensorineural hearing loss|gastrointestinal system cancer|goiter|nontoxic goiter|thyroid gland disease|Cowden disease|hemangioma|cavernous hemangioma|capillary hemangioma|intestinal obstruction|ileus|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|pleomorphic lipoma|lipoma|meningioma|spinal meningioma,ppi
367,378,6392,SDHD,succinate dehydrogenase complex subunit D,4,succinate dehydrogenase activity|electron transfer activity|heme binding|ubiquinone binding|succinate dehydrogenase (ubiquinone) activity,ptosis|congenital ptosis|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z,ppi
368,379,650,BMP2,bone morphogenetic protein 2,26,retinol dehydrogenase activity|signaling receptor binding|transforming growth factor beta receptor binding|phosphatase activator activity|SMAD binding|protein heterodimerization activity|BMP receptor binding|cytokine activity,bone disease|cartilage disease|connective tissue disease|craniosynostosis|iron metabolism disease|hemochromatosis|Wilson disease|myopia|stomach cancer|kidney failure|uremia|Lown-Ganong-Levine syndrome|Wolff-Parkinson-White syndrome|breast cancer|brachydactyly,ppi
369,380,8436,SDPR,serum deprivation response,11,phosphatidylserine binding|phospholipid binding|protein kinase C binding,Hirschsprung's disease,ppi
370,382,10640,EXOC5,exocyst complex component 5,66,,,ppi
371,383,6396,SEC13,SEC13 homolog; nuclear pore and COPII coat complex component,83,structural molecule activity|identical protein binding,,ppi
372,384,6397,SEC14L1,SEC14 like lipid binding 1,8,molecular function regulator,,ppi
373,385,23541,SEC14L2,SEC14 like lipid binding 2,2,phospholipid binding|vitamin E binding,,ppi
374,386,651,BMP3,bone morphogenetic protein 3,7,signaling receptor binding|BMP receptor binding|transforming growth factor beta receptor binding|cytokine activity,,ppi
375,387,9554,SEC22B,SEC22 homolog B; vesicle trafficking protein (gene/pseudogene),87,SNAP receptor activity,,ppi
376,388,10484,SEC23A,Sec23 homolog A; coat complex II component,105,zinc ion binding|GTPase activator activity|protein binding,cryptorchidism|dental caries|clubfoot|arthropathy|arthritis|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|cavernous hemangioma|capillary hemangioma|angioma serpiginosum,ppi
377,389,10483,SEC23B,Sec23 homolog B; coat complex II component,58,GTPase activator activity|protein binding|zinc ion binding,congenital dyserythropoietic anemia|cerebellar disease|cholecystolithiasis|choledocholithiasis|goiter|nontoxic goiter|thyroid gland disease|Cowden disease|hemangioma|cavernous hemangioma|capillary hemangioma|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|pleomorphic lipoma|lipoma|meningioma|spinal meningioma|acoustic neuroma|intraventricular meningioma|pituitary adenoma,ppi
378,390,10802,SEC24A,SEC24 homolog A; COPII coat complex component,63,zinc ion binding,,ppi
379,391,10427,SEC24B,SEC24 homolog B; COPII coat complex component,46,zinc ion binding,,ppi
380,392,9632,SEC24C,SEC24 homolog C; COPII coat complex component,77,zinc ion binding,bipolar disorder|ptosis|congenital ptosis|isolated cleft palate|cleft palate|constipation|dental caries|DiGeorge syndrome|velocardiofacial syndrome|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect,ppi
381,393,9871,SEC24D,SEC24 homolog D; COPII coat complex component,35,zinc ion binding,hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|enophthalmos|orbital disease|exophthalmos|placental insufficiency|senile degeneration of brain|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|craniosynostosis|oligohydramnios|Cole-Carpenter syndrome,ppi
382,394,6398,SECTM1,secreted and transmembrane 1,2,,,ppi
383,395,652,BMP4,bone morphogenetic protein 4,26,cytokine activity|chemoattractant activity|BMP receptor binding|transforming growth factor beta receptor binding,psoriatic arthritis|rheumatoid arthritis|ptosis|congenital ptosis|large intestine cancer|colorectal cancer|cryptorchidism|neurohypophyseal diabetes insipidus|diabetes insipidus|enophthalmos|orbital disease|exophthalmos|hiatus hernia|congenital diaphragmatic hernia|microphthalmia|arthropathy|arthritis|prolactinoma|cataract|craniosynostosis,ppi
384,396,6400,SEL1L,SEL1L ERAD E3 ligase adaptor subunit,59,,,ppi
385,397,6401,SELE,selectin E,20,transmembrane signaling receptor activity|sialic acid binding|phospholipase binding|oligosaccharide binding,atrial fibrillation|heart disease|cardiovascular system disease|brain ischemia|atopic dermatitis|IgA glomerulonephritis|multiple sclerosis|angioedema|hypertension|essential hypertension|coronary artery disease|allergic contact dermatitis,ppi
386,398,8991,SELENBP1,selenium binding protein 1,64,,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|large intestine cancer|colorectal cancer|lung benign neoplasm|schizophreniform disorder|schizoaffective disorder|schizophrenia|stomach cancer|ovarian cancer,ppi
387,399,653,BMP5,bone morphogenetic protein 5,7,BMP receptor binding|transforming growth factor beta receptor binding|cytokine activity,,ppi
388,400,6402,SELL,selectin L,15,calcium ion binding|heparin binding|carbohydrate binding|glycosphingolipid binding|oligosaccharide binding,IgA glomerulonephritis|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction,ppi
389,401,6403,SELP,selectin P,10,lipopolysaccharide binding|calcium ion binding|heparin binding|sialic acid binding|fucose binding|glycosphingolipid binding|oligosaccharide binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|allergic hypersensitivity disease|hypertension|essential hypertension|coronary artery disease,ppi
390,402,6404,SELPLG,selectin P ligand,16,signaling receptor binding,amyotrophic lateral sclerosis type 1,ppi
391,403,10371,SEMA3A,semaphorin 3A,4,neuropilin binding|chemorepellent activity|semaphorin receptor binding,cryptorchidism|schizophrenia|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|eunuchism|hypogonadism,ppi
392,404,7869,SEMA3B,semaphorin 3B,7,chemorepellent activity|semaphorin receptor binding|neuropilin binding,endometrial cancer|endometrial carcinoma|neuroblastoma,ppi
393,405,10512,SEMA3C,semaphorin 3C,4,semaphorin receptor binding|chemorepellent activity|neuropilin binding,constipation|Hirschsprung's disease|intestinal obstruction|ileus|megacolon|toxic megacolon|double outlet right ventricle,ppi
394,407,9723,SEMA3E,semaphorin 3E,1,neuropilin binding|semaphorin receptor binding|chemorepellent activity,autistic disorder|ptosis|congenital ptosis|choanal atresia|cleft lip|isolated cleft palate|cleft palate|coloboma|cryptorchidism|sensorineural hearing loss|double outlet right ventricle|patent ductus arteriosus|esophageal atresia|esophagitis|peptic esophagitis|gastroesophageal reflux disease|hypertrophy of breast|infant gynecomastia|gynecomastia|heart septal defect,ppi
395,408,6405,SEMA3F,semaphorin 3F,8,chemorepellent activity|semaphorin receptor binding|neuropilin binding,endometrial cancer|endometrial carcinoma,ppi
396,409,64218,SEMA4A,semaphorin 4A,5,chemorepellent activity|neuropilin binding|semaphorin receptor binding,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|retinitis pigmentosa 35,ppi
397,410,654,BMP6,bone morphogenetic protein 6,10,protein heterodimerization activity|BMP receptor binding|cytokine activity|transforming growth factor beta receptor binding,rheumatoid arthritis|iron metabolism disease|hemochromatosis|Wilson disease|adult T-cell leukemia|acute T cell leukemia|arthropathy|arthritis|allergic contact dermatitis,ppi
398,411,10509,SEMA4B,semaphorin 4B,5,chemorepellent activity|neuropilin binding|semaphorin receptor binding,,ppi
399,412,54910,SEMA4C,semaphorin 4C,24,semaphorin receptor binding|neuropilin binding|chemorepellent activity,,ppi
400,413,10507,SEMA4D,semaphorin 4D,9,transmembrane signaling receptor activity|signaling receptor binding|semaphorin receptor binding|signaling receptor activity|neuropilin binding|chemorepellent activity,,ppi
401,414,10505,SEMA4F,ssemaphorin 4F,14,semaphorin receptor binding|neuropilin binding|chemorepellent activity,malignant mesothelioma|benign mesothelioma,ppi
402,415,57715,SEMA4G,semaphorin 4G,9,neuropilin binding|semaphorin receptor binding|chemorepellent activity,,ppi
403,417,54437,SEMA5B,semaphorin 5B,9,semaphorin receptor binding|chemorepellent activity,,ppi
404,418,57556,SEMA6A,semaphorin 6A,17,chemorepellent activity|semaphorin receptor binding,,ppi
405,420,655,BMP7,bone morphogenetic protein 7,44,transforming growth factor beta receptor binding|cytokine activity|BMP receptor binding,endometriosis of uterus|endometriosis|prostate cancer|prostate carcinoma|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|stomach cancer|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
406,422,8482,SEMA7A,semaphorin 7A (John Milton Hagen blood group),19,integrin binding|neuropilin binding|semaphorin receptor binding|chemorepellent activity,,ppi
407,423,6406,SEMG1,semenogelin I,34,metal ion binding,,ppi
408,424,6407,SEMG2,semenogelin II,32,metal ion binding,,ppi
409,425,656,BMP8B,bone morphogenetic protein 8b,11,BMP receptor binding|cytokine activity|transforming growth factor beta receptor binding,,ppi
410,426,55964,SEPT3,septin 3,30,GTPase activity|protein-containing complex scaffold activity,,ppi
411,427,6414,SELENOP,selenoprotein P,4,selenium binding,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|large intestine cancer|colorectal cancer|endometriosis of uterus|endometriosis|male infertility|lung benign neoplasm|central nervous system disease|nervous system disease|autonomic neuropathy|prostate cancer|prostate carcinoma|neurodegenerative disease,ppi
412,428,6415,SELENOW,selenoprotein W,1,,epilepsy,ppi
413,430,728492,SERF1B,small EDRK-rich factor 1B,5,,,ppi
414,431,10169,SERF2,small EDRK-rich factor 2,16,,,ppi
415,432,27230,SERP1,stress associated endoplasmic reticulum protein 1,16,,,ppi
416,433,657,BMPR1A,bone morphogenetic protein receptor type 1A,88,protein serine/threonine kinase activity|transmembrane receptor protein serine/threonine kinase activity|ATP binding|protein homodimerization activity|SMAD binding|BMP receptor activity|growth factor binding|transforming growth factor beta-activated receptor activity|transforming growth factor beta receptor activity; type I,anemia|macrocytic anemia|colon cancer|colonic benign neoplasm|large intestine cancer|microphthalmia|Cowden disease|hypokalemia|juvenile polyposis syndrome|chromosome 10q23 deletion syndrome,ppi
417,434,6418,SET,SET nuclear proto-oncogene,152,protein phosphatase inhibitor activity|protein phosphatase regulator activity|histone binding,,ppi
418,435,9869,SETDB1,SET domain bifurcated 1,154,chromatin binding|promoter-specific chromatin binding,melanoma|skin melanoma|schizophrenia|malignant mesothelioma|benign mesothelioma,ppi
419,436,6419,SETMAR,SET domain and mariner transposase fusion gene,15,single-stranded DNA endodeoxyribonuclease activity|DNA binding|double-stranded DNA binding|single-stranded DNA binding|endonuclease activity|histone methyltransferase activity (H3-K4 specific)|histone methyltransferase activity (H3-K36 specific),,ppi
420,437,23544,SEZ6L,seizure related 6 homolog like,1,,bipolar disorder,ppi
421,438,10291,SF3A1,splicing factor 3a subunit 1,192,RNA binding,,ppi
422,439,8175,SF3A2,splicing factor 3a subunit 2,153,RNA binding,,ppi
423,440,10946,SF3A3,splicing factor 3a subunit 3,131,RNA binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
424,441,23451,SF3B1,splicing factor 3b subunit 1,208,RNA binding|mRNA binding,chronic lymphocytic leukemia|Richter's syndrome|retinal detachment|uveal melanoma|malignant mesothelioma|benign mesothelioma|malignant iris melanoma|malignant ciliary body melanoma|malignant choroid melanoma|essential thrombocythemia|myelodysplastic syndrome,ppi
425,442,10992,SF3B2,splicing factor 3b subunit 2,151,RNA binding,,ppi
426,443,658,BMPR1B,bone morphogenetic protein receptor type 1B,67,protein serine/threonine kinase activity|transmembrane receptor protein serine/threonine kinase activity|ATP binding|SMAD binding|transforming growth factor beta-activated receptor activity|growth factor binding|transforming growth factor beta receptor activity; type I,clubfoot|microphthalmia|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|prostate cancer|prostate carcinoma|acromesomelic dysplasia; Grebe type|hypogonadism|spindle cell sarcoma|epithelioid sarcoma|sarcoma|cancer|brachydactyly|fibular hypoplasia and complex brachydactyly,ppi
427,444,23450,SF3B3,splicing factor 3b subunit 3,205,,,ppi
428,445,10262,SF3B4,splicing factor 3b subunit 4,118,RNA binding,ptosis|congenital ptosis|cleft lip|isolated cleft palate|cleft palate|clubfoot|sensorineural hearing loss|Hirschsprung's disease|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|megacolon|toxic megacolon|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|tetralogy of Fallot|angioedema|humeroradial synostosis,ppi
429,446,2810,SFN,stratifin,296,protein kinase C inhibitor activity|cadherin binding,tongue squamous cell carcinoma|squamous cell carcinoma|esophageal cancer|lung cancer|lung adenocarcinoma|esophagus squamous cell carcinoma|liver cancer|hepatocellular carcinoma,ppi
430,447,6421,SFPQ,splicing factor proline and glutamine rich,218,transcription regulatory region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|chromatin binding|RNA binding|transcription regulatory region DNA binding|E-box binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|seborrheic keratosis|skin disease|actinic keratosis,ppi
431,448,6422,SFRP1,secreted frizzled related protein 1,7,cysteine-type endopeptidase activity|drug binding|heparin binding|Wnt-protein binding|Wnt-activated receptor activity,bipolar disorder|large intestine cancer|colorectal cancer|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|inflammatory bowel disease|leiomyoma|uterine fibroid|breast cancer,ppi
432,449,6423,SFRP2,secreted frizzled related protein 2,19,fibronectin binding|integrin binding|Wnt-protein binding|receptor ligand activity|Wnt-activated receptor activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|large intestine cancer|colorectal cancer|inflammatory bowel disease|breast cancer,ppi
433,450,6424,SFRP4,secreted frizzled related protein 4,37,Wnt-protein binding|Wnt-activated receptor activity,large intestine cancer|colorectal cancer|dental caries|diabetes mellitus|type 2 diabetes mellitus,ppi
434,452,659,BMPR2,bone morphogenetic protein receptor type 2,66,activin receptor activity; type II|BMP receptor activity|growth factor binding|SMAD binding|transforming growth factor beta-activated receptor activity|transforming growth factor beta receptor activity; type II,hypertension|essential hypertension|primary pulmonary hypertension|pulmonary hypertension|pulmonary venoocclusive disease|hereditary hemorrhagic telangiectasia|capillary disease|telangiectasis|hyperandrogenism|congestive heart failure|breast cancer,ppi
435,453,6426,SRSF1,serine and arginine rich splicing factor 1,182,RNA binding|mRNA binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|schizophrenia,ppi
436,454,6434,TRA2B,transformer 2 beta homolog (Drosophila),93,RNA binding|mRNA binding|pre-mRNA binding|identical protein binding,,ppi
437,455,9295,SRSF11,serine and arginine rich splicing factor 11,90,RNA binding,,ppi
438,456,6427,SRSF2,serine and arginine rich splicing factor 2,126,transcription corepressor activity|RNA binding,,ppi
439,457,9169,SCAF11,SR-related CTD associated factor 11,37,RNA binding,,ppi
440,458,6428,SRSF3,serine and arginine rich splicing factor 3,140,RNA binding,bipolar disorder,ppi
441,459,6429,SRSF4,serine and arginine rich splicing factor 4,52,RNA binding,,ppi
442,460,6430,SRSF5,serine and arginine rich splicing factor 5,123,RNA binding,gallbladder disease|liver disease|toxic encephalopathy,ppi
443,461,6431,SRSF6,serine and arginine rich splicing factor 6,70,RNA binding|pre-mRNA binding,,ppi
444,462,6432,SRSF7,serine and arginine rich splicing factor 7,124,RNA binding,,ppi
445,463,660,BMX,BMX non-receptor tyrosine kinase,49,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity,,ppi
446,464,6433,SFSWAP,splicing factor SWAP homolog,14,,autistic disorder,ppi
447,465,8683,SRSF9,serine and arginine rich splicing factor 9,75,RNA binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
448,466,653509,SFTPA1,surfactant protein A1,7,lipid transporter activity|monosaccharide binding|lipopolysaccharide binding,idiopathic interstitial pneumonia|idiopathic pulmonary fibrosis,ppi
449,467,729238,SFTPA2,surfactant protein A2,4,monosaccharide binding|lipopolysaccharide binding,idiopathic interstitial pneumonia|idiopathic pulmonary fibrosis,ppi
450,468,43,ACHE,acetylcholinesterase (Cartwright blood group),13,amyloid-beta binding|acetylcholinesterase activity|cholinesterase activity|collagen binding|hydrolase activity|serine hydrolase activity|acetylcholine binding|protein homodimerization activity|laminin binding|carboxylic ester hydrolase activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|amyloidosis|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma,ppi
451,469,661,POLR3D,RNA polymerase III subunit D,39,RNA polymerase III activity,,ppi
452,470,6439,SFTPB,surfactant protein B,1,,hiatus hernia|congenital diaphragmatic hernia|primary pulmonary hypertension|pulmonary hypertension|lung disease|lung benign neoplasm|pulmonary alveolar proteinosis|adult respiratory distress syndrome|newborn respiratory distress syndrome|interstitial lung disease|desquamative interstitial pneumonia,ppi
453,471,6440,SFTPC,surfactant protein C,27,,lung cancer|bronchiolo-alveolar adenocarcinoma|hiatus hernia|congenital diaphragmatic hernia|primary polycythemia|primary pulmonary hypertension|pulmonary hypertension|liver cirrhosis|pneumonia|polycystic ovary syndrome|pulmonary alveolar proteinosis|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|adult respiratory distress syndrome|newborn respiratory distress syndrome|lung adenocarcinoma|interstitial lung disease|idiopathic pulmonary fibrosis,ppi
454,472,6441,SFTPD,surfactant protein D,8,carbohydrate binding|lipopolysaccharide binding|monosaccharide binding,lung benign neoplasm,ppi
455,473,6442,SGCA,sarcoglycan alpha,19,,pseudosarcomatous fibromatosis|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y|autosomal recessive limb-girdle muscular dystrophy type 2O|autosomal recessive limb-girdle muscular dystrophy type 2P,ppi
456,474,6443,SGCB,sarcoglycan beta,12,,Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y|autosomal recessive limb-girdle muscular dystrophy type 2O|autosomal recessive limb-girdle muscular dystrophy type 2P,ppi
457,475,6444,SGCD,sarcoglycan delta,10,,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
458,476,8910,SGCE,sarcoglycan epsilon,6,,agoraphobia|alcohol dependence|alcohol abuse|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|obsessive-compulsive disorder|dystonia|generalized dystonia,ppi
459,477,6445,SGCG,sarcoglycan gamma,22,,pseudosarcomatous fibromatosis|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y|autosomal recessive limb-girdle muscular dystrophy type 2O,ppi
460,478,646,BNC1,basonuclin 1,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
461,479,6446,SGK1,serum/glucocorticoid regulated kinase 1,105,protein serine/threonine kinase activity|protein serine/threonine/tyrosine kinase activity|calcium channel regulator activity|potassium channel regulator activity|sodium channel regulator activity|chloride channel regulator activity,diabetic autonomic neuropathy|diabetic polyneuropathy|diabetic neuropathy|acute myeloid leukemia|neurotic disorder|endogenous depression|melancholia|kidney failure|uremia|major depressive disorder|mental depression,ppi
462,480,23678,SGK3,serum/glucocorticoid regulated kinase family member 3,22,protein kinase activity|calcium channel regulator activity|potassium channel regulator activity|sodium channel regulator activity|chloride channel regulator activity|protein serine/threonine kinase activity,,ppi
463,481,6447,SCG5,secretogranin V,7,enzyme inhibitor activity|GTP binding|unfolded protein binding,large intestine cancer|colorectal cancer|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
464,482,8879,SGPL1,sphingosine-1-phosphate lyase 1,50,sphinganine-1-phosphate aldolase activity|pyridoxal phosphate binding,,ppi
465,483,6448,SGSH,N-sulfoglucosamine sulfohydrolase,11,N-sulfoglucosamine sulfohydrolase activity|sulfuric ester hydrolase activity,sensorineural hearing loss|epilepsy|hypertrichosis|intellectual disability|learning disability|mucopolysaccharidosis|mucopolysaccharidosis II|mucopolysaccharidosis VI|mucopolysaccharidosis III|mucopolysaccharidosis IV|visual epilepsy|mucopolysaccharidosis I|hypertrophic cardiomyopathy 1,ppi
466,484,6449,SGTA,small glutamine rich tetratricopeptide repeat containing alpha,162,protein self-association|protein-containing complex scaffold activity,,ppi
467,485,662,BNIP1,BCL2 interacting protein 1,32,SNAP receptor activity,,ppi
468,486,4068,SH2D1A,SH2 domain containing 1A,36,SH3/SH2 adaptor activity,anemia|macrocytic anemia|myelitis|encephalomyelitis|encephalitis|hepatic coma|hepatic encephalopathy|primary immunodeficiency disease|lymphosarcoma|lymphoma|central nervous system lymphoma|autoimmune lymphoproliferative syndrome|lymphoproliferative syndrome 1|lymphoproliferative syndrome 2|autoimmune lymphoproliferative syndrome type 2A|autoimmune lymphoproliferative syndrome type 2B|autoimmune lymphoproliferative syndrome type 3|meningitis|pancytopenia|thrombocytopenia,ppi
469,487,9047,SH2D2A,SH2 domain containing 2A,44,SH3/SH2 adaptor activity,,ppi
470,488,6450,SH3BGR,SH3 domain binding glutamate rich protein,5,SH3/SH2 adaptor activity,,ppi
471,489,6451,SH3BGRL,SH3 domain binding glutamate rich protein like,15,SH3/SH2 adaptor activity,,ppi
472,490,23616,SH3BP1,SH3 domain binding protein 1,21,GTPase activator activity|Rac GTPase binding,,ppi
473,491,6452,SH3BP2,SH3 domain binding protein 2,35,SH3 domain binding,cherubism|exostosis|enophthalmos|orbital disease|exophthalmos|blindness|nutritional optic neuropathy,ppi
474,492,23677,SH3BP4,SH3 domain binding protein 4,44,GDP-dissociation inhibitor activity,,ppi
475,493,9467,SH3BP5,SH3 domain binding protein 5,22,protein kinase inhibitor activity,,ppi
476,494,663,BNIP2,BCL2 interacting protein 2,18,GTPase activator activity|calcium ion binding|exopolyphosphatase activity,,ppi
477,495,6455,SH3GL1,SH3 domain containing GRB2 like 1; endophilin A2,76,cadherin binding,acute myeloid leukemia,ppi
478,496,6456,SH3GL2,SH3 domain containing GRB2 like 2; endophilin A1,68,,,ppi
479,497,6457,SH3GL3,SH3 domain containing GRB2 like 3; endophilin A3,54,,,ppi
480,498,51100,SH3GLB1,SH3 domain containing GRB2 like endophilin B1,98,cadherin binding,,ppi
481,499,56904,SH3GLB2,SH3 domain containing GRB2 like endophilin B2,32,cadherin binding,,ppi
482,500,6461,SHB,SH2 domain containing adaptor protein B,28,phosphotyrosine residue binding,,ppi
483,501,6462,SHBG,sex hormone binding globulin,61,androgen binding,alcohol dependence|alcohol abuse|diabetes mellitus|type 2 diabetes mellitus|prostate cancer|prostate carcinoma|psychologic dyspareunia|premature ejaculation|metabolic syndrome X,ppi
484,502,664,BNIP3,BCL2 interacting protein 3,22,protein homodimerization activity|protein heterodimerization activity,multiple myeloma|prostate cancer|prostate carcinoma|stomach cancer,ppi
485,503,6464,SHC1,SHC adaptor protein 1,289,transmembrane receptor protein tyrosine kinase adaptor activity|Ras guanyl-nucleotide exchange factor activity|epidermal growth factor receptor binding|phospholipid binding|receptor tyrosine kinase binding,amyotrophic lateral sclerosis type 1,ppi
486,504,7979,SEM1,SEM1; 26S proteasome complex subunit,135,,,ppi
487,505,6468,FBXW4,F-box and WD repeat domain containing 4,51,ubiquitin-protein transferase activity,,ppi
488,506,6469,SHH,sonic hedgehog,12,endopeptidase activity|patched binding|calcium ion binding|zinc ion binding|morphogen activity|laminin-1 binding,choanal atresia|coloboma|epilepsy|microphthalmia|placental insufficiency|hydronephrosis|intellectual disability|learning disability|secondary Parkinson disease|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|holoprosencephaly|porencephaly|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X,ppi
489,507,665,BNIP3L,BCL2 interacting protein 3 like,35,lamin binding|protein homodimerization activity|protein heterodimerization activity,,ppi
490,508,6470,SHMT1,serine hydroxymethyltransferase 1,52,translation repressor activity; mRNA regulatory element binding|glycine hydroxymethyltransferase activity|pyridoxal phosphate binding|protein homodimerization activity|mRNA 5'-UTR binding|serine binding|amino acid binding|cobalt ion binding|zinc ion binding,Langerhans-cell histiocytosis|lymphosarcoma|lymphoma|reticulosarcoma|non-Hodgkin lymphoma|B-cell lymphoma|central nervous system disease|nervous system disease|autonomic neuropathy|schizophrenia|breast cancer,ppi
491,509,6472,SHMT2,serine hydroxymethyltransferase 2,405,chromatin binding|glycine hydroxymethyltransferase activity|pyridoxal phosphate binding|identical protein binding|serine binding|zinc ion binding|amino acid binding|cobalt ion binding,lung cancer|non-small cell lung carcinoma,ppi
492,510,6473,SHOX,short stature homeobox,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,achondroplasia|Laron syndrome|obesity|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|Leri-Weill dyschondrosteosis|osteogenesis imperfecta|Ehlers-Danlos syndrome|cherubism|exostosis|periarthritis|tendinitis,ppi
493,511,6474,SHOX2,short stature homeobox 2,5,DNA-binding transcription factor activity; RNA polymerase II-specific,bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
494,512,6476,SI,sucrase-isomaltase,1,alpha-1;4-glucosidase activity|sucrose alpha-glucosidase activity,acute urate nephropathy,ppi
495,513,6477,SIAH1,siah E3 ubiquitin protein ligase 1,167,ubiquitin-protein transferase activity|zinc ion binding|ubiquitin protein ligase activity|ubiquitin conjugating enzyme binding,,ppi
496,514,6478,SIAH2,siah E3 ubiquitin protein ligase 2,71,transcription corepressor activity|ubiquitin-protein transferase activity|ubiquitin conjugating enzyme binding|ubiquitin protein ligase activity,lens disease,ppi
497,515,6480,ST6GAL1,ST6 beta-galactoside alpha-2;6-sialyltransferase 1,17,beta-galactoside alpha-2;6-sialyltransferase activity|sialyltransferase activity,diabetes mellitus|type 2 diabetes mellitus|allergic contact dermatitis,ppi
498,516,84620,ST6GAL2,ST6 beta-galactoside alpha-2;6-sialyltransferase 2,2,beta-galactoside alpha-2;6-sialyltransferase activity,,ppi
499,517,6482,ST3GAL1,ST3 beta-galactoside alpha-2;3-sialyltransferase 1,15,beta-galactoside (CMP) alpha-2;3-sialyltransferase activity,bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
500,518,6483,ST3GAL2,ST3 beta-galactoside alpha-2;3-sialyltransferase 2,9,beta-galactoside (CMP) alpha-2;3-sialyltransferase activity|monosialoganglioside sialyltransferase activity,,ppi
501,519,6484,ST3GAL4,ST3 beta-galactoside alpha-2;3-sialyltransferase 4,20,beta-galactoside (CMP) alpha-2;3-sialyltransferase activity|monosialoganglioside sialyltransferase activity,salivary gland adenoid cystic carcinoma,ppi
502,520,6487,ST3GAL3,ST3 beta-galactoside alpha-2;3-sialyltransferase 3,5,beta-galactoside (CMP) alpha-2;3-sialyltransferase activity,infantile epileptic encephalopathy|autosomal recessive non-syndromic intellectual disability|Ohtahara syndrome,ppi
503,521,10610,ST6GALNAC2,ST6 N-acetylgalactosaminide alpha-2;6-sialyltransferase 2,1,alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase activity|sialyltransferase activity,IgA glomerulonephritis,ppi
504,522,6489,ST8SIA1,ST8 alpha-N-acetyl-neuraminide alpha-2;8-sialyltransferase 1,10,alpha-N-acetylneuraminate alpha-2;8-sialyltransferase activity|sialyltransferase activity,gallbladder disease|liver disease|toxic encephalopathy,ppi
505,523,666,BOK,BOK; BCL2 family apoptosis regulator,4,protein homodimerization activity|protein heterodimerization activity,,ppi
506,524,8128,ST8SIA2,ST8 alpha-N-acetyl-neuraminide alpha-2;8-sialyltransferase 2,2,alpha-N-acetylneuraminate alpha-2;8-sialyltransferase activity|sialic acid binding,autistic disorder|bipolar disorder|schizophrenia,ppi
507,525,7903,ST8SIA4,ST8 alpha-N-acetyl-neuraminide alpha-2;8-sialyltransferase 4,66,alpha-N-acetylneuraminate alpha-2;8-sialyltransferase activity|sialic acid binding,schizophrenia,ppi
508,526,8869,ST3GAL5,ST3 beta-galactoside alpha-2;3-sialyltransferase 5,3,beta-galactoside (CMP) alpha-2;3-sialyltransferase activity|neolactotetraosylceramide alpha-2;3-sialyltransferase activity|sialyltransferase activity|lactosylceramide alpha-2;3-sialyltransferase activity,focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|optic atrophy|status epilepticus|basal ganglia disease|cortical blindness|visual epilepsy,ppi
509,527,8778,SIGLEC5,sialic acid binding Ig like lectin 5,11,,,ppi
510,528,946,SIGLEC6,sialic acid binding Ig like lectin 6,4,,systemic lupus erythematosus,ppi
511,529,27036,SIGLEC7,sialic acid binding Ig like lectin 7,8,signaling receptor activity,,ppi
512,530,27181,SIGLEC8,sialic acid binding Ig like lectin 8,1,transmembrane signaling receptor activity,,ppi
513,531,27180,SIGLEC9,sialic acid binding Ig like lectin 9,2,carbohydrate binding,,ppi
514,532,6491,STIL,SCL/TAL1 interrupting locus,91,,intellectual disability|learning disability|syndromic X-linked intellectual disability 94|vesicoureteral reflux|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|septooptic dysplasia|microcephaly,ppi
515,533,6490,PMEL,premelanosome protein,49,,melanoma|skin melanoma,ppi
516,534,6492,SIM1,single-minded family bHLH transcription factor 1,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|protein heterodimerization activity,hyperglycemia|Zollinger-Ellison syndrome|hyperinsulinism|bulimia nervosa|obesity|ophthalmoplegia|mechanical strabismus|hypertropia|beriberi|pellagra|craniosynostosis|amnestic disorder|retrograde amnesia|Horner's syndrome|attention deficit hyperactivity disorder|breast cancer,ppi
517,535,6493,SIM2,single-minded family bHLH transcription factor 2,25,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,isolated cleft palate|cleft palate,ppi
518,536,8487,GEMIN2,gem nuclear organelle associated protein 2,57,,,ppi
519,537,6494,SIPA1,signal-induced proliferation-associated 1,17,GTPase activator activity,melanoma|skin melanoma,ppi
520,538,22933,SIRT2,sirtuin 2,75,chromatin binding|histone deacetylase activity|zinc ion binding|NAD-dependent histone deacetylase activity|protein deacetylase activity|NAD-dependent protein deacetylase activity|tubulin deacetylase activity|ubiquitin binding|NAD-dependent histone deacetylase activity (H4-K16 specific)|NAD+ binding|NAD+ ADP-ribosyltransferase activity,mood disorder,ppi
521,539,6495,SIX1,SIX homeobox 1,19,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|sequence-specific DNA binding|transcription regulatory region DNA binding|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|transcription regulatory region sequence-specific DNA binding,tuberous sclerosis|Marfan syndrome|situs inversus|polyp of middle ear|cholesteatoma|isolated cleft palate|cleft palate|sensorineural hearing loss|Meckel syndrome|autosomal dominant polycystic kidney disease|vesicoureteral reflux|branchiootorenal syndrome|multinodular goiter|Potter's syndrome|renal agenesis|branchiootic syndrome|autosomal dominant nonsyndromic deafness 23,ppi
522,540,10736,SIX2,SIX homeobox 2,20,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region sequence-specific DNA binding|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|amyotrophic lateral sclerosis type 1,ppi
523,541,6496,SIX3,SIX homeobox 3,8,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|transcription regulatory region sequence-specific DNA binding,constipation|neurohypophyseal diabetes insipidus|diabetes insipidus|epilepsy|liver cancer|intellectual disability|learning disability|microphthalmia|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|holoprosencephaly|isolated cleft palate|porencephaly|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X,ppi
524,542,51804,SIX4,SIX homeobox 4,10,DNA-binding transcription factor activity; RNA polymerase II-specific|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|transcription regulatory region sequence-specific DNA binding,,ppi
525,543,147912,SIX5,SIX homeobox 5,7,DNA-binding transcription factor activity; RNA polymerase II-specific|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|transcription regulatory region sequence-specific DNA binding,branchiootorenal syndrome,ppi
526,544,4990,SIX6,SIX homeobox 6,3,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region sequence-specific DNA binding|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific,ptosis|congenital ptosis|coloboma|cryptorchidism|neurohypophyseal diabetes insipidus|diabetes insipidus|patent ductus arteriosus|esophageal atresia|enophthalmos|orbital disease|exophthalmos|sensorineural hearing loss|ventricular septal defect|spastic diplegia|spastic monoplegia|spastic quadriplegia|cerebral palsy|microphthalmia|myopia|cataract,ppi
527,545,10419,PRMT5,protein arginine methyltransferase 5,197,transcription corepressor activity|methyltransferase activity|methyl-CpG binding|histone-arginine N-methyltransferase activity|protein-arginine N-methyltransferase activity|protein-arginine omega-N symmetric methyltransferase activity|histone methyltransferase activity (H4-R3 specific)|protein heterodimerization activity|E-box binding,,ppi
528,546,9525,VPS4B,vacuolar protein sorting 4 homolog B,44,ATPase activity|ATPase activity; coupled|identical protein binding|protein homodimerization activity|microtubule-severing ATPase activity,,ppi
529,547,6497,SKI,SKI proto-oncogene,124,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|zinc ion binding|histone deacetylase inhibitor activity|SMAD binding,aortic aneurysm|autistic disorder|ptosis|congenital ptosis|clubfoot|constipation|craniosynostosis|enophthalmos|orbital disease|exophthalmos|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|umbilical hernia|omphalocele|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain,ppi
530,548,6498,SKIL,SKI like proto-oncogene,109,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|SMAD binding,postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|seborrheic keratosis|skin disease|actinic keratosis,ppi
531,549,6499,SKIV2L,Ski2 like RNA helicase,32,ATP-dependent RNA helicase activity,colitis|ileitis|ileocolitis|gastroenteritis|placental insufficiency|primary immunodeficiency disease|liver cirrhosis|celiac disease,ppi
532,550,6500,SKP1,S-phase kinase associated protein 1,250,ubiquitin-protein transferase activity|beta-catenin binding|ubiquitin protein ligase activity,,ppi
533,551,667,DST,dystonin,74,microtubule plus-end binding|microtubule binding|structural molecule activity,clubfoot|pseudosarcomatous fibromatosis|sensory peripheral neuropathy|hereditary sensory neuropathy|epidermolysis bullosa simplex,ppi
534,552,6502,SKP2,S-phase kinase associated protein 2,173,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|ovarian cancer|liver cancer|hepatocellular carcinoma,ppi
535,553,6503,SLA,Src like adaptor,21,non-membrane spanning protein tyrosine kinase activity,vitiligo,ppi
536,554,6504,SLAMF1,signaling lymphocytic activation molecule family member 1,112,antigen binding|transmembrane signaling receptor activity,,ppi
537,555,7884,SLBP,stem-loop binding protein,32,RNA binding|mRNA binding|histone pre-mRNA stem-loop binding|histone pre-mRNA DCP binding,,ppi
538,556,6554,SLC10A1,solute carrier family 10 member 1,1,bile acid:sodium symporter activity,hepatitis B,ppi
539,557,6555,SLC10A2,solute carrier family 10 member 2,1,bile acid:sodium symporter activity,central nervous system disease|nervous system disease|autonomic neuropathy|steatorrhea|substance abuse|substance-related disorder,ppi
540,559,4891,SLC11A2,solute carrier family 11 member 2,9,copper ion transmembrane transporter activity|iron ion transmembrane transporter activity|manganese ion transmembrane transporter activity|cadmium ion transmembrane transporter activity|ferrous iron transmembrane transporter activity|lead ion transmembrane transporter activity|solute:proton symporter activity|cadmium ion binding|transition metal ion transmembrane transporter activity|nickel cation binding|manganese ion binding|cobalt ion transmembrane transporter activity|zinc ion binding|copper ion binding|iron ion binding|nickel cation transmembrane transporter activity|cobalt ion binding,anemia|macrocytic anemia|iron metabolism disease|hemochromatosis|Wilson disease|gallbladder disease|liver disease|liver cancer|hypochromic anemia|deficiency anemia|microcytic anemia|hypochromic microcytic anemia,ppi
541,560,30061,SLC40A1,solute carrier family 40 member 1,4,iron ion transmembrane transporter activity|ferrous iron transmembrane transporter activity|iron channel activity,anemia|macrocytic anemia|autistic disorder|endometriosis of uterus|endometriosis|iron metabolism disease|hemochromatosis|Wilson disease|liver cancer|fatty liver disease,ppi
542,561,6557,SLC12A1,solute carrier family 12 member 1,2,sodium:potassium:chloride symporter activity|sodium ion transmembrane transporter activity|sodium:chloride symporter activity|potassium:chloride symporter activity,Liddle syndrome|Conn's syndrome|Bartter disease|primary hyperaldosteronism|constipation|epilepsy|polyhydramnios|Waterhouse-Friderichsen syndrome|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hypokalemia|intellectual disability|learning disability|calcium metabolism disease|calcinosis|visual epilepsy|hypoparathyroidism|pseudohypoparathyroidism|placental insufficiency,ppi
543,562,6558,SLC12A2,solute carrier family 12 member 2,31,sodium:potassium:chloride symporter activity|ammonium transmembrane transporter activity|sodium ion transmembrane transporter activity|potassium:chloride symporter activity|sodium:chloride symporter activity,heart disease|cardiovascular system disease|epilepsy|complex partial epilepsy|temporal lobe epilepsy|hypertension|essential hypertension|movement disease|lingual-facial-buccal dyskinesia|prostate cancer|prostate carcinoma|schizophreniform disorder|schizoaffective disorder|schizophrenia|glucose intolerance|prediabetes syndrome,ppi
544,563,6559,SLC12A3,solute carrier family 12 member 3,11,transporter activity|sodium:chloride symporter activity|sodium:potassium:chloride symporter activity|potassium:chloride symporter activity|sodium ion transmembrane transporter activity,epilepsy|hypertension|essential hypertension|hypokalemia|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|visual epilepsy|hypoparathyroidism|pseudohypoparathyroidism|vascular disease|Gitelman syndrome|chondrocalcinosis|musculoskeletal system disease|renal hypomagnesemia 2,ppi
545,564,6560,SLC12A4,solute carrier family 12 member 4,26,potassium:chloride symporter activity,,ppi
546,565,9990,SLC12A6,solute carrier family 12 member 6,17,potassium:chloride symporter activity,bipolar disorder|ptosis|congenital ptosis|pseudosarcomatous fibromatosis|epilepsy|intellectual disability|learning disability|polyneuropathy|peripheral nervous system disease|neuropathy|schizophreniform disorder|schizoaffective disorder|visual epilepsy|sensory peripheral neuropathy|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy|craniosynostosis|neuritis|motor neuritis,ppi
547,566,10723,SLC12A7,solute carrier family 12 member 7,16,potassium:chloride symporter activity,urinary bladder cancer,ppi
548,567,6561,SLC13A1,solute carrier family 13 member 1,2,sodium:sulfate symporter activity|citrate transmembrane transporter activity|succinate transmembrane transporter activity|sodium:dicarboxylate symporter activity,,ppi
549,568,9058,SLC13A2,solute carrier family 13 member 2,11,low-affinity sodium:dicarboxylate symporter activity,,ppi
550,570,8170,SLC14A2,solute carrier family 14 member 2,2,urea transmembrane transporter activity|cell adhesion molecule binding,,ppi
551,571,668,FOXL2,forkhead box L2,66,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|cysteine-type endopeptidase regulator activity involved in apoptotic process,blepharophimosis|ptosis|congenital ptosis|large intestine cancer|colorectal cancer|hyperopia|premature menopause|androgen insensitivity syndrome|microphthalmia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|mechanical strabismus|hypertropia|blepharophimosis; ptosis; and epicanthus inversus syndrome|cornea plana|Peters anomaly|premature ovarian failure,ppi
552,572,6564,SLC15A1,solute carrier family 15 member 1,64,peptide:proton symporter activity|dipeptide transmembrane transporter activity|oligopeptide transmembrane transporter activity|peptide transmembrane transporter activity,,ppi
553,573,6565,SLC15A2,solute carrier family 15 member 2,3,peptide:proton symporter activity|oligopeptide transmembrane transporter activity|peptide transmembrane transporter activity|dipeptide transmembrane transporter activity,melanoma|skin melanoma,ppi
554,574,6566,SLC16A1,solute carrier family 16 member 1,32,monocarboxylic acid transmembrane transporter activity|lactate transmembrane transporter activity|mevalonate transmembrane transporter activity,colon cancer|colonic benign neoplasm|hypoglycemic coma|hyperinsulinemic hypoglycemia,ppi
555,575,6567,SLC16A2,solute carrier family 16 member 2,6,transporter activity|monocarboxylic acid transmembrane transporter activity|thyroid hormone transmembrane transporter activity,cerebellar disease|pseudosarcomatous fibromatosis|clubfoot|congenital hypothyroidism|myxedema|hypothyroidism|leukodystrophy|syndromic X-linked intellectual disability 94|paraplegia|muscular atrophy|locked-in syndrome|quadriplegia|Allan-Herndon-Dudley syndrome|autistic disorder,ppi
556,576,9123,SLC16A3,solute carrier family 16 member 3,8,RNA binding|monocarboxylic acid transmembrane transporter activity|lactate transmembrane transporter activity,,ppi
557,577,9122,SLC16A4,solute carrier family 16 member 4,3,monocarboxylic acid transmembrane transporter activity,,ppi
558,578,9121,SLC16A5,solute carrier family 16 member 5,2,monocarboxylic acid transmembrane transporter activity,,ppi
559,579,9120,SLC16A6,solute carrier family 16 member 6,6,monocarboxylic acid transmembrane transporter activity,endometriosis of uterus|endometriosis,ppi
560,580,9194,SLC16A7,solute carrier family 16 member 7,2,pyruvate secondary active transmembrane transporter activity|monocarboxylic acid transmembrane transporter activity|lactate transmembrane transporter activity|pyruvate transmembrane transporter activity,obesity,ppi
561,581,6568,SLC17A1,solute carrier family 17 member 1,1,sodium-dependent phosphate transmembrane transporter activity|sialic acid transmembrane transporter activity,,ppi
562,582,669,BPGM,bisphosphoglycerate mutase,22,bisphosphoglycerate mutase activity,cholecystitis|cholecystolithiasis|choledocholithiasis|normocytic anemia,ppi
563,583,10246,SLC17A2,solute carrier family 17 member 2,51,sodium:phosphate symporter activity|sialic acid transmembrane transporter activity,liver cirrhosis,ppi
564,585,10050,SLC17A4,solute carrier family 17 member 4,1,sodium:phosphate symporter activity|sialic acid transmembrane transporter activity,,ppi
565,586,26503,SLC17A5,solute carrier family 17 member 5,3,carbohydrate:proton symporter activity|sialic acid transmembrane transporter activity|sialic acid:proton symporter activity,alcohol dependence|alcohol abuse|ptosis|congenital ptosis|cerebellar disease|epilepsy|alternating exotropia|exotropia|monocular exotropia|gingival overgrowth|gingival hypertrophy|congestive heart failure|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|melanoma|skin melanoma|intellectual disability|learning disability,ppi
566,587,6570,SLC18A1,solute carrier family 18 member A1,55,monoamine transmembrane transporter activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia,ppi
567,588,6571,SLC18A2,solute carrier family 18 member A2,4,monoamine transmembrane transporter activity,alcohol dependence|alcohol abuse|bipolar disorder|ptosis|congenital ptosis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|central nervous system disease|nervous system disease|autonomic neuropathy|Parkinson's disease|schizophrenia|lingual-facial-buccal dyskinesia|secondary Parkinson disease|cocaine abuse|cocaine dependence,ppi
568,590,6573,SLC19A1,solute carrier family 19 member 1,3,folic acid transmembrane transporter activity|folate:anion antiporter activity|folic acid binding,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|autistic disorder|urinary bladder cancer|cleft lip|isolated cleft palate|cleft palate|colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|Down syndrome|central nervous system disease|nervous system disease|autonomic neuropathy|acute lymphocytic leukemia,ppi
569,591,10560,SLC19A2,solute carrier family 19 member 2,30,folic acid transmembrane transporter activity|thiamine transmembrane transporter activity,megaloblastic anemia|sideroblastic anemia|sick sinus syndrome|diabetic ketoacidosis|diabetes mellitus|sensorineural hearing loss|heart septal defect|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|spontaneous ocular nystagmus,ppi
570,592,6505,SLC1A1,solute carrier family 1 member 1,34,L-glutamate transmembrane transporter activity|high-affinity glutamate transmembrane transporter activity|chloride transmembrane transporter activity|amino acid transmembrane transporter activity|glutamate:sodium symporter activity|cysteine transmembrane transporter activity,bipolar disorder|brain disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometriosis of uterus|endometriosis|epilepsy|complex partial epilepsy|temporal lobe epilepsy|visual epilepsy|dicarboxylic aminoaciduria,ppi
571,593,670,BPHL,biphenyl hydrolase like,9,alpha-amino-acid esterase activity,,ppi
572,594,6506,SLC1A2,solute carrier family 1 member 2,11,L-glutamate transmembrane transporter activity|high-affinity glutamate transmembrane transporter activity|amino acid transmembrane transporter activity|glutamate:sodium symporter activity,alcohol dependence|alcohol abuse|progressive muscular atrophy|amyotrophic lateral sclerosis|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|schizophrenia|stomach cancer|cocaine abuse|cocaine dependence|mood disorder,ppi
573,595,6507,SLC1A3,solute carrier family 1 member 3,12,L-glutamate transmembrane transporter activity|high-affinity glutamate transmembrane transporter activity|amino acid transmembrane transporter activity|glutamate:sodium symporter activity,autistic disorder|bipolar disorder|epilepsy|hemiplegia|schizophrenia|visual epilepsy|migraine|episodic ataxia|episodic ataxia type 6,ppi
574,596,6509,SLC1A4,solute carrier family 1 member 4,4,chloride channel activity|amino acid transmembrane transporter activity|L-alanine transmembrane transporter activity|L-cystine transmembrane transporter activity|L-glutamine transmembrane transporter activity|L-proline transmembrane transporter activity|L-serine transmembrane transporter activity|L-threonine transmembrane transporter activity|L-hydroxyproline transmembrane transporter activity,bipolar disorder|intellectual disability|learning disability|schizophrenia|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|locked-in syndrome|quadriplegia,ppi
575,597,6510,SLC1A5,solute carrier family 1 member 5,62,amino acid transmembrane transporter activity|neutral amino acid transmembrane transporter activity|L-glutamine transmembrane transporter activity|signaling receptor activity,schizophrenia,ppi
576,598,6511,SLC1A6,solute carrier family 1 member 6,3,high-affinity glutamate transmembrane transporter activity|amino acid transmembrane transporter activity|L-aspartate transmembrane transporter activity,bipolar disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
577,599,6512,SLC1A7,solute carrier family 1 member 7,2,L-glutamate transmembrane transporter activity|high-affinity glutamate transmembrane transporter activity|amino acid transmembrane transporter activity,,ppi
578,600,6574,SLC20A1,solute carrier family 20 member 1,25,sodium:phosphate symporter activity|sodium-dependent phosphate transmembrane transporter activity|signaling receptor activity|sodium:inorganic phosphate symporter activity|inorganic phosphate transmembrane transporter activity,endometriosis of uterus|endometriosis|aortic valve stenosis,ppi
579,601,6575,SLC20A2,solute carrier family 20 member 2,14,sodium:phosphate symporter activity|sodium-dependent phosphate transmembrane transporter activity|signaling receptor activity|inorganic phosphate transmembrane transporter activity|sodium:inorganic phosphate symporter activity,basal ganglia disease|calcium metabolism disease|nephrocalcinosis|calcinosis|syndromic X-linked intellectual disability type 10|choreatic disease|recurrent corneal erosion|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|epilepsy|placental insufficiency|schizophreniform disorder|schizoaffective disorder|visual epilepsy|thrombocytopenia,ppi
580,602,671,BPI,bactericidal/permeability-increasing protein,1,lipopolysaccharide binding,,ppi
581,603,28232,SLCO3A1,solute carrier organic anion transporter family member 3A1,4,sodium-independent organic anion transmembrane transporter activity,alcohol dependence|alcohol abuse,ppi
582,604,28231,SLCO4A1,solute carrier organic anion transporter family member 4A1,2,thyroid hormone transmembrane transporter activity|sodium-independent organic anion transmembrane transporter activity,,ppi
583,605,6578,SLCO2A1,solute carrier organic anion transporter family member 2A1,1,lipid transporter activity|prostaglandin transmembrane transporter activity|sodium-independent organic anion transmembrane transporter activity,arthropathy|arthritis|ptosis|congenital ptosis|clubfoot|secondary hypertrophic osteoarthropathy|primary hypertrophic osteoarthropathy|acrodermatitis|seborrheic keratosis|seborrheic infantile dermatitis|seborrheic dermatitis|acne,ppi
584,606,6579,SLCO1A2,solute carrier organic anion transporter family member 1A2,4,organic anion transmembrane transporter activity|bile acid transmembrane transporter activity|sodium-independent organic anion transmembrane transporter activity,,ppi
585,607,10599,SLCO1B1,solute carrier organic anion transporter family member 1B1,9,bile acid transmembrane transporter activity|sodium-independent organic anion transmembrane transporter activity|thyroid hormone transmembrane transporter activity,familial periodic paralysis|myopathy|bilirubin metabolic disorder|Dubin-Johnson syndrome|breast cancer,ppi
586,608,10380,BPNT1,3'(2'); 5'-bisphosphate nucleotidase 1,59,3'(2');5'-bisphosphate nucleotidase activity,,ppi
587,610,11309,SLCO2B1,solute carrier organic anion transporter family member 2B1,1,organic anion transmembrane transporter activity|sodium-independent organic anion transmembrane transporter activity|bile acid transmembrane transporter activity,,ppi
588,611,6580,SLC22A1,solute carrier family 22 member 1,2,organic cation transmembrane transporter activity,colon cancer|colonic benign neoplasm|obesity,ppi
589,612,5002,SLC22A18,solute carrier family 22 member 18,26,drug transmembrane transporter activity|drug:proton antiporter activity,alcohol dependence|alcohol abuse|breast cancer|lung cancer|bronchiolo-alveolar adenocarcinoma|lung benign neoplasm|embryonal rhabdomyosarcoma|botryoid rhabdomyosarcoma|breast carcinoma|bronchus carcinoma|lung carcinoma|bronchus cancer|hereditary breast ovarian cancer syndrome,ppi
590,614,6582,SLC22A2,solute carrier family 22 member 2,9,neurotransmitter transporter activity|organic cation transmembrane transporter activity,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
591,615,6581,SLC22A3,solute carrier family 22 member 3,3,organic cation transmembrane transporter activity|quaternary ammonium group transmembrane transporter activity,myocarditis|prostate cancer|prostate carcinoma|substance abuse|substance-related disorder,ppi
592,616,6583,SLC22A4,solute carrier family 22 member 4,4,nucleotide binding|secondary active organic cation transmembrane transporter activity|carnitine transmembrane transporter activity|cation:cation antiporter activity|quaternary ammonium group transmembrane transporter activity,rheumatoid arthritis|inflammatory bowel disease|myocarditis,ppi
593,617,6584,SLC22A5,solute carrier family 22 member 5,8,carnitine transmembrane transporter activity|drug transmembrane transporter activity|quaternary ammonium group transmembrane transporter activity,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
594,618,673,BRAF,B-Raf proto-oncogene; serine/threonine kinase,61,protein kinase activity|protein serine/threonine kinase activity|calcium ion binding,sick sinus syndrome|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|ptosis|congenital ptosis|blood coagulation disease|lung cancer|bronchiolo-alveolar adenocarcinoma|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|large intestine cancer,ppi
595,619,9356,SLC22A6,solute carrier family 22 member 6,20,inorganic anion exchanger activity|organic anion transmembrane transporter activity|anion:anion antiporter activity,calcium metabolism disease|nephrocalcinosis|calcinosis,ppi
596,620,10864,SLC22A7,solute carrier family 22 member 7,1,anion:anion antiporter activity|sodium-independent organic anion transmembrane transporter activity,,ppi
597,621,9376,SLC22A8,solute carrier family 22 member 8,1,inorganic anion exchanger activity|anion:anion antiporter activity,fatty liver disease|influenza|liver cirrhosis,ppi
598,622,9962,SLC23A2,solute carrier family 23 member 2,3,nucleobase transmembrane transporter activity|L-ascorbic acid transmembrane transporter activity|sodium-dependent L-ascorbate transmembrane transporter activity|L-ascorbate:sodium symporter activity,cholestasis,ppi
599,623,9963,SLC23A1,solute carrier family 23 member 1,16,L-ascorbate:sodium symporter activity|sodium ion transmembrane transporter activity|nucleobase transmembrane transporter activity|L-ascorbic acid transmembrane transporter activity|dehydroascorbic acid transmembrane transporter activity|sodium-dependent L-ascorbate transmembrane transporter activity,cholestasis,ppi
600,624,9187,SLC24A1,solute carrier family 24 member 1,6,calcium; potassium:sodium antiporter activity|calcium channel activity,night blindness|congenital stationary night blindness|hereditary night blindness,ppi
601,628,6576,SLC25A1,solute carrier family 25 member 1,61,citrate transmembrane transporter activity|tricarboxylic acid transmembrane transporter activity,epilepsy|schizophrenia|visual epilepsy|brain disease|congenital myasthenic syndrome|L-2-hydroxyglutaric aciduria,ppi
602,629,1468,SLC25A10,solute carrier family 25 member 10,65,dicarboxylic acid transmembrane transporter activity|sulfate transmembrane transporter activity|thiosulfate transmembrane transporter activity|succinate transmembrane transporter activity|antiporter activity|oxaloacetate transmembrane transporter activity|malate transmembrane transporter activity,,ppi
603,630,8402,SLC25A11,solute carrier family 25 member 11,65,RNA binding|oxoglutarate:malate antiporter activity,adult respiratory distress syndrome|newborn respiratory distress syndrome,ppi
604,631,8604,SLC25A12,solute carrier family 25 member 12,36,L-glutamate transmembrane transporter activity|calcium ion binding|acidic amino acid transmembrane transporter activity|L-aspartate transmembrane transporter activity|identical protein binding,rheumatoid arthritis|autistic disorder|epilepsy|schizophrenia|visual epilepsy,ppi
605,632,10165,SLC25A13,solute carrier family 25 member 13,68,transporter activity|L-glutamate transmembrane transporter activity|calcium ion binding|acidic amino acid transmembrane transporter activity|L-aspartate transmembrane transporter activity|identical protein binding,brain edema|intrahepatic cholestasis|liver cirrhosis|acute pancreatitis|pancreatitis|liver disease|urea cycle disorder|chorea-acanthocytosis|abetalipoproteinemia|hypolipoproteinemia|Tangier disease|Norum disease|citrullinemia|liver cancer|hepatocellular carcinoma|fatty liver disease,ppi
606,633,9016,SLC25A14,solute carrier family 25 member 14,8,malate transmembrane transporter activity|antiporter activity|oxaloacetate transmembrane transporter activity|succinate transmembrane transporter activity|thiosulfate transmembrane transporter activity|sulfate transmembrane transporter activity,,ppi
607,634,10166,SLC25A15,solute carrier family 25 member 15,15,L-ornithine transmembrane transporter activity,early myoclonic encephalopathy|Unverricht-Lundborg syndrome|intellectual disability|learning disability|liver disease|urea cycle disorder|cerebral degeneration|ornithine translocase deficiency|ornithine carbamoyltransferase deficiency|gyrate atrophy|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy,ppi
608,635,8034,SLC25A16,solute carrier family 25 member 16,20,secondary active transmembrane transporter activity|antiporter activity,,ppi
609,636,10478,SLC25A17,solute carrier family 25 member 17,30,adenine nucleotide transmembrane transporter activity|ATP transmembrane transporter activity|ADP transmembrane transporter activity|coenzyme A transmembrane transporter activity|FAD transmembrane transporter activity|FMN transmembrane transporter activity|NAD transmembrane transporter activity|AMP transmembrane transporter activity,,ppi
610,637,83733,SLC25A18,solute carrier family 25 member 18,4,amino acid:proton symporter activity|L-glutamate transmembrane transporter activity|L-aspartate transmembrane transporter activity,,ppi
611,638,5250,SLC25A3,solute carrier family 25 member 3,185,phosphate:proton symporter activity|protein-containing complex binding|inorganic phosphate transmembrane transporter activity,lactic acidosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|familial periodic paralysis|myopathy,ppi
612,639,8315,BRAP,BRCA1 associated protein,52,ubiquitin-protein transferase activity|nuclear localization sequence binding|ubiquitin protein ligase activity,coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|schizophrenia,ppi
613,640,291,SLC25A4,solute carrier family 25 member 4,56,adenine transmembrane transporter activity|ATP:ADP antiporter activity,lactic acidosis|bipolar disorder|ptosis|congenital ptosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|familial periodic paralysis|myopathy|myopia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|mechanical strabismus|hypertropia|cataract|chronic progressive external ophthalmoplegia|fibromyalgia,ppi
614,641,292,SLC25A5,solute carrier family 25 member 5,239,RNA binding|adenine transmembrane transporter activity|ATP:ADP antiporter activity,,ppi
615,642,293,SLC25A6,solute carrier family 25 member 6,157,ATP:ADP antiporter activity|adenine transmembrane transporter activity,,ppi
616,643,10861,SLC26A1,solute carrier family 26 member 1,1,chloride transmembrane transporter activity|sulfate transmembrane transporter activity|anion:anion antiporter activity|oxalate transmembrane transporter activity|bicarbonate transmembrane transporter activity,primary hyperoxaluria|calcium metabolism disease|nephrocalcinosis|calcinosis|hypercalcemia|phosphorus metabolism disease|nephrolithiasis,ppi
617,644,1836,SLC26A2,solute carrier family 26 member 2,12,sulfate transmembrane transporter activity|oxalate transmembrane transporter activity|bicarbonate transmembrane transporter activity|anion:anion antiporter activity|chloride transmembrane transporter activity,isolated cleft palate|cleft palate|clubfoot|sensorineural hearing loss|achondroplasia|Laron syndrome|auditory system disease|congestive heart failure|placental insufficiency|inguinal hernia|umbilical hernia|omphalocele|polyhydramnios|osteochondrodysplasia|multiple epiphyseal dysplasia|arthropathy|arthritis|osteopetrosis|osteosclerosis|spinal cord disease,ppi
618,645,376497,SLC27A1,solute carrier family 27 member 1,1,long-chain fatty acid-CoA ligase activity|fatty acid transmembrane transporter activity|long-chain fatty acid transporter activity,,ppi
619,646,11001,SLC27A2,solute carrier family 27 member 2,42,long-chain fatty acid-CoA ligase activity|very long-chain fatty acid-CoA ligase activity|phytanate-CoA ligase activity|pristanate-CoA ligase activity|signaling receptor binding|fatty acid transmembrane transporter activity|long-chain fatty acid transporter activity,,ppi
620,647,11000,SLC27A3,solute carrier family 27 member 3,25,long-chain fatty acid-CoA ligase activity|long-chain fatty acid transporter activity,,ppi
621,648,10999,SLC27A4,solute carrier family 27 member 4,15,long-chain fatty acid-CoA ligase activity|fatty acid transmembrane transporter activity|long-chain fatty acid transporter activity,hypereosinophilic syndrome|ichthyosis,ppi
622,649,10998,SLC27A5,solute carrier family 27 member 5,2,long-chain fatty acid-CoA ligase activity|very long-chain fatty acid-CoA ligase activity|long-chain fatty acid transporter activity|fatty acid transmembrane transporter activity,,ppi
623,650,672,BRCA1,BRCA1; DNA repair associated,556,DNA binding|transcription coactivator activity|RNA binding|ubiquitin-protein transferase activity|tubulin binding|transcription regulatory region DNA binding|androgen receptor binding|RNA polymerase binding,breast cancer|constipation|salivary gland adenoid cystic carcinoma|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|mouth disease|pancreatic cancer|prostate cancer|prostate carcinoma|schizophrenia|hereditary breast ovarian cancer syndrome|breast carcinoma|ovarian cancer|peritoneal carcinoma,ppi
624,651,28965,SLC27A6,solute carrier family 27 member 6,20,fatty acid transmembrane transporter activity|long-chain fatty acid transporter activity|long-chain fatty acid-CoA ligase activity,,ppi
625,654,2030,SLC29A1,solute carrier family 29 member 1 (Augustine blood group),22,nucleoside transmembrane transporter activity,alcohol dependence|alcohol abuse|pancreatic cancer,ppi
626,655,3177,SLC29A2,solute carrier family 29 member 2,2,nucleoside transmembrane transporter activity,,ppi
627,656,6513,SLC2A1,solute carrier family 2 member 1,26,glucose transmembrane transporter activity|dehydroascorbic acid transmembrane transporter activity|protein self-association|D-glucose transmembrane transporter activity,hemolytic anemia|carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|colon cancer|colonic benign neoplasm|diabetes mellitus|type 2 diabetes mellitus|epilepsy|liver cancer|intellectual disability|learning disability|inherited metabolic disorder|microcephaly|central nervous system disease,ppi
628,657,6514,SLC2A2,solute carrier family 2 member 2,7,glucose transmembrane transporter activity|hexose transmembrane transporter activity|D-glucose transmembrane transporter activity,diabetes mellitus|type 2 diabetes mellitus|Fanconi syndrome|fatty liver disease|hypokalemia|osteomalacia|rickets|breast cancer|liver cancer|hepatocellular carcinoma|cystinosis,ppi
629,658,6515,SLC2A3,solute carrier family 2 member 3,7,glucose transmembrane transporter activity|glucose binding|dehydroascorbic acid transmembrane transporter activity|D-glucose transmembrane transporter activity,Huntington's disease|chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease|movement disease|lingual-facial-buccal dyskinesia|germ cell cancer|germ cell and embryonal cancer|embryonal cancer|allergic contact dermatitis|cerebral degeneration,ppi
630,659,6517,SLC2A4,solute carrier family 2 member 4,49,glucose transmembrane transporter activity|D-glucose transmembrane transporter activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|diabetes mellitus|type 2 diabetes mellitus,ppi
631,660,675,BRCA2,BRCA2; DNA repair associated,91,single-stranded DNA binding|protein C-terminus binding|H3 histone acetyltransferase activity|H4 histone acetyltransferase activity|histone acetyltransferase activity|gamma-tubulin binding|identical protein binding|protease binding|protein binding,bipolar disorder|breast cancer|esophageal atresia|Fanconi anemia|malignant glioma|gliosarcoma|mixed glioma|leukopenia|lung benign neoplasm|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|intellectual disability|learning disability|adenosarcoma|nephroblastoma|pancreatic cancer|prostate cancer,ppi
632,661,6518,SLC2A5,solute carrier family 2 member 5,11,fructose transmembrane transporter activity|glucose transmembrane transporter activity|fructose binding,breast cancer,ppi
633,662,11182,SLC2A6,solute carrier family 2 member 6,3,glucose transmembrane transporter activity|D-glucose transmembrane transporter activity|carbohydrate:proton symporter activity,,ppi
634,663,7779,SLC30A1,solute carrier family 30 member 1,23,zinc ion transmembrane transporter activity|calcium channel inhibitor activity,epilepsy|visual epilepsy,ppi
635,664,7780,SLC30A2,solute carrier family 30 member 2,8,zinc ion transmembrane transporter activity,dermatitis|intestinal disease|gastrointestinal system disease,ppi
636,665,7781,SLC30A3,solute carrier family 30 member 3,8,zinc-transporting ATPase activity|zinc ion transmembrane transporter activity,schizophrenia,ppi
637,666,7782,SLC30A4,solute carrier family 30 member 4,24,zinc ion transmembrane transporter activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
638,667,1317,SLC31A1,solute carrier family 31 member 1,10,copper ion transmembrane transporter activity,tuberous sclerosis|Marfan syndrome|situs inversus|primary pulmonary hypertension|pulmonary hypertension|prostate cancer|prostate carcinoma|intellectual disability|learning disability,ppi
639,668,1318,SLC31A2,solute carrier family 31 member 2,5,,,ppi
640,669,140679,SLC32A1,solute carrier family 32 member 1,3,amino acid transmembrane transporter activity|gamma-aminobutyric acid:proton symporter activity,schizophrenia,ppi
641,670,6569,SLC34A1,solute carrier family 34 member 1,11,sodium-dependent phosphate transmembrane transporter activity|sodium:phosphate symporter activity,Fanconi syndrome|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|osteoporosis|kidney failure|uremia|osteomalacia|rickets|acute urate nephropathy|hypophosphatemic nephrolithiasis/osteoporosis 1,ppi
642,671,23774,BRD1,bromodomain containing 1,84,histone binding,bipolar disorder|salivary gland adenoid cystic carcinoma|schizophrenia,ppi
643,672,10568,SLC34A2,solute carrier family 34 member 2,14,sodium:phosphate symporter activity|sodium-dependent phosphate transmembrane transporter activity|sodium ion binding|phosphate ion binding,lung cancer|non-small cell lung carcinoma|pulmonary alveolar microlithiasis,ppi
644,673,10559,SLC35A1,solute carrier family 35 member A1,3,CMP-N-acetylneuraminate transmembrane transporter activity|sialic acid transmembrane transporter activity,cellulitis|pneumonia|thrombocytopenia|congenital disorder of glycosylation type II,ppi
645,674,7355,SLC35A2,solute carrier family 35 member A2,6,UDP-galactose transmembrane transporter activity|sialic acid transmembrane transporter activity,epilepsy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|infantile epileptic encephalopathy|congenital disorder of glycosylation type II,ppi
646,675,23443,SLC35A3,solute carrier family 35 member A3,3,UDP-N-acetylglucosamine transmembrane transporter activity,epilepsy|intellectual disability|learning disability|visual epilepsy|autistic disorder,ppi
647,676,54020,SLC37A1,solute carrier family 37 member 1,1,glucose 6-phosphate:inorganic phosphate antiporter activity,,ppi
648,677,6519,SLC3A1,solute carrier family 3 member 1,2,amino acid transmembrane transporter activity|basic amino acid transmembrane transporter activity|L-cystine transmembrane transporter activity|alpha-amylase activity|L-amino acid transmembrane transporter activity,lactic acidosis|ptosis|congenital ptosis|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|epilepsy|bulimia nervosa|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hypogonadism|kidney failure|uremia|visual epilepsy|urinary tract obstruction|acute urate nephropathy|hypotonia-cystinuria syndrome,ppi
649,678,6520,SLC3A2,solute carrier family 3 member 2,70,RNA binding|double-stranded RNA binding|calcium:sodium antiporter activity|neutral amino acid transmembrane transporter activity|cadherin binding,lung benign neoplasm,ppi
650,679,6521,SLC4A1,solute carrier family 4 member 1 (Diego blood group),20,inorganic anion exchanger activity|anion transmembrane transporter activity|bicarbonate transmembrane transporter activity|chloride transmembrane transporter activity|anion:anion antiporter activity|protein membrane anchor,renal tubular acidosis|hemolytic anemia|favism|hereditary elliptocytosis|congenital hemolytic anemia|hematopoietic system disease|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|malaria|calcium metabolism disease|calcinosis|osteomalacia|rickets|hereditary spherocytosis|lactic acidosis|familial periodic paralysis|obsolete Timothy syndrome|hyperkalemic periodic paralysis|hypokalemic periodic paralysis,ppi
651,680,6522,SLC4A2,solute carrier family 4 member 2,28,inorganic anion exchanger activity|anion transmembrane transporter activity,choledochal cyst|primary biliary cirrhosis|autosomal recessive polycystic kidney disease,ppi
652,681,6508,SLC4A3,solute carrier family 4 member 3,4,inorganic anion exchanger activity,heart disease|cardiovascular system disease,ppi
653,682,6046,BRD2,bromodomain containing 2,41,chromatin binding|lysine-acetylated histone binding,glioblastoma multiforme|giant cell glioblastoma|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
654,683,8671,SLC4A4,solute carrier family 4 member 4,6,sodium:bicarbonate symporter activity,renal tubular acidosis|recurrent corneal erosion|glaucoma|intellectual disability|learning disability|cataract|band keratopathy,ppi
655,684,9497,SLC4A7,solute carrier family 4 member 7,31,sodium:bicarbonate symporter activity,,ppi
656,685,9498,SLC4A8,solute carrier family 4 member 8,32,inorganic anion exchanger activity|sodium:bicarbonate symporter activity,,ppi
657,687,6523,SLC5A1,solute carrier family 5 member 1,3,glucose:sodium symporter activity,lactic acidosis|galactosemia,ppi
658,688,6524,SLC5A2,solute carrier family 5 member 2,1,low-affinity glucose:sodium symporter activity|glucose:sodium symporter activity,renal glycosuria|bulimia nervosa,ppi
659,689,6526,SLC5A3,solute carrier family 5 member 3,15,,bipolar disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
660,691,8019,BRD3,bromodomain containing 3,26,chromatin binding|lysine-acetylated histone binding,medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
661,692,6528,SLC5A5,solute carrier family 5 member 5,10,sodium:iodide symporter activity|iodide transmembrane transporter activity,constipation|malignant glioma|gliosarcoma|mixed glioma|goiter|nontoxic goiter|thyroid gland disease|umbilical hernia|omphalocele|congenital hypothyroidism|myxedema|hypothyroidism|kidney cancer|melanoma|skin melanoma|intellectual disability|learning disability|prostate cancer|prostate carcinoma|thyroid cancer,ppi
662,693,8884,SLC5A6,solute carrier family 5 member 6,4,sodium-dependent multivitamin transmembrane transporter activity,,ppi
663,694,6529,SLC6A1,solute carrier family 6 member 1,2,gamma-aminobutyric acid:sodium symporter activity|neurotransmitter binding,alcohol dependence|alcohol abuse|progressive muscular atrophy|amyotrophic lateral sclerosis|cerebellar disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|childhood absence epilepsy|schizophrenia|epilepsy|visual epilepsy|status epilepticus|early myoclonic encephalopathy,ppi
664,696,6539,SLC6A12,solute carrier family 6 member 12,4,amino acid transmembrane transporter activity|gamma-aminobutyric acid:sodium symporter activity|neurotransmitter binding,schizophrenia,ppi
665,697,6540,SLC6A13,solute carrier family 6 member 13,1,gamma-aminobutyric acid:sodium symporter activity|neurotransmitter binding,bipolar disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
666,699,6530,SLC6A2,solute carrier family 6 member 2,5,norepinephrine:sodium symporter activity|monoamine transmembrane transporter activity|dopamine:sodium symporter activity,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertension|essential hypertension|schizophrenia|epilepsy|visual epilepsy|mood disorder,ppi
667,700,6531,SLC6A3,solute carrier family 6 member 3,17,monoamine transmembrane transporter activity|dopamine binding|dopamine:sodium symporter activity,alcohol dependence|alcohol abuse|anxiety disorder|phobic disorder|bipolar disorder|syndromic X-linked intellectual disability type 10|choreatic disease|cocaine abuse|cocaine dependence|constipation|subacute delirium|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|esophagitis|peptic esophagitis,ppi
668,701,676,BRDT,bromodomain testis associated,6,transcription coactivator activity|histone binding|lysine-acetylated histone binding,,ppi
669,702,6532,SLC6A4,solute carrier family 6 member 4,8,serotonin:sodium symporter activity|monoamine transmembrane transporter activity|actin filament binding|serotonin binding,bipolar disorder|mood disorder|alcohol dependence|alcohol abuse|anxiety disorder|phobic disorder|autistic disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|primary pulmonary hypertension|pulmonary hypertension|cannabis dependence|cannabis abuse|obsessive-compulsive disorder|antisocial personality disorder|avoidant personality disorder,ppi
670,703,9152,SLC6A5,solute carrier family 6 member 5,13,glycine:sodium symporter activity,alcohol dependence|alcohol abuse|brain disease|schizophrenia|hyperekplexia 1|hyperekplexia 3,ppi
671,704,6533,SLC6A6,solute carrier family 6 member 6,7,amino acid transmembrane transporter activity|taurine:sodium symporter activity,coronary artery disease,ppi
672,706,6535,SLC6A8,solute carrier family 6 member 8,11,creatine transmembrane transporter activity|creatine:sodium symporter activity|choline transmembrane transporter activity,autistic disorder|ptosis|congenital ptosis|cerebellar disease|syndromic X-linked intellectual disability type 10|choreatic disease|constipation|dystonia|epilepsy|alternating exotropia|exotropia|monocular exotropia|Hirschsprung's disease|hyperopia|megacolon|toxic megacolon|intellectual disability|learning disability|visual epilepsy|stereotypic movement disorder,ppi
673,707,6536,SLC6A9,solute carrier family 6 member 9,8,glycine:sodium symporter activity|glycine transmembrane transporter activity,alcohol dependence|alcohol abuse|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
674,708,6541,SLC7A1,solute carrier family 7 member 1,60,amino acid transmembrane transporter activity|L-lysine transmembrane transporter activity|L-ornithine transmembrane transporter activity|arginine transmembrane transporter activity,prostate cancer|prostate carcinoma,ppi
675,709,56301,SLC7A10,solute carrier family 7 member 10,1,neutral amino acid transmembrane transporter activity|L-serine transmembrane transporter activity|L-amino acid transmembrane transporter activity,schizophrenia,ppi
676,710,23657,SLC7A11,solute carrier family 7 member 11,7,cystine:glutamate antiporter activity|L-amino acid transmembrane transporter activity,contact dermatitis|occupational dermatitis,ppi
677,711,9577,BRE,brain and reproductive organ-expressed (TNFRSF1A modulator),48,peroxisome targeting sequence binding|tumor necrosis factor receptor binding|polyubiquitin modification-dependent protein binding,,ppi
678,712,6542,SLC7A2,solute carrier family 7 member 2,22,amino acid transmembrane transporter activity|basic amino acid transmembrane transporter activity|L-lysine transmembrane transporter activity|L-ornithine transmembrane transporter activity|arginine transmembrane transporter activity,,ppi
679,713,84889,SLC7A3,solute carrier family 7 member 3,14,amino acid transmembrane transporter activity|arginine transmembrane transporter activity|L-lysine transmembrane transporter activity|L-ornithine transmembrane transporter activity,,ppi
680,715,8140,SLC7A5,solute carrier family 7 member 5,17,amino acid transmembrane transporter activity|neutral amino acid transmembrane transporter activity|peptide antigen binding|L-amino acid transmembrane transporter activity,lung benign neoplasm|allergic contact dermatitis,ppi
681,716,9057,SLC7A6,solute carrier family 7 member 6,2,amino acid transmembrane transporter activity|L-amino acid transmembrane transporter activity,,ppi
682,717,9056,SLC7A7,solute carrier family 7 member 7,2,L-amino acid transmembrane transporter activity|basic amino acid transmembrane transporter activity,amino acid metabolic disorder|anemia|macrocytic anemia|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|leukopenia|osteoporosis|acute pancreatitis|pancreatitis|pulmonary alveolar proteinosis|thrombocytopenia|marasmus|kwashiorkor|protein-energy malnutrition|nutrition disease|urea cycle disorder|lysinuric protein intolerance,ppi
683,718,23428,SLC7A8,solute carrier family 7 member 8,3,organic cation transmembrane transporter activity|amino acid transmembrane transporter activity|neutral amino acid transmembrane transporter activity|toxin transmembrane transporter activity|peptide antigen binding|L-amino acid transmembrane transporter activity,endometriosis of uterus|endometriosis,ppi
684,719,11136,SLC7A9,solute carrier family 7 member 9,5,neutral amino acid transmembrane transporter activity|L-cystine transmembrane transporter activity|peptide antigen binding|L-amino acid transmembrane transporter activity,glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|kidney failure|uremia|urinary tract obstruction|acute urate nephropathy,ppi
685,720,6546,SLC8A1,solute carrier family 8 member A1,8,calcium:sodium antiporter activity|calcium ion binding|cytoskeletal protein binding|ankyrin binding|ion channel binding,megacolon|toxic megacolon|epilepsy|visual epilepsy|status epilepticus|coronary artery disease,ppi
686,721,6543,SLC8A2,solute carrier family 8 member A2,7,calcium:sodium antiporter activity,,ppi
687,722,677,ZFP36L1,ZFP36 ring finger protein like 1,19,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA binding|mRNA binding|mRNA 3'-UTR AU-rich region binding|14-3-3 protein binding|mRNA 3'-UTR binding,,ppi
688,723,6547,SLC8A3,solute carrier family 8 member A3,12,calcium:sodium antiporter activity,epilepsy|visual epilepsy|status epilepticus,ppi
689,724,6548,SLC9A1,solute carrier family 9 member A1,41,phosphatidylinositol-4;5-bisphosphate binding|solute:proton antiporter activity|sodium:proton antiporter activity|protein phosphatase 2B binding|protein binding; bridging|protein-containing complex scaffold activity|calcium-dependent protein binding|sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential|potassium:proton antiporter activity,Barrett's esophagus|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|congestive heart failure|autosomal recessive spinocerebellar ataxia 19,ppi
690,725,6549,SLC9A2,solute carrier family 9 member A2,9,sodium:proton antiporter activity|potassium:proton antiporter activity,congestive heart failure,ppi
691,726,6550,SLC9A3,solute carrier family 9 member A3,11,sodium:proton antiporter activity|PDZ domain binding|potassium:proton antiporter activity,congestive heart failure|intestinal obstruction|ileus|congenital secretory sodium diarrhea 8|congenital secretory sodium diarrhea 3,ppi
692,727,9368,SLC9A3R1,SLC9A3 regulator 1,125,chloride channel regulator activity|protein self-association,osteoporosis|acute urate nephropathy|hypophosphatemic nephrolithiasis/osteoporosis 2,ppi
693,728,9351,SLC9A3R2,SLC9A3 regulator 2,83,cadherin binding,hypertension|essential hypertension,ppi
694,729,389015,SLC9A4,solute carrier family 9 member A4,2,sodium:proton antiporter activity|potassium:proton antiporter activity,lactic acidosis,ppi
695,730,6553,SLC9A5,solute carrier family 9 member A5,5,sodium:proton antiporter activity|potassium:proton antiporter activity,,ppi
696,731,10479,SLC9A6,solute carrier family 9 member A6,31,sodium:proton antiporter activity|potassium:proton antiporter activity,autistic disorder|pseudosarcomatous fibromatosis|dystonia|esophagitis|peptic esophagitis|gastroesophageal reflux disease|mutism|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|syndromic X-linked intellectual disability 94|stereotypic movement disorder|mechanical strabismus|hypertropia|epilepsy|visual epilepsy|cerebral degeneration|muscular atrophy,ppi
697,732,678,ZFP36L2,ZFP36 ring finger protein like 2,11,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA binding|AU-rich element binding|mRNA 3'-UTR AU-rich region binding|mRNA 3'-UTR binding,prostate cancer|prostate carcinoma,ppi
698,733,6585,SLIT1,slit guidance ligand 1,5,calcium ion binding,,ppi
699,734,9353,SLIT2,slit guidance ligand 2,13,GTPase inhibitor activity|calcium ion binding|heparin binding|protein homodimerization activity|laminin-1 binding,complex partial epilepsy|temporal lobe epilepsy|lung small cell carcinoma|liver cancer|hepatocellular carcinoma,ppi
700,735,6586,SLIT3,slit guidance ligand 3,4,calcium ion binding,hiatus hernia|congenital diaphragmatic hernia|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
701,736,9748,SLK,STE20 like kinase,27,protein serine/threonine kinase activity|protein homodimerization activity|cadherin binding,substance abuse|substance-related disorder,ppi
702,737,6588,SLN,sarcolipin,6,enzyme inhibitor activity|ATPase binding,,ppi
703,738,25798,BRI3,brain protein I3,2,identical protein binding,,ppi
704,739,6590,SLPI,secretory leukocyte peptidase inhibitor,12,DNA binding|mRNA binding|endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity,,ppi
705,740,6591,SNAI2,snail family transcriptional repressor 2,20,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding|DNA-binding transcription factor activity|DNA binding,esophageal cancer|sensorineural hearing loss|Hirschsprung's disease|megacolon|toxic megacolon|piebaldism|breast cancer|Waardenburg's syndrome,ppi
706,741,6594,SMARCA1,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily a; member 1,47,DNA-binding transcription factor activity; RNA polymerase II-specific|annealing helicase activity|DNA-dependent ATPase activity|nucleosome-dependent ATPase activity,,ppi
707,742,6595,SMARCA2,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily a; member 2,119,transcription coactivator activity|DNA-dependent ATPase activity|transcription regulatory region DNA binding,cryptorchidism|salivary gland adenoid cystic carcinoma|epilepsy|placental insufficiency|schizophrenia|visual epilepsy|syndromic X-linked intellectual disability 94|Coffin-Siris syndrome|malignant mesothelioma|benign mesothelioma,ppi
708,743,6596,HLTF,helicase like transcription factor,55,DNA binding|RNA binding|ubiquitin protein ligase binding|ubiquitin protein ligase activity,kidney cancer,ppi
709,744,6597,SMARCA4,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily a; member 4,230,RNA polymerase I CORE element sequence-specific DNA binding|transcription coactivator activity|transcription corepressor activity|DNA-dependent ATPase activity|lysine-acetylated histone binding|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,Burkitt lymphoma|cryptorchidism|Dandy-Walker syndrome|sensorineural hearing loss|epilepsy|placental insufficiency|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|Sezary's disease|ophthalmoplegia|mechanical strabismus|hypertropia|thoracic cancer|lung small cell carcinoma|lung oat cell carcinoma,ppi
710,745,8467,SMARCA5,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily a; member 5,138,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|ATP binding|ATPase activity|histone binding,extraosseous Ewings sarcoma-primitive neuroepithelial tumor,ppi
711,746,50485,SMARCAL1,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily a like 1,10,DNA-dependent ATPase activity|annealing helicase activity,anemia|macrocytic anemia|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|astigmatism|placental insufficiency|focal segmental glomerulosclerosis|hypertension|essential hypertension|lymphopenia|myopia|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag,ppi
712,747,6598,SMARCB1,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily b; member 1,127,RNA polymerase I CORE element sequence-specific DNA binding|DNA binding|transcription coactivator activity|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|protein binding,cerebellar disease|cryptorchidism|Dandy-Walker syndrome|sensorineural hearing loss|epilepsy|placental insufficiency|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus,ppi
713,748,6599,SMARCC1,SWI/SNF related; matrix associated; actin dependent regulator of chromatin subfamily c member 1,135,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator activity|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|lung benign neoplasm,ppi
714,749,6601,SMARCC2,SWI/SNF related; matrix associated; actin dependent regulator of chromatin subfamily c member 2,160,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator activity|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,,ppi
715,750,6602,SMARCD1,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily d; member 1,118,transcription coactivator activity|protein-containing complex scaffold activity,,ppi
716,751,6603,SMARCD2,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily d; member 2,59,transcription coactivator activity|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,,ppi
717,752,6604,SMARCD3,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily d; member 3,48,transcription coactivator activity,,ppi
718,753,6605,SMARCE1,SWI/SNF related; matrix associated; actin dependent regulator of chromatin; subfamily e; member 1,132,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|transcription coactivator activity|N-acetyltransferase activity|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,cryptorchidism|salivary gland adenoid cystic carcinoma|Dandy-Walker syndrome|sensorineural hearing loss|epilepsy|placental insufficiency|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|Coffin-Siris syndrome|familial meningioma,ppi
719,754,8289,ARID1A,AT-rich interaction domain 1A,68,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription coactivator activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|urinary bladder cancer|Burkitt lymphoma|transitional cell carcinoma|cryptorchidism|salivary gland adenoid cystic carcinoma|Dandy-Walker syndrome|sensorineural hearing loss|endometrial cancer|endometrial carcinoma|epilepsy|placental insufficiency|intellectual disability|learning disability|neuroblastoma|spontaneous ocular nystagmus,ppi
720,755,8243,SMC1A,structural maintenance of chromosomes 1A,147,chromatin binding|RNA binding,generalized anxiety disorder|anxiety disorder|urinary bladder cancer|blepharitis|ptosis|congenital ptosis|cryptorchidism|salivary gland adenoid cystic carcinoma|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|sensorineural hearing loss|hypertrichosis|lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia|intellectual disability|learning disability|myopia,ppi
721,756,27127,SMC1B,structural maintenance of chromosomes 1B,7,,urinary bladder cancer,ppi
722,757,8242,KDM5C,lysine demethylase 5C,51,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding|histone demethylase activity|histone demethylase activity (H3-K4 specific)|methylated histone binding|histone demethylase activity (H3-trimethyl-K4 specific)|chromatin binding|DNA-binding transcription repressor activity; RNA polymerase II-specific,alopecia areata|autistic disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|clubfoot|cryptorchidism|enophthalmos|orbital disease|exophthalmos|epilepsy|hyperopia|myopia|visual epilepsy|syndromic X-linked intellectual disability 94|geographic tongue,ppi
723,758,8284,KDM5D,lysine demethylase 5D,2,DNA-binding transcription factor activity; RNA polymerase II-specific|histone demethylase activity|histone demethylase activity (H3-K4 specific)|androgen receptor binding|chromatin binding|histone demethylase activity (H3-trimethyl-K4 specific)|DNA-binding transcription repressor activity; RNA polymerase II-specific|methylated histone binding,azoospermia,ppi
724,759,6606,SMN1,survival of motor neuron 1; telomeric,226,,atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|progressive muscular atrophy|spinal muscular atrophy|survival motor neuron spinal muscular atrophy|juvenile spinal muscular atrophy|Werdnig-Hoffmann disease|intermediate spinal muscular atrophy|adult spinal muscular atrophy,ppi
725,761,6608,SMO,smoothened; frizzled class receptor,8,drug binding|Wnt-activated receptor activity|Wnt-protein binding|patched binding,blepharophimosis|brain cancer|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|coloboma|craniosynostosis|acute promyelocytic leukemia|maxillary neoplasm|meningioma|spinal meningioma|acoustic neuroma|intraventricular meningioma|pituitary adenoma|intraorbital meningioma|clear cell meningioma|benign meningioma|secretory meningioma|microcystic meningioma,ppi
726,762,23397,NCAPH,non-SMC condensin I complex subunit H,51,chromatin binding|DNA topoisomerase (ATP-hydrolyzing) activator activity|DNA topoisomerase binding,,ppi
727,763,6609,SMPD1,sphingomyelin phosphodiesterase 1,21,sphingomyelin phosphodiesterase activity|zinc ion binding|acid sphingomyelin phosphodiesterase activity|phosphoric diester hydrolase activity,constipation|familial hypercholesterolemia|neonatal jaundice|intellectual disability|learning disability|Niemann-Pick disease|sphingolipidosis|osteoporosis|sea-blue histiocyte syndrome|xanthomatosis|microcytic anemia|chorea-acanthocytosis|abetalipoproteinemia|hypolipoproteinemia|Tangier disease|Norum disease,ppi
728,764,6610,SMPD2,sphingomyelin phosphodiesterase 2,16,sphingomyelin phosphodiesterase activity,,ppi
729,765,23676,SMPX,small muscle protein; X-linked,2,,,ppi
730,766,6611,SMS,spermine synthase,48,spermine synthase activity,rheumatoid arthritis|bipolar disorder|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|epilepsy|intellectual disability|learning disability|osteoporosis|visual epilepsy|mood disorder|syndromic intellectual disability|syndromic X-linked intellectual disability Snyder type,ppi
731,767,6612,SUMO3,small ubiquitin-like modifier 3,437,protein tag,,ppi
732,768,6613,SUMO2,small ubiquitin-like modifier 2,1635,RNA binding|protein tag,,ppi
733,769,6525,SMTN,smoothelin,12,actin binding|structural constituent of muscle,,ppi
734,770,6614,SIGLEC1,sialic acid binding Ig like lectin 1,3,carbohydrate binding,influenza,ppi
735,771,6615,SNAI1,snail family transcriptional repressor 1,74,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,cholestasis|stomach cancer|breast cancer|amyotrophic lateral sclerosis type 1,ppi
736,773,8773,SNAP23,synaptosome associated protein 23,70,SNAP receptor activity|syntaxin binding,coronary artery disease,ppi
737,774,6616,SNAP25,synaptosome associated protein 25,43,calcium-dependent protein binding|syntaxin binding|SNAP receptor activity|syntaxin-1 binding,bipolar disorder|ptosis|congenital ptosis|cerebellar disease|pseudosarcomatous fibromatosis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetes mellitus|type 2 diabetes mellitus|schizophreniform disorder|schizoaffective disorder|tic disorder|congenital myasthenic syndrome,ppi
738,775,9342,SNAP29,synaptosome associated protein 29,74,SNAP receptor activity|syntaxin binding,cerebellar disease|sensorineural hearing loss|ichthyosis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|intellectual disability|learning disability|optic atrophy|polyneuropathy|peripheral nervous system disease|neuropathy|schizophrenia|syndromic X-linked intellectual disability 94|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8,ppi
739,776,6617,SNAPC1,small nuclear RNA activating complex polypeptide 1,14,sequence-specific DNA binding,,ppi
740,777,6618,SNAPC2,small nuclear RNA activating complex polypeptide 2,5,DNA-binding transcription factor activity,,ppi
741,778,6619,SNAPC3,small nuclear RNA activating complex polypeptide 3,10,,,ppi
742,779,6621,SNAPC4,small nuclear RNA activating complex polypeptide 4,13,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
743,780,6622,SNCA,synuclein alpha,215,magnesium ion binding|copper ion binding|calcium ion binding|phospholipid binding|ferrous iron binding|zinc ion binding|oxidoreductase activity|histone binding|identical protein binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|transcription regulatory region DNA binding|tau protein binding|phosphoprotein binding|cuprous ion binding|fatty acid binding|phospholipase D inhibitor activity,alcohol dependence|alcohol abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|Gaucher's disease|iron metabolism disease|hemochromatosis|Wilson disease|multiple system atrophy|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|Parkinson's disease|drug psychosis,ppi
744,781,9627,SNCAIP,synuclein alpha interacting protein,28,,constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|secondary Parkinson disease|Lewy body dementia|Parkinson's disease,ppi
745,782,6620,SNCB,synuclein beta,17,phospholipase inhibitor activity|calcium ion binding|transition metal ion binding|cuprous ion binding,schizophrenia|secondary Parkinson disease|Lewy body dementia,ppi
746,783,6623,SNCG,synuclein gamma,30,,breast cancer,ppi
747,784,150094,SIK1,salt inducible kinase 1,22,magnesium ion binding|protein serine/threonine kinase activity|ATP binding|cAMP response element binding protein binding|14-3-3 protein binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
748,785,6624,FSCN1,fascin actin-bundling protein 1,76,RNA binding|actin binding|drug binding|cadherin binding|actin filament binding,,ppi
749,786,8303,SNN,stannin,5,metal ion binding,,ppi
750,787,6625,SNRNP70,small nuclear ribonucleoprotein U1 subunit 70,218,RNA binding|mRNA binding,alcohol dependence|alcohol abuse,ppi
751,788,6626,SNRPA,small nuclear ribonucleoprotein polypeptide A,103,RNA binding|snRNA stem-loop binding|U1 snRNA binding,,ppi
752,789,6627,SNRPA1,small nuclear ribonucleoprotein polypeptide A',155,RNA binding|U2 snRNA binding,,ppi
753,790,6628,SNRPB,small nuclear ribonucleoprotein polypeptides B and B1,126,RNA binding,isolated cleft palate|cleft palate|placental insufficiency|ventricular septal defect|polyhydramnios|cystic kidney disease|intellectual disability|learning disability|stomach cancer|cleft soft palate|adult respiratory distress syndrome|non-congenital cyst of kidney|porencephaly,ppi
754,791,6629,SNRPB2,small nuclear ribonucleoprotein polypeptide B2,74,snRNA stem-loop binding|U1 snRNA binding,,ppi
755,792,6631,SNRPC,small nuclear ribonucleoprotein polypeptide C,82,RNA binding|single-stranded RNA binding|zinc ion binding|U1 snRNA binding|pre-mRNA 5'-splice site binding,,ppi
756,793,6632,SNRPD1,small nuclear ribonucleoprotein D1 polypeptide,146,RNA binding,,ppi
757,794,6633,SNRPD2,small nuclear ribonucleoprotein D2 polypeptide,136,RNA binding,,ppi
758,795,682,BSG,basigin (Ok blood group),143,monocarboxylic acid transmembrane transporter activity|cadherin binding|cell-cell adhesion mediator activity,schizophrenia|amyotrophic lateral sclerosis type 1,ppi
759,796,6634,SNRPD3,small nuclear ribonucleoprotein D3 polypeptide,127,RNA binding|histone pre-mRNA DCP binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
760,797,6635,SNRPE,small nuclear ribonucleoprotein polypeptide E,152,,alopecia|hypotrichosis,ppi
761,798,6636,SNRPF,small nuclear ribonucleoprotein polypeptide F,151,RNA binding,,ppi
762,799,6637,SNRPG,small nuclear ribonucleoprotein polypeptide G,115,RNA binding,,ppi
763,800,6638,SNRPN,small nuclear ribonucleoprotein polypeptide N,124,,autistic disorder|epilepsy|Zollinger-Ellison syndrome|hyperinsulinism|hyperopia|bulimia nervosa|infertility|intellectual disability|learning disability|obesity|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome,ppi
764,801,6640,SNTA1,syntrophin alpha 1,89,sodium channel regulator activity,long QT syndrome|long QT syndrome 1|status epilepticus|long QT syndrome 12,ppi
765,802,6641,SNTB1,syntrophin beta 1,19,,,ppi
766,803,6645,SNTB2,syntrophin beta 2,40,RNA binding,,ppi
767,804,8927,BSN,bassoon presynaptic cytomatrix protein,8,,heart disease|cardiovascular system disease,ppi
768,805,8926,SNURF,SNRPN upstream reading frame,13,,,ppi
769,806,6642,SNX1,sorting nexin 1,72,epidermal growth factor receptor binding|insulin receptor binding|phosphatidylinositol binding|cadherin binding|protein heterodimerization activity|transferrin receptor binding|leptin receptor binding,,ppi
770,807,6643,SNX2,sorting nexin 2,81,epidermal growth factor receptor binding|insulin receptor binding|cadherin binding|protein heterodimerization activity|transferrin receptor binding|leptin receptor binding|phosphatidylinositol binding,,ppi
771,808,8724,SNX3,sorting nexin 3,98,phosphatidylinositol-5-phosphate binding|phosphatidylinositol-3-phosphate binding|phosphatidylinositol-4-phosphate binding|phosphatidylinositol-3;5-bisphosphate binding,,ppi
772,809,8723,SNX4,sorting nexin 4,26,epidermal growth factor receptor binding|insulin receptor binding|phosphatidylinositol binding|transferrin receptor binding|leptin receptor binding,,ppi
773,810,6646,SOAT1,sterol O-acyltransferase 1,51,fatty-acyl-CoA binding|sterol O-acyltransferase activity|cholesterol binding|cholesterol O-acyltransferase activity,,ppi
774,811,8435,SOAT2,sterol O-acyltransferase 2,4,fatty-acyl-CoA binding|cholesterol binding|transferase activity; transferring acyl groups|cholesterol O-acyltransferase activity,,ppi
775,812,6647,SOD1,superoxide dismutase 1; soluble,170,superoxide dismutase activity|copper ion binding|zinc ion binding|protein phosphatase 2B binding|protein homodimerization activity|Rac GTPase binding|superoxide dismutase copper chaperone activity,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|aortic disease|asphyxia neonatorum|asthma|intrinsic asthma|allergic asthma|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|bipolar disorder|brain ischemia|vertebrobasilar insufficiency|transient cerebral ischemia|neurotic disorder|major depressive disorder,ppi
776,813,683,BST1,bone marrow stromal cell antigen 1,2,NAD+ nucleosidase activity|ADP-ribosyl cyclase activity|cyclic ADP-ribose hydrolase|phosphorus-oxygen lyase activity,lung disease|Parkinson's disease,ppi
777,814,6648,SOD2,superoxide dismutase 2; mitochondrial,80,superoxide dismutase activity|manganese ion binding|metal ion binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|proteinuria|farmer's lung|extrinsic allergic alveolitis|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease,ppi
778,815,6649,SOD3,superoxide dismutase 3; extracellular,2,superoxide dismutase activity|superoxide dismutase copper chaperone activity|copper ion binding|zinc ion binding,contact dermatitis|occupational dermatitis|congestive heart failure|hypertension|essential hypertension|chronic obstructive pulmonary disease|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis,ppi
779,816,6650,CAPN15,calpain 15,9,DNA-binding transcription factor activity|peptidase activity|cysteine-type peptidase activity|calcium-dependent cysteine-type endopeptidase activity,,ppi
780,817,6651,SON,SON DNA binding protein,81,RNA binding,salivary gland adenoid cystic carcinoma,ppi
781,818,6652,SORD,sorbitol dehydrogenase,56,L-iditol 2-dehydrogenase activity|zinc ion binding|carbohydrate binding|D-xylulose reductase activity|NAD binding,perinatal necrotizing enterocolitis,ppi
782,819,6653,SORL1,sortilin related receptor 1,52,amyloid-beta binding|transmembrane signaling receptor activity|low-density lipoprotein particle receptor activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|cholestasis,ppi
783,820,6272,SORT1,sortilin 1,135,nerve growth factor receptor activity|neurotensin receptor activity; non-G-protein coupled,heart disease|cardiovascular system disease|coronary artery disease,ppi
784,821,6654,SOS1,SOS Ras/Rac guanine nucleotide exchange factor 1,69,guanyl-nucleotide exchange factor activity|Ras guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|GTPase activator activity,sick sinus syndrome|ptosis|congenital ptosis|blood coagulation disease|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cryptorchidism|enophthalmos|orbital disease|exophthalmos|gingival overgrowth|gingival hypertrophy|ventricular septal defect|hemorrhagic disease|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome,ppi
785,822,6655,SOS2,SOS Ras/Rho guanine nucleotide exchange factor 2,26,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,sick sinus syndrome|ptosis|congenital ptosis|blood coagulation disease|cryptorchidism|enophthalmos|orbital disease|exophthalmos|heart septal defect|hemorrhagic disease|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome,ppi
786,823,6656,SOX1,SRY-box 1,3,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
787,824,684,BST2,bone marrow stromal cell antigen 2,14,RNA binding|metalloendopeptidase inhibitor activity,,ppi
788,825,6663,SOX10,SRY-box 10,31,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|DNA-binding transcription activator activity; RNA polymerase II-specific,cerebellar disease|constipation|cryptorchidism|sensorineural hearing loss|epilepsy|Hirschsprung's disease|hypogonadism|intestinal obstruction|ileus|megacolon|toxic megacolon|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|polyneuropathy|peripheral nervous system disease|neuropathy,ppi
789,826,6664,SOX11,SRY-box 11,4,transcription regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|enhancer sequence-specific DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|translation factor activity; RNA binding,cryptorchidism|salivary gland adenoid cystic carcinoma|Dandy-Walker syndrome|sensorineural hearing loss|epilepsy|placental insufficiency|hypertrichosis|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|Coffin-Siris syndrome,ppi
790,827,9580,SOX13,SRY-box 13,8,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
791,828,8403,SOX14,SRY-box 14,3,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
792,829,54345,SOX18,SRY-box 18,5,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|transcription regulatory region DNA binding,alopecia|membranoproliferative glomerulonephritis|hypotrichosis|lymphatic system disease|elephantiasis|lymphedema|nail disease|seborrheic keratosis|skin disease|actinic keratosis|chronic kidney disease,ppi
793,830,6657,SOX2,SRY-box 2,354,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|miRNA binding|sequence-specific DNA binding|transcription regulatory region DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,tongue squamous cell carcinoma|squamous cell carcinoma|isolated cleft palate|cleft palate|coloboma|cryptorchidism|sensorineural hearing loss|patent ductus arteriosus|epilepsy|esophageal atresia|ventricular septal defect|spastic diplegia|spastic monoplegia|spastic quadriplegia|cerebral palsy|lung benign neoplasm|microphthalmia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus,ppi
794,831,6665,SOX15,SRY-box 15,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,polycystic ovary syndrome,ppi
795,832,11166,SOX21,SRY-box 21,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
796,833,6666,SOX12,SRY-box 12,3,transcription regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|transcription coactivator activity,,ppi
797,834,6658,SOX3,SRY-box 3,3,RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription corepressor activity,isolated cleft palate|cleft palate|cryptorchidism|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|epilepsy|hypoglycemia|congenital hypothyroidism|myxedema|hypothyroidism|infertility|spontaneous ocular nystagmus|dissociated nystagmus,ppi
798,835,53339,BTBD1,BTB domain containing 1,53,,,ppi
799,836,6659,SOX4,SRY-box 4,27,transcription regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity,salivary gland adenoid cystic carcinoma,ppi
800,837,6660,SOX5,SRY-box 5,35,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,generalized anxiety disorder|anxiety disorder|atrial fibrillation|alternating exotropia|exotropia|monocular exotropia|intellectual disability|learning disability|myopia|optic atrophy|schizophrenia|autistic disorder,ppi
801,838,30812,SOX8,SRY-box 8,19,RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific,polyneuropathy|peripheral nervous system disease|neuropathy,ppi
802,839,6662,SOX9,SRY-box 9,21,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|enhancer sequence-specific DNA binding|chromatin binding|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|protein kinase activity|enhancer binding|DNA-binding transcription activator activity; RNA polymerase II-specific,azoospermia|blepharophimosis|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|sensorineural hearing loss|dysgerminoma|enophthalmos|orbital disease|exophthalmos|gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|hypertrophy of breast|infant gynecomastia|gynecomastia|congenital heart disease|polyhydramnios|hydrocephalus,ppi
803,840,6667,SP1,Sp1 transcription factor,272,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II repressing transcription factor binding|DNA binding|double-stranded DNA binding|DNA-binding transcription factor activity|protein homodimerization activity|bHLH transcription factor binding|sequence-specific DNA binding|transcription regulatory region DNA binding,hyperglycemia|schizophreniform disorder|schizoaffective disorder|schizophrenia|skin benign neoplasm|skin cancer,ppi
804,841,6672,SP100,SP100 nuclear antigen,59,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator activity|transcription corepressor activity,,ppi
805,842,6668,SP2,Sp2 transcription factor,12,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
806,843,6670,SP3,Sp3 transcription factor,39,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding,schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
807,844,6671,SP4,Sp4 transcription factor,19,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding,bipolar disorder|schizophrenia,ppi
808,845,685,BTC,betacellulin,8,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|growth factor activity|epidermal growth factor receptor binding,schizophrenia|erythropoietic protoporphyria|cutaneous porphyria,ppi
809,846,53340,SPA17,sperm autoantigenic protein 17,14,calmodulin binding,,ppi
810,847,6674,SPAG1,sperm associated antigen 1,8,,bronchiectasis|bronchitis|Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|rhinitis|sinusitis|tuberous sclerosis|Marfan syndrome|situs inversus,ppi
811,848,6676,SPAG4,sperm associated antigen 4,3,structural molecule activity|protein membrane anchor,,ppi
812,849,9576,SPAG6,sperm associated antigen 6,3,,,ppi
813,850,9552,SPAG7,sperm associated antigen 7,7,,,ppi
814,852,30014,SPANXA1,sperm protein associated with the nucleus; X-linked; family member A1,4,,,ppi
815,853,6678,SPARC,secreted protein acidic and cysteine rich,23,calcium ion binding|collagen binding|extracellular matrix binding,colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|acute myeloid leukemia|liver cirrhosis|multiple myeloma|osteogenesis imperfecta|Ehlers-Danlos syndrome|osteogenesis imperfecta type 1|osteogenesis imperfecta with opalescent teeth; blue sclerae and wormian bones but without fractures|osteogenesis imperfecta type 8|osteogenesis imperfecta type 7|osteogenesis imperfecta type 17|osteogenesis imperfecta type 3,ppi
816,854,686,BTD,biotinidase,12,biotinidase activity,alopecia|autistic disorder|cerebellar disease|conjunctivitis|sensorineural hearing loss|epilepsy|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|exanthem|keratitis|keratoconjunctivitis|optic atrophy|acrodermatitis|seborrheic keratosis|seborrheic infantile dermatitis|seborrheic dermatitis|visual epilepsy|biotinidase deficiency|urea cycle disorder|dentatorubral-pallidoluysian atrophy,ppi
817,855,8404,SPARCL1,SPARC like 1,11,calcium ion binding|collagen binding|extracellular matrix binding,endometriosis of uterus|endometriosis|epilepsy,ppi
818,856,80208,SPG11,spastic paraplegia 11 (autosomal recessive),5,,hereditary spastic paraplegia 11|Charcot-Marie-Tooth disease axonal type 2X,ppi
819,857,687,KLF9,Kruppel like factor 9,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,endometriosis of uterus|endometriosis|goiter|thyroid gland disease,ppi
820,858,51062,ATL1,atlastin GTPase 1,4,GTPase activity|GTP binding|identical protein binding,hereditary sensory neuropathy|sensory peripheral neuropathy|paraplegia|axonal neuropathy|hereditary spastic paraplegia 3A,ppi
821,859,6683,SPAST,spastin,23,microtubule binding|microtubule-severing ATPase activity|protein-containing complex binding|beta-tubulin binding|ATPase activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|paraplegia|amnestic disorder|retrograde amnesia|hereditary spastic paraplegia 4,ppi
822,860,6687,SPG7,SPG7; paraplegin matrix AAA peptidase subunit,54,metalloendopeptidase activity|peptidase activity|unfolded protein binding,spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|paraplegia|anterior horn cell disease|lateral sclerosis|motor neuron disease|amnestic disorder|retrograde amnesia|cerebral degeneration|hereditary spastic paraplegia 7,ppi
823,861,8877,SPHK1,sphingosine kinase 1,65,magnesium ion binding|DNA binding|calmodulin binding|ATP binding|sphinganine kinase activity|D-erythro-sphingosine kinase activity|sphingosine-1-phosphate receptor activity,inflammatory bowel disease|ulcerative colitis|leukemia|essential thrombocythemia|myelodysplastic syndrome,ppi
824,862,6688,SPI1,Spi-1 proto-oncogene,52,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II transcription factor binding|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|NFAT protein binding,acute myeloid leukemia|lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia,ppi
825,863,6689,SPIB,Spi-B transcription factor,19,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific,primary biliary cirrhosis|portal hypertension|multiple system atrophy|liver cirrhosis|goiter|thyroid gland disease|dermatographia|liver cancer|hepatocellular carcinoma,ppi
826,864,10927,SPIN1,spindlin 1,39,methylated histone binding,,ppi
827,865,6690,SPINK1,serine peptidase inhibitor; Kazal type 1,5,endopeptidase inhibitor activity,diabetic ketoacidosis|diabetes mellitus|pancreatic cancer|acute pancreatitis|pancreatitis|prostate cancer|prostate carcinoma|steatorrhea|exocrine pancreatic insufficiency|pancreatic carcinoma,ppi
828,866,6691,SPINK2,serine peptidase inhibitor; Kazal type 2,26,endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity,,ppi
829,867,6692,SPINT1,serine peptidase inhibitor; Kunitz type 1,6,,,ppi
830,868,10653,SPINT2,serine peptidase inhibitor; Kunitz type 2,108,endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity,choanal atresia|polyhydramnios|placenta disease|congenital secretory sodium diarrhea 8|congenital secretory sodium diarrhea 3,ppi
831,869,10816,SPINT3,serine peptidase inhibitor; Kunitz type 3,1,transforming growth factor beta binding|receptor antagonist activity,,ppi
832,870,6693,SPN,sialophorin,17,,calcium metabolism disease|nephrocalcinosis|calcinosis|heart valve disease,ppi
833,871,689,BTF3,basic transcription factor 3,50,RNA binding|protein binding,,ppi
834,873,6695,SPOCK1,SPARC/osteonectin; cwcv and kazal like domains proteoglycan 1,6,serine-type endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity|calcium ion binding|metalloendopeptidase inhibitor activity|collagen binding|extracellular matrix binding,prostate cancer|prostate carcinoma,ppi
835,874,10418,SPON1,spondin 1,3,extracellular matrix structural constituent,,ppi
836,875,10417,SPON2,spondin 2,1,,prostate cancer|prostate carcinoma,ppi
837,876,8405,SPOP,speckle type BTB/POZ protein,48,ubiquitin protein ligase binding,endometrial cancer|endometrial carcinoma|prostate cancer|prostate carcinoma,ppi
838,877,6696,SPP1,secreted phosphoprotein 1,93,extracellular matrix binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|asbestosis|anthracosilicosis|byssinosis|brain cancer|calcium metabolism disease|nephrocalcinosis|calcinosis|malignant glioma|gliosarcoma|mixed glioma|focal segmental glomerulosclerosis|heart disease|cardiovascular system disease|heart valve disease|allergic hypersensitivity disease,ppi
839,878,6694,SPP2,secreted phosphoprotein 2,1,endopeptidase inhibitor activity,,ppi
840,879,6697,SPR,sepiapterin reductase (7;8-dihydrobiopterin:NADP+ oxidoreductase),50,aldo-keto reductase (NADP) activity|sepiapterin reductase activity|NADP binding,bipolar disorder|cerebellar disease|dystonia|epilepsy|intellectual disability|learning disability|visual epilepsy|basal ganglia disease|focal hand dystonia|blepharospasm|mood disorder,ppi
841,880,6698,SPRR1A,small proline rich protein 1A,5,structural molecule activity|structural constituent of epidermis|protein binding; bridging,tongue squamous cell carcinoma|squamous cell carcinoma|squamous cell papilloma|papilloma,ppi
842,881,6699,SPRR1B,small proline rich protein 1B,8,structural molecule activity|protein binding; bridging,,ppi
843,882,6700,SPRR2A,small proline rich protein 2A,14,structural molecule activity,stomach cancer,ppi
844,884,6703,SPRR2D,small proline rich protein 2D,4,structural molecule activity,,ppi
845,885,6704,SPRR2E,small proline rich protein 2E,6,structural molecule activity|structural constituent of epidermis,,ppi
846,887,6706,SPRR2G,small proline rich protein 2G,2,,,ppi
847,888,6707,SPRR3,small proline rich protein 3,11,structural molecule activity,,ppi
848,889,10252,SPRY1,sprouty RTK signaling antagonist 1,37,,,ppi
849,890,10253,SPRY2,sprouty RTK signaling antagonist 2,123,protein serine/threonine kinase inhibitor activity|protein serine/threonine kinase activator activity,cleft lip|isolated cleft palate|cleft palate|lung disease|lung benign neoplasm,ppi
850,891,10251,SPRY3,sprouty RTK signaling antagonist 3,1,,,ppi
851,892,6708,SPTA1,spectrin alpha; erythrocytic 1,30,Ras guanyl-nucleotide exchange factor activity|structural constituent of cytoskeleton|actin filament binding,hemolytic anemia|favism|hereditary elliptocytosis|congenital hemolytic anemia|hereditary spherocytosis,ppi
852,893,6709,SPTAN1,spectrin alpha; non-erythrocytic 1,202,Ras guanyl-nucleotide exchange factor activity|structural constituent of cytoskeleton|cadherin binding,epilepsy|visual epilepsy|syndromic X-linked intellectual disability 94|infantile epileptic encephalopathy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|locked-in syndrome|quadriplegia|neurodegenerative disease|Ohtahara syndrome,ppi
853,894,6710,SPTB,spectrin beta; erythrocytic,30,actin binding|Ras guanyl-nucleotide exchange factor activity|actin filament binding,hemolytic anemia|fetal erythroblastosis|neonatal anemia|favism|hereditary elliptocytosis|congenital hemolytic anemia|hereditary spherocytosis,ppi
854,895,6711,SPTBN1,spectrin beta; non-erythrocytic 1,154,RNA binding|Ras guanyl-nucleotide exchange factor activity|structural constituent of cytoskeleton|ankyrin binding|cadherin binding,,ppi
855,896,6712,SPTBN2,spectrin beta; non-erythrocytic 2,40,Ras guanyl-nucleotide exchange factor activity|structural constituent of cytoskeleton|cadherin binding,schizophrenia|autosomal dominant cerebellar ataxia|facial nerve disease|geniculate ganglionitis|agnosia|spinocerebellar ataxia type 5|autosomal recessive spinocerebellar ataxia 14,ppi
856,897,10558,SPTLC1,serine palmitoyltransferase long chain base subunit 1,27,serine C-palmitoyltransferase activity,sensorineural hearing loss|hereditary sensory neuropathy|sensory peripheral neuropathy|skin disease|seborrheic keratosis|actinic keratosis|muscular atrophy,ppi
857,898,9517,SPTLC2,serine palmitoyltransferase long chain base subunit 2,16,serine C-palmitoyltransferase activity,hypohidrosis|anhidrosis|hereditary sensory neuropathy|sensory peripheral neuropathy|chronic ulcer of skin,ppi
858,899,6713,SQLE,squalene epoxidase,14,squalene monooxygenase activity,,ppi
859,900,8878,SQSTM1,sequestosome 1,303,protein serine/threonine kinase activity|protein kinase binding|receptor tyrosine kinase binding|ubiquitin protein ligase binding|ionotropic glutamate receptor binding|SH2 domain binding|ubiquitin binding|K63-linked polyubiquitin modification-dependent protein binding|protein kinase C binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|echolalia|congenital hypothyroidism|myxedema|hypothyroidism|communication disorder|language disorder|mutism|Paget's disease of bone|stereotypic movement disorder|cranial nerve palsy,ppi
860,901,10011,SRA1,steroid receptor RNA activator 1,44,steroid receptor RNA activator RNA binding|transcription coactivator activity|nuclear receptor transcription coactivator activity,cryptorchidism|hypertrophy of breast|infant gynecomastia|gynecomastia|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|hypogonadism,ppi
861,902,6714,SRC,SRC proto-oncogene; non-receptor tyrosine kinase,513,protein kinase activity|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|SH3/SH2 adaptor activity|integrin binding|kinase activity|heme binding|cadherin binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|growth factor receptor binding|signaling receptor binding,urinary bladder cancer|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|colitis|ileitis|ileocolitis|gastroenteritis|colon cancer|colonic benign neoplasm|status epilepticus|stomach cancer|autosomal recessive polycystic kidney disease|bladder urothelial carcinoma|uterus leiomyosarcoma|breast cancer,ppi
862,903,6715,SRD5A1,steroid 5 alpha-reductase 1,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity|electron transfer activity|oxidoreductase activity,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometriosis of uterus|endometriosis|polycystic ovary syndrome|prostate cancer|prostate carcinoma,ppi
863,905,6720,SREBF1,sterol regulatory element binding transcription factor 1,64,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|nuclear receptor activity|sterol response element binding,fatty liver disease|chronic kidney disease|obesity|schizophrenia|liver cancer|hepatocellular carcinoma,ppi
864,906,6721,SREBF2,sterol regulatory element binding transcription factor 2,85,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|E-box binding|C-8 sterol isomerase activity,chronic kidney disease|schizophrenia|stomach cancer|liver cancer|hepatocellular carcinoma,ppi
865,907,6722,SRF,serum response factor,81,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|serum response element binding|primary miRNA binding|transcription factor activity; RNA polymerase II core promoter sequence-specific DNA binding|sequence-specific DNA binding|transcription regulatory region DNA binding|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|transcription factor binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
866,908,6717,SRI,sorcin,39,signaling receptor binding|calcium channel regulator activity|calcium ion binding|ion channel binding,,ppi
867,910,6723,SRM,spermidine synthase,29,spermidine synthase activity|protein homodimerization activity,,ppi
868,911,6725,SRMS,src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites,3,protein tyrosine kinase activity|signaling receptor binding|non-membrane spanning protein tyrosine kinase activity,liver cancer,ppi
869,912,6727,SRP14,signal recognition particle 14,98,RNA binding,,ppi
870,913,694,BTG1,BTG anti-proliferation factor 1,21,transcription coregulator activity|kinase binding,multiple myeloma|schizophrenia,ppi
871,914,6728,SRP19,signal recognition particle 19,23,RNA binding|7S RNA binding|ribosome binding,,ppi
872,915,6729,SRP54,signal recognition particle 54,35,RNA binding|GTP binding|drug binding|7S RNA binding|GDP binding|endoplasmic reticulum signal peptide binding|ribonucleoprotein complex binding|GTPase activity,,ppi
873,916,6730,SRP68,signal recognition particle 68,60,RNA binding|7S RNA binding|ribosome binding|signal recognition particle binding,seborrheic keratosis|skin disease|actinic keratosis,ppi
874,917,6731,SRP72,signal recognition particle 72,61,RNA binding|7S RNA binding|ribosome binding,aplastic anemia|cholestasis|sensorineural hearing loss|essential thrombocythemia|myelodysplastic syndrome,ppi
875,919,6732,SRPK1,SRSF protein kinase 1,265,magnesium ion binding|RNA binding|protein kinase activity|protein serine/threonine kinase activity|ATP binding,,ppi
876,920,6733,SRPK2,SRSF protein kinase 2,464,magnesium ion binding|RNA binding|protein serine/threonine kinase activity|ATP binding|14-3-3 protein binding,,ppi
877,921,6734,SRPRA,SRP receptor alpha subunit,49,RNA binding|signal recognition particle binding|GTPase activity,,ppi
878,922,8406,SRPX,sushi repeat containing protein; X-linked,5,,,ppi
879,923,7832,BTG2,BTG anti-proliferation factor 2,22,,liver cancer|hepatocellular carcinoma,ppi
880,924,6736,SRY,sex determining region Y,9,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,azoospermia|cryptorchidism|gonadal dysgenesis|Turner syndrome|46 XY gonadal dysgenesis|mixed gonadal dysgenesis|hypertrophy of breast|infant gynecomastia|gynecomastia|male infertility|osteoporosis|polycystic ovary syndrome|hypogonadism|premature menopause|androgen insensitivity syndrome|eunuchism|hermaphroditism|sex differentiation disease|pseudohermaphroditism|isolated growth hormone deficiency,ppi
881,925,6737,TRIM21,tripartite motif containing 21,95,ubiquitin-protein transferase activity,,ppi
882,926,6738,TROVE2,TROVE domain family member 2,41,RNA binding,,ppi
883,927,6741,SSB,Sjogren syndrome antigen B,118,tRNA binding|RNA binding|mRNA binding|poly(U) RNA binding|sequence-specific mRNA binding|protein homodimerization activity,,ppi
884,928,6742,SSBP1,single stranded DNA binding protein 1,103,chromatin binding|RNA binding|single-stranded DNA binding,seborrheic keratosis|skin disease|actinic keratosis,ppi
885,929,6744,SSFA2,sperm specific antigen 2,53,actin filament binding,,ppi
886,930,10950,BTG3,BTG anti-proliferation factor 3,14,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
887,931,10006,ABI1,abl interactor 1,109,cytoskeletal protein binding|protein-containing complex binding|cadherin binding|SH3 domain binding|transcription factor binding|protein binding|protein tyrosine kinase activator activity,,ppi
888,932,8636,SSNA1,SS nuclear autoantigen 1,21,,,ppi
889,933,8082,SSPN,sarcospan,1,,,ppi
890,934,6745,SSR1,signal sequence receptor subunit 1,85,,,ppi
891,935,6746,SSR2,signal sequence receptor subunit 2,6,,prostate cancer|prostate carcinoma,ppi
892,936,6747,SSR3,signal sequence receptor subunit 3,65,,,ppi
893,937,6748,SSR4,signal sequence receptor subunit 4,104,,enophthalmos|orbital disease|exophthalmos|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|intellectual disability|learning disability|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|congenital disorder of glycosylation type I,ppi
894,938,6749,SSRP1,structure specific recognition protein 1,143,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding,,ppi
895,939,10534,SSSCA1,Sjogren syndrome/scleroderma autoantigen 1,170,,,ppi
896,940,6750,SST,somatostatin,6,hormone activity,Barrett's esophagus|bipolar disorder|VIPoma|pancreatic cholera|endometriosis of uterus|endometriosis|esophageal cancer|hypokalemia|ischemia|pancreatic cancer|acute pancreatitis|pancreatitis|schizophreniform disorder|schizoaffective disorder|schizophrenia|epilepsy|visual epilepsy|neurotic disorder|endogenous depression|melancholia,ppi
897,941,695,BTK,Bruton tyrosine kinase,112,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|ATP binding|phosphatidylinositol-3;4;5-trisphosphate binding,agammaglobulinemia|arthropathy|arthritis|septic arthritis|cellulitis|conjunctivitis|sensorineural hearing loss|myelitis|encephalomyelitis|encephalitis|epididymitis|exanthem|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|primary immunodeficiency disease|meningitis|otitis media|lower respiratory tract disease|paranasal sinus disease,ppi
898,942,6751,SSTR1,somatostatin receptor 1,5,somatostatin receptor activity|G-protein coupled receptor activity|neuropeptide binding,pancreatic cancer|status epilepticus|neuroendocrine tumor,ppi
899,943,6752,SSTR2,somatostatin receptor 2,11,somatostatin receptor activity|neuropeptide binding|G-protein coupled receptor activity,pancreatic cancer|epilepsy|visual epilepsy|status epilepticus|neuroendocrine tumor,ppi
900,944,6753,SSTR3,somatostatin receptor 3,17,neuropeptide binding|G-protein coupled receptor activity,pancreatic cancer|status epilepticus|neuroendocrine tumor|mood disorder,ppi
901,945,6754,SSTR4,somatostatin receptor 4,3,neuropeptide binding|G-protein coupled receptor activity|somatostatin receptor activity,status epilepticus,ppi
902,946,6755,SSTR5,somatostatin receptor 5,8,somatostatin receptor activity|G-protein coupled receptor activity|neuropeptide binding,bipolar disorder|status epilepticus|neurotic disorder|endogenous depression|melancholia|growth hormone secreting pituitary adenoma|major depressive disorder|mental depression,ppi
903,947,6756,SSX1,SSX family member 1,3,transcription corepressor activity,synovial sarcoma,ppi
904,948,6757,SSX2,SSX family member 2,31,,prostate cancer|prostate carcinoma|synovial sarcoma,ppi
905,949,10214,SSX3,SSX family member 3,20,,,ppi
906,951,6758,SSX5,SSX family member 5,5,,,ppi
907,952,6760,SS18,SS18; nBAF chromatin remodeling complex subunit,53,nuclear receptor transcription coactivator activity,synovial sarcoma,ppi
908,953,6767,ST13,suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein),59,protein binding; bridging,,ppi
909,954,6768,ST14,suppression of tumorigenicity 14,20,endopeptidase activity|serine-type peptidase activity,hypotrichosis|ichthyosis|prostate cancer|prostate carcinoma|Netherton syndrome|autosomal recessive congenital ichthyosis 11,ppi
910,955,8434,RECK,reversion inducing cysteine rich protein with kazal motifs,18,endopeptidase inhibitor activity,lung cancer|non-small cell lung carcinoma|cocaine abuse|cocaine dependence|colon cancer|colonic benign neoplasm|glioblastoma multiforme|giant cell glioblastoma,ppi
911,956,11009,IL24,interleukin 24,25,,lung benign neoplasm|pancreatic cancer|prostate cancer|prostate carcinoma|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression|breast cancer,ppi
912,957,696,BTN1A1,butyrophilin subfamily 1 member A1,5,signaling receptor activity|signaling receptor binding,,ppi
913,958,6764,ST5,suppression of tumorigenicity 5,10,Rab guanyl-nucleotide exchange factor activity,,ppi
914,959,7982,ST7,suppression of tumorigenicity 7,28,,,ppi
915,960,6769,STAC,SH3 and cysteine rich domain,18,,allergic contact dermatitis,ppi
916,961,10274,STAG1,stromal antigen 1,33,,,ppi
917,962,10735,STAG2,stromal antigen 2,47,,urinary bladder cancer|transitional cell carcinoma|lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia|Down syndrome,ppi
918,963,10734,STAG3,stromal antigen 3,2,,premature menopause|androgen insensitivity syndrome,ppi
919,964,8027,STAM,signal transducing adaptor molecule,70,SH3/SH2 adaptor activity,,ppi
920,965,10254,STAM2,signal transducing adaptor molecule 2,62,,,ppi
921,966,6770,STAR,steroidogenic acute regulatory protein,6,cholesterol binding,endometrial cancer|endometrial carcinoma|polycystic ovary syndrome|congenital adrenal hyperplasia,ppi
922,967,11120,BTN2A1,butyrophilin subfamily 2 member A1,35,signaling receptor binding,,ppi
923,968,6772,STAT1,signal transducer and activator of transcription 1,200,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|transcription factor activity; RNA polymerase II core promoter sequence-specific DNA binding|double-stranded DNA binding|DNA-binding transcription factor activity|protein homodimerization activity|cadherin binding|promoter-specific chromatin binding,fetal erythroblastosis|autoimmune hemolytic anemia|rheumatoid arthritis|bronchiectasis|chronic mucocutaneous candidiasis|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17,ppi
924,969,6773,STAT2,signal transducer and activator of transcription 2,49,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
925,970,6774,STAT3,signal transducer and activator of transcription 3,295,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|nuclear receptor activity|protein kinase binding|chromatin DNA binding|protein homodimerization activity|transcription regulatory region DNA binding|protein dimerization activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|celiac disease|brain ischemia|cervical cancer|isolated cleft palate,ppi
926,971,6775,STAT4,signal transducer and activator of transcription 4,20,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,agnosia|arthropathy|arthritis|rheumatoid arthritis|Behcet's disease|uveitis|anterior uveitis|ciliary body disease|primary biliary cirrhosis|systemic lupus erythematosus|meningitis|multiple sclerosis|orchitis|systemic scleroderma|scleroderma|aphthous stomatitis|vasculitis|thrombophilia|asthenopia|migraine,ppi
927,972,6776,STAT5A,signal transducer and activator of transcription 5A,107,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|protein tyrosine kinase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|carcinoma|lung benign neoplasm|coronary artery disease|invasive lobular carcinoma|breast ductal carcinoma|breast cancer,ppi
928,973,6777,STAT5B,signal transducer and activator of transcription 5B,81,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|DNA-binding transcription factor activity|protein tyrosine kinase activity|protein dimerization activity,achondroplasia|Laron syndrome|acute promyelocytic leukemia|cutaneous T cell lymphoma,ppi
929,974,6778,STAT6,signal transducer and activator of transcription 6,76,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,atopic dermatitis|congestive heart failure|head and neck cancer|hemangiopericytoma,ppi
930,975,6779,STATH,statherin,7,extracellular matrix constituent; lubricant activity|structural constituent of tooth enamel|hydroxyapatite binding,autistic disorder,ppi
931,976,10385,BTN2A2,butyrophilin subfamily 2 member A2,21,signaling receptor binding,,ppi
932,977,6780,STAU1,staufen double-stranded RNA binding protein 1,351,RNA binding,,ppi
933,978,27067,STAU2,staufen double-stranded RNA binding protein 2,49,RNA binding|double-stranded RNA binding,,ppi
934,980,8614,STC2,stanniocalcin 2,16,enzyme binding|heme binding|protein homodimerization activity,endometriosis of uterus|endometriosis|fatty liver disease|breast cancer,ppi
935,981,6782,HSPA13,heat shock protein family A (Hsp70) member 13,13,ATPase activity; coupled|ATPase activity|heat shock protein binding|ATP binding|protein binding involved in protein folding|unfolded protein binding|misfolded protein binding,,ppi
936,982,6783,SULT1E1,sulfotransferase family 1E member 1,16,aryl sulfotransferase activity|estrone sulfotransferase activity|sulfotransferase activity|flavonol 3-sulfotransferase activity|steroid sulfotransferase activity,gallbladder disease|liver disease|prostate cancer|prostate carcinoma,ppi
937,984,11119,BTN3A1,butyrophilin subfamily 3 member A1,3,signaling receptor binding,,ppi
938,985,6786,STIM1,stromal interaction molecule 1,35,calcium channel regulator activity|calcium ion binding|microtubule plus-end binding,anemia|macrocytic anemia|fetal erythroblastosis|autoimmune hemolytic anemia|blood coagulation disease|enophthalmos|orbital disease|exophthalmos|hemorrhagic disease|hypertension|essential hypertension|ichthyosis|primary immunodeficiency disease|familial periodic paralysis|myopathy|purpura|speech disorder|qualitative platelet defect|Glanzmann's thrombasthenia|thrombocytopenia,ppi
939,986,10963,STIP1,stress induced phosphoprotein 1,213,RNA binding|Hsp90 protein binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|melanoma|skin melanoma,ppi
940,987,6793,STK10,serine/threonine kinase 10,8,protein serine/threonine kinase activity|protein homodimerization activity,testicular cancer|seminoma|testicular germ cell cancer,ppi
941,988,6794,STK11,serine/threonine kinase 11,125,magnesium ion binding|p53 binding|protein serine/threonine kinase activity|ATP binding|protein kinase activator activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|obstructive jaundice|biliary tract disease|tongue squamous cell carcinoma|squamous cell carcinoma|secondary hypertrophic osteoarthropathy|cryptorchidism|gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|hypertrophy of breast|infant gynecomastia|gynecomastia|hypertension|essential hypertension|intussusception,ppi
942,989,11118,BTN3A2,butyrophilin subfamily 3 member A2,6,signaling receptor binding,,ppi
943,990,9212,AURKB,aurora kinase B,172,protein serine/threonine kinase activity|protein serine/threonine/tyrosine kinase activity|histone serine kinase activity,IgA glomerulonephritis|stomach cancer,ppi
944,991,6795,AURKC,aurora kinase C,24,protein kinase activity|protein serine/threonine/tyrosine kinase activity|histone serine kinase activity,male infertility|azoospermia,ppi
945,992,6790,AURKA,aurora kinase A,346,protein kinase activity|protein serine/threonine kinase activity|protein serine/threonine/tyrosine kinase activity|histone serine kinase activity,large intestine cancer|colorectal cancer|kidney cancer|melanoma|skin melanoma|neuroblastoma|polyneuropathy|peripheral nervous system disease|neuropathy|prostate cancer|prostate carcinoma|breast cancer,ppi
946,993,8576,STK16,serine/threonine kinase 16,71,,,ppi
947,995,9262,STK17B,serine/threonine kinase 17b,23,protein kinase activity|protein serine/threonine kinase activity|ATP binding,,ppi
948,996,10733,PLK4,polo like kinase 4,57,protein serine/threonine kinase activity,craniosynostosis|achondroplasia|Laron syndrome|placental insufficiency|glaucoma|intellectual disability|learning disability|microcephaly|microphthalmia|blindness|cataract|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome,ppi
949,997,8859,STK19,serine/threonine kinase 19,9,,basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma,ppi
950,998,6787,NEK4,NIMA related kinase 4,28,protein serine/threonine kinase activity|manganese ion binding,bipolar disorder,ppi
951,999,10384,BTN3A3,butyrophilin subfamily 3 member A3,5,signaling receptor binding,,ppi
952,1000,23617,TSSK2,testis specific serine kinase 2,10,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
953,1001,26576,SRPK3,SRSF protein kinase 3,64,protein serine/threonine kinase activity,,ppi
954,1002,8428,STK24,serine/threonine kinase 24,206,protein kinase activity|protein serine/threonine kinase activity|cadherin binding,,ppi
955,1003,10494,STK25,serine/threonine kinase 25,189,protein kinase activity|protein homodimerization activity|protein serine/threonine kinase activity,,ppi
956,1004,9024,BRSK2,BR serine/threonine kinase 2,8,magnesium ion binding|protein serine/threonine kinase activity|ATP binding|tau-protein kinase activity|ATPase binding|ATPase regulator activity,,ppi
957,1005,6788,STK3,serine/threonine kinase 3,161,magnesium ion binding|protein kinase activity|protein serine/threonine kinase activity|ATP binding|protein serine/threonine kinase activator activity|protein dimerization activity,,ppi
958,1006,56164,STK31,serine/threonine kinase 31,5,nuclease activity,,ppi
959,1007,6789,STK4,serine/threonine kinase 4,290,magnesium ion binding|protein kinase activity|protein serine/threonine kinase activity|ATP binding|protein homodimerization activity|protein serine/threonine kinase activator activity|protein dimerization activity,atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|primary immunodeficiency disease|lymphopenia|common wart,ppi
960,1008,6792,CDKL5,cyclin dependent kinase like 5,17,protein kinase activity|protein serine/threonine kinase activity|ATP binding|kinase activity|Rac GTPase binding|cyclin-dependent protein serine/threonine kinase activity,constipation|sensorineural hearing loss|enophthalmos|orbital disease|exophthalmos|epilepsy|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|esophagitis|peptic esophagitis|gastroesophageal reflux disease|intellectual disability|learning disability|movement disease|lingual-facial-buccal dyskinesia|focal hand dystonia|blepharospasm|Rett syndrome|visual epilepsy|infantile epileptic encephalopathy,ppi
961,1010,201254,CENPX,centromere protein X,26,DNA binding|double-stranded DNA binding,,ppi
962,1011,6801,STRN,striatin,79,calmodulin binding|protein-containing complex binding|protein phosphatase 2A binding|armadillo repeat domain binding,,ppi
963,1012,412,STS,steroid sulfatase (microsomal); isozyme S,25,steryl-sulfatase activity|sulfuric ester hydrolase activity,rheumatoid arthritis|recurrent corneal erosion|cryptorchidism|fatty liver disease|hypohidrosis|anhidrosis|ichthyosis|intellectual disability|learning disability|obesity|congenital ichthyosiform erythroderma|Sjogren-Larsson syndrome|X-linked ichthyosis|acquired hyperkeratosis|attention deficit hyperactivity disorder,ppi
964,1013,10273,STUB1,STIP1 homology and U-box containing protein 1,289,ubiquitin-protein transferase activity|Hsp70 protein binding|protein binding; bridging|TPR domain binding|ubiquitin-ubiquitin ligase activity|protein homodimerization activity|SMAD binding|misfolded protein binding|Hsp90 protein binding|ubiquitin protein ligase activity,autosomal recessive spinocerebellar ataxia 16,ppi
965,1014,8677,STX10,syntaxin 10,20,SNARE binding|SNAP receptor activity,,ppi
966,1015,8676,STX11,syntaxin 11,100,SNAP receptor activity|SNARE binding,hemophagocytic lymphohistiocytosis,ppi
967,1016,10917,BTNL3,butyrophilin like 3,8,signaling receptor binding,,ppi
968,1017,23673,STX12,syntaxin 12,97,SNARE binding|SNAP receptor activity,,ppi
969,1018,8675,STX16,syntaxin 16,18,SNAP receptor activity|SNARE binding,dental enamel hypoplasia|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|autosomal recessive pseudohypoaldosteronism type 1|autosomal dominant pseudohypoaldosteronism type 1|pseudohypoaldosteronism|hypoparathyroidism|pseudohypoparathyroidism|pseudopseudohypoparathyroidism|hyperphosphatemia|cataract,ppi
970,1019,55014,STX17,syntaxin 17,35,SNARE binding|SNAP receptor activity,alopecia areata|melanoma|skin melanoma,ppi
971,1020,6804,STX1A,syntaxin 1A,115,chloride channel inhibitor activity|SNARE binding|SNAP receptor activity,autistic disorder|primary biliary cirrhosis|cystic fibrosis|primary immunodeficiency disease|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|schizophrenia|agammaglobulinemia|exocrine pancreatic insufficiency,ppi
972,1021,6809,STX3,syntaxin 3,66,arachidonic acid binding|SNAP receptor activity|SNARE binding,microvillus inclusion disease,ppi
973,1022,6810,STX4,syntaxin 4,73,sphingomyelin phosphodiesterase activator activity|SNARE binding|SNAP receptor activity,,ppi
974,1023,8945,BTRC,beta-transducin repeat containing E3 ubiquitin protein ligase,391,ubiquitin-protein transferase activity|beta-catenin binding|ubiquitin protein ligase activity|snoRNA binding,,ppi
975,1024,6811,STX5,syntaxin 5,78,SNAP receptor activity|cadherin binding|SNARE binding,,ppi
976,1025,10228,STX6,syntaxin 6,63,SNARE binding|SNAP receptor activity,progressive supranuclear palsy|neuronal ceroid lipofuscinosis 6,ppi
977,1026,8417,STX7,syntaxin 7,95,SNARE binding|chloride channel inhibitor activity|SNAP receptor activity,,ppi
978,1027,9482,STX8,syntaxin 8,54,chloride channel inhibitor activity|SNAP receptor activity|SNARE binding,,ppi
979,1028,6812,STXBP1,syntaxin binding protein 1,70,SNARE binding|RNA binding|syntaxin-1 binding|identical protein binding,cerebellar disease|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|schizophrenia|syndromic X-linked intellectual disability 94|infantile epileptic encephalopathy|paraplegia|status epilepticus|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|photosensitivity disease|photosensitive epilepsy|locked-in syndrome|quadriplegia|visual epilepsy|Dravet syndrome|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy,ppi
980,1029,6813,STXBP2,syntaxin binding protein 2,32,,hemophagocytic lymphohistiocytosis,ppi
981,1030,6814,STXBP3,syntaxin binding protein 3,34,,,ppi
982,1032,8803,SUCLA2,succinate-CoA ligase ADP-forming beta subunit,55,succinate-CoA ligase (ADP-forming) activity,lactic acidosis|basal ganglia disease|ptosis|congenital ptosis|cerebellar disease|dystonia|epilepsy|sensorineural hearing loss|obesity|ophthalmoplegia|polyneuropathy|peripheral nervous system disease|neuropathy|visual epilepsy|mechanical strabismus|hypertropia|blindness|Alzheimer's disease|Pick's disease|cerebral degeneration,ppi
983,1033,8802,SUCLG1,succinate-CoA ligase alpha subunit,20,RNA binding|succinate-CoA ligase (ADP-forming) activity|nucleoside diphosphate kinase activity|GDP binding|succinate-CoA ligase (GDP-forming) activity,lactic acidosis|cerebellar disease|epilepsy|hypoglycemia|visual epilepsy|syndromic X-linked intellectual disability 94|skin disease|seborrheic keratosis|actinic keratosis|stomach cancer|brain disease|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|muscular atrophy|mitochondrial DNA depletion syndrome 9,ppi
984,1034,8801,SUCLG2,succinate-CoA ligase GDP-forming beta subunit,51,succinate-CoA ligase (GDP-forming) activity,endometriosis of uterus|endometriosis|obesity,ppi
985,1035,8780,RIOK3,RIO kinase 3,32,protein serine/threonine kinase activity|caspase binding,,ppi
986,1036,6817,SULT1A1,sulfotransferase family 1A member 1,44,aryl sulfotransferase activity|sulfotransferase activity|flavonol 3-sulfotransferase activity|steroid sulfotransferase activity,colon cancer|colonic benign neoplasm|prostate cancer|prostate carcinoma|urinary system benign neoplasm|mental depression|coronary artery disease,ppi
987,1037,6799,SULT1A2,sulfotransferase family 1A member 2,8,aryl sulfotransferase activity|sulfotransferase activity|flavonol 3-sulfotransferase activity,,ppi
988,1039,6819,SULT1C2,sulfotransferase family 1C member 2,10,aryl sulfotransferase activity|sulfotransferase activity,,ppi
989,1040,27233,SULT1C4,sulfotransferase family 1C member 4,4,aryl sulfotransferase activity|sulfotransferase activity,,ppi
990,1041,6822,SULT2A1,sulfotransferase family 2A member 1,6,aryl sulfotransferase activity|estrone sulfotransferase activity|sulfotransferase activity|bile-salt sulfotransferase activity|steroid sulfotransferase activity,prostate cancer|prostate carcinoma,ppi
991,1042,6820,SULT2B1,sulfotransferase family 2B member 1,11,nucleic acid binding|alcohol sulfotransferase activity|cholesterol binding|steroid sulfotransferase activity|steroid hormone binding,endometrial cancer|endometrial carcinoma|prostate cancer|prostate carcinoma,ppi
992,1043,6821,SUOX,sulfite oxidase,9,sulfite oxidase activity|heme binding|molybdopterin cofactor binding,cerebellar disease|dermatitis|epilepsy|hemiplegia|visual epilepsy|basal ganglia disease|focal hand dystonia|blepharospasm,ppi
993,1044,11198,SUPT16H,SPT16 homolog; facilitates chromatin remodeling subunit,158,RNA binding|nucleosome binding|histone binding,,ppi
994,1045,8464,SUPT3H,SPT3 homolog; SAGA and STAGA complex component,37,transcription coactivator activity|histone acetyltransferase activity|DNA binding|transcription coregulator activity,,ppi
995,1046,6827,SUPT4H1,SPT4 homolog; DSIF elongation factor subunit,27,DNA-binding transcription factor activity|single-stranded RNA binding|RNA polymerase II complex binding,,ppi
996,1047,6829,SUPT5H,SPT5 homolog; DSIF elongation factor subunit,153,RNA binding|mRNA binding,,ppi
997,1048,6830,SUPT6H,SPT6 homolog; histone chaperone,76,DNA-binding transcription factor activity|RNA binding|histone binding|nucleosome binding|obsolete transcription factor activity; core RNA polymerase II binding,,ppi
998,1049,6832,SUPV3L1,Suv3 like RNA helicase,23,DNA binding|DNA helicase activity|RNA binding|double-stranded RNA binding|ATP-dependent RNA helicase activity|helicase activity|3'-5' RNA helicase activity,alopecia|ichthyosis|skin disease,ppi
999,1050,9412,MED21,mediator complex subunit 21,116,transcription coactivator activity|DNA-directed 5'-3' RNA polymerase activity,,ppi
1000,1051,6834,SURF1,SURF1; cytochrome c oxidase assembly factor,28,,lactic acidosis|ptosis|congenital ptosis|cerebellar disease|dystonia|epilepsy|sensorineural hearing loss|hypertrichosis|Leigh disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
1001,1052,6835,SURF2,surfeit 2,57,,,ppi
1002,1053,6836,SURF4,surfeit 4,62,,prostate cancer|prostate carcinoma,ppi
1003,1054,6837,MED22,mediator complex subunit 22,33,,,ppi
1004,1055,6838,SURF6,surfeit 6,30,DNA binding|RNA binding,,ppi
1005,1056,6839,SUV39H1,suppressor of variegation 3-9 homolog 1,183,transcription regulatory region sequence-specific DNA binding|chromatin binding|S-adenosylmethionine-dependent methyltransferase activity|histone-lysine N-methyltransferase activity|histone methyltransferase activity|histone methyltransferase activity (H3-K9 specific),,ppi
1006,1057,699,BUB1,BUB1 mitotic checkpoint serine/threonine kinase,97,protein kinase activity,recurrent corneal erosion|Dandy-Walker syndrome|glaucoma|polyhydramnios|intellectual disability|learning disability|microphthalmia|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J,ppi
1007,1058,6840,SVIL,supervillin,112,actin filament binding,acute myeloid leukemia,ppi
1008,1059,6845,VAMP7,vesicle associated membrane protein 7,24,SNARE binding|SNAP receptor activity,azoospermia|cryptorchidism|gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|hypertrophy of breast|infant gynecomastia|gynecomastia|male infertility|osteoporosis|schizophrenia|sex differentiation disease|hermaphroditism|pseudohermaphroditism|hypogonadism|head and neck squamous cell carcinoma,ppi
1009,1060,6847,SYCP1,synaptonemal complex protein 1,2,,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|pancreatic cancer,ppi
1010,1061,701,BUB1B,BUB1 mitotic checkpoint serine/threonine kinase B,94,protein kinase activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|isolated cleft palate|cleft palate|large intestine cancer|colorectal cancer|recurrent corneal erosion|cryptorchidism|Dandy-Walker syndrome|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|placental insufficiency|glaucoma|polyhydramnios|hydrocephalus,ppi
1011,1062,10388,SYCP2,synaptonemal complex protein 2,1,DNA binding,,ppi
1012,1063,6850,SYK,spleen associated tyrosine kinase,143,phosphotyrosine residue binding|protein kinase activity|protein serine/threonine kinase activity|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity,melanoma|skin melanoma|malignant mesothelioma|benign mesothelioma,ppi
1013,1064,6853,SYN1,synapsin I,51,transporter activity|ATP binding|protein kinase binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|schizophrenia|visual epilepsy|focal epilepsy|partial motor epilepsy|autistic disorder,ppi
1014,1065,6854,SYN2,synapsin II,16,ATP binding,bipolar disorder|schizophrenia|epilepsy|visual epilepsy,ppi
1015,1066,8224,SYN3,synapsin III,3,ATP binding,bipolar disorder|schizophrenia,ppi
1016,1067,8831,SYNGAP1,synaptic Ras GTPase activating protein 1,16,,autistic disorder|epilepsy|communication disorder|language disorder|intellectual disability|learning disability|schizophrenia|autosomal dominant non-syndromic intellectual disability,ppi
1017,1068,9145,SYNGR1,synaptogyrin 1,4,,bipolar disorder|acute myeloid leukemia|systemic lupus erythematosus|schizophrenia,ppi
1018,1069,9144,SYNGR2,synaptogyrin 2,21,,,ppi
1019,1070,47,ACLY,ATP citrate lyase,88,ATP citrate synthase activity|ATP binding,congestive heart failure|obesity|liver cancer|hepatocellular carcinoma,ppi
1020,1071,9143,SYNGR3,synaptogyrin 3,4,,,ppi
1021,1072,23546,SYNGR4,synaptogyrin 4,1,,,ppi
1022,1073,8867,SYNJ1,synaptojanin 1,37,phosphatidylinositol-3-phosphatase activity|phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity|phosphatidylinositol phosphate 5-phosphatase activity|phosphatidylinositol phosphate 4-phosphatase activity|phosphatidylinositol-4-phosphate phosphatase activity|phosphatidylinositol-3;5-bisphosphate 5-phosphatase activity|phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity|inositol-1;4;5-trisphosphate 5-phosphatase activity|inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity|SH3 domain binding,dystonia|epilepsy|intellectual disability|learning disability|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|secondary Parkinson disease|Parkinson's disease,ppi
1023,1074,8871,SYNJ2,synaptojanin 2,18,phosphatidylinositol-3-phosphatase activity|phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity|phosphatidylinositol phosphate 4-phosphatase activity|phosphatidylinositol-3;5-bisphosphate 5-phosphatase activity|phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity|PDZ domain binding|SH3 domain binding|inositol-polyphosphate 5-phosphatase activity|phosphatidylinositol-4-phosphate phosphatase activity,mental depression|breast cancer,ppi
1024,1075,6855,SYP,synaptophysin,40,cholesterol binding|protein self-association,lung cancer|non-small cell lung carcinoma|intellectual disability|learning disability|schizophrenia|autistic disorder|neuronal ceroid lipofuscinosis 6|neuronal ceroid lipofuscinosis 1|non-syndromic X-linked intellectual disability,ppi
1025,1076,6856,SYPL1,synaptophysin like 1,6,,,ppi
1026,1077,6857,SYT1,synaptotagmin 1,58,SNARE binding|calcium-dependent phospholipid binding|1-phosphatidylinositol binding|syntaxin-1 binding|low-density lipoprotein particle receptor binding|clathrin binding|calcium ion binding|syntaxin binding|phosphatidylserine binding,,ppi
1027,1078,9184,BUB3,BUB3; mitotic checkpoint protein,96,ubiquitin binding,recurrent corneal erosion|Dandy-Walker syndrome|glaucoma|polyhydramnios|intellectual disability|learning disability|microphthalmia|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J,ppi
1028,1079,127833,SYT2,synaptotagmin 2,10,calcium-dependent phospholipid binding|inositol 1;3;4;5 tetrakisphosphate binding|calcium ion binding|phosphatidylserine binding|SNARE binding|clathrin binding|syntaxin binding,congenital myasthenic syndrome,ppi
1029,1080,84258,SYT3,synaptotagmin 3,12,calcium-dependent phospholipid binding|SNARE binding|calcium ion binding|clathrin binding|syntaxin binding|phosphatidylserine binding,,ppi
1030,1081,6860,SYT4,synaptotagmin 4,11,SNARE binding|clathrin binding|calcium ion binding|calcium-dependent phospholipid binding|phosphatidylserine binding,melanoma|skin melanoma,ppi
1031,1082,6861,SYT5,synaptotagmin 5,7,calcium ion binding|clathrin binding|phosphatidylserine binding|syntaxin binding|SNARE binding|calcium-dependent phospholipid binding,,ppi
1032,1083,9066,SYT7,synaptotagmin 7,11,calmodulin binding|calcium-dependent phospholipid binding|phosphatidylinositol-4;5-bisphosphate binding|phosphatidylserine binding|calcium ion binding|SNARE binding|clathrin binding,,ppi
1033,1085,6863,TAC1,tachykinin precursor 1,16,signaling receptor binding,alcohol dependence|alcohol abuse|amnestic disorder|dissociative amnesia|bipolar disorder|corneal disease|keratoconus|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|congestive heart failure|esophagitis|peptic esophagitis|gastroesophageal reflux disease|allergic hypersensitivity disease|Balo concentric sclerosis|adrenoleukodystrophy,ppi
1034,1086,11149,BVES,blood vessel epicardial substance,3,structural molecule activity|cAMP binding,autosomal recessive limb-girdle muscular dystrophy type 2X,ppi
1035,1087,6866,TAC3,tachykinin 3,11,signaling receptor binding,generalized anxiety disorder|anxiety disorder|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertrophy of breast|infant gynecomastia|gynecomastia|hypogonadism|osteoporosis|premature menopause|androgen insensitivity syndrome|eunuchism|psychologic dyspareunia|premature ejaculation|isolated growth hormone deficiency,ppi
1036,1088,6867,TACC1,transforming acidic coiled-coil containing protein 1,37,,malignant glioma|gliosarcoma|glioblastoma multiforme|giant cell glioblastoma,ppi
1037,1089,10579,TACC2,transforming acidic coiled-coil containing protein 2,19,nuclear hormone receptor binding,,ppi
1038,1090,10460,TACC3,transforming acidic coiled-coil containing protein 3,77,,urinary bladder cancer|transitional cell carcinoma|malignant glioma|gliosarcoma|glioblastoma multiforme|giant cell glioblastoma,ppi
1039,1091,6869,TACR1,tachykinin receptor 1,48,tachykinin receptor activity|substance P receptor activity,alcohol dependence|alcohol abuse|bipolar disorder|bronchial disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertension|essential hypertension|schizophrenia|mood disorder|attention deficit hyperactivity disorder,ppi
1040,1092,6865,TACR2,tachykinin receptor 2,4,tachykinin receptor activity|substance K receptor activity,bronchial disease,ppi
1041,1093,6870,TACR3,tachykinin receptor 3,4,,alcohol dependence|alcohol abuse|generalized anxiety disorder|anxiety disorder|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertrophy of breast|infant gynecomastia|gynecomastia|hypogonadism|osteoporosis|schizophrenia|premature menopause|androgen insensitivity syndrome|eunuchism,ppi
1042,1094,4072,EPCAM,epithelial cell adhesion molecule,7,protein-containing complex binding|cadherin binding involved in cell-cell adhesion,generalized anxiety disorder|anxiety disorder|colon cancer|colonic benign neoplasm|large intestine cancer|Lynch syndrome|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|glioblastoma multiforme|giant cell glioblastoma|pancreatic cancer|prostate cancer|prostate carcinoma|rectal neoplasm,ppi
1043,1095,4070,TACSTD2,tumor-associated calcium signal transducer 2,8,signaling receptor activity|cadherin binding involved in cell-cell adhesion,corneal dystrophy|endometriosis of uterus|endometriosis|blindness|asthenopia|gelatinous drop-like corneal dystrophy|amblyopia,ppi
1044,1096,6871,TADA2A,transcriptional adaptor 2A,143,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coregulator activity|histone acetyltransferase activity|chromatin binding|transcription coactivator activity,,ppi
1045,1097,9015,TAF1A,TATA-box binding protein associated factor; RNA polymerase I subunit A,31,,,ppi
1046,1098,9014,TAF1B,TATA-box binding protein associated factor; RNA polymerase I subunit B,41,RNA polymerase I CORE element sequence-specific DNA binding|TBP-class protein binding,,ppi
1047,1099,9013,TAF1C,TATA-box binding protein associated factor; RNA polymerase I subunit C,30,RNA polymerase I CORE element sequence-specific DNA binding,autistic disorder,ppi
1048,1100,6872,TAF1,TATA-box binding protein associated factor 1,87,RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator activity|histone acetyltransferase activity|protein serine/threonine kinase activity|kinase activity|sequence-specific DNA binding|ubiquitin conjugating enzyme activity|lysine-acetylated histone binding|acetyl-CoA binding|transcription regulatory region DNA binding|obsolete RNA polymerase II transcription factor activity; TBP-class protein binding; involved in preinitiation complex assembly|TBP-class protein binding|transcription factor activity; RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,syndromic X-linked intellectual disability type 10|choreatic disease|generalized dystonia|torsion dystonia 1|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome,ppi
1049,1101,6873,TAF2,TATA-box binding protein associated factor 2,32,transcription regulatory region DNA binding|transcription factor activity; RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly|obsolete RNA polymerase II transcription factor activity; TBP-class protein binding; involved in preinitiation complex assembly|chromatin binding|sequence-specific DNA binding,intellectual disability|learning disability|autosomal recessive non-syndromic intellectual disability,ppi
1050,1102,6874,TAF4,TATA-box binding protein associated factor 4,57,DNA binding|transcription coactivator activity|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly|transcription factor binding,,ppi
1051,1103,6875,TAF4B,TATA-box binding protein associated factor 4b,12,DNA binding|transcription factor activity; RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly|transcription factor binding,azoospermia,ppi
1052,1104,6877,TAF5,TATA-box binding protein associated factor 5,40,DNA-binding transcription factor activity|transcription regulatory region DNA binding|protein dimerization activity|histone acetyltransferase activity,,ppi
1053,1105,6878,TAF6,TATA-box binding protein associated factor 6,64,DNA binding|DNA-binding transcription factor activity|RNA polymerase II activating transcription factor binding,,ppi
1054,1106,6879,TAF7,TATA-box binding protein associated factor 7,51,transcription coactivator activity|transcription regulatory region DNA binding|DNA-binding transcription factor activity|transcription factor binding|histone acetyltransferase binding,,ppi
1055,1107,6880,TAF9,TATA-box binding protein associated factor 9,112,DNA binding|transcription coactivator activity|transcription regulatory region DNA binding|histone acetyltransferase activity|transcription factor binding|transcription factor activity; RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
1056,1108,6881,TAF10,TATA-box binding protein associated factor 10,74,transcription coactivator activity|estrogen receptor binding|thiol-dependent ubiquitinyl hydrolase activity|RNA polymerase binding|DNA-binding transcription factor activity|histone acetyltransferase activity,,ppi
1057,1109,6882,TAF11,TATA-box binding protein associated factor 11,40,transcription coactivator activity|transcription factor binding,,ppi
1058,1110,6883,TAF12,TATA-box binding protein associated factor 12,51,DNA binding|transcription coactivator activity|transcription factor binding|DNA-binding transcription factor activity|histone acetyltransferase activity|RNA polymerase II activating transcription factor binding|TBP-class protein binding,,ppi
1059,1111,6884,TAF13,TATA-box binding protein associated factor 13,27,DNA-binding transcription factor activity|DNA binding|transcription coregulator activity,,ppi
1060,1112,8148,TAF15,TATA-box binding protein associated factor 15,85,RNA binding,chondrosarcoma|osteosarcoma|bone osteosarcoma|stomach cancer|extraskeletal myxoid chondrosarcoma,ppi
1061,1113,54457,TAF7L,TATA-box binding protein associated factor 7 like,21,transcription coactivator activity|histone acetyltransferase binding|transcription factor binding|transcription regulatory region DNA binding,,ppi
1062,1114,2972,BRF1,BRF1; RNA polymerase III transcription initiation factor subunit,20,,intellectual disability|learning disability,ppi
1063,1115,6876,TAGLN,transgelin,74,,colon cancer|colonic benign neoplasm|endometriosis of uterus|endometriosis|chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease|esophagus squamous cell carcinoma,ppi
1064,1116,8407,TAGLN2,transgelin 2,136,cadherin binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|liver cirrhosis|liver cancer|hepatocellular carcinoma,ppi
1065,1117,6886,TAL1,TAL bHLH transcription factor 1; erythroid differentiation factor,51,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding|E-box binding|RNA polymerase II regulatory region sequence-specific DNA binding,acute lymphocytic leukemia|acute T cell leukemia,ppi
1066,1118,6887,TAL2,TAL bHLH transcription factor 2,10,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,acute lymphocytic leukemia,ppi
1067,1119,6888,TALDO1,transaldolase 1,88,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,anemia|macrocytic anemia|asthma|intrinsic asthma|allergic asthma|patent ductus arteriosus|placental insufficiency|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|liver cirrhosis,ppi
1068,1120,10010,TANK,TRAF family member associated NFKB activator,73,deubiquitinase activator activity|thiol-dependent ubiquitin-specific protease activity,breast cancer,ppi
1069,1121,6892,TAPBP,TAP binding protein,14,peptide antigen-transporting ATPase activity|MHC class I protein binding|peptide antigen binding|TAP1 binding|TAP2 binding|unfolded protein binding,bronchiectasis|bronchiolitis|schizophrenia|chronic ulcer of skin|chronic sphenoidal sinusitis|chronic ethmoiditis|otitis media|MHC class II deficiency|MHC class I deficiency,ppi
1070,1122,6894,TARBP1,TAR (HIV-1) RNA binding protein 1,31,tRNA (guanine) methyltransferase activity,,ppi
1071,1123,6895,TARBP2,TARBP2; RISC loading complex RNA binding subunit,71,double-stranded RNA binding|siRNA binding|pre-mRNA binding|pre-miRNA binding,,ppi
1072,1124,705,BYSL,bystin like,128,RNA binding|snoRNA binding,,ppi
1073,1125,23435,TARDBP,TAR DNA binding protein,325,double-stranded DNA binding|DNA-binding transcription factor activity|RNA binding|mRNA 3'-UTR binding|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|single-stranded RNA binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|stereotypic movement disorder|muscular atrophy|neurodegenerative disease|amyotrophic lateral sclerosis type 10,ppi
1074,1126,6897,TARS,threonyl-tRNA synthetase,87,threonine-tRNA ligase activity|protein homodimerization activity,myositis,ppi
1075,1127,6898,TAT,tyrosine aminotransferase,20,L-tyrosine:2-oxoglutarate aminotransferase activity,intellectual disability|learning disability|skin disease|seborrheic keratosis|actinic keratosis|tyrosinemia|tyrosinemia type II,ppi
1076,1128,8887,TAX1BP1,Tax1 binding protein 1,72,kinase binding,,ppi
1077,1129,6901,TAZ,tafazzin,103,1-acylglycerol-3-phosphate O-acyltransferase activity|O-acyltransferase activity|1-acylglycerophosphocholine O-acyltransferase activity,neutropenia|agranulocytosis|sick sinus syndrome|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B,ppi
1078,1130,23216,TBC1D1,TBC1 domain family member 1,13,GTPase activator activity|Rab GTPase binding,obesity,ppi
1079,1131,6902,TBCA,tubulin folding cofactor A,28,RNA binding|chaperone binding,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
1080,1132,706,TSPO,translocator protein,15,cholesterol binding|cholesterol transporter activity,bipolar disorder|hepatic coma|hepatic encephalopathy,ppi
1081,1133,6903,TBCC,tubulin folding cofactor C,2,GTPase activity|chaperone binding,,ppi
1082,1134,6904,TBCD,tubulin folding cofactor D,55,GTPase activator activity|beta-tubulin binding|chaperone binding,,ppi
1083,1135,6905,TBCE,tubulin folding cofactor E,21,chaperone binding,anemia|macrocytic anemia|bacterial infectious disease|cryptorchidism|dental caries|enophthalmos|orbital disease|exophthalmos|epilepsy|placental insufficiency|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|intellectual disability|learning disability|osteopetrosis|osteosclerosis|visual epilepsy|hypoparathyroidism|pseudohypoparathyroidism,ppi
1084,1136,6906,SERPINA7,serpin family A member 7,7,serine-type endopeptidase inhibitor activity,inherited metabolic disorder,ppi
1085,1137,29110,TBK1,TANK binding kinase 1,163,protein kinase activity|protein serine/threonine kinase activity,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|communication disorder|language disorder|mutism|cerebral degeneration|muscular atrophy|Grn-related frontotemporal lobar degeneration with Tdp43 inclusions|frontotemporal dementia|neurodegenerative disease|progressive bulbar palsy|FTDALS4,ppi
1086,1138,6907,TBL1X,transducin beta like 1X-linked,59,transcription corepressor activity|histone binding|transcription regulatory region DNA binding,autistic disorder,ppi
1087,1139,26608,TBL2,transducin beta like 2,41,RNA binding|phosphoprotein binding,generalized anxiety disorder|anxiety disorder|supravalvular aortic stenosis|autistic disorder|blepharophimosis|brain ischemia|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|basal ganglia disease|focal hand dystonia|blepharospasm|clubfoot|sensorineural hearing loss|inguinal hernia|nephrocalcinosis,ppi
1088,1140,10607,TBL3,transducin beta like 3,63,RNA binding|snoRNA binding,,ppi
1089,1141,6908,TBP,TATA-box binding protein,181,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|RNA polymerase III general transcription initiation factor activity|core promoter binding|obsolete RNA polymerase II transcription factor activity; TBP-class protein binding; involved in preinitiation complex assembly|transcription regulatory region DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase III regulatory region DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity|transcription factor binding,agnosia|syndromic X-linked intellectual disability type 10|choreatic disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|epilepsy|mutism|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|schizophrenia|visual epilepsy|secondary Parkinson disease|paranoid schizophrenia,ppi
1090,1142,9519,TBPL1,TATA-box binding protein like 1,29,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|transcription coactivator activity|RNA polymerase III regulatory region DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|transcription factor binding|DNA-binding transcription factor activity,,ppi
1091,1143,10716,TBR1,T-box; brain 1,14,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,isolated cleft palate|cleft palate|coloboma|epilepsy|intellectual disability|learning disability|microphthalmia|visual epilepsy|cataract|placental insufficiency|autistic disorder,ppi
1092,1144,6899,TBX1,T-box 1,2,DNA-binding transcription factor activity; RNA polymerase II-specific|protein homodimerization activity|sequence-specific DNA binding|DNA-binding transcription factor activity,suppression amblyopia|amblyopia|bipolar disorder|blepharophimosis|ptosis|congenital ptosis|cholecystolithiasis|choledocholithiasis|isolated cleft palate|cleft palate|constipation|dental caries|DiGeorge syndrome|velocardiofacial syndrome|double outlet right ventricle|patent ductus arteriosus|endocrine system disease|epilepsy|monocular esotropia|esotropia,ppi
1093,1145,347853,TBX10,T-box 10,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1094,1146,6913,TBX15,T-box 15,4,DNA-binding transcription factor activity; RNA polymerase II-specific,blepharophimosis|isolated cleft palate|cleft palate|clubfoot|sensorineural hearing loss|enophthalmos|orbital disease|exophthalmos|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus,ppi
1095,1148,9095,TBX19,T-box 19,1,DNA-binding transcription factor activity; RNA polymerase II-specific,alcohol dependence|alcohol abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|neonatal jaundice|adrenocorticotropic hormone deficiency|hypoglycemia|Addison's disease,ppi
1096,1149,6909,TBX2,T-box 2,9,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|sequence-specific DNA binding,patent ductus arteriosus|placental insufficiency|primary pulmonary hypertension|pulmonary hypertension|chromosome 17q23.1-q23.2 deletion syndrome,ppi
1097,1150,57057,TBX20,T-box 20,8,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II transcription factor binding|RNA polymerase II activating transcription factor binding|transcription coactivator activity,patent foramen ovale|atrial heart septal defect|atrial heart septal defect 4,ppi
1098,1151,30009,TBX21,T-box 21,8,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|transcription regulatory region DNA binding,asthma|intrinsic asthma|allergic asthma|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
1099,1152,56652,TWNK,twinkle mtDNA helicase,36,single-stranded DNA binding|5'-3' DNA helicase activity,Perrault syndrome|infantile onset spinocerebellar ataxia|mitochondrial DNA depletion syndrome 3,ppi
1100,1153,50945,TBX22,T-box 22,6,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,isolated cleft palate|cleft palate|coloboma|sensorineural hearing loss|ankyloglossia|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|X-linked cleft palate with or without ankyloglossia,ppi
1101,1154,6926,TBX3,T-box 3,20,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II transcription factor binding|RNA polymerase II activating transcription factor binding|sequence-specific DNA binding,imperforate anus|ventricular septal defect|inguinal hernia|tooth agenesis|anodontia|obesity|pyloric stenosis|stomach cancer|goiter|thyroid gland disease|laryngostenosis|pituitary hypoplasia|breast cancer|ulnar-mammary syndrome,ppi
1102,1155,9496,TBX4,T-box 4,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,isolated cleft palate|cleft palate|clubfoot|patent ductus arteriosus|placental insufficiency|primary pulmonary hypertension|pulmonary hypertension|chromosome 17q23.1-q23.2 deletion syndrome,ppi
1103,1156,6910,TBX5,T-box 5,8,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|sequence-specific DNA binding,atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|hypoplastic left heart syndrome|Klippel-Feil syndrome|spondylolisthesis|atrial fibrillation|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|polydactyly,ppi
1104,1157,6911,TBX6,T-box 6,7,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II transcription factor binding|RNA polymerase II activating transcription factor binding|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|DNA binding,achondroplasia|Laron syndrome|placental insufficiency|Klippel-Feil syndrome|spondylolisthesis|autosomal recessive nonsyndromic deafness 67|spondylocostal dysostosis,ppi
1105,1158,6915,TBXA2R,thromboxane A2 receptor,35,thromboxane A2 receptor activity|guanyl-nucleotide exchange factor activity,blood platelet disease|hemorrhagic disease|pulmonary embolism|rhinitis,ppi
1106,1159,6916,TBXAS1,thromboxane A synthase 1,1,thromboxane-A synthase activity|12-hydroxyheptadecatrienoic acid synthase activity,anemia|macrocytic anemia|Camurati-Engelmann disease|myelofibrosis|osteopetrosis|osteosclerosis|prostate cancer|prostate carcinoma|thrombocytopenia,ppi
1107,1160,55165,CEP55,centrosomal protein 55,108,,polycystic ovary syndrome,ppi
1108,1161,8557,TCAP,titin-cap,36,structural constituent of muscle|protein binding; bridging,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
1109,1162,6917,TCEA1,transcription elongation factor A1,76,,,ppi
1110,1163,6919,TCEA2,transcription elongation factor A2,64,,acute myeloid leukemia,ppi
1111,1164,6920,TCEA3,transcription elongation factor A3,1,,,ppi
1112,1165,9338,TCEAL1,transcription elongation factor A like 1,51,DNA-binding transcription factor activity|WW domain binding,,ppi
1113,1166,6921,ELOC,elongin C,140,ubiquitin-protein transferase activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
1114,1167,6923,ELOB,elongin B,112,ubiquitin protein ligase binding,,ppi
1115,1168,118924,FRA10AC1,FRA10A associated CGG repeat 1,36,,,ppi
1116,1169,6924,ELOA,elongin A,58,,,ppi
1117,1170,6927,HNF1A,HNF1 homeobox A,53,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13,ppi
1118,1171,6938,TCF12,transcription factor 12,79,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|enhancer binding|transcription regulatory region DNA binding|protein heterodimerization activity|protein homodimerization activity|bHLH transcription factor binding,craniosynostosis|sensorineural hearing loss|enophthalmos|orbital disease|exophthalmos|ophthalmoplegia|mechanical strabismus|hypertropia|pseudotumor cerebri|intracranial hypertension|extraskeletal myxoid chondrosarcoma,ppi
1119,1172,6939,TCF15,transcription factor 15 (basic helix-loop-helix),1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,polycystic ovary syndrome,ppi
1120,1173,6940,ZNF354A,zinc finger protein 354A,12,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1121,1174,6941,TCF19,transcription factor 19,16,,colon cancer|colonic benign neoplasm,ppi
1122,1175,64776,C11orf1,chromosome 11 open reading frame 1,1,,,ppi
1123,1176,6928,HNF1B,HNF1 homeobox B,6,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,gout|obstructive jaundice|biliary tract disease|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|diabetic ketoacidosis|diabetes mellitus|type 2 diabetes mellitus|prostate cancer|prostate carcinoma|proteinuria|spermatocele|liver disease|cerebral degeneration|glucose intolerance,ppi
1124,1177,6942,TCF20,transcription factor 20,41,DNA binding|transcription coactivator activity|RNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding,,ppi
1125,1178,6943,TCF21,transcription factor 21,10,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|protein dimerization activity|androgen receptor binding|E-box binding,coronary artery disease,ppi
1126,1179,6929,TCF3,transcription factor 3,168,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|enhancer binding|protein homodimerization activity|protein heterodimerization activity|vitamin D response element binding|E-box binding|bHLH transcription factor binding,agammaglobulinemia|arthropathy|arthritis|Burkitt lymphoma|conjunctivitis|exanthem|primary immunodeficiency disease|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|sinusitis|otitis media|acute lymphocytic leukemia,ppi
1127,1180,6925,TCF4,transcription factor 4,226,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; sequence-specific DNA binding; RNA polymerase recruiting|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|TFIIB-class transcription factor binding|DNA binding|DNA-binding transcription factor activity|protein heterodimerization activity|E-box binding|bHLH transcription factor binding|protein homodimerization activity,astigmatism|bipolar disorder|constipation|cryptorchidism|enophthalmos|orbital disease|exophthalmos|epilepsy|clubfoot|Chandler syndrome|Fuchs' endothelial dystrophy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|heart disease|cardiovascular system disease|liver cancer|microcephaly|myopia|polyneuropathy,ppi
1128,1181,6932,TCF7,transcription factor 7 (T-cell specific; HMG-box),6,DNA-binding transcription factor activity; RNA polymerase II-specific|beta-catenin binding|transcription regulatory region DNA binding|sequence-specific DNA binding,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|systemic lupus erythematosus,ppi
1129,1182,746,TMEM258,transmembrane protein 258,17,,,ppi
1130,1183,83439,TCF7L1,transcription factor 7 like 1,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|beta-catenin binding|sequence-specific DNA binding|chromatin binding|transcription regulatory region DNA binding,thyroid cancer|thyroid adenoma|thyroid carcinoma,ppi
1131,1184,6934,TCF7L2,transcription factor 7 like 2,42,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|beta-catenin binding|sequence-specific DNA binding|transcription regulatory region DNA binding|chromatin binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|bipolar disorder|colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|diabetes mellitus|type 2 diabetes mellitus|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
1132,1185,6935,ZEB1,zinc finger E-box binding homeobox 1,28,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|transcription corepressor activity|zinc ion binding|E-box binding,corneal dystrophy|endometrial cancer|endometrial carcinoma|Chandler syndrome|Fuchs' endothelial dystrophy|oral submucous fibrosis|Sezary's disease|cutaneous T cell lymphoma|coronary artery disease|posterior polymorphous corneal dystrophy|posterior polymorphous corneal dystrophy 1|ovarian cancer|breast cancer|posterior polymorphous corneal dystrophy 3,ppi
1133,1186,6944,VPS72,vacuolar protein sorting 72 homolog,50,,,ppi
1134,1187,6945,MLX,MLX; MAX dimerization protein,26,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,anemia|macrocytic anemia|vascular disease|arthropathy|arthritis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|epilepsy|primary pulmonary hypertension|pulmonary hypertension|hypertensive encephalopathy|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|visual epilepsy|chronic ulcer of skin|Wegener's granulomatosis|Takayasu's arteritis,ppi
1135,1188,10732,TCFL5,transcription factor like 5,2,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
1136,1189,10312,TCIRG1,T-cell immune regulator 1; ATPase H+ transporting V0 subunit a3,22,transporter activity|ATPase binding|proton-transporting ATPase activity; rotational mechanism,anemia|macrocytic anemia|chronic rhinitis|craniosynostosis|sensorineural hearing loss|dental caries|epilepsy|Bell's palsy|facial paralysis|facial nerve disease|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|osteopetrosis,ppi
1137,1190,8115,TCL1A,T-cell leukemia/lymphoma 1A,25,identical protein binding|protein serine/threonine kinase activator activity,,ppi
1138,1191,9623,TCL1B,T-cell leukemia/lymphoma 1B,32,protein serine/threonine kinase activator activity,breast cancer,ppi
1139,1192,747,DAGLA,diacylglycerol lipase alpha,4,acylglycerol lipase activity,,ppi
1140,1193,6947,TCN1,transcobalamin 1,2,,megaloblastic anemia,ppi
1141,1194,6948,TCN2,transcobalamin 2,5,cobalamin binding,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|anemia|macrocytic anemia|megaloblastic anemia|autistic disorder|cerebellar disease|cleft lip|large intestine cancer|colorectal cancer|lymphopenia|intellectual disability|learning disability|pancytopenia|prostate cancer|prostate carcinoma|thrombocytopenia,ppi
1142,1195,6949,TCOF1,treacle ribosome biogenesis factor 1,79,RNA polymerase I core binding|RNA binding|transporter activity,osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|ophthalmoplegia|mechanical strabismus|hypertropia|blindness|Treacher Collins syndrome,ppi
1143,1196,6950,TCP1,t-complex 1,249,RNA binding,prostate cancer|prostate carcinoma|schizophrenia,ppi
1144,1197,6953,TCP10,t-complex 10,4,tubulin binding,,ppi
1145,1198,140290,TCP10L,t-complex 10-like,44,transcription corepressor activity|protein self-association|repressing transcription factor binding|tubulin binding,,ppi
1146,1199,6954,TCP11,t-complex 11,3,,,ppi
1147,1200,8045,RASSF7,Ras association domain family member 7,33,,,ppi
1148,1201,56675,NRIP3,nuclear receptor interacting protein 3,6,,,ppi
1149,1202,56674,TMEM9B,TMEM9 domain family member B,26,,,ppi
1150,1203,56673,C11orf16,chromosome 11 open reading frame 16,2,,,ppi
1151,1204,6988,TCTA,T-cell leukemia translocation altered,2,,,ppi
1152,1205,202500,TCTE1,t-complex-associated-testis-expressed 1,80,,,ppi
1153,1206,6990,DYNLT3,dynein light chain Tctex-type 3,20,,,ppi
1154,1207,6991,TCTE3,t-complex-associated-testis-expressed 3,1,,,ppi
1155,1208,6993,DYNLT1,dynein light chain Tctex-type 1,114,,,ppi
1156,1209,10955,SERINC3,serine incorporator 3,12,L-serine transmembrane transporter activity,prostate cancer|prostate carcinoma,ppi
1157,1210,48,ACO1,aconitase 1,25,RNA binding|aconitate hydratase activity|iron-responsive element binding|3 iron; 4 sulfur cluster binding|4 iron; 4 sulfur cluster binding,arthropathy|arthritis,ppi
1158,1211,56672,AKIP1,A-kinase interacting protein 1,13,,,ppi
1159,1212,6996,TDG,thymine DNA glycosylase,45,magnesium ion binding|DNA binding|damaged DNA binding|double-stranded DNA binding|uracil DNA N-glycosylase activity|ATP binding|pyrimidine-specific mismatch base pair DNA N-glycosylase activity|DNA N-glycosylase activity|mismatched DNA binding|sodium ion binding|chloride ion binding|protein homodimerization activity|protein self-association|G/U mismatch-specific uracil-DNA glycosylase activity,,ppi
1160,1213,6997,TDGF1,teratocarcinoma-derived growth factor 1,33,signaling receptor binding|growth factor activity|nodal binding|activin receptor binding,holoprosencephaly,ppi
1161,1214,6999,TDO2,tryptophan 2;3-dioxygenase,16,tryptophan 2;3-dioxygenase activity|heme binding,autistic disorder|bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
1162,1215,26610,ELP4,elongator acetyltransferase complex subunit 4,18,phosphorylase kinase regulator activity|RNA polymerase II complex binding,aniridia|glaucoma|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cataract,ppi
1163,1216,56165,TDRD1,tudor domain containing 1,7,,,ppi
1164,1217,11022,TDRKH,tudor and KH domain containing,5,,,ppi
1165,1218,7003,TEAD1,TEA domain transcription factor 1,25,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter sequence-specific DNA binding|transcription regulator recruiting activity|DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding|sequence-specific DNA binding|RNA polymerase II transcription factor binding,astigmatism|myopia,ppi
1166,1219,8463,TEAD2,TEA domain transcription factor 2,83,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulator recruiting activity|DNA-binding transcription factor activity|disordered domain specific binding|transcription regulatory region DNA binding|sequence-specific DNA binding|RNA polymerase II transcription factor binding,polycystic ovary syndrome,ppi
1167,1220,7005,TEAD3,TEA domain transcription factor 3,22,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding|sequence-specific DNA binding|RNA polymerase II transcription factor binding,,ppi
1168,1221,7004,TEAD4,TEA domain transcription factor 4,34,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding|sequence-specific DNA binding|RNA polymerase II transcription factor binding,,ppi
1169,1222,7006,TEC,tec protein tyrosine kinase,44,non-membrane spanning protein tyrosine kinase activity|phospholipid binding,,ppi
1170,1223,738,VPS51,VPS51; GARP complex subunit,24,,,ppi
1171,1226,7008,TEF,TEF; PAR bZIP transcription factor,7,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
1172,1227,7009,TMBIM6,transmembrane BAX inhibitor motif containing 6,31,endoribonuclease inhibitor activity,,ppi
1173,1228,7010,TEK,TEK receptor tyrosine kinase,34,protein kinase activity|protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|signaling receptor activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,arteriovenous malformation|blood coagulation disease|complex partial epilepsy|temporal lobe epilepsy|exanthem|hemangioma|cavernous hemangioma|capillary hemangioma|angiosarcoma|hemorrhagic disease|buphthalmos|hydrophthalmos|intestinal volvulus|multiple cutaneous and mucosal venous malformations,ppi
1174,1229,27285,TEKT2,tektin 2,19,,,ppi
1175,1230,7011,TEP1,telomerase associated protein 1,11,RNA binding|telomerase RNA binding|telomerase activity,lung benign neoplasm,ppi
1176,1231,7013,TERF1,telomeric repeat binding factor 1,319,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|double-stranded telomeric DNA binding|DNA binding; bending|telomeric DNA binding|protein homodimerization activity|G-rich strand telomeric DNA binding|telomerase activity,,ppi
1177,1232,7014,TERF2,telomeric repeat binding factor 2,268,DNA-binding transcription factor activity; RNA polymerase II-specific|double-stranded telomeric DNA binding|telomeric DNA binding|G-rich strand telomeric DNA binding|telomerase activity,adult T-cell leukemia|acute T cell leukemia,ppi
1178,1233,55291,PPP6R3,protein phosphatase 6 regulatory subunit 3,68,,,ppi
1179,1234,7015,TERT,telomerase reverse transcriptase,72,tRNA binding|DNA binding|telomerase activity|telomerase RNA reverse transcriptase activity|RNA-directed DNA polymerase activity|RNA-directed 5'-3' RNA polymerase activity|nucleotidyltransferase activity|telomeric DNA binding|protein homodimerization activity|telomerase RNA binding|template-free RNA nucleotidyltransferase,alopecia|anemia|macrocytic anemia|aplastic anemia|urinary bladder cancer|blood coagulation disease|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|lung cancer|bronchiolo-alveolar adenocarcinoma|non-small cell lung carcinoma|cerebellar disease|cervical cancer|Cri-Du-Chat syndrome|dental caries|placental insufficiency|gingival disease|epulis,ppi
1180,1235,7016,TESK1,testis-specific kinase 1,14,,,ppi
1181,1236,10420,TESK2,testis-specific kinase 2,9,protein kinase activity|protein serine/threonine kinase activity,alcohol dependence|alcohol abuse,ppi
1182,1237,56159,TEX11,testis expressed 11,47,,azoospermia,ppi
1183,1239,56157,TEX13A,testis expressed 13A,19,,,ppi
1184,1241,56155,TEX14,testis expressed 14; intercellular bridge forming factor,2,,,ppi
1185,1242,56154,TEX15,testis expressed 15,5,,,ppi
1186,1243,53838,C11orf24,chromosome 11 open reading frame 24,3,,,ppi
1187,1244,7018,TF,transferrin,65,ferrous iron binding|iron chaperone activity|transferrin receptor binding,alcohol dependence|alcohol abuse|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|anemia|macrocytic anemia|hypochromic anemia,ppi
1188,1245,7019,TFAM,transcription factor A; mitochondrial,42,mitochondrial promoter sequence-specific DNA binding|chromatin binding|DNA-binding transcription factor activity|RNA binding|DNA binding; bending|sequence-specific DNA binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|basal cell carcinoma|in situ carcinoma|penis carcinoma in situ|neuronal ceroid lipofuscinosis 1,ppi
1189,1246,7020,TFAP2A,transcription factor AP-2 alpha,141,transcription regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|chromatin binding|transcription coactivator activity|protein homodimerization activity|sequence-specific DNA binding|transcription regulatory region DNA binding|protein dimerization activity|RNA polymerase II regulatory region sequence-specific DNA binding,ptosis|congenital ptosis|cleft lip|isolated cleft palate|cleft palate|cryptorchidism|epilepsy|microphthalmia|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|sensorineural hearing loss|glomus tumor|hemangioma|lymphangioma|chorioangioma|intramuscular hemangioma|histiocytoid hemangioma|cavernous hemangioma,ppi
1190,1247,7021,TFAP2B,transcription factor AP-2 beta,18,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II core promoter sequence-specific DNA binding|enhancer sequence-specific DNA binding|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|transcription corepressor activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|sequence-specific DNA binding|protein dimerization activity|RNA polymerase II regulatory region sequence-specific DNA binding,alcohol dependence|alcohol abuse|ptosis|congenital ptosis|patent ductus arteriosus|ophthalmoplegia|mechanical strabismus|hypertropia|Char syndrome,ppi
1191,1248,7022,TFAP2C,transcription factor AP-2 gamma,89,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|protein dimerization activity|RNA polymerase II regulatory region sequence-specific DNA binding,stomach cancer,ppi
1192,1249,7023,TFAP4,transcription factor AP-4,108,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|sequence-specific DNA binding|transcription regulatory region DNA binding|E-box binding|transcription coactivator activity|protein heterodimerization activity|DNA-binding transcription factor activity,,ppi
1193,1250,7024,TFCP2,transcription factor CP2,117,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|DNA binding|DNA-binding transcription factor activity|sequence-specific DNA binding,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
1194,1251,7027,TFDP1,transcription factor Dp-1,69,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
1195,1252,7029,TFDP2,transcription factor Dp-2,17,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific,malignant mesothelioma|benign mesothelioma,ppi
1196,1253,7030,TFE3,transcription factor binding to IGHM enhancer 3,50,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|alveolar soft part sarcoma,ppi
1197,1254,7942,TFEB,transcription factor EB,25,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding,,ppi
1198,1255,22797,TFEC,transcription factor EC,8,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|transcription corepressor activity,,ppi
1199,1256,7031,TFF1,trefoil factor 1,24,,,ppi
1200,1257,7032,TFF2,trefoil factor 2,3,CXCR4 chemokine receptor binding,,ppi
1201,1258,7033,TFF3,trefoil factor 3,5,,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|stomatitis,ppi
1202,1259,10342,TFG,TRK-fused gene,146,,familial hyperlipidemia|optic atrophy|polyneuropathy|peripheral nervous system disease|neuropathy|locked-in syndrome|quadriplegia|paraplegia|sensory peripheral neuropathy|neuritis|motor neuritis|papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma|critical illness polyneuropathy|extraskeletal myxoid chondrosarcoma|Charcot-Marie-Tooth disease type 2|hereditary spastic paraplegia 57,ppi
1203,1260,740,MRPL49,mitochondrial ribosomal protein L49,45,structural constituent of ribosome,melanoma|skin melanoma,ppi
1204,1261,7035,TFPI,tissue factor pathway inhibitor,19,endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity,thrombotic thrombocytopenic purpura|thrombophilia,ppi
1205,1262,7980,TFPI2,tissue factor pathway inhibitor 2,5,extracellular matrix structural constituent|serine-type endopeptidase inhibitor activity,rheumatoid arthritis|large intestine cancer|colorectal cancer|melanoma|skin melanoma|arthropathy|arthritis|pancreatic cancer|breast cancer|liver cancer|hepatocellular carcinoma,ppi
1206,1263,7036,TFR2,transferrin receptor 2,11,transferrin receptor activity,beta thalassemia|iron metabolism disease|hemochromatosis|Wilson disease|liver cirrhosis|liver disease|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|hypogonadism,ppi
1207,1264,7037,TFRC,transferrin receptor,89,RNA binding|double-stranded RNA binding|transferrin receptor activity,beta thalassemia|urinary bladder cancer|large intestine cancer|colorectal cancer|iron metabolism disease|hemochromatosis|Wilson disease|malignant glioma|gliosarcoma|mixed glioma|chronic lymphocytic leukemia|Richter's syndrome|lung benign neoplasm|Langerhans-cell histiocytosis|lymphosarcoma|lymphoma|reticulosarcoma|non-Hodgkin lymphoma|B-cell lymphoma|obesity,ppi
1208,1265,7038,TG,thyroglobulin,9,,constipation|achondroplasia|Laron syndrome|goiter|nontoxic goiter|thyroid gland disease|umbilical hernia|omphalocele|congenital hypothyroidism|myxedema|hypothyroidism|intellectual disability|learning disability|thyroid cancer|thyroid adenoma|thyroid carcinoma|recurrent hypersomnia|autoimmune thyroiditis,ppi
1209,1266,7039,TGFA,transforming growth factor alpha,17,epidermal growth factor receptor binding|growth factor activity,lung cancer|non-small cell lung carcinoma|head and neck cancer|primary pulmonary hypertension|pulmonary hypertension|tooth agenesis|anodontia|liver cancer|prostate cancer|prostate carcinoma|pustulosis of palm and sole|psoriasis|parapsoriasis|pulmonary edema|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|stomach cancer|hepatocellular carcinoma|hepatoblastoma,ppi
1210,1267,7040,TGFB1,transforming growth factor beta 1,103,type II transforming growth factor beta receptor binding|cytokine activity|transforming growth factor beta receptor binding|type I transforming growth factor beta receptor binding|type III transforming growth factor beta receptor binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|aortic valve insufficiency|asthma|intrinsic asthma|allergic asthma|berylliosis|bipolar disorder|calcium metabolism disease|nephrocalcinosis|calcinosis|tongue squamous cell carcinoma|squamous cell carcinoma|carcinosarcoma|primary biliary cirrhosis|isolated cleft palate|cleft palate,ppi
1211,1268,7041,TGFB1I1,transforming growth factor beta 1 induced transcript 1,42,transcription coactivator activity|androgen receptor binding,,ppi
1212,1269,7042,TGFB2,transforming growth factor beta 2,18,amyloid-beta binding|signaling receptor binding|type II transforming growth factor beta receptor binding|cytokine activity|transforming growth factor beta receptor binding|type III transforming growth factor beta receptor binding|protein homodimerization activity|protein heterodimerization activity,aortic valve insufficiency|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis|isolated cleft palate|cleft palate|endometriosis of uterus|endometriosis|microphthalmia|clubfoot|glaucoma|congenital heart disease|inguinal hernia|hypertension|essential hypertension|congestive heart failure,ppi
1213,1270,7043,TGFB3,transforming growth factor beta 3,14,type II transforming growth factor beta receptor binding|type I transforming growth factor beta receptor binding|type III transforming growth factor beta receptor binding|identical protein binding|transforming growth factor beta binding|transforming growth factor beta receptor binding|cytokine activity,aortic valve insufficiency|isolated cleft palate|cleft palate|enophthalmos|orbital disease|exophthalmos|alternating exotropia|exotropia|monocular exotropia|clubfoot|inguinal hernia|hypertension|essential hypertension|congestive heart failure|mitral valve insufficiency|mitral valve prolapse|placental insufficiency|thoracic aortic aneurysm|Loeys-Dietz syndrome|arrhythmogenic right ventricular dysplasia 1,ppi
1214,1271,741,ZNHIT2,zinc finger HIT-type containing 2,30,,,ppi
1215,1272,7045,TGFBI,transforming growth factor beta induced,10,extracellular matrix structural constituent|cell adhesion molecule binding,corneal dystrophy|corneal ulcer|corneal granular dystrophy|macular corneal dystrophy|ophthalmoplegia|mechanical strabismus|hypertropia|blindness|asthenopia|cataract|recurrent corneal erosion|Meesmann corneal dystrophy|Reis-Bucklers corneal dystrophy|epithelial basement membrane dystrophy|granular corneal dystrophy type II|Thiel-Behnke corneal dystrophy,ppi
1216,1273,7046,TGFBR1,transforming growth factor beta receptor 1,184,protein kinase activity|protein serine/threonine kinase activity|transforming growth factor beta-activated receptor activity|transforming growth factor beta receptor activity; type I|type II transforming growth factor beta receptor binding|ATP binding|SMAD binding|transforming growth factor beta binding|growth factor binding|activin binding,aortic aneurysm|aortic valve insufficiency|large intestine cancer|colorectal cancer|craniosynostosis|patent ductus arteriosus|clubfoot|hypertension|essential hypertension|congestive heart failure|skin benign neoplasm|skin cancer|kidney failure|uremia|isolated cleft palate|thoracic aortic aneurysm|Loeys-Dietz syndrome|autosomal dominant auditory neuropathy 1|coronary artery disease|arterial tortuosity syndrome,ppi
1217,1274,7048,TGFBR2,transforming growth factor beta receptor 2,103,transmembrane receptor protein serine/threonine kinase activity|transforming growth factor beta-activated receptor activity|glycosaminoglycan binding|SMAD binding|transforming growth factor beta binding|transforming growth factor beta receptor activity; type II|activin binding|type I transforming growth factor beta receptor binding|growth factor binding,generalized anxiety disorder|anxiety disorder|aortic aneurysm|aortic valve insufficiency|bone disease|cartilage disease|connective tissue disease|bone cancer|colon cancer|colonic benign neoplasm|large intestine cancer|tongue squamous cell carcinoma|squamous cell carcinoma|clubfoot|Lynch syndrome|constipation|craniosynostosis|neurotic disorder|major depressive disorder|mental depression,ppi
1218,1275,7049,TGFBR3,transforming growth factor beta receptor 3,30,transforming growth factor beta-activated receptor activity|type II transforming growth factor beta receptor binding|transforming growth factor beta receptor binding|glycosaminoglycan binding|heparin binding|coreceptor activity|PDZ domain binding|SMAD binding|transforming growth factor beta binding|transforming growth factor beta receptor activity; type III,intracranial berry aneurysm,ppi
1219,1276,7050,TGIF1,TGFB induced factor homeobox 1,30,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity,ptosis|congenital ptosis|holoprosencephaly|hypotrichosis,ppi
1220,1277,7051,TGM1,transglutaminase 1,38,protein-glutamine gamma-glutamyltransferase activity,alopecia|sensorineural hearing loss|xerophthalmia|dry eye syndrome|ectropion|hypohidrosis|anhidrosis|hypotrichosis|ichthyosis|autosomal recessive congenital ichthyosis 1|congenital ichthyosiform erythroderma|keratosis follicularis|pseudoxanthoma elasticum|mongolian spot|keratitis|keratoconjunctivitis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|gallbladder disease|liver disease,ppi
1221,1278,7052,TGM2,transglutaminase 2,108,protein-glutamine gamma-glutamyltransferase activity,bipolar disorder|brain cancer|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|celiac disease|esophageal cancer|glioblastoma multiforme|giant cell glioblastoma|hypertension|essential hypertension|arthropathy|arthritis|schizophrenia|breast cancer,ppi
1222,1279,7053,TGM3,transglutaminase 3,32,protein-glutamine gamma-glutamyltransferase activity|catalytic activity|calcium ion binding|transferase activity; transferring acyl groups,,ppi
1223,1280,7047,TGM4,transglutaminase 4,6,protein-glutamine gamma-glutamyltransferase activity,,ppi
1224,1281,9333,TGM5,transglutaminase 5,11,protein-glutamine gamma-glutamyltransferase activity,dermatitis|ichthyosis|granuloma annulare|allergic hypersensitivity disease|peeling skin syndrome,ppi
1225,1282,7054,TH,tyrosine hydroxylase,23,tyrosine 3-monooxygenase activity,alcohol dependence|alcohol abuse|bipolar disorder|ptosis|congenital ptosis|brain disease|subacute delirium|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|heart disease|cardiovascular system disease|intellectual disability|learning disability|neuroblastoma|adrenal gland cancer,ppi
1226,1283,7056,THBD,thrombomodulin,6,signaling receptor activity,purpura fulminans|disseminated intravascular coagulation|acute promyelocytic leukemia|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|pulmonary embolism|thrombotic thrombocytopenic purpura|adult respiratory distress syndrome|newborn respiratory distress syndrome|stomach cancer|thrombophilia|protein S deficiency|antithrombin III deficiency|protein C deficiency|hemolytic-uremic syndrome,ppi
1227,1284,7057,THBS1,thrombospondin 1,56,phosphatidylserine binding|fibronectin binding|integrin binding|extracellular matrix structural constituent|calcium ion binding|protein binding|heparin binding|fibroblast growth factor binding|low-density lipoprotein particle binding|identical protein binding|laminin binding|proteoglycan binding|transforming growth factor beta binding|fibrinogen binding|collagen V binding,diabetic angiopathy|diabetic cataract|diabetic retinopathy|liver cirrhosis|interstitial nephritis|pyelonephritis|pyelitis|schizophrenia|breast cancer,ppi
1228,1285,7058,THBS2,thrombospondin 2,14,protein binding,diabetic ketoacidosis|diabetes mellitus|diabetic angiopathy,ppi
1229,1286,7059,THBS3,thrombospondin 3,69,calcium ion binding|heparin binding,,ppi
1230,1287,7060,THBS4,thrombospondin 4,2,integrin binding|calcium ion binding|heparin binding|laminin-1 binding|collagen binding|fibronectin binding|protein binding,,ppi
1231,1288,7062,TCHH,trichohyalin,6,calcium ion binding,,ppi
1232,1289,7064,THOP1,thimet oligopeptidase 1,44,metalloendopeptidase activity,,ppi
1233,1290,7066,THPO,thrombopoietin,4,growth factor activity|signaling receptor binding,hypertension|essential hypertension|myeloproliferative neoplasm|bone marrow cancer|essential thrombocythemia|thrombophilia|thrombocytosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|vertebrobasilar insufficiency|transient cerebral ischemia|blood coagulation disease,ppi
1234,1291,7067,THRA,thyroid hormone receptor; alpha,97,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|thyroid hormone receptor activity|TBP-class protein binding|transcription regulatory region DNA binding|thyroid hormone binding|nuclear receptor transcription coactivator activity|nuclear receptor activity|transcription regulatory region sequence-specific DNA binding|signaling receptor activity|transcription factor binding|RNA polymerase II regulatory region sequence-specific DNA binding,anemia|macrocytic anemia|constipation|congenital hypothyroidism|myxedema|hypothyroidism|endometriosis of uterus|endometriosis|hiatus hernia|congenital diaphragmatic hernia|umbilical hernia|omphalocele|thyroid hormone resistance syndrome,ppi
1235,1292,7068,THRB,thyroid hormone receptor beta,77,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription corepressor activity|thyroid hormone receptor activity|thyroid hormone binding|signaling receptor activity|transcription factor binding|transcription regulatory region sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|nuclear receptor activity|nuclear receptor transcription coactivator activity,constipation|sensorineural hearing loss|enophthalmos|orbital disease|exophthalmos|goiter|nontoxic goiter|thyroid gland disease|hiatus hernia|congenital diaphragmatic hernia|umbilical hernia|omphalocele|Graves' disease|thyrotoxicosis|hyperthyroidism|congenital hypothyroidism|myxedema|hypothyroidism|humeroradial synostosis|cleidocranial dysplasia,ppi
1236,1293,50,ACO2,aconitase 2,51,aconitate hydratase activity|iron ion binding|4 iron; 4 sulfur cluster binding,cerebellar disease|epilepsy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|adult respiratory distress syndrome|newborn respiratory distress syndrome|visual epilepsy|syndromic X-linked intellectual disability 94|ophthalmoplegia|mechanical strabismus|hypertropia|blindness|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia,ppi
1237,1294,744,MPPED2,metallophosphoesterase domain containing 2,11,,,ppi
1238,1295,7069,THRSP,thyroid hormone responsive,23,,,ppi
1239,1296,7070,THY1,Thy-1 cell surface antigen,28,GTPase activator activity|integrin binding|GPI anchor binding|protein kinase binding,retinitis|retinal disease,ppi
1240,1297,7072,TIA1,TIA1 cytotoxic granule associated RNA binding protein,56,RNA binding|poly(A) binding,familial periodic paralysis|myopathy|distal muscular dystrophy,ppi
1241,1298,9220,TIAF1,TGFB1-induced anti-apoptotic factor 1,6,,,ppi
1242,1299,7073,TIAL1,TIA1 cytotoxic granule associated RNA binding protein like 1,80,RNA binding,,ppi
1243,1300,7074,TIAM1,T-cell lymphoma invasion and metastasis 1,40,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|Rac guanyl-nucleotide exchange factor activity,amyotrophic lateral sclerosis type 1,ppi
1244,1301,26230,TIAM2,T-cell lymphoma invasion and metastasis 2,10,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,substance abuse|substance-related disorder,ppi
1245,1302,9093,DNAJA3,DnaJ heat shock protein family (Hsp40) member A3,99,,,ppi
1246,1303,7075,TIE1,tyrosine kinase with immunoglobulin like and EGF like domains 1,16,protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,,ppi
1247,1304,745,MYRF,myelin regulatory factor,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
1248,1305,7071,KLF10,Kruppel like factor 10,22,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|core promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1249,1306,8462,KLF11,Kruppel like factor 11,16,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding,alcohol dependence|alcohol abuse|diabetes mellitus|type 2 diabetes mellitus|maturity-onset diabetes of the young,ppi
1250,1307,8805,TRIM24,tripartite motif containing 24,73,chromatin binding|transcription coactivator activity|protein tyrosine kinase activity|ubiquitin-protein transferase activity|signaling receptor binding|zinc ion binding|estrogen response element binding|lysine-acetylated histone binding|methylated histone binding,papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma|liver cancer|hepatocellular carcinoma,ppi
1251,1308,8914,TIMELESS,timeless circadian clock,34,DNA binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|mood disorder,ppi
1252,1309,26519,TIMM10,translocase of inner mitochondrial membrane 10,22,transporter activity|zinc ion binding|protein transporter activity,rhabdomyosarcoma,ppi
1253,1310,26517,TIMM13,translocase of inner mitochondrial membrane 13,74,zinc ion binding|protein transporter activity,,ppi
1254,1311,1678,TIMM8A,translocase of inner mitochondrial membrane 8 homolog A (yeast),17,,dystonia|myopia|optic atrophy|blindness|asthenopia|cortical blindness|deafness dystonia syndrome,ppi
1255,1312,26521,TIMM8B,translocase of inner mitochondrial membrane 8 homolog B,16,zinc ion binding,,ppi
1256,1313,26520,TIMM9,translocase of inner mitochondrial membrane 9,28,transporter activity|zinc ion binding,,ppi
1257,1314,7076,TIMP1,TIMP metallopeptidase inhibitor 1,15,cytokine activity|metalloendopeptidase inhibitor activity|zinc ion binding|peptidase inhibitor activity|protease binding,aortic valve insufficiency|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|calcium metabolism disease|nephrocalcinosis|calcinosis|primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis|diabetes mellitus|type 2 diabetes mellitus|IgA glomerulonephritis|heart disease|cardiovascular system disease|heart valve disease|iron metabolism disease|hemochromatosis|Wilson disease,ppi
1258,1315,7077,TIMP2,TIMP metallopeptidase inhibitor 2,27,zinc ion binding|peptidase inhibitor activity|protease binding|metalloendopeptidase inhibitor activity,calcium metabolism disease|nephrocalcinosis|calcinosis|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|pleural disease,ppi
1259,1316,7078,TIMP3,TIMP metallopeptidase inhibitor 3,28,metalloendopeptidase inhibitor activity|protease binding,asthma|intrinsic asthma|allergic asthma|bladder disease|colitis|ileitis|ileocolitis|gastroenteritis|gallbladder disease|liver disease|enterobiasis|trichinosis|stomach cancer|toxic encephalopathy|age related macular degeneration|macular degeneration|degeneration of macula and posterior pole,ppi
1260,1317,7079,TIMP4,TIMP metallopeptidase inhibitor 4,3,metalloendopeptidase inhibitor activity|protease binding,prostate cancer|prostate carcinoma|schizophrenia,ppi
1261,1318,26277,TINF2,TERF1 interacting nuclear factor 2,116,telomeric DNA binding|DNA binding,alopecia|anemia|macrocytic anemia|aplastic anemia|blood coagulation disease|bone marrow disease|cerebellar disease|cryptorchidism|sensorineural hearing loss|dental caries|placental insufficiency|gingival disease|epulis|hemorrhagic disease|tooth agenesis|anodontia|primary immunodeficiency disease|leukopenia|hereditary mucosal leukokeratosis|oral mucosa leukoplakia,ppi
1262,1319,7080,NKX2-1,NK2 homeobox 1,21,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II regulatory region DNA binding|intronic transcription regulatory region sequence-specific DNA binding|DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding|intronic transcription regulatory region DNA binding,generalized anxiety disorder|anxiety disorder|cerebellar disease|syndromic X-linked intellectual disability type 10|choreatic disease|congenital hypothyroidism|myxedema|hypothyroidism|dystonia|hiatus hernia|congenital diaphragmatic hernia|lung disease|basal ganglia disease|focal hand dystonia|blepharospasm|papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma,ppi
1263,1320,7082,TJP1,tight junction protein 1,126,cadherin binding,,ppi
1264,1321,9414,TJP2,tight junction protein 2,73,guanylate kinase activity|protein binding; bridging|cadherin binding,intrahepatic cholestasis|portal hypertension|osteomalacia|rickets|steatorrhea|vitamin K deficiency hemorrhagic disease|sensorineural hearing loss,ppi
1265,1322,27134,TJP3,tight junction protein 3,7,,prostate cancer|prostate carcinoma,ppi
1266,1324,7083,TK1,thymidine kinase 1,177,zinc ion binding|nucleoside kinase activity|thymidine kinase activity,large intestine cancer|colorectal cancer,ppi
1267,1325,7084,TK2,thymidine kinase 2; mitochondrial,6,nucleoside kinase activity|deoxynucleoside kinase activity,lactic acidosis|basal ganglia disease|sensorineural hearing loss|epilepsy|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|mitochondrial DNA depletion syndrome 2|mitochondrial DNA depletion syndrome 3,ppi
1268,1326,7086,TKT,transketolase,180,transketolase activity|protein homodimerization activity|cofactor binding,alcohol dependence|alcohol abuse|Wernicke encephalopathy|Wernicke-Korsakoff syndrome,ppi
1269,1327,8277,TKTL1,transketolase like 1,5,,,ppi
1270,1328,7088,TLE1,transducin like enhancer of split 1,116,transcription corepressor activity|transcription factor binding|repressing transcription factor binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
1271,1329,7089,TLE2,transducin like enhancer of split 2,25,transcription corepressor activity|repressing transcription factor binding,,ppi
1272,1330,7090,TLE3,transducin like enhancer of split 3,74,transcription corepressor activity|repressing transcription factor binding,rheumatoid arthritis|breast cancer|amyotrophic lateral sclerosis type 1,ppi
1273,1331,57102,C12orf4,chromosome 12 open reading frame 4,3,,,ppi
1274,1332,7091,TLE4,transducin like enhancer of split 4,32,transcription corepressor activity|repressing transcription factor binding,coronary artery disease,ppi
1275,1333,9874,TLK1,tousled like kinase 1,22,protein serine/threonine kinase activity|ATP binding,salivary gland adenoid cystic carcinoma,ppi
1276,1334,11011,TLK2,tousled like kinase 2,25,protein serine/threonine kinase activity|ATP binding,,ppi
1277,1335,7092,TLL1,tolloid like 1,3,metalloendopeptidase activity|serine-type endopeptidase activity,atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|schizophrenia,ppi
1278,1336,7093,TLL2,tolloid like 2,1,serine-type endopeptidase activity,bipolar disorder,ppi
1279,1337,7094,TLN1,talin 1,101,structural constituent of cytoskeleton|cadherin binding,osteoporosis,ppi
1280,1338,7095,SEC62,SEC62 homolog; preprotein translocation factor,23,signaling receptor activity,,ppi
1281,1339,7096,TLR1,toll like receptor 1,17,transmembrane signaling receptor activity|signaling receptor activity|protein heterodimerization activity|lipopeptide binding|Toll-like receptor 2 binding,leprosy,ppi
1282,1340,7097,TLR2,toll like receptor 2,46,lipopolysaccharide binding|amyloid-beta binding|lipopolysaccharide receptor activity|signaling pattern recognition receptor activity|signaling receptor activity|triacyl lipopeptide binding|peptidoglycan binding|protein heterodimerization activity,rheumatoid arthritis|bipolar disorder|large intestine cancer|colorectal cancer|hypereosinophilic syndrome|keratitis|keratoconjunctivitis|leprosy|schizophrenia|alcohol abuse|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
1283,1341,7098,TLR3,toll like receptor 3,32,double-stranded RNA binding|transmembrane signaling receptor activity|signaling receptor activity,schizophrenia|age related macular degeneration 1,ppi
1284,1342,57103,TIGAR,TP53 induced glycolysis regulatory phosphatase,11,bisphosphoglycerate 2-phosphatase activity|fructose-2;6-bisphosphate 2-phosphatase activity,schizophrenia,ppi
1285,1343,7099,TLR4,toll like receptor 4,44,lipopolysaccharide binding|lipopolysaccharide receptor activity|transmembrane signaling receptor activity|signaling receptor activity,arthropathy|arthritis|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|Behcet's disease|bipolar disorder|large intestine cancer|colorectal cancer|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|contact dermatitis|occupational dermatitis|diabetic autonomic neuropathy|diabetic polyneuropathy|diabetic neuropathy,ppi
1286,1344,7100,TLR5,toll like receptor 5,16,,Legionnaires' disease|systemic lupus erythematosus|prostate cancer|prostate carcinoma,ppi
1287,1345,4071,TM4SF1,transmembrane 4 L six family member 1,8,,,ppi
1288,1346,7102,TSPAN7,tetraspanin 7,8,,intellectual disability|learning disability|non-syndromic X-linked intellectual disability,ppi
1289,1348,7104,TM4SF4,transmembrane 4 L six family member 4,3,,gallbladder disease|liver disease,ppi
1290,1350,7105,TSPAN6,tetraspanin 6,19,,,ppi
1291,1351,7106,TSPAN4,tetraspanin 4,9,antigen binding,,ppi
1292,1352,57097,PARP11,poly(ADP-ribose) polymerase family member 11,10,NAD+ ADP-ribosyltransferase activity,,ppi
1293,1353,53346,TM6SF1,transmembrane 6 superfamily member 1,1,protein binding,,ppi
1294,1355,7107,GPR137B,G protein-coupled receptor 137B,6,,,ppi
1295,1356,7108,TM7SF2,transmembrane 7 superfamily member 2,3,delta14-sterol reductase activity|NADP binding,,ppi
1296,1357,10548,TM9SF1,transmembrane 9 superfamily member 1,9,,,ppi
1297,1358,9375,TM9SF2,transmembrane 9 superfamily member 2,14,,,ppi
1298,1359,8577,TMEFF1,transmembrane protein with EGF like and two follistatin like domains 1,27,,,ppi
1299,1360,23671,TMEFF2,transmembrane protein with EGF like and two follistatin like domains 2,1,,polycystic ovary syndrome|prostate cancer|prostate carcinoma,ppi
1300,1361,7109,TRAPPC10,trafficking protein particle complex 10,32,Rab guanyl-nucleotide exchange factor activity,seborrheic keratosis|skin disease|actinic keratosis,ppi
1301,1362,23670,TMEM2,transmembrane protein 2,15,hyalurononglucosaminidase activity|calcium ion binding|cadherin binding,,ppi
1302,1363,11161,C14orf1,chromosome 14 open reading frame 1,66,protein binding; bridging,,ppi
1303,1364,7110,TMF1,TATA element modulatory factor 1,20,transcription coregulator activity,polycystic ovary syndrome|prostate cancer|prostate carcinoma,ppi
1304,1365,7111,TMOD1,tropomodulin 1,50,actin binding|tropomyosin binding,prostate cancer|prostate carcinoma,ppi
1305,1366,29767,TMOD2,tropomodulin 2,29,tropomyosin binding,,ppi
1306,1367,29766,TMOD3,tropomodulin 3,110,cadherin binding involved in cell-cell adhesion|tropomyosin binding,,ppi
1307,1368,29765,TMOD4,tropomodulin 4,22,tropomyosin binding,,ppi
1308,1369,7112,TMPO,thymopoietin,128,lamin binding|cadherin binding,rheumatoid arthritis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
1309,1370,7113,TMPRSS2,transmembrane protease; serine 2,1,serine-type peptidase activity,prostate cancer|prostate carcinoma,ppi
1310,1371,64699,TMPRSS3,transmembrane protease; serine 3,32,serine-type endopeptidase activity|sodium channel regulator activity,asbestosis|anthracosilicosis|pneumoconiosis|siderosis|bagassosis|autosomal recessive nonsyndromic deafness 8,ppi
1311,1372,56649,TMPRSS4,transmembrane protease; serine 4,4,serine-type endopeptidase activity,,ppi
1312,1373,9168,TMSB10,thymosin beta 10,18,actin monomer binding,bipolar disorder|schizophrenia|allergic contact dermatitis,ppi
1313,1374,9556,C14orf2,chromosome 14 open reading frame 2,2,,,ppi
1314,1375,7114,TMSB4X,thymosin beta 4; X-linked,40,RNA binding|actin monomer binding,prostate cancer|prostate carcinoma|amyotrophic lateral sclerosis type 1,ppi
1315,1376,9087,TMSB4Y,thymosin beta 4; Y-linked,6,actin monomer binding,,ppi
1316,1377,10598,AHSA1,activator of HSP90 ATPase activity 1,192,ATPase activator activity|cadherin binding|chaperone binding,,ppi
1317,1378,7123,CLEC3B,C-type lectin domain family 3 member B,17,calcium ion binding|heparin binding,,ppi
1318,1379,7124,TNF,tumor necrosis factor,117,RNA polymerase II regulatory region sequence-specific DNA binding|cytokine activity|tumor necrosis factor receptor binding|identical protein binding|transcription regulatory region DNA binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|proteinuria|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration,ppi
1319,1380,7126,TNFAIP1,TNF alpha induced protein 1,48,GTP-Rho binding|ubiquitin-protein transferase activity,,ppi
1320,1381,7127,TNFAIP2,TNF alpha induced protein 2,7,SNARE binding,rheumatoid arthritis,ppi
1321,1382,7128,TNFAIP3,TNF alpha induced protein 3,89,ubiquitin-protein transferase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|protein self-association|Lys63-specific deubiquitinase activity|K63-linked polyubiquitin modification-dependent protein binding,rheumatoid arthritis|systemic lupus erythematosus|multiple sclerosis|pustulosis of palm and sole|psoriasis|parapsoriasis|cutaneous T cell lymphoma|Sjogren's syndrome|keratoconjunctivitis sicca,ppi
1322,1383,7130,TNFAIP6,TNF alpha induced protein 6,18,,influenza|seborrheic keratosis|skin disease|actinic keratosis|allergic contact dermatitis|middle cerebral artery infarction,ppi
1323,1384,51,ACOX1,acyl-CoA oxidase 1,43,acyl-CoA oxidase activity|PDZ domain binding|flavin adenine dinucleotide binding|fatty acid binding|palmitoyl-CoA oxidase activity,dystonia|epilepsy|sensorineural hearing loss|tooth agenesis|anodontia|leukodystrophy|myopia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|visual epilepsy|syndromic X-linked intellectual disability 94|speech disorder|ophthalmoplegia|mechanical strabismus,ppi
1324,1386,8797,TNFRSF10A,TNF receptor superfamily member 10a,58,death receptor activity|signaling receptor activity|TRAIL binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|alopecia|anemia|macrocytic anemia|colon cancer|colonic benign neoplasm|esophageal cancer|neutropenia|agranulocytosis|severe congenital neutropenia|polyneuropathy|peripheral nervous system disease|neuropathy|prostate cancer|prostate carcinoma|thrombocytopenia,ppi
1325,1387,8795,TNFRSF10B,TNF receptor superfamily member 10b,65,signaling receptor activity|TRAIL binding,tongue squamous cell carcinoma|squamous cell carcinoma|pancreatic cancer|squamous cell neoplasm|head and neck squamous cell carcinoma,ppi
1326,1388,8794,TNFRSF10C,TNF receptor superfamily member 10c,11,transmembrane signaling receptor activity,,ppi
1327,1389,8793,TNFRSF10D,TNF receptor superfamily member 10d,45,transmembrane signaling receptor activity,,ppi
1328,1390,8792,TNFRSF11A,TNF receptor superfamily member 11a,18,transmembrane signaling receptor activity|tumor necrosis factor-activated receptor activity|signaling receptor activity,anemia|macrocytic anemia|chronic lymphocytic leukemia|Richter's syndrome|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|Paget's disease of bone|osteopetrosis|osteosclerosis|osteosarcoma|bone osteosarcoma,ppi
1329,1391,4982,TNFRSF11B,TNF receptor superfamily member 11b,7,cytokine activity|signaling receptor activity,angioid streaks|rheumatoid arthritis|sensorineural hearing loss|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hypertension|essential hypertension|optic atrophy|osteoporosis|osteopetrosis|osteosclerosis|kidney failure|uremia|hyperphosphatemia|hyperuricemia,ppi
1330,1392,23741,EID1,EP300 interacting inhibitor of differentiation 1,50,transcription corepressor activity|histone acetyltransferase regulator activity|histone acetyltransferase binding,malignant mesothelioma|benign mesothelioma,ppi
1331,1393,8718,TNFRSF25,TNF receptor superfamily member 25,9,tumor necrosis factor-activated receptor activity|signaling receptor activity,,ppi
1332,1394,8764,TNFRSF14,TNF receptor superfamily member 14,78,tumor necrosis factor-activated receptor activity,rheumatoid arthritis|celiac disease,ppi
1333,1395,608,TNFRSF17,TNF receptor superfamily member 17,17,,,ppi
1334,1396,8784,TNFRSF18,TNF receptor superfamily member 18,6,,leishmaniasis,ppi
1335,1397,55504,TNFRSF19,TNF receptor superfamily member 19,42,tumor necrosis factor-activated receptor activity|signaling receptor activity,melanoma|skin melanoma|nasopharynx carcinoma,ppi
1336,1398,7132,TNFRSF1A,TNF receptor superfamily member 1A,237,tumor necrosis factor-activated receptor activity|tumor necrosis factor binding,amyloidosis|arthropathy|arthritis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|brain ischemia|constipation|cystic fibrosis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetes mellitus|type 2 diabetes mellitus|congestive heart failure|erysipelas|exanthem|allergic hypersensitivity disease,ppi
1337,1399,7133,TNFRSF1B,TNF receptor superfamily member 1B,117,,alopecia|autistic disorder|skin benign neoplasm|skin cancer|brain ischemia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetes mellitus|type 2 diabetes mellitus|dermatitis|exanthem|allergic hypersensitivity disease|primary immunodeficiency disease|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|liver cirrhosis,ppi
1338,1400,7293,TNFRSF4,TNF receptor superfamily member 4,8,tumor necrosis factor-activated receptor activity|protein binding,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|primary immunodeficiency disease|pancytopenia,ppi
1339,1401,958,CD40,CD40 molecule,55,signaling receptor activity,rheumatoid arthritis|primary immunodeficiency disease|Kawasaki disease|multiple sclerosis|status epilepticus|immunoglobulin alpha deficiency|selective IgA deficiency disease|selective IgG deficiency disease|X-linked hyper IgM syndrome|breast cancer|CD40 deficiency,ppi
1340,1402,26589,MRPL46,mitochondrial ribosomal protein L46,44,structural constituent of ribosome,,ppi
1341,1403,355,FAS,Fas cell surface death receptor,113,calmodulin binding|signaling receptor activity,fetal erythroblastosis|autoimmune hemolytic anemia|agnosia|arthropathy|arthritis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|Behcet's disease|urinary bladder cancer|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z,ppi
1342,1404,8771,TNFRSF6B,TNF receptor superfamily member 6b,6,signaling receptor activity,,ppi
1343,1405,939,CD27,CD27 molecule,33,transmembrane signaling receptor activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|protein binding,agammaglobulinemia|lymphoproliferative syndrome 2,ppi
1344,1406,943,TNFRSF8,TNF receptor superfamily member 8,26,transmembrane signaling receptor activity,Hodgkin's lymphoma; lymphocytic-histiocytic predominance|Hodgkin's lymphoma|Hodgkin's lymphoma; lymphocytic depletion|Hodgkin's granuloma|Hodgkin's lymphoma; mixed cellularity|malignant mesothelioma|benign mesothelioma,ppi
1345,1407,3604,TNFRSF9,TNF receptor superfamily member 9,12,signaling receptor activity,colon cancer|colonic benign neoplasm|kidney cancer|stomach cancer,ppi
1346,1408,8743,TNFSF10,tumor necrosis factor superfamily member 10,20,signaling receptor binding|zinc ion binding|identical protein binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|endometrial cancer|endometrial carcinoma|glioblastoma multiforme|giant cell glioblastoma|malignant glioma|gliosarcoma|mixed glioma|influenza|kidney cancer,ppi
1347,1409,8600,TNFSF11,tumor necrosis factor superfamily member 11,38,cytokine activity|tumor necrosis factor receptor binding|tumor necrosis factor receptor superfamily binding,anemia|macrocytic anemia|chronic rhinitis|craniosynostosis|sensorineural hearing loss|dental caries|Camurati-Engelmann disease|Bell's palsy|facial paralysis|facial nerve disease|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|chronic lymphocytic leukemia|Richter's syndrome|spontaneous ocular nystagmus,ppi
1348,1410,8742,TNFSF12,tumor necrosis factor superfamily member 12,9,signaling receptor binding,hemolytic anemia|imperforate anus|bronchiectasis|common variable immunodeficiency|primary immunodeficiency disease|lymphopenia|pneumonia|purpura|agammaglobulinemia|liver disease|craniosynostosis|thrombocytopenia|thrombocytopenia due to platelet alloimmunization|autoimmune thrombocytopenic purpura|otitis media|Evans' syndrome,ppi
1349,1411,8741,TNFSF13,tumor necrosis factor superfamily member 13,13,signaling receptor binding,large intestine cancer|colorectal cancer|IgA glomerulonephritis|schizophrenia,ppi
1350,1412,10673,TNFSF13B,tumor necrosis factor superfamily member 13b,50,signaling receptor binding,mood disorder,ppi
1351,1413,8740,TNFSF14,tumor necrosis factor superfamily member 14,9,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,rheumatoid arthritis|multiple sclerosis,ppi
1352,1414,9966,TNFSF15,tumor necrosis factor superfamily member 15,2,signaling receptor binding,primary biliary cirrhosis|inflammatory bowel disease|ulcerative colitis|colitis|ileitis|ileocolitis|gastroenteritis|intestinal infectious disease|portal hypertension|multiple system atrophy|liver cirrhosis|goiter|thyroid gland disease|dermatographia|liver cancer|hepatocellular carcinoma,ppi
1353,1415,8995,TNFSF18,tumor necrosis factor superfamily member 18,1,signaling receptor binding|tumor necrosis factor receptor superfamily binding,,ppi
1354,1416,7292,TNFSF4,tumor necrosis factor superfamily member 4,2,signaling receptor binding|tumor necrosis factor receptor superfamily binding,narcolepsy|systemic lupus erythematosus|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|Balo concentric sclerosis|adrenoleukodystrophy|central nervous system disease|transient global amnesia,ppi
1355,1417,959,CD40LG,CD40 ligand,13,,progressive muscular atrophy|amyotrophic lateral sclerosis|hemolytic anemia|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|dysgammaglobulinemia|gingivitis|hepatitis|allergic hypersensitivity disease|primary pulmonary hypertension|pulmonary hypertension|primary immunodeficiency disease|pneumonia|ulcerative stomatitis|denture stomatitis|stomatitis|thrombocytopenia|immunoglobulin alpha deficiency|selective IgA deficiency disease|selective IgG deficiency disease,ppi
1356,1418,356,FASLG,Fas ligand,93,signaling receptor binding,fetal erythroblastosis|autoimmune hemolytic anemia|rheumatoid arthritis|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|lung cancer|non-small cell lung carcinoma|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E,ppi
1357,1419,970,CD70,CD70 molecule,79,signaling receptor binding,,ppi
1358,1420,944,TNFSF8,tumor necrosis factor superfamily member 8,37,signaling receptor binding,,ppi
1359,1421,8744,TNFSF9,tumor necrosis factor superfamily member 9,31,signaling receptor binding|tumor necrosis factor receptor superfamily binding,contact dermatitis|occupational dermatitis|stomach cancer,ppi
1360,1422,8711,TNK1,tyrosine kinase non receptor 1,22,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|ATP binding,,ppi
1361,1423,8658,TNKS,tankyrase,48,NAD+ ADP-ribosyltransferase activity|zinc ion binding,,ppi
1362,1424,7134,TNNC1,troponin C1; slow skeletal and cardiac type,12,calcium ion binding|troponin I binding|protein homodimerization activity|actin filament binding|calcium-dependent protein binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
1363,1425,7125,TNNC2,troponin C2; fast skeletal type,5,actin binding|calcium ion binding|calcium-dependent protein binding|actin filament binding,,ppi
1364,1426,7135,TNNI1,troponin I1; slow skeletal type,17,,,ppi
1365,1427,7136,TNNI2,troponin I2; fast skeletal type,20,actin binding,clubfoot|familial periodic paralysis|myopathy|distal arthrogryposis,ppi
1366,1428,7137,TNNI3,troponin I3; cardiac type,22,actin binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
1367,1429,7138,TNNT1,troponin T1; slow skeletal type,64,tropomyosin binding|troponin T binding|calcium ion binding|protein binding|calcium-dependent ATPase activity,familial periodic paralysis|myopathy|nemaline myopathy,ppi
1368,1430,7139,TNNT2,troponin T2; cardiac type,10,actin binding|tropomyosin binding|troponin C binding|troponin I binding|calcium-dependent ATPase activity|protein binding|calcium ion binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
1369,1431,7140,TNNT3,troponin T3; fast skeletal type,11,tropomyosin binding|calcium-dependent protein binding|actin binding|calcium-dependent ATPase activity|troponin I binding|troponin C binding|protein binding|calcium ion binding,clubfoot|distal arthrogryposis,ppi
1370,1432,7141,TNP1,transition protein 1,9,DNA binding,,ppi
1371,1433,7142,TNP2,transition protein 2,12,zinc ion binding,,ppi
1372,1434,7143,TNR,tenascin R,16,,,ppi
1373,1435,171017,ZNF384,zinc finger protein 384,13,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
1374,1436,9968,MED12,mediator complex subunit 12,91,transcription coregulator activity|transcription coactivator activity|nuclear receptor transcription coactivator activity|signaling receptor activity|vitamin D receptor binding|thyroid hormone receptor binding,imperforate anus|autistic disorder|blepharophimosis|ptosis|congenital ptosis|choanal atresia|cleft lip|isolated cleft palate|cleft palate|constipation|pseudosarcomatous fibromatosis|cryptorchidism|benign breast phyllodes tumor|breast malignant phyllodes tumor|sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia,ppi
1375,1437,57634,EP400,E1A binding protein p400,50,,,ppi
1376,1438,26058,GIGYF2,GRB10 interacting GYF protein 2,74,RNA binding|cadherin binding|proline-rich region binding,Parkinson's disease,ppi
1377,1439,84629,TNRC18,trinucleotide repeat containing 18,17,,,ppi
1378,1441,11189,CELF3,CUGBP; Elav-like family member 3,10,RNA binding|pre-mRNA binding|mRNA binding,,ppi
1379,1442,10695,CNPY3,canopy FGF signaling regulator 3,26,signaling receptor binding,,ppi
1380,1443,27327,TNRC6A,trinucleotide repeat containing 6A,44,RNA binding,,ppi
1381,1444,27324,TOX3,TOX high mobility group box family member 3,3,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|estrogen response element binding|protein homodimerization activity,male breast cancer|breast cancer,ppi
1382,1445,7145,TNS1,tensin 1,28,RNA binding,,ppi
1383,1446,7148,TNXB,tenascin XB,7,integrin binding|extracellular matrix structural constituent|heparin binding,sick sinus syndrome|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|clubfoot|mitral valve insufficiency|mitral valve prolapse|arthropathy|arthritis|schizophrenia|central nervous system origin vertigo|vesicoureteral reflux|migraine|sensory peripheral neuropathy|fibromyalgia|myositis,ppi
1384,1447,10140,TOB1,transducer of ERBB2; 1,55,SH3/SH2 adaptor activity|receptor tyrosine kinase binding|transcription corepressor activity,endometriosis of uterus|endometriosis,ppi
1385,1448,10766,TOB2,transducer of ERBB2; 2,15,transcription corepressor activity,vitiligo,ppi
1386,1449,10043,TOM1,target of myb1 membrane trafficking protein,36,clathrin binding,bipolar disorder,ppi
1387,1450,10040,TOM1L1,target of myb1 like 1 membrane trafficking protein,61,clathrin binding|ubiquitin binding,prostate cancer|prostate carcinoma,ppi
1388,1451,146691,TOM1L2,target of myb1 like 2 membrane trafficking protein,28,clathrin binding,,ppi
1389,1452,9868,TOMM70,translocase of outer mitochondrial membrane 70,42,protein transmembrane transporter activity,,ppi
1390,1453,7150,TOP1,topoisomerase (DNA) I,174,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA binding|chromatin binding|double-stranded DNA binding|single-stranded DNA binding|RNA binding|DNA topoisomerase type I activity|protein serine/threonine kinase activity|ATP binding|supercoiled DNA binding,,ppi
1391,1454,7153,TOP2A,topoisomerase (DNA) II alpha,103,magnesium ion binding|DNA binding|chromatin binding|RNA binding|DNA topoisomerase type II (ATP-hydrolyzing) activity|DNA-dependent ATPase activity|drug binding|DNA binding; bending|ubiquitin binding,salivary gland adenoid cystic carcinoma|malignant glioma|gliosarcoma|mixed glioma|leukemia|neuroblastoma|polycystic ovary syndrome|prostate cancer|prostate carcinoma|adrenal cortex cancer|adrenocortical carcinoma|adrenal carcinoma|breast cancer,ppi
1392,1455,7155,TOP2B,topoisomerase (DNA) II beta,77,chromatin binding|DNA topoisomerase type II (ATP-hydrolyzing) activity,lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia,ppi
1393,1456,7156,TOP3A,topoisomerase (DNA) III alpha,46,DNA topoisomerase type I activity|DNA topoisomerase activity,,ppi
1394,1457,8940,TOP3B,topoisomerase (DNA) III beta,36,RNA binding|DNA topoisomerase activity,schizophrenia,ppi
1395,1458,27348,TOR1B,torsin family 1 member B,14,ATPase activity,influenza,ppi
1396,1459,27433,TOR2A,torsin family 2 member A,4,,,ppi
1397,1460,64222,TOR3A,torsin family 3 member A,26,ATPase activity,,ppi
1398,1461,7157,TP53,tumor protein p53,1004,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|obsolete transcription factor activity; core RNA polymerase binding|core promoter sequence-specific DNA binding|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|chromatin binding|DNA-binding transcription factor activity|mRNA 3'-UTR binding|copper ion binding|ATP binding|zinc ion binding|identical protein binding|transcription regulatory region DNA binding|promoter-specific chromatin binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|adrenal cortex cancer|adrenal gland cancer|alcohol dependence|alcohol abuse|progressive muscular atrophy|amyotrophic lateral sclerosis|Balkan nephropathy|urinary bladder cancer|colon cancer|colonic benign neoplasm|large intestine cancer|skin benign neoplasm,ppi
1399,1462,7158,TP53BP1,tumor protein p53 binding protein 1,149,transcription coregulator activity|methylated histone binding|ubiquitin modification-dependent histone binding|histone binding,,ppi
1400,1463,8309,ACOX2,acyl-CoA oxidase 2,5,acyl-CoA oxidase activity|pristanoyl-CoA oxidase activity|3alpha;7alpha;12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity|protein homodimerization activity|flavin adenine dinucleotide binding|fatty acid binding,,ppi
1401,1464,7159,TP53BP2,tumor protein p53 binding protein 2,128,SH3/SH2 adaptor activity|p53 binding,,ppi
1402,1465,7161,TP73,tumor protein p73,135,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding,adult T-cell leukemia|acute T cell leukemia|lung small cell carcinoma|alveolar rhabdomyosarcoma,ppi
1403,1466,7162,TPBG,trophoblast glycoprotein,24,,prostate cancer|prostate carcinoma,ppi
1404,1467,7163,TPD52,tumor protein D52,48,calcium ion binding|protein homodimerization activity|protein heterodimerization activity,prostate cancer|prostate carcinoma,ppi
1405,1468,7164,TPD52L1,tumor protein D52-like 1,21,protein homodimerization activity|protein heterodimerization activity,prostate cancer|prostate carcinoma,ppi
1406,1469,7165,TPD52L2,tumor protein D52 like 2,71,RNA binding,,ppi
1407,1470,7166,TPH1,tryptophan hydroxylase 1,10,,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|primary pulmonary hypertension|pulmonary hypertension|schizophrenia|mood disorder,ppi
1408,1471,7167,TPI1,triosephosphate isomerase 1,95,triose-phosphate isomerase activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|hemolytic anemia|congenital nonspherocytic hemolytic anemia|tongue squamous cell carcinoma|squamous cell carcinoma|cholecystitis,ppi
1409,1472,7168,TPM1,tropomyosin 1 (alpha),125,actin binding|structural constituent of cytoskeleton|structural constituent of muscle|identical protein binding|protein homodimerization activity|protein heterodimerization activity|actin filament binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
1410,1473,7169,TPM2,tropomyosin 2 (beta),120,actin binding|structural constituent of muscle|identical protein binding|protein homodimerization activity|protein heterodimerization activity|actin filament binding,ptosis|congenital ptosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q,ppi
1411,1474,7170,TPM3,tropomyosin 3,144,actin filament binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|ptosis|congenital ptosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L,ppi
1412,1475,7171,TPM4,tropomyosin 4,95,calcium ion binding|structural constituent of muscle|identical protein binding|protein homodimerization activity|protein heterodimerization activity|actin filament binding,asbestosis|anthracosilicosis|byssinosis|esophageal cancer|osteoporosis,ppi
1413,1476,7172,TPMT,thiopurine S-methyltransferase,1,thiopurine S-methyltransferase activity|S-adenosyl-L-methionine binding,leukopenia|neutropenia|agranulocytosis|severe congenital neutropenia|thiopurine S-methyltransferase deficiency,ppi
1414,1477,7173,TPO,thyroid peroxidase,2,peroxidase activity,bipolar disorder|constipation|congenital hypothyroidism|myxedema|hypothyroidism|goiter|nontoxic goiter|thyroid gland disease|umbilical hernia|omphalocele|intellectual disability|learning disability|recurrent hypersomnia,ppi
1415,1478,7174,TPP2,tripeptidyl peptidase 2,36,endopeptidase activity|aminopeptidase activity,fetal erythroblastosis|autoimmune hemolytic anemia|systemic lupus erythematosus|lymphopenia|cerebral infarction|cerebrovascular disease|thrombocytopenia|thrombocytopenia due to platelet alloimmunization|autoimmune thrombocytopenic purpura|Evans' syndrome,ppi
1416,1479,7175,TPR,translocated promoter region; nuclear basket protein,196,chromatin binding|RNA binding|mRNA binding|tubulin binding|structural constituent of nuclear pore|heat shock protein binding|protein homodimerization activity|mitogen-activated protein kinase binding|dynein complex binding|transporter activity|protein membrane anchor,thyroid cancer|thyroid adenoma|thyroid carcinoma|papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma,ppi
1417,1480,7177,TPSAB1,tryptase alpha/beta 1,3,serine-type endopeptidase activity|serine-type peptidase activity,bone disease|cartilage disease|connective tissue disease|collagen disease|contact dermatitis|occupational dermatitis|Clostridium difficile colitis|neurocirculatory asthenia|irritable bowel syndrome,ppi
1418,1481,8460,TPST1,tyrosylprotein sulfotransferase 1,12,protein-tyrosine sulfotransferase activity,,ppi
1419,1482,8459,TPST2,tyrosylprotein sulfotransferase 2,16,protein-tyrosine sulfotransferase activity,,ppi
1420,1483,7178,TPT1,tumor protein; translationally-controlled 1,53,RNA binding|calcium ion binding,prostate cancer|prostate carcinoma|schizophrenia,ppi
1421,1484,7179,TPTE,transmembrane phosphatase with tensin homology,103,,,ppi
1422,1485,7180,CRISP2,cysteine rich secretory protein 2,7,,,ppi
1423,1486,6955,TRA,T-cell receptor alpha locus,34,,Balo concentric sclerosis|adrenoleukodystrophy|narcolepsy|central nervous system disease,ppi
1424,1487,7184,HSP90B1,heat shock protein 90 beta family member 1,179,RNA binding|calcium ion binding|protein phosphatase binding|low-density lipoprotein particle receptor binding,bipolar disorder|prostate cancer|prostate carcinoma,ppi
1425,1488,28755,TRAC,T-cell receptor alpha constant,14,,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome,ppi
1426,1489,8717,TRADD,TNFRSF1A associated via death domain,79,,,ppi
1427,1490,7185,TRAF1,TNF receptor associated factor 1,242,,rheumatoid arthritis|patent ductus arteriosus|prostate cancer|prostate carcinoma,ppi
1428,1491,7186,TRAF2,TNF receptor associated factor 2,365,ubiquitin-protein transferase activity|CD40 receptor binding|sphingolipid binding,,ppi
1429,1492,7187,TRAF3,TNF receptor associated factor 3,125,ubiquitin-protein transferase activity,,ppi
1430,1493,9618,TRAF4,TNF receptor associated factor 4,107,DNA binding,,ppi
1431,1494,7188,TRAF5,TNF receptor associated factor 5,64,,,ppi
1432,1495,7189,TRAF6,TNF receptor associated factor 6,566,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme binding,rheumatoid arthritis|hypohidrotic ectodermal dysplasia|coronary artery disease,ppi
1433,1554,8310,ACOX3,acyl-CoA oxidase 3; pristanoyl,9,pristanoyl-CoA oxidase activity|flavin adenine dinucleotide binding|fatty acid binding|acyl-CoA oxidase activity,,ppi
1434,1563,10517,FBXW10,F-box and WD repeat domain containing 10,2,ubiquitin-protein transferase activity,,ppi
1435,1573,752,FMNL1,formin like 1,67,GTPase activating protein binding|Rac GTPase binding|actin filament binding,,ppi
1436,1603,6957,TRB,T cell receptor beta locus,16,,,ppi
1437,1628,28577,TRBV12-3,T cell receptor beta variable 12-3,1,,,ppi
1438,1638,28620,TRBV2,T cell receptor beta variable 2,3,,,ppi
1439,1641,52,ACP1,acid phosphatase 1; soluble,52,,schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
1440,1675,753,LDLRAD4,low density lipoprotein receptor class A domain containing 4,51,,,ppi
1441,1681,6964,TRD,T cell receptor delta locus,3,,,ppi
1442,1689,10755,GIPC1,GIPC PDZ domain containing family member 1,54,actin binding|myosin binding|protein homodimerization activity|cadherin binding,,ppi
1443,1691,10345,TRDN,triadin,38,protein binding; bridging|ion channel binding,epilepsy|visual epilepsy|catecholaminergic polymorphic ventricular tachycardia|catecholaminergic polymorphic ventricular tachycardia 1|catecholaminergic polymorphic ventricular tachycardia 2|catecholaminergic polymorphic ventricular tachycardia 3|catecholaminergic polymorphic ventricular tachycardia 4|catecholaminergic polymorphic ventricular tachycardia 5|central nervous system origin vertigo,ppi
1444,1695,11181,TREH,trehalase,1,alpha;alpha-trehalase activity,,ppi
1445,1696,11277,TREX1,three prime repair exonuclease 1,18,single-stranded DNA binding|3'-5'-exodeoxyribonuclease activity|3'-5' exonuclease activity|MutLalpha complex binding|MutSalpha complex binding|protein homodimerization activity|metal ion binding,agnosia|brain disease|dystonia|epilepsy|basal ganglia disease|focal hand dystonia|blepharospasm|influenza|neonatal jaundice|leukodystrophy|systemic lupus erythematosus|Chilblain lupus|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|purpura|proteinuria|retinitis|retinal disease,ppi
1446,1697,11219,TREX2,three prime repair exonuclease 2,8,magnesium ion binding|3'-5'-exodeoxyribonuclease activity,,ppi
1447,1704,710,SERPING1,serpin family G member 1,19,serine-type endopeptidase inhibitor activity,hereditary angioedema|angioedema|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|influenza|liver cirrhosis|systemic lupus erythematosus|lupus nephritis|granuloma annulare|axonal neuropathy,ppi
1448,1716,7200,TRH,thyrotropin releasing hormone,3,thyrotropin-releasing hormone activity,alcohol dependence|alcohol abuse|amnestic disorder|dissociative amnesia|sick sinus syndrome|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometriosis of uterus|endometriosis|hypertension|essential hypertension|intellectual disability|learning disability|acute myeloid leukemia|Balo concentric sclerosis,ppi
1449,1717,7201,TRHR,thyrotropin releasing hormone receptor,3,,constipation|umbilical hernia|omphalocele|congenital hypothyroidism|myxedema|hypothyroidism|neonatal jaundice|thyroid hormone resistance syndrome,ppi
1450,1718,53,ACP2,acid phosphatase 2; lysosomal,36,,blood coagulation disease,ppi
1451,1719,49860,CRNN,cornulin,23,calcium ion binding,,ppi
1452,1720,7204,TRIO,trio Rho guanine nucleotide exchange factor,31,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,acute myeloid leukemia|liver cancer,ppi
1453,1721,9322,TRIP10,thyroid hormone receptor interactor 10,60,GTPase activator activity,,ppi
1454,1722,9321,TRIP11,thyroid hormone receptor interactor 11,28,transcription coactivator activity,achondroplasia|Laron syndrome|umbilical hernia|omphalocele|polyhydramnios|achondrogenesis type IA,ppi
1455,1723,9320,TRIP12,thyroid hormone receptor interactor 12,62,ubiquitin-protein transferase activity|thyroid hormone receptor binding,,ppi
1456,1724,9319,TRIP13,thyroid hormone receptor interactor 13,125,transcription coregulator activity|ATP binding,,ppi
1457,1725,9326,ZNHIT3,zinc finger HIT-type containing 3,25,thyroid hormone receptor binding,,ppi
1458,1726,9325,TRIP4,thyroid hormone receptor interactor 4,49,transcription coactivator activity|nuclear receptor binding,,ppi
1459,1727,7205,TRIP6,thyroid hormone receptor interactor 6,198,RNA binding|interleukin-1 receptor binding|thyroid hormone receptor binding,,ppi
1460,1728,9324,HMGN3,high mobility group nucleosomal binding domain 3,11,thyroid hormone receptor binding,,ppi
1461,1729,221037,JMJD1C,jumonji domain containing 1C,18,histone demethylase activity (H3-K9 specific)|thyroid hormone receptor binding|transcription regulatory region sequence-specific DNA binding|chromatin DNA binding,autistic disorder|salivary gland adenoid cystic carcinoma|DiGeorge syndrome|velocardiofacial syndrome|double outlet right ventricle,ppi
1462,1730,54583,EGLN1,egl-9 family hypoxia inducible factor 1,39,ferrous iron binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors|enzyme binding|peptidyl-proline dioxygenase activity|peptidyl-proline 4-dioxygenase activity,polycythemia,ppi
1463,1731,7216,TRO,trophinin,25,,,ppi
1464,1732,10024,TROAP,trophinin associated protein,32,,,ppi
1465,1733,10712,FAM189B,family with sequence similarity 189 member B,91,,,ppi
1466,1734,7220,TRPC1,transient receptor potential cation channel subfamily C member 1,20,cation channel activity|calcium channel activity|store-operated calcium channel activity|inositol 1;4;5 trisphosphate binding,,ppi
1467,1735,7222,TRPC3,transient receptor potential cation channel subfamily C member 3,21,calcium channel activity|store-operated calcium channel activity|inositol 1;4;5 trisphosphate binding,bipolar disorder|hypertension|essential hypertension,ppi
1468,1736,7223,TRPC4,transient receptor potential cation channel subfamily C member 4,14,calcium channel activity|store-operated calcium channel activity|inositol 1;4;5 trisphosphate binding,,ppi
1469,1737,7224,TRPC5,transient receptor potential cation channel subfamily C member 5,20,calcium channel activity|store-operated calcium channel activity|inositol 1;4;5 trisphosphate binding,hypertension|essential hypertension,ppi
1470,1738,7225,TRPC6,transient receptor potential cation channel subfamily C member 6,13,cation channel activity|calcium channel activity|protein homodimerization activity|inositol 1;4;5 trisphosphate binding|store-operated calcium channel activity,disease of mental health|focal segmental glomerulosclerosis|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|proteinuria|chronic kidney disease,ppi
1471,1739,7226,TRPM2,transient receptor potential cation channel subfamily M member 2,3,cation channel activity|calcium channel activity|calcium ion binding|calcium-release channel activity|ligand-gated calcium channel activity|hydrolase activity,bipolar disorder|schizophreniform disorder|schizoaffective disorder,ppi
1472,1740,7227,TRPS1,transcriptional repressor GATA binding 1,23,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,dental caries|clubfoot|trichorhinophalangeal syndrome type II|Legg-Calve-Perthes disease|intellectual disability|learning disability|arthropathy|arthritis|trichorhinophalangeal syndrome type I,ppi
1473,1741,8295,TRRAP,transformation/transcription domain associated protein,119,transcription coregulator activity|thiol-dependent ubiquitinyl hydrolase activity,melanoma|skin melanoma|schizophrenia,ppi
1474,1742,7248,TSC1,tuberous sclerosis 1,67,Hsp70 protein binding|ATPase inhibitor activity,astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|autistic disorder|brain disease|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|tongue squamous cell carcinoma,ppi
1475,1743,7249,TSC2,tuberous sclerosis 2,75,GTPase activator activity|phosphatase binding,astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|autistic disorder|brain disease|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|tongue squamous cell carcinoma,ppi
1476,1744,10102,TSFM,Ts translation elongation factor; mitochondrial,33,RNA binding|translation elongation factor activity,lactic acidosis|cerebellar disease|patent ductus arteriosus|dystonia|epilepsy|placental insufficiency|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|optic atrophy|pseudosarcomatous fibromatosis|visual epilepsy,ppi
1477,1745,114960,TSGA13,testis specific 13,2,,,ppi
1478,1746,56893,UBQLN4,ubiquilin 4,188,polyubiquitin modification-dependent protein binding,,ppi
1479,1747,95681,CEP41,centrosomal protein 41,5,,Joubert syndrome|autistic disorder,ppi
1480,1748,89765,RSPH1,radial spoke head 1 homolog,1,,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|primary ciliary dyskinesia 24,ppi
1481,1749,7252,TSHB,thyroid stimulating hormone beta,17,hormone activity,bipolar disorder|constipation|congenital hypothyroidism|myxedema|hypothyroidism|umbilical hernia|omphalocele|syndromic X-linked intellectual disability 94,ppi
1482,1750,7253,TSHR,thyroid stimulating hormone receptor,43,thyroid-stimulating hormone receptor activity|signaling receptor activity|protein-containing complex binding|G-protein coupled peptide receptor activity,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|adrenal gland cancer|constipation|congenital hypothyroidism|myxedema|hypothyroidism|goiter|nontoxic goiter|thyroid gland disease|Graves' disease|thyrotoxicosis|hyperthyroidism|umbilical hernia|omphalocele|lung benign neoplasm|intellectual disability,ppi
1483,1751,7247,TSN,translin,40,DNA binding|sequence-specific DNA binding|single-stranded DNA binding|endoribonuclease activity,,ppi
1484,1752,7257,TSNAX,translin associated factor X,107,DNA binding|RNA binding|protein transporter activity|endoribonuclease activity|single-stranded DNA binding|sequence-specific DNA binding,bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia|mood disorder,ppi
1485,1753,7258,TSPY1,testis specific protein; Y-linked 1,3,,male infertility|Sertoli cell-only syndrome|oligospermia,ppi
1486,1754,7259,TSPYL1,TSPY like 1,38,,cryptorchidism|microphthalmia|eye disease|esophagitis|peptic esophagitis|gastroesophageal reflux disease|cardiac arrest|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|ophthalmoplegia|obstructive sleep apnea|congenital central hypoventilation syndrome|sex differentiation disease|hermaphroditism|pseudohermaphroditism|gonadal dysgenesis|Turner syndrome|Horner's syndrome,ppi
1487,1755,7260,TSSC1,tumor suppressing subtransferable candidate 1,48,,substance abuse|substance-related disorder,ppi
1488,1756,7262,PHLDA2,pleckstrin homology like domain family A member 2,1,,alcohol dependence|alcohol abuse|lung cancer|non-small cell lung carcinoma|osteosarcoma|bone osteosarcoma,ppi
1489,1757,10078,TSSC4,tumor suppressing subtransferable candidate 4,68,protein binding,,ppi
1490,1758,7263,TST,thiosulfate sulfurtransferase,15,thiosulfate sulfurtransferase activity|5S rRNA binding,colitis|ileitis|ileocolitis|gastroenteritis|prostate cancer|prostate carcinoma|liver cancer|hepatocellular carcinoma,ppi
1491,1759,9528,TMEM59,transmembrane protein 59,14,,,ppi
1492,1760,7264,TSTA3,tissue specific transplantation antigen P35B,31,electron transfer activity|isomerase activity|GDP-4-dehydro-D-rhamnose reductase activity|GDP-mannose 3;5-epimerase activity|GDP-L-fucose synthase activity,,ppi
1493,1761,7265,TTC1,tetratricopeptide repeat domain 1,96,unfolded protein binding,,ppi
1494,1762,7266,DNAJC7,DnaJ heat shock protein family (Hsp40) member C7,138,ATPase activator activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
1495,1763,7267,TTC3,tetratricopeptide repeat domain 3,24,ubiquitin-protein transferase activity,,ppi
1496,1764,7268,TTC4,tetratricopeptide repeat domain 4,50,,,ppi
1497,1765,7270,TTF1,transcription termination factor 1,27,,lung cancer|lung adenocarcinoma,ppi
1498,1766,8458,TTF2,transcription termination factor 2,63,DNA-dependent ATPase activity,,ppi
1499,1767,9499,MYOT,myotilin,14,structural constituent of muscle|alpha-actinin binding|axon guidance receptor activity,familial periodic paralysis|myopathy|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y,ppi
1500,1768,54,ACP5,acid phosphatase 5; tartrate resistant,29,acid phosphatase activity|ferrous iron binding|ferric iron binding,rheumatoid arthritis|secondary hyperparathyroidism|congenital hypothyroidism|myxedema|hypothyroidism|obesity|pneumonia|purpura|vitiligo|thrombocytopenia|thrombocytopenia due to platelet alloimmunization|autoimmune thrombocytopenic purpura|Evans' syndrome|combined T cell and B cell immunodeficiency|spondyloepimetaphyseal dysplasia; Strudwick type,ppi
1501,1769,51430,SUCO,SUN domain containing ossification factor,22,,,ppi
1502,1770,7272,TTK,TTK protein kinase,75,,polycystic ovary syndrome,ppi
1503,1771,7273,TTN,titin,133,protein serine/threonine kinase activity|protein tyrosine kinase activity|calcium ion binding|calmodulin binding|structural constituent of muscle|telethonin binding|actinin binding|protein self-association|actin filament binding|structural molecule activity conferring elasticity|muscle alpha-actinin binding,sick sinus syndrome|ptosis|congenital ptosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B,ppi
1504,1772,7274,TTPA,alpha tocopherol transfer protein,3,phosphatidylinositol-4;5-bisphosphate binding|vitamin E binding|phosphatidylinositol-3;4-bisphosphate binding|intermembrane lipid transfer activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|cerebellar disease|familial hypercholesterolemia|anterior horn cell disease|muscular atrophy|central nervous system disease|nervous system disease|autonomic neuropathy|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|retinitis|retinal disease,ppi
1505,1773,7276,TTR,transthyretin,58,thyroid hormone binding,amyloidosis|carpal tunnel syndrome|cerebellar disease|constipation|sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|lung benign neoplasm|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|paraplegia|polyneuropathy|peripheral nervous system disease,ppi
1506,1774,7275,TUB,tubby bipartite transcription factor,12,protein-containing complex binding|phosphatidylinositol binding,astigmatism|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|myopia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
1507,1775,7277,TUBA4A,tubulin alpha 4a,271,structural constituent of cytoskeleton|GTP binding,amyotrophic lateral sclerosis type 22,ppi
1508,1777,712,C1QA,complement C1q A chain,32,serine-type endopeptidase activity,exanthem|IgA glomerulonephritis|membranoproliferative glomerulonephritis|hypersensitivity reaction type III disease|systemic lupus erythematosus|schizophrenia,ppi
1509,1778,51807,TUBA8,tubulin alpha 8,38,structural constituent of cytoskeleton|GTP binding,bipolar disorder|epilepsy|visual epilepsy,ppi
1510,1779,7280,TUBB2A,tubulin beta 2A class IIa,152,structural constituent of cytoskeleton|GTP binding,epilepsy|Creutzfeldt-Jakob disease|acute myeloid leukemia|visual epilepsy,ppi
1511,1780,7283,TUBG1,tubulin gamma 1,246,structural constituent of cytoskeleton|GTP binding,epilepsy|microcephaly|visual epilepsy,ppi
1512,1781,27175,TUBG2,tubulin gamma 2,25,structural molecule activity|GTP binding|structural constituent of cytoskeleton,,ppi
1513,1782,713,C1QB,complement C1q B chain,26,serine-type endopeptidase activity,IgA glomerulonephritis|primary immunodeficiency disease|liver cirrhosis|schizophrenia|coronary artery disease,ppi
1514,1783,7284,TUFM,Tu translation elongation factor; mitochondrial,226,RNA binding|translation elongation factor activity,lactic acidosis|esophageal cancer|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|urea cycle disorder|combined oxidative phosphorylation deficiency,ppi
1515,1784,7286,TUFT1,tuftelin 1,18,structural constituent of tooth enamel,,ppi
1516,1785,7287,TULP1,tubby like protein 1,5,phosphatidylinositol-4;5-bisphosphate binding|actin filament binding|phosphatidylinositol binding,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|epilepsy|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|myopia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus,ppi
1517,1786,7288,TULP2,tubby like protein 2,32,protein-containing complex binding|phosphatidylinositol binding,,ppi
1518,1787,7289,TULP3,tubby like protein 3,110,phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol binding|protein-containing complex binding|intraciliary transport particle A binding,,ppi
1519,1788,7291,TWIST1,twist family bHLH transcription factor 1,44,DNA-binding transcription factor activity; RNA polymerase II-specific|E-box binding,ptosis|congenital ptosis|focal hand dystonia|blepharospasm|isolated cleft palate|cleft palate|craniosynostosis|sensorineural hearing loss|enophthalmos|orbital disease|exophthalmos|congenital heart disease|buphthalmos|hydrophthalmos|stomach cancer|ophthalmoplegia|mechanical strabismus|hypertropia|pseudotumor cerebri|intracranial hypertension,ppi
1520,1789,57045,TWSG1,twisted gastrulation BMP signaling modulator 1,6,transforming growth factor beta binding,holoprosencephaly,ppi
1521,1790,708,C1QBP,complement C1q binding protein,280,complement component C1q binding|transcription corepressor activity|mRNA binding|hyaluronic acid binding|transcription factor binding|kininogen binding|adrenergic receptor binding|mitochondrial ribosome binding|translation activator activity,breast cancer,ppi
1522,1791,7294,TXK,TXK tyrosine kinase,13,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II regulatory region DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|non-membrane spanning protein tyrosine kinase activity,,ppi
1523,1792,7295,TXN,thioredoxin,135,RNA binding,contact dermatitis|occupational dermatitis|gallbladder disease|liver disease|malignant mesothelioma|benign mesothelioma,ppi
1524,1793,9352,TXNL1,thioredoxin like 1,58,disulfide oxidoreductase activity,,ppi
1525,1794,7296,TXNRD1,thioredoxin reductase 1,46,thioredoxin-disulfide reductase activity|methylselenol reductase activity|methylseleninic acid reductase activity,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|large intestine cancer|colorectal cancer|contact dermatitis|occupational dermatitis|epilepsy|malignant mesothelioma|benign mesothelioma|arthropathy|arthritis|coronary artery disease,ppi
1526,1795,7297,TYK2,tyrosine kinase 2,97,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity,agnosia|rheumatoid arthritis|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|primary immunodeficiency disease|uveitis|anterior uveitis|ciliary body disease|primary biliary cirrhosis|multiple sclerosis|pustulosis of palm and sole|psoriasis|parapsoriasis|neurotic disorder|endogenous depression|melancholia|juvenile rheumatoid arthritis|arthropathy,ppi
1527,1796,7298,TYMS,thymidylate synthetase,55,translation repressor activity; mRNA regulatory element binding|thymidylate synthase activity|folic acid binding|sequence-specific mRNA binding,anemia|macrocytic anemia|brain disease|tongue squamous cell carcinoma|squamous cell carcinoma|cleft lip|isolated cleft palate|cleft palate|colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|gastrointestinal system cancer|head and neck cancer|lung benign neoplasm|Langerhans-cell histiocytosis|lymphosarcoma|lymphoma|reticulosarcoma|non-Hodgkin lymphoma,ppi
1528,1797,7299,TYR,tyrosinase,2,monooxygenase activity|monophenol monooxygenase activity|copper ion binding|protein homodimerization activity|protein heterodimerization activity,oculocutaneous albinism|Griscelli syndrome|Griscelli syndrome type 1|Griscelli syndrome type 2|Griscelli syndrome type 3|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|astigmatism|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|sensorineural hearing loss|hyperopia|melanoma|skin melanoma|myopia,ppi
1529,1798,7301,TYRO3,TYRO3 protein tyrosine kinase,32,protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity|Wnt-protein binding,,ppi
1530,1799,7305,TYROBP,TYRO protein tyrosine kinase binding protein,16,,agnosia|syndromic X-linked intellectual disability type 10|choreatic disease|epilepsy|gallbladder disease|liver disease|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|schizophrenia|visual epilepsy|speech disorder|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
1531,1800,714,C1QC,complement C1q C chain,9,serine-type endopeptidase activity,,ppi
1532,1801,7306,TYRP1,tyrosinase related protein 1,8,oxidoreductase activity|protein homodimerization activity|protein heterodimerization activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|oculocutaneous albinism|Griscelli syndrome|Griscelli syndrome type 1|Griscelli syndrome type 2|Griscelli syndrome type 3|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|lung benign neoplasm|melanoma|skin melanoma|spontaneous ocular nystagmus|dissociated nystagmus,ppi
1533,1802,7307,U2AF1,U2 small nuclear RNA auxiliary factor 1,131,RNA binding|pre-mRNA 3'-splice site binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|osteoporosis|essential thrombocythemia|myelodysplastic syndrome,ppi
1534,1803,6675,UAP1,UDP-N-acetylglucosamine pyrophosphorylase 1,23,UDP-N-acetylglucosamine diphosphorylase activity,,ppi
1535,1804,7311,UBA52,ubiquitin A-52 residue ribosomal protein fusion product 1,125,protein tag|ubiquitin protein ligase binding,,ppi
1536,1805,715,C1R,complement C1r,10,serine-type endopeptidase activity|calcium ion binding|serine-type peptidase activity,arthropathy|arthritis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|endometriosis of uterus|endometriosis|gingival disease|epulis|gingival overgrowth|gingival hypertrophy|lupus erythematosus|nephritis|glomerulonephritis|kidney disease|periodontal disease|periodontitis|complement component 2 deficiency|complement component 4a deficiency|complement component 4b deficiency|complement component 6 deficiency,ppi
1537,1806,51271,UBAP1,ubiquitin associated protein 1,17,ubiquitin binding,,ppi
1538,1807,53347,UBASH3A,ubiquitin associated and SH3 domain containing A,20,phosphatase activity,,ppi
1539,1808,7314,UBB,ubiquitin B,252,protein tag|ubiquitin protein ligase binding,isolated cleft palate|cleft palate|epilepsy|gingival overgrowth|gingival hypertrophy|visual epilepsy|cleft soft palate,ppi
1540,1810,7317,UBA1,ubiquitin like modifier activating enzyme 1,236,RNA binding|ubiquitin activating enzyme activity,ptosis|congenital ptosis|tongue squamous cell carcinoma|squamous cell carcinoma|pseudosarcomatous fibromatosis|cryptorchidism|inguinal hernia|progressive muscular atrophy|spinal muscular atrophy|familial periodic paralysis|myopathy|Bell's palsy|facial paralysis,ppi
1541,1811,716,C1S,complement C1s,10,serine-type endopeptidase activity,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|gingival disease|epulis|gingival overgrowth|gingival hypertrophy|systemic lupus erythematosus|periodontal disease|periodontitis|autoimmune hepatitis|autoimmune thyroiditis|anodontia,ppi
1542,1812,9039,UBA3,ubiquitin like modifier activating enzyme 3,37,NEDD8 activating enzyme activity|NEDD8 transferase activity,,ppi
1543,1813,7318,UBA7,ubiquitin like modifier activating enzyme 7,11,ubiquitin-protein transferase activity|ISG15 activating enzyme activity|ubiquitin activating enzyme activity,tongue squamous cell carcinoma|squamous cell carcinoma,ppi
1544,1814,7319,UBE2A,ubiquitin conjugating enzyme E2 A,84,ubiquitin-protein transferase activity|ubiquitin binding|ubiquitin conjugating enzyme activity,echolalia|enophthalmos|orbital disease|exophthalmos|epilepsy|clubfoot|hypertrichosis|intellectual disability|learning disability|visual epilepsy|syndromic intellectual disability|syndromic X-linked intellectual disability Nascimento type,ppi
1545,1815,7320,UBE2B,ubiquitin conjugating enzyme E2 B,80,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,,ppi
1546,1816,7321,UBE2D1,ubiquitin conjugating enzyme E2 D1,278,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity|ubiquitin protein ligase binding,,ppi
1547,1817,7322,UBE2D2,ubiquitin conjugating enzyme E2 D2,243,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity|ubiquitin protein ligase binding,,ppi
1548,1818,7323,UBE2D3,ubiquitin conjugating enzyme E2 D3,232,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity|ubiquitin protein ligase binding,,ppi
1549,1819,7324,UBE2E1,ubiquitin conjugating enzyme E2 E1,134,ubiquitin-protein transferase activity|ISG15 transferase activity|ubiquitin conjugating enzyme activity,seborrheic keratosis|skin disease|actinic keratosis,ppi
1550,1820,7325,UBE2E2,ubiquitin conjugating enzyme E2 E2,84,ubiquitin-protein transferase activity|ISG15 transferase activity|ubiquitin conjugating enzyme activity,diabetes mellitus|type 2 diabetes mellitus,ppi
1551,1821,10477,UBE2E3,ubiquitin conjugating enzyme E2 E3,113,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,,ppi
1552,1822,717,C2,complement C2,7,serine-type endopeptidase activity,dermatomyositis|childhood type dermatomyositis|IgA glomerulonephritis|systemic lupus erythematosus|purpura|age related macular degeneration|macular degeneration|degeneration of macula and posterior pole|age related macular degeneration 1|complement component 2 deficiency,ppi
1553,1823,140739,UBE2F,ubiquitin conjugating enzyme E2 F (putative),20,NEDD8 transferase activity|NEDD8 conjugating enzyme activity|ubiquitin conjugating enzyme activity,,ppi
1554,1824,7326,UBE2G1,ubiquitin conjugating enzyme E2 G1,27,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,,ppi
1555,1825,7327,UBE2G2,ubiquitin conjugating enzyme E2 G2,60,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,,ppi
1556,1826,7328,UBE2H,ubiquitin conjugating enzyme E2 H,91,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,autistic disorder|polycystic ovary syndrome,ppi
1557,1827,7329,UBE2I,ubiquitin conjugating enzyme E2 I,474,RNA binding|SUMO transferase activity|SUMO conjugating enzyme activity,,ppi
1558,1828,7332,UBE2L3,ubiquitin conjugating enzyme E2 L3,145,transcription coactivator activity|RNA binding|ubiquitin-protein transferase activity|enzyme binding|ubiquitin conjugating enzyme activity|ubiquitin-protein transferase activator activity|ubiquitin protein ligase binding,,ppi
1559,1829,22974,TPX2,TPX2; microtubule nucleation factor,45,ATP binding|GTP binding|importin-alpha family protein binding,,ppi
1560,1830,9246,UBE2L6,ubiquitin conjugating enzyme E2 L6,50,ubiquitin-protein transferase activity|ubiquitin binding|ubiquitin conjugating enzyme activity|ISG15 transferase activity|ubiquitin protein ligase binding,influenza,ppi
1561,1831,9040,UBE2M,ubiquitin conjugating enzyme E2 M,93,ubiquitin-protein transferase activity|NEDD8 transferase activity|ubiquitin conjugating enzyme activity,,ppi
1562,1832,7334,UBE2N,ubiquitin conjugating enzyme E2 N,220,RNA binding|ubiquitin-protein transferase activity|ubiquitin binding|ubiquitin conjugating enzyme activity,,ppi
1563,1834,7336,UBE2V2,ubiquitin conjugating enzyme E2 V2,56,ubiquitin conjugating enzyme activity,,ppi
1564,1835,7337,UBE3A,ubiquitin protein ligase E3A,177,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,agnosia|autistic disorder|constipation|enophthalmos|orbital disease|exophthalmos|epilepsy|alternating exotropia|exotropia|monocular exotropia|intellectual disability|learning disability|myopia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|obsessive-compulsive disorder|visual epilepsy,ppi
1565,1836,9354,UBE4A,ubiquitination factor E4A,35,ubiquitin-ubiquitin ligase activity,,ppi
1566,1837,55,ACPP,acid phosphatase; prostate,24,acid phosphatase activity|5'-nucleotidase activity|phosphatase activity|thiamine phosphate phosphatase activity|protein homodimerization activity|lysophosphatidic acid phosphatase activity,,ppi
1567,1838,10277,UBE4B,ubiquitination factor E4B,79,enzyme binding|ubiquitin-ubiquitin ligase activity,,ppi
1568,1839,7341,SUMO1,small ubiquitin-like modifier 1,1161,RNA binding|protein C-terminus binding|transcription factor binding|potassium channel regulator activity|SUMO transferase activity|protein binding; bridging|protein tag,cleft lip|isolated cleft palate|cleft palate|tooth agenesis|anodontia|orofacial cleft,ppi
1569,1840,5412,UBL3,ubiquitin like 3,2,,,ppi
1570,1841,8266,UBL4A,ubiquitin like 4A,295,ubiquitin-like protein transferase activity,,ppi
1571,1842,29855,UBN1,ubinuclein 1,16,DNA-binding transcription factor activity,,ppi
1572,1843,7342,UBP1,upstream binding protein 1 (LBP-1a),30,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription corepressor activity|sequence-specific DNA binding,,ppi
1573,1844,29979,UBQLN1,ubiquilin 1,223,polyubiquitin modification-dependent protein binding,,ppi
1574,1845,29978,UBQLN2,ubiquilin 2,84,,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|muscular atrophy|Grn-related frontotemporal lobar degeneration with Tdp43 inclusions|frontotemporal dementia|neurodegenerative disease|amyotrophic lateral sclerosis type 15,ppi
1575,1847,7343,UBTF,upstream binding transcription factor; RNA polymerase I,95,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase I CORE element sequence-specific DNA binding|RNA polymerase I upstream control element sequence-specific DNA binding|chromatin binding|RNA binding,,ppi
1576,1848,7345,UCHL1,ubiquitin C-terminal hydrolase L1,66,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|omega peptidase activity|thiol-dependent ubiquitinyl hydrolase activity|ubiquitin binding,lung cancer|non-small cell lung carcinoma|esophageal cancer|gallbladder cancer|hiatus hernia|congenital diaphragmatic hernia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|polyneuropathy|peripheral nervous system disease|neuropathy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|neurodegenerative disease|liver cancer,ppi
1577,1849,7347,UCHL3,ubiquitin C-terminal hydrolase L3,87,thiol-dependent ubiquitin-specific protease activity|peptidase activity|NEDD8-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|ubiquitin binding,,ppi
1578,1850,7349,UCN,urocortin,4,neuropeptide hormone activity|corticotropin-releasing hormone activity,anxiety disorder|phobic disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertension|essential hypertension,ppi
1579,1851,7350,UCP1,uncoupling protein 1,3,oxidative phosphorylation uncoupler activity|transmembrane transporter activity|purine ribonucleotide binding|long-chain fatty acid binding|cardiolipin binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
1580,1852,7351,UCP2,uncoupling protein 2,21,oxidative phosphorylation uncoupler activity,bipolar disorder|brain ischemia|diabetes mellitus|type 2 diabetes mellitus|fatty liver disease|hypertension|essential hypertension|obesity|schizophrenia|cerebral infarction|cerebrovascular disease,ppi
1581,1853,7352,UCP3,uncoupling protein 3,4,transporter activity|oxidative phosphorylation uncoupler activity,obesity|prostate cancer|prostate carcinoma,ppi
1582,1854,7353,UFD1L,ubiquitin fusion degradation 1 like (yeast),97,thiol-dependent ubiquitin-specific protease activity,ptosis|congenital ptosis|isolated cleft palate|cleft palate|constipation|dental caries|DiGeorge syndrome|velocardiofacial syndrome|congenital heart disease|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect,ppi
1583,1855,7356,SCGB1A1,secretoglobin family 1A member 1,8,polychlorinated biphenyl binding|protein binding,asthma|intrinsic asthma|allergic asthma|lung disease|adult respiratory distress syndrome|schizophrenia,ppi
1584,1856,7357,UGCG,UDP-glucose ceramide glucosyltransferase,15,ceramide glucosyltransferase activity,coronary artery disease,ppi
1585,1857,7358,UGDH,UDP-glucose 6-dehydrogenase,39,UDP-glucose 6-dehydrogenase activity|electron transfer activity,liver cancer,ppi
1586,1858,7360,UGP2,UDP-glucose pyrophosphorylase 2,71,UTP:glucose-1-phosphate uridylyltransferase activity,,ppi
1587,1860,54097,FAM3B,family with sequence similarity 3 member B,9,cytokine activity,,ppi
1588,1862,7365,UGT2B10,UDP glucuronosyltransferase family 2 member B10,1,glucuronosyltransferase activity|UDP-glycosyltransferase activity,melanoma|skin melanoma,ppi
1589,1864,7366,UGT2B15,UDP glucuronosyltransferase family 2 member B15,1,glucuronosyltransferase activity|retinoic acid binding|UDP-glycosyltransferase activity,prostate cancer|prostate carcinoma,ppi
1590,1866,150082,LCA5L,LCA5L; lebercilin like,7,,,ppi
1591,1867,7363,UGT2B4,UDP glucuronosyltransferase family 2 member B4,1,glucuronosyltransferase activity|retinoic acid binding|UDP-glycosyltransferase activity,,ppi
1592,1868,7364,UGT2B7,UDP glucuronosyltransferase family 2 member B7,2,glucuronosyltransferase activity|retinoic acid binding|UDP-glycosyltransferase activity,urinary bladder cancer,ppi
1593,1869,7368,UGT8,UDP glycosyltransferase 8,22,UDP-galactose:glucosylceramide beta-1;4-galactosyltransferase activity|N-acylsphingosine galactosyltransferase activity|UDP-glycosyltransferase activity,,ppi
1594,1870,29128,UHRF1,ubiquitin like with PHD and ring finger domains 1,67,proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity|ubiquitin-protein transferase activity|zinc ion binding|methyl-CpG binding|nucleosomal histone binding|methylated histone binding|histone binding|identical protein binding|hemi-methylated DNA-binding|ubiquitin protein ligase activity,salivary gland adenoid cystic carcinoma,ppi
1595,1871,115426,UHRF2,ubiquitin like with PHD and ring finger domains 2,60,ubiquitin-protein transferase activity|SUMO transferase activity|histone binding|ubiquitin protein ligase activity,,ppi
1596,1872,8408,ULK1,unc-51 like autophagy activating kinase 1,55,protein serine/threonine kinase activity|kinase activity,,ppi
1597,1873,7369,UMOD,uromodulin,3,IgG binding,gout|hypertension|essential hypertension|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|kidney failure|uremia|familial juvenile hyperuricemic nephropathy|Senior-Loken syndrome|nephronophthisis|hyperuricemia,ppi
1598,1875,7371,UCK2,uridine-cytidine kinase 2,14,nucleoside kinase activity|uridine kinase activity,prostate cancer|prostate carcinoma,ppi
1599,1876,7372,UMPS,uridine monophosphate synthetase,47,orotate phosphoribosyltransferase activity|orotidine-5'-phosphate decarboxylase activity,anemia|macrocytic anemia|sickle cell anemia|beta thalassemia|tongue squamous cell carcinoma|squamous cell carcinoma|colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|patent ductus arteriosus|prostate cancer|prostate carcinoma|hereditary spherocytosis|stomach cancer|orotic aciduria|Diamond-Blackfan anemia|congenital hypoplastic anemia|breast cancer|liver cancer,ppi
1600,1877,9094,UNC119,unc-119 lipid binding chaperone,118,lipid binding,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|primary immunodeficiency disease|lymphopenia|night blindness|congenital stationary night blindness|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|asthenopia|cryptogenic organizing pneumonia,ppi
1601,1878,10497,UNC13B,unc-13 homolog B,23,calmodulin binding|Rab GTPase binding|diacylglycerol binding|syntaxin-1 binding,,ppi
1602,1879,90249,UNC5A,unc-5 netrin receptor A,4,,,ppi
1603,1880,219699,UNC5B,unc-5 netrin receptor B,13,,,ppi
1604,1881,8633,UNC5C,unc-5 netrin receptor C,6,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|schizophrenia,ppi
1605,1883,7374,UNG,uracil DNA glycosylase,19,damaged DNA binding|uracil DNA N-glycosylase activity,Bloom syndrome|large intestine cancer|colorectal cancer|epididymitis|primary immunodeficiency disease|immunoglobulin alpha deficiency|selective IgA deficiency disease|selective IgG deficiency disease|X-linked hyper IgM syndrome|immunodeficiency with hyper IgM type 5,ppi
1606,1884,7378,UPP1,uridine phosphorylase 1,14,uridine phosphorylase activity,allergic contact dermatitis,ppi
1607,1885,11045,UPK1A,uroplakin 1A,81,protein homodimerization activity,,ppi
1608,1886,7348,UPK1B,uroplakin 1B,4,structural molecule activity,breast cancer,ppi
1609,1887,7379,UPK2,uroplakin 2,2,,,ppi
1610,1888,54093,SETD4,SET domain containing 4,11,protein-lysine N-methyltransferase activity,,ppi
1611,1889,7380,UPK3A,uroplakin 3A,2,,Potter's syndrome,ppi
1612,1890,7381,UQCRB,ubiquinol-cytochrome c reductase binding protein,64,ubiquinol-cytochrome-c reductase activity,hypoglycemia|lactic acidosis,ppi
1613,1891,7384,UQCRC1,ubiquinol-cytochrome c reductase core protein I,59,ubiquinol-cytochrome-c reductase activity|metalloendopeptidase activity,,ppi
1614,1892,7385,UQCRC2,ubiquinol-cytochrome c reductase core protein II,154,metalloendopeptidase activity,hypoglycemia|obesity|lactic acidosis|urea cycle disorder|mitochondrial complex III deficiency nuclear type 5,ppi
1615,1893,7386,UQCRFS1,ubiquinol-cytochrome c reductase; Rieske iron-sulfur polypeptide 1,84,ubiquinol-cytochrome-c reductase activity,coronary artery disease,ppi
1616,1894,7388,UQCRH,ubiquinol-cytochrome c reductase hinge protein,42,ubiquinol-cytochrome-c reductase activity,,ppi
1617,1895,7389,UROD,uroporphyrinogen decarboxylase,18,uroporphyrinogen decarboxylase activity,alopecia|hemolytic anemia|systemic scleroderma|scleroderma|localized scleroderma|head and neck cancer|liver cirrhosis|porphyria cutanea tarda|hepatoerythropoietic porphyria|photosensitivity disease|photosensitive epilepsy|liver cancer|hepatocellular carcinoma,ppi
1618,1896,7390,UROS,uroporphyrinogen III synthase,11,uroporphyrinogen-III synthase activity,alopecia|hemolytic anemia|cholecystolithiasis|choledocholithiasis|conjunctivitis|systemic scleroderma|scleroderma|localized scleroderma|hypertrichosis|primary immunodeficiency disease|thrombocytopenia|erythropoietic protoporphyria|cutaneous porphyria|photosensitivity disease|photosensitive epilepsy,ppi
1619,1897,7391,USF1,upstream transcription factor 1,70,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|protein homodimerization activity|sequence-specific DNA binding,familial combined hyperlipidemia,ppi
1620,1898,7392,USF2,upstream transcription factor 2; c-fos interacting,32,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|sequence-specific DNA binding,,ppi
1621,1899,10083,USH1C,USH1 protein network component harmonin,27,spectrin binding,cerebellar disease|sensorineural hearing loss|intellectual disability|learning disability|night blindness|congenital stationary night blindness|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|schizophrenia|scotoma|cataract|Usher syndrome type 1|autosomal recessive nonsyndromic deafness 18A,ppi
1622,1900,49,ACR,acrosin,5,protease binding|DNA binding|amidase activity|serine-type endopeptidase activity|copper ion binding|mannose binding|drug binding|zinc ion binding|fucose binding,,ppi
1623,1901,755,C21orf2,chromosome 21 open reading frame 2,22,,progressive muscular atrophy|amyotrophic lateral sclerosis,ppi
1624,1902,7399,USH2A,usherin,6,collagen binding|myosin binding,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|myopia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy,ppi
1625,1904,7398,USP1,ubiquitin specific peptidase 1,52,thiol-dependent ubiquitin-specific protease activity|peptidase activity|thiol-dependent ubiquitinyl hydrolase activity|cysteine-type endopeptidase activity,,ppi
1626,1905,9100,USP10,ubiquitin specific peptidase 10,65,RNA binding|cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|ion channel binding,,ppi
1627,1906,8237,USP11,ubiquitin specific peptidase 11,159,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
1628,1907,8975,USP13,ubiquitin specific peptidase 13 (isopeptidase T-3),49,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|ubiquitin binding|proteasome binding|BAT3 complex binding|ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,seborrheic keratosis|skin disease|actinic keratosis,ppi
1629,1908,9097,USP14,ubiquitin specific peptidase 14,79,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|endopeptidase inhibitor activity|tRNA guanylyltransferase activity|thiol-dependent ubiquitinyl hydrolase activity|proteasome binding,,ppi
1630,1909,9958,USP15,ubiquitin specific peptidase 15,163,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|ubiquitin modification-dependent histone binding,,ppi
1631,1910,10600,USP16,ubiquitin specific peptidase 16,29,transcription coactivator activity|cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|zinc ion binding|thiol-dependent ubiquitinyl hydrolase activity|histone binding|ubiquitin binding,,ppi
1632,1911,11274,USP18,ubiquitin specific peptidase 18,35,thiol-dependent ubiquitin-specific protease activity|ISG15-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|cysteine-type endopeptidase activity,leiomyosarcoma|epithelioid leiomyosarcoma|myxoid leiomyosarcoma,ppi
1633,1912,10869,USP19,ubiquitin specific peptidase 19,85,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|Hsp90 protein binding,,ppi
1634,1913,9099,USP2,ubiquitin specific peptidase 2,101,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,liver cancer|hepatocellular carcinoma,ppi
1635,1914,10868,USP20,ubiquitin specific peptidase 20,68,cysteine-type endopeptidase activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
1636,1915,27005,USP21,ubiquitin specific peptidase 21,83,transcription coactivator activity|thiol-dependent ubiquitin-specific protease activity|cysteine-type peptidase activity|NEDD8-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
1637,1916,23326,USP22,ubiquitin specific peptidase 22,76,transcription coactivator activity|thiol-dependent ubiquitin-specific protease activity|nuclear receptor transcription coactivator activity|thiol-dependent ubiquitinyl hydrolase activity|H4 histone acetyltransferase activity,,ppi
1638,1917,23358,USP24,ubiquitin specific peptidase 24,26,thiol-dependent ubiquitinyl hydrolase activity|thiol-dependent ubiquitin-specific protease activity|cysteine-type endopeptidase activity,,ppi
1639,1918,29761,USP25,ubiquitin specific peptidase 25,46,thiol-dependent ubiquitin-specific protease activity|peptidase activity|thiol-dependent ubiquitinyl hydrolase activity|ubiquitin binding|ubiquitin-specific protease activity involved in negative regulation of ERAD pathway|cysteine-type endopeptidase activity,,ppi
1640,1919,57646,USP28,ubiquitin specific peptidase 28,57,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|cysteine-type endopeptidase activity,,ppi
1641,1920,9960,USP3,ubiquitin specific peptidase 3,37,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
1642,1921,7375,USP4,ubiquitin specific peptidase 4,109,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
1643,1922,8078,USP5,ubiquitin specific peptidase 5,81,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|ubiquitin binding,,ppi
1644,1923,9098,USP6,ubiquitin specific peptidase 6,12,nucleic acid binding|cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|GTPase activator activity|Rab GTPase binding,,ppi
1645,1924,7874,USP7,ubiquitin specific peptidase 7,333,p53 binding|cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|ubiquitinyl hydrolase activity|Lys48-specific deubiquitinase activity|transcription factor binding,urinary bladder cancer,ppi
1646,1925,9101,USP8,ubiquitin specific peptidase 8,80,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|cadherin binding,generalized anxiety disorder|anxiety disorder|diabetic ketoacidosis|diabetes mellitus|hypertension|essential hypertension|hypokalemia|primary immunodeficiency disease|infertility|lipoatrophic diabetes|lipodystrophy|osteoporosis|meningioma|acoustic neuroma|pituitary adenoma|pituitary cancer|pituitary carcinoma|ACTH-secreting pituitary adenoma|pituitary-dependent Cushing's disease|acute urate nephropathy,ppi
1647,1926,8239,USP9X,ubiquitin specific peptidase 9; X-linked,152,cysteine-type endopeptidase activity|cysteine-type peptidase activity|thiol-dependent ubiquitinyl hydrolase activity|Lys48-specific deubiquitinase activity|thiol-dependent ubiquitin-specific protease activity,intellectual disability|learning disability|non-syndromic X-linked intellectual disability,ppi
1648,1927,8287,USP9Y,ubiquitin specific peptidase 9; Y-linked,12,thiol-dependent ubiquitin-specific protease activity|cysteine-type peptidase activity|co-SMAD binding|cysteine-type endopeptidase activity,azoospermia|male infertility|Sertoli cell-only syndrome|oligospermia,ppi
1649,1928,8433,UTF1,undifferentiated embryonic cell transcription factor 1,4,transcription coactivator activity,,ppi
1650,1929,7402,UTRN,utrophin,73,actin binding,,ppi
1651,1930,10911,UTS2,urotensin 2,4,signaling receptor binding,hypertension|essential hypertension|movement disease|lingual-facial-buccal dyskinesia,ppi
1652,1931,7403,KDM6A,lysine demethylase 6A,34,histone demethylase activity|histone demethylase activity (H3-K27 specific)|chromatin DNA binding|sequence-specific DNA binding|chromatin binding|RNA polymerase II proximal promoter sequence-specific DNA binding,hemolytic anemia|imperforate anus|urinary bladder cancer|ptosis|congenital ptosis|transitional cell carcinoma|isolated cleft palate|cleft palate|congenital hypothyroidism|myxedema|hypothyroidism|cryptorchidism|salivary gland adenoid cystic carcinoma|sensorineural hearing loss|epilepsy|heart septal defect|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4,ppi
1653,1932,7404,UTY,ubiquitously transcribed tetratricopeptide repeat containing; Y-linked,6,histone demethylase activity|RNA polymerase II proximal promoter sequence-specific DNA binding|histone demethylase activity (H3-K27 specific)|sequence-specific DNA binding|chromatin DNA binding|chromatin binding,,ppi
1654,1933,7405,UVRAG,UV radiation resistance associated,59,SNARE binding,,ppi
1655,1934,8409,UXT,ubiquitously expressed prefoldin like chaperone,66,chromatin binding|transcription corepressor activity|microtubule binding|beta-tubulin binding|actin filament binding,prostate cancer|prostate carcinoma,ppi
1656,1935,6843,VAMP1,vesicle associated membrane protein 1,10,,ptosis|congenital ptosis|dystonia|schizophrenia|paraplegia|amnestic disorder|retrograde amnesia|spastic ataxia 1,ppi
1657,1936,6844,VAMP2,vesicle associated membrane protein 2,79,SNARE binding|calmodulin binding|phospholipid binding|syntaxin-1 binding|syntaxin binding|protein self-association|calcium-dependent protein binding,bipolar disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
1658,1937,9341,VAMP3,vesicle associated membrane protein 3,68,,bipolar disorder,ppi
1659,1938,8674,VAMP4,vesicle associated membrane protein 4,49,,,ppi
1660,1939,10791,VAMP5,vesicle associated membrane protein 5,7,protein binding,,ppi
1661,1940,8673,VAMP8,vesicle associated membrane protein 8,42,chloride channel inhibitor activity,,ppi
1662,1941,9218,VAPA,VAMP associated protein A,263,microtubule binding|FFAT motif binding|cadherin binding,bipolar disorder,ppi
1663,1942,9217,VAPB,VAMP associated protein B and C,164,microtubule binding|FFAT motif binding|cadherin binding|beta-tubulin binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|spinal muscular atrophy|muscular atrophy|neurodegenerative disease|amyotrophic lateral sclerosis type 8,ppi
1664,1943,7407,VARS,valyl-tRNA synthetase,92,valine-tRNA ligase activity,,ppi
1665,1944,7408,VASP,vasodilator-stimulated phosphoprotein,95,cadherin binding,,ppi
1666,1945,7409,VAV1,vav guanine nucleotide exchange factor 1,111,DNA-binding transcription factor activity|guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,adult T-cell leukemia|acute T cell leukemia|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|lung cancer|lung adenocarcinoma,ppi
1667,1946,7410,VAV2,vav guanine nucleotide exchange factor 2,79,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
1668,1947,10451,VAV3,vav guanine nucleotide exchange factor 3,29,SH3/SH2 adaptor activity|guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|GTPase activator activity,IgA glomerulonephritis|hypertension|essential hypertension|prostate cancer|prostate carcinoma,ppi
1669,1948,25966,C2CD2,C2 calcium dependent domain containing 2,6,,,ppi
1670,1950,25806,VAX2,ventral anterior homeobox 2,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1671,1951,7411,VBP1,VHL binding protein 1,77,tubulin binding,,ppi
1672,1952,7412,VCAM1,vascular cell adhesion molecule 1,646,integrin binding|primary amine oxidase activity|cell adhesion molecule binding,sickle cell anemia|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|heart disease|cardiovascular system disease|cholestasis|inflammatory bowel disease|ulcerative colitis|hiatus hernia|congenital diaphragmatic hernia|hypertension|essential hypertension|multiple sclerosis|kidney failure|uremia|angioedema|liver cancer,ppi
1673,1953,7414,VCL,vinculin,188,actin binding|beta-catenin binding|cadherin binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
1674,1954,7415,VCP,valosin containing protein,613,RNA binding|ATPase activity|polyubiquitin modification-dependent protein binding|deubiquitinase activator activity,alexia|dyslexia|progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|agnosia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|echolalia|familial periodic paralysis|myopathy|paraplegia|stereotypic movement disorder|Stevens-Johnson syndrome,ppi
1675,1957,7416,VDAC1,voltage dependent anion channel 1,164,voltage-gated anion channel activity,epilepsy|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|mitochondrial myopathy|mitochondrial metabolism disease,ppi
1676,1958,7417,VDAC2,voltage dependent anion channel 2,135,voltage-gated anion channel activity,tongue squamous cell carcinoma|squamous cell carcinoma|epilepsy|arthropathy|arthritis,ppi
1677,1959,7419,VDAC3,voltage dependent anion channel 3,119,voltage-gated anion channel activity,,ppi
1678,1960,7421,VDR,vitamin D (1;25- dihydroxyvitamin D3) receptor,108,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|calcitriol receptor activity|lithocholic acid receptor activity|retinoid X receptor binding|calcitriol binding|lithocholic acid binding|DNA-binding transcription factor activity|vitamin D response element binding|vitamin D binding|nuclear receptor activity|transcription factor binding|nuclear receptor transcription coactivator activity|signaling receptor activity|transcription regulatory region sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,alopecia|bipolar disorder|transitional cell carcinoma|dental caries|dental enamel hypoplasia|complex partial epilepsy|temporal lobe epilepsy|hyperparathyroidism|osteitis fibrosa|secondary hyperparathyroidism|hypertension|essential hypertension|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|chronic lymphocytic leukemia|Richter's syndrome|osteomalacia|rickets|osteoporosis,ppi
1679,1962,7422,VEGFA,vascular endothelial growth factor A,39,fibronectin binding|cytokine activity|growth factor activity|heparin binding|chemoattractant activity|protein homodimerization activity|protein heterodimerization activity|extracellular matrix binding|vascular endothelial growth factor receptor 2 binding|vascular endothelial growth factor receptor 1 binding|vascular endothelial growth factor receptor 3 binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
1680,1963,7423,VEGFB,vascular endothelial growth factor B,14,vascular endothelial growth factor receptor 1 binding|growth factor activity|chemoattractant activity|vascular endothelial growth factor receptor 2 binding|vascular endothelial growth factor receptor 3 binding,pancreatic cancer|breast cancer,ppi
1681,1964,7424,VEGFC,vascular endothelial growth factor C,2,chemoattractant activity|vascular endothelial growth factor receptor 3 binding|growth factor activity,angiosarcoma|elephantiasis|lymphedema|melanoma|skin melanoma|breast cancer|keratosis follicularis|pseudoxanthoma elasticum|mongolian spot|hereditary lymphedema,ppi
1682,1965,7425,VGF,VGF nerve growth factor inducible,8,,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|gastric ulcer|mood disorder,ppi
1683,1966,7428,VHL,von Hippel-Lindau tumor suppressor,460,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|arteriovenous malformation|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|cerebellar disease|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29,ppi
1684,1967,7429,VIL1,villin 1,11,calcium ion binding|phosphatidylinositol-4;5-bisphosphate binding|lysophosphatidic acid binding|protein homodimerization activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|actin filament binding,,ppi
1685,1968,7430,EZR,ezrin,171,RNA binding|actin binding|microtubule binding|cadherin binding|actin filament binding,arthropathy|arthritis|prostate cancer|prostate carcinoma,ppi
1686,1969,7431,VIM,vimentin,344,double-stranded RNA binding|structural constituent of cytoskeleton,carcinosarcoma|liver cirrhosis|kidney disease|nephrosis|arthropathy|arthritis|prostate cancer|prostate carcinoma|retinitis|retinal disease|synovial sarcoma|anterior horn cell disease|amyotrophic lateral sclerosis type 1|amyotrophic lateral sclerosis type 2|amyotrophic lateral sclerosis type 4|lateral sclerosis|motor neuron disease|cataract|malignant mesothelioma|benign mesothelioma,ppi
1687,1970,7432,VIP,vasoactive intestinal peptide,15,hormone activity|neuropeptide hormone activity|peptide hormone receptor binding,autistic disorder|bipolar disorder|bladder disease|Down syndrome|congestive heart failure|prostate cancer|prostate carcinoma|rhinitis|schizophrenia|neurotic disorder|endogenous depression|melancholia|asthma|psychologic dyspareunia|premature ejaculation|mental depression|mood disorder|major depressive disorder|intellectual disability|learning disability,ppi
1688,1971,7433,VIPR1,vasoactive intestinal peptide receptor 1,40,vasoactive intestinal polypeptide receptor activity|G-protein coupled peptide receptor activity|peptide hormone binding,,ppi
1689,1972,7434,VIPR2,vasoactive intestinal peptide receptor 2,97,G-protein coupled receptor activity|peptide hormone binding|vasoactive intestinal polypeptide receptor activity|G-protein coupled peptide receptor activity,bipolar disorder|schizophrenia,ppi
1690,1973,5212,VIT,vitrin,2,glycosaminoglycan binding,,ppi
1691,1974,7436,VLDLR,very low density lipoprotein receptor,12,low-density lipoprotein particle receptor activity|very-low-density lipoprotein particle receptor activity|apolipoprotein binding|very-low-density lipoprotein particle binding|glycoprotein transporter activity|reelin receptor activity,autistic disorder|cerebellar disease|spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|epilepsy|clubfoot|intellectual disability|learning disability|obesity|schizophrenia|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|cataract|lissencephaly|pontocerebellar hypoplasia type 2D,ppi
1692,1976,7439,BEST1,bestrophin 1,2,intracellular calcium activated chloride channel activity|chloride channel activity|bicarbonate transmembrane transporter activity,choroideremia|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hyperopia|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus,ppi
1693,1978,8875,VNN2,vanin 2,39,pantetheine hydrolase activity,atopic dermatitis|pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
1694,1979,7441,VPREB1,pre-B lymphocyte 1,4,,acute lymphocytic leukemia,ppi
1695,1980,29802,VPREB3,pre-B lymphocyte 3,2,,,ppi
1696,1981,9559,VPS26A,VPS26; retromer complex component A,103,protein transporter activity,diabetes mellitus|type 2 diabetes mellitus,ppi
1697,1982,26276,VPS33B,VPS33B; late endosome and lysosome associated,37,,renal tubular acidosis|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|ichthyosis|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|calcium metabolism disease,ppi
1698,1983,27072,VPS41,VPS41; HOPS complex subunit,30,,,ppi
1699,1984,7442,TRPV1,transient receptor potential cation channel subfamily V member 1,10,transmembrane signaling receptor activity|extracellular ligand-gated ion channel activity|excitatory extracellular ligand-gated ion channel activity|calcium channel activity|calmodulin binding|ATP binding|calcium-release channel activity|phosphatidylinositol binding|ion channel activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|urinary bladder cancer|complex partial epilepsy|temporal lobe epilepsy|stomach disease|esophageal disease|esophagitis|peptic esophagitis|gastroesophageal reflux disease|obesity|acute pancreatitis|pancreatitis,ppi
1700,1985,7443,VRK1,vaccinia related kinase 1,79,protein kinase activity|protein serine/threonine kinase activity|protein kinase binding|histone kinase activity (H3-S10 specific)|histone kinase activity (H3-T3 specific),cerebellar disease|intellectual disability|learning disability|progressive muscular atrophy|spinal muscular atrophy|pontocerebellar hypoplasia type 1A,ppi
1701,1986,7444,VRK2,vaccinia related kinase 2,37,protein serine/threonine kinase activity|protein kinase binding|protein domain specific binding,schizophrenia,ppi
1702,1987,7447,VSNL1,visinin like 1,12,,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|schizophrenia,ppi
1703,1988,30813,VSX1,visual system homeobox 1,11,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,astigmatism|congenital stromal corneal dystrophy|X-linked endothelial corneal dystrophy|epithelial basement membrane dystrophy|Lisch epithelial corneal dystrophy|posterior amorphous corneal dystrophy|subepithelial mucinous corneal dystrophy|posterior polymorphous corneal dystrophy|posterior polymorphous corneal dystrophy 1|posterior polymorphous corneal dystrophy 2|posterior polymorphous corneal dystrophy 3|corneal granular dystrophy|macular corneal dystrophy|corneal dystrophy|empty sella syndrome|microphthalmia|glaucoma|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus,ppi
1704,1989,7448,VTN,vitronectin,137,integrin binding|extracellular matrix structural constituent,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|liver cirrhosis,ppi
1705,1990,7450,VWF,von Willebrand factor,25,protease binding|extracellular matrix structural constituent|protein binding|collagen binding|immunoglobulin binding|protein homodimerization activity|chaperone binding,alcohol dependence|alcohol abuse|aortic valve stenosis|atrial fibrillation|heart disease|cardiovascular system disease|congestive heart failure|hemarthrosis|hypertension|essential hypertension|mitral valve insufficiency|mitral valve prolapse|thrombocytopenia|intracranial thrombosis|von Willebrand's disease|factor VIII deficiency,ppi
1706,1991,7453,WARS,tryptophanyl-tRNA synthetase,66,tryptophan-tRNA ligase activity|kinase inhibitor activity|protein homodimerization activity,,ppi
1707,1992,8209,C21orf33,chromosome 21 open reading frame 33,17,,,ppi
1708,1993,10352,WARS2,tryptophanyl tRNA synthetase 2; mitochondrial,4,tryptophan-tRNA ligase activity,,ppi
1709,1994,7454,WAS,Wiskott-Aldrich syndrome,92,GTPase regulator activity|actin filament binding,hemolytic anemia|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|dermatitis|hemarthrosis|primary immunodeficiency disease|inflammatory bowel disease|chronic obstructive pulmonary disease|lymphopenia|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|purpura|sinusitis|skin disease|seborrheic keratosis|actinic keratosis|thrombocytopenia|Wiskott-Aldrich syndrome,ppi
1710,1995,8936,WASF1,WAS protein family member 1,62,protein-containing complex binding|Rac GTPase binding,,ppi
1711,1996,10163,WASF2,WAS protein family member 2,51,protein-containing complex binding|cadherin binding,,ppi
1712,1997,10810,WASF3,WAS protein family member 3,28,,,ppi
1713,1998,8976,WASL,Wiskott-Aldrich syndrome like,82,GTPase regulator activity|actin filament binding,,ppi
1714,1999,7456,WIPF1,WAS/WASL interacting protein family member 1,39,profilin binding|actin filament binding,hemolytic anemia|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|dermatitis|primary immunodeficiency disease|inflammatory bowel disease|chronic obstructive pulmonary disease|lymphopenia|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|purpura|sinusitis|thrombocytopenia|Wiskott-Aldrich syndrome|microcytic anemia|otitis media,ppi
1715,2000,23559,WBP1,WW domain binding protein 1,37,WW domain binding,,ppi
1716,2001,23558,WBP2,WW domain binding protein 2,21,RNA polymerase II proximal promoter sequence-specific DNA binding|transcription coactivator activity|chromatin DNA binding,,ppi
1717,2002,11193,WBP4,WW domain binding protein 4,53,,,ppi
1718,2003,7458,EIF4H,eukaryotic translation initiation factor 4H,61,RNA binding|helicase activity|translation factor activity; RNA binding|cadherin binding|RNA strand annealing activity|ribosomal small subunit binding|RNA strand-exchange activity|translation initiation factor activity,,ppi
1719,2004,51085,MLXIPL,MLX interacting protein like,6,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|carbohydrate response element binding|protein homodimerization activity,blepharophimosis|constipation|pseudosarcomatous fibromatosis|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|sensorineural hearing loss|tooth agenesis|anodontia|chronic kidney disease|intellectual disability|learning disability|mitral valve insufficiency|mitral valve prolapse,ppi
1720,2005,7462,LAT2,linker for activation of T-cells family member 2,8,SH2 domain binding,,ppi
1721,2006,9948,WDR1,WD repeat domain 1,100,actin filament binding,osteoporosis|thrombocytopenia,ppi
1722,2007,10885,WDR3,WD repeat domain 3,37,RNA binding|snoRNA binding,,ppi
1723,2008,10785,WDR4,WD repeat domain 4,54,tRNA (guanine-N7-)-methyltransferase activity,,ppi
1724,2009,11091,WDR5,WD repeat domain 5,207,histone-lysine N-methyltransferase activity|methylated histone binding|histone methyltransferase activity (H3-K4 specific)|histone acetyltransferase activity (H4-K5 specific)|histone acetyltransferase activity (H4-K8 specific)|histone acetyltransferase activity (H4-K16 specific),,ppi
1725,2010,11180,WDR6,WD repeat domain 6,45,RNA binding,,ppi
1726,2011,49856,WRAP73,WD repeat containing; antisense to TP73,106,,,ppi
1727,2012,54014,BRWD1,bromodomain and WD repeat domain containing 1,15,,Sertoli cell-only syndrome|oligospermia,ppi
1728,2013,7465,WEE1,WEE1 G2 checkpoint kinase,39,protein tyrosine kinase activity|kinase activity|protein kinase activity,head and neck squamous cell carcinoma,ppi
1729,2014,7466,WFS1,wolframin ER transmembrane glycoprotein,17,ubiquitin protein ligase binding,megaloblastic anemia|sideroblastic anemia|generalized anxiety disorder|anxiety disorder|bipolar disorder|Cauda equina syndrome|neurogenic bladder|ptosis|congenital ptosis|cerebellar disease|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types,ppi
1730,2015,8456,FOXN1,forkhead box N1,24,DNA-binding transcription factor activity; RNA polymerase II-specific,alopecia|primary immunodeficiency disease|T-cell immunodeficiency; congenital alopecia; and nail dystrophy,ppi
1731,2016,7468,NSD2,nuclear receptor binding SET domain protein 2,179,DNA-binding transcription factor activity; RNA polymerase II-specific|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H4-K20 specific),ptosis|congenital ptosis|cerebellar disease|cleft lip|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|sensorineural hearing loss|epilepsy|enophthalmos|orbital disease|exophthalmos|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3,ppi
1732,2017,54904,NSD3,nuclear receptor binding SET domain protein 3,55,histone-lysine N-methyltransferase activity,acute myeloid leukemia,ppi
1733,2018,7469,NELFA,negative elongation factor complex member A,26,,ptosis|congenital ptosis|cerebellar disease|cleft lip|clubfoot|cryptorchidism|sensorineural hearing loss|epilepsy|placental insufficiency|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect,ppi
1734,2019,8840,WISP1,WNT1 inducible signaling pathway protein 1,3,integrin binding|heparin binding,,ppi
1735,2020,8839,WISP2,WNT1 inducible signaling pathway protein 2,12,heparin binding|integrin binding,,ppi
1736,2021,8838,WISP3,WNT1 inducible signaling pathway protein 3,6,heparin binding|integrin binding,arthropathy|arthritis|neurogenic arthropathy|osteoporosis|osteogenesis imperfecta|Ehlers-Danlos syndrome,ppi
1737,2022,7471,WNT1,Wnt family member 1,13,frizzled binding|cytokine activity|morphogen activity|transcription regulatory region DNA binding|receptor ligand activity,osteoporosis|idiopathic juvenile osteoporosis|osteogenesis imperfecta type 3|osteogenesis imperfecta type 4|osteogenesis imperfecta type 15,ppi
1738,2023,7480,WNT10B,Wnt family member 10B,6,receptor ligand activity|frizzled binding,tooth agenesis|anodontia|breast cancer,ppi
1739,2024,7481,WNT11,Wnt family member 11,7,GTPase activator activity|frizzled binding|protein kinase activator activity|transcription regulatory region DNA binding,congenital diaphragmatic hernia,ppi
1740,2026,7484,WNT9B,Wnt family member 9B,5,receptor ligand activity|frizzled binding,,ppi
1741,2027,7472,WNT2,Wnt family member 2,10,cytokine activity|receptor ligand activity|frizzled binding,autistic disorder|cervical cancer|schizophrenia,ppi
1742,2028,7482,WNT2B,Wnt family member 2B,2,frizzled binding,,ppi
1743,2029,7473,WNT3,Wnt family member 3,3,receptor ligand activity|frizzled binding,imperforate anus|choanal atresia|cleft lip|isolated cleft palate|cleft palate|cryptorchidism|polyhydramnios|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|microphthalmia|optic atrophy|tracheal stenosis|cataract|gastroschisis|Addison's disease|cornea plana|Peters anomaly|lymphosarcoma,ppi
1744,2030,54361,WNT4,Wnt family member 4,29,transcription corepressor activity|receptor ligand activity|frizzled binding,adrenal gland disease|achondroplasia|Laron syndrome|ventricular septal defect|hypertrichosis|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|obesity|prostate cancer|prostate carcinoma|oligohydramnios|congenital diaphragmatic hernia|Addison's disease|Potter's syndrome|ovarian cancer|ovarian carcinoma|acne,ppi
1745,2031,7474,WNT5A,Wnt family member 5A,24,DNA-binding transcription factor activity|frizzled binding|phospholipid binding|transcription regulatory region DNA binding|receptor ligand activity,cervical cancer|cryptorchidism|enophthalmos|orbital disease|exophthalmos|gingival overgrowth|gingival hypertrophy|inguinal hernia|umbilical hernia|omphalocele|hydronephrosis|lung benign neoplasm|intellectual disability|learning disability|cavernous hemangioma|capillary hemangioma|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II,ppi
1746,2032,7475,WNT6,Wnt family member 6,2,frizzled binding,,ppi
1747,2033,7476,WNT7A,Wnt family member 7A,30,cytokine activity|receptor ligand activity|frizzled binding,clubfoot|placental insufficiency|Klippel-Feil syndrome|spondylolisthesis|ovarian cancer|amyotrophic lateral sclerosis type 1|humeroradial synostosis,ppi
1748,2034,7477,WNT7B,Wnt family member 7B,7,receptor ligand activity|frizzled binding,,ppi
1749,2035,7478,WNT8A,Wnt family member 8A,1,frizzled binding|receptor ligand activity,atrial fibrillation,ppi
1750,2037,7485,WRB,tryptophan rich basic protein,15,,,ppi
1751,2038,7486,WRN,Werner syndrome RecQ like helicase,45,magnesium ion binding|four-way junction DNA binding|Y-form DNA binding|bubble DNA binding|DNA binding|DNA helicase activity|ATP-dependent DNA helicase activity|helicase activity|exonuclease activity|3'-5' exonuclease activity|four-way junction helicase activity|ATPase activity|manganese ion binding|protein homodimerization activity|3'-5' DNA helicase activity|protein-containing complex binding|G-quadruplex DNA binding|forked DNA-dependent helicase activity|telomeric D-loop binding|telomeric G-quadruplex DNA binding,diabetic ketoacidosis|diabetes mellitus|type 2 diabetes mellitus|congestive heart failure|hypogonadism|meningioma|spinal meningioma|acoustic neuroma|intraventricular meningioma|pituitary adenoma|intraorbital meningioma|clear cell meningioma|benign meningioma|secretory meningioma|microcystic meningioma|cerebral convexity meningioma|angiomatous meningioma|parasagittal meningioma|psammomatous meningioma|fibrous meningioma,ppi
1752,2039,7490,WT1,Wilms tumor 1,34,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|zinc ion binding|double-stranded methylated DNA binding|sequence-specific DNA binding|transcription regulatory region DNA binding|hemi-methylated DNA-binding,aniridia|ptosis|congenital ptosis|colon cancer|colonic benign neoplasm|cryptorchidism|glaucoma|glioblastoma multiforme|giant cell glioblastoma|nephritis|glomerulonephritis|kidney disease|focal segmental glomerulosclerosis|gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|hiatus hernia|congenital diaphragmatic hernia|hypertension|essential hypertension,ppi
1753,2040,51741,WWOX,WW domain containing oxidoreductase,258,oxidoreductase activity|protein dimerization activity|cofactor binding|coenzyme binding|transcription coactivator activity,azoospermia|tongue squamous cell carcinoma|squamous cell carcinoma|cryptorchidism|epilepsy|esophageal cancer|gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|hypertrophy of breast|infant gynecomastia|gynecomastia|male infertility|intellectual disability|learning disability|osteoporosis|visual epilepsy|stomach cancer|urinary system benign neoplasm|esophageal carcinoma,ppi
1754,2042,7494,XBP1,X-box binding protein 1,35,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|enhancer sequence-specific DNA binding|DNA binding|DNA-binding transcription factor activity|protein heterodimerization activity,bipolar disorder|fatty liver disease|malignant glioma|gliosarcoma|mixed glioma|schizophrenia|glucose intolerance|prediabetes syndrome,ppi
1755,2043,7498,XDH,xanthine dehydrogenase,8,xanthine dehydrogenase activity|xanthine oxidase activity|molybdopterin cofactor binding|flavin adenine dinucleotide binding|2 iron; 2 sulfur cluster binding,autistic disorder|heart disease|cardiovascular system disease|congestive heart failure|hydronephrosis|ischemia|familial periodic paralysis|myopathy|pulmonary embolism|interstitial nephritis|pyelonephritis|pyelitis|thrombocytopenia|purine-pyrimidine metabolic disorder|Arts syndrome|xanthinuria|middle cerebral artery infarction|major depressive disorder|mental depression|endogenous depression,ppi
1756,2045,7504,XK,X-linked Kx blood group,9,transporter activity,disease of mental health|hematopoietic system disease|movement disease|lingual-facial-buccal dyskinesia|neuromuscular disease|polyneuropathy|peripheral nervous system disease|neuropathy|epilepsy|visual epilepsy|chorea-acanthocytosis|abetalipoproteinemia|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
1757,2046,7507,XPA,XPA; DNA damage recognition and repair factor,46,damaged DNA binding,basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|cerebellar disease|conjunctivitis|cryptorchidism|ectropion|entropion|sensorineural hearing loss|hypogonadism|intestinal cancer|intestinal benign neoplasm|keratitis|keratoconjunctivitis|melanoma|skin melanoma|intellectual disability|learning disability|optic atrophy,ppi
1758,2047,7508,XPC,XPC complex subunit; DNA damage recognition and repair factor,77,heteroduplex DNA loop binding|bubble DNA binding|damaged DNA binding|single-stranded DNA binding,amino acid metabolic disorder|autistic disorder|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|conjunctivitis|cryptorchidism|ectropion|entropion|sensorineural hearing loss|hypogonadism|keratitis|keratoconjunctivitis|lung benign neoplasm|melanoma|skin melanoma|optic atrophy|squamous cell papilloma|papilloma,ppi
1759,2048,57109,REXO4,REX4 homolog; 3'-5' exonuclease,31,DNA-binding transcription factor activity|RNA binding,,ppi
1760,2049,7511,XPNPEP1,X-prolyl aminopeptidase 1,73,aminopeptidase activity|manganese ion binding|metalloaminopeptidase activity,,ppi
1761,2051,7514,XPO1,exportin 1,1231,nuclear export signal receptor activity|transporter activity,,ppi
1762,2052,11260,XPOT,exportin for tRNA,61,tRNA binding|Ran GTPase binding,,ppi
1763,2053,9213,XPR1,xenotropic and polytropic retrovirus receptor 1,31,inositol hexakisphosphate binding|virus receptor activity|transmembrane signaling receptor activity|G-protein coupled receptor activity|phosphate ion transmembrane transporter activity|efflux transmembrane transporter activity|signaling receptor activity,basal ganglia disease|calcium metabolism disease|nephrocalcinosis|calcinosis|recurrent corneal erosion|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|placental insufficiency|visual epilepsy|thrombocytopenia|focal hand dystonia|blepharospasm|amnestic disorder|retrograde amnesia|secondary Parkinson disease,ppi
1764,2054,7515,XRCC1,X-ray repair cross complementing 1,81,DNA ligase activity|oxidized DNA binding,malignant glioma|gliosarcoma|mixed glioma|malignant mesothelioma|benign mesothelioma|prostate cancer|prostate carcinoma|schizophrenia|stomach cancer|ulcerative stomatitis|denture stomatitis|stomatitis|granuloma annulare|esophagus squamous cell carcinoma|acute lymphocytic leukemia,ppi
1765,2055,7516,XRCC2,X-ray repair cross complementing 2,13,four-way junction DNA binding,breast cancer|Fanconi anemia|leukopenia|intellectual disability|learning disability|thrombocytopenia|hereditary breast ovarian cancer syndrome,ppi
1766,2056,7517,XRCC3,X-ray repair cross complementing 3,149,four-way junction DNA binding|crossover junction endodeoxyribonuclease activity,basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|esophageal cancer|head and neck cancer|melanoma|skin melanoma|malignant mesothelioma|benign mesothelioma|skin benign neoplasm|skin cancer|stomach cancer|breast cancer,ppi
1767,2057,7518,XRCC4,X-ray repair cross complementing 4,44,DNA binding|ligase activity,acanthosis nigricans|cryptorchidism|diabetic ketoacidosis|diabetes mellitus|enophthalmos|orbital disease|exophthalmos|placental insufficiency|inguinal hernia|congenital hypothyroidism|myxedema|hypothyroidism|lymphosarcoma|lymphoma|central nervous system lymphoma|lymphopenia|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus,ppi
1768,2058,7520,XRCC5,X-ray repair cross complementing 5,254,DNA binding|double-stranded DNA binding|RNA binding|enzyme activator activity|telomeric DNA binding|transcription regulatory region DNA binding|double-stranded telomeric DNA binding|5'-deoxyribose-5-phosphate lyase activity,alcohol dependence|alcohol abuse,ppi
1769,2059,22803,XRN2,5'-3' exoribonuclease 2,88,3'-5'-exoribonuclease activity|transcription termination site sequence-specific DNA binding|RNA binding|nuclease activity|5'-3' exoribonuclease activity|5'-3' exonuclease activity,,ppi
1770,2060,9942,XYLB,xylulokinase,5,xylulokinase activity,,ppi
1771,2061,8565,YARS,tyrosyl-tRNA synthetase,53,RNA binding|tyrosine-tRNA ligase activity|interleukin-8 receptor binding|tRNA binding,Charcot-Marie-Tooth disease dominant intermediate C,ppi
1772,2062,7525,YES1,YES proto-oncogene 1; Src family tyrosine kinase,126,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|signaling receptor binding,double outlet right ventricle|ventricular septal defect,ppi
1773,2063,10730,YME1L1,YME1 like 1 ATPase,43,ATP-dependent peptidase activity,,ppi
1774,2064,29799,YPEL1,yippee like 1,7,,,ppi
1775,2065,7529,YWHAB,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta,426,cadherin binding,,ppi
1776,2066,7531,YWHAE,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon,478,RNA binding|calcium channel regulator activity|potassium channel regulator activity|Rab guanyl-nucleotide exchange factor activity|MHC class II protein complex binding|cadherin binding,bipolar disorder|heart disease|cardiovascular system disease|epilepsy|polyhydramnios|schizophrenia|visual epilepsy|endometrial stromal sarcoma|cerebral degeneration|lissencephaly|Miller-Dieker lissencephaly syndrome|chromosome 17p13.1 deletion syndrome|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|kidney clear cell sarcoma,ppi
1777,2067,7532,YWHAG,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma,469,RNA binding|protein kinase C inhibitor activity,,ppi
1778,2068,7533,YWHAH,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta,303,insulin-like growth factor receptor binding|sodium channel regulator activity|protein domain specific binding,bipolar disorder|schizophrenia|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
1779,2069,10971,YWHAQ,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta,482,,arthropathy|arthritis,ppi
1780,2070,7534,YWHAZ,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta,788,RNA binding|cadherin binding,bipolar disorder|paranoid schizophrenia|delusional disorder,ppi
1781,2071,7528,YY1,YY1 transcription factor,148,four-way junction DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|enhancer sequence-specific DNA binding|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|transcription corepressor activity|RNA binding|zinc ion binding|transcription regulatory region DNA binding|SMAD binding|RNA polymerase II distal enhancer sequence-specific DNA binding|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|RNA polymerase II proximal promoter sequence-specific DNA binding|sequence-specific DNA binding|RNA polymerase II repressing transcription factor binding,cervical cancer|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|intellectual disability|learning disability,ppi
1782,2073,7535,ZAP70,zeta chain of T cell receptor associated protein kinase 70,70,phosphotyrosine residue binding|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|ATP binding,dermatitis|primary immunodeficiency disease|pneumonia|adenosine deaminase deficiency|MHC class II deficiency|severe combined immunodeficiency,ppi
1783,2074,7844,RNF103,ring finger protein 103,13,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
1784,2075,54069,MIS18A,MIS18 kinetochore protein A,52,,,ppi
1785,2076,7541,ZBTB14,zinc finger and BTB domain containing 14,47,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|transcription regulatory region DNA binding,,ppi
1786,2078,7538,ZFP36,ZFP36 ring finger protein,64,RNA binding|single-stranded RNA binding|mRNA binding|AU-rich element binding|heat shock protein binding|mRNA 3'-UTR AU-rich region binding|RNA polymerase binding|14-3-3 protein binding|mRNA 3'-UTR binding,alopecia|arthropathy|arthritis|acrodermatitis|dermatitis|coronary artery disease,ppi
1787,2079,7539,ZFP37,ZFP37 zinc finger protein,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|zinc ion binding,,ppi
1788,2081,9310,ZNF235,zinc finger protein 235,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1789,2082,23660,ZKSCAN5,zinc finger with KRAB and SCAN domains 5,8,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|zinc ion binding,,ppi
1790,2083,7542,ZFPL1,zinc finger protein like 1,21,DNA binding|zinc ion binding,,ppi
1791,2084,7543,ZFX,zinc finger protein; X-linked,6,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator activity,,ppi
1792,2085,7544,ZFY,zinc finger protein; Y-linked,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1793,2086,11244,ZHX1,zinc fingers and homeoboxes 1,59,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity|protein heterodimerization activity,,ppi
1794,2087,7545,ZIC1,Zic family member 1,44,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II regulatory region sequence-specific DNA binding,congenital heart disease|craniosynostosis|sensorineural hearing loss|enophthalmos|orbital disease|exophthalmos|optic papillitis|papilledema|retinal edema|syndromic X-linked intellectual disability 94|ophthalmoplegia|mechanical strabismus|hypertropia|pseudotumor cerebri|intracranial hypertension,ppi
1795,2088,7546,ZIC2,Zic family member 2,12,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|chromatin DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|intellectual disability|learning disability|prostate cancer|prostate carcinoma|schizophrenia|holoprosencephaly|craniosynostosis,ppi
1796,2089,7547,ZIC3,Zic family member 3,6,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,imperforate anus|dextrocardia|patent ductus arteriosus|atrioventricular septal defect|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain,ppi
1797,2090,23619,ZIM2,zinc finger imprinted 2,8,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding,salivary gland adenoid cystic carcinoma,ppi
1798,2091,27173,SLC39A1,solute carrier family 39 member 1,28,zinc ion transmembrane transporter activity|inorganic cation transmembrane transporter activity,prostate cancer|prostate carcinoma,ppi
1799,2092,10269,ZMPSTE24,zinc metallopeptidase STE24,43,metalloexopeptidase activity|metalloendopeptidase activity,alopecia|blepharophimosis|calcium metabolism disease|nephrocalcinosis|calcinosis|choanal atresia|pseudosarcomatous fibromatosis|xerophthalmia|dry eye syndrome|patent ductus arteriosus|entropion|enophthalmos|orbital disease|exophthalmos|placental insufficiency|focal segmental glomerulosclerosis|sensorineural hearing loss|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3,ppi
1800,2093,7556,ZNF10,zinc finger protein 10,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1801,2094,163227,ZNF100,zinc finger protein 100,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1802,2095,94039,ZNF101,zinc finger protein 101,14,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1803,2096,64397,ZNF106,zinc finger protein 106,28,RNA binding|SH3 domain binding,,ppi
1804,2097,51427,ZNF107,zinc finger protein 107,6,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1805,2098,7771,ZNF112,zinc finger protein 112,2,,,ppi
1806,2099,163071,ZNF114,zinc finger protein 114,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1807,2100,51351,ZNF117,zinc finger protein 117,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|zinc ion binding,,ppi
1808,2101,58,ACTA1,actin; alpha 1; skeletal muscle,204,structural constituent of cytoskeleton|ATP binding|myosin binding|ADP binding,ptosis|congenital ptosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q,ppi
1809,2103,7675,ZNF121,zinc finger protein 121,15,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1810,2104,7678,ZNF124,zinc finger protein 124,20,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1811,2105,9980,DOPEY2,dopey family member 2,6,,,ppi
1812,2106,7690,ZNF131,zinc finger protein 131,82,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
1813,2108,7692,ZNF133,zinc finger protein 133,21,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1814,2110,7694,ZNF135,zinc finger protein 135,7,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1815,2111,7695,ZNF136,zinc finger protein 136,8,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity,,ppi
1816,2112,7697,ZNF138,zinc finger protein 138,7,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1817,2113,7561,ZNF14,zinc finger protein 14,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1818,2114,7699,ZNF140,zinc finger protein 140,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
1819,2115,7700,ZNF141,zinc finger protein 141,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1820,2116,7701,ZNF142,zinc finger protein 142,6,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1821,2117,7702,ZNF143,zinc finger protein 143,11,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding,,ppi
1822,2118,7703,PCGF2,polycomb group ring finger 2,59,DNA-binding transcription factor activity|promoter-specific chromatin binding,,ppi
1823,2119,54065,SMIM11A,small integral membrane protein 11A,3,,,ppi
1824,2120,7704,ZBTB16,zinc finger and BTB domain containing 16,126,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|distal enhancer DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|protein homodimerization activity|DNA-binding transcription factor activity|sequence-specific DNA binding,cryptorchidism|acute promyelocytic leukemia|intellectual disability|learning disability|prostate cancer|prostate carcinoma|ophthalmoplegia|mechanical strabismus|hypertropia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
1825,2121,7705,ZNF146,zinc finger protein 146,21,DNA-binding transcription factor activity; RNA polymerase II-specific|heparin binding|zinc ion binding,,ppi
1826,2122,7706,TRIM25,tripartite motif containing 25,101,DNA-binding transcription factor activity|RNA binding|ubiquitin-protein transferase activity|cadherin binding|ubiquitin protein ligase activity,,ppi
1827,2123,7707,ZNF148,zinc finger protein 148,33,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding|transcription regulatory region DNA binding|DNA-binding transcription factor activity,,ppi
1828,2124,7709,ZBTB17,zinc finger and BTB domain containing 17,38,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|core promoter binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1829,2126,7711,ZNF155,zinc finger protein 155,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1830,2127,7712,ZNF157,zinc finger protein 157,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1831,2128,7562,ZNF708,zinc finger protein 708,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1832,2129,7564,ZNF16,zinc finger protein 16,34,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1833,2130,90338,ZNF160,zinc finger protein 160,4,DNA-binding transcription factor activity; RNA polymerase II-specific,prostate cancer|prostate carcinoma|stomach cancer,ppi
1834,2131,7716,VEZF1,vascular endothelial zinc finger 1,3,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
1835,2132,7536,SF1,splicing factor 1,236,transcription corepressor activity|RNA binding,melanoma|skin melanoma,ppi
1836,2133,7718,ZNF165,zinc finger protein 165,23,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1837,2134,55888,ZKSCAN7,zinc finger with KRAB and SCAN domains 7,14,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1838,2135,169841,ZNF169,zinc finger protein 169,47,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1839,2136,7565,ZNF17,zinc finger protein 17,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1840,2137,7726,TRIM26,tripartite motif containing 26,65,DNA binding|metal ion binding,,ppi
1841,2138,7727,ZNF174,zinc finger protein 174,21,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|transcription regulatory region DNA binding,,ppi
1842,2139,7728,ZNF175,zinc finger protein 175,8,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1843,2140,7730,ZNF177,zinc finger protein 177,3,DNA-binding transcription factor activity; RNA polymerase II-specific,stomach cancer,ppi
1844,2142,7566,ZNF18,zinc finger protein 18,9,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
1845,2143,54943,DNAJC28,DnaJ heat shock protein family (Hsp40) member C28,5,,,ppi
1846,2144,7733,ZNF180,zinc finger protein 180,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1847,2145,339318,ZNF181,zinc finger protein 181,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1848,2146,7737,RNF113A,ring finger protein 113A,19,,Dandy-Walker syndrome|placental insufficiency|intellectual disability|learning disability|agammaglobulinemia|photosensitivity disease|photosensitive epilepsy|fundus dystrophy|photosensitive trichothiodystrophy,ppi
1849,2147,7738,ZNF184,zinc finger protein 184,19,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding,,ppi
1850,2148,7739,ZNF185,zinc finger protein 185 (LIM domain),4,zinc ion binding,,ppi
1851,2149,7741,ZSCAN26,zinc finger and SCAN domain containing 26,43,DNA-binding transcription factor activity,,ppi
1852,2150,84221,SPATC1L,spermatogenesis and centriole associated 1-like,15,,,ppi
1853,2151,7743,ZNF189,zinc finger protein 189,24,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1854,2152,7567,ZNF19,zinc finger protein 19,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1855,2153,7745,ZKSCAN8,zinc finger with KRAB and SCAN domains 8,24,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1856,2154,7746,ZSCAN9,zinc finger and SCAN domain containing 9,9,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1857,2155,7748,ZNF195,zinc finger protein 195,9,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding,,ppi
1858,2156,10168,ZNF197,zinc finger protein 197,12,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
1859,2157,7750,ZMYM2,zinc finger MYM-type containing 2,68,protein tyrosine kinase activity|zinc ion binding|DNA-binding transcription factor activity; RNA polymerase II-specific,myeloproliferative neoplasm|bone marrow cancer,ppi
1860,2158,54059,YBEY,ybeY metallopeptidase (putative),68,,,ppi
1861,2159,7549,ZNF2,zinc finger protein 2,72,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding,,ppi
1862,2160,7568,ZNF20,zinc finger protein 20,23,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1863,2161,7752,ZNF200,zinc finger protein 200,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1864,2162,7753,ZNF202,zinc finger protein 202,12,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1865,2163,7755,ZNF205,zinc finger protein 205,12,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding,polycystic ovary syndrome,ppi
1866,2165,7756,ZNF207,zinc finger protein 207,34,DNA-binding transcription factor activity|RNA binding|microtubule binding|zinc ion binding,,ppi
1867,2166,7757,ZNF208,zinc finger protein 208,1,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding,,ppi
1868,2167,59,ACTA2,actin; alpha 2; smooth muscle; aorta,155,protein kinase binding,aortic aneurysm|aortic valve insufficiency|colon cancer|colonic benign neoplasm|cryptorchidism|patent ductus arteriosus|endometriosis of uterus|endometriosis|epilepsy|focal segmental glomerulosclerosis|hepatitis|hypertension|essential hypertension|primary pulmonary hypertension|pulmonary hypertension|ischemia|nephritis|glomerulonephritis|kidney disease|pyoureter,ppi
1869,2168,54058,C21orf58,chromosome 21 open reading frame 58,3,,,ppi
1870,2169,7569,ZNF182,zinc finger protein 182,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1871,2170,10520,ZNF211,zinc finger protein 211,16,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1872,2171,7988,ZNF212,zinc finger protein 212,30,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding,,ppi
1873,2172,7760,ZNF213,zinc finger protein 213,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1874,2173,7761,ZNF214,zinc finger protein 214,12,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding|DNA-binding transcription factor activity,,ppi
1875,2174,7762,ZNF215,zinc finger protein 215,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1876,2175,7763,ZFAND5,zinc finger AN1-type containing 5,18,,prostate cancer|prostate carcinoma,ppi
1877,2176,7764,ZNF217,zinc finger protein 217,13,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding,,ppi
1878,2177,56683,C21orf59,chromosome 21 open reading frame 59,41,,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1,ppi
1879,2179,51222,ZNF219,zinc finger protein 219,42,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
1880,2180,7570,ZNF22,zinc finger protein 22,31,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|zinc ion binding,,ppi
1881,2181,7994,KAT6A,lysine acetyltransferase 6A,35,DNA binding|transcription coactivator activity|histone acetyltransferase activity|transcription factor binding|zinc ion binding|acetyltransferase activity|histone binding|H4 histone acetyltransferase activity,ptosis|congenital ptosis|craniosynostosis|salivary gland adenoid cystic carcinoma|patent ductus arteriosus|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|medulloblastoma|medullomyoblastoma|adult medulloblastoma,ppi
1882,2182,7638,ZNF221,zinc finger protein 221,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding,,ppi
1883,2183,7673,ZNF222,zinc finger protein 222,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1884,2184,7766,ZNF223,zinc finger protein 223,23,DNA binding|DNA-binding transcription factor activity,,ppi
1885,2185,7767,ZNF224,zinc finger protein 224,13,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
1886,2186,7768,ZNF225,zinc finger protein 225,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1887,2187,7769,ZNF226,zinc finger protein 226,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1888,2188,10069,RWDD2B,RWD domain containing 2B,24,,,ppi
1889,2189,7770,ZNF227,zinc finger protein 227,9,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1890,2191,7571,ZNF23,zinc finger protein 23,10,DNA-binding transcription factor activity; RNA polymerase II-specific,liver cancer|hepatocellular carcinoma,ppi
1891,2192,7773,ZNF230,zinc finger protein 230,6,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1892,2193,7775,ZNF232,zinc finger protein 232,46,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1893,2194,10780,ZNF234,zinc finger protein 234,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1894,2195,7776,ZNF236,zinc finger protein 236,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1895,2196,9205,ZMYM5,zinc finger MYM-type containing 5,10,DNA-binding transcription factor activity; RNA polymerase II-specific,polycystic ovary syndrome,ppi
1896,2197,10472,ZBTB18,zinc finger and BTB domain containing 18,17,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|sequence-specific DNA binding,epilepsy|intellectual disability|learning disability|visual epilepsy|autosomal dominant non-syndromic intellectual disability,ppi
1897,2198,8187,ZNF239,zinc finger protein 239,2,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|RNA binding,,ppi
1898,2199,7572,ZNF24,zinc finger protein 24,91,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|zinc ion binding|sequence-specific DNA binding,,ppi
1899,2200,56246,MRAP,melanocortin 2 receptor accessory protein,7,,,ppi
1900,2201,57209,ZNF248,zinc finger protein 248,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1901,2202,219749,ZNF25,zinc finger protein 25,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1902,2203,58500,ZNF250,zinc finger protein 250,51,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1903,2204,90987,ZNF251,zinc finger protein 251,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1904,2205,9534,ZNF254,zinc finger protein 254,6,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1905,2206,10172,ZNF256,zinc finger protein 256,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1906,2208,9204,ZMYM6,zinc finger MYM-type containing 6,35,DNA binding,,ppi
1907,2209,8882,ZPR1,ZPR1 zinc finger,74,translation initiation factor binding,,ppi
1908,2210,7574,ZNF26,zinc finger protein 26,6,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1909,2211,9203,ZMYM3,zinc finger MYM-type containing 3,46,DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific,prostate cancer|prostate carcinoma,ppi
1910,2212,9202,ZMYM4,zinc finger MYM-type containing 4,51,DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1911,2213,10127,ZNF263,zinc finger protein 263,67,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
1912,2214,9422,ZNF264,zinc finger protein 264,24,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1913,2215,9406,ZRANB2,zinc finger RANBP2-type containing 2,87,DNA-binding transcription factor activity|RNA binding,,ppi
1914,2216,10781,ZNF266,zinc finger protein 266,10,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1915,2217,758,MPPED1,metallophosphoesterase domain containing 1,26,,,ppi
1916,2218,10308,ZNF267,zinc finger protein 267,6,DNA-binding transcription factor activity; RNA polymerase II-specific,seborrheic keratosis|skin disease|actinic keratosis,ppi
1917,2219,10795,ZNF268,zinc finger protein 268,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
1918,2220,10793,ZNF273,zinc finger protein 273,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1919,2221,10782,ZNF274,zinc finger protein 274,14,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|DNA-binding transcription factor activity|transcription corepressor activity|sequence-specific DNA binding,,ppi
1920,2222,10838,ZNF275,zinc finger protein 275,1,,,ppi
1921,2223,25776,CBY1,chibby family member 1; beta catenin antagonist,32,beta-catenin binding|protein homodimerization activity,,ppi
1922,2224,11179,ZNF277,zinc finger protein 277,13,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1923,2225,23598,PATZ1,POZ/BTB and AT hook containing zinc finger 1,27,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
1924,2226,7576,ZNF28,zinc finger protein 28,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1925,2227,23528,ZNF281,zinc finger protein 281,52,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity|sequence-specific DNA binding|transcription regulatory region DNA binding|DNA binding,,ppi
1926,2228,8427,ZNF282,zinc finger protein 282,9,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding,,ppi
1927,2229,284349,ZNF283,zinc finger protein 283,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1928,2230,342909,ZNF284,zinc finger protein 284,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding,,ppi
1929,2232,25807,RHBDD3,rhomboid domain containing 3,15,,substance abuse|substance-related disorder,ppi
1930,2233,49855,SCAPER,S-phase cyclin A associated protein in the ER,8,,intellectual disability|learning disability,ppi
1931,2234,26046,LTN1,listerin E3 ubiquitin protein ligase 1,63,ribosomal large subunit binding|ubiquitin protein ligase activity,,ppi
1932,2235,49854,ZBTB21,zinc finger and BTB domain containing 21,22,DNA-binding transcription factor activity; RNA polymerase II-specific|methyl-CpG binding,,ppi
1933,2236,9278,ZBTB22,zinc finger and BTB domain containing 22,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1934,2237,7551,ZNF3,zinc finger protein 3,10,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|zinc ion binding,,ppi
1935,2238,25771,TBC1D22A,TBC1 domain family member 22A,23,protein homodimerization activity|14-3-3 protein binding|Rab GTPase binding|GTPase activator activity,,ppi
1936,2239,90075,ZNF30,zinc finger protein 30,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1937,2241,7579,ZSCAN20,zinc finger and SCAN domain containing 20,57,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1938,2242,55905,RNF114,ring finger protein 114,50,ubiquitin-protein transferase activity,pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
1939,2243,7580,ZNF32,zinc finger protein 32,10,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1940,2244,7581,ZNF33A,zinc finger protein 33A,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding,,ppi
1941,2245,7582,ZNF33B,zinc finger protein 33B,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
1942,2246,80778,ZNF34,zinc finger protein 34,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1943,2247,7584,ZNF35,zinc finger protein 35,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
1944,2248,25829,TMEM184B,transmembrane protein 184B,19,,,ppi
1945,2249,7586,ZKSCAN1,zinc finger with KRAB and SCAN domains 1,28,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1946,2251,7589,ZSCAN21,zinc finger and SCAN domain containing 21,24,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
1947,2252,7592,ZNF41,zinc finger protein 41,5,DNA-binding transcription factor activity; RNA polymerase II-specific,intellectual disability|learning disability|autistic disorder,ppi
1948,2253,7593,MZF1,myeloid zinc finger 1,11,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding,,ppi
1949,2255,51710,ZNF44,zinc finger protein 44,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1950,2256,7596,ZNF45,zinc finger protein 45,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1951,2257,7597,ZBTB25,zinc finger and BTB domain containing 25,25,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
1952,2258,197407,ZNF48,zinc finger protein 48,7,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
1953,2259,25809,TTLL1,tubulin tyrosine ligase like 1,20,tubulin-glutamic acid ligase activity,,ppi
1954,2260,126295,ZNF57,zinc finger protein 57,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1955,2261,7552,ZNF711,zinc finger protein 711,9,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|chromatin DNA binding,intellectual disability|learning disability|autistic disorder,ppi
1956,2262,55007,FAM118A,family with sequence similarity 118 member A,13,,,ppi
1957,2263,7620,ZNF69,zinc finger protein 69,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1958,2264,7553,ZNF7,zinc finger protein 7,10,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1959,2265,23313,KIAA0930,KIAA0930,16,,,ppi
1960,2266,7621,ZNF70,zinc finger protein 70,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1961,2267,58491,ZNF71,zinc finger protein 71,39,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
1962,2268,7625,ZNF74,zinc finger protein 74,5,DNA-binding transcription factor activity; RNA polymerase II-specific,schizophrenia,ppi
1963,2270,7627,ZNF75A,zinc finger protein 75a,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1964,2271,7629,ZNF76,zinc finger protein 76,12,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
1965,2272,58492,ZNF77,zinc finger protein 77,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1966,2273,7633,ZNF79,zinc finger protein 79,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1967,2274,7554,ZNF8,zinc finger protein 8,25,DNA binding|zinc ion binding,,ppi
1968,2275,7634,ZNF80,zinc finger protein 80,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1969,2276,347344,ZNF81,zinc finger protein 81,1,DNA-binding transcription factor activity; RNA polymerase II-specific,non-syndromic X-linked intellectual disability,ppi
1970,2277,55769,ZNF83,zinc finger protein 83,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1971,2279,27436,EML4,echinoderm microtubule associated protein like 4,23,microtubule binding,brain cancer|lung cancer|non-small cell lung carcinoma|lung adenocarcinoma,ppi
1972,2280,7639,ZNF85,zinc finger protein 85,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity,,ppi
1973,2281,7555,CNBP,CCHC-type zinc finger nucleic acid binding protein,156,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA binding,diabetic ketoacidosis|diabetes mellitus|hypogonadism|myotonic dystrophy type 2|myotonic dystrophy type 1|myotonic disease|Sertoli cell-only syndrome|oligospermia|cataract|selective IgG deficiency disease|fibromyalgia|myositis|alopecia|androgenic alopecia,ppi
1974,2283,7644,ZNF91,zinc finger protein 91,8,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|zinc ion binding,,ppi
1975,2284,168374,ZNF92,zinc finger protein 92,17,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|zinc ion binding,,ppi
1976,2285,81931,ZNF93,zinc finger protein 93,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|zinc ion binding,,ppi
1977,2286,6936,GCFC2,GC-rich sequence DNA-binding factor 2,28,RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
1978,2287,9753,ZSCAN12,zinc finger and SCAN domain containing 12,38,,,ppi
1979,2289,7652,ZNF99,zinc finger protein 99,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1980,2290,10320,IKZF1,IKAROS family zinc finger 1,114,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding,inflammatory bowel disease|ulcerative colitis|systemic lupus erythematosus|lymphosarcoma|lymphoma|central nervous system lymphoma|Stevens-Johnson syndrome|granuloma annulare|acute lymphocytic leukemia,ppi
1981,2291,22807,IKZF2,IKAROS family zinc finger 2,20,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region DNA binding|DNA-binding transcription factor activity,adult T-cell leukemia|acute T cell leukemia|acute lymphocytic leukemia,ppi
1982,2292,22806,IKZF3,IKAROS family zinc finger 3,93,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|protein homodimerization activity|sequence-specific DNA binding|protein heterodimerization activity|transcription regulatory region DNA binding,rheumatoid arthritis|asthma|intrinsic asthma|allergic asthma|chronic lymphocytic leukemia|Richter's syndrome|acute lymphocytic leukemia,ppi
1983,2293,64375,IKZF4,IKAROS family zinc finger 4,16,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|zinc ion binding|transcription regulatory region DNA binding,alopecia areata|vitiligo,ppi
1984,2294,718,C3,complement C3,51,serine-type endopeptidase activity|signaling receptor binding|C5L2 anaphylatoxin chemotactic receptor binding,vertebrobasilar insufficiency|transient cerebral ischemia|diabetes mellitus|type 2 diabetes mellitus|membranous glomerulonephritis|primary immunodeficiency disease|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|pemphigus|Henoch-Schoenlein purpura|hypersensitivity vasculitis|kidney failure|uremia|age related macular degeneration|macular degeneration|degeneration of macula and posterior pole|middle cerebral artery infarction|age related macular degeneration 9|hemolytic-uremic syndrome,ppi
1985,2295,53349,ZFYVE1,zinc finger FYVE-type containing 1,10,1-phosphatidylinositol binding|phosphatidylinositol-3;4;5-trisphosphate binding|zinc ion binding|phosphatidylinositol-3;4-bisphosphate binding,,ppi
1986,2296,30834,ZNRD1,zinc ribbon domain containing 1,23,DNA-directed 5'-3' RNA polymerase activity|RNA polymerase I activity,stomach cancer,ppi
1987,2298,7783,ZP2,zona pellucida glycoprotein 2,4,coreceptor activity,,ppi
1988,2299,7784,ZP3,zona pellucida glycoprotein 3,10,carbohydrate binding|receptor ligand activity|acrosin binding,,ppi
1989,2300,719,C3AR1,complement C3a receptor 1,94,complement component C3a receptor activity|G-protein coupled receptor activity,,ppi
1990,2301,27000,DNAJC2,DnaJ heat shock protein family (Hsp40) member C2,19,DNA-binding transcription factor activity; RNA polymerase II-specific|ATPase activator activity|chromatin binding|RNA binding|histone binding|ubiquitin modification-dependent histone binding,,ppi
1991,2302,9183,ZW10,zw10 kinetochore protein,58,centromeric DNA binding,osteosarcoma|bone osteosarcoma,ppi
1992,2303,11130,ZWINT,ZW10 interacting kinetochore protein,95,,,ppi
1993,2304,7789,ZXDA,zinc finger; X-linked; duplicated A,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
1994,2305,158586,ZXDB,zinc finger; X-linked; duplicated B,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
1995,2306,60,ACTB,actin beta,462,structural constituent of cytoskeleton|structural constituent of postsynaptic actin cytoskeleton|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,aortic valve stenosis|bipolar disorder|ptosis|congenital ptosis|cleft lip|isolated cleft palate|cleft palate|coloboma|cryptorchidism|patent ductus arteriosus|dysostosis|dystonia|epilepsy|megaesophagus|achalasia|esophageal cancer|sensorineural hearing loss|primary immunodeficiency disease|lung benign neoplasm|intellectual disability,ppi
1996,2307,7791,ZYX,zyxin,115,RNA binding,,ppi
1997,2308,81794,ADAMTS10,ADAM metallopeptidase with thrombospondin type 1 motif 10,7,,Weill-Marchesani syndrome,ppi
1998,2309,56999,ADAMTS9,ADAM metallopeptidase with thrombospondin type 1 motif 9,1,metallopeptidase activity,diabetes mellitus|type 2 diabetes mellitus,ppi
1999,2310,57379,AICDA,activation induced cytidine deaminase,53,cytidine deaminase activity|RNA binding,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|lymphoblastic leukemia|myeloid leukemia|X-linked hyper IgM syndrome|immunodeficiency with hyper-IgM type 2,ppi
2000,2311,55437,STRADB,STE20-related kinase adaptor beta,16,protein kinase activity|protein serine/threonine kinase activity,,ppi
2001,2312,66008,TRAK2,trafficking kinesin protein 2,36,signaling receptor binding|GABA receptor binding|myosin binding,,ppi
2002,2313,57763,ANKRA2,ankyrin repeat family A member 2,31,ubiquitin protein ligase binding|histone deacetylase binding,,ppi
2003,2314,7984,ARHGEF5,Rho guanine nucleotide exchange factor 5,22,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|GTP binding,prostate cancer|prostate carcinoma,ppi
2004,2315,51300,TIMMDC1,translocase of inner mitochondrial membrane domain containing 1,58,,,ppi
2005,2316,84100,ARL6,ADP ribosylation factor like GTPase 6,16,phospholipid binding|GTP binding,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|Laurence-Moon syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 4|Bardet-Biedl syndrome 5|Bardet-Biedl syndrome 6|Bardet-Biedl syndrome 7|Bardet-Biedl syndrome 8|Bardet-Biedl syndrome 9|Bardet-Biedl syndrome 10|Bardet-Biedl syndrome 11|Bardet-Biedl syndrome 12|Bardet-Biedl syndrome 13|Bardet-Biedl syndrome 14|Bardet-Biedl syndrome 15,ppi
2006,2317,27032,ATP2C1,ATPase secretory pathway Ca2+ transporting 1,13,calcium-transporting ATPase activity|manganese-transporting ATPase activity|proton-exporting ATPase activity; phosphorylative mechanism,granuloma annulare|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|acquired hyperkeratosis,ppi
2007,2319,56650,CLDND1,claudin domain containing 1,20,,,ppi
2008,2320,53335,BCL11A,B-cell CLL/lymphoma 11A,34,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding|DNA-binding transcription factor activity,agnosia|salivary gland adenoid cystic carcinoma|communication disorder|polycystic ovary syndrome|schizophrenia,ppi
2009,2321,64919,BCL11B,B-cell CLL/lymphoma 11B,19,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,lymphosarcoma|lymphoma|central nervous system lymphoma|acute T cell leukemia,ppi
2010,2322,720,C4A,complement C4A (Rodgers blood group),32,,arthropathy|arthritis|Behcet's disease|nephritis|glomerulonephritis|kidney disease|primary immunodeficiency disease|systemic lupus erythematosus|meningitis|orchitis|aphthous stomatitis|vasculitis|thrombophilia|asthenopia|migraine|fibromyalgia|myositis|complement component 2 deficiency|complement component 4a deficiency|complement component 4b deficiency,ppi
2011,2324,11228,RASSF8,Ras association domain family member 8,46,,lung small cell carcinoma,ppi
2012,2325,8125,ANP32A,acidic nuclear phosphoprotein 32 family member A,66,RNA binding|histone binding,,ppi
2013,2326,29965,CDIP1,cell death inducing p53 target 1,2,,,ppi
2014,2327,8725,URI1,URI1; prefoldin like chaperone,59,chromatin binding|transcription corepressor activity|phosphatase inhibitor activity,ovarian cancer,ppi
2015,2328,25789,TMEM59L,transmembrane protein 59 like,10,,,ppi
2016,2329,57136,APMAP,adipocyte plasma membrane associated protein,21,arylesterase activity,,ppi
2017,2330,59271,EVA1C,eva-1 homolog C,37,heparin binding,,ppi
2018,2331,721,C4B,complement C4B (Chido blood group),3,complement component C1q binding|serine-type endopeptidase activity|complement binding|carbohydrate binding,autistic disorder|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|meningitis|hepatitis|autoimmune hepatitis|complement component 4b deficiency,ppi
2019,2332,26150,RIBC2,RIB43A domain with coiled-coils 2,27,,breast cancer,ppi
2020,2333,57467,HHATL,hedgehog acyltransferase-like,1,,,ppi
2021,2334,64327,LMBR1,limb development membrane protein 1,36,,acheiropody|syndactyly|polydactyly,ppi
2022,2335,64434,NOM1,nucleolar protein with MIF4G domain 1,40,RNA binding,,ppi
2023,2336,23196,FAM120A,family with sequence similarity 120A,59,RNA binding,,ppi
2024,2337,83698,CALN1,calneuron 1,1,,,ppi
2025,2339,722,C4BPA,complement component 4 binding protein alpha,14,RNA binding,schizophrenia,ppi
2026,2341,51192,CKLF,chemokine like factor,2,chemokine activity,,ppi
2027,2342,24140,FTSJ1,FtsJ RNA methyltransferase homolog 1 (E. coli),111,tRNA (guanosine-2'-O-)-methyltransferase activity|tRNA (cytosine-2'-O-)-methyltransferase activity|tRNA methyltransferase activity,intellectual disability|learning disability|non-syndromic X-linked intellectual disability,ppi
2028,2343,50856,CLEC4A,C-type lectin domain family 4 member A,1,transmembrane signaling receptor activity|calcium ion binding|mannose binding|carbohydrate binding,allergic hypersensitivity disease,ppi
2029,2344,170482,CLEC4C,C-type lectin domain family 4 member C,2,,,ppi
2030,2345,128822,CST9,cystatin 9,5,,,ppi
2031,2346,57834,CYP4F11,cytochrome P450 family 4 subfamily F member 11,1,monooxygenase activity|fatty acid binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen|heme binding,,ppi
2032,2347,57062,DDX24,DEAD-box helicase 24,166,RNA binding|RNA helicase activity,,ppi
2033,2348,28955,DEXI,Dexi homolog,2,,,ppi
2034,2349,50506,DUOX2,dual oxidase 2,1,calcium ion binding|NAD(P)H oxidase activity,constipation|congenital hypothyroidism|myxedema|hypothyroidism|goiter|nontoxic goiter|thyroid gland disease|umbilical hernia|omphalocele|intellectual disability|learning disability|recurrent hypersomnia,ppi
2035,2350,9718,ECE2,endothelin converting enzyme 2,15,metalloendopeptidase activity,,ppi
2036,2351,9538,EI24,EI24; autophagy associated transmembrane protein,7,,prostate cancer|prostate carcinoma,ppi
2037,2352,64097,EPB41L4A,erythrocyte membrane protein band 4.1 like 4A,4,,,ppi
2038,2353,725,C4BPB,complement component 4 binding protein beta,15,,schizophrenia,ppi
2039,2354,30001,ERO1A,endoplasmic reticulum oxidoreductase 1 alpha,28,disulfide oxidoreductase activity|oxidoreductase activity|protein disulfide isomerase activity|protein disulfide oxidoreductase activity,,ppi
2040,2355,83715,ESPN,espin,1,SH3 domain binding|actin filament binding,sensorineural hearing loss|central nervous system origin vertigo|inner ear disease|vestibular disease|autosomal recessive nonsyndromic deafness 36,ppi
2041,2356,55137,FIGN,fidgetin; microtubule severing factor,3,ATPase activity|microtubule-severing ATPase activity,,ppi
2042,2357,63979,FIGNL1,fidgetin like 1,31,magnesium ion binding|hydrolase activity|ATPase activity|microtubule-severing ATPase activity,,ppi
2043,2358,10463,SLC30A9,solute carrier family 30 member 9,14,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
2044,2359,11345,GABARAPL2,GABA type A receptor associated protein like 2,551,SNARE binding|microtubule binding|beta-tubulin binding|GABA receptor binding|ATPase binding,,ppi
2045,2360,55366,LGR4,leucine rich repeat containing G protein-coupled receptor 4,212,transmembrane signaling receptor activity|G-protein coupled receptor activity|G-protein coupled peptide receptor activity,schizophrenia,ppi
2046,2361,23784,POTEH,POTE ankyrin domain family member H,1,,,ppi
2047,2362,51778,MYOZ2,myozenin 2,16,protein phosphatase 2B binding|actin binding|telethonin binding|FATZ binding,hypertrophic cardiomyopathy 16,ppi
2048,2363,83873,GPR61,G protein-coupled receptor 61,1,arrestin family protein binding,,ppi
2049,2365,81491,GPR63,G protein-coupled receptor 63,1,G-protein coupled receptor activity,,ppi
2050,2367,51704,GPRC5B,G protein-coupled receptor class C group 5 member B,18,G-protein coupled receptor binding|protein kinase binding|protein kinase activator activity,,ppi
2051,2368,55890,GPRC5C,G protein-coupled receptor class C group 5 member C,33,protein kinase activator activity,,ppi
2052,2369,727,C5,complement C5,9,signaling receptor binding|chemokine activity,primary immunodeficiency disease|complement component 2 deficiency|complement component 4a deficiency|complement component 4b deficiency|complement component 6 deficiency|complement component 7 deficiency|type I complement component 8 deficiency|type II complement component 8 deficiency|complement component 9 deficiency|complement deficiency|complement component 5 deficiency,ppi
2053,2370,55507,GPRC5D,G protein-coupled receptor class C group 5 member D,2,protein kinase activator activity,bipolar disorder|neurotic disorder|endogenous depression|melancholia|mood disorder|major depressive disorder|mental depression,ppi
2054,2371,284110,GSDMA,gasdermin A,10,phosphatidylinositol-4-phosphate binding|phosphatidylinositol-4;5-bisphosphate binding|phosphatidylserine binding,,ppi
2055,2372,9446,GSTO1,glutathione S-transferase omega 1,37,glutathione transferase activity|oxidoreductase activity|glutathione dehydrogenase (ascorbate) activity|methylarsonate reductase activity,leukemia|lung disease|prostate cancer|prostate carcinoma|seborrheic keratosis|skin disease|actinic keratosis|esophagus squamous cell carcinoma|neurodegenerative disease,ppi
2056,2373,55869,HDAC8,histone deacetylase 8,35,histone deacetylase activity|transcription factor binding,Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome|Cockayne syndrome|Noonan syndrome|Aarskog syndrome|Wilson-Turner syndrome,ppi
2057,2374,83444,INO80B,INO80 complex subunit B,24,,,ppi
2058,2375,30811,HUNK,hormonally up-regulated Neu-associated kinase,3,protein serine/threonine kinase activity,,ppi
2059,2376,24138,IFIT5,interferon induced protein with tetratricopeptide repeats 5,27,tRNA binding|RNA cap binding|double-stranded DNA binding|RNA binding|single-stranded RNA binding|poly(U) RNA binding,influenza,ppi
2060,2377,10827,FAM114A2,family with sequence similarity 114 member A2,15,purine nucleotide binding,,ppi
2061,2378,24137,KIF4A,kinesin family member 4A,27,microtubule motor activity|ATPase activity|microtubule binding,epilepsy|intellectual disability|learning disability|visual epilepsy,ppi
2062,2380,51348,KLRF1,killer cell lectin like receptor F1,5,transmembrane signaling receptor activity|MHC class I receptor activity,,ppi
2063,2381,84247,LDOC1L,leucine zipper down-regulated in cancer 1 like,7,,substance abuse|substance-related disorder,ppi
2064,2382,23175,LPIN1,lipin 1,11,phosphatidate phosphatase activity|transcription coactivator activity,fibromyalgia|myositis|myoglobinuria,ppi
2065,2383,56925,LXN,latexin,17,,melanoma|skin melanoma,ppi
2066,2384,8581,LY6D,lymphocyte antigen 6 complex; locus D,4,,,ppi
2067,2385,51306,FAM13B,family with sequence similarity 13 member B,8,GTPase activator activity,,ppi
2068,2386,81631,MAP1LC3B,microtubule associated protein 1 light chain 3 beta,369,microtubule binding,,ppi
2069,2387,440738,MAP1LC3C,microtubule associated protein 1 light chain 3 gamma,60,microtubule binding,,ppi
2070,2388,57192,MCOLN1,mucolipin 1,4,cation channel activity|calcium channel activity|iron ion transmembrane transporter activity|intracellular phosphatidylinositol-3;5-bisphosphate-sensitive cation channel activity|ligand-gated calcium channel activity|NAADP-sensitive calcium-release channel activity,glycoproteinosis,ppi
2071,2389,255231,MCOLN2,mucolipin 2,1,calcium channel activity|NAADP-sensitive calcium-release channel activity,,ppi
2072,2390,55283,MCOLN3,mucolipin 3,57,calcium channel activity|NAADP-sensitive calcium-release channel activity,,ppi
2073,2391,51307,FAM53C,family with sequence similarity 53 member C,15,,,ppi
2074,2392,56955,MEPE,matrix extracellular phosphoglycoprotein,13,extracellular matrix structural constituent|extracellular matrix protein binding,,ppi
2075,2395,51780,KDM3B,lysine demethylase 3B,31,histone demethylase activity|transcription regulatory region sequence-specific DNA binding|histone demethylase activity (H3-K9 specific)|chromatin DNA binding,,ppi
2076,2396,54860,MS4A12,membrane spanning 4-domains A12,4,,,ppi
2077,2398,64232,MS4A5,membrane spanning 4-domains A5,1,,,ppi
2078,2399,64231,MS4A6A,membrane spanning 4-domains A6A,1,,IgA glomerulonephritis,ppi
2079,2400,58475,MS4A7,membrane spanning 4-domains A7,3,,,ppi
2080,2401,728,C5AR1,complement C5a receptor 1,9,complement component C5a receptor activity|G-protein coupled receptor activity,toxic shock syndrome,ppi
2081,2404,140609,NEK7,NIMA related kinase 7,24,protein serine/threonine kinase activity,,ppi
2082,2405,284086,NEK8,NIMA related kinase 8,39,,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|nephronophthisis,ppi
2083,2406,27018,BEX3,brain expressed X-linked 3,30,cysteine-type endopeptidase activator activity involved in apoptotic process,,ppi
2084,2407,22795,NID2,nidogen 2,23,extracellular matrix structural constituent|collagen binding,,ppi
2085,2408,729,C6,complement C6,13,,calcium metabolism disease|nephrocalcinosis|calcinosis|heart valve disease|complement component 2 deficiency|complement component 4a deficiency|complement component 4b deficiency|complement component 6 deficiency|complement component 7 deficiency|type I complement component 8 deficiency|type II complement component 8 deficiency|complement component 9 deficiency|complement deficiency,ppi
2086,2409,60491,NIF3L1,NGG1 interacting factor 3 like 1,127,,,ppi
2087,2410,7827,NPHS2,NPHS2; podocin,6,,proteinuria|congestive heart failure|focal segmental glomerulosclerosis|familial hyperlipidemia|kidney disease|nephrosis|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome,ppi
2088,2411,9476,NAPSA,napsin A aspartic peptidase,7,endopeptidase activity|aspartic-type endopeptidase activity|peptidase activity,,ppi
2089,2412,51706,CYB5R1,cytochrome b5 reductase 1,19,cytochrome-b5 reductase activity; acting on NAD(P)H|FAD binding,,ppi
2090,2413,50814,NSDHL,NAD(P) dependent steroid dehydrogenase-like,25,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity|oxidoreductase activity|oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor,cleft lip|epilepsy|heart septal defect|umbilical hernia|omphalocele|hydronephrosis|intellectual disability|learning disability|nail disease|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|congenital ichthyosiform erythroderma|Sjogren-Larsson syndrome|ventricular septal defect|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8,ppi
2091,2416,80714,PBX4,PBX homeobox 4,4,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
2092,2417,57575,PCDH10,protocadherin 10,13,,alcohol dependence|alcohol abuse|autistic disorder,ppi
2093,2418,27445,PCLO,piccolo presynaptic cytomatrix protein,6,calcium ion binding|profilin binding|calcium-dependent phospholipid binding,bipolar disorder|sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|enophthalmos|orbital disease|exophthalmos|optic atrophy|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|craniosynostosis|pontocerebellar hypoplasia type 3,ppi
2094,2419,22984,PDCD11,programmed cell death 11,51,RNA binding,,ppi
2095,2421,57157,PHTF2,putative homeodomain transcription factor 2,3,,,ppi
2096,2424,28227,PPP2R3B,protein phosphatase 2 regulatory subunit B''beta,16,phosphoprotein phosphatase activity|protein serine/threonine phosphatase activity|protein phosphatase regulator activity,,ppi
2097,2425,58497,PRUNE1,prune exopolyphosphatase,15,tubulin binding|phosphatase activity|exopolyphosphatase activity,,ppi
2098,2426,27303,RBMS3,RNA binding motif single stranded interacting protein 3,9,poly(A) binding|poly(U) RNA binding|mRNA 3'-UTR AU-rich region binding|mRNA 3'-UTR binding|RNA binding,,ppi
2099,2427,51132,RLIM,ring finger protein; LIM domain interacting,37,transcription corepressor activity|ubiquitin-protein transferase activity,intellectual disability|learning disability|prostate cancer|prostate carcinoma,ppi
2100,2428,10758,TRAF3IP2,TRAF3 interacting protein 2,36,,psoriatic arthritis|blepharitis|chronic mucocutaneous candidiasis|angular cheilitis|cheilitis|lip disease|exanthem|pustulosis of palm and sole|psoriasis|parapsoriasis|chronic ulcer of skin|granuloma annulare|meibomian cyst|hordeolum|acquired hyperkeratosis,ppi
2101,2429,51127,TRIM17,tripartite motif containing 17,26,ubiquitin-protein transferase activity,,ppi
2102,2430,57093,TRIM49,tripartite motif containing 49,7,,,ppi
2103,2431,25897,RNF19A,ring finger protein 19A; RBR E3 ubiquitin protein ligase,18,ubiquitin-protein transferase activity|transcription factor binding|ubiquitin protein ligase activity|ubiquitin conjugating enzyme binding,,ppi
2104,2432,64221,ROBO3,roundabout guidance receptor 3,7,cell-cell adhesion mediator activity,autistic disorder,ppi
2105,2433,57096,RPGRIP1,retinitis pigmentosa GTPase regulator interacting protein 1,59,,spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|Leber congenital amaurosis|fundus dystrophy|Leber congenital amaurosis 6,ppi
2106,2434,27156,RSPH14,radial spoke head 14 homolog,18,,,ppi
2107,2435,80274,SCUBE1,signal peptide; CUB domain and EGF like domain containing 1,2,calcium ion binding|identical protein binding|protein heterodimerization activity,,ppi
2108,2438,56606,SLC2A9,solute carrier family 2 member 9,1,carbohydrate:proton symporter activity|urate transmembrane transporter activity|transmembrane transporter activity,gout|hyperuricemia,ppi
2109,2439,81539,SLC38A1,solute carrier family 38 member 1,53,amino acid:sodium symporter activity|amino acid transmembrane transporter activity|neutral amino acid transmembrane transporter activity|L-amino acid transmembrane transporter activity,,ppi
2110,2440,54407,SLC38A2,solute carrier family 38 member 2,25,amino acid transmembrane transporter activity,schizophrenia,ppi
2111,2442,54971,BANP,BTG3 associated nuclear protein,104,,,ppi
2112,2443,10615,SPAG5,sperm associated antigen 5,83,microtubule binding,,ppi
2113,2444,730,C7,complement C7,4,,complement component 2 deficiency|complement component 4a deficiency|complement component 4b deficiency|complement component 6 deficiency|complement component 7 deficiency|type I complement component 8 deficiency|type II complement component 8 deficiency|complement component 9 deficiency|complement deficiency,ppi
2114,2445,57515,SERINC1,serine incorporator 1,33,protein binding; bridging,,ppi
2115,2446,27242,TNFRSF21,TNF receptor superfamily member 21,9,,progressive muscular atrophy|amyotrophic lateral sclerosis|prostate cancer|prostate carcinoma,ppi
2116,2447,57348,TTYH1,tweety family member 1,1,chloride channel activity|iron ion transmembrane transporter activity|volume-sensitive chloride channel activity|intracellular calcium activated chloride channel activity,,ppi
2117,2448,89910,UBE3B,ubiquitin protein ligase E3B,7,ubiquitin conjugating enzyme activity,,ppi
2118,2450,54809,SAMD9,sterile alpha motif domain containing 9,10,,calcium metabolism disease|nephrocalcinosis|calcinosis|conjunctivitis|placental insufficiency|gingivitis|influenza|intestinal disease|gastrointestinal system disease|skin disease|seborrheic keratosis|actinic keratosis|X-linked adrenal hypoplasia congenita|normophosphatemic familial tumoral calcinosis|essential thrombocythemia|myelodysplastic syndrome,ppi
2119,2451,9706,ULK2,unc-51 like autophagy activating kinase 2,54,protein serine/threonine kinase activity,malignant mesothelioma|benign mesothelioma,ppi
2120,2452,81622,UNC93B1,unc-93 homolog B1 (C. elegans),32,Toll-like receptor binding,liver cirrhosis,ppi
2121,2453,83844,USP26,ubiquitin specific peptidase 26,5,thiol-dependent ubiquitinyl hydrolase activity|cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity,Sertoli cell-only syndrome,ppi
2122,2454,389856,USP27X,ubiquitin specific peptidase 27; X-linked,5,thiol-dependent ubiquitin-specific protease activity|Lys63-specific deubiquitinase activity|Lys48-specific deubiquitinase activity,,ppi
2123,2455,55737,VPS35,VPS35; retromer complex component,86,protein transporter activity,Parkinson's disease|schizophrenia,ppi
2124,2456,27183,VPS4A,vacuolar protein sorting 4 homolog A,35,ATP binding|ATPase activity|ATPase activity; coupled|microtubule-severing ATPase activity,,ppi
2125,2457,219285,SAMD9L,sterile alpha motif domain containing 9 like,4,,,ppi
2126,2458,23335,WDR7,WD repeat domain 7,7,,,ppi
2127,2459,149297,FAM78B,family with sequence similarity 78 member B,5,,,ppi
2128,2460,56242,ZNF253,zinc finger protein 253,3,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding,,ppi
2129,2461,113835,ZNF257,zinc finger protein 257,1,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding,,ppi
2130,2462,339324,ZNF260,zinc finger protein 260,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2131,2463,136991,ASZ1,ankyrin repeat; SAM and basic leucine zipper domain containing 1,1,,prostate cancer|prostate carcinoma,ppi
2132,2464,57335,ZNF286A,zinc finger protein 286A,12,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2133,2465,57336,ZNF287,zinc finger protein 287,1,,,ppi
2134,2466,26137,ZBTB20,zinc finger and BTB domain containing 20,14,DNA-binding transcription factor activity; RNA polymerase II-specific,anemia|macrocytic anemia|ptosis|congenital ptosis|sensorineural hearing loss|enophthalmos|orbital disease|exophthalmos|epilepsy|hypertrophy of breast|infant gynecomastia|gynecomastia|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|hypogonadism|intellectual disability|learning disability|familial periodic paralysis,ppi
2135,2467,84364,ARFGAP2,ADP ribosylation factor GTPase activating protein 2,19,GTPase activator activity,stomach cancer,ppi
2136,2468,57343,ZNF304,zinc finger protein 304,1,DNA-binding transcription factor activity; RNA polymerase II-specific|promoter-specific chromatin binding,,ppi
2137,2469,55079,FEZF2,FEZ family zinc finger 2,1,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding|chromatin DNA binding|sequence-specific DNA binding,,ppi
2138,2470,57693,ZNF317,zinc finger protein 317,18,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2139,2472,57099,AVEN,apoptosis and caspase activation inhibitor,9,,lung cancer|non-small cell lung carcinoma,ppi
2140,2473,57448,BIRC6,baculoviral IAP repeat containing 6,61,ubiquitin-protein transferase activity|cysteine-type endopeptidase inhibitor activity|ubiquitin conjugating enzyme activity,,ppi
2141,2474,53405,CLIC5,chloride intracellular channel 5,13,,sensorineural hearing loss,ppi
2142,2475,25932,CLIC4,chloride intracellular channel 4,48,chloride channel activity,arthropathy|arthritis|prostate cancer|prostate carcinoma,ppi
2143,2476,59274,MESDC1,mesoderm development candidate 1,2,actin binding,,ppi
2144,2477,731,C8A,complement C8 alpha chain,4,,primary immunodeficiency disease|systemic lupus erythematosus|meningitis|type I complement component 8 deficiency,ppi
2145,2478,23184,MESDC2,mesoderm development candidate 2,30,,,ppi
2146,2479,10332,CLEC4M,C-type lectin domain family 4 member M,9,virus receptor activity|carbohydrate binding|ICAM-3 receptor activity|signaling receptor activity|peptide antigen binding|virion binding,,ppi
2147,2480,754,PTTG1IP,pituitary tumor-transforming 1 interacting protein,6,,,ppi
2148,2481,9605,VPS9D1,VPS9 domain containing 1,1,transporter activity,,ppi
2149,2482,51382,ATP6V1D,ATPase H+ transporting V1 subunit D,54,proton-transporting ATPase activity; rotational mechanism|protein binding,,ppi
2150,2483,10331,B3GNT3,UDP-GlcNAc:betaGal beta-1;3-N-acetylglucosaminyltransferase 3,22,UDP-galactose:beta-N-acetylglucosamine beta-1;3-galactosyltransferase activity|N-acetyllactosaminide beta-1;3-N-acetylglucosaminyltransferase activity|acetylgalactosaminyltransferase activity,,ppi
2151,2484,10330,CNPY2,canopy FGF signaling regulator 2,19,,stomach cancer,ppi
2152,2485,732,C8B,complement C8 beta chain,3,,primary immunodeficiency disease|meningitis|type II complement component 8 deficiency,ppi
2153,2486,10329,TMEM5,transmembrane protein 5,14,ribitol beta-1;4-xylosyltransferase activity,gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S,ppi
2154,2487,10396,ATP8A1,ATPase phospholipid transporting 8A1,2,phospholipid-translocating ATPase activity|cation-transporting ATPase activity,,ppi
2155,2488,30012,TLX3,T-cell leukemia homeobox 3,17,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2156,2489,51761,ATP8A2,ATPase phospholipid transporting 8A2,4,phospholipid-translocating ATPase activity,cerebellar disease|spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|epilepsy|intellectual disability|learning disability|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|muscular atrophy|cerebellar ataxia; mental retardation and dysequlibrium syndrome,ppi
2157,2490,57198,ATP8B2,ATPase phospholipid transporting 8B2,15,phospholipid-translocating ATPase activity,,ppi
2158,2492,79895,ATP8B4,ATPase phospholipid transporting 8B4 (putative),2,phospholipid-translocating ATPase activity,,ppi
2159,2493,57787,MARK4,microtubule affinity regulating kinase 4,58,protein serine/threonine kinase activity|ATP binding|microtubule binding|gamma-tubulin binding|ubiquitin binding|tau-protein kinase activity,,ppi
2160,2494,57085,AGTRAP,angiotensin II receptor associated protein,78,,,ppi
2161,2495,733,C8G,complement C8 gamma chain,6,,,ppi
2162,2496,10079,ATP9A,ATPase phospholipid transporting 9A (putative),31,phospholipid-translocating ATPase activity,,ppi
2163,2498,57194,ATP10A,ATPase phospholipid transporting 10A (putative),1,phospholipid-translocating ATPase activity,autistic disorder,ppi
2164,2499,23120,ATP10B,ATPase phospholipid transporting 10B (putative),1,phospholipid-translocating ATPase activity,,ppi
2165,2500,54108,CHRAC1,chromatin accessibility complex 1,31,DNA binding|DNA-directed DNA polymerase activity|protein heterodimerization activity,,ppi
2166,2501,54107,POLE3,DNA polymerase epsilon 3; accessory subunit,28,histone acetyltransferase activity,,ppi
2167,2503,57205,ATP10D,ATPase phospholipid transporting 10D (putative),1,magnesium ion binding|phospholipid-translocating ATPase activity|ATP binding,,ppi
2168,2504,734,OSGIN2,oxidative stress induced growth inhibitor family member 2,1,growth factor activity,,ppi
2169,2505,23250,ATP11A,ATPase phospholipid transporting 11A,3,phospholipid-translocating ATPase activity,idiopathic interstitial pneumonia|idiopathic pulmonary fibrosis,ppi
2170,2506,23200,ATP11B,ATPase phospholipid transporting 11B (putative),2,phospholipid-translocating ATPase activity|ion transmembrane transporter activity,,ppi
2171,2507,286410,ATP11C,ATPase phospholipid transporting 11C,32,phospholipid-translocating ATPase activity,,ppi
2172,2508,55764,IFT122,intraflagellar transport 122,27,,Kartagener syndrome|primary ciliary dyskinesia|craniosynostosis|microphthalmia|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|Sensenbrenner syndrome,ppi
2173,2509,59272,ACE2,angiotensin I converting enzyme 2,7,virus receptor activity|endopeptidase activity|carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding|metallopeptidase activity|peptidyl-dipeptidase activity|exopeptidase activity,hypertension|essential hypertension|abdominal aortic aneurysm|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
2174,2510,11160,ERLIN2,ER lipid raft associated 2,101,protein tyrosine kinase activity|cholesterol binding,paraplegia|ophthalmoplegia|mechanical strabismus|hypertropia|muscular atrophy|hereditary spastic paraplegia 18|intellectual disability|learning disability,ppi
2175,2511,59269,HIVEP3,human immunodeficiency virus type I enhancer binding protein 3,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2176,2512,9806,SPOCK2,SPARC/osteonectin; cwcv and kazal like domains proteoglycan 2,3,calcium ion binding|metalloendopeptidase inhibitor activity|extracellular matrix binding|collagen binding,,ppi
2177,2513,50859,SPOCK3,SPARC/osteonectin; cwcv and kazal like domains proteoglycan 3,6,metalloendopeptidase inhibitor activity|extracellular matrix binding|collagen binding|calcium ion binding,,ppi
2178,2514,342096,GOLGA6A,golgin A6 family member A,1,,,ppi
2179,2515,54858,PGPEP1,pyroglutamyl-peptidase I,7,,,ppi
2180,2516,56892,C8orf4,chromosome 8 open reading frame 4,2,Notch binding,,ppi
2181,2517,8857,FCGBP,Fc fragment of IgG binding protein,8,,stomach cancer,ppi
2182,2518,51438,MAGEC2,MAGE family member C2,27,ubiquitin protein ligase binding,,ppi
2183,2519,23476,BRD4,bromodomain containing 4,79,RNA polymerase II complex binding|p53 binding|chromatin binding|lysine-acetylated histone binding,alopecia|colon cancer|colonic benign neoplasm|glioblastoma multiforme|giant cell glioblastoma|primary pulmonary hypertension|pulmonary hypertension|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|osteosarcoma|bone osteosarcoma|prostate cancer|prostate carcinoma|thyroid cancer|thyroid adenoma|thyroid carcinoma|polycystic kidney disease 1,ppi
2184,2521,24149,ZNF318,zinc finger protein 318,41,protein homodimerization activity,,ppi
2185,2522,94104,PAXBP1,PAX3 and PAX7 binding protein 1,22,proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
2186,2523,735,C9,complement C9,7,,dermatomyositis|childhood type dermatomyositis|facial dermatosis|primary immunodeficiency disease|opiate dependence|granuloma annulare|age related macular degeneration|macular degeneration|degeneration of macula and posterior pole|malignant mesothelioma|benign mesothelioma|liver cancer|hepatocellular carcinoma|complement component 9 deficiency|age related macular degeneration 15,ppi
2187,2524,26232,FBXO2,F-box protein 2,43,ubiquitin-protein transferase activity,,ppi
2188,2525,26273,FBXO3,F-box protein 3,22,ubiquitin-protein transferase activity,,ppi
2189,2526,26272,FBXO4,F-box protein 4,21,ubiquitin-protein transferase activity,,ppi
2190,2527,26271,FBXO5,F-box protein 5,34,ubiquitin ligase inhibitor activity,,ppi
2191,2528,26270,FBXO6,F-box protein 6,617,ubiquitin-protein transferase activity|protein binding,Stevens-Johnson syndrome,ppi
2192,2529,25793,FBXO7,F-box protein 7,72,ubiquitin-protein transferase activity|ubiquitin binding|protein kinase binding,clubfoot|dystonia|basal ganglia disease|focal hand dystonia|blepharospasm|Parkinson's disease|autosomal recessive early-onset Parkinson disease 15,ppi
2193,2530,26269,FBXO8,F-box protein 8,8,,,ppi
2194,2531,26268,FBXO9,F-box protein 9,9,ubiquitin-protein transferase activity,,ppi
2195,2532,26267,FBXO10,F-box protein 10,9,ubiquitin-protein transferase activity,,ppi
2196,2534,80204,FBXO11,F-box protein 11,66,ubiquitin-protein transferase activity|protein-arginine N-methyltransferase activity,,ppi
2197,2535,23014,FBXO21,F-box protein 21,31,ubiquitin-protein transferase activity,,ppi
2198,2536,26263,FBXO22,F-box protein 22,13,ubiquitin-protein transferase activity,,ppi
2199,2537,26262,TSPAN17,tetraspanin 17,46,ubiquitin-protein transferase activity,,ppi
2200,2538,26261,FBXO24,F-box protein 24,15,ubiquitin-protein transferase activity,,ppi
2201,2539,26260,FBXO25,F-box protein 25,196,ubiquitin-protein transferase activity,,ppi
2202,2540,26259,FBXW8,F-box and WD repeat domain containing 8,46,ubiquitin-protein transferase activity,urinary bladder cancer,ppi
2203,2541,25827,FBXL2,F-box and leucine rich repeat protein 2,24,ubiquitin-protein transferase activity,,ppi
2204,2542,26224,FBXL3,F-box and leucine rich repeat protein 3,14,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,bipolar disorder,ppi
2205,2543,26223,FBXL21,F-box and leucine rich repeat protein 21 (gene/pseudogene),6,,schizophrenia,ppi
2206,2544,26235,FBXL4,F-box and leucine rich repeat protein 4,38,ubiquitin-protein transferase activity,lactic acidosis|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|leukodystrophy|visual epilepsy|brain disease|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|placental insufficiency|muscular atrophy|mitochondrial DNA depletion syndrome 13,ppi
2207,2545,26234,FBXL5,F-box and leucine rich repeat protein 5,40,ubiquitin-protein transferase activity|iron ion binding,,ppi
2208,2546,26233,FBXL6,F-box and leucine rich repeat protein 6,10,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
2209,2547,23194,FBXL7,F-box and leucine rich repeat protein 7,10,ubiquitin-protein transferase activity,,ppi
2210,2548,26231,LRRC29,leucine rich repeat containing 29,5,ubiquitin-protein transferase activity,,ppi
2211,2549,22992,KDM2A,lysine demethylase 2A,32,DNA-binding transcription factor activity; RNA polymerase II-specific|histone demethylase activity|histone demethylase activity (H3-K36 specific),,ppi
2212,2550,23291,FBXW11,F-box and WD repeat domain containing 11,406,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
2213,2551,26190,FBXW2,F-box and WD repeat domain containing 2,28,ubiquitin-protein transferase activity,,ppi
2214,2552,84909,C9orf3,chromosome 9 open reading frame 3,15,aminopeptidase activity|metallopeptidase activity,atrial fibrillation,ppi
2215,2553,84678,KDM2B,lysine demethylase 2B,24,DNA binding|histone demethylase activity,schizophrenia,ppi
2216,2554,54850,FBXL12,F-box and leucine rich repeat protein 12,37,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
2217,2555,54461,FBXW5,F-box and WD repeat domain containing 5,43,ubiquitin-protein transferase activity,,ppi
2218,2556,64839,FBXL17,F-box and leucine rich repeat protein 17,24,ubiquitin protein ligase activity,,ppi
2219,2557,201456,FBXO15,F-box protein 15,9,ubiquitin-protein transferase activity,,ppi
2220,2558,157574,FBXO16,F-box protein 16,2,,,ppi
2221,2559,23732,FRRS1L,ferric chelate reductase 1 like,1,,,ppi
2222,2560,84893,FBXO18,F-box protein; helicase; 18,21,DNA helicase activity|double-stranded DNA binding|single-stranded DNA binding|DNA translocase activity|3'-5' DNA helicase activity|ATP-dependent 3'-5' DNA helicase activity|ATP binding,,ppi
2223,2561,55117,SLC6A15,solute carrier family 6 member 15,28,neurotransmitter transporter activity|amino acid transmembrane transporter activity|proline:sodium symporter activity,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
2224,2566,140886,PABPC5,poly(A) binding protein cytoplasmic 5,3,RNA binding|poly(U) RNA binding|mRNA 3'-UTR binding|poly(A) binding,,ppi
2225,2567,23731,TMEM245,transmembrane protein 245,12,,schizophrenia,ppi
2226,2568,29844,TFPT,TCF3 fusion partner,43,DNA binding,,ppi
2227,2569,25873,RPL36,ribosomal protein L36,148,RNA binding|structural constituent of ribosome,,ppi
2228,2570,9794,MAML1,mastermind like transcriptional coactivator 1,24,transcription coactivator activity,,ppi
2229,2571,9370,ADIPOQ,adiponectin; C1Q and collagen domain containing,9,signaling receptor binding|cytokine activity|hormone activity|sialic acid binding|identical protein binding,rheumatoid arthritis|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|diabetic ketoacidosis|diabetes mellitus|type 2 diabetes mellitus|congestive heart failure|opiate dependence|morphine dependence|heroin dependence|hypertension|essential hypertension|chronic kidney disease,ppi
2230,2572,114569,MAL2,mal; T-cell differentiation protein 2 (gene/pseudogene),21,structural constituent of myelin sheath,,ppi
2231,2573,83483,PLVAP,plasmalemma vesicle associated protein,9,,,ppi
2232,2574,27287,VENTX,VENT homeobox,13,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
2233,2575,54942,FAM206A,family with sequence similarity 206 member A,7,actin monomer binding|actin filament binding,,ppi
2234,2577,55353,LAPTM4B,lysosomal protein transmembrane 4 beta,24,ceramide binding|phosphatidylinositol bisphosphate binding,,ppi
2235,2578,11094,CACFD1,calcium channel flower domain containing 1,2,,,ppi
2236,2579,55814,BDP1,B double prime 1; subunit of RNA polymerase III transcription initiation factor IIIB,16,TFIIIC-class transcription factor complex binding,,ppi
2237,2580,222663,SCUBE3,signal peptide; CUB domain and EGF like domain containing 3,4,,,ppi
2238,2581,59277,NTN4,netrin 4,9,,,ppi
2239,2582,57396,CLK4,CDC like kinase 4,19,protein serine/threonine kinase activity,,ppi
2240,2583,11093,ADAMTS13,ADAM metallopeptidase with thrombospondin type 1 motif 13,2,integrin binding|calcium ion binding|metallopeptidase activity|zinc ion binding,hemolytic-uremic syndrome|neonatal jaundice|proteinuria|thrombotic thrombocytopenic purpura|thrombocytopenia|hemolytic anemia|autoimmune thrombocytopenic purpura|Evans' syndrome,ppi
2241,2584,23499,MACF1,microtubule-actin crosslinking factor 1,72,RNA binding|actin binding|ATPase activity|cadherin binding|microtubule minus-end binding|actin filament binding|structural molecule activity,,ppi
2242,2585,8086,AAAS,aladin WD repeat nucleoporin,28,,adrenal cortical hypofunction|Addison's disease|cerebellar disease|epilepsy|megaesophagus|achalasia|multiple system atrophy|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|intellectual disability|learning disability|optic atrophy|prostate cancer|prostate carcinoma|visual epilepsy|blindness|triple-A syndrome|Horner's syndrome,ppi
2243,2586,8907,AP1M1,adaptor related protein complex 1 mu 1 subunit,74,,,ppi
2244,2587,11092,SPACA9,sperm acrosome associated 9,12,,,ppi
2245,2588,85235,HIST1H2AH,histone cluster 1 H2A family member h,4,DNA binding,,ppi
2246,2589,51621,KLF13,Kruppel like factor 13,13,DNA-binding transcription factor activity; RNA polymerase II-specific,endometriosis of uterus|endometriosis,ppi
2247,2590,759,CA1,carbonic anhydrase 1,4,arylesterase activity|carbonate dehydratase activity|hydro-lyase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|asbestosis|anthracosilicosis|pneumoconiosis|siderosis|bagassosis|stomach cancer|esophagus squamous cell carcinoma,ppi
2248,2591,58538,MPP4,membrane palmitoylated protein 4,2,,,ppi
2249,2592,8642,DCHS1,dachsous cadherin-related 1,5,,imperforate anus|blepharophimosis|ptosis|congenital ptosis|clubfoot|sensorineural hearing loss|intellectual disability|learning disability|mitral valve insufficiency|mitral valve prolapse|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type,ppi
2250,2593,56934,CA10,carbonic anhydrase 10,26,,,ppi
2251,2594,51512,GTSE1,G2 and S-phase expressed 1,139,,,ppi
2252,2595,770,CA11,carbonic anhydrase 11,11,carbonate dehydratase activity,,ppi
2253,2596,58985,IL22RA1,interleukin 22 receptor subunit alpha 1,7,interferon receptor activity,,ppi
2254,2597,79444,BIRC7,baculoviral IAP repeat containing 7,32,ubiquitin-protein transferase activity|cysteine-type endopeptidase inhibitor activity|enzyme binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|ubiquitin protein ligase activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
2255,2598,84549,MAK16,MAK16 homolog,66,RNA binding,,ppi
2256,2600,51298,THEG,theg spermatid protein,3,,,ppi
2257,2601,29106,SCG3,secretogranin III,9,RNA binding,,ppi
2258,2603,8560,DEGS1,delta 4-desaturase; sphingolipid 1,37,electron transfer activity|sphingolipid delta-4 desaturase activity,prostate cancer|prostate carcinoma,ppi
2259,2604,771,CA12,carbonic anhydrase 12,11,carbonate dehydratase activity,,ppi
2260,2605,79983,POF1B,premature ovarian failure; 1B,36,actin filament binding,premature ovarian failure,ppi
2261,2606,56344,CABP5,calcium binding protein 5,7,calcium ion binding,,ppi
2262,2608,8061,FOSL1,FOS like 1; AP-1 transcription factor subunit,32,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
2263,2609,23632,CA14,carbonic anhydrase 14,47,carbonate dehydratase activity,,ppi
2264,2610,9986,RCE1,Ras converting CAAX endopeptidase 1,2,endopeptidase activity|metalloendopeptidase activity|cysteine-type endopeptidase activity,,ppi
2265,2611,10204,NUTF2,nuclear transport factor 2,39,Ran GTPase binding|structural constituent of nuclear pore|protein transporter activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
2266,2612,10664,CTCF,CCCTC-binding factor,69,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity|zinc ion binding|chromatin insulator sequence binding|sequence-specific DNA binding|transcription regulatory region DNA binding,cryptorchidism|hyperopia|intellectual disability|learning disability|schizophrenia|ophthalmoplegia|mechanical strabismus|hypertropia|cutaneous T cell lymphoma|Down syndrome|autosomal dominant non-syndromic intellectual disability,ppi
2267,2613,9114,ATP6V0D1,ATPase H+ transporting V0 subunit d1,104,proton-transporting ATPase activity; rotational mechanism|proton-exporting ATPase activity; phosphorylative mechanism,,ppi
2268,2614,58508,KMT2C,lysine methyltransferase 2C,31,RNA binding|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K4 specific)|transcription coactivator activity|histone binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|urinary bladder cancer|transitional cell carcinoma|salivary gland adenoid cystic carcinoma|acute myeloid leukemia|Sezary's disease|stomach cancer|bile duct carcinoma|bile duct adenocarcinoma|intrahepatic cholangiocarcinoma|cholangiocarcinoma|esophagus squamous cell carcinoma|liver cancer|hepatocellular carcinoma,ppi
2269,2615,10048,RANBP9,RAN binding protein 9,157,Ras guanyl-nucleotide exchange factor activity|Ran GTPase binding,schizophrenia,ppi
2270,2617,760,CA2,carbonic anhydrase 2,20,arylesterase activity|carbonate dehydratase activity|zinc ion binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|anemia|macrocytic anemia|dental caries|Camurati-Engelmann disease|intellectual disability|learning disability|osteonecrosis|osteopetrosis|osteosclerosis|osteoporosis|polyneuropathy|peripheral nervous system disease|neuropathy|stomach cancer|thrombocytopenia,ppi
2271,2618,10296,MAEA,macrophage erythroblast attacher,42,actin binding|ubiquitin-protein transferase activity,diabetes mellitus|type 2 diabetes mellitus,ppi
2272,2620,64072,CDH23,cadherin related 23,12,,asbestosis|anthracosilicosis|pneumoconiosis|siderosis|bagassosis|Usher syndrome type 1|autosomal recessive nonsyndromic deafness 12|Usher syndrome type 1D,ppi
2273,2621,10249,GLYAT,glycine-N-acyltransferase,7,transferase activity; transferring acyl groups|glycine N-acyltransferase activity|glycine N-benzoyltransferase activity,bipolar disorder,ppi
2274,2622,10287,RGS19,regulator of G-protein signaling 19,20,,,ppi
2275,2623,59286,UBL5,ubiquitin like 5,24,protein tag,,ppi
2276,2624,761,CA3,carbonic anhydrase 3,2,carbonate dehydratase activity,obesity|asbestosis|anthracosilicosis|pneumoconiosis|siderosis|bagassosis,ppi
2277,2625,54212,SNTG1,syntrophin gamma 1,10,,,ppi
2278,2626,54221,SNTG2,syntrophin gamma 2,14,,autistic disorder,ppi
2279,2627,59344,ALOXE3,arachidonate lipoxygenase 3,24,oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen|hepoxilin A3 synthase activity,autosomal recessive congenital ichthyosis 1|congenital ichthyosiform erythroderma|keratosis follicularis|pseudoxanthoma elasticum|mongolian spot|prostate cancer|prostate carcinoma|autosomal recessive congenital ichthyosis 2|autosomal recessive congenital ichthyosis 3|autosomal recessive congenital ichthyosis 4A|autosomal recessive congenital ichthyosis 5|autosomal recessive congenital ichthyosis 6|autosomal recessive congenital ichthyosis 7|autosomal recessive congenital ichthyosis 8|autosomal recessive congenital ichthyosis 9|autosomal recessive congenital ichthyosis 10,ppi
2280,2628,9709,HERPUD1,homocysteine inducible ER protein with ubiquitin like domain 1,33,,alcohol dependence|alcohol abuse|prostate cancer|prostate carcinoma,ppi
2281,2629,79187,FSD1,fibronectin type III and SPRY domain containing 1,55,microtubule binding|protein homodimerization activity,stomach cancer,ppi
2282,2630,57795,BRINP2,BMP/retinoic acid inducible neural specific 2,7,,,ppi
2283,2631,60343,FAM3A,family with sequence similarity 3 member A,10,,,ppi
2284,2632,762,CA4,carbonic anhydrase 4,8,carbonate dehydratase activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|asthenopia,ppi
2285,2633,58529,MYOZ1,myozenin 1,17,FATZ binding|telethonin binding|actin binding,,ppi
2286,2634,83856,FSD1L,fibronectin type III and SPRY domain containing 1 like,2,,,ppi
2287,2635,23191,CYFIP1,cytoplasmic FMR1 interacting protein 1,72,protein-containing complex binding|Rac GTPase binding|actin filament binding|RNA 7-methylguanosine cap binding,schizophrenia,ppi
2288,2636,26999,CYFIP2,cytoplasmic FMR1 interacting protein 2,57,RNA 7-methylguanosine cap binding,,ppi
2289,2637,11317,RBPJL,recombination signal binding protein for immunoglobulin kappa J region like,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
2290,2638,84957,RELT,RELT tumor necrosis factor receptor,20,,,ppi
2291,2639,64806,IL25,interleukin 25,3,interleukin-17E receptor binding,,ppi
2292,2640,763,CA5A,carbonic anhydrase 5A,4,carbonate dehydratase activity,lactic acidosis|hypoglycemia|urea cycle disorder,ppi
2293,2641,57722,IGDCC4,immunoglobulin superfamily DCC subclass member 4,3,,,ppi
2294,2642,50964,SOST,sclerostin,23,transcription factor binding,ptosis|congenital ptosis|sensorineural hearing loss|Camurati-Engelmann disease|monocular esotropia|esotropia|enophthalmos|orbital disease|exophthalmos|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|osteopetrosis,ppi
2295,2643,11237,RNF24,ring finger protein 24,2,,,ppi
2296,2644,11238,CA5B,carbonic anhydrase 5B,4,carbonate dehydratase activity,,ppi
2297,2645,85476,GFM1,G elongation factor mitochondrial 1,24,RNA binding|translation elongation factor activity|GTPase activity,combined oxidative phosphorylation deficiency,ppi
2298,2646,64111,NPVF,neuropeptide VF precursor,3,,,ppi
2299,2647,57380,MRS2,MRS2; magnesium transporter,33,magnesium ion transmembrane transporter activity,,ppi
2300,2648,83596,BCL2L12,BCL2 like 12,8,,,ppi
2301,2650,162681,C18orf54,chromosome 18 open reading frame 54,4,,,ppi
2302,2651,57716,PRX,periaxin,9,,hereditary motor and sensory neuropathy with agenesis of the corpus callosum|hereditary neuropathy with liability to pressure palsies|Charcot-Marie-Tooth disease type 1A|Charcot-Marie-Tooth disease type 1F|Charcot-Marie-Tooth disease type 1D|Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease type 1B|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease type 2A1|Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2B1|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2B|Charcot-Marie-Tooth disease axonal type 2T|Charcot-Marie-Tooth disease type 2R|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease type 2E|Charcot-Marie-Tooth disease axonal type 2H,ppi
2303,2652,10961,ERP29,endoplasmic reticulum protein 29,24,protein homodimerization activity|chaperone binding|protein disulfide isomerase activity,prostate cancer|prostate carcinoma|lung cancer|lung adenocarcinoma|liver cancer|hepatocellular carcinoma,ppi
2304,2653,765,CA6,carbonic anhydrase 6,5,carbonate dehydratase activity,,ppi
2305,2655,58158,NEUROD4,neuronal differentiation 4,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2306,2656,63974,NEUROD6,neuronal differentiation 6,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2307,2657,63973,NEUROG2,neurogenin 2,2,DNA-binding transcription factor activity; RNA polymerase II-specific|E-box binding,,ppi
2308,2658,50674,NEUROG3,neurogenin 3,42,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription coactivator activity|chromatin DNA binding,congenital malabsorptive diarrhea 4,ppi
2309,2660,57282,SLC4A10,solute carrier family 4 member 10,4,inorganic anion exchanger activity|sodium:bicarbonate symporter activity,epilepsy|frontal lobe epilepsy|pseudotumor cerebri|intracranial hypertension|intellectual disability|learning disability,ppi
2310,2661,29988,SLC2A8,solute carrier family 2 member 8,9,glucose transmembrane transporter activity|D-glucose transmembrane transporter activity|carbohydrate:proton symporter activity,,ppi
2311,2662,22950,SLC4A1AP,solute carrier family 4 member 1 adaptor protein,33,mRNA binding,,ppi
2312,2663,60598,KCNK15,potassium two pore domain channel subfamily K member 15,7,potassium channel activity|voltage-gated ion channel activity|potassium ion leak channel activity,,ppi
2313,2664,53630,BCO1,beta-carotene oxygenase 1,2,beta-carotene 15;15'-monooxygenase activity|carotenoid dioxygenase activity|retinal isomerase activity,skin disease|seborrheic keratosis|actinic keratosis,ppi
2314,2665,479,ATP12A,ATPase H+/K+ transporting non-gastric alpha2 subunit,57,sodium:potassium-exchanging ATPase activity|potassium:proton exchanging ATPase activity,,ppi
2315,2666,56548,CHST7,carbohydrate sulfotransferase 7,2,N-acetylglucosamine 6-O-sulfotransferase activity|chondroitin 6-sulfotransferase activity,,ppi
2316,2667,57468,SLC12A5,solute carrier family 12 member 5,2,chloride transmembrane transporter activity|potassium:chloride symporter activity,epilepsy|complex partial epilepsy|temporal lobe epilepsy|schizophrenia|visual epilepsy|status epilepticus|mood disorder,ppi
2317,2668,53919,SLCO1C1,solute carrier organic anion transporter family member 1C1,3,thyroid hormone transmembrane transporter activity|sodium-independent organic anion transmembrane transporter activity|bile acid transmembrane transporter activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
2318,2669,767,CA8,carbonic anhydrase 8,32,,cerebellar disease|spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|epilepsy|intellectual disability|learning disability|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|muscular atrophy|cerebellar ataxia; mental retardation and dysequlibrium syndrome,ppi
2319,2671,81832,NETO1,neuropilin and tolloid like 1,1,,,ppi
2320,2672,64210,MMS19,MMS19 homolog; cytosolic iron-sulfur assembly component,197,transcription coactivator activity|receptor signaling complex scaffold activity|protein binding; bridging,,ppi
2321,2673,79058,ASPSCR1,ASPSCR1; UBX domain containing tether for SLC2A4,46,,alveolar soft part sarcoma,ppi
2322,2674,63951,DMRTA1,DMRT like family A1,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2323,2675,80326,WNT10A,Wnt family member 10A,1,receptor ligand activity|frizzled binding,tooth agenesis|anodontia|lymphosarcoma|B-cell lymphoma,ppi
2324,2676,768,CA9,carbonic anhydrase 9,31,carbonate dehydratase activity,carcinoma|primary pulmonary hypertension|pulmonary hypertension|chronic myeloid leukemia|breast ductal carcinoma,ppi
2325,2677,26047,CNTNAP2,contactin associated protein-like 2,9,,alcohol dependence|alcohol abuse|autistic disorder|bipolar disorder|epilepsy|communication disorder|intellectual disability|learning disability|schizophrenia|visual epilepsy|stuttering|neurotic disorder|endogenous depression|melancholia|lung small cell carcinoma|major depressive disorder|mental depression|Pitt-Hopkins syndrome,ppi
2326,2678,55717,WDR11,WD repeat domain 11,24,,malignant glioma|gliosarcoma|mixed glioma|schizophrenia|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|eunuchism|substance abuse|substance-related disorder,ppi
2327,2679,79937,CNTNAP3,contactin associated protein-like 3,32,,,ppi
2328,2680,84435,ADGRA1,adhesion G protein-coupled receptor A1,1,G-protein coupled receptor activity,,ppi
2329,2681,166647,ADGRA3,adhesion G protein-coupled receptor A3,2,,,ppi
2330,2682,9478,CABP1,calcium binding protein 1,11,enzyme inhibitor activity|nuclear localization sequence binding,,ppi
2331,2683,51463,GPR89B,G protein-coupled receptor 89B,21,,,ppi
2332,2684,57211,ADGRG6,adhesion G protein-coupled receptor G6,1,G-protein coupled receptor activity|collagen binding|laminin binding|extracellular matrix binding,idiopathic scoliosis,ppi
2333,2685,162967,ZNF320,zinc finger protein 320,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2334,2686,100131017,ZNF316,zinc finger protein 316,12,,,ppi
2335,2687,282890,ZNF311,zinc finger protein 311,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2336,2688,55900,ZNF302,zinc finger protein 302,13,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2337,2689,51475,CABP2,calcium binding protein 2,3,calcium channel regulator activity,sensorineural hearing loss,ppi
2338,2690,114821,ZBED9,zinc finger BED-type containing 9,7,,,ppi
2339,2691,80317,ZKSCAN3,zinc finger with KRAB and SCAN domains 3,13,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|chromatin binding|DNA-binding transcription factor activity|sequence-specific DNA binding,large intestine cancer|colorectal cancer,ppi
2340,2692,387032,ZKSCAN4,zinc finger with KRAB and SCAN domains 4,29,DNA-binding transcription factor activity; RNA polymerase II-specific,schizophrenia,ppi
2341,2693,57010,CABP4,calcium binding protein 4,1,calcium ion binding,congenital stationary night blindness,ppi
2342,2694,11178,LZTS1,leucine zipper tumor suppressor 1,5,DNA binding|DNA-binding transcription factor activity,tongue squamous cell carcinoma|squamous cell carcinoma|esophageal cancer|prostate cancer|prostate carcinoma|squamous cell neoplasm,ppi
2343,2695,54766,BTG4,BTG anti-proliferation factor 4,1,,,ppi
2344,2696,30011,SH3KBP1,SH3 domain containing kinase binding protein 1,223,,colon cancer|colonic benign neoplasm,ppi
2345,2697,84695,LOXL3,lysyl oxidase like 3,14,fibronectin binding|protein-lysine 6-oxidase activity|copper ion binding,,ppi
2346,2698,11051,NUDT21,nudix hydrolase 21,145,RNA binding|mRNA binding|AU-rich element binding|identical protein binding,,ppi
2347,2699,11052,CPSF6,cleavage and polyadenylation specific factor 6,98,RNA binding|mRNA binding|ribosomal large subunit binding|exon-exon junction complex binding,,ppi
2348,2700,9750,FAM65B,family with sequence similarity 65 member B,11,14-3-3 protein binding,,ppi
2349,2701,93986,FOXP2,forkhead box P2,28,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|protein homodimerization activity|sequence-specific DNA binding,agnosia|autistic disorder|bipolar disorder|salivary gland adenoid cystic carcinoma|communication disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome,ppi
2350,2702,94015,TTYH2,tweety family member 2,4,volume-sensitive chloride channel activity|intracellular calcium activated chloride channel activity,,ppi
2351,2704,773,CACNA1A,calcium voltage-gated channel subunit alpha1 A,103,voltage-gated calcium channel activity|calcium channel activity|high voltage-gated calcium channel activity|syntaxin binding,generalized anxiety disorder|anxiety disorder|bipolar disorder|cerebellar disease|dystonia|childhood absence epilepsy|hemiplegia|movement disease|lingual-facial-buccal dyskinesia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|schizophreniform disorder|schizoaffective disorder|central nervous system origin vertigo|autosomal dominant cerebellar ataxia|migraine|sensory peripheral neuropathy|migraine with aura,ppi
2352,2705,64005,MYO1G,myosin IG,9,phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3;4;5-trisphosphate binding|phosphatidylinositol-3;4-bisphosphate binding,,ppi
2353,2706,64137,ABCG4,ATP binding cassette subfamily G member 4,2,cholesterol transporter activity|protein homodimerization activity|sterol-transporting ATPase activity|ATPase activity; coupled to transmembrane movement of substances,,ppi
2354,2707,64240,ABCG5,ATP binding cassette subfamily G member 5,4,ATPase activity; coupled to transmembrane movement of substances|ATP binding|ATPase activity|cholesterol transporter activity|drug transmembrane transporter activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|lipid metabolism disorder|prostate cancer|prostate carcinoma|xanthomatosis,ppi
2355,2708,64241,ABCG8,ATP binding cassette subfamily G member 8,13,ATPase activity; coupled to transmembrane movement of substances|ATP binding|ATPase activity|cholesterol transporter activity|drug transmembrane transporter activity,coronary artery disease|gallbladder disease,ppi
2356,2709,774,CACNA1B,calcium voltage-gated channel subunit alpha1 B,15,voltage-gated calcium channel activity|calcium channel activity,bipolar disorder|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|polyneuropathy|peripheral nervous system disease|neuropathy|schizophrenia|dystonia|generalized dystonia,ppi
2357,2710,83737,ITCH,itchy E3 ubiquitin protein ligase,181,ubiquitin-protein transferase activity|ubiquitin-like protein transferase activity|ubiquitin protein ligase activity,,ppi
2358,2711,775,CACNA1C,calcium voltage-gated channel subunit alpha1 C,20,voltage-gated calcium channel activity|high voltage-gated calcium channel activity|voltage-gated calcium channel activity involved in cardiac muscle cell action potential|voltage-gated calcium channel activity involved in AV node cell action potential,sick sinus syndrome|atrial fibrillation|autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertension|essential hypertension|hypoglycemia|primary immunodeficiency disease|schizophreniform disorder|schizoaffective disorder|schizophrenia|syndactyly|mood disorder|Brugada syndrome,ppi
2359,2712,10110,SGK2,SGK2; serine/threonine kinase 2,17,potassium channel regulator activity|sodium channel regulator activity|protein serine/threonine kinase activity,,ppi
2360,2713,8710,SERPINB7,serpin family B member 7,11,serine-type endopeptidase inhibitor activity,nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis,ppi
2361,2714,10608,MXD4,MAX dimerization protein 4,6,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity,,ppi
2362,2717,58524,DMRT3,doublesex and mab-3 related transcription factor 3,27,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2363,2718,776,CACNA1D,calcium voltage-gated channel subunit alpha1 D,4,voltage-gated calcium channel activity|calcium channel activity|ankyrin binding|voltage-gated calcium channel activity involved in cardiac muscle cell action potential|voltage-gated calcium channel activity involved SA node cell action potential|high voltage-gated calcium channel activity,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|sensorineural hearing loss|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypertension|essential hypertension|primary pulmonary hypertension|pulmonary hypertension|hypokalemia,ppi
2364,2720,63946,DMRTC2,DMRT like family C2,2,DNA-binding transcription factor activity; RNA polymerase II-specific|protein homodimerization activity,,ppi
2365,2721,63948,DMRTB1,DMRT like family B with proline rich C-terminal 1,19,DNA-binding transcription factor activity; RNA polymerase II-specific|protein homodimerization activity,,ppi
2366,2722,55937,APOM,apolipoprotein M,7,lipid transporter activity|phospholipid binding|antioxidant activity,,ppi
2367,2723,7919,DDX39B,DExD-box helicase 39B,102,RNA binding|ATP-dependent RNA helicase activity|RNA-dependent ATPase activity|ATPase activity|U6 snRNA binding|U4 snRNA binding|ATP-dependent protein binding,,ppi
2368,2724,7916,PRRC2A,proline rich coiled-coil 2A,72,RNA binding,,ppi
2369,2725,7917,BAG6,BCL2 associated athanogene 6,288,polyubiquitin modification-dependent protein binding|ribosome binding|misfolded protein binding|proteasome binding,,ppi
2370,2726,777,CACNA1E,calcium voltage-gated channel subunit alpha1 E,3,voltage-gated calcium channel activity|calcium channel activity,,ppi
2371,2727,7918,GPANK1,G-patch domain and ankyrin repeats 1,17,,,ppi
2372,2728,7920,ABHD16A,abhydrolase domain containing 16A,24,acylglycerol lipase activity|lysophospholipase activity,,ppi
2373,2730,9277,WDR46,WD repeat domain 46,97,RNA binding,stomach cancer,ppi
2374,2731,29113,C6orf15,chromosome 6 open reading frame 15,3,,,ppi
2375,2732,778,CACNA1F,calcium voltage-gated channel subunit alpha1 F,2,voltage-gated calcium channel activity|high voltage-gated calcium channel activity,oculocutaneous albinism|Griscelli syndrome|Griscelli syndrome type 1|Griscelli syndrome type 2|Griscelli syndrome type 3|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|astigmatism|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|myopia|night blindness|congenital stationary night blindness,ppi
2376,2733,54535,CCHCR1,coiled-coil alpha-helical rod protein 1,76,,prostate cancer|prostate carcinoma,ppi
2377,2734,58496,LY6G5B,lymphocyte antigen 6 complex; locus G5B,8,identical protein binding,,ppi
2378,2736,259215,LY6G6F,lymphocyte antigen 6 complex; locus G6F,2,,,ppi
2379,2738,80740,LY6G6C,lymphocyte antigen 6 complex; locus G6C,2,identical protein binding,,ppi
2380,2739,80739,C6orf25,chromosome 6 open reading frame 25,3,,,ppi
2381,2740,401251,SAPCD1,suppressor APC domain containing 1,7,,,ppi
2382,2741,80737,VWA7,von Willebrand factor A domain containing 7,2,,,ppi
2383,2742,8913,CACNA1G,calcium voltage-gated channel subunit alpha1 G,3,low voltage-gated calcium channel activity|voltage-gated calcium channel activity involved in AV node cell action potential|voltage-gated calcium channel activity involved SA node cell action potential,intellectual disability|learning disability,ppi
2384,2743,57819,LSM2,LSM2 homolog; U6 small nuclear RNA and mRNA degradation associated,69,RNA binding|U6 snRNA binding,,ppi
2385,2746,80864,EGFL8,EGF like domain multiple 8,9,signaling receptor binding,,ppi
2386,2747,63940,GPSM3,G-protein signaling modulator 3,10,protein binding,,ppi
2387,2748,63943,FKBPL,FK506 binding protein like,57,,breast cancer,ppi
2388,2749,8912,CACNA1H,calcium voltage-gated channel subunit alpha1 H,7,voltage-gated ion channel activity|low voltage-gated calcium channel activity,autistic disorder|childhood absence epilepsy,ppi
2389,2750,85236,HIST1H2BK,histone cluster 1 H2B family member k,22,DNA binding,breast cancer,ppi
2390,2751,8911,CACNA1I,calcium voltage-gated channel subunit alpha1 I,3,voltage-gated calcium channel activity|low voltage-gated calcium channel activity,,ppi
2391,2755,779,CACNA1S,calcium voltage-gated channel subunit alpha1 S,8,voltage-gated calcium channel activity|high voltage-gated calcium channel activity,constipation|Graves' disease|thyrotoxicosis|hyperthyroidism|hypokalemia|malignant hyperthermia|obesity|locked-in syndrome|quadriplegia|pseudosarcomatous fibromatosis|Plummer's disease|familial periodic paralysis|obsolete Timothy syndrome|hyperkalemic periodic paralysis|hypokalemic periodic paralysis|hyperglycemia,ppi
2392,2759,7936,NELFE,negative elongation factor complex member E,36,RNA binding,,ppi
2393,2760,781,CACNA2D1,calcium voltage-gated channel auxiliary subunit alpha2delta 1,33,voltage-gated calcium channel activity|voltage-gated calcium channel activity involved in cardiac muscle cell action potential|voltage-gated calcium channel activity involved in bundle of His cell action potential,colon cancer|colonic benign neoplasm|hypertension|essential hypertension|Brugada syndrome|Brugada syndrome 1|short QT syndrome,ppi
2394,2761,64236,PDLIM2,PDZ and LIM domain 2,13,,,ppi
2395,2762,56978,PRDM8,PR/SET domain 8,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2396,2764,56980,PRDM10,PR/SET domain 10,15,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2397,2767,59336,PRDM13,PR/SET domain 13,1,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin DNA binding|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|histone methyltransferase activity,,ppi
2398,2768,63977,PRDM15,PR/SET domain 15,10,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|promoter-specific chromatin binding,,ppi
2399,2769,9254,CACNA2D2,calcium voltage-gated channel auxiliary subunit alpha2delta 2,14,voltage-gated calcium channel activity,syndromic X-linked intellectual disability type 10|choreatic disease|childhood absence epilepsy,ppi
2400,2770,63976,PRDM16,PR/SET domain 16,7,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator activity|histone-lysine N-methyltransferase activity|sequence-specific DNA binding,migraine|chromosome 1p36 deletion syndrome,ppi
2401,2771,63978,PRDM14,PR/SET domain 14,42,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin DNA binding|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,testicular cancer|seminoma|testicular germ cell cancer|acute lymphocytic leukemia,ppi
2402,2772,8099,CDK2AP1,cyclin dependent kinase 2 associated protein 1,55,,,ppi
2403,2773,63982,ANO3,anoctamin 3,6,intracellular calcium activated chloride channel activity,,ppi
2404,2774,23089,PEG10,paternally expressed 10,39,RNA binding,,ppi
2405,2775,55503,TRPV6,transient receptor potential cation channel subfamily V member 6,16,calcium channel activity|calmodulin binding|ion channel activity,polycystic ovary syndrome,ppi
2406,2776,23596,OPN3,opsin 3,4,G-protein coupled receptor activity|G-protein coupled photoreceptor activity|photoreceptor activity,,ppi
2407,2777,83463,MXD3,MAX dimerization protein 3,27,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2408,2778,782,CACNB1,calcium voltage-gated channel auxiliary subunit beta 1,14,voltage-gated calcium channel activity|high voltage-gated calcium channel activity,,ppi
2409,2779,23269,MGA,MGA; MAX dimerization protein,54,DNA-binding transcription factor activity; RNA polymerase II-specific,salivary gland adenoid cystic carcinoma,ppi
2410,2780,10592,SMC2,structural maintenance of chromosomes 2,92,,,ppi
2411,2781,10051,SMC4,structural maintenance of chromosomes 4,70,ATP binding,,ppi
2412,2782,51072,MEMO1,mediator of cell motility 1,37,,,ppi
2413,2783,56853,CELF4,CUGBP; Elav-like family member 4,2,translation repressor activity; mRNA regulatory element binding|pre-mRNA binding|BRE binding|mRNA binding|RNA binding,,ppi
2414,2784,783,CACNB2,calcium voltage-gated channel auxiliary subunit beta 2,5,voltage-gated calcium channel activity|calcium channel activity|actin filament binding|high voltage-gated calcium channel activity|voltage-gated calcium channel activity involved in cardiac muscle cell action potential|voltage-gated calcium channel activity involved in AV node cell action potential,atrial fibrillation|bipolar disorder|schizophrenia|Brugada syndrome|Brugada syndrome 1|Brugada syndrome 4,ppi
2415,2786,60482,SLC5A7,solute carrier family 5 member 7,2,choline:sodium symporter activity|choline transmembrane transporter activity|choline binding,neurotic disorder|endogenous depression|melancholia|mental depression|mood disorder|congenital myasthenic syndrome|major depressive disorder,ppi
2416,2787,64478,CSMD1,CUB and Sushi multiple domains 1,4,,bipolar disorder|pustulosis of palm and sole|psoriasis|parapsoriasis|schizophrenia|substance abuse|substance-related disorder,ppi
2417,2788,54148,MRPL39,mitochondrial ribosomal protein L39,83,RNA binding|proline-tRNA ligase activity,,ppi
2418,2789,784,CACNB3,calcium voltage-gated channel auxiliary subunit beta 3,12,calcium channel regulator activity|calcium channel activity|voltage-gated calcium channel activity|high voltage-gated calcium channel activity,,ppi
2419,2790,64978,MRPL38,mitochondrial ribosomal protein L38,108,,,ppi
2420,2791,51253,MRPL37,mitochondrial ribosomal protein L37,71,RNA binding|structural constituent of ribosome,,ppi
2421,2792,64983,MRPL32,mitochondrial ribosomal protein L32,48,RNA binding|structural constituent of ribosome,,ppi
2422,2793,51263,MRPL30,mitochondrial ribosomal protein L30,26,,,ppi
2423,2794,79590,MRPL24,mitochondrial ribosomal protein L24,62,,,ppi
2424,2795,785,CACNB4,calcium voltage-gated channel auxiliary subunit beta 4,13,calcium channel activity|voltage-gated calcium channel activity|high voltage-gated calcium channel activity,idiopathic generalized epilepsy|generalized epilepsy with febrile seizures plus|juvenile myoclonic epilepsy|episodic ataxia|episodic ataxia type 5,ppi
2425,2796,65003,MRPL11,mitochondrial ribosomal protein L11,66,RNA binding|structural constituent of ribosome|rRNA binding,,ppi
2426,2797,51258,MRPL51,mitochondrial ribosomal protein L51,32,structural constituent of ribosome,,ppi
2427,2798,64949,MRPS26,mitochondrial ribosomal protein S26,59,RNA binding,,ppi
2428,2799,54460,MRPS21,mitochondrial ribosomal protein S21,33,RNA binding|structural constituent of ribosome,,ppi
2429,2800,51373,MRPS17,mitochondrial ribosomal protein S17,13,structural constituent of ribosome,,ppi
2430,2801,51021,MRPS16,mitochondrial ribosomal protein S16,41,structural constituent of ribosome,lactic acidosis|patent ductus arteriosus|congestive heart failure|liver disease|placental insufficiency|combined oxidative phosphorylation deficiency,ppi
2431,2802,63931,MRPS14,mitochondrial ribosomal protein S14,47,RNA binding|structural constituent of ribosome,,ppi
2432,2803,786,CACNG1,calcium voltage-gated channel auxiliary subunit gamma 1,1,calcium channel regulator activity,,ppi
2433,2804,64963,MRPS11,mitochondrial ribosomal protein S11,89,RNA binding|structural constituent of ribosome|small ribosomal subunit rRNA binding|mRNA 5'-UTR binding,stomach cancer,ppi
2434,2805,64968,MRPS6,mitochondrial ribosomal protein S6,22,structural constituent of ribosome|small ribosomal subunit rRNA binding,coronary artery disease,ppi
2435,2806,9801,MRPL19,mitochondrial ribosomal protein L19,56,structural constituent of ribosome,breast cancer,ppi
2436,2807,63875,MRPL17,mitochondrial ribosomal protein L17,42,structural constituent of ribosome,,ppi
2437,2808,29088,MRPL15,mitochondrial ribosomal protein L15,63,RNA binding|structural constituent of ribosome,,ppi
2438,2809,124995,MRPL10,mitochondrial ribosomal protein L10,72,RNA binding|structural constituent of ribosome,,ppi
2439,2810,51069,MRPL2,mitochondrial ribosomal protein L2,49,RNA binding|structural constituent of ribosome,,ppi
2440,2811,60680,CELF5,CUGBP; Elav-like family member 5,13,pre-mRNA binding|RNA binding|mRNA binding,,ppi
2441,2813,10369,CACNG2,calcium voltage-gated channel auxiliary subunit gamma 2,24,calcium channel activity|channel regulator activity|voltage-gated calcium channel activity,schizophrenia|autosomal dominant non-syndromic intellectual disability,ppi
2442,2814,51455,REV1,REV1; DNA directed polymerase,23,deoxycytidyl transferase activity,,ppi
2443,2815,9404,LPXN,leupaxin,55,transcription coregulator activity,,ppi
2444,2816,9759,HDAC4,histone deacetylase 4,142,RNA polymerase II proximal promoter sequence-specific DNA binding|histone deacetylase activity|zinc ion binding|SUMO transferase activity|potassium ion binding|protein deacetylase activity|sequence-specific DNA binding|transcription regulatory region DNA binding,urinary bladder cancer|neurotic disorder|major depressive disorder|mental depression|contact dermatitis|occupational dermatitis|dermatitis|enophthalmos|orbital disease|exophthalmos|epilepsy|umbilical hernia|omphalocele|intellectual disability|learning disability|obesity|schizophrenia|visual epilepsy|cocaine abuse|cocaine dependence,ppi
2445,2817,10013,HDAC6,histone deacetylase 6,285,RNA polymerase II proximal promoter sequence-specific DNA binding|histone deacetylase activity|microtubule binding|enzyme binding|polyubiquitin modification-dependent protein binding|tubulin deacetylase activity|alpha-tubulin binding|tau protein binding|misfolded protein binding|Hsp90 protein binding|dynein complex binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|placental insufficiency|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|melanoma|skin melanoma|microphthalmia|prostate cancer|prostate carcinoma|ovarian cancer,ppi
2446,2818,9734,HDAC9,histone deacetylase 9,65,transcription corepressor activity|histone deacetylase activity|transcription factor binding|protein deacetylase activity|repressing transcription factor binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|cerebral infarction|cerebrovascular disease,ppi
2447,2819,51564,HDAC7,histone deacetylase 7,72,SUMO transferase activity|14-3-3 protein binding,,ppi
2448,2820,10014,HDAC5,histone deacetylase 5,342,RNA polymerase II proximal promoter sequence-specific DNA binding|histone deacetylase activity|protein deacetylase activity|transcription regulatory region DNA binding,neurotic disorder|adjustment disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|cocaine abuse|cocaine dependence,ppi
2449,2821,10368,CACNG3,calcium voltage-gated channel auxiliary subunit gamma 3,4,voltage-gated calcium channel activity|channel regulator activity,,ppi
2450,2822,480,ATP1A4,ATPase Na+/K+ transporting subunit alpha 4,10,sodium:potassium-exchanging ATPase activity,,ppi
2451,2823,56776,FMN2,formin 2,14,actin binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
2452,2824,137868,SGCZ,sarcoglycan zeta,14,,,ppi
2453,2825,29956,CERS2,ceramide synthase 2,45,sphingosine N-acyltransferase activity,,ppi
2454,2826,58157,NGB,neuroglobin,17,oxygen carrier activity,,ppi
2455,2827,60468,BACH2,BTB domain and CNC homolog 2,15,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II distal enhancer sequence-specific DNA binding,celiac disease|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17,ppi
2456,2828,55584,CHRNA9,cholinergic receptor nicotinic alpha 9 subunit,71,ligand-gated ion channel activity|acetylcholine-gated cation-selective channel activity|extracellular ligand-gated ion channel activity,,ppi
2457,2829,27092,CACNG4,calcium voltage-gated channel auxiliary subunit gamma 4,17,calcium channel regulator activity|calcium channel activity|channel regulator activity|voltage-gated calcium channel activity,,ppi
2458,2830,54443,ANLN,anillin actin binding protein,147,actin binding|cadherin binding|GTP-Rho binding,focal segmental glomerulosclerosis|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|polycystic ovary syndrome|proteinuria,ppi
2459,2831,80022,MYO15B,myosin XVB,18,,,ppi
2460,2832,57142,RTN4,reticulon 4,117,RNA binding|cadherin binding,bipolar disorder|schizophrenia,ppi
2461,2834,26575,RGS17,regulator of G-protein signaling 17,18,,cannabis dependence|cannabis abuse,ppi
2462,2835,56949,XAB2,XPA binding protein 2,69,,,ppi
2463,2836,27091,CACNG5,calcium voltage-gated channel auxiliary subunit gamma 5,39,voltage-gated calcium channel activity|ion transmembrane transporter activity|channel regulator activity,bipolar disorder|schizophrenia,ppi
2464,2837,51209,RAB9B,RAB9B; member RAS oncogene family,12,GDP binding|GTPase activity,,ppi
2465,2838,25799,ZNF324,zinc finger protein 324,22,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2466,2839,64288,ZSCAN31,zinc finger and SCAN domain containing 31,12,DNA-binding transcription factor activity; RNA polymerase II-specific,schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
2467,2840,55759,WDR12,WD repeat domain 12,68,,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
2468,2841,57472,CNOT6,CCR4-NOT transcription complex subunit 6,32,exoribonuclease activity|poly(A)-specific ribonuclease activity,,ppi
2469,2842,29883,CNOT7,CCR4-NOT transcription complex subunit 7,55,3'-5'-exoribonuclease activity|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|DNA-binding transcription factor activity|exoribonuclease activity|poly(A)-specific ribonuclease activity,,ppi
2470,2843,9639,ARHGEF10,Rho guanine nucleotide exchange factor 10,16,Rho guanyl-nucleotide exchange factor activity|guanyl-nucleotide exchange factor activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
2471,2844,284695,ZNF326,zinc finger protein 326,64,RNA polymerase II complex binding|RNA binding,,ppi
2472,2845,26206,SPAG8,sperm associated antigen 8,17,,,ppi
2473,2846,57804,POLD4,DNA polymerase delta 4; accessory subunit,11,DNA-directed DNA polymerase activity,,ppi
2474,2847,56937,PMEPA1,prostate transmembrane protein; androgen induced 1,8,,,ppi
2475,2848,23039,XPO7,exportin 7,97,nuclear export signal receptor activity,,ppi
2476,2849,51031,GLOD4,glyoxalase domain containing 4,38,cadherin binding,,ppi
2477,2851,64499,TPSB2,tryptase beta 2 (gene/pseudogene),16,,,ppi
2478,2852,51728,POLR3K,RNA polymerase III subunit K,14,DNA-directed 5'-3' RNA polymerase activity|RNA polymerase III activity,stomach cancer,ppi
2479,2853,57585,CRAMP1,cramped chromatin regulator homolog 1,18,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding,,ppi
2480,2854,8131,NPRL3,NPR3 like; GATOR1 complex subunit,18,GTPase activator activity,,ppi
2481,2855,10919,EHMT2,euchromatic histone lysine methyltransferase 2,137,protein-lysine N-methyltransferase activity|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K9 specific)|histone methyltransferase activity (H3-K27 specific)|promoter-specific chromatin binding,infertility|acute myeloid leukemia|lung benign neoplasm|cocaine abuse|cocaine dependence|ulcerative stomatitis|denture stomatitis|stomatitis|ovarian cancer|ovarian carcinoma,ppi
2482,2856,64333,ARHGAP9,Rho GTPase activating protein 9,8,GTPase activator activity|phosphatidylinositol-3;4;5-trisphosphate binding,coronary artery vasospasm,ppi
2483,2857,51764,GNG13,G protein subunit gamma 13,9,,,ppi
2484,2858,23348,DOCK9,dedicator of cytokinesis 9,19,guanyl-nucleotide exchange factor activity|cadherin binding,bipolar disorder,ppi
2485,2859,51734,MSRB1,methionine sulfoxide reductase B1,3,actin binding|zinc ion binding|peptide-methionine (R)-S-oxide reductase activity,schizophrenia,ppi
2486,2861,9091,PIGQ,phosphatidylinositol glycan anchor biosynthesis class Q,14,phosphatidylinositol N-acetylglucosaminyltransferase activity,,ppi
2487,2862,90861,HN1L,hematological and neurological expressed 1 like,18,,,ppi
2488,2864,84326,METTL26,methyltransferase like 26,2,,,ppi
2489,2865,84331,MCRIP2,MAPK regulated corepressor interacting protein 2,7,,,ppi
2490,2866,339123,JMJD8,jumonji domain containing 8,14,,,ppi
2491,2867,146330,FBXL16,F-box and leucine rich repeat protein 16,11,ubiquitin-protein transferase activity,,ppi
2492,2868,79006,METRN,meteorin; glial cell differentiation regulator,3,,,ppi
2493,2869,65990,FAM173A,family with sequence similarity 173 member A,9,,,ppi
2494,2870,124093,CCDC78,coiled-coil domain containing 78,1,,centronuclear myopathy,ppi
2495,2871,64788,LMF1,lipase maturation factor 1,18,,,ppi
2496,2873,79622,SNRNP25,small nuclear ribonucleoprotein U11/U12 subunit 25,11,,,ppi
2497,2874,83986,FAM234A,family with sequence similarity 234 member A,6,,,ppi
2498,2875,81889,FAHD1,fumarylacetoacetate hydrolase domain containing 1,30,oxaloacetate decarboxylase activity|acetylpyruvate hydrolase activity|fumarylpyruvate hydrolase activity,,ppi
2499,2877,113000,RPUSD1,RNA pseudouridylate synthase domain containing 1,1,,,ppi
2500,2878,115939,TSR3,TSR3; acp transferase ribosome maturation factor,22,transferase activity,,ppi
2501,2879,84264,HAGHL,hydroxyacylglutathione hydrolase-like,1,,,ppi
2502,2881,64428,NARFL,nuclear prelamin A recognition factor like,13,4 iron; 4 sulfur cluster binding,,ppi
2503,2882,64714,PDIA2,protein disulfide isomerase family A member 2,26,disulfide oxidoreductase activity|peptide disulfide oxidoreductase activity|peptidyl-proline 4-dioxygenase activity|protein disulfide isomerase activity,,ppi
2504,2883,64718,UNKL,unkempt family like zinc finger,8,DNA-binding transcription factor activity; RNA polymerase II-specific|ubiquitin-protein transferase activity|protein binding,,ppi
2505,2884,55833,UBAP2,ubiquitin associated protein 2,28,RNA binding|cadherin binding,alcohol dependence|alcohol abuse,ppi
2506,2886,10677,AVIL,advillin,27,actin binding,,ppi
2507,2887,7940,LST1,leukocyte specific transcript 1,3,,,ppi
2508,2888,23365,ARHGEF12,Rho guanine nucleotide exchange factor 12,30,G-protein coupled receptor binding|guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,acute myeloid leukemia,ppi
2509,2890,60528,ELAC2,elaC ribonuclease Z 2,59,RNA binding|tRNA-specific ribonuclease activity,prostate cancer|prostate carcinoma|combined oxidative phosphorylation deficiency,ppi
2510,2891,56704,JPH1,junctophilin 1,41,calcium-release channel activity,,ppi
2511,2892,57158,JPH2,junctophilin 2,3,phosphatidylserine binding|phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3;4;5-trisphosphate binding|phosphatidylinositol-5-phosphate binding|calcium-release channel activity|phosphatidylinositol-3-phosphate binding|phosphatidylinositol-4-phosphate binding|phosphatidic acid binding|phosphatidylinositol-3;5-bisphosphate binding,hypertrophic cardiomyopathy 17,ppi
2512,2893,57338,JPH3,junctophilin 3,4,calcium-release channel activity,large intestine cancer|colorectal cancer,ppi
2513,2894,79673,ZNF329,zinc finger protein 329,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2514,2895,788,SLC25A20,solute carrier family 25 member 20,19,acyl carnitine transmembrane transporter activity,atrioventricular block|epilepsy|hypoglycemia|pseudosarcomatous fibromatosis|visual epilepsy|catecholaminergic polymorphic ventricular tachycardia|catecholaminergic polymorphic ventricular tachycardia 1|catecholaminergic polymorphic ventricular tachycardia 2|catecholaminergic polymorphic ventricular tachycardia 3|catecholaminergic polymorphic ventricular tachycardia 4|catecholaminergic polymorphic ventricular tachycardia 5|liver disease|urea cycle disorder|cardiac arrest|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
2515,2896,25777,SUN2,Sad1 and UNC84 domain containing 2,70,lamin binding|microtubule binding|protein membrane anchor,,ppi
2516,2897,29760,BLNK,B-cell linker,43,transmembrane receptor protein tyrosine kinase adaptor activity|SH3/SH2 adaptor activity,agammaglobulinemia|arthropathy|arthritis|conjunctivitis|exanthem|primary immunodeficiency disease|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|sinusitis|chronic sphenoidal sinusitis|chronic ethmoiditis|otitis media,ppi
2517,2898,23152,CIC,capicua transcriptional repressor,19,DNA-binding transcription factor activity; RNA polymerase II-specific,autosomal dominant cerebellar ataxia|intellectual disability|learning disability,ppi
2518,2899,84675,TRIM55,tripartite motif containing 55,96,,,ppi
2519,2901,55351,STK32B,serine/threonine kinase 32B,2,protein serine/threonine kinase activity,,ppi
2520,2902,10432,RBM14,RNA binding motif protein 14,129,transcription coregulator activity|RNA binding|protein binding; bridging|nuclear receptor transcription coactivator activity,,ppi
2521,2903,89777,SERPINB12,serpin family B member 12,20,serine-type endopeptidase inhibitor activity|enzyme binding,,ppi
2522,2904,89778,SERPINB11,serpin family B member 11 (gene/pseudogene),9,serine-type endopeptidase inhibitor activity,,ppi
2523,2905,56956,LHX9,LIM homeobox 9,11,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity,,ppi
2524,2906,64324,NSD1,nuclear receptor binding SET domain protein 1,36,RNA polymerase II proximal promoter sequence-specific DNA binding|chromatin binding|transcription coregulator activity|transcription corepressor activity|zinc ion binding|histone-lysine N-methyltransferase activity|estrogen receptor binding|histone methyltransferase activity (H4-K20 specific)|retinoic acid receptor binding|retinoid X receptor binding|thyroid hormone receptor binding|histone methyltransferase activity (H3-K36 specific)|androgen receptor binding,autistic disorder|Perlman syndrome|Sotos syndrome|Beckwith-Wiedemann syndrome|salivary gland adenoid cystic carcinoma|acute myeloid leukemia|Weaver syndrome|intellectual disability|learning disability,ppi
2525,2907,60496,AASDHPPT,aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase,38,magnesium ion binding|holo-[acyl-carrier-protein] synthase activity,,ppi
2526,2908,91319,DERL3,derlin 3,5,,,ppi
2527,2909,83606,GUCD1,guanylyl cyclase domain containing 1,11,,prostate cancer|prostate carcinoma,ppi
2528,2911,790,CAD,carbamoyl-phosphate synthetase 2; aspartate transcarbamylase; and dihydroorotase,173,aspartate carbamoyltransferase activity|carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity|dihydroorotase activity|protein kinase activity|ATP binding|zinc ion binding|identical protein binding|aspartate binding|carbamoyl-phosphate synthase (ammonia) activity,renal tubular acidosis|sickle cell anemia|beta thalassemia|epilepsy|visual epilepsy|hereditary spherocytosis|urea cycle disorder|abetalipoproteinemia|Diamond-Blackfan anemia|congenital hypoplastic anemia|congenital disorder of glycosylation type I,ppi
2529,2912,55512,SMPD3,sphingomyelin phosphodiesterase 3,20,,leukemia|essential thrombocythemia|myelodysplastic syndrome,ppi
2530,2914,22931,RAB18,RAB18; member RAS oncogene family,27,GTPase activity|GDP binding,blepharophimosis|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types,ppi
2531,2915,10073,SNUPN,snurportin 1,30,RNA cap binding,,ppi
2532,2916,64386,MMP25,matrix metallopeptidase 25,2,,,ppi
2533,2917,10632,ATP5L,ATP synthase; H+ transporting; mitochondrial Fo complex subunit G,57,transmembrane transporter activity|ATPase activity|proton-transporting ATP synthase activity; rotational mechanism,,ppi
2534,2918,51586,MED15,mediator complex subunit 15,67,,schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
2535,2919,56547,MMP26,matrix metallopeptidase 26,18,,seborrheic keratosis|skin disease|actinic keratosis,ppi
2536,2920,64066,MMP27,matrix metallopeptidase 27,1,,,ppi
2537,2921,140707,BRI3BP,BRI3 binding protein,22,,,ppi
2538,2922,10715,CERS1,ceramide synthase 1,3,sphingosine N-acyltransferase activity,intellectual disability|learning disability|visual epilepsy,ppi
2539,2923,25819,NOCT,nocturnin,29,DNA-binding transcription factor activity|mRNA binding|poly(A)-specific ribonuclease activity,,ppi
2540,2924,7862,BRPF1,bromodomain and PHD finger containing 1,29,histone acetyltransferase activity (H3-K23 specific),,ppi
2541,2925,27154,BRPF3,bromodomain and PHD finger containing 3,20,,,ppi
2542,2926,64881,PCDH20,protocadherin 20,48,RNA binding,,ppi
2543,2927,23607,CD2AP,CD2 associated protein,110,structural constituent of cytoskeleton|cadherin binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|focal segmental glomerulosclerosis|hypertension|essential hypertension|proteinuria|kidney failure,ppi
2544,2928,25837,RAB26,RAB26; member RAS oncogene family,6,GTP binding|GMP binding|GTPase activity,,ppi
2545,2929,8618,CADPS,calcium dependent secretion activator,49,protein kinase binding,,ppi
2546,2930,64407,RGS18,regulator of G-protein signaling 18,5,,,ppi
2547,2931,26053,AUTS2,autism susceptibility candidate 2,21,chromatin binding|protein binding,autistic disorder|ptosis|congenital ptosis|spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|epilepsy|intellectual disability|learning disability|schizophrenia|autosomal dominant non-syndromic intellectual disability,ppi
2548,2932,51715,RAB23,RAB23; member RAS oncogene family,6,GTPase activity,craniosynostosis|cryptorchidism|patent ductus arteriosus|sensorineural hearing loss|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|umbilical hernia|omphalocele|hydronephrosis|intellectual disability,ppi
2549,2933,54433,GAR1,GAR1 ribonucleoprotein,87,RNA binding|box H/ACA snoRNA binding,hematopoietic system disease|dyskeratosis congenita,ppi
2550,2934,64403,CDH24,cadherin 24,6,calcium ion binding|cadherin binding|cytoskeletal protein binding|protein homodimerization activity,,ppi
2551,2935,27253,PCDH17,protocadherin 17,11,,schizophrenia,ppi
2552,2936,54510,PCDH18,protocadherin 18,3,,,ppi
2553,2937,51046,ST8SIA3,ST8 alpha-N-acetyl-neuraminide alpha-2;8-sialyltransferase 3,12,alpha-N-acetylneuraminate alpha-2;8-sialyltransferase activity|sialyltransferase activity|sialic acid binding,,ppi
2554,2938,57526,PCDH19,protocadherin 19,2,,epilepsy|early myoclonic encephalopathy|infantile epileptic encephalopathy|Dravet syndrome|autistic disorder|Ohtahara syndrome|early infantile epileptic encephalopathy 9,ppi
2555,2939,283349,RASSF3,Ras association domain family member 3,26,,,ppi
2556,2941,66037,BOLL,boule homolog; RNA binding protein,13,translation activator activity|mRNA 3'-UTR binding,large intestine cancer|colorectal cancer,ppi
2557,2942,65008,MRPL1,mitochondrial ribosomal protein L1,86,RNA binding,,ppi
2558,2943,51073,MRPL4,mitochondrial ribosomal protein L4,125,RNA binding|structural constituent of ribosome,,ppi
2559,2944,65005,MRPL9,mitochondrial ribosomal protein L9,87,RNA binding|structural constituent of ribosome,breast cancer,ppi
2560,2945,28998,MRPL13,mitochondrial ribosomal protein L13,69,RNA binding|structural constituent of ribosome|mRNA binding,tongue squamous cell carcinoma|squamous cell carcinoma|stomach cancer|breast cancer,ppi
2561,2946,64928,MRPL14,mitochondrial ribosomal protein L14,52,RNA binding,,ppi
2562,2947,9391,CIAO1,cytosolic iron-sulfur assembly component 1,117,,,ppi
2563,2948,64109,CRLF2,cytokine receptor-like factor 2,3,cytokine receptor activity|cytokine binding|interleukin-11 receptor activity|interleukin-11 binding,acute lymphocytic leukemia,ppi
2564,2949,64207,IRF2BPL,interferon regulatory factor 2 binding protein like,17,DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
2565,2950,64376,IKZF5,IKAROS family zinc finger 5,55,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|zinc ion binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding,,ppi
2566,2953,57502,NLGN4X,neuroligin 4; X-linked,4,chloride ion binding|neurexin family protein binding|protein homodimerization activity|cell adhesion molecule binding|signaling receptor activity,alcohol dependence|alcohol abuse|autistic disorder|Asperger syndrome,ppi
2567,2954,84628,NTNG2,netrin G2,1,,bipolar disorder|schizophrenia,ppi
2568,2955,54413,NLGN3,neuroligin 3,76,signaling receptor activity|neurexin family protein binding|cell adhesion molecule binding,autistic disorder|Asperger syndrome,ppi
2569,2956,57555,NLGN2,neuroligin 2,19,neurexin family protein binding|cell adhesion molecule binding|signaling receptor activity,schizophrenia,ppi
2570,2957,22871,NLGN1,neuroligin 1,11,amyloid-beta binding|PDZ domain binding|signaling receptor activity|neurexin family protein binding|protein dimerization activity|cell adhesion molecule binding|scaffold protein binding,autistic disorder|bipolar disorder|schizophrenia,ppi
2571,2958,64518,TEKT3,tektin 3,11,,,ppi
2572,2959,85358,SHANK3,SH3 and multiple ankyrin repeat domains 3,29,protein C-terminus binding|zinc ion binding|SH3 domain binding|GKAP/Homer scaffold activity|ionotropic glutamate receptor binding|protein self-association|scaffold protein binding|receptor signaling complex scaffold activity,autistic disorder|communication disorder|bipolar disorder|schizophrenia|intellectual disability|learning disability,ppi
2573,2960,22941,SHANK2,SH3 and multiple ankyrin repeat domains 2,30,GKAP/Homer scaffold activity|ionotropic glutamate receptor binding|receptor signaling complex scaffold activity,autistic disorder|intellectual disability|learning disability,ppi
2574,2961,4499,MT1M,metallothionein 1M,2,zinc ion binding|metal ion binding,,ppi
2575,2962,57213,SPRYD7,SPRY domain containing 7,8,,,ppi
2576,2963,23566,LPAR3,lysophosphatidic acid receptor 3,2,G-protein coupled receptor activity|lipid binding,,ppi
2577,2964,53637,S1PR5,sphingosine-1-phosphate receptor 5,10,,,ppi
2578,2965,70,ACTC1,actin; alpha; cardiac muscle 1,86,ATP binding|ATPase activity|myosin binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
2579,2966,64651,CSRNP1,cysteine and serine rich nuclear protein 1,7,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
2580,2967,165904,XIRP1,xin actin binding repeat containing 1,8,RNA binding|actin binding,,ppi
2581,2968,129446,XIRP2,xin actin binding repeat containing 2,7,actin binding,,ppi
2582,2969,146862,UNC45B,unc-45 myosin chaperone B,8,Hsp90 protein binding,heart disease|cardiovascular system disease|cataract 43,ppi
2583,2970,202333,CMYA5,cardiomyopathy associated 5,18,,schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
2584,2971,55227,LRRC1,leucine rich repeat containing 1,26,,,ppi
2585,2972,29117,BRD7,bromodomain containing 7,59,transcription coactivator activity|transcription corepressor activity|transcription factor binding|histone binding|transcription regulatory region DNA binding|lysine-acetylated histone binding,,ppi
2586,2973,9891,NUAK1,NUAK family kinase 1,26,protein serine/threonine kinase activity,multiple myeloma,ppi
2587,2974,9419,CRIPT,CXXC repeat containing interactor of PDZ3 domain,16,microtubule binding|PDZ domain binding|protein-containing complex binding|scaffold protein binding,anemia|macrocytic anemia|clubfoot|enophthalmos|orbital disease|exophthalmos,ppi
2588,2975,28981,IFT81,intraflagellar transport 81,41,tubulin binding,,ppi
2589,2976,9214,FCMR,Fc fragment of IgM receptor,3,,,ppi
2590,2978,114897,C1QTNF1,C1q and tumor necrosis factor related protein 1,6,collagen binding,,ppi
2591,2979,114898,C1QTNF2,C1q and tumor necrosis factor related protein 2,28,,,ppi
2592,2980,114899,C1QTNF3,C1q and tumor necrosis factor related protein 3,2,,schizophrenia,ppi
2593,2983,64663,SPANXC,SPANX family member C,1,,,ppi
2594,2984,64648,SPANXD,SPANX family member D,1,,,ppi
2595,2985,79870,BAALC,brain and acute leukemia; cytoplasmic,3,,acute myeloid leukemia,ppi
2596,2986,57591,MKL1,megakaryoblastic leukemia (translocation) 1,28,transcription coactivator activity|actin binding|actin monomer binding,,ppi
2597,2987,59338,PLEKHA1,pleckstrin homology domain containing A1,16,phosphatidylinositol-3;4-bisphosphate binding|PDZ domain binding,age related macular degeneration 1,ppi
2598,2988,59339,PLEKHA2,pleckstrin homology domain containing A2,4,fibronectin binding|laminin binding|phosphatidylinositol-3;4-bisphosphate binding|PDZ domain binding,,ppi
2599,2989,65977,PLEKHA3,pleckstrin homology domain containing A3,3,phosphatidylinositol-4-phosphate binding|ceramide 1-phosphate transporter activity|lipid binding|ceramide 1-phosphate binding,,ppi
2600,2990,57664,PLEKHA4,pleckstrin homology domain containing A4,7,phosphatidylinositol-3-phosphate binding,,ppi
2601,2991,793,CALB1,calbindin 1,8,calcium ion binding|zinc ion binding,bipolar disorder|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|schizophrenia,ppi
2602,2992,51699,VPS29,VPS29; retromer complex component,76,protein transporter activity,,ppi
2603,2993,128178,EDARADD,EDAR associated death domain,13,,tooth agenesis|anodontia|hypohidrotic ectodermal dysplasia,ppi
2604,2994,114905,C1QTNF7,C1q and tumor necrosis factor related protein 7,1,,,ppi
2605,2995,114904,C1QTNF6,C1q and tumor necrosis factor related protein 6,4,,diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21|type 1 diabetes mellitus 22,ppi
2606,2996,114902,C1QTNF5,C1q and tumor necrosis factor related protein 5,1,,lens disease|age related macular degeneration|macular degeneration|degeneration of macula and posterior pole|late-onset retinal degenration,ppi
2607,2998,54828,BCAS3,BCAS3; microtubule associated cell migration factor,38,chromatin binding|acetyltransferase activator activity|histone binding|beta-tubulin binding,,ppi
2608,2999,27429,HTRA2,HtrA serine peptidase 2,73,serine-type endopeptidase activity|peptidase activity|serine-type peptidase activity|identical protein binding|unfolded protein binding,vertebrobasilar insufficiency|transient cerebral ischemia|secondary Parkinson disease|Parkinson's disease,ppi
2609,3000,151011,SEPT10,septin 10,28,protein-containing complex scaffold activity|GTPase activity,,ppi
2610,3001,794,CALB2,calbindin 2,6,calcium ion binding,uveitis|ciliary body disease|iris disease|panuveitis|malignant mesothelioma|benign mesothelioma|amyotrophic lateral sclerosis type 1,ppi
2611,3002,10620,ARID3B,AT-rich interaction domain 3B,22,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
2612,3003,29121,CLEC2D,C-type lectin domain family 2 member D,74,transmembrane signaling receptor activity,,ppi
2613,3004,64743,WDR13,WD repeat domain 13,4,,,ppi
2614,3005,7802,DNALI1,dynein axonemal light intermediate chain 1,17,dynein heavy chain binding,,ppi
2615,3006,56605,ERO1B,endoplasmic reticulum oxidoreductase 1 beta,22,oxidoreductase activity|unfolded protein binding|protein disulfide isomerase activity|protein disulfide oxidoreductase activity,,ppi
2616,3008,79192,IRX1,iroquois homeobox 1,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding,lung disease,ppi
2617,3010,795,S100G,S100 calcium binding protein G,1,,,ppi
2618,3011,79191,IRX3,iroquois homeobox 3,1,DNA-binding transcription factor activity; RNA polymerase II-specific,lung disease,ppi
2619,3012,10265,IRX5,iroquois homeobox 5,1,DNA-binding transcription factor activity; RNA polymerase II-specific,hypochromic anemia|cryptorchidism|sensorineural hearing loss|congenital heart disease|inguinal hernia|hypoparathyroidism|pseudohypoparathyroidism|excessive tearing|lacrimal apparatus disease|lung disease|myopia|microcytic anemia|craniosynostosis|tooth agenesis|anodontia,ppi
2620,3014,79148,MMP28,matrix metallopeptidase 28,2,metalloendopeptidase activity,,ppi
2621,3015,55653,BCAS4,breast carcinoma amplified sequence 4,11,,,ppi
2622,3016,64063,PRSS22,protease; serine 22,2,,,ppi
2623,3017,8909,ENDOU,endonuclease; poly(U) specific,2,RNA binding|endoribonuclease activity|growth factor activity|serine-type peptidase activity|manganese ion binding,,ppi
2624,3018,796,CALCA,calcitonin related polypeptide alpha,11,,alcohol dependence|alcohol abuse|autistic disorder|bipolar disorder|Down syndrome|congestive heart failure|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hypertension|essential hypertension|primary pulmonary hypertension|pulmonary hypertension|arthropathy|arthritis|prostate cancer|prostate carcinoma|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis,ppi
2625,3019,11098,PRSS23,protease; serine 23,38,,melanoma|skin melanoma,ppi
2626,3020,57410,SCYL1,SCY1 like pseudokinase 1,29,protein tyrosine kinase activity|cadherin binding,,ppi
2627,3021,11146,GLMN,glomulin; FKBP associated protein,77,ubiquitin protein ligase binding|ubiquitin-protein transferase inhibitor activity,skin disease|seborrheic keratosis|actinic keratosis,ppi
2628,3022,22861,NLRP1,NLR family pyrin domain containing 1,20,ATP binding|cysteine-type endopeptidase activator activity involved in apoptotic process,Clouston syndrome|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|corneal neovascularization,ppi
2629,3023,23645,PPP1R15A,protein phosphatase 1 regulatory subunit 15A,32,protein phosphatase 1 binding|protein phosphatase regulator activity|protein phosphatase activator activity,,ppi
2630,3025,55651,NHP2,NHP2 ribonucleoprotein,40,RNA binding|box H/ACA snoRNA binding,anemia|macrocytic anemia|aplastic anemia|blood coagulation disease|dental caries|placental insufficiency|gingival disease|epulis|hemorrhagic disease|tooth agenesis|anodontia|lacrimal duct obstruction|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|liver cirrhosis|intellectual disability|learning disability|osteoporosis|pancytopenia|periodontal disease,ppi
2631,3026,55505,NOP10,NOP10 ribonucleoprotein,21,telomerase RNA binding|box H/ACA snoRNA binding,anemia|macrocytic anemia|aplastic anemia|blood coagulation disease|dental caries|placental insufficiency|gingival disease|epulis|hemorrhagic disease|tooth agenesis|anodontia|lacrimal duct obstruction|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|intellectual disability|learning disability|osteoporosis|periodontal disease|periodontitis|postinflammatory pulmonary fibrosis,ppi
2632,3028,797,CALCB,calcitonin related polypeptide beta,1,neuropeptide hormone activity,,ppi
2633,3029,284040,CDRT4,CMT1A duplicated region transcript 4,2,,,ppi
2634,3030,51206,GP6,glycoprotein VI platelet,12,transmembrane signaling receptor activity|collagen binding|signaling receptor activity,,ppi
2635,3031,146822,CDRT15,CMT1A duplicated region transcript 15,9,,,ppi
2636,3032,63826,SRR,serine racemase,8,magnesium ion binding|L-serine ammonia-lyase activity|calcium ion binding|ATP binding|D-serine ammonia-lyase activity|glycine binding|threonine racemase activity|pyridoxal phosphate binding|serine racemase activity|protein homodimerization activity,schizophrenia,ppi
2637,3033,54504,CPVL,carboxypeptidase; vitellogenic like,52,serine-type carboxypeptidase activity,,ppi
2638,3034,71,ACTG1,actin gamma 1,188,structural constituent of cytoskeleton|profilin binding,coloboma|osteoporosis|autosomal dominant nonsyndromic deafness|autosomal recessive nonsyndromic deafness|X-linked nonsyndromic deafness|autosomal dominant auditory neuropathy 1|autosomal recessive nonsyndromic deafness 101|autosomal recessive nonsyndromic deafness 102|autosomal recessive nonsyndromic deafness 103|autosomal recessive nonsyndromic deafness 104|autosomal recessive nonsyndromic deafness 105|autosomal recessive nonsyndromic deafness 12|autosomal recessive nonsyndromic deafness 13|autosomal recessive nonsyndromic deafness 14|autosomal recessive nonsyndromic deafness 15|autosomal recessive nonsyndromic deafness 16|autosomal recessive nonsyndromic deafness 17|autosomal recessive nonsyndromic deafness 18A|autosomal recessive nonsyndromic deafness 18B|autosomal recessive nonsyndromic deafness 1A,ppi
2639,3035,799,CALCR,calcitonin receptor,16,calcitonin binding|amylin receptor activity|calcitonin receptor activity,nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|osteoporosis,ppi
2640,3036,28996,HIPK2,homeodomain interacting protein kinase 2,69,RNA polymerase II activating transcription factor binding|transcription corepressor activity|protein kinase activity|protein serine/threonine kinase activity|transcription coactivator activity,,ppi
2641,3037,64850,ETNPPL,ethanolamine-phosphate phospho-lyase,2,ethanolamine-phosphate phospho-lyase activity,schizophrenia,ppi
2642,3038,23303,KIF13B,kinesin family member 13B,12,microtubule motor activity|14-3-3 protein binding|microtubule binding|ATPase activity,,ppi
2643,3039,25930,PTPN23,protein tyrosine phosphatase; non-receptor type 23,60,protein tyrosine phosphatase activity,,ppi
2644,3040,60386,SLC25A19,solute carrier family 25 member 19,14,deoxynucleotide transmembrane transporter activity|thiamine pyrophosphate transmembrane transporter activity|thiamine transmembrane transporter activity,,ppi
2645,3041,800,CALD1,caldesmon 1,43,tropomyosin binding|cadherin binding,rheumatoid arthritis,ppi
2646,3042,170506,DHX36,DEAH-box helicase 36,56,RNA polymerase II proximal promoter sequence-specific DNA binding|G-quadruplex RNA binding|single-stranded DNA binding|RNA binding|double-stranded RNA binding|DNA-dependent ATPase activity|histone deacetylase binding|transcription regulatory region DNA binding|G-quadruplex DNA binding|telomerase RNA binding|ATP-dependent DNA helicase activity|ATP-dependent 3'-5' RNA helicase activity,,ppi
2647,3043,89874,SLC25A21,solute carrier family 25 member 21,6,alpha-ketoglutarate transmembrane transporter activity,,ppi
2648,3044,64902,AGXT2,alanine--glyoxylate aminotransferase 2,2,alanine-glyoxylate transaminase activity,inherited metabolic disorder|schizophrenia,ppi
2649,3045,6785,ELOVL4,ELOVL fatty acid elongase 4,5,G-protein coupled photoreceptor activity|fatty acid elongase activity,choroid disease|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|hypohidrosis|anhidrosis|retinitis pigmentosa 30|age related macular degeneration|macular degeneration|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|angioedema|Stargardt disease,ppi
2650,3046,54898,ELOVL2,ELOVL fatty acid elongase 2,10,fatty acid elongase activity,male infertility,ppi
2651,3047,64100,ELSPBP1,epididymal sperm binding protein 1,13,heparin binding,,ppi
2652,3048,64834,ELOVL1,ELOVL fatty acid elongase 1,9,fatty acid elongase activity,,ppi
2653,3049,801,CALM1,calmodulin 1,410,,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|cardiac arrest|cannabis dependence|cannabis abuse|phencyclidine abuse|long QT syndrome,ppi
2654,3050,56987,BBX,BBX; HMG-box containing,28,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2655,3052,64901,RANBP17,RAN binding protein 17,8,GTP binding|nuclear export signal receptor activity,,ppi
2656,3054,64849,SLC13A3,solute carrier family 13 member 3,5,high-affinity sodium:dicarboxylate symporter activity|sodium:dicarboxylate symporter activity|citrate transmembrane transporter activity|succinate transmembrane transporter activity,,ppi
2657,3055,65062,TMEM237,transmembrane protein 237,41,,Joubert syndrome,ppi
2658,3056,65061,CDK15,cyclin dependent kinase 15,97,protein serine/threonine kinase activity|cyclin binding|cyclin-dependent protein serine/threonine kinase activity,,ppi
2659,3057,79800,CARF,calcium responsive transcription factor,5,DNA binding|DNA-binding transcription factor activity,,ppi
2660,3058,65059,RAPH1,Ras association (RalGDS/AF-6) and pleckstrin homology domains 1,19,,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
2661,3059,151254,ALS2CR11,amyotrophic lateral sclerosis 2 chromosome region candidate 11,19,,,ppi
2662,3060,130540,ALS2CR12,amyotrophic lateral sclerosis 2 chromosome region candidate 12,6,,,ppi
2663,3061,150864,FAM117B,family with sequence similarity 117 member B,25,,,ppi
2664,3062,130026,ICA1L,islet cell autoantigen 1 like,2,,,ppi
2665,3063,117583,PARD3B,par-3 family cell polarity regulator beta,10,phosphatidylinositol binding,,ppi
2666,3065,94233,OPN4,opsin 4,4,11-cis retinal binding|G-protein coupled photoreceptor activity,endogenous depression,ppi
2667,3067,9663,LPIN2,lipin 2,4,transcription coactivator activity|phosphatidate phosphatase activity,congenital dyserythropoietic anemia|congestive heart failure|osteopetrosis|osteosclerosis|synovitis|tenosynovitis|fibromyalgia|myositis|chronic recurrent multifocal osteomyelitis|skin disease|acne|Diamond-Blackfan anemia|congenital hypoplastic anemia,ppi
2668,3068,64900,LPIN3,lipin 3,9,phosphatidate phosphatase activity|transcription coactivator activity,,ppi
2669,3069,51529,ANAPC11,anaphase promoting complex subunit 11,47,ubiquitin-ubiquitin ligase activity|ubiquitin protein ligase activity|cullin family protein binding|ubiquitin-protein transferase activity,,ppi
2670,3070,55506,H2AFY2,H2A histone family member Y2,102,RNA polymerase II regulatory region sequence-specific DNA binding|chromatin DNA binding|transcription regulatory region DNA binding|DNA binding,,ppi
2671,3073,55766,H2AFJ,H2A histone family member J,6,DNA binding,,ppi
2672,3074,9846,GAB2,GRB2 associated binding protein 2,48,transmembrane receptor protein tyrosine kinase adaptor activity|phosphatidylinositol-3;4;5-trisphosphate binding|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-3;4-bisphosphate binding,melanoma|skin melanoma,ppi
2673,3075,57447,NDRG2,NDRG family member 2,13,,vertebrobasilar insufficiency|transient cerebral ischemia|colon cancer|colonic benign neoplasm|cataract,ppi
2674,3076,136853,SSC4D,scavenger receptor cysteine rich family member with 4 domains,1,,,ppi
2675,3077,57446,NDRG3,NDRG family member 3,13,,,ppi
2676,3078,201266,SLC39A11,solute carrier family 39 member 11,27,zinc ion transmembrane transporter activity,,ppi
2677,3079,83795,KCNK16,potassium two pore domain channel subfamily K member 16,24,potassium channel activity|potassium ion leak channel activity,diabetes mellitus|type 2 diabetes mellitus,ppi
2678,3080,89822,KCNK17,potassium two pore domain channel subfamily K member 17,1,potassium channel activity|potassium ion leak channel activity,,ppi
2679,3081,65009,NDRG4,NDRG family member 4,8,,,ppi
2680,3083,116369,SLC26A8,solute carrier family 26 member 8,3,chloride channel activity|sulfate transmembrane transporter activity|oxalate transmembrane transporter activity|bicarbonate transmembrane transporter activity|chloride transmembrane transporter activity|anion:anion antiporter activity,schizophrenia|azoospermia,ppi
2681,3084,115019,SLC26A9,solute carrier family 26 member 9,1,chloride channel activity|anion:anion antiporter activity|oxalate transmembrane transporter activity|sulfate transmembrane transporter activity|bicarbonate transmembrane transporter activity|chloride transmembrane transporter activity,intestinal obstruction|ileus,ppi
2682,3087,65010,SLC26A6,solute carrier family 26 member 6,18,inorganic anion exchanger activity|bicarbonate transmembrane transporter activity|chloride transmembrane transporter activity|sulfate transmembrane transporter activity|anion:anion antiporter activity|formate transmembrane transporter activity|efflux transmembrane transporter activity|formate efflux transmembrane transporter activity|oxalate transmembrane transporter activity|PDZ domain binding,,ppi
2683,3088,54948,MRPL16,mitochondrial ribosomal protein L16,47,rRNA binding|structural constituent of ribosome,,ppi
2684,3089,29074,MRPL18,mitochondrial ribosomal protein L18,43,structural constituent of ribosome|5S rRNA binding,,ppi
2685,3090,55052,MRPL20,mitochondrial ribosomal protein L20,44,RNA binding|structural constituent of ribosome,,ppi
2686,3091,219927,MRPL21,mitochondrial ribosomal protein L21,43,RNA binding|structural constituent of ribosome,,ppi
2687,3092,29093,MRPL22,mitochondrial ribosomal protein L22,47,RNA binding|structural constituent of ribosome,,ppi
2688,3093,51264,MRPL27,mitochondrial ribosomal protein L27,33,RNA binding|structural constituent of ribosome,,ppi
2689,3094,10573,MRPL28,mitochondrial ribosomal protein L28,75,RNA binding|structural constituent of ribosome,,ppi
2690,3095,9553,MRPL33,mitochondrial ribosomal protein L33,14,,,ppi
2691,3096,64981,MRPL34,mitochondrial ribosomal protein L34,30,structural constituent of ribosome,,ppi
2692,3097,51318,MRPL35,mitochondrial ribosomal protein L35,43,structural constituent of ribosome,,ppi
2693,3099,64979,MRPL36,mitochondrial ribosomal protein L36,2,,,ppi
2694,3100,64976,MRPL40,mitochondrial ribosomal protein L40,73,RNA binding,,ppi
2695,3101,64975,MRPL41,mitochondrial ribosomal protein L41,70,RNA binding|structural constituent of ribosome,,ppi
2696,3102,28977,MRPL42,mitochondrial ribosomal protein L42,70,RNA binding|structural constituent of ribosome,,ppi
2697,3103,51116,MRPS2,mitochondrial ribosomal protein S2,59,structural constituent of ribosome,,ppi
2698,3104,55272,IMP3,IMP3; U3 small nucleolar ribonucleoprotein,30,RNA binding|snoRNA binding|rRNA binding|structural constituent of ribosome,,ppi
2699,3105,64969,MRPS5,mitochondrial ribosomal protein S5,70,RNA binding|structural constituent of ribosome,,ppi
2700,3106,51081,MRPS7,mitochondrial ribosomal protein S7,81,RNA binding|structural constituent of ribosome|mRNA binding|rRNA binding,breast cancer,ppi
2701,3107,72,ACTG2,actin; gamma 2; smooth muscle; enteric,17,,colon cancer|colonic benign neoplasm|polyhydramnios|vesicoureteral reflux|intestinal pseudo-obstruction|paralytic ileus|megacystis-microcolon-intestinal hypoperistalsis syndrome|Meckel syndrome|autosomal dominant polycystic kidney disease,ppi
2702,3108,64965,MRPS9,mitochondrial ribosomal protein S9,110,RNA binding|structural constituent of ribosome,,ppi
2703,3109,55173,MRPS10,mitochondrial ribosomal protein S10,45,,,ppi
2704,3110,64960,MRPS15,mitochondrial ribosomal protein S15,57,RNA binding|structural constituent of ribosome,,ppi
2705,3111,56945,MRPS22,mitochondrial ribosomal protein S22,77,structural constituent of ribosome,breast cancer|combined oxidative phosphorylation deficiency,ppi
2706,3112,51649,MRPS23,mitochondrial ribosomal protein S23,60,RNA binding,breast cancer,ppi
2707,3113,64951,MRPS24,mitochondrial ribosomal protein S24,39,RNA binding|structural constituent of ribosome,,ppi
2708,3114,64432,MRPS25,mitochondrial ribosomal protein S25,36,structural constituent of ribosome,,ppi
2709,3115,23107,MRPS27,mitochondrial ribosomal protein S27,93,tRNA binding|rRNA binding|mitochondrial ribosome binding,,ppi
2710,3116,28957,MRPS28,mitochondrial ribosomal protein S28,58,RNA binding,breast cancer,ppi
2711,3117,78988,MRPL57,mitochondrial ribosomal protein L57,28,structural constituent of ribosome,,ppi
2712,3118,55168,MRPS18A,mitochondrial ribosomal protein S18A,26,structural constituent of ribosome,,ppi
2713,3119,28973,MRPS18B,mitochondrial ribosomal protein S18B,45,structural constituent of ribosome,stomach cancer,ppi
2714,3120,84545,MRPL43,mitochondrial ribosomal protein L43,38,RNA binding|structural constituent of ribosome,,ppi
2715,3121,810,CALML3,calmodulin like 3,60,enzyme regulator activity|calcium ion binding,,ppi
2716,3122,388951,TSPYL6,TSPY like 6,45,,,ppi
2717,3124,200765,TIGD1,tigger transposable element derived 1,3,,,ppi
2718,3125,9043,SPAG9,sperm associated antigen 9,69,kinesin binding|receptor signaling complex scaffold activity|MAP-kinase scaffold activity|JUN kinase binding,,ppi
2719,3126,26973,CHORDC1,cysteine and histidine rich domain containing 1,58,,,ppi
2720,3127,10003,NAALAD2,N-acetylated alpha-linked acidic dipeptidase 2,4,carboxypeptidase activity|serine-type peptidase activity|dipeptidyl-peptidase activity|dipeptidase activity,,ppi
2721,3128,389058,SP5,Sp5 transcription factor,1,DNA-binding transcription factor activity; RNA polymerase II-specific,prostate cancer|prostate carcinoma,ppi
2722,3129,80320,SP6,Sp6 transcription factor,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
2723,3131,10407,SPAG11B,sperm associated antigen 11B,1,,,ppi
2724,3132,28999,KLF15,Kruppel like factor 15,15,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|transcription regulatory region DNA binding,prostate cancer|prostate carcinoma,ppi
2725,3133,10577,NPC2,NPC intracellular cholesterol transporter 2,25,cholesterol binding|cholesterol transporter activity,narcolepsy|cerebellar disease|dystonia|epilepsy|neonatal jaundice|intellectual disability|learning disability|schizophreniform disorder|schizoaffective disorder|sea-blue histiocyte syndrome|visual epilepsy|stereotypic movement disorder|Niemann-Pick disease,ppi
2726,3134,57674,RNF213,ring finger protein 213,27,ubiquitin-protein transferase activity|ATPase activity,Moyamoya disease,ppi
2727,3135,65125,WNK1,WNK lysine deficient protein kinase 1,106,protein kinase activity|protein serine/threonine kinase activity|ATP binding|chloride channel inhibitor activity|phosphatase binding|protein kinase activator activity,hypertension|essential hypertension|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|autosomal recessive pseudohypoaldosteronism type 1|autosomal dominant pseudohypoaldosteronism type 1|pseudohypoaldosteronism|Charcot-Marie-Tooth disease|hereditary sensory neuropathy,ppi
2728,3136,65268,WNK2,WNK lysine deficient protein kinase 2,15,protein serine/threonine kinase activity|ATP binding,,ppi
2729,3137,65267,WNK3,WNK lysine deficient protein kinase 3,6,protein kinase activity|protein serine/threonine kinase activity|ATP binding|chloride channel inhibitor activity,schizophrenia,ppi
2730,3138,65266,WNK4,WNK lysine deficient protein kinase 4,20,protein serine/threonine kinase activity|ATP binding|chloride channel inhibitor activity,hypertension|essential hypertension|autosomal recessive pseudohypoaldosteronism type 1|autosomal dominant pseudohypoaldosteronism type 1|pseudohypoaldosteronism|schizophrenia,ppi
2731,3139,25780,RASGRP3,RAS guanyl releasing protein 3,11,guanyl-nucleotide exchange factor activity|Ras guanyl-nucleotide exchange factor activity|GTPase activator activity|calcium ion binding|diacylglycerol binding,systemic lupus erythematosus,ppi
2732,3140,811,CALR,calreticulin,159,complement component C1q binding|DNA binding|RNA binding|mRNA binding|calcium ion binding|zinc ion binding|carbohydrate binding|protein binding involved in protein folding|androgen receptor binding|unfolded protein binding|chaperone binding,bipolar disorder|large intestine cancer|colorectal cancer|hypertension|essential hypertension|myelofibrosis|myeloproliferative neoplasm|bone marrow cancer|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|prostate cancer|prostate carcinoma|drug psychosis|schizophreniform disorder|schizoaffective disorder|schizophrenia|paranoid schizophrenia|delusional disorder,ppi
2733,3141,92211,CDHR1,cadherin related family member 1,3,,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
2734,3142,9641,IKBKE,inhibitor of kappa light polypeptide gene enhancer in B-cells; kinase epsilon,370,protein kinase activity|NF-kappaB-inducing kinase activity|K48-linked polyubiquitin modification-dependent protein binding|K63-linked polyubiquitin modification-dependent protein binding|protein serine/threonine kinase activity,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
2735,3143,26020,LRP10,LDL receptor related protein 10,33,,,ppi
2736,3144,338339,CLEC4D,C-type lectin domain family 4 member D,1,,lung disease,ppi
2737,3145,26253,CLEC4E,C-type lectin domain family 4 member E,3,,lung disease,ppi
2738,3147,64581,CLEC7A,C-type lectin domain family 7 member A,20,signaling pattern recognition receptor activity|carbohydrate binding|MHC protein binding,chronic mucocutaneous candidiasis,ppi
2739,3148,30968,STOML2,stomatin like 2,85,signaling receptor binding|cardiolipin binding,contact dermatitis|occupational dermatitis,ppi
2740,3149,9399,STOML1,stomatin like 1,9,,,ppi
2741,3150,23229,ARHGEF9,Cdc42 guanine nucleotide exchange factor 9,4,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,epilepsy|visual epilepsy|syndromic X-linked intellectual disability 94|hyperekplexia 1|autistic disorder|infantile epileptic encephalopathy|Ohtahara syndrome,ppi
2742,3151,10282,BET1,Bet1 golgi vesicular membrane trafficking protein,25,,,ppi
2743,3152,10580,SORBS1,sorbin and SH3 domain containing 1,48,actin binding|SH3/SH2 adaptor activity|insulin receptor binding|cytoskeletal protein binding,,ppi
2744,3153,63971,KIF13A,kinesin family member 13A,18,microtubule motor activity|microtubule binding|ATPase activity,,ppi
2745,3154,65975,STK33,serine/threonine kinase 33,12,protein serine/threonine kinase activity,,ppi
2746,3155,51155,HN1,hematological and neurological expressed 1,16,,,ppi
2747,3156,57127,RHBG,Rh family B glycoprotein (gene/pseudogene),1,ammonium transmembrane transporter activity,,ppi
2748,3157,9583,ENTPD4,ectonucleoside triphosphate diphosphohydrolase 4,8,nucleoside-diphosphatase activity|nucleoside-triphosphatase activity|uridine-diphosphatase activity,schizophrenia,ppi
2749,3158,23263,MCF2L,MCF.2 cell line derived transforming sequence like,10,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|phosphatidylinositol binding,,ppi
2750,3159,11311,VPS45,vacuolar protein sorting 45 homolog,35,,anemia|macrocytic anemia|primary polycythemia|leukopenia|thrombocytopenia|neutropenia|agranulocytosis|severe congenital neutropenia,ppi
2751,3160,813,CALU,calumenin,132,calcium ion binding,,ppi
2752,3161,9826,ARHGEF11,Rho guanine nucleotide exchange factor 11,37,G-protein coupled receptor binding|guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,schizophrenia,ppi
2753,3162,65018,PINK1,PTEN induced putative kinase 1,64,magnesium ion binding|protease binding|protein kinase activity|protein serine/threonine kinase activity|ATP binding|calcium-dependent protein kinase activity|kinase activity|peptidase activator activity|protein kinase B binding,neuroblastoma|Parkinson's disease|schizophrenia|neurotic disorder|endogenous depression|melancholia|secondary Parkinson disease|major depressive disorder|mental depression|autosomal recessive early-onset Parkinson disease 6,ppi
2754,3163,27074,LAMP3,lysosomal associated membrane protein 3,68,,influenza,ppi
2755,3164,55823,VPS11,VPS11; CORVET/HOPS core subunit,59,syntaxin binding|protein binding; bridging,hypomyelinating leukodystrophy 12,ppi
2756,3165,64601,VPS16,VPS16; CORVET/HOPS core subunit,48,actin binding,,ppi
2757,3166,57172,CAMK1G,calcium/calmodulin dependent protein kinase IG,10,calmodulin-dependent protein kinase activity|calmodulin binding,,ppi
2758,3167,54556,ING3,inhibitor of growth family member 3,47,methylated histone binding|histone acetyltransferase activity,head and neck squamous cell carcinoma,ppi
2759,3168,8536,CAMK1,calcium/calmodulin dependent protein kinase I,115,calmodulin-dependent protein kinase activity|calmodulin binding,,ppi
2760,3169,10276,NET1,neuroepithelial cell transforming 1,12,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
2761,3170,66036,MTMR9,myotubularin related protein 9,28,phosphatidylinositol-3-phosphatase activity|phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity,,ppi
2762,3171,83943,IMMP2L,inner mitochondrial membrane peptidase subunit 2,1,peptidase activity,autistic disorder,ppi
2763,3172,27283,TINAG,tubulointerstitial nephritis antigen,25,nucleotide binding|cysteine-type endopeptidase activity,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
2764,3173,815,CAMK2A,calcium/calmodulin dependent protein kinase II alpha,75,protein serine/threonine kinase activity|calmodulin-dependent protein kinase activity|Ras guanyl-nucleotide exchange factor activity|calcium-dependent protein serine/threonine kinase activity|kinase activity|glutamate receptor binding|calmodulin binding,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|iron metabolism disease|hemochromatosis|Wilson disease|cocaine abuse|cocaine dependence,ppi
2765,3174,8601,RGS20,regulator of G-protein signaling 20,87,GTPase activator activity,cannabis dependence|cannabis abuse,ppi
2766,3175,10455,ECI2,enoyl-CoA delta isomerase 2,33,dodecenoyl-CoA delta-isomerase activity,,ppi
2767,3176,9988,DMTF1,cyclin D binding myb like transcription factor 1,8,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
2768,3177,81693,AMN,amnion associated transmembrane protein,1,,congestive heart failure|megaloblastic anemia|pernicious anemia,ppi
2769,3178,81792,ADAMTS12,ADAM metallopeptidase with thrombospondin type 1 motif 12,13,metalloendopeptidase activity,schizophrenia,ppi
2770,3179,816,CAMK2B,calcium/calmodulin dependent protein kinase II beta,54,protein serine/threonine kinase activity|Ras guanyl-nucleotide exchange factor activity|calmodulin binding|calmodulin-dependent protein kinase activity,cannabis dependence|cannabis abuse|phencyclidine abuse|drug psychosis|schizophrenia|cocaine abuse|cocaine dependence,ppi
2771,3180,60676,PAPPA2,pappalysin 2,5,metalloendopeptidase activity|metallopeptidase activity|zinc ion binding,,ppi
2772,3182,170626,XAGE3,X antigen family member 3,15,,,ppi
2773,3183,817,CAMK2D,calcium/calmodulin dependent protein kinase II delta,95,protein serine/threonine kinase activity|calmodulin-dependent protein kinase activity|Ras guanyl-nucleotide exchange factor activity|sodium channel inhibitor activity|ion channel binding|calmodulin binding,polycystic ovary syndrome|coronary artery disease,ppi
2774,3184,26136,TES,testin LIM domain protein,60,RNA binding|zinc ion binding|cadherin binding,glioblastoma multiforme|giant cell glioblastoma,ppi
2775,3185,83540,NUF2,NUF2; NDC80 kinetochore complex component,44,,,ppi
2776,3186,157313,CDCA2,cell division cycle associated 2,23,,,ppi
2777,3187,83461,CDCA3,cell division cycle associated 3,27,,,ppi
2778,3188,55038,CDCA4,cell division cycle associated 4,27,,,ppi
2779,3189,113130,CDCA5,cell division cycle associated 5,52,chromatin binding,,ppi
2780,3190,83879,CDCA7,cell division cycle associated 7,7,,,ppi
2781,3191,55143,CDCA8,cell division cycle associated 8,51,,,ppi
2782,3192,818,CAMK2G,calcium/calmodulin dependent protein kinase II gamma,64,protein serine/threonine kinase activity|calcium-dependent protein serine/threonine phosphatase activity|Ras guanyl-nucleotide exchange factor activity|calmodulin binding|calmodulin-dependent protein kinase activity,,ppi
2783,3193,78987,CRELD1,cysteine rich with EGF like domains 1,24,,atrial heart septal defect 1|atrioventricular septal defect,ppi
2784,3194,9719,ADAMTSL2,ADAMTS like 2,2,,aortic valve stenosis|pseudosarcomatous fibromatosis|epilepsy|congestive heart failure|heart valve disease|inherited metabolic disorder|mitral valve stenosis|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|visual epilepsy|tracheal stenosis|tricuspid valve stenosis,ppi
2785,3195,92949,ADAMTSL1,ADAMTS like 1,7,,,ppi
2786,3196,57188,ADAMTSL3,ADAMTS like 3,6,,schizophrenia,ppi
2787,3197,11333,PDAP1,PDGFA associated protein 1,22,RNA binding,,ppi
2788,3198,26154,ABCA12,ATP binding cassette subfamily A member 12,2,lipid transporter activity|ATP binding|lipid-transporting ATPase activity|ATPase activity; coupled to transmembrane movement of substances,alopecia|large intestine cancer|colorectal cancer|sensorineural hearing loss|ectropion|enophthalmos|orbital disease|exophthalmos|hypohidrosis|anhidrosis|hypotrichosis|ichthyosis|keratitis|keratoconjunctivitis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|nail disease|autosomal recessive congenital ichthyosis 1|congenital ichthyosiform erythroderma|autosomal recessive congenital ichthyosis 2,ppi
2789,3199,154664,ABCA13,ATP binding cassette subfamily A member 13,5,ATPase activity; coupled to transmembrane movement of substances,bipolar disorder|large intestine cancer|colorectal cancer|schizophrenia,ppi
2790,3201,814,CAMK4,calcium/calmodulin dependent protein kinase IV,19,calmodulin-dependent protein kinase activity|calmodulin binding|calcium-dependent protein serine/threonine kinase activity,alcohol dependence|alcohol abuse|cocaine abuse|cocaine dependence|morphine dependence,ppi
2791,3202,94160,ABCC12,ATP binding cassette subfamily C member 12,1,ATPase activity; coupled to transmembrane movement of substances,bone marrow disease,ppi
2792,3203,81831,NETO2,neuropilin and tolloid like 2,31,,salivary gland adenoid cystic carcinoma,ppi
2793,3204,64768,IPPK,inositol-pentakisphosphate 2-kinase,98,protein-containing complex scaffold activity|inositol pentakisphosphate 2-kinase activity,,ppi
2794,3205,79102,RNF26,ring finger protein 26,26,zinc ion binding|ubiquitin protein ligase activity,,ppi
2795,3206,137994,LETM2,leucine zipper and EF-hand containing transmembrane protein 2,3,,,ppi
2796,3207,9360,PPIG,peptidylprolyl isomerase G,47,RNA binding|peptidyl-prolyl cis-trans isomerase activity|cyclosporin A binding|unfolded protein binding,,ppi
2797,3208,10465,PPIH,peptidylprolyl isomerase H,29,peptidyl-prolyl cis-trans isomerase activity|cyclosporin A binding|ribonucleoprotein complex binding|unfolded protein binding,,ppi
2798,3209,55742,PARVA,parvin alpha,47,cadherin binding|actin binding,substance abuse|substance-related disorder,ppi
2799,3210,29780,PARVB,parvin beta,16,actin binding,,ppi
2800,3211,64098,PARVG,parvin gamma,16,actin binding,,ppi
2801,3212,57453,DSCAML1,DS cell adhesion molecule like 1,4,protein homodimerization activity|cell-cell adhesion mediator activity,alcohol dependence|alcohol abuse,ppi
2802,3213,112398,EGLN2,egl-9 family hypoxia inducible factor 2,26,ferrous iron binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors|oxygen sensor activity|peptidyl-proline 4-dioxygenase activity,nicotine dependence,ppi
2803,3214,112399,EGLN3,egl-9 family hypoxia inducible factor 3,239,oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors|peptidyl-proline 4-dioxygenase activity,,ppi
2804,3215,64320,RNF25,ring finger protein 25,20,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
2805,3217,388015,RTL1,retrotransposon-like 1,1,,,ppi
2806,3218,339403,RXFP4,relaxin/insulin like family peptide receptor 4,4,G-protein coupled peptide receptor activity|galanin receptor activity,,ppi
2807,3220,117159,DCD,dermcidin,71,RNA binding,liver cancer,ppi
2808,3221,57642,COL20A1,collagen type XX alpha 1 chain,10,calcium ion binding|mannose binding,,ppi
2809,3222,79913,ACTR5,ARP5 actin-related protein 5 homolog,38,,,ppi
2810,3223,93973,ACTR8,ARP8 actin-related protein 8 homolog,22,,,ppi
2811,3224,79443,FYCO1,FYVE and coiled-coil domain containing 1,54,,cataract 18,ppi
2812,3225,65217,PCDH15,protocadherin related 15,1,,cochlear disease|sensorineural hearing loss|substance abuse|substance-related disorder|Usher syndrome|retinitis pigmentosa-deafness syndrome|Usher syndrome type 1|Usher syndrome type 1D|autosomal recessive nonsyndromic deafness 23|Usher syndrome type 1F,ppi
2813,3227,79442,LRRC2,leucine rich repeat containing 2,2,,,ppi
2814,3228,10522,DEAF1,DEAF1; transcription factor,25,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|intellectual disability|learning disability|autosomal dominant non-syndromic intellectual disability,ppi
2815,3229,115207,KCTD12,potassium channel tetramerization domain containing 12,30,RNA binding,bipolar disorder|schizophrenia|mood disorder,ppi
2816,3231,9825,SPATA2,spermatogenesis associated 2,29,,,ppi
2817,3233,23275,POFUT2,protein O-fucosyltransferase 2,4,peptide-O-fucosyltransferase activity,,ppi
2818,3234,50848,F11R,F11 receptor,23,cadherin binding,,ppi
2819,3235,58494,JAM2,junctional adhesion molecule 2,11,,,ppi
2820,3236,10894,LYVE1,lymphatic vessel endothelial hyaluronan receptor 1,4,signaling receptor activity|transmembrane signaling receptor activity|hyaluronic acid binding,,ppi
2821,3237,84254,CAMKK1,calcium/calmodulin dependent protein kinase kinase 1,32,calmodulin-dependent protein kinase activity|calmodulin binding|protein serine/threonine kinase activity,central nervous system disease|nervous system disease|autonomic neuropathy,ppi
2822,3241,10645,CAMKK2,calcium/calmodulin dependent protein kinase kinase 2,32,protein tyrosine kinase activity|calcium ion binding|calmodulin binding,schizophrenia,ppi
2823,3248,79339,OR51B4,olfactory receptor family 51 subfamily B member 4,1,olfactory receptor activity,,ppi
2824,3249,819,CAMLG,calcium modulating ligand,22,,,ppi
2825,3253,820,CAMP,cathelicidin antimicrobial peptide,7,lipopolysaccharide binding,,ppi
2826,3262,821,CANX,calnexin,264,RNA binding,coronary artery disease,ppi
2827,3263,283617,OR4K3,olfactory receptor family 4 subfamily K member 3 (gene/pseudogene),1,,,ppi
2828,3266,79324,OR51G1,olfactory receptor family 51 subfamily G member 1 (gene/pseudogene),1,olfactory receptor activity,,ppi
2829,3267,822,CAPG,capping actin protein; gelsolin like,31,protein-containing complex binding|cadherin binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|acute myeloid leukemia|lung cancer|lung adenocarcinoma,ppi
2830,3275,823,CAPN1,calpain 1,126,endopeptidase activity|calcium-dependent cysteine-type endopeptidase activity|calcium ion binding,melanoma|skin melanoma|optic neuritis,ppi
2831,3278,79295,OR5H6,olfactory receptor family 5 subfamily H member 6 (gene/pseudogene),1,olfactory receptor activity|odorant binding,,ppi
2832,3280,11132,CAPN10,calpain 10,5,SNARE binding|calcium-dependent cysteine-type endopeptidase activity|cytoskeletal protein binding,diabetes mellitus|type 2 diabetes mellitus|intellectual disability|learning disability,ppi
2833,3284,11131,CAPN11,calpain 11,6,peptidase activity|calcium-dependent cysteine-type endopeptidase activity,,ppi
2834,3290,824,CAPN2,calpain 2,68,calcium-dependent cysteine-type endopeptidase activity|cytoskeletal protein binding|cysteine-type peptidase activity,acute myeloid leukemia,ppi
2835,3295,825,CAPN3,calpain 3,21,catalytic activity|calcium-dependent cysteine-type endopeptidase activity|calcium ion binding|peptidase activity|cysteine-type peptidase activity|structural constituent of muscle|sodium ion binding|protein-containing complex scaffold activity|ligase regulator activity,pseudosarcomatous fibromatosis|hypereosinophilic syndrome|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y,ppi
2836,3299,826,CAPNS1,calpain small subunit 1,70,endopeptidase activity|calcium-dependent cysteine-type endopeptidase activity,prostate cancer|prostate carcinoma,ppi
2837,3302,726,CAPN5,calpain 5,3,calcium-dependent cysteine-type endopeptidase activity,retinal detachment|uveitis|ciliary body disease|iris disease|panuveitis|proliferative vitreoretinopathy,ppi
2838,3304,390155,OR5T1,olfactory receptor family 5 subfamily T member 1,1,dopamine binding|dopamine neurotransmitter receptor activity; coupled via Gi/Go|adrenergic receptor activity,,ppi
2839,3309,827,CAPN6,calpain 6,17,microtubule binding|calcium-dependent cysteine-type endopeptidase activity,,ppi
2840,3313,23473,CAPN7,calpain 7,12,endopeptidase activity,,ppi
2841,3314,338662,OR8D4,olfactory receptor family 8 subfamily D member 4,1,olfactory receptor activity|odorant binding,,ppi
2842,3321,219874,OR6T1,olfactory receptor family 6 subfamily T member 1,1,G-protein coupled serotonin receptor activity|G-protein coupled receptor activity|neurotransmitter receptor activity,,ppi
2843,3322,388743,CAPN8,calpain 8,4,calcium-dependent cysteine-type endopeptidase activity,,ppi
2844,3326,390113,OR4X1,olfactory receptor family 4 subfamily X member 1 (gene/pseudogene),1,,,ppi
2845,3329,10466,COG5,component of oligomeric golgi complex 5,31,,intellectual disability|learning disability|congenital disorder of glycosylation type II,ppi
2846,3330,83549,UCK1,uridine-cytidine kinase 1,6,nucleoside kinase activity|uridine kinase activity,,ppi
2847,3331,10753,CAPN9,calpain 9,2,calcium-dependent cysteine-type endopeptidase activity,,ppi
2848,3332,23190,UBXN4,UBX domain protein 4,32,,,ppi
2849,3333,81488,POLR2M,RNA polymerase II subunit M,56,,,ppi
2850,3334,50509,COL5A3,collagen type V alpha 3 chain,4,extracellular matrix structural constituent|collagen binding|extracellular matrix structural constituent conferring tensile strength|heparin binding,,ppi
2851,3335,80712,ESX1,ESX homeobox 1,2,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
2852,3336,64399,HHIP,hedgehog interacting protein,5,zinc ion binding|hedgehog family protein binding,liver cancer|hepatocellular carcinoma,ppi
2853,3337,80832,APOL4,apolipoprotein L4,2,lipid binding,schizophrenia,ppi
2854,3339,80831,APOL5,apolipoprotein L5,7,high-density lipoprotein particle binding|lipid binding,,ppi
2855,3340,828,CAPS,calcyphosine,2,,,ppi
2856,3341,80830,APOL6,apolipoprotein L6,7,lipid binding,influenza,ppi
2857,3342,94274,PPP1R14A,protein phosphatase 1 regulatory inhibitor subunit 14A,15,protein serine/threonine phosphatase inhibitor activity,large intestine cancer|colorectal cancer|malignant mesothelioma|benign mesothelioma,ppi
2858,3344,26064,RAI14,retinoic acid induced 14,57,,,ppi
2859,3345,79400,NOX5,NADPH oxidase 5,13,proton channel activity|superoxide-generating NADPH oxidase activity|heme binding|flavin adenine dinucleotide binding|NADP binding,,ppi
2860,3346,79368,FCRL2,Fc receptor like 2,2,,,ppi
2861,3347,112401,BIRC8,baculoviral IAP repeat containing 8,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process|ubiquitin protein ligase activity,,ppi
2862,3348,26512,INTS6,integrator complex subunit 6,63,transmembrane signaling receptor activity,,ppi
2863,3349,829,CAPZA1,capping actin protein of muscle Z-line alpha subunit 1,113,cadherin binding|actin filament binding,esophagus squamous cell carcinoma,ppi
2864,3350,84705,GTPBP3,GTP binding protein 3 (mitochondrial),15,,combined oxidative phosphorylation deficiency,ppi
2865,3351,9839,ZEB2,zinc finger E-box binding homeobox 2,32,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|phosphatase regulator activity|sequence-specific DNA binding,patent ductus arteriosus|congenital heart disease|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|breast cancer|Mowat-Wilson syndrome|pulmonary valve stenosis,ppi
2866,3352,55118,CRTAC1,cartilage acidic protein 1,19,,,ppi
2867,3353,10294,DNAJA2,DnaJ heat shock protein family (Hsp40) member A2,109,ATPase activator activity|unfolded protein binding,,ppi
2868,3354,55466,DNAJA4,DnaJ heat shock protein family (Hsp40) member A4,47,unfolded protein binding,,ppi
2869,3355,11080,DNAJB4,DnaJ heat shock protein family (Hsp40) member B4,60,ATPase activator activity|unfolded protein binding|chaperone binding,,ppi
2870,3356,25822,DNAJB5,DnaJ heat shock protein family (Hsp40) member B5,41,chaperone binding|unfolded protein binding,,ppi
2871,3357,10049,DNAJB6,DnaJ heat shock protein family (Hsp40) member B6,81,ATPase activator activity|heat shock protein binding|unfolded protein binding|chaperone binding,Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y|autosomal recessive limb-girdle muscular dystrophy type 2O|autosomal recessive limb-girdle muscular dystrophy type 2P,ppi
2872,3358,51726,DNAJB11,DnaJ heat shock protein family (Hsp40) member B11,92,,,ppi
2873,3359,80745,THUMPD2,THUMP domain containing 2,6,tRNA (guanine) methyltransferase activity,,ppi
2874,3360,54788,DNAJB12,DnaJ heat shock protein family (Hsp40) member B12,15,,,ppi
2875,3361,29952,DPP7,dipeptidyl peptidase 7,12,dipeptidyl-peptidase activity,,ppi
2876,3362,80329,ULBP1,UL16 binding protein 1,10,natural killer cell lectin-like receptor binding,,ppi
2877,3363,80328,ULBP2,UL16 binding protein 2,15,natural killer cell lectin-like receptor binding,stomach cancer,ppi
2878,3364,79465,ULBP3,UL16 binding protein 3,19,natural killer cell lectin-like receptor binding,alopecia areata,ppi
2879,3365,57731,SPTBN4,spectrin beta; non-erythrocytic 4,21,actin binding|Ras guanyl-nucleotide exchange factor activity|structural constituent of cytoskeleton|ankyrin binding|spectrin binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|polycystic ovary syndrome,ppi
2880,3366,80271,ITPKC,inositol-trisphosphate 3-kinase C,4,inositol-1;4;5-trisphosphate 3-kinase activity,coronary aneurysm|Kawasaki disease,ppi
2881,3368,830,CAPZA2,capping actin protein of muscle Z-line alpha subunit 2,249,actin filament binding,,ppi
2882,3369,50616,IL22,interleukin 22,3,interleukin-22 receptor binding,autoimmune hepatitis|middle cerebral artery infarction,ppi
2883,3370,116379,IL22RA2,interleukin 22 receptor subunit alpha 2,4,interleukin-22 binding|interleukin-22 receptor activity,,ppi
2884,3371,51560,RAB6B,RAB6B; member RAS oncogene family,51,GTPase activity,,ppi
2885,3372,25830,SULT4A1,sulfotransferase family 4A member 1,11,aryl sulfotransferase activity|sulfotransferase activity,schizophreniform disorder|schizoaffective disorder|schizophrenia|bipolar disorder,ppi
2886,3374,51199,NIN,ninein,121,,achondroplasia|Laron syndrome|epilepsy|placental insufficiency|visual epilepsy|syndromic X-linked intellectual disability 94|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|Leri-Weill dyschondrosteosis|Seckel syndrome,ppi
2887,3376,80975,TMPRSS5,transmembrane protease; serine 5,8,peptidase activity,,ppi
2888,3378,832,CAPZB,capping actin protein of muscle Z-line beta subunit,120,actin binding|cadherin binding|actin filament binding,,ppi
2889,3382,50837,TAS2R7,taste 2 receptor member 7,14,taste receptor activity|bitter taste receptor activity,,ppi
2890,3384,50836,TAS2R8,taste 2 receptor member 8,1,taste receptor activity|bitter taste receptor activity,,ppi
2891,3387,50838,TAS2R13,taste 2 receptor member 13,3,taste receptor activity|bitter taste receptor activity,,ppi
2892,3388,23729,SHPK,sedoheptulokinase,10,sedoheptulokinase activity,asphyxia neonatorum|inguinal hernia|portal hypertension|kidney failure|uremia|steatorrhea|hyperglycemia,ppi
2893,3391,57110,HRASLS,HRAS like suppressor,1,,,ppi
2894,3392,9283,GPR37L1,G protein-coupled receptor 37 like 1,2,G-protein coupled peptide receptor activity|prosaposin receptor activity,,ppi
2895,3393,80705,TSGA10,testis specific 10,46,,,ppi
2896,3394,80700,UBXN6,UBX domain protein 6,59,,,ppi
2897,3395,23411,SIRT1,sirtuin 1,265,transcription corepressor activity|histone deacetylase activity|NAD-dependent histone deacetylase activity|deacetylase activity|protein deacetylase activity|NAD-dependent protein deacetylase activity|NAD-dependent histone deacetylase activity (H3-K9 specific)|NAD+ ADP-ribosyltransferase activity|p53 binding|protein C-terminus binding|NAD+ binding|mitogen-activated protein kinase binding|nuclear hormone receptor binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|bHLH transcription factor binding|protein domain specific binding,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|bipolar disorder|brain cancer|colitis|ileitis|ileocolitis|gastroenteritis|demyelinating disease|diabetic ketoacidosis|diabetes mellitus|type 2 diabetes mellitus|diabetic cataract|diabetic retinopathy|fatty liver disease,ppi
2898,3396,833,CARS,cysteinyl-tRNA synthetase,49,tRNA binding|cysteine-tRNA ligase activity|ATP binding|protein homodimerization activity,alcohol dependence|alcohol abuse,ppi
2899,3397,23410,SIRT3,sirtuin 3,56,zinc ion binding|NAD-dependent protein deacetylase activity|sequence-specific DNA binding|NAD+ ADP-ribosyltransferase activity|NAD-dependent histone deacetylase activity|NAD+ binding,tongue squamous cell carcinoma|squamous cell carcinoma|obesity|gestational diabetes,ppi
2900,3398,23409,SIRT4,sirtuin 4,110,NAD+ ADP-ribosyltransferase activity|biotinidase activity|lipoamidase activity|NAD-dependent protein deacetylase activity,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
2901,3399,23408,SIRT5,sirtuin 5,21,zinc ion binding|NAD-dependent protein deacetylase activity|protein-malonyllysine demalonylase activity|protein-succinyllysine desuccinylase activity|protein-glutaryllysine deglutarylase activity|NAD+ binding|NAD+ ADP-ribosyltransferase activity,schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
2902,3400,51548,SIRT6,sirtuin 6,173,NAD+ ADP-ribosyltransferase activity|NAD(P)+-protein-arginine ADP-ribosyltransferase activity|zinc ion binding|NAD-dependent histone deacetylase activity|NAD-dependent protein deacetylase activity|NAD-dependent histone deacetylase activity (H3-K9 specific)|NAD+ binding,,ppi
2903,3401,51547,SIRT7,sirtuin 7,662,chromatin binding|NAD-dependent histone deacetylase activity (H3-K18 specific),fatty liver disease|systemic scleroderma|scleroderma,ppi
2904,3402,94005,PIGS,phosphatidylinositol glycan anchor biosynthesis class S,35,GPI-anchor transamidase activity,,ppi
2905,3403,51604,PIGT,phosphatidylinositol glycan anchor biosynthesis class T,38,GPI-anchor transamidase activity,hemolytic anemia|restrictive cardiomyopathy|patent ductus arteriosus|epilepsy|paroxysmal nocturnal hemoglobinuria|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hyperopia|cystic kidney disease|calcium metabolism disease|calcinosis|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
2906,3404,8092,ALX1,ALX homeobox 1,5,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity,isolated cleft palate|cleft palate|intellectual disability|learning disability|microphthalmia|craniosynostosis,ppi
2907,3406,84988,PPP1R16A,protein phosphatase 1 regulatory subunit 16A,24,,,ppi
2908,3407,79660,PPP1R3B,protein phosphatase 1 regulatory subunit 3B,12,,,ppi
2909,3408,90673,PPP1R3E,protein phosphatase 1 regulatory subunit 3E,1,[phosphorylase] phosphatase activity,,ppi
2910,3409,89801,PPP1R3F,protein phosphatase 1 regulatory subunit 3F,5,glycogen binding,,ppi
2911,3410,648791,PPP1R3G,protein phosphatase 1 regulatory subunit 3G,1,,,ppi
2912,3411,55607,PPP1R9A,protein phosphatase 1 regulatory subunit 9A,36,actin filament binding,,ppi
2913,3412,54776,PPP1R12C,protein phosphatase 1 regulatory subunit 12C,19,phosphatase regulator activity|enzyme inhibitor activity,,ppi
2914,3413,81554,RCC1L,RCC1 like,35,RNA binding|guanyl-nucleotide exchange factor activity|rRNA binding,,ppi
2915,3414,23368,PPP1R13B,protein phosphatase 1 regulatory subunit 13B,45,p53 binding,,ppi
2916,3415,84919,PPP1R15B,protein phosphatase 1 regulatory subunit 15B,19,,,ppi
2917,3416,81706,PPP1R14C,protein phosphatase 1 regulatory inhibitor subunit 14C,5,protein serine/threonine phosphatase inhibitor activity,,ppi
2918,3418,55892,MYNN,myoneurin,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|zinc ion binding|DNA binding,,ppi
2919,3419,143662,MUC15,mucin 15; cell surface associated,2,,,ppi
2920,3420,9698,PUM1,pumilio RNA binding family member 1,48,RNA binding|mRNA 3'-UTR binding|miRNA binding,,ppi
2921,3421,23369,PUM2,pumilio RNA binding family member 2,27,RNA binding|mRNA 3'-UTR binding|miRNA binding,,ppi
2922,3422,64783,RBM15,RNA binding motif protein 15,51,RNA binding|mRNA binding,,ppi
2923,3423,57586,SYT13,synaptotagmin 13,1,calcium-dependent phospholipid binding|calcium ion binding|syntaxin binding|clathrin binding|SNARE binding|phosphatidylserine binding,cocaine abuse|cocaine dependence,ppi
2924,3424,83550,GPR101,G protein-coupled receptor 101,2,adrenergic receptor activity,hyperpituitarism|acromegaly,ppi
2925,3425,83551,TAAR8,trace amine associated receptor 8,1,G-protein coupled receptor activity|trace-amine receptor activity,,ppi
2926,3426,81543,LRRC3,leucine rich repeat containing 3,9,,,ppi
2927,3427,7837,PXDN,peroxidasin,24,peroxidase activity|interleukin-1 receptor antagonist activity|extracellular matrix structural constituent|heme binding,acute myeloid leukemia|sclerocornea,ppi
2928,3428,81833,SPACA1,sperm acrosome associated 1,65,,,ppi
2929,3429,83942,TSSK1B,testis specific serine kinase 1B,17,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
2930,3430,27131,SNX5,sorting nexin 5,46,dynactin binding|phosphatidylinositol binding|cadherin binding|protein heterodimerization activity,stomach cancer,ppi
2931,3431,8573,CASK,calcium/calmodulin dependent serine protein kinase,91,guanylate kinase activity,cerebellar disease|isolated cleft palate|cleft palate|epilepsy|sensorineural hearing loss|hypohidrosis|anhidrosis|intellectual disability|learning disability|microcephaly|myopia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|blindness,ppi
2932,3432,58533,SNX6,sorting nexin 6,72,dynactin binding|protein heterodimerization activity,,ppi
2933,3433,51375,SNX7,sorting nexin 7,17,,,ppi
2934,3434,29886,SNX8,sorting nexin 8,25,phosphatidylinositol binding,,ppi
2935,3435,51429,SNX9,sorting nexin 9,60,1-phosphatidylinositol binding|phosphatidylinositol binding|cadherin binding|Arp2/3 complex binding,,ppi
2936,3436,29887,SNX10,sorting nexin 10,3,1-phosphatidylinositol binding,anemia|macrocytic anemia|chronic rhinitis|craniosynostosis|sensorineural hearing loss|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|osteopetrosis|osteosclerosis|otitis media|thrombocytopenia|blindness|Brown's tendon sheath syndrome,ppi
2937,3437,29916,SNX11,sorting nexin 11,23,phosphatidylinositol phosphate binding,,ppi
2938,3438,29934,SNX12,sorting nexin 12,28,phosphatidylinositol binding,,ppi
2939,3439,57231,SNX14,sorting nexin 14,20,phosphatidylinositol-3;5-bisphosphate binding,cerebellar disease|intellectual disability|learning disability|autosomal recessive spinocerebellar ataxia 20,ppi
2940,3440,29907,SNX15,sorting nexin 15,11,,,ppi
2941,3441,9784,SNX17,sorting nexin 17,42,signaling receptor binding|phosphatidylinositol binding|low-density lipoprotein particle receptor binding,,ppi
2942,3442,64089,SNX16,sorting nexin 16,5,phosphatidylinositol binding,,ppi
2943,3443,10914,PAPOLA,poly(A) polymerase alpha,56,magnesium ion binding|polynucleotide adenylyltransferase activity|ATP binding|manganese ion binding,,ppi
2944,3444,64895,PAPOLG,poly(A) polymerase gamma,9,polynucleotide adenylyltransferase activity|metal ion binding,,ppi
2945,3445,80829,ZFP91,ZFP91 zinc finger protein,28,DNA-binding transcription factor activity; RNA polymerase II-specific|ubiquitin-protein transferase activity,,ppi
2946,3446,7798,LUZP1,leucine zipper protein 1,61,,,ppi
2947,3447,9892,SNAP91,synaptosome associated protein 91,17,protein kinase binding,,ppi
2948,3448,55616,ASAP3,ArfGAP with SH3 domain; ankyrin repeat and PH domain 3,18,GTPase activator activity,,ppi
2949,3449,23509,POFUT1,protein O-fucosyltransferase 1,14,fucosyltransferase activity|peptide-O-fucosyltransferase activity,Dowling-Degos disease|reticulate acropigmentation of Kitamura,ppi
2950,3450,834,CASP1,caspase 1,59,endopeptidase activity|cysteine-type endopeptidase activity|cysteine-type endopeptidase activator activity involved in apoptotic process|identical protein binding|cysteine-type endopeptidase activity involved in apoptotic process|cysteine-type endopeptidase activity involved in apoptotic signaling pathway,proteinuria|allergic hypersensitivity disease|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|obesity|pneumonia|status epilepticus|hyperhomocysteinemia|amyotrophic lateral sclerosis type 1,ppi
2951,3457,843,CASP10,caspase 10,47,cysteine-type endopeptidase activity|cysteine-type endopeptidase activity involved in apoptotic signaling pathway|cysteine-type endopeptidase activity involved in apoptotic process,fetal erythroblastosis|autoimmune hemolytic anemia|hypereosinophilic syndrome|lymphosarcoma|lymphoma|central nervous system lymphoma|Langerhans-cell histiocytosis|reticulosarcoma|non-Hodgkin lymphoma|B-cell lymphoma|melanoma|skin melanoma|nephritis|glomerulonephritis|kidney disease|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|skin benign neoplasm|skin cancer,ppi
2952,3466,254879,OR2T6,olfactory receptor family 2 subfamily T member 6,1,olfactory receptor activity,,ppi
2953,3467,23581,CASP14,caspase 14,28,endopeptidase activity|cysteine-type endopeptidase activity|cysteine-type endopeptidase activity involved in apoptotic process,,ppi
2954,3469,343171,OR2W3,olfactory receptor family 2 subfamily W member 3,1,olfactory receptor activity,,ppi
2955,3474,835,CASP2,caspase 2,36,cysteine-type endopeptidase activity|enzyme binding|cysteine-type endopeptidase activity involved in apoptotic process,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|intellectual disability|learning disability,ppi
2956,3480,836,CASP3,caspase 3,180,aspartic-type endopeptidase activity|cysteine-type endopeptidase activity|peptidase activity|cysteine-type endopeptidase activator activity involved in apoptotic process|cysteine-type endopeptidase activity involved in apoptotic process|cysteine-type endopeptidase activity involved in apoptotic signaling pathway|cysteine-type endopeptidase activity involved in execution phase of apoptosis,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|calcium metabolism disease|nephrocalcinosis|calcinosis|brain ischemia|inflammatory bowel disease,ppi
2957,3482,150681,OR6B3,olfactory receptor family 6 subfamily B member 3,2,olfactory receptor activity|odorant binding,,ppi
2958,3484,837,CASP4,caspase 4,58,cysteine-type endopeptidase activity|cysteine-type endopeptidase activity involved in apoptotic signaling pathway|cysteine-type endopeptidase activity involved in apoptotic process,schizophrenia,ppi
2959,3485,838,CASP5,caspase 5,6,cysteine-type endopeptidase activity|cysteine-type peptidase activity|cysteine-type endopeptidase activity involved in apoptotic process|cysteine-type endopeptidase activity involved in apoptotic signaling pathway,,ppi
2960,3486,839,CASP6,caspase 6,44,cysteine-type endopeptidase activity|cysteine-type peptidase activity|cysteine-type endopeptidase activity involved in execution phase of apoptosis|cysteine-type endopeptidase activity involved in apoptotic process,,ppi
2961,3489,840,CASP7,caspase 7,81,cysteine-type endopeptidase activity|peptidase activity|cysteine-type peptidase activity|cysteine-type endopeptidase activity involved in execution phase of apoptosis|cysteine-type endopeptidase activity involved in apoptotic process,acute myeloid leukemia|vitiligo|breast cancer,ppi
2962,3493,841,CASP8,caspase 8,180,cysteine-type endopeptidase activity|peptidase activity|cysteine-type peptidase activity|cysteine-type endopeptidase activity involved in apoptotic process|cysteine-type endopeptidase activity involved in apoptotic signaling pathway|death effector domain binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|asthma|intrinsic asthma|allergic asthma|bipolar disorder|lung cancer|non-small cell lung carcinoma|cervical cancer|large intestine cancer|colorectal cancer|contact dermatitis|occupational dermatitis|diabetes mellitus|type 2 diabetes mellitus|dermatitis|congestive heart failure,ppi
2963,3497,9994,CASP8AP2,caspase 8 associated protein 2,23,transcription corepressor activity|death receptor binding|cysteine-type endopeptidase activator activity involved in apoptotic process|peptidase activator activity involved in apoptotic process|SUMO polymer binding,,ppi
2964,3503,842,CASP9,caspase 9,50,cysteine-type endopeptidase activity|enzyme activator activity|peptidase activity|SH3 domain binding|protein kinase binding|cysteine-type endopeptidase activity involved in apoptotic signaling pathway|cysteine-type endopeptidase activity involved in apoptotic process,brain ischemia|vertebrobasilar insufficiency|transient cerebral ischemia|congestive heart failure|central nervous system disease|nervous system disease|autonomic neuropathy|polyneuropathy|peripheral nervous system disease|neuropathy|prostate cancer|prostate carcinoma|retinal detachment,ppi
2965,3506,844,CASQ1,calsequestrin 1,2,calcium ion binding|identical protein binding,familial periodic paralysis|myopathy|fibromyalgia|myositis,ppi
2966,3508,845,CASQ2,calsequestrin 2,47,calcium ion binding|protein homodimerization activity|calcium-dependent protein binding,epilepsy|visual epilepsy|catecholaminergic polymorphic ventricular tachycardia|catecholaminergic polymorphic ventricular tachycardia 1|catecholaminergic polymorphic ventricular tachycardia 2|catecholaminergic polymorphic ventricular tachycardia 3|catecholaminergic polymorphic ventricular tachycardia 4|catecholaminergic polymorphic ventricular tachycardia 5|central nervous system origin vertigo,ppi
2967,3515,846,CASR,calcium sensing receptor,10,phosphatidylinositol phospholipase C activity|G-protein coupled receptor activity|calcium ion binding|amino acid binding|protein homodimerization activity,alopecia|anemia|macrocytic anemia|generalized anxiety disorder|anxiety disorder|sick sinus syndrome|calcium metabolism disease|nephrocalcinosis|calcinosis|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|hypercalcemia|phosphorus metabolism disease|hyperparathyroidism,ppi
2968,3517,144125,OR2AG1,olfactory receptor family 2 subfamily AG member 1 (gene/pseudogene),1,olfactory receptor activity,,ppi
2969,3520,831,CAST,calpastatin,46,RNA binding|endopeptidase inhibitor activity|calcium-dependent cysteine-type endopeptidase inhibitor activity|cadherin binding|protease binding,nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|hepatitis|angular cheilitis|cheilitis|lip disease,ppi
2970,3523,847,CAT,catalase,59,catalase activity|antioxidant activity|oxidoreductase activity; acting on peroxide as acceptor|heme binding|protein homodimerization activity|NADP binding,alcohol dependence|alcohol abuse|aortic disease|rheumatoid arthritis|asphyxia neonatorum|asthma|intrinsic asthma|allergic asthma|autistic disorder|Behcet's disease|lung cancer|non-small cell lung carcinoma|brain ischemia|diabetic ketoacidosis|diabetes mellitus|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6,ppi
2971,3527,283093,OR4C12,olfactory receptor family 4 subfamily C member 12,1,,,ppi
2972,3533,219983,OR4D6,olfactory receptor family 4 subfamily D member 6,2,,,ppi
2973,3536,219431,OR4S2,olfactory receptor family 4 subfamily S member 2,3,,,ppi
2974,3541,81285,OR51E2,olfactory receptor family 51 subfamily E member 2,9,steroid hormone receptor activity|olfactory receptor activity|signaling receptor activity,,ppi
2975,3566,120787,OR52W1,olfactory receptor family 52 subfamily W member 1,1,olfactory receptor activity,,ppi
2976,3576,857,CAV1,caveolin 1,211,patched binding|structural molecule activity|cholesterol binding|peptidase activator activity|protein-containing complex scaffold activity|inward rectifier potassium channel inhibitor activity|ion channel binding|protein kinase binding,acanthosis nigricans|hyperpituitarism|acromegaly|arthropathy|arthritis|atrial fibrillation|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types,ppi
2977,3577,858,CAV2,caveolin 2,15,protein homodimerization activity|protein kinase binding|structural molecule activity|protein-containing complex scaffold activity,rheumatoid arthritis|atrial fibrillation|open-angle glaucoma|prostate cancer|prostate carcinoma,ppi
2978,3583,859,CAV3,caveolin 3,55,calcium channel regulator activity|protein C-terminus binding|sodium channel regulator activity|potassium channel inhibitor activity|protein-containing complex scaffold activity|protein-containing complex binding|connexin binding|ion channel binding|structural molecule activity,sick sinus syndrome|congenital heart disease|congestive heart failure|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S,ppi
2979,3590,10367,MICU1,mitochondrial calcium uptake 1,27,calcium ion binding,basal ganglia disease|intellectual disability|learning disability|movement disease|lingual-facial-buccal dyskinesia|familial periodic paralysis|myopathy,ppi
2980,3594,390151,OR8H2,olfactory receptor family 8 subfamily H member 2,1,odorant binding|olfactory receptor activity,,ppi
2981,3611,862,RUNX1T1,RUNX1 translocation partner 1,65,transcription corepressor activity,acute myeloid leukemia|lung small cell carcinoma,ppi
2982,3620,9139,CBFA2T2,CBFA2/RUNX1 translocation partner 2,29,transcription corepressor activity,,ppi
2983,3623,863,CBFA2T3,CBFA2/RUNX1 translocation partner 3,27,transcription corepressor activity,,ppi
2984,3631,865,CBFB,core-binding factor beta subunit,42,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|transcription coactivator activity|DNA binding,isolated cleft palate|cleft palate|congenital heart disease|acute myeloid leukemia,ppi
2985,3633,866,SERPINA6,serpin family A member 6,9,serine-type endopeptidase inhibitor activity|steroid binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|fatty liver disease|hypertension|essential hypertension|liver cirrhosis,ppi
2986,3636,867,CBL,Cbl proto-oncogene,267,DNA-binding transcription factor activity|ubiquitin-protein transferase activity|cadherin binding|ubiquitin protein ligase activity|receptor tyrosine kinase binding|SH3 domain binding,aortic valve stenosis|ptosis|congenital ptosis|cryptorchidism|mitral valve insufficiency|mitral valve prolapse|vasculitis|capillary hemangioma|juvenile myelomonocytic leukemia,ppi
2987,3637,868,CBLB,Cbl proto-oncogene B,69,zinc ion binding|ubiquitin protein ligase activity|receptor tyrosine kinase binding|SH3 domain binding,multiple sclerosis,ppi
2988,3640,869,CBLN1,cerebellin 1 precursor,1,,,ppi
2989,3645,147381,CBLN2,cerebellin 2 precursor,1,,primary pulmonary hypertension|pulmonary hypertension,ppi
2990,3646,26121,PRPF31,pre-mRNA processing factor 31,157,RNA binding|U4 snRNA binding|U4atac snRNA binding|ribonucleoprotein complex binding,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
2991,3647,83660,TLN2,talin 2,31,actin binding|structural molecule activity,,ppi
2992,3648,27333,GOLIM4,golgi integral membrane protein 4,44,,,ppi
2993,3649,29124,LGALS13,galectin 13,13,,,ppi
2994,3650,10618,TGOLN2,trans-golgi network protein 2,71,,goiter|thyroid gland disease|mood disorder,ppi
2995,3651,51280,GOLM1,golgi membrane protein 1,41,,,ppi
2996,3652,64083,GOLPH3,golgi phosphoprotein 3,45,phosphatidylinositol-4-phosphate binding,,ppi
2997,3653,64746,ACBD3,acyl-CoA binding domain containing 3,35,,,ppi
2998,3654,8036,SHOC2,SHOC2; leucine rich repeat scaffold protein,16,protein phosphatase 1 binding|protein phosphatase regulator activity|protein phosphatase binding|protein serine/threonine phosphatase activity,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|hair disease|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain,ppi
2999,3655,51360,MBTPS2,membrane bound transcription factor peptidase; site 2,5,metalloendopeptidase activity,alopecia|blepharitis|isolated cleft palate|cleft palate|conjunctivitis|corneal dystrophy|corneal ulcer|cryptorchidism|sensorineural hearing loss|Clouston syndrome|ectropion|epilepsy|placental insufficiency|inguinal hernia|umbilical hernia|omphalocele|Hirschsprung's disease|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus,ppi
3000,3656,8720,MBTPS1,membrane bound transcription factor peptidase; site 1,18,metalloendopeptidase activity|serine-type endopeptidase activity,prostate cancer|prostate carcinoma|liver cancer|hepatocellular carcinoma,ppi
3001,3657,22953,P2RX2,purinergic receptor P2X 2,24,purinergic nucleotide receptor activity|extracellularly ATP-gated cation channel activity|ATP binding|ligand-gated ion channel activity|ATP-gated ion channel activity,sensorineural hearing loss|epilepsy|autosomal dominant nonsyndromic deafness 41,ppi
3002,3658,871,SERPINH1,serpin family H member 1,99,RNA binding|collagen binding|serine-type endopeptidase inhibitor activity,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia|inguinal hernia|ischemia,ppi
3003,3659,55799,CACNA2D3,calcium voltage-gated channel auxiliary subunit alpha2delta 3,1,voltage-gated calcium channel activity,,ppi
3004,3660,7873,MANF,mesencephalic astrocyte derived neurotrophic factor,11,RNA binding,pancreatic cancer,ppi
3005,3661,27309,ZNF330,zinc finger protein 330,4,metal ion binding,,ppi
3006,3662,81490,PTDSS2,phosphatidylserine synthase 2,7,transferase activity,,ppi
3007,3663,11005,SPINK5,serine peptidase inhibitor; Kazal type 5,2,serine-type endopeptidase inhibitor activity,acanthosis nigricans|hereditary angioedema|angioedema|asthma|intrinsic asthma|allergic asthma|dermatitis|epilepsy|intellectual disability|learning disability|prostate cancer|prostate carcinoma|visual epilepsy|autosomal recessive congenital ichthyosis 1|congenital ichthyosiform erythroderma|autosomal recessive congenital ichthyosis 2|autosomal recessive congenital ichthyosis 3|autosomal recessive congenital ichthyosis 4A|autosomal recessive congenital ichthyosis 5|autosomal recessive congenital ichthyosis 6,ppi
3008,3664,10243,GPHN,gephyrin,34,nitrate reductase activity|molybdopterin cofactor binding|molybdopterin molybdotransferase activity|molybdopterin adenylyltransferase activity,alcohol dependence|alcohol abuse|epilepsy|inguinal hernia|umbilical hernia|omphalocele|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|visual epilepsy|hyperekplexia 1|cocaine abuse|cocaine dependence,ppi
3009,3665,58189,WFDC1,WAP four-disulfide core domain 1,7,,melanoma|skin melanoma,ppi
3010,3666,83657,DYNLRB2,dynein light chain roadblock-type 2,9,microtubule motor activity|dynein intermediate chain binding,,ppi
3011,3667,83658,DYNLRB1,dynein light chain roadblock-type 1,34,microtubule motor activity|dynein intermediate chain binding,,ppi
3012,3668,9829,DNAJC6,DnaJ heat shock protein family (Hsp40) member C6,8,clathrin binding,dystonia|epilepsy|intellectual disability|learning disability|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|secondary Parkinson disease|Parkinson's disease,ppi
3013,3669,22826,DNAJC8,DnaJ heat shock protein family (Hsp40) member C8,36,,,ppi
3014,3670,64577,ALDH8A1,aldehyde dehydrogenase 8 family member A1,12,retinal dehydrogenase activity,,ppi
3015,3671,8854,ALDH1A2,aldehyde dehydrogenase 1 family member A2,5,retinal dehydrogenase activity|3-chloroallyl aldehyde dehydrogenase activity|retinal binding|aldehyde dehydrogenase (NAD) activity,myelomeningocele|arthropathy|arthritis|prostate cancer|prostate carcinoma|schizophrenia|secondary Parkinson disease,ppi
3016,3672,81629,TSSK3,testis specific serine kinase 3,21,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
3017,3673,50944,SHANK1,SH3 and multiple ankyrin repeat domains 1,18,protein C-terminus binding|SH3 domain binding|GKAP/Homer scaffold activity|somatostatin receptor binding|ionotropic glutamate receptor binding|identical protein binding|protein-containing complex binding|ankyrin repeat binding|scaffold protein binding|receptor signaling complex scaffold activity,anxiety disorder|phobic disorder|autistic disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|developmental coordination disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
3018,3675,8655,DYNLL1,dynein light chain LC8-type 1,234,ATP-dependent microtubule motor activity; plus-end-directed|dynein intermediate chain binding|dynein light intermediate chain binding,brain ischemia,ppi
3019,3676,80332,ADAM33,ADAM metallopeptidase domain 33,40,metalloendopeptidase activity|zinc ion binding,asthma,ppi
3020,3677,203102,ADAM32,ADAM metallopeptidase domain 32,21,,,ppi
3021,3678,873,CBR1,carbonyl reductase 1,50,carbonyl reductase (NADPH) activity|oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor|prostaglandin-E2 9-reductase activity,colon cancer|colonic benign neoplasm|prostate cancer|prostate carcinoma|irritant dermatitis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|liver cancer|hepatocellular carcinoma,ppi
3022,3679,81624,DIAPH3,diaphanous related formin 3,36,cadherin binding,autosomal dominant auditory neuropathy 1,ppi
3023,3680,89858,SIGLEC12,sialic acid binding Ig like lectin 12 (gene/pseudogene),11,,,ppi
3024,3681,51265,CDKL3,cyclin dependent kinase like 3,20,protein kinase activity|cyclin-dependent protein serine/threonine kinase activity,,ppi
3025,3682,10302,SNAPC5,small nuclear RNA activating complex polypeptide 5,15,,,ppi
3026,3683,51517,NCKIPSD,NCK interacting protein with SH3 domain,59,cytoskeletal protein binding,,ppi
3027,3684,81542,TMX1,thioredoxin related transmembrane protein 1,55,disulfide oxidoreductase activity,,ppi
3028,3685,51561,IL23A,interleukin 23 subunit alpha,7,interleukin-23 receptor binding,rheumatoid arthritis|pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
3029,3686,55422,ZNF331,zinc finger protein 331,58,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding,seborrheic keratosis|skin disease|actinic keratosis,ppi
3030,3687,874,CBR3,carbonyl reductase 3,19,carbonyl reductase (NADPH) activity|NADPH binding,,ppi
3031,3688,56172,ANKH,ANKH inorganic pyrophosphate transport regulator,2,inorganic phosphate transmembrane transporter activity|inorganic diphosphate transmembrane transporter activity,endometriosis of uterus|endometriosis|chondrocalcinosis|craniometaphyseal dysplasia,ppi
3032,3689,81563,C1orf21,chromosome 1 open reading frame 21,5,,,ppi
3033,3690,79168,LILRA6,leukocyte immunoglobulin like receptor A6,1,,,ppi
3034,3691,875,CBS,cystathionine-beta-synthase,70,cystathionine beta-synthase activity|oxygen binding|heme binding|pyridoxal phosphate binding|protein homodimerization activity|nitrite reductase (NO-forming) activity|carbon monoxide binding|nitric oxide binding|modified amino acid binding|S-adenosyl-L-methionine binding|cysteine synthase activity,suppression amblyopia|amblyopia|arteriovenous malformation|bipolar disorder|heart disease|cardiovascular system disease|brain ischemia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetes mellitus|type 2 diabetes mellitus|epilepsy|glaucoma|inguinal hernia|homocystinuria|hypertension,ppi
3035,3692,114823,LENG8,leukocyte receptor cluster member 8,41,,,ppi
3036,3693,79165,LENG1,leukocyte receptor cluster member 1,51,,,ppi
3037,3694,23547,LILRA4,leukocyte immunoglobulin like receptor A4,1,coreceptor activity,chronic lymphocytic leukemia|Richter's syndrome,ppi
3038,3695,55643,BTBD2,BTB domain containing 2,39,,,ppi
3039,3696,79143,MBOAT7,membrane bound O-acyltransferase domain containing 7,42,1-acylglycerol-3-phosphate O-acyltransferase activity|2-acylglycerol-3-phosphate O-acyltransferase activity|lysophospholipid acyltransferase activity,alcoholic liver cirrhosis,ppi
3040,3697,79042,TSEN34,tRNA splicing endonuclease subunit 34,15,tRNA-intron endonuclease activity,microcephaly|movement disease|lingual-facial-buccal dyskinesia|pontocerebellar hypoplasia type 2C|intellectual disability|learning disability,ppi
3041,3698,80324,PUS1,pseudouridylate synthase 1,49,tRNA binding|steroid receptor RNA activator RNA binding|RNA binding|pseudouridine synthase activity,stomach cancer|myopathy; lactic acidosis; and sideroblastic anemia,ppi
3042,3699,10951,CBX1,chromobox 1,138,chromatin binding,prostate cancer|prostate carcinoma,ppi
3043,3700,57216,VANGL2,VANGL planar cell polarity protein 2,35,,anencephaly|myelomeningocele|tethered spinal cord syndrome,ppi
3044,3701,81839,VANGL1,VANGL planar cell polarity protein 1,41,,,ppi
3045,3702,64754,SMYD3,SET and MYND domain containing 3,32,histone-lysine N-methyltransferase activity,,ppi
3046,3703,8301,PICALM,phosphatidylinositol binding clathrin assembly protein,100,1-phosphatidylinositol binding|phosphatidylinositol-4;5-bisphosphate binding|clathrin binding|clathrin heavy chain binding|clathrin adaptor activity|cadherin binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|acute myeloid leukemia,ppi
3047,3704,27237,ARHGEF16,Rho guanine nucleotide exchange factor 16,16,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|cadherin binding,,ppi
3048,3705,64131,XYLT1,xylosyltransferase 1,3,protein xylosyltransferase activity,keratosis follicularis|pseudoxanthoma elasticum|mongolian spot|substance abuse|substance-related disorder|Desbuquois dysplasia,ppi
3049,3706,64132,XYLT2,xylosyltransferase 2,14,magnesium ion binding|manganese ion binding|protein xylosyltransferase activity,keratosis follicularis|pseudoxanthoma elasticum|mongolian spot,ppi
3050,3707,51164,DCTN4,dynactin subunit 4,36,,primary biliary cirrhosis|cystic fibrosis|primary immunodeficiency disease|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|agammaglobulinemia|exocrine pancreatic insufficiency,ppi
3051,3708,23246,BOP1,block of proliferation 1,59,RNA binding|ribonucleoprotein complex binding,stomach cancer,ppi
3052,3709,84733,CBX2,chromobox 2,59,,46 XY gonadal dysgenesis,ppi
3053,3710,10161,LPAR6,lysophosphatidic acid receptor 6,57,G-protein coupled receptor activity,alopecia|hypotrichosis,ppi
3054,3711,30820,KCNIP1,potassium voltage-gated channel interacting protein 1,6,calcium ion binding|potassium channel regulator activity,,ppi
3055,3712,30819,KCNIP2,potassium voltage-gated channel interacting protein 2,10,A-type (transient outward) potassium channel activity|calcium ion binding|potassium channel regulator activity|ER retention sequence binding|voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,,ppi
3056,3713,30818,KCNIP3,potassium voltage-gated channel interacting protein 3,23,DNA binding|transcription corepressor activity|potassium channel regulator activity,,ppi
3057,3714,286530,P2RY8,purinergic receptor P2Y8,28,G-protein coupled receptor activity,acute lymphocytic leukemia,ppi
3058,3715,85474,LBX2,ladybird homeobox 2,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3059,3716,152831,KLB,klotho beta,2,Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|beta-glucosidase activity,,ppi
3060,3717,10668,CGRRF1,cell growth regulator with ring finger domain 1,34,,,ppi
3061,3718,22829,NLGN4Y,neuroligin 4; Y-linked,3,cell adhesion molecule binding|neurexin family protein binding|signaling receptor activity,,ppi
3062,3719,11335,CBX3,chromobox 3,168,,,ppi
3063,3720,56995,TULP4,tubby like protein 4,7,phosphatidylinositol binding,,ppi
3064,3721,10969,EBNA1BP2,EBNA1 binding protein 2,130,RNA binding,,ppi
3065,3722,83700,JAM3,junctional adhesion molecule 3,8,,,ppi
3066,3723,81848,SPRY4,sprouty RTK signaling antagonist 4,11,,acute myeloid leukemia|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|eunuchism|testicular cancer|seminoma|testicular germ cell cancer,ppi
3067,3724,83659,TEKT1,tektin 1,9,,,ppi
3068,3725,8535,CBX4,chromobox 4,129,transcription corepressor activity|SUMO transferase activity|SUMO binding,,ppi
3069,3727,83648,FAM167A,family with sequence similarity 167 member A,48,protein binding,,ppi
3070,3728,23468,CBX5,chromobox 5,207,protein binding; bridging|methylated histone binding|ribonucleoprotein complex binding|protein-containing complex binding|repressing transcription factor binding,,ppi
3071,3729,51742,ARID4B,AT-rich interaction domain 4B,34,DNA-binding transcription factor activity; RNA polymerase II-specific|histone deacetylase activity|transcription regulatory region DNA binding,salivary gland adenoid cystic carcinoma,ppi
3072,3730,84639,IL1F10,interleukin 1 family member 10 (theta),2,cytokine activity|interleukin-1 receptor binding,,ppi
3073,3733,400916,CHCHD10,coiled-coil-helix-coiled-coil-helix domain containing 10,68,,progressive muscular atrophy|amyotrophic lateral sclerosis|FTDALS2,ppi
3074,3734,23466,CBX6,chromobox 6,94,,,ppi
3075,3735,26525,IL36RN,interleukin 36 receptor antagonist,16,cytokine activity|interleukin-1 receptor binding,pustulosis of palm and sole|psoriasis|parapsoriasis|granuloma annulare|impetigo herpetiformis|skin disease,ppi
3076,3736,27179,IL36A,interleukin 36; alpha,11,interleukin-1 receptor binding|cytokine activity,,ppi
3077,3737,27178,IL37,interleukin 37,10,interleukin-1 receptor binding|cytokine activity,,ppi
3078,3738,27177,IL36B,interleukin 36; beta,1,interleukin-1 receptor binding|cytokine activity,,ppi
3079,3739,84109,QRFPR,pyroglutamylated RFamide peptide receptor,1,G-protein coupled receptor activity,,ppi
3080,3740,80895,ILKAP,ILK associated serine/threonine phosphatase,55,,,ppi
3081,3741,83699,SH3BGRL2,SH3 domain binding glutamate rich protein like 2,5,,,ppi
3082,3742,83442,SH3BGRL3,SH3 domain binding glutamate rich protein like 3,7,,,ppi
3083,3743,26256,CABYR,calcium binding tyrosine phosphorylation regulated,4,calcium ion binding|SH3 domain binding|protein heterodimerization activity,large intestine cancer|colorectal cancer,ppi
3084,3744,23492,CBX7,chromobox 7,38,,multiple myeloma,ppi
3085,3745,246777,SPESP1,sperm equatorial segment protein 1,1,,,ppi
3086,3747,26040,SETBP1,SET binding protein 1,11,DNA-binding transcription factor activity; RNA polymerase II-specific,ptosis|congenital ptosis|clubfoot|epilepsy|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|hydronephrosis|hypertrichosis|communication disorder|acute myeloid leukemia|lymphoblastic leukemia,ppi
3087,3748,9821,RB1CC1,RB1 inducible coiled-coil 1,95,protein-containing complex scaffold activity|protein kinase binding,schizophrenia|breast cancer|breast carcinoma,ppi
3088,3749,140469,MYO3B,myosin IIIB,7,,,ppi
3089,3750,83481,EPPK1,epiplakin 1,71,RNA binding|keratin filament binding|structural molecule activity,,ppi
3090,3751,85021,REPS1,RALBP1 associated Eps domain containing 1,47,,,ppi
3091,3752,81603,TRIM8,tripartite motif containing 8,81,zinc ion binding,,ppi
3092,3753,9659,PDE4DIP,phosphodiesterase 4D interacting protein,138,enzyme binding|protein-containing complex scaffold activity,,ppi
3093,3754,83741,TFAP2D,transcription factor AP-2 delta,1,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
3094,3755,94025,MUC16,mucin 16; cell surface associated,7,,proteinuria|ovarian cancer,ppi
3095,3757,84958,SYTL1,synaptotagmin like 1,6,neurexin family protein binding,,ppi
3096,3758,54843,SYTL2,synaptotagmin like 2,12,phosphatidylserine binding|phosphatidylinositol-4;5-bisphosphate binding|phosphatase binding|neurexin family protein binding,,ppi
3097,3759,64101,LRRC4,leucine rich repeat containing 4,12,,,ppi
3098,3760,94120,SYTL3,synaptotagmin like 3,4,,,ppi
3099,3761,94121,SYTL4,synaptotagmin like 4,20,phospholipid binding|neurexin family protein binding,,ppi
3100,3762,94122,SYTL5,synaptotagmin like 5,6,,,ppi
3101,3763,22899,ARHGEF15,Rho guanine nucleotide exchange factor 15,9,Rho guanyl-nucleotide exchange factor activity,,ppi
3102,3764,26039,SS18L1,SS18L1; nBAF chromatin remodeling complex subunit,41,,,ppi
3103,3765,51188,SS18L2,SS18 like 2,11,,,ppi
3104,3766,51163,DBR1,debranching RNA lariats 1,12,RNA binding|RNA lariat debranching enzyme activity,progressive muscular atrophy|amyotrophic lateral sclerosis,ppi
3105,3767,84561,SLC12A8,solute carrier family 12 member 8,1,potassium:chloride symporter activity,,ppi
3106,3768,84343,HPS3,HPS3; biogenesis of lysosomal organelles complex 2 subunit 1,9,,Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome 3,ppi
3107,3769,57817,HAMP,hepcidin antimicrobial peptide,3,,alcohol dependence|alcohol abuse|anemia|macrocytic anemia|beta thalassemia|biliary atresia|iron metabolism disease|hemochromatosis|Wilson disease|chronic kidney disease,ppi
3108,3770,84085,FBXO30,F-box protein 30,25,ubiquitin-protein transferase activity,,ppi
3109,3771,8631,SKAP1,src kinase associated phosphoprotein 1,93,SH3/SH2 adaptor activity|SH3 domain binding|SH2 domain binding,ovarian cancer,ppi
3110,3772,8649,LAMTOR3,late endosomal/lysosomal adaptor; MAPK and MTOR activator 3,83,guanyl-nucleotide exchange factor activity|protein-containing complex scaffold activity,,ppi
3111,3773,8874,ARHGEF7,Rho guanine nucleotide exchange factor 7,57,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
3112,3774,9221,NOLC1,nucleolar and coiled-body phosphoprotein 1,119,RNA polymerase I core binding|RNA binding,,ppi
3113,3775,89790,SIGLEC10,sialic acid binding Ig like lectin 10,9,SH2 domain binding,,ppi
3114,3776,340146,SLC35D3,solute carrier family 35 member D3,3,,,ppi
3115,3777,114132,SIGLEC11,sialic acid binding Ig like lectin 11,3,sialic acid binding,,ppi
3116,3778,84449,ZNF333,zinc finger protein 333,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3117,3779,51594,NBAS,neuroblastoma amplified sequence,22,SNARE binding,Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|enophthalmos|orbital disease|exophthalmos|optic atrophy|stomach cancer|craniosynostosis,ppi
3118,3780,9103,FCGR2C,Fc fragment of IgG receptor IIc (gene/pseudogene),9,transmembrane signaling receptor activity,thrombocytopenia|autoimmune thrombocytopenic purpura|Evans' syndrome|blood coagulation disease,ppi
3119,3781,10678,B3GNT2,UDP-GlcNAc:betaGal beta-1;3-N-acetylglucosaminyltransferase 2,29,UDP-galactose:beta-N-acetylglucosamine beta-1;3-galactosyltransferase activity|N-acetyllactosaminide beta-1;3-N-acetylglucosaminyltransferase activity|acetylgalactosaminyltransferase activity,rheumatoid arthritis|Graves' disease|thyrotoxicosis|hyperthyroidism|schizophrenia,ppi
3120,3782,10915,TCERG1,transcription elongation regulator 1,90,transcription coactivator activity|transcription corepressor activity|RNA binding|RNA polymerase binding,,ppi
3121,3783,51284,TLR7,toll like receptor 7,5,double-stranded RNA binding|single-stranded RNA binding|siRNA binding|signaling pattern recognition receptor activity,neurotic disorder|endogenous depression|melancholia|allergic contact dermatitis|major depressive disorder|mental depression,ppi
3122,3784,51311,TLR8,toll like receptor 8,2,DNA binding|RNA binding|double-stranded RNA binding|single-stranded RNA binding|signaling receptor activity|signaling pattern recognition receptor activity,contact dermatitis|occupational dermatitis,ppi
3123,3785,54106,TLR9,toll like receptor 9,25,1-phosphatidylinositol-3-kinase activity|siRNA binding|protein homodimerization activity|unmethylated CpG binding|signaling pattern recognition receptor activity,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|pseudosarcomatous fibromatosis|skin disease|intestinal schistosomiasis,ppi
3124,3786,81793,TLR10,toll like receptor 10,11,transmembrane signaling receptor activity,,ppi
3125,3787,883,KYAT1,kynurenine aminotransferase 1,11,transaminase activity|kynurenine-oxoglutarate transaminase activity|L-phenylalanine:pyruvate aminotransferase activity|cysteine-S-conjugate beta-lyase activity|L-glutamine:pyruvate aminotransferase activity,kidney cancer|neurotic disorder|endogenous depression|melancholia|mental depression|major depressive disorder,ppi
3126,3788,55975,KLHL7,kelch like family member 7,18,protein homodimerization activity,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|cold-induced sweating syndrome|retinitis pigmentosa 42,ppi
3127,3789,1238,ACKR2,atypical chemokine receptor 2,17,chemokine receptor activity|scavenger receptor activity|chemokine binding|C-C chemokine binding|C-C chemokine receptor activity,,ppi
3128,3790,29785,CYP2S1,cytochrome P450 family 2 subfamily S member 1,36,retinoic acid 4-hydroxylase activity|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|heme binding,pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
3129,3792,11055,ZPBP,zona pellucida binding protein,3,,,ppi
3130,3793,56886,UGGT1,UDP-glucose glycoprotein glucosyltransferase 1,61,UDP-glucose:glycoprotein glucosyltransferase activity|unfolded protein binding,,ppi
3131,3794,55757,UGGT2,UDP-glucose glycoprotein glucosyltransferase 2,13,UDP-glucose:glycoprotein glucosyltransferase activity|unfolded protein binding,,ppi
3132,3795,136319,MTPN,myotrophin,45,,,ppi
3133,3797,84807,NFKBID,NFKB inhibitor delta,8,,,ppi
3134,3798,79796,ALG9,ALG9; alpha-1;2-mannosyltransferase,34,alpha-1;2-mannosyltransferase activity|mannosyltransferase activity,congenital disorder of glycosylation type I,ppi
3135,3799,55023,PHIP,pleckstrin homology domain interacting protein,28,insulin receptor binding|lysine-acetylated histone binding,Sjogren's syndrome|keratoconjunctivitis sicca,ppi
3136,3800,23648,SSBP3,single stranded DNA binding protein 3,34,RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
3137,3801,170463,SSBP4,single stranded DNA binding protein 4,22,RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
3138,3802,80351,TNKS2,tankyrase 2,50,NAD+ ADP-ribosyltransferase activity,,ppi
3139,3803,29970,SCHIP1,schwannomin interacting protein 1,48,,,ppi
3140,3804,83992,CTTNBP2,cortactin binding protein 2,30,,coronary artery disease,ppi
3141,3805,881,CCIN,calicin,2,,,ppi
3142,3806,51332,SPTBN5,spectrin beta; non-erythrocytic 5,3,actin binding|Ras guanyl-nucleotide exchange factor activity|kinesin binding|spectrin binding|myosin tail binding|dynactin binding|protein self-association|dynein intermediate chain binding,,ppi
3143,3807,80012,PHC3,polyhomeotic homolog 3,30,,,ppi
3144,3808,79369,B3GNT4,UDP-GlcNAc:betaGal beta-1;3-N-acetylglucosaminyltransferase 4,2,UDP-galactose:beta-N-acetylglucosamine beta-1;3-galactosyltransferase activity|N-acetyllactosaminide beta-1;3-N-acetylglucosaminyltransferase activity|acetylgalactosaminyltransferase activity,,ppi
3145,3809,84002,B3GNT5,UDP-GlcNAc:betaGal beta-1;3-N-acetylglucosaminyltransferase 5,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1;3-acetylglucosaminyltransferase activity|UDP-galactose:beta-N-acetylglucosamine beta-1;3-galactosyltransferase activity|acetylgalactosaminyltransferase activity|N-acetyllactosaminide beta-1;3-N-acetylglucosaminyltransferase activity,,ppi
3146,3810,11041,B4GAT1,beta-1;4-glucuronyltransferase 1,45,N-acetyllactosaminide beta-1;3-N-acetylglucosaminyltransferase activity|glucuronosyltransferase activity,Dandy-Walker syndrome|epilepsy|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L,ppi
3147,3811,8935,SKAP2,src kinase associated phosphoprotein 2,19,SH3/SH2 adaptor activity,,ppi
3148,3812,885,CCK,cholecystokinin,6,hormone activity|neuropeptide hormone activity,alcohol dependence|alcohol abuse|gastroenteritis|intestinal disease|gastrointestinal system disease|proctitis|gallbladder disease|liver disease|acute pancreatitis|pancreatitis|schizophrenia|epilepsy|visual epilepsy|gastric ulcer|toxic encephalopathy|Wernicke-Korsakoff syndrome|bipolar disorder,ppi
3149,3813,55585,UBE2Q1,ubiquitin conjugating enzyme E2 Q1,20,ubiquitin conjugating enzyme activity,,ppi
3150,3814,886,CCKAR,cholecystokinin A receptor,3,cholecystokinin receptor activity,alcohol dependence|alcohol abuse|bipolar disorder|gallbladder cancer|schizophreniform disorder|schizoaffective disorder|schizophrenia|paranoid schizophrenia|delusional disorder|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
3151,3815,85313,PPIL4,peptidylprolyl isomerase like 4,24,RNA binding,,ppi
3152,3816,54509,RHOF,ras homolog family member F; filopodia associated,13,GTPase activity|protein kinase binding|GTP binding,,ppi
3153,3818,887,CCKBR,cholecystokinin B receptor,19,cholecystokinin receptor activity|gastrin receptor activity|type B gastrin/cholecystokinin receptor binding|1-phosphatidylinositol-3-kinase regulator activity,obsessive-compulsive disorder|panic disorder|cocaine abuse|cocaine dependence,ppi
3154,3819,11155,LDB3,LIM domain binding 3,15,,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
3155,3820,51433,ANAPC5,anaphase promoting complex subunit 5,70,ubiquitin protein ligase activity,,ppi
3156,3821,10128,LRPPRC,leucine rich pentatricopeptide repeat containing,135,RNA binding|microtubule binding|beta-tubulin binding|actin filament binding,lactic acidosis|cerebellar disease|hypertrichosis|hyperglycemia|hypoglycemia|ophthalmoplegia|mechanical strabismus|hypertropia|Leigh disease,ppi
3157,3822,55201,MAP1S,microtubule associated protein 1S,41,DNA binding|microtubule binding|tubulin binding|beta-tubulin binding|actin filament binding|deoxyribonuclease activity|actin binding,,ppi
3158,3823,23593,HEBP2,heme binding protein 2,6,heme binding,liver cancer,ppi
3159,3824,50628,GEMIN4,gem nuclear organelle associated protein 4,91,,alcohol dependence|alcohol abuse|schizophrenia,ppi
3160,3825,147495,APCDD1,APC down-regulated 1,6,Wnt-protein binding,hypotrichosis,ppi
3161,3826,84033,OBSCN,obscurin; cytoskeletal calmodulin and titin-interacting RhoGEF,25,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|structural constituent of muscle,,ppi
3162,3827,29966,STRN3,striatin 3,82,calmodulin binding|protein-containing complex binding|protein phosphatase 2A binding|armadillo repeat domain binding,,ppi
3163,3828,29888,STRN4,striatin 4,100,calmodulin binding|protein-containing complex binding|protein phosphatase 2A binding|armadillo repeat domain binding,,ppi
3164,3829,93979,CPA5,carboxypeptidase A5,13,metallocarboxypeptidase activity,,ppi
3165,3831,889,KRIT1,KRIT1; ankyrin repeat containing,18,phosphatidylinositol-4;5-bisphosphate binding|microtubule binding|GTPase regulator activity|protein-containing complex binding,epilepsy|visual epilepsy|skin disease|seborrheic keratosis|actinic keratosis,ppi
3166,3834,55243,KIRREL,kin of IRRE like (Drosophila),25,,,ppi
3167,3835,283987,HID1,HID1 domain containing,9,,,ppi
3168,3836,9182,RASSF9,Ras association domain family member 9,36,transporter activity,,ppi
3169,3837,51200,CPA4,carboxypeptidase A4,23,metallocarboxypeptidase activity,,ppi
3170,3838,56300,IL36G,interleukin 36; gamma,6,interleukin-1 receptor binding|cytokine activity,,ppi
3171,3839,114625,ERMAP,erythroblast membrane associated protein (Scianna blood group),15,signaling receptor binding,,ppi
3172,3840,10953,TOMM34,translocase of outer mitochondrial membrane 34,43,,,ppi
3173,3841,23627,PRND,prion protein 2 (dublet),1,copper ion binding,,ppi
3174,3842,51297,BPIFA1,BPI fold containing family A member 1,12,,,ppi
3175,3843,11034,DSTN,destrin; actin depolymerizing factor,102,actin filament binding,,ppi
3176,3844,63908,NAPB,NSF attachment protein beta,19,soluble NSF attachment protein activity|syntaxin binding,,ppi
3177,3845,10398,MYL9,myosin light chain 9,18,structural constituent of muscle,vascular disease|brain edema,ppi
3178,3846,27111,SDCBP2,syndecan binding protein 2,42,phosphatidylinositol-4;5-bisphosphate binding|protein homodimerization activity,,ppi
3179,3847,55423,SIRPG,signal regulatory protein gamma,4,,,ppi
3180,3848,11047,ADRM1,adhesion regulating molecule 1,79,endopeptidase activator activity|proteasome binding|ubiquitin binding,,ppi
3181,3850,9885,OSBPL2,oxysterol binding protein like 2,11,sterol transporter activity|cholesterol binding|sterol binding|lipid binding,sensorineural hearing loss,ppi
3182,3851,51340,CRNKL1,crooked neck pre-mRNA splicing factor 1,64,RNA binding,,ppi
3183,3852,10621,POLR3F,RNA polymerase III subunit F,42,double-stranded DNA binding|DNA-directed 5'-3' RNA polymerase activity|RNA polymerase III activity,,ppi
3184,3853,60436,TGIF2,TGFB induced factor homeobox 2,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
3185,3854,27304,MOCS3,molybdenum cofactor synthesis 3,21,thiosulfate sulfurtransferase activity|nucleotidyltransferase activity|sulfurtransferase activity|URM1 activating enzyme activity,,ppi
3186,3855,23394,ADNP,activity dependent neuroprotector homeobox,56,DNA-binding transcription factor activity; RNA polymerase II-specific,autistic disorder|ptosis|congenital ptosis|hyperopia|communication disorder|language disorder|intellectual disability|learning disability|obesity|obsessive-compulsive disorder|schizophrenia|stereotypic movement disorder|ophthalmoplegia|mechanical strabismus|hypertropia|blindness|autosomal dominant non-syndromic intellectual disability,ppi
3187,3856,10979,FERMT2,fermitin family member 2,61,phosphatidylinositol-3;4;5-trisphosphate binding,urinary bladder cancer|angle-closure glaucoma|primary angle-closure glaucoma|chronic closed-angle glaucoma,ppi
3188,3857,11054,OGFR,opioid growth factor receptor,19,opioid receptor activity,,ppi
3189,3859,8900,CCNA1,cyclin A1,84,protein kinase binding|protein kinase activity|cyclin-dependent protein serine/threonine kinase regulator activity,head and neck squamous cell carcinoma|liver cancer|hepatocellular carcinoma,ppi
3190,3860,57829,ZP4,zona pellucida glycoprotein 4,1,,,ppi
3191,3861,56265,CPXM1,carboxypeptidase X; M14 family member 1,2,metallocarboxypeptidase activity,,ppi
3192,3862,10565,ARFGEF1,ADP ribosylation factor guanine nucleotide exchange factor 1,29,guanyl-nucleotide exchange factor activity|protein kinase A regulatory subunit binding|GTPase activator activity|ARF guanyl-nucleotide exchange factor activity,,ppi
3193,3863,85509,MBD3L1,methyl-CpG binding domain protein 3 like 1,24,methyl-CpG binding,,ppi
3194,3864,890,CCNA2,cyclin A2,122,cyclin-dependent protein kinase activity|cyclin-dependent protein serine/threonine kinase regulator activity|protein kinase activity|protein kinase binding,schizophrenia|intellectual disability|learning disability,ppi
3195,3867,9824,ARHGAP11A,Rho GTPase activating protein 11A,18,GTPase activator activity,,ppi
3196,3868,54986,ULK4,unc-51 like kinase 4,4,,bipolar disorder|multiple myeloma|schizophrenia,ppi
3197,3869,85329,LGALS12,galectin 12,3,lactose binding,,ppi
3198,3870,23173,METAP1,methionyl aminopeptidase 1,15,aminopeptidase activity|metalloexopeptidase activity,,ppi
3199,3871,891,CCNB1,cyclin B1,165,cyclin-dependent protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase activator activity|protein kinase binding|cyclin-dependent protein serine/threonine kinase regulator activity|protein kinase activity|histone kinase activity,polycystic ovary syndrome,ppi
3200,3872,128869,PIGU,phosphatidylinositol glycan anchor biosynthesis class U,28,GPI-anchor transamidase activity|GPI anchor binding,,ppi
3201,3873,80336,PABPC1L,poly(A) binding protein cytoplasmic 1 like,6,mRNA 3'-UTR binding|poly(U) RNA binding|RNA binding|poly(A) binding,,ppi
3202,3874,63905,MANBAL,mannosidase beta like,5,protein binding,,ppi
3203,3875,9133,CCNB2,cyclin B2,36,cyclin-dependent protein serine/threonine kinase activity|cadherin binding|cyclin-dependent protein serine/threonine kinase regulator activity|protein kinase binding|protein kinase activity,,ppi
3204,3876,140628,GATA5,GATA binding protein 5,3,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding|obsolete transcription factor activity; RNA polymerase II transcription factor binding|RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,large intestine cancer|colorectal cancer|ventricular septal defect|tetralogy of Fallot|familial atrial fibrillation,ppi
3205,3877,63926,ANKEF1,ankyrin repeat and EF-hand domain containing 1,4,,,ppi
3206,3878,58495,OVOL2,ovo like zinc finger 2,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,pilomatrixoma|hair follicle neoplasm|posterior polymorphous corneal dystrophy|posterior polymorphous corneal dystrophy 1,ppi
3207,3880,55713,ZNF334,zinc finger protein 334,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3208,3881,63925,ZNF335,zinc finger protein 335,15,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region DNA binding,,ppi
3209,3882,64412,GZF1,GDNF inducible zinc finger protein 1,14,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|distal enhancer DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
3210,3883,26152,ZNF337,zinc finger protein 337,9,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3211,3884,892,CCNC,cyclin C,83,protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase regulator activity,,ppi
3212,3885,85395,FAM207A,family with sequence similarity 207 member A,20,,,ppi
3213,3887,55902,ACSS2,acyl-CoA synthetase short-chain family member 2,5,acetate-CoA ligase activity|AMP binding,,ppi
3214,3888,54505,DHX29,DExH-box helicase 29,27,RNA binding|ribosomal small subunit binding|cadherin binding|ATP-dependent 3'-5' RNA helicase activity,,ppi
3215,3889,55544,RBM38,RNA binding motif protein 38,7,RNA binding|mRNA 3'-UTR binding|mRNA binding,,ppi
3216,3890,27063,ANKRD1,ankyrin repeat domain 1,20,DNA binding|transcription coactivator activity|transcription corepressor activity|RNA polymerase II sequence-specific DNA-binding transcription factor binding|titin binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
3217,3891,595,CCND1,cyclin D1,121,transcription corepressor activity|cyclin-dependent protein serine/threonine kinase activity|proline-rich region binding|cyclin-dependent protein serine/threonine kinase regulator activity|protein kinase activity|protein kinase binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|anemia|macrocytic anemia|bone marrow disease|brain cancer|tongue squamous cell carcinoma|squamous cell carcinoma|transitional cell carcinoma|cecal benign neoplasm|cecum cancer|cervical cancer|colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|salivary gland adenoid cystic carcinoma,ppi
3218,3892,55074,OXR1,oxidation resistance 1,10,,,ppi
3219,3893,64344,HIF3A,hypoxia inducible factor 3 alpha subunit,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3220,3895,51655,RASD1,ras related dexamethasone induced 1,12,,prostate cancer|prostate carcinoma,ppi
3221,3896,79071,ELOVL6,ELOVL fatty acid elongase 6,1,fatty acid elongase activity,congestive heart failure,ppi
3222,3897,894,CCND2,cyclin D2,26,protein kinase binding|cyclin-dependent protein serine/threonine kinase regulator activity|protein kinase activity,colon cancer|colonic benign neoplasm|diabetes mellitus|type 2 diabetes mellitus|epilepsy|ventricular septal defect|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|acute myeloid leukemia|mitral valve insufficiency|mitral valve prolapse|prostate cancer|prostate carcinoma|schizophrenia|visual epilepsy|coronary artery disease|ovarian cancer,ppi
3223,3898,116039,OSR2,odd-skipped related transciption factor 2,3,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,endometriosis of uterus|endometriosis,ppi
3224,3899,23635,SSBP2,single stranded DNA binding protein 2,26,single-stranded DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,prostate cancer|prostate carcinoma,ppi
3225,3900,26580,BSCL2,BSCL2; seipin lipid droplet biogenesis associated,37,,acanthosis nigricans|hyperpituitarism|acromegaly|acute pancreatitis|pancreatitis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|diabetic ketoacidosis|diabetes mellitus|lipoatrophic diabetes|lipodystrophy|dystonia|epilepsy|umbilical hernia|omphalocele|hypertrichosis|Zollinger-Ellison syndrome|hyperinsulinism,ppi
3226,3901,116154,PHACTR3,phosphatase and actin regulator 3,29,,,ppi
3227,3903,55661,DDX27,DEAD-box helicase 27,87,RNA binding,,ppi
3228,3904,9757,KMT2B,lysine methyltransferase 2B,44,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K4 specific),liver cancer|hepatocellular carcinoma,ppi
3229,3905,55914,ERBIN,erbb2 interacting protein,107,ErbB-2 class receptor binding|structural constituent of cytoskeleton,salivary gland adenoid cystic carcinoma,ppi
3230,3906,89781,HPS4,HPS4; biogenesis of lysosomal organelles complex 3 subunit 2,2,guanyl-nucleotide exchange factor activity,schizophrenia|Hermansky-Pudlak syndrome 1,ppi
3231,3907,114299,PALM2,paralemmin 2,16,,,ppi
3232,3908,54873,PALMD,palmdelphin,8,,,ppi
3233,3909,83758,RBP5,retinol binding protein 5,4,retinoid binding,,ppi
3234,3910,23157,SEPT6,septin 6,39,GTP binding|protein-containing complex scaffold activity|GTPase activity,,ppi
3235,3911,896,CCND3,cyclin D3,54,cyclin-dependent protein serine/threonine kinase regulator activity|protein kinase binding|protein kinase activity,,ppi
3236,3912,26051,PPP1R16B,protein phosphatase 1 regulatory subunit 16B,32,protein phosphatase regulator activity,,ppi
3237,3913,63941,NECAB3,N-terminal EF-hand calcium binding protein 3,7,,,ppi
3238,3914,55738,ARFGAP1,ADP ribosylation factor GTPase activating protein 1,68,GTPase activator activity,central nervous system disease|nervous system disease|autonomic neuropathy,ppi
3239,3915,10564,ARFGEF2,ADP ribosylation factor guanine nucleotide exchange factor 2,45,guanyl-nucleotide exchange factor activity|ARF guanyl-nucleotide exchange factor activity|protein kinase A regulatory subunit binding|GABA receptor binding,epilepsy|intellectual disability|learning disability|visual epilepsy|syndromic X-linked intellectual disability 94|locked-in syndrome|quadriplegia|infantile epileptic encephalopathy|periventricular nodular heterotopia,ppi
3240,3916,22903,BTBD3,BTB domain containing 3,5,,,ppi
3241,3917,22918,CD93,CD93 molecule,36,complement component C1q binding|signaling receptor activity,,ppi
3242,3918,27296,TP53TG5,TP53 target 5,5,,,ppi
3243,3919,54994,GID8,GID complex subunit 8 homolog,48,,,ppi
3244,3920,55184,DZANK1,double zinc ribbon and ankyrin repeat domains 1,5,,,ppi
3245,3921,55617,TASP1,taspase 1,3,threonine-type endopeptidase activity|hydrolase activity|beta-aspartyl-peptidase activity|asparaginase activity,,ppi
3246,3922,24148,PRPF6,pre-mRNA processing factor 6,114,transcription coactivator activity|RNA binding|ribonucleoprotein complex binding,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|blindness,ppi
3247,3923,60625,DHX35,DEAH-box helicase 35,25,RNA binding|ATP-dependent 3'-5' RNA helicase activity,,ppi
3248,3924,54498,SMOX,spermine oxidase,6,polyamine oxidase activity|spermine:oxygen oxidoreductase (spermidine-forming) activity|oxidoreductase activity,cerebral infarction|cerebrovascular disease|mood disorder,ppi
3249,3925,10616,RBCK1,RANBP2-type and C3HC4-type zinc finger containing 1,95,ubiquitin-protein transferase activity|ubiquitin binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
3250,3926,55857,KIZ,kizuna centrosomal protein,13,,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
3251,3927,55257,MRGBP,MRG domain binding protein,67,,,ppi
3252,3928,54915,YTHDF1,YTH N6-methyladenosine RNA binding protein 1,62,RNA binding|ribosome binding|N6-methyladenosine-containing RNA binding,,ppi
3253,3929,26090,ABHD12,abhydrolase domain containing 12,10,lysophospholipase activity|acylglycerol lipase activity,sensorineural hearing loss|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|polyneuropathy|peripheral nervous system disease|neuropathy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy,ppi
3254,3930,55614,KIF16B,kinesin family member 16B,12,phosphatidylinositol-3;4;5-trisphosphate binding|ATP-dependent microtubule motor activity; plus-end-directed|phosphatidylinositol-3-phosphate binding|phosphatidylinositol-3;4-bisphosphate binding|phosphatidylinositol-3;5-bisphosphate binding|microtubule binding|microtubule motor activity|ATPase activity,,ppi
3255,3931,23582,CCNDBP1,cyclin D1 binding protein 1,89,,,ppi
3256,3932,55969,C20orf24,chromosome 20 open reading frame 24,55,,,ppi
3257,3934,54976,C20orf27,chromosome 20 open reading frame 27,10,,,ppi
3258,3935,25876,SPEF1,sperm flagellar 1,3,microtubule binding,,ppi
3259,3936,55317,AP5S1,adaptor related protein complex 5 sigma 1 subunit,2,,,ppi
3260,3937,29058,TMEM230,transmembrane protein 230,11,,Parkinson's disease,ppi
3261,3938,55741,EDEM2,ER degradation enhancing alpha-mannosidase like protein 2,45,mannosyl-oligosaccharide 1;2-alpha-mannosidase activity,schizophrenia,ppi
3262,3939,57091,CASS4,Cas scaffolding protein family member 4,4,,,ppi
3263,3940,56259,CTNNBL1,catenin beta like 1,64,,,ppi
3264,3941,51654,CDK5RAP1,CDK5 regulatory subunit associated protein 1,19,protein kinase binding|4 iron; 4 sulfur cluster binding,,ppi
3265,3942,55861,DBNDD2,dysbindin domain containing 2,6,,,ppi
3266,3943,55251,PCMTD2,protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2,16,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,,ppi
3267,3944,79953,SYNDIG1,synapse differentiation inducing 1,3,glutamate receptor binding|protein homodimerization activity,mental depression,ppi
3268,3945,25980,AAR2,AAR2 splicing factor homolog,28,,,ppi
3269,3946,149986,LSM14B,LSM family member 14B,21,RNA binding,,ppi
3270,3947,51750,RTEL1,regulator of telomere elongation helicase 1,47,ATP-dependent DNA helicase activity|ATP binding|DNA polymerase binding,anemia|macrocytic anemia|blood coagulation disease|dental caries|placental insufficiency|gingival disease|epulis|malignant glioma|gliosarcoma|mixed glioma|hemorrhagic disease|tooth agenesis|anodontia|primary immunodeficiency disease|leukopenia|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|intellectual disability|learning disability|periodontal disease,ppi
3271,3948,55612,FERMT1,fermitin family member 1,16,,angular cheilitis|cheilitis|lip disease|colitis|ileitis|ileocolitis|gastroenteritis|dental caries|dermatitis|esophagitis|peptic esophagitis|gastroesophageal reflux disease|gingival disease|epulis|gingivitis|ichthyosis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|hereditary mucosal leukokeratosis|oral mucosa leukoplakia,ppi
3272,3949,898,CCNE1,cyclin E1,82,transcription coactivator activity|cyclin-dependent protein serine/threonine kinase activity|androgen receptor binding|cyclin-dependent protein serine/threonine kinase regulator activity|protein kinase activity|protein kinase binding,urinary bladder cancer|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|ovarian cancer|breast cancer|liver cancer|hepatocellular carcinoma,ppi
3273,3950,51507,RTFDC1,replication termination factor 2 domain containing 1,20,,,ppi
3274,3951,55245,UQCC1,ubiquinol-cytochrome c reductase complex assembly factor 1,27,,,ppi
3275,3952,51012,PRELID3B,PRELI domain containing 3B,6,phosphatidic acid transporter activity,,ppi
3276,3953,55321,TMEM74B,transmembrane protein 74B,1,,,ppi
3277,3954,80025,PANK2,pantothenate kinase 2,14,pantothenate kinase activity,neurodegeneration with brain iron accumulation|neurodegeneration with brain iron accumulation 2a|neurodegeneration with brain iron accumulation 2b|neurodegeneration with brain iron accumulation 3|neurodegeneration with brain iron accumulation 4|neurodegeneration with brain iron accumulation 5|neurodegeneration with brain iron accumulation 6|pantothenate kinase-associated neurodegeneration|schizophrenia|neurodegenerative disease,ppi
3278,3956,51575,ESF1,ESF1 nucleolar pre-rRNA processing protein homolog,29,RNA binding,,ppi
3279,3957,79133,NDUFAF5,NADH:ubiquinone oxidoreductase complex assembly factor 5,35,,Leigh disease|mitochondrial complex I deficiency,ppi
3280,3958,9134,CCNE2,cyclin E2,17,cyclin-dependent protein serine/threonine kinase activity|protein kinase binding|protein kinase activity|cyclin-dependent protein serine/threonine kinase regulator activity,endometriosis of uterus|endometriosis|polycystic ovary syndrome|malignant mesothelioma|benign mesothelioma,ppi
3281,3960,51098,IFT52,intraflagellar transport 52,25,protein C-terminus binding,craniosynostosis|tooth agenesis|anodontia|osteoporosis|Sensenbrenner syndrome,ppi
3282,3962,57325,KAT14,lysine acetyltransferase 14,29,histone acetyltransferase activity|LIM domain binding,,ppi
3283,3963,26013,L3MBTL1,l(3)mbt-like 1 (Drosophila),91,chromatin binding|nucleosome binding|nucleosomal histone binding|methylated histone binding,,ppi
3284,3964,57644,MYH7B,myosin heavy chain 7B,30,,,ppi
3285,3965,51126,NAA20,N(alpha)-acetyltransferase 20; NatB catalytic subunit,15,peptide alpha-N-acetyltransferase activity,,ppi
3286,3966,57727,NCOA5,nuclear receptor coactivator 5,45,RNA binding,,ppi
3287,3967,899,CCNF,cyclin F,13,ubiquitin-protein transferase activity|protein kinase binding|cyclin-dependent protein serine/threonine kinase regulator activity|protein kinase activity,,ppi
3288,3968,9054,NFS1,NFS1; cysteine desulfurase,41,cysteine desulfurase activity|protein homodimerization activity,,ppi
3289,3969,10528,NOP56,NOP56 ribonucleoprotein,277,RNA binding|snoRNA binding|cadherin binding,stomach cancer|agnosia|spinocerebellar ataxia type 36,ppi
3290,3970,55968,NSFL1C,NSFL1 cofactor,83,ubiquitin binding,,ppi
3291,3971,29107,NXT1,nuclear transport factor 2 like export factor 1,14,protein transporter activity,,ppi
3292,3972,57144,PAK5,p21 (RAC1) activated kinase 5,71,Rac GTPase binding|protein serine/threonine kinase activity,schizophreniform disorder|schizoaffective disorder,ppi
3293,3973,23236,PLCB1,phospholipase C beta 1,25,phosphatidylinositol phospholipase C activity|phospholipase C activity|GTPase activator activity|calmodulin binding|phosphatidylinositol-4;5-bisphosphate binding|protein homodimerization activity,bipolar disorder|colon cancer|colonic benign neoplasm|schizophrenia|infantile epileptic encephalopathy|neurotic disorder|endogenous depression|melancholia|epilepsy|visual epilepsy|focal epilepsy|partial motor epilepsy|major depressive disorder|mental depression|Ohtahara syndrome|essential thrombocythemia|myelodysplastic syndrome,ppi
3294,3974,10005,ACOT8,acyl-CoA thioesterase 8,14,acetyl-CoA hydrolase activity|CoA hydrolase activity|palmitoyl-CoA hydrolase activity|acyl-CoA hydrolase activity|medium-chain acyl-CoA hydrolase activity|long-chain acyl-CoA hydrolase activity,,ppi
3295,3975,900,CCNG1,cyclin G1,42,protein kinase binding|cyclin-dependent protein serine/threonine kinase regulator activity|protein kinase activity,lung benign neoplasm,ppi
3296,3976,11264,PXMP4,peroxisomal membrane protein 4,1,,,ppi
3297,3977,22913,RALY,RALY heterogeneous nuclear ribonucleoprotein,102,transcription coregulator activity|RNA binding,,ppi
3298,3978,28954,REM1,RRAD and GEM like GTPase 1,9,GTP binding,,ppi
3299,3979,9584,RBM39,RNA binding motif protein 39,176,RNA binding,,ppi
3300,3980,57167,SALL4,spalt like transcription factor 4,5,DNA-binding transcription factor activity; RNA polymerase II-specific,Duane retraction syndrome|Duane-radial ray syndrome,ppi
3301,3981,25939,SAMHD1,SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1,79,nucleic acid binding|RNA binding|ribonuclease activity|zinc ion binding|dGTPase activity|triphosphoric monoester hydrolase activity|dGTP binding,leukodystrophy|Chilblain lupus|holoprosencephaly|photosensitivity disease|photosensitive epilepsy|Aicardi-Goutieres syndrome|porencephaly,ppi
3302,3982,50861,STMN3,stathmin 3,5,protein domain specific binding|tubulin binding,,ppi
3303,3983,51614,ERGIC3,ERGIC and golgi 3,65,,,ppi
3304,3984,10326,SIRPB1,signal regulatory protein beta 1,5,,schizophrenia,ppi
3305,3985,901,CCNG2,cyclin G2,14,protein kinase binding|protein kinase activity|cyclin-dependent protein serine/threonine kinase regulator activity,,ppi
3306,3986,56731,SLC2A4RG,SLC2A4 regulator,1,DNA-binding transcription factor activity,,ppi
3307,3987,9751,SNPH,syntaphilin,3,syntaxin-1 binding,,ppi
3308,3988,57119,EPPIN,epididymal peptidase inhibitor,4,,,ppi
3309,3989,51497,NELFCD,negative elongation factor complex member C/D,50,,,ppi
3310,3990,23051,ZHX3,zinc fingers and homeoboxes 3,10,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|protein homodimerization activity|protein heterodimerization activity|transcription corepressor activity,,ppi
3311,3991,23054,NCOA6,nuclear receptor coactivator 6,91,chromatin binding|transcription coactivator activity|estrogen receptor binding|retinoid X receptor binding|thyroid hormone receptor binding|nuclear receptor transcription coactivator activity,endometriosis of uterus|endometriosis,ppi
3312,3992,11065,UBE2C,ubiquitin conjugating enzyme E2 C,71,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,breast cancer,ppi
3313,3993,54963,UCKL1,uridine-cytidine kinase 1 like 1,13,uridine kinase activity,,ppi
3314,3994,10406,WFDC2,WAP four-disulfide core domain 2,11,endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity|aspartic-type endopeptidase inhibitor activity,,ppi
3315,3995,902,CCNH,cyclin H,56,DNA-dependent ATPase activity|RNA polymerase II CTD heptapeptide repeat kinase activity|cyclin-dependent protein serine/threonine kinase regulator activity,,ppi
3316,3996,55734,ZFP64,ZFP64 zinc finger protein,27,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3317,3997,53407,STX18,syntaxin 18,40,,,ppi
3318,3998,50855,PARD6A,par-6 family cell polarity regulator alpha,68,transcription factor binding|Rho GTPase binding|GTP-dependent protein binding|protein kinase C binding,,ppi
3319,3999,10136,CELA3A,chymotrypsin like elastase family member 3A,12,serine-type endopeptidase activity,,ppi
3320,4000,23436,CELA3B,chymotrypsin like elastase family member 3B,1,serine-type endopeptidase activity|peptidase activity,exocrine pancreatic insufficiency,ppi
3321,4001,94137,RP1L1,RP1 like 1,5,,occult macular dystrophy,ppi
3322,4002,55075,UACA,uveal autoantigen with coiled-coil domains and ankyrin repeats,48,,,ppi
3323,4003,84619,ZGPAT,zinc finger CCCH-type and G-patch domain containing,64,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
3324,4004,10983,CCNI,cyclin I,11,cyclin-dependent protein serine/threonine kinase regulator activity|protein kinase activity|protein kinase binding,,ppi
3325,4005,83482,SCRT1,scratch family transcriptional repressor 1,1,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|DNA binding,,ppi
3326,4007,114034,TOE1,target of EGR1; member 1 (nuclear),57,3'-5'-exoribonuclease activity|DNA-binding transcription factor activity; RNA polymerase II-specific|poly(A)-specific ribonuclease activity|snRNA binding,,ppi
3327,4008,124925,SEZ6,seizure related 6 homolog,2,,,ppi
3328,4012,140880,CST11,cystatin 11,1,,,ppi
3329,4013,8812,CCNK,cyclin K,40,protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase activity|RNA polymerase II CTD heptapeptide repeat kinase activity|cyclin-dependent protein serine/threonine kinase regulator activity,,ppi
3330,4014,23624,CBLC,Cbl proto-oncogene C,53,phosphotyrosine residue binding|epidermal growth factor receptor binding|zinc ion binding|SH3 domain binding|ubiquitin protein ligase activity|receptor tyrosine kinase binding,,ppi
3331,4015,57332,CBX8,chromobox 8,143,methylated histone binding,,ppi
3332,4016,8973,CHRNA6,cholinergic receptor nicotinic alpha 6 subunit,1,ligand-gated ion channel activity|acetylcholine receptor activity|acetylcholine binding|extracellular ligand-gated ion channel activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|nicotine dependence,ppi
3333,4018,57054,DAZ3,deleted in azoospermia 3,1,translation activator activity|mRNA 3'-UTR binding,,ppi
3334,4019,57135,DAZ4,deleted in azoospermia 4,5,translation activator activity|mRNA 3'-UTR binding,,ppi
3335,4020,414325,DEFB103A,defensin beta 103A,1,,,ppi
3336,4021,54332,GDAP1,ganglioside induced differentiation associated protein 1,12,,clubfoot|pseudosarcomatous fibromatosis|polyneuropathy|peripheral nervous system disease|neuropathy|Charcot-Marie-Tooth disease recessive intermediate A|Charcot-Marie-Tooth disease axonal type 2K|Charcot-Marie-Tooth disease axonal type 2H|Charcot-Marie-Tooth disease type 4A,ppi
3337,4022,56903,PAPOLB,poly(A) polymerase beta,5,polynucleotide adenylyltransferase activity,,ppi
3338,4023,7251,TSG101,tumor susceptibility 101,187,DNA binding|ubiquitin binding|protein-containing complex binding|virion binding,breast cancer|breast carcinoma,ppi
3339,4024,57617,VPS18,VPS18; CORVET/HOPS core subunit,57,syntaxin binding|protein binding; bridging,,ppi
3340,4025,113878,DTX2,deltex E3 ubiquitin ligase 2,46,,brain cancer,ppi
3341,4026,23321,TRIM2,tripartite motif containing 2,32,ubiquitin-protein transferase activity|zinc ion binding|ubiquitin protein ligase activity,clubfoot|arthropathy|arthritis|axonal neuropathy|adult respiratory distress syndrome|Charcot-Marie-Tooth disease type 2R,ppi
3342,4027,54440,SASH3,SAM and SH3 domain containing 3,5,,,ppi
3343,4029,8626,TP63,tumor protein p63,137,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|alopecia|hypohidrosis|anhidrosis|bladder diverticulum|blepharitis|blepharophimosis|ptosis|congenital ptosis|lactocele|breast disease|tongue squamous cell carcinoma|squamous cell carcinoma|choanal atresia|cleft lip|isolated cleft palate,ppi
3344,4030,85004,RERG,RAS like estrogen regulated growth inhibitor,1,GTPase activity|GDP binding|estrogen receptor binding,,ppi
3345,4031,162979,ZNF296,zinc finger protein 296,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|obsolete transcription factor activity; RNA polymerase II transcription factor binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
3346,4032,23113,CUL9,cullin 9,19,,,ppi
3347,4033,89780,WNT3A,Wnt family member 3A,25,transcription coactivator activity|receptor ligand activity|frizzled binding,idiopathic juvenile osteoporosis,ppi
3348,4034,54840,APTX,aprataxin,29,chromatin binding|damaged DNA binding|double-stranded DNA binding|double-stranded RNA binding|phosphoglycolate phosphatase activity|DNA 5'-adenosine monophosphate hydrolase activity|mismatched DNA binding|single-stranded DNA binding|single-strand break-containing DNA binding,cerebellar disease|dystonia|polyneuropathy|peripheral nervous system disease|neuropathy|chronic progressive external ophthalmoplegia|ataxia with oculomotor apraxia type 1|coenzyme Q10 deficiency disease,ppi
3349,4035,79987,SVEP1,sushi; von Willebrand factor type A; EGF and pentraxin domain containing 1,6,,,ppi
3350,4036,79727,LIN28A,lin-28 homolog A,87,G-quadruplex RNA binding|RNA binding|miRNA binding|polysome binding|sequence-specific mRNA binding,,ppi
3351,4037,10539,GLRX3,glutaredoxin 3,97,RNA binding|identical protein binding|protein binding|glutathione disulfide oxidoreductase activity,,ppi
3352,4038,65258,MPPE1,metallophosphoesterase 1,72,phosphoric diester hydrolase activity|manganese ion binding|GPI anchor binding,bipolar disorder,ppi
3353,4040,904,CCNT1,cyclin T1,75,DNA binding|protein serine/threonine kinase activity|7SK snRNA binding|cyclin-dependent protein serine/threonine kinase regulator activity,,ppi
3354,4041,25801,GCA,grancalcin,21,calcium ion binding,,ppi
3355,4042,89782,LMLN,leishmanolysin like peptidase,6,peptidase activity,,ppi
3356,4043,84905,ZNF341,zinc finger protein 341,8,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding,,ppi
3357,4044,64377,CHST8,carbohydrate sulfotransferase 8,33,N-acetylgalactosamine 4-O-sulfotransferase activity,,ppi
3358,4046,51156,SERPINA10,serpin family A member 10,8,serine-type endopeptidase inhibitor activity,thrombophilia|protein S deficiency|antithrombin III deficiency|protein C deficiency,ppi
3359,4047,89797,NAV2,neuron navigator 2,15,,schizophrenia,ppi
3360,4048,89795,NAV3,neuron navigator 3,6,microtubule binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|opiate dependence,ppi
3361,4049,57190,SELENON,selenoprotein N,23,,Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y|autosomal recessive limb-girdle muscular dystrophy type 2O|autosomal recessive limb-girdle muscular dystrophy type 2P,ppi
3362,4050,12,SERPINA3,serpin family A member 3,39,DNA binding|serine-type endopeptidase inhibitor activity,chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease|prostate cancer|prostate carcinoma|schizophreniform disorder|schizoaffective disorder,ppi
3363,4051,51412,ACTL6B,actin like 6B,27,transcription coactivator activity|structural constituent of cytoskeleton,,ppi
3364,4052,905,CCNT2,cyclin T2,21,chromatin binding|protein serine/threonine kinase activity|7SK snRNA binding|cyclin-dependent protein serine/threonine kinase regulator activity,,ppi
3365,4053,79783,SUGCT,succinyl-CoA:glutarate-CoA transferase,14,succinate-hydroxymethylglutarate CoA-transferase activity,pancreatic cancer|migraine,ppi
3366,4054,136647,MPLKIP,M-phase specific PLK1 interacting protein,18,,nonphotosensitive trichothiodystrophy|photosensitive trichothiodystrophy,ppi
3367,4056,81566,CSRNP2,cysteine and serine rich nuclear protein 2,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|phosphatase binding,,ppi
3368,4057,84676,TRIM63,tripartite motif containing 63,98,titin binding,anterior horn cell disease|muscular atrophy|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
3369,4058,57159,TRIM54,tripartite motif containing 54,128,zinc ion binding,,ppi
3370,4059,51666,ASB4,ankyrin repeat and SOCS box containing 4,26,ubiquitin-protein transferase activity|ubiquitin protein ligase binding,,ppi
3371,4060,51665,ASB1,ankyrin repeat and SOCS box containing 1,22,ubiquitin protein ligase activity,,ppi
3372,4061,51676,ASB2,ankyrin repeat and SOCS box containing 2,38,ubiquitin protein ligase activity,,ppi
3373,4062,51130,ASB3,ankyrin repeat and SOCS box containing 3,61,,,ppi
3374,4063,64921,CASD1,CAS1 domain containing 1,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,,ppi
3375,4064,55233,MOB1A,MOB kinase activator 1A,57,,,ppi
3376,4065,81035,COLEC12,collectin subfamily member 12,33,scavenger receptor activity|galactose binding|signaling pattern recognition receptor activity|low-density lipoprotein particle binding|extracellular matrix structural constituent,substance abuse|substance-related disorder,ppi
3377,4066,79175,ZNF343,zinc finger protein 343,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3378,4067,93664,CADPS2,calcium dependent secretion activator 2,27,,autistic disorder|cholestasis|schizophrenia|substance abuse|substance-related disorder,ppi
3379,4068,1230,CCR1,C-C motif chemokine receptor 1,35,phosphatidylinositol phospholipase C activity|chemokine receptor activity|C-C chemokine receptor activity|C-C chemokine binding|chemokine (C-C motif) ligand 5 binding|chemokine (C-C motif) ligand 7 binding|chemokine binding,arthropathy|arthritis|Behcet's disease|contact dermatitis|occupational dermatitis|allergic hypersensitivity disease|gallbladder disease|liver disease|meningitis|orchitis|pneumonia|aphthous stomatitis|vasculitis|thrombophilia|asthenopia|migraine|fibromyalgia|myositis|acne|liver cancer,ppi
3380,4069,29104,N6AMT1,N-6 adenine-specific DNA methyltransferase 1 (putative),3,protein methyltransferase activity|S-adenosylmethionine-dependent methyltransferase activity,,ppi
3381,4070,89846,FGD3,FYVE; RhoGEF and PH domain containing 3,3,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|small GTPase binding,,ppi
3382,4071,90865,IL33,interleukin 33,10,cytokine activity,asthma|intrinsic asthma|allergic asthma|atopic dermatitis|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
3383,4073,729230,CCR2,C-C motif chemokine receptor 2,12,chemokine receptor activity|CCR2 chemokine receptor binding|protein homodimerization activity|C-C chemokine binding|chemokine binding|C-C chemokine receptor activity,allergic hypersensitivity disease|gallbladder disease|liver disease|pneumonia|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|status epilepticus|allergic contact dermatitis,ppi
3384,4074,55072,RNF31,ring finger protein 31,75,ubiquitin-protein transferase activity|ubiquitin binding,,ppi
3385,4075,54841,BIVM,basic; immunoglobulin-like variable motif containing,1,,,ppi
3386,4077,94101,ORMDL1,ORMDL sphingolipid biosynthesis regulator 1,9,,,ppi
3387,4078,29095,ORMDL2,ORMDL sphingolipid biosynthesis regulator 2,9,,,ppi
3388,4079,94103,ORMDL3,ORMDL sphingolipid biosynthesis regulator 3,10,,asthma|intrinsic asthma|allergic asthma|inflammatory bowel disease|ulcerative colitis,ppi
3389,4080,51129,ANGPTL4,angiopoietin like 4,26,enzyme inhibitor activity,breast cancer|coronary artery disease,ppi
3390,4081,1232,CCR3,C-C motif chemokine receptor 3,19,chemokine receptor activity|C-C chemokine binding|chemokine binding|C-C chemokine receptor activity,atopic dermatitis|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|status epilepticus,ppi
3391,4082,84938,ATG4C,autophagy related 4C cysteine peptidase,13,cysteine-type endopeptidase activity|peptidase activity,,ppi
3392,4083,51705,EMCN,endomucin,2,,,ppi
3393,4084,25972,UNC50,unc-50 inner nuclear membrane RNA binding protein,2,,,ppi
3394,4085,84279,PRADC1,protease associated domain containing 1,6,,,ppi
3395,4086,23401,FRAT2,FRAT2; WNT signaling pathway regulator,13,,,ppi
3396,4087,10728,PTGES3,prostaglandin E synthase 3,132,telomerase activity|prostaglandin-E synthase activity|unfolded protein binding|Hsp90 protein binding|chaperone binding,,ppi
3397,4088,1233,CCR4,C-C motif chemokine receptor 4,8,chemokine receptor activity|C-C chemokine receptor activity|chemokine binding|C-C chemokine binding,celiac disease|brain ischemia|malignant glioma|gliosarcoma|mixed glioma|adult T-cell leukemia|acute T cell leukemia|liver cancer|Sezary's disease,ppi
3398,4089,116931,MED12L,mediator complex subunit 12 like,13,transcription coactivator activity,,ppi
3399,4090,56288,PARD3,par-3 family cell polarity regulator,81,phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3;4;5-trisphosphate binding|phosphatidylinositol-3-phosphate binding|phosphatidylinositol binding,,ppi
3400,4091,55311,ZNF444,zinc finger protein 444,35,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
3401,4092,146845,CFAP52,cilia and flagella associated protein 52,14,,,ppi
3402,4094,57486,NLN,neurolysin,20,metalloendopeptidase activity,,ppi
3403,4095,10298,PAK4,p21 (RAC1) activated kinase 4,60,protein kinase activity|protein serine/threonine kinase activity|cadherin binding involved in cell-cell adhesion|Rac GTPase binding,,ppi
3404,4096,1234,CCR5,C-C motif chemokine receptor 5 (gene/pseudogene),45,actin binding|phosphatidylinositol phospholipase C activity|chemokine receptor activity|coreceptor activity|C-C chemokine receptor activity|chemokine binding|chemokine (C-C motif) ligand 5 binding|C-C chemokine binding,atopic dermatitis|hepatitis C|nephritis|glomerulonephritis|kidney disease|schizophrenia|West Nile encephalitis|West Nile fever|type 1 diabetes mellitus 22,ppi
3405,4097,142940,TRUB1,TruB pseudouridine synthase family member 1,13,pseudouridine synthase activity,,ppi
3406,4098,56924,PAK6,p21 (RAC1) activated kinase 6,26,cadherin binding|Rac GTPase binding|protein serine/threonine kinase activity,prostate cancer|prostate carcinoma,ppi
3407,4099,23373,CRTC1,CREB regulated transcription coactivator 1,11,cAMP response element binding protein binding,Barrett's esophagus|esophagus adenocarcinoma|mood disorder,ppi
3408,4100,8028,MLLT10,myeloid/lymphoid or mixed-lineage leukemia; translocated to; 10,20,chromatin binding|DNA-binding transcription factor activity|nucleosome binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|acute myeloid leukemia|melanoma|skin melanoma|meningioma|spinal meningioma|acoustic neuroma|intraventricular meningioma|pituitary adenoma|intraorbital meningioma|clear cell meningioma|benign meningioma|secretory meningioma|microcystic meningioma,ppi
3409,4101,23062,GGA2,golgi associated; gamma adaptin ear containing; ARF binding protein 2,40,ADP-ribosylation factor binding,,ppi
3410,4102,51022,GLRX2,glutaredoxin 2,6,protein disulfide isomerase activity|arsenate reductase (glutaredoxin) activity|electron transfer activity|glutathione disulfide oxidoreductase activity,,ppi
3411,4103,55331,ACER3,alkaline ceramidase 3,2,phytoceramidase activity,melanoma|skin melanoma,ppi
3412,4104,93649,MYOCD,myocardin,16,RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II sequence-specific DNA-binding transcription factor binding,,ppi
3413,4105,5116,PCNT,pericentrin,70,,bipolar disorder|craniosynostosis|dental enamel hypoplasia|diabetes mellitus|type 2 diabetes mellitus|placental insufficiency|glaucoma|sensorineural hearing loss|hyperopia|intellectual disability|learning disability|schizophreniform disorder|schizoaffective disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I,ppi
3414,4106,1235,CCR6,C-C motif chemokine receptor 6,3,chemokine receptor activity|C-C chemokine receptor activity|C-C chemokine binding|signaling receptor activity|chemokine binding,arthropathy|arthritis|rheumatoid arthritis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|inflammatory bowel disease|ulcerative colitis|pseudosarcomatous fibromatosis|dental caries|esophagitis|peptic esophagitis|gastroesophageal reflux disease|allergic hypersensitivity disease|pneumonia|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|chronic ulcer of skin|vitiligo|CREST syndrome,ppi
3415,4107,94097,SFXN5,sideroflexin 5,22,,,ppi
3416,4108,54940,OCIAD1,OCIA domain containing 1,77,,,ppi
3417,4109,83452,RAB33B,RAB33B; member RAS oncogene family,13,GTPase activity,Smith-McCort dysplasia,ppi
3418,4110,84552,PARD6G,par-6 family cell polarity regulator gamma,21,protein kinase C binding|Rho GTPase binding,,ppi
3419,4112,81551,STMN4,stathmin 4,18,tubulin binding,,ppi
3420,4113,1236,CCR7,C-C motif chemokine receptor 7,6,G-protein coupled receptor activity|C-C chemokine receptor activity|C-C motif chemokine 19 receptor activity|C-C motif chemokine 21 receptor activity|chemokine (C-C motif) ligand 21 binding|C-C chemokine binding|chemokine binding|chemokine (C-C motif) ligand 19 binding,adult T-cell leukemia|acute T cell leukemia|status epilepticus,ppi
3421,4114,54933,RHBDL2,rhomboid like 2,2,serine-type endopeptidase activity,,ppi
3422,4115,55679,LIMS2,LIM zinc finger domain containing 2,15,,autosomal recessive limb-girdle muscular dystrophy type 2W,ppi
3423,4116,94081,SFXN1,sideroflexin 1,67,,,ppi
3424,4117,118980,SFXN2,sideroflexin 2,18,,,ppi
3425,4118,81855,SFXN3,sideroflexin 3,55,,,ppi
3426,4119,119559,SFXN4,sideroflexin 4,20,,combined oxidative phosphorylation deficiency,ppi
3427,4120,10424,PGRMC2,progesterone receptor membrane component 2,22,steroid hormone receptor activity|heme binding,,ppi
3428,4121,1237,CCR8,C-C motif chemokine receptor 8,6,chemokine receptor activity|coreceptor activity|C-C chemokine binding|chemokine binding|C-C chemokine receptor activity,status epilepticus,ppi
3429,4122,10857,PGRMC1,progesterone receptor membrane component 1,64,heme binding,prostate cancer|prostate carcinoma,ppi
3430,4123,84532,ACSS1,acyl-CoA synthetase short-chain family member 1,7,acetate-CoA ligase activity,,ppi
3431,4125,140685,ZBTB46,zinc finger and BTB domain containing 46,24,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3432,4126,84969,TOX2,TOX high mobility group box family member 2,7,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
3433,4127,128434,VSTM2L,V-set and transmembrane domain containing 2 like,4,cell-cell adhesion mediator activity,,ppi
3434,4129,51230,PHF20,PHD finger protein 20,17,DNA-binding transcription factor activity; RNA polymerase II-specific|histone acetyltransferase activity (H4-K5 specific)|histone acetyltransferase activity (H4-K8 specific)|histone acetyltransferase activity (H4-K16 specific),,ppi
3435,4131,10881,ACTL7A,actin like 7A,4,structural constituent of cytoskeleton,,ppi
3436,4132,10803,CCR9,C-C motif chemokine receptor 9,1,chemokine receptor activity|chemokine binding|C-C chemokine binding|C-C chemokine receptor activity,allergic hypersensitivity disease|pneumonia|status epilepticus,ppi
3437,4133,200232,FAM209A,family with sequence similarity 209 member A,1,,,ppi
3438,4135,116151,FAM210B,family with sequence similarity 210 member B,9,,,ppi
3439,4136,58476,TP53INP2,tumor protein p53 inducible nuclear protein 2,2,,,ppi
3440,4137,51526,OSER1,oxidative stress responsive serine rich 1,6,,,ppi
3441,4138,140688,NOL4L,nucleolar protein 4 like,5,,,ppi
3442,4139,92747,BPIFB1,BPI fold containing family B member 1,15,,,ppi
3443,4140,51554,ACKR4,atypical chemokine receptor 4,11,chemokine receptor activity|chemokine binding|C-C chemokine binding|C-C chemokine receptor activity,,ppi
3444,4141,65992,DDRGK1,DDRGK domain containing 1,35,RNA polymerase II repressing transcription factor binding,,ppi
3445,4142,140710,SOGA1,suppressor of glucose; autophagy associated 1,23,,,ppi
3446,4143,140711,TLDC2,TBC/LysM-associated domain containing 2,5,,,ppi
3447,4144,79183,TTPAL,alpha tocopherol transfer protein like,3,,,ppi
3448,4147,164395,TTLL9,tubulin tyrosine ligase like 9,5,,liver cancer|polycystic ovary syndrome,ppi
3449,4148,81572,PDRG1,p53 and DNA damage regulated 1,36,,liver cancer,ppi
3450,4149,9034,CCRL2,C-C motif chemokine receptor like 2,8,chemokine binding|C-C chemokine receptor activity|C-C chemokine binding,seborrheic keratosis|skin disease|actinic keratosis,ppi
3451,4150,128876,FAM83C,family with sequence similarity 83 member C,1,,,ppi
3452,4151,81610,FAM83D,family with sequence similarity 83 member D,26,microtubule binding,,ppi
3453,4152,90187,EMILIN3,elastin microfibril interfacer 3,12,extracellular matrix structural constituent,,ppi
3454,4153,140699,MROH8,maestro heat like repeat family member 8,1,,,ppi
3455,4154,140733,MACROD2,MACRO domain containing 2,2,hydrolase activity; acting on glycosyl bonds|deacetylase activity,autistic disorder|liver cancer|substance abuse|substance-related disorder,ppi
3456,4158,9973,CCS,copper chaperone for superoxide dismutase,16,copper ion binding|protein disulfide oxidoreductase activity|cadherin binding|superoxide dismutase activity|superoxide dismutase copper chaperone activity|zinc ion binding,hepatitis,ppi
3457,4161,140809,SRXN1,sulfiredoxin 1,38,oxidoreductase activity; acting on a sulfur group of donors|sulfiredoxin activity,,ppi
3458,4162,128637,TBC1D20,TBC1 domain family member 20,4,GTPase activator activity|Rab GTPase binding,Warburg micro syndrome 1|Warburg micro syndrome,ppi
3459,4163,128653,C20orf141,chromosome 20 open reading frame 141,1,,,ppi
3460,4164,128486,FITM2,fat storage inducing transmembrane protein 2,24,,,ppi
3461,4166,140832,WFDC10A,WAP four-disulfide core domain 10A,2,,,ppi
3462,4167,140838,NANP,N-acetylneuraminic acid phosphatase,8,N-acylneuraminate-9-phosphatase activity,,ppi
3463,4169,81928,CABLES2,Cdk5 and Abl enzyme substrate 2,7,,,ppi
3464,4170,140893,RBBP8NL,RBBP8 N-terminal like,1,single-stranded DNA binding|double-stranded DNA binding|flap-structured DNA binding|double-strand/single-strand DNA junction binding|single-stranded DNA endodeoxyribonuclease activity|damaged DNA binding|Y-form DNA binding,,ppi
3465,4172,84515,MCM8,minichromosome maintenance 8 homologous recombination repair factor,26,,,ppi
3466,4173,54675,CRLS1,cardiolipin synthase 1,4,1-acylglycerol-3-phosphate O-acyltransferase activity|CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity|2-acylglycerol-3-phosphate O-acyltransferase activity|cardiolipin synthase activity,,ppi
3467,4174,10576,CCT2,chaperonin containing TCP1 subunit 2,301,protein binding involved in protein folding|unfolded protein binding,osteoporosis,ppi
3468,4175,140706,CCM2L,CCM2 like scaffolding protein,3,,,ppi
3469,4176,90203,SNX21,sorting nexin family member 21,33,phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3-phosphate binding,,ppi
3470,4177,90204,ZSWIM1,zinc finger SWIM-type containing 1,2,,,ppi
3471,4178,140825,NEURL2,neuralized E3 ubiquitin protein ligase 2,1,,,ppi
3472,4179,140831,ZSWIM3,zinc finger SWIM-type containing 3,1,,,ppi
3473,4181,7203,CCT3,chaperonin containing TCP1 subunit 3,309,RNA binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
3474,4182,116092,DNTTIP1,deoxynucleotidyltransferase terminal interacting protein 1,30,DNA binding|nucleosome binding|protein homodimerization activity,,ppi
3475,4186,79980,DSN1,DSN1 homolog; MIS12 kinetochore complex component,51,,,ppi
3476,4190,10575,CCT4,chaperonin containing TCP1 subunit 4,235,RNA binding,,ppi
3477,4191,63939,FAM217B,family with sequence similarity 217 member B,11,,,ppi
3478,4192,128866,CHMP4B,charged multivesicular body protein 4B,103,identical protein binding|cadherin binding,cataract 31 multiple types|cataract 16 multiple types,ppi
3479,4194,55816,DOK5,docking protein 5,19,,bipolar disorder,ppi
3480,4195,343637,RSPO4,R-spondin 4,2,frizzled binding,anonychia congenita|nonsyndromic congenital nail disorder 4,ppi
3481,4196,81030,ZBP1,Z-DNA binding protein 1,18,DNA binding|left-handed Z-DNA binding,,ppi
3482,4197,80341,BPIFB2,BPI fold containing family B member 2,2,,,ppi
3483,4198,359710,BPIFB3,BPI fold containing family B member 3,2,,,ppi
3484,4200,22948,CCT5,chaperonin containing TCP1 subunit 5,217,mRNA 3'-UTR binding|mRNA 5'-UTR binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|hypobetalipoproteinemia|paraplegia|axonal neuropathy|breast cancer,ppi
3485,4201,26133,TRPC4AP,transient receptor potential cation channel subfamily C member 4 associated protein,49,calcium channel activity|phosphatase binding,,ppi
3486,4202,140730,RIMS4,regulating synaptic membrane exocytosis 4,4,ion channel binding|Rab GTPase binding,,ppi
3487,4203,140823,ROMO1,reactive oxygen species modulator 1,4,,,ppi
3488,4205,83541,FAM110A,family with sequence similarity 110 member A,23,,,ppi
3489,4207,63910,SLC17A9,solute carrier family 17 member 9,1,,porokeratosis,ppi
3490,4208,116835,HSPA12B,heat shock protein family A (Hsp70) member 12B,6,,,ppi
3491,4210,112858,TP53RK,TP53 regulating kinase,205,p53 binding|protein serine/threonine kinase activity,,ppi
3492,4212,10880,ACTL7B,actin like 7B,1,structural constituent of cytoskeleton,,ppi
3493,4213,908,CCT6A,chaperonin containing TCP1 subunit 6A,252,RNA binding,,ppi
3494,4214,63935,PCIF1,PDX1 C-terminal inhibiting factor 1,14,,,ppi
3495,4215,140683,BPIFA2,BPI fold containing family A member 2,9,lipopolysaccharide binding,substance abuse|substance-related disorder,ppi
3496,4217,92667,MGME1,mitochondrial genome maintenance exonuclease 1,16,single-stranded DNA exodeoxyribonuclease activity,ophthalmoplegia|mitochondrial myopathy|mitochondrial metabolism disease|mitochondrial DNA depletion syndrome 11,ppi
3497,4218,140850,DEFB127,defensin beta 127,13,,,ppi
3498,4219,57186,RALGAPA2,Ral GTPase activating protein catalytic alpha subunit 2,7,GTPase activator activity|protein heterodimerization activity,,ppi
3499,4220,164312,LRRN4,leucine rich repeat neuronal 4,1,,,ppi
3500,4221,58490,RPRD1B,regulation of nuclear pre-mRNA domain containing 1B,76,RNA polymerase II complex binding,,ppi
3501,4222,10693,CCT6B,chaperonin containing TCP1 subunit 6B,109,protein transporter activity,Burkitt lymphoma,ppi
3502,4224,64773,PCED1A,PC-esterase domain containing 1A,10,,,ppi
3503,4229,92675,DTD1,D-tyrosyl-tRNA deacylase 1,14,aminoacyl-tRNA editing activity|D-tyrosyl-tRNA(Tyr) deacylase activity,,ppi
3504,4230,10574,CCT7,chaperonin containing TCP1 subunit 7,259,,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|stomach cancer,ppi
3505,4231,149951,COMMD7,COMM domain containing 7,17,NF-kappaB binding,,ppi
3506,4232,128710,SLX4IP,SLX4 interacting protein,26,,,ppi
3507,4234,140680,C20orf96,chromosome 20 open reading frame 96,4,,,ppi
3508,4235,57761,TRIB3,tribbles pseudokinase 3,40,transcription corepressor activity|protein kinase binding|ubiquitin protein ligase binding|ubiquitin-protein transferase regulator activity|kinase activity|mitogen-activated protein kinase kinase binding,metabolic syndrome X,ppi
3509,4236,80023,NRSN2,neurensin 2,7,,,ppi
3510,4237,10694,CCT8,chaperonin containing TCP1 subunit 8,205,ATPase activity; coupled|cadherin binding,,ppi
3511,4238,85364,ZCCHC3,zinc finger CCHC-type containing 3,28,RNA binding,,ppi
3512,4239,140689,CBLN4,cerebellin 4 precursor,15,,,ppi
3513,4240,84701,COX4I2,cytochrome c oxidase subunit 4I2,3,cytochrome-c oxidase activity,,ppi
3514,4241,128821,CST9L,cystatin 9-like,6,,,ppi
3515,4242,140690,CTCFL,CCCTC-binding factor like,20,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|histone binding|sequence-specific DNA binding|transcription regulatory region DNA binding,,ppi
3516,4243,80331,DNAJC5,DnaJ heat shock protein family (Hsp40) member C5,10,,neuronal ceroid lipofuscinosis 4B|neuronal ceroid lipofuscinosis,ppi
3517,4244,128853,DUSP15,dual specificity phosphatase 15,22,protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|phosphatase activity,,ppi
3518,4245,26164,MTG2,mitochondrial ribosome associated GTPase 2,19,GTPase activity,,ppi
3519,4246,85366,MYLK2,myosin light chain kinase 2,27,calmodulin-dependent protein kinase activity|myosin light chain kinase activity|calmodulin binding|myosin light chain binding,hypertrophic cardiomyopathy 1,ppi
3520,4247,79716,NPEPL1,aminopeptidase-like 1,21,,,ppi
3521,4248,84612,PARD6B,par-6 family cell polarity regulator beta,83,Rho GTPase binding|protein kinase C binding,,ppi
3522,4250,128646,SIRPD,signal regulatory protein delta,5,,,ppi
3523,4251,140902,R3HDML,R3H domain containing like,1,,schizophrenia|mental depression,ppi
3524,4252,2829,XCR1,X-C motif chemokine receptor 1,2,chemokine binding|C-C chemokine receptor activity|C-C chemokine binding,,ppi
3525,4253,140732,SUN5,Sad1 and UNC84 domain containing 5,1,protein membrane anchor,,ppi
3526,4255,140901,STK35,serine/threonine kinase 35,16,protein kinase activity,,ppi
3527,4257,81027,TUBB1,tubulin beta 1 class VI,93,GTP binding|structural constituent of cytoskeleton,platelet-type bleeding disorder 16,ppi
3528,4258,10322,SMYD5,SMYD family member 5,4,,,ppi
3529,4259,84441,MAML2,mastermind like transcriptional coactivator 2,10,transcription coactivator activity,,ppi
3530,4260,124912,SPACA3,sperm acrosome associated 3,7,lysozyme activity,,ppi
3531,4261,114571,SLC22A9,solute carrier family 22 member 9,68,anion:anion antiporter activity|sodium-independent organic anion transmembrane transporter activity|short-chain fatty acid transmembrane transporter activity,,ppi
3532,4262,10413,YAP1,Yes associated protein 1,145,transcription coactivator activity|transcription corepressor activity|transcription regulatory region DNA binding,sensorineural hearing loss|intellectual disability|learning disability|microphthalmia|neuroblastoma|ovarian cancer|head and neck squamous cell carcinoma,ppi
3533,4263,10435,CDC42EP2,CDC42 effector protein 2,7,GTPase activator activity|GTP-Rho binding,,ppi
3534,4264,10131,TRAP1,TNF receptor associated protein 1,108,RNA binding|tumor necrosis factor receptor binding,arthropathy|arthritis|stomach cancer,ppi
3535,4265,81029,WNT5B,Wnt family member 5B,4,frizzled binding,salivary gland adenoid cystic carcinoma|leiomyoma|uterine fibroid,ppi
3536,4266,80704,SLC19A3,solute carrier family 19 member 3,5,thiamine transmembrane transporter activity,basal ganglia disease|Leigh disease|biotin-responsive basal ganglia disease,ppi
3537,4267,51384,WNT16,Wnt family member 16,11,frizzled binding,,ppi
3538,4268,10908,PNPLA6,patatin like phospholipase domain containing 6,25,lysophospholipase activity,cerebellar disease|cryptorchidism|achondroplasia|Laron syndrome|hypertrophy of breast|infant gynecomastia|gynecomastia|sensorineural hearing loss|Laurence-Moon syndrome|Bardet-Biedl syndrome|intellectual disability|learning disability|central nervous system disease|nervous system disease|autonomic neuropathy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity,ppi
3539,4269,23539,SLC16A8,solute carrier family 16 member 8,2,monocarboxylic acid transmembrane transporter activity|lactate transmembrane transporter activity,age related macular degeneration|macular degeneration|degeneration of macula and posterior pole,ppi
3540,4270,642636,RAD21L1,RAD21 cohesin complex component like 1,1,chromatin binding,,ppi
3541,4271,55534,MAML3,mastermind like transcriptional coactivator 3,14,transcription coactivator activity,salivary gland adenoid cystic carcinoma|congenital heart disease|spindle cell sarcoma|epithelioid sarcoma|sarcoma|cancer,ppi
3542,4272,94056,SYAP1,synapse associated protein 1,22,,,ppi
3543,4273,116159,CYYR1,cysteine and tyrosine rich 1,3,,,ppi
3544,4274,89122,TRIM4,tripartite motif containing 4,12,,,ppi
3545,4275,85363,TRIM5,tripartite motif containing 5,50,ubiquitin-protein transferase activity|signaling pattern recognition receptor activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
3546,4276,117854,TRIM6,tripartite motif containing 6,6,ubiquitin protein ligase activity,,ppi
3547,4277,81786,TRIM7,tripartite motif containing 7,13,,,ppi
3548,4278,929,CD14,CD14 molecule,33,lipopolysaccharide binding|opsonin receptor activity|peptidoglycan receptor activity|lipoteichoic acid binding|lipopeptide binding,asthma|intrinsic asthma|allergic asthma|dermatitis|gout|liver cirrhosis|schizophrenia|fatty liver disease,ppi
3549,4279,55521,TRIM36,tripartite motif containing 36,17,ubiquitin-protein transferase activity|alpha-tubulin binding,,ppi
3550,4280,81559,TRIM11,tripartite motif containing 11,66,,,ppi
3551,4281,9830,TRIM14,tripartite motif containing 14,8,,,ppi
3552,4282,89870,TRIM15,tripartite motif containing 15,39,,,ppi
3553,4283,23087,TRIM35,tripartite motif containing 35,46,,,ppi
3554,4284,9844,ELMO1,engulfment and cell motility 1,25,guanyl-nucleotide exchange factor activity,Stevens-Johnson syndrome|Barrett's esophagus|esophagus adenocarcinoma,ppi
3555,4285,27247,NFU1,NFU1 iron-sulfur cluster scaffold,11,iron ion binding|4 iron; 4 sulfur cluster binding,lactic acidosis|primary pulmonary hypertension|pulmonary hypertension|multiple mitochondrial dysfunctions syndrome 1,ppi
3556,4286,114088,TRIM9,tripartite motif containing 9,79,ubiquitin-protein transferase activity,,ppi
3557,4287,11074,TRIM31,tripartite motif containing 31,22,,,ppi
3558,4288,51592,TRIM33,tripartite motif containing 33,100,ubiquitin-protein transferase activity,papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma,ppi
3559,4289,51733,UPB1,beta-ureidopropionase 1,1,beta-ureidopropionase activity,autistic disorder|bladder diverticulum|dystonia|disease of metabolism|infantile epileptic encephalopathy|speech disorder,ppi
3560,4290,90007,MIDN,midnolin,8,kinase binding,,ppi
3561,4292,87,ACTN1,actinin alpha 1,162,double-stranded RNA binding|integrin binding|vinculin binding|nuclear receptor transcription coactivator activity|protein homodimerization activity|actin filament binding,thrombocytopenia|platelet-type bleeding disorder 16,ppi
3562,4293,977,CD151,CD151 molecule (Raph blood group),10,integrin binding,sensorineural hearing loss|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
3563,4295,94059,LENG9,leukocyte receptor cluster member 9,3,,,ppi
3564,4297,9332,CD163,CD163 molecule,5,scavenger receptor activity,carotid artery disease|IgA glomerulonephritis|schizophrenia,ppi
3565,4300,79856,SNX22,sorting nexin 22,8,,,ppi
3566,4301,8763,CD164,CD164 molecule,9,,,ppi
3567,4302,930,CD19,CD19 molecule,30,phosphatidylinositol-4;5-bisphosphate 3-kinase activity,agammaglobulinemia|hemolytic anemia|imperforate anus|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|bronchiectasis|common variable immunodeficiency|conjunctivitis|primary immunodeficiency disease|lymphosarcoma|lymphoma|central nervous system lymphoma|lymphopenia|meningitis|pneumonia|purpura|liver disease|immunoglobulin alpha deficiency|selective IgA deficiency disease|selective IgG deficiency disease,ppi
3568,4303,909,CD1A,CD1a molecule,5,exogenous lipid antigen binding|endogenous lipid antigen binding|lipopeptide binding,,ppi
3569,4304,57292,KIR2DL5A,killer cell immunoglobulin like receptor; two Ig domains and long cytoplasmic tail 5A,2,,,ppi
3570,4307,94134,ARHGAP12,Rho GTPase activating protein 12,10,GTPase activator activity,,ppi
3571,4308,910,CD1B,CD1b molecule,51,endogenous lipid antigen binding|lipopeptide binding|exogenous lipid antigen binding,,ppi
3572,4309,29960,MRM2,mitochondrial rRNA methyltransferase 2,11,rRNA (uridine-2'-O-)-methyltransferase activity,,ppi
3573,4310,10916,MAGED2,MAGE family member D2,81,,Bartter disease type 1,ppi
3574,4311,137872,ADHFE1,alcohol dehydrogenase; iron containing 1,2,hydroxyacid-oxoacid transhydrogenase activity,,ppi
3575,4312,124590,USH1G,USH1 protein network component sans,3,spectrin binding,Usher syndrome type 1|Usher syndrome type 1G,ppi
3576,4314,25861,WHRN,whirlin,4,,bipolar disorder|sensorineural hearing loss|myopia|night blindness|congenital stationary night blindness|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|scotoma|cataract|Usher syndrome|Usher syndrome type 2D|autosomal recessive nonsyndromic deafness 31,ppi
3577,4318,11315,PARK7,Parkinsonism associated deglycase,100,transcription coactivator activity|mRNA binding|copper ion binding|peptidase activity|superoxide dismutase copper chaperone activity|oxidoreductase activity; acting on peroxide as acceptor|tyrosine 3-monooxygenase activator activity|L-dopa decarboxylase activator activity|protein deglycase activity|protein homodimerization activity|cadherin binding|mercury ion binding|cupric ion binding|cuprous ion binding|core promoter binding|double-stranded DNA binding|single-stranded DNA binding,generalized anxiety disorder|anxiety disorder|focal hand dystonia|blepharospasm|osteoporosis|Parkinson's disease|secondary Parkinson disease|perinatal necrotizing enterocolitis|amyotrophic lateral sclerosis|autosomal recessive early-onset Parkinson disease 7|liver cancer|hepatocellular carcinoma,ppi
3578,4319,912,CD1D,CD1d molecule,8,beta-2-microglobulin binding|lipid antigen binding|exogenous lipid antigen binding|endogenous lipid antigen binding|lipopeptide binding,,ppi
3579,4320,26031,OSBPL3,oxysterol binding protein like 3,30,sterol transporter activity|cholesterol binding|lipid binding|sterol binding,,ppi
3580,4321,84290,CAPNS2,calpain small subunit 2,16,calcium-dependent cysteine-type endopeptidase activity,,ppi
3581,4322,51439,FAM8A1,family with sequence similarity 8 member A1,35,,,ppi
3582,4324,10346,TRIM22,tripartite motif containing 22,10,DNA-binding transcription factor activity|transcription corepressor activity,influenza,ppi
3583,4325,913,CD1E,CD1e molecule,28,exogenous lipid antigen binding|lipopeptide binding|endogenous lipid antigen binding,,ppi
3584,4326,22954,TRIM32,tripartite motif containing 32,87,transcription coactivator activity|RNA binding|ubiquitin-protein transferase activity|myosin binding|Tat protein binding|translation initiation factor binding|ubiquitin binding|protein self-association|ubiquitin protein ligase activity,hypertension|essential hypertension|hypogonadism|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|intellectual disability|learning disability|familial periodic paralysis|myopathy|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D,ppi
3585,4327,151742,PPM1L,protein phosphatase; Mg2+/Mn2+ dependent 1L,4,protein serine/threonine phosphatase activity,obesity,ppi
3586,4328,10155,TRIM28,tripartite motif containing 28,319,DNA binding|chromatin binding|transcription coactivator activity|transcription corepressor activity|RNA binding|ubiquitin-protein transferase activity|zinc ion binding|SUMO transferase activity|ubiquitin protein ligase binding|Krueppel-associated box domain binding|promoter-specific chromatin binding|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
3587,4329,55695,NSUN5,NOP2/Sun RNA methyltransferase family member 5,20,RNA binding,,ppi
3588,4330,114883,OSBPL9,oxysterol binding protein like 9,23,sterol transporter activity|sterol binding|lipid binding,,ppi
3589,4332,114880,OSBPL6,oxysterol binding protein like 6,19,sterol transporter activity|sterol binding|lipid binding|cholesterol binding,,ppi
3590,4333,79663,HSPBAP1,HSPB1 associated protein 1,7,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|nonpapillary renal cell carcinoma|hereditary conventional renal cell carcinoma,ppi
3591,4334,914,CD2,CD2 molecule,21,signaling receptor activity,rheumatoid arthritis|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome,ppi
3592,4335,10392,NOD1,nucleotide binding oligomerization domain containing 1,34,cysteine-type endopeptidase activator activity involved in apoptotic process|identical protein binding|peptidoglycan binding|CARD domain binding,central nervous system disease|nervous system disease|autonomic neuropathy,ppi
3593,4336,64170,CARD9,caspase recruitment domain family member 9,78,,inflammatory bowel disease|ulcerative colitis|IgA glomerulonephritis|ankylosing spondylitis|chronic mucocutaneous candidiasis,ppi
3594,4337,114879,OSBPL5,oxysterol binding protein like 5,19,phosphatidylserine binding|phospholipid transporter activity|oxysterol binding|cholesterol binding|phosphatidylinositol-4-phosphate binding|lipid binding|sterol transporter activity|sterol binding,alcohol dependence|alcohol abuse,ppi
3595,4338,84433,CARD11,caspase recruitment domain family member 11,32,guanylate kinase activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|atopic dermatitis|adult T-cell leukemia|acute T cell leukemia|Sezary's disease|cutaneous T cell lymphoma,ppi
3596,4339,84674,CARD6,caspase recruitment domain family member 6,4,,,ppi
3597,4340,114884,OSBPL10,oxysterol binding protein like 10,20,phosphatidylserine binding|phospholipid transporter activity|cholesterol binding|sterol transporter activity|lipid binding|sterol binding,,ppi
3598,4341,114882,OSBPL8,oxysterol binding protein like 8,39,phosphatidylserine binding|phospholipid transporter activity|cholesterol binding|phosphatidylinositol-4-phosphate binding|lipid binding|sterol binding|sterol transporter activity,,ppi
3599,4342,114885,OSBPL11,oxysterol binding protein like 11,21,lipid binding|sterol binding|sterol transporter activity,,ppi
3600,4343,114876,OSBPL1A,oxysterol binding protein like 1A,17,phospholipid binding|sterol transporter activity|cholesterol binding|lipid binding|sterol binding,,ppi
3601,4344,88,ACTN2,actinin alpha 2,123,Ras guanyl-nucleotide exchange factor activity|integrin binding|phosphatidylinositol-4;5-bisphosphate binding|cytoskeletal protein binding|structural constituent of muscle|protein homodimerization activity|protein dimerization activity|FATZ binding|titin Z domain binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
3602,4345,114548,NLRP3,NLR family pyrin domain containing 3,54,transcription factor binding|peptidoglycan binding|sequence-specific DNA binding,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|food allergy|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis,ppi
3603,4346,23567,ZNF346,zinc finger protein 346,31,RNA binding|double-stranded RNA binding|miRNA binding,,ppi
3604,4347,112744,IL17F,interleukin 17F,2,cytokine activity|cytokine binding|protein homodimerization activity,chronic mucocutaneous candidiasis,ppi
3605,4348,114049,WBSCR22,Williams-Beuren syndrome chromosome region 22,21,RNA binding|methyltransferase activity|rRNA (guanine) methyltransferase activity|protein heterodimerization activity,,ppi
3606,4349,114327,EFHC1,EF-hand domain containing 1,24,protein C-terminus binding|alpha-tubulin binding,childhood absence epilepsy|juvenile myoclonic epilepsy,ppi
3607,4350,83451,ABHD11,abhydrolase domain containing 11,15,,,ppi
3608,4352,30835,CD209,CD209 molecule,17,mannose binding|carbohydrate binding|peptide antigen binding|virion binding,Japanese encephalitis|dengue disease|viral infectious disease|yellow fever|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|pulmonary tuberculosis|tuberculous pneumothorax,ppi
3609,4353,84277,DNAJC30,DnaJ heat shock protein family (Hsp40) member C30,16,,,ppi
3610,4354,246269,LACE1,lactation elevated 1,8,ATPase activity,bipolar disorder,ppi
3611,4355,58484,NLRC4,NLR family CARD domain containing 4,14,magnesium ion binding|ATP binding|protein homodimerization activity|identical protein binding,gastroenteritis,ppi
3612,4356,55553,SOX6,SRY-box 6,17,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,schizophrenia,ppi
3613,4357,29775,CARD10,caspase recruitment domain family member 10,12,receptor signaling complex scaffold activity,,ppi
3614,4359,933,CD22,CD22 molecule,19,,,ppi
3615,4360,90070,LACRT,lacritin,45,fibronectin binding|protein binding|collagen binding|growth factor activity|laminin-1 binding,,ppi
3616,4362,51582,AZIN1,antizyme inhibitor 1,16,ornithine decarboxylase activator activity|ornithine decarboxylase activity,,ppi
3617,4363,81502,HM13,histocompatibility minor 13,27,peptidase activity|aspartic endopeptidase activity; intramembrane cleaving|protein homodimerization activity,,ppi
3618,4364,92086,GGTLC1,gamma-glutamyltransferase light chain 1,2,,,ppi
3619,4366,171169,SPACA4,sperm acrosome associated 4,7,,,ppi
3620,4367,9934,P2RY14,purinergic receptor P2Y14,3,UDP-activated nucleotide receptor activity|G-protein coupled purinergic nucleotide receptor activity,,ppi
3621,4369,115817,DHRS1,dehydrogenase/reductase 1,8,,,ppi
3622,4370,79092,CARD14,caspase recruitment domain family member 14,9,,pityriasis rubra pilaris|pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
3623,4372,80150,ASRGL1,asparaginase like 1,6,asparaginase activity|beta-aspartyl-peptidase activity|N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity|hydrolase activity,allergic contact dermatitis,ppi
3624,4373,342931,RFPL4A,ret finger protein like 4A,2,,,ppi
3625,4374,100133941,CD24,CD24 molecule,4,protein tyrosine kinase activator activity,multiple sclerosis,ppi
3626,4378,56923,NMUR2,neuromedin U receptor 2,24,neuromedin U receptor activity|G-protein coupled receptor activity|intracellular calcium activated chloride channel activity|GTP binding|neuromedin U binding,alcohol dependence|alcohol abuse,ppi
3627,4379,56911,MAP3K7CL,MAP3K7 C-terminal like,6,,,ppi
3628,4380,54149,C21orf91,chromosome 21 open reading frame 91,4,,,ppi
3629,4381,9855,FARP2,FERM; ARH/RhoGEF and pleckstrin domain protein 2,23,Rho guanyl-nucleotide exchange factor activity|Rac guanyl-nucleotide exchange factor activity,autistic disorder|chronic lymphocytic leukemia|Richter's syndrome,ppi
3630,4382,51729,WBP11,WW domain binding protein 11,55,single-stranded DNA binding|RNA binding,,ppi
3631,4383,55342,STRBP,spermatid perinuclear RNA binding protein,61,RNA binding|single-stranded RNA binding|double-stranded RNA binding,,ppi
3632,4384,55660,PRPF40A,pre-mRNA processing factor 40 homolog A,205,RNA binding,,ppi
3633,4385,94240,EPSTI1,epithelial stromal interaction 1,18,,,ppi
3634,4386,51684,SUFU,SUFU negative regulator of hedgehog signaling,49,transcription corepressor activity|transcription factor binding,nevoid basal cell carcinoma syndrome|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|cleft lip|isolated cleft palate|cleft palate|glaucoma|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|microphthalmia|syringoma,ppi
3635,4387,9744,ACAP1,ArfGAP with coiled-coil; ankyrin repeat and PH domains 1,13,,,ppi
3636,4388,114294,LACTB,lactamase beta,22,peptidase activity,obesity,ppi
3637,4389,23527,ACAP2,ArfGAP with coiled-coil; ankyrin repeat and PH domains 2,7,,,ppi
3638,4390,84203,TXNDC2,thioredoxin domain containing 2,1,thioredoxin-disulfide reductase activity,,ppi
3639,4392,51151,SLC45A2,solute carrier family 45 member 2,13,sucrose:proton symporter activity,oculocutaneous albinism|Griscelli syndrome|Griscelli syndrome type 1|Griscelli syndrome type 2|Griscelli syndrome type 3|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|melanoma|skin melanoma|spontaneous ocular nystagmus|dissociated nystagmus,ppi
3640,4393,51314,NME8,NME/NM23 family member 8,5,microtubule binding,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|sinusitis|primary ciliary dyskinesia 6,ppi
3641,4394,83693,HSDL1,hydroxysteroid dehydrogenase like 1,23,,,ppi
3642,4395,54472,TOLLIP,toll interacting protein,82,ubiquitin conjugating enzyme binding|ubiquitin binding,,ppi
3643,4397,135458,HUS1B,HUS1 checkpoint clamp component B,15,,,ppi
3644,4398,11033,ADAP1,ArfGAP with dual PH domains 1,24,GTPase activator activity|inositol 1;3;4;5 tetrakisphosphate binding,,ppi
3645,4399,55803,ADAP2,ArfGAP with dual PH domains 2,9,phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3;4;5-trisphosphate binding|protein binding; bridging|phosphatidylinositol-3;4-bisphosphate binding|inositol 1;3;4;5 tetrakisphosphate binding,,ppi
3646,4400,84747,UNC119B,unc-119 lipid binding chaperone B,14,lipid binding,,ppi
3647,4401,115201,ATG4A,autophagy related 4A cysteine peptidase,15,cysteine-type peptidase activity|cysteine-type endopeptidase activity,,ppi
3648,4402,54878,DPP8,dipeptidyl peptidase 8,28,dipeptidyl-peptidase activity,,ppi
3649,4403,55367,PIDD1,p53-induced death domain protein 1,36,death receptor binding|volume-sensitive anion channel activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
3650,4404,64760,FAM160B2,family with sequence similarity 160 member B2,7,,,ppi
3651,4405,57178,ZMIZ1,zinc finger MIZ-type containing 1,24,,celiac disease|large intestine cancer|colorectal cancer,ppi
3652,4406,57047,PLSCR2,phospholipid scramblase 2,1,calcium ion binding|phospholipid scramblase activity,,ppi
3653,4407,57048,PLSCR3,phospholipid scramblase 3,9,calcium ion binding|phospholipid scramblase activity,,ppi
3654,4408,23305,ACSL6,acyl-CoA synthetase long-chain family member 6,3,long-chain fatty acid-CoA ligase activity|protein homodimerization activity,schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
3655,4409,57088,PLSCR4,phospholipid scramblase 4,22,calcium ion binding|phospholipid scramblase activity,schizophrenia|lung small cell carcinoma,ppi
3656,4410,116442,RAB39B,RAB39B; member RAS oncogene family,24,GTPase activity,autistic disorder|epilepsy|non-syndromic X-linked intellectual disability|intellectual disability|learning disability,ppi
3657,4411,89,ACTN3,actinin alpha 3 (gene/pseudogene),26,integrin binding|structural constituent of muscle|protein homodimerization activity,,ppi
3658,4412,27071,DAPP1,dual adaptor of phosphotyrosine and 3-phosphoinositides 1,24,phospholipid binding|phosphatidylinositol-3;4;5-trisphosphate binding|phosphatidylinositol-3;4-bisphosphate binding|PDZ domain binding,arthropathy|arthritis,ppi
3659,4413,8572,PDLIM4,PDZ and LIM domain 4,8,protein homodimerization activity,osteoporosis|polycystic ovary syndrome,ppi
3660,4414,162494,RHBDL3,rhomboid like 3,4,,,ppi
3661,4417,114757,CYGB,cytoglobin,4,peroxidase activity|oxygen carrier activity|nitric oxide dioxygenase activity,,ppi
3662,4418,132204,SYNPR,synaptoporin,2,,,ppi
3663,4419,117177,RAB3IP,RAB3A interacting protein,44,Rab guanyl-nucleotide exchange factor activity,,ppi
3664,4420,117178,SSX2IP,SSX family member 2 interacting protein,228,,,ppi
3665,4421,79791,FBXO31,F-box protein 31,25,ubiquitin-protein transferase activity,,ppi
3666,4422,23176,SEPT8,septin 8,29,GTPase activity|protein-containing complex scaffold activity,,ppi
3667,4423,7809,BSND,barttin CLCNK type accessory beta subunit,4,voltage-gated chloride channel activity|chloride channel activity,congestive heart failure|sensorineural hearing loss|polyhydramnios|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypokalemia|intellectual disability|learning disability|kidney failure|uremia|Bartter disease type 4a,ppi
3668,4424,117531,TMC1,transmembrane channel like 1,4,mechanosensitive ion channel activity|voltage-gated calcium channel activity|ion channel activity,autosomal recessive nonsyndromic deafness 7|autosomal dominant nonsyndromic deafness 36,ppi
3669,4425,51274,KLF3,Kruppel like factor 3,10,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
3670,4426,164656,TMPRSS6,transmembrane protease; serine 6,4,metalloendopeptidase activity|serine-type endopeptidase activity,microcytic anemia|hypochromic anemia|deficiency anemia,ppi
3671,4427,353141,LCE2D,late cornified envelope 2D,13,structural molecule activity,,ppi
3672,4428,83871,RAB34,RAB34; member RAS oncogene family,21,GTPase activity,,ppi
3673,4429,54734,RAB39A,RAB39A; member RAS oncogene family,15,GTP binding|GTPase activity,,ppi
3674,4430,120071,LARGE2,LARGE xylosyl- and glucuronyltransferase 2,18,glucuronosyltransferase activity|manganese ion binding|UDP-xylosyltransferase activity|xylosyltransferase activity,,ppi
3675,4431,64284,RAB17,RAB17; member RAS oncogene family,17,GTPase activity|GDP binding,,ppi
3676,4432,51552,RAB14,RAB14; member RAS oncogene family,57,GTPase activity|GTP binding|GDP binding,,ppi
3677,4433,84084,RAB6C,RAB6C; member RAS oncogene family,6,GTPase activity,,ppi
3678,4434,51703,ACSL5,acyl-CoA synthetase long-chain family member 5,5,long-chain fatty acid-CoA ligase activity,,ppi
3679,4436,27120,DKKL1,dickkopf like acrosomal protein 1,77,co-receptor binding|receptor antagonist activity,,ppi
3680,4437,940,CD28,CD28 molecule,20,SH3/SH2 adaptor activity|coreceptor activity|identical protein binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,alopecia|rheumatoid arthritis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|berylliosis|skin benign neoplasm|skin cancer|dermatitis|exanthem|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|primary immunodeficiency disease|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|adult T-cell leukemia|acute T cell leukemia|mycosis fungoides|Sezary's disease|granuloma annulare|cutaneous T cell lymphoma,ppi
3681,4438,10421,CD2BP2,CD2 cytoplasmic tail binding protein 2,93,ribonucleoprotein complex binding,,ppi
3682,4439,945,CD33,CD33 molecule,17,signaling receptor activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|acute myeloid leukemia,ppi
3683,4440,81,ACTN4,actinin alpha 4,151,RNA polymerase II regulatory region sequence-specific DNA binding|nucleoside binding|RNA binding|actin binding|integrin binding|nuclear receptor transcription coactivator activity|chromatin DNA binding|protein homodimerization activity|actin filament binding,congestive heart failure|focal segmental glomerulosclerosis|familial hyperlipidemia|proteinuria,ppi
3684,4441,29108,PYCARD,PYD and CARD domain containing,58,cysteine-type endopeptidase activator activity involved in apoptotic process|protein homodimerization activity|cysteine-type endopeptidase activity involved in apoptotic process,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|proteinuria|calcium metabolism disease|nephrocalcinosis|calcinosis|lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|large intestine cancer|colorectal cancer|heart valve disease|nephritis|glomerulonephritis|kidney disease|pyoureter,ppi
3685,4443,353132,LCE1B,late cornified envelope 1B,22,structural molecule activity,,ppi
3686,4444,353144,LCE3C,late cornified envelope 3C,16,structural molecule activity,pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
3687,4445,199834,LCE4A,late cornified envelope 4A,23,structural molecule activity,,ppi
3688,4447,84648,LCE3D,late cornified envelope 3D,2,structural molecule activity,pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
3689,4448,79365,BHLHE41,basic helix-loop-helix family member e41,38,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II activating transcription factor binding|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription corepressor activity|protein homodimerization activity|histone deacetylase binding|bHLH transcription factor binding|MRF binding|protein heterodimerization activity|E-box binding|transcription factor binding|sequence-specific double-stranded DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|sequence-specific DNA binding,bipolar disorder,ppi
3690,4449,65993,MRPS34,mitochondrial ribosomal protein S34,82,structural constituent of ribosome,,ppi
3691,4450,947,CD34,CD34 molecule,5,carbohydrate binding,schizophreniform disorder|schizoaffective disorder|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
3692,4451,11069,RAPGEF4,Rap guanine nucleotide exchange factor 4,14,guanyl-nucleotide exchange factor activity|Ras guanyl-nucleotide exchange factor activity|Ras GTPase binding|cAMP binding,,ppi
3693,4452,11200,CHEK2,checkpoint kinase 2,151,protein serine/threonine kinase activity|kinase activity|protein homodimerization activity,adrenal cortex cancer|breast cancer|skin benign neoplasm|skin cancer|colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|malignant glioma|gliosarcoma|mixed glioma|lung benign neoplasm|lymphosarcoma|lymphoma|central nervous system lymphoma|Langerhans-cell histiocytosis|reticulosarcoma|non-Hodgkin lymphoma|B-cell lymphoma|meningioma,ppi
3694,4453,84925,DIRC2,disrupted in renal carcinoma 2,1,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
3695,4454,10411,RAPGEF3,Rap guanine nucleotide exchange factor 3,14,guanyl-nucleotide exchange factor activity|Rap guanyl-nucleotide exchange factor activity,chronic obstructive pulmonary disease|trypanosomiasis|Q fever|typhus,ppi
3696,4455,948,CD36,CD36 molecule,27,amyloid-beta binding|low-density lipoprotein particle receptor activity|scavenger receptor activity|lipid binding|low-density lipoprotein particle binding|transforming growth factor beta binding|thrombospondin receptor activity|lipoprotein particle binding|oxidised low-density lipoprotein particle receptor activity,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
3697,4456,92259,MRPS36,mitochondrial ribosomal protein S36,7,structural constituent of ribosome|oxoglutarate dehydrogenase (succinyl-transferring) activity,,ppi
3698,4457,10240,MRPS31,mitochondrial ribosomal protein S31,78,RNA binding,,ppi
3699,4458,51023,MRPS18C,mitochondrial ribosomal protein S18C,25,structural constituent of ribosome,,ppi
3700,4459,51650,MRPS33,mitochondrial ribosomal protein S33,30,structural constituent of ribosome,,ppi
3701,4460,60488,MRPS35,mitochondrial ribosomal protein S35,82,RNA binding|structural constituent of ribosome,,ppi
3702,4461,23095,KIF1B,kinesin family member 1B,62,microtubule motor activity|ATPase activity|kinesin binding|ATP-dependent microtubule motor activity; plus-end-directed|microtubule binding,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
3703,4462,10553,HTATIP2,HIV-1 Tat interactive protein 2,10,transcription coactivator activity,liver cancer|hepatocellular carcinoma,ppi
3704,4463,10250,SRRM1,serine and arginine repetitive matrix 1,166,RNA binding,,ppi
3705,4464,23524,SRRM2,serine/arginine repetitive matrix 2,260,RNA binding|C2H2 zinc finger domain binding,,ppi
3706,4465,949,SCARB1,scavenger receptor class B member 1,31,lipopolysaccharide binding|phosphatidylserine binding|lipopolysaccharide receptor activity|scavenger receptor activity|transporter activity|1-phosphatidylinositol binding|low-density lipoprotein particle binding|high-density lipoprotein particle receptor activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|hepatitis C|chronic kidney disease|cannabis dependence|cannabis abuse|phencyclidine abuse|cocaine abuse|cocaine dependence|fatty liver disease,ppi
3707,4466,255061,TAC4,tachykinin 4 (hemokinin),4,signaling receptor binding,,ppi
3708,4467,58191,CXCL16,C-X-C motif chemokine ligand 16,14,low-density lipoprotein particle receptor activity|scavenger receptor activity|chemokine activity,,ppi
3709,4468,7871,SLMAP,sarcolemma associated protein,64,,Brugada syndrome|Brugada syndrome 1,ppi
3710,4470,29896,TRA2A,transformer 2 alpha homolog,163,RNA binding,seborrheic keratosis|skin disease|actinic keratosis,ppi
3711,4471,27290,SPINK4,serine peptidase inhibitor; Kazal type 4,7,,,ppi
3712,4472,10663,CXCR6,C-X-C motif chemokine receptor 6,1,G-protein coupled receptor activity|C-C chemokine binding|C-C chemokine receptor activity|chemokine binding,,ppi
3713,4473,64219,PJA1,praja ring finger ubiquitin ligase 1,61,ubiquitin protein ligase activity,,ppi
3714,4474,950,SCARB2,scavenger receptor class B member 2,32,transmembrane signaling receptor activity|scavenger receptor activity,anemia|macrocytic anemia|focal segmental glomerulosclerosis|splenic disease|splenic infarction|hypersplenism|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|osteonecrosis|osteopetrosis,ppi
3715,4475,65080,MRPL44,mitochondrial ribosomal protein L44,69,RNA binding|double-stranded RNA binding|ribonuclease III activity,combined oxidative phosphorylation deficiency,ppi
3716,4476,84311,MRPL45,mitochondrial ribosomal protein L45,56,,,ppi
3717,4477,57129,MRPL47,mitochondrial ribosomal protein L47,70,structural constituent of ribosome,,ppi
3718,4478,51642,MRPL48,mitochondrial ribosomal protein L48,38,,,ppi
3719,4479,54534,MRPL50,mitochondrial ribosomal protein L50,108,,,ppi
3720,4480,122704,MRPL52,mitochondrial ribosomal protein L52,35,structural constituent of ribosome,,ppi
3721,4481,59348,ZNF350,zinc finger protein 350,10,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding,,ppi
3722,4482,79370,BCL2L14,BCL2 like 14,18,,,ppi
3723,4483,64112,MOAP1,modulator of apoptosis 1,29,,,ppi
3724,4484,951,CD37,CD37 molecule,6,,,ppi
3725,4485,222894,FERD3L,Fer3 like bHLH transcription factor,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3726,4486,116966,WDR17,WD repeat domain 17,1,,liver cancer,ppi
3727,4487,92291,CAPN13,calpain 13,12,calcium-dependent cysteine-type endopeptidase activity,,ppi
3728,4489,8862,APLN,apelin,6,signaling receptor binding|hormone activity|apelin receptor binding,,ppi
3729,4490,64147,KIF9,kinesin family member 9,14,protein dimerization activity|microtubule binding|microtubule motor activity|ATPase activity,,ppi
3730,4491,55754,TMEM30A,transmembrane protein 30A,65,aminophospholipid transmembrane transporter activity|phospholipid-translocating ATPase activity,,ppi
3731,4492,64073,C19orf33,chromosome 19 open reading frame 33,3,,,ppi
3732,4494,952,CD38,CD38 molecule,9,NAD+ nucleosidase activity|phosphorus-oxygen lyase activity,proteinuria|coronary artery disease,ppi
3733,4495,10988,METAP2,methionyl aminopeptidase 2,56,RNA binding|aminopeptidase activity|metalloexopeptidase activity,,ppi
3734,4496,81611,ANP32E,acidic nuclear phosphoprotein 32 family member E,36,phosphatase inhibitor activity|histone binding,,ppi
3735,4499,10541,ANP32B,acidic nuclear phosphoprotein 32 family member B,76,histone binding|RNA polymerase binding,,ppi
3736,4500,10009,ZBTB33,zinc finger and BTB domain containing 33,52,DNA-binding transcription factor activity; RNA polymerase II-specific|methyl-CpG binding|sequence-specific DNA binding,,ppi
3737,4501,56957,OTUD7B,OTU deubiquitinase 7B,24,thiol-dependent ubiquitin-specific protease activity|cysteine-type peptidase activity|thiol-dependent ubiquitinyl hydrolase activity|Lys48-specific deubiquitinase activity|K63-linked polyubiquitin modification-dependent protein binding,,ppi
3738,4502,116540,MRPL53,mitochondrial ribosomal protein L53,57,,,ppi
3739,4503,116541,MRPL54,mitochondrial ribosomal protein L54,12,RNA binding,,ppi
3740,4504,128308,MRPL55,mitochondrial ribosomal protein L55,44,structural constituent of ribosome,,ppi
3741,4505,56478,EIF4ENIF1,eukaryotic translation initiation factor 4E nuclear import factor 1,48,RNA binding|protein transporter activity,,ppi
3742,4506,10897,YIF1A,Yip1 interacting factor homolog A; membrane trafficking protein,19,,liver cancer,ppi
3743,4507,375519,GJB7,gap junction protein beta 7,51,gap junction channel activity,,ppi
3744,4508,27229,TUBGCP4,tubulin gamma complex associated protein 4,99,structural constituent of cytoskeleton|gamma-tubulin binding|microtubule minus-end binding,epilepsy|placental insufficiency|intellectual disability|learning disability|microphthalmia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|blindness|cerebral degeneration|microcephaly and chorioretinopathy 1,ppi
3745,4509,51293,CD320,CD320 molecule,27,calcium ion binding|cobalamin-transporting ATPase activity|cobalamin binding,methylmalonic acidemia due to transcobalamin receptor defect,ppi
3746,4511,10134,BCAP31,B-cell receptor-associated protein 31,88,,dystonia|sensorineural hearing loss|intellectual disability|learning disability|locked-in syndrome|quadriplegia|syndromic X-linked intellectual disability 94|ophthalmoplegia|mechanical strabismus|hypertropia|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
3747,4512,22938,SNW1,SNW domain containing 1,664,transcription coactivator activity|transcription corepressor activity|RNA binding|nuclear hormone receptor binding|vitamin D receptor binding|retinoic acid receptor binding|SMAD binding,,ppi
3748,4513,114815,SORCS1,sortilin related VPS10 domain containing receptor 1,2,neuropeptide receptor activity,,ppi
3749,4514,57537,SORCS2,sortilin related VPS10 domain containing receptor 2,4,neuropeptide receptor activity,bipolar disorder,ppi
3750,4515,22986,SORCS3,sortilin related VPS10 domain containing receptor 3,3,neuropeptide receptor activity,,ppi
3751,4516,10121,ACTR1A,ARP1 actin-related protein 1 homolog A; centractin alpha,66,,,ppi
3752,4517,23414,ZFPM2,zinc finger protein; FOG family member 2,19,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator activity|transcription corepressor activity|zinc ion binding|RNA polymerase II transcription factor binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,azoospermia|cryptorchidism|enophthalmos|orbital disease|exophthalmos|placental insufficiency|gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|hypertrophy of breast|infant gynecomastia|gynecomastia|hiatus hernia|congenital diaphragmatic hernia|male infertility|osteoporosis|tetralogy of Fallot|sex differentiation disease|hermaphroditism|pseudohermaphroditism,ppi
3753,4518,10627,MYL12A,myosin light chain 12A,68,,,ppi
3754,4519,51138,COPS4,COP9 signalosome subunit 4,93,NEDD8-specific protease activity,,ppi
3755,4520,57084,SLC17A6,solute carrier family 17 member 6,1,L-glutamate transmembrane transporter activity|neurotransmitter transporter activity,bipolar disorder|intellectual disability|learning disability|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
3756,4521,57030,SLC17A7,solute carrier family 17 member 7,1,L-glutamate transmembrane transporter activity|sodium:inorganic phosphate symporter activity|neurotransmitter transporter activity|sodium-dependent phosphate transmembrane transporter activity,bipolar disorder|intellectual disability|learning disability|schizophrenia|epilepsy|visual epilepsy,ppi
3757,4522,11044,PAPD7,poly(A) RNA polymerase D7; non-canonical,5,SMC family protein binding|polynucleotide adenylyltransferase activity,,ppi
3758,4523,23625,FAM89B,family with sequence similarity 89 member B,1,transcription corepressor binding,,ppi
3759,4524,10203,CALCRL,calcitonin receptor like receptor,6,G-protein coupled receptor activity|protein transporter activity|calcitonin gene-related peptide receptor activity|adrenomedullin receptor activity,allergic contact dermatitis,ppi
3760,4525,64400,AKTIP,AKT interacting protein,51,ubiquitin-like protein transferase activity,,ppi
3761,4526,10333,TLR6,toll like receptor 6,7,signaling receptor activity|identical protein binding|lipopeptide binding|Toll-like receptor 2 binding,prostate cancer|prostate carcinoma,ppi
3762,4527,55294,FBXW7,F-box and WD repeat domain containing 7,208,ubiquitin-protein transferase activity|cyclin binding|protein binding; bridging|phosphothreonine residue binding|ubiquitin-protein transferase activator activity|ubiquitin binding,basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|salivary gland adenoid cystic carcinoma|endometrial cancer|endometrial carcinoma|malignant glioma|gliosarcoma|mixed glioma|esophagus squamous cell carcinoma|breast cancer|acute T cell leukemia,ppi
3763,4528,10772,SRSF10,serine and arginine rich splicing factor 10,87,RNA binding|RS domain binding|unfolded protein binding,endometrial cancer|endometrial carcinoma|polycystic ovary syndrome|schizophrenia|ovarian cancer,ppi
3764,4529,63876,PKNOX2,PBX/knotted 1 homeobox 2,7,DNA-binding transcription factor activity; RNA polymerase II-specific,alcohol dependence|alcohol abuse|schizophrenia,ppi
3765,4530,64794,DDX31,DEAD-box helicase 31,107,RNA binding,,ppi
3766,4531,22907,DHX30,DExH-box helicase 30,114,chromatin binding|RNA binding|double-stranded RNA binding|ATP-dependent RNA helicase activity|G-quadruplex RNA binding|ATP-dependent 3'-5' RNA helicase activity|ATP-dependent DNA helicase activity,,ppi
3767,4532,55760,DHX32,DEAH-box helicase 32 (putative),8,ATP-dependent 3'-5' RNA helicase activity|RNA binding,,ppi
3768,4533,56919,DHX33,DEAH-box helicase 33,15,rDNA binding|RNA binding|double-stranded RNA binding|mRNA binding|ATP-dependent 3'-5' RNA helicase activity,,ppi
3769,4534,9704,DHX34,DExH-box helicase 34,7,RNA binding|ATP-dependent 3'-5' RNA helicase activity,,ppi
3770,4535,114335,CGB1,chorionic gonadotropin beta subunit 1,1,hormone activity,,ppi
3771,4536,114336,CGB2,chorionic gonadotropin beta subunit 2,14,hormone activity,,ppi
3772,4537,23639,LRRC6,leucine rich repeat containing 6,8,,bronchiectasis|bronchitis|Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|rhinitis|tuberous sclerosis|Marfan syndrome|situs inversus|primary ciliary dyskinesia 19,ppi
3773,4538,915,CD3D,CD3d molecule,18,transcription coactivator activity|transmembrane signaling receptor activity|protein homodimerization activity,primary immunodeficiency disease|primary biliary cirrhosis|gallbladder disease|liver disease|lymphopenia|adenosine deaminase deficiency|MHC class II deficiency|severe combined immunodeficiency|allergic contact dermatitis|toxic encephalopathy,ppi
3774,4539,114907,FBXO32,F-box protein 32,18,ubiquitin-protein transferase activity,anterior horn cell disease|muscular atrophy,ppi
3775,4540,84693,MCEE,methylmalonyl-CoA epimerase,3,methylmalonyl-CoA epimerase activity,,ppi
3776,4541,399664,MEX3D,mex-3 RNA binding family member D,12,RNA binding|AU-rich element binding,,ppi
3777,4542,387521,TMEM189,transmembrane protein 189,30,,,ppi
3778,4543,30832,ZNF354C,zinc finger protein 354C,17,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3779,4544,916,CD3E,CD3e molecule,36,transmembrane signaling receptor activity|protein kinase binding|receptor signaling complex scaffold activity|T cell receptor binding|protein homodimerization activity,rheumatoid arthritis|primary immunodeficiency disease|adenosine deaminase deficiency|MHC class II deficiency|severe combined immunodeficiency,ppi
3780,4545,27107,ZBTB11,zinc finger and BTB domain containing 11,17,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3781,4546,399694,SHC4,SHC adaptor protein 4,10,receptor tyrosine kinase binding,,ppi
3782,4547,25792,CIZ1,CDKN1A interacting zinc finger protein 1,23,,dystonia|prostate cancer|prostate carcinoma|Ewing sarcoma,ppi
3783,4548,10150,MBNL2,muscleblind like splicing regulator 2,8,RNA binding,,ppi
3784,4549,51385,ZNF589,zinc finger protein 589,4,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
3785,4550,917,CD3G,CD3g molecule,7,transmembrane signaling receptor activity|receptor signaling complex scaffold activity|T cell receptor binding|protein homodimerization activity,dermatitis|primary immunodeficiency disease,ppi
3786,4551,9588,PRDX6,peroxiredoxin 6,95,glutathione peroxidase activity|protein homodimerization activity|cadherin binding|calcium-independent phospholipase A2 activity|protein binding|peroxidase activity,contact dermatitis|occupational dermatitis|Down syndrome|lung benign neoplasm|adult respiratory distress syndrome|newborn respiratory distress syndrome|schizophrenia|coronary artery disease|liver cancer|hepatocellular carcinoma,ppi
3787,4552,116983,ACAP3,ArfGAP with coiled-coil; ankyrin repeat and PH domains 3,6,,,ppi
3788,4553,50813,COPS7A,COP9 signalosome subunit 7A,92,,stomach cancer,ppi
3789,4554,27300,ZNF544,zinc finger protein 544,11,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
3790,4555,64708,COPS7B,COP9 signalosome subunit 7B,65,,,ppi
3791,4556,399671,HEATR4,HEAT repeat containing 4,2,,,ppi
3792,4557,23090,ZNF423,zinc finger protein 423,23,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding,ptosis|congenital ptosis|cerebellar disease|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|Meckel syndrome|autosomal dominant polycystic kidney disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|Senior-Loken syndrome|nephronophthisis|fundus dystrophy|autistic disorder,ppi
3793,4558,27033,ZBTB32,zinc finger and BTB domain containing 32,20,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription corepressor activity|zinc ion binding,,ppi
3794,4559,10773,ZBTB6,zinc finger and BTB domain containing 6,9,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3795,4560,116443,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,6,NMDA glutamate receptor activity|glycine binding|protein phosphatase 2A binding,bipolar disorder|schizophrenia|psychologic dyspareunia|premature ejaculation,ppi
3796,4561,116444,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B,3,cation channel activity|glycine binding|neurotransmitter receptor activity|neurotransmitter binding|calcium channel activity,,ppi
3797,4562,64689,GORASP1,golgi reassembly stacking protein 1,53,,,ppi
3798,4563,919,CD247,CD247 molecule,124,protein homodimerization activity,agnosia|hypereosinophilic syndrome|primary immunodeficiency disease|uveitis|anterior uveitis|ciliary body disease|systemic scleroderma|scleroderma|juvenile rheumatoid arthritis|arthropathy|arthritis|neurogenic arthropathy,ppi
3799,4564,80031,SEMA6D,semaphorin 6D,2,neuropilin binding|chemorepellent activity|semaphorin receptor binding,substance abuse|substance-related disorder,ppi
3800,4567,81870,KRTAP9-9,keratin associated protein 9-9,1,,,ppi
3801,4569,83755,KRTAP4-12,keratin associated protein 4-12,108,,,ppi
3802,4571,83896,KRTAP3-1,keratin associated protein 3-1,3,,,ppi
3803,4572,83897,KRTAP3-2,keratin associated protein 3-2,29,,,ppi
3804,4573,920,CD4,CD4 molecule,110,transmembrane signaling receptor activity|extracellular matrix structural constituent|zinc ion binding|coreceptor activity|signaling receptor activity|interleukin-16 receptor activity|MHC class II protein binding|protein homodimerization activity|protein tyrosine kinase binding,Duchenne muscular dystrophy|muscular dystrophy,ppi
3805,4574,80896,NPL,N-acetylneuraminate pyruvate lyase,4,N-acetylneuraminate lyase activity,,ppi
3806,4575,81627,TRMT1L,tRNA methyltransferase 1 like,37,RNA binding|tRNA (guanine-N2-)-methyltransferase activity,,ppi
3807,4576,79577,CDC73,cell division cycle 73,257,RNA polymerase II complex binding,parathyroid carcinoma|parathyroid adenoma|hyperparathyroidism,ppi
3808,4577,116496,FAM129A,family with sequence similarity 129 member A,6,,,ppi
3809,4578,54823,SWT1,SWT1; RNA endoribonuclease homolog,2,,,ppi
3810,4579,80267,EDEM3,ER degradation enhancing alpha-mannosidase like protein 3,10,mannosyl-oligosaccharide 1;2-alpha-mannosidase activity,,ppi
3811,4580,81626,SHCBP1L,SHC binding and spindle associated 1 like,1,,,ppi
3812,4581,23057,NMNAT2,nicotinamide nucleotide adenylyltransferase 2,1,nicotinamide-nucleotide adenylyltransferase activity|nicotinate-nucleotide adenylyltransferase activity,,ppi
3813,4582,23127,COLGALT2,collagen beta(1-O)galactosyltransferase 2,40,procollagen galactosyltransferase activity,,ppi
3814,4583,116461,TSEN15,tRNA splicing endonuclease subunit 15,11,,,ppi
3815,4584,9887,SMG7,SMG7; nonsense mediated mRNA decay factor,36,telomeric DNA binding|protein phosphatase 2A binding|telomerase RNA binding|ribonuclease activity,,ppi
3816,4585,135250,RAET1E,retinoic acid early transcript 1E,19,natural killer cell lectin-like receptor binding,,ppi
3817,4586,353091,RAET1G,retinoic acid early transcript 1G,2,natural killer cell lectin-like receptor binding,,ppi
3818,4588,10120,ACTR1B,ARP1 actin-related protein 1 homolog B; centractin beta,55,,,ppi
3819,4590,9690,UBE3C,ubiquitin protein ligase E3C,43,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,,ppi
3820,4591,11060,WWP2,WW domain containing E3 ubiquitin protein ligase 2,185,RNA polymerase II transcription factor binding|ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
3821,4593,51366,UBR5,ubiquitin protein ligase E3 component n-recognin 5,167,ubiquitin-protein transferase activity|ubiquitin-ubiquitin ligase activity|ubiquitin protein ligase activity,,ppi
3822,4594,57154,SMURF1,SMAD specific E3 ubiquitin protein ligase 1,383,ubiquitin-protein transferase activity|phospholipid binding|activin binding|ubiquitin protein ligase activity,,ppi
3823,4595,197131,UBR1,ubiquitin protein ligase E3 component n-recognin 1,81,leucine binding|ubiquitin protein ligase activity,Johanson-Blizzard syndrome,ppi
3824,4596,64750,SMURF2,SMAD specific E3 ubiquitin protein ligase 2,156,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
3825,4597,960,CD44,CD44 molecule (Indian blood group),122,collagen binding|hyaluronic acid binding|cytokine receptor activity|transmembrane signaling receptor activity,contact dermatitis|occupational dermatitis|IgA glomerulonephritis|acute myeloid leukemia|acute promyelocytic leukemia|pancreatic cancer|seborrheic keratosis|skin disease|actinic keratosis|stomach cancer|vitiligo,ppi
3826,4598,85397,RGS8,regulator of G-protein signaling 8,4,GTPase activator activity,,ppi
3827,4599,51174,TUBD1,tubulin delta 1,6,GTP binding|structural constituent of cytoskeleton,,ppi
3828,4600,56997,COQ8A,coenzyme Q8A,40,kinase activity|ADP binding|protein kinase activity,coenzyme Q10 deficiency disease,ppi
3829,4601,116729,PPP1R27,protein phosphatase 1 regulatory subunit 27,1,phosphatase binding,,ppi
3830,4602,117154,DACH2,dachshund family transcription factor 2,7,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,,ppi
3831,4603,162466,PHOSPHO1,phosphoethanolamine/phosphocholine phosphatase,55,pyrophosphatase activity|phosphocholine phosphatase activity|phosphoethanolamine phosphatase activity,,ppi
3832,4604,26038,CHD5,chromodomain helicase DNA binding protein 5,21,H3K27me3 modified histone binding,large intestine cancer|colorectal cancer|neuroblastoma,ppi
3833,4605,8220,DGCR14,DiGeorge syndrome critical region gene 14,47,,blepharophimosis|isolated cleft palate|cleft palate|endocrine system disease|ventricular septal defect|inguinal hernia|umbilical hernia|omphalocele|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|intellectual disability|learning disability|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X|Nance-Horan syndrome|Muenke Syndrome,ppi
3834,4606,8226,PUDP,pseudouridine 5'-phosphatase,10,hydrolase activity|magnesium ion binding,,ppi
3835,4607,961,CD47,CD47 molecule,35,thrombospondin receptor activity,,ppi
3836,4608,8578,SCARF1,scavenger receptor class F member 1,2,transmembrane signaling receptor activity|scavenger receptor activity|low-density lipoprotein particle binding,,ppi
3837,4609,8602,NOP14,NOP14 nucleolar protein,29,RNA binding|snoRNA binding,,ppi
3838,4610,8603,FAM193A,family with sequence similarity 193 member A,4,,,ppi
3839,4611,8834,TMEM11,transmembrane protein 11,34,,,ppi
3840,4613,55613,MTMR8,myotubularin related protein 8,15,phosphatidylinositol-3-phosphatase activity|phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity,,ppi
3841,4614,8848,TSC22D1,TSC22 domain family member 1,164,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3842,4615,8872,CDC123,cell division cycle 123,13,,,ppi
3843,4616,9117,SEC22C,SEC22 homolog C; vesicle trafficking protein,7,,,ppi
3844,4617,9136,RRP9,ribosomal RNA processing 9; small subunit (SSU) processome component; homolog (yeast),31,RNA binding|U3 snoRNA binding|snoRNA binding,stomach cancer,ppi
3845,4618,962,CD48,CD48 molecule,13,,schizophrenia,ppi
3846,4619,9235,IL32,interleukin 32,16,,colon cancer|colonic benign neoplasm|kidney cancer|Sezary's disease|stomach cancer|allergic contact dermatitis,ppi
3847,4620,9256,TSPOAP1,TSPO associated protein 1,20,benzodiazepine receptor binding,,ppi
3848,4621,9296,ATP6V1F,ATPase H+ transporting V1 subunit F,53,proton transmembrane transporter activity|ATPase activity; uncoupled|ATPase coupled ion transmembrane transporter activity,,ppi
3849,4622,9306,SOCS6,suppressor of cytokine signaling 6,51,1-phosphatidylinositol-3-kinase regulator activity,,ppi
3850,4623,9315,NREP,neuronal regeneration related protein,7,,fatty liver disease,ppi
3851,4624,9344,TAOK2,TAO kinase 2,23,protein serine/threonine kinase activity|MAP kinase kinase kinase activity,,ppi
3852,4625,9392,TGFBRAP1,transforming growth factor beta receptor associated protein 1,29,transforming growth factor beta receptor binding|SMAD binding,,ppi
3853,4626,9450,LY86,lymphocyte antigen 86,2,,calcium metabolism disease|nephrocalcinosis|calcinosis|heart valve disease,ppi
3854,4627,140467,ZNF358,zinc finger protein 358,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3855,4628,9473,THEMIS2,thymocyte selection associated family member 2,3,,breast cancer,ppi
3856,4629,9477,MED20,mediator complex subunit 20,122,DNA-directed 5'-3' RNA polymerase activity|transcription coactivator activity,,ppi
3857,4630,9516,LITAF,lipopolysaccharide induced TNF factor,45,RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|zinc ion binding,Charcot-Marie-Tooth disease type 1C,ppi
3858,4631,9537,TP53I11,tumor protein p53 inducible protein 11,5,,,ppi
3859,4632,9586,CREB5,cAMP responsive element binding protein 5,52,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
3860,4633,9589,WTAP,Wilms tumor 1 associated protein,26,,,ppi
3861,4634,100131439,CD300LD,CD300 molecule like family member d,1,,,ppi
3862,4635,9643,MORF4L2,mortality factor 4 like 2,105,,,ppi
3863,4636,921,CD5,CD5 molecule,25,transmembrane signaling receptor activity|signaling receptor activity,rheumatoid arthritis|chronic lymphocytic leukemia|Richter's syndrome,ppi
3864,4637,9646,CTR9,CTR9 homolog; Paf1/RNA polymerase II complex component,112,RNA polymerase II complex binding,,ppi
3865,4638,9649,RALGPS1,Ral GEF with PH domain and SH3 binding motif 1,5,guanyl-nucleotide exchange factor activity|Ral guanyl-nucleotide exchange factor activity,urinary bladder cancer,ppi
3866,4639,9655,SOCS5,suppressor of cytokine signaling 5,11,1-phosphatidylinositol-3-kinase regulator activity,,ppi
3867,4640,9670,IPO13,importin 13,36,nuclear localization sequence binding|protein transporter activity,,ppi
3868,4641,9693,RAPGEF2,Rap guanine nucleotide exchange factor 2,67,Ras guanyl-nucleotide exchange factor activity|GTPase activator activity|calcium ion binding|Rap guanyl-nucleotide exchange factor activity|diacylglycerol binding|PDZ domain binding|cAMP binding|beta-1 adrenergic receptor binding|WW domain binding|phosphatidic acid binding|cGMP binding,,ppi
3869,4642,9697,TRAM2,translocation associated membrane protein 2,6,,,ppi
3870,4643,9700,ESPL1,extra spindle pole bodies like 1; separase,39,catalytic activity|cysteine-type peptidase activity|cysteine-type endopeptidase activity,urinary bladder cancer|transitional cell carcinoma|salivary gland adenoid cystic carcinoma,ppi
3871,4644,83855,KLF16,Kruppel like factor 16,21,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3872,4645,9712,USP6NL,USP6 N-terminal like,15,GTPase activator activity|Rab GTPase binding,melanoma|skin melanoma,ppi
3873,4646,9722,NOS1AP,nitric oxide synthase 1 adaptor protein,52,nitric-oxide synthase binding,long QT syndrome|long QT syndrome 1|schizophrenia,ppi
3874,4647,963,CD53,CD53 molecule,10,,,ppi
3875,4648,9733,SART3,squamous cell carcinoma antigen recognized by T-cells 3,156,RNA binding|U6 snRNA binding|U4 snRNA binding|U6atac snRNA binding|histone binding,,ppi
3876,4649,10401,PIAS3,protein inhibitor of activated STAT 3,60,SUMO transferase activity,cervical cancer,ppi
3877,4650,9771,RAPGEF5,Rap guanine nucleotide exchange factor 5,29,Ras guanyl-nucleotide exchange factor activity|Rap guanyl-nucleotide exchange factor activity,bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
3878,4651,9774,BCLAF1,BCL2 associated transcription factor 1,107,DNA binding|RNA binding,lung small cell carcinoma,ppi
3879,4652,9787,DLGAP5,DLG associated protein 5,24,phosphoprotein phosphatase activity,,ppi
3880,4653,9796,PHYHIP,phytanoyl-CoA 2-hydroxylase interacting protein,33,,,ppi
3881,4654,9810,RNF40,ring finger protein 40,96,mRNA 3'-UTR binding|ubiquitin-protein transferase activity,,ppi
3882,4655,9823,ARMCX2,armadillo repeat containing; X-linked 2,3,,,ppi
3883,4656,9833,MELK,maternal embryonic leucine zipper kinase,24,protein serine/threonine kinase activity|non-membrane spanning protein tyrosine kinase activity|calcium ion binding,,ppi
3884,4657,503542,SPRN,shadow of prion protein homolog (zebrafish),1,nucleic acid binding,,ppi
3885,4658,347734,SLC35B2,solute carrier family 35 member B2,23,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,,ppi
3886,4659,9896,FIG4,FIG4 phosphoinositide 5-phosphatase,7,phosphatidylinositol-3;5-bisphosphate 5-phosphatase activity,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|Charcot-Marie-Tooth disease type 2|hereditary motor and sensory neuropathy with agenesis of the corpus callosum|hereditary neuropathy with liability to pressure palsies|Charcot-Marie-Tooth disease type 1A|Charcot-Marie-Tooth disease type 1F|Charcot-Marie-Tooth disease type 1D|Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease type 1B|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease type 2A1|Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2B1|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2B|Charcot-Marie-Tooth disease axonal type 2T,ppi
3887,4660,9899,SV2B,synaptic vesicle glycoprotein 2B,3,,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
3888,4661,9902,MRC2,mannose receptor C type 2,25,collagen binding|transmembrane signaling receptor activity,,ppi
3889,4662,9915,ARNT2,aryl hydrocarbon receptor nuclear translocator 2,65,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|aryl hydrocarbon receptor binding|protein heterodimerization activity,Cauda equina syndrome|neurogenic bladder|isolated cleft palate|cleft palate|cryptorchidism|neurohypophyseal diabetes insipidus|diabetes insipidus|enophthalmos|orbital disease|exophthalmos|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|hydronephrosis|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy,ppi
3890,4663,9927,MFN2,mitofusin 2,22,GTPase activity,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|pseudosarcomatous fibromatosis|pleomorphic lipoma|lipoma|optic atrophy|Troyer syndrome|Mast syndrome|MASA syndrome|SPOAN syndrome|Charcot-Marie-Tooth disease type 5|hereditary spastic paraplegia 10|hereditary spastic paraplegia 11|hereditary spastic paraplegia 12|hereditary spastic paraplegia 13|hereditary spastic paraplegia 14,ppi
3891,4664,9931,HELZ,helicase with zinc finger,38,RNA binding,,ppi
3892,4665,9985,REC8,REC8 meiotic recombination protein,12,chromatin binding,melanoma|skin melanoma|prostate cancer|prostate carcinoma,ppi
3893,4666,965,CD58,CD58 molecule,13,signaling receptor binding,multiple sclerosis,ppi
3894,4667,548313,SSX4B,SSX family member 4B,4,,,ppi
3895,4668,195827,AAED1,AhpC/TSA antioxidant enzyme domain containing 1,2,antioxidant activity,,ppi
3896,4669,10021,HCN4,hyperpolarization activated cyclic nucleotide gated potassium channel 4,5,intracellular cAMP-activated cation channel activity|voltage-gated sodium channel activity|voltage-gated potassium channel activity|voltage-gated potassium channel activity involved in SA node cell action potential depolarization,atrial fibrillation|sick sinus syndrome|catecholaminergic polymorphic ventricular tachycardia|catecholaminergic polymorphic ventricular tachycardia 1|catecholaminergic polymorphic ventricular tachycardia 2|catecholaminergic polymorphic ventricular tachycardia 3|catecholaminergic polymorphic ventricular tachycardia 4|catecholaminergic polymorphic ventricular tachycardia 5|mood disorder|Brugada syndrome|Brugada syndrome 1|Brugada syndrome 8,ppi
3897,4670,10044,SH2D3C,SH2 domain containing 3C,14,SH3/SH2 adaptor activity,,ppi
3898,4671,10045,SH2D3A,SH2 domain containing 3A,8,SH3/SH2 adaptor activity,,ppi
3899,4672,10158,PDZK1IP1,PDZK1 interacting protein 1,4,,prostate cancer|prostate carcinoma,ppi
3900,4673,10170,DHRS9,dehydrogenase/reductase 9,10,alcohol dehydrogenase (NAD) activity|retinol dehydrogenase activity|racemase and epimerase activity|testosterone dehydrogenase (NAD+) activity,,ppi
3901,4674,10213,PSMD14,proteasome 26S subunit; non-ATPase 14,125,metallopeptidase activity|thiol-dependent ubiquitinyl hydrolase activity|endopeptidase activator activity|Lys63-specific deubiquitinase activity|proteasome binding|thiol-dependent ubiquitin-specific protease activity,,ppi
3902,4675,966,CD59,CD59 molecule,31,complement binding,hemolytic anemia|paroxysmal nocturnal hemoglobinuria|muscular atrophy,ppi
3903,4676,10217,CTDSPL,CTD small phosphatase like,84,phosphoprotein phosphatase activity|RNA polymerase II CTD heptapeptide repeat phosphatase activity,,ppi
3904,4677,10221,TRIB1,tribbles pseudokinase 1,25,protein kinase inhibitor activity|mitogen-activated protein kinase kinase binding|ubiquitin protein ligase binding|ubiquitin-protein transferase regulator activity|protein kinase activity|ATP binding,coronary artery disease,ppi
3905,4678,10225,CD96,CD96 molecule,14,,cryptorchidism|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|patent ductus arteriosus|epilepsy|gingival overgrowth|gingival hypertrophy|ventricular septal defect|intellectual disability|learning disability|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|craniosynostosis|umbilical hernia|omphalocele,ppi
3906,4679,10226,PLIN3,perilipin 3,72,cadherin binding,,ppi
3907,4680,10227,MFSD10,major facilitator superfamily domain containing 10,5,tetracycline transmembrane transporter activity|organic anion transmembrane transporter activity,,ppi
3908,4682,10244,RABEPK,Rab9 effector protein with kelch motifs,14,,,ppi
3909,4683,10247,RIDA,reactive intermediate imine deaminase A homolog,26,RNA binding|endoribonuclease activity; producing 3'-phosphomonoesters|deaminase activity,,ppi
3910,4684,10278,EFS,embryonal Fyn-associated substrate,26,,,ppi
3911,4685,10097,ACTR2,ARP2 actin related protein 2 homolog,145,structural constituent of cytoskeleton|actin filament binding,schizophrenia,ppi
3912,4686,922,CD5L,CD5 molecule like,1,,,ppi
3913,4687,10285,SMNDC1,survival motor neuron domain containing 1,45,RNA binding,,ppi
3914,4688,10290,SPEG,SPEG complex locus,5,protein kinase activity,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
3915,4689,10295,BCKDK,branched chain ketoacid dehydrogenase kinase,30,protein serine/threonine kinase activity|ATP binding|kinase activity|[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,autistic disorder|epilepsy|intellectual disability|learning disability|visual epilepsy,ppi
3916,4690,10318,TNIP1,TNFAIP3 interacting protein 1,99,mitogen-activated protein kinase binding,systemic lupus erythematosus|pustulosis of palm and sole|psoriasis|parapsoriasis|systemic scleroderma|scleroderma|breast cancer|Sjogren's syndrome|keratoconjunctivitis sicca,ppi
3917,4691,10321,CRISP3,cysteine rich secretory protein 3,1,,ectopic pregnancy,ppi
3918,4692,10324,KLHL41,kelch like family member 41,13,,nemaline myopathy,ppi
3919,4693,373156,GSTK1,glutathione S-transferase kappa 1,117,glutathione transferase activity|glutathione peroxidase activity,arthropathy|arthritis|prostate cancer|prostate carcinoma,ppi
3920,4694,10403,NDC80,NDC80; kinetochore complex component,83,,,ppi
3921,4695,923,CD6,CD6 molecule,10,lipopolysaccharide binding|lipoteichoic acid binding,multiple sclerosis,ppi
3922,4697,10436,EMG1,EMG1; N1-specific pseudouridine methyltransferase,28,RNA binding|rRNA (pseudouridine) methyltransferase activity|rRNA binding,cryptorchidism|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|arthropathy|arthritis|neurogenic arthropathy|placental insufficiency|Bowen-Conradi syndrome,ppi
3923,4698,56998,CTNNBIP1,catenin beta interacting protein 1,30,beta-catenin binding,,ppi
3924,4699,10446,LRRN2,leucine rich repeat neuronal 2,16,signaling receptor activity,,ppi
3925,4700,10456,HAX1,HCLS1 associated protein X-1,151,interleukin-1 binding|protein N-terminus binding,leukemia|hematologic cancer|neutropenia|agranulocytosis|severe congenital neutropenia|essential thrombocythemia|myelodysplastic syndrome,ppi
3926,4701,10462,CLEC10A,C-type lectin domain family 10 member A,2,,bipolar disorder|coronary artery disease,ppi
3927,4702,10489,LRRC41,leucine rich repeat containing 41,20,protein homodimerization activity,,ppi
3928,4703,10492,SYNCRIP,synaptotagmin binding cytoplasmic RNA interacting protein,335,RNA binding,,ppi
3929,4704,10493,VAT1,vesicle amine transport 1,23,,,ppi
3930,4705,967,CD63,CD63 molecule,28,,,ppi
3931,4706,10519,CIB1,calcium and integrin binding 1,26,calcium ion binding|calcium-dependent protein kinase inhibitor activity|protein serine/threonine kinase inhibitor activity|protein membrane anchor,,ppi
3932,4707,116986,AGAP2,ArfGAP with GTPase domain; ankyrin repeat and PH domain 2,18,GTPase activity,,ppi
3933,4708,116987,AGAP1,ArfGAP with GTPase domain; ankyrin repeat and PH domain 1,22,phospholipid binding,autistic disorder,ppi
3934,4709,116988,AGAP3,ArfGAP with GTPase domain; ankyrin repeat and PH domain 3,15,GTPase activity|polyubiquitin modification-dependent protein binding,,ppi
3935,4710,116984,ARAP2,ArfGAP with RhoGAP domain; ankyrin repeat and PH domain 2,1,GTPase activator activity|phosphatidylinositol-3;4;5-trisphosphate binding,,ppi
3936,4711,116985,ARAP1,ArfGAP with RhoGAP domain; ankyrin repeat and PH domain 1,25,GTPase activator activity|phosphatidylinositol-3;4;5-trisphosphate binding,,ppi
3937,4712,83899,KRTAP9-2,keratin associated protein 9-2,55,,,ppi
3938,4713,83900,KRTAP9-3,keratin associated protein 9-3,4,,,ppi
3939,4715,968,CD68,CD68 molecule,15,,psoriatic arthritis|ischemia|chronic kidney disease|amyotrophic lateral sclerosis type 1,ppi
3940,4716,10523,CHERP,calcium homeostasis endoplasmic reticulum protein,71,RNA binding,,ppi
3941,4717,10525,HYOU1,hypoxia up-regulated 1,82,chaperone binding,spinocerebellar ataxia type 17,ppi
3942,4718,10529,NEBL,nebulette,35,cytoskeletal protein binding|structural constituent of muscle|actin filament binding,,ppi
3943,4719,56929,FEM1C,fem-1 homolog C,11,,,ppi
3944,4720,55527,FEM1A,fem-1 homolog A,10,ubiquitin-protein transferase activity,,ppi
3945,4721,10533,ATG7,autophagy related 7,64,ubiquitin activating enzyme activity|Atg12 activating enzyme activity|protein homodimerization activity|Atg8 activating enzyme activity,anemia|macrocytic anemia|lymphopenia,ppi
3946,4722,84918,LRP11,LDL receptor related protein 11,17,phosphoprotein binding,,ppi
3947,4723,10550,ARL6IP5,ADP ribosylation factor like GTPase 6 interacting protein 5,49,,stomach cancer,ppi
3948,4724,10561,IFI44,interferon induced protein 44,2,,influenza,ppi
3949,4725,10569,SLU7,SLU7 homolog; splicing factor,33,second spliceosomal transesterification activity|zinc ion binding|pre-mRNA 3'-splice site binding,,ppi
3950,4726,969,CD69,CD69 molecule,6,transmembrane signaling receptor activity|protein homodimerization activity,arthropathy|arthritis|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20,ppi
3951,4727,84649,DGAT2,diacylglycerol O-acyltransferase 2,2,diacylglycerol O-acyltransferase activity|protein homodimerization activity,,ppi
3952,4728,10590,SCGN,secretagogin; EF-hand calcium binding protein,22,calcium ion binding,,ppi
3953,4729,10595,ERN2,endoplasmic reticulum to nucleus signaling 2,1,magnesium ion binding|endonuclease activity|protein serine/threonine kinase activity|ATP binding,,ppi
3954,4730,10602,CDC42EP3,CDC42 effector protein 3,9,cytoskeletal regulatory protein binding|GTP-Rho binding,schizophrenia,ppi
3955,4731,84991,RBM17,RNA binding motif protein 17,57,,autosomal dominant cerebellar ataxia,ppi
3956,4732,10605,PAIP1,poly(A) binding protein interacting protein 1,43,translation activator activity,,ppi
3957,4733,10609,P3H4,prolyl 3-hydroxylase family member 4 (non-enzymatic),25,,,ppi
3958,4734,10613,ERLIN1,ER lipid raft associated 1,44,cholesterol binding,,ppi
3959,4735,56005,MYDGF,myeloid derived growth factor,12,,,ppi
3960,4736,54954,FAM120C,family with sequence similarity 120C,11,RNA binding,,ppi
3961,4737,924,CD7,CD7 molecule,11,signaling receptor activity,amyotrophic lateral sclerosis type 1,ppi
3962,4738,10617,STAMBP,STAM binding protein,70,thiol-dependent ubiquitin-specific protease activity|Lys63-specific deubiquitinase activity,ptosis|congenital ptosis|brain disease|isolated cleft palate|cleft palate|sensorineural hearing loss|epilepsy|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|microcephaly,ppi
3963,4739,10625,IVNS1ABP,influenza virus NS1A binding protein,69,,prostate cancer|prostate carcinoma,ppi
3964,4740,10628,TXNIP,thioredoxin interacting protein,43,,rheumatoid arthritis|endometriosis of uterus|endometriosis,ppi
3965,4741,10631,POSTN,periostin,3,extracellular matrix structural constituent|heparin binding|metal ion binding|cell adhesion molecule binding,large intestine cancer|colorectal cancer|Duchenne muscular dystrophy|muscular dystrophy,ppi
3966,4742,10633,RASL10A,RAS like family 10 member A,5,,,ppi
3967,4743,10634,GAS2L1,growth arrest specific 2 like 1,27,thyroid hormone receptor binding,acute myeloid leukemia|schizophrenia,ppi
3968,4744,10635,RAD51AP1,RAD51 associated protein 1,16,double-stranded DNA binding|single-stranded DNA binding|RNA binding,,ppi
3969,4746,10652,YKT6,YKT6 v-SNARE homolog (S. cerevisiae),52,SNAP receptor activity|protein-cysteine S-palmitoyltransferase activity|cadherin binding,,ppi
3970,4747,971,CD72,CD72 molecule,10,transmembrane signaling receptor activity|signaling receptor binding,,ppi
3971,4748,10660,LBX1,ladybird homeobox 1,1,DNA-binding transcription factor activity; RNA polymerase II-specific,bipolar disorder|breast cancer,ppi
3972,4749,10666,CD226,CD226 molecule,5,,large intestine cancer|colorectal cancer|endometriosis of uterus|endometriosis|systemic lupus erythematosus,ppi
3973,4751,10670,RRAGA,Ras related GTP binding A,40,GTPase activity|GTP binding|protein homodimerization activity|protein heterodimerization activity|phosphoprotein binding,,ppi
3974,4752,10671,DCTN6,dynactin subunit 6,38,,,ppi
3975,4753,10771,ZMYND11,zinc finger MYND-type containing 11,50,double-stranded DNA binding|transcription corepressor activity|zinc ion binding|methylated histone binding,autistic disorder|ptosis|congenital ptosis|intellectual disability|learning disability,ppi
3976,4754,10776,ARPP19,cAMP regulated phosphoprotein 19,7,signaling receptor binding|potassium channel regulator activity|phosphatase inhibitor activity|protein phosphatase regulator activity|protein phosphatase 2A binding|protein phosphatase inhibitor activity,,ppi
3977,4755,10777,ARPP21,cAMP regulated phosphoprotein 21,2,,,ppi
3978,4756,10808,HSPH1,heat shock protein family H (Hsp110) member 1,124,adenyl-nucleotide exchange factor activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
3979,4757,972,CD74,CD74 molecule,19,cytokine receptor activity|MHC class II protein complex binding|MHC class II protein binding|MHC class II protein binding; via antigen binding groove|identical protein binding|protein binding involved in protein folding,lung cancer|non-small cell lung carcinoma|hepatitis|breast cancer,ppi
3980,4758,10817,FRS3,fibroblast growth factor receptor substrate 3,36,Ras guanyl-nucleotide exchange factor activity,,ppi
3981,4759,10818,FRS2,fibroblast growth factor receptor substrate 2,33,transmembrane receptor protein tyrosine kinase adaptor activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|phosphatase activator activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,,ppi
3982,4760,10842,PPP1R17,protein phosphatase 1 regulatory subunit 17,1,,familial hypercholesterolemia,ppi
3983,4761,10847,SRCAP,Snf2 related CREBBP activator protein,42,transcription coactivator activity|histone acetyltransferase activity|histone binding|ATPase activity,celiac disease|constipation|salivary gland adenoid cystic carcinoma|enophthalmos|orbital disease|exophthalmos|placental insufficiency|hypertrichosis|intellectual disability|learning disability|speech disorder,ppi
3984,4762,149428,BNIPL,BCL2 interacting protein like,15,exopolyphosphatase activity,,ppi
3985,4763,10870,HCST,hematopoietic cell signal transducer,4,phosphatidylinositol 3-kinase binding|signaling receptor binding,,ppi
3986,4765,10877,CFHR4,complement factor H related 4,2,lipid transporter activity,hemolytic-uremic syndrome,ppi
3987,4766,973,CD79A,CD79a molecule,56,protein homodimerization activity,agammaglobulinemia|arthropathy|arthritis|conjunctivitis|exanthem|primary immunodeficiency disease|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|sinusitis|otitis media,ppi
3988,4767,10878,CFHR3,complement factor H related 3,4,,IgA glomerulonephritis|age related macular degeneration 1|hemolytic-uremic syndrome,ppi
3989,4768,9258,MFHAS1,malignant fibrous histiocytoma amplified sequence 1,7,GTP binding|protein phosphatase 2A binding,,ppi
3990,4769,116448,OLIG1,oligodendrocyte transcription factor 1,22,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
3991,4770,10900,RUNDC3A,RUN domain containing 3A,41,GTPase regulator activity,,ppi
3992,4771,10901,DHRS4,dehydrogenase/reductase 4,49,3-keto sterol reductase activity|carbonyl reductase (NADPH) activity|oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor|alcohol dehydrogenase [NAD(P)+] activity|NADP-retinol dehydrogenase activity,,ppi
3993,4772,10960,LMAN2,lectin; mannose binding 2,30,mannose binding|carbohydrate binding,,ppi
3994,4773,10910,SUGT1,SGT1 homolog; MIS12 kinetochore complex assembly cochaperone,105,,,ppi
3995,4774,10929,SRSF8,serine and arginine rich splicing factor 8,34,RNA binding,,ppi
3996,4775,10933,MORF4L1,mortality factor 4 like 1,114,,salivary gland adenoid cystic carcinoma,ppi
3997,4776,974,CD79B,CD79b molecule,107,protein homodimerization activity,agammaglobulinemia|arthropathy|arthritis|conjunctivitis|exanthem|primary immunodeficiency disease|gallbladder disease|liver disease|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|sinusitis|chronic sphenoidal sinusitis|chronic ethmoiditis|otitis media,ppi
3998,4777,10944,C11orf58,chromosome 11 open reading frame 58,51,,,ppi
3999,4778,10970,CKAP4,cytoskeleton associated protein 4,102,RNA binding,,ppi
4000,4779,55144,LRRC8D,leucine rich repeat containing 8 family member D,5,volume-sensitive anion channel activity,,ppi
4001,4780,10952,SEC61B,Sec61 translocon beta subunit,53,RNA binding|ARF guanyl-nucleotide exchange factor activity|P-P-bond-hydrolysis-driven protein transmembrane transporter activity,,ppi
4002,4781,10956,OS9,OS9; endoplasmic reticulum lectin,120,protein binding,,ppi
4003,4783,10959,TMED2,transmembrane p24 trafficking protein 2,68,,coronary artery disease,ppi
4004,4784,10962,MLLT11,myeloid/lymphoid or mixed-lineage leukemia; translocated to; 11,8,,juvenile myelomonocytic leukemia,ppi
4005,4785,10972,TMED10,transmembrane p24 trafficking protein 10,67,,,ppi
4006,4786,10978,CLP1,cleavage and polyadenylation factor I subunit 1,18,ATP binding|polydeoxyribonucleotide kinase activity|ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,cryptorchidism|monocular esotropia|esotropia|enophthalmos|orbital disease|exophthalmos|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|brain disease|cerebral degeneration|pontocerebellar hypoplasia type 10,ppi
4007,4788,10096,ACTR3,ARP3 actin related protein 3 homolog,102,structural constituent of cytoskeleton|actin filament binding,,ppi
4008,4789,941,CD80,CD80 molecule,5,coreceptor activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,celiac disease|primary biliary cirrhosis|vitiligo,ppi
4009,4790,11010,GLIPR1,GLI pathogenesis related 1,9,,adenosarcoma|nephroblastoma,ppi
4010,4791,51588,PIAS4,protein inhibitor of activated STAT 4,103,zinc ion binding|SUMO transferase activity|SUMO ligase activity,,ppi
4011,4792,11037,STON1,stonin 1,1,,,ppi
4012,4793,11059,WWP1,WW domain containing E3 ubiquitin protein ligase 1,88,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
4013,4794,11061,CNMD,chondromodulin,6,,,ppi
4014,4795,11072,DUSP14,dual specificity phosphatase 14,63,RNA binding,,ppi
4015,4796,11073,TOPBP1,topoisomerase (DNA) II binding protein 1,63,protein C-terminus binding,chronic lymphocytic leukemia|Richter's syndrome,ppi
4016,4797,11078,TRIOBP,TRIO and F-actin binding protein,37,GTP-Rho binding|myosin II binding|actin filament binding,autosomal recessive nonsyndromic deafness 28,ppi
4017,4798,975,CD81,CD81 molecule,223,virus receptor activity|integrin binding|MHC class II protein complex binding,hemolytic anemia|imperforate anus|bronchiectasis|common variable immunodeficiency|hepatitis C|primary immunodeficiency disease|lymphopenia|pneumonia|purpura|agammaglobulinemia|liver disease|craniosynostosis|thrombocytopenia|thrombocytopenia due to platelet alloimmunization|autoimmune thrombocytopenic purpura|otitis media|Evans' syndrome,ppi
4018,4799,11097,NUPL2,nucleoporin like 2,19,RNA binding|nuclear export signal receptor activity,,ppi
4019,4800,11100,HNRNPUL1,heterogeneous nuclear ribonucleoprotein U like 1,138,RNA binding,,ppi
4020,4801,11116,FGFR1OP,FGFR1 oncogene partner,134,protein tyrosine kinase activity|protein tyrosine kinase inhibitor activity|protein homodimerization activity,,ppi
4021,4802,11126,CD160,CD160 molecule,3,signaling receptor binding|MHC class I receptor activity|signaling receptor activity,cocaine abuse|cocaine dependence|morphine dependence,ppi
4022,4803,11135,CDC42EP1,CDC42 effector protein 1,20,cadherin binding involved in cell-cell adhesion|GTP-Rho binding,,ppi
4023,4804,11137,PWP1,PWP1 homolog; endonuclein,53,,,ppi
4024,4805,11143,KAT7,lysine acetyltransferase 7,63,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA replication origin binding|transcription regulatory region DNA binding|histone acetyltransferase activity|H4 histone acetyltransferase activity|histone binding,,ppi
4025,4806,11157,LSM6,LSM6 homolog; U6 small nuclear RNA and mRNA degradation associated,47,RNA binding,,ppi
4026,4807,11196,SEC23IP,SEC23 interacting protein,47,RNA binding|phospholipase activity,,ppi
4027,4808,144165,PRICKLE1,prickle planar cell polarity protein 1,9,,early myoclonic encephalopathy|Unverricht-Lundborg syndrome|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy,ppi
4028,4809,11213,IRAK3,interleukin 1 receptor associated kinase 3,20,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
4029,4810,23245,ASTN2,astrotactin 2,3,calcium ion binding|inositol 1;3;4;5 tetrakisphosphate binding,autistic disorder|bipolar disorder|schizophrenia|migraine without aura,ppi
4030,4811,11234,HPS5,HPS5; biogenesis of lysosomal organelles complex 2 subunit 2,16,,oculocutaneous albinism|Griscelli syndrome|Griscelli syndrome type 1|Griscelli syndrome type 2|Griscelli syndrome type 3|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|thrombocytopenia|Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome 5,ppi
4031,4812,11236,RNF139,ring finger protein 139,21,ubiquitin-protein transferase activity|ligase activity|ubiquitin-like protein transferase activity|signaling receptor activity|ubiquitin protein ligase activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|nonpapillary renal cell carcinoma|hereditary conventional renal cell carcinoma,ppi
4032,4813,51131,PHF11,PHD finger protein 11,6,,asthma|intrinsic asthma|allergic asthma,ppi
4033,4815,117247,SLC16A10,solute carrier family 16 member 10,13,amino acid transmembrane transporter activity,,ppi
4034,4816,11267,SNF8,SNF8; ESCRT-II complex subunit,38,transcription factor binding|channel regulator activity,,ppi
4035,4817,11319,ECD,ecdysoneless cell cycle regulator,57,transcription coactivator activity|histone acetyltransferase binding,,ppi
4036,4818,9308,CD83,CD83 molecule,42,,rheumatoid arthritis|seborrheic keratosis|skin disease|actinic keratosis,ppi
4037,4819,11321,GPN1,GPN-loop GTPase 1,65,GTPase activity,,ppi
4038,4820,131890,GRK7,G protein-coupled receptor kinase 7,4,rhodopsin kinase activity,,ppi
4039,4821,11326,VSIG4,V-set and immunoglobulin domain containing 4,64,,IgA glomerulonephritis|acute myeloid leukemia,ppi
4040,4822,11334,TUSC2,tumor suppressor candidate 2,8,,,ppi
4041,4823,11340,EXOSC8,exosome component 8,68,AU-rich element binding|exoribonuclease activity,sensorineural hearing loss|progressive muscular atrophy|spinal muscular atrophy|blindness|cerebral degeneration|pontocerebellar hypoplasia type 1A,ppi
4042,4824,11341,SCRG1,stimulator of chondrogenesis 1,1,,,ppi
4043,4825,51106,TFB1M,transcription factor B1; mitochondrial,18,rRNA (adenine-N6;N6-)-dimethyltransferase activity|RNA binding,,ppi
4044,4826,11343,MGLL,monoglyceride lipase,4,lysophospholipase activity|acylglycerol lipase activity,alcohol dependence|alcohol abuse|osteoporosis|substance abuse|substance-related disorder,ppi
4045,4827,91304,TMEM259,transmembrane protein 259,21,,,ppi
4046,4828,8832,CD84,CD84 molecule,5,,,ppi
4047,4829,22794,CASC3,cancer susceptibility candidate 3,51,RNA binding|identical protein binding,,ppi
4048,4830,22824,HSPA4L,heat shock protein family A (Hsp70) member 4 like,85,ATP binding,,ppi
4049,4831,22827,PUF60,poly(U) binding splicing factor 60,142,RNA binding|cadherin binding,coloboma|heart septal defect|cystic kidney disease|malignant mesothelioma|benign mesothelioma|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|Klippel-Feil syndrome|spondylolisthesis|Potter's syndrome|non-congenital cyst of kidney,ppi
4050,4833,81614,NIPA2,non imprinted in Prader-Willi/Angelman syndrome 2,2,,,ppi
4051,4834,85407,NKD1,naked cuticle homolog 1,4,,,ppi
4052,4835,85409,NKD2,naked cuticle homolog 2,22,,,ppi
4053,4836,942,CD86,CD86 molecule,7,coreceptor activity|signaling receptor activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,contact dermatitis|occupational dermatitis|gallbladder disease|liver disease|multiple myeloma,ppi
4054,4837,51121,RPL26L1,ribosomal protein L26 like 1,156,structural constituent of ribosome|RNA binding,,ppi
4055,4838,22872,SEC31A,SEC31 homolog A; COPII coat complex component,61,structural molecule activity,,ppi
4056,4839,22874,PLEKHA6,pleckstrin homology domain containing A6,8,,schizophrenia,ppi
4057,4840,22876,INPP5F,inositol polyphosphate-5-phosphatase F,1,phosphatidylinositol phosphate 5-phosphatase activity|phosphatidylinositol phosphate 4-phosphatase activity|protein homodimerization activity|phosphatidylinositol-4-phosphate phosphatase activity,,ppi
4058,4841,22877,MLXIP,MLX interacting protein,6,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
4059,4842,22895,RPH3A,rabphilin 3A,23,calcium ion binding|calcium-dependent phospholipid binding|phosphatidylinositol-4;5-bisphosphate binding|zinc ion binding|selenium binding|phosphate ion binding|protein-containing complex binding|inositol 1;4;5 trisphosphate binding|phosphatidylinositol phosphate binding,,ppi
4060,4843,22900,CARD8,caspase recruitment domain family member 8,51,cysteine-type endopeptidase activator activity involved in apoptotic process|protein homodimerization activity,gout|pleural disease,ppi
4061,4845,22908,SACM1L,SAC1 suppressor of actin mutations 1-like (yeast),17,phosphatidylinositol-3-phosphatase activity|phosphatase activity|phosphatidylinositol phosphate 4-phosphatase activity|phosphatidylinositol-4-phosphate phosphatase activity,,ppi
4062,4846,925,CD8A,CD8a molecule,18,coreceptor activity|MHC class I protein binding,bronchiectasis|chronic obstructive pulmonary disease,ppi
4063,4847,22920,KIFAP3,kinesin associated protein 3,76,,,ppi
4064,4848,22921,MSRB2,methionine sulfoxide reductase B2,7,DNA-binding transcription factor activity|actin binding|zinc ion binding|peptide-methionine (R)-S-oxide reductase activity,,ppi
4065,4849,22927,HABP4,hyaluronan binding protein 4,37,,,ppi
4066,4850,22930,RAB3GAP1,RAB3 GTPase activating protein catalytic subunit 1,35,guanyl-nucleotide exchange factor activity|GTPase activator activity|Rab guanyl-nucleotide exchange factor activity,ptosis|congenital ptosis|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38,ppi
4067,4851,22936,ELL2,elongation factor for RNA polymerase II 2,25,,,ppi
4068,4852,22985,ACIN1,apoptotic chromatin condensation inducer 1,121,nucleic acid binding|RNA binding|ATPase activity|enzyme binding,,ppi
4069,4853,23017,FAIM2,Fas apoptotic inhibitory molecule 2,3,,,ppi
4070,4854,23022,PALLD,palladin; cytoskeletal associated protein,45,muscle alpha-actinin binding|cell-cell adhesion mediator activity,pancreatic cancer,ppi
4071,4855,23048,FNBP1,formin binding protein 1,38,,,ppi
4072,4856,926,CD8B,CD8b molecule,4,coreceptor activity|MHC class I protein binding,,ppi
4073,4857,23075,SWAP70,SWAP switching B-cell complex subunit 70,33,cadherin binding,,ppi
4074,4858,23081,KDM4C,lysine demethylase 4C,12,zinc ion binding|histone demethylase activity|histone demethylase activity (H3-K9 specific)|histone demethylase activity (H3-K36 specific)|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|chromatin binding|methylated histone binding,medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|Wernicke-Korsakoff syndrome,ppi
4075,4859,23085,ERC1,ELKS/RAB6-interacting/CAST family member 1,72,Rab GTPase binding|PDZ domain binding|leucine zipper domain binding|cadherin binding,papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma,ppi
4076,4860,23092,ARHGAP26,Rho GTPase activating protein 26,21,GTPase activator activity|phospholipid binding,schizophreniform disorder|schizoaffective disorder|juvenile myelomonocytic leukemia,ppi
4077,4861,23098,SARM1,sterile alpha and TIR motif containing 1,28,,respiratory syncytial virus infectious disease,ppi
4078,4862,23118,TAB2,TGF-beta activated kinase 1/MAP3K7 binding protein 2,126,K63-linked polyubiquitin modification-dependent protein binding,aortic valve insufficiency|aortic valve stenosis|atrial fibrillation|ventricular septal defect|tetralogy of Fallot|aortic aneurysm|subvalvular aortic stenosis,ppi
4079,4863,10106,CTDSP2,CTD small phosphatase 2,38,RNA polymerase II CTD heptapeptide repeat phosphatase activity|phosphoprotein phosphatase activity,,ppi
4080,4864,23122,CLASP2,cytoplasmic linker associated protein 2,50,microtubule binding|microtubule plus-end binding,,ppi
4081,4865,23163,GGA3,golgi associated; gamma adaptin ear containing; ARF binding protein 3,41,ADP-ribosylation factor binding,,ppi
4082,4866,23209,MLC1,megalencephalic leukoencephalopathy with subcortical cysts 1,11,protein transporter activity|protein-containing complex binding,bipolar disorder|cerebellar disease|salivary gland adenoid cystic carcinoma|epilepsy|schizophrenia|visual epilepsy,ppi
4083,4867,23212,RRS1,ribosome biogenesis regulator homolog,175,RNA binding|5S rRNA binding,,ppi
4084,4868,23224,SYNE2,spectrin repeat containing nuclear envelope protein 2,50,actin binding,sick sinus syndrome|atrial fibrillation|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G,ppi
4085,4869,23233,EXOC6B,exocyst complex component 6B,16,,,ppi
4086,4870,23283,CSTF2T,cleavage stimulation factor subunit 2 tau variant,29,RNA binding|mRNA binding,,ppi
4087,4871,23308,ICOSLG,inducible T-cell costimulator ligand,7,signaling receptor binding,celiac disease|inflammatory bowel disease|ulcerative colitis,ppi
4088,4872,23332,CLASP1,cytoplasmic linker associated protein 1,39,microtubule binding|kinetochore binding|microtubule plus-end binding,,ppi
4089,4873,23345,SYNE1,spectrin repeat containing nuclear envelope protein 1,44,RNA binding|actin binding|protein homodimerization activity|actin filament binding,bipolar disorder|cerebellar disease|large intestine cancer|colorectal cancer|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R,ppi
4090,4874,928,CD9,CD9 molecule,30,integrin binding,lung cancer|non-small cell lung carcinoma|large intestine cancer|colorectal cancer|glioblastoma multiforme|giant cell glioblastoma|acute myeloid leukemia|liver cirrhosis|germ cell cancer|germ cell and embryonal cancer|embryonal cancer|prostate cancer|prostate carcinoma,ppi
4091,4875,23370,ARHGEF18,Rho/Rac guanine nucleotide exchange factor 18,8,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
4092,4876,23385,NCSTN,nicastrin,145,endopeptidase activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|hidradenitis suppurativa|hidradenitis|pompholyx,ppi
4093,4877,116832,RPL39L,ribosomal protein L39 like,2,,,ppi
4094,4878,23395,LARS2,leucyl-tRNA synthetase 2; mitochondrial,22,leucine-tRNA ligase activity,bipolar disorder|premature menopause|androgen insensitivity syndrome|schizophrenia|Perrault syndrome,ppi
4095,4879,23404,EXOSC2,exosome component 2,60,3'-5'-exoribonuclease activity|7S RNA binding|exoribonuclease activity|RNA binding,liver cancer,ppi
4096,4880,23405,DICER1,dicer 1; ribonuclease III,78,double-stranded RNA binding|endoribonuclease activity|ribonuclease III activity|siRNA binding|pre-miRNA binding|deoxyribonuclease I activity,basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|endometriosis of uterus|endometriosis|sex cord-gonadal stromal tumor|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|Sertoli cell-only syndrome,ppi
4097,4881,90,ACVR1,activin A receptor type 1,81,protein kinase activity|protein serine/threonine kinase activity|transmembrane receptor protein serine/threonine kinase activity|ATP binding|peptide hormone binding|protein homodimerization activity|SMAD binding|activin binding|transforming growth factor beta binding|activin receptor activity; type I|BMP receptor activity|growth factor binding|transforming growth factor beta receptor activity; type I|transforming growth factor beta-activated receptor activity,alopecia|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|sensorineural hearing loss|fibrodysplasia ossificans progressiva|myositis ossificans|gliosarcoma|mixed glioma|Klippel-Feil syndrome|spondylolisthesis|breast cancer,ppi
4098,4882,23512,SUZ12,SUZ12 polycomb repressive complex 2 subunit,357,methylated histone binding|histone methyltransferase activity|histone methyltransferase activity (H3-K27 specific)|chromatin DNA binding,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|endometrial cancer|endometrial carcinoma|glioblastoma multiforme|giant cell glioblastoma|malignant glioma|gliosarcoma|mixed glioma|melanoma|skin melanoma|acoustic neuroma|neurilemmoma|cellular schwannoma|melanotic neurilemmoma|plexiform schwannoma|malignant peripheral nerve sheath tumor,ppi
4099,4883,23526,ARHGAP45,Rho GTPase activating protein 45,5,GTPase activator activity,pre-eclampsia,ppi
4100,4884,23534,TNPO3,transportin 3,81,signaling receptor activity|protein transporter activity|nuclear localization sequence binding,primary biliary cirrhosis|portal hypertension|multiple system atrophy|liver cirrhosis|goiter|thyroid gland disease|dermatographia|autosomal dominant limb-girdle muscular dystrophy type 1F|liver cancer|hepatocellular carcinoma,ppi
4101,4885,50937,CDON,cell adhesion associated; oncogene regulated,11,,hypoglycemia|congenital hypothyroidism|myxedema|hypothyroidism|holoprosencephaly,ppi
4102,4890,170691,ADAMTS17,ADAM metallopeptidase with thrombospondin type 1 motif 17,1,,liver cancer|Weill-Marchesani syndrome,ppi
4103,4891,976,ADGRE5,adhesion G protein-coupled receptor E5,52,transmembrane signaling receptor activity|G-protein coupled receptor activity,lung disease,ppi
4104,4892,170692,ADAMTS18,ADAM metallopeptidase with thrombospondin type 1 motif 18,5,,,ppi
4105,4894,55662,HIF1AN,hypoxia inducible factor 1 alpha subunit inhibitor,172,iron ion binding|zinc ion binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors|oxygen sensor activity|carboxylic acid binding|peptidyl-histidine dioxygenase activity|peptidyl-asparagine 3-dioxygenase activity|protein homodimerization activity|cofactor binding,,ppi
4106,4895,117144,CATSPER1,cation channel sperm associated 1,34,,azoospermia,ppi
4107,4896,51006,SLC35C2,solute carrier family 35 member C2,1,,,ppi
4108,4897,140545,RNF32,ring finger protein 32,42,,,ppi
4109,4898,55801,IL26,interleukin 26,1,cytokine activity,,ppi
4110,4899,978,CDA,cytidine deaminase,38,nucleoside binding|cytidine deaminase activity|zinc ion binding|protein homodimerization activity,breast cancer,ppi
4111,4900,84679,SLC9A7,solute carrier family 9 member A7,4,sodium:proton antiporter activity|potassium:proton antiporter activity|protein homodimerization activity,,ppi
4112,4901,84548,TMEM185A,transmembrane protein 185A,59,,,ppi
4113,4902,29986,SLC39A2,solute carrier family 39 member 2,3,zinc ion transmembrane transporter activity,,ppi
4114,4903,29985,SLC39A3,solute carrier family 39 member 3,8,zinc ion transmembrane transporter activity,bipolar disorder|schizophreniform disorder|schizoaffective disorder,ppi
4115,4904,55630,SLC39A4,solute carrier family 39 member 4,101,zinc ion transmembrane transporter activity,acrodermatitis|alopecia|blepharitis|cerebellar disease|angular cheilitis|cheilitis|lip disease|conjunctivitis|glossitis|hypogonadism|paronychia|chronic ulcer of skin|geographic tongue|fissured tongue|granuloma annulare|asthenopia|acrodermatitis enteropathica|cerebral degeneration|meibomian cyst|hordeolum,ppi
4116,4905,146059,CDAN1,codanin 1,14,,congenital dyserythropoietic anemia,ppi
4117,4906,11262,SP140,SP140 nuclear body protein,1,DNA-binding transcription factor activity,chronic lymphocytic leukemia|Richter's syndrome,ppi
4118,4907,55871,CBWD1,COBW domain containing 1,78,,,ppi
4119,4908,117579,RLN3,relaxin 3,3,G-protein coupled receptor binding,coronary artery disease,ppi
4120,4909,117246,FTSJ3,FtsJ homolog 3,134,RNA binding|rRNA (uridine-2'-O-)-methyltransferase activity|rRNA (guanine) methyltransferase activity,,ppi
4121,4910,10133,OPTN,optineurin,113,polyubiquitin modification-dependent protein binding|K63-linked polyubiquitin modification-dependent protein binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|myopia|Paget's disease of bone|muscular atrophy|primary open angle glaucoma|neurodegenerative disease|amyotrophic lateral sclerosis type 12,ppi
4122,4911,30833,NT5C,5'; 3'-nucleotidase; cytosolic,7,nucleotidase activity|5'-nucleotidase activity|pyrimidine nucleotide binding,large intestine cancer|colorectal cancer,ppi
4123,4912,23557,SNAPIN,SNAP associated protein,94,SNARE binding,,ppi
4124,4913,23568,ARL2BP,ADP ribosylation factor like GTPase 2 binding protein,12,transcription coactivator activity|GTPase regulator activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|asthenopia,ppi
4125,4914,23580,CDC42EP4,CDC42 effector protein 4,28,RNA binding|GTP-Rho binding,,ppi
4126,4915,23583,SMUG1,single-strand-selective monofunctional uracil-DNA glycosylase 1,4,uracil DNA N-glycosylase activity|single-strand selective uracil DNA N-glycosylase activity|DNA N-glycosylase activity|oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,,ppi
4127,4916,23584,VSIG2,V-set and immunoglobulin domain containing 2,29,,,ppi
4128,4917,23589,CARHSP1,calcium regulated heat stable protein 1,28,DNA-binding transcription factor activity; RNA polymerase II-specific|mRNA 3'-UTR binding|phosphatase binding,,ppi
4129,4918,23594,ORC6,origin recognition complex subunit 6,33,DNA replication origin binding,cryptorchidism|placental insufficiency|osteogenesis imperfecta|Ehlers-Danlos syndrome|Meier-Gorlin syndrome,ppi
4130,4919,23597,ACOT9,acyl-CoA thioesterase 9,39,acetyl-CoA hydrolase activity|acyl-CoA hydrolase activity,,ppi
4131,4920,23623,RUSC1,RUN and SH3 domain containing 1,16,actin binding|SH3/SH2 adaptor activity,,ppi
4132,4921,23637,RABGAP1,RAB GTPase activating protein 1,46,GTPase activator activity|tubulin binding|Rab GTPase binding,,ppi
4133,4922,23643,LY96,lymphocyte antigen 96,5,lipopolysaccharide receptor activity|coreceptor activity,rheumatoid arthritis|large intestine cancer|colorectal cancer,ppi
4134,4923,23644,EDC4,enhancer of mRNA decapping 4,61,,,ppi
4135,4924,23646,PLD3,phospholipase D family member 3,26,,,ppi
4136,4925,23647,ARFIP2,ADP ribosylation factor interacting protein 2,37,GTP binding|cadherin binding|Rac GTPase binding|phosphatidylinositol-4-phosphate binding|phospholipid binding,,ppi
4137,4926,23658,LSM5,LSM5 homolog; U6 small nuclear RNA and mRNA degradation associated,43,RNA binding,polycystic ovary syndrome,ppi
4138,4927,23659,PLA2G15,phospholipase A2 group XV,3,lysophospholipase activity|phospholipid binding|O-acyltransferase activity|calcium-independent phospholipase A2 activity,,ppi
4139,4928,23786,BCL2L13,BCL2 like 13,17,cysteine-type endopeptidase activator activity involved in apoptotic process,,ppi
4140,4929,24144,TFIP11,tuftelin interacting protein 11,150,,,ppi
4141,4930,24147,FJX1,four jointed box 1,2,,,ppi
4142,4931,83849,SYT15,synaptotagmin 15,1,calcium-dependent phospholipid binding|phosphatidylserine binding|SNARE binding|calcium ion binding|clathrin binding,,ppi
4143,4932,25782,RAB3GAP2,RAB3 GTPase activating non-catalytic protein subunit 2,25,enzyme activator activity|enzyme regulator activity|protein heterodimerization activity|Rab guanyl-nucleotide exchange factor activity,clubfoot|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types,ppi
4144,4933,10549,PRDX4,peroxiredoxin 4,68,thioredoxin peroxidase activity,hyperglycemia|allergic contact dermatitis|glucose intolerance|prediabetes syndrome,ppi
4145,4934,989,SEPT7,septin 7,78,structural molecule activity|cadherin binding|protein-containing complex scaffold activity|GTPase activity,schizophrenia,ppi
4146,4935,26995,TRUB2,TruB pseudouridine synthase family member 2,46,RNA binding,,ppi
4147,4936,84171,LOXL4,lysyl oxidase like 4,17,protein-lysine 6-oxidase activity,urinary bladder cancer,ppi
4148,4937,91653,BOC,BOC cell adhesion associated; oncogene regulated,14,,,ppi
4149,4938,55577,NAGK,N-acetylglucosamine kinase,83,N-acetylglucosamine kinase activity,prostate cancer|prostate carcinoma,ppi
4150,4939,51196,PLCE1,phospholipase C epsilon 1,8,phosphatidylinositol phospholipase C activity|phospholipase C activity|guanyl-nucleotide exchange factor activity|Ras GTPase binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|congestive heart failure|focal segmental glomerulosclerosis|dengue hemorrhagic fever|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|proteinuria|stomach cancer|esophagus squamous cell carcinoma,ppi
4151,4940,50865,HEBP1,heme binding protein 1,9,heme binding,,ppi
4152,4941,51379,CRLF3,cytokine receptor like factor 3,17,DNA binding,,ppi
4153,4942,80070,ADAMTS20,ADAM metallopeptidase with thrombospondin type 1 motif 20,1,,melanoma|skin melanoma,ppi
4154,4943,55664,CDC37L1,cell division cycle 37 like 1,28,chaperone binding|heat shock protein binding|unfolded protein binding,,ppi
4155,4944,8556,CDC14A,cell division cycle 14A,53,phosphoprotein phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity,,ppi
4156,4945,140458,ASB5,ankyrin repeat and SOCS box containing 5,22,,,ppi
4157,4946,140459,ASB6,ankyrin repeat and SOCS box containing 6,52,,,ppi
4158,4947,140460,ASB7,ankyrin repeat and SOCS box containing 7,48,,,ppi
4159,4948,140461,ASB8,ankyrin repeat and SOCS box containing 8,24,,,ppi
4160,4949,140462,ASB9,ankyrin repeat and SOCS box containing 9,36,,,ppi
4161,4950,136371,ASB10,ankyrin repeat and SOCS box containing 10,26,,,ppi
4162,4951,140456,ASB11,ankyrin repeat and SOCS box containing 11,14,,,ppi
4163,4952,10439,OLFM1,olfactomedin 1,14,,prostate cancer|prostate carcinoma,ppi
4164,4953,93145,OLFM2,olfactomedin 2,44,,,ppi
4165,4954,8555,CDC14B,cell division cycle 14B,126,protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity,,ppi
4166,4955,10562,OLFM4,olfactomedin 4,35,protein homodimerization activity|cadherin binding,endometriosis of uterus|endometriosis,ppi
4167,4956,114609,TIRAP,TIR domain containing adaptor protein,50,phosphatidylinositol-4;5-bisphosphate binding|protein binding; bridging|protein homodimerization activity|protein heterodimerization activity,malaria|prostate cancer|prostate carcinoma|tuberculosis,ppi
4168,4957,51079,NDUFA13,NADH:ubiquinone oxidoreductase subunit A13,71,NADH dehydrogenase activity|ATP binding|NADH dehydrogenase (ubiquinone) activity,Leigh disease|papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma|thyroid Hurthle cell carcinoma,ppi
4169,4958,84519,ACRBP,acrosin binding protein,2,,prostate cancer|prostate carcinoma,ppi
4170,4959,92797,HELB,DNA helicase B,9,single-stranded DNA-dependent ATP-dependent DNA helicase activity|ATP-dependent 5'-3' DNA helicase activity|RNA binding|ATP-dependent 3'-5' RNA helicase activity,,ppi
4171,4960,117608,ZNF354B,zinc finger protein 354B,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
4172,4961,22856,CHSY1,chondroitin sulfate synthase 1,18,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity|N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,syndactyly|autosomal dominant nonsyndromic deafness|autosomal recessive nonsyndromic deafness|X-linked nonsyndromic deafness|autosomal dominant auditory neuropathy 1|autosomal recessive nonsyndromic deafness 101|autosomal recessive nonsyndromic deafness 102|autosomal recessive nonsyndromic deafness 103|autosomal recessive nonsyndromic deafness 104|autosomal recessive nonsyndromic deafness 105|autosomal recessive nonsyndromic deafness 12|autosomal recessive nonsyndromic deafness 13|autosomal recessive nonsyndromic deafness 14|autosomal recessive nonsyndromic deafness 15|autosomal recessive nonsyndromic deafness 16|autosomal recessive nonsyndromic deafness 17|autosomal recessive nonsyndromic deafness 18A|autosomal recessive nonsyndromic deafness 18B|autosomal recessive nonsyndromic deafness 1A|autosomal recessive nonsyndromic deafness 1B,ppi
4173,4962,170680,PSORS1C2,psoriasis susceptibility 1 candidate 2,1,,multiple myeloma,ppi
4174,4963,91,ACVR1B,activin A receptor type 1B,45,protein serine/threonine kinase activity|transmembrane receptor protein serine/threonine kinase activity|ATP binding|activin receptor activity; type I|ubiquitin protein ligase binding|SMAD binding|activin-activated receptor activity|activin binding|transforming growth factor beta receptor activity; type I|transforming growth factor beta-activated receptor activity|growth factor binding,,ppi
4175,4964,8881,CDC16,cell division cycle 16,150,,,ppi
4176,4965,54674,LRRN3,leucine rich repeat neuronal 3,3,,autistic disorder,ppi
4177,4967,58986,TMEM8A,transmembrane protein 8A,8,,,ppi
4178,4968,729515,TMEM242,transmembrane protein 242,6,,,ppi
4179,4969,23299,BICD2,BICD cargo adaptor 2,34,Rab GTPase binding|dynactin binding|dynein complex binding,clubfoot|progressive muscular atrophy|spinal muscular atrophy,ppi
4180,4970,27148,STK36,serine/threonine kinase 36,14,protein serine/threonine kinase activity|ATP binding|transcription factor binding,,ppi
4181,4971,57647,DHX37,DEAH-box helicase 37,23,RNA binding|ATP-dependent 3'-5' RNA helicase activity,,ppi
4182,4972,9785,DHX38,DEAH-box helicase 38,52,RNA binding|ATP-dependent 3'-5' RNA helicase activity,,ppi
4183,4973,78989,COLEC11,collectin subfamily member 11,12,DNA binding|serine-type endopeptidase activity|calcium ion binding|mannose binding|fucose binding|oligosaccharide binding|calcium-dependent carbohydrate binding|monosaccharide binding,incontinentia pigmenti achromians|3MC syndrome|3MC syndrome 3|3MC syndrome 1|3MC syndrome 2,ppi
4184,4974,23181,DIP2A,disco interacting protein 2 homolog A,42,,,ppi
4185,4975,983,CDK1,cyclin dependent kinase 1,221,protein kinase activity|protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase activity|RNA polymerase II CTD heptapeptide repeat kinase activity|cyclin binding|histone kinase activity|cyclin-dependent protein kinase activity,,ppi
4186,4976,10090,UST,uronyl 2-sulfotransferase,20,sulfotransferase activity,endometriosis of uterus|endometriosis,ppi
4187,4977,9727,RAB11FIP3,RAB11 family interacting protein 3,20,Rab GTPase binding|protein homodimerization activity|ADP-ribosylation factor binding,,ppi
4188,4978,25788,RAD54B,RAD54 homolog B (S. cerevisiae),39,DNA helicase activity|RNA helicase activity|DNA translocase activity,lymphosarcoma|lymphoma|central nervous system lymphoma,ppi
4189,4979,25790,CFAP45,cilia and flagella associated protein 45,4,,malignant mesothelioma|benign mesothelioma,ppi
4190,4980,991,CDC20,cell division cycle 20,160,,,ppi
4191,4982,83901,KRTAP9-8,keratin associated protein 9-8,1,,,ppi
4192,4983,63916,ELMO2,engulfment and cell motility 2,19,,,ppi
4193,4984,91074,ANKRD30A,ankyrin repeat domain 30A,1,DNA binding|DNA-binding transcription factor activity,,ppi
4194,4985,8697,CDC23,cell division cycle 23,120,ubiquitin-protein transferase activity,,ppi
4195,4986,10626,TRIM16,tripartite motif containing 16,16,DNA binding,,ppi
4196,4987,57094,CPA6,carboxypeptidase A6,10,metallocarboxypeptidase activity,familial temporal lobe epilepsy 5,ppi
4197,4988,993,CDC25A,cell division cycle 25A,83,phosphoprotein phosphatase activity|protein tyrosine phosphatase activity,,ppi
4198,4989,9735,KNTC1,kinetochore associated 1,26,,,ppi
4199,4990,57180,ACTR3B,ARP3 actin related protein 3 homolog B,34,,,ppi
4200,4991,25803,SPDEF,SAM pointed domain containing ETS transcription factor,14,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding,ovarian cancer,ppi
4201,4992,23287,AGTPBP1,ATP/GTP binding protein 1,18,metallocarboxypeptidase activity|tubulin binding,,ppi
4202,4993,25804,LSM4,LSM4 homolog; U6 small nuclear RNA and mRNA degradation associated,57,RNA binding|PH domain binding|U6 snRNA binding,,ppi
4203,4994,994,CDC25B,cell division cycle 25B,56,phosphoprotein phosphatase activity|protein tyrosine phosphatase activity,,ppi
4204,4995,25816,TNFAIP8,TNF alpha induced protein 8,22,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,esophagus squamous cell carcinoma,ppi
4205,4996,25843,MOB4,MOB family member 4; phocein,90,,,ppi
4206,4997,25855,BRMS1,breast cancer metastasis suppressor 1,65,histone deacetylase activity|NF-kappaB binding|histone deacetylase binding,,ppi
4207,4998,25885,POLR1A,RNA polymerase I subunit A,93,RNA polymerase I activity|chromatin binding|DNA-directed 5'-3' RNA polymerase activity,choanal atresia|isolated cleft palate|cleft palate|patent ductus arteriosus|heart septal defect|acrofacial dysostosis Cincinnati type,ppi
4208,4999,25890,ABI3BP,ABI family member 3 binding protein,9,extracellular matrix structural constituent,endometriosis of uterus|endometriosis|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
4209,5000,140432,RNF113B,ring finger protein 113B,6,,,ppi
4210,5001,64946,CENPH,centromere protein H,35,kinetochore binding,,ppi
4211,5002,117283,IP6K3,inositol hexakisphosphate kinase 3,16,inositol-1;3;4;5;6-pentakisphosphate kinase activity|inositol hexakisphosphate kinase activity|inositol heptakisphosphate kinase activity|inositol hexakisphosphate 6-kinase activity|inositol 5-diphosphate pentakisphosphate 5-kinase activity|inositol diphosphate tetrakisphosphate kinase activity,,ppi
4212,5003,995,CDC25C,cell division cycle 25C,70,phosphoprotein phosphatase activity|protein tyrosine phosphatase activity,schizophrenia,ppi
4213,5004,23178,PASK,PAS domain containing serine/threonine kinase,86,protein serine/threonine kinase activity|phosphatidylinositol binding,autistic disorder,ppi
4214,5005,22800,RRAS2,related RAS viral (r-ras) oncogene homolog 2,40,,juvenile myelomonocytic leukemia,ppi
4215,5006,55835,CENPJ,centromere protein J,151,tubulin binding,Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome|Cockayne syndrome|Noonan syndrome|Aarskog syndrome|microcephaly,ppi
4216,5007,56992,KIF15,kinesin family member 15,27,DNA binding|motor activity|microtubule binding|ATPase activity|microtubule motor activity,IgA glomerulonephritis,ppi
4217,5008,23650,TRIM29,tripartite motif containing 29,103,DNA-binding transcription factor activity|cadherin binding involved in cell-cell adhesion,,ppi
4218,5009,79033,ERI3,ERI1 exoribonuclease family member 3,9,RNA binding|3'-5'-exoribonuclease activity,,ppi
4219,5010,51663,ZFR,zinc finger RNA binding protein,78,RNA binding|single-stranded RNA binding|double-stranded RNA binding,,ppi
4220,5011,10957,PNRC1,proline rich nuclear receptor coactivator 1,21,,,ppi
4221,5012,58503,OPRPN,opiorphin prepropeptide,3,endopeptidase inhibitor activity|peptidase inhibitor activity,,ppi
4222,5013,996,CDC27,cell division cycle 27,121,,,ppi
4223,5014,22881,ANKRD6,ankyrin repeat domain 6,7,,,ppi
4224,5015,27069,GHITM,growth hormone inducible transmembrane protein,52,,,ppi
4225,5016,22999,RIMS1,regulating synaptic membrane exocytosis 1,27,RNA binding|Rab GTPase binding|GTPase regulator activity|ion channel binding,autistic disorder|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|night blindness|congenital stationary night blindness|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|blindness|asthenopia,ppi
4226,5017,9699,RIMS2,regulating synaptic membrane exocytosis 2,18,ion channel binding|Rab GTPase binding,schizophrenia|lung small cell carcinoma,ppi
4227,5018,25913,POT1,protection of telomeres 1,208,telomerase inhibitor activity|telomeric DNA binding|single-stranded telomeric DNA binding|telomeric D-loop binding|G-rich strand telomeric DNA binding|8-hydroxy-2'-deoxyguanosine DNA binding|G-rich single-stranded DNA binding|telomeric G-quadruplex DNA binding,chronic lymphocytic leukemia|Richter's syndrome|lymphoblastic leukemia|myeloid leukemia|lymphatic system disease|melanoma|skin melanoma|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag|oligodendroglioma|childhood oligodendroglioma|adult oligodendroglioma|mixed oligodendroglioma-astrocytoma|skin benign neoplasm|skin cancer|familial melanoma|dysplastic nevus syndrome,ppi
4228,5019,51013,EXOSC1,exosome component 1,61,RNA binding|exoribonuclease activity,,ppi
4229,5020,79723,SUV39H2,suppressor of variegation 3-9 homolog 2,67,transcription regulatory region sequence-specific DNA binding|zinc ion binding|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K9 specific)|S-adenosyl-L-methionine binding,,ppi
4230,5021,116519,APOA5,apolipoprotein A5,7,phospholipid binding|enzyme activator activity|heparin binding|lipid binding|enzyme binding|phosphatidylcholine binding|lipase activator activity|lipoprotein lipase activator activity|cholesterol transporter activity|cholesterol binding|phosphatidylcholine-sterol O-acyltransferase activator activity,hyperlipoproteinemia type III|familial hypertriglyceridemia|hyperlipoproteinemia type IV|hyperlipoproteinemia type V|familial lipoprotein lipase deficiency|coronary artery disease,ppi
4231,5022,79767,ELMO3,engulfment and cell motility 3,15,,,ppi
4232,5023,984,CDK11B,cyclin dependent kinase 11B,45,RNA binding|protein kinase activity|protein serine/threonine kinase activity|ATP binding|cyclin-dependent protein serine/threonine kinase activity,,ppi
4233,5024,9466,IL27RA,interleukin 27 receptor subunit alpha,32,transmembrane signaling receptor activity|cytokine receptor activity|cytokine binding|interleukin-27 receptor activity,asbestosis|anthracosilicosis|pneumoconiosis|siderosis|bagassosis,ppi
4234,5025,11018,TMED1,transmembrane p24 trafficking protein 1,19,signaling receptor binding,,ppi
4235,5026,57153,SLC44A2,solute carrier family 44 member 2,1,choline transmembrane transporter activity,,ppi
4236,5027,25865,PRKD2,protein kinase D2,54,protein kinase activity|protein serine/threonine kinase activity,chronic lymphocytic leukemia|Richter's syndrome|polycystic ovary syndrome,ppi
4237,5028,153090,DAB2IP,DAB2 interacting protein,40,SH3 domain binding|protein kinase binding|phosphatidylinositol-3-phosphate binding|signaling adaptor activity|phosphatidylinositol 3-kinase regulatory subunit binding|phosphatidylinositol 3-kinase binding|protein-containing complex binding|cadherin binding|protein phosphatase 2A binding|phosphatidylinositol-4-phosphate binding|14-3-3 protein binding|Toll-like receptor 4 binding,lung benign neoplasm|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|prostate cancer|prostate carcinoma|pulmonary embolism|intermittent claudication|abdominal aortic aneurysm,ppi
4238,5030,50484,RRM2B,ribonucleotide reductase regulatory TP53 inducible subunit M2B,16,ribonucleoside-diphosphate reductase activity; thioredoxin disulfide as acceptor,lactic acidosis|cerebellar disease|sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|Kearns-Sayre syndrome|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|intellectual disability|learning disability|visual epilepsy|ophthalmoplegia,ppi
4239,5031,80196,RNF34,ring finger protein 34,30,ubiquitin protein ligase activity|phosphatidylinositol phosphate binding,colon cancer|colonic benign neoplasm,ppi
4240,5032,55290,BRF2,BRF2; RNA polymerase III transcription initiation factor subunit,60,RNA polymerase III type 3 promoter DNA binding,,ppi
4241,5033,93492,TPTE2,transmembrane phosphoinositide 3-phosphatase and tensin homolog 2,53,phosphatidylinositol-3;4-bisphosphate 3-phosphatase activity,,ppi
4242,5034,92,ACVR2A,activin A receptor type 2A,36,protein serine/threonine kinase activity|transmembrane receptor protein serine/threonine kinase activity|coreceptor activity|BMP receptor activity|activin-activated receptor activity|type I transforming growth factor beta receptor binding|transforming growth factor beta-activated receptor activity|activin binding|growth factor binding|SMAD binding|transforming growth factor beta receptor activity; type II,,ppi
4243,5035,728642,CDK11A,cyclin dependent kinase 11A,61,protein kinase activity|protein serine/threonine kinase activity|ATP binding|cyclin-dependent protein serine/threonine kinase activity,,ppi
4244,5036,129685,TAF8,TATA-box binding protein associated factor 8,29,,,ppi
4245,5037,27344,PCSK1N,proprotein convertase subtilisin/kexin type 1 inhibitor,8,endopeptidase inhibitor activity|signaling receptor binding,salivary gland adenoid cystic carcinoma,ppi
4246,5038,257194,NEGR1,neuronal growth regulator 1,4,,obesity,ppi
4247,5039,83860,TAF3,TATA-box binding protein associated factor 3,29,,,ppi
4248,5040,27097,TAF5L,TATA-box binding protein associated factor 5 like,38,DNA-binding transcription factor activity|transcription coactivator activity|histone acetyltransferase activity,,ppi
4249,5041,10629,TAF6L,TATA-box binding protein associated factor 6 like,33,DNA binding|transcription coactivator activity|histone acetyltransferase activity|RNA polymerase II activating transcription factor binding|DNA-binding transcription factor activity,,ppi
4250,5042,51616,TAF9B,TATA-box binding protein associated factor 9b,34,transcription corepressor activity|thiol-dependent ubiquitinyl hydrolase activity|transcription factor activity; RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly|transcription factor binding|transcription regulatory region DNA binding|histone acetyltransferase activity,,ppi
4251,5043,9044,BTAF1,B-TFIID TATA-box binding protein associated factor 1,45,DNA-binding transcription factor activity,,ppi
4252,5044,10245,TIMM17B,translocase of inner mitochondrial membrane 17 homolog B (yeast),17,protein transmembrane transporter activity,,ppi
4253,5045,9063,PIAS2,protein inhibitor of activated STAT 2,90,transcription coactivator activity|SUMO transferase activity|androgen receptor binding|SUMO ligase activity,,ppi
4254,5046,100287932,TIMM23,translocase of inner mitochondrial membrane 23,35,protein transmembrane transporter activity,,ppi
4255,5047,51447,IP6K2,inositol hexakisphosphate kinase 2,12,inositol-1;3;4;5;6-pentakisphosphate kinase activity|inositol hexakisphosphate kinase activity|inositol heptakisphosphate kinase activity|inositol 5-diphosphate pentakisphosphate 5-kinase activity|inositol diphosphate tetrakisphosphate kinase activity,Huntington's disease,ppi
4256,5048,10440,TIMM17A,translocase of inner mitochondrial membrane 17 homolog A (yeast),12,protein transmembrane transporter activity,,ppi
4257,5049,10469,TIMM44,translocase of inner mitochondrial membrane 44,53,chaperone binding,,ppi
4258,5050,29928,TIMM22,translocase of inner mitochondrial membrane 22,6,protein transmembrane transporter activity|mitochondrion targeting sequence binding,,ppi
4259,5051,122042,RXFP2,relaxin/insulin like family peptide receptor 2,2,G-protein coupled peptide receptor activity,cryptorchidism,ppi
4260,5052,121340,SP7,Sp7 transcription factor,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DEAD/H-box RNA helicase binding,osteogenesis imperfecta type 4,ppi
4261,5054,10879,SMR3B,submaxillary gland androgen regulated protein 3B,11,endopeptidase inhibitor activity,,ppi
4262,5055,51322,WAC,WW domain containing adaptor with coiled-coil,38,RNA polymerase II complex binding|chromatin binding,,ppi
4263,5056,84062,DTNBP1,dystrobrevin binding protein 1,135,,alcohol dependence|alcohol abuse|disease of mental health|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|drug psychosis|schizophrenia|mood disorder|Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome 7,ppi
4264,5057,84174,SLA2,Src like adaptor 2,11,SH3/SH2 adaptor activity|1-phosphatidylinositol-3-kinase regulator activity,,ppi
4265,5058,8621,CDK13,cyclin dependent kinase 13,56,RNA binding|protein kinase activity|RNA polymerase II CTD heptapeptide repeat kinase activity|transcription regulatory region DNA binding|cyclin binding|transcription factor binding|cyclin-dependent protein serine/threonine kinase activity,,ppi
4266,5059,55794,DDX28,DEAD-box helicase 28,45,RNA binding|rRNA binding,,ppi
4267,5060,132851,SPATA4,spermatogenesis associated 4,3,,,ppi
4268,5062,997,CDC34,cell division cycle 34,63,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,,ppi
4269,5063,10594,PRPF8,pre-mRNA processing factor 8,176,RNA binding|K63-linked polyubiquitin modification-dependent protein binding|pre-mRNA intronic binding|U1 snRNA binding|U5 snRNA binding|U2 snRNA binding|second spliceosomal transesterification activity|U6 snRNA binding,glaucoma|sensorineural hearing loss|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy,ppi
4270,5064,51095,TRNT1,tRNA nucleotidyl transferase 1,24,tRNA binding|ATP binding|5'-3' RNA polymerase activity|ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,sideroblastic anemia|agammaglobulinemia,ppi
4271,5065,254065,BRWD3,bromodomain and WD repeat domain containing 3,10,,non-syndromic X-linked intellectual disability,ppi
4272,5066,200315,APOBEC3A,apolipoprotein B mRNA editing enzyme catalytic subunit 3A,2,cytidine deaminase activity|deoxycytidine deaminase activity|RNA binding,schizophreniform disorder|schizoaffective disorder|breast cancer,ppi
4273,5067,9875,URB1,URB1 ribosome biogenesis 1 homolog (S. cerevisiae),32,RNA binding,,ppi
4274,5069,8899,PRPF4B,pre-mRNA processing factor 4B,68,RNA binding|protein kinase activity|cyclin-dependent protein serine/threonine kinase activity,,ppi
4275,5070,9416,DDX23,DEAD-box helicase 23,77,RNA binding|ATP-dependent RNA helicase activity|ATP-dependent helicase activity,,ppi
4276,5071,9129,PRPF3,pre-mRNA processing factor 3,129,RNA binding,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
4277,5072,9128,PRPF4,pre-mRNA processing factor 4,130,U4 snRNA binding|U6 snRNA binding,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|retinal degeneration|cone-rod dystrophy,ppi
4278,5073,11140,CDC37,cell division cycle 37,328,protein tyrosine kinase activity|unfolded protein binding|heat shock protein binding|chaperone binding,,ppi
4279,5074,51362,CDC40,cell division cycle 40,55,RNA binding,,ppi
4280,5075,8559,PRPF18,pre-mRNA processing factor 18,6,second spliceosomal transesterification activity,,ppi
4281,5076,9582,APOBEC3B,apolipoprotein B mRNA editing enzyme catalytic subunit 3B,12,RNA binding|deoxycytidine deaminase activity|cytidine deaminase activity,urinary bladder cancer|tongue squamous cell carcinoma|squamous cell carcinoma|cervical cancer|head and neck cancer|lung cancer|lung adenocarcinoma|breast cancer,ppi
4282,5077,27350,APOBEC3C,apolipoprotein B mRNA editing enzyme catalytic subunit 3C,16,RNA binding|cytidine deaminase activity,schizophreniform disorder|schizoaffective disorder,ppi
4283,5078,140564,APOBEC3D,apolipoprotein B mRNA editing enzyme catalytic subunit 3D,54,,,ppi
4284,5079,200316,APOBEC3F,apolipoprotein B mRNA editing enzyme catalytic subunit 3F,16,RNA binding|cytidine deaminase activity|zinc ion binding,,ppi
4285,5081,27010,TPK1,thiamin pyrophosphokinase 1,1,thiamine diphosphokinase activity,lactic acidosis|cerebellar disease|dystonia|central nervous system origin vertigo,ppi
4286,5082,53371,NUP54,nucleoporin 54,47,structural constituent of nuclear pore,,ppi
4287,5083,998,CDC42,cell division cycle 42,245,GTPase activity|protein serine/threonine kinase activity|GTP binding|protein kinase binding|ubiquitin protein ligase activity,adrenal gland cancer|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|schizophrenia,ppi
4288,5084,26018,LRIG1,leucine rich repeats and immunoglobulin like domains 1,27,,,ppi
4289,5085,10865,ARID5A,AT-rich interaction domain 5A,21,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|transcription corepressor activity|transcription factor binding|estrogen receptor binding|sequence-specific DNA binding|retinoid X receptor binding|thyroid hormone receptor binding|androgen receptor binding|transcription regulatory region DNA binding,,ppi
4290,5086,84159,ARID5B,AT-rich interaction domain 5B,18,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|transcription coactivator activity|histone demethylase activity|transcription regulatory region DNA binding,rheumatoid arthritis|salivary gland adenoid cystic carcinoma|Graves' disease|thyrotoxicosis|hyperthyroidism|acute lymphocytic leukemia,ppi
4291,5087,10138,YAF2,YY1 associated factor 2,60,transcription coactivator activity|transcription corepressor activity,,ppi
4292,5088,10926,DBF4,DBF4 zinc finger,24,enzyme activator activity|protein serine/threonine kinase activator activity|protein kinase binding,,ppi
4293,5089,10157,AASS,aminoadipate-semialdehyde synthase,8,saccharopine dehydrogenase (NADP+; L-lysine-forming) activity|saccharopine dehydrogenase (NAD+; L-glutamate-forming) activity|saccharopine dehydrogenase activity,anemia|macrocytic anemia|epilepsy|spastic diplegia|spastic monoplegia|spastic quadriplegia|cerebral palsy|intellectual disability|learning disability|visual epilepsy|kidney disease|hyperlysinemia,ppi
4294,5090,55081,IFT57,intraflagellar transport 57,136,,,ppi
4295,5091,134728,IRAK1BP1,interleukin 1 receptor associated kinase 1 binding protein 1,4,,Sjogren's syndrome|keratoconjunctivitis sicca,ppi
4296,5092,29777,ABT1,activator of basal transcription 1,25,transcription coactivator activity|RNA binding,stomach cancer,ppi
4297,5093,8476,CDC42BPA,CDC42 binding protein kinase alpha,29,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
4298,5094,9457,FHL5,four and a half LIM domains 5,25,,migraine,ppi
4299,5095,55860,ACTR10,actin-related protein 10 homolog,37,,,ppi
4300,5096,50808,AK3,adenylate kinase 3,9,nucleoside triphosphate adenylate kinase activity|adenylate kinase activity,,ppi
4301,5097,55821,ALLC,allantoicase,1,,,ppi
4302,5098,51172,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,14,,,ppi
4303,5099,54518,APBB1IP,amyloid beta precursor protein binding family B member 1 interacting protein,14,,,ppi
4304,5100,9578,CDC42BPB,CDC42 binding protein kinase beta,31,magnesium ion binding|protein kinase activity|protein serine/threonine kinase activity|ATP binding,,ppi
4305,5101,51434,ANAPC7,anaphase promoting complex subunit 7,65,,,ppi
4306,5102,10603,SH2B2,SH2B adaptor protein 2,25,SH3/SH2 adaptor activity|JAK pathway signal transduction adaptor activity|transmembrane receptor protein tyrosine kinase adaptor activity,,ppi
4307,5103,57522,SRGAP1,SLIT-ROBO Rho GTPase activating protein 1,13,GTPase activator activity|Rac GTPase binding,follicular thyroid carcinoma,ppi
4308,5104,59340,HRH4,histamine receptor H4,4,histamine receptor activity|G-protein coupled serotonin receptor activity|G-protein coupled receptor activity|G-protein coupled acetylcholine receptor activity|neurotransmitter receptor activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|stomach cancer,ppi
4309,5105,54778,RNF111,ring finger protein 111,70,SUMO polymer binding|ubiquitin protein ligase activity|SMAD binding,,ppi
4310,5106,10924,SMPDL3A,sphingomyelin phosphodiesterase acid like 3A,4,phosphoric diester hydrolase activity|zinc ion binding|sphingomyelin phosphodiesterase activity,endometriosis of uterus|endometriosis,ppi
4311,5107,8318,CDC45,cell division cycle 45,40,single-stranded DNA binding|chromatin binding|DNA replication origin binding|3'-5' DNA helicase activity,Meier-Gorlin syndrome,ppi
4312,5108,64844,MARCH7,membrane associated ring-CH-type finger 7,39,protein binding,,ppi
4313,5109,8815,BANF1,barrier to autointegration factor 1,72,protein C-terminus binding|LEM domain binding,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|pseudosarcomatous fibromatosis|enophthalmos|orbital disease|exophthalmos|primary pulmonary hypertension|pulmonary hypertension|osteoporosis,ppi
4314,5110,9743,ARHGAP32,Rho GTPase activating protein 32,44,GTPase activator activity,schizophrenia,ppi
4315,5111,93,ACVR2B,activin A receptor type 2B,50,protein serine/threonine kinase activity|activin receptor activity; type II|transforming growth factor beta receptor activity; type II|activin binding|type I transforming growth factor beta receptor binding|growth factor binding|SMAD binding|transforming growth factor beta-activated receptor activity,dextrocardia|atrioventricular septal defect|ventricular septal defect|tuberous sclerosis|Marfan syndrome|situs inversus|visceral heterotaxy,ppi
4316,5114,148170,CDC42EP5,CDC42 effector protein 5,2,GTP-Rho binding,,ppi
4317,5115,84911,ZNF382,zinc finger protein 382,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
4318,5117,23529,CLCF1,cardiotrophin-like cytokine factor 1,5,cytokine activity|ciliary neurotrophic factor receptor binding|growth factor activity|protein heterodimerization activity,hypohidrosis|anhidrosis|malignant hyperthermia|Bell's palsy|facial paralysis|cold-induced sweating syndrome,ppi
4319,5118,84059,ADGRV1,adhesion G protein-coupled receptor V1,23,G-protein coupled receptor activity|calcium ion binding,Usher syndrome|Usher syndrome type 2D|Usher syndrome type 2C,ppi
4320,5120,143244,EIF5AL1,eukaryotic translation initiation factor 5A-like 1,7,,,ppi
4321,5121,987,LRBA,LPS responsive beige-like anchor protein,28,,fetal erythroblastosis|autoimmune hemolytic anemia|arthropathy|arthritis|asthma|intrinsic asthma|allergic asthma|bronchiectasis|secondary hypertrophic osteoarthropathy|colitis|ileitis|ileocolitis|gastroenteritis|conjunctivitis|gastritis|congenital hypothyroidism|myxedema|hypothyroidism|primary immunodeficiency disease|pneumonia,ppi
4322,5122,50515,CHST11,carbohydrate sulfotransferase 11,4,N-acetylgalactosamine 4-O-sulfotransferase activity|chondroitin 4-sulfotransferase activity,,ppi
4323,5123,55501,CHST12,carbohydrate sulfotransferase 12,22,chondroitin 4-sulfotransferase activity|3'-phosphoadenosine 5'-phosphosulfate binding,,ppi
4324,5124,64106,NPFFR1,neuropeptide FF receptor 1,1,G-protein coupled receptor activity|neuropeptide receptor activity,,ppi
4325,5125,8110,DPF3,double PHD fingers 3,44,zinc ion binding|histone binding|histone acetyltransferase activity,,ppi
4326,5126,51195,RAPGEFL1,Rap guanine nucleotide exchange factor like 1,3,,,ppi
4327,5127,57530,CGN,cingulin,33,actin binding|cadherin binding,,ppi
4328,5128,988,CDC5L,cell division cycle 5 like,665,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|RNA binding|WD40-repeat domain binding,,ppi
4329,5129,27159,CHIA,chitinase; acidic,18,lysozyme activity|chitinase activity|chitin binding|carbohydrate binding,,ppi
4330,5130,11261,CHP1,calcineurin like EF-hand protein 1,22,transporter activity|calcium ion binding|microtubule binding|potassium channel regulator activity|kinase binding|calcium-dependent protein binding,,ppi
4331,5131,56996,SLC12A9,solute carrier family 12 member 9,20,cation:chloride symporter activity|potassium:chloride symporter activity,,ppi
4332,5132,116449,CLNK,cytokine dependent hematopoietic cell linker,29,SH3/SH2 adaptor activity,vitiligo,ppi
4333,5133,990,CDC6,cell division cycle 6,65,nucleotide binding|DNA replication origin binding,cryptorchidism|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|polycystic ovary syndrome|Meier-Gorlin syndrome,ppi
4334,5134,64326,RFWD2,ring finger and WD repeat domain 2,91,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,autistic disorder,ppi
4335,5135,23186,RCOR1,REST corepressor 1,64,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|histone deacetylase activity|transcription regulatory region DNA binding|DNA-binding transcription factor activity|transcription factor binding,colon cancer|colonic benign neoplasm,ppi
4336,5137,9238,TBRG4,transforming growth factor beta regulator 4,37,RNA binding,,ppi
4337,5138,22883,CLSTN1,calsyntenin 1,38,amyloid-beta binding,,ppi
4338,5140,51302,CYP39A1,cytochrome P450 family 39 subfamily A member 1,5,oxysterol 7-alpha-hydroxylase activity|steroid 7-alpha-hydroxylase activity,,ppi
4339,5141,8317,CDC7,cell division cycle 7,34,protein kinase activity|kinase activity|protein serine/threonine kinase activity,,ppi
4340,5143,10800,CYSLTR1,cysteinyl leukotriene receptor 1,1,galanin receptor activity|G-protein coupled peptide receptor activity,,ppi
4341,5144,57412,AS3MT,arsenite methyltransferase,1,arsenite methyltransferase activity|methylarsonite methyltransferase activity,urinary bladder cancer|carcinoma|attention deficit hyperactivity disorder,ppi
4342,5145,378108,TRIM74,tripartite motif containing 74,46,,,ppi
4343,5146,29015,SLC43A3,solute carrier family 43 member 3,7,,IgA glomerulonephritis,ppi
4344,5147,10611,PDLIM5,PDZ and LIM domain 5,86,actin binding|protein kinase C binding|actinin binding|cadherin binding involved in cell-cell adhesion,bipolar disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|coronary artery disease|major depressive disorder|mental depression,ppi
4345,5149,90952,ESAM,endothelial cell adhesion molecule,4,,schizophrenia,ppi
4346,5150,25898,RCHY1,ring finger and CHY zinc finger domain containing 1,82,ubiquitin-protein transferase activity|zinc ion binding,,ppi
4347,5151,999,CDH1,cadherin 1,691,beta-catenin binding|cadherin binding|cell adhesion molecule binding|protein homodimerization activity|cytoskeletal protein binding|calcium ion binding,urinary bladder cancer|tongue squamous cell carcinoma|squamous cell carcinoma|inflammatory bowel disease|ulcerative colitis|large intestine cancer|colorectal cancer|salivary gland adenoid cystic carcinoma|dysgerminoma|endometrial cancer|endometrial carcinoma|atrophic gastritis|malignant mesothelioma|benign mesothelioma|pancreatic cancer|prostate cancer|prostate carcinoma|stomach cancer|peripheral vascular disease|invasive lobular carcinoma,ppi
4348,5152,9867,PJA2,praja ring finger ubiquitin ligase 2,31,ubiquitin-protein transferase activity|protein kinase A catalytic subunit binding|protein kinase A regulatory subunit binding|ubiquitin protein ligase activity,,ppi
4349,5154,55012,PPP2R3C,protein phosphatase 2 regulatory subunit B''gamma,25,,,ppi
4350,5155,1008,CDH10,cadherin 10,7,cytoskeletal protein binding|protein homodimerization activity|calcium ion binding|cadherin binding,alcohol dependence|alcohol abuse|autistic disorder,ppi
4351,5156,51053,GMNN,geminin; DNA replication inhibitor,77,chromatin binding,Meier-Gorlin syndrome,ppi
4352,5157,57165,GJC2,gap junction protein gamma 2,1,gap junction channel activity involved in cell communication by electrical coupling,lymphedema|keratosis follicularis|pseudoxanthoma elasticum|mongolian spot|hereditary lymphedema|hypomyelinating leukodystrophy 2|hereditary spastic paraplegia 44,ppi
4353,5159,80318,GKAP1,G kinase anchoring protein 1,19,,,ppi
4354,5160,84328,LZIC,leucine zipper and CTNNBIP1 domain containing,11,,,ppi
4355,5161,26297,SERGEF,secretion regulating guanine nucleotide exchange factor,5,Ran guanyl-nucleotide exchange factor activity,,ppi
4356,5162,94,ACVRL1,activin A receptor like type 1,23,protein serine/threonine kinase activity|transmembrane receptor protein serine/threonine kinase activity|transforming growth factor beta-activated receptor activity|transforming growth factor beta receptor activity; type I|ATP binding|activin receptor activity; type I|SMAD binding|activin binding|BMP receptor activity|growth factor binding,anemia|macrocytic anemia|intracranial abscess|cholecystitis|epilepsy|hemangioma|cavernous hemangioma|capillary hemangioma|hypertension|essential hypertension|portal hypertension|primary pulmonary hypertension|pulmonary hypertension|liver cirrhosis|polycythemia vera|Chuvash polycythemia|acquired polycythemia|stress polycythemia|erythropoietin polycythemia|polycythemia,ppi
4357,5163,1009,CDH11,cadherin 11,6,calcium ion binding|protein homodimerization activity|cadherin binding|cytoskeletal protein binding,alcohol dependence|alcohol abuse,ppi
4358,5164,26003,GORASP2,golgi reassembly stacking protein 2,118,,,ppi
4359,5165,55363,HEMGN,hemogen,44,,,ppi
4360,5166,1010,CDH12,cadherin 12,4,calcium ion binding|cadherin binding|protein homodimerization activity|cytoskeletal protein binding,alcohol dependence|alcohol abuse,ppi
4361,5167,9456,HOMER1,homer scaffolding protein 1,47,signaling adaptor activity|G-protein coupled glutamate receptor binding,alcohol dependence|alcohol abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|cocaine abuse|cocaine dependence,ppi
4362,5168,9455,HOMER2,homer scaffolding protein 2,16,G-protein coupled glutamate receptor binding,schizophrenia|cocaine abuse|cocaine dependence|autosomal dominant nonsyndromic deafness 68,ppi
4363,5169,9454,HOMER3,homer scaffolding protein 3,52,G-protein coupled glutamate receptor binding,salivary gland adenoid cystic carcinoma,ppi
4364,5170,139716,GAB3,GRB2 associated binding protein 3,9,,,ppi
4365,5171,25946,ZNF385A,zinc finger protein 385A,3,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding|mRNA 3'-UTR binding,,ppi
4366,5172,1012,CDH13,cadherin 13,32,low-density lipoprotein particle binding|cadherin binding|adiponectin binding|lipoprotein particle binding|cytoskeletal protein binding|protein homodimerization activity|calcium ion binding,alcohol dependence|alcohol abuse|Barrett's esophagus|lung cancer|non-small cell lung carcinoma|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|esophageal cancer|lung benign neoplasm|prostate cancer|prostate carcinoma|substance abuse|substance-related disorder|liver cancer|hepatocellular carcinoma,ppi
4367,5174,84684,INSM2,INSM transcriptional repressor 2,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
4368,5175,1013,CDH15,cadherin 15,10,cytoskeletal protein binding|calcium ion binding|protein homodimerization activity|cadherin binding,alcohol dependence|alcohol abuse|intellectual disability|learning disability|polycystic ovary syndrome|autosomal dominant non-syndromic intellectual disability,ppi
4369,5176,122953,JDP2,Jun dimerization protein 2,26,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding,liver cancer|hepatocellular carcinoma,ppi
4370,5177,1014,CDH16,cadherin 16,3,,,ppi
4371,5178,83999,KREMEN1,kringle containing transmembrane protein 1,1,,schizophrenia,ppi
4372,5179,84696,ABHD1,abhydrolase domain containing 1,1,short-chain carboxylesterase activity|lipase activity|acylglycerol lipase activity,,ppi
4373,5180,10025,MED16,mediator complex subunit 16,66,transcription coregulator activity|transcription coactivator activity|thyroid hormone receptor coactivator activity|signaling receptor activity|vitamin D receptor binding|thyroid hormone receptor binding,endometriosis of uterus|endometriosis,ppi
4374,5181,51451,LCMT1,leucine carboxyl methyltransferase 1,12,protein C-terminal carboxyl O-methyltransferase activity|S-adenosylmethionine-dependent methyltransferase activity|protein C-terminal leucine carboxyl O-methyltransferase activity,,ppi
4375,5182,9836,LCMT2,leucine carboxyl methyltransferase 2,17,tRNA methyltransferase activity,,ppi
4376,5183,1015,CDH17,cadherin 17,1,transporter activity|proton-dependent oligopeptide secondary active transmembrane transporter activity|protein homodimerization activity|cadherin binding|calcium ion binding|cytoskeletal protein binding,bipolar disorder|schizophreniform disorder|schizoaffective disorder,ppi
4377,5184,84967,LSM10,LSM10; U7 small nuclear RNA associated,18,histone pre-mRNA DCP binding,,ppi
4378,5185,56339,METTL3,methyltransferase like 3,19,mRNA binding|RNA methyltransferase activity|mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity|protein heterodimerization activity|S-adenosyl-L-methionine binding,,ppi
4379,5186,50488,MINK1,misshapen like kinase 1,29,protein kinase activity|protein serine/threonine kinase activity|ATP binding,,ppi
4380,5188,1016,CDH18,cadherin 18,5,cadherin binding|calcium ion binding|cytoskeletal protein binding|protein homodimerization activity,alcohol dependence|alcohol abuse,ppi
4381,5189,54749,EPDR1,ependymin related 1,15,,angle-closure glaucoma|primary angle-closure glaucoma|chronic closed-angle glaucoma,ppi
4382,5190,57538,ALPK3,alpha kinase 3,1,,,ppi
4383,5191,23013,SPEN,spen family transcriptional repressor,61,obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|RNA binding,,ppi
4384,5192,10948,STARD3,StAR related lipid transfer domain containing 3,17,cholesterol binding|protein homodimerization activity,prostate cancer|prostate carcinoma,ppi
4385,5193,28513,CDH19,cadherin 19,24,calcium ion binding|cadherin binding|protein homodimerization activity|cytoskeletal protein binding,,ppi
4386,5194,51074,APIP,APAF1 interacting protein,31,zinc ion binding|methylthioribulose 1-phosphate dehydratase activity,,ppi
4387,5195,23522,KAT6B,lysine acetyltransferase 6B,9,histone acetyltransferase activity|transcription factor binding|acetyltransferase activity|histone binding|H4 histone acetyltransferase activity,sick sinus syndrome|ptosis|congenital ptosis|blood coagulation disease|clubfoot|cryptorchidism|sensorineural hearing loss|epilepsy|enophthalmos|orbital disease|exophthalmos|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9,ppi
4388,5196,375616,KCP,kielin/chordin-like protein,1,,,ppi
4389,5197,23787,MTCH1,mitochondrial carrier 1,61,,,ppi
4390,5198,23788,MTCH2,mitochondrial carrier 2,85,,obesity,ppi
4391,5199,220064,ORAOV1,oral cancer overexpressed 1,6,,,ppi
4392,5200,1000,CDH2,cadherin 2,79,beta-catenin binding|calcium ion binding|cytoskeletal protein binding|cadherin binding|protein homodimerization activity,status epilepticus|stomach cancer|coronary artery disease,ppi
4393,5201,60314,C12orf10,chromosome 12 open reading frame 10,33,,,ppi
4394,5202,137075,CLDN23,claudin 23,1,identical protein binding,,ppi
4395,5203,80762,NDFIP1,Nedd4 family interacting protein 1,41,WW domain binding,,ppi
4396,5204,23154,NCDN,neurochondrin,29,,,ppi
4397,5205,51465,UBE2J1,ubiquitin conjugating enzyme E2 J1,38,ubiquitin conjugating enzyme activity,,ppi
4398,5207,57863,CADM3,cell adhesion molecule 3,1,protein homodimerization activity,,ppi
4399,5208,83593,RASSF5,Ras association domain family member 5,52,,kidney cancer|neuroblastoma,ppi
4400,5209,51283,BFAR,bifunctional apoptosis regulator,18,protein binding; bridging|ubiquitin protein ligase activity|caspase binding,,ppi
4401,5210,84759,PCGF1,polycomb group ring finger 1,122,promoter-specific chromatin binding,,ppi
4402,5211,54756,IL17RD,interleukin 17 receptor D,6,interleukin-17 receptor activity,cryptorchidism|salivary gland adenoid cystic carcinoma|hypertrophy of breast|infant gynecomastia|gynecomastia|hypogonadism|prostate cancer|prostate carcinoma|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|eunuchism,ppi
4403,5213,54820,NDE1,nudE neurodevelopment protein 1,60,microtubule binding,clubfoot|epilepsy|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|enophthalmos|orbital disease|exophthalmos|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|schizophreniform disorder|schizoaffective disorder|schizophrenia|visual epilepsy,ppi
4404,5214,1001,CDH3,cadherin 3,11,protein homodimerization activity|calcium ion binding|cytoskeletal protein binding|cadherin binding,inflammatory bowel disease|ulcerative colitis|dental caries|Clouston syndrome|hypotrichosis|retinitis pigmentosa 30|age related macular degeneration|macular degeneration|nail disease|retinitis|retinal disease|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|syndactyly,ppi
4405,5215,81565,NDEL1,nudE neurodevelopment protein 1 like 1,106,microtubule binding,schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
4406,5216,170685,NUDT10,nudix hydrolase 10,7,diphosphoinositol-polyphosphate diphosphatase activity|inositol bisdiphosphate tetrakisphosphate diphosphatase activity|inositol diphosphate pentakisphosphate diphosphatase activity|bis(5'-adenosyl)-hexaphosphatase activity|m7G(5')pppN diphosphatase activity|bis(5'-adenosyl)-pentaphosphatase activity|endopolyphosphatase activity,,ppi
4407,5217,51667,NUB1,negative regulator of ubiquitin like proteins 1,24,,,ppi
4408,5219,1002,CDH4,cadherin 4,6,cytoskeletal protein binding|cadherin binding|protein homodimerization activity|calcium ion binding,,ppi
4409,5220,64425,POLR1E,RNA polymerase I subunit E,52,RNA polymerase I activity,,ppi
4410,5221,57532,NUFIP2,NUFIP2; FMR1 interacting protein 2,70,RNA binding,schizophrenia,ppi
4411,5222,29126,CD274,CD274 molecule,48,,allergic hypersensitivity disease|substance abuse|substance-related disorder|liver cancer|hepatocellular carcinoma,ppi
4412,5223,64065,PERP,PERP; TP53 apoptosis effector,1,,,ppi
4413,5224,1003,CDH5,cadherin 5,90,calcium ion binding|cadherin binding|protein homodimerization activity|cytoskeletal protein binding,alcohol dependence|alcohol abuse|large intestine cancer|colorectal cancer|primary biliary cirrhosis|breast cancer,ppi
4414,5225,64858,DCLRE1B,DNA cross-link repair 1B,15,5'-3' exonuclease activity|protein homodimerization activity|5'-3' exodeoxyribonuclease activity|damaged DNA binding,,ppi
4415,5226,64421,DCLRE1C,DNA cross-link repair 1C,37,single-stranded DNA endodeoxyribonuclease activity|endonuclease activity|5'-3' exonuclease activity|5'-3' exodeoxyribonuclease activity|damaged DNA binding,MHC class II deficiency|severe combined immunodeficiency|Omenn syndrome,ppi
4416,5227,57120,GOPC,golgi associated PDZ and coiled-coil motif containing,129,,melanoma|skin melanoma,ppi
4417,5228,55124,PIWIL2,piwi like RNA-mediated gene silencing 2,7,endoribonuclease activity|piRNA binding,,ppi
4418,5229,55768,NGLY1,N-glycanase 1,21,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,NGLY1-deficiency,ppi
4419,5230,64091,POPDC2,popeye domain containing 2,23,cAMP binding,,ppi
4420,5231,64208,POPDC3,popeye domain containing 3,1,cAMP binding,,ppi
4421,5232,1004,CDH6,cadherin 6,6,calcium ion binding|cadherin binding|cytoskeletal protein binding|protein homodimerization activity,,ppi
4422,5233,57630,SH3RF1,SH3 domain containing ring finger 1,52,MAP-kinase scaffold activity|ubiquitin protein ligase activity,,ppi
4423,5234,64840,PORCN,porcupine homolog (Drosophila),6,palmitoleoyltransferase activity,focal dermal hypoplasia,ppi
4424,5235,64388,GREM2,gremlin 2; DAN family BMP antagonist,3,heparin binding,,ppi
4425,5236,1005,CDH7,cadherin 7,6,protein homodimerization activity|cadherin binding|calcium ion binding|cytoskeletal protein binding,bipolar disorder|large intestine cancer|colorectal cancer|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
4426,5237,9937,DCLRE1A,DNA cross-link repair 1A,5,5'-3' exodeoxyribonuclease activity|damaged DNA binding,,ppi
4427,5238,51365,PLA1A,phospholipase A1 member A,4,phosphatidylserine 1-acylhydrolase activity,,ppi
4428,5239,58155,PTBP2,polypyrimidine tract binding protein 2,26,RNA binding,,ppi
4429,5240,10531,PITRM1,pitrilysin metallopeptidase 1,42,metalloendopeptidase activity|enzyme activator activity|metallopeptidase activity|zinc ion binding,,ppi
4430,5241,25945,NECTIN3,nectin cell adhesion molecule 3,31,protein homodimerization activity|signaling receptor activity|cell adhesion molecule binding,,ppi
4431,5242,1006,CDH8,cadherin 8,17,protein homodimerization activity|cytoskeletal protein binding|calcium ion binding|cadherin binding,alcohol dependence|alcohol abuse,ppi
4432,5243,57510,XPO5,exportin 5,81,RNA binding|mRNA binding|nuclear export signal receptor activity|Ran GTPase binding|pre-miRNA binding,nephrotic syndrome,ppi
4433,5244,27342,RABGEF1,RAB guanine nucleotide exchange factor 1,65,Rab guanyl-nucleotide exchange factor activity,,ppi
4434,5245,9135,RABEP1,rabaptin; RAB GTPase binding effector protein 1,55,,,ppi
4435,5246,29098,RANGRF,RAN guanine nucleotide release factor,19,guanyl-nucleotide exchange factor activity|Ran guanyl-nucleotide exchange factor activity|Ran GTPase binding|protein transporter activity|sodium channel regulator activity,,ppi
4436,5247,1007,CDH9,cadherin 9,8,cadherin binding|protein homodimerization activity|cytoskeletal protein binding|calcium ion binding,alcohol dependence|alcohol abuse|autistic disorder,ppi
4437,5248,57786,RBAK,RB associated KRAB zinc finger,11,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding,,ppi
4438,5249,55156,ARMC1,armadillo repeat containing 1,44,,,ppi
4439,5250,57589,RIC1,RIC1 homolog; RAB6A GEF complex partner 1,1,Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding,,ppi
4440,5251,10171,RCL1,RNA terminal phosphate cyclase like 1,19,RNA-3'-phosphate cyclase activity|endoribonuclease activity,,ppi
4441,5252,10556,RPP30,ribonuclease P/MRP subunit p30,40,RNA binding|ribonuclease P activity,,ppi
4442,5253,51367,POP5,POP5 homolog; ribonuclease P/MRP subunit,14,ribonuclease P activity,,ppi
4443,5254,10423,CDIPT,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,34,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,,ppi
4444,5255,54763,ROPN1,rhophilin associated tail protein 1,26,,,ppi
4445,5256,9249,DHRS3,dehydrogenase/reductase 3,6,nucleotide binding|electron transfer activity|NADP-retinol dehydrogenase activity|retinol dehydrogenase activity,,ppi
4446,5257,54938,SARS2,seryl-tRNA synthetase 2; mitochondrial,43,RNA binding|serine-tRNA ligase activity|ATP binding,anemia|macrocytic anemia|diabetic ketoacidosis|diabetes mellitus|primary pulmonary hypertension|pulmonary hypertension|leukopenia|proteinuria|thrombocytopenia|hyperuricemia|chronic kidney disease,ppi
4447,5258,388228,SBK1,SH3 domain binding kinase 1,6,protein serine/threonine kinase activity,,ppi
4448,5259,95,ACY1,aminoacylase 1,28,aminoacylase activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|epilepsy|sensorineural hearing loss|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
4449,5260,8558,CDK10,cyclin dependent kinase 10,20,protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase activity,,ppi
4450,5261,56477,CCL28,C-C motif chemokine ligand 28,6,chemokine activity,,ppi
4451,5262,55176,SEC61A2,Sec61 translocon alpha 2 subunit,9,protein transmembrane transporter activity|signal sequence binding,,ppi
4452,5263,23024,PDZRN3,PDZ domain containing ring finger 3,15,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
4453,5264,9403,SELENOF,selenoprotein F,13,,,ppi
4454,5265,1017,CDK2,cyclin dependent kinase 2,734,protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase activity|cyclin binding|cyclin-dependent protein kinase activity|histone kinase activity,melanoma|skin melanoma,ppi
4455,5266,27240,SIT1,signaling threshold regulating transmembrane adaptor 1,7,SH2 domain binding|kinase binding,,ppi
4456,5267,10572,SIVA1,SIVA1 apoptosis inducing factor,31,virus receptor activity,,ppi
4457,5268,414149,ACBD7,acyl-CoA binding domain containing 7,11,,,ppi
4458,5269,27347,STK39,serine/threonine kinase 39,39,protein serine/threonine kinase activity|kinase activity,autistic disorder|hypertension|essential hypertension,ppi
4459,5270,23478,SEC11A,SEC11 homolog A; signal peptidase complex subunit,22,peptidase activity,,ppi
4460,5271,56882,CDC42SE1,CDC42 small effector 1,11,GTPase inhibitor activity|structural molecule activity,,ppi
4461,5272,1018,CDK3,cyclin dependent kinase 3,53,cyclin-dependent protein serine/threonine kinase activity,,ppi
4462,5273,81537,SGPP1,sphingosine-1-phosphate phosphatase 1,26,sphingosine-1-phosphate phosphatase activity|dihydrosphingosine-1-phosphate phosphatase activity,,ppi
4463,5274,25943,C20orf194,chromosome 20 open reading frame 194,3,,,ppi
4464,5275,200734,SPRED2,sprouty related EVH1 domain containing 2,20,stem cell factor receptor binding|protein serine/threonine kinase inhibitor activity,rheumatoid arthritis,ppi
4465,5276,148066,ZNRF4,zinc and ring finger 4,80,ubiquitin protein ligase activity,,ppi
4466,5277,83449,PMFBP1,polyamine modulated factor 1 binding protein 1,1,,,ppi
4467,5278,80146,UXS1,UDP-glucuronate decarboxylase 1,37,protein homodimerization activity|UDP-glucuronate decarboxylase activity|NAD+ binding,,ppi
4468,5279,1019,CDK4,cyclin dependent kinase 4,216,cyclin-dependent protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase regulator activity,brain cancer|liposarcoma|pleomorphic liposarcoma|lymphatic system disease|melanoma|skin melanoma|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag|stomach cancer|brain stem cancer|atypical lipomatous tumor|sclerosing liposarcoma|inflammatory liposarcoma|familial melanoma|dysplastic nevus syndrome|liver cancer|hepatocellular carcinoma,ppi
4469,5280,11129,CLASRP,CLK4 associating serine/arginine rich protein,34,,,ppi
4470,5281,171024,SYNPO2,synaptopodin 2,21,filamin binding|muscle alpha-actinin binding|alpha-actinin binding|14-3-3 protein binding|actin binding,ovarian cancer|ovarian carcinoma,ppi
4471,5282,57475,PLEKHH1,pleckstrin homology; MyTH4 and FERM domain containing H1,22,,,ppi
4472,5284,55362,TMEM63B,transmembrane protein 63B,88,,,ppi
4473,5285,23433,RHOQ,ras homolog family member Q,21,GTPase activity|protein kinase binding|GTP binding,,ppi
4474,5286,1020,CDK5,cyclin dependent kinase 5,205,protein kinase activity|protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase activity|ErbB-2 class receptor binding|kinase activity|acetylcholine receptor activator activity|ErbB-3 class receptor binding|tau-protein kinase activity|microtubule binding,hypertrichosis|elephantiasis|lymphedema|schizophrenia|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|cocaine abuse|cocaine dependence|morphine dependence,ppi
4475,5287,51339,DACT1,dishevelled binding antagonist of beta catenin 1,28,protein kinase C binding|beta-catenin binding|protein kinase A binding|delta-catenin binding,anencephaly|myelomeningocele,ppi
4476,5288,8851,CDK5R1,cyclin dependent kinase 5 regulatory subunit 1,48,protein kinase activity|calcium ion binding|kinase activity|cyclin-dependent protein kinase 5 activator activity|alpha-tubulin binding|protein serine/threonine kinase activator activity|cadherin binding|beta-tubulin binding,brain disease|schizophrenia,ppi
4477,5290,10099,TSPAN3,tetraspanin 3,53,,,ppi
4478,5291,10098,TSPAN5,tetraspanin 5,62,,,ppi
4479,5293,115650,TNFRSF13C,TNF receptor superfamily member 13C,5,,common variable immunodeficiency,ppi
4480,5294,60401,EDA2R,ectodysplasin A2 receptor,14,tumor necrosis factor-activated receptor activity|signaling receptor activity,hypohidrotic ectodermal dysplasia,ppi
4481,5295,64102,TNMD,tenomodulin,1,,,ppi
4482,5296,23590,PDSS1,decaprenyl diphosphate synthase subunit 1,8,protein heterodimerization activity|trans-hexaprenyltranstransferase activity,aortic valve insufficiency|primary pulmonary hypertension|pulmonary hypertension|mitral valve insufficiency|mitral valve prolapse|obesity|optic atrophy|polyneuropathy|peripheral nervous system disease|neuropathy|coenzyme Q10 deficiency disease,ppi
4483,5297,8941,CDK5R2,cyclin dependent kinase 5 regulatory subunit 2,6,actin binding|cyclin-dependent protein kinase 5 activator activity,,ppi
4484,5298,54210,TREM1,triggering receptor expressed on myeloid cells 1,2,,gallbladder disease|liver disease|schizophrenia,ppi
4485,5299,54209,TREM2,triggering receptor expressed on myeloid cells 2,1,phospholipid binding|signaling receptor activity,agnosia|alexia|dyslexia|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|progressive muscular atrophy|amyotrophic lateral sclerosis,ppi
4486,5300,51444,RNF138,ring finger protein 138,45,single-stranded DNA binding|ubiquitin protein ligase activity,,ppi
4487,5301,51567,TDP2,tyrosyl-DNA phosphodiesterase 2,35,magnesium ion binding|single-stranded DNA binding|transcription corepressor activity|manganese ion binding|tyrosyl-RNA phosphodiesterase activity|5'-tyrosyl-DNA phosphodiesterase activity,,ppi
4488,5302,1021,CDK6,cyclin dependent kinase 6,124,cyclin-dependent protein serine/threonine kinase activity|ATP binding,rheumatoid arthritis|glioblastoma multiforme|giant cell glioblastoma|acute myeloid leukemia|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|intellectual disability|learning disability|syndromic X-linked intellectual disability 94|vesicoureteral reflux|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type,ppi
4489,5303,253959,RALGAPA1,Ral GTPase activating protein catalytic alpha subunit 1,12,GTPase activator activity,,ppi
4490,5304,25828,TXN2,thioredoxin 2,59,,myelomeningocele|tethered spinal cord syndrome,ppi
4491,5305,22888,UBOX5,U-box domain containing 5,26,ubiquitin-ubiquitin ligase activity,,ppi
4492,5307,1022,CDK7,cyclin dependent kinase 7,83,transcription coactivator activity|protein kinase activity|protein serine/threonine kinase activity|DNA-dependent ATPase activity|RNA polymerase II CTD heptapeptide repeat kinase activity|kinase activity|androgen receptor binding|cyclin-dependent protein serine/threonine kinase activity,,ppi
4493,5308,345651,ACTBL2,actin; beta like 2,185,,,ppi
4494,5309,114131,UCN3,urocortin 3,3,G-protein coupled receptor binding,lung disease|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
4495,5311,8825,LIN7A,lin-7 homolog A; crumbs cell polarity complex component,38,L27 domain binding,,ppi
4496,5312,64130,LIN7B,lin-7 homolog B; crumbs cell polarity complex component,14,L27 domain binding,,ppi
4497,5313,55327,LIN7C,lin-7 homolog C; crumbs cell polarity complex component,41,L27 domain binding,,ppi
4498,5314,1024,CDK8,cyclin dependent kinase 8,125,protein kinase activity|protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase activity,,ppi
4499,5315,11138,TBC1D8,TBC1 domain family member 8,4,Rab GTPase binding|GTPase activator activity,,ppi
4500,5316,143187,VTI1A,vesicle transport through interaction with t-SNAREs 1A,12,SNAP receptor activity|SNARE binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|large intestine cancer|colorectal cancer,ppi
4501,5317,10490,VTI1B,vesicle transport through interaction with t-SNAREs 1B,88,SNARE binding|chloride channel inhibitor activity|SNAP receptor activity,,ppi
4502,5318,58480,RHOU,ras homolog family member U,129,GTP binding|GTPase activity|protein kinase binding,,ppi
4503,5319,60485,SAV1,salvador family WW domain containing protein 1,89,,,ppi
4504,5320,64328,XPO4,exportin 4,46,nuclear export signal receptor activity,,ppi
4505,5321,51776,MAP3K20,mitogen-activated protein kinase kinase kinase 20,45,magnesium ion binding|RNA binding|protein serine/threonine kinase activity|MAP kinase kinase kinase activity|ATP binding,,ppi
4506,5322,56252,YLPM1,YLP motif containing 1,47,RNA binding,,ppi
4507,5323,1025,CDK9,cyclin dependent kinase 9,274,DNA binding|chromatin binding|protein kinase activity|protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase activity|RNA polymerase II CTD heptapeptide repeat kinase activity|kinase activity|7SK snRNA binding|cyclin binding|transcription factor binding|transcription regulatory region DNA binding,,ppi
4508,5324,10056,FARSB,phenylalanyl-tRNA synthetase beta subunit,52,phenylalanine-tRNA ligase activity,,ppi
4509,5325,140612,ZFP28,ZFP28 zinc finger protein,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
4510,5326,51268,PIPOX,pipecolic acid and sarcosine oxidase,9,sarcosine oxidase activity|L-pipecolate oxidase activity,peroxisomal disease,ppi
4511,5327,50626,CYHR1,cysteine and histidine rich 1,26,,,ppi
4512,5329,23211,ZC3H4,zinc finger CCCH-type containing 4,32,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding|DNA-binding transcription factor activity|RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,,ppi
4513,5330,23293,SMG6,SMG6; nonsense mediated mRNA decay factor,18,endoribonuclease activity|telomeric DNA binding|telomerase RNA binding|ribonuclease activity,,ppi
4514,5331,8814,CDKL1,cyclin dependent kinase like 1,12,cyclin-dependent protein serine/threonine kinase activity,,ppi
4515,5332,154796,AMOT,angiomotin,111,signaling receptor activity|angiostatin binding,,ppi
4516,5333,154810,AMOTL1,angiomotin like 1,26,identical protein binding,,ppi
4517,5334,51421,AMOTL2,angiomotin like 2,77,,,ppi
4518,5335,93185,IGSF8,immunoglobulin superfamily member 8,189,,,ppi
4519,5336,55719,SLF2,SMC5-SMC6 complex localization factor 2,10,,,ppi
4520,5337,10964,IFI44L,interferon induced protein 44 like,2,,influenza,ppi
4521,5339,84618,NT5C1A,5'-nucleotidase; cytosolic IA,3,5'-nucleotidase activity,,ppi
4522,5340,8999,CDKL2,cyclin dependent kinase like 2,7,protein kinase activity|cyclin-dependent protein serine/threonine kinase activity,,ppi
4523,5341,51251,NT5C3A,5'-nucleotidase; cytosolic IIIA,18,tRNA 2'-phosphotransferase activity|magnesium ion binding|5'-nucleotidase activity,hemolytic anemia|congenital nonspherocytic hemolytic anemia|hemoglobinuria,ppi
4524,5342,10212,DDX39A,DExD-box helicase 39A,95,RNA binding|ATPase activity,,ppi
4525,5343,80142,PTGES2,prostaglandin E synthase 2,25,lyase activity|heme binding|glutathione binding|prostaglandin-E synthase activity,thyroid cancer|thyroid adenoma|thyroid carcinoma,ppi
4526,5344,79095,C9orf16,chromosome 9 open reading frame 16,13,,,ppi
4527,5346,11145,PLA2G16,phospholipase A2 group XVI,4,phospholipase A2 activity|phospholipase A1 activity|transferase activity; transferring acyl groups,,ppi
4528,5347,54554,WDR5B,WD repeat domain 5B,25,,,ppi
4529,5348,29906,ST8SIA5,ST8 alpha-N-acetyl-neuraminide alpha-2;8-sialyltransferase 5,2,alpha-N-acetylneuraminate alpha-2;8-sialyltransferase activity|sialyltransferase activity,,ppi
4530,5349,56927,GPR108,G protein-coupled receptor 108,7,,,ppi
4531,5350,57720,GPR107,G protein-coupled receptor 107,8,,,ppi
4532,5352,84365,NIFK,nucleolar protein interacting with the FHA domain of MKI67,156,RNA binding,,ppi
4533,5353,246184,CDC26,cell division cycle 26,36,,,ppi
4534,5354,1026,CDKN1A,cyclin dependent kinase inhibitor 1A,276,cyclin-dependent protein serine/threonine kinase activity|protein kinase inhibitor activity|cyclin-dependent protein serine/threonine kinase inhibitor activity|cyclin-dependent protein kinase activating kinase activity,hyperpituitarism|acromegaly|urinary bladder cancer|transitional cell carcinoma|colon cancer|colonic benign neoplasm|esophagitis|peptic esophagitis|gastroesophageal reflux disease|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hyperparathyroidism|osteitis fibrosa|insulinoma|intestinal cancer|intestinal benign neoplasm|nephritis,ppi
4535,5355,84269,CHCHD5,coiled-coil-helix-coiled-coil-helix domain containing 5,1,,,ppi
4536,5356,254956,MORN5,MORN repeat containing 5,3,,,ppi
4537,5357,26088,GGA1,golgi associated; gamma adaptin ear containing; ARF binding protein 1,70,protein heterodimerization activity,,ppi
4538,5358,96764,TGS1,trimethylguanosine synthase 1,39,RNA methyltransferase activity|RNA trimethylguanosine synthase activity,,ppi
4539,5359,79786,KLHL36,kelch like family member 36,21,,,ppi
4540,5360,27284,SULT1B1,sulfotransferase family 1B member 1,4,aryl sulfotransferase activity|sulfotransferase activity,,ppi
4541,5361,27090,ST6GALNAC4,ST6 N-acetylgalactosaminide alpha-2;6-sialyltransferase 4,6,alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase activity|sialyltransferase activity|(alpha-N-acetylneuraminyl-2;3-beta-galactosyl-1;3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,,ppi
4542,5362,11329,STK38,serine/threonine kinase 38,53,magnesium ion binding|protein serine/threonine kinase activity|ATP binding|cadherin binding,,ppi
4543,5363,23012,STK38L,serine/threonine kinase 38 like,21,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
4544,5364,25960,ADGRA2,adhesion G protein-coupled receptor A2,2,,,ppi
4545,5365,1027,CDKN1B,cyclin dependent kinase inhibitor 1B,95,cyclin-dependent protein serine/threonine kinase activity|protein kinase inhibitor activity|cyclin-dependent protein serine/threonine kinase inhibitor activity|transforming growth factor beta receptor; cytoplasmic mediator activity|protein phosphatase binding|chaperone binding|protein kinase binding|protein-containing complex binding|Hsp70 protein binding,hyperpituitarism|acromegaly|esophagitis|peptic esophagitis|gastroesophageal reflux disease|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hyperparathyroidism|osteitis fibrosa|insulinoma|intestinal cancer|intestinal benign neoplasm|kidney cancer|liver cancer|lung benign neoplasm|multiple endocrine neoplasia type 1|malignant mesothelioma|benign mesothelioma|peptic ulcer disease,ppi
4546,5366,25988,HINFP,histone H4 transcription factor,39,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|transcription regulatory region DNA binding,,ppi
4547,5367,25996,REXO2,RNA exonuclease 2,14,3'-5' exonuclease activity|3'-5'-exoribonuclease activity,,ppi
4548,5368,56994,CHPT1,choline phosphotransferase 1,29,diacylglycerol cholinephosphotransferase activity|diacylglycerol binding|phosphotransferase activity; for other substituted phosphate groups|ethanolaminephosphotransferase activity,adult respiratory distress syndrome|newborn respiratory distress syndrome,ppi
4549,5369,25998,IBTK,inhibitor of Bruton tyrosine kinase,72,protein kinase binding|protein tyrosine kinase inhibitor activity,,ppi
4550,5370,26019,UPF2,UPF2 regulator of nonsense transcripts homolog (yeast),104,telomeric DNA binding,,ppi
4551,5371,26035,GLCE,glucuronic acid epimerase,15,racemase and epimerase activity; acting on carbohydrates and derivatives|heparosan-N-sulfate-glucuronate 5-epimerase activity,,ppi
4552,5372,26061,HACL1,2-hydroxyacyl-CoA lyase 1,11,carbon-carbon lyase activity|thiamine pyrophosphate binding|cofactor binding,cholestasis,ppi
4553,5373,140691,TRIM69,tripartite motif containing 69,40,ubiquitin-protein transferase activity,mental depression|melancholia,ppi
4554,5374,26086,GPSM1,G-protein signaling modulator 1,27,GDP-dissociation inhibitor activity,cocaine abuse|cocaine dependence,ppi
4555,5375,23511,NUP188,nucleoporin 188,45,structural constituent of nuclear pore,,ppi
4556,5376,1028,CDKN1C,cyclin dependent kinase inhibitor 1C,24,protein kinase inhibitor activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|Perlman syndrome|Sotos syndrome|Beckwith-Wiedemann syndrome|cryptorchidism|endometrial cancer|endometrial carcinoma|enophthalmos|orbital disease|exophthalmos|placental insufficiency|hydronephrosis|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hypogonadism,ppi
4557,5377,26135,SERBP1,SERPINE1 mRNA binding protein 1,131,RNA binding|mRNA 3'-UTR binding|cadherin binding,stomach cancer,ppi
4558,5378,26146,TRAF3IP1,TRAF3 interacting protein 1,83,,hypertension|essential hypertension|retinitis pigmentosa 30|age related macular degeneration|macular degeneration|premature menopause|androgen insensitivity syndrome|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|ophthalmoplegia|mechanical strabismus|hypertropia|renal infectious disease|interstitial nephritis|pyelonephritis,ppi
4559,5379,26168,SENP3,SUMO1/sentrin/SMT3 specific peptidase 3,122,,,ppi
4560,5380,26355,FAM162A,family with sequence similarity 162 member A,24,,,ppi
4561,5381,26762,HAVCR1,hepatitis A virus cellular receptor 1,1,virus receptor activity,focal segmental glomerulosclerosis|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|proteinuria,ppi
4562,5382,27020,NPTN,neuroplastin,9,type 1 fibroblast growth factor receptor binding|cell adhesion molecule binding|cell-cell adhesion mediator activity,hypertension|essential hypertension|schizophrenia|coronary artery disease,ppi
4563,5383,27113,BBC3,BCL2 binding component 3,9,,Burkitt lymphoma|brain ischemia|esophageal cancer,ppi
4564,5384,27125,AFF4,AF4/FMR2 family member 4,40,DNA-binding transcription factor activity|double-stranded DNA binding,cryptorchidism|patent ductus arteriosus|enophthalmos|orbital disease|exophthalmos|esophagitis|peptic esophagitis|gastroesophageal reflux disease|congenital heart disease|heart septal defect|lung disease|intellectual disability|learning disability|obesity|aspiration pneumonia|aspiration pneumonitis|tracheal stenosis|vesicoureteral reflux,ppi
4565,5385,1029,CDKN2A,cyclin dependent kinase inhibitor 2A,197,RNA binding|cyclin-dependent protein serine/threonine kinase inhibitor activity|NF-kappaB binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|adrenal gland cancer|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|urinary bladder cancer|brain cancer|lung cancer|non-small cell lung carcinoma,ppi
4566,5386,27130,INVS,inversin,13,,hypertension|essential hypertension|premature menopause|androgen insensitivity syndrome|pulmonary valve insufficiency|blindness|oligohydramnios|chronic pyelonephritis|Senior-Loken syndrome|nephronophthisis|fundus dystrophy,ppi
4567,5387,27231,NMRK2,nicotinamide riboside kinase 2,7,ribosylnicotinamide kinase activity|ribosylnicotinate kinase activity,,ppi
4568,5388,79624,ARMT1,acidic residue methyltransferase 1,37,S-adenosylmethionine-dependent methyltransferase activity|protein carboxyl O-methyltransferase activity,,ppi
4569,5389,27258,LSM3,LSM3 homolog; U6 small nuclear RNA and mRNA degradation associated,52,RNA binding,,ppi
4570,5390,55336,FBXL8,F-box and leucine rich repeat protein 8,6,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
4571,5391,64802,NMNAT1,nicotinamide nucleotide adenylyltransferase 1,37,nicotinamide-nucleotide adenylyltransferase activity|nicotinate-nucleotide adenylyltransferase activity,optic atrophy|retinal degeneration|age related macular degeneration|macular degeneration|degeneration of macula and posterior pole|Leber congenital amaurosis|Leber congenital amaurosis 9|coloboma,ppi
4572,5392,91687,CENPL,centromere protein L,11,,,ppi
4573,5393,1030,CDKN2B,cyclin dependent kinase inhibitor 2B,20,cyclin-dependent protein serine/threonine kinase inhibitor activity,hyperpituitarism|acromegaly|esophagitis|peptic esophagitis|gastroesophageal reflux disease|glaucoma|malignant glioma|gliosarcoma|mixed glioma|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hyperparathyroidism|osteitis fibrosa|insulinoma|lymphatic system disease|lymphosarcoma|lymphoma|central nervous system lymphoma|melanoma,ppi
4574,5394,22853,LMTK2,lemur tyrosine kinase 2,28,protein serine/threonine kinase activity|protein phosphatase inhibitor activity|ATP binding|transmembrane signaling receptor activity|protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity,prostate cancer|prostate carcinoma,ppi
4575,5395,140767,NRSN1,neurensin 1,2,,urinary bladder cancer,ppi
4576,5396,140890,SREK1,splicing regulatory glutamic acid and lysine rich protein 1,82,RNA binding,,ppi
4577,5397,80174,DBF4B,DBF4 zinc finger B,17,protein kinase activator activity|protein kinase binding|protein serine/threonine kinase activator activity,,ppi
4578,5398,130560,SPATA3,spermatogenesis associated 3,8,,,ppi
4579,5399,261729,STEAP2,STEAP2 metalloreductase,2,transporter activity|ferric-chelate reductase (NADPH) activity|cupric reductase activity,,ppi
4580,5400,27288,RBMXL2,RNA binding motif protein; X-linked like 2,20,mRNA binding,,ppi
4581,5401,27294,DHDH,dihydrodiol dehydrogenase,2,NAD(P)+ transhydrogenase activity|electron transfer activity|D-xylose 1-dehydrogenase (NADP+) activity,prostate cancer|prostate carcinoma,ppi
4582,5402,27297,CRCP,CGRP receptor component,24,DNA-directed 5'-3' RNA polymerase activity|RNA polymerase III activity,,ppi
4583,5403,27301,APEX2,apurinic/apyrimidinic endodeoxyribonuclease 2,23,phosphodiesterase I activity|DNA-(apurinic or apyrimidinic site) endonuclease activity|double-stranded DNA 3'-5' exodeoxyribonuclease activity,,ppi
4584,5404,1031,CDKN2C,cyclin dependent kinase inhibitor 2C,46,cyclin-dependent protein serine/threonine kinase inhibitor activity,hyperpituitarism|acromegaly|esophagitis|peptic esophagitis|gastroesophageal reflux disease|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hyperparathyroidism|osteitis fibrosa|insulinoma|multiple endocrine neoplasia type 1|peptic ulcer disease|prolactinoma|Zollinger-Ellison syndrome|hyperinsulinism|gastrin secretion abnormality|thyroid cancer|thyroid adenoma|thyroid carcinoma,ppi
4585,5405,27306,HPGDS,hematopoietic prostaglandin D synthase,4,magnesium ion binding|glutathione transferase activity|prostaglandin-D synthase activity|calcium ion binding,bipolar disorder|gallbladder disease|liver disease|drug psychosis|schizophreniform disorder|schizoaffective disorder|schizophrenia|mood disorder|testicular cancer|seminoma|testicular germ cell cancer,ppi
4586,5406,27315,PGAP2,post-GPI attachment to proteins 2,4,protein transporter activity,syndromic X-linked intellectual disability 94|hyperphosphatemia,ppi
4587,5407,27332,ZNF638,zinc finger protein 638,67,double-stranded DNA binding|RNA binding,,ppi
4588,5408,27338,UBE2S,ubiquitin conjugating enzyme E2 S,67,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,,ppi
4589,5409,27339,PRPF19,pre-mRNA processing factor 19,183,ubiquitin-ubiquitin ligase activity|ubiquitin protein ligase activity|ubiquitin-protein transferase activity,stomach cancer,ppi
4590,5410,27340,UTP20,UTP20; small subunit processome component,38,RNA binding,,ppi
4591,5411,28511,NKIRAS2,NFKB inhibitor interacting Ras like 2,15,GTPase activity,,ppi
4592,5412,28512,NKIRAS1,NFKB inhibitor interacting Ras like 1,11,GTPase activity,,ppi
4593,5413,97,ACYP1,acylphosphatase 1,1,acylphosphatase activity,,ppi
4594,5414,1032,CDKN2D,cyclin dependent kinase inhibitor 2D,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,lymphatic system disease|melanoma|skin melanoma|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag|stomach cancer|familial melanoma|dysplastic nevus syndrome,ppi
4595,5415,28991,COMMD5,COMM domain containing 5,15,,,ppi
4596,5416,29079,MED4,mediator complex subunit 4,364,transcription coregulator activity|nuclear receptor transcription coactivator activity|signaling receptor activity|vitamin D receptor binding|thyroid hormone receptor binding,endometriosis of uterus|endometriosis,ppi
4597,5417,29102,DROSHA,drosha ribonuclease III,47,lipopolysaccharide binding|RNA binding|ribonuclease III activity|protein homodimerization activity|primary miRNA binding|double-stranded RNA binding,male infertility|schizophrenia,ppi
4598,5418,29109,FHOD1,formin homology 2 domain containing 1,38,protein self-association,,ppi
4599,5419,79009,DDX50,DExD-box helicase 50,46,RNA binding,,ppi
4600,5420,150472,CBWD2,COBW domain containing 2,17,,,ppi
4601,5421,23099,ZBTB43,zinc finger and BTB domain containing 43,29,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
4602,5422,80824,DUSP16,dual specificity phosphatase 16,45,phosphoprotein phosphatase activity|phosphatase activity|MAP kinase tyrosine/serine/threonine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity,,ppi
4603,5423,1033,CDKN3,cyclin dependent kinase inhibitor 3,30,protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity,liver cancer|hepatocellular carcinoma,ppi
4604,5424,29122,PRSS50,protease; serine 50,25,threonine-type endopeptidase activity,,ppi
4605,5425,8846,ALKBH1,alkB homolog 1; histone H2A dioxygenase,1,tRNA binding|DNA-(apurinic or apyrimidinic site) endonuclease activity|ferrous iron binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors|methylcytosine dioxygenase activity|tRNA demethylase activity|dioxygenase activity,,ppi
4606,5426,29800,ZDHHC1,zinc finger DHHC-type containing 1,6,DNA binding|palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,,ppi
4607,5427,125170,MIEF2,mitochondrial elongation factor 2,7,,,ppi
4608,5428,140775,SMCR8,Smith-Magenis syndrome chromosome region; candidate 8,10,protein kinase inhibitor activity|Rab guanyl-nucleotide exchange factor activity,,ppi
4609,5429,29803,REPIN1,replication initiator 1,34,RNA binding,,ppi
4610,5430,29841,GRHL1,grainyhead like transcription factor 1,3,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|chromatin DNA binding|sequence-specific DNA binding|transcription regulatory region DNA binding|DNA-binding transcription factor activity,,ppi
4611,5431,29842,TFCP2L1,transcription factor CP2 like 1,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity|sequence-specific DNA binding,,ppi
4612,5432,29843,SENP1,SUMO1/sentrin specific peptidase 1,48,endopeptidase activity|SUMO-specific endopeptidase activity|SUMO-specific isopeptidase activity,,ppi
4613,5433,29893,PSMC3IP,PSMC3 interacting protein,23,nuclear receptor transcription coactivator activity,gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|premature menopause|androgen insensitivity syndrome|prostate cancer|prostate carcinoma|46 XX gonadal dysgenesis|hermaphroditism,ppi
4614,5434,51166,AADAT,aminoadipate aminotransferase,1,kynurenine-oxoglutarate transaminase activity|2-aminoadipate transaminase activity,,ppi
4615,5435,29942,PURG,purine rich element binding protein G,1,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|double-stranded DNA binding|purine-rich negative regulatory element binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
4616,5436,29946,SERTAD3,SERTA domain containing 3,10,,,ppi
4617,5437,29950,SERTAD1,SERTA domain containing 1,39,,colon cancer|colonic benign neoplasm|mood disorder,ppi
4618,5438,84148,KAT8,lysine acetyltransferase 8,39,histone acetyltransferase activity|transcription factor binding|acetyltransferase activity|methylated histone binding|histone acetyltransferase activity (H4-K5 specific)|histone acetyltransferase activity (H4-K8 specific)|histone acetyltransferase activity (H4-K16 specific)|histone binding,schizophrenia,ppi
4619,5439,50487,PLA2G3,phospholipase A2 group III,2,phospholipase A2 activity|calcium-dependent phospholipase A2 activity,,ppi
4620,5440,50489,CD207,CD207 molecule,7,mannose binding|carbohydrate binding,,ppi
4621,5441,50512,PODXL2,podocalyxin like 2,12,glycosaminoglycan binding,,ppi
4622,5442,50624,CUZD1,CUB and zona pellucida like domains 1,1,,,ppi
4623,5443,50632,CALY,calcyon neuron specific vesicular protein,4,clathrin light chain binding,schizophrenia|cocaine abuse|cocaine dependence|morphine dependence,ppi
4624,5444,50651,SLC45A1,solute carrier family 45 member 1,1,,,ppi
4625,5445,50804,MYEF2,myelin expression factor 2,46,RNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|mRNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
4626,5446,50863,NTM,neurotrimin,15,,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
4627,5447,51009,DERL2,derlin 2,41,,,ppi
4628,5448,51010,EXOSC3,exosome component 3,35,3'-5'-exoribonuclease activity|exoribonuclease activity|RNA binding,pseudosarcomatous fibromatosis|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|mechanical strabismus|hypertropia|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|muscular atrophy|pontocerebellar hypoplasia type 1A|pontocerebellar hypoplasia type 1B,ppi
4629,5449,51052,PRLH,prolactin releasing hormone,1,hormone activity,,ppi
4630,5450,51070,NOSIP,nitric oxide synthase interacting protein,31,RNA binding,,ppi
4631,5451,117145,THEM4,thioesterase superfamily member 4,15,palmitoyl-CoA hydrolase activity|acyl-CoA hydrolase activity,liver cancer|hepatocellular carcinoma,ppi
4632,5452,51087,YBX2,Y-box binding protein 2,14,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
4633,5453,93643,TJAP1,tight junction associated protein 1,16,,,ppi
4634,5454,1036,CDO1,cysteine dioxygenase type 1,10,cysteine dioxygenase activity,diabetes mellitus|type 2 diabetes mellitus,ppi
4635,5455,118426,BORCS5,BLOC-1 related complex subunit 5,9,,,ppi
4636,5456,10542,LAMTOR5,late endosomal/lysosomal adaptor; MAPK and MTOR activator 5,88,guanyl-nucleotide exchange factor activity|protein-containing complex scaffold activity,breast cancer,ppi
4637,5457,57418,WDR18,WD repeat domain 18,58,,,ppi
4638,5458,90378,SAMD1,sterile alpha motif domain containing 1,51,,,ppi
4639,5459,79054,TRPM8,transient receptor potential cation channel subfamily M member 8,12,calcium channel activity,migraine|migraine without aura,ppi
4640,5460,259249,MRGPRX1,MAS related GPR family member X1,4,transmembrane signaling receptor activity|G-protein coupled receptor activity,,ppi
4641,5461,51109,RDH11,retinol dehydrogenase 11 (all-trans/9-cis/11-cis),23,retinol dehydrogenase activity|oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor|NADP-retinol dehydrogenase activity,fundus dystrophy,ppi
4642,5462,51134,CEP83,centrosomal protein 83,18,,renal infectious disease|interstitial nephritis|pyelonephritis|Senior-Loken syndrome|nephronophthisis,ppi
4643,5463,51135,IRAK4,interleukin 1 receptor associated kinase 4,27,protein kinase activity|protein serine/threonine kinase activity,primary immunodeficiency disease|prostate cancer|prostate carcinoma,ppi
4644,5464,51146,A4GNT,alpha-1;4-N-acetylglucosaminyltransferase,20,acetylglucosaminyltransferase activity,,ppi
4645,5466,51247,PAIP2,poly(A) binding protein interacting protein 2,13,translation repressor activity,,ppi
4646,5467,51250,C6orf203,chromosome 6 open reading frame 203,29,,,ppi
4647,5468,51299,NRN1,neuritin 1,20,,schizophrenia,ppi
4648,5470,51308,REEP2,receptor accessory protein 2,6,,paraplegia|hereditary spastic paraplegia 72,ppi
4649,5471,140801,RPL10L,ribosomal protein L10 like,85,structural constituent of ribosome,,ppi
4650,5472,126792,B3GALT6,beta-1;3-galactosyltransferase 6,5,UDP-galactosyltransferase activity|galactosylxylosylprotein 3-beta-galactosyltransferase activity|galactosyltransferase activity,Ehlers-Danlos syndrome progeroid type,ppi
4651,5473,1038,CDR1,cerebellar degeneration related protein 1,2,,,ppi
4652,5475,8634,RTCA,RNA 3'-terminal phosphate cyclase,33,RNA binding|RNA-3'-phosphate cyclase activity,,ppi
4653,5476,117194,MRGPRX2,MAS related GPR family member X2,1,G-protein coupled receptor activity|mast cell secretagogue receptor activity,,ppi
4654,5477,54538,ROBO4,roundabout guidance receptor 4,11,signaling receptor activity|cell-cell adhesion mediator activity,autistic disorder,ppi
4655,5478,116085,SLC22A12,solute carrier family 22 member 12,4,urate transmembrane transporter activity,,ppi
4656,5479,1039,CDR2,cerebellar degeneration related protein 2,67,,,ppi
4657,5480,118427,OLFM3,olfactomedin 3,10,,,ppi
4658,5481,80036,TRPM3,transient receptor potential cation channel subfamily M member 3,6,cation channel activity|calcium channel activity,,ppi
4659,5482,54795,TRPM4,transient receptor potential cation channel subfamily M member 4,8,calcium activated cation channel activity|sodium channel activity|calcium ion binding,sick sinus syndrome|Brugada syndrome|Brugada syndrome 1|atrioventricular block,ppi
4660,5483,54822,TRPM7,transient receptor potential cation channel subfamily M member 7,21,calcium channel activity,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|familial adenomatous polyposis|large intestine cancer|colorectal cancer|acute urate nephropathy|nephrolithiasis|liver cirrhosis|amyotrophic lateral sclerosis,ppi
4661,5484,140803,TRPM6,transient receptor potential cation channel subfamily M member 6,4,calcium channel activity,intestinal hypomagnesemia 1,ppi
4662,5485,162417,NAGS,N-acetylglutamate synthase,1,acetyl-CoA:L-glutamate N-acetyltransferase activity|acetylglutamate kinase activity|arginine binding,urea cycle disorder,ppi
4663,5486,79147,FKRP,fukutin related protein,17,,Walker-Warburg syndrome|muscular dystrophy-dystroglycanopathy type B6|autosomal recessive limb-girdle muscular dystrophy type 2I|muscular dystrophy-dystroglycanopathy type B5|muscular dystrophy-dystroglycanopathy,ppi
4664,5487,29941,PKN3,protein kinase N3,41,protein kinase activity|protein serine/threonine kinase activity,,ppi
4665,5488,14,AAMP,angio associated migratory cell protein,33,heparin binding|unfolded protein binding,,ppi
4666,5489,98,ACYP2,acylphosphatase 2,2,acylphosphatase activity,,ppi
4667,5490,1040,CDS1,CDP-diacylglycerol synthase 1,14,diacylglycerol cholinephosphotransferase activity|phosphatidate cytidylyltransferase activity,,ppi
4668,5491,84844,PHF5A,PHD finger protein 5A,36,DNA-binding transcription factor activity|RNA binding,,ppi
4669,5492,10452,TOMM40,translocase of outer mitochondrial membrane 40,121,protein transmembrane transporter activity,schizophreniform disorder|schizoaffective disorder|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
4670,5493,56993,TOMM22,translocase of outer mitochondrial membrane 22,74,protein transmembrane transporter activity,,ppi
4671,5494,167826,OLIG3,oligodendrocyte transcription factor 3,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
4672,5495,55340,GIMAP5,GTPase; IMAP family member 5,12,GTP binding,,ppi
4673,5496,11188,NISCH,nischarin,24,protein kinase binding|structural constituent of cytoskeleton,,ppi
4674,5497,152007,GLIPR2,GLI pathogenesis related 2,7,protein homodimerization activity,,ppi
4675,5498,64359,NXN,nucleoredoxin,14,,large intestine cancer|colorectal cancer,ppi
4676,5499,8760,CDS2,CDP-diacylglycerol synthase 2,8,phosphatidate cytidylyltransferase activity,,ppi
4677,5500,54834,GDAP2,ganglioside induced differentiation associated protein 2,4,,,ppi
4678,5501,55190,NUDT11,nudix hydrolase 11,2,diphosphoinositol-polyphosphate diphosphatase activity|inositol bisdiphosphate tetrakisphosphate diphosphatase activity|inositol diphosphate pentakisphosphate diphosphatase activity|m7G(5')pppN diphosphatase activity|bis(5'-adenosyl)-pentaphosphatase activity|endopolyphosphatase activity|bis(5'-adenosyl)-hexaphosphatase activity,,ppi
4679,5502,55540,IL17RB,interleukin 17 receptor B,31,cytokine receptor activity|interleukin-17 receptor activity,,ppi
4680,5503,55746,NUP133,nucleoporin 133,61,structural constituent of nuclear pore,,ppi
4681,5504,23279,NUP160,nucleoporin 160,58,structural constituent of nuclear pore,,ppi
4682,5505,79665,DHX40,DEAH-box helicase 40,22,ATP-dependent 3'-5' RNA helicase activity|RNA binding,,ppi
4683,5506,60685,ZFAND3,zinc finger AN1-type containing 3,3,,diabetes mellitus|type 2 diabetes mellitus,ppi
4684,5507,1041,CDSN,corneodesmosin,18,protein homodimerization activity,asthma|intrinsic asthma|allergic asthma|granuloma annulare|hypotrichosis|peeling skin syndrome,ppi
4685,5508,11272,PRR4,proline rich 4 (lacrimal),6,,,ppi
4686,5509,11322,TMC6,transmembrane channel like 6,3,mechanosensitive ion channel activity|ion channel activity,basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|epidermodysplasia verruciformis|acrodermatitis|seborrheic keratosis|seborrheic infantile dermatitis|seborrheic dermatitis|skin disease|common wart,ppi
4687,5510,94241,TP53INP1,tumor protein p53 inducible nuclear protein 1,13,antioxidant activity,,ppi
4688,5511,123722,FSD2,fibronectin type III and SPRY domain containing 2,43,,,ppi
4689,5512,388753,COA6,cytochrome c oxidase assembly factor 6,4,RNA binding|copper ion binding,,ppi
4690,5513,55357,TBC1D2,TBC1 domain family member 2,17,GTPase activator activity|Rab GTPase binding,,ppi
4691,5514,221830,TWISTNB,TWIST neighbor,20,DNA-directed 5'-3' RNA polymerase activity|RNA polymerase I activity,,ppi
4692,5515,55644,OSGEP,O-sialoglycoprotein endopeptidase,74,,,ppi
4693,5516,24139,EML2,echinoderm microtubule associated protein like 2,13,microtubule binding|tubulin binding,,ppi
4694,5517,129080,EMID1,EMI domain containing 1,8,,,ppi
4695,5518,196528,ARID2,AT-rich interaction domain 2,29,DNA-binding transcription factor activity; RNA polymerase II-specific,liver cancer|hepatocellular carcinoma,ppi
4696,5519,136227,COL26A1,collagen type XXVI alpha 1 chain,4,,,ppi
4697,5520,10765,KDM5B,lysine demethylase 5B,66,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription corepressor activity|zinc ion binding|histone demethylase activity|histone demethylase activity (H3-K4 specific)|histone demethylase activity (H3-trimethyl-K4 specific)|histone demethylase activity (H3-dimethyl-K4 specific)|histone binding|sequence-specific double-stranded DNA binding|methylated histone binding|chromatin binding|DNA-binding transcription repressor activity; RNA polymerase II-specific,colon cancer|colonic benign neoplasm,ppi
4698,5521,1043,CD52,CD52 molecule,1,,,ppi
4699,5522,57492,ARID1B,AT-rich interaction domain 1B,45,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator activity,neuroblastoma|Coffin-Siris syndrome|liver cancer|hepatocellular carcinoma|chromosome 6q24-q25 deletion syndrome,ppi
4700,5523,55589,BMP2K,BMP2 inducible kinase,41,protein serine/threonine kinase activity|phosphatase regulator activity,,ppi
4701,5524,246175,CNOT6L,CCR4-NOT transcription complex subunit 6 like,30,poly(A)-specific ribonuclease activity,,ppi
4702,5525,55388,MCM10,minichromosome maintenance 10 replication initiation factor,58,DNA replication origin binding|double-stranded DNA binding|single-stranded DNA binding,,ppi
4703,5526,10991,SLC38A3,solute carrier family 38 member 3,5,L-histidine transmembrane transporter activity|amino acid transmembrane transporter activity|L-alanine transmembrane transporter activity|L-asparagine transmembrane transporter activity|L-glutamine transmembrane transporter activity,,ppi
4704,5527,83401,ELOVL3,ELOVL fatty acid elongase 3,2,fatty acid elongase activity,,ppi
4705,5528,116285,ACSM1,acyl-CoA synthetase medium-chain family member 1,4,acyl-CoA ligase activity|CoA-ligase activity|butyrate-CoA ligase activity|fatty-acyl-CoA synthase activity|fatty acid ligase activity,lung benign neoplasm|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
4706,5529,1044,CDX1,caudal type homeobox 1,60,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|methyl-CpG binding|transcription regulatory region DNA binding|DNA-binding transcription factor activity|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
4707,5530,152006,RNF38,ring finger protein 38,15,ubiquitin-protein transferase activity,,ppi
4708,5531,168507,PKD1L1,polycystin 1 like 1; transient receptor potential channel interacting,1,calcium channel activity,,ppi
4709,5532,170589,GPHA2,glycoprotein hormone alpha 2,22,thyrotropin-releasing hormone receptor binding|protein heterodimerization activity,melanoma|skin melanoma,ppi
4710,5533,122876,GPHB5,glycoprotein hormone beta 5,1,thyrotropin-releasing hormone receptor binding|protein heterodimerization activity|hormone activity,,ppi
4711,5534,138474,TAF1L,TATA-box binding protein associated factor 1 like,9,DNA-binding transcription factor activity; RNA polymerase II-specific|histone acetyltransferase activity|protein serine/threonine kinase activity|lysine-acetylated histone binding|transcription factor activity; RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly|TBP-class protein binding|sequence-specific DNA binding|obsolete RNA polymerase II transcription factor activity; TBP-class protein binding; involved in preinitiation complex assembly,,ppi
4712,5537,1045,CDX2,caudal type homeobox 2,19,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|methyl-CpG binding|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
4713,5538,170302,ARX,aristaless related homeobox,17,DNA-binding transcription factor activity; RNA polymerase II-specific,infantile epileptic encephalopathy|Partington syndrome|lissencephaly|Ohtahara syndrome,ppi
4714,5539,84650,EBPL,emopamil binding protein like,3,C-8 sterol isomerase activity|steroid delta-isomerase activity,,ppi
4715,5540,84706,GPT2,glutamic--pyruvic transaminase 2,15,L-alanine:2-oxoglutarate aminotransferase activity,,ppi
4716,5541,56910,STARD7,StAR related lipid transfer domain containing 7,20,,,ppi
4717,5542,80352,RNF39,ring finger protein 39,1,,,ppi
4718,5545,154091,SLC2A12,solute carrier family 2 member 12,56,D-glucose transmembrane transporter activity|glucose transmembrane transporter activity|carbohydrate:proton symporter activity,,ppi
4719,5546,51296,SLC15A3,solute carrier family 15 member 3,8,peptide:proton symporter activity|oligopeptide transmembrane transporter activity|peptide transmembrane transporter activity,,ppi
4720,5547,9027,NAT8,N-acetyltransferase 8 (putative),2,lysine N-acetyltransferase activity; acting on acetyl phosphate as donor|cysteine-S-conjugate N-acetyltransferase activity,,ppi
4721,5548,92745,SLC38A5,solute carrier family 38 member 5,5,amino acid transmembrane transporter activity|glycine transmembrane transporter activity,,ppi
4722,5549,56946,EMSY,EMSY; BRCA2 interacting transcriptional repressor,48,,atopic dermatitis|polycystic ovary syndrome|breast cancer,ppi
4723,5550,285282,RABL3,RAB; member of RAS oncogene family like 3,21,GTPase activity,,ppi
4724,5551,51309,ARMCX1,armadillo repeat containing; X-linked 1,5,,,ppi
4725,5552,51327,AHSP,alpha hemoglobin stabilizing protein,7,hemoglobin binding|unfolded protein binding,,ppi
4726,5553,51329,ARL6IP4,ADP ribosylation factor like GTPase 6 interacting protein 4,31,RNA binding,,ppi
4727,5554,51335,NGRN,neugrin; neurite outgrowth associated,35,RNA binding|rRNA binding,,ppi
4728,5555,51341,ZBTB7A,zinc finger and BTB domain containing 7A,33,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|histone acetyltransferase binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding,glioblastoma multiforme|giant cell glioblastoma|acute myeloid leukemia|prostate cancer|prostate carcinoma,ppi
4729,5556,149076,ZNF362,zinc finger protein 362,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
4730,5557,1046,CDX4,caudal type homeobox 4,7,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
4731,5558,10402,ST3GAL6,ST3 beta-galactoside alpha-2;3-sialyltransferase 6,6,beta-galactoside (CMP) alpha-2;3-sialyltransferase activity|beta-galactoside alpha-2;3-sialyltransferase activity,,ppi
4732,5559,11197,WIF1,WNT inhibitory factor 1,11,Wnt-protein binding|signaling receptor binding,large intestine cancer|colorectal cancer|esophageal cancer|nasopharynx carcinoma|stomach cancer,ppi
4733,5560,51393,TRPV2,transient receptor potential cation channel subfamily V member 2,2,ion channel activity|cation channel activity|calcium channel activity|ion transmembrane transporter activity,,ppi
4734,5561,59341,TRPV4,transient receptor potential cation channel subfamily V member 4,19,actin binding|protein kinase C binding|cation channel activity|calcium channel activity|calmodulin binding|microtubule binding|stretch-activated; cation-selective; calcium channel activity|SH2 domain binding|alpha-tubulin binding|beta-tubulin binding|actin filament binding|ion channel activity,bone disease|cartilage disease|connective tissue disease|Charcot-Marie-Tooth disease type 2|hereditary motor and sensory neuropathy with agenesis of the corpus callosum|hereditary neuropathy with liability to pressure palsies|Charcot-Marie-Tooth disease type 1A|Charcot-Marie-Tooth disease type 1F|Charcot-Marie-Tooth disease type 1D|Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease type 1B|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease type 2A1|Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2B1|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2B|Charcot-Marie-Tooth disease axonal type 2T|Charcot-Marie-Tooth disease type 2R,ppi
4735,5562,162514,TRPV3,transient receptor potential cation channel subfamily V member 3,1,calcium channel activity|ion channel activity,,ppi
4736,5563,147007,TMEM199,transmembrane protein 199,26,,,ppi
4737,5576,245934,DEFB121,defensin beta 121,9,,,ppi
4738,5583,9425,CDYL,chromodomain Y-like,40,chromatin binding|transcription corepressor activity|methylated histone binding|crotonyl-CoA hydratase activity,lung small cell carcinoma,ppi
4739,5584,152137,CCDC50,coiled-coil domain containing 50,13,,autosomal dominant nonsyndromic deafness 44,ppi
4740,5585,158135,TTLL11,tubulin tyrosine ligase like 11,3,tubulin-glutamic acid ligase activity,,ppi
4741,5586,202559,KHDRBS2,KH RNA binding domain containing; signal transduction associated 2,96,,melanoma|skin melanoma,ppi
4742,5587,140596,DEFB104A,defensin beta 104A,6,,,ppi
4743,5588,10657,KHDRBS1,KH RNA binding domain containing; signal transduction associated 1,182,DNA binding|RNA binding|poly(A) binding|poly(U) RNA binding|identical protein binding,,ppi
4744,5589,10656,KHDRBS3,KH RNA binding domain containing; signal transduction associated 3,41,RNA binding|identical protein binding,,ppi
4745,5590,51773,RSF1,remodeling and spacing factor 1,22,histone binding|ATPase activity|histone acetyltransferase activity,,ppi
4746,5591,166378,SPATA5,spermatogenesis associated 5,21,ATPase activity,schizophrenia,ppi
4747,5592,55867,SLC22A11,solute carrier family 22 member 11,6,inorganic anion exchanger activity|organic anion transmembrane transporter activity|sodium-independent organic anion transmembrane transporter activity,,ppi
4748,5594,64321,SOX17,SRY-box 17,6,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription regulatory region DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific,large intestine cancer|colorectal cancer|vesicoureteral reflux,ppi
4749,5595,130399,ACVR1C,activin A receptor type 1C,4,protein serine/threonine kinase activity|activin receptor activity; type I|nodal binding|metal ion binding|transforming growth factor beta receptor activity; type I|SMAD binding|activin binding|growth factor binding|transforming growth factor beta-activated receptor activity,,ppi
4750,5596,64805,P2RY12,purinergic receptor P2Y12,60,ADP receptor activity|guanyl-nucleotide exchange factor activity|G-protein coupled purinergic nucleotide receptor activity,systemic lupus erythematosus|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|platelet-type bleeding disorder 8,ppi
4751,5597,90423,ATP6V1E2,ATPase H+ transporting V1 subunit E2,4,,,ppi
4752,5598,84133,ZNRF3,zinc and ring finger 3,11,ubiquitin-protein transferase activity|ubiquitin protein ligase activity|frizzled binding,pancreatic cancer|adrenal cortex cancer|adrenocortical carcinoma|adrenal carcinoma,ppi
4753,5599,85378,TUBGCP6,tubulin gamma complex associated protein 6,27,microtubule binding|gamma-tubulin binding|structural constituent of cytoskeleton|microtubule minus-end binding,microcephaly and chorioretinopathy 1,ppi
4754,5600,83933,HDAC10,histone deacetylase 10,36,histone deacetylase activity|protein deacetylase activity|histone deacetylase binding,,ppi
4755,5601,51738,GHRL,ghrelin and obestatin prepropeptide,11,G-protein coupled receptor binding|growth hormone-releasing hormone activity|protein tyrosine kinase activator activity|ghrelin receptor binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|colitis|ileitis|ileocolitis|gastroenteritis|inflammatory bowel disease|ulcerative colitis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|esophageal cancer|congestive heart failure|obesity,ppi
4756,5602,50511,SYCP3,synaptonemal complex protein 3,7,,azoospermia,ppi
4757,5603,387597,ILDR2,immunoglobulin like domain containing receptor 2,1,,,ppi
4758,5604,57549,IGSF9,immunoglobulin superfamily member 9,1,cell-cell adhesion mediator activity,,ppi
4759,5605,51347,TAOK3,TAO kinase 3,11,protein serine/threonine kinase activity|protein kinase inhibitor activity|transferase activity|MAP kinase kinase kinase activity,,ppi
4760,5606,51714,SELENOT,selenoprotein T,14,thioredoxin-disulfide reductase activity|selenium binding,,ppi
4761,5607,51363,CHST15,carbohydrate sulfotransferase 15,24,3'-phosphoadenosine 5'-phosphosulfate binding|N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,,ppi
4762,5608,51386,EIF3L,eukaryotic translation initiation factor 3 subunit L,75,RNA binding|translation initiation factor activity,,ppi
4763,5609,634,CEACAM1,carcinoembryonic antigen related cell adhesion molecule 1,21,calmodulin binding|bile acid transmembrane transporter activity|identical protein binding|protein homodimerization activity|protein dimerization activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|lung benign neoplasm,ppi
4764,5610,51458,RHCG,Rh family C glycoprotein,1,ammonium transmembrane transporter activity|ankyrin binding,,ppi
4765,5611,51473,DCDC2,doublecortin domain containing 2,4,,cholestasis|sensorineural hearing loss|schizophrenia|liver cirrhosis|alexia|dyslexia|Senior-Loken syndrome|nephronophthisis|autosomal recessive nonsyndromic deafness 66,ppi
4766,5612,23002,DAAM1,dishevelled associated activator of morphogenesis 1,35,,,ppi
4767,5613,23500,DAAM2,dishevelled associated activator of morphogenesis 2,17,,schizophrenia,ppi
4768,5614,92126,DSEL,dermatan sulfate epimerase-like,2,chondroitin-glucuronate 5-epimerase activity,,ppi
4769,5615,84295,PHF6,PHD finger protein 6,48,DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA binding|sequence-specific DNA binding,Borjeson-Forssman-Lehmann syndrome|acute T cell leukemia,ppi
4770,5616,53947,A4GALT,alpha 1;4-galactosyltransferase,6,galactosyltransferase activity,Burkitt lymphoma,ppi
4771,5617,1084,CEACAM3,carcinoembryonic antigen related cell adhesion molecule 3,4,,,ppi
4772,5618,84700,MYO18B,myosin XVIIIB,6,,malignant mesothelioma|benign mesothelioma,ppi
4773,5619,55916,NXT2,nuclear transport factor 2 like export factor 2,22,protein transporter activity,,ppi
4774,5620,51330,TNFRSF12A,TNF receptor superfamily member 12A,10,,coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction,ppi
4775,5621,23495,TNFRSF13B,TNF receptor superfamily member 13B,33,signaling receptor activity,hemolytic anemia|imperforate anus|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|bronchiectasis|common variable immunodeficiency|conjunctivitis|primary immunodeficiency disease|lymphosarcoma|lymphoma|central nervous system lymphoma|lymphopenia|meningitis|multiple myeloma|pneumonia|purpura|agammaglobulinemia|liver disease|immunoglobulin alpha deficiency|selective IgA deficiency disease,ppi
4776,5622,27246,RNF115,ring finger protein 115,42,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,breast cancer,ppi
4777,5623,10587,TXNRD2,thioredoxin reductase 2,17,thioredoxin-disulfide reductase activity,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
4778,5624,26027,ACOT11,acyl-CoA thioesterase 11,3,acyl-CoA hydrolase activity|fatty-acyl-CoA binding|palmitoyl-CoA hydrolase activity|long-chain fatty acyl-CoA binding,,ppi
4779,5625,10454,TAB1,TGF-beta activated kinase 1 (MAP3K7) binding protein 1,150,enzyme activator activity,polycystic ovary syndrome,ppi
4780,5629,51513,ETV7,ETS variant 7,8,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
4781,5630,51540,SCLY,selenocysteine lyase,31,selenocysteine lyase activity,,ppi
4782,5631,375593,TRIM73,tripartite motif containing 73,2,,,ppi
4783,5632,338376,IFNE,interferon epsilon,10,type I interferon receptor binding|cytokine activity,,ppi
4784,5633,51657,STYXL1,serine/threonine/tyrosine interacting like 1,16,pseudophosphatase activity|protein phosphatase inhibitor activity,,ppi
4785,5634,51678,MPP6,membrane palmitoylated protein 6,43,,,ppi
4786,5635,57835,SLC4A5,solute carrier family 4 member 5,1,sodium:bicarbonate symporter activity,,ppi
4787,5636,60681,FKBP10,FK506 binding protein 10,25,,osteogenesis imperfecta type 3|osteogenesis imperfecta type 4|Bruck syndrome|age related macular degeneration 4,ppi
4788,5637,1048,CEACAM5,carcinoembryonic antigen related cell adhesion molecule 5,7,GPI anchor binding|identical protein binding|protein homodimerization activity,,ppi
4789,5638,51727,CMPK1,cytidine/uridine monophosphate kinase 1,19,nucleoside diphosphate kinase activity|uridine kinase activity|nucleoside monophosphate kinase activity,,ppi
4790,5639,51744,CD244,CD244 molecule,40,MHC class I protein binding,rheumatoid arthritis,ppi
4791,5640,51752,ERAP1,endoplasmic reticulum aminopeptidase 1,22,endopeptidase activity|aminopeptidase activity|interleukin-1; type II receptor binding|metalloexopeptidase activity|zinc ion binding|peptide binding|metalloaminopeptidase activity,arthropathy|arthritis|Behcet's disease|hypertension|essential hypertension|meningitis|orchitis|pustulosis of palm and sole|psoriasis|parapsoriasis|ankylosing spondylitis|aphthous stomatitis|vasculitis|thrombophilia|asthenopia|migraine|fibromyalgia|myositis|acne,ppi
4792,5641,51765,STK26,serine/threonine protein kinase 26,154,magnesium ion binding|protein kinase activity|ATP binding|protein serine/threonine kinase activity,,ppi
4793,5642,51805,COQ3,coenzyme Q3; methyltransferase,15,O-methyltransferase activity|decaprenyldihydroxybenzoate methyltransferase activity|3-demethylubiquinone-10 3-O-methyltransferase activity,,ppi
4794,5643,54810,GIPC2,GIPC PDZ domain containing family member 2,11,,,ppi
4795,5644,51160,VPS28,VPS28; ESCRT-I subunit,63,ubiquitin binding|protein-containing complex binding,,ppi
4796,5645,65082,VPS33A,VPS33A; CORVET/HOPS core subunit,27,,,ppi
4797,5646,4680,CEACAM6,carcinoembryonic antigen related cell adhesion molecule 6,6,identical protein binding|protein heterodimerization activity,,ppi
4798,5647,51806,CALML5,calmodulin like 5,51,calcium ion binding|enzyme regulator activity,,ppi
4799,5648,53358,SHC3,SHC adaptor protein 3,21,Ras guanyl-nucleotide exchange factor activity|receptor tyrosine kinase binding,,ppi
4800,5649,53373,TPCN1,two pore segment channel 1,9,NAADP-sensitive calcium-release channel activity,Sertoli cell-only syndrome|oligospermia,ppi
4801,5650,126326,GIPC3,GIPC PDZ domain containing family member 3,4,,autosomal recessive nonsyndromic deafness 15,ppi
4802,5651,54165,DCUN1D1,defective in cullin neddylation 1 domain containing 1,232,ubiquitin-like protein binding|ubiquitin conjugating enzyme binding|cullin family protein binding,,ppi
4803,5652,54206,ERRFI1,ERBB receptor feedback inhibitor 1,91,GTPase activator activity,endometriosis of uterus|endometriosis|polycystic ovary syndrome,ppi
4804,5653,54328,GPR173,G protein-coupled receptor 173,1,G-protein coupled receptor activity|gonadotropin-releasing hormone receptor activity,,ppi
4805,5654,54414,SIAE,sialic acid acetylesterase,53,sialate O-acetylesterase activity,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome,ppi
4806,5655,54499,TMCO1,transmembrane and coiled-coil domains 1,45,calcium channel activity,open-angle glaucoma|enterocele|polyhydramnios|intellectual disability|learning disability|ophthalmoplegia|mechanical strabismus|hypertropia|osteogenesis imperfecta|Ehlers-Danlos syndrome|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|craniosynostosis|cerebral degeneration|Klippel-Feil syndrome|spondylolisthesis,ppi
4807,5656,54512,EXOSC4,exosome component 4,89,3'-5'-exoribonuclease activity|AU-rich element binding|exoribonuclease activity,,ppi
4808,5657,1087,CEACAM7,carcinoembryonic antigen related cell adhesion molecule 7,2,,,ppi
4809,5658,127665,ZNF648,zinc finger protein 648,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
4810,5659,54545,MTMR12,myotubularin related protein 12,23,,,ppi
4811,5660,54606,DDX56,DEAD-box helicase 56,104,RNA binding|ATP-dependent RNA helicase activity,,ppi
4812,5661,22891,ZNF365,zinc finger protein 365,4,,narcolepsy|atopic dermatitis|Balo concentric sclerosis|adrenoleukodystrophy|central nervous system disease|transient global amnesia|breast cancer,ppi
4813,5662,83595,SOX7,SRY-box 7,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding,,ppi
4814,5663,161436,EML5,echinoderm microtubule associated protein like 5,5,microtubule binding,schizophrenia,ppi
4815,5664,1088,CEACAM8,carcinoembryonic antigen related cell adhesion molecule 8,4,protein heterodimerization activity,,ppi
4816,5665,57513,CASKIN2,CASK interacting protein 2,8,,,ppi
4817,5668,55111,PLEKHJ1,pleckstrin homology domain containing J1,13,,,ppi
4818,5669,51440,HPCAL4,hippocalcin like 4,12,,,ppi
4819,5670,55300,PI4K2B,phosphatidylinositol 4-kinase type 2 beta,19,1-phosphatidylinositol 4-kinase activity,bipolar disorder|schizophrenia,ppi
4820,5671,140738,TMEM37,transmembrane protein 37,6,,,ppi
4821,5672,57124,CD248,CD248 molecule,3,extracellular matrix binding|extracellular matrix protein binding,,ppi
4822,5673,54715,RBFOX1,RNA binding protein; fox-1 homolog 1,52,RNA binding|mRNA binding,autistic disorder|epilepsy|visual epilepsy,ppi
4823,5674,54764,ZRANB1,zinc finger RANBP2-type containing 1,30,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|K63-linked polyubiquitin modification-dependent protein binding,,ppi
4824,5676,23551,RASD2,RASD family member 2,21,GTPase activity,schizophrenia,ppi
4825,5677,54825,CDHR2,cadherin related family member 2,4,cell adhesion molecule binding,,ppi
4826,5678,54836,BSPRY,B-box and SPRY domain containing,24,,,ppi
4827,5679,55024,BANK1,B-cell scaffold protein with ankyrin repeats 1,5,,systemic lupus erythematosus,ppi
4828,5680,55034,MOCOS,molybdenum cofactor sulfurase,24,Mo-molybdopterin cofactor sulfurase activity,xanthinuria,ppi
4829,5681,55040,EPN3,epsin 3,31,,,ppi
4830,5682,83692,CD99L2,CD99 molecule like 2,15,,,ppi
4831,5683,57111,RAB25,RAB25; member RAS oncogene family,22,GTPase activity,,ppi
4832,5684,55114,ARHGAP17,Rho GTPase activating protein 17,52,GTPase activator activity|Rac GTPase binding,,ppi
4833,5685,55170,PRMT6,protein arginine methyltransferase 6,118,histone-arginine N-methyltransferase activity|protein-arginine N-methyltransferase activity|protein-arginine omega-N monomethyltransferase activity|protein-arginine omega-N asymmetric methyltransferase activity|histone methyltransferase activity|histone binding|histone methyltransferase activity (H4-R3 specific)|histone methyltransferase activity (H3-R2 specific)|histone methyltransferase activity (H2A-R3 specific),,ppi
4834,5686,55198,APPL2,adaptor protein; phosphotyrosine interacting with PH domain and leucine zipper 2,33,,prostate cancer|prostate carcinoma|substance abuse|substance-related disorder,ppi
4835,5687,55213,RCBTB1,RCC1 and BTB domain containing protein 1,20,,alcohol dependence|alcohol abuse|schizophrenia,ppi
4836,5688,51084,CRYL1,crystallin lambda 1,36,L-gulonate 3-dehydrogenase activity|NAD+ binding,prostate cancer|prostate carcinoma|perinatal necrotizing enterocolitis,ppi
4837,5689,55234,SMU1,DNA replication regulator and spliceosomal factor,54,,,ppi
4838,5690,55250,ELP2,elongator acetyltransferase complex subunit 2,35,RNA polymerase II complex binding,intellectual disability|learning disability,ppi
4839,5691,284252,KCTD1,potassium channel tetramerization domain containing 1,20,transcription corepressor activity,,ppi
4840,5692,55274,PHF10,PHD finger protein 10,35,histone acetyltransferase activity|histone binding,,ppi
4841,5693,280636,SELENOH,selenoprotein H,5,RNA binding,,ppi
4842,5694,55486,PARL,presenilin associated rhomboid like,12,endopeptidase activity,schizophrenia,ppi
4843,5695,55502,HES6,hes family bHLH transcription factor 6,6,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coregulator activity|transcription factor binding|RNA polymerase II regulatory region sequence-specific DNA binding|transcription corepressor activity|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific double-stranded DNA binding|sequence-specific DNA binding,mood disorder,ppi
4844,5696,84218,TBC1D3F,TBC1 domain family member 3F,4,Rab GTPase binding|GTPase activator activity,,ppi
4845,5697,55591,VEZT,vezatin; adherens junctions transmembrane protein,22,,,ppi
4846,5698,55600,ITLN1,intelectin 1,12,calcium ion binding|oligosaccharide binding,diabetes mellitus|type 2 diabetes mellitus|malignant mesothelioma|benign mesothelioma,ppi
4847,5699,55647,RAB20,RAB20; member RAS oncogene family,1,GTPase activity,,ppi
4848,5700,55666,NPLOC4,NPL4 homolog; ubiquitin recognition factor,109,ubiquitin binding|ubiquitin protein ligase binding,,ppi
4849,5701,55669,MFN1,mitofusin 1,15,GTPase activity,neuronal ceroid lipofuscinosis 1,ppi
4850,5702,23011,RAB21,RAB21; member RAS oncogene family,24,GTPase activity|GTP binding|GDP binding,,ppi
4851,5703,245973,ATP6V1C2,ATPase H+ transporting V1 subunit C2,25,protein dimerization activity|proton-exporting ATPase activity; phosphorylative mechanism|proton-transporting ATPase activity; rotational mechanism,,ppi
4852,5704,127124,ATP6V1G3,ATPase H+ transporting V1 subunit G3,1,,,ppi
4853,5705,245972,ATP6V0D2,ATPase H+ transporting V0 subunit d2,18,proton-transporting ATPase activity; rotational mechanism|proton-exporting ATPase activity; phosphorylative mechanism,stomach cancer,ppi
4854,5706,114793,FMNL2,formin like 2,12,cadherin binding,,ppi
4855,5707,55716,LMBR1L,limb development membrane protein 1 like,7,transmembrane signaling receptor activity,,ppi
4856,5708,55727,BTBD7,BTB domain containing 7,2,,,ppi
4857,5710,55740,ENAH,enabled homolog (Drosophila),58,,acute myeloid leukemia,ppi
4858,5711,55798,METTL2B,methyltransferase like 2B,6,tRNA (cytosine) methyltransferase activity|tRNA (cytosine-3-)-methyltransferase activity,,ppi
4859,5712,55809,TRERF1,transcriptional regulating factor 1,11,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coregulator activity|DNA binding; bending|nuclear receptor transcription coactivator activity|transcription factor binding|transcription regulatory region DNA binding,breast cancer,ppi
4860,5713,57105,CYSLTR2,cysteinyl leukotriene receptor 2,2,leukotriene receptor activity|galanin receptor activity|G-protein coupled peptide receptor activity,postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|uveal melanoma|malignant iris melanoma,ppi
4861,5714,80325,ABTB1,ankyrin repeat and BTB domain containing 1,9,,,ppi
4862,5715,29927,SEC61A1,Sec61 translocon alpha 1 subunit,69,ribosome binding|signal sequence binding|protein transmembrane transporter activity,,ppi
4863,5716,23480,SEC61G,Sec61 translocon gamma subunit,5,protein transporter activity,,ppi
4864,5717,56852,RAD18,RAD18; E3 ubiquitin protein ligase,80,Y-form DNA binding|damaged DNA binding|polyubiquitin modification-dependent protein binding|identical protein binding|ubiquitin protein ligase activity|single-stranded DNA-dependent ATPase activity,,ppi
4865,5718,55813,UTP6,UTP6; small subunit processome component,23,snoRNA binding,,ppi
4866,5719,55819,RNF130,ring finger protein 130,30,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,prostate cancer|prostate carcinoma,ppi
4867,5720,55825,PECR,peroxisomal trans-2-enoyl-CoA reductase,11,trans-2-enoyl-CoA reductase (NADPH) activity|2;4-dienoyl-CoA reductase (NADPH) activity,intellectual disability|learning disability,ppi
4868,5721,55872,PBK,PDZ binding kinase,110,protein serine/threonine kinase activity,polycystic ovary syndrome,ppi
4869,5722,142684,RAB40A,RAB40A; member RAS oncogene family,14,GTPase activity,,ppi
4870,5723,10966,RAB40B,RAB40B; member RAS oncogene family,13,GTPase activity,,ppi
4871,5724,57799,RAB40C,RAB40C; member RAS oncogene family,10,GTPase activity,,ppi
4872,5725,84839,RAX2,retina and anterior neural fold homeobox 2,1,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,retinal degeneration|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|age related macular degeneration 6,ppi
4873,5726,155382,VPS37D,VPS37D; ESCRT-I subunit,10,,,ppi
4874,5727,55907,CMAS,cytidine monophosphate N-acetylneuraminic acid synthetase,21,N-acylneuraminate cytidylyltransferase activity,,ppi
4875,5728,55929,DMAP1,DNA methyltransferase 1 associated protein 1,69,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II repressing transcription factor binding|transcription corepressor activity,,ppi
4876,5729,55997,CFC1,cripto; FRL-1; cryptic family 1,1,activin receptor binding|nodal binding|signaling receptor binding,double outlet right ventricle|visceral heterotaxy,ppi
4877,5730,347517,RAB41,RAB41; member RAS oncogene family,6,GTPase activity,,ppi
4878,5731,56052,ALG1,ALG1; chitobiosyldiphosphodolichol beta-mannosyltransferase,9,mannosyltransferase activity|chitobiosyldiphosphodolichol beta-mannosyltransferase activity,congenital disorder of glycosylation type I,ppi
4879,5732,151987,PPP4R2,protein phosphatase 4 regulatory subunit 2,60,protein phosphatase regulator activity|protein binding; bridging,,ppi
4880,5733,29990,PILRB,paired immunoglobin-like type 2 receptor beta,7,MHC class I protein binding,,ppi
4881,5734,474381,H2AFB2,H2A histone family member B2,1,,,ppi
4882,5735,144195,SLC2A14,solute carrier family 2 member 14,8,D-glucose transmembrane transporter activity,,ppi
4883,5736,23195,MDN1,midasin AAA ATPase 1,54,ATPase activity|unfolded protein binding,,ppi
4884,5737,51606,ATP6V1H,ATPase H+ transporting V1 subunit H,54,enzyme regulator activity|ATPase activity,,ppi
4885,5738,23406,COTL1,coactosin like F-actin binding protein 1,28,actin binding,breast cancer,ppi
4886,5739,10159,ATP6AP2,ATPase H+ transporting accessory protein 2,110,,intellectual disability|learning disability|secondary Parkinson disease|visual epilepsy|syndromic X-linked intellectual disability Hedera type,ppi
4887,5740,170850,KCNG3,potassium voltage-gated channel modifier subfamily G member 3,5,delayed rectifier potassium channel activity|voltage-gated potassium channel activity,,ppi
4888,5741,55217,TMLHE,trimethyllysine hydroxylase; epsilon,13,trimethyllysine dioxygenase activity|oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen,autistic disorder,ppi
4889,5742,54558,SPATA6,spermatogenesis associated 6,2,,,ppi
4890,5743,23071,ERP44,endoplasmic reticulum protein 44,83,protein disulfide isomerase activity,prostate cancer|prostate carcinoma,ppi
4891,5745,171177,RHOV,ras homolog family member V,2,GTPase activity|GTP binding|protein kinase binding,,ppi
4892,5746,27289,RND1,Rho family GTPase 1,16,GTPase activity|protein kinase binding|GTP binding,,ppi
4893,5747,8153,RND2,Rho family GTPase 2,11,protein kinase binding|GTPase activity|GTP binding,,ppi
4894,5748,167465,ZNF366,zinc finger protein 366,5,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|estrogen receptor binding,substance abuse|substance-related disorder|breast cancer,ppi
4895,5749,84276,NICN1,nicolin 1,9,,,ppi
4896,5750,171023,ASXL1,additional sex combs like 1; transcriptional regulator,33,transcription coactivator activity|retinoic acid receptor binding|peroxisome proliferator activated receptor binding|chromatin binding,acute promyelocytic leukemia|juvenile myelomonocytic leukemia,ppi
4897,5751,145270,PRIMA1,proline rich membrane anchor 1,1,,Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y|autosomal recessive limb-girdle muscular dystrophy type 2O|autosomal recessive limb-girdle muscular dystrophy type 2P,ppi
4898,5753,80270,HSD3B7,hydroxy-delta-5-steroid dehydrogenase; 3 beta- and steroid delta-isomerase 7,12,3-beta-hydroxy-delta5-steroid dehydrogenase activity|cholest-5-ene-3-beta;7-alpha-diol 3-beta-dehydrogenase activity|oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor|oxidoreductase activity,cholestasis|congenital bile acid synthesis defect,ppi
4899,5755,388403,YPEL2,yippee like 2,2,,,ppi
4900,5756,83719,YPEL3,yippee like 3,11,,,ppi
4901,5758,51646,YPEL5,yippee like 5,25,,,ppi
4902,5759,1050,CEBPA,CCAAT/enhancer binding protein alpha,111,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription coactivator activity|protein homodimerization activity|transcription regulatory region DNA binding,tongue squamous cell carcinoma|squamous cell carcinoma|head and neck cancer|acute myeloid leukemia|acute promyelocytic leukemia|skin benign neoplasm|skin cancer|liver cancer|hepatocellular carcinoma,ppi
4903,5760,91151,TIGD7,tigger transposable element derived 7,5,,,ppi
4904,5761,81789,TIGD6,tigger transposable element derived 6,19,,,ppi
4905,5762,166815,TIGD2,tigger transposable element derived 2,1,,,ppi
4906,5763,220359,TIGD3,tigger transposable element derived 3,4,,,ppi
4907,5764,201798,TIGD4,tigger transposable element derived 4,2,,,ppi
4908,5765,84948,TIGD5,tigger transposable element derived 5,42,actin filament binding,,ppi
4909,5766,51702,PADI3,peptidyl arginine deiminase 3,16,protein-arginine deiminase activity,,ppi
4910,5767,1051,CEBPB,CCAAT/enhancer binding protein beta,88,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|protein homodimerization activity|protein heterodimerization activity,brain ischemia|fatty liver disease|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|liver cancer|hepatocellular carcinoma,ppi
4911,5768,57728,WDR19,WD repeat domain 19,21,,asphyxiating thoracic dystrophy 1|Senior-Loken syndrome|Sensenbrenner syndrome|nephronophthisis|asphyxiating thoracic dystrophy 5|craniometaphyseal dysplasia,ppi
4912,5769,11240,PADI2,peptidyl arginine deiminase 2,1,protein-arginine deiminase activity,schizophrenia,ppi
4913,5770,84681,HINT2,histidine triad nucleotide binding protein 2,3,,,ppi
4914,5771,55603,FAM46A,family with sequence similarity 46 member A,61,RNA binding,,ppi
4915,5772,148022,TICAM1,toll like receptor adaptor molecule 1,39,,asbestosis|anthracosilicosis|pneumoconiosis|siderosis|bagassosis|respiratory syncytial virus infectious disease,ppi
4916,5773,10202,DHRS2,dehydrogenase/reductase 2,32,carbonyl reductase (NADPH) activity,,ppi
4917,5774,1052,CEBPD,CCAAT/enhancer binding protein delta,30,DNA-binding transcription factor activity; RNA polymerase II-specific,acute myeloid leukemia|prolactinoma|coronary artery disease|liver cancer|hepatocellular carcinoma,ppi
4918,5776,79019,CENPM,centromere protein M,15,,,ppi
4919,5777,171425,CLYBL,citrate lyase beta like,4,magnesium ion binding|malate synthase activity|(3S)-citramalyl-CoA lyase activity,,ppi
4920,5779,57569,ARHGAP20,Rho GTPase activating protein 20,2,GTPase activator activity,,ppi
4921,5780,84818,IL17RC,interleukin 17 receptor C,46,interleukin-17 receptor activity,chronic mucocutaneous candidiasis|prostate cancer|prostate carcinoma,ppi
4922,5781,145264,SERPINA12,serpin family A member 12,39,serine-type endopeptidase inhibitor activity,,ppi
4923,5782,1053,CEBPE,CCAAT/enhancer binding protein epsilon,48,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,acute promyelocytic leukemia|Chediak-Higashi syndrome|Pelger-Huet anomaly|acute lymphocytic leukemia,ppi
4924,5783,9807,IP6K1,inositol hexakisphosphate kinase 1,16,inositol-1;3;4;5;6-pentakisphosphate kinase activity|inositol hexakisphosphate kinase activity|inositol heptakisphosphate kinase activity|inositol 5-diphosphate pentakisphosphate 5-kinase activity|inositol diphosphate tetrakisphosphate kinase activity,,ppi
4925,5785,282618,IFNL1,interferon lambda 1,3,signaling receptor binding,,ppi
4926,5786,282616,IFNL2,interferon lambda 2,3,signaling receptor binding,,ppi
4927,5787,282617,IFNL3,interferon lambda 3,3,signaling receptor binding,asthma|intrinsic asthma|allergic asthma|atopic dermatitis|food allergy|hepatitis C|schizophrenia|neurotic disorder|endogenous depression|melancholia|head and neck squamous cell carcinoma|major depressive disorder|mental depression,ppi
4928,5788,29943,PADI1,peptidyl arginine deiminase 1,4,protein-arginine deiminase activity,,ppi
4929,5789,23569,PADI4,peptidyl arginine deiminase 4,14,protein-arginine deiminase activity|calcium ion binding|arginine deiminase activity|arginine binding|protein homodimerization activity,rheumatoid arthritis|schizophrenia,ppi
4930,5790,1054,CEBPG,CCAAT/enhancer binding protein gamma,31,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|transcription factor binding|sequence-specific DNA binding|protein heterodimerization activity,,ppi
4931,5791,81876,RAB1B,RAB1B; member RAS oncogene family,84,GTP binding|GTPase activity,coronary artery disease,ppi
4932,5792,9746,CLSTN3,calsyntenin 3,7,,,ppi
4933,5794,57541,ZNF398,zinc finger protein 398,23,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
4934,5796,91404,SESTD1,SEC14 and spectrin domain containing 1,15,phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-5-phosphate binding|phosphatidylinositol-3-phosphate binding|phosphatidylinositol-3;4-bisphosphate binding|phosphatidylinositol-4-phosphate binding|phosphatidic acid binding|phosphatidylinositol-3;5-bisphosphate binding|phosphatidylserine binding|1-phosphatidylinositol binding|phosphatidylcholine binding,,ppi
4935,5797,9689,BZW1,basic leucine zipper and W2 domains 1,42,RNA binding|cadherin binding,melanoma|skin melanoma,ppi
4936,5798,91683,SYT12,synaptotagmin 12,16,phosphatidylserine binding|calcium-dependent phospholipid binding|clathrin binding|calcium ion binding|SNARE binding,,ppi
4937,5799,92304,SCGB3A1,secretoglobin family 3A member 1,9,cytokine activity,endometriosis of uterus|endometriosis,ppi
4938,5800,389376,SFTA2,surfactant associated 2,8,,,ppi
4939,5802,51816,CECR1,cat eye syndrome chromosome region; candidate 1,1,adenosine deaminase activity|growth factor activity|zinc ion binding|adenosine receptor binding|proteoglycan binding,vascular disease|arthropathy|arthritis|cerebellar disease|epilepsy|hemiplegia|hypertension|essential hypertension|primary immunodeficiency disease|ophthalmoplegia|nodular nonsuppurative panniculitis|panniculitis|polyneuropathy|peripheral nervous system disease|neuropathy|purpura|visual epilepsy|cerebral infarction|cerebrovascular disease|central nervous system origin vertigo,ppi
4940,5803,117156,SCGB3A2,secretoglobin family 3A member 2,1,,asthma|intrinsic asthma|allergic asthma,ppi
4941,5805,10648,SCGB1D1,secretoglobin family 1D member 1,72,protein heterodimerization activity,,ppi
4942,5806,10647,SCGB1D2,secretoglobin family 1D member 2,10,,,ppi
4943,5807,56916,SMARCAD1,SWI/SNF-related; matrix-associated actin-dependent regulator of chromatin; subfamily a; containing DEAD/H box 1,141,nucleic acid binding|DNA binding,,ppi
4944,5808,207063,DHRSX,dehydrogenase/reductase X-linked,4,,,ppi
4945,5809,27443,CECR2,CECR2; histone acetyl-lysine reader,5,,,ppi
4946,5810,10193,RNF41,ring finger protein 41,72,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,bipolar disorder|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
4947,5811,51035,UBXN1,UBX domain protein 1,150,polyubiquitin modification-dependent protein binding|ubiquitin protein ligase binding|K48-linked polyubiquitin modification-dependent protein binding|ubiquitin binding|K6-linked polyubiquitin modification-dependent protein binding,stomach cancer,ppi
4948,5812,171482,FAM9A,family with sequence similarity 9 member A,20,,,ppi
4949,5813,171483,FAM9B,family with sequence similarity 9 member B,116,,,ppi
4950,5814,171484,FAM9C,family with sequence similarity 9 member C,1,,,ppi
4951,5815,79814,AGMAT,agmatinase,16,agmatinase activity,,ppi
4952,5816,23036,ZNF292,zinc finger protein 292,11,DNA-binding transcription factor activity; RNA polymerase II-specific,large intestine cancer|colorectal cancer,ppi
4953,5817,333929,SNAI3,snail family transcriptional repressor 3,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,perinatal necrotizing enterocolitis,ppi
4954,5818,23390,ZDHHC17,zinc finger DHHC-type containing 17,241,magnesium ion transmembrane transporter activity|palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,,ppi
4955,5819,54503,ZDHHC13,zinc finger DHHC-type containing 13,6,magnesium ion transmembrane transporter activity|palmitoyltransferase activity,alopecia|amyloidosis|osteoporosis,ppi
4956,5820,90226,UCN2,urocortin 2,2,G-protein coupled receptor binding,congestive heart failure,ppi
4957,5821,9026,HIP1R,huntingtin interacting protein 1 related,68,phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3;4;5-trisphosphate binding|clathrin binding|phosphatidylinositol binding|protein homodimerization activity|phosphatidylinositol-3;4-bisphosphate binding|actin filament binding|phosphatidylinositol-3;5-bisphosphate binding|clathrin adaptor activity|clathrin light chain binding,bipolar disorder,ppi
4958,5822,11153,FICD,FIC domain containing,2,ATP binding|protein homodimerization activity|protein adenylylhydrolase activity|chaperone binding|protein adenylyltransferase activity,,ppi
4959,5823,25763,HYPM,huntingtin interacting protein M,5,DNA binding,,ppi
4960,5824,25764,HYPK,huntingtin interacting protein K,65,,,ppi
4961,5825,29072,SETD2,SET domain containing 2,35,protein-lysine N-methyltransferase activity|histone-lysine N-methyltransferase activity|alpha-tubulin binding|histone methyltransferase activity (H3-K36 specific),papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|salivary gland adenoid cystic carcinoma|benign breast phyllodes tumor|breast malignant phyllodes tumor|hypoglycemia|leukemia|intellectual disability|learning disability|obesity|Perlman syndrome|Sotos syndrome|Beckwith-Wiedemann syndrome|malignant mesothelioma|benign mesothelioma,ppi
4962,5826,192669,AGO3,argonaute 3; RISC catalytic component,71,RNA binding|double-stranded RNA binding|single-stranded RNA binding|endoribonuclease activity|miRNA binding|endoribonuclease activity; cleaving miRNA-paired mRNA,,ppi
4963,5827,9681,DEPDC5,DEP domain containing 5,13,protein-containing complex binding|GTPase activator activity,epilepsy|visual epilepsy|familial temporal lobe epilepsy 1|liver cancer|hepatocellular carcinoma,ppi
4964,5828,192670,AGO4,argonaute 4; RISC catalytic component,77,double-stranded RNA binding|single-stranded RNA binding|miRNA binding,,ppi
4965,5829,22949,PTGR1,prostaglandin reductase 1,14,,,ppi
4966,5830,27440,CECR5,cat eye syndrome chromosome region; candidate 5,16,,,ppi
4967,5832,10965,ACOT2,acyl-CoA thioesterase 2,9,acyl-CoA hydrolase activity,coronary artery disease,ppi
4968,5833,4253,MIA2,melanoma inhibitory activity 2,52,enzyme activator activity|lipoprotein transporter activity,,ppi
4969,5834,63922,CHTF18,chromosome transmission fidelity factor 18,26,DNA clamp loader activity|single-stranded DNA-dependent ATPase activity,,ppi
4970,5835,84868,HAVCR2,hepatitis A virus cellular receptor 2,76,,,ppi
4971,5836,132014,IL17RE,interleukin 17 receptor E,12,interleukin-17 receptor activity,,ppi
4972,5837,27439,CECR6,cat eye syndrome chromosome region; candidate 6,1,,,ppi
4973,5838,54879,ST7L,suppression of tumorigenicity 7 like,16,,,ppi
4974,5840,440822,PIWIL3,piwi like RNA-mediated gene silencing 3,1,,Sertoli cell-only syndrome|oligospermia,ppi
4975,5841,143689,PIWIL4,piwi like RNA-mediated gene silencing 4,11,piRNA binding|endoribonuclease activity,Sertoli cell-only syndrome|oligospermia,ppi
4976,5843,79661,NEIL1,nei like DNA glycosylase 1,4,DNA-(apurinic or apyrimidinic site) endonuclease activity|hydrolase activity; acting on glycosyl bonds|DNA N-glycosylase activity,fatty liver disease|Zollinger-Ellison syndrome|hyperinsulinism|familial hyperlipidemia|obesity|glucose intolerance|prediabetes syndrome|metabolic syndrome X,ppi
4977,5844,51056,LAP3,leucine aminopeptidase 3,35,aminopeptidase activity|metalloexopeptidase activity,,ppi
4978,5845,90411,MCFD2,multiple coagulation factor deficiency 2,44,,,ppi
4979,5846,84937,ZNRF1,zinc and ring finger 1,24,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
4980,5847,128240,NAXE,NAD(P)HX epimerase,16,NADPHX epimerase activity|NADHX epimerase activity,,ppi
4981,5850,51533,PHF7,PHD finger protein 7,33,,,ppi
4982,5851,55625,ZDHHC7,zinc finger DHHC-type containing 7,11,palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,,ppi
4983,5853,392862,GRID2IP,Grid2 interacting protein,1,,,ppi
4984,5854,246243,RNASEH1,ribonuclease H1,11,nucleic acid binding|RNA binding|RNA-DNA hybrid ribonuclease activity|ribonuclease activity,,ppi
4985,5855,135114,HINT3,histidine triad nucleotide binding protein 3,10,,,ppi
4986,5856,51201,ZDHHC2,zinc finger DHHC-type containing 2,2,palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,liver cancer,ppi
4987,5857,51304,ZDHHC3,zinc finger DHHC-type containing 3,6,palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,,ppi
4988,5858,55146,ZDHHC4,zinc finger DHHC-type containing 4,1,protein-cysteine S-palmitoyltransferase activity,,ppi
4989,5859,25921,ZDHHC5,zinc finger DHHC-type containing 5,17,palmitoyltransferase activity,,ppi
4990,5860,29801,ZDHHC8,zinc finger DHHC-type containing 8,2,palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,bipolar disorder|schizophrenia,ppi
4991,5861,51114,ZDHHC9,zinc finger DHHC-type containing 9,20,palmitoyltransferase activity|Ras palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,clubfoot|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|intellectual disability|learning disability|speech disorder|ophthalmoplegia|mechanical strabismus|hypertropia|attention deficit hyperactivity disorder|syndromic X-linked intellectual disability Raymond type,ppi
4992,5862,51065,RPS27L,ribosomal protein S27 like,97,RNA binding|translation activator activity|cysteine-type endopeptidase activator activity involved in apoptotic process|structural constituent of ribosome,,ppi
4993,5863,51154,MRTO4,MRT4 homolog; ribosome maturation factor,67,RNA binding,,ppi
4994,5864,51187,RSL24D1,ribosomal L24 domain containing 1,24,structural constituent of ribosome|RNA binding,,ppi
4995,5865,1056,CEL,carboxyl ester lipase,3,,diabetes mellitus|type 2 diabetes mellitus|maturity-onset diabetes of the young,ppi
4996,5866,23545,ATP6V0A2,ATPase H+ transporting V0 subunit a2,57,ATPase binding|proton-transporting ATPase activity; rotational mechanism,clubfoot|cryptorchidism|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|Dandy-Walker syndrome|dental caries|epilepsy|placental insufficiency|inguinal hernia|umbilical hernia|omphalocele|lipoatrophic diabetes|lipodystrophy|intellectual disability|learning disability|myopia|visual epilepsy,ppi
4997,5867,200879,LIPH,lipase H,51,phospholipase activity|heparin binding,hypotrichosis,ppi
4998,5868,150290,DUSP18,dual specificity phosphatase 18,20,protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|phosphatase activity,,ppi
4999,5869,55178,MRM3,mitochondrial rRNA methyltransferase 3,57,RNA binding|rRNA (guanosine-2'-O-)-methyltransferase activity,,ppi
5000,5870,23037,PDZD2,PDZ domain containing 2,12,,,ppi
5001,5871,9620,CELSR1,cadherin EGF LAG seven-pass G-type receptor 1,15,transmembrane signaling receptor activity|G-protein coupled receptor activity|protein dimerization activity,schizophrenia,ppi
5002,5872,140032,RPS4Y2,ribosomal protein S4; Y-linked 2,3,structural constituent of ribosome,,ppi
5003,5873,90665,TBL1Y,transducin beta like 1; Y-linked,29,transcription corepressor activity,,ppi
5004,5876,54894,RNF43,ring finger protein 43,21,ubiquitin-protein transferase activity|ubiquitin protein ligase activity|frizzled binding,large intestine cancer|colorectal cancer|endometrial cancer|endometrial carcinoma|stomach cancer|bile duct carcinoma|bile duct adenocarcinoma|intrahepatic cholangiocarcinoma|cholangiocarcinoma,ppi
5005,5877,115352,FCRL3,Fc receptor like 3,5,,Graves' disease|thyrotoxicosis|hyperthyroidism|autoimmune thyroiditis,ppi
5006,5878,83417,FCRL4,Fc receptor like 4,5,,,ppi
5007,5879,83416,FCRL5,Fc receptor like 5,6,,,ppi
5008,5880,115350,FCRL1,Fc receptor like 1,1,coreceptor activity,,ppi
5009,5881,1058,CENPA,centromere protein A,86,chromatin binding|nucleosomal DNA binding,,ppi
5010,5883,51110,LACTB2,lactamase beta 2,21,single-stranded RNA binding|endoribonuclease activity|zinc ion binding,,ppi
5011,5884,22882,ZHX2,zinc fingers and homeoboxes 2,17,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity|protein homodimerization activity|protein heterodimerization activity,,ppi
5012,5885,23111,SPG20,spastic paraplegia 20 (Troyer syndrome),44,,paraplegia|Barrett's esophagus|esophagus adenocarcinoma|Troyer syndrome,ppi
5013,5887,114990,VASN,vasorin,72,cadherin binding|transforming growth factor beta binding,liver cancer|hepatocellular carcinoma,ppi
5014,5888,10535,RNASEH2A,ribonuclease H2 subunit A,44,RNA-DNA hybrid ribonuclease activity|ribonuclease activity,dystonia|placental insufficiency|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|leukodystrophy|pancytopenia|thrombocytopenia|holoprosencephaly|liver disease|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|Aicardi-Goutieres syndrome|porencephaly,ppi
5015,5889,445571,CBWD3,COBW domain containing 3,23,,,ppi
5016,5890,1059,CENPB,centromere protein B,65,chromatin binding|satellite DNA binding|centromeric DNA binding|sequence-specific DNA binding,,ppi
5017,5891,200350,FOXD4L1,forkhead box D4-like 1,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5018,5894,64843,ISL2,ISL LIM homeobox 2,10,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
5019,5895,192668,CYS1,cystin 1,1,,,ppi
5020,5896,192666,KRT24,keratin 24,17,,,ppi
5021,5897,57554,LRRC7,leucine rich repeat containing 7,16,ionotropic glutamate receptor binding,cocaine abuse|cocaine dependence,ppi
5022,5898,125997,MBD3L2,methyl-CpG binding domain protein 3 like 2,10,methyl-CpG binding,stomach cancer,ppi
5023,5899,84196,USP48,ubiquitin specific peptidase 48,32,thiol-dependent ubiquitin-specific protease activity|cysteine-type endopeptidase activity,,ppi
5024,5900,113510,HELQ,helicase; POLQ-like,4,,,ppi
5025,5901,54602,NDFIP2,Nedd4 family interacting protein 2,19,WW domain binding,,ppi
5026,5902,51203,NUSAP1,nucleolar and spindle associated protein 1,34,RNA binding|microtubule binding,,ppi
5027,5903,112755,STX1B,syntaxin 1B,30,protein kinase binding|SNAP receptor activity|SNARE binding,epilepsy|generalized epilepsy with febrile seizures plus,ppi
5028,5904,1060,CENPC,centromere protein C,40,DNA binding|centromeric DNA binding,,ppi
5029,5906,55904,KMT2E,lysine methyltransferase 2E,44,histone-lysine N-methyltransferase activity|methylated histone binding,leukemia|lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia,ppi
5030,5907,56990,CDC42SE2,CDC42 small effector 2,10,structural molecule activity,schizophrenia,ppi
5031,5908,81501,DCSTAMP,dendrocyte expressed seven transmembrane protein,2,,endometriosis of uterus|endometriosis|Paget's disease of bone,ppi
5032,5909,51124,IER3IP1,immediate early response 3 interacting protein 1,16,,ptosis|congenital ptosis|diabetic ketoacidosis|diabetes mellitus|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|intellectual disability|learning disability|infantile epileptic encephalopathy|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy,ppi
5033,5910,85359,DGCR6L,DiGeorge syndrome critical region gene 6-like,12,,,ppi
5034,5911,51090,PLLP,plasmolipin,5,structural constituent of myelin sheath,schizophrenia|malignant mesothelioma|benign mesothelioma,ppi
5035,5912,81579,PLA2G12A,phospholipase A2 group XIIA,11,phospholipase A2 activity|calcium-dependent phospholipase A2 activity,,ppi
5036,5913,84647,PLA2G12B,phospholipase A2 group XIIB,3,,,ppi
5037,5914,64216,TFB2M,transcription factor B2; mitochondrial,14,transcription coregulator activity|RNA binding|rRNA (adenine-N6;N6-)-dimethyltransferase activity,,ppi
5038,5915,1062,CENPE,centromere protein E,38,microtubule motor activity|microtubule binding|kinetochore binding|ATPase activity,craniosynostosis|epilepsy|placental insufficiency|glaucoma|intellectual disability|learning disability|visual epilepsy|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome,ppi
5039,5916,63915,BLOC1S5,biogenesis of lysosomal organelles complex 1 subunit 5,19,,,ppi
5040,5918,57663,USP29,ubiquitin specific peptidase 29,3,thiol-dependent ubiquitinyl hydrolase activity|cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity,,ppi
5041,5919,91977,MYOZ3,myozenin 3,9,telethonin binding|actin binding|FATZ binding,,ppi
5042,5921,90655,TGIF2LY,TGFB induced factor homeobox 2 like; Y-linked,27,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5043,5922,1063,CENPF,centromere protein F,51,chromatin binding|dynein complex binding,Kartagener syndrome|primary ciliary dyskinesia|isolated cleft palate|cleft palate|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|breast cancer,ppi
5044,5923,90316,TGIF2LX,TGFB induced factor homeobox 2 like; X-linked,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5045,5924,84263,HSDL2,hydroxysteroid dehydrogenase like 2,28,,liver cancer,ppi
5046,5925,10309,CCNO,cyclin O,8,protein kinase binding|protein kinase activity|cyclin-dependent protein serine/threonine kinase regulator activity,bronchiectasis|Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|obstructive lung disease|primary ciliary dyskinesia 29,ppi
5047,5926,55787,TXLNG,taxilin gamma,46,protein heterodimerization activity,,ppi
5048,5927,11064,CNTRL,centriolin,192,protein tyrosine kinase activity,,ppi
5049,5928,167410,LIX1,limb and CNS expressed 1,2,,,ppi
5050,5929,23266,ADGRL2,adhesion G protein-coupled receptor L2,14,latrotoxin receptor activity|G-protein coupled receptor activity,,ppi
5051,5930,57460,PPM1H,protein phosphatase; Mg2+/Mn2+ dependent 1H,31,phosphoprotein phosphatase activity,,ppi
5052,5931,163702,IFNLR1,interferon lambda receptor 1,3,cytokine receptor activity,pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
5053,5932,124540,MSI2,musashi RNA binding protein 2,42,RNA binding,,ppi
5054,5933,55815,TSNAXIP1,translin associated factor X interacting protein 1,9,,,ppi
5055,5934,23353,SUN1,Sad1 and UNC84 domain containing 1,27,protein membrane anchor,,ppi
5056,5935,56311,ANKRD7,ankyrin repeat domain 7,2,,alcohol dependence|alcohol abuse,ppi
5057,5936,84645,C22orf23,chromosome 22 open reading frame 23,2,,,ppi
5058,5937,11190,CEP250,centrosomal protein 250,239,,,ppi
5059,5938,80339,PNPLA3,patatin like phospholipase domain containing 3,4,1-acylglycerol-3-phosphate O-acyltransferase activity|lipoprotein lipase activity|phospholipase A2 activity|triglyceride lipase activity|acylglycerol O-acyltransferase activity|lysophosphatidic acid binding|long-chain fatty acyl-CoA binding|lysophosphatidic acid acyltransferase activity|mono-olein transacylation activity|diolein transacylation activity,fatty liver disease|alcoholic liver cirrhosis|alcoholic hepatitis|liver cirrhosis,ppi
5060,5939,91754,NEK9,NIMA related kinase 9,41,,,ppi
5061,5940,152110,NEK10,NIMA related kinase 10,3,protein kinase activity,,ppi
5062,5941,79858,NEK11,NIMA related kinase 11,8,protein serine/threonine kinase activity|ATP binding,,ppi
5063,5942,83746,L3MBTL2,L3MBTL2 polycomb repressive complex 1 subunit,70,methylated histone binding,medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
5064,5943,23119,HIC2,HIC ZBTB transcriptional repressor 2,22,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
5065,5945,129025,ZNF280A,zinc finger protein 280A,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
5066,5946,10426,TUBGCP3,tubulin gamma complex associated protein 3,144,structural molecule activity|structural constituent of cytoskeleton|gamma-tubulin binding|microtubule minus-end binding,,ppi
5067,5947,10844,TUBGCP2,tubulin gamma complex associated protein 2,94,microtubule minus-end binding|gamma-tubulin binding|structural constituent of cytoskeleton,,ppi
5068,5948,100,ADA,adenosine deaminase,22,adenosine deaminase activity|zinc ion binding,alopecia|fetal erythroblastosis|autoimmune hemolytic anemia|asthma|intrinsic asthma|allergic asthma|autistic disorder|congestive heart failure|hypereosinophilic syndrome|lung benign neoplasm|lymphopenia|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|pneumonia|sinusitis|spinal cord disease|syringomyelia|lymphosarcoma,ppi
5069,5949,114791,TUBGCP5,tubulin gamma complex associated protein 5,26,microtubule binding|microtubule minus-end binding|structural constituent of cytoskeleton|gamma-tubulin binding,,ppi
5070,5950,65078,RTN4R,reticulon 4 receptor,11,heparin binding|chondroitin sulfate binding|signaling receptor activity|neuregulin receptor activity|ganglioside GM1 binding|ganglioside GT1b binding,schizophrenia,ppi
5071,5951,150921,TCF23,transcription factor 23,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5072,5952,84570,COL25A1,collagen type XXV alpha 1 chain,4,amyloid-beta binding|heparin binding|extracellular matrix structural constituent,Duane retraction syndrome|ptosis|congenital ptosis|congenital fibrosis of the extraocular muscles,ppi
5073,5953,64064,OXCT2,3-oxoacid CoA-transferase 2,14,3-oxoacid CoA-transferase activity,,ppi
5074,5954,25800,SLC39A6,solute carrier family 39 member 6,18,zinc ion transmembrane transporter activity,esophagus squamous cell carcinoma|breast cancer,ppi
5075,5955,79705,LRRK1,leucine rich repeat kinase 1,82,,,ppi
5076,5956,163087,ZNF383,zinc finger protein 383,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5077,5957,283455,KSR2,kinase suppressor of ras 2,129,,,ppi
5078,5958,120892,LRRK2,leucine rich repeat kinase 2,469,GTPase activity|protein kinase activity|protein serine/threonine kinase activity|MAP kinase kinase activity|GTPase activator activity|GTP binding|microtubule binding|tubulin binding|kinase activity|receptor signaling complex scaffold activity|GTP-dependent protein kinase activity|peroxidase inhibitor activity|co-receptor binding|beta-catenin destruction complex binding|Rho GTPase binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|endometriosis of uterus|endometriosis|Parkinson's disease|schizophrenia|mental depression|secondary Parkinson disease|autosomal dominant Parkinson disease 8,ppi
5079,5959,83548,COG3,component of oligomeric golgi complex 3,39,protein transporter activity,,ppi
5080,5960,9350,CER1,cerberus 1; DAN family BMP antagonist,11,morphogen activity|BMP binding|protein homodimerization activity,,ppi
5081,5961,25839,COG4,component of oligomeric golgi complex 4,39,,cerebellar disease|liver disease|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|congenital disorder of glycosylation type II,ppi
5082,5962,57511,COG6,component of oligomeric golgi complex 6,63,,congenital disorder of glycosylation type II,ppi
5083,5963,91949,COG7,component of oligomeric golgi complex 7,28,,congenital disorder of glycosylation type II,ppi
5084,5964,84342,COG8,component of oligomeric golgi complex 8,21,,congenital disorder of glycosylation type II,ppi
5085,5965,51303,FKBP11,FK506 binding protein 11,6,,,ppi
5086,5966,55033,FKBP14,FK506 binding protein 14,30,,clubfoot|familial periodic paralysis|myopathy|myopia|muscular atrophy,ppi
5087,5967,11020,IFT27,intraflagellar transport 27,51,GTPase activity,bipolar disorder|hypertension|essential hypertension|hypogonadism|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|kidney failure|uremia|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|polydactyly|Laurence-Moon syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 1,ppi
5088,5969,23166,STAB1,stabilin 1,7,low-density lipoprotein particle receptor activity|scavenger receptor activity|protein disulfide oxidoreductase activity|low-density lipoprotein particle binding,bipolar disorder,ppi
5089,5970,55576,STAB2,stabilin 2,8,low-density lipoprotein particle receptor activity|scavenger receptor activity|hyaluronic acid binding|protein disulfide oxidoreductase activity|low-density lipoprotein particle binding,,ppi
5090,5971,1066,CES1,carboxylesterase 1,3,sterol esterase activity|carboxylic ester hydrolase activity|triglyceride lipase activity,lung benign neoplasm|inherited metabolic disorder|opiate dependence|obesity|cocaine abuse|cocaine dependence,ppi
5091,5973,55582,KIF27,kinesin family member 27,4,microtubule binding|ATPase activity|microtubule motor activity,,ppi
5092,5974,283578,TMED8,transmembrane p24 trafficking protein family member 8,7,,,ppi
5093,5975,137970,UNC5D,unc-5 netrin receptor D,1,,,ppi
5094,5976,353299,RGSL1,regulator of G-protein signaling like 1,2,,,ppi
5095,5977,148281,SYT6,synaptotagmin 6,20,syntaxin binding|clathrin binding|protein homodimerization activity|calcium-dependent phospholipid binding|SNARE binding|calcium ion binding|phosphatidylserine binding,,ppi
5096,5978,22905,EPN2,epsin 2,17,cadherin binding,,ppi
5097,5979,8824,CES2,carboxylesterase 2,1,carboxylic ester hydrolase activity,cocaine abuse|cocaine dependence,ppi
5098,5980,26119,LDLRAP1,low density lipoprotein receptor adaptor protein 1,14,phosphotyrosine residue binding|phosphatidylinositol-4;5-bisphosphate binding|receptor signaling complex scaffold activity|clathrin binding|signaling adaptor activity|AP-2 adaptor complex binding|clathrin adaptor activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|nutmeg liver|familial hypercholesterolemia|familial hyperlipidemia|hypertension|essential hypertension|congestive heart failure|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|renal artery obstruction|aortic atherosclerosis|fatty liver disease,ppi
5099,5981,10147,SUGP2,SURP and G-patch domain containing 2,39,RNA binding,,ppi
5100,5982,57794,SUGP1,SURP and G-patch domain containing 1,62,RNA binding,,ppi
5101,5983,57563,KLHL8,kelch like family member 8,22,,,ppi
5102,5984,51144,HSD17B12,hydroxysteroid 17-beta dehydrogenase 12,49,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,,ppi
5103,5985,84816,RTN4IP1,reticulon 4 interacting protein 1,20,,,ppi
5104,5986,91039,DPP9,dipeptidyl peptidase 9,46,,idiopathic interstitial pneumonia|idiopathic pulmonary fibrosis,ppi
5105,5987,51454,GULP1,GULP; engulfment adaptor PTB domain containing 1,14,,goiter|thyroid gland disease,ppi
5106,5988,23491,CES3,carboxylesterase 3,10,carboxylic ester hydrolase activity|triglyceride lipase activity|sterol esterase activity,adult respiratory distress syndrome|newborn respiratory distress syndrome|coronary artery disease,ppi
5107,5989,65244,SPATS2,spermatogenesis associated serine rich 2,18,RNA binding,,ppi
5108,5991,51542,VPS54,VPS54; GARP complex subunit,8,syntaxin binding,,ppi
5109,5992,89857,KLHL6,kelch like family member 6,8,,,ppi
5110,5993,25914,RTTN,rotatin,2,,epilepsy|visual epilepsy,ppi
5111,5994,266629,SEC14L3,SEC14 like lipid binding 3,2,,,ppi
5112,5995,83732,RIOK1,RIO kinase 1,40,,,ppi
5113,5996,22996,TTC39A,tetratricopeptide repeat domain 39A,1,,liver cancer,ppi
5114,5997,23165,NUP205,nucleoporin 205,62,structural constituent of nuclear pore,Paget's disease of bone|nephrotic syndrome,ppi
5115,5998,1068,CETN1,centrin 1,47,microtubule binding|heterotrimeric G-protein binding|G-protein beta/gamma-subunit complex binding|calcium ion binding,schizophrenia,ppi
5116,5999,56171,DNAH7,dynein axonemal heavy chain 7,2,microtubule motor activity|dynein light intermediate chain binding|dynein intermediate chain binding|dynein light chain binding|ATP-dependent microtubule motor activity; minus-end-directed,,ppi
5117,6000,30062,RAX,retina and anterior neural fold homeobox,1,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,melanoma|skin melanoma|microphthalmia|blepharophimosis|sclerocornea|isolated microphthalmia 1|isolated microphthalmia 3,ppi
5118,6001,10447,FAM3C,family with sequence similarity 3 member C,35,cytokine activity,,ppi
5119,6002,131177,FAM3D,family with sequence similarity 3 member D,1,cytokine activity,schizophrenia,ppi
5120,6003,55599,RNPC3,RNA binding region (RNP1; RRM) containing 3,16,pre-mRNA intronic binding|U12 snRNA binding,isolated growth hormone deficiency type IA,ppi
5121,6004,23203,PMPCA,peptidase; mitochondrial processing alpha subunit,69,metalloendopeptidase activity,cerebellar disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cataract|agnosia|autosomal recessive spinocerebellar ataxia 2,ppi
5122,6006,64398,MPP5,membrane palmitoylated protein 5,38,,,ppi
5123,6007,1069,CETN2,centrin 2,60,calcium ion binding|heterotrimeric G-protein binding|G-protein beta/gamma-subunit complex binding|microtubule binding,,ppi
5124,6008,55755,CDK5RAP2,CDK5 regulatory subunit associated protein 2,67,calmodulin binding|microtubule binding|gamma-tubulin binding|transcription regulatory region DNA binding,microcephaly,ppi
5125,6009,80279,CDK5RAP3,CDK5 regulatory subunit associated protein 3,57,protein kinase binding|ubiquitin-like protein ligase binding,,ppi
5126,6010,51428,DDX41,DEAD-box helicase 41,173,RNA binding,,ppi
5127,6011,11325,DDX42,DEAD-box helicase 42,49,RNA binding,,ppi
5128,6012,55510,DDX43,DEAD-box helicase 43,9,ATP-dependent RNA helicase activity,,ppi
5129,6013,1070,CETN3,centrin 3,26,microtubule binding|calcium ion binding,,ppi
5130,6014,9879,DDX46,DEAD-box helicase 46,49,RNA binding,,ppi
5131,6015,51202,DDX47,DEAD-box helicase 47,60,RNA binding,,ppi
5132,6016,9775,EIF4A3,eukaryotic translation initiation factor 4A3,284,RNA binding|mRNA binding|ATP-dependent RNA helicase activity|ATP binding|poly(A) binding,isolated cleft palate|cleft palate|clubfoot|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X|Nance-Horan syndrome|Muenke Syndrome|Warburg micro syndrome 1|Warburg micro syndrome 2|Warburg micro syndrome 3|Warburg micro syndrome 4|Mobius syndrome|Goldenhar syndrome|Weissenbacher-Zweymuller syndrome,ppi
5133,6017,54555,DDX49,DEAD-box helicase 49,9,RNA binding,,ppi
5134,6018,345275,HSD17B13,hydroxysteroid 17-beta dehydrogenase 13,3,steroid dehydrogenase activity,,ppi
5135,6019,286204,CRB2,crumbs 2; cell polarity complex component,4,enzyme binding|aspartic-type endopeptidase inhibitor activity,,ppi
5136,6020,1071,CETP,cholesteryl ester transfer protein,5,lipid transporter activity|phospholipid transporter activity|lipid binding|cholesterol binding|cholesterol transporter activity|triglyceride binding|phosphatidylcholine binding,heart disease|cardiovascular system disease|familial hypercholesterolemia|familial hyperlipidemia|hypertension|essential hypertension,ppi
5137,6021,9705,ST18,ST18; C2H2C-type zinc finger,1,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,alcohol dependence|alcohol abuse,ppi
5138,6022,163732,CITED4,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4,4,transcription coactivator activity,,ppi
5139,6023,10973,ASCC3,activating signal cointegrator 1 complex subunit 3,38,RNA binding|ATP-dependent 3'-5' DNA helicase activity|ATP-dependent helicase activity,intellectual disability|learning disability,ppi
5140,6024,29118,DDX25,DEAD-box helicase 25,1,ATP-dependent RNA helicase activity|ATP binding,,ppi
5141,6025,54514,DDX4,DEAD-box helicase 4,13,ATPase activity,,ppi
5142,6026,55179,FAIM,Fas apoptotic inhibitory molecule,3,,,ppi
5143,6027,8260,NAA10,N(alpha)-acetyltransferase 10; NatA catalytic subunit,61,peptide alpha-N-acetyltransferase activity|N-acetyltransferase activity|acetyltransferase activity|ribosome binding|peptide-glutamate-N-acetyltransferase activity|peptide-serine-N-acetyltransferase activity,imperforate anus|ptosis|congenital ptosis|cleft lip|cryptorchidism|sensorineural hearing loss|epilepsy|enophthalmos|orbital disease|exophthalmos|glaucoma|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9,ppi
5144,6029,56850,GRIPAP1,GRIP1 associated protein 1,26,,,ppi
5145,6030,160622,GRASP,general receptor for phosphoinositides 1 associated scaffold protein,8,,,ppi
5146,6031,23426,GRIP1,glutamate receptor interacting protein 1,54,transcription coactivator activity|beta-catenin binding|receptor signaling complex scaffold activity|androgen receptor binding,imperforate anus|cleft lip|isolated cleft palate|cleft palate|recurrent corneal erosion|cryptorchidism|congenital heart disease|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|laryngostenosis|myelomeningocele|intellectual disability|learning disability|microphthalmia|schizophrenia|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I,ppi
5147,6032,85417,CCNB3,cyclin B3,2,cyclin-dependent protein serine/threonine kinase regulator activity|protein kinase activity|protein kinase binding,osteosarcoma|bone osteosarcoma,ppi
5148,6036,113263,GLCCI1,glucocorticoid induced 1,9,,,ppi
5149,6037,55802,DCP1A,decapping mRNA 1A,49,mRNA binding,,ppi
5150,6039,171586,ABHD3,abhydrolase domain containing 3,6,phospholipase A2 activity|phospholipase A1 activity|short-chain carboxylesterase activity|acylglycerol lipase activity|lipase activity,,ppi
5151,6041,152518,NFXL1,nuclear transcription factor; X-box binding like 1,9,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,cholestasis,ppi
5152,6042,221613,HIST1H2AA,histone cluster 1 H2A family member a,26,DNA binding,,ppi
5153,6043,10428,CFDP1,craniofacial development protein 1,12,,,ppi
5154,6044,255626,HIST1H2BA,histone cluster 1 H2B family member a,100,DNA binding,,ppi
5155,6045,80380,PDCD1LG2,programmed cell death 1 ligand 2,1,,,ppi
5156,6046,55958,KLHL9,kelch like family member 9,18,ubiquitin-protein transferase activity,,ppi
5157,6047,23517,SKIV2L2,Ski2 like RNA helicase 2,112,RNA binding|ATP-dependent RNA helicase activity,,ppi
5158,6048,135644,TRIM40,tripartite motif containing 40,7,,,ppi
5159,6049,55893,ZNF395,zinc finger protein 395,8,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
5160,6050,9886,RHOBTB1,Rho related BTB domain containing 1,18,GTP binding|protein kinase binding|GTPase activity,,ppi
5161,6051,1072,CFL1,cofilin 1,169,actin filament binding,myelomeningocele|tethered spinal cord syndrome|esophagus squamous cell carcinoma|breast cancer,ppi
5162,6052,29944,PNMA3,paraneoplastic Ma antigen 3,5,,,ppi
5163,6053,114824,PNMA5,paraneoplastic Ma antigen family member 5,36,,,ppi
5164,6054,64446,DNAI2,dynein axonemal intermediate chain 2,12,microtubule motor activity|ATP-dependent microtubule motor activity; plus-end-directed|dynein light chain binding|dynein heavy chain binding,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|primary ciliary dyskinesia 9,ppi
5165,6055,51143,DYNC1LI1,dynein cytoplasmic 1 light intermediate chain 1,51,RNA binding|GDP binding|GTP binding|dynein heavy chain binding,,ppi
5166,6056,57152,SLURP1,secreted LY6/PLAUR domain containing 1,2,cytokine activity|acetylcholine receptor activator activity,nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|mal de Meleda,ppi
5167,6057,85445,CNTNAP4,contactin associated protein like 4,6,,,ppi
5168,6059,9610,RIN1,Ras and Rab interactor 1,31,Rab guanyl-nucleotide exchange factor activity,melanoma|skin melanoma,ppi
5169,6060,1073,CFL2,cofilin 2,43,actin filament binding,nemaline myopathy,ppi
5170,6061,54453,RIN2,Ras and Rab interactor 2,10,Rab guanyl-nucleotide exchange factor activity|GTPase regulator activity,alopecia|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|clubfoot|gingival overgrowth|gingival hypertrophy|umbilical hernia|omphalocele|hypertrichosis,ppi
5171,6062,79890,RIN3,Ras and Rab interactor 3,48,Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding,Paget's disease of bone,ppi
5172,6063,79109,MAPKAP1,mitogen-activated protein kinase associated protein 1,34,phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3;4;5-trisphosphate binding|Ras GTPase binding|phosphatidylinositol-3;4-bisphosphate binding|phosphatidic acid binding|phosphatidylinositol-3;5-bisphosphate binding,,ppi
5173,6064,126433,FBXO27,F-box protein 27,11,ubiquitin-protein transferase activity|protein binding,,ppi
5174,6065,115290,FBXO17,F-box protein 17,19,ubiquitin-protein transferase activity|protein binding,,ppi
5175,6066,56655,POLE4,DNA polymerase epsilon 4; accessory subunit,16,,,ppi
5176,6067,23221,RHOBTB2,Rho related BTB domain containing 2,21,protein kinase binding|GTPase activity|GTP binding,polyneuropathy|peripheral nervous system disease|neuropathy,ppi
5177,6068,22836,RHOBTB3,Rho related BTB domain containing 3,34,ATP binding|ATPase activity|GTPase activity|GTP binding|protein kinase binding,,ppi
5178,6069,55212,BBS7,Bardet-Biedl syndrome 7,73,,hypertension|essential hypertension|hypogonadism|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|polydactyly|Laurence-Moon syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 4,ppi
5179,6070,8837,CFLAR,CASP8 and FADD like apoptosis regulator,64,enzyme activator activity|cysteine-type endopeptidase activity involved in apoptotic process,Hodgkin's lymphoma; lymphocytic-histiocytic predominance|Hodgkin's lymphoma|Hodgkin's lymphoma; lymphocytic depletion|Hodgkin's granuloma|Hodgkin's lymphoma; mixed cellularity|leukemia|pancreatic cancer|essential thrombocythemia|myelodysplastic syndrome,ppi
5180,6071,399909,PCNX3,pecanex homolog 3 (Drosophila),21,,systemic lupus erythematosus,ppi
5181,6072,206358,SLC36A1,solute carrier family 36 member 1,6,amino acid transmembrane transporter activity|glycine transmembrane transporter activity|L-proline transmembrane transporter activity|amino acid:proton symporter activity|proton transmembrane transporter activity|L-alanine transmembrane transporter activity,,ppi
5182,6074,346157,ZNF391,zinc finger protein 391,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5183,6075,8030,CCDC6,coiled-coil domain containing 6,67,structural constituent of cytoskeleton,papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma,ppi
5184,6076,8227,AKAP17A,A-kinase anchoring protein 17A,31,RNA binding|protein kinase A binding,,ppi
5185,6077,8568,RRP1,ribosomal RNA processing 1,36,RNA binding,,ppi
5186,6078,9130,FAM50A,family with sequence similarity 50 member A,10,RNA binding,,ppi
5187,6079,22914,KLRK1,killer cell lectin like receptor K1,7,signaling receptor activity|protein homodimerization activity|MHC class I protein binding|kinase binding|MHC class Ib receptor activity|protein binding,melanoma|skin melanoma,ppi
5188,6080,26240,FAM50B,family with sequence similarity 50 member B,17,,,ppi
5189,6081,346171,ZFP57,ZFP57 zinc finger protein,4,DNA-binding transcription factor activity; RNA polymerase II-specific,diabetic ketoacidosis|diabetes mellitus|transient neonatal diabetes mellitus,ppi
5190,6082,84467,FBN3,fibrillin 3,14,extracellular matrix structural constituent,,ppi
5191,6083,10537,UBD,ubiquitin D,651,proteasome binding|protein binding,primary biliary cirrhosis|liver cancer|hepatocellular carcinoma,ppi
5192,6085,23446,SLC44A1,solute carrier family 44 member 1,11,choline transmembrane transporter activity,,ppi
5193,6086,27109,ATP5S,ATP synthase; H+ transporting; mitochondrial Fo complex subunit s (factor B),14,proton transmembrane transporter activity,,ppi
5194,6087,102,ADAM10,ADAM metallopeptidase domain 10,28,endopeptidase activity|metalloendopeptidase activity|signaling receptor binding|integrin binding|metallopeptidase activity|protein kinase binding|protein homodimerization activity,Dowling-Degos disease|reticulate acropigmentation of Kitamura|breast cancer|Alzheimer's disease 18,ppi
5195,6088,57645,POGK,pogo transposable element with KRAB domain,10,,,ppi
5196,6089,23126,POGZ,pogo transposable element with ZNF domain,53,DNA-binding transcription factor activity; RNA polymerase II-specific,intellectual disability|learning disability|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|autosomal dominant nonsyndromic deafness|autosomal recessive nonsyndromic deafness|X-linked nonsyndromic deafness|autosomal dominant auditory neuropathy 1|autosomal recessive nonsyndromic deafness 101|autosomal recessive nonsyndromic deafness 102|autosomal recessive nonsyndromic deafness 103|autosomal recessive nonsyndromic deafness 104|autosomal recessive nonsyndromic deafness 105|autosomal recessive nonsyndromic deafness 12|autosomal recessive nonsyndromic deafness 13|autosomal recessive nonsyndromic deafness 14|autosomal recessive nonsyndromic deafness 15|autosomal recessive nonsyndromic deafness 16,ppi
5197,6090,91647,ATPAF2,ATP synthase mitochondrial F1 complex assembly factor 2,36,,mitochondrial complex V (ATP synthase) deficiency; nuclear type 1,ppi
5198,6091,64756,ATPAF1,ATP synthase mitochondrial F1 complex assembly factor 1,11,,obesity,ppi
5199,6092,23261,CAMTA1,calmodulin binding transcription activator 1,2,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding,cerebral degeneration|nonprogressive cerebellar atxia with mental retardation,ppi
5200,6093,23125,CAMTA2,calmodulin binding transcription activator 2,5,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|transcription factor binding|histone deacetylase binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
5201,6094,28969,BZW2,basic leucine zipper and W2 domains 2,62,cadherin binding,,ppi
5202,6095,10376,TUBA1B,tubulin alpha 1b,148,double-stranded RNA binding|structural molecule activity|structural constituent of cytoskeleton|GTP binding,osteoporosis,ppi
5203,6096,117155,CATSPER2,cation channel sperm associated 2,1,,,ppi
5204,6098,84063,KIRREL2,kin of IRRE like 2 (Drosophila),10,identical protein binding,,ppi
5205,6099,79803,HPS6,HPS6; biogenesis of lysosomal organelles complex 2 subunit 3,12,Rab GTPase binding,Hermansky-Pudlak syndrome 1,ppi
5206,6100,84307,ZNF397,zinc finger protein 397,37,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5207,6102,252839,TMEM9,transmembrane protein 9,15,,,ppi
5208,6103,252884,ZNF396,zinc finger protein 396,15,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5209,6105,83594,NUDT12,nudix hydrolase 12,14,NAD+ diphosphatase activity|NADH pyrophosphatase activity|hydrolase activity,,ppi
5210,6106,25961,NUDT13,nudix hydrolase 13,5,pyrophosphatase activity,,ppi
5211,6107,51103,NDUFAF1,NADH:ubiquinone oxidoreductase complex assembly factor 1,44,unfolded protein binding,lactic acidosis|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|hypoglycemia|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
5212,6108,317719,KLHL10,kelch like family member 10,35,,azoospermia,ppi
5213,6109,128209,KLF17,Kruppel like factor 17,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
5214,6110,115908,CTHRC1,collagen triple helix repeat containing 1,2,,,ppi
5215,6111,84124,ZNF394,zinc finger protein 394,8,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
5216,6112,10848,PPP1R13L,protein phosphatase 1 regulatory subunit 13 like,28,transcription corepressor activity|cadherin binding,leukemia,ppi
5217,6113,246744,STH,saitohin,1,,schizophrenia,ppi
5218,6114,1080,CFTR,cystic fibrosis transmembrane conductance regulator,236,chloride channel activity|intracellularly ATP-gated chloride channel activity|bicarbonate transmembrane transporter activity|chloride transmembrane transporter activity|ATPase activity|chloride channel regulator activity|chloride channel inhibitor activity|PDZ domain binding|ATPase-coupled anion transmembrane transporter activity|ATPase activity; coupled to transmembrane movement of substances,alcohol dependence|alcohol abuse|asthma|intrinsic asthma|allergic asthma|azoospermia|bronchiectasis|primary biliary cirrhosis|choledochal cyst|large intestine cancer|colorectal cancer|cystic fibrosis|hiatus hernia|congenital diaphragmatic hernia|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|primary immunodeficiency disease|male infertility|acute pancreatitis,ppi
5219,6115,1081,CGA,glycoprotein hormones; alpha polypeptide,7,hormone activity|follicle-stimulating hormone activity,adrenal gland disease|hemiplegia|Sertoli cell-only syndrome|oligospermia|ovarian disease|uterine disease,ppi
5220,6116,148327,CREB3L4,cAMP responsive element binding protein 3 like 4,9,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5221,6117,84699,CREB3L3,cAMP responsive element binding protein 3 like 3,22,transcription regulatory region sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|protein homodimerization activity,hyperlipoproteinemia type V|familial lipoprotein lipase deficiency,ppi
5222,6118,90993,CREB3L1,cAMP responsive element binding protein 3 like 1,38,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|chromatin binding|cAMP response element binding|transcription regulatory region DNA binding,osteogenesis imperfecta type 3,ppi
5223,6119,66002,CYP4F12,cytochrome P450 family 4 subfamily F member 12,7,monooxygenase activity|arachidonic acid epoxygenase activity|alkane 1-monooxygenase activity|leukotriene-B4 20-monooxygenase activity,,ppi
5224,6120,93183,PIGM,phosphatidylinositol glycan anchor biosynthesis class M,14,,epilepsy|visual epilepsy|thrombophilia,ppi
5225,6121,56848,SPHK2,sphingosine kinase 2,6,sphinganine kinase activity|Ras GTPase binding|D-erythro-sphingosine kinase activity|sphingosine-1-phosphate receptor activity,middle cerebral artery infarction,ppi
5226,6122,1082,CGB3,chorionic gonadotropin beta subunit 3,5,,hypogonadism,ppi
5227,6124,27012,KCNV1,potassium voltage-gated channel modifier subfamily V member 1,3,ion channel inhibitor activity|potassium channel regulator activity|voltage-gated potassium channel activity,,ppi
5228,6126,90134,KCNH7,potassium voltage-gated channel subfamily H member 7,1,voltage-gated potassium channel activity,,ppi
5229,6129,343450,KCNT2,potassium sodium-activated channel subfamily T member 2,6,intracellular sodium activated potassium channel activity|outward rectifier potassium channel activity,,ppi
5230,6131,143570,XRRA1,X-ray radiation resistance associated 1,2,,,ppi
5231,6132,199720,GGN,gametogenetin,6,ubiquitin protein ligase binding|protein dimerization activity,,ppi
5232,6133,353497,POLN,DNA polymerase nu,10,DNA-directed DNA polymerase activity|5'-3' exonuclease activity,,ppi
5233,6134,166785,MMAA,methylmalonic aciduria (cobalamin deficiency) cblA type,2,GTPase activity|GTP binding|identical protein binding|protein homodimerization activity,methylmalonic acidemia cb1A type,ppi
5234,6135,64135,IFIH1,interferon induced with helicase C domain 1,16,double-stranded RNA binding|single-stranded RNA binding|zinc ion binding,Graves' disease|thyrotoxicosis|hyperthyroidism|influenza|systemic lupus erythematosus|pustulosis of palm and sole|psoriasis|parapsoriasis|vitiligo|immunoglobulin alpha deficiency|selective IgA deficiency disease|Aicardi-Goutieres syndrome|type 1 diabetes mellitus 19,ppi
5235,6136,27040,LAT,linker for activation of T-cells,41,SH3/SH2 adaptor activity|Ras guanyl-nucleotide exchange factor activity|protein kinase binding,gallbladder disease|liver disease|toxic encephalopathy|amyotrophic lateral sclerosis type 1,ppi
5236,6140,8545,CGGBP1,CGG triplet repeat binding protein 1,18,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|double-stranded DNA binding,,ppi
5237,6142,259287,TAS2R41,taste 2 receptor member 41,16,bitter taste receptor activity,,ppi
5238,6143,55775,TDP1,tyrosyl-DNA phosphodiesterase 1,16,double-stranded DNA binding|single-stranded DNA binding|3'-tyrosyl-DNA phosphodiesterase activity,,ppi
5239,6147,55359,STYK1,serine/threonine/tyrosine kinase 1,2,non-membrane spanning protein tyrosine kinase activity,,ppi
5240,6148,85293,KRTAP3-3,keratin associated protein 3-3,4,,,ppi
5241,6151,142679,DUSP19,dual specificity phosphatase 19,75,protein kinase inhibitor activity|MAP-kinase scaffold activity|protein kinase activator activity|mitogen-activated protein kinase kinase kinase binding|JUN kinase phosphatase activity,,ppi
5242,6152,79134,TMEM185B,transmembrane protein 185B,1,,,ppi
5243,6153,100132476,KRTAP4-7,keratin associated protein 4-7,14,,,ppi
5244,6155,4185,ADAM11,ADAM metallopeptidase domain 11,3,integrin binding|metallopeptidase activity,,ppi
5245,6156,85291,KRTAP4-2,keratin associated protein 4-2,70,,,ppi
5246,6157,57402,S100A14,S100 calcium binding protein A14,21,calcium ion binding|chemokine receptor binding,,ppi
5247,6158,85280,KRTAP9-4,keratin associated protein 9-4,30,,,ppi
5248,6161,730755,KRTAP2-3,keratin associated protein 2-3,10,,,ppi
5249,6166,653240,KRTAP4-11,keratin associated protein 4-11,15,,,ppi
5250,6167,728318,KRTAP9-1,keratin associated protein 9-1,1,,,ppi
5251,6172,337880,KRTAP11-1,keratin associated protein 11-1,4,,,ppi
5252,6174,140258,KRTAP13-1,keratin associated protein 13-1,9,,,ppi
5253,6175,337960,KRTAP13-3,keratin associated protein 13-3,1,,,ppi
5254,6177,254950,KRTAP15-1,keratin associated protein 15-1,1,,,ppi
5255,6178,337963,KRTAP23-1,keratin associated protein 23-1,3,,,ppi
5256,6183,337879,KRTAP8-1,keratin associated protein 8-1,5,,,ppi
5257,6188,337972,KRTAP19-5,keratin associated protein 19-5,12,,,ppi
5258,6190,337974,KRTAP19-7,keratin associated protein 19-7,5,,,ppi
5259,6196,55333,SYNJ2BP,synaptojanin 2 binding protein,25,ionotropic glutamate receptor binding,,ppi
5260,6197,252969,NEIL2,nei like DNA glycosylase 2,6,DNA N-glycosylase activity|DNA-(apurinic or apyrimidinic site) endonuclease activity,,ppi
5261,6198,9863,MAGI2,membrane associated guanylate kinase; WW and PDZ domain containing 2,24,receptor signaling complex scaffold activity|SMAD binding|type II activin receptor binding,anxiety disorder|phobic disorder|bipolar disorder|salivary gland adenoid cystic carcinoma|schizophrenia,ppi
5262,6199,115727,RASGRP4,RAS guanyl releasing protein 4,5,Ras guanyl-nucleotide exchange factor activity|diacylglycerol binding|GTP-dependent protein binding,,ppi
5263,6200,414301,DDI1,DNA damage inducible 1 homolog 1,13,,,ppi
5264,6201,51380,CSAD,cysteine sulfinic acid decarboxylase,12,,,ppi
5265,6202,9695,EDEM1,ER degradation enhancing alpha-mannosidase like protein 1,36,mannosyl-oligosaccharide 1;2-alpha-mannosidase activity|misfolded protein binding,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
5266,6203,133396,IL31RA,interleukin 31 receptor A,26,transcription coactivator activity|cytokine receptor activity|protein kinase binding|cytokine binding,primary cutaneous amyloidosis,ppi
5267,6204,130340,AP1S3,adaptor related protein complex 1 sigma 3 subunit,6,,pustulosis of palm and sole|psoriasis|impetigo herpetiformis,ppi
5268,6205,149420,PDIK1L,PDLIM1 interacting kinase 1 like,8,protein kinase activity,schizophrenia,ppi
5269,6206,266743,NPAS4,neuronal PAS domain protein 4,3,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|protein heterodimerization activity,bipolar disorder|schizophrenia,ppi
5270,6207,56938,ARNTL2,aryl hydrocarbon receptor nuclear translocator like 2,23,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity|E-box binding,bipolar disorder|alcohol abuse,ppi
5271,6208,51181,DCXR,dicarbonyl and L-xylulose reductase,19,oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor|L-xylulose reductase (NADP+) activity|carbonyl reductase (NADPH) activity,obesity|prostate cancer|prostate carcinoma|renal glycosuria,ppi
5272,6209,57704,GBA2,glucosylceramidase beta 2,12,glucosylceramidase activity|beta-glucosidase activity,hereditary spastic paraplegia 46,ppi
5273,6210,79178,THTPA,thiamine triphosphatase,16,magnesium ion binding|hydrolase activity|thiamin-triphosphatase activity,,ppi
5274,6211,9760,TOX,thymocyte selection associated high mobility group box,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5275,6212,165082,ADGRF3,adhesion G protein-coupled receptor F3,1,,,ppi
5276,6215,139378,ADGRG4,adhesion G protein-coupled receptor G4,1,G-protein coupled receptor activity,,ppi
5277,6216,84446,BRSK1,BR serine/threonine kinase 1,9,magnesium ion binding|protein serine/threonine kinase activity|ATP binding|gamma-tubulin binding|tau-protein kinase activity,,ppi
5278,6217,51231,VRK3,vaccinia related kinase 3,16,protein phosphatase binding|protein serine/threonine kinase activity,,ppi
5279,6218,85481,PSKH2,protein serine kinase H2,9,,,ppi
5280,6219,55781,RIOK2,RIO kinase 2,273,protein kinase activity,,ppi
5281,6220,15,AANAT,aralkylamine N-acetyltransferase,5,aralkylamine N-acetyltransferase activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
5282,6221,8038,ADAM12,ADAM metallopeptidase domain 12,13,metallopeptidase activity,schizophrenia,ppi
5283,6222,51435,SCARA3,scavenger receptor class A member 3,47,scavenger receptor activity|calcium ion binding|mannose binding,,ppi
5284,6223,166614,DCLK2,doublecortin like kinase 2,6,,,ppi
5285,6224,22955,SCMH1,sex comb on midleg homolog 1 (Drosophila),28,,,ppi
5286,6226,85443,DCLK3,doublecortin like kinase 3,1,protein kinase activity,,ppi
5287,6227,204851,HIPK1,homeodomain interacting protein kinase 1,23,,,ppi
5288,6228,147746,HIPK4,homeodomain interacting protein kinase 4,33,,,ppi
5289,6229,55175,KLHL11,kelch like family member 11,9,,,ppi
5290,6230,23059,CLUAP1,clusterin associated protein 1,26,,,ppi
5291,6231,221188,ADGRG5,adhesion G protein-coupled receptor G5,80,G-protein coupled receptor activity,,ppi
5292,6234,90933,TRIM41,tripartite motif containing 41,104,,,ppi
5293,6235,287015,TRIM42,tripartite motif containing 42,64,,,ppi
5294,6236,129868,TRIM43,tripartite motif containing 43,19,,,ppi
5295,6237,54765,TRIM44,tripartite motif containing 44,53,,aniridia|glaucoma|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cataract|Axenfeld-Rieger syndrome|cornea plana|Peters anomaly,ppi
5296,6238,135892,TRIM50,tripartite motif containing 50,13,,,ppi
5297,6239,80263,TRIM45,tripartite motif containing 45,14,,,ppi
5298,6240,80128,TRIM46,tripartite motif containing 46,34,,,ppi
5299,6241,91107,TRIM47,tripartite motif containing 47,18,ubiquitin-protein transferase activity,,ppi
5300,6243,259217,HSPA12A,heat shock protein family A (Hsp70) member 12A,25,,schizophrenia|neurotic disorder|endogenous depression|melancholia|substance abuse|substance-related disorder|major depressive disorder|mental depression,ppi
5301,6244,84767,TRIM51,tripartite motif-containing 51,3,,,ppi
5302,6245,84851,TRIM52,tripartite motif containing 52,7,,,ppi
5303,6246,127343,DMBX1,diencephalon/mesencephalon homeobox 1,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
5304,6247,56262,LRRC8A,leucine rich repeat containing 8 family member A,23,volume-sensitive anion channel activity|anion channel activity,agammaglobulinemia,ppi
5305,6248,81844,TRIM56,tripartite motif containing 56,20,RNA binding|ubiquitin-protein transferase activity,,ppi
5306,6251,79169,C1orf35,chromosome 1 open reading frame 35,33,RNA binding|protein binding,,ppi
5307,6252,22983,MAST1,microtubule associated serine/threonine kinase 1,43,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
5308,6253,23139,MAST2,microtubule associated serine/threonine kinase 2,36,magnesium ion binding|ATP binding|microtubule binding|protein serine/threonine kinase activity,,ppi
5309,6254,23031,MAST3,microtubule associated serine/threonine kinase 3,44,protein serine/threonine kinase activity,,ppi
5310,6255,375449,MAST4,microtubule associated serine/threonine kinase family member 4,3,protein serine/threonine kinase activity,,ppi
5311,6256,57143,ADCK1,aarF domain containing kinase 1,36,,,ppi
5312,6257,90956,ADCK2,aarF domain containing kinase 2,15,,,ppi
5313,6258,79934,COQ8B,coenzyme Q8B,32,protein kinase activity|kinase activity,nephrotic syndrome,ppi
5314,6259,84930,MASTL,microtubule associated serine/threonine kinase like,23,protein serine/threonine kinase activity|kinase activity|protein phosphatase 2A binding,thrombocytopenia,ppi
5315,6261,81796,SLCO5A1,solute carrier organic anion transporter family member 5A1,1,sodium-independent organic anion transmembrane transporter activity,,ppi
5316,6262,259266,ASPM,abnormal spindle microtubule assembly,95,,salivary gland adenoid cystic carcinoma|polycystic ovary syndrome|microcephaly,ppi
5317,6264,118460,EXOSC6,exosome component 6,59,RNA binding|exoribonuclease activity,,ppi
5318,6265,146852,ODF4,outer dense fiber of sperm tails 4,5,,,ppi
5319,6266,84181,CHD6,chromodomain helicase DNA binding protein 6,19,DNA-dependent ATPase activity,urinary bladder cancer|transitional cell carcinoma|neuroblastoma,ppi
5320,6267,139760,GPR119,G protein-coupled receptor 119,1,,,ppi
5321,6269,221527,ZBTB12,zinc finger and BTB domain containing 12,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5322,6270,155368,WBSCR27,Williams Beuren syndrome chromosome region 27,4,,,ppi
5323,6271,57733,GBA3,glucosylceramidase beta 3 (gene/pseudogene),2,glucosylceramidase activity|beta-galactosidase activity|beta-glucosidase activity|glycosylceramidase activity,substance abuse|substance-related disorder,ppi
5324,6273,9984,THOC1,THO complex 1,91,,,ppi
5325,6274,10189,ALYREF,Aly/REF export factor,132,RNA binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
5326,6275,84321,THOC3,THO complex 3,36,,,ppi
5327,6276,57187,THOC2,THO complex 2,109,mRNA binding,,ppi
5328,6277,8563,THOC5,THO complex 5,66,mRNA binding,,ppi
5329,6278,92610,TIFA,TRAF interacting protein with forkhead associated domain,19,,,ppi
5330,6279,57827,C6orf47,chromosome 6 open reading frame 47,4,,,ppi
5331,6280,259197,NCR3,natural cytotoxicity triggering receptor 3,6,,malaria,ppi
5332,6281,50854,C6orf48,chromosome 6 open reading frame 48,2,,,ppi
5333,6282,58473,PLEKHB1,pleckstrin homology domain containing B1,13,,,ppi
5334,6283,23230,VPS13A,vacuolar protein sorting 13 homolog A,23,,generalized anxiety disorder|anxiety disorder|cerebellar disease|syndromic X-linked intellectual disability type 10|choreatic disease|dystonia|epilepsy|familial periodic paralysis|myopathy|polyneuropathy|peripheral nervous system disease|neuropathy|schizophreniform disorder|schizoaffective disorder|visual epilepsy|sensory peripheral neuropathy|lingual-facial-buccal dyskinesia|amnestic disorder|retrograde amnesia|dysgraphia,ppi
5335,6284,57134,MAN1C1,mannosidase alpha class 1C member 1,1,mannosyl-oligosaccharide 1;2-alpha-mannosidase activity|calcium ion binding,,ppi
5336,6285,85456,TNKS1BP1,tankyrase 1 binding protein 1,44,enzyme binding|cadherin binding|ankyrin repeat binding,,ppi
5337,6286,259232,NALCN,sodium leak channel; non-selective,5,cation channel activity|sodium channel activity|leak channel activity,schizophrenia|distal arthrogryposis|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X|Nance-Horan syndrome|Muenke Syndrome|Warburg micro syndrome 1|Warburg micro syndrome 2|Warburg micro syndrome 3|Warburg micro syndrome 4|Mobius syndrome|Goldenhar syndrome|Weissenbacher-Zweymuller syndrome,ppi
5338,6287,1163,CKS1B,CDC28 protein kinase regulatory subunit 1B,50,cyclin-dependent protein serine/threonine kinase activator activity|histone binding|protein kinase binding|ubiquitin binding,,ppi
5339,6288,120425,JAML,junction adhesion molecule like,1,protein homodimerization activity,,ppi
5340,6289,23399,CTDNEP1,CTD nuclear envelope phosphatase 1,51,protein serine/threonine phosphatase activity|phosphoprotein phosphatase activity,,ppi
5341,6290,79885,HDAC11,histone deacetylase 11,143,histone deacetylase activity|transcription factor binding,,ppi
5342,6291,253738,EBF3,early B-cell factor 3,7,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
5343,6292,55870,ASH1L,ASH1 like histone lysine methyltransferase,12,DNA-binding transcription factor activity; RNA polymerase II-specific|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K36 specific),liver cancer,ppi
5344,6293,64924,SLC30A5,solute carrier family 30 member 5,33,zinc ion transmembrane transporter activity|zinc ion binding,,ppi
5345,6294,1101,CHAD,chondroadherin,3,,,ppi
5346,6295,64641,EBF2,early B-cell factor 2,1,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
5347,6296,84249,PSD2,pleckstrin and Sec7 domain containing 2,3,,,ppi
5348,6297,23362,PSD3,pleckstrin and Sec7 domain containing 3,11,ARF guanyl-nucleotide exchange factor activity,malignant glioma|gliosarcoma|mixed glioma|schizophrenia,ppi
5349,6299,79571,GCC1,GRIP and coiled-coil domain containing 1,50,,cannabis dependence|cannabis abuse|phencyclidine abuse|cocaine abuse|cocaine dependence,ppi
5350,6300,23550,PSD4,pleckstrin and Sec7 domain containing 4,5,,,ppi
5351,6301,11030,RBPMS,RNA binding protein with multiple splicing,184,transcription coactivator activity|RNA binding|poly(A) binding|snRNA stem-loop binding,,ppi
5352,6302,348093,RBPMS2,RNA binding protein with multiple splicing 2,7,mRNA binding|snRNA stem-loop binding,,ppi
5353,6303,10036,CHAF1A,chromatin assembly factor 1 subunit A,83,chromatin binding|unfolded protein binding,mouth disease,ppi
5354,6304,149233,IL23R,interleukin 23 receptor,6,interleukin-23 receptor activity|interleukin-23 binding|interleukin-12 receptor binding|cytokine receptor activity|cytokine binding,Behcet's disease|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|leprosy|pustulosis of palm and sole|psoriasis|parapsoriasis|ankylosing spondylitis,ppi
5355,6305,23586,DDX58,DExD/H-box helicase 58,45,double-stranded RNA binding|single-stranded RNA binding|zinc ion binding,glaucoma|hepatitis C|influenza|pustulosis of palm and sole|psoriasis|parapsoriasis|acquired hyperkeratosis,ppi
5356,6306,261734,NPHP4,nephrocystin 4,45,structural molecule activity,Senior-Loken syndrome|nephronophthisis,ppi
5357,6309,8208,CHAF1B,chromatin assembly factor 1 subunit B,44,chromatin binding|histone binding|unfolded protein binding,mouth disease,ppi
5358,6312,152273,FGD5,FYVE; RhoGEF and PH domain containing 5,3,guanyl-nucleotide exchange factor activity|small GTPase binding,breast cancer,ppi
5359,6313,79155,TNIP2,TNFAIP3 interacting protein 2,37,protein kinase binding|polyubiquitin modification-dependent protein binding,,ppi
5360,6314,160728,SLC5A8,solute carrier family 5 member 8,21,monocarboxylic acid transmembrane transporter activity|passive transmembrane transporter activity,colon cancer|colonic benign neoplasm|hyperuricemia,ppi
5361,6315,1103,CHAT,choline O-acetyltransferase,11,choline O-acetyltransferase activity,ptosis|congenital ptosis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|angle-closure glaucoma|primary angle-closure glaucoma|chronic closed-angle glaucoma|retinitis|retinal disease|schizophrenia|epilepsy|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|congenital myasthenic syndrome,ppi
5362,6316,23234,DNAJC9,DnaJ heat shock protein family (Hsp40) member C9,39,heat shock protein binding,,ppi
5363,6317,81608,FIP1L1,factor interacting with PAPOLA and CPSF1,67,RNA binding,acute promyelocytic leukemia|disseminated eosinophilic collagen disease,ppi
5364,6318,121512,FGD4,FYVE; RhoGEF and PH domain containing 4,4,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|small GTPase binding,Charcot-Marie-Tooth disease type 4H,ppi
5365,6319,148252,DIRAS1,DIRAS family GTPase 1,7,GTPase activity|GTP binding,,ppi
5366,6320,29968,PSAT1,phosphoserine aminotransferase 1,42,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,lung cancer|non-small cell lung carcinoma|isolated cleft palate|cleft palate|epilepsy|placental insufficiency|ichthyosis|schizophrenia|visual epilepsy|Neu-Laxova syndrome 1|PSAT deficiency|Neu-Laxova syndrome 2,ppi
5367,6321,1104,RCC1,regulator of chromosome condensation 1,109,chromatin binding|Ran guanyl-nucleotide exchange factor activity|Ran GTPase binding|nucleosome binding|nucleosomal DNA binding|histone binding|sulfate binding,,ppi
5368,6322,90161,HS6ST2,heparan sulfate 6-O-sulfotransferase 2,7,heparan sulfate 6-O-sulfotransferase activity,,ppi
5369,6325,80381,CD276,CD276 molecule,10,signaling receptor binding,liver cancer|hepatocellular carcinoma,ppi
5370,6326,10233,LRRC23,leucine rich repeat containing 23,2,motor activity|dynein heavy chain binding|alpha-tubulin binding,,ppi
5371,6327,55624,POMGNT1,protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1;2-),25,acetylglucosaminyltransferase activity|manganese ion binding|beta-1;3-galactosyl-O-glycosyl-glycoprotein beta-1;3-N-acetylglucosaminyltransferase activity,coloboma|epilepsy|glaucoma|sensorineural hearing loss|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|buphthalmos|hydrophthalmos|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|microphthalmia|familial periodic paralysis|myopathy,ppi
5372,6328,1102,RCBTB2,RCC1 and BTB domain containing protein 2,20,Ran guanyl-nucleotide exchange factor activity,,ppi
5373,6329,84630,TTBK1,tau tubulin kinase 1,9,protein serine/threonine kinase activity,,ppi
5374,6330,146057,TTBK2,tau tubulin kinase 2,11,protein kinase activity|protein serine/threonine kinase activity|tau-protein kinase activity|microtubule plus-end binding,autosomal dominant cerebellar ataxia|spinocerebellar ataxia type 11,ppi
5375,6332,84669,USP32,ubiquitin specific peptidase 32,40,thiol-dependent ubiquitin-specific protease activity,,ppi
5376,6333,125111,GJD3,gap junction protein delta 3,1,gap junction channel activity involved in cardiac conduction electrical coupling,,ppi
5377,6334,1105,CHD1,chromodomain helicase DNA binding protein 1,32,ATP-dependent DNA helicase activity|methylated histone binding,,ppi
5378,6335,135138,PACRG,PARK2 coregulated,22,actin binding|Hsp70 protein binding|alpha-tubulin binding|beta-tubulin binding|Hsp90 protein binding|chaperone binding,leprosy,ppi
5379,6337,81025,GJA9,gap junction protein alpha 9,1,,,ppi
5380,6338,25924,MYRIP,myosin VIIA and Rab interacting protein,6,zinc ion binding|Rab GTPase binding|actin binding|myosin binding,,ppi
5381,6339,246778,IL27,interleukin 27,2,signaling receptor binding|interleukin-27 receptor binding,diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21|type 1 diabetes mellitus 22,ppi
5382,6340,79844,ZDHHC11,zinc finger DHHC-type containing 11,11,protein-cysteine S-palmitoyltransferase activity,,ppi
5383,6341,84885,ZDHHC12,zinc finger DHHC-type containing 12,1,palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,,ppi
5384,6342,9557,CHD1L,chromodomain helicase DNA binding protein 1 like,66,nucleotide binding|ATP-dependent DNA helicase activity|ATPase activity,substance abuse|substance-related disorder,ppi
5385,6343,64429,ZDHHC6,zinc finger DHHC-type containing 6,17,palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,,ppi
5386,6344,9754,STARD8,StAR related lipid transfer domain containing 8,1,GTPase activator activity,large intestine cancer|colorectal cancer|breast cancer,ppi
5387,6345,57519,STARD9,StAR related lipid transfer domain containing 9,10,microtubule motor activity|microtubule binding,,ppi
5388,6346,90627,STARD13,StAR related lipid transfer domain containing 13,17,GTPase activator activity,,ppi
5389,6347,9882,TBC1D4,TBC1 domain family member 4,62,Rab GTPase binding|GTPase activator activity,,ppi
5390,6348,9779,TBC1D5,TBC1 domain family member 5,22,AP-2 adaptor complex binding|retromer complex binding|Rab GTPase binding|GTPase activator activity,,ppi
5391,6349,57576,KIF17,kinesin family member 17,21,microtubule binding|ATPase activity|microtubule motor activity|ATP-dependent microtubule motor activity; plus-end-directed,schizophrenia,ppi
5392,6350,64129,TINAGL1,tubulointerstitial nephritis antigen like 1,22,extracellular matrix structural constituent|cysteine-type endopeptidase activity,,ppi
5393,6351,83930,STARD3NL,STARD3 N-terminal like,5,cholesterol binding|protein homodimerization activity,,ppi
5394,6352,1106,CHD2,chromodomain helicase DNA binding protein 2,19,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA binding|RNA binding|ATP-dependent DNA helicase activity|histone binding,cerebellar disease|epilepsy|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|childhood absence epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|antisocial personality disorder|avoidant personality disorder|narcissistic personality disorder|status epilepticus|brain disease|visual epilepsy|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy|autistic disorder|childhood onset epileptic encephalopathy,ppi
5395,6353,113540,CMTM1,CKLF like MARVEL transmembrane domain containing 1,1,,,ppi
5396,6354,146225,CMTM2,CKLF like MARVEL transmembrane domain containing 2,2,,,ppi
5397,6355,123920,CMTM3,CKLF like MARVEL transmembrane domain containing 3,9,,,ppi
5398,6356,146223,CMTM4,CKLF like MARVEL transmembrane domain containing 4,10,,,ppi
5399,6357,116173,CMTM5,CKLF like MARVEL transmembrane domain containing 5,51,,,ppi
5400,6358,54918,CMTM6,CKLF like MARVEL transmembrane domain containing 6,19,,,ppi
5401,6360,152189,CMTM8,CKLF like MARVEL transmembrane domain containing 8,1,structural constituent of myelin sheath,,ppi
5402,6361,1107,CHD3,chromodomain helicase DNA binding protein 3,163,RNA binding|ATP-dependent DNA helicase activity|helicase activity|histone deacetylase activity|zinc ion binding,Sezary's disease,ppi
5403,6363,9928,KIF14,kinesin family member 14,62,ATP binding|microtubule binding|ATP-dependent microtubule motor activity; plus-end-directed|tubulin binding|ATPase activity|PDZ domain binding|microtubule motor activity,placental insufficiency|oligohydramnios|Potter's syndrome,ppi
5404,6364,23328,SASH1,SAM and SH3 domain containing 1,16,protein C-terminus binding|protein kinase binding|mitogen-activated protein kinase kinase kinase binding|protein-containing complex scaffold activity,,ppi
5405,6365,57657,HCN3,hyperpolarization activated cyclic nucleotide gated potassium channel 3,3,voltage-gated sodium channel activity|voltage-gated potassium channel activity,,ppi
5406,6366,114790,STK11IP,serine/threonine kinase 11 interacting protein,17,protein kinase binding|structural constituent of cytoskeleton,,ppi
5407,6367,80144,FRAS1,Fraser extracellular matrix complex subunit 1,32,extracellular matrix structural constituent,Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X|Nance-Horan syndrome|Muenke Syndrome|Warburg micro syndrome 1|Warburg micro syndrome 2|Warburg micro syndrome 3|Warburg micro syndrome 4|Mobius syndrome|Goldenhar syndrome|Weissenbacher-Zweymuller syndrome,ppi
5408,6368,57572,DOCK6,dedicator of cytokinesis 6,20,,Adams-Oliver syndrome,ppi
5409,6369,1108,CHD4,chromodomain helicase DNA binding protein 4,145,DNA binding|ATP-dependent DNA helicase activity|histone deacetylase activity|zinc ion binding|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,endometrial cancer|endometrial carcinoma|schizophrenia,ppi
5410,6370,85440,DOCK7,dedicator of cytokinesis 7,81,Rac GTPase binding,,ppi
5411,6371,81704,DOCK8,dedicator of cytokinesis 8,44,guanyl-nucleotide exchange factor activity,neuroblastoma|Job's syndrome|intellectual disability|learning disability,ppi
5412,6372,9732,DOCK4,dedicator of cytokinesis 4,18,GTPase activator activity|Rac GTPase binding,autistic disorder|schizophrenia,ppi
5413,6374,83872,HMCN1,hemicentin 1,4,signaling receptor activity|cell adhesion molecule binding|protein homodimerization activity,age related macular degeneration 1,ppi
5414,6375,84448,ABLIM2,actin binding LIM protein family member 2,6,actin filament binding,,ppi
5415,6376,221833,SP8,Sp8 transcription factor,4,DNA-binding transcription factor activity; RNA polymerase II-specific,bipolar disorder|schizophreniform disorder|schizoaffective disorder,ppi
5416,6377,151871,DPPA2,developmental pluripotency associated 2,19,,,ppi
5417,6378,359787,DPPA3,developmental pluripotency associated 3,1,methylated histone binding,germ cell cancer|germ cell and embryonal cancer|embryonal cancer,ppi
5418,6379,55211,DPPA4,developmental pluripotency associated 4,102,,,ppi
5419,6381,57620,STIM2,stromal interaction molecule 2,18,calcium channel regulator activity|calcium ion binding|store-operated calcium channel activity,,ppi
5420,6382,89927,C16orf45,chromosome 16 open reading frame 45,20,,,ppi
5421,6383,92799,SHKBP1,SH3KBP1 binding protein 1,35,,,ppi
5422,6385,26952,SMR3A,submaxillary gland androgen regulated protein 3A,2,endopeptidase inhibitor activity,,ppi
5423,6386,63892,THADA,THADA; armadillo repeat containing,36,,diabetes mellitus|type 2 diabetes mellitus,ppi
5424,6387,89869,PLCZ1,phospholipase C zeta 1,7,phosphatidylinositol phospholipase C activity|phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-5-phosphate binding|phosphatidylinositol-3-phosphate binding,,ppi
5425,6388,26118,WSB1,WD repeat and SOCS box containing 1,13,ubiquitin-protein transferase activity,,ppi
5426,6389,55884,WSB2,WD repeat and SOCS box containing 2,36,,,ppi
5427,6390,64184,EDDM3B,epididymal protein 3B,1,,,ppi
5428,6391,401152,C4orf3,chromosome 4 open reading frame 3,7,,,ppi
5429,6394,170384,FUT11,fucosyltransferase 11,23,alpha-(1->3)-fucosyltransferase activity,,ppi
5430,6395,84750,FUT10,fucosyltransferase 10,2,alpha-(1->3)-fucosyltransferase activity,,ppi
5431,6396,26574,AATF,apoptosis antagonizing transcription factor,75,RNA binding,,ppi
5432,6397,55041,PLEKHB2,pleckstrin homology domain containing B2,21,phosphatidylinositol-3;4;5-trisphosphate binding,,ppi
5433,6398,54187,NANS,N-acetylneuraminate synthase,58,N-acylneuraminate cytidylyltransferase activity|N-acylneuraminate-9-phosphate synthase activity,cerebellar disease|hypertrichosis|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|skin disease|seborrheic keratosis|actinic keratosis|craniosynostosis,ppi
5434,6399,26499,PLEK2,pleckstrin 2,3,,prostate cancer|prostate carcinoma,ppi
5435,6400,23208,SYT11,synaptotagmin 11,12,protein homodimerization activity|calcium ion binding|calcium-dependent phospholipid binding|clathrin binding|phosphatidylserine binding|SNARE binding,schizophrenia,ppi
5436,6401,84873,ADGRG7,adhesion G protein-coupled receptor G7,2,G-protein coupled receptor activity,,ppi
5437,6402,112574,SNX18,sorting nexin 18,24,phosphatidylinositol-4;5-bisphosphate binding,,ppi
5438,6403,54386,TERF2IP,TERF2 interacting protein,158,telomeric DNA binding|G-rich strand telomeric DNA binding,lymphatic system disease|melanoma|skin melanoma|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag|familial melanoma|dysplastic nevus syndrome,ppi
5439,6404,92912,UBE2Q2,ubiquitin conjugating enzyme E2 Q2,22,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,,ppi
5440,6405,1111,CHEK1,checkpoint kinase 1,108,protein kinase activity|protein serine/threonine kinase activity|kinase activity|histone kinase activity (H3-T11 specific),schizophrenia|breast cancer,ppi
5441,6406,9701,PPP6R2,protein phosphatase 6 regulatory subunit 2,64,,,ppi
5442,6407,51316,PLAC8,placenta specific 8,4,,,ppi
5443,6408,219348,PLAC9,placenta specific 9,4,,,ppi
5444,6409,64781,CERK,ceramide kinase,45,magnesium ion binding|ceramide kinase activity,,ppi
5445,6410,56413,LTB4R2,leukotriene B4 receptor 2,2,leukotriene receptor activity|leukotriene B4 receptor activity|G-protein coupled peptide receptor activity|galanin receptor activity,,ppi
5446,6411,25821,MTO1,mitochondrial tRNA translation optimization 1,25,RNA binding|flavin adenine dinucleotide binding,lactic acidosis|sick sinus syndrome|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|hypoglycemia|placental insufficiency|combined oxidative phosphorylation deficiency,ppi
5447,6412,89932,PAPLN,papilin; proteoglycan like sulfated glycoprotein,9,,,ppi
5448,6413,81562,LMAN2L,lectin; mannose binding 2 like,33,mannose binding,bipolar disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|schizophrenia,ppi
5449,6414,90019,SYT8,synaptotagmin 8,1,calcium-dependent phospholipid binding|phosphatidylserine binding|clathrin binding|syntaxin binding|SNARE binding|calcium ion binding,,ppi
5450,6415,143425,SYT9,synaptotagmin 9,6,syntaxin binding|clathrin binding|calcium ion binding|SNARE binding|phosphatidylserine binding|calcium-dependent phospholipid binding,,ppi
5451,6416,341359,SYT10,synaptotagmin 10,3,calcium ion binding|phosphatidylserine binding|SNARE binding|syntaxin binding|calcium-dependent phospholipid binding|clathrin binding,,ppi
5452,6417,266727,MDGA1,MAM domain containing glycosylphosphatidylinositol anchor 1,1,,bipolar disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
5453,6418,118424,UBE2J2,ubiquitin conjugating enzyme E2 J2,16,ubiquitin conjugating enzyme activity,,ppi
5454,6419,122651,RNASE11,ribonuclease A family member 11 (inactive),1,ribonuclease activity,,ppi
5455,6420,91875,TTC5,tetratricopeptide repeat domain 5,36,,,ppi
5456,6423,84659,RNASE7,ribonuclease A family member 7,21,lipopolysaccharide binding|ribonuclease activity|peptidoglycan binding,,ppi
5457,6424,1112,FOXN3,forkhead box N3,17,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5458,6425,64745,METTL17,methyltransferase like 17,31,,,ppi
5459,6426,57147,SCYL3,SCY1 like pseudokinase 3,11,kinase activity,,ppi
5460,6427,55681,SCYL2,SCY1 like pseudokinase 2,39,,,ppi
5461,6428,344387,CDKL4,cyclin dependent kinase like 4,9,cyclin-dependent protein serine/threonine kinase activity,,ppi
5462,6429,130013,ACMSD,aminocarboxymuconate semialdehyde decarboxylase,3,aminocarboxymuconate-semialdehyde decarboxylase activity|zinc ion binding,,ppi
5463,6430,1113,CHGA,chromogranin A,12,,lung cancer|non-small cell lung carcinoma|adrenal gland cancer|duodenum cancer|heart cancer|phaeochromocytoma|small intestine cancer|schizophrenia,ppi
5464,6431,114784,CSMD2,CUB and Sushi multiple domains 2,7,,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia,ppi
5465,6432,114788,CSMD3,CUB and Sushi multiple domains 3,1,,autistic disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|substance abuse|substance-related disorder,ppi
5466,6434,114783,LMTK3,lemur tyrosine kinase 3,2,,,ppi
5467,6435,285220,EPHA6,EPH receptor A6,5,protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity|transmembrane-ephrin receptor activity,,ppi
5468,6436,10188,TNK2,tyrosine kinase non receptor 2,85,protein serine/threonine/tyrosine kinase activity|protein tyrosine kinase activity|GTPase inhibitor activity|epidermal growth factor receptor binding|WW domain binding|non-membrane spanning protein tyrosine kinase activity,liver cancer,ppi
5469,6437,90809,TMEM55B,transmembrane protein 55B,9,phosphatidylinositol-4;5-bisphosphate 4-phosphatase activity,,ppi
5470,6438,8751,ADAM15,ADAM metallopeptidase domain 15,40,metalloendopeptidase activity|integrin binding|metallopeptidase activity,,ppi
5471,6439,1114,CHGB,chromogranin B,37,hormone activity,schizophrenia,ppi
5472,6440,415117,STX19,syntaxin 19,20,SNAP receptor activity|SNARE binding,,ppi
5473,6441,57466,SCAF4,SR-related CTD associated factor 4,32,RNA binding,,ppi
5474,6442,55676,SLC30A6,solute carrier family 30 member 6,20,zinc ion transmembrane transporter activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
5475,6443,148867,SLC30A7,solute carrier family 30 member 7,20,,esophageal cancer,ppi
5476,6444,221935,SDK1,sidekick cell adhesion molecule 1,7,identical protein binding,,ppi
5477,6445,54549,SDK2,sidekick cell adhesion molecule 2,10,,,ppi
5478,6446,23189,KANK1,KN motif and ankyrin repeat domains 1,24,beta-catenin binding,alcohol dependence|alcohol abuse|spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|intellectual disability|learning disability|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|locked-in syndrome|quadriplegia,ppi
5479,6447,415116,PIM3,Pim-3 proto-oncogene; serine/threonine kinase,5,protein serine/threonine kinase activity,,ppi
5480,6448,64067,NPAS3,neuronal PAS domain protein 3,2,DNA-binding transcription factor activity; RNA polymerase II-specific|protein heterodimerization activity,bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
5481,6449,55837,EAPP,E2F associated phosphoprotein,23,,,ppi
5482,6450,79931,TNIP3,TNFAIP3 interacting protein 3,25,polyubiquitin modification-dependent protein binding,,ppi
5483,6451,64175,P3H1,prolyl 3-hydroxylase 1,82,procollagen-proline 3-dioxygenase activity|protein-containing complex binding|collagen binding,osteogenesis imperfecta|Ehlers-Danlos syndrome|osteogenesis imperfecta type 1|osteogenesis imperfecta with opalescent teeth; blue sclerae and wormian bones but without fractures|osteogenesis imperfecta type 8|osteogenesis imperfecta type 7|osteogenesis imperfecta type 17|osteogenesis imperfecta type 3|osteogenesis imperfecta type 4|osteogenesis imperfecta type 2|osteogenesis imperfecta type 13|osteogenesis imperfecta type 14|osteogenesis imperfecta type 5|osteogenesis imperfecta type 16|osteogenesis imperfecta type 10|osteogenesis imperfecta type 15|osteogenesis imperfecta type 12|osteogenesis imperfecta type 9|osteogenesis imperfecta type 6|osteogenesis imperfecta type 11,ppi
5484,6452,55214,P3H2,prolyl 3-hydroxylase 2,12,procollagen-proline 3-dioxygenase activity,cataract,ppi
5485,6453,10536,P3H3,prolyl 3-hydroxylase 3,19,procollagen-proline 3-dioxygenase activity,arthropathy|arthritis,ppi
5486,6454,11314,CD300A,CD300a molecule,4,phosphatidylserine binding|phosphatidylethanolamine binding|signaling receptor activity,,ppi
5487,6455,1116,CHI3L1,chitinase 3 like 1,6,extracellular matrix structural constituent|chitin binding|chitinase activity,glioblastoma multiforme|giant cell glioblastoma|malignant glioma|gliosarcoma|mixed glioma|arthropathy|arthritis|schizophrenia,ppi
5488,6456,10871,CD300C,CD300c molecule,5,transmembrane signaling receptor activity,,ppi
5489,6458,22843,PPM1E,protein phosphatase; Mg2+/Mn2+ dependent 1E,29,protein serine/threonine phosphatase activity,large intestine cancer|colorectal cancer,ppi
5490,6459,54769,DIRAS2,DIRAS family GTPase 2,10,GTP binding,,ppi
5491,6460,1117,CHI3L2,chitinase 3 like 2,2,chitin binding|chitinase activity,,ppi
5492,6461,326625,MMAB,methylmalonic aciduria (cobalamin deficiency) cblB type,17,cob(I)yrinic acid a;c-diamide adenosyltransferase activity|cobalamin binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|methylmalonic acidemia cb1B type,ppi
5493,6462,285605,DTWD2,DTW domain containing 2,13,,,ppi
5494,6463,257218,SHPRH,SNF2 histone linker PHD RING helicase,18,ubiquitin-protein transferase activity|ubiquitin protein ligase binding|ubiquitin protein ligase activity,,ppi
5495,6464,23097,CDK19,cyclin dependent kinase 19,62,cyclin-dependent protein serine/threonine kinase activity,,ppi
5496,6465,340371,NRBP2,nuclear receptor binding protein 2,6,protein serine/threonine kinase activity,,ppi
5497,6467,266740,MAGEA2B,MAGE family member A2B,17,,,ppi
5498,6468,57118,CAMK1D,calcium/calmodulin dependent protein kinase ID,37,calmodulin binding|calmodulin-dependent protein kinase activity,,ppi
5499,6469,81849,ST6GALNAC5,ST6 N-acetylgalactosaminide alpha-2;6-sialyltransferase 5,3,alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase activity|sialyltransferase activity,rheumatoid arthritis,ppi
5500,6470,256435,ST6GALNAC3,ST6 N-acetylgalactosaminide alpha-2;6-sialyltransferase 3,14,alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase activity|sialyltransferase activity,,ppi
5501,6471,23258,DENND5A,DENN domain containing 5A,5,Rab guanyl-nucleotide exchange factor activity,,ppi
5502,6472,23316,CUX2,cut like homeobox 2,1,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding,bipolar disorder,ppi
5503,6473,51272,BET1L,Bet1 golgi vesicular membrane trafficking protein like,11,SNAP receptor activity,,ppi
5504,6474,55605,KIF21A,kinesin family member 21A,53,ATPase activity|microtubule motor activity|microtubule binding,monocular esotropia|esotropia|alternating exotropia|exotropia|monocular exotropia|lung small cell carcinoma|congenital fibrosis of the extraocular muscles,ppi
5505,6475,26511,CHIC2,cysteine rich hydrophobic domain 2,29,,acute myeloid leukemia,ppi
5506,6476,79070,KDELC1,KDEL motif containing 1,6,glucosyltransferase activity,,ppi
5507,6477,80114,BICC1,BicC family RNA binding protein 1,2,RNA binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
5508,6478,25942,SIN3A,SIN3 transcription regulator family member A,226,transcription regulatory region sequence-specific DNA binding|protein deacetylase activity|transcription corepressor activity|histone deacetylase activity,autistic disorder|cryptorchidism|sensorineural hearing loss|achondroplasia|Laron syndrome|enophthalmos|orbital disease|exophthalmos|placental insufficiency|inguinal hernia|polyhydramnios|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|hyperopia|hypogonadism|primary immunodeficiency disease|intestinal atresia|intellectual disability,ppi
5509,6479,23309,SIN3B,SIN3 transcription regulator family member B,70,histone deacetylase activity|transcription corepressor activity,,ppi
5510,6480,23210,JMJD6,arginine demethylase and lysine hydroxylase,131,RNA binding|single-stranded RNA binding|iron ion binding|histone demethylase activity|histone demethylase activity (H3-R2 specific)|histone demethylase activity (H4-R3 specific)|identical protein binding|peptidyl-lysine 5-dioxygenase activity,,ppi
5511,6481,51226,COPZ2,coatomer protein complex subunit zeta 2,3,,,ppi
5512,6482,79893,GGNBP2,gametogenetin binding protein 2,6,,,ppi
5513,6483,79087,ALG12,ALG12; alpha-1;6-mannosyltransferase,9,mannosyltransferase activity,congenital disorder of glycosylation type I,ppi
5514,6484,389941,C1QL3,complement C1q like 3,1,,,ppi
5515,6485,1118,CHIT1,chitinase 1,4,hydrolase activity; hydrolyzing O-glycosyl compounds|chitinase activity|chitin binding|endochitinase activity,Gaucher's disease,ppi
5516,6486,59349,KLHL12,kelch like family member 12,57,,,ppi
5517,6487,219790,RTKN2,rhotekin 2,6,GTP-Rho binding,schizophrenia,ppi
5518,6488,79646,PANK3,pantothenate kinase 3,1,pantothenate kinase activity|ATP binding|vitamin binding|protein homodimerization activity|acetyl-CoA binding,,ppi
5519,6489,55229,PANK4,pantothenate kinase 4,22,,,ppi
5520,6490,10144,FAM13A,family with sequence similarity 13 member A,7,GTPase activator activity,chronic obstructive pulmonary disease|idiopathic interstitial pneumonia|idiopathic pulmonary fibrosis,ppi
5521,6491,54768,HYDIN,HYDIN; axonemal central pair apparatus protein,2,,bronchiectasis|Kartagener syndrome|primary ciliary dyskinesia|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|primary ciliary dyskinesia 1|rhinitis,ppi
5522,6492,51535,PPHLN1,periphilin 1,57,RNA binding,,ppi
5523,6493,1119,CHKA,choline kinase alpha,6,choline kinase activity|ethanolamine kinase activity|drug binding,myelomeningocele|tethered spinal cord syndrome,ppi
5524,6494,220965,FAM13C,family with sequence similarity 13 member C,17,,,ppi
5525,6496,9540,TP53I3,tumor protein p53 inducible protein 3,10,NADPH:quinone reductase activity|quinone binding|NADPH binding,,ppi
5526,6497,55922,NKRF,NFKB repressing factor,40,RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA binding,,ppi
5527,6498,79085,SLC25A23,solute carrier family 25 member 23,18,ATP transmembrane transporter activity,,ppi
5528,6499,1120,CHKB,choline kinase beta,1,choline kinase activity|ethanolamine kinase activity,epilepsy|ichthyosis|intellectual disability|learning disability|familial periodic paralysis|myopathy|Balo concentric sclerosis|adrenoleukodystrophy|narcolepsy|central nervous system disease|visual epilepsy|Bell's palsy|facial paralysis|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D,ppi
5529,6500,8835,SOCS2,suppressor of cytokine signaling 2,24,SH3/SH2 adaptor activity|growth hormone receptor binding|1-phosphatidylinositol-3-kinase regulator activity,Balo concentric sclerosis|adrenoleukodystrophy|narcolepsy|central nervous system disease|schizophrenia|allergic contact dermatitis,ppi
5530,6501,8651,SOCS1,suppressor of cytokine signaling 1,66,protein kinase inhibitor activity|kinase inhibitor activity|1-phosphatidylinositol-3-kinase regulator activity,gallbladder disease|liver disease|allergic contact dermatitis,ppi
5531,6502,9647,PPM1F,protein phosphatase; Mg2+/Mn2+ dependent 1F,31,protein serine/threonine phosphatase activity|calmodulin-dependent protein phosphatase activity,,ppi
5532,6503,10752,CHL1,cell adhesion molecule L1 like,6,,ptosis|congenital ptosis|isolated cleft palate|cleft palate|cryptorchidism|sensorineural hearing loss|atrioventricular septal defect|placental insufficiency|schizophrenia|craniosynostosis|3p- syndrome|intellectual disability|learning disability,ppi
5533,6504,9021,SOCS3,suppressor of cytokine signaling 3,82,protein kinase inhibitor activity|1-phosphatidylinositol-3-kinase regulator activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|endometrial cancer|endometrial carcinoma|gallbladder disease|liver disease|atopic dermatitis 4|liver cancer|hepatocellular carcinoma,ppi
5534,6505,122809,SOCS4,suppressor of cytokine signaling 4,18,,,ppi
5535,6506,84547,PGBD1,piggyBac transposable element derived 1,24,,schizophrenia,ppi
5536,6507,267002,PGBD2,piggyBac transposable element derived 2,1,,,ppi
5537,6508,1121,CHM,CHM; Rab escort protein 1,81,Rab geranylgeranyltransferase activity|Rab GTPase binding,choroideremia|myopia|night blindness|congenital stationary night blindness|blindness,ppi
5538,6509,267004,PGBD3,piggyBac transposable element derived 3,3,,,ppi
5539,6511,124056,NOXO1,NADPH oxidase organizer 1,2,phospholipid binding|superoxide-generating NADPH oxidase activator activity|phosphatidylinositol binding,,ppi
5540,6512,79605,PGBD5,piggyBac transposable element derived 5,2,,,ppi
5541,6513,347730,LRRTM1,leucine rich repeat transmembrane neuronal 1,38,,schizophrenia,ppi
5542,6514,26045,LRRTM2,leucine rich repeat transmembrane neuronal 2,12,,,ppi
5543,6515,1122,CHML,CHM like; Rab escort protein 2,24,Rab GTPase binding,,ppi
5544,6517,80059,LRRTM4,leucine rich repeat transmembrane neuronal 4,2,,,ppi
5545,6518,51364,ZMYND10,zinc finger MYND-type containing 10,10,,bronchiectasis|bronchitis|Kartagener syndrome|primary ciliary dyskinesia|infertility|primary ciliary dyskinesia 1|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|rhinitis|sinusitis|tuberous sclerosis|Marfan syndrome|situs inversus|primary ciliary dyskinesia 22,ppi
5546,6519,283417,DPY19L2,dpy-19 like 2,2,mannosyltransferase activity,,ppi
5547,6520,342908,ZNF404,zinc finger protein 404,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5548,6522,161003,STOML3,stomatin like 3,3,,,ppi
5549,6523,84289,ING5,inhibitor of growth family member 5,51,methylated histone binding,,ppi
5550,6524,10474,TADA3,transcriptional adaptor 3,73,DNA-binding transcription factor activity|transcription coactivator activity|thiol-dependent ubiquitinyl hydrolase activity|histone acetyltransferase activity,,ppi
5551,6525,51147,ING4,inhibitor of growth family member 4,46,transcription coactivator activity|methylated histone binding,,ppi
5552,6526,55705,IPO9,importin 9,98,protein transporter activity|histone binding,,ppi
5553,6527,79711,IPO4,importin 4,67,protein transporter activity|nuclear localization sequence binding,,ppi
5554,6528,254428,SLC41A1,solute carrier family 41 member 1,4,magnesium ion transmembrane transporter activity|transmembrane transporter activity|magnesium:sodium antiporter activity|divalent inorganic cation transmembrane transporter activity,,ppi
5555,6529,1123,CHN1,chimerin 1,14,SH3/SH2 adaptor activity|GTPase activator activity,blepharophimosis|Duane retraction syndrome|enophthalmos|orbital disease|exophthalmos|sensorineural hearing loss|partial third-nerve palsy|total third-nerve palsy|oculomotor nerve paralysis|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
5556,6531,57820,CCNB1IP1,cyclin B1 interacting protein 1,13,,,ppi
5557,6532,338567,KCNK18,potassium two pore domain channel subfamily K member 18,2,potassium channel activity|outward rectifier potassium channel activity|potassium ion leak channel activity,migraine,ppi
5558,6533,1124,CHN2,chimerin 2,15,SH3/SH2 adaptor activity|GTPase activator activity,liver cancer,ppi
5559,6534,51119,SBDS,SBDS ribosome assembly guanine nucleotide exchange factor,62,RNA binding|microtubule binding|rRNA binding|ribosome binding,anemia|macrocytic anemia|dermatitis|ichthyosis|acute myeloid leukemia|intellectual disability|learning disability|calcium metabolism disease|nephrocalcinosis|calcinosis|hypercalcemia|phosphorus metabolism disease|pancytopenia|steatorrhea|thrombocytopenia|liver disease|placental insufficiency|exocrine pancreatic insufficiency|Shwachman-Diamond syndrome|essential thrombocythemia,ppi
5560,6535,84864,MINA,MYC induced nuclear antigen,26,histone demethylase activity,lung benign neoplasm,ppi
5561,6536,8646,CHRD,chordin,29,cytokine binding,,ppi
5562,6537,6868,ADAM17,ADAM metallopeptidase domain 17,29,metalloendopeptidase activity|Notch binding|metallopeptidase activity,blepharitis|colitis|ileitis|ileocolitis|gastroenteritis|hypereosinophilic syndrome|paronychia|granuloma annulare|meibomian cyst|hordeolum|skin disease|celiac disease,ppi
5563,6538,1128,CHRM1,cholinergic receptor muscarinic 1,6,phosphatidylinositol phospholipase C activity|neurotransmitter receptor activity|G-protein coupled acetylcholine receptor activity|G-protein coupled serotonin receptor activity|G-protein coupled receptor activity,brain ischemia|epilepsy|schizophrenia|visual epilepsy,ppi
5564,6539,1129,CHRM2,cholinergic receptor muscarinic 2,10,G-protein coupled acetylcholine receptor activity|neurotransmitter receptor activity|G-protein coupled serotonin receptor activity|G-protein coupled receptor activity,alcohol dependence|alcohol abuse|bipolar disorder|Cauda equina syndrome|neurogenic bladder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9,ppi
5565,6540,1131,CHRM3,cholinergic receptor muscarinic 3,57,phosphatidylinositol phospholipase C activity|G-protein coupled acetylcholine receptor activity|signaling receptor activity|acetylcholine binding|neurotransmitter receptor activity|G-protein coupled serotonin receptor activity|G-protein coupled receptor activity,imperforate anus|bipolar disorder|bladder disease|clubfoot|constipation|cryptorchidism|patent ductus arteriosus|congenital heart disease|hydronephrosis|liver cirrhosis|kidney failure|uremia|skin disease|seborrheic keratosis|actinic keratosis|neurotic disorder|endogenous depression|melancholia|vesicoureteral reflux|oligohydramnios,ppi
5566,6541,1132,CHRM4,cholinergic receptor muscarinic 4,58,neurotransmitter receptor activity|G-protein coupled receptor activity|G-protein coupled acetylcholine receptor activity|G-protein coupled serotonin receptor activity,schizophrenia,ppi
5567,6542,1133,CHRM5,cholinergic receptor muscarinic 5,1,phosphatidylinositol phospholipase C activity|G-protein coupled acetylcholine receptor activity|G-protein coupled receptor activity|neurotransmitter receptor activity|G-protein coupled serotonin receptor activity,cannabis dependence|cannabis abuse|schizophrenia|cocaine abuse|cocaine dependence,ppi
5568,6543,1134,CHRNA1,cholinergic receptor nicotinic alpha 1 subunit,4,ion channel activity|ligand-gated ion channel activity|acetylcholine-gated cation-selective channel activity|acetylcholine receptor activity|acetylcholine binding|extracellular ligand-gated ion channel activity,ptosis|congenital ptosis|isolated cleft palate|cleft palate|pseudosarcomatous fibromatosis|congestive heart failure|placental insufficiency|polyhydramnios|malignant hyperthermia|ophthalmoplegia|cystic lymphangioma|Bell's palsy|facial paralysis|congenital myasthenic syndrome|multiple pterygium syndrome|progressive bulbar palsy,ppi
5569,6544,1135,CHRNA2,cholinergic receptor nicotinic alpha 2 subunit,2,ligand-gated ion channel activity|acetylcholine receptor activity|acetylcholine-gated cation-selective channel activity|extracellular ligand-gated ion channel activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|visual epilepsy|autosomal dominant nocturnal frontal lobe epilepsy 4,ppi
5570,6547,1136,CHRNA3,cholinergic receptor nicotinic alpha 3 subunit,32,ligand-gated ion channel activity|acetylcholine receptor activity|acetylcholine-gated cation-selective channel activity|acetylcholine binding|extracellular ligand-gated ion channel activity,alcohol dependence|alcohol abuse|lung benign neoplasm|schizophrenia|epilepsy|visual epilepsy|nicotine dependence|cocaine abuse|cocaine dependence|morphine dependence,ppi
5571,6550,401994,OR14I1,olfactory receptor family 14 subfamily I member 1,1,olfactory receptor activity|odorant binding,,ppi
5572,6552,284521,OR2L13,olfactory receptor family 2 subfamily L member 13,1,olfactory receptor activity,,ppi
5573,6553,1137,CHRNA4,cholinergic receptor nicotinic alpha 4 subunit,10,ligand-gated ion channel activity|acetylcholine receptor activity|acetylcholine-gated cation-selective channel activity|acetylcholine binding|extracellular ligand-gated ion channel activity,alcohol dependence|alcohol abuse|autistic disorder|cocaine abuse|cocaine dependence|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|epilepsy|central nervous system disease|nervous system disease|autonomic neuropathy|schizophrenia|visual epilepsy|frontal lobe epilepsy|focal epilepsy,ppi
5574,6556,1138,CHRNA5,cholinergic receptor nicotinic alpha 5 subunit,11,ligand-gated ion channel activity|acetylcholine receptor activity|acetylcholine-gated cation-selective channel activity|acetylcholine binding|extracellular ligand-gated ion channel activity,alcohol dependence|alcohol abuse|anxiety disorder|phobic disorder|lung benign neoplasm|schizophrenia|epilepsy|visual epilepsy|nicotine dependence|substance abuse|substance-related disorder|cocaine abuse|cocaine dependence|morphine dependence,ppi
5575,6563,1139,CHRNA7,cholinergic receptor nicotinic alpha 7 subunit,6,,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|autistic disorder|bipolar disorder|idiopathic generalized epilepsy|lung benign neoplasm|intellectual disability,ppi
5576,6566,1140,CHRNB1,cholinergic receptor nicotinic beta 1 subunit,2,channel activity|ligand-gated ion channel activity|acetylcholine binding|acetylcholine receptor activity|acetylcholine-gated cation-selective channel activity|extracellular ligand-gated ion channel activity,ptosis|congenital ptosis|ophthalmoplegia|muscular atrophy|Bell's palsy|facial paralysis|congenital myasthenic syndrome,ppi
5577,6570,1141,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,6,ligand-gated ion channel activity|acetylcholine receptor activity|acetylcholine-gated cation-selective channel activity|acetylcholine binding|extracellular ligand-gated ion channel activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|anxiety disorder|phobic disorder|autistic disorder|epilepsy|schizophrenia,ppi
5578,6574,1142,CHRNB3,cholinergic receptor nicotinic beta 3 subunit,3,channel activity|ligand-gated ion channel activity|acetylcholine receptor activity|extracellular ligand-gated ion channel activity|acetylcholine binding,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|cocaine abuse|cocaine dependence|morphine dependence|nicotine dependence,ppi
5579,6576,1143,CHRNB4,cholinergic receptor nicotinic beta 4 subunit,6,ligand-gated ion channel activity|acetylcholine receptor activity|acetylcholine-gated cation-selective channel activity|extracellular ligand-gated ion channel activity|acetylcholine binding,alcohol dependence|alcohol abuse|lung benign neoplasm|epilepsy|visual epilepsy|cocaine abuse|cocaine dependence|morphine dependence,ppi
5580,6577,1144,CHRND,cholinergic receptor nicotinic delta subunit,54,ligand-gated ion channel activity|acetylcholine receptor activity|acetylcholine binding|extracellular ligand-gated ion channel activity,ptosis|congenital ptosis|isolated cleft palate|cleft palate|pseudosarcomatous fibromatosis|congestive heart failure|placental insufficiency|polyhydramnios|malignant hyperthermia|ophthalmoplegia|cystic lymphangioma|Bell's palsy|facial paralysis|congenital myasthenic syndrome|multiple pterygium syndrome,ppi
5581,6578,9486,CHST10,carbohydrate sulfotransferase 10,19,sulfotransferase activity|HNK-1 sulfotransferase activity,,ppi
5582,6579,60682,SMAP1,small ArfGAP 1,12,,,ppi
5583,6580,280658,SSX7,SSX family member 7,2,,,ppi
5584,6583,92736,OTOP2,otopetrin 2,1,proton channel activity,,ppi
5585,6585,285641,SLC36A3,solute carrier family 36 member 3,1,amino acid transmembrane transporter activity|proton transmembrane transporter activity|L-proline transmembrane transporter activity|glycine transmembrane transporter activity|L-alanine transmembrane transporter activity|amino acid:proton symporter activity,,ppi
5586,6586,1145,CHRNE,cholinergic receptor nicotinic epsilon subunit,2,cation transmembrane transporter activity|ligand-gated ion channel activity|acetylcholine receptor activity|extracellular ligand-gated ion channel activity|acetylcholine binding,ptosis|congenital ptosis|ophthalmoplegia|mechanical strabismus|hypertropia|muscular atrophy|Bell's palsy|facial paralysis|congenital myasthenic syndrome|progressive bulbar palsy,ppi
5587,6588,51086,TNNI3K,TNNI3 interacting kinase,8,protein kinase activity,atrial fibrillation|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
5588,6589,221357,GSTA5,glutathione S-transferase alpha 5,1,glutathione transferase activity,hypertension|essential hypertension,ppi
5589,6590,55970,GNG12,G protein subunit gamma 12,25,PDZ domain binding|phosphate ion binding,,ppi
5590,6591,94235,GNG8,G protein subunit gamma 8,5,GTPase activity|protein binding,gallbladder disease|liver disease,ppi
5591,6592,134957,STXBP5,syntaxin binding protein 5,12,syntaxin-1 binding|Rab GTPase binding|syntaxin binding|GTPase activator activity,,ppi
5592,6593,29091,STXBP6,syntaxin binding protein 6,15,cadherin binding involved in cell-cell adhesion|GTP-Rho binding|phosphatidylinositol-4;5-bisphosphate binding,autistic disorder,ppi
5593,6594,91833,WDR20,WD repeat domain 20,35,thiol-dependent ubiquitinyl hydrolase activity,,ppi
5594,6595,1146,CHRNG,cholinergic receptor nicotinic gamma subunit,12,channel activity|ligand-gated ion channel activity|acetylcholine receptor activity|acetylcholine binding|extracellular ligand-gated ion channel activity,ptosis|congenital ptosis|isolated cleft palate|cleft palate|clubfoot|pseudosarcomatous fibromatosis|cryptorchidism|diaphragmatic eventration|congestive heart failure|placental insufficiency|inguinal hernia|umbilical hernia|omphalocele|polyhydramnios|hypogonadism|malignant hyperthermia|syndactyly|cystic lymphangioma|congenital diaphragmatic hernia|Noonan syndrome 1,ppi
5595,6596,84073,MYCBPAP,MYCBP associated protein,6,,,ppi
5596,6597,51377,UCHL5,ubiquitin C-terminal hydrolase L5,204,RNA binding|thiol-dependent ubiquitin-specific protease activity|endopeptidase inhibitor activity|proteasome binding,,ppi
5597,6598,22848,AAK1,AP2 associated kinase 1,21,protein serine/threonine kinase activity|Notch binding|AP-2 adaptor complex binding,,ppi
5598,6599,1130,LYST,lysosomal trafficking regulator,35,,suppression amblyopia|amblyopia|anemia|macrocytic anemia|blood coagulation disease|Chediak-Higashi syndrome|Pelger-Huet anomaly|congestive heart failure|epilepsy|gingival disease|epulis|gingivitis|hemorrhagic disease|primary immunodeficiency disease|leukopenia|lymphosarcoma|lymphoma|central nervous system lymphoma|intellectual disability|learning disability,ppi
5599,6601,51207,DUSP13,dual specificity phosphatase 13,79,phosphatase activity,,ppi
5600,6602,83903,GSG2,germ cell associated 2; haspin,23,protein kinase activity|ATP binding|histone kinase activity (H3-T3 specific)|protein serine/threonine kinase activity,,ppi
5601,6603,127933,UHMK1,U2AF homology motif kinase 1,5,protein serine/threonine kinase activity|ATP binding|transferase activity|ribonucleoprotein complex binding,bipolar disorder|schizophrenia,ppi
5602,6605,22929,SEPHS1,selenophosphate synthetase 1,53,GTP binding|selenide; water dikinase activity,,ppi
5603,6606,22928,SEPHS2,selenophosphate synthetase 2,13,selenide; water dikinase activity,,ppi
5604,6607,440275,EIF2AK4,eukaryotic translation initiation factor 2 alpha kinase 4,29,tRNA binding|protein serine/threonine kinase activity|eukaryotic translation initiation factor 2alpha kinase activity|protein kinase activity,amino acid metabolic disorder|hair disease|primary pulmonary hypertension|pulmonary hypertension|immune system disease|familial periodic paralysis|myopathy|pulmonary venoocclusive disease,ppi
5605,6608,81607,NECTIN4,nectin cell adhesion molecule 4,21,cell adhesion molecule binding|signaling receptor activity|protein homodimerization activity,,ppi
5606,6609,343035,RD3,retinal degeneration 3,12,,Leber congenital amaurosis|Leber congenital amaurosis 12,ppi
5607,6610,8534,CHST1,carbohydrate sulfotransferase 1,2,sulfotransferase activity|keratan sulfotransferase activity|N-acetylglucosamine 6-O-sulfotransferase activity,,ppi
5608,6611,51102,MECR,mitochondrial trans-2-enoyl-CoA reductase,12,trans-2-enoyl-CoA reductase (NADPH) activity,,ppi
5609,6612,29982,NRBF2,nuclear receptor binding factor 2,29,,,ppi
5610,6613,51117,COQ4,coenzyme Q4,14,,,ppi
5611,6614,252983,STXBP4,syntaxin binding protein 4,28,,,ppi
5612,6615,9982,FGFBP1,fibroblast growth factor binding protein 1,5,heparin binding,,ppi
5613,6616,80273,GRPEL1,GrpE like 1; mitochondrial,54,unfolded protein binding|adenyl-nucleotide exchange factor activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
5614,6617,93107,KCNG4,potassium voltage-gated channel modifier subfamily G member 4,7,delayed rectifier potassium channel activity|voltage-gated potassium channel activity,,ppi
5615,6618,169522,KCNV2,potassium voltage-gated channel modifier subfamily V member 2,6,voltage-gated potassium channel activity,cone dystrophy,ppi
5616,6619,10769,PLK2,polo like kinase 2,49,protein serine/threonine kinase activity|ATP-dependent protein binding,,ppi
5617,6620,8728,ADAM19,ADAM metallopeptidase domain 19,8,metalloendopeptidase activity,,ppi
5618,6622,10256,CNKSR1,connector enhancer of kinase suppressor of Ras 1,30,protein binding; bridging,intellectual disability|learning disability,ppi
5619,6623,22866,CNKSR2,connector enhancer of kinase suppressor of Ras 2,19,,intellectual disability|learning disability,ppi
5620,6624,9883,POM121,POM121 transmembrane nucleoporin,60,structural constituent of nuclear pore|nuclear localization sequence binding,,ppi
5621,6625,25989,ULK3,unc-51 like kinase 3,7,protein serine/threonine kinase activity,,ppi
5622,6627,54507,ADAMTSL4,ADAMTS like 4,104,,cataract,ppi
5623,6628,197257,LDHD,lactate dehydrogenase D,40,flavin adenine dinucleotide binding|D-lactate dehydrogenase (cytochrome) activity|D-lactate dehydrogenase activity,,ppi
5624,6629,9469,CHST3,carbohydrate sulfotransferase 3,6,sulfotransferase activity|chondroitin 6-sulfotransferase activity|N-acetylglucosamine 6-O-sulfotransferase activity,suppression amblyopia|amblyopia|aortic valve insufficiency|aortic valve stenosis|isolated cleft palate|cleft palate|clubfoot|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|sensorineural hearing loss|monocular esotropia|esotropia|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5,ppi
5625,6631,84976,DISP1,dispatched RND transporter family member 1,3,peptide transmembrane transporter activity,holoprosencephaly,ppi
5626,6633,80821,DDHD1,DDHD domain containing 1,2,phospholipase activity,hereditary spastic paraplegia 28,ppi
5627,6634,63967,CLSPN,claspin,37,,,ppi
5628,6635,83445,GSG1,germ cell associated 1,3,,,ppi
5629,6636,59350,RXFP1,relaxin/insulin like family peptide receptor 1,9,G-protein coupled receptor activity|G-protein coupled peptide receptor activity,endometriosis of uterus|endometriosis,ppi
5630,6637,59352,LGR6,leucine rich repeat containing G protein-coupled receptor 6,1,transmembrane signaling receptor activity|G-protein coupled receptor activity,large intestine cancer|colorectal cancer|breast cancer,ppi
5631,6638,10164,CHST4,carbohydrate sulfotransferase 4,3,N-acetylglucosamine 6-O-sulfotransferase activity|sulfotransferase activity,,ppi
5632,6639,124583,CANT1,calcium activated nucleotidase 1,18,guanosine-diphosphatase activity|calcium ion binding|protein homodimerization activity|adenosine-diphosphatase activity|uridine-diphosphatase activity,Desbuquois dysplasia,ppi
5633,6641,317749,DHRS4L2,dehydrogenase/reductase 4 like 2,6,,,ppi
5634,6642,23214,XPO6,exportin 6,43,protein transporter activity,substance abuse|substance-related disorder,ppi
5635,6643,9852,EPM2AIP1,EPM2A interacting protein 1,21,,,ppi
5636,6645,23371,TNS2,tensin 2,115,,,ppi
5637,6647,1147,CHUK,conserved helix-loop-helix ubiquitous kinase,167,protein kinase activity|IkappaB kinase activity|protein homodimerization activity|protein heterodimerization activity|scaffold protein binding|protein serine/threonine kinase activity,isolated cleft palate|cleft palate|skin disease|umbilical hernia|omphalocele|cocoon syndrome,ppi
5638,6648,22990,PCNX1,pecanex homolog 1 (Drosophila),3,,,ppi
5639,6649,54813,KLHL28,kelch like family member 28,13,,,ppi
5640,6650,122769,LRR1,leucine rich repeat protein 1,25,,,ppi
5641,6651,29954,POMT2,protein O-mannosyltransferase 2,21,,imperforate anus|cleft lip|isolated cleft palate|cleft palate|coloboma|pseudosarcomatous fibromatosis|recurrent corneal erosion|cryptorchidism|Dandy-Walker syndrome|epilepsy|glaucoma|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|buphthalmos|hydrophthalmos|hyperopia|intellectual disability|learning disability,ppi
5642,6652,9901,SRGAP3,SLIT-ROBO Rho GTPase activating protein 3,24,GTPase activator activity|Rac GTPase binding,schizophrenia|astrocytoma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|juvenile astrocytoma|intellectual disability|learning disability,ppi
5643,6653,57089,ENTPD7,ectonucleoside triphosphate diphosphohydrolase 7,23,nucleoside-triphosphatase activity,,ppi
5644,6654,132884,EVC2,EvC ciliary complex subunit 2,85,,Ellis-Van Creveld syndrome,ppi
5645,6655,122970,ACOT4,acyl-CoA thioesterase 4,1,succinyl-CoA hydrolase activity|acyl-CoA hydrolase activity,,ppi
5646,6656,338917,VSX2,visual system homeobox 2,15,DNA-binding transcription factor activity; RNA polymerase II-specific,isolated microphthalmia 1|microphthalmia|isolated microphthalmia 2,ppi
5647,6657,57217,TTC7A,tetratricopeptide repeat domain 7A,4,,multiple intestinal atresia,ppi
5648,6658,23380,SRGAP2,SLIT-ROBO Rho GTPase activating protein 2,32,GTPase activator activity|protein homodimerization activity|Rac GTPase binding,,ppi
5649,6659,23360,FNBP4,formin binding protein 4,22,,,ppi
5650,6660,83982,IFI27L2,interferon alpha inducible protein 27 like 2,2,,,ppi
5651,6662,1149,CIDEA,cell death-inducing DFFA-like effector a,13,protein homodimerization activity,congestive heart failure|liver cancer|obesity,ppi
5652,6663,80230,RUFY1,RUN and FYVE domain containing 1,59,,,ppi
5653,6664,55680,RUFY2,RUN and FYVE domain containing 2,13,,,ppi
5654,6665,161882,ZFPM1,zinc finger protein; FOG family member 1,11,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II transcription factor binding,,ppi
5655,6666,142689,ASB12,ankyrin repeat and SOCS box containing 12,28,ubiquitin protein ligase activity,,ppi
5656,6667,388585,HES5,hes family bHLH transcription factor 5,2,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription factor binding|transcription corepressor activity|sequence-specific double-stranded DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|sequence-specific DNA binding,brain cancer|central nervous system disease|nervous system disease|autonomic neuropathy,ppi
5657,6668,79754,ASB13,ankyrin repeat and SOCS box containing 13,17,,,ppi
5658,6669,142686,ASB14,ankyrin repeat and SOCS box containing 14,21,,,ppi
5659,6670,142685,ASB15,ankyrin repeat and SOCS box containing 15,19,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
5660,6671,92591,ASB16,ankyrin repeat and SOCS box containing 16,25,,,ppi
5661,6672,127247,ASB17,ankyrin repeat and SOCS box containing 17,21,,,ppi
5662,6673,27141,CIDEB,cell death-inducing DFFA-like effector b,4,,,ppi
5663,6674,401036,ASB18,ankyrin repeat and SOCS box containing 18,23,,,ppi
5664,6675,2515,ADAM2,ADAM metallopeptidase domain 2,10,integrin binding|metallopeptidase activity,,ppi
5665,6676,8483,CILP,cartilage intermediate layer protein,3,extracellular matrix structural constituent|alkaline phosphatase activity|nucleotide diphosphatase activity,,ppi
5666,6677,54566,EPB41L4B,erythrocyte membrane protein band 4.1 like 4B,13,structural constituent of cytoskeleton,,ppi
5667,6678,57669,EPB41L5,erythrocyte membrane protein band 4.1 like 5,55,,,ppi
5668,6679,1153,CIRBP,cold inducible RNA binding protein,84,RNA binding|mRNA 3'-UTR binding|translation repressor activity|small ribosomal subunit rRNA binding|poly(U) RNA binding,coronary artery disease|autistic disorder,ppi
5669,6680,25949,SYF2,SYF2 pre-mRNA splicing factor,40,RNA binding,,ppi
5670,6681,283629,TSSK4,testis specific serine kinase 4,3,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
5671,6682,161424,NOP9,NOP9 nucleolar protein,53,RNA binding,breast cancer,ppi
5672,6683,283635,FAM177A1,family with sequence similarity 177 member A1,26,,,ppi
5673,6684,84916,UTP4,UTP4; small subunit processome component,40,RNA binding,,ppi
5674,6685,161198,CLEC14A,C-type lectin domain family 14 member A,5,extracellular matrix protein binding|extracellular matrix binding,,ppi
5675,6686,254170,FBXO33,F-box protein 33,12,,,ppi
5676,6689,122773,KLHDC1,kelch domain containing 1,3,,,ppi
5677,6690,145447,ABHD12B,abhydrolase domain containing 12B,1,,,ppi
5678,6691,122786,FRMD6,FERM domain containing 6,29,,,ppi
5679,6692,1154,CISH,cytokine inducible SH2 containing protein,31,1-phosphatidylinositol-3-kinase regulator activity,malaria|allergic contact dermatitis,ppi
5680,6693,93487,MAPK1IP1L,mitogen-activated protein kinase 1 interacting protein 1 like,25,,,ppi
5681,6694,387332,TBPL2,TATA-box binding protein like 2,8,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase III regulatory region DNA binding|transcription factor binding|RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
5682,6695,122830,NAA30,N(alpha)-acetyltransferase 30; NatC catalytic subunit,5,peptide alpha-N-acetyltransferase activity,,ppi
5683,6697,145407,C14orf37,chromosome 14 open reading frame 37,5,,,ppi
5684,6700,11113,CIT,citron rho-interacting serine/threonine kinase,22,protein serine/threonine kinase activity|PDZ domain binding|scaffold protein binding,syndromic X-linked intellectual disability 94|vesicoureteral reflux|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|septooptic dysplasia|microcephaly,ppi
5685,6701,91748,ELMSAN1,ELM2 and Myb/SANT domain containing 1,42,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding|transcription factor binding,,ppi
5686,6702,145483,FAM161B,family with sequence similarity 161 member B,4,,,ppi
5687,6703,80127,BBOF1,basal body orientation factor 1,1,,polycystic ovary syndrome,ppi
5688,6704,91750,LIN52,lin-52 DREAM MuvB core complex component,8,,,ppi
5689,6705,122961,ISCA2,iron-sulfur cluster assembly 2,4,2 iron; 2 sulfur cluster binding|4 iron; 4 sulfur cluster binding|iron ion binding,multiple mitochondrial dysfunctions syndrome 4,ppi
5690,6706,145567,TTC7B,tetratricopeptide repeat domain 7B,3,,,ppi
5691,6707,123036,TC2N,tandem C2 domains; nuclear,4,,,ppi
5692,6708,4435,CITED1,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1,13,chromatin binding|DNA-binding transcription factor activity|transcription coactivator activity|protein homodimerization activity|transcription regulatory region DNA binding|LBD domain binding,,ppi
5693,6710,145389,SLC38A6,solute carrier family 38 member 6,9,amino acid transmembrane transporter activity,,ppi
5694,6711,25833,POU2F3,POU class 2 homeobox 3,2,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
5695,6712,54799,MBTD1,mbt domain containing 1,31,methylated histone binding,,ppi
5696,6714,55715,DOK4,docking protein 4,44,,,ppi
5697,6715,91179,SCARF2,scavenger receptor class F member 2,9,,,ppi
5698,6716,10370,CITED2,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2,15,chromatin binding|DNA-binding transcription factor activity|transcription coactivator activity|transcription corepressor activity|histone acetyltransferase binding,cryptorchidism|enophthalmos|orbital disease|exophthalmos|placental insufficiency|heart septal defect|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|anterior horn cell disease|muscular atrophy,ppi
5699,6717,317705,VN1R5,vomeronasal 1 receptor 5 (gene/pseudogene),2,,,ppi
5700,6720,55568,GALNT10,polypeptide N-acetylgalactosaminyltransferase 10,5,polypeptide N-acetylgalactosaminyltransferase activity,,ppi
5701,6721,10902,BRD8,bromodomain containing 8,40,DNA-binding transcription factor activity|thyroid hormone receptor activity,endometriosis of uterus|endometriosis,ppi
5702,6722,63917,GALNT11,polypeptide N-acetylgalactosaminyltransferase 11,15,polypeptide N-acetylgalactosaminyltransferase activity|Notch binding,,ppi
5703,6723,80314,EPC1,enhancer of polycomb homolog 1,34,histone acetyltransferase activity,,ppi
5704,6724,79695,GALNT12,polypeptide N-acetylgalactosaminyltransferase 12,38,polypeptide N-acetylgalactosaminyltransferase activity,large intestine cancer|colorectal cancer,ppi
5705,6725,11117,EMILIN1,elastin microfibril interfacer 1,57,extracellular matrix constituent conferring elasticity|identical protein binding|integrin binding involved in cell-matrix adhesion,,ppi
5706,6726,84034,EMILIN2,elastin microfibril interfacer 2,7,extracellular matrix constituent conferring elasticity,,ppi
5707,6727,166793,ZBTB49,zinc finger and BTB domain containing 49,11,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
5708,6728,51361,HOOK1,hook microtubule tethering protein 1,31,dynein light intermediate chain binding|microtubule binding,,ppi
5709,6729,29911,HOOK2,hook microtubule tethering protein 2,52,microtubule binding|dynein light intermediate chain binding,,ppi
5710,6730,79812,MMRN2,multimerin 2,3,extracellular matrix structural constituent,,ppi
5711,6731,54475,NLE1,notchless homolog 1,37,,,ppi
5712,6732,1155,TBCB,tubulin folding cofactor B,46,,,ppi
5713,6733,79849,PDZD3,PDZ domain containing 3,17,ion channel inhibitor activity|guanylate cyclase inhibitor activity,,ppi
5714,6735,58485,TRAPPC1,trafficking protein particle complex 1,26,Rab guanyl-nucleotide exchange factor activity,,ppi
5715,6736,115362,GBP5,guanylate binding protein 5,8,protein homodimerization activity,,ppi
5716,6737,90135,BTBD6,BTB domain containing 6,6,,,ppi
5717,6738,83539,CHST9,carbohydrate sulfotransferase 9,5,N-acetylgalactosamine 4-O-sulfotransferase activity|chondroitin 4-sulfotransferase activity,,ppi
5718,6739,57623,ZFAT,zinc finger and AT-hook domain containing,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding,autoimmune thyroiditis,ppi
5719,6741,26586,CKAP2,cytoskeleton associated protein 2,37,,,ppi
5720,6742,10325,RRAGB,Ras related GTP binding B,36,GTPase activity|GTP binding|guanyl ribonucleotide binding|protein heterodimerization activity,,ppi
5721,6743,64121,RRAGC,Ras related GTP binding C,29,magnesium ion binding|GTPase activity|GTP binding|GDP binding|protein heterodimerization activity,,ppi
5722,6744,58528,RRAGD,Ras related GTP binding D,47,GTPase activity|GTP binding|GDP binding|protein heterodimerization activity,,ppi
5723,6745,55628,ZNF407,zinc finger protein 407,6,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5724,6746,113746,ODF3,outer dense fiber of sperm tails 3,1,,,ppi
5725,6748,54926,UBE2R2,ubiquitin conjugating enzyme E2 R2,38,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,,ppi
5726,6749,138716,RPP25L,ribonuclease P/MRP subunit p25 like,21,RNA binding,,ppi
5727,6750,1152,CKB,creatine kinase B,94,creatine kinase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|schizophrenia|stomach cancer|lung small cell carcinoma,ppi
5728,6751,65083,NOL6,nucleolar protein 6,52,RNA binding,,ppi
5729,6752,25853,DCAF12,DDB1 and CUL4 associated factor 12,17,,,ppi
5730,6753,347240,KIF24,kinesin family member 24,9,microtubule motor activity|ATPase activity|microtubule binding,,ppi
5731,6754,57462,KIAA1161,KIAA1161,15,hydrolase activity; hydrolyzing O-glycosyl compounds,,ppi
5732,6755,84688,C9orf24,chromosome 9 open reading frame 24,11,,,ppi
5733,6756,203259,FAM219A,family with sequence similarity 219 member A,31,,,ppi
5734,6757,1158,CKM,creatine kinase; M-type,25,creatine kinase activity,colon cancer|colonic benign neoplasm|ischemia|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction,ppi
5735,6758,282679,AQP11,aquaporin 11,1,water channel activity,,ppi
5736,6760,27095,TRAPPC3,trafficking protein particle complex 3,33,Rab guanyl-nucleotide exchange factor activity,,ppi
5737,6761,51399,TRAPPC4,trafficking protein particle complex 4,38,Rab guanyl-nucleotide exchange factor activity,,ppi
5738,6762,157922,CAMSAP1,calmodulin regulated spectrin associated protein 1,27,calmodulin binding|microtubule binding|spectrin binding|microtubule minus-end binding,,ppi
5739,6763,10248,POP7,POP7 homolog; ribonuclease P/MRP subunit,34,RNA binding|ribonuclease P activity,,ppi
5740,6764,1159,CKMT1B,creatine kinase; mitochondrial 1B,40,,,ppi
5741,6765,201299,RDM1,RAD52 motif containing 1,3,,,ppi
5742,6768,79751,SLC25A22,solute carrier family 25 member 22,33,amino acid:proton symporter activity|L-glutamate transmembrane transporter activity|L-aspartate transmembrane transporter activity,infantile epileptic encephalopathy|Ohtahara syndrome,ppi
5743,6769,9766,SUSD6,sushi domain containing 6,6,,,ppi
5744,6770,9895,TECPR2,tectonin beta-propeller repeat containing 2,11,,esophagitis|peptic esophagitis|gastroesophageal reflux disease|paraplegia|Troyer syndrome|Mast syndrome|MASA syndrome|SPOAN syndrome|Charcot-Marie-Tooth disease type 5|hereditary spastic paraplegia 10|hereditary spastic paraplegia 11|hereditary spastic paraplegia 12|hereditary spastic paraplegia 13|hereditary spastic paraplegia 14|hereditary spastic paraplegia 15|hereditary spastic paraplegia 16|hereditary spastic paraplegia 17|hereditary spastic paraplegia 18|hereditary spastic paraplegia 19|hereditary spastic paraplegia 2,ppi
5745,6771,9692,KIAA0391,KIAA0391,25,ribonuclease P activity,,ppi
5746,6772,23116,FAM179B,family with sequence similarity 179 member B,5,,,ppi
5747,6773,1160,CKMT2,creatine kinase; mitochondrial 2,14,creatine kinase activity,,ppi
5748,6774,9786,KIAA0586,KIAA0586,11,,anencephaly|cerebellar disease|isolated cleft palate|cleft palate|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|polyhydramnios|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain,ppi
5749,6775,23357,ANGEL1,angel homolog 1,12,eukaryotic initiation factor 4E binding|protein domain specific binding,,ppi
5750,6776,22863,ATG14,autophagy related 14,25,,,ppi
5751,6777,23093,TTLL5,tubulin tyrosine ligase like 5,17,tubulin-glutamic acid ligase activity,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|night blindness|congenital stationary night blindness|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|asthenopia,ppi
5752,6778,22846,VASH1,vasohibin 1,10,,,ppi
5753,6779,57544,TXNDC16,thioredoxin domain containing 16,26,,,ppi
5754,6780,57578,UNC79,unc-79 homolog (C. elegans),3,,,ppi
5755,6781,440193,CCDC88C,coiled-coil domain containing 88C,17,PDZ domain binding|protein self-association|microtubule binding|dynein light intermediate chain binding,,ppi
5756,6782,266812,NAP1L5,nucleosome assembly protein 1 like 5,31,,,ppi
5757,6783,10001,MED6,mediator complex subunit 6,57,transcription coactivator activity|RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,,ppi
5758,6784,112950,MED8,mediator complex subunit 8,64,RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
5759,6785,79789,CLMN,calmin,6,actin filament binding,,ppi
5760,6786,114822,RHPN1,rhophilin Rho GTPase binding protein 1,40,,polycystic ovary syndrome,ppi
5761,6787,85415,RHPN2,rhophilin Rho GTPase binding protein 2,17,,large intestine cancer|colorectal cancer,ppi
5762,6788,157506,RDH10,retinol dehydrogenase 10,2,retinol dehydrogenase activity|NADP-retinol dehydrogenase activity,,ppi
5763,6789,145226,RDH12,retinol dehydrogenase 12 (all-trans/9-cis/11-cis),23,retinol dehydrogenase activity|NADP-retinol dehydrogenase activity,retinal degeneration|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|Leber congenital amaurosis|fundus dystrophy|Leber congenital amaurosis 3|Leber congenital amaurosis 13,ppi
5764,6790,112724,RDH13,retinol dehydrogenase 13,33,NADP-retinol dehydrogenase activity,,ppi
5765,6791,57665,RDH14,retinol dehydrogenase 14 (all-trans/9-cis/11-cis),10,NADP-retinol dehydrogenase activity,,ppi
5766,6792,64841,GNPNAT1,glucosamine-phosphate N-acetyltransferase 1,17,glucosamine 6-phosphate N-acetyltransferase activity|monosaccharide binding,,ppi
5767,6793,401409,RAB19,RAB19; member RAS oncogene family,1,GTPase activity,,ppi
5768,6794,339122,RAB43,RAB43; member RAS oncogene family,3,GTPase activity,,ppi
5769,6795,10923,SUB1,SUB1 homolog; transcriptional regulator,81,single-stranded DNA binding|transcription coactivator activity|RNA binding,,ppi
5770,6796,54205,CYCS,cytochrome c; somatic,76,heme binding|electron transporter; transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity|protein serine/threonine phosphatase activity,brain ischemia|vertebrobasilar insufficiency|transient cerebral ischemia|fatty liver disease|ischemia|obesity|thrombocytopenia,ppi
5771,6797,284656,EPHA10,EPH receptor A10,5,protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity|transmembrane-ephrin receptor activity,,ppi
5772,6798,64682,ANAPC1,anaphase promoting complex subunit 1,76,ubiquitin protein ligase activity,alcohol dependence|alcohol abuse,ppi
5773,6799,29882,ANAPC2,anaphase promoting complex subunit 2,56,,,ppi
5774,6800,29945,ANAPC4,anaphase promoting complex subunit 4,56,ubiquitin-protein transferase activity|protein phosphatase binding,,ppi
5775,6801,64582,GPR135,G protein-coupled receptor 135,3,arrestin family protein binding,,ppi
5776,6804,353345,GPR141,G protein-coupled receptor 141,12,G-protein coupled receptor activity,,ppi
5777,6805,30000,TNPO2,transportin 2,68,nuclear localization sequence binding|protein transporter activity,polycystic ovary syndrome,ppi
5778,6806,16,AARS,alanyl-tRNA synthetase,59,aminoacyl-tRNA editing activity|alanine-tRNA ligase activity|amino acid binding|tRNA binding|ATP binding|Ser-tRNA(Ala) hydrolase activity,focal hand dystonia|blepharospasm|syndromic X-linked intellectual disability type 10|choreatic disease|placental insufficiency|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|polyneuropathy|peripheral nervous system disease|neuropathy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|axonal neuropathy|muscular atrophy|Charcot-Marie-Tooth disease axonal type 2N,ppi
5779,6807,8747,ADAM21,ADAM metallopeptidase domain 21,26,metallopeptidase activity,,ppi
5780,6808,1164,CKS2,CDC28 protein kinase regulatory subunit 2,34,protein kinase binding|cyclin-dependent protein serine/threonine kinase activator activity|histone binding|ubiquitin binding,polycystic ovary syndrome,ppi
5781,6809,255738,PCSK9,proprotein convertase subtilisin/kexin type 9,29,RNA binding|serine-type endopeptidase activity|sodium channel inhibitor activity|low-density lipoprotein particle binding|receptor inhibitor activity|apolipoprotein binding|very-low-density lipoprotein particle binding|apolipoprotein receptor binding|protein self-association|low-density lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding,familial hypercholesterolemia|coronary artery disease,ppi
5782,6810,26585,GREM1,gremlin 1; DAN family BMP antagonist,3,morphogen activity|transmembrane receptor protein tyrosine kinase activator activity|BMP binding|vascular endothelial growth factor receptor 2 binding|receptor ligand activity,large intestine cancer|colorectal cancer|familial adenomatous polyposis|islet cell tumor|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|stomach cancer,ppi
5783,6811,11056,DDX52,DExD-box helicase 52,45,RNA binding,,ppi
5784,6812,10486,CAP2,CAP; adenylate cyclase-associated protein; 2 (yeast),21,adenylate cyclase binding|actin binding,,ppi
5785,6813,10487,CAP1,adenylate cyclase associated protein 1,55,adenylate cyclase binding|actin binding,osteoporosis,ppi
5786,6814,79797,ZNF408,zinc finger protein 408,89,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|exudative vitreoretinopathy|retinitis pigmentosa 72,ppi
5787,6815,25929,GEMIN5,gem nuclear organelle associated protein 5,80,RNA 7-methylguanosine cap binding|RNA binding|mRNA 3'-UTR binding|snRNA binding|U1 snRNA binding|U4 snRNA binding|U4atac snRNA binding|ribosome binding,,ppi
5788,6816,79833,GEMIN6,gem nuclear organelle associated protein 6,29,,,ppi
5789,6817,79760,GEMIN7,gem nuclear organelle associated protein 7,35,,,ppi
5790,6818,23032,USP33,ubiquitin specific peptidase 33,45,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|zinc ion binding|thiol-dependent ubiquitinyl hydrolase activity|ubiquitin binding,,ppi
5791,6819,57478,USP31,ubiquitin specific peptidase 31,4,thiol-dependent ubiquitin-specific protease activity,,ppi
5792,6820,57558,USP35,ubiquitin specific peptidase 35,1,thiol-dependent ubiquitin-specific protease activity|cysteine-type endopeptidase activity,,ppi
5793,6821,57602,USP36,ubiquitin specific peptidase 36,38,RNA binding|thiol-dependent ubiquitin-specific protease activity|cysteine-type endopeptidase activity,,ppi
5794,6822,57695,USP37,ubiquitin specific peptidase 37,97,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
5795,6823,84101,USP44,ubiquitin specific peptidase 44,11,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
5796,6824,84749,USP30,ubiquitin specific peptidase 30,23,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
5797,6825,9736,USP34,ubiquitin specific peptidase 34,60,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
5798,6826,84640,USP38,ubiquitin specific peptidase 38,12,thiol-dependent ubiquitin-specific protease activity|cysteine-type endopeptidase activity,,ppi
5799,6827,84132,USP42,ubiquitin specific peptidase 42,36,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|cysteine-type endopeptidase activity,,ppi
5800,6828,55230,USP40,ubiquitin specific peptidase 40,1,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity,,ppi
5801,6829,373856,USP41,ubiquitin specific peptidase 41,1,,,ppi
5802,6830,10713,USP39,ubiquitin specific peptidase 39,99,,,ppi
5803,6831,124739,USP43,ubiquitin specific peptidase 43,33,ISG15-specific protease activity,,ppi
5804,6832,81609,SNX27,sorting nexin family member 27,74,phosphatidylinositol-3-phosphate binding|phosphatidylinositol binding,,ppi
5805,6833,9924,PAN2,PAN2 poly(A) specific ribonuclease subunit,344,3'-5'-exoribonuclease activity|poly(A)-specific ribonuclease activity,cholestasis,ppi
5806,6834,64854,USP46,ubiquitin specific peptidase 46,40,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|cysteine-type endopeptidase activity,bipolar disorder|schizophrenia|major depressive disorder|mental depression|endogenous depression|melancholia,ppi
5807,6835,55031,USP47,ubiquitin specific peptidase 47,85,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|ubiquitinyl hydrolase activity|cysteine-type endopeptidase activity,,ppi
5808,6836,25862,USP49,ubiquitin specific peptidase 49,51,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|histone binding,,ppi
5809,6837,373509,USP50,ubiquitin specific peptidase 50,28,thiol-dependent ubiquitin-specific protease activity,,ppi
5810,6838,85015,USP45,ubiquitin specific peptidase 45,31,thiol-dependent ubiquitin-specific protease activity,,ppi
5811,6840,317781,DDX51,DEAD-box helicase 51,32,RNA binding,malignant mesothelioma|benign mesothelioma,ppi
5812,6841,168400,DDX53,DEAD-box helicase 53,4,,,ppi
5813,6842,79039,DDX54,DEAD-box helicase 54,70,transcription corepressor activity|RNA binding|ATP-dependent RNA helicase activity|signaling receptor binding|estrogen receptor binding,liver cancer|polycystic ovary syndrome,ppi
5814,6843,57696,DDX55,DEAD-box helicase 55,22,RNA binding,,ppi
5815,6844,90957,DHX57,DExH-box helicase 57,60,RNA binding|ATP-dependent 3'-5' RNA helicase activity,,ppi
5816,6845,123016,TTC8,tetratricopeptide repeat domain 8,15,,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|Laurence-Moon syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 4|Bardet-Biedl syndrome 5|Bardet-Biedl syndrome 6|Bardet-Biedl syndrome 7|Bardet-Biedl syndrome 8|Bardet-Biedl syndrome 9|Bardet-Biedl syndrome 10|Bardet-Biedl syndrome 11|Bardet-Biedl syndrome 12|Bardet-Biedl syndrome 13|Bardet-Biedl syndrome 14|Bardet-Biedl syndrome 15,ppi
5817,6846,350383,GPR142,G protein-coupled receptor 142,1,,,ppi
5818,6847,64215,DNAJC1,DnaJ heat shock protein family (Hsp40) member C1,23,DNA-binding transcription factor activity; RNA polymerase II-specific|ATPase activator activity,melanoma|skin melanoma,ppi
5819,6848,122481,AK7,adenylate kinase 7,4,adenylate kinase activity|cytidylate kinase activity|nucleoside diphosphate kinase activity|nucleoside kinase activity,,ppi
5820,6849,55729,ATF7IP,activating transcription factor 7 interacting protein,92,,germ cell cancer|germ cell and embryonal cancer|embryonal cancer|testicular cancer,ppi
5821,6850,122622,ADSSL1,adenylosuccinate synthase like 1,4,adenylosuccinate synthase activity|GTP binding|phosphate ion binding,,ppi
5822,6851,122416,ANKRD9,ankyrin repeat domain 9,2,ion channel binding,,ppi
5823,6852,145376,PPP1R36,protein phosphatase 1 regulatory subunit 36,1,,,ppi
5824,6853,91612,CHURC1,churchill domain containing 1,5,,,ppi
5825,6854,53616,ADAM22,ADAM metallopeptidase domain 22,17,integrin binding,,ppi
5826,6855,161142,FAM71D,family with sequence similarity 71 member D,3,,,ppi
5827,6856,55640,FLVCR2,feline leukemia virus subgroup C cellular receptor family member 2,3,heme transporter activity|heme binding,pseudosarcomatous fibromatosis|Dandy-Walker syndrome|placental insufficiency|polyhydramnios|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain,ppi
5828,6857,283576,ZDHHC22,zinc finger DHHC-type containing 22,1,protein-cysteine S-palmitoyltransferase activity,,ppi
5829,6859,283600,SLC25A47,solute carrier family 25 member 47,2,acyl carnitine transmembrane transporter activity,,ppi
5830,6862,122402,TDRD9,tudor domain containing 9,2,ATPase activity|ATP-dependent 3'-5' RNA helicase activity|RNA binding,,ppi
5831,6863,374569,ASPG,asparaginase,1,asparaginase activity,anemia|macrocytic anemia|cholecystolithiasis|choledocholithiasis|leukopenia|thrombocytopenia|cholelithiasis,ppi
5832,6864,113146,AHNAK2,AHNAK nucleoprotein 2,22,,,ppi
5833,6865,122616,C14orf79,chromosome 14 open reading frame 79,1,clathrin binding,,ppi
5834,6866,283643,C14orf80,chromosome 14 open reading frame 80,19,,,ppi
5835,6867,1176,AP3S1,adaptor related protein complex 3 sigma 1 subunit,57,transporter activity,,ppi
5836,6869,51218,GLRX5,glutaredoxin 5,25,glutathione disulfide oxidoreductase activity|protein binding,anemia|macrocytic anemia|sideroblastic anemia,ppi
5837,6872,256281,NUDT14,nudix hydrolase 14,9,UDP-sugar diphosphatase activity,,ppi
5838,6873,57862,ZNF410,zinc finger protein 410,16,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5839,6874,4935,GPR143,G protein-coupled receptor 143,3,G-protein coupled receptor activity|dopamine binding|L-DOPA receptor activity|L-DOPA binding|tyrosine binding,suppression amblyopia|amblyopia|astigmatism|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|mechanical strabismus|hypertropia|blindness|asthenopia|ocular albinism,ppi
5840,6875,643866,CBLN3,cerebellin 3 precursor,3,,,ppi
5841,6876,51167,CYB5R4,cytochrome b5 reductase 4,1,cytochrome-b5 reductase activity; acting on NAD(P)H|NAD(P)H oxidase activity|oxidoreductase activity; acting on NAD(P)H; heme protein as acceptor,,ppi
5842,6878,145482,PTGR2,prostaglandin reductase 2,9,15-oxoprostaglandin 13-oxidase activity|zinc ion binding,,ppi
5843,6879,1179,CLCA1,chloride channel accessory 1,3,metalloendopeptidase activity|chloride channel activity|intracellular calcium activated chloride channel activity,,ppi
5844,6880,376267,RAB15,RAB15; member RAS oncogene family,7,GTPase activity,,ppi
5845,6882,85446,ZFHX2,zinc finger homeobox 2,1,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding|transcription regulatory region DNA binding,,ppi
5846,6883,57680,CHD8,chromodomain helicase DNA binding protein 8,63,p53 binding|DNA binding|DNA helicase activity|chromatin binding|ATP binding|beta-catenin binding|DNA-dependent ATPase activity|methylated histone binding|histone binding,autistic disorder|gastroenteritis|intestinal disease|gastrointestinal system disease|proctitis,ppi
5847,6884,63874,ABHD4,abhydrolase domain containing 4,2,hydrolase activity|carboxylic ester hydrolase activity,,ppi
5848,6885,55147,RBM23,RNA binding motif protein 23,48,RNA binding|mRNA binding|U1 snRNP binding,,ppi
5849,6886,84502,JPH4,junctophilin 4,57,calcium-release channel activity,,ppi
5850,6887,25831,HECTD1,HECT domain E3 ubiquitin protein ligase 1,61,,,ppi
5851,6888,9635,CLCA2,chloride channel accessory 2,3,metalloendopeptidase activity|chloride channel activity|intracellular calcium activated chloride channel activity,,ppi
5852,6889,9878,TOX4,TOX high mobility group box family member 4,57,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5853,6890,60686,C14orf93,chromosome 14 open reading frame 93,5,RNA binding,,ppi
5854,6891,54930,HAUS4,HAUS augmin like complex subunit 4,47,,,ppi
5855,6892,57594,HOMEZ,homeobox and leucine zipper encoding,34,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|DNA-binding transcription factor activity,,ppi
5856,6893,57523,NYNRIN,NYN domain and retroviral integrase containing,6,,,ppi
5857,6894,23351,KHNYN,KH and NYN domain containing,4,,,ppi
5858,6895,92703,TMEM183A,transmembrane protein 183A,3,,,ppi
5859,6896,55726,ASUN,asunder; spermatogenesis regulator,26,,,ppi
5860,6897,51026,GOLT1B,golgi transport 1B,174,,,ppi
5861,6898,339344,MYPOP,Myb related transcription factor; partner of profilin,3,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
5862,6900,55334,SLC39A9,solute carrier family 39 member 9,44,,,ppi
5863,6901,51528,JKAMP,JNK1/MAPK8-associated membrane protein,8,,,ppi
5864,6902,54916,TMEM260,transmembrane protein 260,8,,,ppi
5865,6903,55051,NRDE2,NRDE-2; necessary for RNA interference; domain containing,4,,,ppi
5866,6904,55102,ATG2B,autophagy related 2B,24,,lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia|myeloproliferative neoplasm|bone marrow cancer,ppi
5867,6905,55172,DNAAF2,dynein axonemal assembly factor 2,80,,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|tuberous sclerosis|Marfan syndrome|situs inversus|chronic sphenoidal sinusitis|chronic ethmoiditis|otitis media|primary ciliary dyskinesia 10,ppi
5868,6906,55195,C14orf105,chromosome 14 open reading frame 105,18,,,ppi
5869,6907,1180,CLCN1,chloride voltage-gated channel 1,8,voltage-gated chloride channel activity|protein homodimerization activity,congenital myopathy|myotonia congenita,ppi
5870,6908,55320,MIS18BP1,MIS18 binding protein 1,16,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
5871,6909,55745,AP5M1,adaptor related protein complex 5 mu 1 subunit,6,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
5872,6911,9533,POLR1C,RNA polymerase I subunit C,116,DNA-directed 5'-3' RNA polymerase activity|RNA polymerase III activity|RNA polymerase I activity,cerebellar disease|isolated cleft palate|cleft palate|tooth agenesis|anodontia|leukodystrophy|intellectual disability|learning disability|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|ophthalmoplegia|mechanical strabismus|hypertropia|blindness|Treacher Collins syndrome|hypogonadism|hypomyelinating leukodystrophy 7 with or without oligodontia and-or hypogonadotropic hypogonadism|hypomyelinating leukodystrophy 11,ppi
5873,6912,55343,SLC35C1,solute carrier family 35 member C1,1,GDP-fucose transmembrane transporter activity,epilepsy|gingival disease|epulis|otitis media|periodontal disease|periodontitis|pneumonia|visual epilepsy|syndromic X-linked intellectual disability 94|cerebral degeneration|leukocyte adhesion deficiency|congenital disorder of glycosylation type II,ppi
5874,6913,8745,ADAM23,ADAM metallopeptidase domain 23,5,integrin binding|metallopeptidase activity,,ppi
5875,6914,1181,CLCN2,chloride voltage-gated channel 2,26,voltage-gated chloride channel activity,childhood absence epilepsy|malignant glioma|gliosarcoma|mixed glioma|idiopathic generalized epilepsy|generalized epilepsy with febrile seizures plus|juvenile myoclonic epilepsy,ppi
5876,6915,55030,FBXO34,F-box protein 34,16,,,ppi
5877,6917,115677,NOSTRIN,nitric oxide synthase trafficking,6,,,ppi
5878,6918,145173,B3GLCT,beta 3-glucosyltransferase,19,transferase activity; transferring glycosyl groups|acetylglucosaminyltransferase activity,,ppi
5879,6919,92960,PEX11G,peroxisomal biogenesis factor 11 gamma,3,,,ppi
5880,6920,1182,CLCN3,chloride voltage-gated channel 3,12,chloride channel activity|PDZ domain binding|protein homodimerization activity|protein heterodimerization activity|volume-sensitive chloride channel activity|solute:proton antiporter activity|voltage-gated chloride channel activity|chloride ion binding,malignant glioma|gliosarcoma|mixed glioma|stomach cancer|nasopharynx carcinoma,ppi
5881,6921,55668,GPATCH2L,G-patch domain containing 2 like,38,,,ppi
5882,6922,51241,COX16,COX16; cytochrome c oxidase assembly homolog,7,,,ppi
5883,6923,55218,EXD2,exonuclease 3'-5' domain containing 2,17,single-stranded DNA 3'-5' exodeoxyribonuclease activity|3'-5' exonuclease activity,,ppi
5884,6925,55671,PPP4R3A,protein phosphatase 4 regulatory subunit 3A,69,,,ppi
5885,6927,51077,FCF1,FCF1 rRNA-processing protein,60,RNA binding,,ppi
5886,6928,83694,RPS6KL1,ribosomal protein S6 kinase like 1,2,,,ppi
5887,6930,8816,DCAF5,DDB1 and CUL4 associated factor 5,38,,,ppi
5888,6931,8193,DPF1,double PHD fingers 1,16,histone acetyltransferase activity|histone binding,,ppi
5889,6932,26153,KIF26A,kinesin family member 26A,4,microtubule binding|microtubule motor activity|ATPase activity,,ppi
5890,6933,26094,DCAF4,DDB1 and CUL4 associated factor 4,27,,,ppi
5891,6934,1184,CLCN5,chloride voltage-gated channel 5,10,chloride channel activity|antiporter activity|solute:proton antiporter activity|voltage-gated chloride channel activity|chloride ion binding,malignant glioma|gliosarcoma|mixed glioma|focal segmental glomerulosclerosis|goiter|nontoxic goiter|thyroid gland disease|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|calcium metabolism disease|calcinosis|osteomalacia|rickets|proteinuria|kidney failure|uremia|renal osteodystrophy|acute urate nephropathy|osteogenesis imperfecta,ppi
5892,6935,23588,KLHDC2,kelch domain containing 2,49,,,ppi
5893,6936,245806,VGLL2,vestigial like family member 2,3,transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding,melanoma|skin melanoma,ppi
5894,6937,51004,COQ6,coenzyme Q6; monooxygenase,33,,focal segmental glomerulosclerosis|sensorineural hearing loss|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|proteinuria|neurofibromatosis|neurilemmomatosis|coenzyme Q10 deficiency disease,ppi
5895,6938,51466,EVL,Enah/Vasp-like,50,profilin binding|SH3 domain binding,large intestine cancer|colorectal cancer|breast cancer,ppi
5896,6939,92359,CRB3,crumbs 3; cell polarity complex component,7,,,ppi
5897,6940,64838,FNDC4,fibronectin type III domain containing 4,19,,chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease,ppi
5898,6941,1185,CLCN6,chloride voltage-gated channel 6,5,voltage-gated chloride channel activity|antiporter activity|protein binding,,ppi
5899,6942,252995,FNDC5,fibronectin type III domain containing 5,9,,,ppi
5900,6943,54905,CYP2W1,cytochrome P450 family 2 subfamily W member 1,4,monooxygenase activity|steroid hydroxylase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|heme binding,,ppi
5901,6944,260293,CYP4X1,cytochrome P450 family 4 subfamily X member 1,1,,,ppi
5902,6945,84932,RAB2B,RAB2B; member RAS oncogene family,35,GTPase activity,,ppi
5903,6946,56257,MEPCE,methylphosphate capping enzyme,187,RNA binding|RNA methyltransferase activity|S-adenosylmethionine-dependent methyltransferase activity|O-methyltransferase activity|snRNA binding,,ppi
5904,6947,161253,REM2,RRAD and GEM like GTPase 2,1,GTP binding,,ppi
5905,6948,161742,SPRED1,sprouty related EVH1 domain containing 1,17,stem cell factor receptor binding|phosphatase binding|protein serine/threonine kinase inhibitor activity,neurofibromatosis,ppi
5906,6949,1186,CLCN7,chloride voltage-gated channel 7,27,chloride channel activity|voltage-gated chloride channel activity|protein binding,anemia|macrocytic anemia|arthropathy|arthritis|chronic rhinitis|craniosynostosis|sensorineural hearing loss|Bell's palsy|facial paralysis|facial nerve disease|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|osteoarthritis,ppi
5907,6950,84962,AJUBA,ajuba LIM protein,26,transcription corepressor activity|alpha-catenin binding,esophagus squamous cell carcinoma,ppi
5908,6951,257144,GCSAM,germinal center associated signaling and motility,1,,,ppi
5909,6952,23295,MGRN1,mahogunin ring finger 1,45,ubiquitin-protein transferase activity,,ppi
5910,6953,51460,SFMBT1,Scm-like with four mbt domains 1,26,transcription corepressor activity|histone binding,,ppi
5911,6954,57713,SFMBT2,Scm-like with four mbt domains 2,4,histone binding,,ppi
5912,6955,80344,DCAF11,DDB1 and CUL4 associated factor 11,41,,,ppi
5913,6956,22890,ZBTB1,zinc finger and BTB domain containing 1,105,DNA-binding transcription factor activity; RNA polymerase II-specific|protein homodimerization activity|protein heterodimerization activity|K63-linked polyubiquitin modification-dependent protein binding,,ppi
5914,6957,1187,CLCNKA,chloride voltage-gated channel Ka,1,voltage-gated chloride channel activity,congestive heart failure|sensorineural hearing loss|polyhydramnios|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypertension|essential hypertension|hypokalemia|intellectual disability|learning disability|kidney failure|uremia|Bartter disease type 4a|Bartter disease type 4b,ppi
5915,6958,26984,SEC22A,SEC22 homolog A; vesicle trafficking protein,15,transporter activity,,ppi
5916,6959,9818,NUP58,nucleoporin 58,46,nuclear localization sequence binding|structural constituent of nuclear pore,,ppi
5917,6960,221150,SKA3,spindle and kinetochore associated complex subunit 3,44,,,ppi
5918,6961,83852,SETDB2,SET domain bifurcated 2,13,histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K9 specific),,ppi
5919,6962,376132,LRRC10,leucine rich repeat containing 10,5,actin binding,,ppi
5920,6963,55608,ANKRD10,ankyrin repeat domain 10,5,,,ppi
5921,6964,29880,ALG5,ALG5; dolichyl-phosphate beta-glucosyltransferase,11,oligosaccharyl transferase activity|dolichyl-phosphate beta-glucosyltransferase activity,,ppi
5922,6967,55017,C14orf119,chromosome 14 open reading frame 119,4,,,ppi
5923,6968,25983,NGDN,neuroguidin,23,RNA binding,,ppi
5924,6970,51016,EMC9,ER membrane protein complex subunit 9,9,,,ppi
5925,6971,29082,CHMP4A,charged multivesicular body protein 4A,38,identical protein binding,,ppi
5926,6972,56948,SDR39U1,short chain dehydrogenase/reductase family 39U member 1,5,,,ppi
5927,6973,25938,HEATR5A,HEAT repeat containing 5A,7,,,ppi
5928,6974,112487,DTD2,D-tyrosyl-tRNA deacylase 2 (putative),3,Ala-tRNA(Thr) hydrolase activity|aminoacyl-tRNA editing activity|D-tyrosyl-tRNA(Tyr) deacylase activity,,ppi
5929,6975,80224,NUBPL,nucleotide binding protein like,5,4 iron; 4 sulfur cluster binding,mitochondrial myopathy|mitochondrial metabolism disease|mitochondrial complex I deficiency,ppi
5930,6976,26037,SIPA1L1,signal induced proliferation associated 1 like 1,29,,,ppi
5931,6977,54802,TRIT1,tRNA isopentenyltransferase 1,4,tRNA dimethylallyltransferase activity,,ppi
5932,6978,122011,CSNK1A1L,casein kinase 1 alpha 1 like,15,protein serine/threonine kinase activity,,ppi
5933,6979,81617,CAB39L,calcium binding protein 39 like,9,protein serine/threonine kinase activity,,ppi
5934,6980,80209,PROSER1,proline and serine rich 1,5,,,ppi
5935,6981,51719,CAB39,calcium binding protein 39,45,protein kinase activator activity|protein serine/threonine kinase activator activity|protein serine/threonine kinase activity,,ppi
5936,6983,10208,USPL1,ubiquitin specific peptidase like 1,27,SUMO binding|SUMO-specific isopeptidase activity|ubiquitin binding,,ppi
5937,6984,26050,SLITRK5,SLIT and NTRK like family member 5,4,,obsessive-compulsive disorder,ppi
5938,6985,22862,FNDC3A,fibronectin type III domain containing 3A,31,RNA binding,,ppi
5939,6986,114798,SLITRK1,SLIT and NTRK like family member 1,1,,Gilles de la Tourette syndrome|trichotillomania,ppi
5940,6987,55425,GPALPP1,GPALPP motifs containing 1,19,,,ppi
5941,6989,11339,OIP5,Opa interacting protein 5,44,,,ppi
5942,6991,85413,SLC22A16,solute carrier family 22 member 16,29,amine transmembrane transporter activity|organic cation transmembrane transporter activity|carnitine transmembrane transporter activity,bipolar disorder,ppi
5943,6992,169026,SLC30A8,solute carrier family 30 member 8,1,zinc ion transmembrane transporter activity|zinc ion binding|protein homodimerization activity,diabetes mellitus|type 2 diabetes mellitus|schizophrenia,ppi
5944,6994,142680,SLC34A3,solute carrier family 34 member 3,2,sodium:phosphate symporter activity|sodium-dependent phosphate transmembrane transporter activity,hereditary hypophosphatemic rickets with hypercalciuria,ppi
5945,6995,79596,RNF219,ring finger protein 219,34,,,ppi
5946,6996,23143,LRCH1,leucine rich repeats and calponin homology domain containing 1,12,,,ppi
5947,6997,79774,GRTP1,growth hormone regulated TBC protein 1,5,GTPase activator activity|Rab GTPase binding,,ppi
5948,6998,283489,CHAMP1,chromosome alignment maintaining phosphoprotein 1,36,,,ppi
5949,6999,51028,VPS36,vacuolar protein sorting 36 homolog,36,ubiquitin binding,,ppi
5950,7001,55015,PRPF39,pre-mRNA processing factor 39,17,pre-mRNA 5'-splice site binding,,ppi
5951,7002,83734,ATG10,autophagy related 10,18,Atg12 transferase activity,,ppi
5952,7003,83707,TRPT1,tRNA phosphotransferase 1,6,,,ppi
5953,7004,64093,SMOC1,SPARC related modular calcium binding 1,23,,microphthalmia with limb anomalies,ppi
5954,7005,9076,CLDN1,claudin 1,14,virus receptor activity|identical protein binding,alopecia|primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis|dental enamel hypoplasia|contact dermatitis|occupational dermatitis|endometriosis of uterus|endometriosis|hematopoietic system disease|tooth agenesis|anodontia|hypotrichosis|ichthyosis|breast cancer,ppi
5955,7006,55269,PSPC1,paraspeckle component 1,46,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding|E-box binding|transcription regulatory region sequence-specific DNA binding,,ppi
5956,7007,9724,UTP14C,UTP14; small subunit processome component homolog C (S. cerevisiae),11,,,ppi
5957,7008,85416,ZIC5,Zic family member 5,1,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
5958,7009,64094,SMOC2,SPARC related modular calcium binding 2,1,calcium ion binding,dentin dysplasia,ppi
5959,7010,23483,TGDS,TDP-glucose 4;6-dehydratase,8,,cleft lip|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|dextrocardia|epilepsy|placental insufficiency|ventricular septal defect|inguinal hernia|umbilical hernia|omphalocele|visual epilepsy|cystic lymphangioma|otitis media,ppi
5960,7011,29103,DNAJC15,DnaJ heat shock protein family (Hsp40) member C15,7,protein transporter activity|ATPase activator activity,melanoma|skin melanoma,ppi
5961,7012,64062,RBM26,RNA binding motif protein 26,46,RNA binding|mRNA binding,,ppi
5962,7013,55208,DCUN1D2,defective in cullin neddylation 1 domain containing 2,18,ubiquitin-like protein binding|ubiquitin conjugating enzyme binding|cullin family protein binding,,ppi
5963,7014,55002,TMCO3,transmembrane and coiled-coil domains 3,39,,,ppi
5964,7015,9071,CLDN10,claudin 10,3,identical protein binding,,ppi
5965,7016,51371,POMP,proteasome maturation protein,46,,ichthyosis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|autosomal recessive congenital ichthyosis 1|congenital ichthyosiform erythroderma|autosomal recessive congenital ichthyosis 2|autosomal recessive congenital ichthyosis 3|autosomal recessive congenital ichthyosis 4A|autosomal recessive congenital ichthyosis 5|autosomal recessive congenital ichthyosis 6|autosomal recessive congenital ichthyosis 7|autosomal recessive congenital ichthyosis 8|autosomal recessive congenital ichthyosis 9|autosomal recessive congenital ichthyosis 10,ppi
5966,7017,22821,RASA3,RAS p21 protein activator 3,10,calcium-release channel activity,,ppi
5967,7018,65110,UPF3A,UPF3 regulator of nonsense transcripts homolog A (yeast),43,structural constituent of nuclear pore|telomeric DNA binding|mRNA binding,,ppi
5968,7019,60592,SCOC,short coiled-coil protein,33,,,ppi
5969,7020,55632,G2E3,G2/M-phase specific E3 ubiquitin protein ligase,6,,,ppi
5970,7021,9069,CLDN12,claudin 12,5,identical protein binding,,ppi
5971,7022,166336,PRICKLE2,prickle planar cell polarity protein 2,4,,liver cancer,ppi
5972,7023,79683,ZDHHC14,zinc finger DHHC-type containing 14,1,palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,,ppi
5973,7025,51527,GSKIP,GSK3B interacting protein,6,protein kinase inhibitor activity|beta-catenin binding,lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia|myeloproliferative neoplasm|bone marrow cancer,ppi
5974,7026,55148,UBR7,ubiquitin protein ligase E3 component n-recognin 7 (putative),34,,intellectual disability|learning disability,ppi
5975,7027,55778,ZNF839,zinc finger protein 839,4,,,ppi
5976,7028,63894,VIPAS39,VPS33B interacting protein; apical-basolateral polarity regulator; spe-39 homolog,14,,ARC syndrome,ppi
5977,7029,64430,PCNX4,pecanex homolog 4 (Drosophila),4,,,ppi
5978,7031,78990,OTUB2,OTU deubiquitinase; ubiquitin aldehyde binding 2,43,thiol-dependent ubiquitin-specific protease activity|ubiquitin binding|NEDD8-specific protease activity,,ppi
5979,7032,79609,VCPKMT,valosin containing protein lysine methyltransferase,14,protein-lysine N-methyltransferase activity,,ppi
5980,7033,79696,ZC2HC1C,zinc finger C2HC-type containing 1C,23,,,ppi
5981,7034,84520,GON7,GON7; KEOPS complex subunit homolog,15,,,ppi
5982,7035,90141,EFCAB11,EF-hand calcium binding domain 11,3,calcium ion binding|microtubule binding,schizophrenia,ppi
5983,7036,145508,CEP128,centrosomal protein 128,273,,,ppi
5984,7037,24146,CLDN15,claudin 15,1,identical protein binding,,ppi
5985,7039,171546,SPTSSA,serine palmitoyltransferase small subunit A,5,serine C-palmitoyltransferase activity,,ppi
5986,7040,283638,CEP170B,centrosomal protein 170B,21,,,ppi
5987,7041,9870,AREL1,apoptosis resistant E3 ubiquitin protein ligase 1,14,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
5988,7042,26030,PLEKHG3,pleckstrin homology and RhoGEF domain containing G3,15,,,ppi
5989,7043,85457,CIPC,CLOCK interacting pacemaker,14,,,ppi
5990,7044,387914,SHISA2,shisa family member 2,3,,,ppi
5991,7045,10129,FRY,FRY microtubule binding protein,4,,intellectual disability|learning disability,ppi
5992,7046,23091,ZC3H13,zinc finger CCCH-type containing 13,59,RNA binding,,ppi
5993,7047,28984,RGCC,regulator of cell cycle,9,protein kinase binding|protein kinase activator activity,coronary artery disease,ppi
5994,7048,10686,CLDN16,claudin 16,2,magnesium ion transmembrane transporter activity|identical protein binding,renal tubular acidosis|astigmatism|epilepsy|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hyperopia|myopia|calcium metabolism disease|calcinosis|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|hypoparathyroidism|pseudohypoparathyroidism,ppi
5995,7049,121793,TEX29,testis expressed 29,18,,,ppi
5996,7050,126328,NDUFA11,NADH:ubiquinone oxidoreductase subunit A11,43,,mitochondrial complex I deficiency,ppi
5997,7051,54539,NDUFB11,NADH:ubiquinone oxidoreductase subunit B11,58,,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
5998,7052,51324,SPG21,spastic paraplegia 21 (autosomal recessive; Mast syndrome),41,,alcohol dependence|alcohol abuse|paraplegia|Mast syndrome,ppi
5999,7054,285362,SUMF1,sulfatase modifying factor 1,16,oxidoreductase activity|Formylglycine-generating oxidase activity|cupric ion binding,mucosulfatidosis,ppi
6000,7055,26285,CLDN17,claudin 17,1,identical protein binding,,ppi
6001,7056,259240,WFDC9,WAP four-disulfide core domain 9,4,,,ppi
6002,7057,55364,IMPACT,impact RWD domain protein,19,,bipolar disorder,ppi
6003,7059,56729,RETN,resistin,7,,diabetes mellitus|type 2 diabetes mellitus|congestive heart failure|opiate dependence|morphine dependence|heroin dependence|chronic kidney disease|metabolic syndrome X,ppi
6004,7060,51208,CLDN18,claudin 18,2,identical protein binding,,ppi
6005,7061,58472,SQRDL,sulfide quinone reductase-like (yeast),28,sulfide:quinone oxidoreductase activity|FAD binding,,ppi
6006,7062,23213,SULF1,sulfatase 1,6,arylsulfatase activity|N-acetylglucosamine-6-sulfatase activity|glycosaminoglycan binding,ovarian cancer,ppi
6007,7063,55959,SULF2,sulfatase 2,18,arylsulfatase activity|N-acetylglucosamine-6-sulfatase activity|glycosaminoglycan binding,endometriosis of uterus|endometriosis,ppi
6008,7064,84107,ZIC4,Zic family member 4,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
6009,7065,29992,PILRA,paired immunoglobin like type 2 receptor alpha,16,MHC class I protein binding,,ppi
6010,7066,80063,ATF7IP2,activating transcription factor 7 interacting protein 2,4,,,ppi
6011,7068,51030,TVP23B,trans-golgi network vesicle protein 23 homolog B,2,,,ppi
6012,7069,149461,CLDN19,claudin 19,3,identical protein binding,renal hypomagnesemia 5 with ocular involvement,ppi
6013,7070,286887,KRT6C,keratin 6C,22,,nonepidermolytic palmoplantar keratoderma,ppi
6014,7071,125972,CALR3,calreticulin 3,11,calcium ion binding,hypertrophic cardiomyopathy 19,ppi
6015,7072,9075,CLDN2,claudin 2,10,identical protein binding,acute pancreatitis|pancreatitis,ppi
6016,7073,165545,DQX1,DEAQ-box RNA dependent ATPase 1,12,ATP-dependent 3'-5' RNA helicase activity|RNA binding,,ppi
6017,7074,374454,KRT77,keratin 77,20,,,ppi
6018,7075,54474,KRT20,keratin 20,28,structural constituent of cytoskeleton,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|cecal benign neoplasm|cecum cancer|stomach cancer,ppi
6019,7076,25870,SUMF2,sulfatase modifying factor 2,10,,,ppi
6020,7077,23047,PDS5B,PDS5 cohesin associated factor B,45,DNA binding|ATP binding,,ppi
6021,7078,9684,LRRC14,leucine rich repeat containing 14,8,kinase binding,,ppi
6022,7079,49861,CLDN20,claudin 20,2,identical protein binding,,ppi
6023,7080,80183,RUBCNL,RUN and cysteine rich domain containing beclin 1 interacting protein like,10,,,ppi
6024,7081,222484,LNX2,ligand of numb-protein X 2,63,,,ppi
6025,7082,51082,POLR1D,RNA polymerase I subunit D,43,RNA polymerase I activity|DNA-directed 5'-3' RNA polymerase activity|RNA polymerase III activity,choanal atresia|isolated cleft palate|cleft palate|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|ophthalmoplegia|mechanical strabismus|hypertropia|blindness|substance abuse|substance-related disorder|Treacher Collins syndrome,ppi
6026,7083,55812,SPATA7,spermatogenesis associated 7,11,,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|Leber congenital amaurosis|Leber congenital amaurosis 3,ppi
6027,7084,51562,MBIP,MAP3K12 binding inhibitory protein 1,82,protein kinase inhibitor activity|molybdopterin synthase activity,,ppi
6028,7085,163223,ZNF676,zinc finger protein 676,1,DNA-binding transcription factor activity; RNA polymerase II-specific,goiter|thyroid gland disease,ppi
6029,7086,340205,TREML1,triggering receptor expressed on myeloid cells like 1,2,,,ppi
6030,7088,130872,AHSA2,activator of HSP90 ATPase homolog 2,4,,,ppi
6031,7090,65109,UPF3B,UPF3 regulator of nonsense transcripts homolog B (yeast),55,RNA binding|mRNA binding|structural constituent of nuclear pore,autistic disorder|syndromic X-linked intellectual disability 14,ppi
6032,7092,127018,LYPLAL1,lysophospholipase like 1,2,lysophospholipase activity|palmitoyl-(protein) hydrolase activity|carboxylic ester hydrolase activity,,ppi
6033,7093,140576,S100A16,S100 calcium binding protein A16,38,RNA binding|calcium ion binding,,ppi
6034,7094,64319,FBRS,fibrosin,23,growth factor activity,,ppi
6035,7095,9788,MTSS1,MTSS1; I-BAR domain containing,10,actin monomer binding,stomach cancer,ppi
6036,7096,55777,MBD5,methyl-CpG binding domain protein 5,20,chromatin binding|DNA binding,bipolar disorder|autosomal dominant non-syndromic intellectual disability,ppi
6037,7097,114785,MBD6,methyl-CpG binding domain protein 6,7,chromatin binding|DNA binding,,ppi
6038,7098,654790,PCP4L1,Purkinje cell protein 4 like 1,1,,,ppi
6039,7099,353238,PADI6,peptidyl arginine deiminase 6,1,protein-arginine deiminase activity,,ppi
6040,7100,1365,CLDN3,claudin 3,9,transmembrane signaling receptor activity,prostate cancer|prostate carcinoma|stomach cancer,ppi
6041,7102,57590,WDFY1,WD repeat and FYVE domain containing 1,34,1-phosphatidylinositol binding|zinc ion binding,,ppi
6042,7103,51141,INSIG2,insulin induced gene 2,36,,,ppi
6043,7104,55554,KLK15,kallikrein related peptidase 15,10,serine-type endopeptidase activity|serine-type peptidase activity,,ppi
6044,7105,84172,POLR1B,RNA polymerase I subunit B,65,DNA-directed 5'-3' RNA polymerase activity|RNA polymerase I activity,,ppi
6045,7106,55743,CHFR,checkpoint with forkhead and ring finger domains,62,nucleotide binding|ubiquitin-protein transferase activity,lung cancer|non-small cell lung carcinoma|endometrial cancer|endometrial carcinoma|stomach cancer,ppi
6046,7107,84231,TRAF7,TNF receptor associated factor 7,50,ubiquitin-protein transferase activity|zinc ion binding,malignant mesothelioma|benign mesothelioma,ppi
6047,7108,9781,RNF144A,ring finger protein 144A,25,ubiquitin protein ligase activity|ubiquitin conjugating enzyme binding,,ppi
6048,7110,1364,CLDN4,claudin 4,6,transmembrane signaling receptor activity|chloride channel activity|identical protein binding,polycystic ovary syndrome|invasive ductal carcinoma|breast cancer,ppi
6049,7112,29922,NME7,NME/NM23 family member 7,69,,substance abuse|substance-related disorder,ppi
6050,7113,23137,SMC5,structural maintenance of chromosomes 5,18,,,ppi
6051,7114,79677,SMC6,structural maintenance of chromosomes 6,54,,,ppi
6052,7115,7122,CLDN5,claudin 5,4,identical protein binding,schizophrenia,ppi
6053,7116,51690,LSM7,LSM7 homolog; U6 small nuclear RNA and mRNA degradation associated,40,U6 snRNA binding|RNA binding,,ppi
6054,7117,51691,LSM8,LSM8 homolog; U6 small nuclear RNA associated,68,RNA binding|U6 snRNA binding,,ppi
6055,7118,27257,LSM1,LSM1 homolog; mRNA degradation associated,42,RNA binding|RNA cap binding,,ppi
6056,7119,83990,BRIP1,BRCA1 interacting protein C-terminal helicase 1,33,DNA binding|ATP-dependent DNA helicase activity,breast cancer|Fanconi anemia|hereditary breast ovarian cancer syndrome|ovarian cancer,ppi
6057,7120,147138,TMC8,transmembrane channel like 8,2,ion channel activity|mechanosensitive ion channel activity,epidermodysplasia verruciformis,ppi
6058,7121,63904,DUSP21,dual specificity phosphatase 21,47,protein tyrosine phosphatase activity,,ppi
6059,7122,149708,WFDC5,WAP four-disulfide core domain 5,7,,,ppi
6060,7124,280664,WFDC10B,WAP four-disulfide core domain 10B,1,,,ppi
6061,7125,9074,CLDN6,claudin 6,1,virus receptor activity|identical protein binding,,ppi
6062,7127,115825,WDFY2,WD repeat and FYVE domain containing 2,26,,,ppi
6063,7128,219333,USP12,ubiquitin specific peptidase 12,35,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
6064,7129,337867,UBAC2,UBA domain containing 2,59,,Behcet's disease,ppi
6065,7130,122945,NOXRED1,NADP dependent oxidoreductase domain containing 1,1,,,ppi
6066,7131,112849,L3HYPDH,trans-L-3-hydroxyproline dehydratase,17,hydro-lyase activity|proline racemase activity,,ppi
6067,7132,112840,WDR89,WD repeat domain 89,11,,,ppi
6068,7133,1366,CLDN7,claudin 7,9,identical protein binding,prostate cancer|prostate carcinoma|ovarian cancer|ovarian carcinoma,ppi
6069,7135,84334,APOPT1,apoptogenic 1; mitochondrial,2,,,ppi
6070,7136,84193,SETD3,SET domain containing 3,19,transcription coactivator activity|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K36 specific)|protein-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K4 specific),,ppi
6071,7138,81892,SLIRP,SRA stem-loop interacting RNA binding protein,49,RNA binding,,ppi
6072,7139,80017,C14orf159,chromosome 14 open reading frame 159,7,D-glutamate cyclase activity,,ppi
6073,7140,79944,L2HGDH,L-2-hydroxyglutarate dehydrogenase,16,2-hydroxyglutarate dehydrogenase activity|(S)-2-hydroxy-acid oxidase activity,epilepsy|L-2-hydroxyglutaric aciduria|intellectual disability|learning disability,ppi
6074,7141,9073,CLDN8,claudin 8,4,identical protein binding,,ppi
6075,7143,283375,SLC39A5,solute carrier family 39 member 5,45,zinc ion transmembrane transporter activity,myopia,ppi
6076,7144,126961,HIST2H3C,histone cluster 2 H3 family member c,113,,,ppi
6077,7146,92815,HIST3H2A,histone cluster 3 H2A,11,DNA binding,,ppi
6078,7147,317772,HIST2H2AB,histone cluster 2 H2A family member b,59,DNA binding,,ppi
6079,7148,79882,ZC3H14,zinc finger CCCH-type containing 14,51,RNA binding|poly(A) binding,,ppi
6080,7150,121504,HIST4H4,histone cluster 4 H4,319,,,ppi
6081,7152,84312,BRMS1L,breast cancer metastasis-suppressor 1-like,27,histone deacetylase binding|histone deacetylase activity,,ppi
6082,7153,128312,HIST3H2BB,histone cluster 3 H2B family member b,17,DNA binding,,ppi
6083,7154,10143,CLEC3A,C-type lectin domain family 3 member A,41,,,ppi
6084,7155,386672,KRTAP10-4,keratin associated protein 10-4,7,,,ppi
6085,7157,386681,KRTAP10-8,keratin associated protein 10-8,153,,,ppi
6086,7158,386678,KRTAP10-11,keratin associated protein 10-11,15,,,ppi
6087,7159,353332,KRTAP12-1,keratin associated protein 12-1,12,,,ppi
6088,7160,9976,CLEC2B,C-type lectin domain family 2 member B,1,,,ppi
6089,7161,353323,KRTAP12-2,keratin associated protein 12-2,21,,,ppi
6090,7163,386684,KRTAP12-4,keratin associated protein 12-4,9,,,ppi
6091,7165,23601,CLEC5A,C-type lectin domain family 5 member A,18,virus receptor activity|protein binding,dengue hemorrhagic fever,ppi
6092,7166,64285,RHBDF1,rhomboid 5 homolog 1,4,serine-type endopeptidase activity,,ppi
6093,7167,55796,MBNL3,muscleblind like splicing regulator 3,7,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding,,ppi
6094,7169,9900,SV2A,synaptic vesicle glycoprotein 2A,10,protein kinase binding,schizophrenia,ppi
6095,7170,10201,NME6,NME/NM23 nucleoside diphosphate kinase 6,9,nucleoside diphosphate kinase activity,,ppi
6096,7171,23471,TRAM1,translocation associated membrane protein 1,19,signaling receptor activity,,ppi
6097,7172,57018,CCNL1,cyclin L1,18,cyclin-dependent protein serine/threonine kinase regulator activity,,ppi
6098,7173,81669,CCNL2,cyclin L2,55,cyclin-dependent protein serine/threonine kinase regulator activity,,ppi
6099,7174,116337,PANX3,pannexin 3,1,gap junction hemi-channel activity,,ppi
6100,7175,284541,CYP4A22,cytochrome P450 family 4 subfamily A member 22,1,laurate hydroxylase activity|16-hydroxypalmitate dehydrogenase activity|arachidonic acid omega-hydroxylase activity,,ppi
6101,7176,57404,CYP20A1,cytochrome P450 family 20 subfamily A member 1,4,,,ppi
6102,7179,56603,CYP26B1,cytochrome P450 family 26 subfamily B member 1,2,retinoic acid binding|retinoic acid 4-hydroxylase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen|heme binding,mouth disease|obesity|schizophrenia,ppi
6103,7180,113612,CYP2U1,cytochrome P450 family 2 subfamily U member 1,1,monooxygenase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|steroid hydroxylase activity|heme binding,hereditary spastic paraplegia 56,ppi
6104,7182,84912,SLC35B4,solute carrier family 35 member B4,3,UDP-N-acetylglucosamine transmembrane transporter activity|UDP-xylose transmembrane transporter activity|GDP-fucose transmembrane transporter activity|3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,,ppi
6105,7183,51449,PCYOX1,prenylcysteine oxidase 1,16,prenylcysteine oxidase activity,,ppi
6106,7184,56888,KCMF1,potassium channel modulatory factor 1,62,,,ppi
6107,7185,23339,VPS39,VPS39; HOPS complex subunit,23,,schizophrenia|breast cancer,ppi
6108,7186,51162,EGFL7,EGF like domain multiple 7,30,signaling receptor binding,,ppi
6109,7187,23281,MTUS2,microtubule associated tumor suppressor candidate 2,193,microtubule binding,,ppi
6110,7188,55578,SUPT20H,SPT20 homolog; SAGA complex component,29,,,ppi
6111,7189,51569,UFM1,ubiquitin fold modifier 1,81,,,ppi
6112,7190,83752,LONP2,lon peptidase 2; peroxisomal,20,peptidase activity,,ppi
6113,7191,142683,ITLN2,intelectin 2,3,,,ppi
6114,7192,10863,ADAM28,ADAM metallopeptidase domain 28,1,metallopeptidase activity,lung benign neoplasm,ppi
6115,7193,1047,CLGN,calmegin,37,,,ppi
6116,7194,151295,SLC23A3,solute carrier family 23 member 3,2,,schizophrenia,ppi
6117,7195,79947,DHDDS,dehydrodolichyl diphosphate synthase subunit,5,polyprenyltransferase activity,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|retinitis pigmentosa 59,ppi
6118,7196,22894,DIS3,DIS3 homolog; exosome endoribonuclease and 3'-5' exoribonuclease,57,3'-5'-exoribonuclease activity|endonuclease activity|guanyl-nucleotide exchange factor activity,,ppi
6119,7197,259173,ALS2CL,ALS2 C-terminal like,1,Rab guanyl-nucleotide exchange factor activity,schizophrenia,ppi
6120,7198,8100,IFT88,intraflagellar transport 88,60,kinesin binding,liver cancer|autosomal recessive polycystic kidney disease|polydactyly,ppi
6121,7199,387923,SERP2,stress associated endoplasmic reticulum protein family member 2,3,,,ppi
6122,7200,7965,AIMP2,aminoacyl tRNA synthetase complex interacting multifunctional protein 2,94,,,ppi
6123,7201,23239,PHLPP1,PH domain and leucine rich repeat protein phosphatase 1,86,protein serine/threonine phosphatase activity,,ppi
6124,7202,283652,SLC24A5,solute carrier family 24 member 5,3,calcium; potassium:sodium antiporter activity|calcium channel activity,,ppi
6125,7203,81550,TDRD3,tudor domain containing 3,33,chromatin binding|transcription coactivator activity|RNA binding|methylated histone binding,,ppi
6126,7204,163589,TDRD5,tudor domain containing 5,1,,,ppi
6127,7205,64780,MICAL1,microtubule associated monooxygenase; calponin and LIM domain containing 1,31,actin binding|monooxygenase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen|FAD binding,,ppi
6128,7206,1192,CLIC1,chloride intracellular channel 1,68,chloride channel activity|cadherin binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|arthropathy|arthritis|esophagus squamous cell carcinoma|breast cancer,ppi
6129,7208,341019,DCDC1,doublecortin domain containing 1,1,,,ppi
6130,7209,55636,CHD7,chromodomain helicase DNA binding protein 7,31,chromatin binding,alopecia|generalized anxiety disorder|anxiety disorder|autistic disorder|ptosis|congenital ptosis|choanal atresia|cleft lip|isolated cleft palate|cleft palate|coloboma|cryptorchidism|sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|double outlet right ventricle,ppi
6131,7210,284904,SEC14L4,SEC14 like lipid binding 4,8,,,ppi
6132,7211,51194,IPO11,importin 11,70,protein transporter activity,alcohol dependence|alcohol abuse,ppi
6133,7212,163051,ZNF709,zinc finger protein 709,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6134,7213,1193,CLIC2,chloride intracellular channel 2,6,glutathione peroxidase activity|glutathione transferase activity|chloride channel activity,epilepsy|congestive heart failure|visual epilepsy|X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome,ppi
6135,7214,84330,ZNF414,zinc finger protein 414,38,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6136,7215,23198,PSME4,proteasome activator subunit 4,37,peptidase activator activity|lysine-acetylated histone binding|proteasome binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
6137,7216,55786,ZNF415,zinc finger protein 415,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6138,7217,56896,DPYSL5,dihydropyrimidinase like 5,22,,,ppi
6139,7219,9022,CLIC3,chloride intracellular channel 3,10,chloride channel activity,,ppi
6140,7220,219855,SLC37A2,solute carrier family 37 member 2,1,glucose 6-phosphate:inorganic phosphate antiporter activity,,ppi
6141,7221,55659,ZNF416,zinc finger protein 416,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6142,7222,147687,ZNF417,zinc finger protein 417,69,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6143,7223,147686,ZNF418,zinc finger protein 418,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6144,7224,79744,ZNF419,zinc finger protein 419,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6145,7225,147923,ZNF420,zinc finger protein 420,18,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6146,7226,54102,CLIC6,chloride intracellular channel 6,4,D2 dopamine receptor binding|D3 dopamine receptor binding|D4 dopamine receptor binding,,ppi
6147,7227,84255,SLC37A3,solute carrier family 37 member 3,22,glucose 6-phosphate:inorganic phosphate antiporter activity,,ppi
6148,7228,79770,TXNDC15,thioredoxin domain containing 15,41,,,ppi
6149,7229,285195,SLC9A9,solute carrier family 9 member A9,1,sodium:proton antiporter activity|potassium:proton antiporter activity,autistic disorder,ppi
6150,7230,51735,RAPGEF6,Rap guanine nucleotide exchange factor 6,25,guanyl-nucleotide exchange factor activity|Ras GTPase binding|GTP-dependent protein binding|phosphatidic acid binding,schizophrenia,ppi
6151,7231,56951,C5orf15,chromosome 5 open reading frame 15,3,,,ppi
6152,7232,10103,TSPAN1,tetraspanin 1,2,,,ppi
6153,7233,10100,TSPAN2,tetraspanin 2,22,,,ppi
6154,7234,90139,TSPAN18,tetraspanin 18,2,,schizophrenia,ppi
6155,7235,115286,SLC25A26,solute carrier family 25 member 26,3,S-adenosyl-L-methionine transmembrane transporter activity,,ppi
6156,7236,29957,SLC25A24,solute carrier family 25 member 24,34,ATP transmembrane transporter activity|calcium ion binding,,ppi
6157,7238,94239,H2AFV,H2A histone family member V,44,DNA binding,,ppi
6158,7239,55800,SCN3B,sodium voltage-gated channel beta subunit 3,68,voltage-gated sodium channel activity|sodium channel regulator activity|voltage-gated sodium channel activity involved in cardiac muscle cell action potential|ion channel binding|sodium channel inhibitor activity,Brugada syndrome|Brugada syndrome 1|familial atrial fibrillation|Brugada syndrome 7,ppi
6159,7242,128239,IQGAP3,IQ motif containing GTPase activating protein 3,27,,,ppi
6160,7243,9124,PDLIM1,PDZ and LIM domain 1,34,cadherin binding involved in cell-cell adhesion,,ppi
6161,7244,117581,TWIST2,twist family bHLH transcription factor 2,10,,Barber-Say syndrome|ablepharon macrostomia syndrome,ppi
6162,7245,23133,PHF8,PHD finger protein 8,62,chromatin binding|iron ion binding|zinc ion binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors|histone demethylase activity|histone demethylase activity (H3-K9 specific)|methylated histone binding|histone demethylase activity (H4-K20 specific)|histone demethylase activity (H3-K36 specific)|histone demethylase activity (H3-K27 specific),cleft lip|cryptorchidism|intellectual disability|learning disability|syndromic X-linked intellectual disability Siderius type,ppi
6163,7246,390443,RNASE9,ribonuclease A family member 9 (inactive),1,ribonuclease activity,,ppi
6164,7247,84735,CNDP1,carnosine dipeptidase 1,15,dipeptidase activity,intellectual disability|learning disability,ppi
6165,7248,124626,ZPBP2,zona pellucida binding protein 2,13,,,ppi
6166,7249,338440,ANO9,anoctamin 9,2,intracellular calcium activated chloride channel activity,,ppi
6167,7250,1195,CLK1,CDC like kinase 1,167,protein serine/threonine kinase activity|non-membrane spanning protein tyrosine kinase activity,,ppi
6168,7251,65065,NBEAL1,neurobeachin like 1,9,,,ppi
6169,7252,150696,PROM2,prominin 2,1,cholesterol binding,,ppi
6170,7253,139135,PASD1,PAS domain containing 1,2,,,ppi
6171,7254,1196,CLK2,CDC like kinase 2,98,protein serine/threonine kinase activity,,ppi
6172,7255,155054,ZNF425,zinc finger protein 425,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6173,7256,121278,TPH2,tryptophan hydroxylase 2,3,,autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia|paranoid schizophrenia|delusional disorder|substance abuse|substance-related disorder|alcohol abuse|mood disorder|cocaine abuse|cocaine dependence|morphine dependence,ppi
6174,7257,30010,NXPH1,neurexophilin 1,1,signaling receptor binding,,ppi
6175,7258,54466,SPIN2A,spindlin family member 2A,4,methylated histone binding,,ppi
6176,7259,55140,ELP3,elongator acetyltransferase complex subunit 3,41,phosphorylase kinase regulator activity|acetyltransferase activity|RNA polymerase II complex binding,,ppi
6177,7260,11086,ADAM29,ADAM metallopeptidase domain 29,1,metallopeptidase activity,,ppi
6178,7261,116138,KLHDC3,kelch domain containing 3,52,chromatin binding,,ppi
6179,7262,93377,OPALIN,oligodendrocytic myelin paranodal and inner loop protein,1,,,ppi
6180,7263,79811,SLTM,SAFB like transcription modulator,31,RNA binding|sequence-specific DNA binding,,ppi
6181,7264,1198,CLK3,CDC like kinase 3,89,RNA binding|protein serine/threonine kinase activity,,ppi
6182,7265,79413,ZBED2,zinc finger BED-type containing 2,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6183,7266,84327,ZBED3,zinc finger BED-type containing 3,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6184,7267,84243,ZDHHC18,zinc finger DHHC-type containing 18,16,palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,,ppi
6185,7268,131540,ZDHHC19,zinc finger DHHC-type containing 19,1,protein-cysteine S-palmitoyltransferase activity,,ppi
6186,7269,84287,ZDHHC16,zinc finger DHHC-type containing 16,2,palmitoyltransferase activity,,ppi
6187,7270,58526,MID1IP1,MID1 interacting protein 1,12,,,ppi
6188,7271,64837,KLC2,kinesin light chain 2,74,kinesin binding|cadherin binding,SPOAN syndrome,ppi
6189,7272,147700,KLC3,kinesin light chain 3,72,,,ppi
6190,7273,161725,OTUD7A,OTU deubiquitinase 7A,2,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|K63-linked polyubiquitin modification-dependent protein binding,,ppi
6191,7274,9889,ZBED4,zinc finger BED-type containing 4,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6192,7275,79088,ZNF426,zinc finger protein 426,18,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6193,7276,23256,SCFD1,sec1 family domain containing 1,59,syntaxin binding,progressive muscular atrophy|amyotrophic lateral sclerosis,ppi
6194,7277,23315,SLC9A8,solute carrier family 9 member A8,1,sodium:proton antiporter activity|potassium:proton antiporter activity,,ppi
6195,7278,285231,FBXW12,F-box and WD repeat domain containing 12,3,ubiquitin-protein transferase activity,,ppi
6196,7279,1200,TPP1,tripeptidyl peptidase 1,29,endopeptidase activity|peptidase activity|serine-type peptidase activity|tripeptidyl-peptidase activity|peptide binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|cerebellar disease|epilepsy|focal hand dystonia|blepharospasm|early myoclonic encephalopathy,ppi
6197,7280,80210,ARMC9,armadillo repeat containing 9,9,,,ppi
6198,7281,59345,GNB4,G protein subunit beta 4,68,protein-containing complex binding,large intestine cancer|colorectal cancer|Charcot-Marie-Tooth disease dominant intermediate F,ppi
6199,7282,84447,SYVN1,synoviolin 1,95,ubiquitin protein ligase activity|ubiquitin-specific protease binding|unfolded protein binding,,ppi
6200,7283,253430,IPMK,inositol polyphosphate multikinase,1,inositol tetrakisphosphate 3-kinase activity|inositol tetrakisphosphate 6-kinase activity|inositol-1;4;5-trisphosphate 3-kinase activity|inositol tetrakisphosphate 5-kinase activity,,ppi
6201,7284,1201,CLN3,CLN3; battenin,91,unfolded protein binding,generalized anxiety disorder|anxiety disorder|epilepsy|retinitis pigmentosa 30|age related macular degeneration|macular degeneration|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|neuronal ceroid lipofuscinosis 4B|neuronal ceroid lipofuscinosis 1|neuronal ceroid lipofuscinosis 7|neuronal ceroid lipofuscinosis 8|neuronal ceroid lipofuscinosis 8 northern epilepsy variant|neuronal ceroid lipofuscinosis 10|neuronal ceroid lipofuscinosis 2|neuronal ceroid lipofuscinosis 13,ppi
6202,7285,84553,FAXC,failed axon connections homolog,5,,,ppi
6203,7286,151354,FAM84A,family with sequence similarity 84 member A,1,,polycystic ovary syndrome,ppi
6204,7287,83667,SESN2,sestrin 2,14,oxidoreductase activity; acting on peroxide as acceptor|sulfiredoxin activity|leucine binding,,ppi
6205,7288,55120,FANCL,Fanconi anemia complementation group L,40,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,anemia|macrocytic anemia|esophageal atresia|Fanconi anemia|leukopenia|intellectual disability|learning disability|thrombocytopenia|capillary hemangioma,ppi
6206,7289,253832,ZDHHC20,zinc finger DHHC-type containing 20,2,zinc ion binding|palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,,ppi
6207,7290,340481,ZDHHC21,zinc finger DHHC-type containing 21,8,palmitoyltransferase activity|protein-cysteine S-palmitoyltransferase activity,,ppi
6208,7291,23001,WDFY3,WD repeat and FYVE domain containing 3,63,1-phosphatidylinositol binding,,ppi
6209,7292,113829,SLC35A4,solute carrier family 35 member A4,1,sialic acid transmembrane transporter activity,,ppi
6210,7293,57113,TRPC7,transient receptor potential cation channel subfamily C member 7,4,calcium channel activity|store-operated calcium channel activity|inositol 1;4;5 trisphosphate binding,bipolar disorder,ppi
6211,7294,9765,ZFYVE16,zinc finger FYVE-type containing 16,11,1-phosphatidylinositol binding|phosphatidylinositol-3;4;5-trisphosphate binding|protein transporter activity,,ppi
6212,7295,79666,PLEKHF2,pleckstrin homology and FYVE domain containing 2,67,phosphatidylinositol binding,,ppi
6213,7296,84936,ZFYVE19,zinc finger FYVE-type containing 19,43,phosphatidylinositol-3-phosphate binding,,ppi
6214,7297,64145,RBSN,rabenosyn; RAB effector,24,zinc ion binding,,ppi
6215,7298,1203,CLN5,ceroid-lipofuscinosis; neuronal 5,42,mannose binding,epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|retinal degeneration|visual epilepsy|agnosia|neuronal ceroid lipofuscinosis 5,ppi
6216,7299,79038,ZFYVE21,zinc finger FYVE-type containing 21,24,,,ppi
6217,7300,23503,ZFYVE26,zinc finger FYVE-type containing 26,22,phosphatidylinositol-3-phosphate binding,cerebellar disease|retinitis pigmentosa 30|age related macular degeneration|macular degeneration|intellectual disability|learning disability|schizophreniform disorder|schizoaffective disorder|paraplegia|blindness|hereditary spastic paraplegia 15,ppi
6218,7301,51479,ANKFY1,ankyrin repeat and FYVE domain containing 1,41,Rab GTPase binding|phosphatidylinositol phosphate binding,urinary bladder cancer,ppi
6219,7302,79156,PLEKHF1,pleckstrin homology and FYVE domain containing 1,3,phosphatidylinositol-5-phosphate binding|phosphatidylinositol-3-phosphate binding|phosphatidylinositol-4-phosphate binding|phosphatidylinositol binding,ovarian cancer,ppi
6220,7303,112714,TUBA3E,tubulin alpha 3e,23,structural constituent of cytoskeleton|GTP binding,,ppi
6221,7304,7846,TUBA1A,tubulin alpha 1a,397,structural molecule activity|structural constituent of cytoskeleton|GTP binding,cerebellar disease|epilepsy|visual epilepsy|syndromic X-linked intellectual disability 94|coronary artery disease|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|septooptic dysplasia|locked-in syndrome|quadriplegia,ppi
6222,7305,27295,PDLIM3,PDZ and LIM domain 3,14,,,ppi
6223,7306,84790,TUBA1C,tubulin alpha 1c,231,structural molecule activity|GTP binding|structural constituent of cytoskeleton,stomach cancer,ppi
6224,7307,54982,CLN6,ceroid-lipofuscinosis; neuronal 6; late infantile; variant,11,protein homodimerization activity,cerebellar disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|basal ganglia disease|focal hand dystonia|blepharospasm|neuronal ceroid lipofuscinosis 4B|neuronal ceroid lipofuscinosis 1|neuronal ceroid lipofuscinosis 7|neuronal ceroid lipofuscinosis 8|neuronal ceroid lipofuscinosis 8 northern epilepsy variant|neuronal ceroid lipofuscinosis 10|neuronal ceroid lipofuscinosis 2|neuronal ceroid lipofuscinosis 13|neuronal ceroid lipofuscinosis 5,ppi
6225,7308,10383,TUBB4B,tubulin beta 4B class IVb,181,double-stranded RNA binding|MHC class I protein binding|unfolded protein binding|structural constituent of cytoskeleton|GTP binding,,ppi
6226,7309,10381,TUBB3,tubulin beta 3 class III,305,GTP binding|structural constituent of cytoskeleton,suppression amblyopia|amblyopia|ptosis|congenital ptosis|alternating exotropia|exotropia|monocular exotropia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|mechanical strabismus|hypertropia|ovarian cancer|breast cancer|congenital fibrosis of the extraocular muscles,ppi
6227,7310,347688,TUBB8,tubulin beta 8 class VIII,99,GTP binding|structural constituent of cytoskeleton,,ppi
6228,7311,10382,TUBB4A,tubulin beta 4A class IVa,125,calcium ion binding|structural constituent of cytoskeleton|GTP binding,hypomyelinating leukodystrophy 6,ppi
6229,7312,51175,TUBE1,tubulin epsilon 1,8,structural constituent of cytoskeleton|GTP binding,,ppi
6230,7313,84617,TUBB6,tubulin beta 6 class V,89,GTP binding|structural constituent of cytoskeleton,,ppi
6231,7314,203068,TUBB,tubulin beta class I,350,structural molecule activity|MHC class I protein binding|GTP binding|structural constituent of cytoskeleton,,ppi
6232,7317,333926,PPM1J,protein phosphatase; Mg2+/Mn2+ dependent 1J,16,,,ppi
6233,7318,79651,RHBDF2,rhomboid 5 homolog 2,6,serine-type endopeptidase activity,,ppi
6234,7319,84971,ATG4D,autophagy related 4D cysteine peptidase,7,,,ppi
6235,7320,2055,CLN8,ceroid-lipofuscinosis; neuronal 8,29,,cerebellar disease|epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|schizophreniform disorder|schizoaffective disorder|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|agnosia|neuronal ceroid lipofuscinosis 8|neuronal ceroid lipofuscinosis 8 northern epilepsy variant,ppi
6236,7321,23192,ATG4B,autophagy related 4B cysteine peptidase,29,endopeptidase activity|cysteine-type endopeptidase activity|cysteine-type peptidase activity,,ppi
6237,7322,55032,SLC35A5,solute carrier family 35 member A5,8,sialic acid transmembrane transporter activity,,ppi
6238,7323,83937,RASSF4,Ras association domain family member 4,7,,,ppi
6239,7324,54821,ERCC6L,ERCC excision repair 6 like; spindle assembly checkpoint helicase,29,DNA translocase activity,,ppi
6240,7325,119467,CLRN3,clarin 3,1,,,ppi
6241,7326,166824,RASSF6,Ras association domain family member 6,9,,,ppi
6242,7327,79901,CYBRD1,cytochrome b reductase 1,21,ferric-chelate reductase activity|oxidoreductase activity; oxidizing metal ions|oxidoreductase activity,,ppi
6243,7328,10237,SLC35B1,solute carrier family 35 member B1,1,UDP-galactose transmembrane transporter activity,,ppi
6244,7330,11085,ADAM30,ADAM metallopeptidase domain 30,12,metallopeptidase activity|zinc ion binding,,ppi
6245,7331,1207,CLNS1A,chloride nucleotide-sensitive channel 1A,99,RNA binding|protein heterodimerization activity,melanoma|skin melanoma,ppi
6246,7333,79939,SLC35E1,solute carrier family 35 member E1,17,,,ppi
6247,7334,126299,ZNF428,zinc finger protein 428,17,,,ppi
6248,7335,90649,ZNF486,zinc finger protein 486,1,,,ppi
6249,7336,80264,ZNF430,zinc finger protein 430,7,DNA-binding transcription factor activity; RNA polymerase II-specific,polycystic ovary syndrome,ppi
6250,7337,170959,ZNF431,zinc finger protein 431,11,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding,,ppi
6251,7338,9668,ZNF432,zinc finger protein 432,1,DNA-binding transcription factor activity; RNA polymerase II-specific,large intestine cancer|colorectal cancer|breast cancer,ppi
6252,7339,163059,ZNF433,zinc finger protein 433,6,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6253,7340,54925,ZSCAN32,zinc finger and SCAN domain containing 32,36,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6254,7341,80345,ZSCAN16,zinc finger and SCAN domain containing 16,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6255,7342,80818,ZNF436,zinc finger protein 436,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6256,7343,55818,KDM3A,lysine demethylase 3A,24,iron ion binding|histone demethylase activity|histone demethylase activity (H3-K9 specific)|androgen receptor binding|transcription regulatory region sequence-specific DNA binding|chromatin DNA binding,,ppi
6257,7344,57649,PHF12,PHD finger protein 12,36,transcription corepressor activity|phosphatidylinositol binding,,ppi
6258,7346,131578,LRRC15,leucine rich repeat containing 15,54,fibronectin binding|collagen binding|laminin binding,,ppi
6259,7348,9575,CLOCK,clock circadian regulator,34,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|obsolete transcriptional activator activity; RNA polymerase II transcription factor binding|DNA binding|DNA-binding transcription factor activity|histone acetyltransferase activity|chromatin DNA binding|sequence-specific DNA binding|E-box binding,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|mood disorder|cocaine abuse|cocaine dependence|morphine dependence,ppi
6260,7349,219931,TPCN2,two pore segment channel 2,53,voltage-gated calcium channel activity|NAADP-sensitive calcium-release channel activity,,ppi
6261,7350,255631,COL24A1,collagen type XXIV alpha 1 chain,1,extracellular matrix structural constituent,,ppi
6262,7352,57628,DPP10,dipeptidyl peptidase like 10,4,potassium channel regulator activity|dipeptidyl-peptidase activity,liver cancer|autistic disorder,ppi
6263,7353,57463,AMIGO1,adhesion molecule with Ig like domain 1,25,potassium channel regulator activity,,ppi
6264,7355,196743,PAOX,polyamine oxidase,1,polyamine oxidase activity|N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity|oxidoreductase activity,cerebral infarction|cerebrovascular disease,ppi
6265,7356,8192,CLPP,caseinolytic mitochondrial matrix peptidase proteolytic subunit,74,serine-type endopeptidase activity|peptidase activity,sensorineural hearing loss|Perrault syndrome|hypogonadism,ppi
6266,7357,116113,FOXP4,forkhead box P4,16,DNA-binding transcription factor activity; RNA polymerase II-specific,prostate cancer|prostate carcinoma,ppi
6267,7358,165829,GPR156,G protein-coupled receptor 156,69,G-protein coupled GABA receptor activity,,ppi
6268,7359,388697,HRNR,hornerin,42,structural constituent of epidermis,,ppi
6269,7360,1208,CLPS,colipase,4,,,ppi
6270,7361,54874,FNBP1L,formin binding protein 1 like,26,cadherin binding,,ppi
6271,7362,84219,WDR24,WD repeat domain 24,20,,,ppi
6272,7364,83591,THAP2,THAP domain containing 2,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6273,7365,90326,THAP3,THAP domain containing 3,5,DNA-binding transcription factor activity; RNA polymerase II-specific,polycystic ovary syndrome,ppi
6274,7366,55145,THAP1,THAP domain containing 1,66,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|zinc ion binding|protein homodimerization activity|sequence-specific DNA binding,dystonia|generalized dystonia|torsion dystonia 1|focal hand dystonia|blepharospasm,ppi
6275,7368,23516,SLC39A14,solute carrier family 39 member 14,6,zinc ion transmembrane transporter activity,,ppi
6276,7369,91252,SLC39A13,solute carrier family 39 member 13,4,zinc ion transmembrane transporter activity,bone disease|cartilage disease|connective tissue disease|collagen disease|osteogenesis imperfecta|Ehlers-Danlos syndrome,ppi
6277,7370,221074,SLC39A12,solute carrier family 39 member 12,70,zinc ion transmembrane transporter activity,melanoma|skin melanoma,ppi
6278,7371,57181,SLC39A10,solute carrier family 39 member 10,22,zinc ion transmembrane transporter activity,,ppi
6279,7372,64116,SLC39A8,solute carrier family 39 member 8,26,zinc ion transmembrane transporter activity,,ppi
6280,7374,55508,SLC35E3,solute carrier family 35 member E3,1,,,ppi
6281,7375,84870,RSPO3,R-spondin 3,4,frizzled binding,breast cancer,ppi
6282,7376,84539,MCHR2,melanin concentrating hormone receptor 2,1,G-protein coupled peptide receptor activity,bipolar disorder|schizophrenia,ppi
6283,7377,57621,ZBTB2,zinc finger and BTB domain containing 2,25,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
6284,7378,27302,BMP10,bone morphogenetic protein 10,4,hormone activity|receptor serine/threonine kinase binding|transforming growth factor beta receptor binding|cytokine activity,,ppi
6285,7379,1209,CLPTM1,CLPTM1; transmembrane protein,15,,pancreatic cancer,ppi
6286,7380,84154,RPF2,ribosome production factor 2 homolog,80,RNA binding|5S rRNA binding|rRNA binding,,ppi
6287,7381,221336,BEND6,BEN domain containing 6,1,transcription corepressor activity,,ppi
6288,7382,112495,GTF3C6,general transcription factor IIIC subunit 6,12,DNA binding,,ppi
6289,7383,90594,ZNF439,zinc finger protein 439,16,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6290,7384,126070,ZNF440,zinc finger protein 440,13,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6291,7386,56897,WRNIP1,Werner helicase interacting protein 1,38,ATPase activity|single-stranded DNA-dependent ATPase activity|enzyme activator activity,,ppi
6292,7388,10224,ZNF443,zinc finger protein 443,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6293,7389,57524,CASKIN1,CASK interacting protein 1,5,,,ppi
6294,7390,10845,CLPX,caseinolytic mitochondrial matrix peptidase chaperone subunit,53,ATP binding|peptidase activator activity|ATPase activity|ATP-dependent peptidase activity,,ppi
6295,7391,137964,GPAT4,glycerol-3-phosphate acyltransferase 4,13,1-acylglycerol-3-phosphate O-acyltransferase activity|glycerol-3-phosphate O-acyltransferase activity,,ppi
6296,7393,55003,PAK1IP1,PAK1 interacting protein 1,31,,,ppi
6297,7394,284161,GDPD1,glycerophosphodiester phosphodiesterase domain containing 1,27,lysophospholipase activity,,ppi
6298,7395,57480,PLEKHG1,pleckstrin homology and RhoGEF domain containing G1,16,,nicotine dependence,ppi
6299,7396,56895,AGPAT4,1-acylglycerol-3-phosphate O-acyltransferase 4,10,1-acylglycerol-3-phosphate O-acyltransferase activity|transferase activity; transferring acyl groups,,ppi
6300,7397,55326,AGPAT5,1-acylglycerol-3-phosphate O-acyltransferase 5,12,1-acylglycerol-3-phosphate O-acyltransferase activity|transferase activity; transferring acyl groups,,ppi
6301,7398,79712,GTDC1,glycosyltransferase like domain containing 1,1,,,ppi
6302,7399,9860,LRIG2,leucine rich repeats and immunoglobulin like domains 2,4,,constipation|cryptorchidism|hydronephrosis|kidney failure|uremia|urethral obstruction|vesicoureteral reflux|urinary tract obstruction|urofacial syndrome,ppi
6303,7401,54880,BCOR,BCL6 corepressor,131,transcription corepressor activity|heat shock protein binding|transcription regulatory region DNA binding|ubiquitin-protein transferase activity,imperforate anus|aortic valve stenosis|blepharophimosis|ptosis|congenital ptosis|cleft lip|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types,ppi
6304,7402,283209,PGM2L1,phosphoglucomutase 2 like 1,7,phosphoglucomutase activity|glucose-1;6-bisphosphate synthase activity,,ppi
6305,7403,1211,CLTA,clathrin light chain A,71,clathrin heavy chain binding,,ppi
6306,7404,51605,TRMT6,tRNA methyltransferase 6,47,RNA binding,,ppi
6307,7405,85403,EAF1,ELL associated factor 1,69,,,ppi
6308,7406,22873,DZIP1,DAZ interacting zinc finger protein 1,5,,,ppi
6309,7407,1212,CLTB,clathrin light chain B,72,clathrin heavy chain binding,,ppi
6310,7408,125061,AFMID,arylformamidase,5,,,ppi
6311,7409,388552,BLOC1S3,biogenesis of lysosomal organelles complex 1 subunit 3,10,,polycystic ovary syndrome|schizophrenia|Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome 8,ppi
6312,7410,80216,ALPK1,alpha kinase 1,5,,,ppi
6313,7411,1213,CLTC,clathrin heavy chain,339,RNA binding|double-stranded RNA binding|structural molecule activity|protein kinase binding|clathrin light chain binding|disordered domain specific binding|ankyrin binding|arrestin family protein binding|peptide binding|identical protein binding|low-density lipoprotein particle receptor binding|heat shock protein binding,,ppi
6314,7413,548593,SLX1A,SLX1 homolog A; structure-specific endonuclease subunit,66,,,ppi
6315,7414,8218,CLTCL1,clathrin heavy chain like 1,74,identical protein binding|clathrin light chain binding,,ppi
6316,7415,10714,POLD3,DNA polymerase delta 3; accessory subunit,29,DNA-directed DNA polymerase activity,large intestine cancer|colorectal cancer,ppi
6317,7417,26054,SENP6,SUMO1/sentrin specific peptidase 6,15,SUMO-specific endopeptidase activity,,ppi
6318,7418,57125,PLXDC1,plexin domain containing 1,3,,,ppi
6319,7419,9804,TOMM20,translocase of outer mitochondrial membrane 20,58,P-P-bond-hydrolysis-driven protein transmembrane transporter activity|unfolded protein binding|protein transmembrane transporter activity|mitochondrion targeting sequence binding,,ppi
6320,7420,1191,CLU,clusterin,147,amyloid-beta binding|ubiquitin protein ligase binding|chaperone binding|misfolded protein binding|ATPase activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
6321,7421,94234,FOXQ1,forkhead box Q1,104,DNA-binding transcription factor activity; RNA polymerase II-specific,breast cancer,ppi
6322,7422,51522,TMEM14C,transmembrane protein 14C,9,,,ppi
6323,7423,51534,VTA1,vesicle trafficking 1,41,,,ppi
6324,7424,9749,PHACTR2,phosphatase and actin regulator 2,16,,,ppi
6325,7425,135154,SDHAF4,succinate dehydrogenase complex assembly factor 4,7,succinate dehydrogenase (ubiquinone) activity,,ppi
6326,7426,57583,TMEM181,transmembrane protein 181,3,toxic substance binding,,ppi
6327,7427,22828,SCAF8,SR-related CTD associated factor 8,20,RNA polymerase II complex binding|mRNA binding,,ppi
6328,7429,352999,C6orf58,chromosome 6 open reading frame 58,3,,,ppi
6329,7430,23294,ANKS1A,ankyrin repeat and sterile alpha motif domain containing 1A,27,,coronary artery disease,ppi
6330,7431,64422,ATG3,autophagy related 3,45,Atg8 ligase activity|Atg12 transferase activity|ubiquitin-like protein transferase activity,,ppi
6331,7432,126374,WTIP,Wilms tumor 1 interacting protein,11,transcription corepressor activity,,ppi
6332,7433,112939,NACC1,nucleus accumbens associated 1,35,,,ppi
6333,7434,79697,C14orf169,chromosome 14 open reading frame 169,10,iron ion binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors|histone demethylase activity (H3-K4 specific)|histone demethylase activity (H3-K36 specific),,ppi
6334,7435,1215,CMA1,chymase 1,10,endopeptidase activity|serine-type endopeptidase activity|serine-type peptidase activity,hypertension|essential hypertension|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis,ppi
6335,7436,22859,ADGRL1,adhesion G protein-coupled receptor L1,33,latrotoxin receptor activity|cell adhesion molecule binding|G-protein coupled receptor activity,,ppi
6336,7437,23284,ADGRL3,adhesion G protein-coupled receptor L3,9,G-protein coupled receptor activity|calcium ion binding,attention deficit hyperactivity disorder,ppi
6337,7440,57633,LRRN1,leucine rich repeat neuronal 1,3,,,ppi
6338,7441,56950,SMYD2,SET and MYND domain containing 2,46,RNA polymerase II complex binding|lysine N-methyltransferase activity|protein-lysine N-methyltransferase activity|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K36 specific),,ppi
6339,7442,64168,NECAB1,N-terminal EF-hand calcium binding protein 1,12,,,ppi
6340,7443,282991,BLOC1S2,biogenesis of lysosomal organelles complex 1 subunit 2,33,gamma-tubulin binding,,ppi
6341,7444,51442,VGLL1,vestigial like family member 1,4,transcription coactivator activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding,,ppi
6342,7445,150572,SMYD1,SET and MYND domain containing 1,21,,,ppi
6343,7447,349565,NMNAT3,nicotinamide nucleotide adenylyltransferase 3,4,nicotinate-nucleotide adenylyltransferase activity|nicotinamide-nucleotide adenylyltransferase activity,polycystic ovary syndrome,ppi
6344,7448,221692,PHACTR1,phosphatase and actin regulator 1,3,actin binding,coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|migraine without aura|coronary artery disease,ppi
6345,7449,79632,FAM184A,family with sequence similarity 184 member A,15,,substance abuse|substance-related disorder,ppi
6346,7450,10799,RPP40,ribonuclease P/MRP subunit p40,19,,,ppi
6347,7451,51389,RWDD1,RWD domain containing 1,6,,,ppi
6348,7452,54993,ZSCAN2,zinc finger and SCAN domain containing 2,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6349,7453,25842,ASF1A,anti-silencing function 1A histone chaperone,53,chromatin binding|histone binding,melanoma|skin melanoma,ppi
6350,7454,55723,ASF1B,anti-silencing function 1B histone chaperone,52,,,ppi
6351,7456,81688,C6orf62,chromosome 6 open reading frame 62,3,,,ppi
6352,7457,55856,ACOT13,acyl-CoA thioesterase 13,25,acyl-CoA hydrolase activity,,ppi
6353,7458,9625,AATK,apoptosis associated tyrosine kinase,54,,,ppi
6354,7459,118490,MSS51,MSS51 mitochondrial translational activator,2,,schizophrenia,ppi
6355,7461,84898,PLXDC2,plexin domain containing 2,31,,,ppi
6356,7462,84168,ANTXR1,anthrax toxin receptor 1,55,transmembrane signaling receptor activity|collagen binding|actin filament binding,,ppi
6357,7463,27145,FILIP1,filamin A interacting protein 1,5,,stomach cancer,ppi
6358,7464,51557,LGSN,lengsin; lens protein with glutamine synthetase domain,2,glutamate-ammonia ligase activity,,ppi
6359,7465,266553,OFCC1,orofacial cleft 1 candidate 1,10,,schizophrenia,ppi
6360,7466,353274,ZNF445,zinc finger protein 445,17,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6361,7467,284697,BTBD8,BTB domain containing 8,2,,,ppi
6362,7468,55278,QRSL1,glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1,10,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,,ppi
6363,7469,57224,NHSL1,NHS like 1,8,,,ppi
6364,7470,57505,AARS2,alanyl-tRNA synthetase 2; mitochondrial,29,alanine-tRNA ligase activity|tRNA binding|amino acid binding|ATP binding,leukoencephalopathy with vanishing white matter|combined oxidative phosphorylation deficiency,ppi
6365,7471,25844,YIPF3,Yip1 domain family member 3,100,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
6366,7472,9820,CUL7,cullin 7,640,,autistic disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|placental insufficiency|clubfoot|Klippel-Feil syndrome|spondylolisthesis|3-M syndrome,ppi
6367,7473,55776,SAYSD1,SAYSVFN motif domain containing 1,1,,,ppi
6368,7476,55843,ARHGAP15,Rho GTPase activating protein 15,9,GTPase activator activity,,ppi
6369,7477,353219,KAAG1,kidney associated antigen 1,1,,,ppi
6370,7478,57531,HACE1,HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1,14,ubiquitin-protein transferase activity|Rab GTPase binding|ubiquitin protein ligase activity,neuroblastoma,ppi
6371,7479,29078,NDUFAF4,NADH:ubiquinone oxidoreductase complex assembly factor 4,44,,lactic acidosis|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|hypoglycemia|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
6372,7480,93663,ARHGAP18,Rho GTPase activating protein 18,4,GTPase activator activity|cadherin binding,schizophrenia,ppi
6373,7481,55663,ZNF446,zinc finger protein 446,35,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6374,7482,65982,ZSCAN18,zinc finger and SCAN domain containing 18,12,,,ppi
6375,7483,203523,ZNF449,zinc finger protein 449,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6376,7484,51406,NOL7,nucleolar protein 7,16,RNA binding,,ppi
6377,7485,51696,HECA,hdc homolog; cell cycle regulator,2,,,ppi
6378,7486,116150,NUS1,NUS1 dehydrodolichyl diphosphate synthase subunit,20,prenyltransferase activity,melanoma|skin melanoma,ppi
6379,7487,83394,PITPNM3,PITPNM family member 3,4,calcium ion binding|phosphatidylinositol transporter activity|receptor tyrosine kinase binding|phospholipase activity,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
6380,7488,57605,PITPNM2,phosphatidylinositol transfer protein membrane associated 2,6,calcium ion binding|phosphatidylinositol transporter activity|receptor tyrosine kinase binding|phosphatidylinositol binding|phosphatidylcholine binding|phosphatidylcholine transporter activity,,ppi
6381,7489,26207,PITPNC1,phosphatidylinositol transfer protein; cytoplasmic 1,9,phosphatidylinositol transporter activity|phosphatidylinositol binding|phosphatidic acid binding|phosphatidylglycerol binding|phosphatidylcholine transporter activity|phosphatidylcholine binding,,ppi
6382,7490,54901,CDKAL1,CDK5 regulatory subunit associated protein 1 like 1,24,N6-threonylcarbomyladenosine methylthiotransferase activity,diabetes mellitus|type 2 diabetes mellitus,ppi
6383,7491,54516,MTRF1L,mitochondrial translational release factor 1 like,6,,,ppi
6384,7492,222658,KCTD20,potassium channel tetramerization domain containing 20,8,,,ppi
6385,7493,91749,MFSD4B,major facilitator superfamily domain containing 4B,7,glucose transmembrane transporter activity,,ppi
6386,7494,83861,RSPH3,radial spoke 3 homolog,5,,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1,ppi
6387,7495,25902,MTHFD1L,methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like,37,formate-tetrahydrofolate ligase activity|ATP binding|protein homodimerization activity|methylenetetrahydrofolate dehydrogenase (NADP+) activity|methenyltetrahydrofolate cyclohydrolase activity,,ppi
6388,7497,221421,RSPH9,radial spoke head 9 homolog,14,,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|primary ciliary dyskinesia 12,ppi
6389,7498,9587,MAD2L1BP,MAD2L1 binding protein,33,,,ppi
6390,7499,134266,GRPEL2,GrpE like 2; mitochondrial,12,adenyl-nucleotide exchange factor activity|unfolded protein binding,,ppi
6391,7500,84947,SERAC1,serine active site containing 1,6,,sensorineural hearing loss|dystonia|lipid metabolism disorder|3-methylglutaconic aciduria with deafness; encephalopathy; and Leigh-like syndrome,ppi
6392,7501,10667,FARS2,phenylalanyl-tRNA synthetase 2; mitochondrial,48,tRNA binding|phenylalanine-tRNA ligase activity,lactic acidosis|epilepsy|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|combined oxidative phosphorylation deficiency,ppi
6393,7502,26002,MOXD1,monooxygenase DBH like 1,24,copper ion binding|dopamine beta-monooxygenase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced ascorbate as one donor; and incorporation of one atom of oxygen,,ppi
6394,7503,79446,WDR25,WD repeat domain 25,9,,,ppi
6395,7504,9481,SLC25A27,solute carrier family 25 member 27,2,,schizophrenia,ppi
6396,7505,51256,TBC1D7,TBC1 domain family member 7,21,GTPase activator activity,,ppi
6397,7506,114826,SMYD4,SET and MYND domain containing 4,2,,medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
6398,7508,55298,RNF121,ring finger protein 121,2,ubiquitin protein ligase activity,,ppi
6399,7509,389434,IYD,iodotyrosine deiodinase,5,FMN binding|oxidoreductase activity|iodide peroxidase activity,congenital hypothyroidism,ppi
6400,7510,79694,MANEA,mannosidase endo-alpha,23,glycoprotein endo-alpha-1;2-mannosidase activity|alpha-mannosidase activity,polycystic ovary syndrome|cocaine abuse|cocaine dependence|paranoid schizophrenia|delusional disorder,ppi
6401,7511,81567,TXNDC5,thioredoxin domain containing 5,88,,rheumatoid arthritis|prostate cancer|prostate carcinoma|schizophrenia,ppi
6402,7512,116254,GINM1,glycoprotein integral membrane 1,61,,,ppi
6403,7513,114801,TMEM200A,transmembrane protein 200A,10,,,ppi
6404,7514,28978,TMEM14A,transmembrane protein 14A,8,,,ppi
6405,7515,23070,CMTR1,cap methyltransferase 1,15,mRNA (nucleoside-2'-O-)-methyltransferase activity,,ppi
6406,7516,51020,HDDC2,HD domain containing 2,6,,,ppi
6407,7518,60487,TRMT11,tRNA methyltransferase 11 homolog,11,tRNA (guanine-N2-)-methyltransferase activity,,ppi
6408,7519,135112,NCOA7,nuclear receptor coactivator 7,14,nuclear receptor transcription coactivator activity|nuclear hormone receptor binding,,ppi
6409,7520,11231,SEC63,SEC63 homolog; protein translocation regulator,44,RNA binding|signaling receptor activity|protein transporter activity|ATP-dependent helicase activity,heart disease|cardiovascular system disease|cystic kidney disease|Meckel syndrome|autosomal dominant polycystic kidney disease|polycystic liver disease|non-congenital cyst of kidney,ppi
6410,7521,83443,SF3B5,splicing factor 3b subunit 5,36,,,ppi
6411,7522,57579,FAM135A,family with sequence similarity 135 member A,2,,,ppi
6412,7523,57534,MIB1,mindbomb E3 ubiquitin protein ligase 1,63,ubiquitin-protein transferase activity,epilepsy|visual epilepsy,ppi
6413,7524,151888,BTLA,B and T lymphocyte associated,4,,,ppi
6414,7525,79966,SCD5,stearoyl-CoA desaturase 5,5,stearoyl-CoA 9-desaturase activity|oxidoreductase activity|iron ion binding,,ppi
6415,7526,100128327,TRAPPC3L,trafficking protein particle complex 3 like,12,Rab guanyl-nucleotide exchange factor activity,,ppi
6416,7527,26036,ZNF451,zinc finger protein 451,28,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|SUMO ligase activity,,ppi
6417,7528,79865,TREML2,triggering receptor expressed on myeloid cells like 2,14,signaling receptor activity,,ppi
6418,7529,221301,FAM26D,family with sequence similarity 26 member D,15,,,ppi
6419,7531,54438,GFOD1,glucose-fructose oxidoreductase domain containing 1,40,,,ppi
6420,7532,63933,MCUR1,mitochondrial calcium uniporter regulator 1,3,,,ppi
6421,7533,25901,CCDC28A,coiled-coil domain containing 28A,14,,,ppi
6422,7535,9444,QKI,QKI; KH domain containing RNA binding,75,RNA binding,malignant glioma|gliosarcoma|mixed glioma|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
6423,7536,51596,CUTA,cutA divalent cation tolerance homolog,25,copper ion binding,,ppi
6424,7538,63027,SLC22A23,solute carrier family 22 member 23,14,,,ppi
6425,7539,22832,CEP162,centrosomal protein 162,135,,,ppi
6426,7540,389362,PSMG4,proteasome assembly chaperone 4,24,,,ppi
6427,7541,84498,FAM120B,family with sequence similarity 120B,13,,,ppi
6428,7542,23506,GLTSCR1L,GLTSCR1 like,11,,,ppi
6429,7543,65989,DLK2,delta like non-canonical Notch ligand 2,31,,,ppi
6430,7544,221477,C6orf89,chromosome 6 open reading frame 89,4,,,ppi
6431,7545,113115,MTFR2,mitochondrial fission regulator 2,15,,,ppi
6432,7546,345930,ECT2L,epithelial cell transforming 2 like,1,,,ppi
6433,7547,9841,ZBTB24,zinc finger and BTB domain containing 24,57,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region DNA binding|DNA-binding transcription factor activity,anemia|macrocytic anemia|bronchitis|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|primary immunodeficiency disease|lymphopenia|intellectual disability|learning disability|pneumonia|agammaglobulinemia,ppi
6434,7548,29940,DSE,dermatan sulfate epimerase,10,chondroitin-glucuronate 5-epimerase activity,clubfoot|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|inguinal hernia|craniosynostosis,ppi
6435,7549,57333,RCN3,reticulocalbin 3,11,calcium ion binding,arthropathy|arthritis,ppi
6436,7550,116225,ZMYND19,zinc finger MYND-type containing 19,43,,,ppi
6437,7551,79845,RNF122,ring finger protein 122,9,,,ppi
6438,7552,63891,RNF123,ring finger protein 123,42,ubiquitin-protein transferase activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
6439,7553,80742,PRR3,proline rich 3,27,RNA binding,,ppi
6440,7554,54941,RNF125,ring finger protein 125,23,zinc ion binding|ubiquitin protein ligase activity,generalized anxiety disorder|anxiety disorder|spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|xerophthalmia|dry eye syndrome|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|hypertrichosis|hypoglycemia|Sjogren's syndrome,ppi
6441,7555,55658,RNF126,ring finger protein 126,110,ubiquitin protein ligase activity,,ppi
6442,7556,79836,LONRF3,LON peptidase N-terminal domain and ring finger 3,8,,,ppi
6443,7557,79589,RNF128,ring finger protein 128; E3 ubiquitin protein ligase,14,ubiquitin protein ligase activity,,ppi
6444,7558,168433,RNF133,ring finger protein 133,2,ubiquitin protein ligase activity,,ppi
6445,7559,29116,MYLIP,myosin regulatory light chain interacting protein,25,ubiquitin-protein transferase activity|cytoskeletal protein binding|ubiquitin protein ligase activity,endometriosis of uterus|endometriosis,ppi
6446,7560,84108,PCGF6,polycomb group ring finger 6,106,DNA binding|DNA-binding transcription factor activity|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
6447,7561,404672,GTF2H5,general transcription factor IIH subunit 5,18,,photosensitive trichothiodystrophy,ppi
6448,7562,84282,RNF135,ring finger protein 135,17,ubiquitin-protein transferase activity|ribonucleoprotein complex binding,intellectual disability|learning disability,ppi
6449,7563,50862,RNF141,ring finger protein 141,6,ubiquitin-protein transferase activity,,ppi
6450,7564,55128,TRIM68,tripartite motif containing 68,34,ubiquitin-protein transferase activity,,ppi
6451,7566,9656,MDC1,mediator of DNA damage checkpoint 1,201,,,ppi
6452,7567,57826,RAP2C,RAP2C; member of RAS oncogene family,20,transcription coactivator activity|GTP binding|GDP binding,,ppi
6453,7568,121268,RHEBL1,Ras homolog enriched in brain like 1,14,GTP binding,,ppi
6454,7569,57595,PDZD4,PDZ domain containing 4,3,ubiquitin protein ligase activity,,ppi
6455,7570,55288,RHOT1,ras homolog family member T1,20,GTP binding|GTPase activity,,ppi
6456,7571,89941,RHOT2,ras homolog family member T2,45,GTPase activity|GTP binding,,ppi
6457,7572,134637,ADAT2,adenosine deaminase; tRNA specific 2,3,tRNA-specific adenosine-34 deaminase activity,,ppi
6458,7573,84946,LTV1,LTV1 ribosome biogenesis factor,39,,,ppi
6459,7575,340152,ZC3H12D,zinc finger CCCH-type containing 12D,1,,,ppi
6460,7576,55005,RMND1,required for meiotic nuclear division 1 homolog,32,,lactic acidosis|renal tubular acidosis|sensorineural hearing loss|familial periodic paralysis|myopathy|liver disease|cerebral degeneration|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|septooptic dysplasia|renal agenesis|combined oxidative phosphorylation deficiency,ppi
6461,7577,80129,CCDC170,coiled-coil domain containing 170,3,,,ppi
6462,7579,387082,SUMO4,small ubiquitin-like modifier 4,99,protein tag,type 1 diabetes mellitus 5,ppi
6463,7580,348995,NUP43,nucleoporin 43,48,,,ppi
6464,7582,154197,PNLDC1,PARN like; ribonuclease domain containing 1,12,poly(A)-specific ribonuclease activity|3'-5'-exoribonuclease activity,,ppi
6465,7583,79969,ATAT1,alpha tubulin acetyltransferase 1,3,lysine N-acetyltransferase activity; acting on acetyl phosphate as donor|tubulin N-acetyltransferase activity|coenzyme binding,,ppi
6466,7584,139604,MAGEB16,MAGE family member B16,1,,,ppi
6467,7585,267012,DAOA,D-amino acid oxidase activator,1,enzyme activator activity,bipolar disorder|mood disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia,ppi
6468,7587,222696,ZSCAN23,zinc finger and SCAN domain containing 23,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6469,7588,23033,DOPEY1,dopey family member 1,2,,,ppi
6470,7589,79152,FA2H,fatty acid 2-hydroxylase,4,fatty acid alpha-hydroxylase activity,hereditary spastic paraplegia 35,ppi
6471,7590,54985,HCFC1R1,host cell factor C1 regulator 1,3,,,ppi
6472,7591,57326,PBXIP1,PBX homeobox interacting protein 1,49,transcription corepressor activity,,ppi
6473,7592,285676,ZNF454,zinc finger protein 454,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6474,7593,221458,KIF6,kinesin family member 6,6,microtubule binding|microtubule motor activity|ATPase activity,coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction,ppi
6475,7594,222643,UNC5CL,unc-5 family C-terminal like,16,peptidase activity,,ppi
6476,7595,26034,IPCEF1,interaction protein for cytohesin exchange factors 1,6,peroxidase activity|oxygen carrier activity,lymphoblastic leukemia|myeloid leukemia|allergic contact dermatitis,ppi
6477,7596,84894,LINGO1,leucine rich repeat and Ig domain containing 1,19,epidermal growth factor receptor binding,essential tremor,ppi
6478,7598,158038,LINGO2,leucine rich repeat and Ig domain containing 2,12,,liver cancer,ppi
6479,7599,80232,WDR26,WD repeat domain 26,78,,,ppi
6480,7600,138715,ARID3C,AT-rich interaction domain 3C,1,DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
6481,7601,1240,CMKLR1,chemerin chemokine-like receptor 1,2,G-protein coupled receptor activity|chemokine receptor activity|signaling receptor activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
6482,7602,83887,TTLL2,tubulin tyrosine ligase like 2,1,,,ppi
6483,7603,79747,ADGB,androglobin,1,,,ppi
6484,7604,57221,ARFGEF3,ARFGEF family member 3,19,,,ppi
6485,7605,84830,ADTRP,androgen dependent TFPI regulating protein,3,hydrolase activity,coronary artery disease,ppi
6486,7606,64771,C6orf106,chromosome 6 open reading frame 106,12,ubiquitin binding,,ppi
6487,7607,54887,UHRF1BP1,UHRF1 binding protein 1,23,histone deacetylase binding,systemic lupus erythematosus,ppi
6488,7608,10591,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,10,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,,ppi
6489,7609,22858,ICK,intestinal cell kinase,38,magnesium ion binding|protein kinase activity|protein serine/threonine kinase activity|ATP binding,cleft lip|isolated cleft palate|cleft palate|cryptorchidism|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|syndactyly|holoprosencephaly|polydactyly|sex differentiation disease|hermaphroditism|pseudohermaphroditism|Addison's disease|endocrine-cerebro-osteodysplasia syndrome,ppi
6490,7610,135295,SRSF12,serine and arginine rich splicing factor 12,19,RNA binding|RS domain binding|unfolded protein binding,,ppi
6491,7611,114792,KLHL32,kelch like family member 32,12,,,ppi
6492,7612,25957,PNISR,PNN interacting serine and arginine rich protein,18,RNA binding,,ppi
6493,7613,221302,ZUFSP,zinc finger with UFM1 specific peptidase domain,5,,,ppi
6494,7614,79872,CBLL1,Cbl proto-oncogene like 1,15,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
6495,7615,57497,LRFN2,leucine rich repeat and fibronectin type III domain containing 2,1,,,ppi
6496,7616,114781,BTBD9,BTB domain containing 9,26,,restless legs syndrome|schizophrenia,ppi
6497,7617,58527,ABRACL,ABRA C-terminal like,5,,,ppi
6498,7618,168002,DACT2,dishevelled binding antagonist of beta catenin 2,4,protein kinase C binding|beta-catenin binding|transcription factor binding|protein kinase A binding|delta-catenin binding,liver cancer,ppi
6499,7619,112609,MRAP2,melanocortin 2 receptor accessory protein 2,62,,,ppi
6500,7620,168090,C6orf118,chromosome 6 open reading frame 118,5,,,ppi
6501,7621,84300,UQCC2,ubiquinol-cytochrome c reductase complex assembly factor 2,27,,,ppi
6502,7623,154467,CCDC167,coiled-coil domain containing 167,5,,,ppi
6503,7624,79981,FRMD1,FERM domain containing 1,44,,,ppi
6504,7625,221496,LEMD2,LEM domain containing 2,36,,cataract 46 juvenile-onset,ppi
6505,7626,221476,PI16,peptidase inhibitor 16,12,,,ppi
6506,7627,285848,PNPLA1,patatin like phospholipase domain containing 1,11,triglyceride lipase activity,ichthyosis|autosomal recessive congenital ichthyosis 1|congenital ichthyosiform erythroderma|autosomal recessive congenital ichthyosis 2|autosomal recessive congenital ichthyosis 3|autosomal recessive congenital ichthyosis 4A|autosomal recessive congenital ichthyosis 5|autosomal recessive congenital ichthyosis 6|autosomal recessive congenital ichthyosis 7|autosomal recessive congenital ichthyosis 8|autosomal recessive congenital ichthyosis 9|autosomal recessive congenital ichthyosis 10,ppi
6507,7628,387263,C6orf120,chromosome 6 open reading frame 120,15,,,ppi
6508,7629,253769,WDR27,WD repeat domain 27,2,,,ppi
6509,7631,340204,CLPSL1,colipase like 1,12,,,ppi
6510,7632,222662,LHFPL5,lipoma HMGIC fusion partner-like 5,3,,autosomal recessive nonsyndromic deafness 67,ppi
6511,7633,401285,TCP10L2,t-complex 10-like 2,6,tubulin binding,,ppi
6512,7635,221443,OARD1,O-acyl-ADP-ribose deacylase 1,7,purine nucleoside binding|deacetylase activity,,ppi
6513,7636,65981,CAPRIN2,caprin family member 2,6,,,ppi
6514,7637,55515,ASIC4,acid sensing ion channel subunit family member 4,40,ion channel activity|sodium ion transmembrane transporter activity,,ppi
6515,7638,51279,C1RL,complement C1r subcomponent like,4,serine-type endopeptidase activity,,ppi
6516,7639,88455,ANKRD13A,ankyrin repeat domain 13A,32,,,ppi
6517,7640,126206,NLRP5,NLR family pyrin domain containing 5,9,,,ppi
6518,7641,83743,GRWD1,glutamate rich WD repeat containing 1,61,chromatin binding|DNA replication origin binding|RNA binding|histone binding,,ppi
6519,7642,55811,ADCY10,adenylate cyclase 10; soluble,3,adenylate cyclase activity|bicarbonate binding,,ppi
6520,7643,647024,C6orf132,chromosome 6 open reading frame 132,1,,,ppi
6521,7644,23304,UBR2,ubiquitin protein ligase E3 component n-recognin 2,59,ubiquitin-protein transferase activity|leucine binding|ubiquitin protein ligase activity,,ppi
6522,7645,171558,PTCRA,pre T-cell antigen receptor alpha,8,,polycystic ovary syndrome,ppi
6523,7646,9783,RIMS3,regulating synaptic membrane exocytosis 3,4,ion channel binding|Rab GTPase binding,schizophrenia,ppi
6524,7647,256158,HMCN2,hemicentin 2,1,,,ppi
6525,7648,23510,KCTD2,potassium channel tetramerization domain containing 2,21,protein-containing complex binding|cullin family protein binding,,ppi
6526,7649,54869,EPS8L1,EPS8 like 1,11,actin binding|cadherin binding|Rho guanyl-nucleotide exchange factor activity|Rac guanyl-nucleotide exchange factor activity,,ppi
6527,7650,64787,EPS8L2,EPS8 like 2,17,actin binding|cadherin binding|Rho guanyl-nucleotide exchange factor activity|Rac guanyl-nucleotide exchange factor activity,,ppi
6528,7651,79574,EPS8L3,EPS8 like 3,5,Rac guanyl-nucleotide exchange factor activity|actin filament binding|actin binding,prostate cancer|prostate carcinoma,ppi
6529,7652,65985,AACS,acetoacetyl-CoA synthetase,5,acetoacetate-CoA ligase activity,,ppi
6530,7653,9696,CROCC,ciliary rootlet coiled-coil; rootletin,24,structural molecule activity|kinesin binding,,ppi
6531,7654,79897,RPP21,ribonuclease P/MRP subunit p21,11,ribonuclease P activity,,ppi
6532,7655,221545,C6orf136,chromosome 6 open reading frame 136,3,,,ppi
6533,7656,147040,KCTD11,potassium channel tetramerization domain containing 11,3,,,ppi
6534,7658,54936,ADPRHL2,ADP-ribosylhydrolase like 2,11,poly(ADP-ribose) glycohydrolase activity,,ppi
6535,7659,51133,KCTD3,potassium channel tetramerization domain containing 3,39,,,ppi
6536,7660,84266,ALKBH7,alkB homolog 7,3,,,ppi
6537,7661,147409,DSG4,desmoglein 4,39,,hypotrichosis|monilethrix,ppi
6538,7662,60481,ELOVL5,ELOVL fatty acid elongase 5,8,fatty acid elongase activity,schizophrenia|spinocerebellar ataxia type 38,ppi
6539,7663,150678,COPS9,COP9 signalosome subunit 9,17,,,ppi
6540,7665,29123,ANKRD11,ankyrin repeat domain 11,30,,autistic disorder|cryptorchidism|epilepsy|intellectual disability|learning disability|visual epilepsy|syndactyly|KBG syndrome,ppi
6541,7666,54808,DYM,dymeclin,18,,intellectual disability|learning disability|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|schizophrenia|speech disorder|osteogenesis imperfecta|Ehlers-Danlos syndrome|Smith-McCort dysplasia,ppi
6542,7667,390598,SKOR1,SKI family transcriptional corepressor 1,1,DNA-binding transcription factor activity; RNA polymerase II-specific|SMAD binding,,ppi
6543,7668,129807,NEU4,neuraminidase 4,18,exo-alpha-sialidase activity,,ppi
6544,7669,146760,RTN4RL1,reticulon 4 receptor like 1,6,heparin binding|chondroitin sulfate binding|signaling receptor activity,,ppi
6545,7670,282974,STK32C,serine/threonine kinase 32C,8,protein serine/threonine kinase activity,,ppi
6546,7671,23161,SNX13,sorting nexin 13,9,phosphatidylinositol-3-phosphate binding|phosphatidylinositol binding,,ppi
6547,7672,81847,RNF146,ring finger protein 146,40,ubiquitin-protein transferase activity|ubiquitin protein ligase activity|poly-ADP-D-ribose binding,,ppi
6548,7673,51450,PRRX2,paired related homeobox 2,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
6549,7674,221400,TDRD6,tudor domain containing 6,2,,,ppi
6550,7675,347736,NME9,NME/NM23 family member 9,1,,,ppi
6551,7677,55166,CENPQ,centromere protein Q,32,,,ppi
6552,7678,79682,CENPU,centromere protein U,61,,,ppi
6553,7679,389396,GLYATL3,glycine-N-acyltransferase like 3,1,,,ppi
6554,7680,81846,SBF2,SET binding factor 2,22,Rab guanyl-nucleotide exchange factor activity,Charcot-Marie-Tooth disease type 4B2,ppi
6555,7681,8050,PDHX,pyruvate dehydrogenase complex component X,33,pyruvate dehydrogenase (NAD+) activity,lactic acidosis|cerebellar disease|dystonia|epilepsy|intellectual disability|learning disability|optic atrophy|visual epilepsy|paraplegia|craniosynostosis|locked-in syndrome|quadriplegia|pyruvate decarboxylase deficiency,ppi
6556,7682,135398,C6orf141,chromosome 6 open reading frame 141,73,,,ppi
6557,7683,401265,KLHL31,kelch like family member 31,2,,,ppi
6558,7685,90523,MLIP,muscular LMNA interacting protein,1,,,ppi
6559,7686,84940,CORO6,coronin 6,17,,,ppi
6560,7687,222584,FAM83B,family with sequence similarity 83 member B,20,protein kinase binding|phospholipase D activity,,ppi
6561,7688,54511,HMGCLL1,3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1,2,hydroxymethylglutaryl-CoA lyase activity|metal ion binding,,ppi
6562,7689,57691,KIAA1586,KIAA1586,3,SUMO ligase activity,,ppi
6563,7690,221749,PXDC1,PX domain containing 1,4,,,ppi
6564,7691,222826,FAM217A,family with sequence similarity 217 member A,1,,,ppi
6565,7692,57128,LYRM4,LYR motif containing 4,21,,schizophrenia|combined oxidative phosphorylation deficiency,ppi
6566,7694,115004,MB21D1,Mab-21 domain containing 1,5,DNA binding|chromatin binding|double-stranded DNA binding|cyclic-GMP-AMP synthase activity,,ppi
6567,7695,154007,SNRNP48,small nuclear ribonucleoprotein U11/U12 subunit 48,10,,,ppi
6568,7696,285855,RPL7L1,ribosomal protein L7 like 1,28,RNA binding|structural constituent of ribosome,,ppi
6569,7697,83931,STK40,serine/threonine kinase 40,23,,,ppi
6570,7698,88745,RRP36,ribosomal RNA processing 36,4,RNA binding,,ppi
6571,7700,79627,OGFRL1,opioid growth factor receptor like 1,1,,,ppi
6572,7701,90025,UBE3D,ubiquitin protein ligase E3D,16,ubiquitin protein ligase activity,,ppi
6573,7703,81853,TMEM14B,transmembrane protein 14B,15,,,ppi
6574,7704,112611,RWDD2A,RWD domain containing 2A,2,,,ppi
6575,7705,56884,FSTL5,follistatin like 5,2,,,ppi
6576,7706,167681,PRSS35,protease; serine 35,4,,,ppi
6577,7707,23105,FSTL4,follistatin like 4,3,,,ppi
6578,7708,134701,RIPPLY2,ripply transcriptional repressor 2,13,,spondylocostal dysostosis,ppi
6579,7709,56833,SLAMF8,SLAM family member 8,1,,,ppi
6580,7710,114836,SLAMF6,SLAM family member 6,7,,,ppi
6581,7711,25950,RWDD3,RWD domain containing 3,6,,,ppi
6582,7712,57823,SLAMF7,SLAM family member 7,18,,,ppi
6583,7713,51099,ABHD5,abhydrolase domain containing 5,12,lysophosphatidic acid acyltransferase activity|triglyceride lipase activity|carboxylic ester hydrolase activity,alopecia|cerebellar disease|ectropion|sensorineural hearing loss|hematopoietic system disease|intellectual disability|learning disability|familial periodic paralysis|myopathy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|mechanical strabismus|hypertropia|autosomal recessive congenital ichthyosis 1|congenital ichthyosiform erythroderma|autosomal recessive congenital ichthyosis 2|autosomal recessive congenital ichthyosis 3,ppi
6584,7714,256380,SCML4,sex comb on midleg-like 4 (Drosophila),3,,,ppi
6585,7715,57406,ABHD6,abhydrolase domain containing 6,5,acylglycerol lipase activity|phospholipase activity,,ppi
6586,7716,121643,FOXN4,forkhead box N4,3,DNA-binding transcription factor activity; RNA polymerase II-specific|enhancer sequence-specific DNA binding|chromatin binding|DNA-binding transcription factor activity,,ppi
6587,7718,57150,SMIM8,small integral membrane protein 8,1,,,ppi
6588,7720,154313,CFAP206,cilia and flagella associated protein 206,28,,,ppi
6589,7721,57038,RARS2,arginyl-tRNA synthetase 2; mitochondrial,23,RNA binding|arginine-tRNA ligase activity,pontocerebellar hypoplasia type 1A|pontocerebellar hypoplasia type 6,ppi
6590,7722,55122,AKIRIN2,akirin 2,18,,,ppi
6591,7723,135293,PM20D2,peptidase M20 domain containing 2,19,dipeptidase activity|para-aminobenzoyl-glutamate hydrolase activity,,ppi
6592,7724,84883,AIFM2,apoptosis inducing factor; mitochondria associated 2,4,DNA binding|electron-transferring-flavoprotein dehydrogenase activity|flavin adenine dinucleotide binding,,ppi
6593,7725,27293,SMPDL3B,sphingomyelin phosphodiesterase acid like 3B,7,phosphoric diester hydrolase activity,,ppi
6594,7726,23552,CDK20,cyclin dependent kinase 20,38,cyclin-dependent protein serine/threonine kinase activity,alcohol dependence|alcohol abuse,ppi
6595,7727,114987,WDR31,WD repeat domain 31,1,,,ppi
6596,7728,54442,KCTD5,potassium channel tetramerization domain containing 5,32,protein-containing complex binding|cullin family protein binding,,ppi
6597,7729,80173,IFT74,intraflagellar transport 74,52,beta-tubulin binding,,ppi
6598,7730,51754,TMEM8B,transmembrane protein 8B,2,,,ppi
6599,7732,84280,BTBD10,BTB domain containing 10,11,,,ppi
6600,7733,145864,HAPLN3,hyaluronan and proteoglycan link protein 3,12,,schizophrenia,ppi
6601,7734,80760,ITIH5,inter-alpha-trypsin inhibitor heavy chain family member 5,10,,,ppi
6602,7735,145282,MIPOL1,mirror-image polydactyly 1,42,,polydactyly,ppi
6603,7736,54542,RC3H2,ring finger and CCCH-type domains 2,20,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|RNA binding|double-stranded RNA binding|ubiquitin-protein transferase activity|RNA stem-loop binding,,ppi
6604,7737,7978,MTERF1,mitochondrial transcription termination factor 1,13,double-stranded DNA binding|RNA binding,,ppi
6605,7738,338322,NLRP10,NLR family pyrin domain containing 10,3,GTPase activity|ATPase activity,,ppi
6606,7739,56623,INPP5E,inositol polyphosphate-5-phosphatase E,4,phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity|inositol-polyphosphate 5-phosphatase activity,Kartagener syndrome|primary ciliary dyskinesia|obesity|leukoplakia of penis|Joubert syndrome|intellectual disability|learning disability,ppi
6607,7740,253714,MMS22L,MMS22 like; DNA repair protein,27,,,ppi
6608,7741,222546,RFX6,regulatory factor X6,25,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|transcription regulatory region DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity,melanoma|skin melanoma|prostate cancer|prostate carcinoma,ppi
6609,7742,285761,DCBLD1,discoidin; CUB and LCCL domain containing 1,4,,melanoma|skin melanoma,ppi
6610,7743,1259,CNGA1,cyclic nucleotide gated channel alpha 1,1,intracellular cGMP-activated cation channel activity|intracellular cAMP-activated cation channel activity|cGMP binding,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
6611,7744,54935,DUSP23,dual specificity phosphatase 23,65,protein tyrosine/serine/threonine phosphatase activity|phosphatase activity|protein tyrosine phosphatase activity|protein serine/threonine phosphatase activity,,ppi
6612,7745,92483,LDHAL6B,lactate dehydrogenase A like 6B,36,L-lactate dehydrogenase activity,breast cancer,ppi
6613,7746,222553,SLC35F1,solute carrier family 35 member F1,4,,,ppi
6614,7747,254394,MCM9,minichromosome maintenance 9 homologous recombination repair factor,10,,,ppi
6615,7748,221322,TBC1D32,TBC1 domain family member 32,6,,,ppi
6616,7749,154214,RNF217,ring finger protein 217,5,ubiquitin-protein transferase activity|ubiquitin protein ligase activity|ubiquitin conjugating enzyme binding,,ppi
6617,7750,387103,CENPW,centromere protein W,3,,,ppi
6618,7751,55862,ECHDC1,ethylmalonyl-CoA decarboxylase 1,11,carboxy-lyase activity|enoyl-CoA hydratase activity,melanoma|skin melanoma,ppi
6619,7752,1260,CNGA2,cyclic nucleotide gated channel alpha 2,2,intracellular cAMP-activated cation channel activity|intracellular cGMP-activated cation channel activity|cGMP binding,,ppi
6620,7754,154807,VKORC1L1,vitamin K epoxide reductase complex subunit 1 like 1,17,vitamin-K-epoxide reductase (warfarin-sensitive) activity,,ppi
6621,7755,161582,DYX1C1,dyslexia susceptibility 1 candidate 1,14,estrogen receptor binding,Kartagener syndrome|primary ciliary dyskinesia|male infertility|primary ciliary dyskinesia 1|alexia|dyslexia,ppi
6622,7756,387104,SOGA3,SOGA family member 3,7,,,ppi
6623,7757,113220,KIF12,kinesin family member 12,3,microtubule binding|ATPase activity|microtubule motor activity,,ppi
6624,7758,27236,ARFIP1,ADP ribosylation factor interacting protein 1,61,phosphatidylinositol-4-phosphate binding|phospholipid binding,,ppi
6625,7759,28976,ACAD9,acyl-CoA dehydrogenase family member 9,83,long-chain-acyl-CoA dehydrogenase activity|medium-chain-acyl-CoA dehydrogenase activity|fatty-acyl-CoA binding|very-long-chain-acyl-CoA dehydrogenase activity,lactic acidosis|brain edema|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q,ppi
6626,7760,55054,ATG16L1,autophagy related 16 like 1,57,ubiquitin-like protein transferase activity,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease,ppi
6627,7761,101,ADAM8,ADAM metallopeptidase domain 8,3,serine-type endopeptidase activity|calcium ion binding|metallopeptidase activity|zinc ion binding|protein self-association,,ppi
6628,7762,1261,CNGA3,cyclic nucleotide gated channel alpha 3,26,intracellular cGMP-activated cation channel activity|ligand-gated ion channel activity|cGMP binding|intracellular cAMP-activated cation channel activity,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|alternating exotropia|exotropia|monocular exotropia|night blindness|hyperopia|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|blindness,ppi
6629,7764,1258,CNGB1,cyclic nucleotide gated channel beta 1,4,intracellular cGMP-activated cation channel activity|ligand-gated ion channel activity|cGMP binding|intracellular cAMP-activated cation channel activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
6630,7765,11062,DUS4L,dihydrouridine synthase 4 like,6,tRNA dihydrouridine synthase activity,,ppi
6631,7767,51635,DHRS7,dehydrogenase/reductase 7,34,,fatty liver disease,ppi
6632,7768,132789,GNPDA2,glucosamine-6-phosphate deaminase 2,17,glucosamine-6-phosphate deaminase activity|identical protein binding,obesity,ppi
6633,7769,56616,DIABLO,diablo IAP-binding mitochondrial protein,54,,brain ischemia|Huntington's disease|prostate cancer|prostate carcinoma|autosomal dominant nonsyndromic deafness 64,ppi
6634,7770,56889,TM9SF3,transmembrane 9 superfamily member 3,14,,,ppi
6635,7772,117248,GALNT15,polypeptide N-acetylgalactosaminyltransferase 15,2,polypeptide N-acetylgalactosaminyltransferase activity,,ppi
6636,7773,399979,SNX19,sorting nexin 19,8,,,ppi
6637,7774,28966,SNX24,sorting nexin 24,25,,,ppi
6638,7775,23560,GTPBP4,GTP binding protein 4,131,RNA binding|GTPase activity|GTP binding,,ppi
6639,7777,221711,SYCP2L,synaptonemal complex protein 2 like,1,,,ppi
6640,7778,221662,RBM24,RNA binding motif protein 24,26,mRNA 3'-UTR binding|mRNA 3'-UTR AU-rich region binding|pre-mRNA intronic binding|mRNA CDS binding|sequence-specific mRNA binding|mRNA binding|RNA binding,,ppi
6641,7779,1263,PLK3,polo like kinase 3,17,p53 binding|protein serine/threonine kinase activity,,ppi
6642,7781,1264,CNN1,calponin 1,23,,,ppi
6643,7782,346007,EYS,eyes shut homolog (Drosophila),1,,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|retinitis pigmentosa 25,ppi
6644,7783,221294,NT5DC1,5'-nucleotidase domain containing 1,8,5'-nucleotidase activity,melanoma|skin melanoma,ppi
6645,7786,23270,TSPYL4,TSPY like 4,20,,melanoma|skin melanoma,ppi
6646,7787,1265,CNN2,calponin 2,29,cadherin binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
6647,7788,285753,CEP57L1,centrosomal protein 57 like 1,74,microtubule binding,,ppi
6648,7790,254228,FAM26E,family with sequence similarity 26 member E,1,,,ppi
6649,7791,387357,THEMIS,thymocyte selection associated,7,,alcohol dependence|alcohol abuse|celiac disease,ppi
6650,7792,1266,CNN3,calponin 3,51,cadherin binding involved in cell-cell adhesion,prostate cancer|prostate carcinoma,ppi
6651,7794,116843,SLC18B1,solute carrier family 18 member B1,1,,,ppi
6652,7795,154075,SAMD3,sterile alpha motif domain containing 3,7,,,ppi
6653,7796,54806,AHI1,Abelson helper integration site 1,34,,autistic disorder|bipolar disorder|ptosis|congenital ptosis|cerebellar disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|retinal degeneration|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|schizophrenia|blindness|immunoglobulin alpha deficiency|selective IgA deficiency disease|Joubert syndrome,ppi
6654,7797,378884,NHLRC1,NHL repeat containing E3 ubiquitin protein ligase 1,22,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,Unverricht-Lundborg syndrome|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy|Lafora disease,ppi
6655,7798,221656,KDM1B,lysine demethylase 1B,27,zinc ion binding|histone demethylase activity|histone demethylase activity (H3-dimethyl-K4 specific)|histone demethylase activity (H3-monomethyl-K4 specific)|histone binding|FAD binding|oxidoreductase activity,,ppi
6656,7799,255488,RNF144B,ring finger protein 144B,60,ubiquitin-protein transferase activity|ubiquitin protein ligase activity|ubiquitin conjugating enzyme binding,,ppi
6657,7800,154141,MBOAT1,membrane bound O-acyltransferase domain containing 1,31,1-acylglycerol-3-phosphate O-acyltransferase activity|2-acylglycerol-3-phosphate O-acyltransferase activity,,ppi
6658,7801,1267,CNP,2';3'-cyclic nucleotide 3' phosphodiesterase,30,2';3'-cyclic-nucleotide 3'-phosphodiesterase activity,schizophreniform disorder|schizoaffective disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
6659,7802,9856,KIAA0319,KIAA0319,3,,alexia|dyslexia,ppi
6660,7803,55604,CARMIL1,capping protein regulator and myosin 1 linker 1,15,protein-containing complex binding,,ppi
6661,7804,222698,NKAPL,NFKB activating protein like,4,,schizophrenia,ppi
6662,7805,150465,TTL,tubulin tyrosine ligase,6,tubulin-tyrosine ligase activity,,ppi
6663,7806,407738,FAM19A1,family with sequence similarity 19 member A1; C-C motif chemokine like,4,,,ppi
6664,7808,1268,CNR1,cannabinoid receptor 1,8,cannabinoid receptor activity,alcohol dependence|alcohol abuse|anxiety disorder|phobic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometriosis of uterus|endometriosis|complex partial epilepsy|temporal lobe epilepsy|Huntington's disease|liver cirrhosis|cannabis dependence|cannabis abuse|movement disease,ppi
6665,7809,284467,FAM19A3,family with sequence similarity 19 member A3; C-C motif chemokine like,73,,,ppi
6666,7810,151647,FAM19A4,family with sequence similarity 19 member A4; C-C motif chemokine like,52,,breast cancer,ppi
6667,7812,27244,SESN1,sestrin 1,5,leucine binding|oxidoreductase activity; acting on peroxide as acceptor,,ppi
6668,7813,80724,ACAD10,acyl-CoA dehydrogenase family member 10,21,acyl-CoA dehydrogenase activity,,ppi
6669,7814,8754,ADAM9,ADAM metallopeptidase domain 9,28,metalloendopeptidase activity|protein kinase C binding|integrin binding|collagen binding|metallopeptidase activity|SH3 domain binding|laminin binding,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|night blindness|congenital stationary night blindness|prostate cancer|prostate carcinoma|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|blindness|asthenopia,ppi
6670,7815,1269,CNR2,cannabinoid receptor 2,2,,alcohol dependence|alcohol abuse|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|immune system disease|acute myeloid leukemia|liver cirrhosis|cannabis dependence|cannabis abuse|pancreatic cancer,ppi
6671,7816,51000,SLC35B3,solute carrier family 35 member B3,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,,ppi
6672,7817,55633,TBC1D22B,TBC1 domain family member 22B,102,14-3-3 protein binding|Rab GTPase binding|GTPase activator activity,,ppi
6673,7818,29924,EPN1,epsin 1,74,,,ppi
6674,7819,9667,SAFB2,scaffold attachment factor B2,68,RNA binding|sequence-specific DNA binding,,ppi
6675,7820,51660,MPC1,mitochondrial pyruvate carrier 1,3,pyruvate transmembrane transporter activity,lactic acidosis|hypoglycemia|substance abuse|substance-related disorder,ppi
6676,7821,51390,AIG1,androgen induced 1,3,hydrolase activity,,ppi
6677,7822,51631,LUC7L2,LUC7 like 2; pre-mRNA splicing factor,177,RNA binding|mRNA binding,,ppi
6678,7823,80856,LNPK,lunapark; ER junction formation factor,32,identical protein binding,,ppi
6679,7824,58190,CTDSP1,CTD small phosphatase 1,22,RNA polymerase II CTD heptapeptide repeat phosphatase activity|phosphoprotein phosphatase activity,,ppi
6680,7825,64759,TNS3,tensin 3,35,,,ppi
6681,7826,167838,TXLNB,taxilin beta,40,,,ppi
6682,7827,404220,C6orf201,chromosome 6 open reading frame 201,3,,,ppi
6683,7828,285782,CAGE1,cancer antigen 1,7,,,ppi
6684,7829,644378,GCNT6,glucosaminyl (N-acetyl) transferase 6,1,,,ppi
6685,7830,89953,KLC4,kinesin light chain 4,60,,,ppi
6686,7831,55107,ANO1,anoctamin 1,2,calcium activated cation channel activity|intracellular calcium activated chloride channel activity|voltage-gated chloride channel activity|chloride channel activity|iodide transmembrane transporter activity,,ppi
6687,7832,10794,ZNF460,zinc finger protein 460,27,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6688,7833,92283,ZNF461,zinc finger protein 461,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6689,7834,9729,KIAA0408,KIAA0408,29,,,ppi
6690,7835,23314,SATB2,SATB homeobox 2,47,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding,isolated cleft palate|cleft palate|clubfoot|epilepsy|inguinal hernia|intellectual disability|learning disability|visual epilepsy|syndromic X-linked intellectual disability 94|lung small cell carcinoma|chromosome 2q32-q33 deletion syndrome,ppi
6691,7836,387119,CEP85L,centrosomal protein 85 like,8,,,ppi
6692,7837,10867,TSPAN9,tetraspanin 9,1,,,ppi
6693,7838,23554,TSPAN12,tetraspanin 12,3,Wnt-activated receptor activity,exudative vitreoretinopathy,ppi
6694,7839,57176,VARS2,valyl-tRNA synthetase 2; mitochondrial,10,valine-tRNA ligase activity,combined oxidative phosphorylation deficiency,ppi
6695,7840,27075,TSPAN13,tetraspanin 13,3,calcium channel regulator activity,,ppi
6696,7841,51142,CHCHD2,coiled-coil-helix-coiled-coil-helix domain containing 2,96,sequence-specific DNA binding,,ppi
6697,7842,51619,UBE2D4,ubiquitin conjugating enzyme E2 D4 (putative),97,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity|ubiquitin protein ligase binding,,ppi
6698,7843,54543,TOMM7,translocase of outer mitochondrial membrane 7,18,protein transmembrane transporter activity,,ppi
6699,7844,55971,BAIAP2L1,BAI1 associated protein 2 like 1,31,proline-rich region binding|cadherin binding involved in cell-cell adhesion,rheumatoid arthritis,ppi
6700,7846,28962,OSTM1,osteopetrosis associated transmembrane protein 1,14,,hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|osteopetrosis|osteosclerosis,ppi
6701,7847,10210,TOPORS,TOP1 binding arginine/serine rich protein,63,DNA binding|ubiquitin-protein transferase activity|SUMO transferase activity|ubiquitin protein ligase activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|osteosarcoma|bone osteosarcoma|cone-rod dystrophy|retinitis pigmentosa,ppi
6702,7849,338324,S100A7A,S100 calcium binding protein A7A,5,protein self-association,polycystic ovary syndrome,ppi
6703,7850,222235,FBXL13,F-box and leucine rich repeat protein 13,4,ubiquitin-protein transferase activity,,ppi
6704,7852,135656,DPCR1,diffuse panbronchiolitis critical region 1,1,,,ppi
6705,7853,80228,ORAI2,ORAI calcium release-activated calcium modulator 2,6,store-operated calcium channel activity,,ppi
6706,7854,161835,FSIP1,fibrous sheath interacting protein 1,4,,,ppi
6707,7855,401024,FSIP2,fibrous sheath interacting protein 2,2,,,ppi
6708,7856,284654,RSPO1,R-spondin 1,15,frizzled binding,ovarian cancer|ovarian carcinoma,ppi
6709,7857,23235,SIK2,salt inducible kinase 2,41,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
6710,7858,222236,NAPEPLD,N-acyl phosphatidylethanolamine phospholipase D,1,zinc ion binding|N-acylphosphatidylethanolamine-specific phospholipase D activity,,ppi
6711,7859,58499,ZNF462,zinc finger protein 462,22,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6712,7860,135228,CD109,CD109 molecule,30,,large intestine cancer|colorectal cancer|breast cancer,ppi
6713,7861,8635,RNASET2,ribonuclease T2,11,ribonuclease activity|endoribonuclease activity,brain disease|Graves' disease|thyrotoxicosis|hyperthyroidism,ppi
6714,7862,10467,ZNHIT1,zinc finger HIT-type containing 1,24,nucleosome binding|histone deacetylase binding,,ppi
6715,7863,51024,FIS1,fission; mitochondrial 1,29,,neuronal ceroid lipofuscinosis 1,ppi
6716,7864,1270,CNTF,ciliary neurotrophic factor,18,growth factor activity|ciliary neurotrophic factor receptor binding|cytokine activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|amyotrophic lateral sclerosis type 1,ppi
6717,7865,51608,GET4,golgi to ER traffic protein 4,60,,,ppi
6718,7866,51622,CCZ1,CCZ1 homolog; vacuolar protein trafficking and biogenesis associated,14,guanyl-nucleotide exchange factor activity,,ppi
6719,7868,85477,SCIN,scinderin,17,phosphatidylserine binding|actin binding|calcium ion binding|1-phosphatidylinositol binding|phosphatidylinositol-4;5-bisphosphate binding|actin filament binding,,ppi
6720,7869,81628,TSC22D4,TSC22 domain family member 4,81,DNA-binding transcription factor activity; RNA polymerase II-specific|protein binding,,ppi
6721,7870,83862,TMEM120A,transmembrane protein 120A,14,,,ppi
6722,7871,54476,RNF216,ring finger protein 216,23,ubiquitin protein ligase activity,cerebellar disease|hypertrophy of breast|infant gynecomastia|gynecomastia|infertility|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|speech disorder|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III,ppi
6723,7872,375298,CERKL,ceramide kinase like,9,,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|retinitis pigmentosa 26,ppi
6724,7873,9510,ADAMTS1,ADAM metallopeptidase with thrombospondin type 1 motif 1,21,metallopeptidase activity,lung cancer|non-small cell lung carcinoma|breast cancer|liver cancer|hepatocellular carcinoma,ppi
6725,7874,1271,CNTFR,ciliary neurotrophic factor receptor,15,ciliary neurotrophic factor receptor activity|cytokine receptor activity|cytokine binding|interleukin-27 receptor binding,,ppi
6726,7875,144715,RAD9B,RAD9 checkpoint clamp component B,5,3'-5' exonuclease activity,,ppi
6727,7876,221927,BRAT1,BRCA1 associated ATM activator 1,25,,,ppi
6728,7877,79034,C7orf26,chromosome 7 open reading frame 26,11,,,ppi
6729,7878,79020,C7orf25,chromosome 7 open reading frame 25,25,,,ppi
6730,7879,65999,LRRC61,leucine rich repeat containing 61,2,dynein heavy chain binding|motor activity|alpha-tubulin binding,,ppi
6731,7880,79017,GGCT,gamma-glutamylcyclotransferase,12,gamma-glutamylcyclotransferase activity|protein homodimerization activity,,ppi
6732,7881,83787,ARMC10,armadillo repeat containing 10,3,,,ppi
6733,7882,79161,TMEM243,transmembrane protein 243,1,,,ppi
6734,7883,83605,CCM2,CCM2 scaffolding protein,16,,cerebral cavernous malformation 2,ppi
6735,7884,83590,TMUB1,transmembrane and ubiquitin like domain containing 1,26,,,ppi
6736,7885,1272,CNTN1,contactin 1,30,,polyhydramnios|placental insufficiency|Compton-North congenital myopathy,ppi
6737,7886,23158,TBC1D9,TBC1 domain family member 9,19,Rab GTPase binding|GTPase activator activity,,ppi
6738,7887,91752,ZNF804A,zinc finger protein 804A,2,,bipolar disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|schizophrenia|substance abuse|substance-related disorder|mood disorder,ppi
6739,7889,114780,PKD1L2,polycystin 1 like 2 (gene/pseudogene),3,calcium channel activity,,ppi
6740,7890,342372,PKD1L3,polycystin 1 like 3; transient receptor potential channel interacting,3,sour taste receptor activity|cation channel activity|cation transmembrane transporter activity|calcium channel activity,,ppi
6741,7891,221960,CCZ1B,CCZ1 homolog B; vacuolar protein trafficking and biogenesis associated,4,,,ppi
6742,7893,58498,MYL7,myosin light chain 7,1,,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
6743,7894,6900,CNTN2,contactin 2,38,identical protein binding|cell-cell adhesion mediator activity,epilepsy|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|visual epilepsy|focal epilepsy|partial motor epilepsy,ppi
6744,7895,113763,ZBED6CL,ZBED6 C-terminal like,1,,,ppi
6745,7896,115416,MALSU1,mitochondrial assembly of ribosomal large subunit 1,33,ribosomal large subunit binding,,ppi
6746,7897,136895,C7orf31,chromosome 7 open reading frame 31,5,,,ppi
6747,7898,155066,ATP6V0E2,ATPase H+ transporting V0 subunit e2,1,ATPase coupled ion transmembrane transporter activity|proton-transporting ATPase activity; rotational mechanism,,ppi
6748,7900,168391,GALNTL5,polypeptide N-acetylgalactosaminyltransferase-like 5,2,transferase activity; transferring glycosyl groups|Notch binding,,ppi
6749,7901,9828,ARHGEF17,Rho guanine nucleotide exchange factor 17,13,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
6750,7902,146712,B3GNTL1,UDP-GlcNAc:betaGal beta-1;3-N-acetylglucosaminyltransferase-like 1,2,,,ppi
6751,7903,26145,IRF2BP1,interferon regulatory factor 2 binding protein 1,25,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
6752,7904,359948,IRF2BP2,interferon regulatory factor 2 binding protein 2,23,DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,acute promyelocytic leukemia,ppi
6753,7905,5067,CNTN3,contactin 3,2,,autistic disorder|allergic contact dermatitis,ppi
6754,7906,441531,PGAM4,phosphoglycerate mutase family member 4,2,phosphoglycerate mutase activity,,ppi
6755,7907,118429,ANTXR2,anthrax toxin receptor 2,13,transmembrane signaling receptor activity,pseudosarcomatous fibromatosis|gingival overgrowth|gingival hypertrophy|osteoporosis|ankylosing spondylitis,ppi
6756,7908,89884,LHX4,LIM homeobox 4,32,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|methyl-CpG binding|sequence-specific DNA binding,hypopituitarism,ppi
6757,7909,26468,LHX6,LIM homeobox 6,22,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,schizophrenia,ppi
6758,7910,203054,ADCK5,aarF domain containing kinase 5,11,,,ppi
6759,7911,152330,CNTN4,contactin 4,6,cell-cell adhesion mediator activity,alcohol dependence|alcohol abuse|autistic disorder|bipolar disorder|3p- syndrome,ppi
6760,7912,55785,FGD6,FYVE; RhoGEF and PH domain containing 6,11,guanyl-nucleotide exchange factor activity|small GTPase binding,malignant mesothelioma|benign mesothelioma,ppi
6761,7913,64506,CPEB1,cytoplasmic polyadenylation element binding protein 1,15,translation repressor activity; mRNA regulatory element binding|mRNA 3'-UTR AU-rich region binding|ribosome binding|mRNA 3'-UTR binding|translation factor activity; RNA binding,chronic lymphocytic leukemia|Richter's syndrome,ppi
6762,7914,132864,CPEB2,cytoplasmic polyadenylation element binding protein 2,1,translation repressor activity; mRNA regulatory element binding|RNA binding|GTPase inhibitor activity|mRNA 3'-UTR AU-rich region binding|ribosome binding|ribosomal large subunit binding|ribosomal small subunit binding|mRNA 3'-UTR binding|translation factor activity; RNA binding,,ppi
6763,7915,22849,CPEB3,cytoplasmic polyadenylation element binding protein 3,5,translation repressor activity; mRNA regulatory element binding|RNA binding|mRNA 3'-UTR binding|translation factor activity; RNA binding|RNA stem-loop binding|mRNA 3'-UTR AU-rich region binding|ribosome binding,,ppi
6764,7916,80315,CPEB4,cytoplasmic polyadenylation element binding protein 4,7,RNA binding|mRNA 3'-UTR binding|ribosome binding|translation repressor activity; mRNA regulatory element binding|translation factor activity; RNA binding,,ppi
6765,7917,25928,SOSTDC1,sclerostin domain containing 1,5,BMP binding|BMP receptor activity,,ppi
6766,7918,10980,COPS6,COP9 signalosome subunit 6,305,,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
6767,7919,53942,CNTN5,contactin 5,3,,,ppi
6768,7920,135927,C7orf34,chromosome 7 open reading frame 34,1,,,ppi
6769,7921,25948,KBTBD2,kelch repeat and BTB domain containing 2,6,,,ppi
6770,7922,57001,SDHAF3,succinate dehydrogenase complex assembly factor 3,12,,alcohol dependence|alcohol abuse,ppi
6771,7927,222229,LRWD1,leucine rich repeats and WD repeat domain containing 1,42,chromatin binding|methyl-CpG binding|methylated histone binding,,ppi
6772,7929,84060,RBM48,RNA binding motif protein 48,50,,,ppi
6773,7930,26157,GIMAP2,GTPase; IMAP family member 2,4,GTP binding,,ppi
6774,7931,155038,GIMAP8,GTPase; IMAP family member 8,8,GTP binding,,ppi
6775,7932,9509,ADAMTS2,ADAM metallopeptidase with thrombospondin type 1 motif 2,19,metalloendopeptidase activity|metallopeptidase activity,blepharochalasis|gingival overgrowth|gingival hypertrophy|inguinal hernia|umbilical hernia|omphalocele|hypertrichosis|tooth agenesis|anodontia|myopia|malignant mesothelioma|benign mesothelioma,ppi
6776,7933,1690,COCH,cochlin,16,collagen binding,central nervous system origin vertigo|autosomal dominant nonsyndromic deafness 9,ppi
6777,7934,136051,ZNF786,zinc finger protein 786,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
6778,7935,157680,VPS13B,vacuolar protein sorting 13 homolog B,11,,,ppi
6779,7936,402569,KPNA7,karyopherin subunit alpha 7,4,,,ppi
6780,7937,8161,COIL,coilin,96,,,ppi
6781,7938,1300,COL10A1,collagen type X alpha 1 chain,12,extracellular matrix structural constituent,craniosynostosis|sensorineural hearing loss|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|Schmid metaphyseal chondrodysplasia|osteogenesis imperfecta|Ehlers-Danlos syndrome,ppi
6782,7939,1301,COL11A1,collagen type XI alpha 1 chain,5,extracellular matrix structural constituent|protein binding; bridging|extracellular matrix binding,suppression amblyopia|amblyopia|astigmatism|isolated cleft palate|cleft palate|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41,ppi
6783,7940,55112,WDR60,WD repeat domain 60,19,dynein heavy chain binding|ATP-dependent microtubule motor activity; plus-end-directed|dynein light chain binding,cleft lip|autosomal recessive polycystic kidney disease|cryptorchidism|ventricular septal defect|polyhydramnios|hydronephrosis|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|syndactyly|hand-foot-genital syndrome|polydactyly|asphyxiating thoracic dystrophy 1|sex differentiation disease|hermaphroditism|pseudohermaphroditism|asphyxiating thoracic dystrophy 3|short-rib thoracic dysplasia 8 with or without polydactyly,ppi
6784,7941,55131,RBM28,RNA binding motif protein 28,85,RNA binding,alopecia|pseudosarcomatous fibromatosis|dental caries|hypertrophy of breast|infant gynecomastia|gynecomastia|tooth agenesis|anodontia|hypogonadism|intellectual disability|learning disability|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag|muscular atrophy,ppi
6785,7942,55744,COA1,cytochrome c oxidase assembly factor 1 homolog,19,,,ppi
6786,7943,55750,AGK,acylglycerol kinase,34,acylglycerol kinase activity,Sengers syndrome,ppi
6787,7944,1302,COL11A2,collagen type XI alpha 2 chain,7,extracellular matrix structural constituent conferring tensile strength|protein binding; bridging|extracellular matrix structural constituent,bone disease|cartilage disease|connective tissue disease|chondromalacia|articular cartilage disease|isolated cleft palate|cleft palate|pseudosarcomatous fibromatosis|enophthalmos|orbital disease|exophthalmos|microphthalmia|eye disease|sensorineural hearing loss|arthropathy|arthritis|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome,ppi
6788,7945,55281,TMEM140,transmembrane protein 140,2,,,ppi
6789,7946,55303,GIMAP4,GTPase; IMAP family member 4,2,GTP binding,,ppi
6790,7947,80028,FBXL18,F-box and leucine rich repeat protein 18,44,,,ppi
6791,7948,60561,RINT1,RAD50 interactor 1,76,protein binding,,ppi
6792,7949,1303,COL12A1,collagen type XII alpha 1 chain,8,extracellular matrix structural constituent conferring tensile strength,pseudosarcomatous fibromatosis|familial periodic paralysis|myopathy|malignant mesothelioma|benign mesothelioma|Bell's palsy|facial paralysis|Ullrich congenital muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J,ppi
6793,7950,79989,TTC26,tetratricopeptide repeat domain 26,25,,,ppi
6794,7951,83891,SNX25,sorting nexin 25,5,,,ppi
6795,7952,79706,PRKRIP1,PRKR interacting protein 1 (IL11 inducible),12,double-stranded RNA binding|protein kinase inhibitor activity|protein kinase binding,,ppi
6796,7953,64792,IFT22,intraflagellar transport 22,25,GTPase activity,,ppi
6797,7954,221806,VWDE,von Willebrand factor D and EGF domains,8,signaling receptor binding,,ppi
6798,7955,84928,TMEM209,transmembrane protein 209,13,,,ppi
6799,7956,285973,ATG9B,autophagy related 9B,4,,,ppi
6800,7958,1305,COL13A1,collagen type XIII alpha 1 chain,6,heparin binding|extracellular matrix structural constituent,ptosis|congenital ptosis|esophagitis|peptic esophagitis|gastroesophageal reflux disease|congenital myasthenic syndrome|progressive bulbar palsy,ppi
6801,7959,54784,ALKBH4,alkB homolog 4; lysine demethylase,11,actin binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors|demethylase activity,,ppi
6802,7960,54892,NCAPG2,non-SMC condensin II complex subunit G2,16,methylated histone binding,,ppi
6803,7961,54468,MIOS,meiosis regulator for oocyte development,29,,,ppi
6804,7962,54927,CHCHD3,coiled-coil-helix-coiled-coil-helix domain containing 3,69,DNA-binding transcription repressor activity; RNA polymerase II-specific|phosphatase binding|protein-containing complex scaffold activity,substance abuse|substance-related disorder,ppi
6805,7963,7373,COL14A1,collagen type XIV alpha 1 chain,34,RNA binding|extracellular matrix structural constituent|collagen binding|extracellular matrix structural constituent conferring tensile strength|protein binding; bridging,colon cancer|colonic benign neoplasm|large intestine cancer|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|Hodgkin's lymphoma; lymphocytic-histiocytic predominance|Hodgkin's lymphoma|Hodgkin's lymphoma; lymphocytic depletion|Hodgkin's granuloma|Hodgkin's lymphoma; mixed cellularity|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|pancreatic cancer|bladder urothelial carcinoma|pancreatic carcinoma,ppi
6806,7964,64224,HERPUD2,HERPUD family member 2,5,,,ppi
6807,7966,474344,GIMAP6,GTPase; IMAP family member 6,2,GTP binding,,ppi
6808,7967,64761,PARP12,poly(ADP-ribose) polymerase family member 12,16,RNA binding,influenza,ppi
6809,7968,1306,COL15A1,collagen type XV alpha 1 chain,3,extracellular matrix structural constituent conferring tensile strength|extracellular matrix structural constituent,,ppi
6810,7969,79689,STEAP4,STEAP4 metalloreductase,2,cupric reductase activity|ferric-chelate reductase (NADPH) activity,prostate cancer|prostate carcinoma,ppi
6811,7970,1307,COL16A1,collagen type XVI alpha 1 chain,3,integrin binding|extracellular matrix structural constituent conferring tensile strength|extracellular matrix structural constituent,,ppi
6812,7971,254048,UBN2,ubinuclein 2,13,,,ppi
6813,7972,1308,COL17A1,collagen type XVII alpha 1 chain,13,extracellular matrix structural constituent,anemia|macrocytic anemia|dental caries|tooth agenesis|anodontia|asthenopia|excessive tearing|lacrimal apparatus disease|junctional epidermolysis bullosa non-Herlitz type|junctional epidermolysis bullosa|Clouston syndrome,ppi
6814,7974,222223,KIAA1324L,KIAA1324 like,1,,,ppi
6815,7975,155061,ZNF746,zinc finger protein 746,287,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding|ubiquitin protein ligase binding,,ppi
6816,7976,80781,COL18A1,collagen type XVIII alpha 1 chain,37,extracellular matrix structural constituent conferring tensile strength|extracellular matrix structural constituent,calcium metabolism disease|nephrocalcinosis|calcinosis|heart valve disease|angiosarcoma|intellectual disability|learning disability,ppi
6817,7977,154881,KCTD7,potassium channel tetramerization domain containing 7,2,,progressive myoclonus epilepsy,ppi
6818,7978,219578,ZNF804B,zinc finger protein 804B,1,,,ppi
6819,7979,1310,COL19A1,collagen type XIX alpha 1 chain,1,extracellular matrix structural constituent|protein binding; bridging,,ppi
6820,7980,221785,ZSCAN25,zinc finger and SCAN domain containing 25,22,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6821,7982,9827,RGP1,RGP1 homolog; RAB6A GEF complex partner 1,4,Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding,,ppi
6822,7983,154790,CLEC2L,C-type lectin domain family 2 member L,2,,,ppi
6823,7984,1277,COL1A1,collagen type I alpha 1 chain,70,extracellular matrix structural constituent conferring tensile strength|identical protein binding|platelet-derived growth factor binding|extracellular matrix structural constituent,aortic valve insufficiency|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|calcium metabolism disease|nephrocalcinosis|calcinosis|skin benign neoplasm|skin cancer|cellulitis|primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis|sensorineural hearing loss|amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C,ppi
6824,7985,1278,COL1A2,collagen type I alpha 2 chain,43,extracellular matrix structural constituent|extracellular matrix structural constituent conferring tensile strength|protein binding; bridging|identical protein binding|platelet-derived growth factor binding,aortic valve insufficiency|sensorineural hearing loss|amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia,ppi
6825,7986,154865,IQUB,IQ motif and ubiquitin domain containing,20,,,ppi
6826,7987,23145,SSPO,SCO-spondin,7,,,ppi
6827,7988,9507,ADAMTS4,ADAM metallopeptidase with thrombospondin type 1 motif 4,35,metalloendopeptidase activity|peptidase activity|metallopeptidase activity,,ppi
6828,7989,1280,COL2A1,collagen type II alpha 1 chain,46,extracellular matrix structural constituent conferring tensile strength|identical protein binding|platelet-derived growth factor binding|extracellular matrix structural constituent,arthropathy|arthritis|chondrosarcoma|isolated cleft palate|cleft palate|clubfoot|pseudosarcomatous fibromatosis|sensorineural hearing loss|achondroplasia|Laron syndrome|congestive heart failure|Maffucci syndrome|hereditary multiple exostoses|Ollier disease|enophthalmos|orbital disease|exophthalmos|glaucoma|osteoarthritis|inguinal hernia,ppi
6829,7990,644150,WIPF3,WAS/WASL interacting protein family member 3,5,actin filament binding,,ppi
6830,7991,222950,NYAP1,neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1,7,,,ppi
6831,7992,1281,COL3A1,collagen type III alpha 1 chain,20,integrin binding|extracellular matrix structural constituent|extracellular matrix structural constituent conferring tensile strength|platelet-derived growth factor binding,alopecia|aortic valve insufficiency|clubfoot|cryptorchidism|dental caries|osteogenesis imperfecta|Ehlers-Danlos syndrome|enophthalmos|orbital disease|exophthalmos|fatty liver disease|gingival disease|epulis|glaucoma|inguinal hernia|hyperglycemia|Zollinger-Ellison syndrome|hyperinsulinism|hypertension|essential hypertension,ppi
6832,7993,1282,COL4A1,collagen type IV alpha 1 chain,36,extracellular matrix structural constituent|extracellular matrix structural constituent conferring tensile strength|platelet-derived growth factor binding,hemolytic anemia|epilepsy|alternating exotropia|exotropia|monocular exotropia|focal segmental glomerulosclerosis|hemiplegia|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|cystic kidney disease|intellectual disability|learning disability|lipoid nephrosis,ppi
6833,7994,1284,COL4A2,collagen type IV alpha 2 chain,52,extracellular matrix structural constituent|extracellular matrix structural constituent conferring tensile strength,epilepsy|hemiplegia|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|visual epilepsy|lung small cell carcinoma|porencephaly,ppi
6834,7995,375607,NAT16,N-acetyltransferase 16 (putative),8,transferase activity; transferring acyl groups other than amino-acyl groups,,ppi
6835,7996,286006,LSMEM1,leucine rich single-pass membrane protein 1,3,,,ppi
6836,7997,1285,COL4A3,collagen type IV alpha 3 chain,22,integrin binding|structural molecule activity|metalloendopeptidase inhibitor activity|extracellular matrix structural constituent,sensorineural hearing loss|nephritis|glomerulonephritis|kidney disease|hypertension|essential hypertension|myopia|Alport syndrome|calcium metabolism disease|nephrocalcinosis|calcinosis|hypercalcemia|phosphorus metabolism disease|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|proteinuria|cataract|autosomal dominant Alport syndrome|autosomal recessive Alport syndrome,ppi
6837,7998,285598,ARL10,ADP ribosylation factor like GTPase 10,25,,,ppi
6838,8000,342977,NANOS3,nanos C2HC-type zinc finger 3,3,RNA binding,,ppi
6839,8001,10087,COL4A3BP,collagen type IV alpha 3 binding protein,27,ceramide binding|intermembrane ceramide transfer activity|ceramide 1-phosphate transporter activity|phosphatidylinositol-4-phosphate binding|ceramide 1-phosphate binding|lipid binding,bruxism|lung cancer|non-small cell lung carcinoma|sensorineural hearing loss|intellectual disability|learning disability|stereotypic movement disorder|oligohydramnios|cortical blindness|visual epilepsy,ppi
6840,8002,135932,TMEM139,transmembrane protein 139,3,,,ppi
6841,8003,1286,COL4A4,collagen type IV alpha 4 chain,13,extracellular matrix structural constituent,sensorineural hearing loss|hypertension|essential hypertension|myopia|nephritis|glomerulonephritis|kidney disease|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|proteinuria|cataract|Alport syndrome|autosomal dominant Alport syndrome|autosomal recessive Alport syndrome,ppi
6842,8004,1287,COL4A5,collagen type IV alpha 5 chain,32,extracellular matrix structural constituent,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
6843,8005,1288,COL4A6,collagen type IV alpha 6 chain,18,extracellular matrix structural constituent,sensorineural hearing loss|X-linked nonsyndromic deafness,ppi
6844,8006,203547,VMA21,VMA21 vacuolar H+-ATPase homolog (S. cerevisiae),32,,,ppi
6845,8007,1289,COL5A1,collagen type V alpha 1 chain,24,integrin binding|heparin binding|extracellular matrix structural constituent conferring tensile strength|platelet-derived growth factor binding|extracellular matrix structural constituent,clubfoot|cryptorchidism|dental caries|enophthalmos|orbital disease|exophthalmos|esophagitis|peptic esophagitis|gastroesophageal reflux disease|glaucoma|inguinal hernia|umbilical hernia|omphalocele|hypokalemia|mitral valve insufficiency|mitral valve prolapse|myopia|syringoma|skin papilloma|hidradenoma,ppi
6846,8008,11096,ADAMTS5,ADAM metallopeptidase with thrombospondin type 1 motif 5,3,metalloendopeptidase activity|integrin binding|metallopeptidase activity,,ppi
6847,8009,1290,COL5A2,collagen type V alpha 2 chain,6,extracellular matrix structural constituent conferring tensile strength|extracellular matrix structural constituent,clubfoot|esophagitis|peptic esophagitis|gastroesophageal reflux disease|inguinal hernia|umbilical hernia|omphalocele|liver cirrhosis|mitral valve insufficiency|mitral valve prolapse|myopia|arthropathy|arthritis|varicose veins|congenital diaphragmatic hernia|aortic aneurysm|type I Ehlers-Danlos syndrome,ppi
6848,8010,1291,COL6A1,collagen type VI alpha 1 chain,30,extracellular matrix structural constituent conferring tensile strength|platelet-derived growth factor binding,heart disease|cardiovascular system disease|clubfoot|pseudosarcomatous fibromatosis|lung benign neoplasm|familial periodic paralysis|myopathy|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J,ppi
6849,8011,1292,COL6A2,collagen type VI alpha 2 chain,33,extracellular matrix structural constituent conferring tensile strength,heart disease|cardiovascular system disease|clubfoot|pseudosarcomatous fibromatosis|familial periodic paralysis|myopathy|arthropathy|arthritis|focal hand dystonia|blepharospasm|muscular atrophy|Bell's palsy|facial paralysis|Ullrich congenital muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C,ppi
6850,8013,1293,COL6A3,collagen type VI alpha 3 chain,6,extracellular matrix structural constituent conferring tensile strength,heart disease|cardiovascular system disease|clubfoot|pseudosarcomatous fibromatosis|familial periodic paralysis|myopathy|focal hand dystonia|blepharospasm|dystonia|generalized dystonia|Bell's palsy|facial paralysis|Ullrich congenital muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D,ppi
6851,8015,1294,COL7A1,collagen type VII alpha 1 chain,22,extracellular matrix structural constituent conferring tensile strength,alopecia|anemia|macrocytic anemia|blepharitis|tongue squamous cell carcinoma|squamous cell carcinoma|angular cheilitis|cheilitis|lip disease|large intestine cancer|colorectal cancer|conjunctivitis|constipation|pseudosarcomatous fibromatosis|dental caries|dental enamel hypoplasia|ectropion|tongue disease|osteoporosis|epidermolysis bullosa dystrophica,ppi
6852,8016,56975,FAM20C,FAM20C; golgi associated secretory pathway kinase,70,protein serine/threonine kinase activity|manganese ion binding|phosphotransferase activity; alcohol group as acceptor,,ppi
6853,8017,389125,MUSTN1,musculoskeletal; embryonic nuclear protein 1,1,,,ppi
6854,8019,1295,COL8A1,collagen type VIII alpha 1 chain,24,extracellular matrix structural constituent conferring tensile strength|extracellular matrix structural constituent,tuberous sclerosis|Marfan syndrome|situs inversus,ppi
6855,8020,1296,COL8A2,collagen type VIII alpha 2 chain,16,extracellular matrix structural constituent|extracellular matrix structural constituent conferring tensile strength|protein binding; bridging,corneal dystrophy|recurrent corneal erosion|Chandler syndrome|Fuchs' endothelial dystrophy|corneal degeneration|posterior polymorphous corneal dystrophy|posterior polymorphous corneal dystrophy 1|posterior polymorphous corneal dystrophy 2,ppi
6856,8021,1297,COL9A1,collagen type IX alpha 1 chain,11,extracellular matrix structural constituent conferring tensile strength|extracellular matrix structural constituent,suppression amblyopia|amblyopia|astigmatism|isolated cleft palate|cleft palate|sensorineural hearing loss|osteochondrodysplasia|multiple epiphyseal dysplasia|myopia|arthropathy|arthritis|mucopolysaccharidosis IV|retinal detachment|retinitis|retinal disease|cataract|chondrodysplasia punctata,ppi
6857,8022,1298,COL9A2,collagen type IX alpha 2 chain,8,extracellular matrix structural constituent conferring tensile strength|extracellular matrix structural constituent,suppression amblyopia|amblyopia|astigmatism|isolated cleft palate|cleft palate|sensorineural hearing loss|myopia|arthropathy|arthritis|retinal detachment|cataract|chondrodysplasia punctata|osteoarthritis|osteogenesis imperfecta|Ehlers-Danlos syndrome|multiple epiphyseal dysplasia,ppi
6858,8023,255374,MBLAC1,metallo-beta-lactamase domain containing 1,2,,,ppi
6859,8024,1299,COL9A3,collagen type IX alpha 3 chain,4,extracellular matrix structural constituent conferring tensile strength|extracellular matrix structural constituent,suppression amblyopia|amblyopia|astigmatism|isolated cleft palate|cleft palate|sensorineural hearing loss|myopia|arthropathy|arthritis|retinal detachment|cataract|chondrodysplasia punctata|multiple epiphyseal dysplasia,ppi
6860,8025,9805,SCRN1,secernin 1,19,,arthropathy|arthritis|stomach cancer,ppi
6861,8026,23008,KLHDC10,kelch domain containing 10,16,,,ppi
6862,8027,23072,HECW1,HECT; C2 and WW domain containing E3 ubiquitin protein ligase 1,22,ubiquitin protein ligase activity,,ppi
6863,8028,23148,NACAD,NAC alpha domain containing,15,,,ppi
6864,8029,9907,AP5Z1,adaptor related protein complex 5 zeta 1 subunit,5,,paraplegia|hereditary spastic paraplegia 48,ppi
6865,8030,26024,PTCD1,pentatricopeptide repeat domain 1,30,tRNA binding|RNA binding,,ppi
6866,8031,23242,COBL,cordon-bleu WH2 repeat protein,31,actin monomer binding,,ppi
6867,8032,11174,ADAMTS6,ADAM metallopeptidase with thrombospondin type 1 motif 6,2,metallopeptidase activity,,ppi
6868,8033,10584,COLEC10,collectin subfamily member 10,14,serine-type endopeptidase activity|chemoattractant activity|mannose binding|monosaccharide binding,,ppi
6869,8034,9865,TRIL,TLR4 interactor with leucine rich repeats,1,lipopolysaccharide binding,,ppi
6870,8035,9747,TCAF1,TRPM8 channel associated factor 1,27,ion channel binding,,ppi
6871,8036,9715,FAM131B,family with sequence similarity 131 member B,31,,,ppi
6872,8037,9678,PHF14,PHD finger protein 14,21,,,ppi
6873,8038,23382,AHCYL2,adenosylhomocysteinase like 2,67,adenosylhomocysteinase activity,prostate cancer|prostate carcinoma,ppi
6874,8039,23333,DPY19L1,dpy-19 like 1,15,mannosyltransferase activity,,ppi
6875,8040,23366,KIAA0895,KIAA0895,1,,,ppi
6876,8041,221981,THSD7A,thrombospondin type 1 domain containing 7A,4,,,ppi
6877,8042,23386,NUDCD3,NudC domain containing 3,124,unfolded protein binding,liver cancer,ppi
6878,8043,57464,STRIP2,striatin interacting protein 2,19,,,ppi
6879,8044,222255,ATXN7L1,ataxin 7 like 1,7,,,ppi
6880,8045,57488,ESYT2,extended synaptotagmin 2,28,calcium ion binding|calcium-dependent phospholipid binding|phosphatidylethanolamine binding|phosphatidylcholine binding|phosphatidylinositol binding|cadherin binding,,ppi
6881,8046,27147,DENND2A,DENN domain containing 2A,1,Rab guanyl-nucleotide exchange factor activity,,ppi
6882,8047,27153,ZNF777,zinc finger protein 777,10,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6883,8048,25851,TECPR1,tectonin beta-propeller repeat containing 1,11,phosphatidylinositol-3-phosphate binding,,ppi
6884,8049,54467,ANKIB1,ankyrin repeat and IBR domain containing 1,5,ubiquitin conjugating enzyme binding|ubiquitin protein ligase activity,,ppi
6885,8050,57670,KIAA1549,KIAA1549,21,DNA-binding transcription factor activity; RNA polymerase II-specific,astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|juvenile astrocytoma,ppi
6886,8052,80727,TTYH3,tweety family member 3,26,intracellular calcium activated chloride channel activity|chloride channel activity|volume-sensitive chloride channel activity,,ppi
6887,8053,80820,EEPD1,endonuclease/exonuclease/phosphatase family domain containing 1,12,,,ppi
6888,8055,64753,CCDC136,coiled-coil domain containing 136,78,,,ppi
6889,8056,55698,RADIL,Rap associating with DIL domain,34,,,ppi
6890,8057,84626,KRBA1,KRAB-A domain containing 1,23,,,ppi
6891,8058,83637,ZMIZ2,zinc finger MIZ-type containing 2,25,nuclear receptor transcription coactivator activity,,ppi
6892,8059,155185,AMZ1,archaelysin family metallopeptidase 1,12,peptidase activity,,ppi
6893,8060,253980,KCTD13,potassium channel tetramerization domain containing 13,27,GTP-Rho binding|ubiquitin-protein transferase activity,,ppi
6894,8061,200845,KCTD6,potassium channel tetramerization domain containing 6,28,ankyrin binding|cullin family protein binding,,ppi
6895,8063,8292,COLQ,collagen like tail subunit of asymmetric acetylcholinesterase,18,extracellular matrix structural constituent|heparin binding,ptosis|congenital ptosis|ophthalmoplegia,ppi
6896,8065,168620,BHLHA15,basic helix-loop-helix family member a15,44,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
6897,8066,1311,COMP,cartilage oligomeric matrix protein,7,extracellular matrix structural constituent|calcium ion binding|collagen binding|heparin binding|heparan sulfate proteoglycan binding|fibronectin binding|protease binding|vitamin D binding,arthropathy|Legg-Calve-Perthes disease|arthritis|osteoarthritis|sensory peripheral neuropathy|chondrodysplasia punctata|pseudoachondroplasia|osteogenesis imperfecta|Ehlers-Danlos syndrome|multiple epiphyseal dysplasia,ppi
6898,8067,1312,COMT,catechol-O-methyltransferase,26,methyltransferase activity|O-methyltransferase activity|catechol O-methyltransferase activity,bipolar disorder|mood disorder|alcohol dependence|alcohol abuse|autistic disorder|disease of mental health|ptosis|congenital ptosis|isolated cleft palate|cleft palate|constipation|dental caries|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|DiGeorge syndrome|velocardiofacial syndrome,ppi
6899,8068,340543,TCEAL5,transcription elongation factor A like 5,4,WW domain binding,,ppi
6900,8069,11173,ADAMTS7,ADAM metallopeptidase with thrombospondin type 1 motif 7,2,metalloendopeptidase activity|metallopeptidase activity,polycystic ovary syndrome|coronary artery disease,ppi
6901,8070,1314,COPA,coatomer protein complex subunit alpha,104,,arthropathy|arthritis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|interstitial lung disease,ppi
6902,8071,222068,TMED4,transmembrane p24 trafficking protein 4,25,,,ppi
6903,8072,1315,COPB1,coatomer protein complex subunit beta 1,107,,,ppi
6904,8073,222171,PRR15,proline rich 15,2,,,ppi
6905,8074,223082,ZNRF2,zinc and ring finger 2,22,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
6906,8075,9276,COPB2,coatomer protein complex subunit beta 2,73,,,ppi
6907,8076,11316,COPE,coatomer protein complex subunit epsilon,54,,,ppi
6908,8077,1316,KLF6,Kruppel like factor 6,20,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|double-stranded DNA binding,prostate cancer|prostate carcinoma|stomach cancer|stomach carcinoma,ppi
6909,8078,22820,COPG1,coatomer protein complex subunit gamma 1,87,,malignant mesothelioma|benign mesothelioma,ppi
6910,8079,26958,COPG2,coatomer protein complex subunit gamma 2,44,,,ppi
6911,8080,8533,COPS3,COP9 signalosome subunit 3,94,,,ppi
6912,8081,339479,BRINP3,BMP/retinoic acid inducible neural specific 3,18,,,ppi
6913,8082,386617,KCTD8,potassium channel tetramerization domain containing 8,3,,,ppi
6914,8083,90693,CCDC126,coiled-coil domain containing 126,3,,,ppi
6915,8085,10987,COPS5,COP9 signalosome subunit 5,785,transcription coactivator activity|translation initiation factor activity|thiol-dependent ubiquitin-specific protease activity|metallopeptidase activity|NEDD8-specific protease activity,Stevens-Johnson syndrome|liver cancer|hepatocellular carcinoma,ppi
6916,8086,54793,KCTD9,potassium channel tetramerization domain containing 9,37,protein self-association|cullin family protein binding,,ppi
6917,8089,54664,TMEM106B,transmembrane protein 106B,3,,,ppi
6918,8090,79065,ATG9A,autophagy related 9A,60,,,ppi
6919,8093,84262,PSMG3,proteasome assembly chaperone 3,51,,,ppi
6920,8094,84310,C7orf50,chromosome 7 open reading frame 50,29,RNA binding,,ppi
6921,8096,92092,ZC3HAV1L,zinc finger CCCH-type containing; antiviral 1 like,18,,,ppi
6922,8098,22818,COPZ1,coatomer protein complex subunit zeta 1,29,,,ppi
6923,8100,78996,C7orf49,chromosome 7 open reading frame 49,1,,,ppi
6924,8101,10229,COQ7,coenzyme Q7; hydroxylase,22,,,ppi
6925,8105,9969,MED13,mediator complex subunit 13,51,transcription coregulator activity|transcription coactivator activity|nuclear receptor transcription coactivator activity|signaling receptor activity|vitamin D receptor binding|thyroid hormone receptor binding,,ppi
6926,8106,103,ADAR,adenosine deaminase; RNA specific,72,RNA binding|double-stranded RNA adenosine deaminase activity|double-stranded RNA binding|tRNA-specific adenosine deaminase activity,generalized dystonia|torsion dystonia 1|holoprosencephaly|dyschromatosis symmetrica hereditaria|striatonigral degeneration|Aicardi-Goutieres syndrome|porencephaly,ppi
6927,8107,474382,H2AFB1,H2A histone family member B1,2,DNA binding,,ppi
6928,8108,11151,CORO1A,coronin 1A,53,RNA binding|actin monomer binding|cytoskeletal protein binding|protein homodimerization activity|phosphatidylinositol 3-kinase binding|actin filament binding,primary immunodeficiency disease|lymphopenia|tuberculosis,ppi
6929,8109,57175,CORO1B,coronin 1B,71,identical protein binding|cadherin binding|actin filament binding|Arp2/3 complex binding,,ppi
6930,8110,23603,CORO1C,coronin 1C,115,actin filament binding,lung cancer|non-small cell lung carcinoma|IgA glomerulonephritis,ppi
6931,8111,7464,CORO2A,coronin 2A,35,,,ppi
6932,8112,10391,CORO2B,coronin 2B,10,actin binding,,ppi
6933,8114,1325,CORT,cortistatin,9,neuropeptide hormone activity|G-protein coupled receptor binding|double-stranded DNA binding|chromatin binding,,ppi
6934,8115,10495,ENOX2,ecto-NOX disulfide-thiol exchanger 2,12,protein disulfide oxidoreductase activity,malignant mesothelioma|benign mesothelioma,ppi
6935,8116,104,ADARB1,adenosine deaminase; RNA specific B1,24,RNA binding|double-stranded RNA adenosine deaminase activity|mRNA binding|tRNA-specific adenosine deaminase activity|double-stranded RNA binding,bipolar disorder|polycystic ovary syndrome|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
6936,8117,1352,COX10,COX10; heme A:farnesyltransferase cytochrome c oxidase assembly factor,1,farnesyltranstransferase activity|protoheme IX farnesyltransferase activity|cytochrome-c oxidase activity,lactic acidosis|anemia|macrocytic anemia|ptosis|congenital ptosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|dystonia|epilepsy|sensorineural hearing loss|hypertrichosis|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia,ppi
6937,8118,1353,COX11,COX11; cytochrome c oxidase copper chaperone,11,cytochrome-c oxidase activity|electron transfer activity,,ppi
6938,8119,1355,COX15,COX15; cytochrome c oxidase assembly homolog,24,cytochrome-c oxidase activity|oxidoreductase activity; acting on the CH-CH group of donors|oxidoreductase activity; acting on NAD(P)H; heme protein as acceptor,lactic acidosis|ptosis|congenital ptosis|cerebellar disease|dystonia|epilepsy|sensorineural hearing loss|hypertrichosis|Leigh disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
6939,8120,10063,COX17,COX17; cytochrome c oxidase copper chaperone,27,copper ion binding|copper chaperone activity|cuprous ion binding,hepatitis|lung benign neoplasm,ppi
6940,8122,1327,COX4I1,cytochrome c oxidase subunit 4I1,69,cytochrome-c oxidase activity,,ppi
6941,8123,283820,NOMO2,NODAL modulator 2,13,,,ppi
6942,8124,9377,COX5A,cytochrome c oxidase subunit 5A,67,electron transfer activity|cytochrome-c oxidase activity,,ppi
6943,8125,1329,COX5B,cytochrome c oxidase subunit 5B,46,cytochrome-c oxidase activity,coronary artery disease,ppi
6944,8126,105,ADARB2,adenosine deaminase; RNA specific B2 (inactive),8,RNA binding|double-stranded RNA binding|single-stranded RNA binding|double-stranded RNA adenosine deaminase activity|tRNA-specific adenosine deaminase activity,substance abuse|substance-related disorder,ppi
6945,8127,1337,COX6A1,cytochrome c oxidase subunit 6A1,15,cytochrome-c oxidase activity|enzyme regulator activity,Charcot-Marie-Tooth disease recessive intermediate D,ppi
6946,8129,389549,FEZF1,FEZ family zinc finger 1,2,DNA-binding transcription factor activity; RNA polymerase II-specific,isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|eunuchism,ppi
6947,8130,1339,COX6A2,cytochrome c oxidase subunit 6A2,11,enzyme regulator activity|cytochrome-c oxidase activity,,ppi
6948,8131,23536,ADAT1,adenosine deaminase; tRNA specific 1,3,RNA binding|tRNA-specific adenosine deaminase activity,,ppi
6949,8132,1340,COX6B1,cytochrome c oxidase subunit 6B1,43,cytochrome-c oxidase activity,lactic acidosis|anemia|macrocytic anemia|ptosis|congenital ptosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|intellectual disability|learning disability|optic atrophy|proteinuria|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|visual epilepsy|liver disease,ppi
6950,8133,346562,GNAT3,G protein subunit alpha transducin 3,4,GTPase activity|GTP binding|G-protein beta/gamma-subunit complex binding|G-protein coupled receptor binding,male infertility,ppi
6951,8135,1345,COX6C,cytochrome c oxidase subunit 6C,35,,,ppi
6952,8137,1347,COX7A2,cytochrome c oxidase subunit 7A2,20,,,ppi
6953,8139,9167,COX7A2L,cytochrome c oxidase subunit 7A2 like,15,,,ppi
6954,8140,1349,COX7B,cytochrome c oxidase subunit 7B,5,,Clouston syndrome|microphthalmia,ppi
6955,8141,54877,ZCCHC2,zinc finger CCHC-type containing 2,1,,influenza,ppi
6956,8143,79842,ZBTB3,zinc finger and BTB domain containing 3,25,,,ppi
6957,8144,1350,COX7C,cytochrome c oxidase subunit 7C,5,cytochrome-c oxidase activity,obesity,ppi
6958,8145,83884,SLC25A2,solute carrier family 25 member 2,2,L-ornithine transmembrane transporter activity,,ppi
6959,8146,29926,GMPPA,GDP-mannose pyrophosphorylase A,16,,adrenal cortical hypofunction|Addison's disease|epilepsy|megaesophagus|achalasia|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|intellectual disability|learning disability|visual epilepsy|blindness|triple-A syndrome|Horner's syndrome,ppi
6960,8147,90293,KLHL13,kelch like family member 13,30,ubiquitin-protein transferase activity,,ppi
6961,8148,29925,GMPPB,GDP-mannose pyrophosphorylase B,37,,cerebellar disease|isolated cleft palate|cleft palate|epilepsy|glaucoma|sensorineural hearing loss|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|intellectual disability|learning disability|familial periodic paralysis|myopathy|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B,ppi
6962,8149,143879,KBTBD3,kelch repeat and BTB domain containing 3,1,,,ppi
6963,8150,8189,SYMPK,symplekin,59,,stomach cancer,ppi
6964,8151,126204,NLRP13,NLR family pyrin domain containing 13,2,,,ppi
6965,8152,91662,NLRP12,NLR family pyrin domain containing 12,20,cysteine-type endopeptidase activator activity involved in apoptotic process,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
6966,8153,338323,NLRP14,NLR family pyrin domain containing 14,1,,,ppi
6967,8154,1351,COX8A,cytochrome c oxidase subunit 8A,4,,cytochrome-c oxidase deficiency disease,ppi
6968,8156,338321,NLRP9,NLR family pyrin domain containing 9,5,,,ppi
6969,8157,63923,TNN,tenascin N,4,,,ppi
6970,8158,147945,NLRP4,NLR family pyrin domain containing 4,8,,,ppi
6971,8161,79623,GALNT14,polypeptide N-acetylgalactosaminyltransferase 14,4,polypeptide N-acetylgalactosaminyltransferase activity,,ppi
6972,8162,199713,NLRP7,NLR family pyrin domain containing 7,2,aspartic-type endopeptidase inhibitor activity,gestational trophoblastic neoplasm,ppi
6973,8163,55655,NLRP2,NLR family pyrin domain containing 2,24,,,ppi
6974,8164,55635,DEPDC1,DEP domain containing 1,14,,,ppi
6975,8165,1356,CP,ceruloplasmin,16,ferroxidase activity|oxidoreductase activity; oxidizing metal ions,proteinuria|anemia|macrocytic anemia|rheumatoid arthritis|autistic disorder|focal hand dystonia|blepharospasm|brain disease|cerebellar disease|syndromic X-linked intellectual disability type 10|choreatic disease|colon cancer|colonic benign neoplasm|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetic ketoacidosis,ppi
6976,8166,80243,PREX2,phosphatidylinositol-3;4;5-trisphosphate dependent Rac exchange factor 2,7,GTPase activator activity|Rac guanyl-nucleotide exchange factor activity,,ppi
6977,8167,151556,GPR155,G protein-coupled receptor 155,2,,autistic disorder,ppi
6978,8169,64798,DEPTOR,DEP domain containing MTOR interacting protein,21,,,ppi
6979,8170,56983,POGLUT1,protein O-glucosyltransferase 1,27,UDP-glucosyltransferase activity|UDP-xylosyltransferase activity|glucosyltransferase activity,Dowling-Degos disease|reticulate acropigmentation of Kitamura,ppi
6980,8171,221409,SPATS1,spermatogenesis associated serine rich 1,3,,,ppi
6981,8172,9260,PDLIM7,PDZ and LIM domain 7,145,,,ppi
6982,8173,1357,CPA1,carboxypeptidase A1,1,metallocarboxypeptidase activity,,ppi
6983,8174,51170,HSD17B11,hydroxysteroid 17-beta dehydrogenase 11,11,estradiol 17-beta-dehydrogenase activity|steroid dehydrogenase activity,,ppi
6984,8175,23389,MED13L,mediator complex subunit 13 like,25,transcription coregulator activity,dextro-looped transposition of the great arteries 1|dextro-looped transposition of the great arteries 3|dextro-looped transposition of the great arteries|intellectual disability|learning disability,ppi
6985,8176,9862,MED24,mediator complex subunit 24,74,transcription coregulator activity|nuclear receptor transcription coactivator activity|signaling receptor activity|vitamin D receptor binding|thyroid hormone receptor binding,,ppi
6986,8177,9967,THRAP3,thyroid hormone receptor associated protein 3,136,RNA polymerase II distal enhancer sequence-specific DNA binding|transcription coregulator activity|transcription coactivator activity|RNA binding|nuclear receptor transcription coactivator activity|signaling receptor activity|vitamin D receptor binding|thyroid hormone receptor binding|phosphoprotein binding,,ppi
6987,8178,55670,PEX26,peroxisomal biogenesis factor 26,6,protein-containing complex binding,adrenal cortical hypofunction|Addison's disease|ptosis|congenital ptosis|cerebellar disease|recurrent corneal erosion|cryptorchidism|epilepsy|sensorineural hearing loss|hydronephrosis|gallbladder disease|liver disease|movement disease|lingual-facial-buccal dyskinesia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus,ppi
6988,8179,386677,KRTAP10-1,keratin associated protein 10-1,72,,,ppi
6989,8181,386682,KRTAP10-3,keratin associated protein 10-3,277,,,ppi
6990,8182,386680,KRTAP10-5,keratin associated protein 10-5,101,,,ppi
6991,8183,1358,CPA2,carboxypeptidase A2,6,carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding,,ppi
6992,8184,386675,KRTAP10-7,keratin associated protein 10-7,208,,,ppi
6993,8185,386676,KRTAP10-9,keratin associated protein 10-9,157,,,ppi
6994,8187,55206,SBNO1,strawberry notch homolog 1,12,,schizophrenia,ppi
6995,8188,80117,ARL14,ADP ribosylation factor like GTPase 14,5,GTP binding,,ppi
6996,8189,83998,REG4,regenerating family member 4,6,heparin binding|mannan binding|calcium ion binding|transmembrane signaling receptor activity,stomach cancer,ppi
6997,8190,9682,KDM4A,lysine demethylase 4A,47,zinc ion binding|histone demethylase activity|histone demethylase activity (H3-K9 specific)|methylated histone binding|histone demethylase activity (H3-K36 specific)|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|chromatin binding,,ppi
6998,8191,8273,SLC10A3,solute carrier family 10 member 3,2,,,ppi
6999,8195,9767,JADE3,jade family PHD finger 3,13,,,ppi
7000,8196,148479,PHF13,PHD finger protein 13,4,chromatin binding|methylated histone binding,,ppi
7001,8197,23338,JADE2,jade family PHD finger 2,21,,,ppi
7002,8198,143471,PSMA8,proteasome subunit alpha 8,37,endopeptidase activity,,ppi
7003,8199,85301,COL27A1,collagen type XXVII alpha 1 chain,1,extracellular matrix structural constituent,,ppi
7004,8203,91522,COL23A1,collagen type XXIII alpha 1 chain,3,extracellular matrix structural constituent,,ppi
7005,8204,123228,SENP8,SUMO/sentrin peptidase family member; NEDD8 specific,20,NEDD8-specific protease activity,,ppi
7006,8207,147798,TMC4,transmembrane channel like 4,1,ion channel activity|mechanosensitive ion channel activity,,ppi
7007,8208,79838,TMC5,transmembrane channel like 5,1,mechanosensitive ion channel activity|ion channel activity,,ppi
7008,8209,18,ABAT,4-aminobutyrate aminotransferase,35,4-aminobutyrate transaminase activity|pyridoxal phosphate binding|succinate-semialdehyde dehydrogenase binding,autistic disorder|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|leukodystrophy|visual epilepsy|GABA aminotransferase deficiency,ppi
7009,8210,1361,CPB2,carboxypeptidase B2,7,metallocarboxypeptidase activity,amenorrhea|obesity,ppi
7010,8211,79905,TMC7,transmembrane channel like 7,4,mechanosensitive ion channel activity|ion channel activity,,ppi
7011,8212,1362,CPD,carboxypeptidase D,22,metallocarboxypeptidase activity,,ppi
7012,8213,220002,CYB561A3,cytochrome b561 family member A3,2,oxidoreductase activity,,ppi
7013,8214,54757,FAM20A,FAM20A; golgi associated secretory pathway pseudokinase,5,protein serine/threonine kinase activator activity|protein serine/threonine kinase activity|phosphotransferase activity; alcohol group as acceptor,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia|gingival overgrowth|gingival hypertrophy,ppi
7014,8215,9917,FAM20B,FAM20B; glycosaminoglycan xylosylkinase,22,phosphotransferase activity; alcohol group as acceptor,,ppi
7015,8216,135886,WBSCR28,Williams-Beuren syndrome chromosome region 28,1,,,ppi
7016,8217,8233,ZRSR2,zinc finger CCCH-type; RNA binding motif and serine/arginine rich 2,48,pre-mRNA 3'-splice site binding,juvenile myelomonocytic leukemia,ppi
7017,8218,199746,U2AF1L4,U2 small nuclear RNA auxiliary factor 1 like 4,6,pre-mRNA 3'-splice site binding,,ppi
7018,8219,140883,ZNF280B,zinc finger protein 280B,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding,,ppi
7019,8220,23034,SAMD4A,sterile alpha motif domain containing 4A,18,RNA binding|translation repressor activity|mRNA binding,substance abuse|substance-related disorder,ppi
7020,8221,150684,COMMD1,copper metabolism domain containing 1,72,copper ion binding|phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3;4;5-trisphosphate binding|phosphatidylinositol-3;4-bisphosphate binding|phosphatidic acid binding|phosphatidylinositol-3;5-bisphosphate binding,hepatitis|allergic hypersensitivity disease|liver cirrhosis,ppi
7021,8223,84572,GNPTG,N-acetylglucosamine-1-phosphate transferase gamma subunit,15,protein homodimerization activity,pseudo-Hurler polydystrophy,ppi
7022,8224,64174,DPEP2,dipeptidase 2,24,,,ppi
7023,8225,64180,DPEP3,dipeptidase 3,5,,,ppi
7024,8226,1363,CPE,carboxypeptidase E,29,carboxypeptidase activity|metallocarboxypeptidase activity,endocrine system disease|obesity,ppi
7025,8227,124359,CDYL2,chromodomain Y-like 2,9,transcription corepressor activity,,ppi
7026,8228,90390,MED30,mediator complex subunit 30,44,transcription coregulator activity|nuclear receptor transcription coactivator activity|signaling receptor activity|vitamin D receptor binding|thyroid hormone receptor binding,,ppi
7027,8229,154043,CNKSR3,CNKSR family member 3,11,,,ppi
7028,8230,84456,L3MBTL3,l(3)mbt-like 3 (Drosophila),43,,medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
7029,8232,55788,LMBRD1,LMBR1 domain containing 1,5,cobalamin-transporting ATPase activity,methylmalonic aciduria and homocystinuria type cblF,ppi
7030,8233,23376,UFL1,UFM1 specific ligase 1,31,UFM1 transferase activity,,ppi
7031,8234,57673,BEND3,BEN domain containing 3,22,rDNA binding,,ppi
7032,8235,57107,PDSS2,decaprenyl diphosphate synthase subunit 2,12,protein heterodimerization activity|trans-hexaprenyltranstransferase activity,coenzyme Q10 deficiency disease,ppi
7033,8236,340719,NANOS1,nanos C2HC-type zinc finger 1,6,translation repressor activity,malignant mesothelioma|benign mesothelioma,ppi
7034,8237,84071,ARMC2,armadillo repeat containing 2,2,,,ppi
7035,8238,134829,CLVS2,clavesin 2,3,phosphatidylinositol-3;5-bisphosphate binding,schizophrenia,ppi
7036,8239,51768,TM7SF3,transmembrane 7 superfamily member 3,2,,,ppi
7037,8240,221079,ARL5B,ADP ribosylation factor like GTPase 5B,18,GTP binding,melanoma|skin melanoma,ppi
7038,8241,349667,RTN4RL2,reticulon 4 receptor-like 2,3,signaling receptor activity,,ppi
7039,8242,10195,ALG3,ALG3; alpha-1;3- mannosyltransferase,15,alpha-1;3-mannosyltransferase activity,clubfoot|epilepsy|optic atrophy|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|isolated cleft palate|celiac disease|infantile epileptic encephalopathy|congenital disorder of glycosylation type I,ppi
7040,8243,55845,BRK1,BRICK1; SCAR/WAVE actin nucleating complex subunit,33,protein-containing complex binding|Rac GTPase binding,,ppi
7041,8244,63827,BCAN,brevican,16,,,ppi
7042,8245,143686,SESN3,sestrin 3,4,oxidoreductase activity; acting on peroxide as acceptor|leucine binding,prostate cancer|prostate carcinoma,ppi
7043,8246,151531,UPP2,uridine phosphorylase 2,2,uridine phosphorylase activity,autistic disorder,ppi
7044,8248,55270,NUDT15,nudix hydrolase 15,4,8-oxo-7;8-dihydroguanosine triphosphate pyrophosphatase activity|nucleoside-diphosphatase activity|8-oxo-7;8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity|nucleoside-triphosphate diphosphatase activity,,ppi
7045,8249,119391,GSTO2,glutathione S-transferase omega 2,12,glutathione transferase activity|oxidoreductase activity|glutathione dehydrogenase (ascorbate) activity,urinary bladder cancer,ppi
7046,8250,122553,TRAPPC6B,trafficking protein particle complex 6B,18,Rab guanyl-nucleotide exchange factor activity,,ppi
7047,8251,126003,TRAPPC5,trafficking protein particle complex 5,37,Rab guanyl-nucleotide exchange factor activity,,ppi
7048,8252,6399,TRAPPC2,trafficking protein particle complex 2,48,Rab guanyl-nucleotide exchange factor activity,osteoarthritis|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV,ppi
7049,8253,79090,TRAPPC6A,trafficking protein particle complex 6A,18,Rab guanyl-nucleotide exchange factor activity,,ppi
7050,8254,55588,MED29,mediator complex subunit 29,95,,,ppi
7051,8256,55611,OTUB1,OTU deubiquitinase; ubiquitin aldehyde binding 1,393,thiol-dependent ubiquitin-specific protease activity|NEDD8-specific protease activity|ubiquitin binding,,ppi
7052,8257,83714,NRIP2,nuclear receptor interacting protein 2,6,,,ppi
7053,8259,84236,RHBDD1,rhomboid domain containing 1,14,endopeptidase activity|serine-type endopeptidase activity,,ppi
7054,8260,57414,RHBDD2,rhomboid domain containing 2,11,,,ppi
7055,8261,115703,ARHGAP33,Rho GTPase activating protein 33,3,GTPase activator activity,,ppi
7056,8262,158880,USP51,ubiquitin specific peptidase 51,5,chromatin binding|thiol-dependent ubiquitin-specific protease activity|histone binding,,ppi
7057,8263,124935,SLC43A2,solute carrier family 43 member 2,3,amino acid transmembrane transporter activity|L-amino acid transmembrane transporter activity|neutral amino acid transmembrane transporter activity,,ppi
7058,8264,84068,SLC10A7,solute carrier family 10 member 7,10,,cholestasis,ppi
7059,8265,284111,SLC13A5,solute carrier family 13 member 5,2,citrate transmembrane transporter activity|sodium:dicarboxylate symporter activity|succinate transmembrane transporter activity,fatty liver disease,ppi
7060,8266,10815,CPLX1,complexin 1,38,SNARE binding,bipolar disorder|ptosis|congenital ptosis|cleft lip|isolated cleft palate|cleft palate|clubfoot|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|enophthalmos|orbital disease|exophthalmos|placental insufficiency|esophagitis|peptic esophagitis,ppi
7061,8267,121260,SLC15A4,solute carrier family 15 member 4,11,peptide:proton symporter activity|peptide transmembrane transporter activity|L-histidine transmembrane transporter activity|oligopeptide transmembrane transporter activity,systemic lupus erythematosus,ppi
7062,8268,115584,SLC5A11,solute carrier family 5 member 11,2,polyol transmembrane transporter activity,,ppi
7063,8269,157724,SLC7A13,solute carrier family 7 member 13,1,L-amino acid transmembrane transporter activity,,ppi
7064,8270,162515,SLC16A11,solute carrier family 16 member 11,4,pyruvate transmembrane transporter activity|monocarboxylic acid transmembrane transporter activity,,ppi
7065,8272,51310,SLC22A17,solute carrier family 22 member 17,1,transmembrane signaling receptor activity|transmembrane transporter activity,,ppi
7066,8273,55315,SLC29A3,solute carrier family 29 member 3,1,nucleoside transmembrane transporter activity,sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|systemic scleroderma|scleroderma|localized scleroderma|diabetic ketoacidosis|diabetes mellitus|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9,ppi
7067,8275,26127,FGFR1OP2,FGFR1 oncogene partner 2,52,protein tyrosine kinase activity,myeloproliferative neoplasm|bone marrow cancer,ppi
7068,8276,10814,CPLX2,complexin 2,12,SNARE binding|syntaxin-1 binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
7069,8277,79633,FAT4,FAT atypical cadherin 4,22,,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|melanoma|skin melanoma|stomach cancer|esophagus squamous cell carcinoma|Hennekam syndrome|cystic kidney disease|autosomal dominant polycystic kidney disease|Van Maldergem syndrome|periventricular nodular heterotopia,ppi
7070,8278,1368,CPM,carboxypeptidase M,23,carboxypeptidase activity|metallocarboxypeptidase activity,endometriosis of uterus|endometriosis|asbestosis|anthracosilicosis|silicosis,ppi
7071,8279,54798,DCHS2,dachsous cadherin-related 2,1,,,ppi
7072,8280,120114,FAT3,FAT atypical cadherin 3,20,,esophagus squamous cell carcinoma,ppi
7073,8281,80237,ELL3,elongation factor for RNA polymerase II 3,19,enhancer binding,,ppi
7074,8282,8178,ELL,elongation factor for RNA polymerase II,34,phosphatase binding,,ppi
7075,8283,55840,EAF2,ELL associated factor 2,19,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific,lung benign neoplasm|prostate cancer|prostate carcinoma|lymphosarcoma|B-cell lymphoma|liver cancer|hepatocellular carcinoma,ppi
7076,8284,59343,SENP2,SUMO1/sentrin/SMT3 specific peptidase 2,36,SUMO-specific endopeptidase activity,,ppi
7077,8285,54827,NXPE4,neurexophilin and PC-esterase domain family member 4,2,,,ppi
7078,8286,1369,CPN1,carboxypeptidase N subunit 1,9,metallocarboxypeptidase activity,skin disease|seborrheic keratosis|actinic keratosis,ppi
7079,8287,1370,CPN2,carboxypeptidase N subunit 2,4,metallocarboxypeptidase activity|enzyme regulator activity,,ppi
7080,8288,26151,NAT9,N-acetyltransferase 9 (putative),13,,,ppi
7081,8289,79005,SCNM1,sodium channel modifier 1,53,,,ppi
7082,8290,284996,RNF149,ring finger protein 149,24,ubiquitin protein ligase activity,,ppi
7083,8291,57484,RNF150,ring finger protein 150,13,ubiquitin protein ligase activity,,ppi
7084,8292,157807,CLVS1,clavesin 1,1,phosphatidylinositol-3;5-bisphosphate binding,,ppi
7085,8293,8904,CPNE1,copine 1,33,phosphatidylserine binding|endopeptidase activity|transporter activity|calcium ion binding|calcium-dependent phospholipid binding|protein homodimerization activity,,ppi
7086,8294,83854,ANGPTL6,angiopoietin like 6,1,,,ppi
7087,8296,83851,SYT16,synaptotagmin 16,16,,,ppi
7088,8297,255928,SYT14,synaptotagmin 14,1,,autosomal recessive spinocerebellar ataxia 11,ppi
7089,8298,389692,MAFA,MAF bZIP transcription factor A,12,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|protein homodimerization activity|protein heterodimerization activity|sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
7090,8299,164091,PAQR7,progestin and adipoQ receptor family member 7,2,signaling receptor activity,,ppi
7091,8300,201294,UNC13D,unc-13 homolog D,11,Rab GTPase binding,hemophagocytic lymphohistiocytosis,ppi
7092,8301,55344,PLCXD1,phosphatidylinositol specific phospholipase C X domain containing 1,2,,,ppi
7093,8302,440279,UNC13C,unc-13 homolog C,1,syntaxin-1 binding|calmodulin binding,,ppi
7094,8303,221184,CPNE2,copine 2,58,calcium-dependent phospholipid binding,,ppi
7095,8304,23025,UNC13A,unc-13 homolog A,69,calmodulin binding|syntaxin-1 binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|muscular atrophy|neurodegenerative disease,ppi
7096,8305,83706,FERMT3,fermitin family member 3,37,integrin binding,blood platelet disease|osteopetrosis|osteosclerosis|leukocyte adhesion deficiency,ppi
7097,8306,168544,ZNF467,zinc finger protein 467,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7098,8308,11338,U2AF2,U2 small nuclear RNA auxiliary factor 2,395,RNA binding|pre-mRNA 3'-splice site binding|poly-pyrimidine tract binding,,ppi
7099,8309,29929,ALG6,ALG6; alpha-1;3-glucosyltransferase,10,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity|glucosyltransferase activity|dolichyl pyrophosphate Man9GlcNAc2 alpha-1;3-glucosyltransferase activity,cerebellar disease|epilepsy|factor XI deficiency|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|thrombophilia|protein S deficiency|antithrombin III deficiency|protein C deficiency|congenital disorder of glycosylation type I,ppi
7100,8310,55629,PNRC2,proline rich nuclear receptor coactivator 2,24,,,ppi
7101,8311,85365,ALG2,ALG2; alpha-1;3/1;6-mannosyltransferase,18,alpha-1;3-mannosyltransferase activity|calcium-dependent protein binding,congenital disorder of glycosylation type I|congenital myasthenic syndrome,ppi
7102,8312,8895,CPNE3,copine 3,24,RNA binding|protein serine/threonine kinase activity|transporter activity|calcium-dependent phospholipid binding|calcium-dependent protein binding|receptor tyrosine kinase binding,prostate cancer|prostate carcinoma,ppi
7103,8313,112483,SAT2,spermidine/spermine N1-acetyltransferase family member 2,7,diamine N-acetyltransferase activity|N-acetyltransferase activity|spermidine binding,,ppi
7104,8314,79053,ALG8,ALG8; alpha-1;3-glucosyltransferase,27,alpha-1;3-mannosyltransferase activity|dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity|dolichyl pyrophosphate Man9GlcNAc2 alpha-1;3-glucosyltransferase activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|congenital disorder of glycosylation type I,ppi
7105,8315,84920,ALG10,ALG10; alpha-1;2-glucosyltransferase,24,,,ppi
7106,8316,378708,CENPS,centromere protein S,23,DNA binding|chromatin binding|double-stranded DNA binding,,ppi
7107,8317,87178,PNPT1,polyribonucleotide nucleotidyltransferase 1,37,3'-5'-exoribonuclease activity|RNA binding|polyribonucleotide nucleotidyltransferase activity|poly(U) RNA binding|poly(G) binding|miRNA binding,autosomal recessive nonsyndromic deafness 70|liver cancer|hepatocellular carcinoma|combined oxidative phosphorylation deficiency,ppi
7108,8318,57697,FANCM,Fanconi anemia complementation group M,40,chromatin binding,Fanconi anemia,ppi
7109,8319,51637,C14orf166,chromosome 14 open reading frame 166,80,RNA polymerase II complex binding|RNA binding,,ppi
7110,8320,131034,CPNE4,copine 4,39,calcium-dependent phospholipid binding,,ppi
7111,8321,11169,WDHD1,WD repeat and HMG-box DNA binding protein 1,49,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding,,ppi
7112,8323,163778,SPRR4,small proline rich protein 4,1,structural molecule activity,,ppi
7113,8324,127435,PODN,podocan,6,collagen binding|extracellular matrix structural constituent conferring compression resistance,,ppi
7114,8326,9817,KEAP1,kelch like ECH associated protein 1,124,transcription factor binding,lung cancer|non-small cell lung carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|gallbladder cancer|gastroenteritis|intestinal disease|gastrointestinal system disease|proctitis|keratosis|prostate cancer|prostate carcinoma,ppi
7115,8327,388561,ZNF761,zinc finger protein 761,2,,,ppi
7116,8328,57699,CPNE5,copine 5,30,calcium-dependent phospholipid binding,,ppi
7117,8329,10156,RASA4,RAS p21 protein activator 4,7,GTPase activator activity,,ppi
7118,8330,9685,CLINT1,clathrin interactor 1,92,cadherin binding,schizophrenia,ppi
7119,8331,51078,THAP4,THAP domain containing 4,12,DNA-binding transcription factor activity; RNA polymerase II-specific|heme binding|protein homodimerization activity,,ppi
7120,8332,168451,THAP5,THAP domain containing 5,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7121,8333,152815,THAP6,THAP domain containing 6,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7122,8334,9362,CPNE6,copine 6,15,phosphatidylserine binding|transporter activity|calcium ion binding|calcium-dependent phospholipid binding,,ppi
7123,8335,80764,THAP7,THAP domain containing 7,62,DNA-binding transcription factor activity; RNA polymerase II-specific|C2H2 zinc finger domain binding|identical protein binding|protein N-terminus binding,,ppi
7124,8336,199745,THAP8,THAP domain containing 8,9,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7125,8337,79725,THAP9,THAP domain containing 9,3,DNA-binding transcription factor activity; RNA polymerase II-specific|transposase activity|sequence-specific DNA binding,,ppi
7126,8338,56906,THAP10,THAP domain containing 10,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7127,8339,57215,THAP11,THAP domain containing 11,40,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|zinc ion binding,,ppi
7128,8340,54536,EXOC6,exocyst complex component 6,46,,,ppi
7129,8341,25956,SEC31B,SEC31 homolog B; COPII coat complex component,14,structural molecule activity,,ppi
7130,8342,285440,CYP4V2,cytochrome P450 family 4 subfamily V member 2,5,monooxygenase activity,Bietti crystalline corneoretinal dystrophy,ppi
7131,8343,474354,LRRC18,leucine rich repeat containing 18,1,volume-sensitive anion channel activity,,ppi
7132,8344,107,ADCY1,adenylate cyclase 1,2,adenylate cyclase activity|calcium- and calmodulin-responsive adenylate cyclase activity,lung small cell carcinoma,ppi
7133,8345,27132,CPNE7,copine 7,28,transporter activity|calcium-dependent phospholipid binding,,ppi
7134,8346,26959,HBP1,HMG-box transcription factor 1,31,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7135,8347,84623,KIRREL3,kin of IRRE like 3 (Drosophila),2,,autosomal dominant non-syndromic intellectual disability,ppi
7136,8348,338645,LUZP2,leucine zipper protein 2,2,,,ppi
7137,8349,55183,RIF1,replication timing regulatory factor 1,172,,,ppi
7138,8351,1371,CPOX,coproporphyrinogen oxidase,16,coproporphyrinogen oxidase activity|protein homodimerization activity,favism|hereditary elliptocytosis|hemoglobinopathy|congenital hemolytic anemia|generalized anxiety disorder|anxiety disorder|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertension|essential hypertension|polyneuropathy|peripheral nervous system disease|neuropathy|diaphragm disease|hereditary coproporphyria,ppi
7139,8352,79784,MYH14,myosin heavy chain 14,53,ATPase activity|actin-dependent ATPase activity|actin filament binding,prostate cancer|prostate carcinoma|angioma serpiginosum|autosomal dominant nonsyndromic deafness 4A,ppi
7140,8353,284098,PIGW,phosphatidylinositol glycan anchor biosynthesis class W,8,O-acyltransferase activity|glucosaminyl-phosphotidylinositol O-acyltransferase activity,,ppi
7141,8354,23265,EXOC7,exocyst complex component 7,61,,,ppi
7142,8355,84720,PIGO,phosphatidylinositol glycan anchor biosynthesis class O,17,mannose-ethanolamine phosphotransferase activity,,ppi
7143,8356,84627,ZNF469,zinc finger protein 469,2,,corneal disease|keratoconus|arthropathy|skin disease|brittle cornea syndrome,ppi
7144,8357,56287,GKN1,gastrokine 1,11,,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|stomach cancer,ppi
7145,8358,9648,GCC2,GRIP and coiled-coil domain containing 2,30,,,ppi
7146,8359,254827,NAALADL2,N-acetylated alpha-linked acidic dipeptidase like 2,17,,,ppi
7147,8360,378807,CATSPER4,cation channel sperm associated 4,4,,,ppi
7148,8361,353324,SPATA12,spermatogenesis associated 12,2,,,ppi
7149,8362,221178,SPATA13,spermatogenesis associated 13,12,guanyl-nucleotide exchange factor activity|Rac guanyl-nucleotide exchange factor activity,,ppi
7150,8363,79582,SPAG16,sperm associated antigen 16,6,,,ppi
7151,8364,57573,ZNF471,zinc finger protein 471,6,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7152,8365,386618,KCTD4,potassium channel tetramerization domain containing 4,4,,,ppi
7153,8366,27151,CPAMD8,C3 and PZP like; alpha-2-macroglobulin domain containing 8,3,,large intestine cancer|colorectal cancer,ppi
7154,8367,1373,CPS1,carbamoyl-phosphate synthase 1,54,carbamoyl-phosphate synthase (ammonia) activity|modified amino acid binding|carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity|aspartate carbamoyltransferase activity|dihydroorotase activity,brain edema|cerebellar disease|epilepsy|intellectual disability|learning disability|persistent fetal circulation syndrome|visual epilepsy|urea cycle disorder|carbamoyl phosphate synthetase I deficiency disease,ppi
7155,8368,79876,UBA5,ubiquitin like modifier activating enzyme 5,86,UFM1 activating enzyme activity,cholestasis,ppi
7156,8369,347735,SERINC2,serine incorporator 2,9,,alcohol dependence|alcohol abuse,ppi
7157,8370,57452,GALNT16,polypeptide N-acetylgalactosaminyltransferase 16,8,polypeptide N-acetylgalactosaminyltransferase activity,,ppi
7158,8371,146310,RNF151,ring finger protein 151,2,,,ppi
7159,8372,83892,KCTD10,potassium channel tetramerization domain containing 10,45,ubiquitin-protein transferase activity,,ppi
7160,8373,170575,GIMAP1,GTPase; IMAP family member 1,2,GTP binding,,ppi
7161,8374,51171,HSD17B14,hydroxysteroid 17-beta dehydrogenase 14,17,estradiol 17-beta-dehydrogenase activity|testosterone 17-beta-dehydrogenase (NADP+) activity,,ppi
7162,8375,25888,ZNF473,zinc finger protein 473,16,DNA binding,,ppi
7163,8376,29894,CPSF1,cleavage and polyadenylation specific factor 1,70,mRNA 3'-UTR AU-rich region binding,stomach cancer,ppi
7164,8377,643836,ZFP62,ZFP62 zinc finger protein,17,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7165,8378,114805,GALNT13,polypeptide N-acetylgalactosaminyltransferase 13,5,polypeptide N-acetylgalactosaminyltransferase activity,,ppi
7166,8380,58517,RBM25,RNA binding motif protein 25,84,RNA binding|mRNA binding,,ppi
7167,8382,84665,MYPN,myopalladin,16,cell-cell adhesion mediator activity,restrictive cardiomyopathy|dilated cardiomyopathy 1KK,ppi
7168,8383,83544,DNAL1,dynein axonemal light chain 1,2,alpha-tubulin binding|dynein heavy chain binding|motor activity,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|primary ciliary dyskinesia 16,ppi
7169,8384,80168,MOGAT2,monoacylglycerol O-acyltransferase 2,1,2-acylglycerol O-acyltransferase activity,,ppi
7170,8385,346606,MOGAT3,monoacylglycerol O-acyltransferase 3,1,2-acylglycerol O-acyltransferase activity,,ppi
7171,8386,53981,CPSF2,cleavage and polyadenylation specific factor 2,56,,,ppi
7172,8390,90827,ZNF479,zinc finger protein 479,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7173,8391,51692,CPSF3,cleavage and polyadenylation specific factor 3,57,RNA binding|endoribonuclease activity|5'-3' exonuclease activity,,ppi
7174,8392,493860,CCDC73,coiled-coil domain containing 73,1,,,ppi
7175,8393,10898,CPSF4,cleavage and polyadenylation specific factor 4,35,RNA binding,,ppi
7176,8394,401190,RGS7BP,regulator of G-protein signaling 7 binding protein,3,,,ppi
7177,8395,390980,ZNF805,zinc finger protein 805,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7178,8397,1374,CPT1A,carnitine palmitoyltransferase 1A,43,carnitine O-palmitoyltransferase activity,renal tubular acidosis|sick sinus syndrome|diabetic ketoacidosis|diabetes mellitus|type 2 diabetes mellitus|epilepsy|hypoglycemia|chronic kidney disease|visual epilepsy|speech disorder|liver disease|urea cycle disorder|muscular atrophy|breast cancer|fatty liver disease,ppi
7179,8398,200958,MUC20,mucin 20; cell surface associated,24,,,ppi
7180,8399,23474,ETHE1,ETHE1; persulfide dioxygenase,14,iron ion binding|sulfur dioxygenase activity|hydrolase activity; acting on ester bonds,lactic acidosis|cerebellar disease|epilepsy|basal ganglia disease|focal hand dystonia|blepharospasm|intellectual disability|learning disability|purpura|visual epilepsy|brain disease|ethylmalonic encephalopathy,ppi
7181,8400,1375,CPT1B,carnitine palmitoyltransferase 1B,2,carnitine O-palmitoyltransferase activity,liver cancer|Balo concentric sclerosis|adrenoleukodystrophy|narcolepsy|central nervous system disease|coronary artery disease,ppi
7182,8401,342538,NACA2,nascent polypeptide associated complex alpha subunit 2,21,,,ppi
7183,8402,339345,NANOS2,nanos C2HC-type zinc finger 2,21,,male infertility,ppi
7184,8403,23063,WAPL,WAPL cohesin release factor,52,,,ppi
7185,8404,414157,C10orf62,chromosome 10 open reading frame 62,8,,,ppi
7186,8405,65987,KCTD14,potassium channel tetramerization domain containing 14,4,,,ppi
7187,8406,219770,GJD4,gap junction protein delta 4,1,,,ppi
7188,8407,79047,KCTD15,potassium channel tetramerization domain containing 15,21,,obesity,ppi
7189,8408,23555,TSPAN15,tetraspanin 15,20,,,ppi
7190,8409,108,ADCY2,adenylate cyclase 2,3,magnesium ion binding|adenylate cyclase activity|adenylate cyclase binding|manganese ion binding|protein heterodimerization activity,asthma|intrinsic asthma|allergic asthma|bipolar disorder,ppi
7191,8410,1376,CPT2,carnitine palmitoyltransferase 2,31,carnitine O-palmitoyltransferase activity,sick sinus syndrome|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
7192,8411,64081,PBLD,phenazine biosynthesis like protein domain containing,11,,,ppi
7193,8412,80201,HKDC1,hexokinase domain containing 1,4,mannokinase activity|fructokinase activity|glucokinase activity,,ppi
7194,8413,81619,TSPAN14,tetraspanin 14,4,,,ppi
7195,8414,118471,PRAP1,proline rich acidic protein 1,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7196,8415,147657,ZNF480,zinc finger protein 480,1,DNA-binding transcription factor activity; RNA polymerase II-specific,schizophrenia,ppi
7197,8418,8630,HSD17B6,hydroxysteroid 17-beta dehydrogenase 6,11,catalytic activity|electron transfer activity|oxidoreductase activity,,ppi
7198,8420,22854,NTNG1,netrin G1,3,cell-cell adhesion mediator activity,bipolar disorder|large intestine cancer|colorectal cancer|sensorineural hearing loss|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|intellectual disability|learning disability|movement disease|lingual-facial-buccal dyskinesia|Rett syndrome|schizophrenia|visual epilepsy|cerebral degeneration|acute urate nephropathy,ppi
7199,8422,92014,SLC25A51,solute carrier family 25 member 51,13,,,ppi
7200,8423,147407,SLC25A52,solute carrier family 25 member 52,1,,,ppi
7201,8424,54899,PXK,PX domain containing serine/threonine kinase like,16,nucleotide binding|protein kinase activity|ATP binding,rheumatoid arthritis|systemic lupus erythematosus,ppi
7202,8425,162239,ZFP1,ZFP1 zinc finger protein,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7203,8426,146198,ZFP90,ZFP90 zinc finger protein,2,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
7204,8427,8532,CPZ,carboxypeptidase Z,3,metallocarboxypeptidase activity,,ppi
7205,8428,92822,ZNF276,zinc finger protein 276,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7206,8429,23412,COMMD3,COMM domain containing 3,37,,,ppi
7207,8430,56952,PRTFDC1,phosphoribosyl transferase domain containing 1,24,magnesium ion binding|hypoxanthine phosphoribosyltransferase activity,tongue squamous cell carcinoma|squamous cell carcinoma|ovarian cancer,ppi
7208,8431,728113,ANXA8L1,annexin A8-like 1,7,calcium ion binding|calcium-dependent phospholipid binding|phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3;4;5-trisphosphate binding|phosphatidylinositol-3;4-bisphosphate binding|actin filament binding,,ppi
7209,8432,144568,A2ML1,alpha-2-macroglobulin like 1,26,peptidase inhibitor activity,Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome|Cockayne syndrome|Noonan syndrome|Aarskog syndrome|Noonan syndrome 1|otitis media,ppi
7210,8433,79777,ACBD4,acyl-CoA binding domain containing 4,3,,,ppi
7211,8434,91452,ACBD5,acyl-CoA binding domain containing 5,17,,,ppi
7212,8435,84320,ACBD6,acyl-CoA binding domain containing 6,4,,intellectual disability|learning disability,ppi
7213,8436,1378,CR1,complement C3b/C4b receptor 1 (Knops blood group),13,complement component C3b binding|complement component C4b binding|complement component C4b receptor activity|complement component C3b receptor activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|malaria|Plasmodium falciparum malaria,ppi
7214,8439,10464,PIBF1,progesterone immunomodulatory binding factor 1,47,interleukin-4 receptor binding,placental abruption,ppi
7215,8440,219771,CCNY,cyclin Y,16,cyclin-dependent protein serine/threonine kinase regulator activity,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease,ppi
7216,8441,11067,C10orf10,chromosome 10 open reading frame 10,8,,endometriosis of uterus|endometriosis|chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease|breast cancer,ppi
7217,8442,220972,MARCH8,membrane associated ring-CH-type finger 8,8,ubiquitin-protein transferase activity,esophageal cancer,ppi
7218,8443,28985,MCTS1,MCTS1; re-initiation and release factor,44,,,ppi
7219,8444,1380,CR2,complement C3d receptor 2,11,complement binding|DNA binding|complement receptor activity|transmembrane signaling receptor activity|protein homodimerization activity,hemolytic anemia|imperforate anus|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|bronchiectasis|common variable immunodeficiency|conjunctivitis|primary immunodeficiency disease|systemic lupus erythematosus|lymphosarcoma|lymphoma|central nervous system lymphoma|lymphopenia|meningitis|pneumonia|purpura|agammaglobulinemia|liver disease|immunoglobulin alpha deficiency|selective IgA deficiency disease,ppi
7220,8445,57805,CCAR2,cell cycle and apoptosis regulator 2,139,RNA polymerase II complex binding|RNA binding|enzyme inhibitor activity|nuclear receptor transcription coactivator activity,,ppi
7221,8446,404550,C16orf74,chromosome 16 open reading frame 74,2,,,ppi
7222,8447,64645,MFSD14A,major facilitator superfamily domain containing 14A,1,,,ppi
7223,8448,30815,ST6GALNAC6,ST6 N-acetylgalactosaminide alpha-2;6-sialyltransferase 6,4,alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase activity|sialyltransferase activity,,ppi
7224,8449,81873,ARPC5L,actin related protein 2/3 complex subunit 5 like,39,actin filament binding,,ppi
7225,8450,89853,MVB12B,multivesicular body subunit 12B,10,lipid binding|ubiquitin binding,,ppi
7226,8451,91283,MSANTD3,Myb/SANT DNA binding domain containing 3,14,identical protein binding,,ppi
7227,8452,28989,NTMT1,N-terminal Xaa-Pro-Lys N-methyltransferase 1,23,protein methyltransferase activity|histone methyltransferase activity|N-terminal protein N-methyltransferase activity,,ppi
7228,8453,26130,GAPVD1,GTPase activating protein and VPS9 domains 1,40,guanyl-nucleotide exchange factor activity|Rab guanyl-nucleotide exchange factor activity|GTPase activating protein binding|cadherin binding,,ppi
7229,8454,84641,MFSD14B,major facilitator superfamily domain containing 14B,3,,,ppi
7230,8455,54914,FOCAD,focadhesin,8,,,ppi
7231,8456,158358,KIAA2026,KIAA2026,6,,,ppi
7232,8458,1381,CRABP1,cellular retinoic acid binding protein 1,5,retinoid binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|liver cancer|esophagus squamous cell carcinoma,ppi
7233,8459,29991,OBP2A,odorant binding protein 2A,8,odorant binding,,ppi
7234,8460,29989,OBP2B,odorant binding protein 2B,1,odorant binding,,ppi
7235,8461,89882,TPD52L3,tumor protein D52 like 3,7,,,ppi
7236,8462,57684,ZBTB26,zinc finger and BTB domain containing 26,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7237,8463,158399,ZNF483,zinc finger protein 483,29,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7238,8464,83744,ZNF484,zinc finger protein 484,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
7239,8465,23077,MYCBP2,MYC binding protein 2; E3 ubiquitin protein ligase,72,guanyl-nucleotide exchange factor activity|zinc ion binding|Ran GTPase binding|ubiquitin protein ligase activity,,ppi
7240,8466,55035,NOL8,nucleolar protein 8,28,RNA binding,,ppi
7241,8467,158293,FAM120AOS,family with sequence similarity 120A opposite strand,1,,,ppi
7242,8468,1382,CRABP2,cellular retinoic acid binding protein 2,13,retinoid binding,,ppi
7243,8469,10498,CARM1,coactivator associated arginine methyltransferase 1,123,transcription coactivator activity|beta-catenin binding|protein methyltransferase activity|histone-arginine N-methyltransferase activity|protein-arginine N-methyltransferase activity|nuclear receptor transcription coactivator activity|protein-arginine omega-N asymmetric methyltransferase activity|histone methyltransferase activity (H3-R17 specific)|histone methyltransferase activity|transcription regulatory region DNA binding|lysine-acetylated histone binding,pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
7244,8471,254295,PHYHD1,phytanoyl-CoA dioxygenase domain containing 1,3,,,ppi
7245,8472,23307,FKBP15,FK506 binding protein 15,34,,substance abuse|substance-related disorder,ppi
7246,8473,158326,FREM1,FRAS1 related extracellular matrix 1,1,,microphthalmia|congenital diaphragmatic hernia|Potter's syndrome,ppi
7247,8474,109,ADCY3,adenylate cyclase 3,15,adenylate cyclase activity,bipolar disorder|diabetic angiopathy|mood disorder,ppi
7248,8475,8738,CRADD,CASP2 and RIPK1 domain containing adaptor with death domain,22,protease binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|intellectual disability|learning disability|autosomal recessive non-syndromic intellectual disability,ppi
7249,8476,90701,SEC11C,SEC11 homolog C; signal peptidase complex subunit,19,peptidase activity,,ppi
7250,8477,28972,SPCS1,signal peptidase complex subunit 1,15,,,ppi
7251,8480,22845,DOLK,dolichol kinase,14,dolichol kinase activity,blood coagulation disease|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
7252,8481,55268,ECHDC2,enoyl-CoA hydratase domain containing 2,13,enoyl-CoA hydratase activity,,ppi
7253,8482,133121,ENPP6,ectonucleotide pyrophosphatase/phosphodiesterase 6,40,phosphoric diester hydrolase activity|glycerophosphocholine cholinephosphodiesterase activity|glycerophosphodiester phosphodiesterase activity,,ppi
7254,8483,64114,TMBIM1,transmembrane BAX inhibitor motif containing 1,6,death receptor binding,,ppi
7255,8484,253725,WASHC2C,WASH complex subunit 2C,15,phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3;4;5-trisphosphate binding|phosphatidylinositol-5-phosphate binding|phosphatidylinositol-3-phosphate binding|phosphatidylinositol-3;4-bisphosphate binding|phosphatidylinositol-4-phosphate binding|phosphatidylinositol-3;5-bisphosphate binding|retromer complex binding,,ppi
7256,8485,387680,WASHC2A,WASH complex subunit 2A,33,,,ppi
7257,8486,26128,KIF1BP,KIF1 binding protein,67,,ptosis|congenital ptosis|isolated cleft palate|cleft palate|corneal ulcer|Hirschsprung's disease|megacolon|toxic megacolon|intellectual disability|learning disability|microcephaly|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly,ppi
7258,8487,1384,CRAT,carnitine O-acetyltransferase,9,carnitine O-acetyltransferase activity,,ppi
7259,8488,55222,LRRC20,leucine rich repeat containing 20,2,,,ppi
7260,8489,26095,PTPN20,protein tyrosine phosphatase; non-receptor type 20,8,,,ppi
7261,8490,158405,KIAA1958,KIAA1958,12,,,ppi
7262,8492,644890,MEIG1,meiosis/spermiogenesis associated 1,2,,,ppi
7263,8493,23418,CRB1,crumbs 1; cell polarity complex component,9,,epilepsy|monocular esotropia|esotropia|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hyperopia|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy,ppi
7264,8494,54875,CNTLN,centlein,8,protein binding; bridging,,ppi
7265,8495,55071,C9orf40,chromosome 9 open reading frame 40,9,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7266,8496,54619,CCNJ,cyclin J,5,cyclin-dependent protein serine/threonine kinase regulator activity|protein kinase activity|protein kinase binding,,ppi
7267,8497,138199,CARNMT1,carnosine N-methyltransferase 1,43,carnosine N-methyltransferase activity|S-adenosylmethionine-dependent methyltransferase activity,,ppi
7268,8502,439996,IFIT1B,interferon induced protein with tetratricopeptide repeats 1B,6,RNA binding,,ppi
7269,8505,729262,NUTM2B,NUT family member 2B,1,,endometrial stromal sarcoma|kidney clear cell sarcoma,ppi
7270,8508,1385,CREB1,cAMP responsive element binding protein 1,160,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|obsolete transcriptional activator activity; RNA polymerase II transcription factor binding|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription coregulator activity|cAMP response element binding,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|cocaine dependence|opiate dependence|morphine dependence|heroin dependence|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|schizophrenia|cocaine abuse|mood disorder,ppi
7271,8509,54754,NUTM2F,NUT family member 2F,3,,,ppi
7272,8511,340654,LIPM,lipase family member M,1,lipoprotein lipase activity|lipase activity,,ppi
7273,8514,119016,AGAP4,ArfGAP with GTPase domain; ankyrin repeat and PH domain 4,3,,,ppi
7274,8515,143241,DYDC1,DPY30 domain containing 1,15,,,ppi
7275,8516,642517,AGAP9,ArfGAP with GTPase domain; ankyrin repeat and PH domain 9,1,,,ppi
7276,8518,729092,AGAP5,ArfGAP with GTPase domain; ankyrin repeat and PH domain 5,1,,,ppi
7277,8519,84332,DYDC2,DPY30 domain containing 2,1,,,ppi
7278,8520,10488,CREB3,cAMP responsive element binding protein 3,228,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
7279,8523,81894,SLC25A28,solute carrier family 25 member 28,3,iron ion transmembrane transporter activity,,ppi
7280,8526,80005,DOCK5,dedicator of cytokinesis 5,66,guanyl-nucleotide exchange factor activity,,ppi
7281,8527,55619,DOCK10,dedicator of cytokinesis 10,6,guanyl-nucleotide exchange factor activity,,ppi
7282,8528,1387,CREBBP,CREB binding protein,369,proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II activating transcription factor binding|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|chromatin binding|damaged DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|histone acetyltransferase activity|acetyltransferase activity|peptide N-acetyltransferase activity|MRF binding,agoraphobia|sick sinus syndrome|autistic disorder|bipolar disorder|urinary bladder cancer|ptosis|congenital ptosis|tongue squamous cell carcinoma|squamous cell carcinoma|transitional cell carcinoma|coloboma|constipation|pseudosarcomatous fibromatosis|cryptorchidism|salivary gland adenoid cystic carcinoma|sensorineural hearing loss|dental enamel hypoplasia|neurotic disorder|major depressive disorder|endogenous depression,ppi
7283,8529,221937,FOXK1,forkhead box K1,96,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
7284,8530,338599,DUPD1,dual specificity phosphatase and pro isomerase domain containing 1,12,protein tyrosine/serine/threonine phosphatase activity|protein homodimerization activity,,ppi
7285,8531,139818,DOCK11,dedicator of cytokinesis 11,11,guanyl-nucleotide exchange factor activity,,ppi
7286,8532,54906,FAM208B,family with sequence similarity 208 member B,32,,,ppi
7287,8533,79710,MORC4,MORC family CW-type zinc finger 4,14,,,ppi
7288,8534,55063,ZCWPW1,zinc finger CW-type and PWWP domain containing 1,2,,,ppi
7289,8535,91734,IDI2,isopentenyl-diphosphate delta isomerase 2,12,isopentenyl-diphosphate delta-isomerase activity,,ppi
7290,8537,1388,ATF6B,activating transcription factor 6 beta,35,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
7291,8538,116224,FAM122A,family with sequence similarity 122A,18,protein serine/threonine phosphatase inhibitor activity,,ppi
7292,8542,9890,PLPPR4,phospholipid phosphatase related 4,4,phosphatidate phosphatase activity|lipid phosphatase activity|phosphatase activity,,ppi
7293,8543,79948,PLPPR3,phospholipid phosphatase related 3,8,phosphatase activity|lipid phosphatase activity|phosphatidate phosphatase activity,,ppi
7294,8544,144402,CPNE8,copine 8,16,calcium-dependent phospholipid binding,,ppi
7295,8545,196883,ADCY4,adenylate cyclase 4,1,adenylate cyclase activity|protein kinase C binding,,ppi
7296,8546,1389,CREBL2,cAMP responsive element binding protein like 2,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
7297,8547,22865,SLITRK3,SLIT and NTRK like family member 3,2,,,ppi
7298,8548,139065,SLITRK4,SLIT and NTRK like family member 4,2,,,ppi
7299,8549,84189,SLITRK6,SLIT and NTRK like family member 6,1,,,ppi
7300,8550,93550,ZFAND4,zinc finger AN1-type containing 4,3,,,ppi
7301,8551,9790,BMS1,BMS1; ribosome biogenesis factor,27,RNA binding|GTP binding|U3 snoRNA binding|GTPase activity,chronic ulcer of skin|Clouston syndrome,ppi
7302,8552,84890,ADO,2-aminoethanethiol dioxygenase,6,cysteamine dioxygenase activity,,ppi
7303,8553,219736,STOX1,storkhead box 1,5,RNA polymerase II regulatory region sequence-specific DNA binding,pre-eclampsia,ppi
7304,8554,8804,CREG1,cellular repressor of E1A stimulated genes 1,10,transcription corepressor activity,prostate cancer|prostate carcinoma,ppi
7305,8555,54838,WBP1L,WW domain binding protein 1-like,2,,,ppi
7306,8557,27291,R3HCC1L,R3H domain and coiled-coil containing 1 like,11,,,ppi
7307,8558,159195,USP54,ubiquitin specific peptidase 54,47,,,ppi
7308,8559,222389,BEND7,BEN domain containing 7,39,,,ppi
7309,8560,119032,BORCS7,BLOC-1 related complex subunit 7,3,,,ppi
7310,8561,84795,PYROXD2,pyridine nucleotide-disulphide oxidoreductase domain 2,3,,,ppi
7311,8562,118487,CHCHD1,coiled-coil-helix-coiled-coil-helix domain containing 1,8,RNA binding,,ppi
7312,8563,219738,C10orf35,chromosome 10 open reading frame 35,23,,,ppi
7313,8564,1390,CREM,cAMP responsive element modulator,38,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|cAMP response element binding protein binding,bipolar disorder|diabetic angiopathy|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|schizophrenia|neurotic disorder|endogenous depression|melancholia|allergic contact dermatitis|major depressive disorder|mental depression,ppi
7314,8565,220963,SLC16A9,solute carrier family 16 member 9,4,monocarboxylic acid transmembrane transporter activity,,ppi
7315,8566,221061,FAM171A1,family with sequence similarity 171 member A1,8,,,ppi
7316,8568,90550,MCU,mitochondrial calcium uniporter,29,calcium channel activity|uniporter activity,,ppi
7317,8569,92565,FANK1,fibronectin type III and ankyrin repeat domains 1,7,,,ppi
7318,8570,23053,ZSWIM8,zinc finger SWIM-type containing 8,19,,,ppi
7319,8571,221078,NSUN6,NOP2/Sun RNA methyltransferase family member 6,3,tRNA binding|tRNA (cytosine-5-)-methyltransferase activity,,ppi
7320,8572,27143,PALD1,phosphatase domain containing; paladin 1,11,protein tyrosine phosphatase activity|protein serine/threonine phosphatase activity,,ppi
7321,8574,79933,SYNPO2L,synaptopodin 2 like,1,actin binding,,ppi
7322,8575,256536,TCERG1L,transcription elongation regulator 1 like,1,RNA polymerase binding,large intestine cancer|colorectal cancer,ppi
7323,8576,79861,TUBAL3,tubulin alpha like 3,17,structural constituent of cytoskeleton|GTP binding,,ppi
7324,8577,118738,ZNF488,zinc finger protein 488,16,,,ppi
7325,8579,55526,DHTKD1,dehydrogenase E1 and transketolase domain containing 1,13,oxoglutarate dehydrogenase (succinyl-transferring) activity,muscular atrophy|attention deficit hyperactivity disorder|Charcot-Marie-Tooth disease axonal type 2Q,ppi
7326,8580,1392,CRH,corticotropin releasing hormone,5,signaling receptor binding|hormone activity|neuropeptide hormone activity|corticotropin-releasing hormone activity,alcohol dependence|alcohol abuse|alopecia|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|anxiety disorder|phobic disorder,ppi
7327,8581,1393,CRHBP,corticotropin releasing hormone binding protein,13,peptide binding|corticotropin-releasing hormone binding,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|cocaine abuse|cocaine dependence|mood disorder,ppi
7328,8582,54557,SGTB,small glutamine rich tetratricopeptide repeat containing beta,87,protein-containing complex scaffold activity,,ppi
7329,8583,1394,CRHR1,corticotropin releasing hormone receptor 1,9,corticotrophin-releasing factor receptor activity|corticotropin-releasing hormone binding|corticotropin-releasing hormone receptor activity|peptide hormone binding,alcohol dependence|alcohol abuse|anxiety disorder|phobic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|contact dermatitis|occupational dermatitis|schizophreniform disorder|schizoaffective disorder|cocaine abuse|cocaine dependence|mood disorder,ppi
7330,8584,257169,C9orf43,chromosome 9 open reading frame 43,4,,,ppi
7331,8585,22837,COBLL1,cordon-bleu WH2 repeat protein like 1,14,cadherin binding,,ppi
7332,8586,23515,MORC3,MORC family CW-type zinc finger 3,18,,,ppi
7333,8587,22880,MORC2,MORC family CW-type zinc finger 2,14,,Charcot-Marie-Tooth disease axonal type 2Z,ppi
7334,8589,26057,ANKRD17,ankyrin repeat domain 17,45,chromatin binding|RNA binding,,ppi
7335,8590,84376,HOOK3,hook microtubule tethering protein 3,28,microtubule binding|dynactin binding|dynein intermediate chain binding|dynein light intermediate chain binding,polycystic ovary syndrome,ppi
7336,8591,80013,FAM188A,family with sequence similarity 188 member A,31,cysteine-type carboxypeptidase activity|Lys48-specific deubiquitinase activity,,ppi
7337,8592,1395,CRHR2,corticotropin releasing hormone receptor 2,5,corticotrophin-releasing factor receptor activity|peptide hormone binding|corticotropin-releasing hormone receptor activity,anxiety disorder|phobic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertension|essential hypertension|lung disease|cocaine abuse|cocaine dependence|mood disorder,ppi
7338,8596,84858,ZNF503,zinc finger protein 503,11,,,ppi
7339,8597,51232,CRIM1,cysteine rich transmembrane BMP regulator 1,5,insulin-like growth factor-activated receptor activity|PDZ domain binding,,ppi
7340,8600,54832,VPS13C,vacuolar protein sorting 13 homolog C,16,,Parkinson's disease,ppi
7341,8601,55187,VPS13D,vacuolar protein sorting 13 homolog D,4,,,ppi
7342,8606,111,ADCY5,adenylate cyclase 5,8,adenylate cyclase activity|adenylate cyclase binding|protein heterodimerization activity,alcohol dependence|alcohol abuse|generalized anxiety disorder|anxiety disorder|syndromic X-linked intellectual disability type 10|choreatic disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetes mellitus|type 2 diabetes mellitus|dystonia|hypertension|essential hypertension|osteoporosis|facial nerve disease|geniculate ganglionitis,ppi
7343,8607,1396,CRIP1,cysteine rich protein 1,42,AT DNA binding|zinc ion binding|DNA binding; bending|peptide binding,,ppi
7344,8608,440023,KRTAP5-6,keratin associated protein 5-6,26,,,ppi
7345,8612,3846,KRTAP5-9,keratin associated protein 5-9,105,,,ppi
7346,8615,83874,TBC1D10A,TBC1 domain family member 10A,14,cadherin binding|GTPase activator activity|Rab GTPase binding,,ppi
7347,8616,1397,CRIP2,cysteine rich protein 2,24,zinc ion binding,,ppi
7348,8617,353189,SLCO4C1,solute carrier organic anion transporter family member 4C1,4,sodium-independent organic anion transmembrane transporter activity,,ppi
7349,8618,133482,SLCO6A1,solute carrier organic anion transporter family member 6A1,12,sodium-independent organic anion transmembrane transporter activity,,ppi
7350,8619,55808,ST6GALNAC1,ST6 N-acetylgalactosaminide alpha-2;6-sialyltransferase 1,2,alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase activity|sialyltransferase activity,schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
7351,8620,54733,SLC35F2,solute carrier family 35 member F2,12,,,ppi
7352,8622,80255,SLC35F5,solute carrier family 35 member F5,8,,,ppi
7353,8623,387509,GPR153,G protein-coupled receptor 153,1,,schizophrenia,ppi
7354,8624,25934,NIPSNAP3A,nipsnap homolog 3A,29,,,ppi
7355,8625,1398,CRK,CRK proto-oncogene; adaptor protein,364,SH3/SH2 adaptor activity|protein self-association|protein phosphorylated amino acid binding,coronary artery disease,ppi
7356,8627,84895,MIGA2,mitoguardin 2,10,protein homodimerization activity|protein heterodimerization activity,,ppi
7357,8630,134391,GPR151,G protein-coupled receptor 151,1,G-protein coupled receptor activity,,ppi
7358,8631,9853,RUSC2,RUN and SH3 domain containing 2,17,,,ppi
7359,8632,344758,GPR149,G protein-coupled receptor 149,1,neuropeptide binding|G-protein coupled receptor activity|melanin-concentrating hormone receptor activity,,ppi
7360,8634,1399,CRKL,CRK like proto-oncogene; adaptor protein,137,RNA binding|SH3/SH2 adaptor activity|cadherin binding,DiGeorge syndrome|velocardiofacial syndrome|enophthalmos|orbital disease|exophthalmos|placental insufficiency|clubfoot|communication disorder|language disorder|intellectual disability|learning disability|chromosome 22q11.2 deletion syndrome; distal,ppi
7361,8636,55848,PLGRKT,plasminogen receptor with a C-terminal lysine,5,protein binding,,ppi
7362,8637,9652,TTC37,tetratricopeptide repeat domain 37,28,,cholestasis|enophthalmos|orbital disease|exophthalmos|placental insufficiency|polyhydramnios|liver cirrhosis|isolated cleft palate|celiac disease,ppi
7363,8638,9244,CRLF1,cytokine receptor like factor 1,6,protein heterodimerization activity|cytokine activity|ciliary neurotrophic factor receptor binding|cytokine binding|cytokine receptor activity,clubfoot|dental caries|hypohidrosis|anhidrosis|malignant hyperthermia|Bell's palsy|facial paralysis|cold-induced sweating syndrome,ppi
7364,8639,79692,ZNF322,zinc finger protein 322,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7365,8641,253650,ANKRD18A,ankyrin repeat domain 18A,4,,lung benign neoplasm,ppi
7366,8644,1400,CRMP1,collapsin response mediator protein 1,102,,schizophrenia,ppi
7367,8645,92609,TIMM50,translocase of inner mitochondrial membrane 50,147,phosphoprotein phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|interleukin-2 receptor binding|ribonucleoprotein complex binding,,ppi
7368,8646,10020,GNE,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,33,UDP-N-acetylglucosamine 2-epimerase activity|N-acylmannosamine kinase activity,epilepsy|inguinal hernia|congenital hypothyroidism|myxedema|hypothyroidism|visual epilepsy|obstructive sleep apnea|congenital central hypoventilation syndrome|inclusion body myositis|sialuria|attention deficit hyperactivity disorder,ppi
7369,8647,50514,DEC1,deleted in esophageal cancer 1,31,,tongue squamous cell carcinoma|squamous cell carcinoma|esophageal cancer|squamous cell neoplasm,ppi
7370,8648,54677,CROT,carnitine O-octanoyltransferase,10,carnitine O-octanoyltransferase activity,,ppi
7371,8649,79001,VKORC1,vitamin K epoxide reductase complex subunit 1,90,vitamin-K-epoxide reductase (warfarin-sensitive) activity,aortic aneurysm|blood coagulation disease|atherosclerosis|arteriosclerotic cardiovascular disease|coronary artery disease|cerebral infarction|cerebrovascular disease|vascular disease,ppi
7372,8650,9644,SH3PXD2A,SH3 and PX domains 2A,23,superoxide-generating NADPH oxidase activator activity|phosphatidylinositol binding,schizophrenia,ppi
7373,8651,84210,ANKRD20A1,ankyrin repeat domain 20 family member A1,2,,,ppi
7374,8653,1401,CRP,C-reactive protein,57,complement component C1q binding|calcium ion binding|low-density lipoprotein particle binding|choline binding|virion binding,anxiety disorder|phobic disorder|rheumatoid arthritis|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|heart disease|cardiovascular system disease|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6,ppi
7375,8655,256691,MAMDC2,MAM domain containing 2,5,,,ppi
7376,8657,375759,C9orf50,chromosome 9 open reading frame 50,1,,,ppi
7377,8659,403313,PLPP6,phospholipid phosphatase 6,2,hydrolase activity|lipid phosphatase activity,,ppi
7378,8660,401548,SNX30,sorting nexin family member 30,5,,,ppi
7379,8661,79269,DCAF10,DDB1 and CUL4 associated factor 10,35,,,ppi
7380,8663,283149,BCL9L,B-cell CLL/lymphoma 9-like,6,transcription coactivator activity|beta-catenin binding,,ppi
7381,8664,57512,GPR158,G protein-coupled receptor 158,2,,,ppi
7382,8665,55876,GSDMB,gasdermin B,8,phosphatidylinositol-4;5-bisphosphate binding|phosphatidylserine binding|phosphatidylinositol-4-phosphate binding,asthma|intrinsic asthma|allergic asthma,ppi
7383,8666,57007,ACKR3,atypical chemokine receptor 3,15,scavenger receptor activity|C-X-C chemokine receptor activity|C-X-C chemokine binding|C-C chemokine binding|chemokine binding|C-C chemokine receptor activity,rheumatoid arthritis|large intestine cancer|colorectal cancer|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
7384,8668,23432,GPR161,G protein-coupled receptor 161,16,G-protein coupled receptor activity,hypoglycemia|congenital hypothyroidism|myxedema|hypothyroidism,ppi
7385,8669,85458,DIXDC1,DIX domain containing 1,18,gamma-tubulin binding,anxiety disorder|phobic disorder|autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia,ppi
7386,8670,25976,TIPARP,TCDD inducible poly(ADP-ribose) polymerase,2,NAD+ ADP-ribosyltransferase activity|enhancer binding,alcohol dependence|alcohol abuse|ovarian cancer,ppi
7387,8671,23187,PHLDB1,pleckstrin homology like domain family B member 1,10,,malignant glioma|gliosarcoma|mixed glioma,ppi
7388,8672,91010,FMNL3,formin like 3,7,GTPase activating protein binding,,ppi
7389,8673,165721,DNAJB8,DnaJ heat shock protein family (Hsp40) member B8,14,protein binding involved in protein folding|unfolded protein binding,,ppi
7390,8674,112,ADCY6,adenylate cyclase 6,20,adenylate cyclase activity|protein kinase C binding|protein kinase binding,,ppi
7391,8675,9282,MED14,mediator complex subunit 14,77,transcription coregulator activity|transcription coactivator activity|nuclear receptor transcription coactivator activity|signaling receptor activity|vitamin D receptor binding,endometriosis of uterus|endometriosis,ppi
7392,8676,54970,TTC12,tetratricopeptide repeat domain 12,4,,alcohol dependence|alcohol abuse,ppi
7393,8677,79956,ERMP1,endoplasmic reticulum metallopeptidase 1,25,,,ppi
7394,8678,158219,TTC39B,tetratricopeptide repeat domain 39B,7,,,ppi
7395,8679,57474,ZNF490,zinc finger protein 490,27,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7396,8680,126069,ZNF491,zinc finger protein 491,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7397,8683,201516,ZSCAN4,zinc finger and SCAN domain containing 4,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7398,8684,79149,ZSCAN5A,zinc finger and SCAN domain containing 5A,21,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7399,8685,221035,REEP3,receptor accessory protein 3,5,,autistic disorder,ppi
7400,8686,284312,ZSCAN1,zinc finger and SCAN domain containing 1,50,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7401,8687,84838,ZNF496,zinc finger protein 496,31,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
7402,8688,162968,ZNF497,zinc finger protein 497,1,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region DNA binding|DNA-binding transcription factor activity,,ppi
7403,8689,84878,ZBTB45,zinc finger and BTB domain containing 45,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7404,8690,26048,ZNF500,zinc finger protein 500,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7405,8691,115560,ZNF501,zinc finger protein 501,4,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region DNA binding|DNA-binding transcription factor activity,,ppi
7406,8692,91392,ZNF502,zinc finger protein 502,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7407,8693,93210,PGAP3,post-GPI attachment to proteins 3,2,hydrolase activity; acting on ester bonds,,ppi
7408,8694,9439,MED23,mediator complex subunit 23,172,transcription coactivator activity,intellectual disability|learning disability|autosomal recessive non-syndromic intellectual disability,ppi
7409,8695,64764,CREB3L2,cAMP responsive element binding protein 3 like 2,16,DNA-binding transcription factor activity; RNA polymerase II-specific|cAMP response element binding|transcription regulatory region DNA binding,,ppi
7410,8696,56829,ZC3HAV1,zinc finger CCCH-type containing; antiviral 1,139,RNA binding|cadherin binding|NAD+ ADP-ribosyltransferase activity|NAD+ binding,,ppi
7411,8697,51148,CERCAM,cerebral endothelial cell adhesion molecule,23,,,ppi
7412,8698,84986,ARHGAP19,Rho GTPase activating protein 19,14,GTPase activator activity,,ppi
7413,8699,57584,ARHGAP21,Rho GTPase activating protein 21,44,GTPase activator activity,,ppi
7414,8700,83641,FAM107B,family with sequence similarity 107 member B,4,,,ppi
7415,8701,143384,CACUL1,CDK2 associated cullin domain 1,3,,,ppi
7416,8702,254427,PROSER2,proline and serine rich 2,36,,,ppi
7417,8703,283078,MKX,mohawk homeobox,10,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7418,8704,9721,GPRIN2,G protein regulated inducer of neurite outgrowth 2,13,,bipolar disorder,ppi
7419,8705,55844,PPP2R2D,protein phosphatase 2 regulatory subunit Bdelta,109,protein phosphatase regulator activity|protein serine/threonine phosphatase activity,,ppi
7420,8706,256297,PTF1A,pancreas specific transcription factor; 1a,14,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,cerebellar disease|pancreatic agenesis,ppi
7421,8708,54550,NECAB2,N-terminal EF-hand calcium binding protein 2,66,A2A adenosine receptor binding|type 5 metabotropic glutamate receptor binding,,ppi
7422,8709,79603,CERS4,ceramide synthase 4,2,sphingosine N-acyltransferase activity,,ppi
7423,8710,91012,CERS5,ceramide synthase 5,8,sphingosine N-acyltransferase activity,,ppi
7424,8711,9440,MED17,mediator complex subunit 17,79,transcription coregulator activity|transcription coactivator activity|nuclear receptor transcription coactivator activity|signaling receptor activity|vitamin D receptor binding|thyroid hormone receptor binding,endometriosis of uterus|endometriosis|epilepsy|visual epilepsy|infantile epileptic encephalopathy,ppi
7425,8712,201965,RWDD4,RWD domain containing 4,8,,,ppi
7426,8713,204219,CERS3,ceramide synthase 3,1,DNA-binding transcription factor activity; RNA polymerase II-specific|sphingosine N-acyltransferase activity,autosomal recessive congenital ichthyosis 1|congenital ichthyosiform erythroderma|autosomal recessive congenital ichthyosis 2|autosomal recessive congenital ichthyosis 3|autosomal recessive congenital ichthyosis 4A|autosomal recessive congenital ichthyosis 5|autosomal recessive congenital ichthyosis 6|autosomal recessive congenital ichthyosis 7|autosomal recessive congenital ichthyosis 8|autosomal recessive congenital ichthyosis 9|autosomal recessive congenital ichthyosis 10|Weill-Marchesani syndrome,ppi
7427,8714,253152,EPHX4,epoxide hydrolase 4,1,,,ppi
7428,8715,79575,ABHD8,abhydrolase domain containing 8,1,carboxylic ester hydrolase activity,,ppi
7429,8716,9441,MED26,mediator complex subunit 26,102,transcription coregulator activity|transcription coactivator activity,,ppi
7430,8718,55709,KBTBD4,kelch repeat and BTB domain containing 4,19,,,ppi
7431,8720,339221,ENPP7,ectonucleotide pyrophosphatase/phosphodiesterase 7,9,sphingomyelin phosphodiesterase activity|zinc ion binding,,ppi
7432,8721,9442,MED27,mediator complex subunit 27,43,transcription coactivator activity,,ppi
7433,8722,9443,MED7,mediator complex subunit 7,59,transcription coactivator activity,,ppi
7434,8723,440515,ZNF506,zinc finger protein 506,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7435,8724,26073,POLDIP2,DNA polymerase delta interacting protein 2,70,,,ppi
7436,8725,84271,POLDIP3,DNA polymerase delta interacting protein 3,57,RNA binding,,ppi
7437,8726,22847,ZNF507,zinc finger protein 507,17,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7438,8727,57504,MTA3,metastasis associated 1 family member 3,73,DNA-binding transcription factor activity; RNA polymerase II-specific|histone deacetylase activity|transcription coactivator activity|histone deacetylase binding|transcription corepressor activity|obsolete transcription factor activity; transcription factor binding|RNA polymerase II repressing transcription factor binding,,ppi
7439,8728,200576,PIKFYVE,phosphoinositide kinase; FYVE-type zinc finger containing,12,1-phosphatidylinositol-4-phosphate 5-kinase activity|phosphatidylinositol-3;5-bisphosphate 5-phosphatase activity,Fleck corneal dystrophy,ppi
7440,8729,79837,PIP4K2C,phosphatidylinositol-5-phosphate 4-kinase type 2 gamma,36,1-phosphatidylinositol-5-phosphate 4-kinase activity,bipolar disorder|schizophrenia,ppi
7441,8731,57718,PPP4R4,protein phosphatase 4 regulatory subunit 4,4,protein phosphatase regulator activity,,ppi
7442,8732,51550,CINP,cyclin dependent kinase 2 interacting protein,18,,,ppi
7443,8733,10491,CRTAP,cartilage associated protein,31,protein-containing complex binding,enophthalmos|orbital disease|exophthalmos|hydronephrosis|osteogenesis imperfecta|Ehlers-Danlos syndrome|osteogenesis imperfecta type 1|osteogenesis imperfecta with opalescent teeth; blue sclerae and wormian bones but without fractures|osteogenesis imperfecta type 8|osteogenesis imperfecta type 7|osteogenesis imperfecta type 17|osteogenesis imperfecta type 3|osteogenesis imperfecta type 4|osteogenesis imperfecta type 2|osteogenesis imperfecta type 13|osteogenesis imperfecta type 14|osteogenesis imperfecta type 5|osteogenesis imperfecta type 16|osteogenesis imperfecta type 10|osteogenesis imperfecta type 15,ppi
7444,8734,115708,TRMT61A,tRNA methyltransferase 61A,27,mRNA (adenine-N1-)-methyltransferase activity|tRNA (adenine-N1-)-methyltransferase activity,,ppi
7445,8735,64423,INF2,inverted formin; FH2 and WH2 domain containing,31,,focal segmental glomerulosclerosis|Charcot-Marie-Tooth disease dominant intermediate E,ppi
7446,8737,728239,MAGED4,MAGE family member D4,14,,,ppi
7447,8738,23241,PACS2,phosphofurin acidic cluster sorting protein 2,13,ion channel binding,,ppi
7448,8740,158809,MAGEB6,MAGE family member B6,5,,,ppi
7449,8741,81890,QTRT1,queuine tRNA-ribosyltransferase catalytic subunit 1,20,queuine tRNA-ribosyltransferase activity|protein homodimerization activity|protein heterodimerization activity,,ppi
7450,8742,139081,MAGEC3,MAGE family member C3,2,,,ppi
7451,8743,373863,DND1,DND microRNA-mediated repression inhibitor 1,10,AU-rich element binding|miRNA binding|mRNA binding,,ppi
7452,8744,113,ADCY7,adenylate cyclase 7,4,adenylate cyclase activity,alcohol dependence|alcohol abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|acute myeloid leukemia|schizophrenia|mood disorder,ppi
7453,8745,1404,HAPLN1,hyaluronan and proteoglycan link protein 1,8,extracellular matrix structural constituent conferring compression resistance,rheumatoid arthritis|large intestine cancer|colorectal cancer|achondroplasia|Laron syndrome,ppi
7454,8746,57568,SIPA1L2,signal induced proliferation associated 1 like 2,30,,,ppi
7455,8747,23094,SIPA1L3,signal induced proliferation associated 1 like 3,28,,,ppi
7456,8748,387496,RASL11A,RAS like family 11 member A,1,,endometriosis of uterus|endometriosis,ppi
7457,8749,22850,ADNP2,ADNP homeobox 2,12,DNA-binding transcription factor activity; RNA polymerase II-specific,schizophrenia,ppi
7458,8750,65997,RASL11B,RAS like family 11 member B,6,,,ppi
7459,8751,55252,ASXL2,additional sex combs like 2; transcriptional regulator,18,peroxisome proliferator activated receptor binding|chromatin binding,urinary bladder cancer|acute myeloid leukemia,ppi
7460,8752,55623,THUMPD1,THUMP domain containing 1,24,RNA binding,,ppi
7461,8754,389206,BEND4,BEN domain containing 4,1,,,ppi
7462,8755,25904,CNOT10,CCR4-NOT transcription complex subunit 10,39,,,ppi
7463,8756,23076,RRP1B,ribosomal RNA processing 1B,79,transcription coactivator activity|RNA binding,,ppi
7464,8757,144455,E2F7,E2F transcription factor 7,9,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity|transcription corepressor activity|DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|transcription factor binding|sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
7465,8758,317754,POTED,POTE ankyrin domain family member D,1,,,ppi
7466,8759,79817,MOB3B,MOB kinase activator 3B,7,,,ppi
7467,8760,253782,CERS6,ceramide synthase 6,17,DNA-binding transcription factor activity; RNA polymerase II-specific|sphingosine N-acyltransferase activity,substance abuse|substance-related disorder,ppi
7468,8761,1406,CRX,cone-rod homeobox,48,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|nuclear hormone receptor binding,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|epilepsy|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus,ppi
7469,8762,9925,ZBTB5,zinc finger and BTB domain containing 5,18,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
7470,8764,1407,CRY1,cryptochrome circadian clock 1,139,DNA binding|double-stranded DNA binding|blue light photoreceptor activity|deoxyribodipyrimidine photo-lyase activity|DNA (6-4) photolyase activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|chronic myeloid leukemia,ppi
7471,8765,80852,GRIP2,glutamate receptor interacting protein 2,12,,,ppi
7472,8766,25841,ABTB2,ankyrin repeat and BTB domain containing 2,9,,,ppi
7473,8767,64395,GMCL1,germ cell-less; spermatogenesis associated 1,95,,,ppi
7474,8768,121551,BTBD11,BTB domain containing 11,1,,liver cancer,ppi
7475,8769,84464,SLX4,SLX4 structure-specific endonuclease subunit,169,endodeoxyribonuclease activity|enzyme activator activity|crossover junction endodeoxyribonuclease activity|5'-flap endonuclease activity|3'-flap endonuclease activity,Fanconi anemia,ppi
7476,8770,138151,NACC2,NACC family member 2,10,RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|histone deacetylase activity|protein homodimerization activity,,ppi
7477,8771,57659,ZBTB4,zinc finger and BTB domain containing 4,11,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|methyl-CpG binding|methyl-CpNpG binding|protein homodimerization activity|sequence-specific DNA binding|DNA binding|DNA-binding transcription factor activity,,ppi
7478,8772,1408,CRY2,cryptochrome circadian clock 2,147,transcription regulatory region sequence-specific DNA binding|DNA binding|damaged DNA binding|single-stranded DNA binding|blue light photoreceptor activity|FAD binding|deoxyribodipyrimidine photo-lyase activity|DNA (6-4) photolyase activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|chronic myeloid leukemia,ppi
7479,8773,1409,CRYAA,crystallin alpha A,18,unfolded protein binding,suppression amblyopia|amblyopia|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|glaucoma|myopia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|mechanical strabismus|hypertropia|uveitis|ciliary body disease|iris disease|panuveitis|blindness|cataract|cornea plana,ppi
7480,8774,1410,CRYAB,crystallin alpha B,108,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z,ppi
7481,8775,114,ADCY8,adenylate cyclase 8,3,adenylate cyclase activity|calcium- and calmodulin-responsive adenylate cyclase activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetic angiopathy|mood disorder,ppi
7482,8780,253175,CDY1B,chromodomain Y-linked 1B,2,,,ppi
7483,8781,203611,CDY2B,chromodomain Y-linked 2B,1,,,ppi
7484,8782,64591,TSPY2,testis specific protein; Y-linked 2,1,,,ppi
7485,8783,9811,CTIF,cap binding complex dependent translation initiation factor,7,translation activator activity,,ppi
7486,8784,9270,ITGB1BP1,integrin subunit beta 1 binding protein 1,20,GDP-dissociation inhibitor activity|integrin binding|protein transporter activity|protein-containing complex binding,,ppi
7487,8785,1411,CRYBA1,crystallin beta A1,7,,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
7488,8786,1412,CRYBA2,crystallin beta A2,6,,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
7489,8787,159119,HSFY2,heat shock transcription factor; Y-linked 2,21,,,ppi
7490,8788,1413,CRYBA4,crystallin beta A4,24,,myopia|cataract|cataract 16 multiple types|cornea plana|Peters anomaly|cataract 23,ppi
7491,8789,1414,CRYBB1,crystallin beta B1,7,,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
7492,8790,159163,RBMY1F,RNA binding motif protein; Y-linked; family 1; member F,15,,,ppi
7493,8791,1415,CRYBB2,crystallin beta B2,8,structural molecule activity,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38,ppi
7494,8794,55967,NDUFA12,NADH:ubiquinone oxidoreductase subunit A12,78,NADH dehydrogenase (ubiquinone) activity,Leigh disease,ppi
7495,8795,84680,ACCS,1-aminocyclopropane-1-carboxylate synthase homolog (inactive),3,pyridoxal phosphate binding|protein homodimerization activity|1-aminocyclopropane-1-carboxylate synthase activity,,ppi
7496,8796,342667,STAC2,SH3 and cysteine rich domain 2,4,,,ppi
7497,8798,132949,AASDH,aminoadipate-semialdehyde dehydrogenase,5,acid-thiol ligase activity,,ppi
7498,8799,90459,ERI1,exoribonuclease 1,6,3'-5'-exoribonuclease activity|3'-5' exonuclease activity|rRNA binding|ribosome binding|histone pre-mRNA stem-loop binding,,ppi
7499,8800,55831,EMC3,ER membrane protein complex subunit 3,39,,,ppi
7500,8801,115,ADCY9,adenylate cyclase 9,17,adenylate cyclase activity,,ppi
7501,8802,1417,CRYBB3,crystallin beta B3,6,,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
7502,8803,118812,MORN4,MORN repeat containing 4,15,,,ppi
7503,8804,64343,AZI2,5-azacytidine induced 2,18,,,ppi
7504,8805,170572,HTR3C,5-hydroxytryptamine receptor 3C,82,serotonin-gated cation-selective channel activity|extracellular ligand-gated ion channel activity,autistic disorder,ppi
7505,8806,200909,HTR3D,5-hydroxytryptamine receptor 3D,4,serotonin-gated cation-selective channel activity|extracellular ligand-gated ion channel activity,schizophrenia,ppi
7506,8807,285242,HTR3E,5-hydroxytryptamine receptor 3E,7,serotonin-gated cation-selective channel activity|extracellular ligand-gated ion channel activity,schizophrenia,ppi
7507,8808,83858,ATAD3B,ATPase family; AAA domain containing 3B,45,zinc ion binding,,ppi
7508,8809,375056,MIA3,MIA family member 3; ER export factor,50,lipoprotein transporter activity,coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|coronary artery disease,ppi
7509,8810,139322,APOOL,apolipoprotein O like,40,protein binding,,ppi
7510,8811,89876,MAATS1,MYCBP associated and testis expressed 1,6,,,ppi
7511,8812,10152,ABI2,abl interactor 2,108,DNA binding|cytoskeletal adaptor activity|SH3 domain binding|kinase binding|protein-containing complex binding|Rac GTPase binding|proline-rich region binding|protein binding|ubiquitin protein ligase binding,,ppi
7512,8813,55323,LARP6,La ribonucleoprotein domain family member 6,3,RNA stem-loop binding|mRNA 5'-UTR binding|sequence-specific mRNA binding,,ppi
7513,8814,30836,DNTTIP2,deoxynucleotidyltransferase terminal interacting protein 2,30,RNA binding,,ppi
7514,8815,170622,COMMD6,COMM domain containing 6,28,,,ppi
7515,8816,60312,AFAP1,actin filament associated protein 1,30,,,ppi
7516,8817,81569,ACTL8,actin like 8,12,,,ppi
7517,8819,339451,KLHL17,kelch like family member 17,5,protein-containing complex scaffold activity|actin filament binding,,ppi
7518,8820,64431,ACTR6,ARP6 actin-related protein 6 homolog,35,,,ppi
7519,8822,139741,ACTRT1,actin related protein T1,6,,,ppi
7520,8823,83729,INHBE,inhibin beta E subunit,15,transforming growth factor beta receptor binding|cytokine activity,chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease,ppi
7521,8824,57409,MIF4GD,MIF4G domain containing,23,translation activator activity,,ppi
7522,8825,57405,SPC25,SPC25; NDC80 kinetochore complex component,34,,,ppi
7523,8828,64318,NOC3L,NOC3 like DNA replication regulator,55,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding|chromatin binding,,ppi
7524,8829,26060,APPL1,adaptor protein; phosphotyrosine interacting with PH domain and leucine zipper 1,99,,diabetes mellitus|type 2 diabetes mellitus|maturity-onset diabetes of the young,ppi
7525,8830,10297,APC2,APC2; WNT signaling pathway regulator,22,beta-catenin binding|gamma-catenin binding,large intestine cancer|colorectal cancer|hypoglycemia|inflammatory bowel disease|intellectual disability|learning disability|obesity|Perlman syndrome|Sotos syndrome|Beckwith-Wiedemann syndrome|breast cancer,ppi
7526,8831,79827,CLMP,CXADR like membrane protein,6,,intestinal pseudo-obstruction|paralytic ileus,ppi
7527,8832,51094,ADIPOR1,adiponectin receptor 1,25,adiponectin binding|adipokinetic hormone receptor activity|signaling receptor activity,chronic kidney disease,ppi
7528,8833,79602,ADIPOR2,adiponectin receptor 2,6,adiponectin binding|adipokinetic hormone receptor activity|signaling receptor activity,,ppi
7529,8834,25937,WWTR1,WW domain containing transcription regulator 1,43,transcription coactivator activity,anterior horn cell disease|muscular atrophy,ppi
7530,8835,10974,ADIRF,adipogenesis regulatory factor,2,,,ppi
7531,8836,729533,FAM72A,family with sequence similarity 72 member A,1,,,ppi
7532,8838,115761,ARL11,ADP ribosylation factor like GTPase 11,5,GTP binding,chronic lymphocytic leukemia|Richter's syndrome|ovarian cancer,ppi
7533,8839,64225,ATL2,atlastin GTPase 2,34,GTPase activity|identical protein binding,,ppi
7534,8840,151188,ARL6IP6,ADP ribosylation factor like GTPase 6 interacting protein 6,17,,,ppi
7535,8841,116969,ART5,ADP-ribosyltransferase 5,1,NAD+ ADP-ribosyltransferase activity,,ppi
7536,8842,153222,CREBRF,CREB3 regulatory factor,4,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
7537,8843,121536,AEBP2,AE binding protein 2,29,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7538,8844,57082,KNL1,kinetochore scaffold 1,36,,microcephaly,ppi
7539,8845,163590,TOR1AIP2,torsin 1A interacting protein 2,68,ATPase activator activity,,ppi
7540,8846,246181,AKR7L,aldo-keto reductase family 7 like (gene/pseudogene),1,aldo-keto reductase (NADP) activity,,ppi
7541,8847,83878,USHBP1,USH1 protein network component harmonin binding protein 1,120,,,ppi
7542,8848,9407,TMPRSS11D,transmembrane protease; serine 11D,1,peptidase activity,,ppi
7543,8849,83853,ROPN1L,rhophilin associated tail protein 1 like,6,,,ppi
7544,8850,158798,AKAP14,A-kinase anchoring protein 14,12,protein kinase A regulatory subunit binding,,ppi
7545,8851,130589,GALM,galactose mutarotase,6,aldose 1-epimerase activity,,ppi
7546,8852,51566,ARMCX3,armadillo repeat containing; X-linked 3,36,,,ppi
7547,8855,113457,TUBA3D,tubulin alpha 3d,106,,,ppi
7548,8856,347902,AMIGO2,adhesion molecule with Ig like domain 2,4,,,ppi
7549,8857,391002,PRAMEF8,PRAME family member 8,1,,,ppi
7550,8858,386724,AMIGO3,adhesion molecule with Ig like domain 3,14,,,ppi
7551,8859,63897,HEATR6,HEAT repeat containing 6,20,RNA binding,,ppi
7552,8860,10393,ANAPC10,anaphase promoting complex subunit 10,44,,,ppi
7553,8861,10218,ANGPTL7,angiopoietin like 7,14,,,ppi
7554,8862,375248,ANKRD36,ankyrin repeat domain 36,4,,,ppi
7555,8863,1418,CRYGA,crystallin gamma A,1,structural constituent of eye lens,,ppi
7556,8864,83464,APH1B,aph-1 homolog B; gamma-secretase subunit,7,peptidase activity|endopeptidase activity,,ppi
7557,8866,134549,SHROOM1,shroom family member 1,4,actin filament binding,,ppi
7558,8867,58477,SRPRB,SRP receptor beta subunit,148,,,ppi
7559,8868,29974,A1CF,APOBEC1 complementation factor,11,RNA binding|single-stranded RNA binding|double-stranded RNA binding,,ppi
7560,8870,1419,CRYGB,crystallin gamma B,1,structural constituent of eye lens,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
7561,8871,51374,ATRAID,all-trans retinoic acid induced differentiation factor,5,,,ppi
7562,8872,28986,MAGEH1,MAGE family member H1,19,,,ppi
7563,8874,339487,ZBTB8OS,zinc finger and BTB domain containing 8 opposite strand,7,,,ppi
7564,8875,51326,ARL17A,ADP ribosylation factor like GTPase 17A,2,,,ppi
7565,8876,64411,ARAP3,ArfGAP with RhoGAP domain; ankyrin repeat and PH domain 3,7,GTPase activator activity|phosphatidylinositol-3;4;5-trisphosphate binding|phosphatidylinositol-3;4-bisphosphate binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
7566,8877,8470,SORBS2,sorbin and SH3 domain containing 2,57,RNA binding|structural constituent of cytoskeleton|cytoskeletal adaptor activity|structural constituent of muscle,,ppi
7567,8878,83857,TMTC1,transmembrane and tetratricopeptide repeat containing 1,3,,,ppi
7568,8879,116,ADCYAP1,adenylate cyclase activating polypeptide 1,35,neuropeptide hormone activity|pituitary adenylate cyclase activating polypeptide activity|peptide hormone receptor binding|pituitary adenylate cyclase-activating polypeptide receptor binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|esophagus squamous cell carcinoma|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|low compliance bladder,ppi
7569,8880,1420,CRYGC,crystallin gamma C,8,structural constituent of eye lens,suppression amblyopia|amblyopia|myopia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|blindness|cataract|cornea plana|Peters anomaly|cataract 2 multiple types|cataract 16 multiple types,ppi
7570,8881,164668,APOBEC3H,apolipoprotein B mRNA editing enzyme catalytic subunit 3H,1,cytidine deaminase activity|RNA binding,,ppi
7571,8882,51593,SRRT,serrate; RNA effector molecule,88,DNA binding|RNA binding,bipolar disorder|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
7572,8883,22901,ARSG,arylsulfatase G,21,arylsulfatase activity,,ppi
7573,8884,84164,ASCC2,activating signal cointegrator 1 complex subunit 2,60,,,ppi
7574,8885,91703,ACY3,aminoacylase 3,14,aminoacylase activity,,ppi
7575,8886,57559,STAMBPL1,STAM binding protein like 1,52,Lys63-specific deubiquitinase activity|thiol-dependent ubiquitin-specific protease activity,,ppi
7576,8887,80709,AKNA,AT-hook transcription factor,2,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
7577,8888,1421,CRYGD,crystallin gamma D,3,structural constituent of eye lens,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
7578,8889,10190,TXNDC9,thioredoxin domain containing 9,67,cadherin binding,,ppi
7579,8890,79572,ATP13A3,ATPase 13A3,11,,,ppi
7580,8891,54998,AURKAIP1,aurora kinase A interacting protein 1,44,,,ppi
7581,8892,84153,RNASEH2C,ribonuclease H2 subunit C,9,,Aicardi-Goutieres syndrome,ppi
7582,8893,83666,PARP9,poly(ADP-ribose) polymerase family member 9,10,obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|NAD+ ADP-ribosyltransferase activity|enzyme inhibitor activity|ADP-D-ribose binding|NAD+ binding,,ppi
7583,8894,51760,SYT17,synaptotagmin 17,21,syntaxin binding|calcium-dependent phospholipid binding|calcium ion binding|clathrin binding|SNARE binding|phosphatidylserine binding,,ppi
7584,8896,27077,B9D1,B9 domain containing 1,23,hedgehog receptor activity,cerebellar disease|isolated cleft palate|cleft palate|clubfoot|autosomal recessive polycystic kidney disease|cryptorchidism|intellectual disability|learning disability|microphthalmia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|oligohydramnios|cataract|sex differentiation disease|hermaphroditism|pseudohermaphroditism|cornea plana,ppi
7585,8897,86,ACTL6A,actin like 6A,129,chromatin binding|transcription coactivator activity|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,,ppi
7586,8898,257019,FRMD3,FERM domain containing 3,11,,,ppi
7587,8899,84913,ATOH8,atonal bHLH transcription factor 8,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|E-box binding,,ppi
7588,8900,83877,TM2D2,TM2 domain containing 2,14,,,ppi
7589,8901,80213,TM2D3,TM2 domain containing 3,29,,,ppi
7590,8903,55973,BCAP29,B-cell receptor associated protein 29,16,,,ppi
7591,8904,90427,BMF,Bcl2 modifying factor,16,,chronic lymphocytic leukemia|Richter's syndrome,ppi
7592,8905,26228,STAP1,signal transducing adaptor family member 1,19,transmembrane receptor protein tyrosine kinase adaptor activity|phospholipid binding,,ppi
7593,8906,23174,ZCCHC14,zinc finger CCHC-type containing 14,8,,alcohol dependence|alcohol abuse,ppi
7594,8908,283358,B4GALNT3,beta-1;4-N-acetyl-galactosaminyltransferase 3,3,acetylgalactosaminyltransferase activity,,ppi
7595,8909,85479,DNAJC5B,DnaJ heat shock protein family (Hsp40) member C5 beta,1,,,ppi
7596,8911,146664,MGAT5B,mannosyl (alpha-1;6-)-glycoprotein beta-1;6-N-acetyl-glucosaminyltransferase; isozyme B,22,alpha-1;6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,polycystic ovary syndrome,ppi
7597,8913,83941,TM2D1,TM2 domain containing 1,2,amyloid-beta binding|G-protein coupled receptor activity,,ppi
7598,8914,113452,TMEM54,transmembrane protein 54,6,,,ppi
7599,8916,79690,GAL3ST4,galactose-3-O-sulfotransferase 4,2,3'-phosphoadenosine 5'-phosphosulfate binding|galactose 3-O-sulfotransferase activity|proteoglycan sulfotransferase activity,,ppi
7600,8917,80014,WWC2,WW and C2 domain containing 2,16,protein-containing complex scaffold activity,,ppi
7601,8918,57801,HES4,hes family bHLH transcription factor 4,14,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor binding|sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific double-stranded DNA binding|transcription corepressor activity|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
7602,8919,25893,TRIM58,tripartite motif containing 58,6,,,ppi
7603,8920,51319,RSRC1,arginine and serine rich coiled-coil 1,35,,,ppi
7604,8921,51286,CEND1,cell cycle exit and neuronal differentiation 1,3,,,ppi
7605,8922,168667,BMPER,BMP binding endothelial regulator,3,,opiate dependence,ppi
7606,8923,51317,PHF21A,PHD finger protein 21A,32,histone deacetylase activity,epilepsy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|craniosynostosis|cherubism|exostosis|periarthritis|tendinitis,ppi
7607,8924,11332,ACOT7,acyl-CoA thioesterase 7,38,fatty-acyl-CoA binding|palmitoyl-CoA hydrolase activity|long-chain fatty acyl-CoA binding|acyl-CoA hydrolase activity|protein homodimerization activity,,ppi
7608,8925,146227,BEAN1,brain expressed; associated with NEDD4; 1,2,,spinocerebellar ataxia type 31,ppi
7609,8926,51236,HGH1,HGH1 homolog,19,,,ppi
7610,8927,51673,TPPP3,tubulin polymerization promoting protein family member 3,1,tubulin binding,,ppi
7611,8928,57596,BEGAIN,brain enriched guanylate kinase associated,28,,,ppi
7612,8929,11076,TPPP,tubulin polymerization promoting protein,11,microtubule binding|tubulin binding,,ppi
7613,8930,374860,ANKRD30B,ankyrin repeat domain 30B,1,,,ppi
7614,8931,157638,FAM84B,family with sequence similarity 84 member B,20,,,ppi
7615,8932,155465,AGR3,anterior gradient 3; protein disulphide isomerase family member,14,dystroglycan binding,,ppi
7616,8933,25884,CHRDL2,chordin like 2,8,,,ppi
7617,8934,1427,CRYGS,crystallin gamma S,3,,cataract|cataract 20 multiple types|cataract 16 multiple types,ppi
7618,8935,55299,BRIX1,BRX1; biogenesis of ribosomes,119,RNA binding,,ppi
7619,8936,653121,ZBTB8A,zinc finger and BTB domain containing 8A,55,,,ppi
7620,8937,92552,ATXN3L,ataxin 3 like,7,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
7621,8938,81616,ACSBG2,acyl-CoA synthetase bubblegum family member 2,3,long-chain fatty acid-CoA ligase activity|very long-chain fatty acid-CoA ligase activity|acyl-CoA hydrolase activity,,ppi
7622,8939,51495,HACD3,3-hydroxyacyl-CoA dehydratase 3,66,GTPase activator activity|3-hydroxyacyl-CoA dehydratase activity|enzyme binding,,ppi
7623,8942,81558,FAM117A,family with sequence similarity 117 member A,3,,,ppi
7624,8943,1428,CRYM,crystallin mu,4,transcription corepressor activity|protein homodimerization activity|thiomorpholine-carboxylate dehydrogenase activity|NADP binding|thyroid hormone binding|hormone binding|oxidoreductase activity; acting on the CH-NH2 group of donors; NAD or NADP as acceptor,sensorineural hearing loss|autosomal dominant nonsyndromic deafness 40,ppi
7625,8944,27079,RPUSD2,RNA pseudouridylate synthase domain containing 2,27,RNA binding|pseudouridine synthase activity,,ppi
7626,8946,10882,C1QL1,complement C1q like 1,20,,,ppi
7627,8947,79184,BRCC3,BRCA1/BRCA2-containing complex subunit 3,56,thiol-dependent ubiquitin-specific protease activity|metallopeptidase activity|enzyme regulator activity|polyubiquitin modification-dependent protein binding|thiol-dependent ubiquitinyl hydrolase activity|Lys63-specific deubiquitinase activity,Moyamoya disease,ppi
7628,8948,23523,CABIN1,calcineurin binding protein 1,30,protein phosphatase inhibitor activity|nucleosome binding,schizophrenia,ppi
7629,8949,51150,SDF4,stromal cell derived factor 4,89,calcium ion binding|identical protein binding,schizophrenia,ppi
7630,8950,1429,CRYZ,crystallin zeta,25,mRNA 3'-UTR binding|NADPH:quinone reductase activity|NADPH binding|NADH binding,schizophrenia|neurotic disorder|endogenous depression|melancholia|mood disorder|major depressive disorder|mental depression,ppi
7631,8951,55450,CAMK2N1,calcium/calmodulin dependent protein kinase II inhibitor 1,2,calcium-dependent protein kinase inhibitor activity,,ppi
7632,8953,163688,CALML6,calmodulin like 6,1,calcium ion binding|enzyme regulator activity,,ppi
7633,8954,94032,CAMK2N2,calcium/calmodulin dependent protein kinase II inhibitor 2,3,,,ppi
7634,8956,117,ADCYAP1R1,ADCYAP receptor type I,3,signaling receptor activity|peptide hormone binding|G-protein coupled peptide receptor activity,asthma|intrinsic asthma|allergic asthma|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia,ppi
7635,8957,9946,CRYZL1,crystallin zeta like 1,14,NADPH:quinone reductase activity|NADP binding,,ppi
7636,8958,374393,FAM111B,family with sequence similarity 111 member B,8,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
7637,8959,56475,RPRM,reprimo; TP53 dependent G2 arrest mediator candidate,9,,Barrett's esophagus|esophageal cancer,ppi
7638,8960,124641,OVCA2,ovarian tumor suppressor candidate 2,3,hydrolase activity|NADP binding|dihydrofolate reductase activity,,ppi
7639,8961,64800,EFCAB6,EF-hand calcium binding domain 6,4,,,ppi
7640,8962,93661,CAPZA3,capping actin protein of muscle Z-line alpha subunit 3,2,actin filament binding,,ppi
7641,8963,55330,BLOC1S4,biogenesis of lysosomal organelles complex 1 subunit 4,12,,,ppi
7642,8965,493856,CISD2,CDGSH iron sulfur domain 2,35,RNA binding|protein homodimerization activity|2 iron; 2 sulfur cluster binding,Wolfram syndrome 1|Wolfram syndrome|Wolfram syndrome 2,ppi
7643,8966,148113,CILP2,cartilage intermediate layer protein 2,5,alkaline phosphatase activity|nucleotide diphosphatase activity,,ppi
7644,8967,57130,ATP13A1,ATPase 13A1,10,manganese-transporting ATPase activity,,ppi
7645,8968,9541,CIR1,corepressor interacting with RBPJ; 1,24,DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription corepressor activity,,ppi
7646,8969,10153,CEBPZ,CCAAT/enhancer binding protein zeta,77,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|RNA binding,,ppi
7647,8970,10849,CD3EAP,CD3e molecule associated protein,30,RNA binding,,ppi
7648,8971,1431,CS,citrate synthase,43,RNA binding|citrate (Si)-synthase activity,congestive heart failure|obesity|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
7649,8972,83940,TATDN1,TatD DNase domain containing 1,36,3'-5'-exodeoxyribonuclease activity,liver cancer|hepatocellular carcinoma,ppi
7650,8973,166979,CDC20B,cell division cycle 20B,19,,,ppi
7651,8974,51755,CDK12,cyclin dependent kinase 12,44,protein kinase activity|RNA polymerase II CTD heptapeptide repeat kinase activity|cyclin-dependent protein serine/threonine kinase activity|transcription factor binding|transcription regulatory region DNA binding|cyclin binding,,ppi
7652,8977,9236,CCPG1,cell cycle progression 1,30,,,ppi
7653,8978,63924,CIDEC,cell death inducing DFFA like effector c,5,,allergic contact dermatitis|familial partial lipodystrophy,ppi
7654,8979,131450,CD200R1,CD200 receptor 1,8,signaling receptor activity,,ppi
7655,8980,55749,CCAR1,cell division cycle and apoptosis regulator 1,58,RNA polymerase II distal enhancer sequence-specific DNA binding|transcription coactivator activity|transcription corepressor activity|RNA binding|nuclear receptor transcription coactivator activity,,ppi
7656,8981,9857,CEP350,centrosomal protein 350,55,,,ppi
7657,8982,9911,TMCC2,transmembrane and coiled-coil domain family 2,36,,,ppi
7658,8983,9514,GAL3ST1,galactose-3-O-sulfotransferase 1,11,sulfotransferase activity,,ppi
7659,8984,25875,LETMD1,LETM1 domain containing 1,26,,,ppi
7660,8986,92749,DRC1,dynein regulatory complex subunit 1,3,,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1,ppi
7661,8987,221002,RASGEF1A,RasGEF domain family member 1A,1,Ras guanyl-nucleotide exchange factor activity,,ppi
7662,8988,132158,GLYCTK,glycerate kinase,14,glycerate kinase activity,,ppi
7663,8989,51603,METTL13,methyltransferase like 13,30,,,ppi
7664,8990,51067,YARS2,tyrosyl-tRNA synthetase 2,45,tRNA binding|RNA binding|tyrosine-tRNA ligase activity|ATP binding|tyrosine binding,lactic acidosis|anemia|macrocytic anemia|sideroblastic anemia|ptosis|congenital ptosis|glaucoma|intellectual disability|learning disability|familial periodic paralysis|myopathy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|mechanical strabismus|hypertropia|mitochondrial myopathy|mitochondrial metabolism disease,ppi
7665,8991,51068,NMD3,NMD3 ribosome export adaptor,68,RNA binding|protein binding; bridging|ribosomal large subunit binding,,ppi
7666,8992,50999,TMED5,transmembrane p24 trafficking protein 5,5,,,ppi
7667,8993,51011,FAHD2A,fumarylacetoacetate hydrolase domain containing 2A,12,,,ppi
7668,8994,51014,TMED7,transmembrane p24 trafficking protein 7,14,,cholestasis,ppi
7669,8995,51015,ISOC1,isochorismatase domain containing 1,43,,,ppi
7670,8996,51018,RRP15,ribosomal RNA processing 15 homolog,35,,,ppi
7671,8997,51019,WASHC3,WASH complex subunit 3,68,,,ppi
7672,8998,51643,TMBIM4,transmembrane BAX inhibitor motif containing 4,33,,,ppi
7673,8999,51001,MTERF3,mitochondrial transcription termination factor 3,32,transcription regulatory region DNA binding,,ppi
7674,9000,51002,TPRKB,TP53RK binding protein,43,,,ppi
7675,9001,51003,MED31,mediator complex subunit 31,81,transcription coactivator activity,,ppi
7676,9002,51647,FAM96B,family with sequence similarity 96 member B,72,,,ppi
7677,9003,51005,AMDHD2,amidohydrolase domain containing 2,4,N-acetylglucosamine-6-phosphate deacetylase activity,,ppi
7678,9004,51027,BOLA1,bolA family member 1,24,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7679,9005,51029,DESI2,desumoylating isopeptidase 2,1,Lys63-specific deubiquitinase activity|Lys48-specific deubiquitinase activity,ovarian cancer,ppi
7680,9006,51651,PTRH2,peptidyl-tRNA hydrolase 2,49,aminoacyl-tRNA hydrolase activity,cerebellar disease|clubfoot|alternating exotropia|exotropia|monocular exotropia|sensorineural hearing loss|congenital hypothyroidism|myxedema|hypothyroidism|intellectual disability|learning disability|prostate cancer|prostate carcinoma|steatorrhea|craniosynostosis|liver cirrhosis,ppi
7681,9007,51008,ASCC1,activating signal cointegrator 1 complex subunit 1,36,,Barrett's esophagus|esophageal cancer|esophageal carcinoma,ppi
7682,9008,51071,DERA,deoxyribose-phosphate aldolase,17,deoxyribose-phosphate aldolase activity,,ppi
7683,9009,51611,DPH5,diphthamide biosynthesis 5,13,diphthine synthase activity,,ppi
7684,9010,51076,CUTC,cutC copper transporter,17,copper ion binding,,ppi
7685,9011,51092,SIDT2,SID1 transmembrane family member 2,16,AP-2 adaptor complex binding|AP-1 adaptor complex binding|nucleic acid transmembrane transporter activity,,ppi
7686,9012,51093,RRNAD1,ribosomal RNA adenine dimethylase domain containing 1,1,,,ppi
7687,9013,51096,UTP18,UTP18; small subunit processome component,29,RNA binding,,ppi
7688,9014,51097,SCCPDH,saccharopine dehydrogenase (putative),45,,,ppi
7689,9015,25813,SAMM50,SAMM50 sorting and assembly machinery component,38,,,ppi
7690,9016,51101,ZC2HC1A,zinc finger C2HC-type containing 1A,13,,,ppi
7691,9017,51104,ABHD17B,abhydrolase domain containing 17B,19,palmitoyl-(protein) hydrolase activity,,ppi
7692,9018,51629,SLC25A39,solute carrier family 25 member 39,4,,,ppi
7693,9019,8531,YBX3,Y-box binding protein 3,111,DNA-binding transcription factor activity; RNA polymerase II-specific|double-stranded DNA binding|DNA-binding transcription factor activity|transcription corepressor activity|RNA binding|mRNA 3'-UTR binding|Rho GTPase binding,,ppi
7694,9020,51105,PHF20L1,PHD finger protein 20-like 1,34,,,ppi
7695,9021,51633,OTUD6B,OTU domain containing 6B,27,thiol-dependent ubiquitinyl hydrolase activity,,ppi
7696,9022,51634,RBMX2,RNA binding motif protein; X-linked 2,18,RNA binding|first spliceosomal transesterification activity,,ppi
7697,9023,51111,KMT5B,lysine methyltransferase 5B,7,histone-lysine N-methyltransferase activity,,ppi
7698,9024,51112,TRAPPC12,trafficking protein particle complex 12,22,Rab guanyl-nucleotide exchange factor activity|endopeptidase activity,,ppi
7699,9025,51115,RMDN1,regulator of microtubule dynamics 1,8,,,ppi
7700,9026,27341,RRP7A,ribosomal RNA processing 7 homolog A,54,RNA binding,,ppi
7701,9027,57132,CHMP1B,charged multivesicular body protein 1B,28,,bipolar disorder,ppi
7702,9028,55349,CHDH,choline dehydrogenase,13,choline dehydrogenase activity,,ppi
7703,9029,10390,CEPT1,choline/ethanolamine phosphotransferase 1,24,diacylglycerol cholinephosphotransferase activity|ethanolaminephosphotransferase activity|phosphotransferase activity; for other substituted phosphate groups,,ppi
7704,9030,55790,CSGALNACT1,chondroitin sulfate N-acetylgalactosaminyltransferase 1,13,acetylgalactosaminyltransferase activity|peptidoglycan glycosyltransferase activity|glucuronosyltransferase activity|metal ion binding|glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity|glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,,ppi
7705,9031,79586,CHPF,chondroitin polymerizing factor,11,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity|N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,,ppi
7706,9032,55454,CSGALNACT2,chondroitin sulfate N-acetylgalactosaminyltransferase 2,60,acetylgalactosaminyltransferase activity|glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,,ppi
7707,9033,337876,CHSY3,chondroitin sulfate synthase 3,15,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity|N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,,ppi
7708,9034,158511,CSAG1,chondrosarcoma associated gene 1,3,,,ppi
7709,9035,83850,ESYT3,extended synaptotagmin 3,3,phosphatidylinositol binding|calcium-dependent phospholipid binding|phosphatidylcholine binding|phosphatidylethanolamine binding|calcium ion binding,,ppi
7710,9036,149013,NBPF12,neuroblastoma breakpoint family member 12,1,,,ppi
7711,9037,54953,C1orf27,chromosome 1 open reading frame 27,6,,,ppi
7712,9038,118,ADD1,adducin 1,65,RNA binding|actin binding|spectrin binding|cadherin binding|actin filament binding|structural molecule activity,hypertension|essential hypertension|liver cancer|hepatocellular carcinoma,ppi
7713,9039,56834,GPR137,G protein-coupled receptor 137,3,,,ppi
7714,9040,56851,EMC7,ER membrane protein complex subunit 7,34,,,ppi
7715,9041,29890,RBM15B,RNA binding motif protein 15B,35,RNA binding,,ppi
7716,9042,64151,NCAPG,non-SMC condensin I complex subunit G,52,,,ppi
7717,9043,9918,NCAPD2,non-SMC condensin I complex subunit D2,50,histone binding|chromatin binding,,ppi
7718,9044,84955,NUDCD1,NudC domain containing 1,37,,,ppi
7719,9045,10903,MTMR11,myotubularin related protein 11,16,,,ppi
7720,9046,81037,CLPTM1L,CLPTM1 like,16,,urinary bladder cancer|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|lung cancer|non-small cell lung carcinoma|cervical cancer|lymphoblastic leukemia|myeloid leukemia|lung benign neoplasm|prostate cancer|prostate carcinoma|lung adenocarcinoma,ppi
7721,9047,51747,LUC7L3,LUC7 like 3 pre-mRNA splicing factor,62,RNA binding|mRNA binding,,ppi
7722,9048,1434,CSE1L,chromosome segregation 1 like,136,nuclear export signal receptor activity|protein transporter activity,,ppi
7723,9049,51177,PLEKHO1,pleckstrin homology domain containing O1,49,,,ppi
7724,9050,121549,ASCL4,achaete-scute family bHLH transcription factor 4,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
7725,9052,25999,CLIP3,CAP-Gly domain containing linker protein 3,11,microtubule binding|ganglioside binding,,ppi
7726,9053,51204,TACO1,translational activator of cytochrome c oxidase I,13,,lactic acidosis|anemia|macrocytic anemia|ptosis|congenital ptosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|Leigh disease|intellectual disability|learning disability|optic atrophy|proteinuria|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|visual epilepsy,ppi
7727,9054,51751,HIGD1B,HIG1 hypoxia inducible domain family member 1B,1,,,ppi
7728,9055,80790,CMIP,c-Maf inducing protein,5,,,ppi
7729,9056,1435,CSF1,colony stimulating factor 1,12,cytokine activity|macrophage colony-stimulating factor receptor binding|growth factor activity|protein homodimerization activity,Paget's disease of bone|malignant mesothelioma|benign mesothelioma|breast cancer,ppi
7730,9057,113251,LARP4,La ribonucleoprotein domain family member 4,25,RNA binding|poly(A) binding,polycystic ovary syndrome,ppi
7731,9058,10260,DENND4A,DENN domain containing 4A,20,DNA binding|Rab guanyl-nucleotide exchange factor activity,,ppi
7732,9059,9607,CARTPT,CART prepropeptide,4,,alcohol dependence|alcohol abuse|anxiety disorder|phobic disorder|bipolar disorder|cocaine abuse|cocaine dependence|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|Graves' disease|thyrotoxicosis|hyperthyroidism|obesity|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
7733,9060,25920,NELFB,negative elongation factor complex member B,61,,,ppi
7734,9061,55602,CDKN2AIP,CDKN2A interacting protein,55,p53 binding,,ppi
7735,9062,29919,C18orf8,chromosome 18 open reading frame 8,14,,,ppi
7736,9063,389136,VGLL3,vestigial like family member 3,2,transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding,,ppi
7737,9064,51388,NIP7,NIP7; nucleolar pre-rRNA processing protein,32,RNA binding,,ppi
7738,9065,51118,UTP11,UTP11; small subunit processome component homolog (S. cerevisiae),11,RNA binding,,ppi
7739,9066,1436,CSF1R,colony stimulating factor 1 receptor,26,macrophage colony-stimulating factor receptor activity|cytokine binding|protein homodimerization activity|transmembrane receptor protein tyrosine kinase activity|protein tyrosine kinase activity|transmembrane signaling receptor activity,agnosia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|acute myeloid leukemia|mutism|amnestic disorder|retrograde amnesia|breast cancer,ppi
7740,9067,339302,CPLX4,complexin 4,9,SNARE binding,,ppi
7741,9069,10920,COPS8,COP9 signalosome subunit 8,61,,,ppi
7742,9070,151835,CPNE9,copine family member 9,1,calcium-dependent phospholipid binding,,ppi
7743,9071,56913,C1GALT1,core 1 synthase; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1,7,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,,ppi
7744,9072,29071,C1GALT1C1,C1GALT1 specific chaperone 1,15,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome,ppi
7745,9074,1437,CSF2,colony stimulating factor 2,15,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|cytokine activity,neutropenia|agranulocytosis|amnestic disorder|dissociative amnesia|anemia|macrocytic anemia|aplastic anemia|rheumatoid arthritis|large intestine cancer|colorectal cancer|eyelid disease|congestive heart failure|visceral leishmaniasis|acute myeloid leukemia|liver cancer|Langerhans-cell histiocytosis|lymphosarcoma|lymphoma|reticulosarcoma|non-Hodgkin lymphoma,ppi
7746,9075,60560,NAA35,N(alpha)-acetyltransferase 35; NatC auxiliary subunit,6,peptide alpha-N-acetyltransferase activity,,ppi
7747,9077,30827,CXXC1,CXXC finger protein 1,46,DNA-binding transcription factor activity; RNA polymerase II-specific|unmethylated CpG binding|histone methyltransferase activity (H3-K4 specific),,ppi
7748,9078,64693,CTAGE1,cutaneous T-cell lymphoma-associated antigen 1,1,lipoprotein transporter activity,,ppi
7749,9079,55088,CCDC186,coiled-coil domain containing 186,11,,,ppi
7750,9080,1438,CSF2RA,colony stimulating factor 2 receptor alpha subunit,10,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|signaling receptor activity|cytokine binding|cytokine receptor activity,schizophrenia|pulmonary alveolar proteinosis,ppi
7751,9081,80323,CCDC68,coiled-coil domain containing 68,12,,schizophrenia,ppi
7752,9082,57661,PHRF1,PHD and ring finger domains 1,15,RNA polymerase binding,systemic lupus erythematosus,ppi
7753,9083,84951,TNS4,tensin 4,14,,,ppi
7754,9084,54921,CHTF8,chromosome transmission fidelity factor 8,17,,,ppi
7755,9085,51267,CLEC1A,C-type lectin domain family 1 member A,1,transmembrane signaling receptor activity,,ppi
7756,9086,51266,CLEC1B,C-type lectin domain family 1 member B,3,transmembrane signaling receptor activity,,ppi
7757,9087,64866,CDCP1,CUB domain containing protein 1,14,protein binding,substance abuse|substance-related disorder,ppi
7758,9088,64061,TSPYL2,TSPY like 2,29,rDNA binding,endometrial cancer|endometrial carcinoma,ppi
7759,9089,1439,CSF2RB,colony stimulating factor 2 receptor beta common subunit,33,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|signaling receptor activity|interleukin-3 receptor activity|interleukin-5 receptor activity,schizophreniform disorder|schizoaffective disorder|pulmonary alveolar proteinosis|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
7760,9090,100287171,WASHC1,WASH complex subunit 1,14,alpha-tubulin binding,,ppi
7761,9091,51191,HERC5,HECT and RLD domain containing E3 ubiquitin protein ligase 5,48,RNA binding|ubiquitin-protein transferase activity|ISG15 transferase activity,endometriosis of uterus|endometriosis|influenza,ppi
7762,9093,80777,CYB5B,cytochrome b5 type B,38,heme binding,,ppi
7763,9094,51700,CYB5R2,cytochrome b5 reductase 2,8,cytochrome-b5 reductase activity; acting on NAD(P)H|FAD binding,,ppi
7764,9095,1440,CSF3,colony stimulating factor 3,2,cytokine activity|growth factor activity|granulocyte colony-stimulating factor receptor binding,neutropenia|agranulocytosis|anemia|macrocytic anemia|aplastic anemia|urinary bladder cancer|lung cancer|non-small cell lung carcinoma|transitional cell carcinoma|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z,ppi
7765,9096,125965,COX6B2,cytochrome c oxidase subunit 6B2,2,,,ppi
7766,9099,1441,CSF3R,colony stimulating factor 3 receptor,23,signaling receptor activity|cytokine binding|interleukin-3 binding|interleukin-3 receptor activity|cytokine receptor activity,myeloproliferative neoplasm|bone marrow cancer|myeloid leukemia|chronic monocytic leukemia|chronic myeloid leukemia|atypical chronic myeloid leukemia|subacute myeloid leukemia|essential thrombocythemia|myelodysplastic syndrome,ppi
7767,9100,119,ADD2,adducin 2,21,actin binding|spectrin binding|actin filament binding|structural molecule activity,,ppi
7768,9101,1442,CSH1,chorionic somatomammotropin hormone 1,18,growth factor activity|growth hormone receptor binding|hormone activity,Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome|Cockayne syndrome|Noonan syndrome|Aarskog syndrome,ppi
7769,9103,388962,BOLA3,bolA family member 3,18,DNA-binding transcription factor activity; RNA polymerase II-specific,multiple mitochondrial dysfunctions syndrome 2,ppi
7770,9104,1444,CSHL1,chorionic somatomammotropin hormone like 1,3,hormone activity|growth hormone receptor binding|growth factor activity,,ppi
7771,9106,51350,KRT76,keratin 76,12,,,ppi
7772,9107,9119,KRT75,keratin 75,23,,,ppi
7773,9108,84324,SARNP,SAP domain containing ribonucleoprotein,69,RNA binding,,ppi
7774,9109,84656,GLYR1,glyoxylate reductase 1 homolog,76,methylated histone binding|histone binding,,ppi
7775,9111,134526,ACOT12,acyl-CoA thioesterase 12,6,acetyl-CoA hydrolase activity|acyl-CoA hydrolase activity|ATP binding|long-chain fatty acyl-CoA binding|fatty-acyl-CoA binding|palmitoyl-CoA hydrolase activity,,ppi
7776,9112,55748,CNDP2,CNDP dipeptidase 2 (metallopeptidase M20 family),50,carboxypeptidase activity,fatty liver disease,ppi
7777,9113,84514,GHDC,GH3 domain containing,19,,,ppi
7778,9114,1445,CSK,c-src tyrosine kinase,149,protein tyrosine kinase activity|protein C-terminus binding|kinase activity,systemic lupus erythematosus,ppi
7779,9115,56941,HMCES,5-hydroxymethylcytosine binding; ES cell specific,14,,,ppi
7780,9116,56942,CMC2,C-X9-C motif containing 2,2,,breast cancer,ppi
7781,9117,58505,OSTC,oligosaccharyltransferase complex non-catalytic subunit,12,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,,ppi
7782,9118,56943,ENY2,ENY2; transcription and export complex 2 subunit,19,transcription coactivator activity|nuclear receptor transcription coactivator activity|chromatin binding,,ppi
7783,9119,1446,CSN1S1,casein alpha s1,29,,,ppi
7784,9120,162989,DEDD2,death effector domain containing 2,12,receptor signaling complex scaffold activity|DNA binding,,ppi
7785,9121,196513,DCP1B,decapping mRNA 1B,36,mRNA binding,,ppi
7786,9122,167227,DCP2,decapping mRNA 2,65,5'-3' exoribonuclease activity|exoribonuclease activity; producing 5'-phosphomonoesters|m7G(5')pppN diphosphatase activity|telomerase RNA binding,,ppi
7787,9123,79075,DSCC1,DNA replication and sister chromatid cohesion 1,20,DNA clamp loader activity|single-stranded DNA-dependent ATPase activity,,ppi
7788,9124,92737,DNER,delta/notch like EGF repeat containing,5,transmembrane signaling receptor activity|calcium ion binding|clathrin binding,,ppi
7789,9125,196403,DTX3,deltex E3 ubiquitin ligase 3,41,,breast cancer,ppi
7790,9126,23109,DDN,dendrin,3,RNA polymerase II proximal promoter sequence-specific DNA binding|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
7791,9127,140947,DCANP1,dendritic cell associated nuclear protein,1,,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
7792,9128,1448,CSN3,casein kappa,10,,,ppi
7793,9129,10480,EIF3M,eukaryotic translation initiation factor 3 subunit M,50,translation initiation factor activity,,ppi
7794,9131,92181,UBTD2,ubiquitin domain containing 2,11,,,ppi
7795,9132,113189,CHST14,carbohydrate sulfotransferase 14,6,N-acetylgalactosamine 4-O-sulfotransferase activity|phosphate ion binding,clubfoot|arthropathy,ppi
7796,9134,23336,SYNM,synemin,28,structural constituent of cytoskeleton|structural constituent of muscle|vinculin binding|intermediate filament binding,,ppi
7797,9135,129831,RBM45,RNA binding motif protein 45,36,RNA binding|mRNA binding,,ppi
7798,9136,1447,CSN2,casein beta,26,enzyme inhibitor activity|cysteine-type endopeptidase inhibitor activity|calcium ion binding,,ppi
7799,9137,200539,ANKRD23,ankyrin repeat domain 23,3,,,ppi
7800,9138,84722,PSRC1,proline and serine rich coiled-coil 1,18,microtubule binding,,ppi
7801,9140,84105,PCBD2,pterin-4 alpha-carbinolamine dehydratase 2,34,,,ppi
7802,9141,29958,DMGDH,dimethylglycine dehydrogenase,1,RNA binding|electron transfer activity|dimethylglycine dehydrogenase activity|oxidoreductase activity,,ppi
7803,9142,22839,DLGAP4,DLG associated protein 4,28,,,ppi
7804,9143,57050,UTP3,UTP3; small subunit processome component homolog (S. cerevisiae),33,RNA binding,,ppi
7805,9144,26140,TTLL3,tubulin tyrosine ligase like 3,16,protein-glycine ligase activity|protein-glycine ligase activity; initiating,,ppi
7806,9145,25896,INTS7,integrator complex subunit 7,53,,,ppi
7807,9146,729085,FAM198A,family with sequence similarity 198 member A,3,,,ppi
7808,9147,26112,CCDC69,coiled-coil domain containing 69,24,microtubule binding,,ppi
7809,9148,25886,POC1A,POC1 centriolar protein A,96,,Sertoli cell-only syndrome|oligospermia|placental insufficiency,ppi
7810,9149,26065,LSM14A,LSM14A; mRNA processing body assembly factor,23,RNA binding,,ppi
7811,9150,26084,ARHGEF26,Rho guanine nucleotide exchange factor 26,13,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
7812,9151,25917,THUMPD3,THUMP domain containing 3,37,tRNA (guanine) methyltransferase activity,,ppi
7813,9152,25871,NEPRO,nucleolus and neural progenitor protein,41,,,ppi
7814,9153,56905,C15orf39,chromosome 15 open reading frame 39,23,,,ppi
7815,9154,26166,RGS22,regulator of G-protein signaling 22,1,,,ppi
7816,9155,120,ADD3,adducin 3,37,structural constituent of cytoskeleton|spectrin binding|structural molecule activity|actin filament binding,brain ischemia|toxic encephalopathy|spastic quadriplegia,ppi
7817,9156,25962,KIAA1429,KIAA1429,31,RNA binding,,ppi
7818,9157,25894,PLEKHG4,pleckstrin homology and RhoGEF domain containing G4,13,,autosomal dominant cerebellar ataxia|spinocerebellar ataxia type 31,ppi
7819,9158,284403,WDR62,WD repeat domain 62,44,,microcephaly|intellectual disability|learning disability,ppi
7820,9160,1452,CSNK1A1,casein kinase 1 alpha 1,300,protein kinase activity|protein serine/threonine kinase activity|kinase activity,adult T-cell leukemia|acute T cell leukemia,ppi
7821,9161,26000,TBC1D10B,TBC1 domain family member 10B,10,GTPase activator activity|Rab GTPase binding,,ppi
7822,9162,26097,CHTOP,chromatin target of PRMT1,53,RNA binding|methyl-CpG binding,,ppi
7823,9163,203197,TMEM268,transmembrane protein 268,5,,,ppi
7824,9165,25874,MPC2,mitochondrial pyruvate carrier 2,15,pyruvate transmembrane transporter activity,schizophrenia,ppi
7825,9166,26155,NOC2L,NOC2 like nucleolar associated transcriptional repressor,94,chromatin binding|transcription corepressor activity|RNA binding|nucleosome binding|histone binding|repressing transcription factor binding,,ppi
7826,9167,26123,TCTN3,tectonic family member 3,316,,isolated cleft palate|cleft palate|placental insufficiency|ventricular septal defect|intellectual disability|learning disability|polydactyly|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|orofaciodigital syndrome IV|Joubert syndrome with orofaciodigital defect|Joubert syndrome|porencephaly,ppi
7827,9168,1453,CSNK1D,casein kinase 1 delta,96,protein kinase activity|protein serine/threonine kinase activity|cadherin binding,bipolar disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression|advanced sleep phase syndrome 1|advanced sleep phase syndrome 2,ppi
7828,9169,25940,FAM98A,family with sequence similarity 98 member A,40,RNA binding|protein methyltransferase activity,,ppi
7829,9170,26091,HERC4,HECT and RLD domain containing E3 ubiquitin protein ligase 4,38,,,ppi
7830,9171,25963,TMEM87A,transmembrane protein 87A,21,,,ppi
7831,9172,26009,ZZZ3,zinc finger ZZ-type containing 3,42,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7832,9173,25974,MMACHC,methylmalonic aciduria (cobalamin deficiency) cblC type; with homocystinuria,4,oxidoreductase activity|demethylase activity|cyanocobalamin reductase (cyanide-eliminating) activity|glutathione binding|FAD binding,megaloblastic anemia|epilepsy|basal ganglia disease|focal hand dystonia|blepharospasm|hemolytic-uremic syndrome|homocystinuria|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus,ppi
7833,9174,25923,ATL3,atlastin GTPase 3,81,GTPase activity|identical protein binding,hereditary sensory neuropathy|sensory peripheral neuropathy|acquired hyperkeratosis|Hajdu-Cheney syndrome,ppi
7834,9176,54458,PRR13,proline rich 13,23,,lung cancer|non-small cell lung carcinoma,ppi
7835,9177,26022,TMEM98,transmembrane protein 98,2,,choroid disease|glaucoma|microphthalmia|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
7836,9178,1454,CSNK1E,casein kinase 1 epsilon,385,RNA binding|protein kinase activity|protein serine/threonine kinase activity,bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
7837,9179,25880,TMEM186,transmembrane protein 186,24,,,ppi
7838,9180,25906,ANAPC15,anaphase promoting complex subunit 15,42,,,ppi
7839,9181,26156,RSL1D1,ribosomal L1 domain containing 1,85,RNA binding|mRNA 3'-UTR binding|cadherin binding|mRNA 5'-UTR binding,,ppi
7840,9182,25879,DCAF13,DDB1 and CUL4 associated factor 13,32,RNA binding,,ppi
7841,9184,25978,CHMP2B,charged multivesicular body protein 2B,30,cadherin binding,alexia|dyslexia|progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|agnosia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|echolalia|mutism|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome,ppi
7842,9185,25864,ABHD14A,abhydrolase domain containing 14A,28,,,ppi
7843,9186,25977,NECAP1,NECAP endocytosis associated 1,18,,,ppi
7844,9187,53944,CSNK1G1,casein kinase 1 gamma 1,18,protein serine/threonine kinase activity,,ppi
7845,9188,25847,ANAPC13,anaphase promoting complex subunit 13,23,,,ppi
7846,9189,25911,DPCD,deleted in primary ciliary dyskinesia homolog (mouse),11,,,ppi
7847,9190,26122,EPC2,enhancer of polycomb homolog 2,25,histone acetyltransferase activity,,ppi
7848,9191,26001,RNF167,ring finger protein 167,30,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
7849,9192,25927,CNRIP1,cannabinoid receptor interacting protein 1,9,protein C-terminus binding,,ppi
7850,9193,25979,DHRS7B,dehydrogenase/reductase 7B,21,,,ppi
7851,9194,25936,NSL1,NSL1; MIS12 kinetochore complex component,28,,,ppi
7852,9195,93621,MRFAP1,Morf4 family associated protein 1,25,,,ppi
7853,9196,1455,CSNK1G2,casein kinase 1 gamma 2,31,protein serine/threonine kinase activity,,ppi
7854,9197,25840,METTL7A,methyltransferase like 7A,6,,endometriosis of uterus|endometriosis,ppi
7855,9198,26007,TKFC,triokinase and FMN cyclase,25,glycerone kinase activity|FAD-AMP lyase (cyclizing) activity|triokinase activity,,ppi
7856,9199,158931,TCEAL6,transcription elongation factor A like 6,1,,,ppi
7857,9201,26173,INTS1,integrator complex subunit 1,59,,,ppi
7858,9202,25926,NOL11,nucleolar protein 11,32,RNA binding,,ppi
7859,9204,1456,CSNK1G3,casein kinase 1 gamma 3,33,protein kinase activity|protein serine/threonine kinase activity,,ppi
7860,9205,26093,CCDC9,coiled-coil domain containing 9,24,RNA binding,,ppi
7861,9206,25941,TPGS2,tubulin polyglutamylase complex subunit 2,12,,,ppi
7862,9207,26017,FAM32A,family with sequence similarity 32 member A,5,RNA binding,,ppi
7863,9208,26005,C2CD3,C2 calcium dependent domain containing 3,19,,isolated cleft palate|cleft palate|intellectual disability|learning disability|orofaciodigital syndrome I|orofaciodigital syndrome|syndromic X-linked intellectual disability 94|polydactyly|craniosynostosis,ppi
7864,9209,284058,KANSL1,KAT8 regulatory NSL complex subunit 1,49,histone acetyltransferase activity (H4-K5 specific)|histone acetyltransferase activity (H4-K8 specific)|histone acetyltransferase activity (H4-K16 specific)|histone acetyltransferase binding,salivary gland adenoid cystic carcinoma|Down syndrome|Koolen de Vries syndrome|intellectual disability|learning disability,ppi
7865,9210,26147,PHF19,PHD finger protein 19,42,methylated histone binding|nucleosome binding|sequence-specific DNA binding|DNA-binding transcription factor activity,,ppi
7866,9211,26015,RPAP1,RNA polymerase II associated protein 1,53,,,ppi
7867,9212,1457,CSNK2A1,casein kinase 2 alpha 1,536,protein serine/threonine kinase activity|kinase activity|Hsp90 protein binding,tongue squamous cell carcinoma|squamous cell carcinoma|adult T-cell leukemia|acute T cell leukemia|skin benign neoplasm|skin cancer,ppi
7868,9213,55247,NEIL3,nei like DNA glycosylase 3,18,bubble DNA binding|double-stranded DNA binding|single-stranded DNA binding|DNA-(apurinic or apyrimidinic site) endonuclease activity|DNA N-glycosylase activity,,ppi
7869,9214,26010,SPATS2L,spermatogenesis associated serine rich 2 like,20,RNA binding,,ppi
7870,9215,51659,GINS2,GINS complex subunit 2,23,3'-5' DNA helicase activity,salivary gland adenoid cystic carcinoma,ppi
7871,9216,81620,CDT1,chromatin licensing and DNA replication factor 1,66,DNA binding|chromatin binding|DNA polymerase binding,Meier-Gorlin syndrome,ppi
7872,9217,27351,DESI1,desumoylating isopeptidase 1,5,,,ppi
7873,9218,84301,DDI2,DNA damage inducible 1 homolog 2,25,aspartic-type endopeptidase activity|identical protein binding|ubiquitin binding,,ppi
7874,9219,10518,CIB2,calcium and integrin binding family member 2,2,magnesium ion binding|calcium ion binding|protein homodimerization activity,cerebellar disease|sensorineural hearing loss|intellectual disability|learning disability|night blindness|congenital stationary night blindness|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|schizophrenia|scotoma|cataract|Usher syndrome type 1|autosomal recessive nonsyndromic deafness 48|Usher syndrome type 1J,ppi
7875,9220,283106,CSNK2A3,casein kinase 2 alpha 3,1,protein serine/threonine kinase activity,,ppi
7876,9221,117286,CIB3,calcium and integrin binding family member 3,16,magnesium ion binding|calcium ion binding,,ppi
7877,9222,85406,DNAJC14,DnaJ heat shock protein family (Hsp40) member C14,8,,,ppi
7878,9223,148418,SAMD13,sterile alpha motif domain containing 13,1,,,ppi
7879,9224,79930,DOK3,docking protein 3,33,,lung benign neoplasm,ppi
7880,9225,220869,CBWD5,COBW domain containing 5,1,,,ppi
7881,9226,51108,METTL9,methyltransferase like 9,16,,,ppi
7882,9227,84668,FAM126A,family with sequence similarity 126 member A,10,,substance abuse|substance-related disorder|hypomyelinating leukodystrophy 5|intellectual disability|learning disability,ppi
7883,9228,200504,GKN2,gastrokine 2,1,,,ppi
7884,9229,11259,FILIP1L,filamin A interacting protein 1 like,2,,,ppi
7885,9230,1459,CSNK2A2,casein kinase 2 alpha 2,396,protein serine/threonine kinase activity,tongue squamous cell carcinoma|squamous cell carcinoma|skin benign neoplasm|skin cancer,ppi
7886,9231,84661,DPY30,dpy-30; histone methyltransferase complex regulatory subunit,64,histone-lysine N-methyltransferase activity,,ppi
7887,9232,339390,CLEC4G,C-type lectin domain family 4 member G,21,,,ppi
7888,9233,55240,STEAP3,STEAP3 metalloreductase,27,oxidoreductase activity; oxidizing metal ions; NAD or NADP as acceptor|cupric reductase activity|ferric-chelate reductase (NADPH) activity,anemia|macrocytic anemia|azoospermia|hypogonadism|hypochromic microcytic anemia,ppi
7889,9234,80319,CXXC4,CXXC finger protein 4,10,,,ppi
7890,9235,84516,DCTN5,dynactin subunit 5,22,,bipolar disorder,ppi
7891,9236,51626,DYNC2LI1,dynein cytoplasmic 2 light intermediate chain 1,17,ATP-dependent microtubule motor activity; minus-end-directed|dynein heavy chain binding,cryptorchidism|Ellis-Van Creveld syndrome|atrioventricular septal defect|placental insufficiency|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|heart valve disease|tooth agenesis|anodontia|osteochondrodysplasia,ppi
7892,9237,140735,DYNLL2,dynein light chain LC8-type 2,61,ATP-dependent microtubule motor activity; plus-end-directed|dynein intermediate chain binding|dynein light intermediate chain binding,,ppi
7893,9238,58478,ENOPH1,enolase-phosphatase 1,26,acireductone synthase activity,,ppi
7894,9239,1460,CSNK2B,casein kinase 2 beta,300,chromatin binding|protein serine/threonine kinase activity|protein kinase regulator activity|ribonucleoprotein complex binding|identical protein binding|transcription factor binding|signaling receptor binding|protein domain specific binding,tongue squamous cell carcinoma|squamous cell carcinoma|adult T-cell leukemia|acute T cell leukemia|skin benign neoplasm|skin cancer,ppi
7895,9240,56899,ANKS1B,ankyrin repeat and sterile alpha motif domain containing 1B,13,,iron metabolism disease|hemochromatosis|Wilson disease,ppi
7896,9241,51270,TFDP3,transcription factor Dp family member 3,35,DNA-binding transcription factor activity; RNA polymerase II-specific|protein heterodimerization activity,,ppi
7897,9243,25925,ZNF521,zinc finger protein 521,12,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
7898,9244,91156,IGFN1,immunoglobulin-like and fibronectin type III domain containing 1,2,,,ppi
7899,9246,55421,NCBP3,nuclear cap binding subunit 3,50,RNA 7-methylguanosine cap binding|RNA binding|mRNA binding,,ppi
7900,9247,375387,NRROS,negative regulator of reactive oxygen species,18,,,ppi
7901,9248,60678,EEFSEC,eukaryotic elongation factor; selenocysteine-tRNA specific,19,translation elongation factor activity,,ppi
7902,9249,29904,EEF2K,eukaryotic elongation factor 2 kinase,156,protein kinase activity|elongation factor-2 kinase activity|calmodulin binding|translation factor activity; RNA binding,,ppi
7903,9250,57455,REXO1,RNA exonuclease 1 homolog,6,,polycystic ovary syndrome,ppi
7904,9251,162699,ELOA3,elongin A3,3,,,ppi
7905,9252,25909,AHCTF1,AT-hook containing transcription factor 1,40,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7906,9253,64772,ENGASE,endo-beta-N-acetylglucosaminidase,3,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,,ppi
7907,9254,64374,SIL1,SIL1 nucleotide exchange factor,23,unfolded protein binding|adenyl-nucleotide exchange factor activity,primary cerebellar degeneration|disease of metabolism|prostate cancer|prostate carcinoma|cerebellar disease|hereditary spastic paraplegia,ppi
7908,9255,51060,TXNDC12,thioredoxin domain containing 12,25,peptide disulfide oxidoreductase activity,,ppi
7909,9256,131566,DCBLD2,discoidin; CUB and LCCL domain containing 2,11,,polycystic ovary syndrome|stomach cancer,ppi
7910,9257,80306,MED28,mediator complex subunit 28,83,,breast cancer,ppi
7911,9258,58513,EPS15L1,epidermal growth factor receptor pathway substrate 15 like 1,37,cadherin binding,,ppi
7912,9259,345062,PRSS48,protease; serine 48,1,serine-type endopeptidase activity,,ppi
7913,9260,51474,LIMA1,LIM domain and actin binding 1,203,actin monomer binding|cadherin binding|actin filament binding,,ppi
7914,9261,54431,DNAJC10,DnaJ heat shock protein family (Hsp40) member C10,65,ATPase activator activity|protein disulfide oxidoreductase activity|disulfide oxidoreductase activity|oxidoreductase activity; acting on a sulfur group of donors; disulfide as acceptor|chaperone binding|misfolded protein binding,prostate cancer|prostate carcinoma,ppi
7915,9262,10650,PRELID3A,PRELI domain containing 3A,3,phosphatidic acid transporter activity,,ppi
7916,9263,1462,VCAN,versican,29,glycosaminoglycan binding|extracellular matrix structural constituent conferring compression resistance,salivary gland adenoid cystic carcinoma|endometriosis of uterus|endometriosis|glaucoma|myopia|optic atrophy|cataract,ppi
7917,9264,26098,EDRF1,erythroid differentiation regulatory factor 1,37,,,ppi
7918,9265,57020,C16orf62,chromosome 16 open reading frame 62,16,,,ppi
7919,9267,84651,SPINK7,serine peptidase inhibitor; Kazal type 7 (putative),16,protein binding,,ppi
7920,9268,23381,SMG5,SMG5; nonsense mediated mRNA decay factor,20,telomeric DNA binding|protein phosphatase 2A binding|telomerase RNA binding|ribonuclease activity,,ppi
7921,9269,114799,ESCO1,establishment of sister chromatid cohesion N-acetyltransferase 1,12,N-acetyltransferase activity|zinc ion binding|acetyltransferase activity|peptide-lysine-N-acetyltransferase activity,,ppi
7922,9270,54465,ETAA1,Ewing tumor associated antigen 1,6,protein serine/threonine kinase activator activity,pancreatic cancer,ppi
7923,9271,55500,ETNK1,ethanolamine kinase 1,12,ethanolamine kinase activity,,ppi
7924,9272,1463,NCAN,neurocan,7,,bipolar disorder|urinary bladder cancer|schizophrenia,ppi
7925,9273,79813,EHMT1,euchromatic histone lysine methyltransferase 1,48,methyltransferase activity|protein-lysine N-methyltransferase activity|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K9 specific)|histone methyltransferase activity (H3-K27 specific),medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|Kleefstra syndrome,ppi
7926,9274,27335,EIF3K,eukaryotic translation initiation factor 3 subunit K,59,translation initiation factor activity,,ppi
7927,9275,55094,GPATCH1,G-patch domain containing 1,48,,,ppi
7928,9276,149371,EXOC8,exocyst complex component 8,56,,,ppi
7929,9277,1464,CSPG4,chondroitin sulfate proteoglycan 4,16,,,ppi
7930,9278,56915,EXOSC5,exosome component 5,69,3'-5'-exoribonuclease activity|exoribonuclease activity,stomach cancer,ppi
7931,9279,9910,RABGAP1L,RAB GTPase activating protein 1 like,36,GTPase activator activity|Rab GTPase binding,,ppi
7932,9280,160065,PATE1,prostate and testis expressed 1,4,,,ppi
7933,9282,23197,FAF2,Fas associated factor family member 2,243,ubiquitin protein ligase binding|lipase binding|ubiquitin binding|lipase inhibitor activity,prostate cancer|prostate carcinoma,ppi
7934,9283,225689,MAPK15,mitogen-activated protein kinase 15,26,chromatin binding|protein kinase activity|MAP kinase activity|kinase activity|SH3 domain binding,urinary bladder cancer,ppi
7935,9284,81494,CFHR5,complement factor H related 5,3,protein homodimerization activity|protein heterodimerization activity,hemolytic-uremic syndrome,ppi
7936,9286,10675,CSPG5,chondroitin sulfate proteoglycan 5,7,growth factor activity,schizophrenia,ppi
7937,9287,64778,FNDC3B,fibronectin type III domain containing 3B,13,RNA binding,corneal disease|keratoconus|primary open angle glaucoma,ppi
7938,9288,80308,FLAD1,flavin adenine dinucleotide synthetase 1,30,FMN adenylyltransferase activity,,ppi
7939,9289,85302,FBF1,Fas binding factor 1,145,,,ppi
7940,9290,10922,FASTK,Fas activated serine/threonine kinase,11,protein serine/threonine kinase activity,,ppi
7941,9291,129303,TMEM150A,transmembrane protein 150A,9,,,ppi
7942,9292,79068,FTO,FTO; alpha-ketoglutarate dependent dioxygenase,30,ferrous iron binding|oxidative RNA demethylase activity|oxidative DNA demethylase activity|DNA-N1-methyladenine dioxygenase activity|RNA N6-methyladenosine dioxygenase activity,alcohol dependence|alcohol abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetes mellitus|type 2 diabetes mellitus|melanoma|skin melanoma|obesity|mood disorder|breast cancer,ppi
7943,9293,84961,FBXL20,F-box and leucine rich repeat protein 20,6,ubiquitin-protein transferase activity,,ppi
7944,9294,9126,SMC3,structural maintenance of chromosomes 3,150,microtubule motor activity|beta-tubulin binding|dynein complex binding,generalized anxiety disorder|anxiety disorder|blepharitis|ptosis|congenital ptosis|cryptorchidism|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|sensorineural hearing loss|hypertrichosis|lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia|intellectual disability|learning disability|myopia|obsessive-compulsive disorder|syndromic X-linked intellectual disability 94,ppi
7945,9295,28982,FLVCR1,feline leukemia virus subgroup C cellular receptor 1,20,transporter activity|heme transporter activity|heme binding,megaesophagus|achalasia|night blindness|congenital stationary night blindness|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|scotoma|urinary tract obstruction|muscular atrophy,ppi
7946,9296,89885,FATE1,fetal and adult testis expressed 1,54,ubiquitin protein ligase binding,liver cancer|hepatocellular carcinoma,ppi
7947,9297,55109,AGGF1,angiogenic factor with G-patch and FHA domains 1,29,,cellulitis|glomus tumor|hemangioma|lymphangioma|chorioangioma|intramuscular hemangioma|histiocytoid hemangioma|cavernous hemangioma|Holt-Oram syndrome|VACTERL association|thrombocytopenia-absent radius syndrome|Rubinstein-Taybi syndrome|Klippel-Trenaunay syndrome|nail-patella syndrome|pulmonary embolism|venous insufficiency|thrombophilia,ppi
7948,9298,54751,FBLIM1,filamin binding LIM protein 1,12,filamin binding,,ppi
7949,9299,1465,CSRP1,cysteine and glycine rich protein 1,25,RNA binding|zinc ion binding,bipolar disorder|prostate cancer|prostate carcinoma,ppi
7950,9300,83953,FCAMR,Fc fragment of IgA and IgM receptor,1,,,ppi
7951,9301,9645,MICAL2,microtubule associated monooxygenase; calponin and LIM domain containing 2,3,actin binding|oxidoreductase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen|FAD binding,,ppi
7952,9302,57553,MICAL3,microtubule associated monooxygenase; calponin and LIM domain containing 3,37,actin binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen|FAD binding,,ppi
7953,9303,57184,FAM219B,family with sequence similarity 219 member B,8,,,ppi
7954,9304,25992,SNED1,sushi; nidogen and EGF like domains 1,3,,,ppi
7955,9305,151613,TTC14,tetratricopeptide repeat domain 14,15,,,ppi
7956,9306,344558,SH3RF3,SH3 domain containing ring finger 3,5,ubiquitin protein ligase activity,,ppi
7957,9307,1466,CSRP2,cysteine and glycine rich protein 2,18,,,ppi
7958,9308,440689,HIST2H2BF,histone cluster 2 H2B family member f,14,DNA binding,,ppi
7959,9309,374403,TBC1D10C,TBC1 domain family member 10C,8,GTPase activator activity|Rab GTPase binding,,ppi
7960,9310,55684,RABL6,RAB; member RAS oncogene family-like 6,45,GTP binding,intellectual disability|learning disability,ppi
7961,9311,55132,LARP1B,La ribonucleoprotein domain family member 1B,36,RNA binding,,ppi
7962,9313,340706,VWA2,von Willebrand factor A domain containing 2,7,identical protein binding,,ppi
7963,9314,54842,MFSD6,major facilitator superfamily domain containing 6,2,,,ppi
7964,9315,54855,FAM46C,family with sequence similarity 46 member C,9,RNA adenylyltransferase activity,,ppi
7965,9316,54870,QRICH1,glutamine rich 1,43,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7966,9318,54885,TBC1D8B,TBC1 domain family member 8B,1,Rab GTPase binding|GTPase activator activity,,ppi
7967,9319,54922,RASIP1,Ras interacting protein 1,18,,,ppi
7968,9320,55037,PTCD3,pentatricopeptide repeat domain 3,89,RNA binding|rRNA binding|ribosomal small subunit binding,,ppi
7969,9321,54495,TMX3,thioredoxin related transmembrane protein 3,12,thiol oxidase activity,,ppi
7970,9322,8048,CSRP3,cysteine and glycine rich protein 3,16,structural constituent of muscle|telethonin binding|actinin binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
7971,9323,64848,YTHDC2,YTH domain containing 2,41,RNA binding|RNA-dependent ATPase activity|3'-5' RNA helicase activity|N6-methyladenosine-containing RNA binding|ATP-dependent 3'-5' RNA helicase activity,,ppi
7972,9324,80110,ZNF614,zinc finger protein 614,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7973,9325,79611,ACSS3,acyl-CoA synthetase short-chain family member 3,1,acetate-CoA ligase activity,,ppi
7974,9326,79866,BORA,bora; aurora kinase A activator,26,,,ppi
7975,9327,63901,FAM111A,family with sequence similarity 111 member A,4,,,ppi
7976,9329,79733,E2F8,E2F transcription factor 8,8,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity|transcription factor binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding|DNA binding,,ppi
7977,9330,123283,TARSL2,threonyl-tRNA synthetase like 2,35,threonine-tRNA ligase activity,,ppi
7978,9332,1469,CST1,cystatin SN,35,,vasomotor rhinitis|prostate cancer|prostate carcinoma|stomach cancer,ppi
7979,9333,374354,NHLRC2,NHL repeat containing 2,14,,,ppi
7980,9334,282969,FUOM,fucose mutarotase,15,racemase and epimerase activity; acting on carbohydrates and derivatives|fucose binding,,ppi
7981,9336,148266,ZNF569,zinc finger protein 569,5,DNA-binding transcription factor activity; RNA polymerase II-specific,large intestine cancer|colorectal cancer,ppi
7982,9337,375444,C5orf34,chromosome 5 open reading frame 34,14,,,ppi
7983,9339,1470,CST2,cystatin SA,22,,,ppi
7984,9341,374986,MIGA1,mitoguardin 1,13,protein homodimerization activity|protein heterodimerization activity,,ppi
7985,9342,374877,C19orf45,chromosome 19 open reading frame 45,14,,,ppi
7986,9343,375337,TOPAZ1,testis and ovary specific PAZ domain containing 1,2,,,ppi
7987,9344,163259,DENND2C,DENN domain containing 2C,3,Rab guanyl-nucleotide exchange factor activity,,ppi
7988,9345,1471,CST3,cystatin C,12,endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|heart disease|cardiovascular system disease|nephritis|glomerulonephritis|kidney disease,ppi
7989,9346,374879,ZNF699,zinc finger protein 699,3,DNA-binding transcription factor activity; RNA polymerase II-specific,alcohol dependence|alcohol abuse,ppi
7990,9347,126375,ZNF792,zinc finger protein 792,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
7991,9348,146212,KCTD19,potassium channel tetramerization domain containing 19,1,,,ppi
7992,9349,122183,PRR20A,proline rich 20A,38,,,ppi
7993,9351,127253,TYW3,tRNA-yW synthesizing protein 3 homolog,24,tRNA methyltransferase activity,,ppi
7994,9352,284325,C19orf54,chromosome 19 open reading frame 54,4,,,ppi
7995,9354,1472,CST4,cystatin S,37,cysteine-type endopeptidase inhibitor activity,,ppi
7996,9355,376940,ZC3H6,zinc finger CCCH-type containing 6,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,,ppi
7997,9356,200844,C3orf67,chromosome 3 open reading frame 67,2,,,ppi
7998,9357,342527,SMTNL2,smoothelin like 2,16,,,ppi
7999,9358,222194,RSBN1L,round spermatid basic protein 1 like,23,,,ppi
8000,9361,375775,PNPLA7,patatin like phospholipase domain containing 7,2,lysophospholipase activity,,ppi
8001,9362,1473,CST5,cystatin D,8,cysteine-type endopeptidase inhibitor activity,,ppi
8002,9364,375341,C3orf62,chromosome 3 open reading frame 62,11,,,ppi
8003,9368,346689,KLRG2,killer cell lectin like receptor G2,46,,,ppi
8004,9369,375484,SIMC1,SUMO interacting motifs containing 1,21,SUMO polymer binding,,ppi
8005,9370,1474,CST6,cystatin E/M,37,,lung cancer|non-small cell lung carcinoma|melanoma|skin melanoma|prostate cancer|prostate carcinoma|breast cancer,ppi
8006,9374,339416,ANKRD45,ankyrin repeat domain 45,2,,,ppi
8007,9375,285268,ZNF621,zinc finger protein 621,6,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8008,9376,164832,LONRF2,LON peptidase N-terminal domain and ring finger 2,10,,,ppi
8009,9377,127687,C1orf122,chromosome 1 open reading frame 122,8,,,ppi
8010,9378,8530,CST7,cystatin F,10,endopeptidase inhibitor activity,stomach cancer,ppi
8011,9379,375287,RBM43,RNA binding motif protein 43,1,,,ppi
8012,9380,123745,PLA2G4E,phospholipase A2 group IVE,3,lysophospholipase activity|phospholipase A2 activity|phospholipase A1 activity|calcium-dependent phospholipase A2 activity|calcium-dependent phospholipid binding|calcium ion binding,,ppi
8013,9384,286077,FAM83H,family with sequence similarity 83 member H,56,keratin filament binding,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia,ppi
8014,9386,123,PLIN2,perilipin 2,5,,fatty liver disease|stomach cancer,ppi
8015,9388,374786,EFCAB5,EF-hand calcium binding domain 5,1,,,ppi
8016,9390,285180,RUFY4,RUN and FYVE domain containing 4,3,protein binding,,ppi
8017,9392,10906,TRAFD1,TRAF-type zinc finger domain containing 1,27,,,ppi
8018,9393,51066,SSUH2,ssu-2 homolog (C. elegans),1,,,ppi
8019,9394,1475,CSTA,cystatin A,36,cysteine-type endopeptidase inhibitor activity|structural molecule activity|protein binding; bridging,dermatitis|glioblastoma multiforme|giant cell glioblastoma|ichthyosis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|granuloma annulare|allergic hypersensitivity disease|nasopharynx carcinoma,ppi
8020,9395,56935,SMCO4,single-pass membrane protein with coiled-coil domains 4,6,,,ppi
8021,9396,10954,PDIA5,protein disulfide isomerase family A member 5,34,protein disulfide isomerase activity|peptide disulfide oxidoreductase activity|oxidoreductase activity,,ppi
8022,9397,345778,MTX3,metaxin 3,23,,,ppi
8023,9398,100132074,FOXO6,forkhead box O6,10,,,ppi
8024,9399,79874,RABEP2,rabaptin; RAB GTPase binding effector protein 2,35,,,ppi
8025,9400,55810,FOXJ2,forkhead box J2,76,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
8026,9401,360023,ZBTB41,zinc finger and BTB domain containing 41,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8027,9402,1476,CSTB,cystatin B,35,RNA binding|endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity,cerebellar disease|childhood absence epilepsy|glioblastoma multiforme|giant cell glioblastoma|meningioma|spinal meningioma|acoustic neuroma|intraventricular meningioma|pituitary adenoma|intraorbital meningioma|clear cell meningioma|benign meningioma|secretory meningioma|microcystic meningioma|cerebral convexity meningioma|angiomatous meningioma|parasagittal meningioma|psammomatous meningioma|fibrous meningioma|meningothelial meningioma,ppi
8028,9403,9413,FAM189A2,family with sequence similarity 189 member A2,78,,,ppi
8029,9404,117584,RFFL,ring finger and FYVE like domain containing E3 ubiquitin protein ligase,24,ubiquitin protein ligase activity,,ppi
8030,9406,51343,FZR1,fizzy/cell division cycle 20 related 1,131,,,ppi
8031,9407,64223,MLST8,MTOR associated protein; LST8 homolog,47,protein serine/threonine kinase activator activity,,ppi
8032,9411,1477,CSTF1,cleavage stimulation factor subunit 1,42,RNA binding,,ppi
8033,9412,9737,GPRASP1,G protein-coupled receptor associated sorting protein 1,50,,,ppi
8034,9413,114787,GPRIN1,G protein regulated inducer of neurite outgrowth 1,15,,,ppi
8035,9414,25758,KIAA1549L,KIAA1549 like,2,,,ppi
8036,9417,84057,MND1,meiotic nuclear divisions 1,7,double-stranded DNA binding,,ppi
8037,9418,1478,CSTF2,cleavage stimulation factor subunit 2,75,RNA binding|mRNA binding,,ppi
8038,9420,284194,LGALS9B,galectin 9B,6,,,ppi
8039,9422,26056,RAB11FIP5,RAB11 family interacting protein 5,36,gamma-tubulin binding|Rab GTPase binding,autistic disorder,ppi
8040,9423,246176,GAS2L2,growth arrest specific 2 like 2,2,,,ppi
8041,9424,93611,FBXO44,F-box protein 44,14,ubiquitin-protein transferase activity,polycystic ovary syndrome|prostate cancer|prostate carcinoma,ppi
8042,9426,1479,CSTF3,cleavage stimulation factor subunit 3,42,RNA binding|mRNA binding,,ppi
8043,9427,400709,SIGLEC16,sialic acid binding Ig like lectin 16 (gene/pseudogene),1,,,ppi
8044,9428,51291,GMIP,GEM interacting protein,4,GTPase activator activity,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
8045,9429,8987,STBD1,starch binding domain 1,23,polysaccharide binding|glycogen binding,,ppi
8046,9430,55297,CCDC91,coiled-coil domain containing 91,12,,substance abuse|substance-related disorder,ppi
8047,9431,57003,CCDC47,coiled-coil domain containing 47,44,RNA binding|calcium ion binding,,ppi
8048,9432,57002,YAE1D1,Yae1 domain containing 1,31,,,ppi
8049,9433,56947,MFF,mitochondrial fission factor,8,protein homodimerization activity,,ppi
8050,9434,8089,YEATS4,YEATS domain containing 4,108,DNA binding|DNA-binding transcription factor activity|structural constituent of cytoskeleton,liposarcoma|pleomorphic liposarcoma,ppi
8051,9437,7841,MOGS,mannosyl-oligosaccharide glucosidase,42,mannosyl-oligosaccharide glucosidase activity|glucosidase activity,blepharophimosis|epilepsy|sensorineural hearing loss|optic atrophy|visual epilepsy|agammaglobulinemia|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|congenital disorder of glycosylation type II,ppi
8052,9438,26330,GAPDHS,glyceraldehyde-3-phosphate dehydrogenase; spermatogenic,51,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
8053,9439,57678,GPAM,glycerol-3-phosphate acyltransferase; mitochondrial,9,glycerol-3-phosphate O-acyltransferase activity,melanoma|skin melanoma,ppi
8054,9440,9731,CEP104,centrosomal protein 104,74,,cerebellar disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|Joubert syndrome,ppi
8055,9441,51228,GLTP,glycolipid transfer protein,6,lipid binding|glycolipid transporter activity|glycolipid binding|intermembrane lipid transfer activity|ceramide 1-phosphate binding|ceramide 1-phosphate transporter activity,,ppi
8056,9442,126298,IRGQ,immunity related GTPase Q,12,,,ppi
8057,9443,64090,GAL3ST2,galactose-3-O-sulfotransferase 2,1,sulfotransferase activity,,ppi
8058,9444,55830,GLT8D1,glycosyltransferase 8 domain containing 1,7,,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
8059,9445,148423,C1orf52,chromosome 1 open reading frame 52,13,RNA binding,,ppi
8060,9446,51125,GOLGA7,golgin A7,11,protein-cysteine S-palmitoyltransferase activity,,ppi
8061,9447,81555,YIPF5,Yip1 domain family member 5,44,,,ppi
8062,9448,54732,TMED9,transmembrane p24 trafficking protein 9,58,,,ppi
8063,9450,1482,NKX2-5,NK2 homeobox 5,25,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|chromatin binding|DNA-binding transcription factor activity|serum response element binding|sequence-specific DNA binding|transcription regulatory region DNA binding|protein heterodimerization activity,sick sinus syndrome|atrial fibrillation|constipation|congenital hypothyroidism|myxedema|hypothyroidism|cryptorchidism|double outlet right ventricle|enophthalmos|orbital disease|exophthalmos|placental insufficiency|ventricular septal defect|umbilical hernia|omphalocele|myotonic dystrophy type 2|myotonic dystrophy type 1|myotonic disease|syndromic X-linked intellectual disability 94|tetralogy of Fallot,ppi
8064,9451,27076,LYPD3,LY6/PLAUR domain containing 3,118,laminin binding,,ppi
8065,9452,153020,RASGEF1B,RasGEF domain family member 1B,4,Ras guanyl-nucleotide exchange factor activity,,ppi
8066,9453,55204,GOLPH3L,golgi phosphoprotein 3 like,20,phosphatidylinositol-4-phosphate binding,,ppi
8067,9454,51289,RXFP3,relaxin/insulin like family peptide receptor 3,2,G-protein coupled receptor activity|G-protein coupled peptide receptor activity|galanin receptor activity,,ppi
8068,9455,165140,OXER1,oxoeicosanoid receptor 1,1,G-protein coupled receptor activity|5-oxo-6E;8Z;11Z;14Z-icosatetraenoic acid binding|5-hydroxy-6E;8Z;11Z;14Z-icosatetraenoic acid binding|5(S)-hydroxyperoxy-6E;8Z;11Z;14Z-icosatetraenoic acid binding,,ppi
8069,9456,9687,GREB1,growth regulation by estrogen in breast cancer 1,13,,endometriosis of uterus|endometriosis|prostate cancer|prostate carcinoma,ppi
8070,9457,23150,FRMD4B,FERM domain containing 4B,3,,,ppi
8071,9458,8228,PNPLA4,patatin like phospholipase domain containing 4,3,triglyceride lipase activity|retinyl-palmitate esterase activity,,ppi
8072,9459,150379,PNPLA5,patatin like phospholipase domain containing 5,7,triglyceride lipase activity,,ppi
8073,9460,414060,TBC1D3C,TBC1 domain family member 3C,1,,,ppi
8074,9461,83468,GLT8D2,glycosyltransferase 8 domain containing 2,13,,,ppi
8075,9462,50717,DCAF8,DDB1 and CUL4 associated factor 8,60,,axonal neuropathy|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
8076,9463,113201,CASC4,cancer susceptibility candidate 4,8,,alcohol dependence|alcohol abuse,ppi
8077,9464,341567,H1FNT,H1 histone family member N; testis specific,2,nucleosomal DNA binding|double-stranded DNA binding|protein binding,,ppi
8078,9465,124,ADH1A,alcohol dehydrogenase 1A (class I); alpha polypeptide,2,alcohol dehydrogenase (NAD) activity|alcohol dehydrogenase activity; zinc-dependent|retinol dehydrogenase activity,alcohol dependence|alcohol abuse,ppi
8079,9466,55789,DEPDC1B,DEP domain containing 1B,8,GTPase activator activity,,ppi
8080,9467,23215,PRRC2C,proline rich coiled-coil 2C,40,RNA binding,,ppi
8081,9468,81532,MOB2,MOB kinase activator 2,11,,,ppi
8082,9469,58487,CREBZF,CREB/ATF bZIP transcription factor,22,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
8083,9471,1485,CTAG1B,cancer/testis antigen 1B,4,,,ppi
8084,9472,54529,ASNSD1,asparagine synthetase domain containing 1,4,,,ppi
8085,9473,65983,GRAMD3,GRAM domain containing 3,23,,,ppi
8086,9474,51574,LARP7,La ribonucleoprotein domain family member 7,64,RNA binding,achondroplasia|Laron syndrome|syndromic X-linked intellectual disability 94|intellectual disability|learning disability,ppi
8087,9475,441549,CDNF,cerebral dopamine neurotrophic factor,3,,cocaine abuse|cocaine dependence|morphine dependence,ppi
8088,9476,30848,CTAG2,cancer/testis antigen 2,2,,,ppi
8089,9477,84941,HSH2D,hematopoietic SH2 domain containing,16,,,ppi
8090,9478,27102,EIF2AK1,eukaryotic translation initiation factor 2 alpha kinase 1,9,eukaryotic translation initiation factor 2alpha kinase activity|heme binding|protein homodimerization activity|protein kinase activity,hemolytic anemia|adult respiratory distress syndrome|newborn respiratory distress syndrome,ppi
8091,9479,51409,HEMK1,HemK methyltransferase family member 1,6,,,ppi
8092,9480,65991,FUNDC2,FUN14 domain containing 2,28,,,ppi
8093,9481,11007,CCDC85B,coiled-coil domain containing 85B,145,,,ppi
8094,9482,63928,CHP2,calcineurin like EF-hand protein 2,5,calcium ion binding,,ppi
8095,9483,137492,VPS37A,VPS37A; ESCRT-I subunit,15,,hereditary spastic paraplegia 53,ppi
8096,9484,56984,PSMG2,proteasome assembly chaperone 2,46,,,ppi
8097,9485,55365,TMEM176A,transmembrane protein 176A,4,,,ppi
8098,9486,55906,ZC4H2,zinc finger C4H2-type containing,15,,,ppi
8099,9487,51759,C9orf78,chromosome 9 open reading frame 78,32,,,ppi
8100,9488,55908,ANGPTL8,angiopoietin like 8,2,,,ppi
8101,9489,57692,MAGEE1,MAGE family member E1,13,,,ppi
8102,9490,139599,MAGEE2,MAGE family member E2,8,,,ppi
8103,9491,25895,METTL21B,methyltransferase like 21B,54,methyltransferase activity|protein-lysine N-methyltransferase activity,,ppi
8104,9492,1487,CTBP1,C-terminal binding protein 1,164,transcription corepressor activity|protein C-terminus binding|protein domain specific binding|NAD binding,ptosis|congenital ptosis|cleft lip|isolated cleft palate|cleft palate|clubfoot|large intestine cancer|colorectal cancer|epilepsy|enophthalmos|orbital disease|exophthalmos|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|ventricular septal defect|glomus tumor|hemangioma|lymphangioma,ppi
8105,9493,220988,HNRNPA3,heterogeneous nuclear ribonucleoprotein A3,139,RNA binding|mRNA binding,schizophrenia,ppi
8106,9494,113791,PIK3IP1,phosphoinositide-3-kinase interacting protein 1,2,,,ppi
8107,9495,345757,FAM174A,family with sequence similarity 174 member A,48,,,ppi
8108,9496,54541,DDIT4,DNA damage inducible transcript 4,15,,rheumatoid arthritis|leukemia|mouth disease|Parkinson's disease|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
8109,9497,338328,GPIHBP1,glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1,1,protein transmembrane transporter activity|chylomicron binding|lipoprotein particle binding|lipase binding,,ppi
8110,9498,84444,DOT1L,DOT1 like histone lysine methyltransferase,40,histone-lysine N-methyltransferase activity|histone methyltransferase activity|histone methyltransferase activity (H3-K79 specific),lung cancer|lung adenocarcinoma,ppi
8111,9499,54726,OTUD4,OTU deubiquitinase 4,63,RNA binding|thiol-dependent ubiquitin-specific protease activity|protein-containing complex scaffold activity|Lys63-specific deubiquitinase activity,,ppi
8112,9500,1488,CTBP2,C-terminal binding protein 2,115,,prostate cancer|prostate carcinoma,ppi
8113,9501,374897,SBSN,suprabasin,17,,,ppi
8114,9502,10614,HEXIM1,hexamethylene bisacetamide inducible 1,49,cyclin-dependent protein serine/threonine kinase inhibitor activity|snRNA binding|7SK snRNA binding,,ppi
8115,9503,127540,HMGB4,high mobility group box 4,3,,,ppi
8116,9504,56944,OLFML3,olfactomedin like 3,6,,,ppi
8117,9505,360030,NANOGNB,NANOG neighbor homeobox,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8118,9506,170825,GSX2,GS homeobox 2,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,amyotrophic lateral sclerosis type 1,ppi
8119,9507,1486,CTBS,chitobiase,6,chitinase activity,,ppi
8120,9508,84525,HOPX,HOP homeobox,12,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8121,9509,126306,JSRP1,junctional sarcoplasmic reticulum protein 1,8,,polycystic ovary syndrome,ppi
8122,9510,146956,EME1,essential meiotic structure-specific endonuclease 1,28,endodeoxyribonuclease activity|crossover junction endodeoxyribonuclease activity,,ppi
8123,9511,84232,MAF1,MAF1 homolog; negative regulator of RNA polymerase III,17,RNA polymerase III type 1 promoter DNA binding|RNA polymerase III type 2 promoter DNA binding|RNA polymerase III type 3 promoter DNA binding|RNA polymerase III core binding,,ppi
8124,9512,79003,MIS12,MIS12; kinetochore complex component,37,,,ppi
8125,9513,55770,EXOC2,exocyst complex component 2,43,,,ppi
8126,9514,10641,NPRL2,NPR2-like; GATOR1 complex subunit,19,protein kinase activity|GTPase activator activity,schizophrenia,ppi
8127,9515,25900,IFFO1,intermediate filament family orphan 1,22,,,ppi
8128,9516,51213,LUZP4,leucine zipper protein 4,90,,,ppi
8129,9517,29915,HCFC2,host cell factor C2,39,transcription coactivator activity,,ppi
8130,9518,50809,HP1BP3,heterochromatin protein 1 binding protein 3,86,DNA binding|nucleosome binding,neurotic disorder|postpartum depression,ppi
8131,9519,27037,TRMT2A,tRNA methyltransferase 2 homolog A,57,RNA binding,schizophrenia,ppi
8132,9520,54729,NKX1-1,NK1 homeobox 1,2,,,ppi
8133,9521,117245,HRASLS5,HRAS like suppressor family member 5,5,N-acyltransferase activity,,ppi
8134,9522,64342,HS1BP3,HCLS1 binding protein 3,12,protein binding,,ppi
8135,9523,9150,CTDP1,CTD phosphatase subunit 1,61,phosphoprotein phosphatase activity|RNA polymerase II CTD heptapeptide repeat phosphatase activity,cerebellar disease|syndromic X-linked intellectual disability type 10|choreatic disease|clubfoot|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype,ppi
8136,9524,150353,DNAJB7,DnaJ heat shock protein family (Hsp40) member B7,4,,,ppi
8137,9525,57407,NMRAL1,NmrA like redox sensor 1,12,,,ppi
8138,9526,23640,HSPBP1,HSPA (Hsp70) binding protein 1,94,enzyme inhibitor activity|adenyl-nucleotide exchange factor activity,,ppi
8139,9527,1489,CTF1,cardiotrophin 1,6,cytokine activity,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|obesity,ppi
8140,9528,28958,COA3,cytochrome c oxidase assembly factor 3,48,,cytochrome-c oxidase deficiency disease,ppi
8141,9529,28974,C19orf53,chromosome 19 open reading frame 53,5,,,ppi
8142,9530,51123,ZNF706,zinc finger protein 706,6,,,ppi
8143,9531,51122,COMMD2,COMM domain containing 2,36,,,ppi
8144,9532,58493,INIP,INTS3 and NABP interacting protein,11,,,ppi
8145,9533,29062,WDR91,WD repeat domain 91,16,phosphatidylinositol 3-kinase regulator activity,,ppi
8146,9534,25852,ARMC8,armadillo repeat containing 8,70,,,ppi
8147,9535,125,ADH1B,alcohol dehydrogenase 1B (class I); beta polypeptide,7,alcohol dehydrogenase activity; zinc-dependent|zinc ion binding,alcohol dependence|alcohol abuse|cerebral artery occlusion|brain stem infarction|cerebral infarction|cerebrovascular disease|large intestine cancer|colorectal cancer|esophageal cancer|larynx cancer|laryngeal benign neoplasm|obesity|pharynx cancer|schizophreniform disorder|schizoaffective disorder|esophagus squamous cell carcinoma|Wernicke-Korsakoff syndrome,ppi
8148,9536,1490,CTGF,connective tissue growth factor,24,heparin binding|integrin binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|aortic valve insufficiency|arthropathy|arthritis|rheumatoid arthritis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|pseudosarcomatous fibromatosis|dental caries|contact dermatitis|occupational dermatitis|esophagitis|peptic esophagitis|gastroesophageal reflux disease|focal segmental glomerulosclerosis|congestive heart failure,ppi
8149,9537,51276,ZNF571,zinc finger protein 571,2,,,ppi
8150,9538,29068,ZBTB44,zinc finger and BTB domain containing 44,29,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8151,9539,29070,CCDC113,coiled-coil domain containing 113,6,,,ppi
8152,9540,29080,CCDC59,coiled-coil domain containing 59,63,RNA binding,,ppi
8153,9541,29081,METTL5,methyltransferase like 5,1,,,ppi
8154,9542,29083,GTPBP8,GTP binding protein 8 (putative),10,,,ppi
8155,9543,29086,BABAM1,BRISC and BRCA1 A complex member 1,62,,ovarian cancer,ppi
8156,9544,29089,UBE2T,ubiquitin conjugating enzyme E2 T,40,chromatin binding|ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,anemia|macrocytic anemia|Fanconi anemia|leukopenia|intellectual disability|learning disability|pancytopenia|thrombocytopenia,ppi
8157,9545,1491,CTH,cystathionine gamma-lyase,49,cystathionine gamma-lyase activity|carbon-sulfur lyase activity|pyridoxal phosphate binding|L-cystine L-cysteine-lyase (deaminating)|homocysteine desulfhydrase activity|L-cysteine desulfhydrase activity|cystathionine gamma-synthase activity,,ppi
8158,9546,29090,TIMM21,translocase of inner mitochondrial membrane 21,22,,,ppi
8159,9547,29094,LGALSL,galectin like,6,,,ppi
8160,9548,29097,CNIH4,cornichon family AMPA receptor auxiliary protein 4,13,,schizophrenia,ppi
8161,9549,29099,COMMD9,COMM domain containing 9,20,,,ppi
8162,9550,29100,TMEM208,transmembrane protein 208,7,,,ppi
8163,9551,29101,SSU72,SSU72 homolog; RNA polymerase II CTD phosphatase,42,RNA polymerase II CTD heptapeptide repeat phosphatase activity,,ppi
8164,9552,51545,ZNF581,zinc finger protein 581,48,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8165,9553,51259,TMEM216,transmembrane protein 216,243,,anencephaly|ptosis|congenital ptosis|cerebellar disease|isolated cleft palate|cleft palate|autosomal recessive polycystic kidney disease|cryptorchidism|monocular esotropia|esotropia|placental insufficiency|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
8166,9554,51668,HSPB11,heat shock protein family B (small) member 11,18,,,ppi
8167,9555,22879,MON1B,MON1 homolog B; secretory trafficking associated,10,,,ppi
8168,9556,28990,ASTE1,asteroid homolog 1 (Drosophila),14,,,ppi
8169,9557,57095,PITHD1,PITH domain containing 1,20,,,ppi
8170,9558,57408,LRTM1,leucine rich repeats and transmembrane domains 1,1,,,ppi
8171,9559,57415,C3orf14,chromosome 3 open reading frame 14,1,,,ppi
8172,9561,25766,PRPF40B,pre-mRNA processing factor 40 homolog B,10,RNA binding,,ppi
8173,9562,338094,FAM151A,family with sequence similarity 151 member A,1,,,ppi
8174,9563,220074,LRTOMT,leucine rich transmembrane and O-methyltransferase domain containing,2,catechol O-methyltransferase activity,autosomal recessive nonsyndromic deafness 63,ppi
8175,9564,92235,DUSP27,dual specificity phosphatase 27 (putative),1,,,ppi
8176,9565,55432,YOD1,YOD1 deubiquitinase,26,thiol-dependent ubiquitin-specific protease activity|Lys63-specific deubiquitinase activity|ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport; ER to cytosol|Lys48-specific deubiquitinase activity,,ppi
8177,9567,94030,LRRC4B,leucine rich repeat containing 4B,6,,,ppi
8178,9568,91646,TDRD12,tudor domain containing 12,1,,,ppi
8179,9569,90506,LRRC46,leucine rich repeat containing 46,21,,,ppi
8180,9570,92105,INTS4,integrator complex subunit 4,44,,prostate cancer|prostate carcinoma,ppi
8181,9571,93436,ARMC6,armadillo repeat containing 6,76,,,ppi
8182,9572,1493,CTLA4,cytotoxic T-lymphocyte associated protein 4,19,,alopecia|alopecia areata|fetal erythroblastosis|autoimmune hemolytic anemia|rheumatoid arthritis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|bipolar disorder|skin benign neoplasm|skin cancer|celiac disease|brain ischemia|dermatitis|exanthem|Graves' disease|thyrotoxicosis|hyperthyroidism|primary immunodeficiency disease|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis,ppi
8183,9573,90355,C5orf30,chromosome 5 open reading frame 30,13,,,ppi
8184,9574,374946,DRAXIN,dorsal inhibitory axon guidance protein,2,,,ppi
8185,9575,91689,SMDT1,single-pass membrane protein with aspartate rich tail 1,6,,,ppi
8186,9576,27252,KLHL20,kelch like family member 20,71,ubiquitin-protein transferase activity|interferon-gamma binding,,ppi
8187,9577,375061,FAM89A,family with sequence similarity 89 member A,1,,,ppi
8188,9578,91978,TPGS1,tubulin polyglutamylase complex subunit 1,18,,,ppi
8189,9580,375307,CATIP,ciliogenesis associated TTC17 interacting protein,10,,,ppi
8190,9581,93099,DMKN,dermokine,7,,,ppi
8191,9582,129881,CCDC173,coiled-coil domain containing 173,4,,,ppi
8192,9584,57117,INTS12,integrator complex subunit 12,35,,,ppi
8193,9585,283459,GATC,glutamyl-tRNA amidotransferase subunit C,21,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,,ppi
8194,9586,23403,FBXO46,F-box protein 46,21,,,ppi
8195,9587,65057,ACD,ACD; shelterin complex subunit and telomerase recruitment factor,69,telomeric DNA binding|DNA polymerase binding|protein binding involved in negative regulation of telomere maintenance via telomerase|protein-containing complex binding,familial melanoma|dysplastic nevus syndrome|melanoma|dyskeratosis congenita,ppi
8196,9588,29781,NCAPH2,non-SMC condensin II complex subunit H2,99,chromatin binding,,ppi
8197,9589,56270,WDR45B,WD repeat domain 45B,31,phosphatidylinositol-3;5-bisphosphate binding|phosphatidylinositol-3-phosphate binding,intellectual disability|learning disability,ppi
8198,9590,494115,RBMXL1,RNA binding motif protein; X-linked like 1,20,RNA binding,,ppi
8199,9591,57149,LYRM1,LYR motif containing 1,6,,,ppi
8200,9592,84230,LRRC8C,leucine rich repeat containing 8 family member C,7,volume-sensitive anion channel activity,,ppi
8201,9593,84224,NBPF3,neuroblastoma breakpoint family member 3,6,,,ppi
8202,9595,91057,CCDC34,coiled-coil domain containing 34,2,,,ppi
8203,9596,146562,C16orf71,chromosome 16 open reading frame 71,25,,,ppi
8204,9597,64744,SMAP2,small ArfGAP2,25,,,ppi
8205,9598,152185,SPICE1,spindle and centriole associated protein 1,155,,,ppi
8206,9600,90736,FAM104B,family with sequence similarity 104 member B,1,,,ppi
8207,9601,92689,FAM114A1,family with sequence similarity 114 member A1,20,,,ppi
8208,9602,151648,SGO1,shugoshin 1,54,kinase binding,sick sinus syndrome|intestinal disease|gastrointestinal system disease|obsolete chronobiology disease|chronic atrial and intestinal dysrhythmia,ppi
8209,9603,1495,CTNNA1,catenin alpha 1,111,RNA binding|cadherin binding,acute myeloid leukemia|stomach cancer|patterned macular dystrophy 2|microphthalmia|patterned macular dystrophy 1|essential thrombocythemia|myelodysplastic syndrome,ppi
8210,9604,134147,CMBL,carboxymethylenebutenolidase homolog,18,hydrolase activity,,ppi
8211,9605,124245,ZC3H18,zinc finger CCCH-type containing 18,137,RNA binding,,ppi
8212,9606,91661,ZNF765,zinc finger protein 765,3,DNA-binding transcription factor activity; RNA polymerase II-specific,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
8213,9607,92154,MTSS1L,MTSS1L; I-BAR domain containing,3,GTPase activator activity,,ppi
8214,9608,90379,DCAF15,DDB1 and CUL4 associated factor 15,19,,,ppi
8215,9609,91289,LMF2,lipase maturation factor 2,27,,,ppi
8216,9610,91768,CABLES1,Cdk5 and Abl enzyme substrate 1,14,,large intestine cancer|colorectal cancer,ppi
8217,9611,90826,PRMT9,protein arginine methyltransferase 9,9,protein-arginine N-methyltransferase activity|protein-arginine omega-N symmetric methyltransferase activity|protein-arginine omega-N monomethyltransferase activity|protein-arginine omega-N asymmetric methyltransferase activity|histone-arginine N-methyltransferase activity,,ppi
8218,9612,126,ADH1C,alcohol dehydrogenase 1C (class I); gamma polypeptide,2,alcohol dehydrogenase (NAD) activity|alcohol dehydrogenase activity; zinc-dependent|retinol dehydrogenase activity,alcohol dependence|alcohol abuse|Parkinson's disease,ppi
8219,9613,1496,CTNNA2,catenin alpha 2,25,structural constituent of cytoskeleton|cadherin binding,alcohol dependence|alcohol abuse|schizophrenia|stomach cancer,ppi
8220,9614,87769,GGACT,gamma-glutamylamine cyclotransferase,2,gamma-glutamylaminecyclotransferase activity,,ppi
8221,9616,91056,AP5B1,adaptor related protein complex 5 beta 1 subunit,12,,,ppi
8222,9617,93349,SP140L,SP140 nuclear body protein like,6,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8223,9618,85865,GTPBP10,GTP binding protein 10,19,RNA binding,,ppi
8224,9621,29119,CTNNA3,catenin alpha 3,30,cadherin binding,asthma|intrinsic asthma|allergic asthma|catecholaminergic polymorphic ventricular tachycardia|catecholaminergic polymorphic ventricular tachycardia 1|catecholaminergic polymorphic ventricular tachycardia 2|catecholaminergic polymorphic ventricular tachycardia 3|catecholaminergic polymorphic ventricular tachycardia 4|catecholaminergic polymorphic ventricular tachycardia 5|substance abuse|substance-related disorder,ppi
8225,9622,91893,FDXACB1,ferredoxin-fold anticodon binding domain containing 1,5,phenylalanine-tRNA ligase activity|rRNA (uridine-N3-)-methyltransferase activity,,ppi
8226,9623,91664,ZNF845,zinc finger protein 845,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8227,9624,91272,BOD1,biorientation of chromosomes in cell division 1,13,protein phosphatase inhibitor activity,,ppi
8228,9625,144097,C11orf84,chromosome 11 open reading frame 84,20,,,ppi
8229,9626,90525,SHF,Src homology 2 domain containing F,1,,,ppi
8230,9627,92129,RIPPLY1,ripply transcriptional repressor 1,12,,,ppi
8231,9628,90268,OTULIN,OTU deubiquitinase with linear linkage specificity,24,thiol-dependent ubiquitin-specific protease activity|cysteine-type peptidase activity,,ppi
8232,9629,8727,CTNNAL1,catenin alpha like 1,18,,,ppi
8233,9630,93109,TMEM44,transmembrane protein 44,3,basic amino acid transmembrane transporter activity|arginine transmembrane transporter activity|L-lysine transmembrane transporter activity,,ppi
8234,9631,91461,PKDCC,protein kinase domain containing; cytoplasmic,1,protein kinase activity|non-membrane spanning protein tyrosine kinase activity,,ppi
8235,9632,92345,NAF1,nuclear assembly factor 1 ribonucleoprotein,68,RNA binding,,ppi
8236,9633,92906,HNRNPLL,heterogeneous nuclear ribonucleoprotein L like,58,RNA binding|mRNA binding,,ppi
8237,9634,92106,OXNAD1,oxidoreductase NAD binding domain containing 1,7,,,ppi
8238,9635,89944,GLB1L2,galactosidase beta 1 like 2,27,beta-galactosidase activity,,ppi
8239,9636,92691,TMEM169,transmembrane protein 169,1,,,ppi
8240,9638,92935,MARS2,methionyl-tRNA synthetase 2; mitochondrial,13,methionine-tRNA ligase activity,spastic ataxia 3,ppi
8241,9639,90678,LRSAM1,leucine rich repeat and sterile alpha motif containing 1,63,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,Charcot-Marie-Tooth disease type 2|hereditary motor and sensory neuropathy with agenesis of the corpus callosum|hereditary neuropathy with liability to pressure palsies|Charcot-Marie-Tooth disease type 1A|Charcot-Marie-Tooth disease type 1F|Charcot-Marie-Tooth disease type 1D|Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease type 1B|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease type 2A1|Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2B1|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2B|Charcot-Marie-Tooth disease axonal type 2T|Charcot-Marie-Tooth disease type 2R|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease type 2E,ppi
8242,9640,92305,TMEM129,transmembrane protein 129,14,ubiquitin protein ligase activity,,ppi
8243,9641,92979,MARCH9,membrane associated ring-CH-type finger 9,6,,,ppi
8244,9642,1499,CTNNB1,catenin beta 1,412,RNA polymerase II transcription factor binding|chromatin binding|transcription coactivator activity|transcription factor binding|nuclear hormone receptor binding|cadherin binding|androgen receptor binding|alpha-catenin binding|protein phosphatase binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|adrenal gland cancer|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|cecal benign neoplasm|cecum cancer|cervical cancer|colon cancer,ppi
8245,9643,375035,SFT2D2,SFT2 domain containing 2,2,,,ppi
8246,9644,90799,CEP95,centrosomal protein 95,18,,,ppi
8247,9645,119710,C11orf74,chromosome 11 open reading frame 74,10,,,ppi
8248,9646,133308,SLC9B2,solute carrier family 9 member B2,2,monovalent cation:proton antiporter activity|lithium:proton antiporter activity|sodium:proton antiporter activity,,ppi
8249,9647,90113,VWA5B2,von Willebrand factor A domain containing 5B2,2,,,ppi
8250,9648,113730,KLHDC7B,kelch domain containing 7B,1,,,ppi
8251,9650,112937,GLB1L3,galactosidase beta 1 like 3,5,beta-galactosidase activity,,ppi
8252,9651,113828,FAM83F,family with sequence similarity 83 member F,2,,,ppi
8253,9652,1500,CTNND1,catenin delta 1,79,cadherin binding,,ppi
8254,9653,170394,PWWP2B,PWWP domain containing 2B,6,,polycystic ovary syndrome,ppi
8255,9654,113179,ADAT3,adenosine deaminase; tRNA specific 3,4,,,ppi
8256,9655,90580,TIMM29,translocase of inner mitochondrial membrane 29,31,,,ppi
8257,9656,93343,MVB12A,multivesicular body subunit 12A,23,lipid binding|ubiquitin binding,,ppi
8258,9657,113444,SMIM12,small integral membrane protein 12,4,,,ppi
8259,9658,112817,HOGA1,4-hydroxy-2-oxoglutarate aldolase 1,12,4-hydroxy-2-oxoglutarate aldolase activity|protein homodimerization activity,primary hyperoxaluria,ppi
8260,9659,112869,SGF29,SAGA complex associated factor 29,84,methylated histone binding|RNA polymerase II transcription regulator recruiting activity,,ppi
8261,9660,113655,MFSD3,major facilitator superfamily domain containing 3,3,solute:proton symporter activity,,ppi
8262,9661,113174,SAAL1,serum amyloid A like 1,44,,,ppi
8263,9662,152573,SHISA3,shisa family member 3,1,,,ppi
8264,9663,1501,CTNND2,catenin delta 2,24,cadherin binding,bipolar disorder|Cri-Du-Chat syndrome|placental insufficiency|glioblastoma multiforme|giant cell glioblastoma|schizophrenia|syndromic X-linked intellectual disability 94|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
8265,9664,112970,KTI12,KTI12 chromatin associated homolog,4,,,ppi
8266,9665,112885,PHF21B,PHD finger protein 21B,1,,,ppi
8267,9666,93082,NEURL3,neuralized E3 ubiquitin protein ligase 3,1,,,ppi
8268,9667,116071,BATF2,basic leucine zipper ATF-like transcription factor 2,17,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding,melanoma|skin melanoma,ppi
8269,9671,116211,TM4SF19,transmembrane 4 L six family member 19,6,,,ppi
8270,9672,115811,IQCD,IQ motif containing D,2,,,ppi
8271,9673,114928,GPRASP2,G protein-coupled receptor associated sorting protein 2,77,,,ppi
8272,9674,115098,CCDC124,coiled-coil domain containing 124,21,RNA binding,,ppi
8273,9676,115509,ZNF689,zinc finger protein 689,22,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8274,9677,115106,HAUS1,HAUS augmin like complex subunit 1,132,,,ppi
8275,9678,116143,WDR92,WD repeat domain 92,39,ubiquitin binding,,ppi
8276,9679,116238,TLCD1,TLC domain containing 1,5,,,ppi
8277,9680,114984,FLYWCH2,FLYWCH family member 2,25,RNA binding,,ppi
8278,9681,115861,NXNL1,nucleoredoxin-like 1,4,,,ppi
8279,9683,115548,FCHO2,FCH domain only 2,22,phosphatidylserine binding|phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol binding|cytoskeletal protein binding|phospholipid binding|microtubule binding|tubulin binding,,ppi
8280,9684,116441,TM4SF18,transmembrane 4 L six family member 18,6,,,ppi
8281,9685,130951,M1AP,meiosis 1 associated protein,2,,,ppi
8282,9686,128153,SPATA17,spermatogenesis associated 17,1,,,ppi
8283,9687,129138,ANKRD54,ankyrin repeat domain 54,6,,,ppi
8284,9689,132001,TAMM41,TAM41 mitochondrial translocator assembly and maintenance homolog,20,phosphatidate cytidylyltransferase activity,,ppi
8285,9690,93081,TEX30,testis expressed 30,2,,,ppi
8286,9691,91801,ALKBH8,alkB homolog 8; tRNA methyltransferase,11,tRNA binding|iron ion binding|zinc ion binding|tRNA (uracil) methyltransferase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors,,ppi
8287,9692,1503,CTPS1,CTP synthase 1,85,CTP synthase activity,primary immunodeficiency disease|lymphopenia,ppi
8288,9693,130940,CCDC148,coiled-coil domain containing 148,9,,,ppi
8289,9694,127829,ARL8A,ADP ribosylation factor like GTPase 8A,12,GTPase activity|GTP binding|alpha-tubulin binding|beta-tubulin binding,,ppi
8290,9695,129642,MBOAT2,membrane bound O-acyltransferase domain containing 2,2,1-acylglycerol-3-phosphate O-acyltransferase activity|2-acylglycerol-3-phosphate O-acyltransferase activity,,ppi
8291,9696,120224,TMEM45B,transmembrane protein 45B,3,,,ppi
8292,9697,139231,FAM199X,family with sequence similarity 199; X-linked,10,,,ppi
8293,9698,115950,ZNF653,zinc finger protein 653,1,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|receptor antagonist activity|AF-2 domain binding,,ppi
8294,9699,90557,CCDC74A,coiled-coil domain containing 74A,2,,,ppi
8295,9700,91137,SLC25A46,solute carrier family 25 member 46,22,,Charcot-Marie-Tooth disease type 2|hereditary motor and sensory neuropathy with agenesis of the corpus callosum|hereditary neuropathy with liability to pressure palsies|Charcot-Marie-Tooth disease type 1A|Charcot-Marie-Tooth disease type 1F|Charcot-Marie-Tooth disease type 1D|Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease type 1B|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease type 2A1|Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2B1|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2B|Charcot-Marie-Tooth disease axonal type 2T|Charcot-Marie-Tooth disease type 2R|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease type 2E,ppi
8296,9701,92715,DPH7,diphthamide biosynthesis 7,12,,,ppi
8297,9702,127,ADH4,alcohol dehydrogenase 4 (class II); pi polypeptide,3,NADPH:quinone reductase activity|alcohol dehydrogenase (NAD) activity|alcohol dehydrogenase activity; zinc-dependent|retinol dehydrogenase activity|all-trans retinal binding|zinc ion binding|oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor|benzaldehyde dehydrogenase activity|retinol binding|NAD binding,alcohol dependence|alcohol abuse,ppi
8298,9703,56474,CTPS2,CTP synthase 2,33,CTP synthase activity,,ppi
8299,9704,148523,CIART,circadian associated repressor of transcription,6,E-box binding,,ppi
8300,9705,124446,TMEM219,transmembrane protein 219,10,,,ppi
8301,9706,159091,FAM122C,family with sequence similarity 122C,1,,,ppi
8302,9707,157378,TMEM65,transmembrane protein 65,12,,,ppi
8303,9708,148137,PROSER3,proline and serine rich 3,4,,,ppi
8304,9709,221044,UCMA,upper zone of growth plate and cartilage matrix associated,1,,,ppi
8305,9710,130617,ZFAND2B,zinc finger AN1-type containing 2B,26,K48-linked polyubiquitin modification-dependent protein binding,,ppi
8306,9711,129531,MITD1,microtubule interacting and trafficking domain containing 1,15,phosphatidylinositol binding|protein homodimerization activity,,ppi
8307,9713,158471,PRUNE2,prune homolog 2,16,exopolyphosphatase activity,,ppi
8308,9714,1504,CTRB1,chymotrypsinogen B1,7,serine-type endopeptidase activity|serine-type peptidase activity,,ppi
8309,9715,120379,PIH1D2,PIH1 domain containing 2,11,,,ppi
8310,9716,340595,ZCCHC16,zinc finger CCHC-type containing 16,1,,,ppi
8311,9718,51571,FAM49B,family with sequence similarity 49 member B,19,MHC class Ib protein binding; via antigen binding groove,,ppi
8312,9719,55571,CNOT11,CCR4-NOT transcription complex subunit 11,39,,,ppi
8313,9720,440387,CTRB2,chymotrypsinogen B2,1,serine-type endopeptidase activity|serine-type peptidase activity,,ppi
8314,9721,27013,CNPPD1,cyclin Pas1/PHO80 domain containing 1,5,,schizophrenia,ppi
8315,9722,27249,MMADHC,methylmalonic aciduria and homocystinuria; cblD type,14,,megaloblastic anemia|dystonia|epilepsy|homocystinuria|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|cerebral degeneration|methylmalonic aciduria and homocystinuria type cblD,ppi
8316,9723,27248,ERLEC1,endoplasmic reticulum lectin 1,33,protein binding|unfolded protein binding,cholestasis,ppi
8317,9724,27235,COQ2,coenzyme Q2; polyprenyltransferase,15,,lactic acidosis|anemia|macrocytic anemia|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|intellectual disability|learning disability|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|pancytopenia|cone-rod dystrophy,ppi
8318,9726,27106,ARRDC2,arrestin domain containing 2,1,,,ppi
8319,9727,26149,ZNF658,zinc finger protein 658,1,transcription regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
8320,9728,27352,SGSM3,small G protein signaling modulator 3,15,GTPase activator activity|Rab GTPase binding,,ppi
8321,9729,57226,LYRM2,LYR motif containing 2,10,,,ppi
8322,9730,11330,CTRC,chymotrypsin C,8,peptidase activity,,ppi
8323,9731,27245,AHDC1,AT-hook DNA binding motif containing 1,17,,monocular esotropia|esotropia|intellectual disability|learning disability|obstructive sleep apnea,ppi
8324,9732,54432,YIPF1,Yip1 domain family member 1,5,Rab GTPase binding,,ppi
8325,9733,25832,NBPF14,neuroblastoma breakpoint family member 14,2,,,ppi
8326,9734,57185,NIPAL3,NIPA like domain containing 3,3,,prostate cancer|prostate carcinoma,ppi
8327,9735,57035,RSRP1,arginine and serine rich protein 1,22,protein binding,,ppi
8328,9737,56256,SERTAD4,SERTA domain containing 4,14,,,ppi
8329,9738,56255,TMX4,thioredoxin related transmembrane protein 4,24,,,ppi
8330,9739,258010,SVIP,small VCP interacting protein,20,protein self-association,,ppi
8331,9740,153642,ARSK,arylsulfatase family member K,25,arylsulfatase activity,,ppi
8332,9741,1506,CTRL,chymotrypsin like,6,serine-type peptidase activity,schizophrenia,ppi
8333,9742,196527,ANO6,anoctamin 6,28,calcium activated cation channel activity|intracellular calcium activated chloride channel activity|voltage-gated ion channel activity|voltage-gated chloride channel activity,ankylosing spondylitis,ppi
8334,9744,408050,NOMO3,NODAL modulator 3,10,,,ppi
8335,9745,57828,CATSPERG,cation channel sperm associated auxiliary subunit gamma,1,,,ppi
8336,9746,339829,CCDC39,coiled-coil domain containing 39,2,,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1,ppi
8337,9747,84072,HORMAD1,HORMA domain containing 1,2,,,ppi
8338,9748,84080,ENKD1,enkurin domain containing 1,41,,,ppi
8339,9749,54777,CFAP46,cilia and flagella associated protein 46,4,,,ppi
8340,9750,83716,CRISPLD2,cysteine rich secretory protein LCCL domain containing 2,2,glycosaminoglycan binding,gallbladder disease|liver disease|lung disease|toxic encephalopathy,ppi
8341,9751,84083,ZRANB3,zinc finger RANBP2-type containing 3,12,endodeoxyribonuclease activity|annealing helicase activity|K63-linked polyubiquitin modification-dependent protein binding|DNA helicase activity,,ppi
8342,9752,83440,ADPGK,ADP dependent glucokinase,32,ADP-specific glucokinase activity,,ppi
8343,9753,84223,IQCG,IQ motif containing G,2,calmodulin binding,,ppi
8344,9754,54762,GRAMD1C,GRAM domain containing 1C,9,,,ppi
8345,9757,91526,ANKRD44,ankyrin repeat domain 44,23,,,ppi
8346,9759,55596,ZCCHC8,zinc finger CCHC-type containing 8,56,RNA binding,intellectual disability|learning disability,ppi
8347,9760,84078,KBTBD7,kelch repeat and BTB domain containing 7,149,,,ppi
8348,9761,91409,CCDC74B,coiled-coil domain containing 74B,24,,,ppi
8349,9762,81575,APOLD1,apolipoprotein L domain containing 1,4,lipid binding,,ppi
8350,9763,1508,CTSB,cathepsin B,58,cysteine-type endopeptidase activity|serine-type endopeptidase activity|collagen binding|peptidase activity|cysteine-type peptidase activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|glioblastoma multiforme|giant cell glioblastoma|familial periodic paralysis|myopathy|prostate cancer|prostate carcinoma|proteinuria,ppi
8351,9764,54758,KLHDC4,kelch domain containing 4,10,,,ppi
8352,9765,84103,C4orf17,chromosome 4 open reading frame 17,9,,,ppi
8353,9766,84226,C2orf16,chromosome 2 open reading frame 16,1,,,ppi
8354,9767,83448,PUS7L,pseudouridylate synthase 7 like,6,pseudouridine synthase activity,,ppi
8355,9768,284418,FAM71E2,family with sequence similarity 71 member E2,4,,,ppi
8356,9769,1075,CTSC,cathepsin C,22,cysteine-type peptidase activity|phosphatase binding|chaperone binding|cysteine-type endopeptidase activity,clubfoot|gingivitis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|Papillon-Lefevre disease|periodontal disease|aggressive periodontitis|periodontosis|skin disease|seborrheic keratosis|actinic keratosis|stomach cancer|coronary artery disease|allergic contact dermatitis|Hajdu-Cheney syndrome,ppi
8357,9770,83538,TTC25,tetratricopeptide repeat domain 25,20,,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1,ppi
8358,9771,125919,ZNF543,zinc finger protein 543,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8359,9772,64855,FAM129B,family with sequence similarity 129 member B,35,transcription coactivator activity|cadherin binding,,ppi
8360,9773,84069,PLEKHN1,pleckstrin homology domain containing N1,10,,,ppi
8361,9774,440163,RNASE13,ribonuclease A family member 13 (inactive),11,ribonuclease activity,,ppi
8362,9776,92255,LMBRD2,LMBR1 domain containing 2,14,,,ppi
8363,9777,84229,DRC7,dynein regulatory complex subunit 7,2,,,ppi
8364,9778,1509,CTSD,cathepsin D,68,cysteine-type endopeptidase activity|serine-type endopeptidase activity|aspartic-type endopeptidase activity,rheumatoid arthritis|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|cerebellar disease|craniosynostosis|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|arthropathy|arthritis|prostate cancer|prostate carcinoma|retinal degeneration,ppi
8365,9780,84215,ZNF541,zinc finger protein 541,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding|transcription factor binding,,ppi
8366,9782,84070,FAM186B,family with sequence similarity 186 member B,1,,,ppi
8367,9783,84206,MEX3B,mex-3 RNA binding family member B,15,RNA binding|calcium ion binding,,ppi
8368,9784,128,ADH5,alcohol dehydrogenase 5 (class III); chi polypeptide,18,fatty acid binding|zinc ion binding|electron transfer activity|formaldehyde dehydrogenase activity|S-(hydroxymethyl)glutathione dehydrogenase activity,alcohol dependence|alcohol abuse,ppi
8369,9785,1510,CTSE,cathepsin E,12,aspartic-type endopeptidase activity,,ppi
8370,9786,54620,FBXL19,F-box and leucine rich repeat protein 19,16,ubiquitin-protein transferase activity,psoriatic arthritis|pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
8371,9788,57017,COQ9,coenzyme Q9,180,lipid binding|protein homodimerization activity,coenzyme Q10 deficiency disease,ppi
8372,9789,83446,CCDC70,coiled-coil domain containing 70,4,,,ppi
8373,9790,84081,NSRP1,nuclear speckle splicing regulatory protein 1,18,RNA binding|mRNA binding,,ppi
8374,9792,64793,CEP85,centrosomal protein 85,44,,,ppi
8375,9793,8722,CTSF,cathepsin F,11,cysteine-type endopeptidase activity,cerebellar disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|basal ganglia disease|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|visual epilepsy|neuronal ceroid lipofuscinosis 13,ppi
8376,9794,84079,ANKRD27,ankyrin repeat domain 27,18,guanyl-nucleotide exchange factor activity|Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding|SNARE binding,,ppi
8377,9797,84076,TKTL2,transketolase like 2,14,,,ppi
8378,9799,151313,FAHD2B,fumarylacetoacetate hydrolase domain containing 2B,2,,,ppi
8379,9800,83447,SLC25A31,solute carrier family 25 member 31,2,ATP:ADP antiporter activity,,ppi
8380,9801,1511,CTSG,cathepsin G,40,serine-type endopeptidase activity|heparin binding|peptidase activity|serine-type peptidase activity,,ppi
8381,9802,84077,C3orf20,chromosome 3 open reading frame 20,2,,,ppi
8382,9803,81858,SHARPIN,SHANK associated RH domain interactor,40,polyubiquitin modification-dependent protein binding|ubiquitin binding|ubiquitin-protein transferase activity,acrodermatitis|dermatitis|hypereosinophilic syndrome,ppi
8383,9804,91298,C12orf29,chromosome 12 open reading frame 29,2,,,ppi
8384,9805,91355,LRP5L,LDL receptor related protein 5 like,2,Wnt-protein binding|Wnt-activated receptor activity,,ppi
8385,9806,255101,CFAP65,cilia and flagella associated protein 65,2,RNA binding,schizophrenia,ppi
8386,9807,84074,QRICH2,glutamine rich 2,8,,,ppi
8387,9808,55917,CTTNBP2NL,CTTNBP2 N-terminal like,37,protein phosphatase 2A binding,,ppi
8388,9810,128061,C1orf131,chromosome 1 open reading frame 131,36,RNA binding,,ppi
8389,9811,55531,ELMOD1,ELMO domain containing 1,7,GTPase activator activity,,ppi
8390,9812,257160,RNF214,ring finger protein 214,10,ubiquitin-protein transferase activity,,ppi
8391,9813,196500,PIANP,PILR alpha associated neural protein,11,,,ppi
8392,9814,89890,KBTBD6,kelch repeat and BTB domain containing 6,44,,,ppi
8393,9815,440712,C1orf186,chromosome 1 open reading frame 186,14,erythropoietin receptor binding,,ppi
8394,9817,127254,ERICH3,glutamate rich 3,2,,,ppi
8395,9818,1512,CTSH,cathepsin H,21,endopeptidase activity|aminopeptidase activity|cysteine-type endopeptidase activity|serine-type endopeptidase activity|peptidase activity|cysteine-type peptidase activity|cysteine-type endopeptidase activator activity involved in apoptotic process|HLA-A specific activating MHC class I receptor activity|thyroid hormone binding,narcolepsy|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21,ppi
8396,9820,55532,SLC30A10,solute carrier family 30 member 10,4,manganese ion transmembrane transporter activity,dystonia|liver cirrhosis|Parkinson's disease|polycythemia vera|Chuvash polycythemia|acquired polycythemia|stress polycythemia|erythropoietin polycythemia|polycythemia|liver disease|secondary Parkinson disease,ppi
8397,9821,83932,SPRTN,SprT-like N-terminal domain,95,ubiquitin binding|K63-linked polyubiquitin modification-dependent protein binding,progeria|Werner syndrome|liver cancer|hepatocellular carcinoma,ppi
8398,9822,165530,CLEC4F,C-type lectin domain family 4 member F,1,,,ppi
8399,9823,81790,RNF170,ring finger protein 170,24,,,ppi
8400,9824,1513,CTSK,cathepsin K,11,cysteine-type endopeptidase activity|serine-type endopeptidase activity|collagen binding|cysteine-type peptidase activity,dental caries|enophthalmos|orbital disease|exophthalmos|glioblastoma multiforme|giant cell glioblastoma|tooth agenesis|anodontia|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|osteopetrosis|osteosclerosis|schizophrenia|Klippel-Feil syndrome|spondylolisthesis|spondylolysis|craniosynostosis,ppi
8401,9825,83479,DDX59,DEAD-box helicase 59,3,,orofaciodigital syndrome V,ppi
8402,9826,83478,ARHGAP24,Rho GTPase activating protein 24,5,GTPase activator activity,,ppi
8403,9827,84065,TMEM222,transmembrane protein 222,10,,,ppi
8404,9828,84064,HDHD2,haloacid dehalogenase like hydrolase domain containing 2,17,phosphatase activity,,ppi
8405,9829,83989,FAM172A,family with sequence similarity 172 member A,9,siRNA binding,,ppi
8406,9830,84066,TEX35,testis expressed 35,28,,,ppi
8407,9831,83987,CCDC8,coiled-coil domain containing 8,551,protein binding,3-M syndrome,ppi
8408,9833,1514,CTSL,cathepsin L,42,cysteine-type endopeptidase activity|serine-type endopeptidase activity|collagen binding|cysteine-type peptidase activity|histone binding,meningioma|spinal meningioma|acoustic neuroma|intraventricular meningioma|pituitary adenoma|intraorbital meningioma|clear cell meningioma|benign meningioma|secretory meningioma|microcystic meningioma|cerebral convexity meningioma|angiomatous meningioma|parasagittal meningioma|psammomatous meningioma|fibrous meningioma|meningothelial meningioma|transitional meningioma|olfactory groove meningioma|proteinuria|stomach cancer,ppi
8409,9834,57037,ANKMY2,ankyrin repeat and MYND domain containing 2,39,,,ppi
8410,9835,81556,VWA9,von Willebrand factor A domain containing 9,47,,,ppi
8411,9836,81553,FAM49A,family with sequence similarity 49 member A,1,,,ppi
8412,9837,81573,ANKRD13C,ankyrin repeat domain 13C,9,signaling receptor binding,,ppi
8413,9838,139422,MAGEB10,MAGE family member B10,50,,,ppi
8414,9839,84067,FAM160A2,family with sequence similarity 160 member A2,9,,,ppi
8415,9840,1515,CTSV,cathepsin V,35,cysteine-type endopeptidase activity|serine-type endopeptidase activity|cysteine-type peptidase activity,,ppi
8416,9842,84233,TMEM126A,transmembrane protein 126A,24,,,ppi
8417,9844,201626,PDE12,phosphodiesterase 12,32,3'-5'-exoribonuclease activity|exonuclease activity,respiratory syncytial virus infectious disease,ppi
8418,9845,83473,KATNAL2,katanin catalytic subunit A1 like 2,9,microtubule-severing ATPase activity|ATPase activity,,ppi
8419,9846,203447,NRK,Nik related kinase,1,protein serine/threonine kinase activity,,ppi
8420,9847,374900,ZNF568,zinc finger protein 568,4,transcription regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8421,9848,344658,SAMD7,sterile alpha motif domain containing 7,5,,,ppi
8422,9849,163351,GBP6,guanylate binding protein family member 6,3,,,ppi
8423,9850,341640,FREM2,FRAS1 related extracellular matrix protein 2,24,,Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X|Nance-Horan syndrome|Muenke Syndrome|Warburg micro syndrome 1|Warburg micro syndrome 2|Warburg micro syndrome 3|Warburg micro syndrome 4|Mobius syndrome|Goldenhar syndrome|Weissenbacher-Zweymuller syndrome,ppi
8424,9851,132660,LIN54,lin-54 DREAM MuvB core complex component,45,,,ppi
8425,9852,132724,TMPRSS11B,transmembrane protease; serine 11B,53,serine-type peptidase activity,,ppi
8426,9854,221786,FAM200A,family with sequence similarity 200 member A,2,,,ppi
8427,9855,55593,OTUD5,OTU deubiquitinase 5,24,thiol-dependent ubiquitin-specific protease activity|Lys63-specific deubiquitinase activity|ubiquitinyl hydrolase activity|Lys48-specific deubiquitinase activity,,ppi
8428,9856,163786,SASS6,SAS-6 centriolar assembly protein,80,,microcephaly,ppi
8429,9857,84256,FLYWCH1,FLYWCH-type zinc finger 1,8,,,ppi
8430,9858,91050,CCDC149,coiled-coil domain containing 149,2,,,ppi
8431,9859,144348,ZNF664,zinc finger protein 664,6,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8432,9860,84248,FYTTD1,forty-two-three domain containing 1,69,RNA binding|mRNA binding,,ppi
8433,9861,84250,SLF1,SMC5-SMC6 complex localization factor 1,10,,,ppi
8434,9862,282808,RAB40AL,RAB40A; member RAS oncogene family-like,12,GTPase activity,autistic disorder|deafness-intellectual disability; Martin-Probst type syndrome,ppi
8435,9863,84251,SGIP1,SH3 domain GRB2 like endophilin interacting protein 1,7,phospholipid binding|microtubule binding|tubulin binding|cytoskeletal protein binding,alcohol dependence|alcohol abuse,ppi
8436,9864,64420,SUSD1,sushi domain containing 1,13,,,ppi
8437,9865,152926,PPM1K,protein phosphatase; Mg2+/Mn2+ dependent 1K,23,protein serine/threonine phosphatase activity,maple syrup urine disease,ppi
8438,9866,56970,ATXN7L3,ataxin 7 like 3,30,transcription coactivator activity|nuclear receptor transcription coactivator activity,,ppi
8439,9867,55530,SVOP,SV2 related protein,2,,,ppi
8440,9868,146923,RUNDC1,RUN domain containing 1,6,,,ppi
8441,9869,200894,ARL13B,ADP ribosylation factor like GTPase 13B,23,,Joubert syndrome,ppi
8442,9870,1519,CTSO,cathepsin O,5,cysteine-type endopeptidase activity,,ppi
8443,9871,727800,RNF208,ring finger protein 208,5,ubiquitin-protein transferase activity,,ppi
8444,9872,84239,ATP13A4,ATPase 13A4,1,cation-transporting ATPase activity,,ppi
8445,9873,84240,ZCCHC9,zinc finger CCHC-type containing 9,14,RNA binding,,ppi
8446,9875,56243,KIAA1217,KIAA1217,31,,,ppi
8447,9877,115399,LRRC56,leucine rich repeat containing 56,6,,,ppi
8448,9878,148808,MFSD4A,major facilitator superfamily domain containing 4A,12,glucose transmembrane transporter activity,,ppi
8449,9879,55805,LRP2BP,LRP2 binding protein,8,,,ppi
8450,9880,92293,TMEM132C,transmembrane protein 132C,1,,,ppi
8451,9881,157285,PRAG1,PEAK1 related kinase activating pseudokinase 1,6,identical protein binding|ATP binding|protein kinase activity,,ppi
8452,9882,128989,TANGO2,transport and golgi organization 2 homolog,22,,,ppi
8453,9883,160335,TMTC2,transmembrane and tetratricopeptide repeat containing 2,2,,,ppi
8454,9884,169200,TMEM64,transmembrane protein 64,1,,,ppi
8455,9885,83636,C19orf12,chromosome 19 open reading frame 12,2,,ovarian cancer|hereditary spastic paraplegia 43|neurodegeneration with brain iron accumulation 4,ppi
8456,9886,55355,HJURP,Holliday junction recognition protein,19,histone binding,,ppi
8457,9888,203245,NAIF1,nuclear apoptosis inducing factor 1,8,,,ppi
8458,9889,442867,BPY2B,basic charge; Y-linked; 2B,2,,,ppi
8459,9890,1520,CTSS,cathepsin S,9,cysteine-type endopeptidase activity|serine-type endopeptidase activity|collagen binding|laminin binding,contact dermatitis|occupational dermatitis|obesity,ppi
8460,9891,56977,STOX2,storkhead box 2,2,,,ppi
8461,9892,221092,HNRNPUL2,heterogeneous nuclear ribonucleoprotein U like 2,65,RNA binding,,ppi
8462,9893,55529,TMEM55A,transmembrane protein 55A,8,phosphatidylinositol-4;5-bisphosphate 4-phosphatase activity,,ppi
8463,9894,90121,TSR2,TSR2; ribosome maturation factor,10,,Diamond-Blackfan anemia|congenital hypoplastic anemia,ppi
8464,9895,222166,MTURN,maturin; neural progenitor differentiation regulator homolog,2,,,ppi
8465,9896,79157,MFSD11,major facilitator superfamily domain containing 11,4,,,ppi
8466,9897,54623,PAF1,PAF1 homolog; Paf1/RNA polymerase II complex component,64,RNA polymerase II complex binding|chromatin binding,,ppi
8467,9898,1521,CTSW,cathepsin W,1,cysteine-type peptidase activity|cysteine-type endopeptidase activity,,ppi
8468,9901,83786,FRMD8,FERM domain containing 8,7,,,ppi
8469,9902,89848,FCHSD1,FCH and double SH3 domains 1,10,,,ppi
8470,9903,89849,ATG16L2,autophagy related 16 like 2,8,,,ppi
8471,9904,286336,FAM78A,family with sequence similarity 78 member A,3,,,ppi
8472,9905,55677,IWS1,IWS1; SUPT6H interacting protein,37,,,ppi
8473,9906,55055,ZWILCH,zwilch kinetochore protein,11,,,ppi
8474,9907,1522,CTSZ,cathepsin Z,10,carboxypeptidase activity|cysteine-type peptidase activity|cysteine-type endopeptidase activity,acute myeloid leukemia,ppi
8475,9908,55061,SUSD4,sushi domain containing 4,50,,,ppi
8476,9909,55062,WIPI1,WD repeat domain; phosphoinositide interacting 1,15,signaling receptor binding|estrogen receptor binding|phosphatidylinositol-3-phosphate binding|androgen receptor binding|phosphatidylinositol-3;5-bisphosphate binding,chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease,ppi
8477,9910,55064,SPATA6L,spermatogenesis associated 6 like,3,,,ppi
8478,9911,55683,KANSL3,KAT8 regulatory NSL complex subunit 3,12,histone acetyltransferase activity (H4-K5 specific)|histone acetyltransferase activity (H4-K8 specific)|histone acetyltransferase activity (H4-K16 specific),,ppi
8479,9912,55068,ENOX1,ecto-NOX disulfide-thiol exchanger 1,13,,,ppi
8480,9913,56271,BEX4,brain expressed X-linked 4,2,alpha-tubulin binding,,ppi
8481,9914,55069,TMEM248,transmembrane protein 248,19,,,ppi
8482,9915,55070,DET1,de-etiolated homolog 1 (Arabidopsis),38,ubiquitin protein ligase binding|protein-containing complex binding,,ppi
8483,9916,55686,MREG,melanoregulin,7,,,ppi
8484,9917,8029,CUBN,cubilin,14,transporter activity|drug binding|signaling receptor activity|protein homodimerization activity|cargo receptor activity|channel regulator activity|hemoglobin binding,megaloblastic anemia|melanoma|skin melanoma|proteinuria|pernicious anemia,ppi
8485,9919,55687,TRMU,tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase,7,,lactic acidosis|blood coagulation disease|liver disease|hepatitis,ppi
8486,9920,55082,ARGLU1,arginine and glutamate rich 1,33,cadherin binding,,ppi
8487,9921,54478,FAM64A,family with sequence similarity 64 member A,16,,,ppi
8488,9922,55083,KIF26B,kinesin family member 26B,21,microtubule motor activity|ATPase activity|microtubule binding,,ppi
8489,9923,55086,CXorf57,chromosome X open reading frame 57,12,single-stranded DNA binding|RNA binding,,ppi
8490,9924,55090,MED9,mediator complex subunit 9,76,,,ppi
8491,9925,55092,TMEM51,transmembrane protein 51,27,,,ppi
8492,9926,55689,YEATS2,YEATS domain containing 2,40,DNA-binding transcription factor activity; RNA polymerase II-specific|histone binding|modification-dependent protein binding,,ppi
8493,9927,10658,CELF1,CUGBP; Elav-like family member 1,26,translation repressor activity; mRNA regulatory element binding|RNA binding|mRNA binding|pre-mRNA binding|BRE binding,,ppi
8494,9928,55093,WDYHV1,WDYHV motif containing 1,132,protein-N-terminal glutamine amidohydrolase activity,,ppi
8495,9929,55691,FRMD4A,FERM domain containing 4A,4,,substance abuse|substance-related disorder,ppi
8496,9930,55095,SAMD4B,sterile alpha motif domain containing 4B,17,RNA binding|translation repressor activity|mRNA binding,,ppi
8497,9931,55096,EBLN2,endogenous Bornavirus-like nucleoprotein 2,9,,,ppi
8498,9932,55100,WDR70,WD repeat domain 70,16,,,ppi
8499,9933,55101,ATP5SL,ATP5S like,3,ubiquitin-protein transferase activity,,ppi
8500,9934,55693,KDM4D,lysine demethylase 4D,6,histone demethylase activity|histone demethylase activity (H3-K9 specific)|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|methylated histone binding|histone demethylase activity (H3-K36 specific)|DNA-binding transcription repressor activity; RNA polymerase II-specific|chromatin binding,,ppi
8501,9935,55105,GPATCH2,G-patch domain containing 2,6,,,ppi
8502,9936,130,ADH6,alcohol dehydrogenase 6 (class V),8,alcohol dehydrogenase (NAD) activity|alcohol dehydrogenase activity; zinc-dependent|zinc ion binding,alcohol dependence|alcohol abuse,ppi
8503,9937,10659,CELF2,CUGBP; Elav-like family member 2,10,RNA binding|pre-mRNA binding|mRNA binding,schizophrenia|Stevens-Johnson syndrome,ppi
8504,9938,55106,SLFN12,schlafen family member 12,3,,,ppi
8505,9939,55108,BSDC1,BSD domain containing 1,4,,,ppi
8506,9940,54482,TRMT13,tRNA methyltransferase 13 homolog,4,tRNA methyltransferase activity,,ppi
8507,9941,55696,RBM22,RNA binding motif protein 22,40,RNA binding|U6 snRNA binding|pre-mRNA binding,,ppi
8508,9942,55110,MAGOHB,mago homolog B; exon junction complex core component,33,RNA binding,,ppi
8509,9943,54682,MANSC1,MANSC domain containing 1,87,,,ppi
8510,9944,55697,VAC14,Vac14; PIKFYVE complex component,84,signaling receptor activity,,ppi
8511,9945,55113,XKR8,XK related 8,2,,,ppi
8512,9946,79822,ARHGAP28,Rho GTPase activating protein 28,3,,endometriosis of uterus|endometriosis,ppi
8513,9947,8454,CUL1,cullin 1,682,ubiquitin-protein transferase activity|ubiquitin protein ligase activity|ubiquitin protein ligase binding,Stevens-Johnson syndrome,ppi
8514,9948,55116,TMEM39B,transmembrane protein 39B,12,,,ppi
8515,9949,55119,PRPF38B,pre-mRNA processing factor 38B,17,RNA binding,,ppi
8516,9950,54707,GPN2,GPN-loop GTPase 2,11,GTPase activity,,ppi
8517,9951,55700,MAP7D1,MAP7 domain containing 1,41,,,ppi
8518,9952,55125,CEP192,centrosomal protein 192,70,phosphatase binding,,ppi
8519,9953,55701,ARHGEF40,Rho guanine nucleotide exchange factor 40,8,,,ppi
8520,9954,55127,HEATR1,HEAT repeat containing 1,63,RNA binding|snoRNA binding,,ppi
8521,9955,55702,CCDC94,coiled-coil domain containing 94,37,,,ppi
8522,9956,55129,ANO10,anoctamin 10,3,calcium activated cation channel activity|intracellular calcium activated chloride channel activity,spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|autosomal recessive spinocerebellar ataxia 10,ppi
8523,9957,8453,CUL2,cullin 2,435,ubiquitin protein ligase binding|ubiquitin protein ligase activity,inflammatory bowel disease,ppi
8524,9958,55133,SRBD1,S1 RNA binding domain 1,32,mRNA binding|structural constituent of ribosome,,ppi
8525,9959,55135,WRAP53,WD repeat containing antisense to TP53,40,RNA binding|protein-containing complex binding,anemia|macrocytic anemia|blood coagulation disease|tongue squamous cell carcinoma|squamous cell carcinoma|dental caries|placental insufficiency|gingival disease|epulis|hemorrhagic disease|tooth agenesis|anodontia|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|pancytopenia|periodontal disease|periodontitis|chronic ulcer of skin|thrombocytopenia|dyskeratosis congenita,ppi
8526,9960,55704,CCDC88A,coiled-coil domain containing 88A,77,actin binding|microtubule binding|phosphatidylinositol binding|dynein light intermediate chain binding,congestive heart failure|epilepsy|optic atrophy|visual epilepsy|infantile epileptic encephalopathy,ppi
8527,9962,55706,NDC1,NDC1 transmembrane nucleoporin,38,structural constituent of nuclear pore,,ppi
8528,9963,55138,FAM90A1,family with sequence similarity 90 member A1,47,,,ppi
8529,9964,55139,ANKZF1,ankyrin repeat and zinc finger domain containing 1,12,thiol-dependent ubiquitin-specific protease activity,,ppi
8530,9965,55707,NECAP2,NECAP endocytosis associated 2,30,,,ppi
8531,9966,54663,WDR74,WD repeat domain 74,33,,melanoma|skin melanoma,ppi
8532,9967,8452,CUL3,cullin 3,1168,POZ domain binding|ubiquitin-protein transferase activity|ubiquitin protein ligase activity|ubiquitin protein ligase binding,hypertension|essential hypertension|melanoma|skin melanoma|autosomal recessive pseudohypoaldosteronism type 1|autosomal dominant pseudohypoaldosteronism type 1|pseudohypoaldosteronism|lactic acidosis,ppi
8533,9968,55142,HAUS2,HAUS augmin like complex subunit 2,94,,,ppi
8534,9969,55711,FAR2,fatty acyl-CoA reductase 2,13,oxidoreductase activity|fatty-acyl-CoA reductase (alcohol-forming) activity,,ppi
8535,9970,55149,MTPAP,mitochondrial poly(A) polymerase,26,magnesium ion binding|UTP binding|RNA binding|polynucleotide adenylyltransferase activity|ATP binding|manganese ion binding,melanoma|skin melanoma|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|spastic ataxia 4,ppi
8536,9971,55150,C19orf73,chromosome 19 open reading frame 73,3,,,ppi
8537,9972,55151,TMEM38B,transmembrane protein 38B,7,potassium channel activity,osteogenesis imperfecta type 4,ppi
8538,9973,55152,DALRD3,DALR anticodon binding domain containing 3,6,,,ppi
8539,9974,55153,SDAD1,SDA1 domain containing 1,34,,,ppi
8540,9975,55157,DARS2,aspartyl-tRNA synthetase 2; mitochondrial,28,tRNA binding|aspartate-tRNA ligase activity|ATP binding|aspartate-tRNA(Asn) ligase activity,cerebellar disease|pseudosarcomatous fibromatosis|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|axonal neuropathy|muscular atrophy,ppi
8541,9976,55159,RFWD3,ring finger and WD repeat domain 3,50,ubiquitin-protein transferase activity,testicular cancer|seminoma|testicular germ cell cancer,ppi
8542,9977,8451,CUL4A,cullin 4A,288,ubiquitin protein ligase binding|ubiquitin protein ligase activity,Stevens-Johnson syndrome,ppi
8543,9978,55160,ARHGEF10L,Rho guanine nucleotide exchange factor 10 like,4,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
8544,9979,55161,TMEM33,transmembrane protein 33,34,,,ppi
8545,9980,55720,TSR1,TSR1; ribosome maturation factor,121,RNA binding|GTPase activity|U3 snoRNA binding|GTP binding,,ppi
8546,9981,55164,SHQ1,SHQ1; H/ACA ribonucleoprotein assembly factor,12,unfolded protein binding,,ppi
8547,9982,55167,MSL2,male-specific lethal 2 homolog (Drosophila),24,ubiquitin protein ligase activity,,ppi
8548,9983,55721,IQCC,IQ motif containing C,1,,polycystic ovary syndrome,ppi
8549,9984,55171,TBCCD1,TBCC domain containing 1,16,,,ppi
8550,9985,55722,CEP72,centrosomal protein 72,74,,,ppi
8551,9986,55174,INTS10,integrator complex subunit 10,25,,,ppi
8552,9987,8450,CUL4B,cullin 4B,346,damaged DNA binding|ubiquitin protein ligase activity|ubiquitin protein ligase binding,blepharophimosis|cryptorchidism|epilepsy|clubfoot|hypertrophy of breast|infant gynecomastia|gynecomastia|inguinal hernia|hypogonadism|intellectual disability|learning disability|obesity|visual epilepsy|syndromic X-linked intellectual disability 94|syndromic X-linked intellectual disability Cabezas type,ppi
8553,9988,55177,RMDN3,regulator of microtubule dynamics 3,35,,,ppi
8554,9989,55181,SMG8,SMG8; nonsense mediated mRNA decay factor,31,,,ppi
8555,9990,55182,RNF220,ring finger protein 220,13,ubiquitin-protein transferase activity,,ppi
8556,9991,54552,GNL3L,G protein nucleolar 3 like,41,RNA binding,,ppi
8557,9992,55186,SLC25A36,solute carrier family 25 member 36,1,pyrimidine nucleotide transmembrane transporter activity,,ppi
8558,9993,55188,RIC8B,RIC8 guanine nucleotide exchange factor B,21,G-protein alpha-subunit binding|guanyl-nucleotide exchange factor activity|GTPase activator activity,,ppi
8559,9994,55192,DNAJC17,DnaJ heat shock protein family (Hsp40) member C17,13,,,ppi
8560,9995,54496,PRMT7,protein arginine methyltransferase 7,24,histone-arginine N-methyltransferase activity|S-adenosylmethionine-dependent methyltransferase activity|protein-arginine N-methyltransferase activity|[myelin basic protein]-arginine N-methyltransferase activity|protein-arginine omega-N monomethyltransferase activity|protein-arginine omega-N symmetric methyltransferase activity|histone binding|histone methyltransferase activity (H4-R3 specific)|protein-arginine omega-N asymmetric methyltransferase activity,,ppi
8561,9996,55194,EVA1B,eva-1 homolog B,3,,,ppi
8562,9997,55196,KIAA1551,KIAA1551,4,,,ppi
8563,9998,8065,CUL5,cullin 5,406,ubiquitin-protein transferase activity|calcium channel activity|ubiquitin protein ligase binding|signaling receptor activity|ubiquitin protein ligase activity,breast cancer,ppi
8564,9999,55197,RPRD1A,regulation of nuclear pre-mRNA domain containing 1A,48,,,ppi
8565,10000,55199,FAM86C1,family with sequence similarity 86 member C1,3,,,ppi
8566,10001,55200,PLEKHG6,pleckstrin homology and RhoGEF domain containing G6,19,protein binding,,ppi
8567,10002,55731,FAM222B,family with sequence similarity 222 member B,1,,,ppi
8568,10003,55207,ARL8B,ADP ribosylation factor like GTPase 8B,38,GTPase activity|GTP binding|GDP binding|alpha-tubulin binding|beta-tubulin binding,,ppi
8569,10004,55732,C1orf112,chromosome 1 open reading frame 112,22,,,ppi
8570,10005,55209,SETD5,SET domain containing 5,14,,cryptorchidism|intellectual disability|learning disability|obsessive-compulsive disorder|craniosynostosis|autosomal dominant non-syndromic intellectual disability,ppi
8571,10006,55210,ATAD3A,ATPase family; AAA domain containing 3A,101,zinc ion binding,prostate cancer|prostate carcinoma,ppi
8572,10007,55215,FANCI,Fanconi anemia complementation group I,62,DNA polymerase binding,esophageal atresia|Fanconi anemia|leukopenia|intellectual disability|learning disability|thrombocytopenia,ppi
8573,10008,55216,C11orf57,chromosome 11 open reading frame 57,89,,,ppi
8574,10009,1523,CUX1,cut like homeobox 1,55,RNA polymerase II regulatory region sequence-specific DNA binding|protein tyrosine kinase activity|sequence-specific DNA binding,neurotic disorder|endogenous depression|melancholia|mood disorder|major depressive disorder|mental depression,ppi
8575,10010,55735,DNAJC11,DnaJ heat shock protein family (Hsp40) member C11,49,,,ppi
8576,10011,54662,TBC1D13,TBC1 domain family member 13,2,Rab GTPase binding|GTPase activator activity,,ppi
8577,10012,55219,TMEM57,transmembrane protein 57,18,,atherosclerosis|arteriosclerotic cardiovascular disease|coronary artery disease,ppi
8578,10013,55220,KLHDC8A,kelch domain containing 8A,17,,,ppi
8579,10014,55223,TRIM62,tripartite motif containing 62,11,ubiquitin-protein transferase activity,,ppi
8580,10015,55224,ETNK2,ethanolamine kinase 2,5,ethanolamine kinase activity,,ppi
8581,10016,55739,NAXD,NAD(P)HX dehydratase,33,ATP-dependent NAD(P)H-hydrate dehydratase activity,stomach cancer,ppi
8582,10017,55225,RAVER2,ribonucleoprotein; PTB binding 2,6,RNA binding,,ppi
8583,10018,55228,PNMAL1,paraneoplastic Ma antigen family like 1,6,,,ppi
8584,10019,55231,CCDC87,coiled-coil domain containing 87,15,,,ppi
8585,10021,55236,UBA6,ubiquitin like modifier activating enzyme 6,73,FAT10 activating enzyme activity,,ppi
8586,10022,55238,SLC38A7,solute carrier family 38 member 7,11,L-amino acid transmembrane transporter activity|L-glutamine transmembrane transporter activity|amino acid transmembrane transporter activity|L-aspartate transmembrane transporter activity|L-methionine transmembrane transporter activity|L-alanine transmembrane transporter activity|L-serine transmembrane transporter activity|L-histidine transmembrane transporter activity|L-asparagine transmembrane transporter activity|L-glutamate transmembrane transporter activity|L-leucine transmembrane transporter activity,,ppi
8587,10024,55239,OGFOD1,2-oxoglutarate and iron dependent oxygenase domain containing 1,34,peptidyl-proline dioxygenase activity|peptidyl-proline 3-dioxygenase activity,,ppi
8588,10025,55751,TMEM184C,transmembrane protein 184C,2,,,ppi
8589,10026,55244,SLC47A1,solute carrier family 47 member 1,27,drug:proton antiporter activity|monovalent cation:proton antiporter activity|drug transmembrane transporter activity,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
8590,10027,55752,SEPT11,septin 11,41,protein-containing complex scaffold activity|GTPase activity,bipolar disorder|schizophrenia,ppi
8591,10028,1525,CXADR,coxsackie virus and adenovirus receptor,17,connexin binding|cell adhesive protein binding involved in AV node cell-bundle of His cell communication,,ppi
8592,10029,55753,OGDHL,oxoglutarate dehydrogenase-like,8,oxoglutarate dehydrogenase (succinyl-transferring) activity,,ppi
8593,10030,55246,CCDC25,coiled-coil domain containing 25,14,,,ppi
8594,10031,55756,INTS9,integrator complex subunit 9,18,,,ppi
8595,10032,55248,TMEM206,transmembrane protein 206,94,,,ppi
8596,10033,55758,RCOR3,REST corepressor 3,56,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor binding|transcription regulatory region DNA binding|transcription corepressor activity|DNA-binding transcription factor activity,,ppi
8597,10034,54596,L1TD1,LINE1 type transposase domain containing 1,20,single-stranded RNA binding,,ppi
8598,10035,55761,TTC17,tetratricopeptide repeat domain 17,29,,,ppi
8599,10036,55762,ZNF701,zinc finger protein 701,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8600,10037,55253,TYW1,tRNA-yW synthesizing protein 1 homolog,31,,,ppi
8601,10038,55765,C1orf106,chromosome 1 open reading frame 106,24,,inflammatory bowel disease,ppi
8602,10039,131,ADH7,alcohol dehydrogenase 7 (class IV); mu or sigma polypeptide,2,alcohol dehydrogenase (NAD) activity|alcohol dehydrogenase activity; zinc-dependent|aldehyde oxidase activity|retinol dehydrogenase activity|retinol binding|ethanol binding|receptor antagonist activity,alcohol dependence|alcohol abuse|esophageal cancer|larynx cancer|laryngeal benign neoplasm|pharynx cancer,ppi
8603,10040,55254,TMEM39A,transmembrane protein 39A,25,,,ppi
8604,10041,55255,WDR41,WD repeat domain 41,13,Rab guanyl-nucleotide exchange factor activity,,ppi
8605,10042,55258,THNSL2,threonine synthase like 2,2,pyridoxal phosphate binding|serine binding|threonine synthase activity,,ppi
8606,10043,55260,TMEM143,transmembrane protein 143,5,,,ppi
8607,10044,55262,C7orf43,chromosome 7 open reading frame 43,13,,,ppi
8608,10045,55266,TMEM19,transmembrane protein 19,4,,,ppi
8609,10047,55273,TMEM100,transmembrane protein 100,4,,,ppi
8610,10048,55275,VPS53,VPS53; GARP complex subunit,23,,pseudosarcomatous fibromatosis|epilepsy|intellectual disability|learning disability|osteoporosis|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|locked-in syndrome|quadriplegia|pontocerebellar hypoplasia type 2E,ppi
8611,10049,56204,FAM214A,family with sequence similarity 214 member A,8,,,ppi
8612,10050,7852,CXCR4,C-X-C motif chemokine receptor 4,56,actin binding|G-protein coupled receptor activity|coreceptor activity|C-X-C chemokine receptor activity|myosin light chain binding|ubiquitin binding|C-C chemokine binding|C-C chemokine receptor activity|chemokine binding,rheumatoid arthritis|bone marrow disease|selective IgG deficiency disease|WHIM syndrome|breast cancer|common wart,ppi
8613,10051,55277,FGGY,FGGY carbohydrate kinase domain containing,2,D-ribulokinase activity,,ppi
8614,10052,54520,CCDC93,coiled-coil domain containing 93,41,,,ppi
8615,10054,55280,CWF19L1,CWF19-like 1; cell cycle control (S. pombe),13,,intellectual disability|learning disability|autosomal recessive spinocerebellar ataxia 17,ppi
8616,10055,55282,LRRC36,leucine rich repeat containing 36,7,,,ppi
8617,10056,55284,UBE2W,ubiquitin conjugating enzyme E2 W (putative),79,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme activity,,ppi
8618,10057,55285,RBM41,RNA binding motif protein 41,19,pre-mRNA intronic binding|U12 snRNA binding,,ppi
8619,10058,55286,C4orf19,chromosome 4 open reading frame 19,7,,,ppi
8620,10059,55771,PRR11,proline rich 11,95,,,ppi
8621,10061,55287,TMEM40,transmembrane protein 40,1,,,ppi
8622,10062,55289,ACOXL,acyl-CoA oxidase-like,1,pristanoyl-CoA oxidase activity|fatty acid binding|acyl-CoA oxidase activity|flavin adenine dinucleotide binding,chronic lymphocytic leukemia|Richter's syndrome,ppi
8623,10063,55773,TBC1D23,TBC1 domain family member 23,20,,,ppi
8624,10064,55295,KLHL26,kelch like family member 26,26,,,ppi
8625,10065,55296,TBC1D19,TBC1 domain family member 19,7,,,ppi
8626,10067,55308,DDX19A,DEAD-box helicase 19A,29,,,ppi
8627,10068,54491,FAM105A,family with sequence similarity 105 member A,2,thiol-dependent ubiquitin-specific protease activity,,ppi
8628,10069,1527,TEX28,testis expressed 28,24,,,ppi
8629,10070,55779,CFAP44,cilia and flagella associated protein 44,2,,,ppi
8630,10071,55313,CPPED1,calcineurin like phosphoesterase domain containing 1,5,,,ppi
8631,10073,55316,RSAD1,radical S-adenosyl methionine domain containing 1,9,,,ppi
8632,10074,55783,CMTR2,cap methyltransferase 2,6,mRNA (nucleoside-2'-O-)-methyltransferase activity,salivary gland adenoid cystic carcinoma|polycystic ovary syndrome|lung cancer|lung adenocarcinoma,ppi
8633,10075,55784,MCTP2,multiple C2 and transmembrane domain containing 2,2,calcium ion binding|calcium-dependent phospholipid binding,schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression|chromosome 15q26-qter deletion syndrome,ppi
8634,10076,55319,TMA16,translation machinery associated 16 homolog,32,,,ppi
8635,10077,55322,C5orf22,chromosome 5 open reading frame 22,7,,,ppi
8636,10078,55325,UFSP2,UFM1 specific peptidase 2,29,thiolester hydrolase activity|UFM1 hydrolase activity,Legg-Calve-Perthes disease|arthropathy|arthritis,ppi
8637,10079,55328,RNLS,renalase; FAD dependent amine oxidase,1,oxidoreductase activity; acting on NAD(P)H|epinephrine binding|NADH binding|monoamine oxidase activity,,ppi
8638,10080,54665,RSBN1,round spermatid basic protein 1,50,,,ppi
8639,10081,55332,DRAM1,DNA damage regulated autophagy modulator 1,3,,,ppi
8640,10083,55793,FAM63A,family with sequence similarity 63 member A,11,cysteine-type carboxypeptidase activity|K48-linked polyubiquitin modification-dependent protein binding|Lys48-specific deubiquitinase activity,,ppi
8641,10084,55337,C19orf66,chromosome 19 open reading frame 66,32,RNA binding,,ppi
8642,10085,55339,WDR33,WD repeat domain 33,59,RNA binding,,ppi
8643,10086,55341,LSG1,large 60S subunit nuclear export GTPase 1,17,GTPase activity|GTP binding,,ppi
8644,10087,55795,PCID2,PCI domain containing 2,30,double-stranded DNA binding|RNA binding,,ppi
8645,10088,55345,ZGRF1,zinc finger GRF-type containing 1,3,,,ppi
8646,10089,55346,TCP11L1,t-complex 11 like 1,10,,,ppi
8647,10090,55347,ABHD10,abhydrolase domain containing 10,14,hydrolase activity; hydrolyzing O-glycosyl compounds,,ppi
8648,10091,63035,BCORL1,BCL6 corepressor-like 1,22,,salivary gland adenoid cystic carcinoma,ppi
8649,10092,79809,TTC21B,tetratricopeptide repeat domain 21B,13,,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|substance abuse|substance-related disorder|asphyxiating thoracic dystrophy 1|nephronophthisis|Bardet-Biedl syndrome 1|asphyxiating thoracic dystrophy 4,ppi
8650,10093,79719,AAGAB,alpha- and gamma-adaptin binding protein,22,,nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis,ppi
8651,10094,79685,SAP30L,SAP30 like,17,DNA binding|histone deacetylase activity|zinc ion binding|phosphatidylinositol-5-phosphate binding|nucleosome binding|histone binding|non-sequence-specific DNA binding; bending,polycystic ovary syndrome,ppi
8652,10095,80256,FAM214B,family with sequence similarity 214 member B,10,,,ppi
8653,10096,80231,CXorf21,chromosome X open reading frame 21,1,,,ppi
8654,10097,79656,BEND5,BEN domain containing 5,21,,,ppi
8655,10098,80032,ZNF556,zinc finger protein 556,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8656,10099,8481,OFD1,OFD1; centriole and centriolar satellite protein,262,alpha-tubulin binding|gamma-tubulin binding,alopecia|cerebellar disease|Kartagener syndrome|primary ciliary dyskinesia|isolated cleft palate|cleft palate|clubfoot|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|sensorineural hearing loss|dental caries|dental enamel hypoplasia|epilepsy|glaucoma|congenital heart disease|inguinal hernia,ppi
8657,10100,79621,RNASEH2B,ribonuclease H2 subunit B,39,,Aicardi-Goutieres syndrome,ppi
8658,10102,64769,MEAF6,MYST/Esa1 associated factor 6,53,,,ppi
8659,10103,79643,CHMP6,charged multivesicular body protein 6,20,protein-containing complex binding,,ppi
8660,10104,92344,GORAB,golgin; RAB6 interacting,17,,osteoporosis|skin disease,ppi
8661,10105,342357,ZKSCAN2,zinc finger with KRAB and SCAN domains 2,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8662,10107,60673,ATG101,autophagy related 101,51,,,ppi
8663,10108,10046,MAMLD1,mastermind like domain containing 1,1,,hypospadias,ppi
8664,10109,79722,ANKRD55,ankyrin repeat domain 55,11,,rheumatoid arthritis|juvenile rheumatoid arthritis,ppi
8665,10110,80019,UBTD1,ubiquitin domain containing 1,20,,,ppi
8666,10111,79717,PPCS,phosphopantothenoylcysteine synthetase,3,phosphopantothenate--cysteine ligase activity,,ppi
8667,10112,80227,PAAF1,proteasomal ATPase associated factor 1,43,,,ppi
8668,10113,8933,FAM127A,family with sequence similarity 127 member A,21,,,ppi
8669,10114,79998,ANKRD53,ankyrin repeat domain 53,1,,,ppi
8670,10115,79825,EFCC1,EF-hand and coiled-coil domain containing 1,1,,,ppi
8671,10116,64786,TBC1D15,TBC1 domain family member 15,64,GTPase activator activity|Rab GTPase binding,,ppi
8672,10117,79587,CARS2,cysteinyl-tRNA synthetase 2; mitochondrial (putative),8,ATP binding|cysteine-tRNA ligase activity,,ppi
8673,10118,79792,GSDMD,gasdermin D,1,phosphatidylserine binding|phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-4-phosphate binding|phosphatidic acid binding|cardiolipin binding,,ppi
8674,10119,79735,TBC1D17,TBC1 domain family member 17,34,Rab GTPase binding|GTPase activator activity,,ppi
8675,10120,132,ADK,adenosine kinase,17,RNA binding|adenosine kinase activity,cholestasis|epilepsy|schizophrenia|visual epilepsy|liver disease|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|muscular atrophy|fatty liver disease|hypermethioninemia|intellectual disability|learning disability,ppi
8676,10121,1528,CYB5A,cytochrome b5 type A,29,aldo-keto reductase (NADP) activity|cytochrome-c oxidase activity,cryptorchidism|endometriosis of uterus|endometriosis|methemoglobinemia|sulfhemoglobinemia|obesity|osteoporosis|adult respiratory distress syndrome|newborn respiratory distress syndrome|congenital adrenal hyperplasia|hypogonadism,ppi
8677,10122,79672,FN3KRP,fructosamine 3 kinase related protein,14,kinase activity,,ppi
8678,10123,80205,CHD9,chromodomain helicase DNA binding protein 9,23,,,ppi
8679,10125,79734,KCTD17,potassium channel tetramerization domain containing 17,66,cullin family protein binding|protein-containing complex binding,,ppi
8680,10126,79726,WDR59,WD repeat domain 59,35,,,ppi
8681,10128,84125,LRRIQ1,leucine rich repeats and IQ motif containing 1,29,,,ppi
8682,10129,1534,CYB561,cytochrome b561,4,ferric-chelate reductase activity|oxidoreductase activity,,ppi
8683,10130,80055,PGAP1,post-GPI attachment to proteins 1,17,nuclease activity|hydrolase activity; acting on ester bonds|phosphoric ester hydrolase activity|phosphatidylinositol deacylase activity,,ppi
8684,10131,79714,CCDC51,coiled-coil domain containing 51,37,,,ppi
8685,10132,60672,MIIP,migration and invasion inhibitory protein,8,,,ppi
8686,10133,65260,COA7,cytochrome c oxidase assembly factor 7 (putative),21,,,ppi
8687,10134,64943,NT5DC2,5'-nucleotidase domain containing 2,26,5'-nucleotidase activity,,ppi
8688,10135,79888,LPCAT1,lysophosphatidylcholine acyltransferase 1,26,1-acylglycerol-3-phosphate O-acyltransferase activity|2-acylglycerol-3-phosphate O-acyltransferase activity|1-acylglycerophosphocholine O-acyltransferase activity,,ppi
8689,10136,64897,C12orf43,chromosome 12 open reading frame 43,12,protein binding,,ppi
8690,10138,64799,IQCH,IQ motif containing H,2,,melanoma|skin melanoma,ppi
8691,10139,64782,AEN,apoptosis enhancing nuclease,37,exonuclease activity,,ppi
8692,10140,79805,VASH2,vasohibin 2,2,,,ppi
8693,10141,65094,JMJD4,jumonji domain containing 4,21,,,ppi
8694,10142,84128,WDR75,WD repeat domain 75,23,RNA binding,,ppi
8695,10143,81887,LAS1L,LAS1 like; ribosome biogenesis factor,47,RNA binding,Wilson-Turner syndrome,ppi
8696,10144,79959,CEP76,centrosomal protein 76,151,,,ppi
8697,10145,64927,TTC23,tetratricopeptide repeat domain 23,23,protein binding,,ppi
8698,10147,64410,KLHL25,kelch like family member 25,9,,,ppi
8699,10148,79810,PTCD2,pentatricopeptide repeat domain 2,16,RNA binding,,ppi
8700,10149,79674,VEPH1,ventricular zone expressed PH domain containing 1,7,,,ppi
8701,10150,79862,ZNF669,zinc finger protein 669,25,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8702,10151,79840,NHEJ1,non-homologous end joining factor 1,7,DNA end binding,,ppi
8703,10152,84131,CEP78,centrosomal protein 78,19,,,ppi
8704,10153,65251,ZNF649,zinc finger protein 649,3,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region DNA binding|DNA-binding transcription factor activity,,ppi
8705,10154,79649,MAP7D3,MAP7 domain containing 3,39,microtubule binding|tubulin binding,,ppi
8706,10156,79647,AKIRIN1,akirin 1,5,,,ppi
8707,10157,81875,ISG20L2,interferon stimulated exonuclease gene 20 like 2,15,3'-5'-exoribonuclease activity|RNA binding,,ppi
8708,10158,79979,TRMT2B,tRNA methyltransferase 2 homolog B,8,,,ppi
8709,10159,79613,TANGO6,transport and golgi organization 6 homolog,6,,,ppi
8710,10160,60684,TRAPPC11,trafficking protein particle complex 11,18,Rab guanyl-nucleotide exchange factor activity,autosomal recessive limb-girdle muscular dystrophy type 2S,ppi
8711,10161,79915,ATAD5,ATPase family; AAA domain containing 5,17,DNA binding,ovarian cancer|ovarian carcinoma,ppi
8712,10163,79720,VPS37B,VPS37B; ESCRT-I subunit,31,,,ppi
8713,10164,339175,METTL2A,methyltransferase like 2A,15,tRNA (cytosine) methyltransferase activity|tRNA (cytosine-3-)-methyltransferase activity,,ppi
8714,10165,84134,TOMM40L,translocase of outer mitochondrial membrane 40 like,6,protein transmembrane transporter activity,,ppi
8715,10166,84135,UTP15,UTP15; small subunit processome component,43,RNA binding,,ppi
8716,10167,64427,TTC31,tetratricopeptide repeat domain 31,6,,,ppi
8717,10168,64925,CCDC71,coiled-coil domain containing 71,5,,,ppi
8718,10169,64853,AIDA,axin interactor; dorsalization associated,12,,,ppi
8719,10170,79594,MUL1,mitochondrial E3 ubiquitin protein ligase 1,49,ubiquitin-protein transferase activity|SUMO transferase activity,,ppi
8720,10171,56006,SMG9,SMG9; nonsense mediated mRNA decay factor,14,,,ppi
8721,10172,80010,RMI1,RecQ mediated genome instability 1,23,,,ppi
8722,10173,64770,CCDC14,coiled-coil domain containing 14,69,,,ppi
8723,10174,64766,S100PBP,S100P binding protein,2,,,ppi
8724,10175,65095,KRI1,KRI1 homolog,36,RNA binding,,ppi
8725,10176,1535,CYBA,cytochrome b-245 alpha chain,16,electron transfer activity|superoxide-generating NADPH oxidase activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|diabetes mellitus|type 2 diabetes mellitus|dermatitis|chronic granulomatous disease|heart disease|cardiovascular system disease|hypertension|essential hypertension|chronic kidney disease|liver cirrhosis|chronic obstructive pulmonary disease|lupus erythematosus|lymphadenitis|otitis media|lower respiratory tract disease,ppi
8726,10177,84058,WDR54,WD repeat domain 54,24,,,ppi
8727,10178,79691,QTRT2,queuine tRNA-ribosyltransferase accessory subunit 2,11,protein homodimerization activity|protein heterodimerization activity|queuine tRNA-ribosyltransferase activity,,ppi
8728,10179,64860,ARMCX5,armadillo repeat containing; X-linked 5,6,,,ppi
8729,10180,79968,WDR76,WD repeat domain 76,52,DNA binding,,ppi
8730,10181,79867,TCTN2,tectonic family member 2,275,,Joubert syndrome,ppi
8731,10182,64864,RFX7,regulatory factor X7,6,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
8732,10183,64779,MTHFSD,methenyltetrahydrofolate synthetase domain containing,8,RNA binding,,ppi
8733,10184,1536,CYBB,cytochrome b-245 beta chain,11,superoxide-generating NADPH oxidase activity|heme binding|flavin adenine dinucleotide binding|electron transfer activity,diabetic ketoacidosis|diabetes mellitus|dermatitis|chronic granulomatous disease|congestive heart failure|hypertension|essential hypertension|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|chronic kidney disease|chronic obstructive pulmonary disease|lupus erythematosus|lymphadenitis|otitis media|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease,ppi
8734,10185,79798,ARMC5,armadillo repeat containing 5,7,,,ppi
8735,10186,79892,MCMBP,minichromosome maintenance complex binding protein,58,chromatin binding,,ppi
8736,10187,80018,NAA25,N(alpha)-acetyltransferase 25; NatB auxiliary subunit,13,peptide alpha-N-acetyltransferase activity,,ppi
8737,10188,80067,DCAF17,DDB1 and CUL4 associated factor 17,7,,,ppi
8738,10189,65055,REEP1,receptor accessory protein 1,12,microtubule binding|olfactory receptor binding,hereditary spastic paraplegia 31,ppi
8739,10190,80152,CENPT,centromere protein T,21,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8740,10191,79591,C10orf76,chromosome 10 open reading frame 76,5,,,ppi
8741,10192,79631,EFL1,elongation factor like GTPase 1,26,GTPase activity|ribosome binding,,ppi
8742,10193,1537,CYC1,cytochrome c1,92,electron transporter; transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity|electron transporter; transferring electrons within CoQH2-cytochrome c reductase complex activity,lactic acidosis|liver disease|hepatitis|urea cycle disorder|mitochondrial complex III deficiency nuclear type 6,ppi
8743,10194,60493,FASTKD5,FAST kinase domains 5,20,RNA binding|rRNA binding,schizophrenia,ppi
8744,10195,79871,RPAP2,RNA polymerase II associated protein 2,71,protein serine/threonine phosphatase activity|RNA polymerase II CTD heptapeptide repeat phosphatase activity,,ppi
8745,10196,79650,USB1,U6 snRNA biogenesis phosphodiesterase 1,29,3'-5'-exoribonuclease activity,dyskeratosis congenita|poikiloderma with neutropenia,ppi
8746,10197,65979,PHACTR4,phosphatase and actin regulator 4,26,actin binding|protein phosphatase 1 binding|protein phosphatase activator activity,,ppi
8747,10198,63877,FAM204A,family with sequence similarity 204 member A,10,,,ppi
8748,10199,80071,CCDC15,coiled-coil domain containing 15,5,,,ppi
8749,10200,60558,GUF1,GUF1 homolog; GTPase,10,,infantile epileptic encephalopathy,ppi
8750,10201,65250,C5orf42,chromosome 5 open reading frame 42,7,,Joubert syndrome|Joubert syndrome with orofaciodigital defect,ppi
8751,10203,80195,TMEM254,transmembrane protein 254,1,,,ppi
8752,10205,79807,GSTCD,glutathione S-transferase C-terminal domain containing,13,,prostate cancer|prostate carcinoma,ppi
8753,10206,84138,SLC7A6OS,solute carrier family 7 member 6 opposite strand,2,,,ppi
8754,10207,84140,FAM161A,family with sequence similarity 161 member A,70,microtubule binding|identical protein binding,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
8755,10208,79644,SRD5A3,steroid 5 alpha-reductase 3,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity|oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor,Creutzfeldt-Jakob disease|congenital disorder of glycosylation type I|intellectual disability|learning disability,ppi
8756,10209,80254,CEP63,centrosomal protein 63,113,,microcephaly,ppi
8757,10210,84141,EVA1A,eva-1 homolog A; regulator of programmed cell death,4,,,ppi
8758,10211,79670,ZCCHC6,zinc finger CCHC-type containing 6,20,RNA binding|miRNA binding|RNA uridylyltransferase activity|uridylyltransferase activity,,ppi
8759,10212,65980,BRD9,bromodomain containing 9,11,nucleic acid binding|lysine-acetylated histone binding,Sezary's disease,ppi
8760,10213,80219,COQ10B,coenzyme Q10B,11,ubiquinone binding,,ppi
8761,10215,79699,ZYG11B,zyg-11 family member B; cell cycle regulator,41,ubiquitin-protein transferase activity,,ppi
8762,10216,79759,ZNF668,zinc finger protein 668,27,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,malignant glioma|benign ependymoma|myxopapillary ependymoma|cellular ependymoma|tanycytic ependymoma|papillary ependymoma,ppi
8763,10217,80007,C10orf88,chromosome 10 open reading frame 88,23,,,ppi
8764,10218,79676,OGFOD2,2-oxoglutarate and iron dependent oxygenase domain containing 2,3,,,ppi
8765,10219,85360,SYDE1,synapse defective Rho GTPase homolog 1,10,GTPase activator activity,,ppi
8766,10220,64418,TMEM168,transmembrane protein 168,5,,,ppi
8767,10222,80006,TRAPPC13,trafficking protein particle complex 13,18,Rab guanyl-nucleotide exchange factor activity,,ppi
8768,10223,84142,FAM175A,family with sequence similarity 175 member A,22,polyubiquitin modification-dependent protein binding,breast cancer,ppi
8769,10224,1539,CYLC2,cylicin 2,15,,,ppi
8770,10225,79758,DHRS12,dehydrogenase/reductase 12,1,,,ppi
8771,10226,79635,CCDC121,coiled-coil domain containing 121,12,,,ppi
8772,10227,79886,CAAP1,caspase activity and apoptosis inhibitor 1,10,,,ppi
8773,10228,79875,THSD4,thrombospondin type 1 domain containing 4,20,extracellular matrix structural constituent,substance abuse|substance-related disorder,ppi
8774,10229,79567,FAM65A,family with sequence similarity 65 member A,4,14-3-3 protein binding,,ppi
8775,10230,57822,GRHL3,grainyhead like transcription factor 3,6,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|chromatin DNA binding|sequence-specific DNA binding|DNA-binding transcription factor activity,Van der Woude syndrome|isolated cleft palate|cleft soft palate,ppi
8776,10231,1540,CYLD,CYLD lysine 63 deubiquitinase,66,thiol-dependent ubiquitin-specific protease activity|zinc ion binding|thiol-dependent ubiquitinyl hydrolase activity|Lys63-specific deubiquitinase activity,skin benign neoplasm|skin cancer|lung cancer|non-small cell lung carcinoma|listeriosis|thymoma|thymic carcinoma|Brooke-Spiegler syndrome|liver cancer|hepatocellular carcinoma,ppi
8777,10232,79831,KDM8,lysine demethylase 8,5,chromatin binding|histone demethylase activity|histone demethylase activity (H3-K36 specific),,ppi
8778,10233,84144,SYDE2,synapse defective Rho GTPase homolog 2,2,GTPase activator activity,,ppi
8779,10234,79802,HHIPL2,HHIP like 2,1,,,ppi
8780,10235,79755,ZNF750,zinc finger protein 750,1,RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|promoter-specific chromatin binding,,ppi
8781,10236,79698,ZMAT4,zinc finger matrin-type 4,14,,,ppi
8782,10237,79829,NAA40,N(alpha)-acetyltransferase 40; NatD catalytic subunit,22,H4 histone acetyltransferase activity|H2A histone acetyltransferase activity|peptide-serine-N-acetyltransferase activity,,ppi
8783,10238,65263,PYCRL,pyrroline-5-carboxylate reductase-like,29,pyrroline-5-carboxylate reductase activity,,ppi
8784,10239,65264,UBE2Z,ubiquitin conjugating enzyme E2 Z,47,ubiquitin conjugating enzyme activity|cysteine-type endopeptidase inhibitor activity,,ppi
8785,10240,64755,C16orf58,chromosome 16 open reading frame 58,34,,,ppi
8786,10241,80178,C16orf59,chromosome 16 open reading frame 59,10,,,ppi
8787,10242,64795,RMND5A,required for meiotic nuclear division 5 homolog A,49,ubiquitin-protein transferase activity,,ppi
8788,10243,64785,GINS3,GINS complex subunit 3,36,,,ppi
8789,10244,79906,MORN1,MORN repeat containing 1,1,,polycystic ovary syndrome,ppi
8790,10245,92104,TTC30A,tetratricopeptide repeat domain 30A,26,,,ppi
8791,10247,79828,METTL8,methyltransferase like 8,10,tRNA (cytosine-3-)-methyltransferase activity,,ppi
8792,10248,79730,NSUN7,NOP2/Sun RNA methyltransferase family member 7,2,,male infertility,ppi
8793,10249,79752,ZFAND1,zinc finger AN1-type containing 1,1,,,ppi
8794,10250,7461,CLIP2,CAP-Gly domain containing linker protein 2,10,microtubule binding,generalized anxiety disorder|anxiety disorder|supravalvular aortic stenosis|autistic disorder|blepharophimosis|brain ischemia|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|basal ganglia disease|focal hand dystonia|blepharospasm|clubfoot|sensorineural hearing loss|inguinal hernia|nephrocalcinosis,ppi
8795,10252,79954,NOL10,nucleolar protein 10,33,RNA binding,,ppi
8796,10253,59353,TMEM35A,transmembrane protein 35A,1,,,ppi
8797,10255,79943,ZNF696,zinc finger protein 696,16,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8798,10256,79762,C1orf115,chromosome 1 open reading frame 115,1,,,ppi
8799,10257,64747,MFSD1,major facilitator superfamily domain containing 1,2,,,ppi
8800,10259,79616,CCNJL,cyclin J like,38,protein kinase activity|protein kinase binding|cyclin-dependent protein serine/threonine kinase regulator activity,,ppi
8801,10260,79899,PRR5L,proline rich 5 like,6,,,ppi
8802,10261,80095,ZNF606,zinc finger protein 606,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,substance abuse|substance-related disorder,ppi
8803,10262,79982,DNAJB14,DnaJ heat shock protein family (Hsp40) member B14,8,,,ppi
8804,10263,80139,ZNF703,zinc finger protein 703,33,,,ppi
8805,10264,79788,ZNF665,zinc finger protein 665,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8806,10265,80097,MZT2B,mitotic spindle organizing protein 2B,32,,,ppi
8807,10266,84861,KLHL22,kelch like family member 22,49,,,ppi
8808,10268,84866,TMEM25,transmembrane protein 25,85,,breast cancer,ppi
8809,10269,84869,CBR4,carbonyl reductase 4,6,NAD(P)H dehydrogenase (quinone) activity|NADPH dehydrogenase (quinone) activity|3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity|quinone binding|NADPH binding,,ppi
8810,10271,84872,ZC3H10,zinc finger CCCH-type containing 10,14,RNA binding|miRNA binding,,ppi
8811,10272,84874,ZNF514,zinc finger protein 514,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8812,10273,84875,PARP10,poly(ADP-ribose) polymerase family member 10,13,NAD+ ADP-ribosyltransferase activity|K63-linked polyubiquitin modification-dependent protein binding,,ppi
8813,10274,84876,ORAI1,ORAI calcium release-activated calcium modulator 1,10,store-operated calcium channel activity,hypertension|essential hypertension|centronuclear myopathy|congenital structural myopathy|tubular aggregate myopathy,ppi
8814,10276,84881,RPUSD4,RNA pseudouridylate synthase domain containing 4,21,RNA binding,,ppi
8815,10277,256714,MAP7D2,MAP7 domain containing 2,28,,,ppi
8816,10278,133,ADM,adrenomedullin,5,signaling receptor binding|adrenomedullin receptor binding,autistic disorder|bipolar disorder|nephritis|glomerulonephritis|kidney disease|schizophrenia|gastric ulcer,ppi
8817,10279,1583,CYP11A1,cytochrome P450 family 11 subfamily A member 1,9,cholesterol monooxygenase (side-chain-cleaving) activity|heme binding,lactic acidosis|adrenal cortical hypofunction|Addison's disease|cryptorchidism|endometrial cancer|endometrial carcinoma|hypertrophy of breast|infant gynecomastia|gynecomastia|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|osteoporosis|epilepsy|visual epilepsy|congenital adrenal hyperplasia|congenital adrenal insufficiency,ppi
8818,10280,84886,C1orf198,chromosome 1 open reading frame 198,12,,,ppi
8819,10281,84632,AFAP1L2,actin filament associated protein 1 like 2,9,protein tyrosine kinase activator activity,,ppi
8820,10282,84892,POMGNT2,protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1;4-),20,acetylglucosaminyltransferase activity|protein O-GlcNAc transferase activity,Walker-Warburg syndrome|muscular dystrophy-dystroglycanopathy,ppi
8821,10283,84896,ATAD1,ATPase family; AAA domain containing 1,15,ATPase activity,,ppi
8822,10284,84899,TMTC4,transmembrane and tetratricopeptide repeat containing 4,23,,,ppi
8823,10285,84900,RNFT2,ring finger protein; transmembrane 2,1,,,ppi
8824,10286,84901,NFATC2IP,nuclear factor of activated T-cells 2 interacting protein,36,,,ppi
8825,10287,84902,CEP89,centrosomal protein 89,89,,,ppi
8826,10288,84904,ARHGEF39,Rho guanine nucleotide exchange factor 39,7,,,ppi
8827,10289,1584,CYP11B1,cytochrome P450 family 11 subfamily B member 1,1,steroid 11-beta-monooxygenase activity|heme binding|corticosterone 18-monooxygenase activity,hypertrichosis|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypertension|essential hypertension|hypokalemia|osteoporosis|congenital adrenal hyperplasia|glucocorticoid-remediable aldosteronism,ppi
8828,10290,84908,FAM136A,family with sequence similarity 136 member A,53,,,ppi
8829,10291,84910,TMEM87B,transmembrane protein 87B,4,,,ppi
8830,10292,84915,FAM222A,family with sequence similarity 222 member A,7,,,ppi
8831,10293,85369,STRIP1,striatin interacting protein 1,54,,,ppi
8832,10294,84922,FIZ1,FLT3 interacting zinc finger 1,5,DNA-binding transcription factor activity; RNA polymerase II-specific|receptor tyrosine kinase binding,,ppi
8833,10295,84923,FAM104A,family with sequence similarity 104 member A,6,,,ppi
8834,10296,84924,ZNF566,zinc finger protein 566,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8835,10297,1585,CYP11B2,cytochrome P450 family 11 subfamily B member 2,3,steroid 11-beta-monooxygenase activity|steroid hydroxylase activity|heme binding|corticosterone 18-monooxygenase activity,Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypertension|essential hypertension|multiple system atrophy|prostate cancer|prostate carcinoma|glucocorticoid-remediable aldosteronism,ppi
8836,10298,84926,SPRYD3,SPRY domain containing 3,6,,,ppi
8837,10299,84929,FIBCD1,fibrinogen C domain containing 1,1,chitin binding,,ppi
8838,10300,84933,C8orf76,chromosome 8 open reading frame 76,1,,,ppi
8839,10301,84934,RITA1,RBPJ interacting and tubulin associated 1,7,tubulin binding,,ppi
8840,10302,84935,MEDAG,mesenteric estrogen dependent adipogenesis,1,,,ppi
8841,10303,84942,WDR73,WD repeat domain 73,17,,Galloway-Mowat syndrome,ppi
8842,10304,84944,MAEL,maelstrom spermatogenic transposon silencer,15,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
8843,10305,1586,CYP17A1,cytochrome P450 family 17 subfamily A member 1,17,steroid 17-alpha-monooxygenase activity|oxygen binding|heme binding|17-alpha-hydroxyprogesterone aldolase activity,amenorrhea|cryptorchidism|hypertrophy of breast|infant gynecomastia|gynecomastia|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypertension|essential hypertension|malignant hypertension|hypogonadism|hypokalemia|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome,ppi
8844,10306,84950,PRPF38A,pre-mRNA processing factor 38A,41,RNA binding,,ppi
8845,10307,84952,CGNL1,cingulin like 1,12,,schizophrenia,ppi
8846,10308,284391,ZNF844,zinc finger protein 844,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8847,10309,84953,MICALCL,MICAL C-terminal like,1,mitogen-activated protein kinase binding,,ppi
8848,10310,84954,MPND,MPN domain containing,2,,,ppi
8849,10311,54780,NSMCE4A,NSE4 homolog A; SMC5-SMC6 complex component,31,,,ppi
8850,10312,54494,C11orf71,chromosome 11 open reading frame 71,3,,,ppi
8851,10313,54785,BORCS6,BLOC-1 related complex subunit 6,54,,,ppi
8852,10314,1588,CYP19A1,cytochrome P450 family 19 subfamily A member 1,9,steroid hydroxylase activity|electron transfer activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|oxygen binding|heme binding|aromatase activity,acanthosis nigricans|adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|amenorrhea|autistic disorder|cryptorchidism|diabetes mellitus|type 2 diabetes mellitus|endometriosis of uterus|endometriosis|esophageal cancer|fatty liver disease|hypertrophy of breast|infant gynecomastia|gynecomastia|familial hyperlipidemia|hypogonadism,ppi
8853,10315,54790,TET2,tet methylcytosine dioxygenase 2,16,ferrous iron binding|zinc ion binding|methylcytosine dioxygenase activity|iron ion binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|acute promyelocytic leukemia|myelofibrosis|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|plasmacytoma|polycythemia vera|polycythemia|prostate cancer|prostate carcinoma|Sezary's disease|essential thrombocythemia,ppi
8854,10316,55601,DDX60,DExD/H-box helicase 60,4,double-stranded DNA binding|double-stranded RNA binding|single-stranded RNA binding,influenza,ppi
8855,10317,54797,MED18,mediator complex subunit 18,48,,,ppi
8856,10318,54622,ARL15,ADP ribosylation factor like GTPase 15,28,,,ppi
8857,10319,54800,KLHL24,kelch like family member 24,18,,,ppi
8858,10320,54801,HAUS6,HAUS augmin like complex subunit 6,53,,,ppi
8859,10321,54807,ZNF586,zinc finger protein 586,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8860,10322,1543,CYP1A1,cytochrome P450 family 1 subfamily A member 1,71,monooxygenase activity|oxidoreductase activity|oxygen binding|vitamin D 24-hydroxylase activity|estrogen 16-alpha-hydroxylase activity,aortitis|vasculitis|contact dermatitis|occupational dermatitis|allergic hypersensitivity disease|hypertension|essential hypertension|male infertility|kidney cancer|long QT syndrome|chronic obstructive pulmonary disease|prostate cancer|prostate carcinoma|intermittent claudication|mental depression|allergic contact dermatitis|breast cancer|liver cancer|hepatocellular carcinoma,ppi
8861,10323,54811,ZNF562,zinc finger protein 562,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8862,10324,54812,AFTPH,aftiphilin,15,clathrin binding,,ppi
8863,10325,54814,QPCTL,glutaminyl-peptide cyclotransferase like,21,zinc ion binding|glutaminyl-peptide cyclotransferase activity,,ppi
8864,10326,54816,ZNF280D,zinc finger protein 280D,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding,,ppi
8865,10327,54819,ZCCHC10,zinc finger CCHC-type containing 10,52,,,ppi
8866,10328,55609,ZNF280C,zinc finger protein 280C,10,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding,,ppi
8867,10329,55610,VPS50,VPS50; EARP/GARPII complex subunit,32,SNARE binding,,ppi
8868,10330,54826,GIN1,gypsy retrotransposon integrase 1,2,,rheumatoid arthritis,ppi
8869,10331,1544,CYP1A2,cytochrome P450 family 1 subfamily A member 2,6,monooxygenase activity|electron transfer activity|oxidoreductase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|heme binding|demethylase activity|caffeine oxidase activity,tongue squamous cell carcinoma|squamous cell carcinoma|large intestine cancer|colorectal cancer|diabetes mellitus|type 2 diabetes mellitus|gallbladder disease|liver disease|chronic obstructive pulmonary disease|lung benign neoplasm|methemoglobinemia|sulfhemoglobinemia|schizophrenia|splenic disease|splenic infarction|hypersplenism|porphyria cutanea tarda|acute lymphocytic leukemia,ppi
8870,10332,54830,NUP62CL,nucleoporin 62 C-terminal like,8,,,ppi
8871,10333,54463,FAM134B,family with sequence similarity 134 member B,5,,hypohidrosis|anhidrosis|microphthalmia|eye disease|esophagitis|peptic esophagitis|gastroesophageal reflux disease|sensory peripheral neuropathy|paronychia|polyneuropathy|peripheral nervous system disease|neuropathy|Charcot-Marie-Tooth disease|axonal neuropathy|muscular atrophy|Hajdu-Cheney syndrome|hereditary sensory neuropathy,ppi
8872,10334,54839,LRRC49,leucine rich repeat containing 49,30,dynein heavy chain binding|alpha-tubulin binding|motor activity,,ppi
8873,10335,54845,ESRP1,epithelial splicing regulatory protein 1,15,mRNA binding,,ppi
8874,10337,54848,ARHGEF38,Rho guanine nucleotide exchange factor 38,2,Rho guanyl-nucleotide exchange factor activity,,ppi
8875,10338,54849,DEF8,differentially expressed in FDCP 8 homolog,30,,,ppi
8876,10339,1545,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,monooxygenase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|oxygen binding|heme binding,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|tongue squamous cell carcinoma|squamous cell carcinoma|large intestine cancer|colorectal cancer|recurrent corneal erosion|contact dermatitis|occupational dermatitis|buphthalmos|hydrophthalmos|lung benign neoplasm|melanoma|skin melanoma|prostate cancer|prostate carcinoma|mental depression,ppi
8877,10340,54851,ANKRD49,ankyrin repeat domain 49,11,,,ppi
8878,10341,54853,WDR55,WD repeat domain 55,24,,,ppi
8879,10343,54856,GON4L,gon-4 like,9,DNA-binding transcription factor activity; RNA polymerase II-specific,intellectual disability|learning disability,ppi
8880,10344,54857,GDPD2,glycerophosphodiester phosphodiesterase domain containing 2,4,,,ppi
8881,10345,54859,ELP6,elongator acetyltransferase complex subunit 6,30,,,ppi
8882,10346,54546,RNF186,ring finger protein 186,4,,,ppi
8883,10347,54471,MIEF1,mitochondrial elongation factor 1,13,GDP binding|ADP binding,,ppi
8884,10348,55621,TRMT1,tRNA methyltransferase 1,55,RNA binding|tRNA (guanine-N2-)-methyltransferase activity,intellectual disability|learning disability,ppi
8885,10349,54863,TOR4A,torsin family 4 member A,4,,,ppi
8886,10350,54865,GPATCH4,G-patch domain containing 4,106,,,ppi
8887,10351,54867,TMEM214,transmembrane protein 214,42,,,ppi
8888,10352,54868,TMEM104,transmembrane protein 104,3,,,ppi
8889,10353,54872,PIGG,phosphatidylinositol glycan anchor biosynthesis class G,8,phosphotransferase activity; for other substituted phosphate groups|CP2 mannose-ethanolamine phosphotransferase activity,,ppi
8890,10354,55622,TTC27,tetratricopeptide repeat domain 27,41,,,ppi
8891,10355,54876,DCAF16,DDB1 and CUL4 associated factor 16,26,,,ppi
8892,10356,54881,TEX10,testis expressed 10,51,,,ppi
8893,10357,54883,CWC25,CWC25 spliceosome associated protein homolog,5,,,ppi
8894,10358,55626,AMBRA1,autophagy and beclin 1 regulator 1,96,,schizophrenia,ppi
8895,10359,54884,RETSAT,retinol saturase,23,oxidoreductase activity|all-trans-retinol 13;14-reductase activity,Simpson-Golabi-Behmel syndrome,ppi
8896,10360,54886,PLPPR1,phospholipid phosphatase related 1,12,phosphatase activity|phosphatidate phosphatase activity|lipid phosphatase activity,epilepsy|visual epilepsy,ppi
8897,10361,54888,NSUN2,NOP2/Sun RNA methyltransferase family member 2,89,RNA binding|tRNA (cytosine-5-)-methyltransferase activity|methyltransferase activity|tRNA binding,blepharophimosis|ptosis|congenital ptosis|cryptorchidism|sensorineural hearing loss|dermatitis|placental insufficiency|intellectual disability|learning disability|ophthalmoplegia|mechanical strabismus|hypertropia|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1,ppi
8898,10362,54890,ALKBH5,alkB homolog 5; RNA demethylase,7,RNA binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors|oxidative RNA demethylase activity,,ppi
8899,10363,54891,INO80D,INO80 complex subunit D,15,,,ppi
8900,10364,54893,MTMR10,myotubularin related protein 10,16,,,ppi
8901,10366,54896,PQLC2,PQ loop repeat containing 2,1,basic amino acid transmembrane transporter activity|arginine transmembrane transporter activity|L-lysine transmembrane transporter activity,,ppi
8902,10367,54897,CASZ1,castor zinc finger 1,12,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
8903,10368,55631,LRRC40,leucine rich repeat containing 40,29,,,ppi
8904,10369,54900,LAX1,lymphocyte transmembrane adaptor 1,12,protein kinase binding|SH2 domain binding,,ppi
8905,10370,54902,TTC19,tetratricopeptide repeat domain 19,44,,generalized anxiety disorder|anxiety disorder|agnosia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|infertility|central nervous system disease|nervous system disease|autonomic neuropathy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obsessive-compulsive disorder|olivopontocerebellar atrophy,ppi
8906,10371,55634,KRBOX4,KRAB box domain containing 4,15,,,ppi
8907,10372,54436,SH3TC1,SH3 domain and tetratricopeptide repeats 1,1,,large intestine cancer|colorectal cancer,ppi
8908,10373,54908,SPDL1,spindle apparatus coiled-coil protein 1,33,kinetochore binding,,ppi
8909,10374,55638,SYBU,syntabulin,21,,,ppi
8910,10375,54919,DNAAF5,dynein axonemal assembly factor 5,66,dynein intermediate chain binding,bronchitis|Kartagener syndrome|primary ciliary dyskinesia|male infertility|primary ciliary dyskinesia 1|rhinitis|tuberous sclerosis|Marfan syndrome|situs inversus|primary ciliary dyskinesia 18,ppi
8911,10376,54920,DUS2,dihydrouridine synthase 2,6,double-stranded RNA binding|protein kinase inhibitor activity,,ppi
8912,10377,54923,LIME1,Lck interacting transmembrane adaptor 1,7,protein kinase binding,,ppi
8913,10378,54928,IMPAD1,inositol monophosphatase domain containing 1,21,3'(2');5'-bisphosphate nucleotidase activity|3'-nucleotidase activity,sensorineural hearing loss|enophthalmos|orbital disease|exophthalmos,ppi
8914,10379,1591,CYP24A1,cytochrome P450 family 24 subfamily A member 1,4,oxidoreductase activity|heme binding|1-alpha;25-dihydroxyvitamin D3 24-hydroxylase activity,aortic valve stenosis|microphthalmia|eye disease|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|lung benign neoplasm|intellectual disability|learning disability|calcium metabolism disease|calcinosis|osteoporosis|acute urate nephropathy|breast cancer|kidney failure|pulmonary valve stenosis,ppi
8915,10380,54929,TMEM161A,transmembrane protein 161A,12,,,ppi
8916,10381,55646,LYAR,Ly1 antibody reactive,125,DNA binding|RNA binding,,ppi
8917,10382,54931,TRMT10C,tRNA methyltransferase 10C; mitochondrial RNase P subunit,47,tRNA binding|RNA binding|tRNA (guanine-N1-)-methyltransferase activity|tRNA (adenine-N1-)-methyltransferase activity|mRNA (adenine-N1-)-methyltransferase activity|protein binding,,ppi
8918,10383,54932,EXD3,exonuclease 3'-5' domain containing 3,3,3'-5' exonuclease activity,,ppi
8919,10384,54934,KANSL2,KAT8 regulatory NSL complex subunit 2,15,histone acetyltransferase activity (H4-K5 specific)|histone acetyltransferase activity (H4-K8 specific)|histone acetyltransferase activity (H4-K16 specific),,ppi
8920,10385,54708,MARCH5,membrane associated ring-CH-type finger 5,36,ubiquitin-protein transferase activity,,ppi
8921,10386,54937,SOHLH2,spermatogenesis and oogenesis specific basic helix-loop-helix 2,1,DNA-binding transcription factor activity; RNA polymerase II-specific|protein homodimerization activity|protein heterodimerization activity|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
8922,10387,54939,COMMD4,COMM domain containing 4,49,,,ppi
8923,10389,55650,PIGV,phosphatidylinositol glycan anchor biosynthesis class V,1,mannosyltransferase activity|glycolipid mannosyltransferase activity,syndromic X-linked intellectual disability 94,ppi
8924,10390,54947,LPCAT2,lysophosphatidylcholine acyltransferase 2,5,1-acylglycerol-3-phosphate O-acyltransferase activity|2-acylglycerol-3-phosphate O-acyltransferase activity|1-acylglycerophosphocholine O-acyltransferase activity|1-alkylglycerophosphocholine O-acetyltransferase activity,polycystic ovary syndrome,ppi
8925,10391,54517,PUS7,pseudouridylate synthase 7 (putative),44,RNA binding|pseudouridine synthase activity,,ppi
8926,10392,54949,SDHAF2,succinate dehydrogenase complex assembly factor 2,29,,paraganglioma|iron metabolism disease|hemochromatosis|Wilson disease,ppi
8927,10393,55652,SLC48A1,solute carrier family 48 member 1,6,heme transporter activity|heme binding,,ppi
8928,10394,54951,COMMD8,COMM domain containing 8,45,,,ppi
8929,10395,55654,TMEM127,transmembrane protein 127,1,Rab GTPase binding,adrenal gland cancer|duodenum cancer|heart cancer|phaeochromocytoma|small intestine cancer|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|nonpapillary renal cell carcinoma,ppi
8930,10396,54955,C1orf109,chromosome 1 open reading frame 109,51,,,ppi
8931,10397,54956,PARP16,poly(ADP-ribose) polymerase family member 16,24,NAD+ ADP-ribosyltransferase activity|protein serine/threonine kinase activator activity|kinase binding,,ppi
8932,10398,54957,TXNL4B,thioredoxin like 4B,14,,,ppi
8933,10399,54958,TMEM160,transmembrane protein 160,22,,,ppi
8934,10400,54959,ODAM,odontogenic; ameloblast asssociated,5,,,ppi
8935,10401,54960,GEMIN8,gem nuclear organelle associated protein 8,23,,,ppi
8936,10402,54964,C1orf56,chromosome 1 open reading frame 56,1,,,ppi
8937,10403,54965,PIGX,phosphatidylinositol glycan anchor biosynthesis class X,3,,,ppi
8938,10404,54967,CT55,cancer/testis antigen 55,20,,,ppi
8939,10405,55656,INTS8,integrator complex subunit 8,17,,,ppi
8940,10406,55657,ZNF692,zinc finger protein 692,27,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
8941,10407,1593,CYP27A1,cytochrome P450 family 27 subfamily A member 1,6,steroid hydroxylase activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|cerebellar disease|cholecystolithiasis|choledocholithiasis|cholestasis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|epilepsy|basal ganglia disease|focal hand dystonia|blepharospasm,ppi
8942,10408,54968,TMEM70,transmembrane protein 70,30,,lactic acidosis|sick sinus syndrome|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|cryptorchidism|myelitis|encephalomyelitis|encephalitis|placental insufficiency|congestive heart failure|inguinal hernia|umbilical hernia|omphalocele|oligohydramnios|brain disease|mitochondrial encephalomyopathy|urea cycle disorder|cerebral degeneration,ppi
8943,10409,54969,HPF1,histone PARylation factor 1,27,histone binding,,ppi
8944,10410,54973,CPSF3L,cleavage and polyadenylation specific factor 3-like,28,,,ppi
8945,10411,54974,THG1L,tRNA-histidine guanylyltransferase 1 like,27,tRNA binding|magnesium ion binding|ATP binding|GTP binding|tRNA guanylyltransferase activity|nucleotidyltransferase activity,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
8946,10412,54977,SLC25A38,solute carrier family 25 member 38,6,glycine transmembrane transporter activity,anemia|macrocytic anemia|sideroblastic anemia|pyridoxine-refractory autosomal recessive sideroblastic anemia,ppi
8947,10413,54978,SLC35F6,solute carrier family 35 member F6,26,,,ppi
8948,10414,54980,C2orf42,chromosome 2 open reading frame 42,3,,,ppi
8949,10415,54981,NMRK1,nicotinamide riboside kinase 1,2,ribosylnicotinamide kinase activity|ribosylnicotinate kinase activity|uridine kinase activity,,ppi
8950,10416,8270,LAGE3,L antigen family member 3,51,,,ppi
8951,10417,54987,C1orf123,chromosome 1 open reading frame 123,10,,,ppi
8952,10419,54988,ACSM5,acyl-CoA synthetase medium-chain family member 5,15,fatty acid ligase activity|fatty-acyl-CoA synthase activity|acyl-CoA ligase activity,,ppi
8953,10420,54989,ZNF770,zinc finger protein 770,14,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
8954,10421,54991,C1orf159,chromosome 1 open reading frame 159,3,,,ppi
8955,10422,54995,OXSM,3-oxoacyl-ACP synthase; mitochondrial,8,3-oxoacyl-[acyl-carrier-protein] synthase activity,,ppi
8956,10423,54996,MARC2,mitochondrial amidoxime reducing component 2,3,nitrate reductase activity|molybdenum ion binding|molybdopterin cofactor binding,,ppi
8957,10424,54997,TESC,tescalcin,8,magnesium ion binding|calcium ion binding|phosphatase inhibitor activity|protein homodimerization activity,,ppi
8958,10426,55004,LAMTOR1,late endosomal/lysosomal adaptor; MAPK and MTOR activator 1,29,guanyl-nucleotide exchange factor activity|protein-containing complex scaffold activity,,ppi
8959,10427,55006,TRMT61B,tRNA methyltransferase 61B,32,tRNA (adenine-N1-)-methyltransferase activity|rRNA (adenine) methyltransferase activity|mRNA (adenine-N1-)-methyltransferase activity,,ppi
8960,10428,55008,HERC6,HECT and RLD domain containing E3 ubiquitin protein ligase family member 6,9,ubiquitin-protein transferase activity,influenza,ppi
8961,10431,55011,PIH1D1,PIH1 domain containing 1,81,RNA polymerase I CORE element sequence-specific DNA binding|RNA polymerase I upstream control element sequence-specific DNA binding,,ppi
8962,10432,55013,MCUB,mitochondrial calcium uniporter dominant negative beta subunit,8,calcium channel inhibitor activity|ion channel activity|calcium channel activity|uniporter activity,,ppi
8963,10433,55016,MARCH1,membrane associated ring-CH-type finger 1,11,ubiquitin-protein transferase activity|MHC protein binding,,ppi
8964,10434,54621,VSIG10,V-set and immunoglobulin domain containing 10,1,,,ppi
8965,10435,55667,DENND4C,DENN domain containing 4C,9,Rab guanyl-nucleotide exchange factor activity,,ppi
8966,10436,1553,CYP2A13,cytochrome P450 family 2 subfamily A member 13,1,monooxygenase activity|coumarin 7-hydroxylase activity|heme binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen,alcohol dependence|alcohol abuse|lung cancer|lung adenocarcinoma,ppi
8967,10437,55020,TTC38,tetratricopeptide repeat domain 38,12,,,ppi
8968,10438,55022,PID1,phosphotyrosine interaction domain containing 1,16,,,ppi
8969,10439,55026,TMEM255A,transmembrane protein 255A,11,,,ppi
8970,10440,55027,HEATR3,HEAT repeat containing 3,48,unfolded protein binding,,ppi
8971,10441,55672,NBPF1,neuroblastoma breakpoint family member 1,2,,,ppi
8972,10442,54680,ZNHIT6,zinc finger HIT-type containing 6,25,,,ppi
8973,10443,55036,CCDC40,coiled-coil domain containing 40,24,,bronchiectasis|Kartagener syndrome|primary ciliary dyskinesia|infertility|primary ciliary dyskinesia 1|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|sinusitis,ppi
8974,10444,55039,TRMT12,tRNA methyltransferase 12 homolog,5,tRNA methyltransferase activity,,ppi
8975,10446,55048,VPS37C,VPS37C; ESCRT-I subunit,37,,,ppi
8976,10447,55049,C19orf60,chromosome 19 open reading frame 60,7,,,ppi
8977,10448,79658,ARHGAP10,Rho GTPase activating protein 10,12,GTPase activator activity,,ppi
8978,10449,1548,CYP2A6,cytochrome P450 family 2 subfamily A member 6,4,coumarin 7-hydroxylase activity|heme binding|arachidonic acid epoxygenase activity|steroid hydroxylase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|brain disease|large intestine cancer|colorectal cancer|hematopoietic system disease|hepatitis B|hepatitis C|lung benign neoplasm|cannabis dependence|cannabis abuse|nasopharynx carcinoma|opisthorchiasis|prostate cancer|prostate carcinoma|stomach cancer|nicotine dependence,ppi
8979,10450,80221,ACSF2,acyl-CoA synthetase family member 2,14,acyl-CoA ligase activity,,ppi
8980,10451,63898,SH2D4A,SH2 domain containing 4A,56,phosphatase binding,,ppi
8981,10452,728621,CCDC30,coiled-coil domain containing 30,1,,,ppi
8982,10453,65265,C8orf33,chromosome 8 open reading frame 33,66,,,ppi
8983,10454,79990,PLEKHH3,pleckstrin homology; MyTH4 and FERM domain containing H3,12,,,ppi
8984,10456,79745,CLIP4,CAP-Gly domain containing linker protein family member 4,29,,,ppi
8985,10457,1549,CYP2A7,cytochrome P450 family 2 subfamily A member 7,2,oxygen binding|heme binding|arachidonic acid epoxygenase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|steroid hydroxylase activity,,ppi
8986,10458,79607,FAM118B,family with sequence similarity 118 member B,43,,,ppi
8987,10459,80167,ABHD18,abhydrolase domain containing 18,15,,,ppi
8988,10460,79680,C22orf29,chromosome 22 open reading frame 29,10,,,ppi
8989,10461,79600,TCTN1,tectonic family member 1,122,,Joubert syndrome,ppi
8990,10462,80153,EDC3,enhancer of mRNA decapping 3,34,phosphodiesterase decapping endonuclease activity|mRNA binding,,ppi
8991,10463,64789,EXO5,exonuclease 5,1,single-stranded DNA 3'-5' exodeoxyribonuclease activity|protein homodimerization activity|single-stranded DNA 5'-3' exodeoxyribonuclease activity|4 iron; 4 sulfur cluster binding,,ppi
8992,10464,79918,SETD6,SET domain containing 6,3,protein-lysine N-methyltransferase activity|NF-kappaB binding,,ppi
8993,10465,79654,HECTD3,HECT domain E3 ubiquitin protein ligase 3,47,ubiquitin-protein transferase activity,,ppi
8994,10466,79884,MAP9,microtubule associated protein 9,7,microtubule binding,,ppi
8995,10467,80143,SIKE1,suppressor of IKBKE 1,37,,,ppi
8996,10468,79863,RBFA,ribosome binding factor A (putative),16,,,ppi
8997,10469,79921,TCEAL4,transcription elongation factor A like 4,25,WW domain binding,,ppi
8998,10470,79668,PARP8,poly(ADP-ribose) polymerase family member 8,2,NAD+ ADP-ribosyltransferase activity,,ppi
8999,10471,64847,SPATA20,spermatogenesis associated 20,38,,,ppi
9000,10472,79794,C12orf49,chromosome 12 open reading frame 49,17,,,ppi
9001,10473,64926,RASAL3,RAS protein activator like 3,3,,,ppi
9002,10474,79908,BTNL8,butyrophilin like 8,42,signaling receptor binding,,ppi
9003,10476,79818,ZNF552,zinc finger protein 552,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9004,10477,64762,GAREM1,GRB2 associated regulator of MAPK1 subtype 1,10,proline-rich region binding,,ppi
9005,10478,79618,HMBOX1,homeobox containing 1,61,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|double-stranded telomeric DNA binding|telomeric DNA binding|sequence-specific DNA binding|telomerase activity,,ppi
9006,10479,80108,ZFP2,ZFP2 zinc finger protein,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9007,10480,64417,TMEM267,transmembrane protein 267,5,,,ppi
9008,10481,84167,C19orf44,chromosome 19 open reading frame 44,6,,,ppi
9009,10482,80194,TMEM134,transmembrane protein 134,3,,,ppi
9010,10483,79728,PALB2,partner and localizer of BRCA2,45,DNA binding,bipolar disorder|breast cancer|Fanconi anemia|pancreatic cancer|schizophrenia|hereditary breast ovarian cancer syndrome,ppi
9011,10485,56912,IFT46,intraflagellar transport 46,22,protein C-terminus binding,,ppi
9012,10486,60509,AGBL5,ATP/GTP binding protein like 5,5,metallocarboxypeptidase activity|tubulin binding,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
9013,10487,64784,CRTC3,CREB regulated transcription coactivator 3,20,cAMP response element binding protein binding,,ppi
9014,10488,65124,SOWAHC,sosondowah ankyrin repeat domain family member C,7,,,ppi
9015,10489,1555,CYP2B6,cytochrome P450 family 2 subfamily B member 6,4,monooxygenase activity|heme binding|steroid hydroxylase activity|arachidonic acid epoxygenase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen,alcohol dependence|alcohol abuse|chronic kidney disease|schizophreniform disorder|schizoaffective disorder|paranoid schizophrenia|delusional disorder|malignant glioma|gliosarcoma|nicotine dependence,ppi
9016,10490,79675,FASTKD1,FAST kinase domains 1,18,RNA binding,,ppi
9017,10491,79657,RPAP3,RNA polymerase II associated protein 3,88,,,ppi
9018,10492,80004,ESRP2,epithelial splicing regulatory protein 2,8,RNA binding|mRNA binding,,ppi
9019,10493,65123,INTS3,integrator complex subunit 3,67,,,ppi
9020,10494,79832,QSER1,glutamine and serine rich 1,18,,,ppi
9021,10495,80304,WDCP,WD repeat and coiled coil containing,47,,,ppi
9022,10496,84173,ELMOD3,ELMO domain containing 3,4,GTPase activator activity,autosomal recessive nonsyndromic deafness 88,ppi
9023,10497,79974,CPED1,cadherin like and PC-esterase domain containing 1,1,,Creutzfeldt-Jakob disease,ppi
9024,10498,79896,THNSL1,threonine synthase like 1,20,,,ppi
9025,10499,79585,CORO7,coronin 7,26,actin binding,,ppi
9026,10500,79912,PYROXD1,pyridine nucleotide-disulphide oxidoreductase domain 1,8,,,ppi
9027,10501,79612,NAA16,N(alpha)-acetyltransferase 16; NatA auxiliary subunit,16,ribosome binding|peptide alpha-N-acetyltransferase activity|acetyltransferase activity,,ppi
9028,10503,64763,ZNF574,zinc finger protein 574,34,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
9029,10504,65084,TMEM135,transmembrane protein 135,1,,intellectual disability|learning disability,ppi
9030,10505,79637,ARMC7,armadillo repeat containing 7,28,,,ppi
9031,10506,80169,CTC1,CST telomere replication complex component 1,13,single-stranded DNA binding|telomeric DNA binding|G-rich strand telomeric DNA binding,brain disease|calcium metabolism disease|nephrocalcinosis|calcinosis|Coats disease|dyskeratosis congenita|gastric antral vascular ectasia,ppi
9032,10507,80111,C3orf36,chromosome 3 open reading frame 36,1,,,ppi
9033,10508,80233,FAAP100,Fanconi anemia core complex associated protein 100,38,,,ppi
9034,10509,80164,PRR36,proline rich 36,2,,,ppi
9035,10510,79701,OGFOD3,2-oxoglutarate and iron dependent oxygenase domain containing 3,12,,,ppi
9036,10512,80346,REEP4,receptor accessory protein 4,22,microtubule binding,,ppi
9037,10513,84179,MFSD7,major facilitator superfamily domain containing 7,1,,,ppi
9038,10514,80206,FHOD3,formin homology 2 domain containing 3,3,,substance abuse|substance-related disorder,ppi
9039,10515,79894,ZNF672,zinc finger protein 672,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9040,10516,64777,RMND5B,required for meiotic nuclear division 5 homolog B,27,ubiquitin-protein transferase activity,,ppi
9041,10517,79709,COLGALT1,collagen beta(1-O)galactosyltransferase 1,25,procollagen galactosyltransferase activity,,ppi
9042,10519,64852,TUT1,terminal uridylyl transferase 1; U6 snRNA-specific,32,RNA binding|mRNA 3'-UTR binding|polynucleotide adenylyltransferase activity|RNA uridylyltransferase activity,,ppi
9043,10520,79879,CCDC134,coiled-coil domain containing 134,4,,liver cancer,ppi
9044,10521,79639,TMEM53,transmembrane protein 53,1,,,ppi
9045,10522,80148,PQLC1,PQ loop repeat containing 1,1,,,ppi
9046,10523,64757,MARC1,mitochondrial amidoxime reducing component 1,19,nitrate reductase activity|molybdenum ion binding|molybdopterin cofactor binding,,ppi
9047,10524,64419,MTMR14,myotubularin related protein 14,50,phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity,centronuclear myopathy|congenital structural myopathy,ppi
9048,10526,79961,DENND2D,DENN domain containing 2D,27,Rab guanyl-nucleotide exchange factor activity,,ppi
9049,10527,79848,CSPP1,centrosome and spindle pole associated protein 1,53,,Joubert syndrome,ppi
9050,10528,79873,NUDT18,nudix hydrolase 18,36,magnesium ion binding|8-oxo-dGDP phosphatase activity|8-oxo-GDP phosphatase activity|8-hydroxy-dADP phosphatase activity,,ppi
9051,10530,79847,MFSD13A,major facilitator superfamily domain containing 13A,4,,,ppi
9052,10532,79568,MAIP1,matrix AAA peptidase interacting protein 1,51,ribosome binding,,ppi
9053,10533,79768,KATNBL1,katanin regulatory subunit B1 like 1,10,,,ppi
9054,10534,134,ADORA1,adenosine A1 receptor,12,,vertebrobasilar insufficiency|transient cerebral ischemia|ischemia|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|schizophrenia|middle cerebral artery infarction,ppi
9055,10535,1562,CYP2C18,cytochrome P450 family 2 subfamily C member 18,10,monooxygenase activity|oxygen binding|heme binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|arachidonic acid epoxygenase activity|steroid hydroxylase activity,prostate cancer|prostate carcinoma|malignant glioma|gliosarcoma,ppi
9056,10536,79991,STN1,STN1; CST complex subunit,59,single-stranded DNA binding|telomeric DNA binding|single-stranded telomeric DNA binding,idiopathic interstitial pneumonia|idiopathic pulmonary fibrosis,ppi
9057,10537,79922,MRM1,mitochondrial rRNA methyltransferase 1,39,RNA binding|rRNA (guanosine-2'-O-)-methyltransferase activity,,ppi
9058,10539,79573,TTC13,tetratricopeptide repeat domain 13,3,,,ppi
9059,10540,63899,NSUN3,NOP2/Sun RNA methyltransferase family member 3,6,tRNA (cytosine-5-)-methyltransferase activity|methyltransferase activity,,ppi
9060,10541,84186,ZCCHC7,zinc finger CCHC-type containing 7,25,RNA binding,,ppi
9061,10542,1557,CYP2C19,cytochrome P450 family 2 subfamily C member 19,2,monooxygenase activity|steroid hydroxylase activity|oxidoreductase activity|oxygen binding|heme binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|arachidonic acid epoxygenase activity,heart disease|cardiovascular system disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|chronic kidney disease|prostate cancer|prostate carcinoma|premature ovarian failure|substance abuse|substance-related disorder,ppi
9062,10543,80162,PGGHG,protein-glucosylgalactosylhydroxylysine glucosidase,1,protein-glucosylgalactosylhydroxylysine glucosidase activity|alpha;alpha-trehalase activity,,ppi
9063,10544,60559,SPCS3,signal peptidase complex subunit 3,12,peptidase activity,,ppi
9064,10546,79887,PLBD1,phospholipase B domain containing 1,14,lysophospholipase activity|phospholipase A2 activity,lung cancer|non-small cell lung carcinoma,ppi
9065,10547,79919,C2orf54,chromosome 2 open reading frame 54,1,,,ppi
9066,10548,84187,TMEM164,transmembrane protein 164,16,,,ppi
9067,10549,80199,FUZ,fuzzy planar cell polarity protein,19,,congenital heart disease,ppi
9068,10550,1558,CYP2C8,cytochrome P450 family 2 subfamily C member 8,15,monooxygenase activity|caffeine oxidase activity|estrogen 16-alpha-hydroxylase activity|arachidonic acid epoxygenase activity|heme binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|steroid hydroxylase activity,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|central nervous system disease|nervous system disease|autonomic neuropathy|pseudosarcomatous fibromatosis|acute lymphocytic leukemia,ppi
9069,10551,80119,PIF1,PIF1 5'-to-3' DNA helicase,2,magnesium ion binding|ATP binding|single-stranded DNA-dependent ATP-dependent DNA helicase activity|ATP-dependent 5'-3' DNA/RNA helicase activity|telomeric DNA binding|ATP-dependent 5'-3' DNA helicase activity,,ppi
9070,10552,79629,OCEL1,occludin/ELL domain containing 1,3,,,ppi
9071,10553,84188,FAR1,fatty acyl-CoA reductase 1,18,oxidoreductase activity|fatty-acyl-CoA reductase (alcohol-forming) activity,,ppi
9072,10554,79736,TEFM,transcription elongation factor; mitochondrial,11,RNA binding|DNA polymerase processivity factor activity|crossover junction endodeoxyribonuclease activity,,ppi
9073,10555,79843,FAM124B,family with sequence similarity 124 member B,29,,,ppi
9074,10556,79958,DENND1C,DENN domain containing 1C,3,Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding|phosphatidylinositol phosphate binding,,ppi
9075,10558,84190,METTL25,methyltransferase like 25,5,,,ppi
9076,10559,1559,CYP2C9,cytochrome P450 family 2 subfamily C member 9,14,monooxygenase activity|drug binding|steroid hydroxylase activity|oxidoreductase activity|caffeine oxidase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|heme binding|arachidonic acid epoxygenase activity,brain cancer|hematopoietic system disease|interstitial nephritis|pyelonephritis|pyelitis|central nervous system disease|nervous system disease|autonomic neuropathy|neurotic disorder|endogenous depression|melancholia|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|major depressive disorder|mental depression,ppi
9077,10560,79853,TM4SF20,transmembrane 4 L six family member 20,12,,,ppi
9078,10561,64859,NABP1,nucleic acid binding protein 1,19,single-stranded DNA binding,acute promyelocytic leukemia,ppi
9079,10562,80258,EFHC2,EF-hand domain containing 2,41,,,ppi
9080,10563,80179,MYO19,myosin XIX,174,actin binding|ATPase activity,,ppi
9081,10564,84191,FAM96A,family with sequence similarity 96 member A,11,,,ppi
9082,10565,79729,SH3D21,SH3 domain containing 21,2,,,ppi
9083,10566,79877,DCAKD,dephospho-CoA kinase domain containing,17,dephospho-CoA kinase activity,,ppi
9084,10567,63932,CXorf56,chromosome X open reading frame 56,12,,,ppi
9085,10569,79739,TTLL7,tubulin tyrosine ligase like 7,7,alpha-tubulin binding|beta-tubulin binding|tubulin-glutamic acid ligase activity,,ppi
9086,10570,79598,CEP97,centrosomal protein 97,56,,,ppi
9087,10571,79740,ZBBX,zinc finger B-box domain containing,25,,,ppi
9088,10572,80122,MAP3K19,mitogen-activated protein kinase kinase kinase 19,1,protein serine/threonine kinase activity,,ppi
9089,10573,1565,CYP2D6,cytochrome P450 family 2 subfamily D member 6,3,monooxygenase activity|drug binding|oxidoreductase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|heme binding|steroid hydroxylase activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|basal ganglia disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression,ppi
9090,10575,79830,ZMYM1,zinc finger MYM-type containing 1,36,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9091,10576,79669,C3orf52,chromosome 3 open reading frame 52,12,,,ppi
9092,10580,80149,ZC3H12A,zinc finger CCCH-type containing 12A,19,DNA binding|chromatin binding|RNA binding|mRNA binding|mRNA 3'-UTR binding|endoribonuclease activity|exoribonuclease activity|ribonuclease activity|miRNA binding|RNA stem-loop binding|mRNA 3'-UTR AU-rich region binding|ribosome binding|thiol-dependent ubiquitin-specific protease activity,peripheral vascular disease,ppi
9093,10582,79782,LRRC31,leucine rich repeat containing 31,1,,,ppi
9094,10583,80185,TTI2,TELO2 interacting protein 2,24,,intellectual disability|learning disability|autosomal recessive non-syndromic intellectual disability,ppi
9095,10584,80020,FOXRED2,FAD dependent oxidoreductase domain containing 2,34,flavin adenine dinucleotide binding,,ppi
9096,10585,79707,NOL9,nucleolar protein 9,42,ATP binding|polynucleotide 5'-hydroxyl-kinase activity,,ppi
9097,10586,79684,MSANTD2,Myb/SANT DNA binding domain containing 2,3,,,ppi
9098,10587,84197,POMK,protein-O-mannose kinase,66,phosphotransferase activity; alcohol group as acceptor|carbohydrate kinase activity,Walker-Warburg syndrome|muscular dystrophy-dystroglycanopathy type B5|muscular dystrophy-dystroglycanopathy,ppi
9099,10588,80021,TMEM62,transmembrane protein 62,12,,,ppi
9100,10590,80131,LRRC8E,leucine rich repeat containing 8 family member E,19,volume-sensitive anion channel activity,,ppi
9101,10591,79724,ZNF768,zinc finger protein 768,23,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding,,ppi
9102,10592,79731,NARS2,asparaginyl-tRNA synthetase 2; mitochondrial (putative),24,asparagine-tRNA ligase activity,Leigh disease|combined oxidative phosphorylation deficiency,ppi
9103,10594,79823,CAMKMT,calmodulin-lysine N-methyltransferase,27,calmodulin-lysine N-methyltransferase activity,intellectual disability|learning disability|developmental coordination disorder|mitochondrial myopathy|mitochondrial metabolism disease|hypotonia-cystinuria syndrome,ppi
9104,10595,79626,TNFAIP8L2,TNF alpha induced protein 8 like 2,4,,,ppi
9105,10596,79763,ISOC2,isochorismatase domain containing 2,27,,arthropathy|arthritis,ppi
9106,10597,79891,ZNF671,zinc finger protein 671,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9107,10599,79780,CCDC82,coiled-coil domain containing 82,17,,,ppi
9108,10600,79949,PLEKHS1,pleckstrin homology domain containing S1,3,,,ppi
9109,10601,79642,ARSJ,arylsulfatase family member J,5,arylsulfatase activity,,ppi
9110,10603,79864,C11orf63,chromosome 11 open reading frame 63,4,,,ppi
9111,10604,79738,BBS10,Bardet-Biedl syndrome 10,25,,Laurence-Moon syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 4|Bardet-Biedl syndrome 5|Bardet-Biedl syndrome 6|Bardet-Biedl syndrome 7|Bardet-Biedl syndrome 8|Bardet-Biedl syndrome 9|Bardet-Biedl syndrome 10|Bardet-Biedl syndrome 11|Bardet-Biedl syndrome 12|Bardet-Biedl syndrome 13|Bardet-Biedl syndrome 14|Bardet-Biedl syndrome 15|Bardet-Biedl syndrome 16|Bardet-Biedl syndrome 17|Bardet-Biedl syndrome 18,ppi
9112,10605,79993,ELOVL7,ELOVL fatty acid elongase 7,3,fatty acid elongase activity,,ppi
9113,10606,79925,SPEF2,sperm flagellar 2,3,,,ppi
9114,10607,79640,C22orf46,chromosome 22 open reading frame 46,5,,,ppi
9115,10608,79839,CCDC102B,coiled-coil domain containing 102B,96,,,ppi
9116,10609,79841,AGBL2,ATP/GTP binding protein like 2,4,metallocarboxypeptidase activity,,ppi
9117,10610,153769,SH3RF2,SH3 domain containing ring finger 2,37,protein phosphatase 1 binding|phosphatase binding|ubiquitin protein ligase activity,,ppi
9118,10611,135,ADORA2A,adenosine A2a receptor,13,G-protein coupled adenosine receptor activity,anxiety disorder|phobic disorder|rheumatoid arthritis|panic disorder|drug psychosis|schizophrenia|epilepsy|visual epilepsy|mood disorder|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
9119,10612,152816,C4orf26,chromosome 4 open reading frame 26,38,,,ppi
9120,10613,91694,LONRF1,LON peptidase N-terminal domain and ring finger 1,45,ubiquitin-protein transferase activity,,ppi
9121,10614,92370,PXYLP1,2-phosphoxylose phosphatase 1,8,phosphatase activity,,ppi
9122,10615,199704,ZNF585A,zinc finger protein 585A,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
9123,10616,157769,FAM91A1,family with sequence similarity 91 member A1,22,,,ppi
9124,10617,284004,HEXDC,hexosaminidase D,12,hexosaminidase activity,,ppi
9125,10619,118881,COMTD1,catechol-O-methyltransferase domain containing 1,61,S-adenosylmethionine-dependent methyltransferase activity,,ppi
9126,10620,1571,CYP2E1,cytochrome P450 family 2 subfamily E member 1,17,monooxygenase activity|oxidoreductase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen|oxygen binding|heme binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|arachidonic acid epoxygenase activity|steroid hydroxylase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|alcohol dependence|alcohol abuse|lung cancer|non-small cell lung carcinoma|fatty liver disease|alcoholic liver cirrhosis|liver cancer|lung benign neoplasm|Langerhans-cell histiocytosis|lymphosarcoma|lymphoma|reticulosarcoma|non-Hodgkin lymphoma|B-cell lymphoma|obesity,ppi
9127,10621,151050,KANSL1L,KAT8 regulatory NSL complex subunit 1 like,1,histone acetyltransferase activity (H4-K16 specific)|histone acetyltransferase activity (H4-K8 specific)|histone acetyltransferase activity (H4-K5 specific)|histone acetyltransferase binding,,ppi
9128,10622,200172,SLFNL1,schlafen like 1,1,,,ppi
9129,10623,338707,B4GALNT4,beta-1;4-N-acetyl-galactosaminyltransferase 4,5,acetylgalactosaminyltransferase activity,,ppi
9130,10625,196294,IMMP1L,inner mitochondrial membrane peptidase subunit 1,3,,,ppi
9131,10626,149840,C20orf196,chromosome 20 open reading frame 196,2,,,ppi
9132,10627,148304,C1orf74,chromosome 1 open reading frame 74,1,,,ppi
9133,10629,142891,SAMD8,sterile alpha motif domain containing 8,2,ceramide phosphoethanolamine synthase activity|sphingomyelin synthase activity|ceramide cholinephosphotransferase activity,,ppi
9134,10630,151516,ASPRV1,aspartic peptidase; retroviral-like 1,14,aspartic-type endopeptidase activity,,ppi
9135,10631,148741,ANKRD35,ankyrin repeat domain 35,4,,,ppi
9136,10632,130813,C2orf50,chromosome 2 open reading frame 50,2,,,ppi
9137,10635,120406,NXPE2,neurexophilin and PC-esterase domain family member 2,3,,,ppi
9138,10636,151126,ZNF385B,zinc finger protein 385B,2,,,ppi
9139,10637,153443,SRFBP1,serum response factor binding protein 1,9,RNA binding,,ppi
9140,10638,153643,FAM81B,family with sequence similarity 81 member B,4,,,ppi
9141,10641,90853,SPOCD1,SPOC domain containing 1,2,,,ppi
9142,10642,1573,CYP2J2,cytochrome P450 family 2 subfamily J member 2,3,monooxygenase activity|arachidonic acid epoxygenase activity|arachidonic acid 14;15-epoxygenase activity|arachidonic acid 11;12-epoxygenase activity|linoleic acid epoxygenase activity|heme binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen|steroid hydroxylase activity,,ppi
9143,10643,118663,BTBD16,BTB domain containing 16,1,,,ppi
9144,10644,200523,TEX37,testis expressed 37,6,,,ppi
9145,10646,159989,DEUP1,deuterosome assembly protein 1,53,,,ppi
9146,10647,157773,C8orf48,chromosome 8 open reading frame 48,4,,,ppi
9147,10649,728689,EIF3CL,eukaryotic translation initiation factor 3 subunit C-like,36,translation initiation factor activity|translation initiation factor binding,,ppi
9148,10650,124404,SEPT12,septin 12,22,GTP binding|GDP binding|phosphatidylinositol binding|protein homodimerization activity|protein-containing complex scaffold activity|GTPase activity,azoospermia,ppi
9149,10652,150709,ANKAR,ankyrin and armadillo repeat containing,1,,,ppi
9150,10653,220042,DDIAS,DNA damage induced apoptosis suppressor,13,,,ppi
9151,10655,202151,RANBP3L,RAN binding protein 3 like,3,Ran GTPase binding|GTPase activator activity,,ppi
9152,10656,127733,UBXN10,UBX domain protein 10,39,,,ppi
9153,10657,153657,TTC23L,tetratricopeptide repeat domain 23 like,8,protein binding,,ppi
9154,10658,254158,CXorf58,chromosome X open reading frame 58,1,,,ppi
9155,10659,152206,CCDC13,coiled-coil domain containing 13,15,,,ppi
9156,10660,137902,PXDNL,peroxidasin like,7,peroxidase activity|heme binding,,ppi
9157,10661,219287,AMER2,APC membrane recruitment protein 2,1,phosphatidylinositol-4;5-bisphosphate binding|beta-catenin binding,,ppi
9158,10662,220296,HEPACAM,hepatic and glial cell adhesion molecule,1,,macrocephaly-autism syndrome,ppi
9159,10663,124930,ANKRD13B,ankyrin repeat domain 13B,7,,,ppi
9160,10664,148109,FAM187B,family with sequence similarity 187 member B,13,,,ppi
9161,10667,1576,CYP3A4,cytochrome P450 family 3 subfamily A member 4,13,monooxygenase activity|steroid binding|iron ion binding|steroid hydroxylase activity|oxidoreductase activity|oxygen binding|vitamin D3 25-hydroxylase activity|caffeine oxidase activity|testosterone 6-beta-hydroxylase activity|vitamin D 24-hydroxylase activity|estrogen 16-alpha-hydroxylase activity,hepatitis C|osteosarcoma|bone osteosarcoma|prostate cancer|prostate carcinoma|schizophrenia|mental depression|breast cancer,ppi
9162,10668,158506,ZNF645,zinc finger protein 645,6,ubiquitin protein ligase activity,,ppi
9163,10669,158521,FMR1NB,fragile X mental retardation 1 neighbor,9,,,ppi
9164,10670,283659,PRTG,protogenin,3,,,ppi
9165,10671,339965,CCDC158,coiled-coil domain containing 158,12,,,ppi
9166,10673,205860,TRIML2,tripartite motif family like 2,15,,,ppi
9167,10674,146779,EFCAB3,EF-hand calcium binding domain 3,1,,,ppi
9168,10675,1577,CYP3A5,cytochrome P450 family 3 subfamily A member 5,8,monooxygenase activity|oxidoreductase activity|oxygen binding|estrogen 16-alpha-hydroxylase activity,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|prostate cancer|prostate carcinoma|schizophrenia|hypertension|essential hypertension|toxic encephalopathy,ppi
9169,10676,164781,DAW1,dynein assembly factor with WD repeats 1,4,,,ppi
9170,10677,285313,IGSF10,immunoglobulin superfamily member 10,1,,,ppi
9171,10678,283579,C14orf178,chromosome 14 open reading frame 178,1,,,ppi
9172,10679,124222,PAQR4,progestin and adipoQ receptor family member 4,1,signaling receptor activity,,ppi
9173,10680,122060,SLAIN1,SLAIN motif family member 1,10,,,ppi
9174,10681,158763,ARHGAP36,Rho GTPase activating protein 36,14,GTPase activator activity,,ppi
9175,10682,130827,TMEM182,transmembrane protein 182,2,,,ppi
9176,10684,148014,TTC9B,tetratricopeptide repeat domain 9B,5,,neurotic disorder|postpartum depression,ppi
9177,10685,284348,LYPD5,LY6/PLAUR domain containing 5,1,laminin binding,,ppi
9178,10686,150209,AIFM3,apoptosis inducing factor; mitochondria associated 3,9,,,ppi
9179,10687,136,ADORA2B,adenosine A2b receptor,7,,,ppi
9180,10688,1551,CYP3A7,cytochrome P450 family 3 subfamily A member 7,1,monooxygenase activity|steroid hydroxylase activity|oxygen binding|estrogen 16-alpha-hydroxylase activity,,ppi
9181,10689,113802,HENMT1,HEN1 methyltransferase homolog 1,9,O-methyltransferase activity|RNA methyltransferase activity,,ppi
9182,10690,153562,MARVELD2,MARVEL domain containing 2,17,,autosomal recessive nonsyndromic deafness 49,ppi
9183,10691,130132,RFTN2,raftlin family member 2,7,,,ppi
9184,10692,133686,NADK2,NAD kinase 2; mitochondrial,18,NAD+ kinase activity|protein homodimerization activity,,ppi
9185,10693,132320,SCLT1,sodium channel and clathrin linker 1,152,,,ppi
9186,10694,124801,LSM12,LSM12 homolog,38,,,ppi
9187,10695,148103,ZNF599,zinc finger protein 599,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9188,10696,157753,TMEM74,transmembrane protein 74,1,,,ppi
9189,10697,10858,CYP46A1,cytochrome P450 family 46 subfamily A member 1,3,steroid hydroxylase activity|heme binding|cholesterol 24-hydroxylase activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
9190,10698,139324,HDX,highly divergent homeobox,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9191,10699,220108,FAM124A,family with sequence similarity 124 member A,28,,,ppi
9192,10700,148268,ZNF570,zinc finger protein 570,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9193,10701,151473,SLC16A14,solute carrier family 16 member 14,3,monocarboxylic acid transmembrane transporter activity,,ppi
9194,10702,132332,TMEM155,transmembrane protein 155,2,,,ppi
9195,10703,1579,CYP4A11,cytochrome P450 family 4 subfamily A member 11,4,monooxygenase activity|arachidonic acid epoxygenase activity|alkane 1-monooxygenase activity|leukotriene-B4 20-monooxygenase activity,,ppi
9196,10704,126231,ZNF573,zinc finger protein 573,3,,,ppi
9197,10705,147948,ZNF582,zinc finger protein 582,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9198,10706,148156,ZNF558,zinc finger protein 558,9,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9199,10707,254122,SNX32,sorting nexin 32,10,,,ppi
9200,10708,150737,TTC30B,tetratricopeptide repeat domain 30B,46,,,ppi
9201,10710,199990,FAAP20,Fanconi anemia core complex associated protein 20,19,polyubiquitin modification-dependent protein binding|K63-linked polyubiquitin modification-dependent protein binding|ubiquitin-dependent protein binding,,ppi
9202,10711,91351,DDX60L,DEAD-box helicase 60-like,4,,,ppi
9203,10712,121457,IKBIP,IKBKB interacting protein,68,,,ppi
9204,10715,153527,ZMAT2,zinc finger matrin-type 2,42,,,ppi
9205,10716,285315,C3orf33,chromosome 3 open reading frame 33,9,,,ppi
9206,10717,123811,FOPNL,FGFR1OP N-terminal like,14,,,ppi
9207,10719,203062,TSNARE1,t-SNARE domain containing 1,4,SNARE binding|SNAP receptor activity,schizophrenia,ppi
9208,10720,120939,TMEM52B,transmembrane protein 52B,34,,,ppi
9209,10722,1580,CYP4B1,cytochrome P450 family 4 subfamily B member 1,2,monooxygenase activity|oxygen binding,urinary bladder cancer,ppi
9210,10723,158584,FAAH2,fatty acid amide hydrolase 2,1,fatty acid amide hydrolase activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
9211,10725,131870,NUDT16,nudix hydrolase 16,9,magnesium ion binding|mRNA binding|GTP binding|metalloexopeptidase activity|manganese ion binding|snoRNA binding|dITP diphosphatase activity|protein homodimerization activity|m7G(5')pppN diphosphatase activity|cobalt ion binding|dIDP diphosphatase activity|nucleotide phosphatase activity; acting on free nucleotides|XTP binding|ITP binding|IDP phosphatase activity,,ppi
9212,10726,131669,UROC1,urocanate hydratase 1,1,urocanate hydratase activity,intellectual disability|learning disability,ppi
9213,10727,130535,KCTD18,potassium channel tetramerization domain containing 18,5,,,ppi
9214,10728,147660,ZNF578,zinc finger protein 578,6,,,ppi
9215,10729,8529,CYP4F2,cytochrome P450 family 4 subfamily F member 2,8,monooxygenase activity|arachidonic acid epoxygenase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen|alkane 1-monooxygenase activity|leukotriene-B4 20-monooxygenase activity|arachidonic acid omega-hydroxylase activity|alpha-tocopherol omega-hydroxylase activity|tocotrienol omega-hydroxylase activity|20-hydroxy-leukotriene B4 omega oxidase activity|20-aldehyde-leukotriene B4 20-monooxygenase activity,,ppi
9216,10730,149175,MANEAL,mannosidase endo-alpha like,19,alpha-mannosidase activity,,ppi
9217,10731,130162,CLHC1,clathrin heavy chain linker domain containing 1,3,identical protein binding|clathrin light chain binding,,ppi
9218,10732,158234,TRMT10B,tRNA methyltransferase 10B,32,tRNA (guanine-N1-)-methyltransferase activity|tRNA binding,,ppi
9219,10735,146705,TEPSIN,TEPSIN; adaptor related protein complex 4 accessory protein,29,,,ppi
9220,10738,152789,JAKMIP1,janus kinase and microtubule interacting protein 1,7,RNA binding|GABA receptor binding,autistic disorder,ppi
9221,10739,257068,PLCXD2,phosphatidylinositol specific phospholipase C X domain containing 2,1,,,ppi
9222,10740,124045,SPATA33,spermatogenesis associated 33,1,,,ppi
9223,10741,158158,RASEF,RAS and EF-hand domain containing,2,GTP binding|GDP binding|identical protein binding,,ppi
9224,10742,253943,YTHDF3,YTH N6-methyladenosine RNA binding protein 3,19,RNA binding|ribosome binding|N6-methyladenosine-containing RNA binding,,ppi
9225,10743,152756,FAM218A,family with sequence similarity 218 member A,1,,,ppi
9226,10744,131474,CHCHD4,coiled-coil-helix-coiled-coil-helix domain containing 4,27,protein disulfide oxidoreductase activity,,ppi
9227,10745,196740,VSTM4,V-set and transmembrane domain containing 4,1,,,ppi
9228,10746,124808,CCDC43,coiled-coil domain containing 43,9,,,ppi
9229,10747,154743,BMT2,base methyltransferase of 25S rRNA 2 homolog,19,S-adenosyl-L-methionine binding|rRNA (adenine) methyltransferase activity,,ppi
9230,10748,148534,TMEM56,transmembrane protein 56,12,,,ppi
9231,10749,160857,CCDC122,coiled-coil domain containing 122,4,,,ppi
9232,10750,197320,ZNF778,zinc finger protein 778,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9233,10751,11283,CYP4F8,cytochrome P450 family 4 subfamily F member 8,2,monooxygenase activity|alkane 1-monooxygenase activity,,ppi
9234,10753,144423,GLT1D1,glycosyltransferase 1 domain containing 1,3,,,ppi
9235,10755,149465,CFAP57,cilia and flagella associated protein 57,2,,,ppi
9236,10756,163882,CNST,consortin; connexin sorting protein,13,phosphatase binding|connexin binding,goiter|thyroid gland disease,ppi
9237,10757,220001,VWCE,von Willebrand factor C and EGF domains,57,,,ppi
9238,10760,1595,CYP51A1,cytochrome P450 family 51 subfamily A member 1,23,sterol 14-demethylase activity|heme binding,,ppi
9239,10761,127428,TCEANC2,transcription elongation factor A N-terminal and central domain containing 2,23,,,ppi
9240,10762,121506,ERP27,endoplasmic reticulum protein 27,6,peptidyl-proline 4-dioxygenase activity|protein disulfide isomerase activity,,ppi
9241,10763,146540,ZNF785,zinc finger protein 785,73,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9242,10764,130557,ZNF513,zinc finger protein 513,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription regulatory region DNA binding,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|retinitis pigmentosa 58,ppi
9243,10766,150962,PUS10,pseudouridylate synthase 10,1,pseudouridine synthase activity,,ppi
9244,10767,132160,PPM1M,protein phosphatase; Mg2+/Mn2+ dependent 1M,7,RNA polymerase II CTD heptapeptide repeat phosphatase activity|manganese ion binding,,ppi
9245,10768,90527,DUOXA1,dual oxidase maturation factor 1,1,,,ppi
9246,10769,143884,CWF19L2,CWF19-like 2; cell cycle control (S. pombe),48,,,ppi
9247,10770,144717,FAM109A,family with sequence similarity 109 member A,7,,bipolar disorder,ppi
9248,10772,137695,TMEM68,transmembrane protein 68,9,,,ppi
9249,10773,126393,HSPB6,heat shock protein family B (small) member 6,10,protein homodimerization activity|unfolded protein binding,heart disease|cardiovascular system disease,ppi
9250,10774,148362,BROX,BRO1 domain and CAAX motif containing,9,,,ppi
9251,10775,286053,NSMCE2,NSE2/MMS21 homolog; SMC5-SMC6 complex SUMO ligase,27,SUMO transferase activity,,ppi
9252,10776,151278,CCDC140,coiled-coil domain containing 140,2,,,ppi
9253,10777,93058,COQ10A,coenzyme Q10A,3,ubiquinone binding,,ppi
9254,10778,124637,CYB5D1,cytochrome b5 domain containing 1,1,,,ppi
9255,10779,144577,C12orf66,chromosome 12 open reading frame 66,4,,polycystic ovary syndrome,ppi
9256,10780,148811,PM20D1,peptidase M20 domain containing 1,2,,,ppi
9257,10781,9420,CYP7B1,cytochrome P450 family 7 subfamily B member 1,2,oxysterol 7-alpha-hydroxylase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|obstructive jaundice|biliary tract disease|blood coagulation disease|cholestasis|intrahepatic cholestasis|autosomal recessive polycystic kidney disease|fatty liver disease|hemorrhagic disease|lipid metabolism disorder|liver cirrhosis|gallbladder disease|liver disease|optic atrophy|paraplegia|prostate cancer,ppi
9258,10782,147872,CCDC155,coiled-coil domain containing 155,70,,,ppi
9259,10783,125336,LOXHD1,lipoxygenase homology domains 1,2,,autosomal recessive nonsyndromic deafness 77,ppi
9260,10784,283254,HARBI1,harbinger transposase derived 1,1,,,ppi
9261,10785,220081,ERICH6B,glutamate rich 6B,1,,,ppi
9262,10786,123775,C16orf46,chromosome 16 open reading frame 46,1,,,ppi
9263,10787,158067,AK8,adenylate kinase 8,10,adenylate kinase activity|cytidylate kinase activity|nucleoside diphosphate kinase activity|nucleoside kinase activity,,ppi
9264,10789,146849,CCDC42,coiled-coil domain containing 42,4,,,ppi
9265,10790,1582,CYP8B1,cytochrome P450 family 8 subfamily B member 1,5,oxygen binding|7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity|sterol 12-alpha-hydroxylase activity|heme binding,cholestasis,ppi
9266,10791,220136,CFAP53,cilia and flagella associated protein 53,9,,,ppi
9267,10792,165055,CCDC138,coiled-coil domain containing 138,39,,,ppi
9268,10793,144132,DNHD1,dynein heavy chain domain 1,6,dynein intermediate chain binding|dynein light chain binding|dynein light intermediate chain binding|ATP-dependent microtubule motor activity; minus-end-directed,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
9269,10794,79741,CCDC7,coiled-coil domain containing 7,4,,,ppi
9270,10797,158787,RIBC1,RIB43A domain with coiled-coils 1,22,,,ppi
9271,10799,149095,DCST1,DC-STAMP domain containing 1,2,ubiquitin protein ligase activity,,ppi
9272,10800,3491,CYR61,cysteine rich angiogenic inducer 61,13,heparin binding|integrin binding,rheumatoid arthritis|liver cancer|hepatocellular carcinoma,ppi
9273,10802,143098,MPP7,membrane palmitoylated protein 7,11,protein-containing complex scaffold activity|signaling adaptor activity|cadherin binding|protein heterodimerization activity,substance abuse|substance-related disorder,ppi
9274,10804,143872,ARHGAP42,Rho GTPase activating protein 42,5,GTPase activator activity,,ppi
9275,10805,148870,CCDC27,coiled-coil domain containing 27,6,,,ppi
9276,10808,199221,DZIP1L,DAZ interacting zinc finger protein 1 like,4,,,ppi
9277,10809,80125,CCDC33,coiled-coil domain containing 33,101,,,ppi
9278,10811,146279,TEKT5,tektin 5,2,,schizophrenia,ppi
9279,10812,254187,TSGA10IP,testis specific 10 interacting protein,16,,,ppi
9280,10813,149499,LRRC71,leucine rich repeat containing 71,1,,,ppi
9281,10814,219844,HYLS1,HYLS1; centriolar and ciliogenesis associated,4,,Joubert syndrome|hydrolethalus syndrome,ppi
9282,10815,118813,ZFYVE27,zinc finger FYVE-type containing 27,27,protein self-association,hereditary spastic paraplegia 33,ppi
9283,10816,93233,CCDC114,coiled-coil domain containing 114,8,,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1,ppi
9284,10818,127579,DCST2,DC-STAMP domain containing 2,1,,,ppi
9285,10819,118611,C10orf90,chromosome 10 open reading frame 90,4,histone deacetylase binding|alpha-actinin binding,,ppi
9286,10820,126859,AXDND1,axonemal dynein light chain domain containing 1,1,,,ppi
9287,10821,121355,GTSF1,gametocyte specific factor 1,3,,,ppi
9288,10822,151393,RMDN2,regulator of microtubule dynamics 2,8,,,ppi
9289,10826,146434,ZNF597,zinc finger protein 597,10,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
9290,10827,149483,CCDC17,coiled-coil domain containing 17,4,,,ppi
9291,10828,201973,PRIMPOL,primase and DNA directed polymerase,14,chromatin binding|DNA-directed DNA polymerase activity|DNA primase activity|manganese ion binding,myopia,ppi
9292,10829,339855,KY,kyphoscoliosis peptidase,1,,,ppi
9293,10830,162461,TMEM92,transmembrane protein 92,14,,,ppi
9294,10831,285175,UNC80,unc-80 homolog; NALCN activator,8,,,ppi
9295,10833,285093,RTP5,receptor transporter protein 5 (putative),27,olfactory receptor binding,,ppi
9296,10834,151790,WDR49,WD repeat domain 49,1,,,ppi
9297,10836,285368,PRRT3,proline rich transmembrane protein 3,2,,,ppi
9298,10837,284805,C20orf203,chromosome 20 open reading frame 203,2,,,ppi
9299,10838,285489,DOK7,docking protein 7,7,protein kinase binding,congenital myasthenic syndrome,ppi
9300,10839,125488,TTC39C,tetratricopeptide repeat domain 39C,6,,,ppi
9301,10840,283212,KLHL35,kelch like family member 35,6,,,ppi
9302,10841,150275,CCDC117,coiled-coil domain containing 117,11,,,ppi
9303,10842,124997,WDR81,WD repeat domain 81,16,phosphatidylinositol 3-kinase regulator activity|K63-linked polyubiquitin modification-dependent protein binding,cerebellar ataxia; mental retardation and dysequlibrium syndrome,ppi
9304,10843,128272,ARHGEF19,Rho guanine nucleotide exchange factor 19,4,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
9305,10844,196074,METTL15,methyltransferase like 15,20,rRNA (cytosine-N4-)-methyltransferase activity,,ppi
9306,10845,159371,SLC35G1,solute carrier family 35 member G1,1,,,ppi
9307,10846,1600,DAB1,DAB1; reelin adaptor protein,80,,autistic disorder,ppi
9308,10848,283373,ANKRD52,ankyrin repeat domain 52,32,,,ppi
9309,10849,347862,PDDC1,Parkinson disease 7 domain containing 1,44,,,ppi
9310,10850,197259,MLKL,mixed lineage kinase domain like pseudokinase,17,ATP binding|protein-containing complex binding|protein kinase activity|protein serine/threonine kinase activity|JUN kinase kinase kinase activity,,ppi
9311,10852,285464,CRIPAK,cysteine rich PAK1 inhibitor,6,,,ppi
9312,10853,1601,DAB2,DAB2; clathrin adaptor protein,92,clathrin adaptor activity|cargo receptor activity|SMAD binding,,ppi
9313,10854,200162,SPAG17,sperm associated antigen 17,1,,,ppi
9314,10855,200728,TMEM17,transmembrane protein 17,401,,Joubert syndrome with orofaciodigital defect,ppi
9315,10856,126695,KDF1,keratinocyte differentiation factor 1,1,,,ppi
9316,10857,133688,UGT3A1,UDP glycosyltransferase family 3 member A1,1,UDP-glycosyltransferase activity|glucuronosyltransferase activity,,ppi
9317,10858,115196,ZNF554,zinc finger protein 554,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9318,10859,1602,DACH1,dachshund family transcription factor 1,33,proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,,ppi
9319,10860,256051,ZNF549,zinc finger protein 549,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9320,10861,91607,SLFN11,schlafen family member 11,17,tRNA binding|ATPase activity,,ppi
9321,10862,257240,KLHL34,kelch like family member 34,13,,,ppi
9322,10863,201627,DENND6A,DENN domain containing 6A,14,Rab guanyl-nucleotide exchange factor activity,,ppi
9323,10864,253461,ZBTB38,zinc finger and BTB domain containing 38,49,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|methyl-CpG binding|protein homodimerization activity|DNA binding,,ppi
9324,10865,126074,SWSAP1,SWIM-type zinc finger 7 associated protein 1,10,single-stranded DNA binding|ATPase activity,,ppi
9325,10866,152002,XXYLT1,xyloside xylosyltransferase 1,9,magnesium ion binding|manganese ion binding|UDP-xylosyltransferase activity,,ppi
9326,10867,1603,DAD1,defender against cell death 1,23,oligosaccharyl transferase activity|dolichyl-diphosphooligosaccharide-protein glycotransferase activity,,ppi
9327,10868,284131,ENDOV,endonuclease V,12,magnesium ion binding|DNA binding|single-stranded RNA binding|endodeoxyribonuclease activity; producing 5'-phosphomonoesters|endoribonuclease activity; producing 5'-phosphomonoesters,,ppi
9328,10869,284297,SSC5D,scavenger receptor cysteine rich family member with 5 domains,10,fibronectin binding|scavenger receptor activity|laminin binding|extracellular matrix binding,,ppi
9329,10870,163859,SDE2,SDE2 telomere maintenance homolog,8,,,ppi
9330,10871,163033,ZNF579,zinc finger protein 579,35,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding,,ppi
9331,10872,166379,BBS12,Bardet-Biedl syndrome 12,9,,Laurence-Moon syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 4|Bardet-Biedl syndrome 5|Bardet-Biedl syndrome 6|Bardet-Biedl syndrome 7|Bardet-Biedl syndrome 8|Bardet-Biedl syndrome 9|Bardet-Biedl syndrome 10|Bardet-Biedl syndrome 11|Bardet-Biedl syndrome 12|Bardet-Biedl syndrome 13|Bardet-Biedl syndrome 14|Bardet-Biedl syndrome 15|Bardet-Biedl syndrome 16|Bardet-Biedl syndrome 17|Bardet-Biedl syndrome 18,ppi
9332,10873,283897,C16orf54,chromosome 16 open reading frame 54,3,,,ppi
9333,10874,1604,CD55,CD55 molecule (Cromer blood group),29,virus receptor activity|lipid binding,endometriosis of uterus|endometriosis,ppi
9334,10875,152992,TRMT44,tRNA methyltransferase 44 homolog (S. cerevisiae),15,tRNA (uracil) methyltransferase activity,,ppi
9335,10876,164127,CCDC185,coiled-coil domain containing 185,12,,,ppi
9336,10877,162333,MARCH10,membrane associated ring-CH-type finger 10,7,protein binding,,ppi
9337,10879,138009,DCAF4L2,DDB1 and CUL4 associated factor 4 like 2,7,,,ppi
9338,10880,134359,POC5,POC5 centriolar protein,77,,,ppi
9339,10881,170062,FAM47B,family with sequence similarity 47 member B,2,,,ppi
9340,10882,1605,DAG1,dystroglycan 1,56,actin binding|structural constituent of muscle|tubulin binding|SH2 domain binding|laminin-1 binding|alpha-actinin binding,hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|buphthalmos|hydrophthalmos|Lassa fever|leukodystrophy|intellectual disability|learning disability|microphthalmia|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E,ppi
9341,10883,165918,RNF168,ring finger protein 168,47,chromatin binding|ubiquitin-protein transferase activity|nucleosome binding|histone binding|ubiquitin binding|K63-linked polyubiquitin modification-dependent protein binding,,ppi
9342,10885,284076,TTLL6,tubulin tyrosine ligase like 6,4,tubulin binding|protein-glutamic acid ligase activity|tubulin-glutamic acid ligase activity,,ppi
9343,10886,160419,C12orf50,chromosome 12 open reading frame 50,2,mRNA binding,,ppi
9344,10887,256364,EML3,echinoderm microtubule associated protein like 3,9,microtubule binding,,ppi
9345,10890,284071,MEIOC,meiosis specific with coiled-coil domain,3,,,ppi
9346,10891,286234,SPATA31E1,SPATA31 subfamily E member 1,1,,,ppi
9347,10892,146050,ZSCAN29,zinc finger and SCAN domain containing 29,12,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9348,10895,159686,CFAP58,cilia and flagella associated protein 58,7,,,ppi
9349,10896,91133,L3MBTL4,l(3)mbt-like 4 (Drosophila),10,,,ppi
9350,10897,166968,MIER3,MIER family member 3,7,DNA-binding transcription factor activity; RNA polymerase II-specific|histone deacetylase activity|transcription corepressor activity|obsolete transcription factor activity; transcription factor binding|RNA polymerase II repressing transcription factor binding|histone deacetylase binding,,ppi
9351,10898,127294,MYOM3,myomesin 3,3,protein homodimerization activity|structural constituent of muscle|actin filament binding|muscle alpha-actinin binding,,ppi
9352,10899,160492,LMNTD1,lamin tail domain containing 1,2,,lung benign neoplasm,ppi
9353,10900,80217,CFAP43,cilia and flagella associated protein 43,1,,,ppi
9354,10901,168455,CCDC71L,coiled-coil domain containing 71-like,5,,,ppi
9355,10903,162963,ZNF610,zinc finger protein 610,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9356,10904,164592,CCDC116,coiled-coil domain containing 116,13,,,ppi
9357,10905,284358,MAMSTR,MEF2 activating motif and SAP domain containing transcriptional regulator,1,RNA polymerase II transcription factor binding,,ppi
9358,10906,153241,CEP120,centrosomal protein 120,96,,asphyxiating thoracic dystrophy 1|short-rib thoracic dysplasia 13 with or without polydactyly,ppi
9359,10907,254173,TTLL10,tubulin tyrosine ligase like 10,11,protein-glycine ligase activity,,ppi
9360,10908,283685,GOLGA6L2,golgin A6 family-like 2,2,,,ppi
9361,10909,151525,WDSUB1,WD repeat; sterile alpha motif and U-box domain containing 1,1,,,ppi
9362,10910,339976,TRIML1,tripartite motif family like 1,4,,,ppi
9363,10911,219990,OOSP2,oocyte secreted protein 2,1,,,ppi
9364,10913,163183,SYNE4,spectrin repeat containing nuclear envelope family member 4,90,,,ppi
9365,10915,125115,KRT40,keratin 40,297,,,ppi
9366,10916,286464,CFAP47,cilia and flagella associated protein 47,2,,,ppi
9367,10917,286205,SCAI,suppressor of cancer cell invasion,11,transcription corepressor activity,,ppi
9368,10918,1610,DAO,D-amino acid oxidase,8,D-amino-acid oxidase activity|protein dimerization activity|cofactor binding|FAD binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|muscular atrophy|neurodegenerative disease|mood disorder,ppi
9369,10919,148223,C19orf25,chromosome 19 open reading frame 25,29,,,ppi
9370,10920,134265,AFAP1L1,actin filament associated protein 1 like 1,2,,,ppi
9371,10922,285672,SREK1IP1,SREK1 interacting protein 1,27,,,ppi
9372,10923,348487,FAM131C,family with sequence similarity 131 member C,10,,,ppi
9373,10924,255252,LRRC57,leucine rich repeat containing 57,7,,,ppi
9374,10925,1611,DAP,death associated protein,5,death domain binding,inflammatory bowel disease|ulcerative colitis,ppi
9375,10927,219988,PATL1,PAT1 homolog 1; processing body mRNA decay factor,28,RNA binding|poly(U) RNA binding|poly(G) binding,,ppi
9376,10928,284114,TMEM102,transmembrane protein 102,7,,,ppi
9377,10929,126526,C19orf47,chromosome 19 open reading frame 47,12,,,ppi
9378,10930,203286,ANKS6,ankyrin repeat and sterile alpha motif domain containing 6,14,,liver cirrhosis|tuberous sclerosis|Marfan syndrome|situs inversus|polycystic kidney disease 1|cystic kidney disease|autosomal dominant polycystic kidney disease|nephronophthisis,ppi
9379,10931,57604,KIAA1456,KIAA1456,4,tRNA methyltransferase activity|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors|tRNA binding|tRNA (uracil) methyltransferase activity,,ppi
9380,10932,147929,ZNF565,zinc finger protein 565,1,DNA-binding transcription factor activity; RNA polymerase II-specific,schizophrenia,ppi
9381,10933,151176,ERFE,erythroferrone,3,hormone activity,,ppi
9382,10935,7818,DAP3,death associated protein 3,99,RNA binding|structural constituent of ribosome,breast cancer,ppi
9383,10936,148345,C1orf127,chromosome 1 open reading frame 127,2,,,ppi
9384,10938,143279,HECTD2,HECT domain E3 ubiquitin protein ligase 2,4,ubiquitin-protein transferase activity,,ppi
9385,10939,1612,DAPK1,death associated protein kinase 1,57,protein kinase activity|protein serine/threonine kinase activity|calmodulin-dependent protein kinase activity|calmodulin binding|ATP binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|brain cancer|lung cancer|non-small cell lung carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|transitional cell carcinoma|pinguecula|conjunctival disease|salivary gland adenoid cystic carcinoma|acute myeloid leukemia,ppi
9386,10940,129804,FBLN7,fibulin 7,6,,,ppi
9387,10941,283848,CES4A,carboxylesterase 4A,1,carboxylic ester hydrolase activity|sterol esterase activity|triglyceride lipase activity,,ppi
9388,10942,339983,NAT8L,N-acetyltransferase 8 like,4,aspartate N-acetyltransferase activity,,ppi
9389,10943,163115,ZNF781,zinc finger protein 781,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9390,10944,134553,C5orf24,chromosome 5 open reading frame 24,23,,,ppi
9391,10945,286499,FAM133A,family with sequence similarity 133 member A,8,,,ppi
9392,10946,23604,DAPK2,death associated protein kinase 2,10,protein serine/threonine kinase activity|calmodulin binding|ATP binding,,ppi
9393,10948,338699,ANKRD42,ankyrin repeat domain 42,2,,,ppi
9394,10949,129450,TYW5,tRNA-yW synthesizing protein 5,10,tRNA binding|iron ion binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors|protein homodimerization activity,,ppi
9395,10950,284486,THEM5,thioesterase superfamily member 5,2,palmitoyl-CoA hydrolase activity|acyl-CoA hydrolase activity,,ppi
9396,10951,253558,LCLAT1,lysocardiolipin acyltransferase 1,27,1-acylglycerol-3-phosphate O-acyltransferase activity|O-acyltransferase activity|transferase activity; transferring acyl groups,,ppi
9397,10952,283234,CCDC88B,coiled-coil domain containing 88B,5,microtubule binding|dynein light intermediate chain binding,leprosy,ppi
9398,10953,137209,ZNF572,zinc finger protein 572,29,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
9399,10954,255919,CNEP1R1,CTD nuclear envelope phosphatase 1 regulatory subunit 1,3,,,ppi
9400,10955,1613,DAPK3,death associated protein kinase 3,51,protein serine/threonine kinase activity|ATP binding|cAMP response element binding protein binding|Rho GTPase binding|protein homodimerization activity,,ppi
9401,10956,220388,CCDC89,coiled-coil domain containing 89,12,,,ppi
9402,10957,123591,TMEM266,transmembrane protein 266,10,,,ppi
9403,10958,653619,PRAMEF15,PRAME family member 15,1,,,ppi
9404,10961,253635,GPATCH11,G-patch domain containing 11,15,,,ppi
9405,10962,205147,AMER3,APC membrane recruitment protein 3,3,phosphatidylinositol-4;5-bisphosphate binding|beta-catenin binding,,ppi
9406,10963,283742,FAM98B,family with sequence similarity 98 member B,35,RNA binding|protein methyltransferase activity|identical protein binding,,ppi
9407,10964,201931,TMEM192,transmembrane protein 192,22,protein homodimerization activity,,ppi
9408,10965,167153,PAPD4,poly(A) RNA polymerase D4; non-canonical,5,polynucleotide adenylyltransferase activity|5'-3' RNA polymerase activity|adenylyltransferase activity,,ppi
9409,10966,160428,ALDH1L2,aldehyde dehydrogenase 1 family member L2,14,aldehyde dehydrogenase (NAD) activity,,ppi
9410,10968,1615,DARS,aspartyl-tRNA synthetase,90,RNA binding|aminoacylase activity|aspartate-tRNA ligase activity,spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus,ppi
9411,10970,132228,LSMEM2,leucine rich single-pass membrane protein 2,3,,,ppi
9412,10972,91445,RNF185,ring finger protein 185,71,ubiquitin protein ligase activity|ubiquitin-like protein conjugating enzyme binding,,ppi
9413,10973,91574,C12orf65,chromosome 12 open reading frame 65,3,,mitochondrial encephalomyopathy|combined oxidative phosphorylation deficiency|hereditary spastic paraplegia 55,ppi
9414,10974,286128,ZFP41,ZFP41 zinc finger protein,44,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9415,10975,126868,MAB21L3,mab-21 like 3,9,,,ppi
9416,10976,144811,LACC1,laccase domain containing 1,36,copper ion binding,juvenile rheumatoid arthritis,ppi
9417,10980,257629,ANKS4B,ankyrin repeat and sterile alpha motif domain containing 4B,4,,,ppi
9418,10981,126272,EID2B,EP300 interacting inhibitor of differentiation 2B,8,,,ppi
9419,10982,120534,ARL14EP,ADP ribosylation factor like GTPase 14 effector protein,9,,intellectual disability|learning disability,ppi
9420,10983,205327,C2orf69,chromosome 2 open reading frame 69,9,,,ppi
9421,10984,140,ADORA3,adenosine A3 receptor,12,,ischemia|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction,ppi
9422,10985,11083,DIDO1,death inducer-obliterator 1,41,RNA binding,,ppi
9423,10986,127703,C1orf216,chromosome 1 open reading frame 216,26,,,ppi
9424,10987,285521,COX18,COX18; cytochrome c oxidase assembly factor,1,protein transporter activity|membrane insertase activity,,ppi
9425,10991,126638,RPTN,repetin,4,,,ppi
9426,10992,1616,DAXX,death domain associated protein,161,transcription coactivator activity|transcription corepressor activity|protein kinase activator activity|heat shock protein binding|histone binding|protein heterodimerization activity,pancreatic cancer|adrenal cortex cancer|adrenocortical carcinoma|adrenal carcinoma|neuroendocrine tumor,ppi
9427,10993,133584,EGFLAM,EGF like; fibronectin type III and laminin G domains,5,,,ppi
9428,10994,220441,RNF152,ring finger protein 152,5,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
9429,10995,126549,ANKLE1,ankyrin repeat and LEM domain containing 1,1,endonuclease activity,,ppi
9430,10996,132720,C4orf32,chromosome 4 open reading frame 32,22,,,ppi
9431,10997,353116,RILPL1,Rab interacting lysosomal protein like 1,3,dynein light intermediate chain binding|small GTPase binding,,ppi
9432,10998,144108,SPTY2D1,SPT2 chromatin protein domain containing 1,23,RNA polymerase I core binding|DNA binding|histone binding,,ppi
9433,10999,1617,DAZ1,deleted in azoospermia 1,10,translation activator activity|mRNA 3'-UTR binding,azoospermia|male infertility|Sertoli cell-only syndrome|oligospermia,ppi
9434,11001,285025,CCDC141,coiled-coil domain containing 141,3,,,ppi
9435,11002,203111,ERICH5,glutamate rich 5,18,,,ppi
9436,11004,255027,MPV17L,MPV17 mitochondrial inner membrane protein like,2,,,ppi
9437,11006,26528,DAZAP1,DAZ associated protein 1,89,RNA binding|poly(U) RNA binding|poly(G) binding|mRNA 3'-UTR binding,bipolar disorder|schizophrenia,ppi
9438,11008,284992,CCDC150,coiled-coil domain containing 150,3,,,ppi
9439,11012,201633,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,5,signaling receptor binding|identical protein binding,,ppi
9440,11014,9802,DAZAP2,DAZ associated protein 2,100,,,ppi
9441,11015,284451,ODF3L2,outer dense fiber of sperm tails 3 like 2,9,,,ppi
9442,11016,348807,CFAP100,cilia and flagella associated protein 100,4,dynein complex binding,,ppi
9443,11020,283461,C12orf40,chromosome 12 open reading frame 40,1,,,ppi
9444,11021,124817,CNTD1,cyclin N-terminal domain containing 1,1,,,ppi
9445,11023,1618,DAZL,deleted in azoospermia like,6,RNA binding|translation activator activity|mRNA 3'-UTR binding,testicular cancer|seminoma|testicular germ cell cancer,ppi
9446,11024,285051,C2orf61,chromosome 2 open reading frame 61,1,chromatin binding,,ppi
9447,11025,643677,CCDC168,coiled-coil domain containing 168,2,,,ppi
9448,11028,284369,SIGLECL1,SIGLEC family like 1,95,,,ppi
9449,11029,133558,MROH2B,maestro heat like repeat family member 2B,1,,,ppi
9450,11031,139804,RBMXL3,RNA binding motif protein; X-linked like 3,2,mRNA binding,,ppi
9451,11032,129852,C2orf73,chromosome 2 open reading frame 73,3,,,ppi
9452,11033,124535,HSF5,heat shock transcription factor 5,2,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding|sequence-specific DNA binding|DNA-binding transcription factor activity,,ppi
9453,11035,126402,CCDC105,coiled-coil domain containing 105,1,,,ppi
9454,11036,151195,CCNYL1,cyclin Y like 1,34,cyclin-dependent protein serine/threonine kinase regulator activity,,ppi
9455,11037,1620,BRINP1,BMP/retinoic acid inducible neural specific 1,26,,,ppi
9456,11038,165631,PARP15,poly(ADP-ribose) polymerase family member 15,1,obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|NAD+ ADP-ribosyltransferase activity|NAD+ binding,,ppi
9457,11039,150468,CKAP2L,cytoskeleton associated protein 2 like,4,,,ppi
9458,11040,285966,TCAF2,TRPM8 channel associated factor 2,20,ion channel binding,,ppi
9459,11042,348654,GEN1,GEN1; Holliday junction 5' flap endonuclease,3,magnesium ion binding|four-way junction DNA binding|endodeoxyribonuclease activity|crossover junction endodeoxyribonuclease activity|5'-flap endonuclease activity|protein homodimerization activity|single-stranded DNA 5'-3' exodeoxyribonuclease activity|single-stranded DNA 3'-5' exodeoxyribonuclease activity|single-stranded DNA binding|flap endonuclease activity|DNA binding|double-stranded DNA 3'-5' exodeoxyribonuclease activity|double-stranded DNA binding|double-stranded DNA 5'-3' exodeoxyribonuclease activity,,ppi
9460,11043,200132,TCTEX1D1,Tctex1 domain containing 1,1,,,ppi
9461,11045,127544,RNF19B,ring finger protein 19B,46,ubiquitin-protein transferase activity|ubiquitin conjugating enzyme binding|ubiquitin protein ligase activity,,ppi
9462,11046,202018,TAPT1,transmembrane anterior posterior transformation 1,7,growth hormone-releasing hormone receptor activity,,ppi
9463,11047,131583,FAM43A,family with sequence similarity 43 member A,13,,,ppi
9464,11049,1621,DBH,dopamine beta-hydroxylase,5,catalytic activity|dopamine beta-monooxygenase activity|copper ion binding|oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced ascorbate as one donor; and incorporation of one atom of oxygen,alcohol dependence|alcohol abuse|bipolar disorder|ptosis|congenital ptosis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|multiple system atrophy|neuroblastoma|adrenal gland cancer|duodenum cancer|heart cancer|phaeochromocytoma|small intestine cancer|visual epilepsy,ppi
9465,11050,144110,TMEM86A,transmembrane protein 86A,1,alkenylglycerophosphocholine hydrolase activity|alkenylglycerophosphoethanolamine hydrolase activity,,ppi
9466,11051,124975,GGT6,gamma-glutamyltransferase 6,1,,,ppi
9467,11053,286262,TPRN,taperin,23,,autosomal recessive nonsyndromic deafness 79,ppi
9468,11054,163049,ZNF791,zinc finger protein 791,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9469,11056,340252,ZNF680,zinc finger protein 680,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9470,11057,160418,TMTC3,transmembrane and tetratricopeptide repeat containing 3,22,,,ppi
9471,11058,141,ADPRH,ADP-ribosylarginine hydrolase,8,magnesium ion binding|ADP-ribosylarginine hydrolase activity|potassium ion binding|Rab GTPase binding|GTPase activator activity,,ppi
9472,11059,1622,DBI,diazepam binding inhibitor; acyl-CoA binding protein,19,benzodiazepine receptor binding|long-chain fatty acyl-CoA binding|protein dimerization activity,schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
9473,11060,257236,CCDC96,coiled-coil domain containing 96,2,,,ppi
9474,11062,285613,RELL2,RELT like 2,19,,,ppi
9475,11063,206338,LVRN,laeverin,1,peptide binding|metalloaminopeptidase activity|zinc ion binding,,ppi
9476,11064,283899,INO80E,INO80 complex subunit E,35,,,ppi
9477,11066,153129,SLC38A9,solute carrier family 38 member 9,24,amino acid transmembrane transporter activity,liver cancer,ppi
9478,11067,203100,HTRA4,HtrA serine peptidase 4,9,endopeptidase activity,,ppi
9479,11068,285267,ZNF619,zinc finger protein 619,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9480,11069,219654,ZCCHC24,zinc finger CCHC-type containing 24,2,RNA binding,,ppi
9481,11071,147841,SPC24,SPC24; NDC80 kinetochore complex component,41,,,ppi
9482,11072,126789,PUSL1,pseudouridylate synthase-like 1,17,pseudouridine synthase activity,,ppi
9483,11073,10443,N4BP2L2,NEDD4 binding protein 2 like 2,29,transcription corepressor activity,seborrheic keratosis|skin disease|actinic keratosis,ppi
9484,11074,57228,SMAGP,small cell adhesion glycoprotein,2,,,ppi
9485,11075,56931,DUS3L,dihydrouridine synthase 3 like,27,RNA binding|tRNA dihydrouridine synthase activity,,ppi
9486,11076,56965,PARP6,poly(ADP-ribose) polymerase family member 6,10,NAD+ ADP-ribosyltransferase activity,,ppi
9487,11077,375748,ERCC6L2,ERCC excision repair 6 like 2,3,,,ppi
9488,11078,56926,NCLN,nicalin,28,,,ppi
9489,11081,84522,JAGN1,jagunal homolog 1,15,,neutropenia|agranulocytosis|severe congenital neutropenia,ppi
9490,11082,55572,FOXRED1,FAD dependent oxidoreductase domain containing 1,24,oxidoreductase activity,lactic acidosis|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|dystonia|epilepsy|sensorineural hearing loss|hypertrichosis|hypoglycemia|Leigh disease|leukodystrophy|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus,ppi
9491,11083,55573,CDV3,CDV3 homolog,46,,,ppi
9492,11084,84529,C15orf41,chromosome 15 open reading frame 41,3,,congenital dyserythropoietic anemia,ppi
9493,11085,25770,C22orf31,chromosome 22 open reading frame 31,3,,,ppi
9494,11086,51372,TMA7,translation machinery associated 7 homolog,4,,,ppi
9495,11087,51490,SPOUT1,SPOUT domain containing methyltransferase 1,19,RNA binding|miRNA binding,,ppi
9496,11088,51491,NOP16,NOP16 nucleolar protein,29,RNA binding,liver cancer,ppi
9497,11089,51493,RTCB,RNA 2';3'-cyclic phosphate and 5'-OH ligase,86,RNA binding|RNA ligase (ATP) activity,,ppi
9498,11090,51496,CTDSPL2,CTD small phosphatase like 2,24,phosphoprotein phosphatase activity,,ppi
9499,11091,51499,TRIAP1,TP53 regulated inhibitor of apoptosis 1,14,phosphatidic acid transporter activity,,ppi
9500,11092,51501,HIKESHI,Hikeshi; heat shock protein nuclear import factor,12,protein transporter activity|Hsp70 protein binding,melanoma|skin melanoma|stomach cancer|hypomyelinating leukodystrophy 13,ppi
9501,11093,51503,CWC15,CWC15 spliceosome associated protein homolog,29,RNA binding,,ppi
9502,11094,51504,TRMT112,tRNA methyltransferase 11-2 homolog (S. cerevisiae),49,protein methyltransferase activity|protein heterodimerization activity|rRNA (guanine) methyltransferase activity,,ppi
9503,11095,51506,UFC1,ubiquitin-fold modifier conjugating enzyme 1,44,UFM1 transferase activity,,ppi
9504,11096,51510,CHMP5,charged multivesicular body protein 5,54,cadherin binding,acute myeloid leukemia,ppi
9505,11097,51523,CXXC5,CXXC finger protein 5,8,transcription factor binding|sequence-specific DNA binding,,ppi
9506,11098,51524,TMEM138,transmembrane protein 138,1,,ptosis|congenital ptosis|cerebellar disease|coloboma|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|fundus dystrophy|autistic disorder|Joubert syndrome,ppi
9507,11099,51537,MTFP1,mitochondrial fission process 1,13,,,ppi
9508,11100,154791,FMC1,formation of mitochondrial complex V assembly factor 1 homolog,32,,,ppi
9509,11101,81888,HYI,hydroxypyruvate isomerase (putative),12,racemase and epimerase activity; acting on carbohydrates and derivatives,,ppi
9510,11102,1627,DBN1,drebrin 1,244,actin binding|profilin binding|cadherin binding,bipolar disorder|schizophrenia,ppi
9511,11106,84162,KIAA1109,KIAA1109,8,,,ppi
9512,11107,54629,FAM63B,family with sequence similarity 63 member B,24,cysteine-type carboxypeptidase activity|K48-linked polyubiquitin modification-dependent protein binding|K63-linked polyubiquitin modification-dependent protein binding|K11-linked polyubiquitin modification-dependent protein binding|K6-linked polyubiquitin modification-dependent protein binding|Lys48-specific deubiquitinase activity,,ppi
9513,11108,92999,ZBTB47,zinc finger and BTB domain containing 47,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9514,11109,54617,INO80,INO80 complex subunit,33,DNA binding|DNA-dependent ATPase activity|alpha-tubulin binding|ATPase activity|histone binding|ATP-dependent 3'-5' DNA helicase activity,,ppi
9515,11110,56261,GPCPD1,glycerophosphocholine phosphodiesterase 1,2,glycerophosphocholine phosphodiesterase activity,,ppi
9516,11111,727957,MROH1,maestro heat like repeat family member 1,2,,,ppi
9517,11112,340390,WDR97,WD repeat domain 97,1,,,ppi
9518,11113,28988,DBNL,drebrin like,54,actin binding|enzyme activator activity|cadherin binding|actin filament binding,bipolar disorder,ppi
9519,11114,197335,WDR90,WD repeat domain 90,18,,,ppi
9520,11115,254225,RNF169,ring finger protein 169,14,nucleosome binding|K63-linked polyubiquitin modification-dependent protein binding,,ppi
9521,11117,114971,PTPMT1,protein tyrosine phosphatase; mitochondrial 1,84,phosphatidylglycerophosphatase activity|phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity,,ppi
9522,11119,116064,LRRC58,leucine rich repeat containing 58,6,,,ppi
9523,11120,116068,LYSMD3,LysM domain containing 3,2,,nicotine dependence,ppi
9524,11121,1628,DBP,D-box binding PAR bZIP transcription factor,13,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
9525,11122,116228,COX20,COX20; cytochrome c oxidase assembly factor,13,,cytochrome-c oxidase deficiency disease,ppi
9526,11123,116236,ABHD15,abhydrolase domain containing 15,8,,,ppi
9527,11124,118461,C10orf71,chromosome 10 open reading frame 71,5,,,ppi
9528,11125,118987,PDZD8,PDZ domain containing 8,29,,,ppi
9529,11126,119504,ANAPC16,anaphase promoting complex subunit 16,31,,,ppi
9530,11127,119587,CPXM2,carboxypeptidase X; M14 family member 2,2,metallocarboxypeptidase activity,,ppi
9531,11129,120526,DNAJC24,DnaJ heat shock protein family (Hsp40) member C24,2,ATPase activator activity|ferrous iron binding|zinc ion binding,,ppi
9532,11130,1629,DBT,dihydrolipoamide branched chain transacylase E2,59,lipoic acid binding|acetyltransferase activity,lactic acidosis|brain edema|cerebellar disease|epilepsy|hypoglycemia|maple syrup urine disease|intellectual disability|learning disability|acute pancreatitis|pancreatitis|visual epilepsy,ppi
9533,11131,121006,FAM186A,family with sequence similarity 186 member A,2,,,ppi
9534,11132,124411,ZNF720,zinc finger protein 720,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9535,11133,124512,METTL23,methyltransferase like 23,27,,intellectual disability|learning disability,ppi
9536,11134,124751,KRBA2,KRAB-A domain containing 2,4,,,ppi
9537,11135,8653,DDX3Y,DEAD-box helicase 3; Y-linked,28,,azoospermia|male infertility|Sertoli cell-only syndrome|oligospermia,ppi
9538,11136,124773,C17orf64,chromosome 17 open reading frame 64,1,,,ppi
9539,11139,125150,ZSWIM7,zinc finger SWIM-type containing 7,8,,,ppi
9540,11140,125476,INO80C,INO80 complex subunit C,24,,,ppi
9541,11141,125893,ZNF816,zinc finger protein 816,13,DNA-binding transcription factor activity; RNA polymerase II-specific,pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
9542,11142,126075,CCDC159,coiled-coil domain containing 159,1,,,ppi
9543,11143,126208,ZNF787,zinc finger protein 787,9,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9544,11144,126248,WDR88,WD repeat domain 88,2,,,ppi
9545,11145,142,PARP1,poly(ADP-ribose) polymerase 1,283,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|RNA binding|NAD+ ADP-ribosyltransferase activity|protein ADP-ribosylase activity,alopecia|anemia|macrocytic anemia|asthma|intrinsic asthma|allergic asthma|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|brain ischemia|acrodermatitis|dermatitis|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|multiple myeloma,ppi
9546,11146,9201,DCLK1,doublecortin like kinase 1,17,protein kinase activity,bipolar disorder|large intestine cancer|colorectal cancer|schizophrenia,ppi
9547,11147,126353,MISP,mitotic spindle positioning,35,,,ppi
9548,11149,126669,SHE,Src homology 2 domain containing E,5,phosphotyrosine residue binding,,ppi
9549,11151,126917,IFFO2,intermediate filament family orphan 2,2,,,ppi
9550,11152,127262,TPRG1L,tumor protein p63 regulated 1 like,1,,,ppi
9551,11153,128344,PIFO,primary cilia formation,11,gamma-tubulin binding|beta-tubulin binding,,ppi
9552,11154,1630,DCC,DCC netrin 1 receptor,58,transmembrane signaling receptor activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|large intestine cancer|colorectal cancer|melanoma|skin melanoma|schizophrenia|stomach cancer|bladder urothelial carcinoma|uterus leiomyosarcoma|squamous cell neoplasm,ppi
9553,11155,128387,TATDN3,TatD DNase domain containing 3,1,,,ppi
9554,11156,414059,TBC1D3B,TBC1 domain family member 3B,10,Rab GTPase binding|GTPase activator activity,,ppi
9555,11157,128977,C22orf39,chromosome 22 open reading frame 39,7,,,ppi
9556,11158,129293,TRABD2A,TraB domain containing 2A,1,endopeptidase activity|metalloendopeptidase activity|Wnt-protein binding,,ppi
9557,11161,130074,FAM168B,family with sequence similarity 168 member B,3,,,ppi
9558,11163,130576,LYPD6B,LY6/PLAUR domain containing 6B,1,acetylcholine receptor regulator activity,,ppi
9559,11165,130888,FBXO36,F-box protein 36,1,,,ppi
9560,11166,131368,ZPLD1,zona pellucida like domain containing 1,10,,,ppi
9561,11168,132321,C4orf33,chromosome 4 open reading frame 33,3,,,ppi
9562,11172,1632,ECI1,enoyl-CoA delta isomerase 1,11,dodecenoyl-CoA delta-isomerase activity|intramolecular oxidoreductase activity|enoyl-CoA hydratase activity,,ppi
9563,11173,134218,DNAJC21,DnaJ heat shock protein family (Hsp40) member C21,12,RNA binding,,ppi
9564,11174,134285,TMEM171,transmembrane protein 171,57,,,ppi
9565,11175,134548,SOWAHA,sosondowah ankyrin repeat domain family member A,1,,,ppi
9566,11176,136306,SVOPL,SVOP like,1,,,ppi
9567,11177,137886,UBXN2B,UBX domain protein 2B,28,ubiquitin binding,,ppi
9568,11178,138046,RALYL,RALY RNA binding protein-like,42,RNA binding,breast cancer,ppi
9569,11181,138428,PTRH1,peptidyl-tRNA hydrolase 1 homolog,3,RNA binding|aminoacyl-tRNA hydrolase activity,,ppi
9570,11182,1633,DCK,deoxycytidine kinase,21,deoxycytidine kinase activity|drug binding|nucleoside kinase activity|deoxynucleoside kinase activity,,ppi
9571,11183,139886,SPIN4,spindlin family member 4,4,methylated histone binding,,ppi
9572,11184,143458,LDLRAD3,low density lipoprotein receptor class A domain containing 3,3,,substance abuse|substance-related disorder,ppi
9573,11185,144100,PLEKHA7,pleckstrin homology domain containing A7,13,delta-catenin binding,angle-closure glaucoma|primary angle-closure glaucoma|chronic closed-angle glaucoma,ppi
9574,11186,1634,DCN,decorin,43,RNA binding|extracellular matrix structural constituent conferring compression resistance,endometrial cancer|endometrial carcinoma|interstitial nephritis|pyelonephritis|pyelitis|coronary artery disease|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q,ppi
9575,11187,144233,BCDIN3D,BCDIN3 domain containing RNA methyltransferase,4,O-methyltransferase activity|RNA methyltransferase activity,,ppi
9576,11188,144347,RFLNA,refilin A,3,filamin binding,,ppi
9577,11189,144363,ETFRF1,electron transfer flavoprotein regulatory factor 1,16,,,ppi
9578,11190,144501,KRT80,keratin 80,9,,,ppi
9579,11191,144983,HNRNPA1L2,heterogeneous nuclear ribonucleoprotein A1-like 2,25,RNA binding|mRNA binding,,ppi
9580,11192,1636,ACE,angiotensin I converting enzyme,10,endopeptidase activity|drug binding|metallopeptidase activity|exopeptidase activity|tripeptidyl-peptidase activity|peptidyl-dipeptidase activity|zinc ion binding|chloride ion binding|metallodipeptidase activity|dipeptidyl-peptidase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|proteinuria|alcohol dependence|alcohol abuse|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease,ppi
9581,11197,146206,CARMIL2,capping protein regulator and myosin 1 linker 2,5,phospholipid binding|protein-containing complex binding,,ppi
9582,11198,1638,DCT,dopachrome tautomerase,8,dopachrome isomerase activity|copper ion binding|oxidoreductase activity,,ppi
9583,11200,146713,RBFOX3,RNA binding protein; fox-1 homolog 3,5,mRNA binding,,ppi
9584,11201,143,PARP4,poly(ADP-ribose) polymerase family member 4,13,DNA binding|NAD+ ADP-ribosyltransferase activity|enzyme binding,colon cancer|colonic benign neoplasm,ppi
9585,11202,1635,DCTD,dCMP deaminase,11,dCMP deaminase activity,,ppi
9586,11203,146850,PIK3R6,phosphoinositide-3-kinase regulatory subunit 6,2,phosphatidylinositol-4;5-bisphosphate 3-kinase activity|1-phosphatidylinositol-3-kinase regulator activity,,ppi
9587,11204,146909,KIF18B,kinesin family member 18B,16,motor activity|microtubule binding|ATPase activity|microtubule motor activity|ATP-dependent microtubule motor activity; plus-end-directed,,ppi
9588,11206,1639,DCTN1,dynactin subunit 1,250,microtubule binding|tubulin binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|secondary Parkinson disease|muscular atrophy|Bell's palsy|facial paralysis|neurodegenerative disease|mood disorder|amyotrophic lateral sclerosis type 1|Perry syndrome,ppi
9589,11207,147463,ANKRD29,ankyrin repeat domain 29,7,,,ppi
9590,11208,147645,VSIG10L,V-set and immunoglobulin domain containing 10 like,1,,,ppi
9591,11210,147650,SPACA6,sperm acrosome associated 6,1,,,ppi
9592,11211,147670,SMIM17,small integral membrane protein 17,1,,,ppi
9593,11213,10540,DCTN2,dynactin subunit 2,113,spectrin binding,,ppi
9594,11214,147991,DPY19L3,dpy-19 like 3 (C. elegans),8,mannosyltransferase activity,,ppi
9595,11215,148206,ZNF714,zinc finger protein 714,5,,,ppi
9596,11216,11258,DCTN3,dynactin subunit 3,44,structural molecule activity,,ppi
9597,11218,1641,DCX,doublecortin,45,microtubule binding,cerebellar disease|epilepsy|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|syndromic X-linked intellectual disability 94|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|septooptic dysplasia,ppi
9598,11220,149603,RNF187,ring finger protein 187,15,ubiquitin-protein transferase activity,,ppi
9599,11221,23576,DDAH1,dimethylarginine dimethylaminohydrolase 1,14,catalytic activity|dimethylargininase activity|amino acid binding,gallbladder disease|liver disease,ppi
9600,11222,150223,YDJC,YdjC homolog (bacterial),4,magnesium ion binding,,ppi
9601,11223,23564,DDAH2,dimethylarginine dimethylaminohydrolase 2,35,catalytic activity|dimethylargininase activity|amino acid binding,pre-eclampsia|coronary artery disease,ppi
9602,11225,150368,FAM109B,family with sequence similarity 109 member B,7,,,ppi
9603,11228,150946,GAREM2,GRB2 associated regulator of MAPK1 subtype 2,6,,,ppi
9604,11229,1643,DDB2,damage specific DNA binding protein 2,83,DNA binding|damaged DNA binding|ubiquitin-protein transferase activity|protein-containing complex binding,basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|conjunctivitis|cryptorchidism|ectropion|entropion|sensorineural hearing loss|hypogonadism|keratitis|keratoconjunctivitis|melanoma|skin melanoma|optic atrophy|squamous cell papilloma|papilloma|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
9605,11230,1644,DDC,dopa decarboxylase,4,aromatic-L-amino-acid decarboxylase activity|L-dopa decarboxylase activity,disease of mental health|bipolar disorder|ptosis|congenital ptosis|constipation|esophagitis|peptic esophagitis|gastroesophageal reflux disease|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|Parkinson's disease|adrenal gland cancer|duodenum cancer|heart cancer|phaeochromocytoma|small intestine cancer|schizophreniform disorder|schizoaffective disorder,ppi
9606,11231,152485,ZNF827,zinc finger protein 827,7,,,ppi
9607,11233,152687,ZNF595,zinc finger protein 595,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9608,11234,10038,PARP2,poly(ADP-ribose) polymerase 2,98,protein ADP-ribosylase activity|NAD+ ADP-ribosyltransferase activity,lipoatrophic diabetes|lipodystrophy,ppi
9609,11235,50807,ASAP1,ArfGAP with SH3 domain; ankyrin repeat and PH domain 1,49,cadherin binding,urinary bladder cancer|pulmonary tuberculosis|tuberculous pneumothorax,ppi
9610,11237,8853,ASAP2,ArfGAP with SH3 domain; ankyrin repeat and PH domain 2,35,,,ppi
9611,11238,155006,TMEM213,transmembrane protein 213,7,,,ppi
9612,11240,155435,RBM33,RNA binding motif protein 33,23,RNA binding,,ppi
9613,11241,157567,ANKRD46,ankyrin repeat domain 46,23,,,ppi
9614,11242,157570,ESCO2,establishment of sister chromatid cohesion N-acetyltransferase 2,19,N-acetyltransferase activity|acetyltransferase activity,SC phocomelia syndrome|Roberts syndrome,ppi
9615,11243,157657,C8orf37,chromosome 8 open reading frame 37,3,,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
9616,11244,157697,ERICH1,glutamate rich 1,2,,,ppi
9617,11246,161291,TMEM30B,transmembrane protein 30B,76,aminophospholipid transmembrane transporter activity|phospholipid-translocating ATPase activity,melanoma|skin melanoma,ppi
9618,11247,162073,ITPRIPL2,inositol 1;4;5-trisphosphate receptor interacting protein like 2,1,,,ppi
9619,11248,162427,FAM134C,family with sequence similarity 134 member C,53,,,ppi
9620,11249,1649,DDIT3,DNA damage inducible transcript 3,79,transcription regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription corepressor activity|protein homodimerization activity|leucine zipper domain binding|transcription regulatory region DNA binding|protein heterodimerization activity,asbestosis|anthracosilicosis|byssinosis|contact dermatitis|occupational dermatitis|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17,ppi
9621,11250,162993,ZNF846,zinc finger protein 846,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9622,11251,163782,KANK4,KN motif and ankyrin repeat domains 4,14,,,ppi
9623,11252,165324,UBXN2A,UBX domain protein 2A,17,ubiquitin binding,,ppi
9624,11253,167127,UGT3A2,UDP glycosyltransferase family 3 member A2,7,UDP-glycosyltransferase activity,,ppi
9625,11254,168850,ZNF800,zinc finger protein 800,16,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9626,11255,169270,ZNF596,zinc finger protein 596,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9627,11256,169355,IDO2,indoleamine 2;3-dioxygenase 2,9,tryptophan 2;3-dioxygenase activity|indoleamine 2;3-dioxygenase activity,,ppi
9628,11257,8528,DDO,D-aspartate oxidase,2,D-aspartate oxidase activity|cofactor binding,schizophrenia,ppi
9629,11258,169611,OLFML2A,olfactomedin like 2A,1,,,ppi
9630,11260,169981,SPIN3,spindlin family member 3,7,methylated histone binding,,ppi
9631,11261,170261,ZCCHC12,zinc finger CCHC-type containing 12,11,nuclear receptor transcription coactivator activity,,ppi
9632,11264,196264,MPZL3,myelin protein zero like 3,2,,,ppi
9633,11265,1650,DDOST,dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit,106,oligosaccharyl transferase activity|dolichyl-diphosphooligosaccharide-protein glycotransferase activity,constipation|esophagitis|peptic esophagitis|gastroesophageal reflux disease|ophthalmoplegia|mechanical strabismus|hypertropia|liver disease|congenital disorder of glycosylation type I,ppi
9634,11267,196463,PLBD2,phospholipase B domain containing 2,13,,,ppi
9635,11270,197322,ACSF3,acyl-CoA synthetase family member 3,18,acid-thiol ligase activity|very long-chain fatty acid-CoA ligase activity|malonyl-CoA synthetase activity,,ppi
9636,11271,197342,EME2,essential meiotic structure-specific endonuclease subunit 2,4,crossover junction endodeoxyribonuclease activity,,ppi
9637,11272,199675,MCEMP1,mast cell expressed membrane protein 1,1,,,ppi
9638,11274,199920,C1orf168,chromosome 1 open reading frame 168,1,,,ppi
9639,11277,10039,PARP3,poly(ADP-ribose) polymerase family member 3,8,catalytic activity|NAD+ ADP-ribosyltransferase activity|protein ADP-ribosylase activity,,ppi
9640,11278,780,DDR1,discoidin domain receptor tyrosine kinase 1,25,transmembrane receptor protein tyrosine kinase activity|collagen binding|protein tyrosine kinase collagen receptor activity|transmembrane signaling receptor activity|protein tyrosine kinase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|lung benign neoplasm|prostate cancer|prostate carcinoma|schizophrenia,ppi
9641,11279,200186,CRTC2,CREB regulated transcription coactivator 2,31,cAMP response element binding protein binding,,ppi
9642,11280,200205,IBA57,IBA57 homolog; iron-sulfur cluster assembly,20,RNA binding,multiple mitochondrial dysfunctions syndrome 3|hereditary spastic paraplegia 74,ppi
9643,11281,200895,DHFR2,dihydrofolate reductase 2,24,mRNA binding|dihydrofolate reductase activity|NADP binding,,ppi
9644,11282,4921,DDR2,discoidin domain receptor tyrosine kinase 2,15,transmembrane receptor protein tyrosine kinase activity|collagen binding|protein tyrosine kinase collagen receptor activity|transmembrane signaling receptor activity|protein tyrosine kinase activity,enophthalmos|orbital disease|exophthalmos|spinal cord disease|syringomyelia|lung cancer|lung adenocarcinoma|tracheal calcification|osteogenesis imperfecta|Ehlers-Danlos syndrome|chondrodysplasia punctata,ppi
9645,11283,201163,FLCN,folliculin,44,protein-containing complex binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|large intestine cancer|colorectal cancer|liver cancer|nonpapillary renal cell carcinoma|Birt-Hogg-Dube syndrome|renal oncocytoma,ppi
9646,11287,201292,TRIM65,tripartite motif containing 65,22,,,ppi
9647,11288,201514,ZNF584,zinc finger protein 584,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9648,11289,1652,DDT,D-dopachrome tautomerase,6,dopachrome isomerase activity|cytokine receptor binding|phenylpyruvate tautomerase activity,,ppi
9649,11290,201725,C4orf46,chromosome 4 open reading frame 46,7,,,ppi
9650,11291,201895,SMIM14,small integral membrane protein 14,3,,,ppi
9651,11292,202051,SPATA24,spermatogenesis associated 24,35,,,ppi
9652,11293,202134,FAM153B,family with sequence similarity 153 member B,13,,,ppi
9653,11294,203069,R3HCC1,R3H domain and coiled-coil containing 1,3,,,ppi
9654,11295,203522,INTS6L,integrator complex subunit 6 like,7,,,ppi
9655,11296,203859,ANO5,anoctamin 5,2,intracellular calcium activated chloride channel activity,autosomal recessive limb-girdle muscular dystrophy type 2L|distal muscular dystrophy,ppi
9656,11297,204474,PDILT,protein disulfide isomerase like; testis expressed,1,protein disulfide isomerase activity|peptidyl-proline 4-dioxygenase activity,,ppi
9657,11298,1653,DDX1,DEAD-box helicase 1,148,chromatin binding|transcription coregulator activity|RNA binding|RNA helicase activity|nuclease activity|ATP-dependent helicase activity|poly(A) binding|DNA/RNA helicase activity,substance abuse|substance-related disorder,ppi
9658,11299,219854,TMEM218,transmembrane protein 218,3,,,ppi
9659,11300,220213,OTUD1,OTU deubiquitinase 1,9,thiol-dependent ubiquitin-specific protease activity,,ppi
9660,11301,1662,DDX10,DEAD-box helicase 10,34,RNA binding|RNA helicase activity,,ppi
9661,11302,221143,EEF1AKMT1,eukaryotic translation elongation factor 1 alpha lysine methyltransferase 1,6,methyltransferase activity|protein-lysine N-methyltransferase activity,,ppi
9662,11304,1663,DDX11,DEAD/H-box helicase 11,29,DNA binding|chromatin binding|DNA replication origin binding|double-stranded DNA binding|single-stranded DNA binding|single-stranded RNA binding|ATP-dependent DNA helicase activity|helicase activity|ATP-dependent helicase activity|DNA-dependent ATPase activity|RNA-dependent ATPase activity|triplex DNA binding|G-quadruplex DNA binding,sensorineural hearing loss|placental insufficiency|ventricular septal defect|intellectual disability|learning disability|visual pathway disease|coloboma of optic nerve|Warsaw breakage syndrome,ppi
9663,11305,222967,RSPH10B,radial spoke head 10 homolog B,4,,,ppi
9664,11307,253012,HEPACAM2,HEPACAM family member 2,37,,,ppi
9665,11309,253512,SLC25A30,solute carrier family 25 member 30,13,sulfate transmembrane transporter activity|antiporter activity|malate transmembrane transporter activity|thiosulfate transmembrane transporter activity|succinate transmembrane transporter activity|oxaloacetate transmembrane transporter activity,,ppi
9666,11310,253827,MSRB3,methionine sulfoxide reductase B3,18,zinc ion binding|peptide-methionine (R)-S-oxide reductase activity,sensorineural hearing loss|autosomal recessive nonsyndromic deafness 74,ppi
9667,11311,768211,RELL1,RELT like 1,17,,,ppi
9668,11312,1665,DHX15,DEAH-box helicase 15,205,RNA binding|RNA helicase activity|double-stranded RNA binding|ATP-dependent 3'-5' RNA helicase activity,acute myeloid leukemia,ppi
9669,11314,254359,ZDHHC24,zinc finger DHHC-type containing 24,2,protein-cysteine S-palmitoyltransferase activity,,ppi
9670,11315,8449,DHX16,DEAH-box helicase 16,53,RNA binding|RNA helicase activity|ATPase activity|ATP-dependent 3'-5' RNA helicase activity,,ppi
9671,11316,255104,TMCO4,transmembrane and coiled-coil domains 4,2,,,ppi
9672,11317,255189,PLA2G4F,phospholipase A2 group IVF,1,lysophospholipase activity|phospholipase A2 activity|phospholipase A1 activity|calcium-dependent phospholipid binding|calcium-dependent phospholipase A2 activity|calcium ion binding,,ppi
9673,11319,10521,DDX17,DEAD-box helicase 17,184,transcription coactivator activity|RNA binding|RNA helicase activity|RNA-dependent ATPase activity,,ppi
9674,11320,255426,RASGEF1C,RasGEF domain family member 1C,5,,,ppi
9675,11321,255743,NPNT,nephronectin,1,integrin binding,,ppi
9676,11323,255798,SMCO1,single-pass membrane protein with coiled-coil domains 1,2,,,ppi
9677,11324,8886,DDX18,DEAD-box helicase 18,120,RNA binding|ATP-dependent RNA helicase activity,,ppi
9678,11326,256643,CXorf23,chromosome X open reading frame 23,1,,,ppi
9679,11327,257106,ARHGAP30,Rho GTPase activating protein 30,1,GTPase activator activity,polycystic ovary syndrome,ppi
9680,11329,11269,DDX19B,DEAD-box helicase 19B,115,helicase activity,,ppi
9681,11331,282996,RBM20,RNA binding motif protein 20,3,RNA binding,dilated cardiomyopathy 1DD,ppi
9682,11332,11218,DDX20,DEAD-box helicase 20,88,ATP-dependent RNA helicase activity,,ppi
9683,11333,9188,DDX21,DExD-box helicase 21,173,RNA binding|ATP-dependent RNA helicase activity|rRNA binding|snoRNA binding|miRNA binding|7SK snRNA binding,,ppi
9684,11334,283129,MAJIN,membrane anchored junction protein,2,,,ppi
9685,11336,283152,CCDC153,coiled-coil domain containing 153,6,,,ppi
9686,11337,1654,DDX3X,DEAD-box helicase 3; X-linked,217,DNA binding|RNA binding|GTPase activity|ATP-dependent DNA helicase activity|ATP-dependent RNA helicase activity|transcription factor binding|poly(A) binding|eukaryotic initiation factor 4E binding|ATPase activity|nucleoside-triphosphatase activity|translation initiation factor binding|RNA strand annealing activity|RNA stem-loop binding|ribosomal small subunit binding|CTPase activity|protein serine/threonine kinase activator activity|cadherin binding|mRNA 5'-UTR binding,intellectual disability|learning disability|arthropathy|arthritis|malignant mesothelioma|benign mesothelioma,ppi
9687,11338,283219,KCTD21,potassium channel tetramerization domain containing 21,8,histone deacetylase binding|cullin family protein binding,,ppi
9688,11340,283248,RCOR2,REST corepressor 2,10,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding|transcription corepressor activity,,ppi
9689,11341,1655,DDX5,DEAD-box helicase 5,271,RNA binding|RNA helicase activity|mRNA 3'-UTR binding|pre-mRNA binding|ribonucleoprotein complex binding|androgen receptor binding|primary miRNA binding|promoter-specific chromatin binding,endometriosis of uterus|endometriosis,ppi
9690,11342,283337,ZNF740,zinc finger protein 740,9,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region DNA binding|DNA-binding transcription factor activity,,ppi
9691,11343,283377,SPRYD4,SPRY domain containing 4,17,,,ppi
9692,11344,1656,DDX6,DEAD-box helicase 6,105,RNA binding|RNA helicase activity|helicase activity|cadherin binding,rheumatoid arthritis,ppi
9693,11345,283431,GAS2L3,growth arrest specific 2 like 3,13,actin binding|microtubule binding,,ppi
9694,11346,283464,GXYLT1,glucoside xylosyltransferase 1,12,UDP-xylosyltransferase activity,,ppi
9695,11347,1659,DHX8,DEAH-box helicase 8,74,RNA binding|ATP-dependent RNA helicase activity|ATP-dependent 3'-5' RNA helicase activity,,ppi
9696,11348,1660,DHX9,DExH-box helicase 9,271,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II complex binding|regulatory region RNA binding|DNA binding|DNA replication origin binding|double-stranded DNA binding|single-stranded DNA binding|transcription coregulator activity|transcription coactivator activity|RNA binding|RNA helicase activity|double-stranded RNA binding|single-stranded RNA binding|mRNA binding|ATP-dependent DNA helicase activity|ATP-dependent RNA helicase activity|ATP binding|ATPase activity|nucleoside-triphosphatase activity|chromatin DNA binding,,ppi
9697,11349,283537,SLC46A3,solute carrier family 46 member 3,1,,,ppi
9698,11350,151230,KLHL23,kelch like family member 23,25,,,ppi
9699,11351,8554,PIAS1,protein inhibitor of activated STAT 1,131,transcription coactivator activity|transcription corepressor activity|SUMO transferase activity|androgen receptor binding|SUMO ligase activity,seborrheic keratosis|skin disease|actinic keratosis,ppi
9700,11352,1666,DECR1,2;4-dienoyl-CoA reductase 1,33,2;4-dienoyl-CoA reductase (NADPH) activity|oxidoreductase activity; acting on NAD(P)H|NADPH binding,cocaine abuse|cocaine dependence|lipid metabolism disorder,ppi
9701,11353,283807,FBXL22,F-box and leucine rich repeat protein 22,4,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
9702,11355,26063,DECR2,2;4-dienoyl-CoA reductase 2,10,2;4-dienoyl-CoA reductase (NADPH) activity|trans-2-enoyl-CoA reductase (NADPH) activity,,ppi
9703,11357,9191,DEDD,death effector domain containing,32,DNA binding,,ppi
9704,11358,283951,C16orf91,chromosome 16 open reading frame 91,1,,,ppi
9705,11359,283989,TSEN54,tRNA splicing endonuclease subunit 54,10,tRNA-intron endonuclease activity,microcephaly|movement disease|lingual-facial-buccal dyskinesia|pontocerebellar hypoplasia type 1A|pontocerebellar hypoplasia type 2A|pontocerebellar hypoplasia type 4|pontocerebellar hypoplasia type 5|intellectual disability|learning disability,ppi
9706,11361,284001,CCDC57,coiled-coil domain containing 57,52,,,ppi
9707,11363,284021,MILR1,mast cell immunoglobulin like receptor 1,7,,,ppi
9708,11364,284106,CISD3,CDGSH iron sulfur domain 3,75,,,ppi
9709,11365,284207,METRNL,meteorin like; glial cell differentiation regulator,3,hormone activity,,ppi
9710,11368,50619,DEF6,DEF6; guanine nucleotide exchange factor,35,,systemic lupus erythematosus,ppi
9711,11369,284323,ZNF780A,zinc finger protein 780A,3,,,ppi
9712,11371,284352,PPP1R37,protein phosphatase 1 regulatory subunit 37,7,,,ppi
9713,11372,284361,EMC10,ER membrane protein complex subunit 10,15,,,ppi
9714,11373,1667,DEFA1,defensin alpha 1,88,,,ppi
9715,11374,200916,RPL22L1,ribosomal protein L22 like 1,20,,,ppi
9716,11376,284390,ZNF763,zinc finger protein 763,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9717,11378,284434,NWD1,NACHT and WD repeat domain containing 1,1,,,ppi
9718,11379,1668,DEFA3,defensin alpha 3,2,protein homodimerization activity,acute promyelocytic leukemia,ppi
9719,11382,284611,FAM102B,family with sequence similarity 102 member B,5,,,ppi
9720,11383,284612,SYPL2,synaptophysin like 2,12,,,ppi
9721,11384,284615,ANKRD34A,ankyrin repeat domain 34A,1,,,ppi
9722,11385,1670,DEFA5,defensin alpha 5,61,protein homodimerization activity,inflammatory bowel disease|ulcerative colitis|colon cancer|colonic benign neoplasm|IgA glomerulonephritis|von Hippel-Lindau disease|Peutz-Jeghers syndrome,ppi
9723,11386,284677,C1orf204,chromosome 1 open reading frame 204,46,,,ppi
9724,11387,284680,SPATA46,spermatogenesis associated 46,11,,,ppi
9725,11388,1671,DEFA6,defensin alpha 6,16,protein homodimerization activity,inflammatory bowel disease|ulcerative colitis,ppi
9726,11389,594855,CPLX3,complexin 3,17,SNARE binding,,ppi
9727,11391,1672,DEFB1,defensin beta 1,13,CCR6 chemokine receptor binding|identical protein binding,contact dermatitis|occupational dermatitis|prostate cancer|prostate carcinoma,ppi
9728,11392,1673,DEFB4A,defensin beta 4A,2,CCR6 chemokine receptor binding|chemoattractant activity,inflammatory bowel disease,ppi
9729,11393,284958,NT5DC4,5'-nucleotidase domain containing 4,1,,,ppi
9730,11394,7913,DEK,DEK proto-oncogene,66,RNA binding|histone binding,,ppi
9731,11395,285016,FAM150B,family with sequence similarity 150 member B,1,receptor signaling protein tyrosine kinase activator activity|receptor tyrosine kinase binding,,ppi
9732,11396,8562,DENR,density regulated re-initiation and release factor,52,mRNA binding,,ppi
9733,11397,285148,IAH1,isoamyl acetate-hydrolyzing esterase 1 homolog,2,hydrolase activity; acting on ester bonds,,ppi
9734,11398,148,ADRA1A,adrenoceptor alpha 1A,10,alpha1-adrenergic receptor activity|protein heterodimerization activity|adrenergic receptor activity,bipolar disorder|cannabis dependence|cannabis abuse|cocaine abuse|cocaine dependence|liver cirrhosis|schizophrenia|neurotic disorder|endogenous depression|melancholia|morphine dependence|major depressive disorder|mental depression,ppi
9735,11399,1674,DES,desmin,54,structural constituent of cytoskeleton,sick sinus syndrome|atrial fibrillation|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q,ppi
9736,11400,285331,CCDC66,coiled-coil domain containing 66,15,microtubule binding|protein homodimerization activity,,ppi
9737,11401,1675,CFD,complement factor D,3,serine-type endopeptidase activity|serine-type peptidase activity,asbestosis|anthracosilicosis|byssinosis|endometriosis of uterus|endometriosis|nephritis|glomerulonephritis|kidney disease|congestive heart failure|primary immunodeficiency disease|pneumonia|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|complement component 2 deficiency|complement component 4a deficiency|complement component 4b deficiency|complement component 6 deficiency|complement component 7 deficiency|type I complement component 8 deficiency,ppi
9738,11402,285346,ZNF852,zinc finger protein 852,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9739,11403,285381,DPH3,diphthamide biosynthesis 3,8,,,ppi
9740,11404,1676,DFFA,DNA fragmentation factor subunit alpha,52,deoxyribonuclease inhibitor activity,,ppi
9741,11405,285429,DCAF4L1,DDB1 and CUL4 associated factor 4 like 1,4,,,ppi
9742,11406,285498,RNF212,ring finger protein 212,1,SUMO transferase activity,,ppi
9743,11407,1677,DFFB,DNA fragmentation factor subunit beta,26,deoxyribonuclease activity|identical protein binding,,ppi
9744,11408,285513,GPRIN3,GPRIN family member 3,2,,,ppi
9745,11409,285533,RNF175,ring finger protein 175,2,ubiquitin protein ligase activity,,ppi
9746,11411,285636,C5orf51,chromosome 5 open reading frame 51,5,,,ppi
9747,11412,285671,RNF180,ring finger protein 180,2,,,ppi
9748,11415,147,ADRA1B,adrenoceptor alpha 1B,14,protein heterodimerization activity|alpha1-adrenergic receptor activity|adrenergic receptor activity,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|epilepsy|visual epilepsy|toxic encephalopathy|mood disorder,ppi
9749,11417,286046,XKR6,XK related 6,1,,,ppi
9750,11418,642475,MROH6,maestro heat like repeat family member 6,2,,,ppi
9751,11419,286075,ZNF707,zinc finger protein 707,58,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9752,11420,286097,MICU3,mitochondrial calcium uptake family member 3,3,,,ppi
9753,11422,286148,DPY19L4,dpy-19 like 4 (C. elegans),15,mannosyltransferase activity,,ppi
9754,11423,286207,CFAP157,cilia and flagella associated protein 157,1,microtubule binding,,ppi
9755,11425,286257,C9orf142,chromosome 9 open reading frame 142,7,protein-containing complex scaffold activity|protein homodimerization activity,,ppi
9756,11426,286436,H2BFM,H2B histone family member M,1,DNA binding,,ppi
9757,11427,338692,ANKRD13D,ankyrin repeat domain 13D,23,,,ppi
9758,11429,338809,C12orf74,chromosome 12 open reading frame 74,5,,,ppi
9759,11431,339210,C17orf67,chromosome 17 open reading frame 67,2,,,ppi
9760,11432,339229,OXLD1,oxidoreductase like domain containing 1,46,,,ppi
9761,11433,339231,ARL16,ADP ribosylation factor like GTPase 16,4,,,ppi
9762,11435,339287,MSL1,male specific lethal 1 homolog,38,chromatin binding,,ppi
9763,11436,339366,ADAMTSL5,ADAMTS like 5,6,heparin binding,,ppi
9764,11437,339448,C1orf174,chromosome 1 open reading frame 174,12,,,ppi
9765,11439,339745,SPOPL,speckle type BTB/POZ protein like,2,ubiquitin protein ligase binding,,ppi
9766,11443,339834,CCDC36,coiled-coil domain containing 36,37,,,ppi
9767,11445,339967,TMPRSS11A,transmembrane protease; serine 11A,9,,,ppi
9768,11447,340061,TMEM173,transmembrane protein 173,47,transcription factor binding|protein kinase binding|cyclic-di-GMP binding|protein homodimerization activity|cyclic-GMP-AMP binding,Chilblain lupus|esophagus squamous cell carcinoma,ppi
9769,11448,340069,FAM170A,family with sequence similarity 170 member A,14,,,ppi
9770,11449,340156,MYLK4,myosin light chain kinase family member 4,5,myosin light chain kinase activity,,ppi
9771,11450,340277,FAM221A,family with sequence similarity 221 member A,3,,,ppi
9772,11452,340385,ZNF517,zinc finger protein 517,25,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9773,11454,79977,GRHL2,grainyhead like transcription factor 2,7,DNA-binding transcription factor activity; RNA polymerase II-specific|intronic transcription regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|chromatin DNA binding|sequence-specific DNA binding,autosomal dominant nonsyndromic deafness 28,ppi
9774,11455,340542,BEX5,brain expressed X-linked 5,3,,,ppi
9775,11458,343068,PRAMEF5,PRAME family member 5,3,,,ppi
9776,11460,343071,PRAMEF10,PRAME family member 10,2,,,ppi
9777,11461,346653,FAM71F2,family with sequence similarity 71 member F2,2,,,ppi
9778,11462,146,ADRA1D,adrenoceptor alpha 1D,18,adrenergic receptor activity,,ppi
9779,11463,348094,ANKDD1A,ankyrin repeat and death domain containing 1A,2,,,ppi
9780,11464,348180,CTU2,cytosolic thiouridylase subunit 2,30,sulfurtransferase activity,,ppi
9781,11465,348235,SKA2,spindle and kinetochore associated complex subunit 2,12,microtubule binding,,ppi
9782,11466,348262,MCRIP1,MAPK regulated corepressor interacting protein 1,3,,,ppi
9783,11467,348801,LNP1,leukemia NUP98 fusion partner 1,1,,,ppi
9784,11468,348938,NIPAL4,NIPA like domain containing 4,3,,autosomal recessive congenital ichthyosis 1|congenital ichthyosiform erythroderma|autosomal recessive congenital ichthyosis 2|autosomal recessive congenital ichthyosis 3|autosomal recessive congenital ichthyosis 4A|autosomal recessive congenital ichthyosis 5|autosomal recessive congenital ichthyosis 6|autosomal recessive congenital ichthyosis 7|autosomal recessive congenital ichthyosis 8|autosomal recessive congenital ichthyosis 9|autosomal recessive congenital ichthyosis 10,ppi
9785,11469,349136,WDR86,WD repeat domain 86,13,,,ppi
9786,11470,374955,SPATA21,spermatogenesis associated 21,1,,liver cancer|polycystic ovary syndrome,ppi
9787,11472,51058,ZNF691,zinc finger protein 691,2,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region DNA binding|DNA-binding transcription factor activity,,ppi
9788,11473,51059,FAM135B,family with sequence similarity 135 member B,2,,,ppi
9789,11474,51061,TXNDC11,thioredoxin domain containing 11,50,,,ppi
9790,11475,51233,DRICH1,aspartate rich 1,8,,,ppi
9791,11476,51234,EMC4,ER membrane protein complex subunit 4,20,,,ppi
9792,11477,51244,CCDC174,coiled-coil domain containing 174,9,,,ppi
9793,11478,51248,PDZD11,PDZ domain containing 11,18,,,ppi
9794,11480,51252,FAM178B,family with sequence similarity 178 member B,2,,,ppi
9795,11481,51255,RNF181,ring finger protein 181,32,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
9796,11482,51257,MARCH2,membrane associated ring-CH-type finger 2,13,ubiquitin-protein transferase activity,,ppi
9797,11483,51315,KRCC1,lysine rich coiled-coil 1,3,,,ppi
9798,11484,51320,MEX3C,mex-3 RNA binding family member C,101,RNA binding,hypertension|essential hypertension,ppi
9799,11485,51321,AMZ2,archaelysin family metallopeptidase 2,16,peptidase activity,,ppi
9800,11486,54103,GSAP,gamma-secretase activating protein,4,amyloid-beta binding,,ppi
9801,11487,55565,ZNF821,zinc finger protein 821,5,transcription regulatory region DNA binding|DNA-binding transcription factor activity,,ppi
9802,11489,55924,FAM212B,family with sequence similarity 212 member B,9,protein serine/threonine kinase inhibitor activity,,ppi
9803,11490,55954,ZMAT5,zinc finger matrin-type 5,19,,,ppi
9804,11491,57019,CIAPIN1,cytokine induced apoptosis inhibitor 1,48,2 iron; 2 sulfur cluster binding,,ppi
9805,11492,57821,CCDC181,coiled-coil domain containing 181,1,microtubule binding,,ppi
9806,11493,63929,XPNPEP3,X-prolyl aminopeptidase 3,25,aminopeptidase activity|manganese ion binding|metalloaminopeptidase activity,nephronophthisis,ppi
9807,11494,65243,ZFP69B,ZFP69 zinc finger protein B,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9808,11495,89887,ZNF628,zinc finger protein 628,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9809,11496,89958,SAPCD2,suppressor APC domain containing 2,9,,,ppi
9810,11497,90288,EFCAB12,EF-hand calcium binding domain 12,2,,,ppi
9811,11498,90317,ZNF616,zinc finger protein 616,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9812,11499,90321,ZNF766,zinc finger protein 766,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9813,11501,100289635,ZNF605,zinc finger protein 605,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9814,11503,90576,ZNF799,zinc finger protein 799,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9815,11504,90624,LYRM7,LYR motif containing 7,21,,mitochondrial complex III deficiency nuclear type 8,ppi
9816,11505,90637,ZFAND2A,zinc finger AN1-type containing 2A,2,,,ppi
9817,11506,90639,COX19,COX19; cytochrome c oxidase assembly factor,1,,,ppi
9818,11507,90835,CCDC189,coiled-coil domain containing 189,2,,,ppi
9819,11508,90850,ZNF598,zinc finger protein 598,33,RNA binding|ribosome binding|ubiquitin protein ligase activity,,ppi
9820,11509,91373,UAP1L1,UDP-N-acetylglucosamine pyrophosphorylase 1 like 1,6,UDP-N-acetylglucosamine diphosphorylase activity,,ppi
9821,11510,91464,ISX,intestine specific homeobox,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9822,11511,91942,NDUFAF2,NADH:ubiquinone oxidoreductase complex assembly factor 2,16,,Leigh disease|mitochondrial complex I deficiency,ppi
9823,11512,91947,ARRDC4,arrestin domain containing 4,10,protein binding; bridging involved in substrate recognition for ubiquitination,,ppi
9824,11513,91966,CXorf40A,chromosome X open reading frame 40A,1,,,ppi
9825,11515,92482,BBIP1,BBSome interacting protein 1,11,,Laurence-Moon syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 4|Bardet-Biedl syndrome 5|Bardet-Biedl syndrome 6|Bardet-Biedl syndrome 7|Bardet-Biedl syndrome 8|Bardet-Biedl syndrome 9|Bardet-Biedl syndrome 10|Bardet-Biedl syndrome 11|Bardet-Biedl syndrome 12|Bardet-Biedl syndrome 13|Bardet-Biedl syndrome 14|Bardet-Biedl syndrome 15|Bardet-Biedl syndrome 16|Bardet-Biedl syndrome 17|Bardet-Biedl syndrome 18,ppi
9826,11516,92558,BICDL1,BICD family like cargo adaptor 1,1,Rab GTPase binding|dynactin binding,,ppi
9827,11518,92922,CCDC102A,coiled-coil domain containing 102A,24,,,ppi
9828,11519,150,ADRA2A,adrenoceptor alpha 2A,14,alpha2-adrenergic receptor activity|alpha-1B adrenergic receptor binding|heterotrimeric G-protein binding|protein homodimerization activity|protein heterodimerization activity|epinephrine binding|norepinephrine binding|adrenergic receptor activity,alcohol dependence|alcohol abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|heart disease|cardiovascular system disease|hypertension|essential hypertension|panic disorder|schizophrenia|mood disorder,ppi
9829,11520,1687,DFNA5,DFNA5; deafness associated tumor suppressor,18,phosphatidylinositol-4;5-bisphosphate binding|cardiolipin binding,rheumatoid arthritis|sensorineural hearing loss|autosomal dominant nonsyndromic deafness 5,ppi
9830,11521,93380,MMGT1,membrane magnesium transporter 1,110,magnesium ion transmembrane transporter activity|inorganic cation transmembrane transporter activity,,ppi
9831,11523,116135,LRRC3B,leucine rich repeat containing 3B,1,,large intestine cancer|colorectal cancer|stomach cancer,ppi
9832,11524,27346,TMEM97,transmembrane protein 97,13,,,ppi
9833,11525,60490,PPCDC,phosphopantothenoylcysteine decarboxylase,9,phosphopantothenoylcysteine decarboxylase activity,,ppi
9834,11526,60492,CCDC90B,coiled-coil domain containing 90B,29,,,ppi
9835,11527,220134,SKA1,spindle and kinetochore associated complex subunit 1,46,microtubule binding,,ppi
9836,11528,134510,UBLCP1,ubiquitin like domain containing CTD phosphatase 1,31,protein serine/threonine phosphatase activity,,ppi
9837,11529,255520,ELMOD2,ELMO domain containing 2,2,GTPase activator activity,idiopathic interstitial pneumonia|idiopathic pulmonary fibrosis,ppi
9838,11530,23016,EXOSC7,exosome component 7,42,3'-5'-exoribonuclease activity|RNA binding|exoribonuclease activity|AU-rich element binding,,ppi
9839,11531,126133,ALDH16A1,aldehyde dehydrogenase 16 family member A1,22,,gout|Lesch-Nyhan syndrome|hyperuricemia,ppi
9840,11532,219899,TBCEL,tubulin folding cofactor E like,3,,,ppi
9841,11533,80772,CPTP,ceramide-1-phosphate transfer protein,8,phospholipid binding|phospholipid transporter activity|ceramide 1-phosphate binding|ceramide 1-phosphate transporter activity|lipid binding,,ppi
9842,11534,79171,RBM42,RNA binding motif protein 42,68,RNA binding,,ppi
9843,11535,81576,CCDC130,coiled-coil domain containing 130,17,,,ppi
9844,11536,112936,VPS26B,VPS26; retromer complex component B,46,protein transporter activity,,ppi
9845,11537,84726,PRRC2B,proline rich coiled-coil 2B,38,RNA binding,,ppi
9846,11538,84313,VPS25,vacuolar protein sorting 25 homolog,30,protein homodimerization activity|structural molecule activity,,ppi
9847,11539,84779,NAA11,N(alpha)-acetyltransferase 11; NatA catalytic subunit,2,peptide alpha-N-acetyltransferase activity|peptide-glutamate-N-acetyltransferase activity|peptide-serine-N-acetyltransferase activity,,ppi
9848,11540,79363,RSG1,REM2 and RAB like small GTPase 1,7,,,ppi
9849,11541,84314,TMEM107,transmembrane protein 107,4,,,ppi
9850,11542,79411,GLB1L,galactosidase beta 1 like,5,beta-galactosidase activity,,ppi
9851,11543,80758,PRR7,proline rich 7; synaptic,2,,,ppi
9852,11545,84260,TCHP,trichoplein keratin filament binding,57,,,ppi
9853,11546,84261,FBXW9,F-box and WD repeat domain containing 9,5,ubiquitin-protein transferase activity,,ppi
9854,11547,80763,SPX,spexin hormone,1,neuropeptide hormone activity,,ppi
9855,11548,80774,LIMD2,LIM domain containing 2,1,,breast cancer,ppi
9856,11549,80775,TMEM177,transmembrane protein 177,33,,,ppi
9857,11550,84267,C9orf64,chromosome 9 open reading frame 64,14,,,ppi
9858,11551,84272,YIPF4,Yip1 domain family member 4,20,,,ppi
9859,11552,84285,EIF1AD,eukaryotic translation initiation factor 1A domain containing,18,,melanoma|skin melanoma,ppi
9860,11553,84270,CARD19,caspase recruitment domain family member 19,8,CARD domain binding,,ppi
9861,11555,79174,CRELD2,cysteine rich with EGF like domains 2,40,,,ppi
9862,11556,79172,CENPO,centromere protein O,32,protein binding,,ppi
9863,11557,79173,C19orf57,chromosome 19 open reading frame 57,30,protein binding,,ppi
9864,11558,84309,NUDT16L1,nudix hydrolase 16 like 1,24,RNA binding|snoRNA binding|protein homodimerization activity|m7G(5')pppN diphosphatase activity,,ppi
9865,11559,79176,FBXL15,F-box and leucine rich repeat protein 15,21,ubiquitin-protein transferase activity,,ppi
9866,11560,84975,MFSD5,major facilitator superfamily domain containing 5,19,,,ppi
9867,11561,84803,GPAT3,glycerol-3-phosphate acyltransferase 3,9,1-acylglycerol-3-phosphate O-acyltransferase activity|glycerol-3-phosphate O-acyltransferase activity,,ppi
9868,11562,84804,MFSD9,major facilitator superfamily domain containing 9,1,,,ppi
9869,11563,81577,GFOD2,glucose-fructose oxidoreductase domain containing 2,4,,,ppi
9870,11564,79364,ZXDC,ZXD family zinc finger C,17,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
9871,11565,78986,DUSP26,dual specificity phosphatase 26,25,phosphoserine phosphatase activity|phosphoprotein phosphatase activity|protein tyrosine phosphatase activity,,ppi
9872,11566,79140,CCDC28B,coiled-coil domain containing 28B,6,,,ppi
9873,11567,133619,PRRC1,proline rich coiled-coil 1,28,,,ppi
9874,11568,84288,EFCAB2,EF-hand calcium binding domain 2,2,,,ppi
9875,11569,93474,ZNF670,zinc finger protein 670,14,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9876,11570,81932,HDHD3,haloacid dehalogenase like hydrolase domain containing 3,5,,,ppi
9877,11571,147339,C18orf25,chromosome 18 open reading frame 25,39,,,ppi
9878,11573,84769,MPV17L2,MPV17 mitochondrial inner membrane protein like 2,2,,,ppi
9879,11574,84317,CCDC115,coiled-coil domain containing 115,24,unfolded protein binding,,ppi
9880,11575,84302,TMEM246,transmembrane protein 246,14,,,ppi
9881,11576,84303,CHCHD6,coiled-coil-helix-coiled-coil-helix domain containing 6,22,protein binding,,ppi
9882,11577,93129,ORAI3,ORAI calcium release-activated calcium modulator 3,2,store-operated calcium channel activity,,ppi
9883,11578,134288,TMEM174,transmembrane protein 174,2,,,ppi
9884,11579,85016,C11orf70,chromosome 11 open reading frame 70,8,,,ppi
9885,11580,84304,NUDT22,nudix hydrolase 22,2,UDP-sugar diphosphatase activity|metal ion binding|GDP-mannose hydrolase activity,,ppi
9886,11581,84281,C2orf88,chromosome 2 open reading frame 88,10,,,ppi
9887,11582,84775,ZNF607,zinc finger protein 607,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9888,11583,84306,PDCD2L,programmed cell death 2 like,23,,,ppi
9889,11584,84283,TMEM79,transmembrane protein 79,16,,,ppi
9890,11585,84527,ZNF559,zinc finger protein 559,5,DNA-binding transcription factor activity; RNA polymerase II-specific,stomach cancer,ppi
9891,11586,84811,BUD13,BUD13 homolog,24,RNA binding,,ppi
9892,11587,151,ADRA2B,adrenoceptor alpha 2B,6,alpha2-adrenergic receptor activity|epinephrine binding|adrenergic receptor activity,focal hand dystonia|blepharospasm|lung disease|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|epilepsy|visual epilepsy|focal epilepsy|partial motor epilepsy|intellectual disability|learning disability,ppi
9893,11588,92595,ZNF764,zinc finger protein 764,34,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9894,11589,85013,TMEM128,transmembrane protein 128,22,,,ppi
9895,11590,84318,CCDC77,coiled-coil domain containing 77,32,,,ppi
9896,11591,84284,NTPCR,nucleoside-triphosphatase; cancer-related,39,RNA binding,,ppi
9897,11592,83695,RHNO1,RAD9-HUS1-RAD1 interacting nuclear orphan 1,14,,,ppi
9898,11593,84315,MON1A,MON1 homolog A; secretory trafficking associated,10,guanyl-nucleotide exchange factor activity,iron metabolism disease|hemochromatosis|Wilson disease,ppi
9899,11595,84984,CEP19,centrosomal protein 19,102,,,ppi
9900,11596,84985,FAM83A,family with sequence similarity 83 member A,7,protein kinase binding|phosphatidylinositol 3-kinase regulatory subunit binding,,ppi
9901,11597,85014,TMEM141,transmembrane protein 141,3,,,ppi
9902,11598,84316,NAA38,N(alpha)-acetyltransferase 38; NatC auxiliary subunit,20,,,ppi
9903,11599,84992,PIGY,phosphatidylinositol glycan anchor biosynthesis class Y,2,phosphatidylinositol N-acetylglucosaminyltransferase activity,,ppi
9904,11600,84978,FRMD5,FERM domain containing 5,25,integrin binding|protein kinase binding,,ppi
9905,11601,84987,COX14,COX14; cytochrome c oxidase assembly factor,5,,cytochrome-c oxidase deficiency disease,ppi
9906,11602,94107,TMEM203,transmembrane protein 203,2,,,ppi
9907,11603,84817,TXNDC17,thioredoxin domain containing 17,33,peroxidase activity|protein-disulfide reductase activity,esophagus squamous cell carcinoma,ppi
9908,11604,84993,UBL7,ubiquitin like 7,48,,,ppi
9909,11605,84294,UTP23,UTP23; small subunit processome component,34,RNA binding|mRNA 3'-UTR binding|mRNA 5'-UTR binding|small ribosomal subunit rRNA binding,,ppi
9910,11606,84296,GINS4,GINS complex subunit 4,43,3'-5' DNA helicase activity,,ppi
9911,11607,127495,LRRC39,leucine rich repeat containing 39,11,,,ppi
9912,11608,84298,LLPH,LLP homolog; long-term synaptic facilitation,16,basal RNA polymerase II transcription machinery binding|RNA binding,,ppi
9913,11609,84299,MIEN1,migration and invasion enhancer 1,5,,,ppi
9914,11610,91369,ANKRD40,ankyrin repeat domain 40,30,,,ppi
9915,11611,84836,ABHD14B,abhydrolase domain containing 14B,6,hydrolase activity,,ppi
9916,11612,84960,CCDC183,coiled-coil domain containing 183,31,,,ppi
9917,11613,124565,SLC38A10,solute carrier family 38 member 10,11,amino acid transmembrane transporter activity,,ppi
9918,11614,91775,NXPE3,neurexophilin and PC-esterase domain family member 3,8,,,ppi
9919,11615,84329,HVCN1,hydrogen voltage gated channel 1,8,voltage-gated cation channel activity|voltage-gated proton channel activity,,ppi
9920,11616,84842,HPDL,4-hydroxyphenylpyruvate dioxygenase like,15,4-hydroxyphenylpyruvate dioxygenase activity,,ppi
9921,11618,84966,IGSF21,immunoglobin superfamily member 21,32,protein homodimerization activity|cell adhesion molecule binding|signaling receptor activity,urinary bladder cancer,ppi
9922,11619,85012,TCEAL3,transcription elongation factor A like 3,1,WW domain binding,,ppi
9923,11621,85007,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,8,lyase activity,,ppi
9924,11622,84970,C1orf94,chromosome 1 open reading frame 94,73,,,ppi
9925,11623,91523,PCED1B,PC-esterase domain containing 1B,5,,,ppi
9926,11624,93627,TBCK,TBC1 domain containing kinase,5,protein kinase activity|ATP binding|Rab GTPase binding|GTPase activator activity,,ppi
9927,11625,84333,PCGF5,polycomb group ring finger 5,41,DNA-binding transcription factor activity|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
9928,11628,92806,CENPBD1,CENPB DNA-binding domain containing 1,2,,,ppi
9929,11629,115572,FAM46B,family with sequence similarity 46 member B,5,,,ppi
9930,11630,148753,FAM163A,family with sequence similarity 163 member A,6,,,ppi
9931,11632,196410,METTL7B,methyltransferase like 7B,5,,,ppi
9932,11633,170082,TCEANC,transcription elongation factor A N-terminal and central domain containing,37,,,ppi
9933,11634,126282,TNFAIP8L1,TNF alpha induced protein 8 like 1,6,,,ppi
9934,11636,90488,TMEM263,transmembrane protein 263,9,,,ppi
9935,11637,146395,GSG1L,GSG1 like,1,,,ppi
9936,11639,162394,SLFN5,schlafen family member 5,8,,,ppi
9937,11640,199857,ALG14,ALG14; UDP-N-acetylglucosaminyltransferase subunit,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,congenital myasthenic syndrome,ppi
9938,11641,113277,TMEM106A,transmembrane protein 106A,2,,,ppi
9939,11642,90324,CCDC97,coiled-coil domain containing 97,23,,,ppi
9940,11643,138311,FAM69B,family with sequence similarity 69 member B,5,,,ppi
9941,11644,91603,ZNF830,zinc finger protein 830,22,,,ppi
9942,11645,163126,EID2,EP300 interacting inhibitor of differentiation 2,19,SMAD binding,,ppi
9943,11647,90416,C15orf57,chromosome 15 open reading frame 57,4,,,ppi
9944,11648,89891,WDR34,WD repeat domain 34,35,ATP-dependent microtubule motor activity; plus-end-directed|dynein light chain binding|dynein heavy chain binding,asphyxiating thoracic dystrophy 1|asphyxiating thoracic dystrophy 3|short-rib thoracic dysplasia 11 with or without polydactyly,ppi
9945,11649,348013,TMEM255B,transmembrane protein 255B,5,,,ppi
9946,11650,126321,MFSD12,major facilitator superfamily domain containing 12,5,,,ppi
9947,11651,152,ADRA2C,adrenoceptor alpha 2C,5,alpha2-adrenergic receptor activity|protein homodimerization activity|epinephrine binding|adrenergic receptor activity,bipolar disorder|congestive heart failure|mood disorder,ppi
9948,11652,115024,NT5C3B,5'-nucleotidase; cytosolic IIIB,4,5'-nucleotidase activity,,ppi
9949,11653,220164,DOK6,docking protein 6,6,,,ppi
9950,11654,201255,LRRC45,leucine rich repeat containing 45,6,,,ppi
9951,11655,115948,CCDC151,coiled-coil domain containing 151,30,,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1,ppi
9952,11656,286451,YIPF6,Yip1 domain family member 6,8,,,ppi
9953,11657,147184,TMEM99,transmembrane protein 99,1,,,ppi
9954,11659,131408,FAM131A,family with sequence similarity 131 member A,2,,,ppi
9955,11660,283870,BRICD5,BRICHOS domain containing 5,1,,,ppi
9956,11661,92241,RCSD1,RCSD domain containing 1,6,,,ppi
9957,11662,192286,HIGD2A,HIG1 hypoxia inducible domain family member 2A,3,,liver cancer,ppi
9958,11663,200424,TET3,tet methylcytosine dioxygenase 3,23,DNA-binding transcription factor activity; RNA polymerase II-specific|methylcytosine dioxygenase activity|iron ion binding,autistic disorder,ppi
9959,11664,79145,CHCHD7,coiled-coil-helix-coiled-coil-helix domain containing 7,1,,,ppi
9960,11665,493911,PHOSPHO2,phosphatase; orphan 2,4,,,ppi
9961,11666,202374,STK32A,serine/threonine kinase 32A,1,protein serine/threonine kinase activity,,ppi
9962,11667,127255,LRRIQ3,leucine rich repeats and IQ motif containing 3,4,,,ppi
9963,11668,157310,PEBP4,phosphatidylethanolamine binding protein 4,3,protein binding,,ppi
9964,11669,221908,PPP1R35,protein phosphatase 1 regulatory subunit 35,8,,,ppi
9965,11670,118932,ANKRD22,ankyrin repeat domain 22,2,,,ppi
9966,11671,147807,ZNF524,zinc finger protein 524,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9967,11672,221504,ZBTB9,zinc finger and BTB domain containing 9,45,,,ppi
9968,11673,126259,TMIGD2,transmembrane and immunoglobulin domain containing 2,1,coreceptor activity,,ppi
9969,11674,147015,DHRS13,dehydrogenase/reductase 13,5,,,ppi
9970,11675,196441,ZFC3H1,zinc finger C3H1-type containing,87,RNA binding,,ppi
9971,11677,146456,TMED6,transmembrane p24 trafficking protein 6,34,,,ppi
9972,11678,151903,CCDC12,coiled-coil domain containing 12,30,,,ppi
9973,11679,139596,UPRT,uracil phosphoribosyltransferase homolog,9,uridine kinase activity,,ppi
9974,11680,160287,LDHAL6A,lactate dehydrogenase A like 6A,28,,,ppi
9975,11681,56849,TCEAL7,transcription elongation factor A like 7,1,WW domain binding,prostate cancer|prostate carcinoma,ppi
9976,11682,203228,C9orf72,chromosome 9 open reading frame 72,9,Rab GTPase binding|Rab guanyl-nucleotide exchange factor activity,progressive muscular atrophy|amyotrophic lateral sclerosis|bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia|FTDALS1,ppi
9977,11683,160518,DENND5B,DENN domain containing 5B,3,Rab guanyl-nucleotide exchange factor activity,,ppi
9978,11684,149563,C1orf64,chromosome 1 open reading frame 64,2,,,ppi
9979,11685,131965,METTL6,methyltransferase like 6,9,,breast cancer,ppi
9980,11686,128346,C1orf162,chromosome 1 open reading frame 162,3,,,ppi
9981,11687,125228,FAM210A,family with sequence similarity 210 member A,13,,,ppi
9982,11688,116028,RMI2,RecQ mediated genome instability 2,12,,,ppi
9983,11689,65988,ZNF747,zinc finger protein 747,16,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9984,11690,79081,LBHD1,LBH domain containing 1,10,,,ppi
9985,11691,79004,CUEDC2,CUE domain containing 2,20,,,ppi
9986,11692,163154,PRR22,proline rich 22,3,,,ppi
9987,11693,123355,LRRC28,leucine rich repeat containing 28,8,,,ppi
9988,11694,125058,TBC1D16,TBC1 domain family member 16,23,GTPase activator activity|Rab GTPase binding,,ppi
9989,11695,79177,ZNF576,zinc finger protein 576,19,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9990,11696,728294,D2HGDH,D-2-hydroxyglutarate dehydrogenase,14,(R)-2-hydroxyglutarate dehydrogenase activity|FAD binding|D-lactate dehydrogenase (cytochrome) activity,amino acid metabolic disorder|D-2-hydroxyglutaric aciduria,ppi
9991,11697,79080,CCDC86,coiled-coil domain containing 86,23,RNA binding,schizophrenia,ppi
9992,11698,79016,DDA1,DET1 and DDB1 associated 1,80,,,ppi
9993,11699,84056,KATNAL1,katanin catalytic subunit A1 like 1,8,microtubule-severing ATPase activity|ATPase activity,,ppi
9994,11700,79000,AUNIP,aurora kinase A and ninein interacting protein,6,damaged DNA binding,,ppi
9995,11701,84614,ZBTB37,zinc finger and BTB domain containing 37,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
9996,11702,79091,METTL22,methyltransferase like 22,18,protein methyltransferase activity|protein-lysine N-methyltransferase activity,,ppi
9997,11703,79228,THOC6,THO complex 6,52,,,ppi
9998,11704,79414,LRFN3,leucine rich repeat and fibronectin type III domain containing 3,22,,,ppi
9999,11705,133022,TRAM1L1,translocation associated membrane protein 1-like 1,1,,,ppi
10000,11706,196477,CCER1,coiled-coil glutamate rich protein 1,7,,,ppi
10001,11707,133690,CAPSL,calcyphosine like,1,,,ppi
10002,11708,81605,URM1,ubiquitin related modifier 1,18,sulfurtransferase activity,stomach cancer,ppi
10003,11709,145773,FAM81A,family with sequence similarity 81 member A,1,,,ppi
10004,11710,284439,SLC25A42,solute carrier family 25 member 42,1,ATP transmembrane transporter activity|ADP transmembrane transporter activity|coenzyme A transmembrane transporter activity|adenosine-diphosphatase activity|AMP transmembrane transporter activity,,ppi
10005,11711,158747,MOSPD2,motile sperm domain containing 2,22,,,ppi
10006,11712,148254,ZNF555,zinc finger protein 555,6,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10007,11714,285237,C3orf38,chromosome 3 open reading frame 38,3,,,ppi
10008,11715,200403,VWA3B,von Willebrand factor A domain containing 3B,2,,,ppi
10009,11716,132989,C4orf36,chromosome 4 open reading frame 36,1,,,ppi
10010,11717,131375,LYZL4,lysozyme like 4,1,,,ppi
10011,11718,219670,ENKUR,enkurin; TRPC channel interacting protein,1,calmodulin binding,,ppi
10012,11719,164684,WBP2NL,WBP2 N-terminal like,6,WW domain binding|transcription coactivator activity|chromatin DNA binding,,ppi
10013,11720,127281,FAM213B,family with sequence similarity 213 member B,7,oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor|prostaglandin-F synthase activity|antioxidant activity,,ppi
10014,11721,203328,SUSD3,sushi domain containing 3,22,,,ppi
10015,11723,124044,SPATA2L,spermatogenesis associated 2 like,5,,,ppi
10016,11724,166929,SGMS2,sphingomyelin synthase 2,4,sphingomyelin synthase activity|ceramide cholinephosphotransferase activity,,ppi
10017,11725,91147,TMEM67,transmembrane protein 67,75,,liver cirrhosis|Joubert syndrome|Laurence-Moon syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 4|Bardet-Biedl syndrome 5|Bardet-Biedl syndrome 6|Bardet-Biedl syndrome 7|Bardet-Biedl syndrome 8|Bardet-Biedl syndrome 9|Bardet-Biedl syndrome 10|Bardet-Biedl syndrome 11|Bardet-Biedl syndrome 12|Bardet-Biedl syndrome 13|Bardet-Biedl syndrome 14|Bardet-Biedl syndrome 15|Bardet-Biedl syndrome 16,ppi
10018,11726,153745,FAM71B,family with sequence similarity 71 member B,2,,,ppi
10019,11727,254268,AKNAD1,AKNA domain containing 1,4,,,ppi
10020,11728,169966,FAM46D,family with sequence similarity 46 member D,2,RNA adenylyltransferase activity,,ppi
10021,11729,728911,CT45A2,cancer/testis antigen family 45 member A2,2,,,ppi
10022,11730,166863,RBM46,RNA binding motif protein 46,2,,,ppi
10023,11732,93587,TRMT10A,tRNA methyltransferase 10A,11,tRNA binding|RNA binding|tRNA (guanine-N1-)-methyltransferase activity,,ppi
10024,11733,163486,DENND1B,DENN domain containing 1B,2,Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding|phosphatidylinositol phosphate binding,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|primary biliary cirrhosis,ppi
10025,11734,84787,KMT5C,lysine methyltransferase 5C,12,histone-lysine N-methyltransferase activity,,ppi
10026,11735,151649,PP2D1,protein phosphatase 2C like domain containing 1,1,,,ppi
10027,11736,205564,SENP5,SUMO1/sentrin specific peptidase 5,18,SUMO-specific endopeptidase activity,,ppi
10028,11737,151827,LRRC34,leucine rich repeat containing 34,2,,,ppi
10029,11738,84259,DCUN1D5,defective in cullin neddylation 1 domain containing 5,34,ubiquitin conjugating enzyme binding|ubiquitin-like protein binding|cullin family protein binding,,ppi
10030,11739,79035,NABP2,nucleic acid binding protein 2,44,single-stranded DNA binding|G-rich strand telomeric DNA binding|C-rich strand telomeric DNA binding,,ppi
10031,11740,92400,RBM18,RNA binding motif protein 18,12,,,ppi
10032,11742,80755,AARSD1,alanyl-tRNA synthetase domain containing 1,155,Ser-tRNA(Ala) hydrolase activity,,ppi
10033,11743,127396,ZNF684,zinc finger protein 684,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10034,11744,79086,SMIM7,small integral membrane protein 7,1,,,ppi
10035,11745,79036,KXD1,KxDL motif containing 1,48,,,ppi
10036,11746,80746,TSEN2,tRNA splicing endonuclease subunit 2,25,tRNA-intron endonuclease activity,microcephaly|movement disease|lingual-facial-buccal dyskinesia|pontocerebellar hypoplasia type 2B|intellectual disability|learning disability,ppi
10037,11747,246329,STAC3,SH3 and cysteine rich domain 3,21,,Native American myopathy,ppi
10038,11748,79002,C19orf43,chromosome 19 open reading frame 43,13,3'-5' exonuclease activity|5'-3' exonuclease activity,,ppi
10039,11749,84335,AKT1S1,AKT1 substrate 1,20,,,ppi
10040,11750,79142,PHF23,PHD finger protein 23,14,chromatin binding,,ppi
10041,11751,202052,DNAJC18,DnaJ heat shock protein family (Hsp40) member C18,16,,,ppi
10042,11752,8694,DGAT1,diacylglycerol O-acyltransferase 1,10,diacylglycerol O-acyltransferase activity|transferase activity; transferring acyl groups,familial hyperlipidemia|protein-losing enteropathy|congenital diarrhea 7 with exudative enteropathy,ppi
10043,11753,83460,EMC6,ER membrane protein complex subunit 6,11,,,ppi
10044,11754,116372,LYPD1,LY6/PLAUR domain containing 1,19,,,ppi
10045,11755,283237,TTC9C,tetratricopeptide repeat domain 9C,43,,prostate cancer|prostate carcinoma,ppi
10046,11756,201305,SPNS3,sphingolipid transporter 3 (putative),1,,,ppi
10047,11757,92002,FAM58A,family with sequence similarity 58 member A,17,cyclin-dependent protein serine/threonine kinase regulator activity,,ppi
10048,11758,138162,C9orf116,chromosome 9 open reading frame 116,2,,,ppi
10049,11760,285367,RPUSD3,RNA pseudouridylate synthase domain containing 3,29,RNA binding,,ppi
10050,11762,91782,CHMP7,charged multivesicular body protein 7,14,protein transporter activity,,ppi
10051,11763,27042,DIEXF,digestive organ expansion factor homolog (zebrafish),26,RNA binding|rRNA binding|U3 snoRNA binding,Hirschsprung's disease,ppi
10052,11764,126626,GABPB2,GA binding protein transcription factor beta subunit 2,8,transcription regulatory region DNA binding|protein heterodimerization activity,,ppi
10053,11765,133015,PACRGL,PARK2 coregulated like,5,,,ppi
10054,11766,123207,C15orf40,chromosome 15 open reading frame 40,2,,,ppi
10055,11768,118472,ZNF511,zinc finger protein 511,13,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10056,11769,255043,TMEM86B,transmembrane protein 86B,1,ether hydrolase activity|alkenylglycerophosphocholine hydrolase activity|alkenylglycerophosphoethanolamine hydrolase activity,,ppi
10057,11771,9993,DGCR2,DiGeorge syndrome critical region gene 2,9,,blepharophimosis|isolated cleft palate|cleft palate|endocrine system disease|ventricular septal defect|inguinal hernia|umbilical hernia|omphalocele|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|intellectual disability|learning disability|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X|Nance-Horan syndrome|Muenke Syndrome,ppi
10058,11772,79137,FAM134A,family with sequence similarity 134 member A,24,,schizophrenia,ppi
10059,11773,66000,TMEM108,transmembrane protein 108,23,,,ppi
10060,11774,79018,GID4,GID complex subunit 4 homolog,34,ubiquitin protein ligase activity,,ppi
10061,11775,79139,DERL1,derlin 1,116,signaling receptor activity|MHC class I protein binding,Stevens-Johnson syndrome,ppi
10062,11777,78999,LRFN4,leucine rich repeat and fibronectin type III domain containing 4,64,,,ppi
10063,11778,78994,PRR14,proline rich 14,22,,,ppi
10064,11779,79089,TMUB2,transmembrane and ubiquitin like domain containing 2,12,,,ppi
10065,11780,8214,DGCR6,DiGeorge syndrome critical region gene 6,61,,blepharophimosis|isolated cleft palate|cleft palate|endocrine system disease|ventricular septal defect|inguinal hernia|umbilical hernia|omphalocele|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|intellectual disability|learning disability|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X|Nance-Horan syndrome|Muenke Syndrome,ppi
10066,11781,78995,C17orf53,chromosome 17 open reading frame 53,9,,,ppi
10067,11782,79050,NOC4L,nucleolar complex associated 4 homolog,54,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding,,ppi
10068,11783,79041,TMEM38A,transmembrane protein 38A,7,potassium channel activity,,ppi
10069,11784,79064,TMEM223,transmembrane protein 223,30,,,ppi
10070,11785,203260,CCDC107,coiled-coil domain containing 107,20,,,ppi
10071,11786,84265,POLR3GL,RNA polymerase III subunit G like,17,,,ppi
10072,11787,91442,FAAP24,Fanconi anemia core complex associated protein 24,17,chromatin binding,,ppi
10073,11788,257364,SNX33,sorting nexin 33,19,,,ppi
10074,11789,84245,MRI1,methylthioribose-1-phosphate isomerase 1,12,S-methyl-5-thioribose-1-phosphate isomerase activity,,ppi
10075,11790,54487,DGCR8,DGCR8; microprocessor complex subunit,134,double-stranded RNA binding|heme binding|protein homodimerization activity|primary miRNA binding|ribonuclease III activity,disease of mental health|blepharophimosis|isolated cleft palate|cleft palate|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endocrine system disease|ventricular septal defect|inguinal hernia|umbilical hernia|omphalocele|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|intellectual disability|learning disability,ppi
10076,11791,124936,CYB5D2,cytochrome b5 domain containing 2,14,heme binding,,ppi
10077,11792,79188,TMEM43,transmembrane protein 43,42,,Emery-Dreifuss muscular dystrophy|arrhythmogenic right ventricular dysplasia 5,ppi
10078,11793,84273,NOA1,nitric oxide associated 1,33,RNA binding|GTP binding,,ppi
10079,11794,66005,CHID1,chitinase domain containing 1,9,,,ppi
10080,11795,78992,YIPF2,Yip1 domain family member 2,8,Rab GTPase binding,,ppi
10081,11796,78991,PCYOX1L,prenylcysteine oxidase 1 like,10,prenylcysteine oxidase activity,,ppi
10082,11797,123970,C16orf78,chromosome 16 open reading frame 78,3,,,ppi
10083,11798,80723,SLC35G2,solute carrier family 35 member G2,11,,melanoma|skin melanoma,ppi
10084,11799,255758,TCTEX1D2,Tctex1 domain containing 2,24,,,ppi
10085,11800,153396,TMEM161B,transmembrane protein 161B,6,,,ppi
10086,11801,79066,METTL16,methyltransferase like 16,10,RNA binding|mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity|U6 snRNA 3'-end binding|RNA stem-loop binding|U6 snRNA (adenine-(43)-N(6))-methyltransferase activity|23S rRNA (adenine(1618)-N(6))-methyltransferase activity,,ppi
10087,11802,256471,MFSD8,major facilitator superfamily domain containing 8,22,,neuronal ceroid lipofuscinosis 7,ppi
10088,11803,137362,GOT1L1,glutamic-oxaloacetic transaminase 1-like 1,4,L-aspartate:2-oxoglutarate aminotransferase activity,,ppi
10089,11804,126823,KLHDC9,kelch domain containing 9,6,,,ppi
10090,11805,1606,DGKA,diacylglycerol kinase alpha,7,diacylglycerol kinase activity|kinase activity,,ppi
10091,11806,205428,C3orf58,chromosome 3 open reading frame 58,7,,autistic disorder,ppi
10092,11808,143684,FAM76B,family with sequence similarity 76 member B,21,,,ppi
10093,11811,143888,KDELC2,KDEL motif containing 2,5,glucosyltransferase activity,,ppi
10094,11814,222008,VSTM2A,V-set and transmembrane domain containing 2A,3,identical protein binding,,ppi
10095,11815,153,ADRB1,adrenoceptor beta 1,18,beta-adrenergic receptor activity|Ras guanyl-nucleotide exchange factor activity|norepinephrine binding|adrenergic receptor activity|beta1-adrenergic receptor activity|epinephrine binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
10096,11816,1607,DGKB,diacylglycerol kinase beta,1,diacylglycerol kinase activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
10097,11817,143379,C10orf82,chromosome 10 open reading frame 82,1,,substance abuse|substance-related disorder,ppi
10098,11818,285971,ZNF775,zinc finger protein 775,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10099,11820,256309,CCDC110,coiled-coil domain containing 110,5,,,ppi
10100,11821,284257,BOD1L2,biorientation of chromosomes in cell division 1 like 2,1,,,ppi
10101,11822,144406,WDR66,WD repeat domain 66,2,,,ppi
10102,11823,161829,EXD1,exonuclease 3'-5' domain containing 1,1,RNA binding|protein homodimerization activity|3'-5' exonuclease activity,,ppi
10103,11824,133383,SETD9,SET domain containing 9,4,lysine N-methyltransferase activity,,ppi
10104,11825,139105,BEND2,BEN domain containing 2,2,,,ppi
10105,11826,8527,DGKD,diacylglycerol kinase delta,9,diacylglycerol kinase activity|diacylglycerol binding|protein homodimerization activity|protein heterodimerization activity,,ppi
10106,11827,169792,GLIS3,GLIS family zinc finger 3,9,DNA-binding transcription factor activity; RNA polymerase II-specific,diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21|type 1 diabetes mellitus 22,ppi
10107,11828,125875,CLDND2,claudin domain containing 2,1,,,ppi
10108,11830,90231,KIAA2013,KIAA2013,40,,,ppi
10109,11831,201134,CEP112,centrosomal protein 112,3,,,ppi
10110,11832,286514,MAGEB18,MAGE family member B18,8,,,ppi
10111,11835,160140,C11orf65,chromosome 11 open reading frame 65,5,,,ppi
10112,11836,8526,DGKE,diacylglycerol kinase epsilon,14,diacylglycerol kinase activity|kinase activity,lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|proteinuria|membranoproliferative glomerulonephritis,ppi
10113,11837,145645,TERB2,telomere repeat binding bouquet formation protein 2,1,,,ppi
10114,11838,286151,FBXO43,F-box protein 43,2,,,ppi
10115,11839,221687,RNF182,ring finger protein 182,5,ubiquitin-protein transferase activity,large intestine cancer|colorectal cancer|breast cancer,ppi
10116,11840,204962,SLC44A5,solute carrier family 44 member 5,7,choline transmembrane transporter activity,,ppi
10117,11841,285203,EOGT,EGF domain specific O-linked N-acetylglucosamine transferase,20,protein N-acetylglucosaminyltransferase activity,Adams-Oliver syndrome,ppi
10118,11843,79799,UGT2A3,UDP glucuronosyltransferase family 2 member A3,2,glucuronosyltransferase activity|UDP-glycosyltransferase activity,,ppi
10119,11844,146433,IL34,interleukin 34,1,macrophage colony-stimulating factor receptor binding,polycystic ovary syndrome,ppi
10120,11845,1608,DGKG,diacylglycerol kinase gamma,2,diacylglycerol kinase activity,,ppi
10121,11846,199870,FAM76A,family with sequence similarity 76 member A,1,,,ppi
10122,11847,219743,TYSND1,trypsin domain containing 1,14,serine-type endopeptidase activity,,ppi
10123,11848,285600,KIAA0825,KIAA0825,2,,,ppi
10124,11849,284427,SLC25A41,solute carrier family 25 member 41,84,ATP transmembrane transporter activity,,ppi
10125,11851,220047,CCDC83,coiled-coil domain containing 83,7,,,ppi
10126,11852,161514,TBC1D21,TBC1 domain family member 21,1,Rab GTPase binding|GTPase activator activity,,ppi
10127,11853,169693,TMEM252,transmembrane protein 252,2,,,ppi
10128,11854,283971,CLEC18C,C-type lectin domain family 18 member C,1,polysaccharide binding,,ppi
10129,11855,284359,IZUMO1,izumo sperm-egg fusion 1,20,protein homodimerization activity|protein binding involved in heterotypic cell-cell adhesion,,ppi
10130,11856,160851,DGKH,diacylglycerol kinase eta,8,diacylglycerol kinase activity,bipolar disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia,ppi
10131,11857,160298,C11orf42,chromosome 11 open reading frame 42,2,,,ppi
10132,11858,283238,SLC22A24,solute carrier family 22 member 24,1,,,ppi
10133,11859,127795,C1orf87,chromosome 1 open reading frame 87,16,,,ppi
10134,11860,9162,DGKI,diacylglycerol kinase iota,4,diacylglycerol kinase activity,,ppi
10135,11863,255119,C4orf22,chromosome 4 open reading frame 22,2,,,ppi
10136,11864,124152,IQCK,IQ motif containing K,1,,,ppi
10137,11865,200942,KLHDC8B,kelch domain containing 8B,3,,Hodgkin's lymphoma; lymphocytic-histiocytic predominance|Hodgkin's lymphoma|Hodgkin's lymphoma; lymphocytic depletion|Hodgkin's granuloma|Hodgkin's lymphoma; mixed cellularity,ppi
10138,11867,148581,UBE2U,ubiquitin conjugating enzyme E2 U (putative),69,ubiquitin conjugating enzyme activity,,ppi
10139,11868,1609,DGKQ,diacylglycerol kinase theta,9,diacylglycerol kinase activity|transmembrane receptor protein tyrosine kinase activator activity,Sjogren's syndrome|keratoconjunctivitis sicca,ppi
10140,11871,165100,TEX44,testis expressed 44,2,,,ppi
10141,11873,158297,SAXO1,stabilizer of axonemal microtubules 1,17,microtubule binding,,ppi
10142,11875,339669,TEX33,testis expressed 33,10,,,ppi
10143,11876,254528,MEIOB,meiosis specific with OB domains,2,chromatin binding|single-stranded DNA binding|single-stranded DNA 3'-5' exodeoxyribonuclease activity,,ppi
10144,11877,8525,DGKZ,diacylglycerol kinase zeta,27,diacylglycerol kinase activity|kinase activity,coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction,ppi
10145,11878,139212,PIH1D3,PIH1 domain containing 3,6,chaperone binding,,ppi
10146,11879,256586,LYSMD2,LysM domain containing 2,8,,,ppi
10147,11880,143162,FRMPD2,FERM and PDZ domain containing 2,3,1-phosphatidylinositol binding,,ppi
10148,11883,144193,AMDHD1,amidohydrolase domain containing 1,3,hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds; in cyclic amides,,ppi
10149,11885,1716,DGUOK,deoxyguanosine kinase,70,deoxyguanosine kinase activity|nucleoside kinase activity|deoxynucleoside kinase activity,lactic acidosis|epilepsy|portal hypertension|hypoglycemia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|polyneuropathy|peripheral nervous system disease|neuropathy|visual epilepsy|thrombocytopenia|brain disease|liver disease|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy|Alzheimer's disease|Pick's disease,ppi
10150,11887,340419,RSPO2,R-spondin 2,10,frizzled binding,,ppi
10151,11888,219833,C11orf45,chromosome 11 open reading frame 45,1,,,ppi
10152,11889,79159,NOL12,nucleolar protein 12,94,RNA binding|rRNA binding|single-stranded DNA binding|protein binding,,ppi
10153,11890,90362,FAM110B,family with sequence similarity 110 member B,5,,,ppi
10154,11892,1718,DHCR24,24-dehydrocholesterol reductase,23,delta24(24-1) sterol reductase activity|oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor|delta24-sterol reductase activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|epilepsy|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain,ppi
10155,11893,124790,HEXIM2,hexamethylene bisacetamide inducible 2,34,cyclin-dependent protein serine/threonine kinase inhibitor activity|snRNA binding|7SK snRNA binding,,ppi
10156,11894,144321,GLIPR1L2,GLI pathogenesis related 1 like 2,11,,,ppi
10157,11895,285172,FAM126B,family with sequence similarity 126 member B,5,,,ppi
10158,11896,196472,FAM71C,family with sequence similarity 71 member C,8,,,ppi
10159,11897,148789,B3GALNT2,beta-1;3-N-acetylgalactosaminyltransferase 2,12,acetylglucosaminyltransferase activity|acetylgalactosaminyltransferase activity,Walker-Warburg syndrome|muscular dystrophy-dystroglycanopathy,ppi
10160,11898,257062,CATSPERD,cation channel sperm associated auxiliary subunit delta,2,,,ppi
10161,11899,153733,CCDC112,coiled-coil domain containing 112,14,,,ppi
10162,11900,154,ADRB2,adrenoceptor beta 2,259,amyloid-beta binding|beta2-adrenergic receptor activity|potassium channel regulator activity|protein homodimerization activity|norepinephrine binding|adrenergic receptor activity|epinephrine binding,asthma|intrinsic asthma|allergic asthma|autistic disorder|bipolar disorder|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ,ppi
10163,11901,1717,DHCR7,7-dehydrocholesterol reductase,18,7-dehydrocholesterol reductase activity|NADP binding|sterol delta7 reductase activity,autistic disorder|ptosis|congenital ptosis|isolated cleft palate|cleft palate|constipation|cryptorchidism|Dandy-Walker syndrome|sensorineural hearing loss|patent ductus arteriosus|dermatitis|atrioventricular septal defect|epilepsy|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|gingival overgrowth|gingival hypertrophy|atrial heart septal defect 1,ppi
10164,11902,147011,PROCA1,protein interacting with cyclin A1,1,,,ppi
10165,11903,203562,TMEM31,transmembrane protein 31,2,,,ppi
10166,11904,131831,ERICH6,glutamate rich 6,2,,,ppi
10167,11905,169166,SNX31,sorting nexin 31,2,phosphatidylinositol binding,schizophrenia,ppi
10168,11907,132141,IQCF1,IQ motif containing F1,45,calmodulin binding,,ppi
10169,11908,1719,DHFR,dihydrofolate reductase,15,translation repressor activity; mRNA regulatory element binding|mRNA binding|dihydrofolate reductase activity|folic acid binding|drug binding|folate reductase activity|methotrexate binding|NADPH binding|sequence-specific mRNA binding|NADP binding,megaloblastic anemia|rheumatoid arthritis|autistic disorder|cerebellar disease|large intestine cancer|colorectal cancer|childhood absence epilepsy|inherited metabolic disorder|central nervous system disease|nervous system disease|autonomic neuropathy|osteosarcoma|bone osteosarcoma|pancytopenia|thrombocytopenia|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|breast cancer,ppi
10170,11909,160777,CCDC60,coiled-coil domain containing 60,9,,,ppi
10171,11910,253260,RICTOR,RPTOR independent companion of MTOR complex 2,104,enzyme activator activity,,ppi
10172,11912,150365,MEI1,meiotic double-stranded break formation protein 1,1,,,ppi
10173,11913,100131755,ARMCX4,armadillo repeat containing; X-linked 4,1,,,ppi
10174,11914,255057,CBARP,CACN beta subunit associated regulatory protein,10,ion channel binding,,ppi
10175,11915,254863,TMEM256,transmembrane protein 256,15,,,ppi
10176,11918,144699,FBXL14,F-box and leucine rich repeat protein 14,27,ubiquitin-protein transferase activity,,ppi
10177,11919,137682,NDUFAF6,NADH:ubiquinone oxidoreductase complex assembly factor 6,2,,Leigh disease|mitochondrial complex I deficiency,ppi
10178,11920,255394,TCP11L2,t-complex 11 like 2,11,,,ppi
10179,11921,121053,C12orf45,chromosome 12 open reading frame 45,10,,,ppi
10180,11922,257415,FAM133B,family with sequence similarity 133 member B,6,RNA binding,,ppi
10181,11923,245812,CNPY4,canopy FGF signaling regulator 4,8,signaling receptor binding,,ppi
10182,11924,79230,ZNF557,zinc finger protein 557,10,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10183,11925,92714,ARRDC1,arrestin domain containing 1,36,protein binding; bridging involved in substrate recognition for ubiquitination,,ppi
10184,11926,256356,GK5,glycerol kinase 5 (putative),1,glycerol kinase activity,,ppi
10185,11927,80776,B9D2,B9 protein domain 2,65,gamma-tubulin binding,Meckel syndrome,ppi
10186,11928,84859,LRCH3,leucine rich repeats and calponin homology domain containing 3,34,,,ppi
10187,11929,79153,GDPD3,glycerophosphodiester phosphodiesterase domain containing 3,6,,chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease,ppi
10188,11930,79154,DHRS11,dehydrogenase/reductase 11,5,3-keto sterol reductase activity|estradiol 17-beta-dehydrogenase activity|17-beta-ketosteroid reductase activity|17-beta-hydroxysteroid dehydrogenase (NADP+) activity,,ppi
10189,11931,51239,ANKRD39,ankyrin repeat domain 39,5,,,ppi
10190,11932,84268,RPAIN,RPA interacting protein,9,,,ppi
10191,11933,147685,C19orf18,chromosome 19 open reading frame 18,1,,substance abuse|substance-related disorder,ppi
10192,11934,162972,ZNF550,zinc finger protein 550,32,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10193,11935,340307,CTAGE6,CTAGE family member 6,2,lipoprotein transporter activity,,ppi
10194,11936,167359,NIM1K,NIM1 serine/threonine protein kinase,1,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
10195,11937,129563,DIS3L2,DIS3 like 3'-5' exoribonuclease 2,10,3'-5'-exoribonuclease activity|magnesium ion binding|ribonuclease activity|poly(U) RNA binding,adenosarcoma|nephroblastoma|Perlman syndrome,ppi
10196,11938,50846,DHH,desert hedgehog,9,calcium ion binding|zinc ion binding,gonadal dysgenesis|Turner syndrome|46 XY gonadal dysgenesis|mixed gonadal dysgenesis|infertility|polyneuropathy|peripheral nervous system disease|neuropathy|polycystic ovary syndrome|hypogonadism|premature menopause|androgen insensitivity syndrome|eunuchism|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy|gonadoblastoma|muscular atrophy|isolated growth hormone deficiency|isolated growth hormone deficiency type II,ppi
10197,11939,168417,ZNF679,zinc finger protein 679,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10198,11940,84293,FAM213A,family with sequence similarity 213 member A,23,antioxidant activity,,ppi
10199,11941,339500,ZNF678,zinc finger protein 678,1,,,ppi
10200,11942,84336,TMEM101,transmembrane protein 101,2,,,ppi
10201,11943,254887,ZDHHC23,zinc finger DHHC-type containing 23,6,protein-cysteine S-palmitoyltransferase activity,,ppi
10202,11944,84766,CRACR2A,calcium release activated channel regulator 2A,16,calcium ion binding,,ppi
10203,11945,83607,AMMECR1L,AMMECR1 like,11,,,ppi
10204,11946,147719,LYPD4,LY6/PLAUR domain containing 4,66,,,ppi
10205,11947,81689,ISCA1,iron-sulfur cluster assembly 1,28,2 iron; 2 sulfur cluster binding,,ppi
10206,11948,83475,DOHH,deoxyhypusine hydroxylase/monooxygenase,11,iron ion binding|deoxyhypusine monooxygenase activity|cofactor binding,,ppi
10207,11950,84319,CMSS1,cms1 ribosomal small subunit homolog (yeast),27,RNA binding,,ppi
10208,11951,79098,C1orf116,chromosome 1 open reading frame 116,5,,,ppi
10209,11952,169436,STKLD1,serine/threonine kinase like domain containing 1,5,protein serine/threonine kinase activity,,ppi
10210,11953,1723,DHODH,dihydroorotate dehydrogenase (quinone),13,dihydroorotate dehydrogenase activity,sickle cell anemia|beta thalassemia|choanal atresia|cleft lip|isolated cleft palate|cleft palate|cryptorchidism|ectropion|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|pyloric stenosis|hereditary spherocytosis|syndactyly|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|Hailey-Hailey disease,ppi
10211,11954,79180,EFHD2,EF-hand domain family member D2,30,cadherin binding,,ppi
10212,11955,339327,ZNF546,zinc finger protein 546,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10213,11956,79415,C17orf62,chromosome 17 open reading frame 62,8,,,ppi
10214,11957,84765,ZNF577,zinc finger protein 577,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10215,11959,340547,VSIG1,V-set and immunoglobulin domain containing 1,54,,,ppi
10216,11960,145946,SPATA8,spermatogenesis associated 8,19,,,ppi
10217,11962,219621,C10orf107,chromosome 10 open reading frame 107,3,calcium ion binding,,ppi
10218,11963,79094,CHAC1,ChaC glutathione specific gamma-glutamylcyclotransferase 1,1,gamma-glutamylcyclotransferase activity|Notch binding,,ppi
10219,11964,284406,ZFP82,ZFP82 zinc finger protein,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10220,11965,90843,TCEAL8,transcription elongation factor A like 8,4,WW domain binding,,ppi
10221,11966,93134,ZNF561,zinc finger protein 561,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
10222,11967,132299,OCIAD2,OCIA domain containing 2,6,,,ppi
10223,11968,146556,C16orf89,chromosome 16 open reading frame 89,1,,,ppi
10224,11969,149473,CCDC24,coiled-coil domain containing 24,6,,,ppi
10225,11970,126969,SLC44A3,solute carrier family 44 member 3,1,choline transmembrane transporter activity,,ppi
10226,11971,1725,DHPS,deoxyhypusine synthase,51,deoxyhypusine synthase activity,,ppi
10227,11972,84337,ELOF1,elongation factor 1 homolog,9,RNA polymerase II complex binding,,ppi
10228,11974,125113,KRT222,keratin 222,2,,,ppi
10229,11975,163081,ZNF567,zinc finger protein 567,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10230,11976,284273,ZADH2,zinc binding alcohol dehydrogenase domain containing 2,15,13-prostaglandin reductase activity,,ppi
10231,11977,115752,DIS3L,DIS3 like exosome 3'-5' exoribonuclease,26,3'-5'-exoribonuclease activity|endonuclease activity,,ppi
10232,11978,286133,SCARA5,scavenger receptor class A member 5,3,ferritin receptor activity,,ppi
10233,11980,283229,CRACR2B,calcium release activated channel regulator 2B,6,,,ppi
10234,11981,90381,TICRR,TOPBP1 interacting checkpoint and replication regulator,4,chromatin binding,,ppi
10235,11982,359845,RFLNB,refilin B,6,filamin binding,,ppi
10236,11983,148398,SAMD11,sterile alpha motif domain containing 11,8,,,ppi
10237,11984,79447,PAGR1,PAXIP1 associated glutamate rich protein 1,19,estrogen receptor binding,,ppi
10238,11985,84286,TMEM175,transmembrane protein 175,1,potassium channel activity|potassium ion leak channel activity,,ppi
10239,11986,283933,ZNF843,zinc finger protein 843,6,,,ppi
10240,11987,138429,PIP5KL1,phosphatidylinositol-4-phosphate 5-kinase like 1,3,,,ppi
10241,11988,285555,STPG2,sperm tail PG-rich repeat containing 2,3,,,ppi
10242,11989,127002,ATXN7L2,ataxin 7 like 2,9,,,ppi
10243,11990,84752,B3GNT9,UDP-GlcNAc:betaGal beta-1;3-N-acetylglucosaminyltransferase 9,2,N-acetyllactosaminide beta-1;3-N-acetylglucosaminyltransferase activity|acetylgalactosaminyltransferase activity,rheumatoid arthritis,ppi
10244,11991,128077,LIX1L,limb and CNS expressed 1 like,6,,,ppi
10245,11993,79441,HAUS3,HAUS augmin like complex subunit 3,47,,,ppi
10246,11994,79096,C11orf49,chromosome 11 open reading frame 49,21,,,ppi
10247,11995,138065,RNF183,ring finger protein 183,9,ubiquitin protein ligase activity,,ppi
10248,11996,84274,COQ5,coenzyme Q5; methyltransferase,23,2-octaprenyl-6-methoxy-1;4-benzoquinone methylase activity,intellectual disability|learning disability,ppi
10249,11997,200558,APLF,aprataxin and PNKP like factor,38,nucleotide binding|DNA-(apurinic or apyrimidinic site) endonuclease activity|endodeoxyribonuclease activity|3'-5' exonuclease activity,,ppi
10250,11998,284716,RIMKLA,ribosomal modification protein rimK like family member A,3,N-acetyl-L-aspartate-L-glutamate ligase activity,,ppi
10251,11999,144608,C12orf60,chromosome 12 open reading frame 60,1,,,ppi
10252,12000,79135,APOO,apolipoprotein O,4,protein binding,,ppi
10253,12001,115123,MARCH3,membrane associated ring-CH-type finger 3,10,,,ppi
10254,12002,1727,CYB5R3,cytochrome b5 reductase 3,49,cytochrome-b5 reductase activity; acting on NAD(P)H|FAD binding,intellectual disability|learning disability|methemoglobinemia|sulfhemoglobinemia|polycythemia vera|Chuvash polycythemia|acquired polycythemia|stress polycythemia|erythropoietin polycythemia|polycythemia|ophthalmoplegia|mechanical strabismus|hypertropia|maple syrup urine disease,ppi
10255,12003,342926,ZNF677,zinc finger protein 677,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10256,12004,338872,C1QTNF9,C1q and tumor necrosis factor related protein 9,33,,,ppi
10257,12005,286256,LCN12,lipocalin 12,1,retinoic acid binding,,ppi
10258,12006,123879,DCUN1D3,defective in cullin neddylation 1 domain containing 3,16,ubiquitin conjugating enzyme binding|ubiquitin-like protein binding|cullin family protein binding,,ppi
10259,12007,161753,ODF3L1,outer dense fiber of sperm tails 3 like 1,2,,,ppi
10260,12008,339512,CCDC190,coiled-coil domain containing 190,1,,,ppi
10261,12009,124944,C17orf49,chromosome 17 open reading frame 49,27,,,ppi
10262,12010,253143,PRR14L,proline rich 14 like,14,,,ppi
10263,12011,254013,ETFBKMT,electron transfer flavoprotein beta subunit lysine methyltransferase,12,protein-lysine N-methyltransferase activity,,ppi
10264,12012,1728,NQO1,NAD(P)H quinone dehydrogenase 1,27,RNA binding|cytochrome-b5 reductase activity; acting on NAD(P)H|NAD(P)H dehydrogenase (quinone) activity|electron transfer activity|oxidoreductase activity,alcohol dependence|alcohol abuse|asthma|intrinsic asthma|allergic asthma|urinary bladder cancer|lung cancer|non-small cell lung carcinoma|cholestasis|large intestine cancer|colorectal cancer|contact dermatitis|occupational dermatitis|hemolytic-uremic syndrome|hyperglycemia|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
10265,12013,255762,PDZD9,PDZ domain containing 9,1,,,ppi
10266,12014,286676,ILDR1,immunoglobulin like domain containing receptor 1,4,identical protein binding,autosomal recessive nonsyndromic deafness 42,ppi
10267,12015,253639,ZNF620,zinc finger protein 620,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10268,12016,340348,TSPAN33,tetraspanin 33,5,,,ppi
10269,12018,353149,TBC1D26,TBC1 domain family member 26,1,Rab GTPase binding|GTPase activator activity,,ppi
10270,12019,139341,FUNDC1,FUN14 domain containing 1,16,,,ppi
10271,12021,91582,RPS19BP1,ribosomal protein S19 binding protein 1,29,RNA binding,,ppi
10272,12022,159963,SLC5A12,solute carrier family 5 member 12,1,organic acid:sodium symporter activity|lactate transmembrane transporter activity,,ppi
10273,12023,130574,LYPD6,LY6/PLAUR domain containing 6,37,acetylcholine receptor inhibitor activity,,ppi
10274,12024,220323,OAF,out at first homolog,21,,,ppi
10275,12026,81926,ABHD17A,abhydrolase domain containing 17A,19,palmitoyl-(protein) hydrolase activity,,ppi
10276,12028,79072,FASTKD3,FAST kinase domains 3,79,RNA binding,,ppi
10277,12029,79101,TAF1D,TATA-box binding protein associated factor; RNA polymerase I subunit D,52,,seborrheic keratosis|skin disease|actinic keratosis,ppi
10278,12030,1729,DIAPH1,diaphanous related formin 1,62,RNA binding|signaling receptor binding,epilepsy|sensorineural hearing loss|optic atrophy|visual epilepsy|cortical blindness|autosomal dominant nonsyndromic deafness 1,ppi
10279,12031,84246,MED10,mediator complex subunit 10,74,,,ppi
10280,12032,79029,SPATA5L1,spermatogenesis associated 5 like 1,30,ATPase activity,,ppi
10281,12033,192111,PGAM5,PGAM family member 5; mitochondrial serine/threonine protein phosphatase,83,protein serine/threonine phosphatase activity|GTPase activator activity|phosphatase activity|protein-containing complex binding,,ppi
10282,12034,79025,FNDC11,fibronectin type III domain containing 11,25,,,ppi
10283,12036,84826,SFT2D3,SFT2 domain containing 3,1,,,ppi
10284,12037,128338,DRAM2,DNA damage regulated autophagy modulator 2,1,,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
10285,12038,1730,DIAPH2,diaphanous related formin 2,9,signaling receptor binding,premature menopause|androgen insensitivity syndrome|premature ovarian failure,ppi
10286,12039,79073,TMEM109,transmembrane protein 109,17,protein binding,,ppi
10287,12040,79074,C2orf49,chromosome 2 open reading frame 49,10,,,ppi
10288,12041,54537,FAM35A,family with sequence similarity 35 member A,2,,,ppi
10289,12042,79022,TMEM106C,transmembrane protein 106C,2,,,ppi
10290,12043,79024,SMIM2,small integral membrane protein 2,1,,,ppi
10291,12044,79077,DCTPP1,dCTP pyrophosphatase 1,33,magnesium ion binding|nucleoside-triphosphate diphosphatase activity|dCTP diphosphatase activity,,ppi
10292,12045,150165,XKR3,XK related 3,1,,,ppi
10293,12046,283471,TMPRSS12,transmembrane protease; serine 12,17,,,ppi
10294,12047,145553,MDP1,magnesium dependent phosphatase 1,3,,,ppi
10295,12048,348110,ARPIN,actin-related protein 2/3 complex inhibitor,11,,,ppi
10296,12049,152100,CMC1,C-X9-C motif containing 1,3,,,ppi
10297,12051,130916,MTERF4,mitochondrial transcription termination factor 4,10,rRNA binding,,ppi
10298,12052,348793,WDR53,WD repeat domain 53,6,,,ppi
10299,12053,196383,RILPL2,Rab interacting lysosomal protein like 2,7,dynein light intermediate chain binding|small GTPase binding,,ppi
10300,12054,79012,CAMKV,CaM kinase like vesicle associated,59,calmodulin-dependent protein kinase activity|calmodulin binding,,ppi
10301,12055,51669,SARAF,store-operated calcium entry associated regulatory factor,33,,,ppi
10302,12056,1731,SEPT1,septin 1,21,GTPase activity|protein-containing complex scaffold activity,,ppi
10303,12057,51260,PBDC1,polysaccharide biosynthesis domain containing 1,19,,,ppi
10304,12058,284565,NBPF15,neuroblastoma breakpoint family member 15,2,,,ppi
10305,12059,115353,LRRC42,leucine rich repeat containing 42,12,,,ppi
10306,12060,92342,METTL18,methyltransferase like 18,44,,,ppi
10307,12061,79078,C1orf50,chromosome 1 open reading frame 50,4,identical protein binding,,ppi
10308,12062,114932,MRFAP1L1,Morf4 family associated protein 1 like 1,38,,,ppi
10309,12063,202915,TMEM184A,transmembrane protein 184A,27,heparin binding,,ppi
10310,12064,155,ADRB3,adrenoceptor beta 3,4,beta-adrenergic receptor activity|beta3-adrenergic receptor activity|protein homodimerization activity|norepinephrine binding|adrenergic receptor activity|epinephrine binding,congestive heart failure|familial hyperlipidemia|obesity|schizophrenia|neurotic disorder|endogenous depression|melancholia|mood disorder|major depressive disorder|mental depression,ppi
10311,12065,83638,C11orf68,chromosome 11 open reading frame 68,8,RNA binding,melanoma|skin melanoma,ppi
10312,12066,83608,C18orf21,chromosome 18 open reading frame 21,19,,,ppi
10313,12067,81544,GDPD5,glycerophosphodiester phosphodiesterase domain containing 5,40,,,ppi
10314,12068,80305,TRABD,TraB domain containing,14,,,ppi
10315,12069,55435,AP1AR,adaptor related protein complex 1 associated regulatory protein,4,kinesin binding|AP-1 adaptor complex binding,,ppi
10316,12070,55374,TMCO6,transmembrane and coiled-coil domains 6,8,,,ppi
10317,12071,55471,NDUFAF7,NADH:ubiquinone oxidoreductase complex assembly factor 7,26,methyltransferase activity|protein-arginine omega-N symmetric methyltransferase activity,,ppi
10318,12072,55379,LRRC59,leucine rich repeat containing 59,74,RNA binding|cadherin binding,,ppi
10319,12073,400745,SH2D5,SH2 domain containing 5,4,,,ppi
10320,12074,80335,WDR82,WD repeat domain 82,63,histone methyltransferase activity (H3-K4 specific)|chromatin binding,,ppi
10321,12076,29789,OLA1,Obg like ATPase 1,50,ATP binding|ATPase activity|cadherin binding,,ppi
10322,12077,90273,CEACAM21,carcinoembryonic antigen related cell adhesion molecule 21,44,,schizophrenia,ppi
10323,12078,56269,IRGC,immunity related GTPase cinema,15,GTPase activity,,ppi
10324,12079,56181,MTFR1L,mitochondrial fission regulator 1 like,15,,,ppi
10325,12080,56063,TMEM234,transmembrane protein 234,2,,,ppi
10326,12081,431707,LHX8,LIM homeobox 8,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10327,12082,1734,DIO2,iodothyronine deiodinase 2,13,thyroxine 5'-deiodinase activity|selenium binding,bipolar disorder|endometriosis of uterus|endometriosis|malignant mesothelioma|benign mesothelioma|goiter|thyroid gland disease|autistic disorder,ppi
10328,12085,83759,RBM4B,RNA binding motif protein 4B,65,RNA binding,,ppi
10329,12086,60313,GPBP1L1,GC-rich promoter binding protein 1 like 1,47,DNA-binding transcription factor activity,,ppi
10330,12087,81545,FBXO38,F-box protein 38,18,,,ppi
10331,12088,81857,MED25,mediator complex subunit 25,49,,Charcot-Marie-Tooth disease type 2B2,ppi
10332,12089,55352,COPRS,coordinator of PRMT5 and differentiation stimulator,36,histone binding,,ppi
10333,12090,1735,DIO3,iodothyronine deiodinase 3,3,thyroxine 5'-deiodinase activity,schizophrenia|breast cancer|autistic disorder,ppi
10334,12091,25987,TSKU,tsukushi; small leucine rich proteoglycan,2,,,ppi
10335,12092,93426,SYCE1,synaptonemal complex central element protein 1,32,,,ppi
10336,12093,126119,JOSD2,Josephin domain containing 2,14,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
10337,12094,63934,ZNF667,zinc finger protein 667,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10338,12096,115992,RNF166,ring finger protein 166,78,,,ppi
10339,12098,54681,P4HTM,prolyl 4-hydroxylase; transmembrane,4,oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors|procollagen-proline 4-dioxygenase activity,,ppi
10340,12099,29923,HILPDA,hypoxia inducible lipid droplet associated,2,,,ppi
10341,12100,79031,PDCL3,phosducin like 3,18,,,ppi
10342,12101,59082,CARD18,caspase recruitment domain family member 18,2,,lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma,ppi
10343,12102,25836,NIPBL,NIPBL; cohesin loading factor,36,chromatin binding,generalized anxiety disorder|anxiety disorder|astigmatism|blepharitis|ptosis|congenital ptosis|choanal atresia|cleft lip|isolated cleft palate|cleft palate|cryptorchidism|epilepsy|enophthalmos|orbital disease|exophthalmos|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|sensorineural hearing loss,ppi
10344,12103,10642,IGF2BP1,insulin like growth factor 2 mRNA binding protein 1,116,RNA binding|mRNA binding|mRNA 3'-UTR binding|translation regulator activity|mRNA 5'-UTR binding,,ppi
10345,12104,10644,IGF2BP2,insulin like growth factor 2 mRNA binding protein 2,48,RNA binding|mRNA 3'-UTR binding|translation regulator activity|mRNA 5'-UTR binding,diabetes mellitus|type 2 diabetes mellitus|schizophrenia,ppi
10346,12105,10643,IGF2BP3,insulin like growth factor 2 mRNA binding protein 3,96,RNA binding|mRNA 3'-UTR binding|translation regulator activity|mRNA 5'-UTR binding,malignant mesothelioma|benign mesothelioma,ppi
10347,12106,220004,PPP1R32,protein phosphatase 1 regulatory subunit 32,5,phosphatase binding,,ppi
10348,12107,29969,MDFIC,MyoD family inhibitor domain containing,6,Tat protein binding|transcription factor binding,,ppi
10349,12108,9592,IER2,immediate early response 2,30,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding,,ppi
10350,12109,79679,VTCN1,V-set domain containing T cell activation inhibitor 1,2,signaling receptor binding,,ppi
10351,12110,342510,CD300E,CD300e molecule,5,,,ppi
10352,12111,58511,DNASE2B,deoxyribonuclease 2 beta,36,deoxyribonuclease II activity,,ppi
10353,12113,27185,DISC1,disrupted in schizophrenia 1,134,,autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|Asperger syndrome|mood disorder|intellectual disability|learning disability,ppi
10354,12114,84061,MAGT1,magnesium transporter 1,33,magnesium ion transmembrane transporter activity|dolichyl-diphosphooligosaccharide-protein glycotransferase activity,non-syndromic X-linked intellectual disability,ppi
10355,12115,10207,PATJ,PATJ; crumbs cell polarity complex component,60,,prostate cancer|prostate carcinoma|substance abuse|substance-related disorder,ppi
10356,12116,27068,PPA2,pyrophosphatase (inorganic) 2,42,inorganic diphosphatase activity|protein serine/threonine phosphatase activity,,ppi
10357,12117,23592,LEMD3,LEM domain containing 3,45,,pseudosarcomatous fibromatosis|systemic scleroderma|scleroderma|localized scleroderma|placental insufficiency|hyperostosis|melorheostosis|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|osteopoikilosis|osteopetrosis|osteosclerosis,ppi
10358,12118,23423,TMED3,transmembrane p24 trafficking protein 3,14,,,ppi
10359,12119,149628,PYHIN1,pyrin and HIN domain family member 1,122,,asthma|intrinsic asthma|allergic asthma,ppi
10360,12120,81493,SYNC,syncoilin; intermediate filament protein,41,,,ppi
10361,12121,79924,ADM2,adrenomedullin 2,1,protein-containing complex binding,vascular disease|coronary artery disease,ppi
10362,12122,160897,GPR180,G protein-coupled receptor 180,4,,,ppi
10363,12123,156,GRK2,G protein-coupled receptor kinase 2,192,protein kinase activity|G-protein coupled receptor kinase activity|alpha-2A adrenergic receptor binding|Edg-2 lysophosphatidic acid receptor binding|beta-adrenergic receptor kinase activity,tuberous sclerosis|Marfan syndrome|situs inversus|rheumatoid arthritis|heart disease|cardiovascular system disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|congestive heart failure|hypertension|essential hypertension|allergic contact dermatitis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
10364,12124,1736,DKC1,dyskerin pseudouridine synthase 1,142,telomerase activity|RNA binding|pseudouridine synthase activity|telomerase RNA binding,alopecia|anemia|macrocytic anemia|blepharitis|blood coagulation disease|tongue squamous cell carcinoma|squamous cell carcinoma|conjunctivitis|cryptorchidism|dental caries|placental insufficiency|gingival disease|epulis|hemorrhagic disease|Hodgkin's lymphoma; lymphocytic-histiocytic predominance|Hodgkin's lymphoma|Hodgkin's lymphoma; lymphocytic depletion|Hodgkin's granuloma|Hodgkin's lymphoma; mixed cellularity|tooth agenesis,ppi
10365,12125,50640,PNPLA8,patatin like phospholipase domain containing 8,7,phospholipase A2 activity|ATP binding|calcium-independent phospholipase A2 activity,lactic acidosis|dystonia|mitochondrial myopathy|mitochondrial metabolism disease,ppi
10366,12127,83543,AIF1L,allograft inflammatory factor 1 like,6,actin filament binding|calcium ion binding,,ppi
10367,12128,79693,YRDC,yrdC N6-threonylcarbamoyltransferase domain containing,9,nucleotidyltransferase activity|tRNA binding,,ppi
10368,12131,56521,DNAJC12,DnaJ heat shock protein family (Hsp40) member C12,17,,cholestasis,ppi
10369,12132,28952,CCDC22,coiled-coil domain containing 22,96,cullin family protein binding,aortic valve stenosis|isolated cleft palate|cleft palate|cryptorchidism|Dandy-Walker syndrome|patent ductus arteriosus|atrioventricular septal defect|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|hydrocephalus,ppi
10370,12133,22943,DKK1,dickkopf WNT signaling pathway inhibitor 1,16,growth factor activity|co-receptor binding|receptor antagonist activity|low-density lipoprotein particle receptor binding,endometriosis of uterus|endometriosis|osteoporosis|idiopathic juvenile osteoporosis|breast cancer,ppi
10371,12134,90060,CCDC120,coiled-coil domain containing 120,61,,,ppi
10372,12135,11230,PRAF2,PRA1 domain family member 2,26,,,ppi
10373,12136,11152,WDR45,WD repeat domain 45,16,phosphatidylinositol-3-phosphate binding|phosphatidylinositol-3;5-bisphosphate binding,dystonia|intellectual disability|learning disability|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|secondary Parkinson disease|neurodegenerative disease|Horner's syndrome|neurodegeneration with brain iron accumulation|neurodegeneration with brain iron accumulation 5,ppi
10374,12137,150274,HSCB,HscB mitochondrial iron-sulfur cluster cochaperone,726,chaperone binding,,ppi
10375,12138,55509,BATF3,basic leucine zipper ATF-like transcription factor 3,47,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity,leprosy,ppi
10376,12139,133746,JMY,junction mediating and regulatory protein; p53 cofactor,10,transcription coactivator activity|Arp2/3 complex binding,,ppi
10377,12140,221895,JAZF1,JAZF zinc finger 1,10,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity,diabetes mellitus|type 2 diabetes mellitus|endometrial cancer|endometrial carcinoma|systemic lupus erythematosus|prostate cancer|prostate carcinoma|endometrial stromal sarcoma,ppi
10378,12141,57106,NAT14,N-acetyltransferase 14 (putative),20,,,ppi
10379,12142,27123,DKK2,dickkopf WNT signaling pathway inhibitor 2,1,co-receptor binding|receptor antagonist activity,alcohol dependence|alcohol abuse,ppi
10380,12143,9859,CEP170,centrosomal protein 170,182,,,ppi
10381,12144,221955,DAGLB,diacylglycerol lipase beta,23,acylglycerol lipase activity,,ppi
10382,12146,196374,KRT78,keratin 78,17,,,ppi
10383,12147,112802,KRT71,keratin 71,14,,hypotrichosis,ppi
10384,12148,319101,KRT73,keratin 73,11,,Creutzfeldt-Jakob disease,ppi
10385,12149,121391,KRT74,keratin 74,2,,hypotrichosis,ppi
10386,12150,27122,DKK3,dickkopf WNT signaling pathway inhibitor 3,60,receptor antagonist activity|co-receptor binding,schizophrenia,ppi
10387,12151,338785,KRT79,keratin 79,20,,,ppi
10388,12152,140807,KRT72,keratin 72,8,,,ppi
10389,12153,27121,DKK4,dickkopf WNT signaling pathway inhibitor 4,4,co-receptor binding|receptor antagonist activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia,ppi
10390,12154,200185,KRTCAP2,keratinocyte associated protein 2,14,,,ppi
10391,12157,23160,WDR43,WD repeat domain 43,26,RNA binding,,ppi
10392,12158,441381,LRRC24,leucine rich repeat containing 24,2,,,ppi
10393,12159,440026,TMEM41B,transmembrane protein 41B,8,,,ppi
10394,12160,9657,IQCB1,IQ motif containing B1,229,calmodulin binding,epilepsy|hypertension|essential hypertension|corneal disease|keratoconus|premature menopause|androgen insensitivity syndrome|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|visual epilepsy|blindness|cataract|Leber congenital amaurosis|Senior-Loken syndrome|nephronophthisis,ppi
10395,12161,10913,EDAR,ectodysplasin A receptor,8,transmembrane signaling receptor activity|signaling receptor activity,alopecia|hypohidrosis|anhidrosis|Clouston syndrome|tooth agenesis|anodontia|hypotrichosis|hypohidrotic ectodermal dysplasia,ppi
10396,12162,9674,KIAA0040,KIAA0040,2,,alcohol dependence|alcohol abuse,ppi
10397,12163,9938,ARHGAP25,Rho GTPase activating protein 25,29,GTPase activator activity,,ppi
10398,12164,23310,NCAPD3,non-SMC condensin II complex subunit D3,59,methylated histone binding|chromatin binding|histone binding,,ppi
10399,12165,9929,JOSD1,Josephin domain containing 1,24,thiol-dependent ubiquitinyl hydrolase activity|thiol-dependent ubiquitin-specific protease activity,,ppi
10400,12166,23398,PPWD1,peptidylprolyl isomerase domain and WD repeat containing 1,9,peptidyl-prolyl cis-trans isomerase activity|cyclosporin A binding,,ppi
10401,12167,23171,GPD1L,glycerol-3-phosphate dehydrogenase 1-like,29,glycerol-3-phosphate dehydrogenase [NAD+] activity|sodium channel regulator activity|glycerol-3-phosphate dehydrogenase [NAD(P)+] activity|ion channel binding,fatty liver disease|sudden infant death syndrome|Brugada syndrome|Brugada syndrome 1|Brugada syndrome 2,ppi
10402,12168,23065,EMC1,ER membrane protein complex subunit 1,44,,,ppi
10403,12169,9688,NUP93,nucleoporin 93,81,structural constituent of nuclear pore,nephrotic syndrome,ppi
10404,12170,9793,CKAP5,cytoskeleton associated protein 5,109,cadherin binding|microtubule plus-end binding,,ppi
10405,12171,1737,DLAT,dihydrolipoamide S-acetyltransferase,52,dihydrolipoyllysine-residue acetyltransferase activity|pyruvate dehydrogenase (NAD+) activity,lactic acidosis|ptosis|congenital ptosis|cerebellar disease|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|basal ganglia disease|focal hand dystonia|blepharospasm|coronary artery disease|dystonia|pyruvate decarboxylase deficiency,ppi
10406,12172,9703,KIAA0100,KIAA0100,6,,,ppi
10407,12173,9768,PCLAF,PCNA clamp associated factor,807,chromatin binding,,ppi
10408,12174,9789,SPCS2,signal peptidase complex subunit 2,45,peptidase activity,,ppi
10409,12175,9694,EMC2,ER membrane protein complex subunit 2,105,,,ppi
10410,12176,23029,RBM34,RNA binding motif protein 34,138,RNA binding,,ppi
10411,12177,9686,VGLL4,vestigial like family member 4,15,,,ppi
10412,12178,9816,URB2,URB2 ribosome biogenesis 2 homolog (S. cerevisiae),25,,,ppi
10413,12179,9679,FAM53B,family with sequence similarity 53 member B,5,,cocaine abuse|cocaine dependence|morphine dependence,ppi
10414,12180,9812,KIAA0141,KIAA0141,4,,,ppi
10415,12181,10395,DLC1,DLC1 Rho GTPase activating protein,47,GTPase activator activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|stomach cancer|bladder urothelial carcinoma|uterus leiomyosarcoma|ovarian cancer,ppi
10416,12182,23167,EFR3A,EFR3 homolog A,26,,,ppi
10417,12183,23514,SPIDR,scaffolding protein involved in DNA repair,3,,,ppi
10418,12184,23144,ZC3H3,zinc finger CCCH-type containing 3,118,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10419,12185,9761,MLEC,malectin,21,carbohydrate binding,,ppi
10420,12186,23170,TTLL12,tubulin tyrosine ligase like 12,65,,,ppi
10421,12187,23172,FAM175B,family with sequence similarity 175 member B,41,microtubule binding|polyubiquitin modification-dependent protein binding,,ppi
10422,12188,9654,TTLL4,tubulin tyrosine ligase like 4,7,tubulin binding|protein-glutamic acid ligase activity|tubulin-glutamic acid ligase activity,,ppi
10423,12189,9798,IST1,IST1; ESCRT-III associated factor,36,protein-containing complex binding|cadherin binding,,ppi
10424,12190,23199,GSE1,Gse1 coiled-coil protein,44,,,ppi
10425,12191,1738,DLD,dihydrolipoamide dehydrogenase,96,dihydrolipoyl dehydrogenase activity|pyruvate dehydrogenase (NAD+) activity,lactic acidosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|dystonia|epilepsy|hypoglycemia|Leigh disease|maple syrup urine disease|visual epilepsy|brain disease,ppi
10426,12192,9837,GINS1,GINS complex subunit 1,9,3'-5' DNA helicase activity,,ppi
10427,12193,23318,ZCCHC11,zinc finger CCHC-type containing 11,14,RNA binding|miRNA binding|RNA uridylyltransferase activity,,ppi
10428,12194,22993,HMGXB3,HMG-box containing 3,8,DNA-binding transcription factor activity; RNA polymerase II-specific|kinase activity,,ppi
10429,12195,9772,TMEM94,transmembrane protein 94,8,,,ppi
10430,12196,9897,WASHC5,WASH complex subunit 5,24,,imperforate anus|aortic valve stenosis|isolated cleft palate|cleft palate|coloboma|Dandy-Walker syndrome|double outlet right ventricle|atrioventricular septal defect|placental insufficiency|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect,ppi
10431,12197,9926,LPGAT1,lysophosphatidylglycerol acyltransferase 1,16,1-acylglycerol-3-phosphate O-acyltransferase activity|2-acylglycerol-3-phosphate O-acyltransferase activity|transferase activity; transferring acyl groups,,ppi
10432,12198,9640,ZNF592,zinc finger protein 592,22,DNA-binding transcription factor activity; RNA polymerase II-specific,ptosis|congenital ptosis|cerebellar disease|clubfoot|epilepsy|placental insufficiency|focal segmental glomerulosclerosis|intellectual disability|learning disability|microphthalmia|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|proteinuria|kidney failure,ppi
10433,12199,23185,LARP4B,La ribonucleoprotein domain family member 4B,28,RNA binding,,ppi
10434,12200,9797,TATDN2,TatD DNase domain containing 2,8,,,ppi
10435,12201,23117,NPIPB3,nuclear pore complex interacting protein family member B3,2,,,ppi
10436,12203,9658,ZNF516,zinc finger protein 516,11,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|activating transcription factor binding,,ppi
10437,12204,9711,RUBCN,RUN and cysteine rich domain containing beclin 1 interacting protein,9,,cerebellar disease|epilepsy|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|autosomal recessive spinocerebellar ataxia 15,ppi
10438,12205,9778,KIAA0232,KIAA0232,32,,,ppi
10439,12206,9780,PIEZO1,piezo type mechanosensitive ion channel component 1,10,cation channel activity|mechanosensitive ion channel activity,,ppi
10440,12207,23080,AVL9,AVL9 cell migration associated,9,,,ppi
10441,12208,23042,PDXDC1,pyridoxal dependent decarboxylase domain containing 1,43,cadherin binding|pyridoxal phosphate binding|sphinganine-1-phosphate aldolase activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
10442,12209,23168,RTF1,RTF1 homolog; Paf1/RNA polymerase II complex component,44,single-stranded DNA binding|RNA binding|RNA polymerase II C-terminal domain phosphoserine binding,,ppi
10443,12210,9728,SECISBP2L,SECIS binding protein 2 like,9,RNA binding|ribonucleoprotein complex binding|mRNA 3'-UTR binding|selenocysteine insertion sequence binding,,ppi
10444,12211,23142,DCUN1D4,defective in cullin neddylation 1 domain containing 4,16,ubiquitin-like protein binding|ubiquitin conjugating enzyme binding|cullin family protein binding,,ppi
10445,12212,23201,FAM168A,family with sequence similarity 168 member A,29,,stomach cancer,ppi
10446,12213,19,ABCA1,ATP binding cassette subfamily A member 1,55,ATP binding|phospholipid binding|phospholipid transporter activity|anion transmembrane transporter activity|cholesterol binding|ATPase activity|cholesterol transporter activity|apolipoprotein A-I receptor activity|phosphatidylcholine-translocating ATPase activity|phosphatidylserine-translocating ATPase activity|ATPase activity; coupled to transmembrane movement of substances,anemia|macrocytic anemia|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|large intestine cancer|colorectal cancer|recurrent corneal erosion|ectropion|familial hypercholesterolemia|chronic kidney disease|gallbladder disease|liver disease|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|polyneuropathy,ppi
10447,12214,157,GRK3,G protein-coupled receptor kinase 3,11,protein kinase activity|beta-adrenergic receptor kinase activity,bipolar disorder|cocaine abuse|cocaine dependence|schizophrenia|morphine dependence,ppi
10448,12215,1739,DLG1,discs large MAGUK scaffold protein 1,119,guanylate kinase activity|phosphoprotein phosphatase activity|cytoskeletal protein binding|ligand-gated ion channel activity|potassium channel regulator activity|cadherin binding|ionotropic glutamate receptor binding,isolated cleft palate|cleft palate|schizophrenia,ppi
10449,12216,9854,C2CD2L,C2CD2 like,10,phospholipid transporter activity|phosphatidylinositol transporter activity|phosphatidylinositol binding,,ppi
10450,12217,23306,NEMP1,nuclear envelope integral membrane protein 1,22,,,ppi
10451,12218,23149,FCHO1,FCH domain only 1,18,AP-2 adaptor complex binding|phospholipid binding|cytoskeletal protein binding|microtubule binding|tubulin binding,,ppi
10452,12219,23060,ZNF609,zinc finger protein 609,17,,,ppi
10453,12220,9726,ZNF646,zinc finger protein 646,13,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
10454,12222,9919,SEC16A,SEC16 homolog A; endoplasmic reticulum export factor,152,,,ppi
10455,12223,9758,FRMPD4,FERM and PDZ domain containing 4,4,phosphatidylinositol-4;5-bisphosphate binding,intellectual disability|learning disability,ppi
10456,12224,23361,ZNF629,zinc finger protein 629,12,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
10457,12225,9849,ZNF518A,zinc finger protein 518A,21,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10458,12226,1740,DLG2,discs large MAGUK scaffold protein 2,44,guanylate kinase activity|kinase binding|ionotropic glutamate receptor binding,bipolar disorder|melanoma|skin melanoma|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
10459,12227,9739,SETD1A,SET domain containing 1A,38,beta-catenin binding|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K4 specific),schizophrenia,ppi
10460,12228,9881,TRANK1,tetratricopeptide repeat and ankyrin repeat containing 1,3,,,ppi
10461,12229,23135,KDM6B,lysine demethylase 6B,14,histone demethylase activity|histone demethylase activity (H3-K27 specific)|sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|chromatin binding|chromatin DNA binding,salivary gland adenoid cystic carcinoma|intellectual disability|learning disability,ppi
10462,12230,23274,CLEC16A,C-type lectin domain family 16 member A,3,Rab GTPase binding,adrenal cortical hypofunction|Addison's disease|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20,ppi
10463,12231,9880,ZBTB39,zinc finger and BTB domain containing 39,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10464,12232,9710,KIAA0355,KIAA0355,13,,,ppi
10465,12233,9842,PLEKHM1,pleckstrin homology and RUN domain containing M1,9,,osteopetrosis|osteosclerosis,ppi
10466,12234,1741,DLG3,discs large MAGUK scaffold protein 3,77,ligand-gated ion channel activity|kinase binding|phosphatase binding|ionotropic glutamate receptor binding,bipolar disorder|intellectual disability|learning disability|schizophrenia|ophthalmoplegia|mechanical strabismus|hypertropia|neurotic disorder|endogenous depression|melancholia|mood disorder|autistic disorder|major depressive disorder|mental depression,ppi
10467,12235,23392,KIAA0368,KIAA0368,154,,,ppi
10468,12236,80184,CEP290,centrosomal protein 290,119,microtubule minus-end binding,Leber congenital amaurosis|Senior-Loken syndrome|Laurence-Moon syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 4|Bardet-Biedl syndrome 5|Bardet-Biedl syndrome 6|Bardet-Biedl syndrome 7|Bardet-Biedl syndrome 8|Bardet-Biedl syndrome 9|Bardet-Biedl syndrome 10|Bardet-Biedl syndrome 11|Bardet-Biedl syndrome 12|Bardet-Biedl syndrome 13|Bardet-Biedl syndrome 14|Bardet-Biedl syndrome 15|Bardet-Biedl syndrome 16,ppi
10469,12237,23384,SPECC1L,sperm antigen with calponin homology and coiled-coil domains 1 like,51,,imperforate anus|ptosis|congenital ptosis|cleft lip|isolated cleft palate|cleft palate|cryptorchidism|patent ductus arteriosus|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect,ppi
10470,12238,9677,PPIP5K1,diphosphoinositol pentakisphosphate kinase 1,10,inositol-1;3;4;5;6-pentakisphosphate kinase activity|inositol hexakisphosphate kinase activity|inositol heptakisphosphate kinase activity|inositol hexakisphosphate 5-kinase activity|ATP binding|diphosphoinositol-pentakisphosphate kinase activity,,ppi
10471,12239,23243,ANKRD28,ankyrin repeat domain 28,105,,,ppi
10472,12240,9745,ZNF536,zinc finger protein 536,6,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
10473,12241,9905,SGSM2,small G protein signaling modulator 2,16,GTPase activator activity|Rab GTPase binding,,ppi
10474,12242,23140,ZZEF1,zinc finger ZZ-type and EF-hand domain containing 1,58,,,ppi
10475,12243,23130,ATG2A,autophagy related 2A,20,,,ppi
10476,12244,9675,TTI1,TELO2 interacting protein 1,46,,,ppi
10477,12245,1742,DLG4,discs large MAGUK scaffold protein 4,120,Ras guanyl-nucleotide exchange factor activity|ligand-gated ion channel activity|kinase binding|protein phosphatase binding|PDZ domain binding|beta-1 adrenergic receptor binding|D1 dopamine receptor binding|P2Y1 nucleotide receptor binding|acetylcholine receptor binding|ionotropic glutamate receptor binding|protein-containing complex binding|neuroligin family protein binding|scaffold protein binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|polycystic ovary syndrome|schizophrenia|supravalvular aortic stenosis|Williams-Beuren syndrome|mood disorder|autistic disorder,ppi
10478,12246,23378,RRP8,ribosomal RNA processing 8; methyltransferase; homolog (yeast),119,RNA binding|S-adenosylmethionine-dependent methyltransferase activity|methylated histone binding,,ppi
10479,12248,23300,ATMIN,ATM interactor,7,,,ppi
10480,12249,23262,PPIP5K2,diphosphoinositol pentakisphosphate kinase 2,13,inositol-1;3;4;5;6-pentakisphosphate kinase activity|inositol hexakisphosphate kinase activity|inositol heptakisphosphate kinase activity|inositol hexakisphosphate 5-kinase activity|ATP binding|diphosphoinositol-pentakisphosphate kinase activity,,ppi
10481,12250,9673,SLC25A44,solute carrier family 25 member 44,5,,,ppi
10482,12251,9651,PLCH2,phospholipase C eta 2,1,phosphatidylinositol phospholipase C activity,,ppi
10483,12252,23252,OTUD3,OTU deubiquitinase 3,1,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity,,ppi
10484,12253,23248,RPRD2,regulation of nuclear pre-mRNA domain containing 2,29,,,ppi
10485,12254,9231,DLG5,discs large MAGUK scaffold protein 5,30,beta-catenin binding|cytoskeletal protein binding|receptor signaling complex scaffold activity,inflammatory bowel disease,ppi
10486,12255,23334,SZT2,seizure threshold 2 homolog (mouse),11,,ptosis|congenital ptosis|childhood absence epilepsy|focal epilepsy|partial motor epilepsy|visual epilepsy|Ohtahara syndrome,ppi
10487,12256,9903,KLHL21,kelch like family member 21,18,ubiquitin-protein transferase activity,,ppi
10488,12257,25778,DSTYK,dual serine/threonine and tyrosine protein kinase,37,,paraplegia|vitiligo,ppi
10489,12258,9909,DENND4B,DENN domain containing 4B,1,Rab guanyl-nucleotide exchange factor activity,,ppi
10490,12259,9923,ZBTB40,zinc finger and BTB domain containing 40,10,DNA-binding transcription factor activity; RNA polymerase II-specific,intellectual disability|learning disability,ppi
10491,12260,23219,FBXO28,F-box protein 28,57,,,ppi
10492,12261,9229,DLGAP1,DLG associated protein 1,29,protein-containing complex binding,schizophrenia,ppi
10493,12262,9813,EFCAB14,EF-hand calcium binding domain 14,4,,,ppi
10494,12263,9764,KIAA0513,KIAA0513,6,,,ppi
10495,12264,23096,IQSEC2,IQ motif and Sec7 domain 2,4,ARF guanyl-nucleotide exchange factor activity,epilepsy|clubfoot|intellectual disability|learning disability|obesity|visual epilepsy|autistic disorder|chromosome Xp11.23-p11.22 duplication syndrome|non-syndromic X-linked intellectual disability,ppi
10496,12265,9228,DLGAP2,DLG associated protein 2,20,,autistic disorder|schizophrenia,ppi
10497,12267,26032,SUSD5,sushi domain containing 5,9,,,ppi
10498,12268,9847,C2CD5,C2 calcium dependent domain containing 5,27,calcium ion binding|calcium-dependent phospholipid binding,,ppi
10499,12269,26033,ATRNL1,attractin like 1,2,,,ppi
10500,12270,9814,SFI1,SFI1 centrin binding protein,16,phosphatase binding,,ppi
10501,12271,23131,GPATCH8,G-patch domain containing 8,41,RNA binding,,ppi
10502,12272,9832,JAKMIP2,janus kinase and microtubule interacting protein 2,12,,melanoma|skin melanoma,ppi
10503,12273,23247,KIAA0556,KIAA0556,6,,cerebellar disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|Joubert syndrome,ppi
10504,12275,8788,DLK1,delta like non-canonical Notch ligand 1,70,,placental insufficiency|essential thrombocythemia|myelodysplastic syndrome,ppi
10505,12276,114659,LRRC37B,leucine rich repeat containing 37B,1,,,ppi
10506,12277,23078,VWA8,von Willebrand factor A domain containing 8,26,ATPase activity,autistic disorder,ppi
10507,12278,9720,CCDC144A,coiled-coil domain containing 144A,6,,,ppi
10508,12279,23359,FAM189A1,family with sequence similarity 189 member A1,1,,,ppi
10509,12280,23177,CEP68,centrosomal protein 68,11,,,ppi
10510,12281,9742,IFT140,intraflagellar transport 140,28,,anemia|macrocytic anemia|cerebellar disease|cholestasis|epilepsy|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|cystic kidney disease|intellectual disability|learning disability,ppi
10511,12282,23028,KDM1A,lysine demethylase 1A,320,chromatin binding|histone deacetylase activity|transcription factor binding|oxidoreductase activity|nuclear receptor transcription coactivator activity|demethylase activity|histone demethylase activity|histone demethylase activity (H3-K4 specific)|histone demethylase activity (H3-K9 specific)|histone demethylase activity (H3-dimethyl-K4 specific)|telomeric DNA binding|MRF binding|transcription regulatory region DNA binding|flavin adenine dinucleotide binding|androgen receptor binding|telomeric repeat-containing RNA binding,lung cancer|non-small cell lung carcinoma|colon cancer|colonic benign neoplasm,ppi
10512,12283,28514,DLL1,delta like canonical Notch ligand 1,12,,brain cancer|holoprosencephaly|breast cancer,ppi
10513,12285,23232,TBC1D12,TBC1 domain family member 12,1,Rab GTPase binding|GTPase activator activity,,ppi
10514,12287,9831,ZNF623,zinc finger protein 623,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10515,12288,9662,CEP135,centrosomal protein 135,168,,syndromic X-linked intellectual disability 94|vesicoureteral reflux|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|septooptic dysplasia|microcephaly,ppi
10516,12289,23244,PDS5A,PDS5 cohesin associated factor A,65,,,ppi
10517,12290,9858,PPP1R26,protein phosphatase 1 regulatory subunit 26,4,,,ppi
10518,12292,23347,SMCHD1,structural maintenance of chromosomes flexible hinge domain containing 1,36,ATPase activity,choanal atresia|sensorineural hearing loss|hypogonadism|microphthalmia|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S,ppi
10519,12293,9776,ATG13,autophagy related 13,24,protein kinase regulator activity|protein kinase binding,,ppi
10520,12294,23363,OBSL1,obscurin like 1,622,cytoskeletal adaptor activity|structural constituent of muscle|muscle alpha-actinin binding|actin filament binding,placental insufficiency|3-M syndrome,ppi
10521,12295,9877,ZC3H11A,zinc finger CCCH-type containing 11A,55,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding|mRNA binding,breast cancer,ppi
10522,12296,23277,CLUH,clustered mitochondria homolog,43,mRNA binding,,ppi
10523,12297,9819,TSC22D2,TSC22 domain family member 2,48,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10524,12298,9912,ARHGAP44,Rho GTPase activating protein 44,15,GTPase activator activity|phospholipid binding|Rac GTPase binding,,ppi
10525,12299,23061,TBC1D9B,TBC1 domain family member 9B,27,Rab GTPase binding|GTPase activator activity,,ppi
10526,12300,9904,RBM19,RNA binding motif protein 19,40,RNA binding,,ppi
10527,12301,9894,TELO2,telomere maintenance 2,50,protein-containing complex binding|telomeric DNA binding,,ppi
10528,12302,158,ADSL,adenylosuccinate lyase,72,N6-(1;2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity|(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,autistic disorder|epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
10529,12303,54567,DLL4,delta like canonical Notch ligand 4,2,,ventricular septal defect|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|microphthalmia|schizophrenia|chronic ulcer of skin|ophthalmoplegia|mechanical strabismus|hypertropia|syndactyly|tetralogy of Fallot|tricuspid valve insufficiency|cataract|Adams-Oliver syndrome|Clouston syndrome|clubfoot|breast cancer,ppi
10530,12304,23223,RRP12,ribosomal RNA processing 12 homolog,87,RNA binding,,ppi
10531,12305,23141,ANKLE2,ankyrin repeat and LEM domain containing 2,34,protein phosphatase regulator activity|protein phosphatase 2A binding,ptosis|congenital ptosis|cryptorchidism|epilepsy|glaucoma|visual epilepsy|syndromic X-linked intellectual disability 94|vesicoureteral reflux|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|septooptic dysplasia|locked-in syndrome|quadriplegia,ppi
10532,12306,23074,UHRF1BP1L,UHRF1 binding protein 1 like,12,,,ppi
10533,12307,9914,ATP2C2,ATPase secretory pathway Ca2+ transporting 2,1,manganese-transporting ATPase activity|calcium-transporting ATPase activity|proton-exporting ATPase activity; phosphorylative mechanism,,ppi
10534,12309,57449,PLEKHG5,pleckstrin homology and RhoGEF domain containing G5,15,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,polycystic ovary syndrome|Charcot-Marie-Tooth disease recessive intermediate C,ppi
10535,12310,23259,DDHD2,DDHD domain containing 2,15,triglyceride lipase activity|phospholipase activity,intellectual disability|learning disability|paraplegia|ophthalmoplegia|mechanical strabismus|hypertropia|hereditary spastic paraplegia 54,ppi
10536,12311,23231,SEL1L3,SEL1L family member 3,8,,,ppi
10537,12312,9840,TESPA1,thymocyte expressed; positive selection associated 1,14,,,ppi
10538,12313,1743,DLST,dihydrolipoamide S-succinyltransferase,49,dihydrolipoyllysine-residue succinyltransferase activity,Wernicke-Korsakoff syndrome,ppi
10539,12314,9851,KIAA0753,KIAA0753,104,,Joubert syndrome with orofaciodigital defect,ppi
10540,12315,643314,KIAA0754,KIAA0754,4,,,ppi
10541,12316,9922,IQSEC1,IQ motif and Sec7 domain 1,26,,,ppi
10542,12317,23151,GRAMD4,GRAM domain containing 4,4,,,ppi
10543,12318,9873,FCHSD2,FCH and double SH3 domains 2,30,,,ppi
10544,12319,23023,TMCC1,transmembrane and coiled-coil domain family 1,3,protein homodimerization activity|protein heterodimerization activity,,ppi
10545,12321,9725,TMEM63A,transmembrane protein 63A,37,,stomach cancer,ppi
10546,12322,26043,UBXN7,UBX domain protein 7,114,ubiquitin protein ligase binding|ubiquitin binding,,ppi
10547,12323,23276,KLHL18,kelch like family member 18,20,,,ppi
10548,12324,23255,MTCL1,microtubule crosslinking factor 1,29,RNA binding|microtubule binding|protein homodimerization activity,,ppi
10549,12325,23355,VPS8,VPS8; CORVET complex subunit,16,,,ppi
10550,12326,23132,RAD54L2,RAD54-like 2 (S. cerevisiae),24,,,ppi
10551,12327,26052,DNM3,dynamin 3,59,GTPase activity|microtubule binding,,ppi
10552,12328,285527,FRYL,FRY like transcription coactivator,24,,,ppi
10553,12329,23052,ENDOD1,endonuclease domain containing 1,19,,,ppi
10554,12330,23354,HAUS5,HAUS augmin like complex subunit 5,43,,,ppi
10555,12331,23207,PLEKHM2,pleckstrin homology and RUN domain containing M2,6,kinesin binding,,ppi
10556,12332,22885,ABLIM3,actin binding LIM protein family member 3,10,actin filament binding,,ppi
10557,12333,22898,DENND3,DENN domain containing 3,4,Rab guanyl-nucleotide exchange factor activity,,ppi
10558,12334,23253,ANKRD12,ankyrin repeat domain 12,20,,,ppi
10559,12335,23030,KDM4B,lysine demethylase 4B,29,histone demethylase activity|histone demethylase activity (H3-K9 specific)|histone demethylase activity (H3-K36 specific)|DNA-binding transcription repressor activity; RNA polymerase II-specific|methylated histone binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|chromatin binding,medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
10560,12336,26049,FAM169A,family with sequence similarity 169 member A,4,,,ppi
10561,12337,1745,DLX1,distal-less homeobox 1,2,DNA-binding transcription factor activity; RNA polymerase II-specific,autistic disorder|bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
10562,12338,23383,MAU2,MAU2 sister chromatid cohesion factor,10,double-stranded DNA binding,,ppi
10563,12339,22911,WDR47,WD repeat domain 47,17,,,ppi
10564,12340,23301,EHBP1,EH domain binding protein 1,14,,prostate cancer|prostate carcinoma,ppi
10565,12341,22889,KIAA0907,KIAA0907,26,RNA binding,,ppi
10566,12342,23240,KIAA0922,KIAA0922,11,,,ppi
10567,12343,22834,ZNF652,zinc finger protein 652,6,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10568,12344,200933,FBXO45,F-box protein 45,20,ubiquitin-protein transferase activity,schizophrenia,ppi
10569,12345,23035,PHLPP2,PH domain and leucine rich repeat protein phosphatase 2,24,protein serine/threonine phosphatase activity,,ppi
10570,12346,1746,DLX2,distal-less homeobox 2,15,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,autistic disorder,ppi
10571,12347,22982,DIP2C,disco interacting protein 2 homolog C,2,,lung small cell carcinoma,ppi
10572,12348,23220,DTX4,deltex E3 ubiquitin ligase 4,4,ubiquitin-protein transferase activity,salivary gland adenoid cystic carcinoma|pancreatic ductal carcinoma,ppi
10573,12349,22841,RAB11FIP2,RAB11 family interacting protein 2,32,Rab GTPase binding,,ppi
10574,12350,22893,BAHD1,bromo adjacent homology domain containing 1,25,chromatin binding,,ppi
10575,12351,23379,ICE1,interactor of little elongation complex ELL subunit 1,19,protein homodimerization activity,,ppi
10576,12352,22979,EFR3B,EFR3 homolog B,9,,,ppi
10577,12353,23341,DNAJC16,DnaJ heat shock protein family (Hsp40) member C16,12,,,ppi
10578,12354,22904,SBNO2,strawberry notch homolog 2,1,,schizophrenia,ppi
10579,12355,22844,FRMPD1,FERM and PDZ domain containing 1,2,,,ppi
10580,12356,1747,DLX3,distal-less homeobox 3,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia|osteopetrosis|osteosclerosis,ppi
10581,12357,22868,FASTKD2,FAST kinase domains 2,31,RNA binding|rRNA binding,lactic acidosis|anemia|macrocytic anemia|ptosis|congenital ptosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|intellectual disability|learning disability|optic atrophy|proteinuria|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|visual epilepsy|liver disease,ppi
10582,12358,22869,ZNF510,zinc finger protein 510,23,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10583,12359,317662,FAM149B1,family with sequence similarity 149 member B1,2,,,ppi
10584,12360,22981,NINL,ninein like,216,,,ppi
10585,12361,23329,TBC1D30,TBC1 domain family member 30,6,GTPase activator activity|Rab GTPase binding,,ppi
10586,12362,23387,SIK3,SIK family kinase 3,23,magnesium ion binding|protein serine/threonine kinase activity|ATP binding|tau-protein kinase activity,,ppi
10587,12364,22864,R3HDM2,R3H domain containing 2,14,RNA binding,,ppi
10588,12365,23322,RPGRIP1L,RPGRIP1 like,157,,anencephaly|ptosis|congenital ptosis|cerebellar disease|Kartagener syndrome|primary ciliary dyskinesia|cleft lip|isolated cleft palate|cleft palate|coloboma|autosomal recessive polycystic kidney disease|cryptorchidism|eye disease|portal hypertension|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|liver cirrhosis,ppi
10589,12366,22878,TRAPPC8,trafficking protein particle complex 8,23,Rab guanyl-nucleotide exchange factor activity,,ppi
10590,12367,1748,DLX4,distal-less homeobox 4,17,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
10591,12368,22909,FAN1,FANCD2/FANCI-associated nuclease 1,49,magnesium ion binding|5'-3' exonuclease activity|5'-flap endonuclease activity|flap-structured DNA binding|ubiquitin-dependent protein binding,generalized anxiety disorder|anxiety disorder|colon cancer|colonic benign neoplasm|large intestine cancer|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|glioblastoma multiforme|giant cell glioblastoma|proteinuria|rectal neoplasm|rectum cancer|visual epilepsy|renal infectious disease,ppi
10592,12369,23288,IQCE,IQ motif containing E,15,,,ppi
10593,12371,23254,KAZN,kazrin; periplakin interacting protein,4,,,ppi
10594,12372,23325,WASHC4,WASH complex subunit 4,31,,intellectual disability|learning disability|autosomal recessive non-syndromic intellectual disability,ppi
10595,12373,23038,WDTC1,WD and tetratricopeptide repeats 1,32,,,ppi
10596,12374,23108,RAP1GAP2,RAP1 GTPase activating protein 2,4,GTPase activator activity,,ppi
10597,12375,23041,MON2,MON2 homolog; regulator of endosome-to-Golgi trafficking,21,,,ppi
10598,12376,22887,FOXJ3,forkhead box J3,19,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
10599,12377,23331,TTC28,tetratricopeptide repeat domain 28,23,,,ppi
10600,12378,1749,DLX5,distal-less homeobox 5,18,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|transcription regulatory region DNA binding,sensorineural hearing loss,ppi
10601,12380,22980,TCF25,transcription factor 25,31,DNA-binding transcription factor activity,,ppi
10602,12381,22897,CEP164,centrosomal protein 164,87,,hypertension|essential hypertension|premature menopause|androgen insensitivity syndrome|retinal degeneration|blindness|Senior-Loken syndrome|nephronophthisis|fundus dystrophy,ppi
10603,12382,23102,TBC1D2B,TBC1 domain family member 2B,24,Rab GTPase binding|GTPase activator activity,,ppi
10604,12383,23007,PLCH1,phospholipase C eta 1,9,phosphatidylinositol phospholipase C activity|calcium-dependent phospholipase C activity,,ppi
10605,12384,22852,ANKRD26,ankyrin repeat domain 26,17,,thrombocytopenia,ppi
10606,12385,23067,SETD1B,SET domain containing 1B,20,histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K4 specific),,ppi
10607,12386,23271,CAMSAP2,calmodulin regulated spectrin associated protein family member 2,27,microtubule minus-end binding,,ppi
10608,12387,23217,ZFR2,zinc finger RNA binding protein 2,2,single-stranded RNA binding|double-stranded RNA binding,,ppi
10609,12388,1750,DLX6,distal-less homeobox 6,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
10610,12389,23112,TNRC6B,trinucleotide repeat containing 6B,79,RNA binding,polycystic ovary syndrome,ppi
10611,12390,22998,LIMCH1,LIM and calponin homology domains 1,35,myosin II head/neck binding,substance abuse|substance-related disorder|malignant mesothelioma|benign mesothelioma,ppi
10612,12391,23285,KIAA1107,KIAA1107,23,,,ppi
10613,12393,22870,PPP6R1,protein phosphatase 6 regulatory subunit 1,64,,,ppi
10614,12394,57210,SLC45A4,solute carrier family 45 member 4,2,sucrose:proton symporter activity,,ppi
10615,12395,54462,CCSER2,coiled-coil serine rich protein 2,18,,,ppi
10616,12396,57456,KIAA1143,KIAA1143,34,,,ppi
10617,12397,57458,TMCC3,transmembrane and coiled-coil domain family 3,4,,,ppi
10618,12398,159,ADSS,adenylosuccinate synthase,48,adenylosuccinate synthase activity|GTP binding|phosphate ion binding,schizophrenia,ppi
10619,12399,400961,PAIP2B,poly(A) binding protein interacting protein 2B,9,translation repressor activity; mRNA regulatory element binding,,ppi
10620,12400,57461,ISY1,ISY1 splicing factor homolog,52,RNA binding|first spliceosomal transesterification activity,,ppi
10621,12401,57465,TBC1D24,TBC1 domain family member 24,12,,Unverricht-Lundborg syndrome|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy|early myoclonic encephalopathy|autosomal recessive nonsyndromic deafness 86|Ohtahara syndrome|autosomal dominant nonsyndromic deafness 65,ppi
10622,12402,374969,SVBP,small vasohibin binding protein,1,,,ppi
10623,12403,57222,ERGIC1,endoplasmic reticulum-golgi intermediate compartment 1,27,,,ppi
10624,12404,57469,PNMAL2,paraneoplastic Ma antigen family like 2,2,,,ppi
10625,12405,57470,LRRC47,leucine rich repeat containing 47,44,RNA binding|phenylalanine-tRNA ligase activity,,ppi
10626,12406,57471,ERMN,ermin,5,,,ppi
10627,12407,57179,KIAA1191,KIAA1191,22,,,ppi
10628,12408,54531,MIER2,MIER family member 2,30,DNA-binding transcription factor activity; RNA polymerase II-specific|histone deacetylase activity|obsolete transcription factor activity; transcription factor binding|RNA polymerase II repressing transcription factor binding|histone deacetylase binding|transcription corepressor activity,salivary gland adenoid cystic carcinoma,ppi
10629,12409,136242,PRSS37,protease; serine 37,11,,,ppi
10630,12410,57473,ZNF512B,zinc finger protein 512B,79,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10631,12411,57214,CEMIP,cell migration inducing hyaluronan binding protein,2,hyalurononglucosaminidase activity|hyaluronic acid binding|clathrin heavy chain binding|ER retention sequence binding,,ppi
10632,12412,57476,GRAMD1B,GRAM domain containing 1B,17,,,ppi
10633,12414,57514,ARHGAP31,Rho GTPase activating protein 31,2,GTPase activator activity,Adams-Oliver syndrome,ppi
10634,12415,57479,PRR12,proline rich 12,8,,,ppi
10635,12417,57482,KIAA1211,KIAA1211,6,,,ppi
10636,12418,57148,RALGAPB,Ral GTPase activating protein non-catalytic beta subunit,19,GTPase activator activity|protein heterodimerization activity,,ppi
10637,12419,84146,ZNF644,zinc finger protein 644,46,DNA-binding transcription factor activity; RNA polymerase II-specific,myopia,ppi
10638,12420,57182,ANKRD50,ankyrin repeat domain 50,13,,,ppi
10639,12421,57489,ODF2L,outer dense fiber of sperm tails 2 like,18,,,ppi
10640,12422,57493,HEG1,heart development protein with EGF like domains 1,5,,,ppi
10641,12423,57494,RIMKLB,ribosomal modification protein rimK like family member B,2,N-acetyl-L-aspartate-L-glutamate ligase activity|citrate-L-glutamate ligase activity,,ppi
10642,12425,54454,ATAD2B,ATPase family; AAA domain containing 2B,2,lysine-acetylated histone binding|histone binding|chromatin binding|ATPase activity,,ppi
10643,12427,54625,PARP14,poly(ADP-ribose) polymerase family member 14,13,NAD+ ADP-ribosyltransferase activity,,ppi
10644,12428,57506,MAVS,mitochondrial antiviral signaling protein,93,signaling adaptor activity,,ppi
10645,12430,55841,WWC3,WWC family member 3,13,protein-containing complex scaffold activity,,ppi
10646,12431,57507,ZNF608,zinc finger protein 608,3,,,ppi
10647,12432,27152,INTU,inturned planar cell polarity protein,42,,,ppi
10648,12433,57508,INTS2,integrator complex subunit 2,36,,,ppi
10649,12434,285590,SH3PXD2B,SH3 and PX domains 2B,14,phosphatidylinositol-5-phosphate binding|phosphatidylinositol-3-phosphate binding|SH2 domain binding|phosphatidylinositol-3;5-bisphosphate binding|superoxide-generating NADPH oxidase activator activity|phosphatidylinositol binding|phosphatidylinositol-4-phosphate binding,microphthalmia|sensorineural hearing loss,ppi
10650,12435,54439,RBM27,RNA binding motif protein 27,43,RNA binding|mRNA binding,,ppi
10651,12436,57528,KCTD16,potassium channel tetramerization domain containing 16,1,,,ppi
10652,12437,57529,RGAG1,retrotransposon gag domain containing 1,8,,,ppi
10653,12438,57533,TBC1D14,TBC1 domain family member 14,29,Rab GTPase binding|GTPase activator activity,,ppi
10654,12439,57536,KIAA1328,KIAA1328,8,,,ppi
10655,12440,54455,FBXO42,F-box protein 42,15,,,ppi
10656,12441,57539,WDR35,WD repeat domain 35,22,phosphatidylinositol binding,craniosynostosis|asphyxiating thoracic dystrophy 3|Sensenbrenner syndrome|short-rib thoracic dysplasia 7 with or without polydactyly,ppi
10657,12442,57540,DISP3,dispatched RND transporter family member 3,6,,,ppi
10658,12443,57542,KLHL42,kelch like family member 42,42,ubiquitin-protein transferase activity,,ppi
10659,12444,57545,CC2D2A,coiled-coil and C2 domain containing 2A,35,,Joubert syndrome|Meckel syndrome,ppi
10660,12445,57547,ZNF624,zinc finger protein 624,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10661,12446,54532,USP53,ubiquitin specific peptidase 53,23,thiol-dependent ubiquitinyl hydrolase activity,,ppi
10662,12447,55084,SOBP,sine oculis binding protein homolog,6,,schizophreniform disorder|schizoaffective disorder|syndromic X-linked intellectual disability 94,ppi
10663,12448,57551,TAOK1,TAO kinase 1,15,protein kinase activity|protein serine/threonine kinase activity|ATP binding|kinase activity|transferase activity|alpha-tubulin binding|protein serine/threonine kinase activator activity|beta-tubulin binding|MAP kinase kinase kinase activity,,ppi
10664,12449,1755,DMBT1,deleted in malignant brain tumors 1,16,scavenger receptor activity|signaling pattern recognition receptor activity|zymogen binding|calcium-dependent protein binding,colon cancer|colonic benign neoplasm|malignant glioma|gliosarcoma|mixed glioma|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
10665,12450,57552,NCEH1,neutral cholesterol ester hydrolase 1,37,sterol esterase activity,,ppi
10666,12451,57560,IFT80,intraflagellar transport 80,22,,retinal degeneration|polydactyly|asphyxiating thoracic dystrophy 1|asphyxiating thoracic dystrophy 3|cystic kidney disease|autosomal dominant polycystic kidney disease|asphyxiating thoracic dystrophy 2,ppi
10667,12452,57561,ARRDC3,arrestin domain containing 3,39,beta-3 adrenergic receptor binding,breast cancer,ppi
10668,12453,57562,CEP126,centrosomal protein 126,97,,,ppi
10669,12455,57565,KLHL14,kelch like family member 14,10,,,ppi
10670,12456,57223,PPP4R3B,protein phosphatase 4 regulatory subunit 3B,39,,,ppi
10671,12457,57571,CARNS1,carnosine synthase 1,1,ATPase activity|carnosine synthase activity|FMN binding,,ppi
10672,12458,57574,MARCH4,membrane associated ring-CH-type finger 4,4,ubiquitin-protein transferase activity,,ppi
10673,12459,11144,DMC1,DNA meiotic recombinase 1,18,DNA binding|recombinase activity|double-stranded DNA binding|DNA-dependent ATPase activity|single-stranded DNA binding,,ppi
10674,12460,54480,CHPF2,chondroitin polymerizing factor 2,5,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,,ppi
10675,12461,57169,ZNFX1,zinc finger NFX1-type containing 1,30,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding,,ppi
10676,12462,57577,CCDC191,coiled-coil domain containing 191,3,,,ppi
10677,12463,54497,HEATR5B,HEAT repeat containing 5B,11,,,ppi
10678,12464,57587,CFAP97,cilia and flagella associated protein 97,35,,,ppi
10679,12465,57592,ZNF687,zinc finger protein 687,40,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10680,12466,57593,EBF4,early B-cell factor 4,3,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
10681,12467,57597,BAHCC1,BAH domain and coiled-coil containing 1,12,,,ppi
10682,12468,1756,DMD,dystrophin,65,actin binding|structural constituent of cytoskeleton|structural constituent of muscle|myosin binding|nitric-oxide synthase binding,sick sinus syndrome|calcium metabolism disease|nephrocalcinosis|calcinosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P,ppi
10683,12469,57600,FNIP2,folliculin interacting protein 2,12,ATPase inhibitor activity|chaperone binding,,ppi
10684,12470,57606,SLAIN2,SLAIN motif family member 2,52,,,ppi
10685,12471,57608,KIAA1462,KIAA1462,6,,coronary artery disease,ppi
10686,12472,57609,DIP2B,disco interacting protein 2 homolog B,13,,,ppi
10687,12473,57610,RANBP10,RAN binding protein 10,59,,stomach cancer,ppi
10688,12474,57611,ISLR2,immunoglobulin superfamily containing leucine rich repeat 2,1,,,ppi
10689,12475,57613,FAM234B,family with sequence similarity 234 member B,47,,,ppi
10690,12476,57614,KIAA1468,KIAA1468,12,,,ppi
10691,12477,57622,LRFN1,leucine rich repeat and fibronectin type III domain containing 1,20,,,ppi
10692,12478,57624,NYAP2,neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2,9,,,ppi
10693,12479,57631,LRCH2,leucine rich repeats and calponin homology domain containing 2,22,,,ppi
10694,12480,57636,ARHGAP23,Rho GTPase activating protein 23,7,GTPase activator activity,polycystic ovary syndrome,ppi
10695,12481,343069,HNRNPCL1,heterogeneous nuclear ribonucleoprotein C-like 1,37,RNA binding,,ppi
10696,12482,57639,CCDC146,coiled-coil domain containing 146,36,,,ppi
10697,12483,348327,ZNF530,zinc finger protein 530,1,DNA-binding transcription factor activity; RNA polymerase II-specific,schizophrenia,ppi
10698,12484,22995,CEP152,centrosomal protein 152,106,,craniosynostosis|placental insufficiency|glaucoma|intellectual disability|learning disability|syndromic X-linked intellectual disability 94|vesicoureteral reflux|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome,ppi
10699,12485,57643,ZSWIM5,zinc finger SWIM-type containing 5,3,,,ppi
10700,12486,25959,KANK2,KN motif and ankyrin repeat domains 2,61,,nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis,ppi
10701,12487,57648,KIAA1522,KIAA1522,15,,,ppi
10702,12488,57650,KIAA1524,KIAA1524,45,protein homodimerization activity|cadherin binding,,ppi
10703,12489,100499483,CCDC180,coiled-coil domain containing 180,21,,,ppi
10704,12490,57654,UVSSA,UV stimulated scaffold protein A,10,RNA polymerase II complex binding,UV-sensitive syndrome,ppi
10705,12491,57655,GRAMD1A,GRAM domain containing 1A,26,,,ppi
10706,12492,57658,CALCOCO1,calcium binding and coiled-coil domain 1,39,RNA polymerase II distal enhancer sequence-specific DNA binding|transcription coregulator activity|transcription coactivator activity|nuclear receptor transcription coactivator activity|sequence-specific DNA binding|transcription regulatory region DNA binding,,ppi
10707,12493,57662,CAMSAP3,calmodulin regulated spectrin associated protein family member 3,29,microtubule minus-end binding|actin filament binding,,ppi
10708,12494,57666,FBRSL1,fibrosin like 1,11,RNA binding,,ppi
10709,12495,57677,ZFP14,ZFP14 zinc finger protein,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10710,12496,57683,ZDBF2,zinc finger DBF-type containing 2,13,,lung small cell carcinoma,ppi
10711,12497,57685,CACHD1,cache domain containing 1,16,voltage-gated calcium channel activity,,ppi
10712,12498,57687,VAT1L,vesicle amine transport 1 like,7,,,ppi
10713,12499,57688,ZSWIM6,zinc finger SWIM-type containing 6,5,,acromelic frontonasal dysostosis,ppi
10714,12500,57689,LRRC4C,leucine rich repeat containing 4C,24,cell-cell adhesion mediator activity,,ppi
10715,12501,57690,TNRC6C,trinucleotide repeat containing 6C,35,,,ppi
10716,12502,57698,SHTN1,shootin 1,36,cadherin binding|actin filament binding,,ppi
10717,12503,1758,DMP1,dentin matrix acidic phosphoprotein 1,3,integrin binding|calcium ion binding,craniosynostosis|sensorineural hearing loss|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|osteomalacia|rickets|osteopetrosis|osteosclerosis|arthropathy|arthritis|neurogenic arthropathy|autosomal recessive hypophosphatemic rickets|amelogenesis imperfecta|suppurative periapical periodontitis|osteogenesis imperfecta|Ehlers-Danlos syndrome,ppi
10718,12504,57700,FAM160B1,family with sequence similarity 160 member B1,7,,melanoma|skin melanoma,ppi
10719,12505,57701,NCKAP5L,NCK associated protein 5 like,25,,,ppi
10720,12506,57703,CWC22,CWC22 spliceosome associated protein homolog,35,RNA binding,,ppi
10721,12507,57705,WDFY4,WDFY family member 4,1,,,ppi
10722,12508,57706,DENND1A,DENN domain containing 1A,10,Rab guanyl-nucleotide exchange factor activity|phosphatidylinositol-3-phosphate binding|phosphatidylinositol phosphate binding|Rab GTPase binding,,ppi
10723,12509,57707,TLDC1,TBC/LysM-associated domain containing 1,14,,,ppi
10724,12510,57709,SLC7A14,solute carrier family 7 member 14,1,,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|retinitis pigmentosa 68,ppi
10725,12512,57711,ZNF529,zinc finger protein 529,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10726,12513,57719,ANO8,anoctamin 8,1,intracellular calcium activated chloride channel activity,,ppi
10727,12514,1760,DMPK,dystrophia myotonica protein kinase,21,protein serine/threonine kinase activity|ATP binding|myosin phosphatase regulator activity,cholecystolithiasis|choledocholithiasis|endocrine system disease|polyhydramnios|hypogonadism|myotonic dystrophy type 2|myotonic dystrophy type 1|myotonic disease|syndromic X-linked intellectual disability 94|cataract|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|atrophy of testis|muscular atrophy|Bell's palsy|facial paralysis|alopecia|androgenic alopecia,ppi
10728,12515,57721,METTL14,methyltransferase like 14,6,mRNA binding|mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity|S-adenosyl-L-methionine binding,,ppi
10729,12516,57724,EPG5,ectopic P-granules autophagy protein 5 homolog,1,,primary immunodeficiency disease|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|Vici syndrome,ppi
10730,12518,57730,ANKRD36B,ankyrin repeat domain 36B,4,,,ppi
10731,12519,57732,ZFYVE28,zinc finger FYVE-type containing 28,6,phosphatidylinositol-3-phosphate binding,,ppi
10732,12521,1761,DMRT1,doublesex and mab-3 related transcription factor 1,1,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|protein heterodimerization activity|protein homodimerization activity,germ cell cancer|germ cell and embryonal cancer|embryonal cancer|polycystic ovary syndrome|testicular cancer|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|hypogonadism|gonadal dysgenesis|Turner syndrome|46 XY gonadal dysgenesis,ppi
10733,12522,85376,RIMBP3,RIMS binding protein 3,19,benzodiazepine receptor binding,,ppi
10734,12523,85379,KIAA1671,KIAA1671,48,,,ppi
10735,12524,80313,LRRC27,leucine rich repeat containing 27,9,,,ppi
10736,12525,80311,KLHL15,kelch like family member 15,45,,,ppi
10737,12526,80731,THSD7B,thrombospondin type 1 domain containing 7B,1,,alcohol dependence|alcohol abuse,ppi
10738,12527,401145,CCSER1,coiled-coil serine rich protein 1,3,,cocaine abuse|cocaine dependence,ppi
10739,12528,10655,DMRT2,doublesex and mab-3 related transcription factor 2,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10740,12529,80726,KIAA1683,KIAA1683,56,,,ppi
10741,12530,80728,ARHGAP39,Rho GTPase activating protein 39,10,GTPase activator activity,,ppi
10742,12531,80789,INTS5,integrator complex subunit 5,52,,,ppi
10743,12532,80823,BHLHB9,basic helix-loop-helix domain containing; class B; 9,4,protein homodimerization activity,,ppi
10744,12533,80817,CEP44,centrosomal protein 44,133,,,ppi
10745,12534,80816,ASXL3,additional sex combs like 3; transcriptional regulator,2,peroxisome proliferator activated receptor binding|chromatin binding,,ppi
10746,12535,1762,DMWD,dystrophia myotonica; WD repeat containing,60,,,ppi
10747,12536,80851,SH3BP5L,SH3 binding domain protein 5 like,18,protein kinase inhibitor activity,,ppi
10748,12537,85465,SELENOI,selenoprotein I,5,ethanolaminephosphotransferase activity|diacylglycerol cholinephosphotransferase activity|phosphotransferase activity; for other substituted phosphate groups,,ppi
10749,12538,85463,ZC3H12C,zinc finger CCCH-type containing 12C,2,,pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
10750,12540,85461,TANC1,tetratricopeptide repeat; ankyrin repeat and coiled-coil containing 1,23,,,ppi
10751,12541,85460,ZNF518B,zinc finger protein 518B,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10752,12542,85459,CEP295,centrosomal protein 295,16,microtubule binding,,ppi
10753,12543,85453,TSPYL5,TSPY like 5,1,,,ppi
10754,12544,85452,CFAP74,cilia and flagella associated protein 74,5,,,ppi
10755,12545,85451,UNK,unkempt family zinc finger,291,RNA binding|mRNA CDS binding,,ppi
10756,12546,1657,DMXL1,Dmx like 1,7,,malignant glioma|gliosarcoma|mixed glioma,ppi
10757,12547,85450,ITPRIP,inositol 1;4;5-trisphosphate receptor interacting protein,22,,,ppi
10758,12548,150771,ITPRIPL1,inositol 1;4;5-trisphosphate receptor interacting protein-like 1,7,,,ppi
10759,12550,85444,LRRCC1,leucine rich repeat and coiled-coil centrosomal protein 1,21,dynein heavy chain binding|alpha-tubulin binding|motor activity,,ppi
10760,12551,85442,KNDC1,kinase non-catalytic C-lobe domain containing 1,3,Ras guanyl-nucleotide exchange factor activity,,ppi
10761,12552,84460,ZMAT1,zinc finger matrin-type 1,7,,,ppi
10762,12553,84457,PHYHIPL,phytanoyl-CoA 2-hydroxylase interacting protein like,12,,,ppi
10763,12554,84455,EFCAB7,EF-hand calcium binding domain 7,6,,,ppi
10764,12555,23312,DMXL2,Dmx like 2,16,Rab GTPase binding,cerebellar disease|dystonia|intellectual disability|learning disability,ppi
10765,12556,84450,ZNF512,zinc finger protein 512,81,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10766,12557,84445,LZTS2,leucine zipper tumor suppressor 2,257,,,ppi
10767,12559,84437,MSANTD4,Myb/SANT DNA binding domain containing 4 with coiled-coils,4,,,ppi
10768,12560,84436,ZNF528,zinc finger protein 528,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10769,12561,84503,ZNF527,zinc finger protein 527,1,,,ppi
10770,12562,200014,CC2D1B,coiled-coil and C2 domain containing 1B,10,,,ppi
10771,12563,84542,KIAA1841,KIAA1841,5,,,ppi
10772,12564,84530,SRRM4,serine/arginine repetitive matrix 4,2,mRNA binding,central nervous system origin vertigo|inner ear disease|vestibular disease,ppi
10773,12565,1763,DNA2,DNA replication helicase/nuclease 2,35,DNA binding|DNA helicase activity|helicase activity|nuclease activity|ATPase activity|site-specific endodeoxyribonuclease activity; specific for altered base|5'-flap endonuclease activity|5'-3' DNA helicase activity|single-stranded DNA-dependent ATPase activity,ptosis|congenital ptosis|intellectual disability|learning disability|spinal cord disease|chronic progressive external ophthalmoplegia|fibromyalgia|myositis|Bell's palsy|facial paralysis,ppi
10774,12566,84622,ZNF594,zinc finger protein 594,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
10775,12567,729359,PLIN4,perilipin 4,3,,,ppi
10776,12568,114786,XKR4,XK related 4,1,,substance abuse|substance-related disorder,ppi
10777,12569,139170,DCAF12L1,DDB1 and CUL4 associated factor 12 like 1,2,,,ppi
10778,12570,114794,ELFN2,extracellular leucine rich repeat and fibronectin type III domain containing 2,2,,,ppi
10779,12573,25981,DNAH1,dynein axonemal heavy chain 1,1,microtubule motor activity|dynein light intermediate chain binding|dynein light chain binding|ATP-dependent microtubule motor activity; minus-end-directed|dynein intermediate chain binding,,ppi
10780,12574,114800,CCDC85A,coiled-coil domain containing 85A,3,,,ppi
10781,12575,114803,MYSM1,Myb like; SWIRM and MPN domains 1,13,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator activity|thiol-dependent ubiquitin-specific protease activity|metallopeptidase activity|thiol-dependent ubiquitinyl hydrolase activity|histone binding|protein-containing complex binding,,ppi
10782,12576,114804,RNF157,ring finger protein 157,1,,,ppi
10783,12577,114818,KLHL29,kelch like family member 29,19,,,ppi
10784,12578,114825,PWWP2A,PWWP domain containing 2A,6,chromatin binding,,ppi
10785,12580,150726,FBXO41,F-box protein 41,2,ubiquitin-protein transferase activity,,ppi
10786,12581,196385,DNAH10,dynein axonemal heavy chain 10,2,ATP-dependent microtubule motor activity; minus-end-directed|dynein light chain binding|dynein light intermediate chain binding|dynein intermediate chain binding,,ppi
10787,12582,129049,SGSM1,small G protein signaling modulator 1,3,GTPase activator activity|Rab GTPase binding,,ppi
10788,12583,121256,TMEM132D,transmembrane protein 132D,1,,liver cancer|lung small cell carcinoma,ppi
10789,12584,165215,FAM171B,family with sequence similarity 171 member B,14,,,ppi
10790,12585,170954,PPP1R18,protein phosphatase 1 regulatory subunit 18,60,,,ppi
10791,12586,116115,ZNF526,zinc finger protein 526,19,DNA-binding transcription factor activity; RNA polymerase II-specific,intellectual disability|learning disability,ppi
10792,12587,114991,ZNF618,zinc finger protein 618,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10793,12588,126567,C2CD4C,C2 calcium dependent domain containing 4C,1,,,ppi
10794,12589,96459,FNIP1,folliculin interacting protein 1,23,guanyl-nucleotide exchange factor activity|ATPase inhibitor activity|chaperone binding,,ppi
10795,12590,124454,EARS2,glutamyl-tRNA synthetase 2; mitochondrial,5,glutamate-tRNA ligase activity|glutamate-tRNA(Gln) ligase activity,combined oxidative phosphorylation deficiency,ppi
10796,12591,8701,DNAH11,dynein axonemal heavy chain 11,2,dynein light intermediate chain binding|ATP-dependent microtubule motor activity; minus-end-directed|dynein intermediate chain binding|dynein light chain binding,bronchiectasis|Kartagener syndrome|primary ciliary dyskinesia|atherosclerosis|arteriosclerotic cardiovascular disease|coronary artery disease|primary ciliary dyskinesia 1|primary ciliary dyskinesia 7,ppi
10797,12592,89970,RSPRY1,ring finger and SPRY domain containing 1,43,,,ppi
10798,12593,124401,ANKS3,ankyrin repeat and sterile alpha motif domain containing 3,9,,,ppi
10799,12594,170958,ZNF525,zinc finger protein 525,2,,,ppi
10800,12595,170961,ANKRD24,ankyrin repeat domain 24,7,,,ppi
10801,12596,170960,ZNF721,zinc finger protein 721,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10802,12597,147372,CCBE1,collagen and calcium binding EGF domains 1,5,collagen binding,Hennekam syndrome|intellectual disability|learning disability,ppi
10803,12600,340526,RGAG4,retrotransposon gag domain containing 4,2,,,ppi
10804,12601,79834,PEAK1,pseudopodium enriched atypical kinase 1,22,non-membrane spanning protein tyrosine kinase activity|identical protein binding|ATP binding|protein kinase activity,,ppi
10805,12602,340533,KIAA2022,KIAA2022,2,,non-syndromic X-linked intellectual disability,ppi
10806,12603,149041,RC3H1,ring finger and CCCH-type domains 1,171,RNA binding|double-stranded RNA binding|mRNA 3'-UTR binding|ubiquitin-protein transferase activity|zinc ion binding|miRNA binding|RNA stem-loop binding|ubiquitin protein ligase activity,,ppi
10807,12604,23286,WWC1,WW and C2 domain containing 1,42,transcription coactivator activity|protein-containing complex scaffold activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophreniform disorder|schizoaffective disorder|malignant mesothelioma|benign mesothelioma,ppi
10808,12605,112770,GLMP,glycosylated lysosomal membrane protein,65,DNA-binding transcription factor activity|nuclear receptor activity|nuclear receptor transcription coactivator activity|transcription regulatory region DNA binding,,ppi
10809,12606,57393,TMEM27,transmembrane protein 27,1,protein homodimerization activity,,ppi
10810,12607,81930,KIF18A,kinesin family member 18A,27,microtubule binding|ATP-dependent microtubule motor activity; plus-end-directed|microtubule plus-end binding|tubulin-dependent ATPase activity|ATPase activity|microtubule motor activity,,ppi
10811,12608,23046,KIF21B,kinesin family member 21B,31,microtubule motor activity|microtubule binding|ATPase activity,inflammatory bowel disease|ulcerative colitis,ppi
10812,12609,84643,KIF2B,kinesin family member 2B,42,ATPase activity|microtubule motor activity|microtubule binding,,ppi
10813,12610,253190,SERHL2,serine hydrolase-like 2,6,,,ppi
10814,12611,100131827,ZNF717,zinc finger protein 717,2,,,ppi
10815,12612,127602,DNAH14,dynein axonemal heavy chain 14,10,dynein light intermediate chain binding|dynein light chain binding|dynein intermediate chain binding|ATP-dependent microtubule motor activity; minus-end-directed,,ppi
10816,12613,84662,GLIS2,GLIS family zinc finger 2,12,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|transcription regulatory region DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|nephronophthisis,ppi
10817,12614,83888,FGFBP2,fibroblast growth factor binding protein 2,1,,,ppi
10818,12615,91419,ATP23,ATP23 metallopeptidase and ATP synthase assembly factor homolog,13,DNA-dependent protein kinase activity,,ppi
10819,12617,26092,TOR1AIP1,torsin 1A interacting protein 1,55,ATPase activator activity,,ppi
10820,12619,8632,DNAH17,dynein axonemal heavy chain 17,1,,,ppi
10821,12621,353142,LCE3A,late cornified envelope 3A,1,structural molecule activity,,ppi
10822,12623,353145,LCE3E,late cornified envelope 3E,19,structural molecule activity,,ppi
10823,12628,100129271,C1orf68,chromosome 1 open reading frame 68,1,structural molecule activity,,ppi
10824,12629,353139,LCE2A,late cornified envelope 2A,13,structural molecule activity,,ppi
10825,12630,143903,LAYN,layilin,1,hyaluronic acid binding,,ppi
10826,12631,57189,KIAA1147,KIAA1147,6,,,ppi
10827,12632,51157,ZNF580,zinc finger protein 580,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10828,12633,54741,LEPROT,leptin receptor overlapping transcript,2,signaling receptor binding,,ppi
10829,12634,79641,ROGDI,rogdi homolog,12,,,ppi
10830,12635,64105,CENPK,centromere protein K,15,,,ppi
10831,12636,146754,DNAH2,dynein axonemal heavy chain 2,2,microtubule motor activity|ATP-dependent microtubule motor activity; minus-end-directed|dynein intermediate chain binding|dynein light chain binding|dynein light intermediate chain binding,,ppi
10832,12637,116844,LRG1,leucine rich alpha-2-glycoprotein 1,3,,colon cancer|colonic benign neoplasm|familial adenomatous polyposis|islet cell tumor,ppi
10833,12638,80312,TET1,tet methylcytosine dioxygenase 1,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|iron ion binding|methylcytosine dioxygenase activity,schizophreniform disorder|schizoaffective disorder|schizophrenia|autistic disorder,ppi
10834,12639,391004,PRAMEF17,PRAME family member 17,6,,,ppi
10835,12640,404203,SPINK6,serine peptidase inhibitor; Kazal type 6,1,,,ppi
10836,12641,552900,BOLA2,bolA family member 2,16,,,ppi
10837,12642,387893,KMT5A,lysine methyltransferase 5A,23,transcription corepressor activity|lysine N-methyltransferase activity|protein-lysine N-methyltransferase activity|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H4-K20 specific),,ppi
10838,12643,55567,DNAH3,dynein axonemal heavy chain 3,1,microtubule motor activity|dynein light chain binding|dynein light intermediate chain binding|dynein intermediate chain binding|ATP-dependent microtubule motor activity; minus-end-directed,,ppi
10839,12644,64167,ERAP2,endoplasmic reticulum aminopeptidase 2,1,endopeptidase activity|aminopeptidase activity|metallopeptidase activity|zinc ion binding|metalloaminopeptidase activity|peptide binding,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease,ppi
10840,12645,1767,DNAH5,dynein axonemal heavy chain 5,1,dynein intermediate chain binding|dynein light intermediate chain binding|dynein light chain binding|ATP-dependent microtubule motor activity; minus-end-directed,asthma|intrinsic asthma|allergic asthma|Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|tuberous sclerosis|Marfan syndrome|situs inversus|primary ciliary dyskinesia 3,ppi
10841,12646,197258,FUK,fucokinase,2,fucokinase activity,,ppi
10842,12647,29899,GPSM2,G-protein signaling modulator 2,17,GDP-dissociation inhibitor activity|protein self-association|dynein complex binding,hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain,ppi
10843,12649,84458,LCOR,ligand dependent nuclear receptor corepressor,67,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10844,12650,353174,ZACN,zinc activated ion channel,70,zinc ion binding|ligand-gated ion channel activity|extracellular ligand-gated ion channel activity,,ppi
10845,12651,80725,SRCIN1,SRC kinase signaling inhibitor 1,13,protein kinase binding,,ppi
10846,12652,59342,SCPEP1,serine carboxypeptidase 1,18,serine-type carboxypeptidase activity,,ppi
10847,12653,57498,KIDINS220,kinase D interacting substrate 220,47,PDZ domain binding|protein kinase regulator activity,,ppi
10848,12654,51107,APH1A,aph-1 homolog A; gamma-secretase subunit,20,endopeptidase activity,,ppi
10849,12655,1768,DNAH6,dynein axonemal heavy chain 6,3,ATP-dependent microtubule motor activity; minus-end-directed|dynein light intermediate chain binding|dynein light chain binding|dynein intermediate chain binding,,ppi
10850,12656,9650,MTFR1,mitochondrial fission regulator 1,21,,,ppi
10851,12657,22994,CEP131,centrosomal protein 131,84,protein homodimerization activity|protein-containing complex binding,,ppi
10852,12658,9716,AQR,aquarius intron-binding spliceosomal factor,53,RNA binding|mRNA binding,,ppi
10853,12660,64857,PLEKHG2,pleckstrin homology and RhoGEF domain containing G2,9,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
10854,12661,79132,DHX58,DExH-box helicase 58,15,double-stranded RNA binding|single-stranded RNA binding|zinc ion binding,,ppi
10855,12662,1769,DNAH8,dynein axonemal heavy chain 8,2,microtubule motor activity|ATP-dependent microtubule motor activity; minus-end-directed|dynein light intermediate chain binding|dynein light chain binding|dynein intermediate chain binding,bipolar disorder|cocaine abuse|cocaine dependence|substance abuse|substance-related disorder|paranoid schizophrenia|delusional disorder,ppi
10856,12663,65056,GPBP1,GC-rich promoter binding protein 1,22,DNA-binding transcription factor activity,,ppi
10857,12664,113246,C12orf57,chromosome 12 open reading frame 57,11,,intellectual disability|learning disability,ppi
10858,12665,84727,SPSB2,splA/ryanodine receptor domain and SOCS box containing 2,15,ubiquitin-protein transferase activity,,ppi
10859,12666,29105,CFAP20,cilia and flagella associated protein 20,35,RNA binding,,ppi
10860,12667,132954,PDCL2,phosducin like 2,3,,,ppi
10861,12669,51182,HSPA14,heat shock protein family A (Hsp70) member 14,26,heat shock protein binding|misfolded protein binding|protein binding involved in protein folding|ATPase activity|ATPase activity; coupled|unfolded protein binding|ATP binding,mouth disease,ppi
10862,12670,25994,HIGD1A,HIG1 hypoxia inducible domain family member 1A,20,,,ppi
10863,12671,55854,ZC3H15,zinc finger CCCH-type containing 15,43,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding|cadherin binding,,ppi
10864,12672,79718,TBL1XR1,transducin beta like 1 X-linked receptor 1,64,transcription corepressor activity|histone binding|transcription regulatory region DNA binding,acute promyelocytic leukemia|malignant mesothelioma|benign mesothelioma,ppi
10865,12673,1770,DNAH9,dynein axonemal heavy chain 9,3,dynein light chain binding|ATP-dependent microtubule motor activity; minus-end-directed|dynein light intermediate chain binding|dynein intermediate chain binding,,ppi
10866,12674,90990,KIFC2,kinesin family member C2,8,microtubule motor activity|ATPase activity|microtubule binding,,ppi
10867,12675,23367,LARP1,La ribonucleoprotein domain family member 1,203,RNA cap binding|RNA binding|mRNA 3'-UTR binding|translation activator activity|translation initiation factor binding|cadherin binding|mRNA 5'-UTR binding,,ppi
10868,12676,81606,LBH,limb bud and heart development,5,,,ppi
10869,12677,80218,NAA50,N(alpha)-acetyltransferase 50; NatE catalytic subunit,34,peptide alpha-N-acetyltransferase activity|H4 histone acetyltransferase activity|peptidyl-lysine acetyltransferase activity|N-acetyltransferase activity,,ppi
10870,12678,23344,ESYT1,extended synaptotagmin 1,44,calcium ion binding|phosphatidylinositol binding|calcium-dependent phospholipid binding|phosphatidylcholine binding|phosphatidylethanolamine binding,,ppi
10871,12679,22823,MTF2,metal response element binding transcription factor 2,28,methylated histone binding|DNA-binding transcription factor activity|nucleosome binding|sequence-specific DNA binding,,ppi
10872,12680,23005,MAPKBP1,mitogen-activated protein kinase binding protein 1,32,,,ppi
10873,12681,56917,MEIS3,Meis homeobox 3,2,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
10874,12682,27019,DNAI1,dynein axonemal intermediate chain 1,2,motor activity|ATP-dependent microtubule motor activity; plus-end-directed|dynein heavy chain binding|dynein light chain binding,bronchiectasis|chronic rhinitis|Kartagener syndrome|primary ciliary dyskinesia|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|male infertility|primary ciliary dyskinesia 1|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|pneumonia|sinusitis|tuberous sclerosis|Marfan syndrome|situs inversus|chronic sphenoidal sinusitis|chronic ethmoiditis,ppi
10875,12683,28987,NOB1,NIN1/PSMD8 binding protein 1 homolog,35,endoribonuclease activity,,ppi
10876,12684,64426,SUDS3,SDS3 homolog; SIN3A corepressor complex component,28,histone deacetylase activity|histone deacetylase binding,,ppi
10877,12685,26751,SH3YL1,SH3 and SYLF domain containing 1,9,phosphatase binding|phosphatidylinositol binding,,ppi
10878,12686,79801,SHCBP1,SHC binding and spindle associated 1,26,,,ppi
10879,12687,51295,ECSIT,ECSIT signalling integrator,112,oxidoreductase activity; acting on NAD(P)H,,ppi
10880,12688,121599,SPIC,Spi-C transcription factor,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10881,12689,10126,DNAL4,dynein axonemal light chain 4,9,microtubule motor activity|dynein intermediate chain binding|dynein light intermediate chain binding|ATP-dependent microtubule motor activity; plus-end-directed,,ppi
10882,12690,60626,RIC8A,RIC8 guanine nucleotide exchange factor A,45,guanyl-nucleotide exchange factor activity|GTPase activator activity|G-protein alpha-subunit binding,,ppi
10883,12691,84897,TBRG1,transforming growth factor beta regulator 1,7,,,ppi
10884,12692,63893,UBE2O,ubiquitin conjugating enzyme E2 O,100,RNA binding|ubiquitin-protein transferase activity|ubiquitin protein ligase activity|ubiquitin conjugating enzyme activity,,ppi
10885,12693,22835,ZFP30,ZFP30 zinc finger protein,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10886,12694,80303,EFHD1,EF-hand domain family member D1,16,,salivary gland adenoid cystic carcinoma,ppi
10887,12695,91624,NEXN,nexilin F-actin binding protein,37,structural constituent of muscle|actin filament binding|cell-cell adhesion mediator activity,dilated cardiomyopathy 1CC|hypertrophic cardiomyopathy 20,ppi
10888,12696,81788,NUAK2,NUAK family kinase 2,22,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
10889,12697,81671,VMP1,vacuole membrane protein 1,16,,,ppi
10890,12698,1773,DNASE1,deoxyribonuclease 1,4,deoxyribonuclease activity|DNA binding|deoxyribonuclease I activity,systemic lupus erythematosus|proteinuria,ppi
10891,12699,29087,THYN1,thymocyte nuclear protein 1,9,,prostate cancer|prostate carcinoma,ppi
10892,12700,64801,ARV1,ARV1 homolog; fatty acid homeostasis modulator,23,sterol transporter activity,,ppi
10893,12701,9665,KIAA0430,KIAA0430,8,,,ppi
10894,12702,80212,CCDC92,coiled-coil domain containing 92,31,,,ppi
10895,12703,80262,C16orf70,chromosome 16 open reading frame 70,33,,,ppi
10896,12704,57171,DOLPP1,dolichyldiphosphatase 1,10,dolichyldiphosphatase activity,,ppi
10897,12705,64748,PLPPR2,phospholipid phosphatase related 2,23,phosphatase activity|lipid phosphatase activity|phosphatidate phosphatase activity,,ppi
10898,12706,23205,ACSBG1,acyl-CoA synthetase bubblegum family member 1,2,long-chain fatty acid-CoA ligase activity|very long-chain fatty acid-CoA ligase activity,,ppi
10899,12707,375323,LHFPL4,lipoma HMGIC fusion partner-like 4,4,,,ppi
10900,12708,51601,LIPT1,lipoyltransferase 1,8,transferase activity; transferring acyl groups,lactic acidosis|dystonia|basal ganglia disease|focal hand dystonia|blepharospasm|primary pulmonary hypertension|pulmonary hypertension|Leigh disease|liver disease,ppi
10901,12709,1774,DNASE1L1,deoxyribonuclease 1 like 1,5,DNA binding|deoxyribonuclease activity|deoxyribonuclease I activity,,ppi
10902,12710,27165,GLS2,glutaminase 2,11,glutaminase activity,schizophrenia,ppi
10903,12712,51599,LSR,lipolysis stimulated lipoprotein receptor,44,,,ppi
10904,12713,90102,PHLDB2,pleckstrin homology like domain family B member 2,31,cadherin binding,,ppi
10905,12714,119392,SFR1,SWI5 dependent homologous recombination repair protein 1,15,nuclear receptor transcription coactivator activity,,ppi
10906,12715,122258,SPACA7,sperm acrosome associated 7,1,,,ppi
10907,12716,124402,UBALD1,UBA like domain containing 1,2,,,ppi
10908,12719,132671,SPATA18,spermatogenesis associated 18,3,,,ppi
10909,12720,1775,DNASE1L2,deoxyribonuclease 1 like 2,14,DNA binding|calcium ion binding|deoxyribonuclease I activity|deoxyribonuclease activity,prostate cancer|prostate carcinoma,ppi
10910,12721,136263,SSMEM1,serine rich single-pass membrane protein 1,11,,,ppi
10911,12724,374618,TEX9,testis expressed 9,10,,,ppi
10912,12725,317671,RFESD,Rieske Fe-S domain containing,1,2 iron; 2 sulfur cluster binding,,ppi
10913,12726,374864,CCDC178,coiled-coil domain containing 178,1,,,ppi
10914,12728,1776,DNASE1L3,deoxyribonuclease 1 like 3,1,deoxyribonuclease activity|calcium ion binding|deoxyribonuclease I activity|DNA binding,hereditary angioedema|angioedema|arthropathy|arthritis|rheumatoid arthritis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|conjunctivitis|scleritis|exanthem|lung benign neoplasm|systemic lupus erythematosus|nephritis|glomerulonephritis|kidney disease|proteinuria|kidney failure|uremia|uveitis|ciliary body disease,ppi
10915,12729,90353,CTU1,cytosolic thiouridylase subunit 1,29,tRNA binding,,ppi
10916,12730,92346,C1orf105,chromosome 1 open reading frame 105,4,,,ppi
10917,12731,286753,TUSC5,tumor suppressor candidate 5,8,,,ppi
10918,12733,27089,UQCRQ,ubiquinol-cytochrome c reductase complex III subunit VII,82,ubiquinol-cytochrome-c reductase activity,cerebellar disease|dystonia|basal ganglia disease|focal hand dystonia|blepharospasm|intellectual disability|learning disability|syndromic X-linked intellectual disability 94|mitochondrial complex III deficiency nuclear type 4,ppi
10919,12736,345611,IRGM,immunity related GTPase M,9,protein serine/threonine kinase activator activity|CARD domain binding|BH3 domain binding|GTPase activity,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease,ppi
10920,12737,28992,MACROD1,MACRO domain containing 1,31,hydrolase activity; acting on glycosyl bonds|deacetylase activity,,ppi
10921,12738,55259,CASC1,cancer susceptibility candidate 1,5,,lung benign neoplasm,ppi
10922,12739,1777,DNASE2,deoxyribonuclease 2; lysosomal,8,DNA binding|deoxyribonuclease II activity,,ppi
10923,12740,219541,MED19,mediator complex subunit 19,121,transcription factor binding,,ppi
10924,12741,55028,C17orf80,chromosome 17 open reading frame 80,22,,,ppi
10925,12742,10630,PDPN,podoplanin,1,signaling receptor binding|water transmembrane transporter activity|folic acid transmembrane transporter activity|amino acid transmembrane transporter activity|water channel activity,malignant mesothelioma|benign mesothelioma,ppi
10926,12744,66004,LYNX1,Ly6/neurotoxin 1,1,acetylcholine receptor regulator activity|acetylcholine receptor binding|acetylcholine receptor inhibitor activity,,ppi
10927,12745,10019,SH2B3,SH2B adaptor protein 3,14,transmembrane receptor protein tyrosine kinase adaptor activity,celiac disease|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21,ppi
10928,12746,388646,GBP7,guanylate binding protein 7,13,,,ppi
10929,12748,92140,MTDH,metadherin,34,transcription coactivator activity|RNA binding|double-stranded RNA binding|RNA polymerase II transcription factor binding|NF-kappaB binding,breast cancer,ppi
10930,12749,51205,ACP6,acid phosphatase 6; lysophosphatidic,20,lysophosphatidic acid phosphatase activity,,ppi
10931,12750,1778,DYNC1H1,dynein cytoplasmic 1 heavy chain 1,166,RNA binding|ATP-dependent microtubule motor activity; minus-end-directed|dynein light intermediate chain binding|dynein light chain binding|dynein intermediate chain binding,epilepsy|intellectual disability|learning disability|microcephaly|progressive muscular atrophy|spinal muscular atrophy|visual epilepsy|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|septooptic dysplasia|focal epilepsy|partial motor epilepsy|Charcot-Marie-Tooth disease axonal type 2O,ppi
10932,12751,7805,LAPTM5,lysosomal protein transmembrane 5,28,,IgA glomerulonephritis,ppi
10933,12752,119180,LYZL2,lysozyme like 2,54,,,ppi
10934,12754,254773,LYG2,lysozyme g2,27,lysozyme activity,,ppi
10935,12755,116840,CNTROB,centrobin; centriole duplication and spindle assembly protein,123,,polycystic ovary syndrome,ppi
10936,12757,219972,MPEG1,macrophage expressed 1,2,,,ppi
10937,12758,79659,DYNC2H1,dynein cytoplasmic 2 heavy chain 1,24,motor activity|ATP-dependent microtubule motor activity; minus-end-directed|dynein light intermediate chain binding|dynein light chain binding|dynein intermediate chain binding,short-rib thoracic dysplasia 6 with or without polydactyly|asphyxiating thoracic dystrophy 3|asphyxiating thoracic dystrophy 1|breast cancer,ppi
10938,12759,85437,ZCRB1,zinc finger CCHC-type and RNA binding motif containing 1,60,RNA binding,,ppi
10939,12760,27349,MCAT,malonyl-CoA-acyl carrier protein transacylase,41,RNA binding|fatty acid synthase activity|[acyl-carrier-protein] S-malonyltransferase activity,schizophrenia,ppi
10940,12761,23324,MAN2B2,mannosidase alpha class 2B member 2,6,mannan endo-1;6-alpha-mannosidase activity|alpha-mannosidase activity,,ppi
10941,12762,339501,PRSS38,protease; serine 38,1,,,ppi
10942,12764,8896,BUD31,BUD31 homolog,47,DNA-binding transcription factor activity|nuclear receptor transcription coactivator activity|nuclear hormone receptor binding,,ppi
10943,12765,1780,DYNC1I1,dynein cytoplasmic 1 intermediate chain 1,57,motor activity|microtubule motor activity|microtubule binding|spectrin binding|dynein heavy chain binding|ATP-dependent microtubule motor activity; plus-end-directed|dynein light chain binding,polyneuropathy|peripheral nervous system disease|neuropathy,ppi
10944,12766,374882,TMEM205,transmembrane protein 205,14,,,ppi
10945,12767,147744,TMEM190,transmembrane protein 190,3,,,ppi
10946,12769,84466,MEGF10,multiple EGF like domains 10,22,complement component C1q binding|scavenger receptor activity,familial periodic paralysis|myopathy|adult respiratory distress syndrome|newborn respiratory distress syndrome|schizophrenia,ppi
10947,12770,84465,MEGF11,multiple EGF like domains 11,2,,,ppi
10948,12771,55329,MNS1,meiosis specific nuclear structural 1,6,identical protein binding,,ppi
10949,12772,64110,MAGEF1,MAGE family member F1,12,,,ppi
10950,12773,1781,DYNC1I2,dynein cytoplasmic 1 intermediate chain 2,60,microtubule motor activity|dynein light chain binding|ATP-dependent microtubule motor activity; plus-end-directed|dynein heavy chain binding,,ppi
10951,12774,84939,MUM1,melanoma associated antigen (mutated) 1,14,nucleosome binding,,ppi
10952,12776,79083,MLPH,melanophilin,8,myosin binding|Rab GTPase binding|actin binding,Griscelli syndrome type 3,ppi
10953,12777,51573,GDE1,glycerophosphodiester phosphodiesterase 1,20,lysophospholipase activity|glycerophosphodiester phosphodiesterase activity|glycerophosphoinositol glycerophosphodiesterase activity,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
10954,12778,54852,PAQR5,progestin and adipoQ receptor family member 5,2,signaling receptor activity,,ppi
10955,12779,79850,FAM57A,family with sequence similarity 57 member A,3,,,ppi
10956,12780,260425,MAGI3,membrane associated guanylate kinase; WW and PDZ domain containing 3,30,guanylate kinase activity,,ppi
10957,12781,9088,PKMYT1,protein kinase; membrane associated tyrosine/threonine 1,20,protein kinase activity|kinase activity,melanoma|skin melanoma,ppi
10958,12782,79084,WDR77,WD repeat domain 77,123,methyl-CpG binding|protein-arginine N-methyltransferase activity|nuclear receptor transcription coactivator activity,ovarian cancer,ppi
10959,12783,51333,ZNF771,zinc finger protein 771,16,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
10960,12784,51334,PRR16,proline rich 16,7,,,ppi
10961,12785,51337,THEM6,thioesterase superfamily member 6,20,,,ppi
10962,12786,57708,MIER1,MIER1 transcriptional regulator,25,DNA-binding transcription factor activity; RNA polymerase II-specific|histone deacetylase activity|obsolete transcription factor activity; transcription factor binding|transcription corepressor activity|histone deacetylase binding|RNA polymerase II repressing transcription factor binding,,ppi
10963,12788,145873,MESP2,mesoderm posterior bHLH transcription factor 2,3,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,spondylocostal dysostosis,ppi
10964,12789,1783,DYNC1LI2,dynein cytoplasmic 1 light intermediate chain 2,35,dynein heavy chain binding,,ppi
10965,12790,115209,OMA1,OMA1 zinc metallopeptidase,21,metalloendopeptidase activity,,ppi
10966,12792,123263,MTFMT,mitochondrial methionyl-tRNA formyltransferase,6,methionyl-tRNA formyltransferase activity,Leigh disease|combined oxidative phosphorylation deficiency,ppi
10967,12794,723790,HIST2H2AA4,histone cluster 2 H2A family member a4,39,,,ppi
10968,12795,112752,IFT43,intraflagellar transport 43,17,,Sensenbrenner syndrome,ppi
10969,12796,79158,GNPTAB,N-acetylglucosamine-1-phosphate transferase alpha and beta subunits,21,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,inclusion-cell disease|glycoproteinosis|chylomicron retention disease|Fabry disease|lipid storage disease|pseudo-Hurler polydystrophy,ppi
10970,12797,79778,MICALL2,MICAL like 2,9,filamin binding|actin filament binding,,ppi
10971,12798,8076,MFAP5,microfibrillar associated protein 5,4,extracellular matrix structural constituent,aortic valve insufficiency|hypertension|essential hypertension|congestive heart failure|thoracic aortic aneurysm|Loeys-Dietz syndrome|coronary artery disease,ppi
10972,12800,23155,CLCC1,chloride channel CLIC like 1,26,chloride channel activity,,ppi
10973,12801,9933,PUM3,pumilio RNA binding family member 3,130,RNA binding,,ppi
10974,12803,55154,MSTO1,misato 1; mitochondrial distribution and morphology regulator,15,,,ppi
10975,12804,51025,PAM16,presequence translocase associated motor 16 homolog,30,,primary pulmonary hypertension|pulmonary hypertension|placental insufficiency|spondyloepimetaphyseal dysplasia; Strudwick type,ppi
10976,12805,55972,SLC25A40,solute carrier family 25 member 40,1,,,ppi
10977,12806,84275,SLC25A33,solute carrier family 25 member 33,3,pyrimidine nucleotide transmembrane transporter activity,,ppi
10978,12807,84340,GFM2,G elongation factor mitochondrial 2,20,GTPase activity|translation elongation factor activity,,ppi
10979,12808,81034,SLC25A32,solute carrier family 25 member 32,44,folic acid transmembrane transporter activity|FAD transmembrane transporter activity,,ppi
10980,12809,55699,IARS2,isoleucyl-tRNA synthetase 2; mitochondrial,63,isoleucine-tRNA ligase activity,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
10981,12810,1759,DNM1,dynamin 1,83,RNA binding|protein kinase binding|microtubule binding|GTPase activity,epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|antisocial personality disorder|avoidant personality disorder|narcissistic personality disorder|schizophrenia|visual epilepsy|brain disease|autistic disorder,ppi
10982,12811,10059,DNM1L,dynamin 1 like,65,GTPase activity|GTPase activator activity|Rab GTPase binding|GTP-dependent protein binding|protein homodimerization activity|microtubule binding,lactic acidosis|enophthalmos|orbital disease|exophthalmos|microcephaly|optic atrophy|brain disease|coronary artery disease|mitochondrial encephalomyopathy|spontaneous ocular nystagmus|dissociated nystagmus|pathologic nystagmus,ppi
10983,12812,1785,DNM2,dynamin 2,141,GTPase activity|GTP binding|microtubule binding|SH3 domain binding|enzyme binding,ptosis|congenital ptosis|pseudosarcomatous fibromatosis|polyhydramnios|ophthalmoplegia|chronic progressive external ophthalmoplegia|placental insufficiency|Bell's palsy|facial paralysis|centronuclear myopathy|congenital structural myopathy|Charcot-Marie-Tooth disease dominant intermediate B,ppi
10984,12813,1786,DNMT1,DNA methyltransferase 1,99,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA (cytosine-5-)-methyltransferase activity|DNA-methyltransferase activity|promoter-specific chromatin binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|anxiety disorder|phobic disorder|asthma|intrinsic asthma|allergic asthma|bipolar disorder|narcolepsy|cerebellar disease|colon cancer|colonic benign neoplasm|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia,ppi
10985,12814,1787,TRDMT1,tRNA aspartic acid methyltransferase 1,19,tRNA methyltransferase activity|tRNA (cytosine-5-)-methyltransferase activity,,ppi
10986,12815,1788,DNMT3A,DNA methyltransferase 3 alpha,53,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA (cytosine-5-)-methyltransferase activity|DNA-methyltransferase activity,blepharophimosis|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|acute monocytic leukemia|acute promyelocytic leukemia|lung benign neoplasm|Sezary's disease|cutaneous T cell lymphoma|juvenile myelomonocytic leukemia|breast cancer|autistic disorder|intellectual disability|learning disability,ppi
10987,12816,51312,SLC25A37,solute carrier family 25 member 37,1,iron ion transmembrane transporter activity,anemia|macrocytic anemia,ppi
10988,12817,116447,TOP1MT,topoisomerase (DNA) I; mitochondrial,10,DNA topoisomerase type I activity,,ppi
10989,12818,219402,MTIF3,mitochondrial translational initiation factor 3,3,translation factor activity; RNA binding|ribosomal small subunit binding|ribosome binding|translation initiation factor activity,,ppi
10990,12819,57509,MTUS1,microtubule associated tumor suppressor 1,22,microtubule binding,liver cancer|hepatocellular carcinoma,ppi
10991,12820,1789,DNMT3B,DNA methyltransferase 3 beta,73,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|DNA (cytosine-5-)-methyltransferase activity|DNA-methyltransferase activity,anemia|macrocytic anemia|bronchiectasis|bronchitis|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|primary immunodeficiency disease|lymphopenia|intellectual disability|learning disability|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|pneumonia|prostate cancer|prostate carcinoma|schizophrenia|sinusitis,ppi
10992,12821,28956,LAMTOR2,late endosomal/lysosomal adaptor; MAPK and MTOR activator 2,22,guanyl-nucleotide exchange factor activity|protein-containing complex scaffold activity,primary immunodeficiency disease|piebaldism,ppi
10993,12822,129401,NUP35,nucleoporin 35,64,structural constituent of nuclear pore|phospholipid binding|single-stranded DNA binding,,ppi
10994,12823,84451,MAP3K21,mitogen-activated protein kinase kinase kinase 21,10,protein homodimerization activity,,ppi
10995,12824,259230,SGMS1,sphingomyelin synthase 1,2,ceramide phosphoethanolamine synthase activity|sphingomyelin synthase activity|ceramide cholinephosphotransferase activity,,ppi
10996,12825,29947,DNMT3L,DNA methyltransferase 3 like,81,DNA-binding transcription factor activity; RNA polymerase II-specific|enzyme activator activity,schizophrenia,ppi
10997,12826,148932,MOB3C,MOB kinase activator 3C,15,,,ppi
10998,12827,92597,MOB1B,MOB kinase activator 1B,34,kinase activator activity,,ppi
10999,12828,126308,MOB3A,MOB kinase activator 3A,7,,,ppi
11000,12829,85377,MICALL1,MICAL like 1,29,cadherin binding|phosphatidic acid binding,,ppi
11001,12830,64332,NFKBIZ,NFKB inhibitor zeta,4,,,ppi
11002,12831,126364,LRRC25,leucine rich repeat containing 25,1,,,ppi
11003,12832,283385,MORN3,MORN repeat containing 3,17,,,ppi
11004,12833,84000,TMPRSS13,transmembrane protease; serine 13,4,serine-type endopeptidase activity,,ppi
11005,12834,23549,DNPEP,aspartyl aminopeptidase,39,aminopeptidase activity|metalloaminopeptidase activity,,ppi
11006,12835,54737,MPHOSPH8,M-phase phosphoprotein 8,87,methylated histone binding,,ppi
11007,12837,28960,DCPS,decapping enzyme; scavenger,41,RNA 7-methylguanosine cap binding|exoribonuclease activity|m7G(5')pppN diphosphatase activity,enophthalmos|orbital disease|exophthalmos,ppi
11008,12838,79595,SAP130,Sin3A associated protein 130,49,,,ppi
11009,12839,80198,MUS81,MUS81 structure-specific endonuclease subunit,22,endodeoxyribonuclease activity|3'-flap endonuclease activity|crossover junction endodeoxyribonuclease activity,,ppi
11010,12840,51725,FBXO40,F-box protein 40,7,ubiquitin-protein transferase activity,autistic disorder,ppi
11011,12841,140597,TCEAL2,transcription elongation factor A like 2,17,WW domain binding,,ppi
11012,12842,57496,MKL2,MKL1/myocardin like 2,13,transcription coactivator activity|cadherin binding,,ppi
11013,12843,51477,ISYNA1,inositol-3-phosphate synthase 1,38,inositol-3-phosphate synthase activity,salivary gland adenoid cystic carcinoma|polycystic ovary syndrome,ppi
11014,12844,23026,MYO16,myosin XVI,10,actin filament binding,schizophrenia,ppi
11015,12845,140465,MYL6B,myosin light chain 6B,25,motor activity|structural constituent of muscle,,ppi
11016,12846,29895,MYLPF,myosin light chain; phosphorylatable; fast skeletal muscle,7,structural constituent of muscle,,ppi
11017,12847,93408,MYL10,myosin light chain 10,3,,,ppi
11018,12848,91807,MYLK3,myosin light chain kinase 3,7,calmodulin-dependent protein kinase activity|myosin light chain kinase activity,,ppi
11019,12849,103910,MYL12B,myosin light chain 12B,34,,,ppi
11020,12851,55561,CDC42BPG,CDC42 binding protein kinase gamma,6,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
11021,12852,1791,DNTT,DNA nucleotidylexotransferase,9,DNA nucleotidylexotransferase activity,,ppi
11022,12853,55226,NAT10,N-acetyltransferase 10,83,RNA binding|N-acetyltransferase activity|rRNA cytidine N-acetyltransferase activity,,ppi
11023,12854,65220,NADK,NAD kinase,15,NAD+ kinase activity,,ppi
11024,12855,55191,NADSYN1,NAD synthetase 1,9,NAD+ synthase (glutamine-hydrolyzing) activity|glutaminase activity,,ppi
11025,12856,93517,SDR42E1,short chain dehydrogenase/reductase family 42E; member 1,1,oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor|oxidoreductase activity,,ppi
11026,12857,56901,NDUFA4L2,NDUFA4; mitochondrial complex associated like 2,17,cytochrome-c oxidase activity,rheumatoid arthritis,ppi
11027,12858,27158,NDOR1,NADPH dependent diflavin oxidoreductase 1,12,FMN binding|oxidoreductase activity|flavin adenine dinucleotide binding|NADP binding|NADPH-hemoprotein reductase activity,,ppi
11028,12860,26012,NSMF,NMDA receptor synaptonuclear signaling and neuronal migration factor,9,calcium-dependent protein binding,generalized anxiety disorder|anxiety disorder|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertrophy of breast|infant gynecomastia|gynecomastia|osteoporosis|hypogonadism|premature menopause|androgen insensitivity syndrome|eunuchism|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA,ppi
11029,12861,402415,XKRX,XK related; X-linked,9,,,ppi
11030,12862,30837,SOCS7,suppressor of cytokine signaling 7,16,SH3 domain binding|1-phosphatidylinositol-3-kinase regulator activity,,ppi
11031,12863,344148,NCKAP5,NCK associated protein 5,7,,mental depression,ppi
11032,12864,253559,CADM2,cell adhesion molecule 2,1,,,ppi
11033,12865,8448,DOC2A,double C2 domain alpha,11,,,ppi
11034,12866,9683,N4BP1,NEDD4 binding protein 1,10,,,ppi
11035,12867,55728,N4BP2,NEDD4 binding protein 2,12,endonuclease activity|ATP binding|ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,,ppi
11036,12868,23138,N4BP3,NEDD4 binding protein 3,12,,,ppi
11037,12869,57520,HECW2,HECT; C2 and WW domain containing E3 ubiquitin protein ligase 2,296,ubiquitin protein ligase activity,,ppi
11038,12870,80011,FAM192A,family with sequence similarity 192 member A,42,,,ppi
11039,12871,26993,AKAP8L,A-kinase anchoring protein 8 like,51,RNA binding|lamin binding|DEAD/H-box RNA helicase binding|histone deacetylase binding|protein kinase A regulatory subunit binding,,ppi
11040,12872,51701,NLK,nemo like kinase,59,magnesium ion binding|protein kinase activity|protein serine/threonine kinase activity|MAP kinase activity|ATP binding|SH2 domain binding,,ppi
11041,12873,51225,ABI3,ABI family member 3,35,SH3 domain binding|protein binding|identical protein binding,,ppi
11042,12874,8447,DOC2B,double C2 domain beta,5,calcium-dependent phospholipid binding,,ppi
11043,12876,91851,CHRDL1,chordin like 1,8,,megalocornea,ppi
11044,12877,145957,NRG4,neuregulin 4,3,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|signaling receptor binding,,ppi
11045,12878,51652,CHMP3,charged multivesicular body protein 3,30,phosphatidylcholine binding|protein homodimerization activity,,ppi
11046,12879,23114,NFASC,neurofascin,16,,schizophrenia,ppi
11047,12880,29114,TAGLN3,transgelin 3,36,,alcohol dependence|alcohol abuse,ppi
11048,12881,25759,SHC2,SHC adaptor protein 2,13,Ras guanyl-nucleotide exchange factor activity|receptor tyrosine kinase binding,,ppi
11049,12882,1793,DOCK1,dedicator of cytokinesis 1,28,Rho guanyl-nucleotide exchange factor activity|guanyl-nucleotide exchange factor activity,substance abuse|substance-related disorder,ppi
11050,12883,150372,NFAM1,NFAT activating protein with ITAM motif 1,3,transmembrane signaling receptor activity,,ppi
11051,12884,79576,NKAP,NFKB activating protein,59,chromatin binding|RNA binding,,ppi
11052,12885,80145,THOC7,THO complex 7,61,,,ppi
11053,12886,54544,CRCT1,cysteine rich C-terminal 1,22,,,ppi
11054,12887,25912,C1orf43,chromosome 1 open reading frame 43,21,,,ppi
11055,12888,9898,UBAP2L,ubiquitin associated protein 2 like,60,RNA binding,,ppi
11056,12889,56954,NIT2,nitrilase family member 2,25,omega-amidase activity,,ppi
11057,12890,1794,DOCK2,dedicator of cytokinesis 2,33,Rac guanyl-nucleotide exchange factor activity|T cell receptor binding,primary immunodeficiency disease|Barrett's esophagus|esophagus adenocarcinoma,ppi
11058,12891,23479,ISCU,iron-sulfur cluster assembly enzyme,26,iron ion binding|protein-containing complex scaffold activity|iron-sulfur transferase activity|ferrous iron binding|2 iron; 2 sulfur cluster binding|4 iron; 4 sulfur cluster binding,lactic acidosis|sideroblastic anemia|familial periodic paralysis|myopathy|mitochondrial myopathy|mitochondrial metabolism disease,ppi
11059,12892,146722,CD300LF,CD300 molecule like family member f,3,phosphatidylserine binding|interleukin-4 receptor binding|ceramide binding,,ppi
11060,12893,84959,UBASH3B,ubiquitin associated and SH3 domain containing B,110,protein tyrosine phosphatase activity|phosphatase activity,,ppi
11061,12894,79664,ICE2,interactor of little elongation complex ELL subunit 2,37,,cocaine abuse|cocaine dependence|paranoid schizophrenia|delusional disorder,ppi
11062,12896,197358,NLRC3,NLR family CARD domain containing 3,3,phosphatidylinositol 3-kinase regulatory subunit binding,,ppi
11063,12897,1795,DOCK3,dedicator of cytokinesis 3,16,Rac guanyl-nucleotide exchange factor activity,,ppi
11064,12898,79671,NLRX1,NLR family member X1,28,,,ppi
11065,12899,197370,NSMCE1,NSE1 homolog; SMC5-SMC6 complex component,16,ubiquitin-protein transferase activity|protein dimerization activity,,ppi
11066,12900,84419,C15orf48,chromosome 15 open reading frame 48,120,cytochrome-c oxidase activity,,ppi
11067,12901,91614,DEPDC7,DEP domain containing 7,10,GTPase activator activity,,ppi
11068,12902,1796,DOK1,docking protein 1,50,,lung benign neoplasm|ovarian cancer,ppi
11069,12903,58160,NFE4,nuclear factor; erythroid 4,7,proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity|protein homodimerization activity,,ppi
11070,12904,7812,CSDE1,cold shock domain containing E1,72,RNA binding,,ppi
11071,12905,123803,NTAN1,N-terminal asparagine amidase,2,protein-N-terminal asparagine amidohydrolase activity,,ppi
11072,12906,9046,DOK2,docking protein 2,42,,lung benign neoplasm,ppi
11073,12907,10438,C1D,C1D nuclear receptor corepressor,31,RNA binding,alcohol dependence|alcohol abuse,ppi
11074,12908,10241,CALCOCO2,calcium binding and coiled-coil domain 2,177,,,ppi
11075,12909,51530,ZC3HC1,zinc finger C3HC-type containing 1,36,,coronary artery disease,ppi
11076,12910,57122,NUP107,nucleoporin 107,102,structural constituent of nuclear pore,46 XX gonadal dysgenesis,ppi
11077,12911,91181,NUP210L,nucleoporin 210 like,2,,,ppi
11078,12912,26502,NARF,nuclear prelamin A recognition factor,15,lamin binding|4 iron; 4 sulfur cluster binding,,ppi
11079,12913,56890,MDM1,Mdm1 nuclear protein,5,microtubule binding,,ppi
11080,12914,25915,NDUFAF3,NADH:ubiquinone oxidoreductase complex assembly factor 3,41,,lactic acidosis|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|hypoglycemia|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
11081,12915,256646,NUTM1,NUT midline carcinoma family member 1,23,,NUT midline carcinoma,ppi
11082,12916,1797,DXO,decapping exoribonuclease,16,magnesium ion binding|mRNA binding|5'-3' exonuclease activity|RNA pyrophosphohydrolase activity,,ppi
11083,12917,201161,CENPV,centromere protein V,28,,,ppi
11084,12918,64710,NUCKS1,nuclear casein kinase and cyclin dependent kinase substrate 1,19,chromatin binding|double-stranded DNA binding|RNA binding,,ppi
11085,12919,29889,GNL2,G protein nucleolar 2,70,RNA binding|GTPase activity|GTP binding,,ppi
11086,12920,51602,NOP58,NOP58 ribonucleoprotein,129,RNA binding|snoRNA binding,,ppi
11087,12921,79023,NUP37,nucleoporin 37,19,,,ppi
11088,12922,29980,DONSON,downstream neighbor of SON,3,,,ppi
11089,12924,26354,GNL3,G protein nucleolar 3,101,RNA binding|GTP binding|mRNA 5'-UTR binding,,ppi
11090,12925,80347,COASY,Coenzyme A synthase,30,dephospho-CoA kinase activity|pantetheine-phosphate adenylyltransferase activity,neurodegeneration with brain iron accumulation 6,ppi
11091,12926,84166,NLRC5,NLR family CARD domain containing 5,4,RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
11092,12929,83894,TTC29,tetratricopeptide repeat domain 29,16,,,ppi
11093,12930,85478,CCDC65,coiled-coil domain containing 65,5,,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1,ppi
11094,12931,58509,CACTIN,cactin; spliceosome C complex subunit,19,RNA binding,,ppi
11095,12932,285596,FAM153A,family with sequence similarity 153 member A,2,,,ppi
11096,12933,57798,GATAD1,GATA zinc finger domain containing 1,49,DNA-binding transcription factor activity; RNA polymerase II-specific,dilated cardiomyopathy 2B,ppi
11097,12934,83882,TSPAN10,tetraspanin 10,5,,,ppi
11098,12935,57451,TENM2,teneurin transmembrane protein 2,3,protein homodimerization activity|protein heterodimerization activity|cell adhesion molecule binding,substance abuse|substance-related disorder,ppi
11099,12936,55714,TENM3,teneurin transmembrane protein 3,13,protein homodimerization activity|protein heterodimerization activity|cell adhesion molecule binding,cocaine abuse|cocaine dependence,ppi
11100,12937,26011,TENM4,teneurin transmembrane protein 4,1,protein homodimerization activity|cell adhesion molecule binding|protein heterodimerization activity,bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
11101,12938,22906,TRAK1,trafficking kinesin protein 1,17,myosin binding|signaling receptor binding|GABA receptor binding,schizophrenia,ppi
11102,12939,1798,DPAGT1,dolichyl-phosphate N-acetylglucosaminephosphotransferase 1,10,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity|UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,epilepsy|alternating exotropia|exotropia|monocular exotropia|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|stomach cancer|cataract|congenital disorder of glycosylation type I|congenital myasthenic syndrome,ppi
11103,12940,170392,OIT3,oncoprotein induced transcript 3,1,,,ppi
11104,12941,352954,GATS,GATS; stromal antigen 3 opposite strand,13,,,ppi
11105,12942,200931,SLC51A,solute carrier family 51 alpha subunit,6,protein homodimerization activity|protein heterodimerization activity,cholestasis|primary biliary cirrhosis,ppi
11106,12944,113451,AZIN2,antizyme inhibitor 2,10,arginine decarboxylase activity|putrescine transmembrane transporter activity|ornithine decarboxylase activator activity|ornithine decarboxylase activity,,ppi
11107,12945,121214,SDR9C7,short chain dehydrogenase/reductase family 9C member 7,12,retinol dehydrogenase activity,,ppi
11108,12946,23548,TTC33,tetratricopeptide repeat domain 33,17,,,ppi
11109,12947,126014,OSCAR,osteoclast associated; immunoglobulin-like receptor,1,collagen receptor activity,,ppi
11110,12951,84709,MGARP,mitochondria localized glutamic acid rich protein,3,,rheumatoid arthritis,ppi
11111,12953,127700,OSCP1,organic solute carrier partner 1,5,,,ppi
11112,12954,80321,CEP70,centrosomal protein 70,143,,,ppi
11113,12955,283150,FOXR1,forkhead box R1,39,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11114,12957,64393,ZMAT3,zinc finger matrin-type 3,26,RNA binding,,ppi
11115,12958,63970,TP53AIP1,tumor protein p53 regulated apoptosis inducing protein 1,2,,,ppi
11116,12959,54815,GATAD2A,GATA zinc finger domain containing 2A,51,DNA-binding transcription factor activity; RNA polymerase II-specific|protein binding; bridging,,ppi
11117,12960,26471,NUPR1,nuclear protein 1; transcriptional regulator,26,DNA binding,chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease|acute pancreatitis|pancreatitis,ppi
11118,12961,255967,PAN3,PAN3 poly(A) specific ribonuclease subunit,12,poly(A)-specific ribonuclease activity,,ppi
11119,12962,90737,PAGE5,PAGE family member 5,1,,,ppi
11120,12963,158800,RHOXF1,Rhox homeobox family member 1,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
11121,12965,51032,CELA2B,chymotrypsin like elastase family member 2B,15,serine-type endopeptidase activity,,ppi
11122,12966,90480,GADD45GIP1,GADD45G interacting protein 1,65,,,ppi
11123,12967,30850,CDR2L,cerebellar degeneration related protein 2 like,4,,,ppi
11124,12968,10349,ABCA10,ATP binding cassette subfamily A member 10,2,ATPase activity; coupled to transmembrane movement of substances,large intestine cancer|colorectal cancer,ppi
11125,12969,27241,BBS9,Bardet-Biedl syndrome 9,21,,craniosynostosis|hypertension|essential hypertension|hypogonadism|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|polydactyly|Laurence-Moon syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 3,ppi
11126,12970,55827,DCAF6,DDB1 and CUL4 associated factor 6,36,nuclear receptor transcription coactivator activity,prostate cancer|prostate carcinoma,ppi
11127,12972,445329,SULT1A4,sulfotransferase family 1A member 4,16,,,ppi
11128,12974,79917,MAGIX,MAGI family member; X-linked,23,,,ppi
11129,12975,553115,PEF1,penta-EF-hand domain containing 1,32,RNA binding|molecular adaptor activity,,ppi
11130,12976,246330,PELI3,pellino E3 ubiquitin protein ligase family member 3,14,protein serine/threonine kinase activity|ubiquitin protein ligase activity,,ppi
11131,12977,84528,RHOXF2,Rhox homeobox family member 2,58,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11132,12978,64146,PDF,peptide deformylase (mitochondrial),34,peptide deformylase activity,,ppi
11133,12980,114771,PGLYRP3,peptidoglycan recognition protein 3,1,peptidoglycan receptor activity|peptidoglycan binding|N-acetylmuramoyl-L-alanine amidase activity,,ppi
11134,12982,1800,DPEP1,dipeptidase 1 (renal),54,metalloexopeptidase activity|zinc ion binding|dipeptidase activity|GPI anchor binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|metallodipeptidase activity|modified amino acid binding,,ppi
11135,12983,85441,HELZ2,helicase with zinc finger 2,11,RNA binding|nuclear receptor transcription coactivator activity|ATP-dependent RNA helicase activity,,ppi
11136,12984,133522,PPARGC1B,PPARG coactivator 1 beta,20,transcription coregulator activity|RNA binding|estrogen receptor binding|nuclear receptor transcription coactivator activity|transcription factor binding,familial hyperlipidemia|obesity|breast cancer,ppi
11137,12985,57092,PCNP,PEST proteolytic signal containing nuclear protein,17,,,ppi
11138,12986,51555,PEX5L,peroxisomal biogenesis factor 5 like,2,peroxisome targeting sequence binding|peroxisome matrix targeting signal-1 binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
11139,12987,23082,PPRC1,peroxisome proliferator-activated receptor gamma; coactivator-related 1,10,RNA binding|nuclear receptor transcription coactivator activity|transcription factor binding,,ppi
11140,12988,80301,PLEKHO2,pleckstrin homology domain containing O2,21,,,ppi
11141,12989,79960,JADE1,jade family PHD finger 1,23,transcription coactivator activity,,ppi
11142,12990,9489,PGS1,phosphatidylglycerophosphate synthase 1,2,calcium ion binding|CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,,ppi
11143,12991,1801,DPH1,diphthamide biosynthesis 1,32,,,ppi
11144,12992,55361,PI4K2A,phosphatidylinositol 4-kinase type 2 alpha,24,magnesium ion binding|1-phosphatidylinositol 4-kinase activity|ATP binding|AP-3 adaptor complex binding,,ppi
11145,12993,55690,PACS1,phosphofurin acidic cluster sorting protein 1,23,ion channel binding,cryptorchidism|epilepsy|clubfoot|intellectual disability|learning disability|obesity|visual epilepsy|intestinal volvulus|substance abuse|substance-related disorder|agnosia|autosomal dominant non-syndromic intellectual disability,ppi
11146,12994,29085,PHPT1,phosphohistidine phosphatase 1,21,calcium channel inhibitor activity|protein histidine phosphatase activity,,ppi
11147,12995,118788,PIK3AP1,phosphoinositide-3-kinase adaptor protein 1,8,phosphatidylinositol 3-kinase regulatory subunit binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,,ppi
11148,12996,23533,PIK3R5,phosphoinositide-3-kinase regulatory subunit 5,7,G-protein beta/gamma-subunit complex binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|1-phosphatidylinositol-3-kinase regulator activity,spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ataxia with oculomotor apraxia type 3,ppi
11149,12997,54477,PLEKHA5,pleckstrin homology domain containing A5,59,,,ppi
11150,12998,84725,PLEKHA8,pleckstrin homology domain containing A8,7,glycolipid transporter activity|glycolipid binding|phosphatidylinositol-4-phosphate binding|ceramide binding|lipid binding|ceramide 1-phosphate transporter activity|ceramide 1-phosphate binding,,ppi
11151,12999,283748,PLA2G4D,phospholipase A2 group IVD,1,lysophospholipase activity|phospholipase A2 activity|phospholipase A1 activity|calcium-dependent phospholipase A2 activity|calcium-dependent phospholipid binding|calcium ion binding,schizophrenia,ppi
11152,13000,1802,DPH2,DPH2 homolog,21,2-(3-amino-3-carboxypropyl)histidine synthase activity,,ppi
11153,13002,151056,PLB1,phospholipase B1,13,phospholipase A2 activity|retinyl-palmitate esterase activity|lysophospholipase activity,rheumatoid arthritis,ppi
11154,13003,64077,LHPP,phospholysine phosphohistidine inorganic pyrophosphate phosphatase,2,magnesium ion binding|inorganic diphosphatase activity|protein histidine phosphatase activity|phosphatase activity,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
11155,13004,55824,PAG1,phosphoprotein membrane anchor with glycosphingolipid microdomains 1,43,SH3/SH2 adaptor activity|SH2 domain binding,schizophrenia|acute lymphocytic leukemia,ppi
11156,13005,23049,SMG1,SMG1; nonsense mediated mRNA decay associated PI3K related kinase,41,RNA binding|protein kinase activity|protein serine/threonine kinase activity|telomeric DNA binding,,ppi
11157,13006,54984,PINX1,PIN2/TERF1 interacting; telomerase inhibitor 1,114,telomerase inhibitor activity|telomerase RNA binding,,ppi
11158,13007,96626,LIMS3,LIM zinc finger domain containing 3,1,,,ppi
11159,13008,8544,PIR,pirin,53,transcription coregulator activity|quercetin 2;3-dioxygenase activity|metal ion binding,contact dermatitis|occupational dermatitis,ppi
11160,13009,8813,DPM1,dolichyl-phosphate mannosyltransferase subunit 1; catalytic,37,dolichyl-phosphate-mannose-protein mannosyltransferase activity|dolichyl-phosphate beta-D-mannosyltransferase activity,cerebellar disease|patent ductus arteriosus|epilepsy|glomus tumor|hemangioma|lymphangioma|chorioangioma|intramuscular hemangioma|histiocytoid hemangioma|cavernous hemangioma|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F,ppi
11161,13010,23225,NUP210,nucleoporin 210,41,,,ppi
11162,13012,56891,LGALS14,galectin 14,15,,,ppi
11163,13013,11070,TMEM115,transmembrane protein 115,7,identical protein binding,,ppi
11164,13015,254531,LPCAT4,lysophosphatidylcholine acyltransferase 4,10,1-acylglycerol-3-phosphate O-acyltransferase activity|2-acylglycerol-3-phosphate O-acyltransferase activity|lysophospholipid acyltransferase activity,,ppi
11165,13016,8818,DPM2,dolichyl-phosphate mannosyltransferase subunit 2; regulatory,6,dolichyl-phosphate beta-D-mannosyltransferase activity|enzyme regulator activity,epilepsy|optic atrophy|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|congenital disorder of glycosylation type I,ppi
11166,13017,23420,NOMO1,NODAL modulator 1,27,,,ppi
11167,13018,55193,PBRM1,polybromo 1,53,chromatin binding|DNA translocase activity,bipolar disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|schizophreniform disorder|schizoaffective disorder|schizophrenia|thymoma|thymic carcinoma|bile duct carcinoma|bile duct adenocarcinoma|intrahepatic cholangiocarcinoma|cholangiocarcinoma,ppi
11168,13019,54344,DPM3,dolichyl-phosphate mannosyltransferase subunit 3,5,dolichyl-phosphate beta-D-mannosyltransferase activity,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
11169,13020,79932,KIAA0319L,KIAA0319 like,26,,CREST syndrome|limited scleroderma,ppi
11170,13021,57126,CD177,CD177 molecule,3,,,ppi
11171,13022,23649,POLA2,DNA polymerase alpha 2; accessory subunit,60,protein heterodimerization activity,,ppi
11172,13023,11128,POLR3A,RNA polymerase III subunit A,69,DNA-directed 5'-3' RNA polymerase activity|RNA polymerase III activity,cerebellar disease|dystonia|tooth agenesis|anodontia|leukodystrophy|myopia|cerebral degeneration|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|hypogonadism|hypomyelinating leukodystrophy 7 with or without oligodontia and-or hypogonadotropic hypogonadism,ppi
11173,13024,10622,POLR3G,RNA polymerase III subunit G,13,,,ppi
11174,13025,10623,POLR3C,RNA polymerase III subunit C,42,single-stranded DNA binding|DNA-directed 5'-3' RNA polymerase activity|RNA polymerase III activity,,ppi
11175,13026,7905,REEP5,receptor accessory protein 5,76,,cholestasis|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
11176,13027,92840,REEP6,receptor accessory protein 6,31,,,ppi
11177,13029,10072,DPP3,dipeptidyl peptidase 3,26,dipeptidyl-peptidase activity|zinc ion binding,,ppi
11178,13030,10775,POP4,POP4 homolog; ribonuclease P/MRP subunit,34,RNA binding|ribonuclease P activity|ribonuclease MRP activity|ribonuclease P RNA binding,ovarian cancer,ppi
11179,13031,80333,KCNIP4,potassium voltage-gated channel interacting protein 4,16,calcium ion binding|potassium channel regulator activity,,ppi
11180,13032,51186,TCEAL9,transcription elongation factor A like 9,11,WW domain binding,,ppi
11181,13033,64115,VSIR,V-set immunoregulatory receptor,2,endopeptidase activator activity,,ppi
11182,13034,64118,DUS1L,dihydrouridine synthase 1 like,2,tRNA dihydrouridine synthase activity,,ppi
11183,13035,158427,TSTD2,thiosulfate sulfurtransferase like domain containing 2,17,,,ppi
11184,13036,1803,DPP4,dipeptidyl peptidase 4,31,virus receptor activity|serine-type endopeptidase activity|serine-type peptidase activity|dipeptidyl-peptidase activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|proteinuria,ppi
11185,13037,84106,PRAM1,PML-RARA regulated adaptor molecule 1,29,,,ppi
11186,13038,10135,NAMPT,nicotinamide phosphoribosyltransferase,35,nicotinamide phosphoribosyltransferase activity,colitis|ileitis|ileocolitis|gastroenteritis|large intestine cancer|colorectal cancer|obesity|allergic contact dermatitis,ppi
11187,13039,29948,OSGIN1,oxidative stress induced growth inhibitor 1,26,growth factor activity,,ppi
11188,13040,51639,SF3B6,splicing factor 3b subunit 6,82,RNA binding,,ppi
11189,13041,51585,PCF11,PCF11 cleavage and polyadenylation factor subunit,41,mRNA binding|RNA polymerase II complex binding,,ppi
11190,13042,79869,CPSF7,cleavage and polyadenylation specific factor 7,82,RNA binding,,ppi
11191,13043,256933,NPB,neuropeptide B,28,,polycystic ovary syndrome,ppi
11192,13044,1804,DPP6,dipeptidyl peptidase like 6,5,potassium channel regulator activity|dipeptidyl-peptidase activity,suppression amblyopia|amblyopia|progressive muscular atrophy|amyotrophic lateral sclerosis|intellectual disability|learning disability|alternating esotropia|autosomal dominant microcephaly|attention deficit hyperactivity disorder|autistic disorder,ppi
11193,13045,55851,PSENEN,presenilin enhancer gamma-secretase subunit,11,,hidradenitis suppurativa,ppi
11194,13046,29035,C16orf72,chromosome 16 open reading frame 72,4,,,ppi
11195,13047,1805,DPT,dermatopontin,4,extracellular matrix structural constituent,varicose veins,ppi
11196,13048,29057,FAM156A,family with sequence similarity 156 member A,5,,,ppi
11197,13049,1806,DPYD,dihydropyrimidine dehydrogenase,10,dihydropyrimidine dehydrogenase (NADP+) activity|protein homodimerization activity|flavin adenine dinucleotide binding|NADP binding|iron-sulfur cluster binding|uracil binding|dihydrouracil dehydrogenase (NAD+) activity|NADH dehydrogenase activity,astigmatism|autistic disorder|coloboma|colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|enophthalmos|orbital disease|exophthalmos|epilepsy|head and neck cancer|communication disorder|lung benign neoplasm|intellectual disability|learning disability|microphthalmia|myopia|central nervous system disease|nervous system disease,ppi
11198,13050,29028,ATAD2,ATPase family; AAA domain containing 2,22,ATPase activity|chromatin binding|histone binding,,ppi
11199,13051,51237,MZB1,marginal zone B and B1 cell specific protein,2,,,ppi
11200,13052,10940,POP1,POP1 homolog; ribonuclease P/MRP subunit,90,ribonuclease MRP activity|RNA binding|ribonuclease P activity,anauxetic dysplasia 1,ppi
11201,13053,1807,DPYS,dihydropyrimidinase,5,dihydropyrimidinase activity|zinc ion binding,imperforate anus|clubfoot|epilepsy|intellectual disability|learning disability|visual epilepsy|lactic acidosis|dihydropyrimidine dehydrogenase deficiency,ppi
11202,13054,152559,PAQR3,progestin and adipoQ receptor family member 3,6,signaling receptor activity,,ppi
11203,13056,79957,PAQR6,progestin and adipoQ receptor family member 6,1,signaling receptor activity,,ppi
11204,13058,27043,PELP1,proline; glutamate and leucine rich protein 1,79,chromatin binding|RNA binding,,ppi
11205,13059,283208,P4HA3,prolyl 4-hydroxylase subunit alpha 3,64,procollagen-proline 4-dioxygenase activity,,ppi
11206,13060,57146,TMEM159,transmembrane protein 159,9,,,ppi
11207,13061,114908,TMEM123,transmembrane protein 123,3,signaling receptor activity,,ppi
11208,13062,9762,LZTS3,leucine zipper tumor suppressor family member 3,7,,,ppi
11209,13063,1808,DPYSL2,dihydropyrimidinase like 2,55,dihydropyrimidinase activity,alcohol dependence|alcohol abuse|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|bipolar disorder|neurotic disorder|major depressive disorder,ppi
11210,13064,9755,TBKBP1,TBK1 binding protein 1,17,,ankylosing spondylitis,ppi
11211,13065,221120,ALKBH3,alkB homolog 3; alpha-ketoglutaratedependent dioxygenase,48,ferrous iron binding|DNA-N1-methyladenine dioxygenase activity|RNA N1-methyladenosine dioxygenase activity,,ppi
11212,13066,9518,GDF15,growth differentiation factor 15,8,protein homodimerization activity|cytokine activity|transforming growth factor beta receptor binding,sideroblastic anemia|gastrointestinal system cancer|congestive heart failure|melanoma|skin melanoma|mouth disease|prostate cancer|prostate carcinoma|coronary artery disease|liver cancer|hepatocellular carcinoma,ppi
11213,13069,1809,DPYSL3,dihydropyrimidinase like 3,35,SH3 domain binding|chondroitin sulfate binding,,ppi
11214,13070,10570,DPYSL4,dihydropyrimidinase like 4,24,,,ppi
11215,13071,90332,EXOC3L2,exocyst complex component 3 like 2,4,SNARE binding,,ppi
11216,13072,10196,PRMT3,protein arginine methyltransferase 3,48,methyltransferase activity|protein-arginine N-methyltransferase activity|histone-arginine N-methyltransferase activity|protein-arginine omega-N asymmetric methyltransferase activity,,ppi
11217,13073,54469,ZFAND6,zinc finger AN1-type containing 6,15,polyubiquitin modification-dependent protein binding,seborrheic keratosis|skin disease|actinic keratosis,ppi
11218,13074,729967,MORN2,MORN repeat containing 2,6,,,ppi
11219,13075,9601,PDIA4,protein disulfide isomerase family A member 4,73,RNA binding|protein disulfide isomerase activity|peptide disulfide oxidoreductase activity,,ppi
11220,13076,10130,PDIA6,protein disulfide isomerase family A member 6,115,peptide disulfide oxidoreductase activity,,ppi
11221,13077,1810,DR1,down-regulator of transcription 1,38,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|transcription factor binding|TBP-class protein binding|transcription coactivator activity|core promoter binding|obsolete RNA polymerase II transcription factor activity; TBP-class protein binding; involved in preinitiation complex assembly|transcription factor activity; RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,,ppi
11222,13078,26353,HSPB8,heat shock protein family B (small) member 8,34,protein kinase activity,axonal neuropathy|Charcot-Marie-Tooth disease axonal type 2L,ppi
11223,13079,92335,STRADA,STE20-related kinase adaptor alpha,10,protein kinase activator activity|protein serine/threonine kinase activator activity|protein kinase activity|protein serine/threonine kinase activity,medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
11224,13080,64149,C17orf75,chromosome 17 open reading frame 75,13,,,ppi
11225,13081,51400,PPME1,protein phosphatase methylesterase 1,98,protein phosphatase inhibitor activity|protein phosphatase regulator activity|protein phosphatase binding|cadherin binding|protein phosphatase 2A binding|protein C-terminal methylesterase activity,,ppi
11226,13082,29901,SAC3D1,SAC3 domain containing 1,10,,melanoma|skin melanoma,ppi
11227,13083,1811,SLC26A3,solute carrier family 26 member 3,4,DNA-binding transcription factor activity|transcription coregulator activity|transporter activity|inorganic anion exchanger activity|bicarbonate transmembrane transporter activity|chloride transmembrane transporter activity|anion:anion antiporter activity|oxalate transmembrane transporter activity|sulfate transmembrane transporter activity,heart disease|cardiovascular system disease|inflammatory bowel disease|ulcerative colitis|polyhydramnios|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypokalemia|congenital secretory chloride diarrhea 1,ppi
11228,13084,29902,FAM216A,family with sequence similarity 216 member A,1,,,ppi
11229,13085,29903,CCDC106,coiled-coil domain containing 106,20,,,ppi
11230,13087,138639,PTPDC1,protein tyrosine phosphatase domain containing 1,36,protein tyrosine phosphatase activity,,ppi
11231,13088,51185,CRBN,cereblon,108,,ptosis|congenital ptosis|isolated cleft palate|cleft palate|cryptorchidism|sensorineural hearing loss|atrioventricular septal defect|placental insufficiency|craniosynostosis|3p- syndrome|autosomal recessive non-syndromic intellectual disability,ppi
11232,13089,51184,GPN3,GPN-loop GTPase 3,62,GTPase activity,,ppi
11233,13090,56900,TMEM167B,transmembrane protein 167B,1,,,ppi
11234,13091,8225,GTPBP6,GTP binding protein 6 (putative),10,ribosome binding,,ppi
11235,13092,10589,DRAP1,DR1 associated protein 1,33,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity|core promoter binding|obsolete RNA polymerase II transcription factor activity; TBP-class protein binding; involved in preinitiation complex assembly|chromatin binding|transcription factor binding|transcription factor activity; RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly|transcription coactivator activity,melanoma|skin melanoma,ppi
11236,13094,1812,DRD1,dopamine receptor D1,13,dopamine neurotransmitter receptor activity; coupled via Gs|dopamine neurotransmitter receptor activity|dopamine binding|G-protein alpha-subunit binding,alcohol dependence|alcohol abuse|autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|movement disease|lingual-facial-buccal dyskinesia|Parkinson's disease|drug psychosis|schizophrenia|epilepsy|visual epilepsy|cocaine abuse|cocaine dependence,ppi
11237,13096,51397,COMMD10,COMM domain containing 10,27,,,ppi
11238,13097,51398,WDR83OS,WD repeat domain 83 opposite strand,2,,,ppi
11239,13098,28970,C11orf54,chromosome 11 open reading frame 54,34,zinc ion binding|hydrolase activity; acting on ester bonds,,ppi
11240,13099,28971,AAMDC,adipogenesis associated Mth938 domain containing,5,,,ppi
11241,13100,51136,RNFT1,ring finger protein; transmembrane 1,5,,,ppi
11242,13101,9411,ARHGAP29,Rho GTPase activating protein 29,15,GTPase activator activity|PDZ domain binding,lymphosarcoma|B-cell lymphoma,ppi
11243,13102,51290,ERGIC2,ERGIC and golgi 2,22,,,ppi
11244,13103,126006,PCP2,Purkinje cell protein 2,8,guanyl-nucleotide exchange factor activity,,ppi
11245,13104,84129,ACAD11,acyl-CoA dehydrogenase family member 11,49,acyl-CoA dehydrogenase activity|long-chain-acyl-CoA dehydrogenase activity|very-long-chain-acyl-CoA dehydrogenase activity|medium-chain-acyl-CoA dehydrogenase activity,,ppi
11246,13105,26115,TANC2,tetratricopeptide repeat; ankyrin repeat and coiled-coil containing 2,11,,,ppi
11247,13106,23400,ATP13A2,ATPase 13A2,64,zinc ion binding|ATPase activity|cation-transporting ATPase activity|manganese ion binding|phosphatidic acid binding|phosphatidylinositol-3;5-bisphosphate binding|cupric ion binding,focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|neuronal ceroid lipofuscinosis 4B|neuronal ceroid lipofuscinosis 1|neuronal ceroid lipofuscinosis 7|neuronal ceroid lipofuscinosis 8|neuronal ceroid lipofuscinosis 8 northern epilepsy variant|neuronal ceroid lipofuscinosis 10|neuronal ceroid lipofuscinosis 2|neuronal ceroid lipofuscinosis 13|neuronal ceroid lipofuscinosis 5|neuronal ceroid lipofuscinosis 6|neuronal ceroid lipofuscinosis 4A|neuronal ceroid lipofuscinosis 3|neuronal ceroid lipofuscinosis 11|neuronal ceroid lipofuscinosis 9|neuronal ceroid lipofuscinosis|Parkinson's disease,ppi
11248,13107,346389,MACC1,MACC1; MET transcriptional regulator,2,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
11249,13108,27243,CHMP2A,charged multivesicular body protein 2A,47,phosphatidylcholine binding,,ppi
11250,13109,27292,DIMT1,DIM1 dimethyladenosine transferase 1 homolog,53,rRNA (adenine-N6;N6-)-dimethyltransferase activity|RNA binding,,ppi
11251,13111,91869,RFT1,RFT1 homolog,21,,congenital disorder of glycosylation type I,ppi
11252,13112,10422,UBAC1,UBA domain containing 1,64,,,ppi
11253,13113,79581,SLC52A2,solute carrier family 52 member 2,4,riboflavin transmembrane transporter activity,Brown-Vialetto-Van Laere syndrome,ppi
11254,13115,84888,SPPL2A,signal peptide peptidase like 2A,3,aspartic endopeptidase activity; intramembrane cleaving|protein homodimerization activity,,ppi
11255,13116,9581,PREPL,prolyl endopeptidase-like,25,,lactic acidosis|ptosis|congenital ptosis|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|epilepsy|bulimia nervosa|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hypogonadism|visual epilepsy|acute urate nephropathy|hypotonia-cystinuria syndrome,ppi
11256,13117,50486,G0S2,G0/G1 switch 2,2,,,ppi
11257,13118,1813,DRD2,dopamine receptor D2,31,dopamine neurotransmitter receptor activity; coupled via Gi/Go|drug binding|adrenergic receptor activity,agoraphobia|alcohol dependence|alcohol abuse|generalized anxiety disorder|anxiety disorder|phobic disorder|basal ganglia disease|bipolar disorder|cannabis dependence|cannabis abuse|cocaine abuse|cocaine dependence|subacute delirium|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia,ppi
11258,13119,261726,TIPRL,TOR signaling pathway regulator,50,methionine-R-sulfoxide reductase activity,,ppi
11259,13120,26099,SZRD1,SUZ RNA binding domain containing 1,12,,,ppi
11260,13122,51471,NAT8B,N-acetyltransferase 8B (putative; gene/pseudogene),1,lysine N-acetyltransferase activity; acting on acetyl phosphate as donor|N-acetyltransferase activity,,ppi
11261,13124,54862,CC2D1A,coiled-coil and C2 domain containing 1A,35,cadherin binding,syndromic X-linked intellectual disability 94|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression|autosomal recessive non-syndromic intellectual disability,ppi
11262,13125,79971,WLS,wntless Wnt ligand secretion mediator,17,Wnt-protein binding,,ppi
11263,13126,84418,CYSTM1,cysteine rich transmembrane module containing 1,11,,,ppi
11264,13127,1814,DRD3,dopamine receptor D3,16,dopamine neurotransmitter receptor activity; coupled via Gi/Go|drug binding|adrenergic receptor activity|dopamine binding,alcohol dependence|alcohol abuse|autistic disorder|basal ganglia disease|bipolar disorder|cocaine abuse|cocaine dependence|subacute delirium|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|pathological gambling|intermittent explosive disorder|impulse control disorder|kleptomania|movement disease|lingual-facial-buccal dyskinesia,ppi
11265,13128,11017,SNRNP27,small nuclear ribonucleoprotein U4/U6.U5 subunit 27,110,nucleic acid binding,,ppi
11266,13129,7991,TUSC3,tumor suppressor candidate 3,22,magnesium ion transmembrane transporter activity|dolichyl-diphosphooligosaccharide-protein glycotransferase activity,intellectual disability|learning disability|prostate cancer|prostate carcinoma|autosomal recessive non-syndromic intellectual disability,ppi
11267,13130,10162,LPCAT3,lysophosphatidylcholine acyltransferase 3,22,1-acylglycerol-3-phosphate O-acyltransferase activity|2-acylglycerol-3-phosphate O-acyltransferase activity|1-acylglycerophosphocholine O-acyltransferase activity,,ppi
11268,13132,51538,ZCCHC17,zinc finger CCHC-type containing 17,43,RNA binding,,ppi
11269,13133,51368,TEX264,testis expressed 264,43,,,ppi
11270,13134,85027,SMIM3,small integral membrane protein 3,9,,,ppi
11271,13135,169714,QSOX2,quiescin sulfhydryl oxidase 2,25,protein disulfide isomerase activity|flavin-linked sulfhydryl oxidase activity,,ppi
11272,13136,1815,DRD4,dopamine receptor D4,13,dopamine neurotransmitter receptor activity; coupled via Gi/Go|dopamine neurotransmitter receptor activity|drug binding|potassium channel regulator activity|SH3 domain binding|dopamine binding|epinephrine binding|norepinephrine binding|G-protein coupled serotonin receptor activity|neurotransmitter receptor activity|G-protein coupled receptor activity,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|cannabis dependence|cannabis abuse|schizophrenia|chronic tic disorder|transient tic disorder|tic disorder|mood disorder|attention deficit hyperactivity disorder|Parkinson's disease,ppi
11273,13137,25805,BAMBI,BMP and activin membrane bound inhibitor,13,type II transforming growth factor beta receptor binding,,ppi
11274,13138,24142,NAT6,N-acetyltransferase 6,4,N-acetyltransferase activity|acetyl-CoA binding,,ppi
11275,13139,11068,CYB561D2,cytochrome b561 family member D2,3,,,ppi
11276,13140,27166,PRELID1,PRELI domain containing 1,8,phosphatidic acid transporter activity,,ppi
11277,13141,26108,PYGO1,pygopus family PHD finger 1,6,methylated histone binding,,ppi
11278,13142,90780,PYGO2,pygopus family PHD finger 2,21,,,ppi
11279,13143,84305,PYM1,PYM homolog 1; exon junction complex associated factor,77,RNA binding|ribosome binding,,ppi
11280,13144,57026,PDXP,pyridoxal phosphatase,6,magnesium ion binding|phosphoprotein phosphatase activity|heat shock protein binding|pyridoxal phosphatase activity|phosphatase activity,,ppi
11281,13145,1816,DRD5,dopamine receptor D5,5,dopamine neurotransmitter receptor activity; coupled via Gs|dopamine neurotransmitter receptor activity|dopamine binding|G-protein alpha-subunit binding,bipolar disorder|focal hand dystonia|blepharospasm|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophreniform disorder|schizoaffective disorder|attention deficit hyperactivity disorder,ppi
11282,13146,55163,PNPO,pyridoxamine 5'-phosphate oxidase,24,pyridoxamine-phosphate oxidase activity|FMN binding|pyridoxal phosphate binding|protein homodimerization activity,anemia|macrocytic anemia|epilepsy|hypoglycemia|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|schizophrenia|visual epilepsy|status epilepticus|brain disease|lactic acidosis,ppi
11283,13147,260434,PYDC1,pyrin domain containing 1,2,,,ppi
11284,13148,29920,PYCR2,pyrroline-5-carboxylate reductase family member 2,37,pyrroline-5-carboxylate reductase activity,leukodystrophy|muscular atrophy|hypomyelinating leukodystrophy 10,ppi
11285,13149,57546,PDP2,pyruvate dehyrogenase phosphatase catalytic subunit 2,11,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,,ppi
11286,13150,55066,PDPR,pyruvate dehydrogenase phosphatase regulatory subunit,27,[pyruvate dehydrogenase (lipoamide)] phosphatase activity|oxidoreductase activity,,ppi
11287,13151,80223,RAB11FIP1,RAB11 family interacting protein 1,30,Rab GTPase binding,,ppi
11288,13152,83547,RILP,Rab interacting lysosomal protein,13,Rab GTPase binding|dynein light intermediate chain binding|small GTPase binding,,ppi
11289,13153,84440,RAB11FIP4,RAB11 family interacting protein 4,17,protein homodimerization activity|ADP-ribosylation factor binding|Rab GTPase binding,,ppi
11290,13154,326624,RAB37,RAB37; member RAS oncogene family,5,GTPase activity,,ppi
11291,13155,115827,RAB3C,RAB3C; member RAS oncogene family,6,GTPase activity,,ppi
11292,13156,51762,RAB8B,RAB8B; member RAS oncogene family,47,GTPase activity|GDP binding,,ppi
11293,13157,115557,ARHGEF25,Rho guanine nucleotide exchange factor 25,8,,,ppi
11294,13158,23180,RFTN1,raftlin; lipid raft linker 1,10,double-stranded RNA binding,,ppi
11295,13159,55103,RALGPS2,Ral GEF with PH domain and SH3 binding motif 2,4,,,ppi
11296,13160,23179,RGL1,ral guanine nucleotide dissociation stimulator like 1,4,Ral guanyl-nucleotide exchange factor activity,,ppi
11297,13162,22902,RUFY3,RUN and FYVE domain containing 3,13,,seborrheic keratosis|skin disease|actinic keratosis,ppi
11298,13163,154661,RUNDC3B,RUN domain containing 3B,6,,,ppi
11299,13164,57521,RPTOR,regulatory associated protein of MTOR complex 1,105,RNA polymerase III type 1 promoter DNA binding|RNA polymerase III type 2 promoter DNA binding|RNA polymerase III type 3 promoter DNA binding|TFIIIC-class transcription factor complex binding|protein serine/threonine kinase inhibitor activity|protein kinase activator activity|protein binding; bridging|14-3-3 protein binding,nicotine dependence,ppi
11300,13165,51514,DTL,denticleless E3 ubiquitin protein ligase homolog,61,ubiquitin-protein transferase activity,salivary gland adenoid cystic carcinoma,ppi
11301,13166,51285,RASL12,RAS like family 12,12,,,ppi
11302,13167,4733,DRG1,developmentally regulated GTP binding protein 1,60,transcription factor binding,,ppi
11303,13168,51277,DNAJC27,DnaJ heat shock protein family (Hsp40) member C27,1,GTPase activity,,ppi
11304,13169,9908,G3BP2,G3BP stress granule assembly factor 2,75,RNA binding|receptor signaling complex scaffold activity|mRNA binding,,ppi
11305,13170,10146,G3BP1,G3BP stress granule assembly factor 1,143,RNA binding|ATP-dependent DNA helicase activity|ATP-dependent RNA helicase activity|mRNA binding,,ppi
11306,13172,91608,RASL10B,RAS like family 10 member B,26,,polycystic ovary syndrome,ppi
11307,13173,125950,RAVER1,ribonucleoprotein; PTB binding 1,62,RNA binding,,ppi
11308,13174,55920,RCC2,regulator of chromosome condensation 2,62,RNA binding|microtubule binding,,ppi
11309,13175,51720,UIMC1,ubiquitin interaction motif containing 1,72,histone binding|K63-linked polyubiquitin modification-dependent protein binding,,ppi
11310,13176,55791,LRIF1,ligand dependent nuclear receptor interacting factor 1,165,,,ppi
11311,13177,165,AEBP1,AE binding protein 1,2,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|carboxypeptidase activity|extracellular matrix structural constituent|metallocarboxypeptidase activity,,ppi
11312,13178,1819,DRG2,developmentally regulated GTP binding protein 2,18,,,ppi
11313,13179,80349,WDR61,WD repeat domain 61,59,,,ppi
11314,13180,89866,SEC16B,SEC16 homolog B; endoplasmic reticulum export factor,3,,,ppi
11315,13181,388531,RGS9BP,regulator of G-protein signaling 9 binding protein,1,,bradyopsia,ppi
11316,13182,29935,RPA4,replication protein A4,14,single-stranded DNA binding|sequence-specific DNA binding|damaged DNA binding|protein binding|double-stranded DNA binding|G-rich strand telomeric DNA binding,,ppi
11317,13183,11331,PHB2,prohibitin 2,178,estrogen receptor binding,,ppi
11318,13184,7993,UBXN8,UBX domain protein 8,27,,,ppi
11319,13185,56963,RGMA,repulsive guidance molecule family member a,14,coreceptor activity,,ppi
11320,13186,11079,RER1,retention in endoplasmic reticulum sorting receptor 1,36,,,ppi
11321,13187,1820,ARID3A,AT-rich interaction domain 3A,29,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
11322,13188,83546,RTBDN,retbindin,9,riboflavin transmembrane transporter activity|riboflavin binding|signaling receptor activity,malignant glioma|benign ependymoma|myxopapillary ependymoma|cellular ependymoma|tanycytic ependymoma|papillary ependymoma,ppi
11323,13189,195814,SDR16C5,short chain dehydrogenase/reductase family 16C member 5,5,obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|retinol dehydrogenase activity,,ppi
11324,13190,23352,UBR4,ubiquitin protein ligase E3 component n-recognin 4,107,ubiquitin-protein transferase activity,,ppi
11325,13191,23272,FAM208A,family with sequence similarity 208 member A,29,RNA binding,,ppi
11326,13192,116362,RBP7,retinol binding protein 7,6,,,ppi
11327,13193,23101,MCF2L2,MCF.2 cell line derived transforming sequence-like 2,6,,,ppi
11328,13194,1821,DRP2,dystrophin related protein 2,6,,,ppi
11329,13195,58504,ARHGAP22,Rho GTPase activating protein 22,30,GTPase activator activity,,ppi
11330,13196,23164,MPRIP,myosin phosphatase Rho interacting protein,65,cadherin binding,,ppi
11331,13197,64283,ARHGEF28,Rho guanine nucleotide exchange factor 28,10,guanyl-nucleotide exchange factor activity,,ppi
11332,13198,151636,DTX3L,deltex E3 ubiquitin ligase 3L,37,ubiquitin-protein transferase activity|enzyme inhibitor activity|enzyme activator activity|histone binding,,ppi
11333,13199,55312,RFK,riboflavin kinase,8,riboflavin kinase activity,prostate cancer|prostate carcinoma,ppi
11334,13200,64080,RBKS,ribokinase,7,ribokinase activity,,ppi
11335,13201,11102,RPP14,ribonuclease P/MRP subunit p14,23,RNA binding|ribonuclease P activity,,ppi
11336,13202,10557,RPP38,ribonuclease P/MRP subunit p38,50,,melanoma|skin melanoma,ppi
11337,13203,1822,ATN1,atrophin 1,105,transcription corepressor activity|RNA polymerase II transcription factor binding|DNA binding,basal ganglia disease|focal hand dystonia|blepharospasm|Unverricht-Lundborg syndrome|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy,ppi
11338,13204,79608,RIC3,RIC3 acetylcholine receptor chaperone,34,acetylcholine receptor binding,,ppi
11339,13205,23504,RIMBP2,RIMS binding protein 2,3,,,ppi
11340,13206,23317,DNAJC13,DnaJ heat shock protein family (Hsp40) member C13,43,,secondary Parkinson disease|Lewy body dementia,ppi
11341,13207,54700,RRN3,RRN3 homolog; RNA polymerase I transcription factor,24,RNA polymerase I CORE element sequence-specific DNA binding|RNA polymerase I core binding|RNA polymerase I general transcription initiation factor activity,,ppi
11342,13208,55718,POLR3E,RNA polymerase III subunit E,53,RNA polymerase III activity,,ppi
11343,13209,55703,POLR3B,RNA polymerase III subunit B,49,RNA polymerase III activity|DNA-directed 5'-3' RNA polymerase activity,cerebellar disease|cryptorchidism|dystonia|hypertrophy of breast|infant gynecomastia|gynecomastia|tooth agenesis|anodontia|leukodystrophy|myopia|cerebral degeneration|spontaneous ocular nystagmus|dissociated nystagmus|pathologic nystagmus|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome,ppi
11344,13210,171568,POLR3H,RNA polymerase III subunit H,24,DNA-directed 5'-3' RNA polymerase activity|RNA polymerase III activity,,ppi
11345,13211,1823,DSC1,desmocollin 1,34,,melanoma|skin melanoma,ppi
11346,13212,80135,RPF1,ribosome production factor 1 homolog,37,RNA binding|rRNA primary transcript binding,,ppi
11347,13213,54502,RBM47,RNA binding motif protein 47,6,RNA binding,,ppi
11348,13214,27254,CSDC2,cold shock domain containing C2,3,RNA binding|mRNA 3'-UTR binding,,ppi
11349,13215,1824,DSC2,desmocollin 2,20,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|arrhythmogenic right ventricular dysplasia 11,ppi
11350,13216,54913,RPP25,ribonuclease P/MRP subunit p25,22,RNA binding|ribonuclease P activity,,ppi
11351,13217,157869,SBSPON,somatomedin B and thrombospondin type 1 domain containing,3,extracellular matrix structural constituent,,ppi
11352,13218,55556,ENOSF1,enolase superfamily member 1,2,magnesium ion binding|L-fuconate dehydratase activity,,ppi
11353,13219,23505,TMEM131,transmembrane protein 131,22,,,ppi
11354,13220,170591,S100Z,S100 calcium binding protein Z,1,calcium ion binding|protein homodimerization activity,,ppi
11355,13221,58512,DLGAP3,DLG associated protein 3,21,,,ppi
11356,13223,1825,DSC3,desmocollin 3,12,,breast cancer,ppi
11357,13224,343099,CCDC18,coiled-coil domain containing 18,22,,,ppi
11358,13225,131377,KLHL40,kelch like family member 40,42,,nemaline myopathy,ppi
11359,13226,23268,DNMBP,dynamin binding protein,29,Rho guanyl-nucleotide exchange factor activity,,ppi
11360,13228,51246,SHISA5,shisa family member 5,7,,,ppi
11361,13229,23513,SCRIB,scribbled planar cell polarity protein,103,cadherin binding|ionotropic glutamate receptor binding,,ppi
11362,13230,11336,EXOC3,exocyst complex component 3,53,cadherin binding|SNARE binding,,ppi
11363,13231,81929,SEH1L,SEH1 like nucleoporin,70,structural molecule activity|identical protein binding,,ppi
11364,13232,55763,EXOC1,exocyst complex component 1,103,phosphatidylinositol-4;5-bisphosphate binding|GTP-Rho binding,,ppi
11365,13233,90507,SCRN2,secernin 2,15,,,ppi
11366,13234,79634,SCRN3,secernin 3,5,,,ppi
11367,13235,29937,NENF,neudesin neurotrophic factor,35,heme binding,,ppi
11368,13236,113178,SCAMP4,secretory carrier membrane protein 4,6,,,ppi
11369,13237,192683,SCAMP5,secretory carrier membrane protein 5,11,,autistic disorder,ppi
11370,13239,348174,CLEC18A,C-type lectin domain family 18 member A,11,polysaccharide binding,,ppi
11371,13240,60412,EXOC4,exocyst complex component 4,67,,,ppi
11372,13241,1826,DSCAM,DS cell adhesion molecule,2,cell-cell adhesion mediator activity,bipolar disorder|substance abuse|substance-related disorder,ppi
11373,13242,124460,SNX20,sorting nexin 20,17,phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3-phosphate binding,,ppi
11374,13243,26160,IFT172,intraflagellar transport 172,32,,cholestasis|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypertension|essential hypertension|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|osteochondrodysplasia,ppi
11375,13244,58515,SELENOK,selenoprotein K,5,,,ppi
11376,13245,83642,SELENOO,selenoprotein O,14,,,ppi
11377,13246,55829,SELENOS,selenoprotein S,23,antioxidant activity|signaling receptor activity,lung cancer|non-small cell lung carcinoma|prostate cancer|prostate carcinoma,ppi
11378,13247,140606,SELENOM,selenoprotein M,4,,,ppi
11379,13248,348303,SELENOV,selenoprotein V,7,,,ppi
11380,13250,1827,RCAN1,regulator of calcineurin 1,32,DNA binding|DNA-binding transcription factor activity|calcium-dependent protein serine/threonine phosphatase regulator activity,rheumatoid arthritis|Down syndrome|congenital heart disease|Huntington's disease,ppi
11381,13251,56920,SEMA3G,semaphorin 3G,1,signaling receptor binding|semaphorin receptor binding|neuropilin binding|chemorepellent activity,,ppi
11382,13252,123169,LEO1,LEO1 homolog; Paf1/RNA polymerase II complex component,56,RNA polymerase II C-terminal domain phosphoserine binding,,ppi
11383,13253,57337,SENP7,SUMO1/sentrin specific peptidase 7,11,,,ppi
11384,13254,58506,SCAF1,SR-related CTD associated factor 1,24,,,ppi
11385,13255,113675,SDSL,serine dehydratase like,1,hydro-lyase activity|L-serine ammonia-lyase activity|L-threonine ammonia-lyase activity,,ppi
11386,13256,260429,PRSS33,protease; serine 33,6,serine-type endopeptidase activity,,ppi
11387,13257,94031,HTRA3,HtrA serine peptidase 3,1,endopeptidase activity|serine-type peptidase activity,,ppi
11388,13258,10231,RCAN2,regulator of calcineurin 2,24,calcium-dependent protein serine/threonine phosphatase regulator activity,,ppi
11389,13259,83983,TSSK6,testis specific serine kinase 6,22,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
11390,13260,80854,SETD7,SET domain containing lysine methyltransferase 7,47,protein-lysine N-methyltransferase activity|histone-lysine N-methyltransferase activity,,ppi
11391,13261,131601,TPRA1,transmembrane protein adipocyte associated 1,27,G-protein coupled receptor activity,,ppi
11392,13262,10430,TMEM147,transmembrane protein 147,11,,,ppi
11393,13263,117157,SH2D1B,SH2 domain containing 1B,27,protein binding; bridging,,ppi
11394,13264,25970,SH2B1,SH2B adaptor protein 1,20,transmembrane receptor protein tyrosine kinase adaptor activity,autistic disorder|epilepsy|Hirschsprung's disease|Zollinger-Ellison syndrome|hyperinsulinism|bulimia nervosa|communication disorder|language disorder|megacolon|toxic megacolon|intellectual disability|learning disability|obesity|proteinuria|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|visual epilepsy|vesicoureteral reflux|Potter's syndrome,ppi
11395,13265,152503,SH3D19,SH3 domain containing 19,16,,,ppi
11396,13266,374875,HSD11B1L,hydroxysteroid 11-beta dehydrogenase 1 like,1,,,ppi
11397,13267,11123,RCAN3,RCAN family member 3,13,RNA binding|calcium-dependent protein serine/threonine phosphatase regulator activity,,ppi
11398,13268,57619,SHROOM3,shroom family member 3,26,actin filament binding,,ppi
11399,13269,27101,CACYBP,calcyclin binding protein,134,,,ppi
11400,13270,121665,SPPL3,signal peptide peptidase like 3,17,aspartic endopeptidase activity; intramembrane cleaving|protein homodimerization activity,,ppi
11401,13271,57758,SCUBE2,signal peptide; CUB domain and EGF like domain containing 2,1,,,ppi
11402,13272,8624,PSMG1,proteasome assembly chaperone 1,47,proteasome binding,inflammatory bowel disease|ulcerative colitis,ppi
11403,13273,55620,STAP2,signal transducing adaptor family member 2,16,,,ppi
11404,13274,343263,MYBPHL,myosin binding protein H like,7,,,ppi
11405,13276,57168,ASPHD2,aspartate beta-hydroxylase domain containing 2,23,,,ppi
11406,13277,151963,MB21D2,Mab-21 domain containing 2,17,protein-containing complex binding|cadherin binding,,ppi
11407,13279,10311,DSCR3,DSCR3 arrestin fold containing,15,protein transporter activity,,ppi
11408,13280,201164,PLD6,phospholipase D family member 6,12,cardiolipin hydrolase activity|protein homodimerization activity,,ppi
11409,13281,375743,PTAR1,protein prenyltransferase alpha subunit repeat containing 1,7,,,ppi
11410,13282,10281,DSCR4,Down syndrome critical region 4,1,,,ppi
11411,13283,93100,NAPRT,nicotinate phosphoribosyltransferase,35,nicotinate phosphoribosyltransferase activity,,ppi
11412,13284,153328,SLC25A48,solute carrier family 25 member 48,10,acyl carnitine transmembrane transporter activity,,ppi
11413,13285,137392,FAM92A,family with sequence similarity 92 member A,4,,,ppi
11414,13286,201158,TVP23C,trans-golgi network vesicle protein 23 homolog C,13,,,ppi
11415,13287,146894,CD300LG,CD300 molecule like family member g,2,,,ppi
11416,13288,124220,ZG16B,zymogen granule protein 16B,55,,,ppi
11417,13289,91433,RCCD1,RCC1 domain containing 1,20,,,ppi
11418,13290,283985,FADS6,fatty acid desaturase 6,1,,,ppi
11419,13291,51227,PIGP,phosphatidylinositol glycan anchor biosynthesis class P,5,phosphatidylinositol N-acetylglucosaminyltransferase activity,prostate cancer|prostate carcinoma,ppi
11420,13292,338657,CCDC84,coiled-coil domain containing 84,15,,,ppi
11421,13293,199777,ZNF626,zinc finger protein 626,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11422,13294,115704,EVI5L,ecotropic viral integration site 5 like,20,GTPase activator activity|Rab GTPase binding,,ppi
11423,13295,133418,EMB,embigin,13,monocarboxylic acid transmembrane transporter activity|cell-cell adhesion mediator activity,allergic contact dermatitis,ppi
11424,13296,130507,UBR3,ubiquitin protein ligase E3 component n-recognin 3 (putative),40,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
11425,13297,139628,FOXR2,forkhead box R2,36,DNA-binding transcription factor activity; RNA polymerase II-specific,acoustic neuroma|peripheral nervous system neoplasm|neurofibroma|peripheral nerve sheath neoplasm|perineurioma,ppi
11426,13299,151194,METTL21A,methyltransferase like 21A,19,protein methyltransferase activity|protein-lysine N-methyltransferase activity,,ppi
11427,13300,341208,HEPHL1,hephaestin like 1,25,ferroxidase activity|oxidoreductase activity; oxidizing metal ions,,ppi
11428,13301,1828,DSG1,desmoglein 1,48,calcium ion binding|toxic substance binding,acrodermatitis|dermatitis|allergic hypersensitivity disease|hypotrichosis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|disease of metabolism|nail disease,ppi
11429,13302,284069,FAM171A2,family with sequence similarity 171 member A2,21,,,ppi
11430,13304,115294,PCMTD1,protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1,7,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,,ppi
11431,13305,374928,ZNF773,zinc finger protein 773,2,,,ppi
11432,13306,374378,GALNT18,polypeptide N-acetylgalactosaminyltransferase 18,14,polypeptide N-acetylgalactosaminyltransferase activity,,ppi
11433,13307,146542,ZNF688,zinc finger protein 688,1,,,ppi
11434,13308,1829,DSG2,desmoglein 2,39,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
11435,13309,159090,FAM122B,family with sequence similarity 122B,19,,,ppi
11436,13310,375057,STUM,stum; mechanosensory transduction mediator homolog,1,,,ppi
11437,13311,352909,DNAAF3,dynein axonemal assembly factor 3,2,,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|primary ciliary dyskinesia 2,ppi
11438,13312,123720,WHAMM,WAS protein homolog associated with actin; golgi membranes and microtubules,1,microtubule binding|GTP-Rho binding|Arp2/3 complex binding,,ppi
11439,13313,205717,USF3,upstream transcription factor family member 3,1,,,ppi
11440,13314,374654,KIF7,kinesin family member 7,61,microtubule motor activity|microtubule binding|ATPase activity,isolated cleft palate|cleft palate|Pallister-Hall syndrome|acrocallosal syndrome|Joubert syndrome with orofaciodigital defect|Bardet-Biedl syndrome 1|hydrolethalus syndrome|intellectual disability|learning disability,ppi
11441,13315,147837,ZNF563,zinc finger protein 563,9,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11442,13316,653583,PHLDB3,pleckstrin homology like domain family B member 3,25,,,ppi
11443,13317,1830,DSG3,desmoglein 3,7,,,ppi
11444,13318,112476,PRRT2,proline rich transmembrane protein 2,9,syntaxin-1 binding,benign familial infantile epilepsy|benign neonatal seizures|benign familial neonatal epilepsy|familial hemiplegic migraine|intellectual disability|learning disability,ppi
11445,13319,84569,LYZL1,lysozyme like 1,38,,,ppi
11446,13320,130271,PLEKHH2,pleckstrin homology; MyTH4 and FERM domain containing H2,16,actin binding,,ppi
11447,13321,283869,NPW,neuropeptide W,3,,,ppi
11448,13322,1831,TSC22D3,TSC22 domain family member 3,40,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,Zollinger-Ellison syndrome|hyperinsulinism|male infertility|testicular disease,ppi
11449,13323,375686,SPATC1,spermatogenesis and centriole associated 1,3,,,ppi
11450,13324,90522,YIF1B,Yip1 interacting factor homolog B; membrane trafficking protein,9,,,ppi
11451,13325,54521,WDR44,WD repeat domain 44,35,Rab GTPase binding,,ppi
11452,13326,338382,RAB7B,RAB7B; member RAS oncogene family,9,GTPase activity,osteoporosis,ppi
11453,13328,1832,DSP,desmoplakin,136,RNA binding|structural molecule activity|structural constituent of cytoskeleton|protein binding; bridging|cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,alopecia|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
11454,13329,133957,CCDC127,coiled-coil domain containing 127,3,,,ppi
11455,13330,113235,SLC46A1,solute carrier family 46 member 1,2,folic acid transmembrane transporter activity|proton transmembrane transporter activity|heme transporter activity|methotrexate transmembrane transporter activity,alcohol dependence|alcohol abuse|anemia|macrocytic anemia|tropical sprue|pancytopenia|hyperhomocysteinemia,ppi
11456,13331,374659,HDDC3,HD domain containing 3,11,,,ppi
11457,13332,374355,CCDC172,coiled-coil domain containing 172,17,,,ppi
11458,13335,341032,C11orf53,chromosome 11 open reading frame 53,2,,,ppi
11459,13336,131118,DNAJC19,DnaJ heat shock protein family (Hsp40) member C19,27,protein transporter activity|ATPase activator activity,3-methylglutaconic aciduria type 5,ppi
11460,13337,375791,CYSRT1,cysteine rich tail 1,4,,,ppi
11461,13338,1833,EPYC,epiphycan,2,glycosaminoglycan binding,,ppi
11462,13339,91894,C11orf52,chromosome 11 open reading frame 52,2,,,ppi
11463,13340,93323,HAUS8,HAUS augmin like complex subunit 8,53,microtubule binding,,ppi
11464,13341,90806,ANGEL2,angel homolog 2,20,mRNA 3'-UTR binding,,ppi
11465,13342,134492,NUDCD2,NudC domain containing 2,68,unfolded protein binding,,ppi
11466,13343,90871,TMEM261,transmembrane protein 261,4,,,ppi
11467,13344,123872,DNAAF1,dynein axonemal assembly factor 1,5,dynein complex binding,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|primary ciliary dyskinesia 13,ppi
11468,13346,112942,CFAP36,cilia and flagella associated protein 36,8,protein N-terminus binding,,ppi
11469,13347,112479,ERI2,ERI1 exoribonuclease family member 2,3,3'-5'-exoribonuclease activity|single-stranded DNA 3'-5' exodeoxyribonuclease activity,,ppi
11470,13348,92017,SNX29,sorting nexin 29,4,,,ppi
11471,13349,89978,DPH6,diphthamine biosynthesis 6,9,diphthine-ammonia ligase activity,,ppi
11472,13350,90407,TMEM41A,transmembrane protein 41A,4,,,ppi
11473,13351,91368,CDKN2AIPNL,CDKN2A interacting protein N-terminal like,10,,,ppi
11474,13352,112812,FDX2,ferredoxin 2,4,electron transfer activity,,ppi
11475,13353,91408,BTF3L4,basic transcription factor 3 like 4,24,protein binding,,ppi
11476,13354,10299,MARCH6,membrane associated ring-CH-type finger 6,16,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
11477,13355,10907,TXNL4A,thioredoxin like 4A,29,,blepharophimosis|choanal atresia|cleft lip|isolated cleft palate|cleft palate|heart septal defect|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect,ppi
11478,13356,29951,PDZRN4,PDZ domain containing ring finger 4,3,ubiquitin protein ligase activity,asbestosis|anthracosilicosis|silicosis,ppi
11479,13358,414062,CCL3L3,C-C motif chemokine ligand 3 like 3,5,,seborrheic keratosis|skin disease|actinic keratosis,ppi
11480,13359,115265,DDIT4L,DNA damage inducible transcript 4 like,7,,melanoma|skin melanoma,ppi
11481,13360,203427,SLC25A43,solute carrier family 25 member 43,6,,,ppi
11482,13361,65117,RSRC2,arginine and serine rich coiled-coil 2,26,RNA binding,,ppi
11483,13362,25973,PARS2,prolyl-tRNA synthetase 2; mitochondrial (putative),10,proline-tRNA ligase activity,,ppi
11484,13363,56061,UBFD1,ubiquitin family domain containing 1,34,RNA binding|cadherin binding,,ppi
11485,13364,1837,DTNA,dystrobrevin alpha,39,,atrial fibrillation|patent ductus arteriosus|congestive heart failure|ventricular septal defect|mitral valve insufficiency|mitral valve prolapse|hypoplastic left heart syndrome|left ventricular noncompaction,ppi
11486,13365,199692,ZNF627,zinc finger protein 627,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11487,13366,90589,ZNF625,zinc finger protein 625,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11488,13367,162655,ZNF519,zinc finger protein 519,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11489,13368,59307,SIGIRR,single Ig and TIR domain containing,9,,,ppi
11490,13369,55256,ADI1,acireductone dioxygenase 1,19,acireductone dioxygenase [iron(II)-requiring] activity|oxidoreductase activity,prostate cancer|prostate carcinoma,ppi
11491,13370,142678,MIB2,mindbomb E3 ubiquitin protein ligase 2,25,ubiquitin-protein transferase activity,,ppi
11492,13371,23086,EXPH5,exophilin 5,10,Rab GTPase binding,acquired hyperkeratosis,ppi
11493,13372,54434,SSH1,slingshot protein phosphatase 1,35,actin binding|phosphoprotein phosphatase activity,,ppi
11494,13373,1838,DTNB,dystrobrevin beta,45,,,ppi
11495,13374,85464,SSH2,slingshot protein phosphatase 2,20,actin binding|phosphoprotein phosphatase activity,,ppi
11496,13375,54961,SSH3,slingshot protein phosphatase 3,35,actin binding,,ppi
11497,13378,79753,SNIP1,Smad nuclear interacting protein 1,98,RNA binding|mRNA binding,,ppi
11498,13379,118430,MUCL1,mucin like 1,15,,,ppi
11499,13380,94086,HSPB9,heat shock protein family B (small) member 9,13,,,ppi
11500,13381,1839,HBEGF,heparin binding EGF like growth factor,13,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|growth factor activity|heparin binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|epidermal growth factor receptor binding,endometriosis of uterus|endometriosis|epilepsy with generalized tonic-clonic seizures|chronic kidney disease|stomach cancer|perinatal necrotizing enterocolitis,ppi
11501,13382,23585,TMEM50A,transmembrane protein 50A,2,,,ppi
11502,13384,55898,UNC45A,unc-45 myosin chaperone A,89,cadherin binding|Hsp90 protein binding,,ppi
11503,13385,129285,PPP1R21,protein phosphatase 1 regulatory subunit 21,34,,,ppi
11504,13387,54861,SNRK,SNF related kinase,9,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
11505,13388,92421,CHMP4C,charged multivesicular body protein 4C,14,,ovarian cancer,ppi
11506,13389,1840,DTX1,deltex E3 ubiquitin ligase 1,23,transcription coactivator activity|Notch binding,oligodendroglioma|childhood oligodendroglioma|adult oligodendroglioma|mixed oligodendroglioma-astrocytoma|pancreatic ductal carcinoma,ppi
11507,13390,91544,UBXN11,UBX domain protein 11,33,ubiquitin binding,,ppi
11508,13393,51091,SEPSECS,Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase,9,tRNA binding|phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,epilepsy|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|locked-in syndrome|quadriplegia|pontocerebellar hypoplasia type 2D,ppi
11509,13394,1841,DTYMK,deoxythymidylate kinase,10,thymidylate kinase activity|nucleoside monophosphate kinase activity|uridylate kinase activity,,ppi
11510,13395,201595,STT3B,STT3B; catalytic subunit of the oligosaccharyltransferase complex,36,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,congenital disorder of glycosylation type I,ppi
11511,13396,245711,SPDYA,speedy/RINGO cell cycle regulator family member A,5,protein kinase activator activity,,ppi
11512,13397,219938,SPATA19,spermatogenesis associated 19,5,,,ppi
11513,13398,92521,SPECC1,sperm antigen with calponin homology and coiled-coil domains 1,35,,,ppi
11514,13399,23587,ELP5,elongator acetyltransferase complex subunit 5,13,,,ppi
11515,13400,80309,SPHKAP,SPHK1 interactor; AKAP domain containing,4,protein kinase A binding,,ppi
11516,13401,53905,DUOX1,dual oxidase 1,2,NAD(P)H oxidase activity|NADP binding,,ppi
11517,13402,80310,PDGFD,platelet derived growth factor D,20,platelet-derived growth factor receptor binding,coronary artery disease,ppi
11518,13403,83985,SPNS1,sphingolipid transporter 1 (putative),9,,,ppi
11519,13404,56907,SPIRE1,spire type actin nucleation factor 1,8,,,ppi
11520,13405,84501,SPIRE2,spire type actin nucleation factor 2,5,,,ppi
11521,13406,91746,YTHDC1,YTH domain containing 1,62,RNA binding|N6-methyladenosine-containing RNA binding,,ppi
11522,13407,56928,SPPL2B,signal peptide peptidase like 2B,99,aspartic endopeptidase activity; intramembrane cleaving|protein homodimerization activity,,ppi
11523,13408,80176,SPSB1,splA/ryanodine receptor domain and SOCS box containing 1,21,ubiquitin-protein transferase activity,,ppi
11524,13409,90864,SPSB3,splA/ryanodine receptor domain and SOCS box containing 3,19,ubiquitin-protein transferase activity,,ppi
11525,13410,92369,SPSB4,splA/ryanodine receptor domain and SOCS box containing 4,8,ubiquitin-protein transferase activity,,ppi
11526,13411,117143,TADA1,transcriptional adaptor 1,24,transcription coactivator activity|histone acetyltransferase activity,,ppi
11527,13412,9913,SUPT7L,SPT7-like STAGA complex gamma subunit,29,transcription coactivator activity|histone acetyltransferase activity,,ppi
11528,13413,56961,SHD,Src homology 2 domain containing transforming protein D,10,phosphotyrosine residue binding,,ppi
11529,13414,22937,SCAP,SREBF chaperone,24,unfolded protein binding,liver cancer|hepatocellular carcinoma,ppi
11530,13415,11063,SOX30,SRY-box 30,17,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding,lung benign neoplasm,ppi
11531,13416,128229,TSACC,TSSK6 activating cochaperone,3,chaperone binding,,ppi
11532,13417,1843,DUSP1,dual specificity phosphatase 1,42,protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|MAP kinase tyrosine/serine/threonine phosphatase activity|mitogen-activated protein kinase binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|contact dermatitis|occupational dermatitis|endometriosis of uterus|endometriosis|coronary artery disease,ppi
11533,13418,27044,SND1,staphylococcal nuclease and tudor domain containing 1,90,transcription coregulator activity|RNA binding|endonuclease activity|endoribonuclease activity|cadherin binding|RISC complex binding|nuclease activity,autistic disorder|lung benign neoplasm,ppi
11534,13419,151887,CCDC80,coiled-coil domain containing 80,5,,atopic dermatitis,ppi
11535,13420,11221,DUSP10,dual specificity phosphatase 10,24,protein tyrosine/threonine phosphatase activity|JUN kinase binding|phosphatase activity|MAP kinase phosphatase activity|protein tyrosine/serine/threonine phosphatase activity,,ppi
11536,13421,64220,STRA6,stimulated by retinoic acid 6,2,retinol transmembrane transporter activity,congenital heart disease|hiatus hernia|congenital diaphragmatic hernia|lung disease|microphthalmia|Matthew-Wood syndrome|intellectual disability|learning disability,ppi
11537,13422,85439,STON2,stonin 2,37,,alcohol dependence|alcohol abuse|schizophrenia,ppi
11538,13424,54464,XRN1,5'-3' exoribonuclease 1,109,G-quadruplex RNA binding|RNA binding|5'-3' exoribonuclease activity|G-quadruplex DNA binding|telomerase RNA binding,,ppi
11539,13425,137735,ABRA,actin binding Rho activating protein,8,actin binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
11540,13426,55974,SLC50A1,solute carrier family 50 member 1,3,glucoside transmembrane transporter activity|sugar transmembrane transporter activity,,ppi
11541,13427,8446,DUSP11,dual specificity phosphatase 11,52,RNA binding|polynucleotide 5'-phosphatase activity|protein tyrosine phosphatase activity|phosphatase activity|nucleotide phosphatase activity; acting on free nucleotides|mRNA guanylyltransferase activity,,ppi
11542,13428,10055,SAE1,SUMO1 activating enzyme subunit 1,57,ubiquitin activating enzyme activity|protein C-terminus binding|enzyme activator activity|ATP-dependent protein binding|protein heterodimerization activity|SUMO activating enzyme activity,,ppi
11543,13429,10054,UBA2,ubiquitin like modifier activating enzyme 2,88,magnesium ion binding|ATP binding|enzyme activator activity|SUMO activating enzyme activity|protein heterodimerization activity,,ppi
11544,13430,81570,CLPB,ClpB homolog; mitochondrial AAA ATPase chaperonin,57,,3-methylglutaconic aciduria with cataracts; neurologic involvement and neutropenia,ppi
11545,13431,391104,VHLL,von Hippel-Lindau tumor suppressor like,3,ubiquitin protein ligase activity,,ppi
11546,13432,56241,SUSD2,sushi domain containing 2,3,,,ppi
11547,13433,27286,SRPX2,sushi repeat containing protein; X-linked 2,4,hepatocyte growth factor binding|identical protein binding,agnosia|focal epilepsy|partial motor epilepsy|visual epilepsy|Landau-Kleffner syndrome|benign epilepsy with centrotemporal spikes,ppi
11548,13434,116841,SNAP47,synaptosome associated protein 47,28,syntaxin binding|SNAP receptor activity,,ppi
11549,13435,11266,DUSP12,dual specificity phosphatase 12,43,zinc ion binding|phosphatase activity|protein tyrosine/serine/threonine phosphatase activity,,ppi
11550,13436,22987,SV2C,synaptic vesicle glycoprotein 2C,7,,,ppi
11551,13437,11346,SYNPO,synaptopodin,157,actin binding,,ppi
11552,13438,152579,SCFD2,sec1 family domain containing 2,15,,,ppi
11553,13439,27238,GPKOW,G-patch domain and KOW motifs,35,RNA binding,,ppi
11554,13440,1844,DUSP2,dual specificity phosphatase 2,23,protein tyrosine/threonine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|MAP kinase tyrosine/serine/threonine phosphatase activity,,ppi
11555,13441,257397,TAB3,TGF-beta activated kinase 1/MAP3K7 binding protein 3,25,,,ppi
11556,13442,254102,EHBP1L1,EH domain binding protein 1 like 1,11,,,ppi
11557,13443,55080,TAPBPL,TAP binding protein like,7,,,ppi
11558,13444,30851,TAX1BP3,Tax1 binding protein 3,21,,,ppi
11559,13445,200081,TXLNA,taxilin alpha,115,cytokine activity|high molecular weight B cell growth factor receptor binding,,ppi
11560,13446,55832,CAND1,cullin associated and neddylation dissociated 1,660,,,ppi
11561,13447,23066,CAND2,cullin associated and neddylation dissociated 2 (putative),38,,,ppi
11562,13448,1845,DUSP3,dual specificity phosphatase 3,35,protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|phosphatase activity|protein kinase binding|MAP kinase phosphatase activity,lung cancer|non-small cell lung carcinoma,ppi
11563,13450,84541,KBTBD8,kelch repeat and BTB domain containing 8,11,,,ppi
11564,13451,23507,LRRC8B,leucine rich repeat containing 8 family member B,21,volume-sensitive anion channel activity,,ppi
11565,13454,160760,PPTC7,PTC7 protein phosphatase homolog,38,,,ppi
11566,13455,134430,WDR36,WD repeat domain 36,72,RNA binding,asthma|intrinsic asthma|allergic asthma|primary open angle glaucoma|open-angle glaucoma,ppi
11567,13456,81533,ITFG1,integrin alpha FG-GAP repeat containing 1,15,,,ppi
11568,13457,50852,TRAT1,T cell receptor associated transmembrane adaptor 1,14,transmembrane receptor protein tyrosine kinase adaptor activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,,ppi
11569,13458,166,AES,amino-terminal enhancer of split,156,transcription corepressor activity|repressing transcription factor binding,coronary artery disease,ppi
11570,13459,1846,DUSP4,dual specificity phosphatase 4,38,protein tyrosine phosphatase activity|protein tyrosine/threonine phosphatase activity|phosphatase activity|MAP kinase serine/threonine phosphatase activity|MAP kinase tyrosine/serine/threonine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
11571,13460,57616,TSHZ3,teashirt zinc finger homeobox 3,22,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,autistic disorder,ppi
11572,13462,58516,FAM60A,family with sequence similarity 60 member A,54,,,ppi
11573,13464,84691,FAM71F1,family with sequence similarity 71 member F1,2,,,ppi
11574,13465,84690,SPATA22,spermatogenesis associated 22,8,,,ppi
11575,13467,729877,TBC1D3H,TBC1 domain family member 3H,1,Rab GTPase binding|GTPase activator activity,,ppi
11576,13468,1847,DUSP5,dual specificity phosphatase 5,17,protein tyrosine/serine/threonine phosphatase activity|phosphatase activity|MAP kinase tyrosine/serine/threonine phosphatase activity,hypertension|essential hypertension,ppi
11577,13469,85438,CABS1,calcium binding protein; spermatid associated 1,9,calcium ion binding,,ppi
11578,13470,126820,WDR63,WD repeat domain 63,1,dynein heavy chain binding|dynein light chain binding|ATP-dependent microtubule motor activity; plus-end-directed,,ppi
11579,13471,113419,TEX261,testis expressed 261,1,COPII adaptor activity,,ppi
11580,13473,161931,ADAD2,adenosine deaminase domain containing 2,1,double-stranded RNA adenosine deaminase activity|tRNA-specific adenosine deaminase activity|double-stranded RNA binding,,ppi
11581,13474,339906,PRSS42,protease; serine 42,1,serine-type endopeptidase activity,,ppi
11582,13475,377047,PRSS45,protease; serine 45,3,serine-type endopeptidase activity,,ppi
11583,13477,60385,TSKS,testis specific serine kinase substrate,29,protein kinase binding,,ppi
11584,13478,1848,DUSP6,dual specificity phosphatase 6,59,protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|MAP kinase tyrosine/serine/threonine phosphatase activity,generalized anxiety disorder|anxiety disorder|bipolar disorder|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|glioblastoma multiforme|giant cell glioblastoma|hypertrophy of breast|infant gynecomastia|gynecomastia|osteoporosis|schizophrenia|hypogonadism|premature menopause|androgen insensitivity syndrome,ppi
11585,13479,220082,SPERT,spermatid associated,71,,,ppi
11586,13480,84654,SPZ1,spermatogenic leucine zipper 1,10,,stomach cancer,ppi
11587,13481,83639,TEX101,testis expressed 101,3,,,ppi
11588,13485,11036,GTF2A1L,general transcription factor IIA subunit 1 like,25,transcription coactivator activity,,ppi
11589,13486,10412,NSA2,NSA2; ribosome biogenesis homolog,72,RNA binding,primary biliary cirrhosis,ppi
11590,13487,80034,CSRNP3,cysteine and serine rich nuclear protein 3,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,substance abuse|substance-related disorder,ppi
11591,13488,1849,DUSP7,dual specificity phosphatase 7,23,protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|MAP kinase tyrosine/serine/threonine phosphatase activity,,ppi
11592,13490,51075,TMX2,thioredoxin related transmembrane protein 2,25,,,ppi
11593,13491,1850,DUSP8,dual specificity phosphatase 8,37,phosphatase activity|MAP kinase tyrosine/serine/threonine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity,alcohol dependence|alcohol abuse,ppi
11594,13492,80222,TARS2,threonyl-tRNA synthetase 2; mitochondrial (putative),19,aminoacyl-tRNA editing activity|threonine-tRNA ligase activity|protein homodimerization activity,combined oxidative phosphorylation deficiency,ppi
11595,13493,85480,TSLP,thymic stromal lymphopoietin,7,cytokine activity|interleukin-7 receptor binding,proteinuria|asthma|intrinsic asthma|allergic asthma|atopic dermatitis|membranoproliferative glomerulonephritis|eosinophilic esophagitis,ppi
11596,13496,9318,COPS2,COP9 signalosome subunit 2,114,transcription corepressor activity,endometriosis of uterus|endometriosis,ppi
11597,13497,29953,TRHDE,thyrotropin releasing hormone degrading enzyme,16,aminopeptidase activity|peptide binding|metalloaminopeptidase activity|zinc ion binding,,ppi
11598,13498,54962,TIPIN,TIMELESS interacting protein,16,DNA binding,,ppi
11599,13499,9515,STXBP5L,syntaxin binding protein 5 like,3,Rab GTPase binding|GTPase activator activity|syntaxin binding,,ppi
11600,13500,64282,PAPD5,poly(A) RNA polymerase D5; non-canonical,45,RNA binding|polynucleotide adenylyltransferase activity|telomerase RNA binding,,ppi
11601,13501,24150,TP53TG3,TP53 target 3,1,,,ppi
11602,13502,1852,DUSP9,dual specificity phosphatase 9,66,phosphoprotein phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|MAP kinase tyrosine/serine/threonine phosphatase activity,,ppi
11603,13503,55858,TMEM165,transmembrane protein 165,19,,congenital disorder of glycosylation type II,ppi
11604,13504,199223,TTC21A,tetratricopeptide repeat domain 21A,6,,,ppi
11605,13505,392307,FAM221B,family with sequence similarity 221 member B,7,,,ppi
11606,13506,126382,NR2C2AP,nuclear receptor 2C2 associated protein,6,,,ppi
11607,13507,10293,TRAIP,TRAF interacting protein,47,,craniosynostosis|achondroplasia|Laron syndrome|placental insufficiency|glaucoma|intellectual disability|learning disability|microcephaly|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome,ppi
11608,13508,23043,TNIK,TRAF2 and NCK interacting kinase,126,protein kinase activity|protein serine/threonine kinase activity,schizophrenia|seborrheic keratosis|skin disease|actinic keratosis,ppi
11609,13509,80342,TRAF3IP3,TRAF3 interacting protein 3,38,,,ppi
11610,13510,90417,KNSTRN,kinetochore localized astrin/SPAG5 binding protein,38,,tongue squamous cell carcinoma|squamous cell carcinoma,ppi
11611,13511,171392,ZNF675,zinc finger protein 675,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|zinc ion binding,,ppi
11612,13512,256302,NATD1,N-acetyltransferase domain containing 1,4,,,ppi
11613,13513,51224,ELOA2,elongin A2,17,,,ppi
11614,13514,100130302,SUPT20HL1,SPT20 homolog; SAGA complex component-like 1,1,,,ppi
11615,13516,84163,GTF2IRD2,GTF2I repeat domain containing 2,12,protein binding,,ppi
11616,13517,254251,LCORL,ligand dependent nuclear receptor corepressor like,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11617,13518,55536,CDCA7L,cell division cycle associated 7 like,40,,,ppi
11618,13519,57459,GATAD2B,GATA zinc finger domain containing 2B,87,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,autosomal dominant non-syndromic intellectual disability,ppi
11619,13520,80298,MTERF2,mitochondrial transcription termination factor 2,3,DNA binding,,ppi
11620,13521,1854,DUT,deoxyuridine triphosphatase,84,RNA binding|dUTP diphosphatase activity|magnesium ion binding,,ppi
11621,13522,10485,C1orf61,chromosome 1 open reading frame 61,1,,,ppi
11622,13523,93624,TADA2B,transcriptional adaptor 2B,25,DNA-binding transcription factor activity; RNA polymerase II-specific|thiol-dependent ubiquitinyl hydrolase activity|transcription coactivator activity|histone acetyltransferase activity|chromatin binding,,ppi
11623,13524,80155,NAA15,N(alpha)-acetyltransferase 15; NatA auxiliary subunit,56,RNA binding|ribosome binding|acetyltransferase activity|peptide alpha-N-acetyltransferase activity,,ppi
11624,13525,9792,SERTAD2,SERTA domain containing 2,9,,,ppi
11625,13526,29115,SAP30BP,SAP30 binding protein,44,,schizophrenia,ppi
11626,13527,79816,TLE6,transducin like enhancer of split 6,2,transcription corepressor activity|repressing transcription factor binding,,ppi
11627,13529,29914,UBIAD1,UbiA prenyltransferase domain containing 1,6,prenyltransferase activity|antioxidant activity,corneal dystrophy|Schnyder corneal dystrophy,ppi
11628,13530,10289,EIF1B,eukaryotic translation initiation factor 1B,166,RNA binding|ribosomal small subunit binding|translation initiation factor activity,,ppi
11629,13531,9669,EIF5B,eukaryotic translation initiation factor 5B,64,RNA binding|translation initiation factor activity,,ppi
11630,13532,9702,CEP57,centrosomal protein 57,111,microtubule binding,aortic valve insufficiency|recurrent corneal erosion|Dandy-Walker syndrome|placental insufficiency|glaucoma|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|polyhydramnios|intellectual disability|learning disability,ppi
11631,13533,441631,TSPAN11,tetraspanin 11,11,,,ppi
11632,13534,11171,STRAP,serine/threonine kinase receptor associated protein,105,RNA binding,large intestine cancer|colorectal cancer,ppi
11633,13535,9777,TM9SF4,transmembrane 9 superfamily member 4,47,,,ppi
11634,13536,79057,PRRG3,proline rich and Gla domain 3,4,,,ppi
11635,13537,79056,PRRG4,proline rich and Gla domain 4,9,,,ppi
11636,13539,55966,AJAP1,adherens junctions associated protein 1,3,protein-containing complex binding|beta-catenin binding,,ppi
11637,13540,57104,PNPLA2,patatin like phospholipase domain containing 2,18,lipoprotein lipase activity|triglyceride lipase activity|acylglycerol O-acyltransferase activity,heart disease|cardiovascular system disease|polycystic ovary syndrome,ppi
11638,13541,58486,ZBED5,zinc finger BED-type containing 5,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11639,13542,63920,ZBED8,zinc finger BED-type containing 8,12,,,ppi
11640,13544,28951,TRIB2,tribbles pseudokinase 2,26,transcription factor binding|ubiquitin protein ligase binding|ubiquitin-protein transferase regulator activity|nucleotide binding|protein kinase activity|mitogen-activated protein kinase kinase binding,,ppi
11641,13545,124599,CD300LB,CD300 molecule like family member b,2,,,ppi
11642,13546,151246,SGO2,shugoshin 2,49,,,ppi
11643,13547,54952,TRNAU1AP,tRNA selenocysteine 1 associated protein 1,4,RNA binding,,ppi
11644,13548,51149,MRNIP,MRN complex interacting protein,1,chromatin binding,,ppi
11645,13550,199731,CADM4,cell adhesion molecule 4,7,,,ppi
11646,13551,51559,NT5DC3,5'-nucleotidase domain containing 3,8,5'-nucleotidase activity,,ppi
11647,13552,11170,FAM107A,family with sequence similarity 107 member A,30,,malignant glioma|gliosarcoma|mixed glioma,ppi
11648,13553,113091,PTH2,parathyroid hormone 2,2,,,ppi
11649,13554,347733,TUBB2B,tubulin beta 2B class IIb,112,protein heterodimerization activity|GTP binding|structural constituent of cytoskeleton,congenital fibrosis of the extraocular muscles,ppi
11650,13555,286826,LIN9,lin-9 DREAM MuvB core complex component,35,DNA binding,,ppi
11651,13556,23424,TDRD7,tudor domain containing 7,22,mRNA binding,glaucoma|male infertility|influenza|cataract,ppi
11652,13557,83696,TRAPPC9,trafficking protein particle complex 9,39,Rab guanyl-nucleotide exchange factor activity,non-syndromic intellectual disability,ppi
11653,13558,10263,CDK2AP2,cyclin dependent kinase 2 associated protein 2,20,,prostate cancer|prostate carcinoma,ppi
11654,13559,286827,TRIM59,tripartite motif containing 59,11,,,ppi
11655,13560,282809,POC1B,POC1 centriolar protein B,44,,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
11656,13562,1855,DVL1,dishevelled segment polarity protein 1,72,frizzled binding,cryptorchidism|enophthalmos|orbital disease|exophthalmos|gingival overgrowth|gingival hypertrophy|inguinal hernia|umbilical hernia|omphalocele|hydronephrosis|intellectual disability|learning disability|cavernous hemangioma|capillary hemangioma|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome,ppi
11657,13563,353288,KRT26,keratin 26,1,,,ppi
11658,13564,342574,KRT27,keratin 27,6,,,ppi
11659,13565,162605,KRT28,keratin 28,1,,,ppi
11660,13566,9936,CD302,CD302 molecule,4,,,ppi
11661,13567,26470,SEZ6L2,seizure related 6 homolog like 2,11,,autistic disorder,ppi
11662,13569,11066,SNRNP35,small nuclear ribonucleoprotein U11/U12 subunit 35,16,mRNA binding,,ppi
11663,13570,23350,U2SURP,U2 snRNP associated SURP domain containing,61,RNA binding,,ppi
11664,13571,92856,IMP4,IMP4 homolog; U3 small nucleolar ribonucleoprotein,24,rRNA primary transcript binding|snoRNA binding,,ppi
11665,13572,9410,SNRNP40,small nuclear ribonucleoprotein U5 subunit 40,73,RNA binding,,ppi
11666,13573,9343,EFTUD2,elongation factor Tu GTP binding domain containing 2,169,RNA binding,choanal atresia|isolated cleft palate|cleft palate|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|intellectual disability|learning disability|Treacher Collins syndrome|craniosynostosis,ppi
11667,13574,23020,SNRNP200,small nuclear ribonucleoprotein U5 subunit 200,188,RNA binding|ATP-dependent RNA helicase activity|ATP-dependent helicase activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
11668,13575,1856,DVL2,dishevelled segment polarity protein 2,150,frizzled binding,,ppi
11669,13576,134353,LSM11,LSM11; U7 small nuclear RNA associated,26,U7 snRNA binding,,ppi
11670,13577,10975,UQCR11,ubiquinol-cytochrome c reductase; complex III subunit XI,5,electron transfer activity|ubiquinol-cytochrome-c reductase activity,,ppi
11671,13578,29796,UQCR10,ubiquinol-cytochrome c reductase; complex III subunit X,18,ubiquinol-cytochrome-c reductase activity,,ppi
11672,13579,55293,UEVLD,UEV and lactate/malate dehyrogenase domains,8,,,ppi
11673,13580,23264,ZC3H7B,zinc finger CCCH-type containing 7B,16,RNA binding|miRNA binding,,ppi
11674,13581,1857,DVL3,dishevelled segment polarity protein 3,98,frizzled binding|beta-catenin binding|protein heterodimerization activity,Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome|Cockayne syndrome|Noonan syndrome|Aarskog syndrome,ppi
11675,13582,25834,MGAT4C,MGAT4 family member C,34,alpha-1;3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,,ppi
11676,13583,55839,CENPN,centromere protein N,22,,,ppi
11677,13584,55846,ITFG2,integrin alpha FG-GAP repeat containing 2,14,,,ppi
11678,13585,55847,CISD1,CDGSH iron sulfur domain 1,33,,,ppi
11679,13586,79868,ALG13,ALG13; UDP-N-acetylglucosaminyltransferase subunit,18,RNA binding|N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,congenital disorder of glycosylation type I,ppi
11680,13587,55850,USE1,unconventional SNARE in the ER 1,61,,,ppi
11681,13588,55863,TMEM126B,transmembrane protein 126B,19,,mitochondrial complex I deficiency,ppi
11682,13589,55852,TEX2,testis expressed 2,8,lipid binding,,ppi
11683,13590,51693,TRAPPC2L,trafficking protein particle complex 2 like,31,Rab guanyl-nucleotide exchange factor activity,,ppi
11684,13591,93594,TBC1D31,TBC1 domain family member 31,27,,,ppi
11685,13592,84833,USMG5,up-regulated during skeletal muscle growth 5 homolog (mouse),37,,,ppi
11686,13593,55665,URGCP,upregulator of cell proliferation,4,,,ppi
11687,13595,10075,HUWE1,HECT; UBA and WWE domain containing 1; E3 ubiquitin protein ligase,472,DNA binding|RNA binding|ubiquitin-protein transferase activity|ubiquitin protein ligase activity,intellectual disability|learning disability|syndromic X-linked intellectual disability 94|syndromic X-linked intellectual disability type 10|syndromic X-linked intellectual disability Turner type,ppi
11688,13596,257313,UTS2B,urotensin 2B,1,G-protein coupled receptor binding,,ppi
11689,13597,80124,VCPIP1,valosin containing protein interacting protein 1,49,thiol-dependent ubiquitin-specific protease activity,,ppi
11690,13598,60370,AVPI1,arginine vasopressin induced 1,10,,,ppi
11691,13599,79027,ZNF655,zinc finger protein 655,25,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11692,13600,8615,USO1,USO1 vesicle transport factor,82,RNA binding|cadherin binding|protein transporter activity,prostate cancer|prostate carcinoma|seborrheic keratosis|skin disease|actinic keratosis,ppi
11693,13601,116328,C8orf34,chromosome 8 open reading frame 34,4,,,ppi
11694,13602,50853,VILL,villin like,4,structural constituent of cytoskeleton,,ppi
11695,13603,10174,SORBS3,sorbin and SH3 domain containing 3,67,structural constituent of cytoskeleton,,ppi
11696,13604,91543,RSAD2,radical S-adenosyl methionine domain containing 2,4,protein self-association|4 iron; 4 sulfur cluster binding,influenza|coronary artery disease,ppi
11697,13605,1859,DYRK1A,dual specificity tyrosine phosphorylation regulated kinase 1A,80,protein kinase activity|protein serine/threonine kinase activity|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|protein self-association|tau protein binding,autistic disorder|enophthalmos|orbital disease|exophthalmos|intellectual disability|learning disability|cerebral degeneration,ppi
11698,13606,64856,VWA1,von Willebrand factor A domain containing 1,13,extracellular matrix structural constituent,,ppi
11699,13607,9730,DCAF1,DDB1 and CUL4 associated factor 1,109,histone kinase activity (H2A-T120 specific)|estrogen receptor binding,,ppi
11700,13608,117166,WFIKKN1,WAP; follistatin/kazal; immunoglobulin; kunitz and netrin domain containing 1,7,receptor antagonist activity|transforming growth factor beta binding,,ppi
11701,13609,57599,WDR48,WD repeat domain 48,87,thiol-dependent ubiquitinyl hydrolase activity|ubiquitin binding,,ppi
11702,13610,10238,DCAF7,DDB1 and CUL4 associated factor 7,131,,Down syndrome,ppi
11703,13611,124857,WFIKKN2,WAP; follistatin/kazal; immunoglobulin; kunitz and netrin domain containing 2,7,receptor antagonist activity|transforming growth factor beta binding,,ppi
11704,13612,58525,WIZ,widely interspaced zinc finger motifs,70,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11705,13613,9149,DYRK1B,dual specificity tyrosine phosphorylation regulated kinase 1B,66,transcription coactivator activity|protein kinase activity,hypertension|essential hypertension|ovarian cancer|abdominal obesity-metabolic syndrome 3,ppi
11706,13614,55180,LINS1,lines homolog 1,3,,intellectual disability|learning disability,ppi
11707,13615,147179,WIPF2,WAS/WASL interacting protein family member 2,20,actin filament binding,,ppi
11708,13617,56986,DTWD1,DTW domain containing 1,2,,,ppi
11709,13618,54716,SLC6A20,solute carrier family 6 member 20,8,amino acid transmembrane transporter activity|L-proline transmembrane transporter activity,microphthalmia|eye disease|intellectual disability|learning disability|malignant mesothelioma|benign mesothelioma|nephrolithiasis,ppi
11710,13619,8445,DYRK2,dual specificity tyrosine phosphorylation regulated kinase 2,54,magnesium ion binding|protein serine/threonine kinase activity|protein tyrosine kinase activity|ATP binding|manganese ion binding,,ppi
11711,13621,348158,ACSM2B,acyl-CoA synthetase medium-chain family member 2B,1,CoA-ligase activity|fatty acid ligase activity|acyl-CoA ligase activity|fatty-acyl-CoA synthase activity,,ppi
11712,13622,54739,XAF1,XIAP associated factor 1,11,,colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|influenza|stomach cancer,ppi
11713,13623,84707,BEX2,brain expressed X-linked 2,35,,,ppi
11714,13624,55249,YY1AP1,YY1 associated protein 1,33,,,ppi
11715,13625,55552,ZNF823,zinc finger protein 823,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11716,13626,9666,DZIP3,DAZ interacting zinc finger protein 3,65,RNA binding|ubiquitin-protein transferase activity|phosphatase binding|polyubiquitin modification-dependent protein binding,,ppi
11717,13627,79776,ZFHX4,zinc finger homeobox 4,12,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
11718,13628,8444,DYRK3,dual specificity tyrosine phosphorylation regulated kinase 3,7,magnesium ion binding|protein kinase activity|protein serine/threonine kinase activity|ATP binding,,ppi
11719,13629,55205,ZNF532,zinc finger protein 532,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11720,13630,84524,ZC3H8,zinc finger CCCH-type containing 8,19,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA binding|sequence-specific DNA binding|RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,,ppi
11721,13632,51042,ZNF593,zinc finger protein 593,32,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding|ribosomal large subunit binding,stomach cancer,ppi
11722,13633,353355,ZNF233,zinc finger protein 233,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
11723,13634,92285,ZNF585B,zinc finger protein 585B,4,DNA binding,,ppi
11724,13635,132625,ZFP42,ZFP42 zinc finger protein,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding|sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|RNA polymerase II repressing transcription factor binding|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding,,ppi
11725,13636,8798,DYRK4,dual specificity tyrosine phosphorylation regulated kinase 4,18,,,ppi
11726,13637,51193,ZNF639,zinc finger protein 639,11,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding,,ppi
11727,13638,162966,ZNF600,zinc finger protein 600,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11728,13639,65986,ZBTB10,zinc finger and BTB domain containing 10,34,,,ppi
11729,13640,57116,ZNF695,zinc finger protein 695,11,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11730,13641,84914,ZNF587,zinc finger protein 587,45,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11731,13642,90441,ZNF622,zinc finger protein 622,84,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding,,ppi
11732,13643,29066,ZC3H7A,zinc finger CCCH-type containing 7A,7,RNA binding|miRNA binding,,ppi
11733,13644,10444,ZER1,zyg-11 related cell cycle regulator,26,ubiquitin-protein transferase activity,,ppi
11734,13645,653808,ZG16,zymogen granule protein 16,5,,,ppi
11735,13647,51531,TRMO,tRNA methyltransferase O,27,tRNA (adenine-N6-)-methyltransferase activity,,ppi
11736,13649,8291,DYSF,dysferlin,51,calcium ion binding|phospholipid binding|calcium-dependent phospholipid binding,Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y|autosomal recessive limb-girdle muscular dystrophy type 2O|autosomal recessive limb-girdle muscular dystrophy type 2P,ppi
11737,13650,79048,SECISBP2,SECIS binding protein 2,7,RNA binding|mRNA 3'-UTR binding|ribonucleoprotein complex binding|selenocysteine insertion sequence binding,amino acid metabolic disorder,ppi
11738,13651,1861,TOR1A,torsin family 1 member A,33,ATPase activity,focal hand dystonia|blepharospasm|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|generalized dystonia|torsion dystonia 1,ppi
11739,13652,54796,BNC2,basonuclin 2,4,DNA-binding transcription factor activity; RNA polymerase II-specific,isolated cleft palate|cleft palate|ovarian cancer,ppi
11740,13653,90410,IFT20,intraflagellar transport 20,52,,,ppi
11741,13654,151112,ZSWIM2,zinc finger SWIM-type containing 2,7,,,ppi
11742,13655,121227,LRIG3,leucine rich repeats and immunoglobulin like domains 3,13,,,ppi
11743,13658,286319,TUSC1,tumor suppressor candidate 1,2,,,ppi
11744,13659,150483,TEKT4,tektin 4,28,,,ppi
11745,13660,83640,FAM103A1,family with sequence similarity 103 member A1,25,RNA binding|mRNA (guanine-N7-)-methyltransferase activity,,ppi
11746,13661,201232,SLC16A13,solute carrier family 16 member 13,2,monocarboxylic acid transmembrane transporter activity,,ppi
11747,13662,399473,SPRED3,sprouty related EVH1 domain containing 3,1,,,ppi
11748,13663,80000,GREB1L,growth regulation by estrogen in breast cancer 1 like,4,,,ppi
11749,13665,84102,SLC41A2,solute carrier family 41 member 2,2,magnesium ion transmembrane transporter activity,,ppi
11750,13666,54946,SLC41A3,solute carrier family 41 member 3,9,,,ppi
11751,13667,22989,MYH15,myosin heavy chain 15,4,,,ppi
11752,13668,144245,ALG10B,ALG10B; alpha-1;2-glucosyltransferase,4,transferase activity,,ppi
11753,13669,54972,TMEM132A,transmembrane protein 132A,63,,,ppi
11754,13671,399687,MYO18A,myosin XVIIIA,171,RNA binding|ATP binding|ADP binding|actin filament binding|ATPase activity,,ppi
11755,13672,163050,ZNF564,zinc finger protein 564,25,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding,,ppi
11756,13678,1869,E2F1,E2F transcription factor 1,132,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription factor binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,melanoma|skin melanoma|breast cancer|liver cancer|hepatocellular carcinoma,ppi
11757,13679,131076,CCDC58,coiled-coil domain containing 58,17,,,ppi
11758,13680,1870,E2F2,E2F transcription factor 2,27,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription factor binding,,ppi
11759,13681,1871,E2F3,E2F transcription factor 3,37,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|transcription factor binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding,,ppi
11760,13682,1874,E2F4,E2F transcription factor 4,74,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|promoter-specific chromatin binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription factor binding|sequence-specific DNA binding,,ppi
11761,13683,1875,E2F5,E2F transcription factor 5,16,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|transcription factor binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding|DNA binding,,ppi
11762,13684,1876,E2F6,E2F transcription factor 6,65,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription corepressor activity|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription factor binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
11763,13685,1877,E4F1,E4F transcription factor 1,80,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|transcription corepressor activity|cAMP response element binding,,ppi
11764,13686,7044,LEFTY2,left-right determination factor 2,3,cytokine activity|transforming growth factor beta receptor binding,,ppi
11765,13687,9166,EBAG9,estrogen receptor binding site associated; antigen; 9,4,peptidase activator activity involved in apoptotic process,,ppi
11766,13694,403244,OR2T35,olfactory receptor family 2 subfamily T member 35,2,olfactory receptor activity,,ppi
11767,13695,1879,EBF1,early B-cell factor 1,11,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,adult respiratory distress syndrome|newborn respiratory distress syndrome,ppi
11768,13700,1880,GPR183,G protein-coupled receptor 183,34,G-protein coupled receptor activity|oxysterol binding,IgA glomerulonephritis|adult T-cell leukemia|acute T cell leukemia,ppi
11769,13703,10148,EBI3,Epstein-Barr virus induced 3,8,cytokine receptor activity|ciliary neurotrophic factor receptor activity|cytokine binding|interleukin-27 receptor binding,stomach cancer,ppi
11770,13709,390327,OR6C70,olfactory receptor family 6 subfamily C member 70,1,olfactory receptor activity,,ppi
11771,13713,11273,ATXN2L,ataxin 2 like,71,RNA binding|cadherin binding,,ppi
11772,13714,10682,EBP,emopamil binding protein (sterol isomerase),40,steroid delta-isomerase activity|transmembrane signaling receptor activity|drug transmembrane transporter activity|C-8 sterol isomerase activity,alopecia|ptosis|congenital ptosis|cryptorchidism|Dandy-Walker syndrome|sensorineural hearing loss|congestive heart failure|glaucoma|polyhydramnios|hydronephrosis|intellectual disability|learning disability|microphthalmia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|tracheal stenosis|granuloma annulare,ppi
11773,13716,201475,RAB12,RAB12; member RAS oncogene family,10,GDP binding|GTPase activity,coronary artery disease,ppi
11774,13717,404093,CUEDC1,CUE domain containing 1,27,,,ppi
11775,13722,401505,TOMM5,translocase of outer mitochondrial membrane 5,5,protein transporter activity,,ppi
11776,13724,390664,C1QTNF8,C1q and tumor necrosis factor related protein 8,2,,,ppi
11777,13725,728340,GTF2H2C,GTF2H2 family member C,16,,,ppi
11778,13728,285335,SLC9C1,solute carrier family 9 member C1,1,potassium:proton antiporter activity|sodium:proton antiporter activity,,ppi
11779,13729,22884,WDR37,WD repeat domain 37,20,,,ppi
11780,13730,645432,ARRDC5,arrestin domain containing 5,2,,,ppi
11781,13732,375757,SWI5,SWI5 homologous recombination repair protein,2,,,ppi
11782,13733,338761,C1QL4,complement C1q like 4,28,,,ppi
11783,13734,138724,C9orf131,chromosome 9 open reading frame 131,1,,,ppi
11784,13735,399665,FAM102A,family with sequence similarity 102 member A,5,,,ppi
11785,13741,403341,ZBTB34,zinc finger and BTB domain containing 34,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11786,13743,399726,CASC10,cancer susceptibility candidate 10,1,,,ppi
11787,13744,56302,TRPV5,transient receptor potential cation channel subfamily V member 5,22,calcium channel activity|ion channel activity,,ppi
11788,13745,286343,LURAP1L,leucine rich adaptor protein 1 like,10,,,ppi
11789,13749,1889,ECE1,endothelin converting enzyme 1,28,endopeptidase activity|metalloendopeptidase activity|zinc ion binding|peptide hormone binding,constipation|diabetes mellitus|type 2 diabetes mellitus|patent ductus arteriosus|congenital heart disease|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|Hirschsprung's disease|hypertension|essential hypertension,ppi
11790,13750,9427,ECEL1,endothelin converting enzyme like 1,10,metallopeptidase activity,geographic tongue|fissured tongue|distal arthrogryposis,ppi
11791,13751,1890,TYMP,thymidine phosphorylase,20,thymidine phosphorylase activity|transferase activity; transferring pentosyl groups|protein homodimerization activity,lactic acidosis|urinary bladder cancer|ptosis|congenital ptosis|colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|constipation|sensorineural hearing loss|pancreatic cancer|stomach cancer|gastroparesis|marasmus|kwashiorkor|protein-energy malnutrition|nutrition disease|mitochondrial myopathy|mitochondrial metabolism disease|chronic progressive external ophthalmoplegia,ppi
11792,13752,1891,ECH1,enoyl-CoA hydratase 1,116,delta3;5-delta2;4-dienoyl-CoA isomerase activity,,ppi
11793,13753,10939,AFG3L2,AFG3 like matrix AAA peptidase subunit 2,64,metallopeptidase activity|unfolded protein binding,ptosis|congenital ptosis|dystonia|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|focal hand dystonia|blepharospasm|autosomal dominant cerebellar ataxia|muscular atrophy|visual epilepsy|ophthalmoplegia|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy|spinocerebellar ataxia type 28|spastic ataxia 5,ppi
11794,13754,1892,ECHS1,enoyl-CoA hydratase; short chain 1,84,enoyl-CoA hydratase activity,alcohol dependence|alcohol abuse|Leigh disease|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|stomach cancer,ppi
11795,13755,1893,ECM1,extracellular matrix protein 1,32,extracellular matrix structural constituent,alopecia|inflammatory bowel disease|ulcerative colitis|dystonia|epilepsy|lipoid proteinosis|tongue disease|visual epilepsy|skin disease|seborrheic keratosis|actinic keratosis|amnestic disorder|retrograde amnesia|acne|acquired hyperkeratosis|paranoid schizophrenia|delusional disorder|diffuse alopecia areata|common wart,ppi
11796,13756,1842,ECM2,extracellular matrix protein 2,1,integrin binding|collagen V binding|heparin binding,,ppi
11797,13757,1894,ECT2,epithelial cell transforming 2,157,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|GTPase activator activity|protein homodimerization activity,,ppi
11798,13758,1896,EDA,ectodysplasin A,69,signaling receptor binding,hypohidrosis|anhidrosis|dermatitis|tooth agenesis|anodontia|hypotrichosis|melanoma|skin melanoma|hypohidrotic ectodermal dysplasia,ppi
11799,13759,173,AFM,afamin,5,vitamin E binding,,ppi
11800,13760,8721,EDF1,endothelial differentiation related factor 1,34,transcription coactivator activity|RNA binding|DNA-binding transcription factor activity|histone acetyltransferase activity|methyltransferase activity,,ppi
11801,13761,1901,S1PR1,sphingosine-1-phosphate receptor 1,32,G-protein coupled receptor activity|sphingosine-1-phosphate receptor activity,bipolar disorder,ppi
11802,13763,387718,TEX36,testis expressed 36,2,,,ppi
11803,13765,1902,LPAR1,lysophosphatidic acid receptor 1,146,G-protein coupled receptor activity|lysophosphatidic acid binding|lysophosphatidic acid receptor activity,acute myeloid leukemia|prostate cancer|prostate carcinoma|schizophrenia|breast cancer,ppi
11804,13768,100127889,C10orf131,chromosome 10 open reading frame 131,2,,,ppi
11805,13769,401647,GOLGA7B,golgin A7 family member B,3,protein-cysteine S-palmitoyltransferase activity,,ppi
11806,13770,1903,S1PR3,sphingosine-1-phosphate receptor 3,5,G-protein coupled receptor activity|lipid binding,,ppi
11807,13772,389207,GRXCR1,glutaredoxin and cysteine rich domain containing 1,1,,autosomal recessive nonsyndromic deafness 25,ppi
11808,13773,51441,YTHDF2,YTH N6-methyladenosine RNA binding protein 2,45,RNA binding|N6-methyladenosine-containing RNA binding,,ppi
11809,13775,9170,LPAR2,lysophosphatidic acid receptor 2,11,G-protein coupled receptor activity|lipid binding,,ppi
11810,13776,55615,PRR5,proline rich 5,16,,,ppi
11811,13777,404281,YY2,YY2 transcription factor,5,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II repressing transcription factor binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding,,ppi
11812,13779,389840,MAP3K15,mitogen-activated protein kinase kinase kinase 15,7,MAP kinase kinase kinase activity|protein kinase activity,,ppi
11813,13780,9294,S1PR2,sphingosine-1-phosphate receptor 2,24,G-protein coupled receptor activity|lipid binding|sphingosine-1-phosphate receptor activity,sensorineural hearing loss|heart disease|cardiovascular system disease|autosomal recessive nonsyndromic deafness 68,ppi
11814,13781,497661,C18orf32,chromosome 18 open reading frame 32,6,,,ppi
11815,13782,494470,RNF165,ring finger protein 165,8,ubiquitin protein ligase activity,,ppi
11816,13783,174,AFP,alpha fetoprotein,12,,gallbladder disease|liver disease|stomach cancer|breast cancer|liver cancer|hepatocellular carcinoma,ppi
11817,13784,8698,S1PR4,sphingosine-1-phosphate receptor 4,6,G-protein coupled receptor activity|lipid binding,,ppi
11818,13785,201501,ZBTB7C,zinc finger and BTB domain containing 7C,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11819,13788,431705,ASTL,astacin like metalloendopeptidase,5,metalloendopeptidase activity|peptidase activity|aspartic-type peptidase activity|glutamic-type peptidase activity,,ppi
11820,13789,29967,LRP12,LDL receptor related protein 12,28,low-density lipoprotein particle receptor activity,,ppi
11821,13790,392509,ARL13A,ADP ribosylation factor like GTPase 13A,6,,,ppi
11822,13791,389898,UBE2NL,ubiquitin conjugating enzyme E2 N like (gene/pseudogene),4,ubiquitin conjugating enzyme activity,,ppi
11823,13792,160364,CLEC12A,C-type lectin domain family 12 member A,27,,rheumatoid arthritis,ppi
11824,13793,441509,GLRA4,glycine receptor alpha 4,1,extracellularly glycine-gated chloride channel activity|chloride channel activity|glycine binding|extracellular ligand-gated ion channel activity,,ppi
11825,13794,85019,TMEM241,transmembrane protein 241,3,,,ppi
11826,13796,10085,EDIL3,EGF like repeats and discoidin domains 3,10,extracellular matrix structural constituent,arthropathy|arthritis,ppi
11827,13799,153770,PLAC8L1,PLAC8 like 1,1,,,ppi
11828,13800,404552,SCGB1D4,secretoglobin family 1D member 4,26,,,ppi
11829,13801,389874,ZCCHC13,zinc finger CCHC-type containing 13,2,,,ppi
11830,13803,353513,VCY1B,variable charge; Y-linked 1B,1,,,ppi
11831,13804,1906,EDN1,endothelin 1,11,cytokine activity|hormone activity|endothelin A receptor binding|endothelin B receptor binding,sick sinus syndrome|asthma|intrinsic asthma|allergic asthma|atrial fibrillation|heart disease|cardiovascular system disease|bone disease|cartilage disease|connective tissue disease|chondromalacia|articular cartilage disease|cerebrovascular disease|diabetes mellitus|type 2 diabetes mellitus|gastroenteritis|intestinal disease|gastrointestinal system disease|proctitis|focal segmental glomerulosclerosis,ppi
11832,13805,1907,EDN2,endothelin 2,3,hormone activity,,ppi
11833,13806,1908,EDN3,endothelin 3,5,signaling receptor binding|hormone activity,heart disease|cardiovascular system disease|constipation|sensorineural hearing loss|gangliocytoma|Hirschsprung's disease|hypertension|essential hypertension|intestinal obstruction|ileus|megacolon|toxic megacolon|ganglioneuroblastoma|congenital central hypoventilation syndrome|Waardenburg's syndrome,ppi
11834,13808,1909,EDNRA,endothelin receptor type A,24,phosphatidylinositol phospholipase C activity|endothelin receptor activity,isolated cleft palate|cleft palate|diabetes mellitus|type 2 diabetes mellitus|congenital heart disease|hiatus hernia|congenital diaphragmatic hernia|hypertension|essential hypertension|nasopharynx carcinoma|psychologic dyspareunia|premature ejaculation|Treacher Collins syndrome|obstructive sleep apnea|ovarian cancer|migraine|mandibulofacial dysostosis with alopecia,ppi
11835,13810,259282,BOD1L1,biorientation of chromosomes in cell division 1 like 1,31,,,ppi
11836,13811,404636,FAM45A,family with sequence similarity 45 member A,21,,,ppi
11837,13813,126637,TCHHL1,trichohyalin like 1,1,,,ppi
11838,13814,175,AGA,aspartylglucosaminidase,8,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity|hydrolase activity|asparaginase activity|beta-aspartyl-peptidase activity,chylomicron retention disease|Fabry disease|lipid storage disease|dental caries|dystonia|epilepsy|gingival overgrowth|gingival hypertrophy|enterocele|umbilical hernia|omphalocele|intellectual disability|learning disability|mitral valve insufficiency|mitral valve prolapse|schizophrenia|visual epilepsy|speech disorder|Klippel-Feil syndrome|spondylolisthesis,ppi
11839,13815,1910,EDNRB,endothelin receptor type B,31,endothelin receptor activity,oculocutaneous albinism|Griscelli syndrome|Griscelli syndrome type 1|Griscelli syndrome type 2|Griscelli syndrome type 3|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|cerebellar disease|constipation|sensorineural hearing loss|diabetes mellitus|type 2 diabetes mellitus|hiatus hernia|congenital diaphragmatic hernia|Hirschsprung's disease|primary pulmonary hypertension|pulmonary hypertension,ppi
11840,13816,387338,NSUN4,NOP2/Sun RNA methyltransferase family member 4,26,methyltransferase activity|rRNA (cytosine-C5-)-methyltransferase activity,,ppi
11841,13817,203569,PAGE2,PAGE family member 2,5,,,ppi
11842,13819,139425,DCAF8L1,DDB1 and CUL4 associated factor 8 like 1,1,,,ppi
11843,13823,389123,IQCF2,IQ motif containing F2,1,calmodulin binding,,ppi
11844,13824,401067,IQCF3,IQ motif containing F3,1,calmodulin binding,,ppi
11845,13825,1911,PHC1,polyhomeotic homolog 1,33,,germ cell cancer|germ cell and embryonal cancer|embryonal cancer|syndromic X-linked intellectual disability 94|vesicoureteral reflux|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|septooptic dysplasia|microcephaly,ppi
11846,13827,448834,KPRP,keratinocyte proline rich protein,24,,,ppi
11847,13829,1912,PHC2,polyhomeotic homolog 2,90,,,ppi
11848,13830,221154,MICU2,mitochondrial calcium uptake 2,27,,,ppi
11849,13831,121274,ZNF641,zinc finger protein 641,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11850,13832,317649,EIF4E3,eukaryotic translation initiation factor 4E family member 3,5,,,ppi
11851,13835,474383,F8A2,coagulation factor VIII-associated 2,7,,,ppi
11852,13836,8411,EEA1,early endosome antigen 1,62,calmodulin binding|1-phosphatidylinositol binding|zinc ion binding|GTP-dependent protein binding|protein homodimerization activity,,ppi
11853,13839,161823,ADAL,adenosine deaminase like,3,adenosine deaminase activity,,ppi
11854,13841,152877,FAM53A,family with sequence similarity 53 member A,1,,,ppi
11855,13842,388677,NOTCH2NL,notch 2 N-terminal like,239,,,ppi
11856,13844,441024,MTHFD2L,methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like,5,methenyltetrahydrofolate cyclohydrolase activity|methylenetetrahydrofolate dehydrogenase (NAD+) activity|methylenetetrahydrofolate dehydrogenase (NADP+) activity,,ppi
11857,13845,8726,EED,embryonic ectoderm development,486,histone methyltransferase activity|histone methyltransferase activity (H3-K27 specific)|nucleosome binding,acoustic neuroma|neurilemmoma|cellular schwannoma|melanotic neurilemmoma|plexiform schwannoma|malignant peripheral nerve sheath tumor|peripheral nervous system neoplasm|neurofibroma|peripheral nerve sheath neoplasm|perineurioma,ppi
11858,13847,1915,EEF1A1,eukaryotic translation elongation factor 1 alpha 1,532,tRNA binding|RNA binding|translation elongation factor activity|GTP binding|GTPase activity,stomach cancer,ppi
11859,13848,401612,SLC25A53,solute carrier family 25 member 53,1,,,ppi
11860,13849,176,ACAN,aggrecan,19,extracellular matrix structural constituent|extracellular matrix structural constituent conferring compression resistance,rheumatoid arthritis|arthropathy|arthritis|osteochondritis dissecans|asbestosis|anthracosilicosis|pneumoconiosis|siderosis|bagassosis|osteochondrodysplasia|multiple epiphyseal dysplasia|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F,ppi
11861,13850,100132399,GAGE12D,G antigen 12D,1,,,ppi
11862,13857,266747,RGL4,ral guanine nucleotide dissociation stimulator like 4,6,,,ppi
11863,13859,1917,EEF1A2,eukaryotic translation elongation factor 1 alpha 2,179,translation factor activity; RNA binding|GTPase activity|translation elongation factor activity,enophthalmos|orbital disease|exophthalmos|epilepsy|intellectual disability|learning disability|visual epilepsy|syndromic X-linked intellectual disability 94|stomach cancer|infantile epileptic encephalopathy,ppi
11864,13860,399512,SLC25A35,solute carrier family 25 member 35,5,,,ppi
11865,13861,26059,ERC2,ELKS/RAB6-interacting/CAST family member 2,17,,,ppi
11866,13862,167691,LCA5,LCA5; lebercilin,117,protein-containing complex binding,Leber congenital amaurosis|Leber congenital amaurosis 5,ppi
11867,13863,152015,ROPN1B,rhophilin associated tail protein 1B,2,receptor signaling complex scaffold activity|protein homodimerization activity,,ppi
11868,13864,23218,NBEAL2,neurobeachin like 2,6,,myelofibrosis|thrombocytopenia|qualitative platelet defect|Glanzmann's thrombasthenia,ppi
11869,13865,389114,ZNF662,zinc finger protein 662,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11870,13871,123103,KLHL33,kelch like family member 33,13,,,ppi
11871,13873,132430,PABPC4L,poly(A) binding protein cytoplasmic 4 like,9,,,ppi
11872,13877,26749,GAGE2E,G antigen 2E,1,,,ppi
11873,13882,400735,PRAMEF4,PRAME family member 4,1,,,ppi
11874,13883,23015,GOLGA8A,golgin A8 family member A,3,,,ppi
11875,13884,440270,GOLGA8B,golgin A8 family member B,1,,,ppi
11876,13885,728013,CBWD7,COBW domain containing 7,2,,,ppi
11877,13886,644019,CBWD6,COBW domain containing 6,2,,,ppi
11878,13890,653519,GPR89A,G protein-coupled receptor 89A,36,voltage-gated anion channel activity,,ppi
11879,13891,653404,FOXD4L6,forkhead box D4-like 6,26,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11880,13893,728841,NBPF8,neuroblastoma breakpoint family member 8,1,,,ppi
11881,13896,200030,NBPF11,neuroblastoma breakpoint family member 11,1,,,ppi
11882,13898,20,ABCA2,ATP binding cassette subfamily A member 2,19,nucleotide binding|ATP binding|ATPase activity|ATPase activity; coupled to transmembrane movement of substances,,ppi
11883,13899,177,AGER,advanced glycosylation end-product specific receptor,16,amyloid-beta binding|transmembrane signaling receptor activity|scavenger receptor activity|signaling receptor activity|advanced glycation end-product receptor activity,rheumatoid arthritis|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|diabetic angiopathy|hyperglycemia|arthropathy|arthritis|schizophrenia|Lewy body dementia,ppi
11884,13901,727830,SPATA31A3,SPATA31 subfamily A member 3,1,,,ppi
11885,13904,26165,SPATA31A7,SPATA31 subfamily A member 7,2,,,ppi
11886,13905,144404,TMEM120B,transmembrane protein 120B,15,,,ppi
11887,13908,90874,ZNF697,zinc finger protein 697,10,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11888,13909,728577,CNTNAP3B,contactin associated protein-like 3B,16,,,ppi
11889,13910,390916,NUDT19,nudix hydrolase 19,17,acyl-CoA hydrolase activity,,ppi
11890,13913,388611,CD164L2,CD164 molecule like 2,6,,,ppi
11891,13917,440590,ZYG11A,zyg-11 family member A; cell cycle regulator,6,ubiquitin-protein transferase activity,,ppi
11892,13919,440574,MINOS1,mitochondrial inner membrane organizing system 1,26,,,ppi
11893,13920,388633,LDLRAD1,low density lipoprotein receptor class A domain containing 1,16,,,ppi
11894,13921,388695,LYSMD1,LysM domain containing 1,4,,,ppi
11895,13923,1933,EEF1B2,eukaryotic translation elongation factor 1 beta 2,89,translation elongation factor activity,breast cancer|intellectual disability|learning disability,ppi
11896,13924,178,AGL,amylo-alpha-1; 6-glucosidase; 4-alpha-glucanotransferase,60,glycogen debranching enzyme activity|4-alpha-glucanotransferase activity|amylo-alpha-1;6-glucosidase activity,enophthalmos|orbital disease|exophthalmos|glycogen storage disease III|familial hyperlipidemia|hypoglycemia|primary immunodeficiency disease|familial periodic paralysis|myopathy|liver disease|liver cirrhosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
11897,13925,1936,EEF1D,eukaryotic translation elongation factor 1 delta,185,translation factor activity; RNA binding|cadherin binding,,ppi
11898,13926,9521,EEF1E1,eukaryotic translation elongation factor 1 epsilon 1,53,,,ppi
11899,13927,1937,EEF1G,eukaryotic translation elongation factor 1 gamma,300,cadherin binding,,ppi
11900,13928,1938,EEF2,eukaryotic translation elongation factor 2,219,RNA binding|cadherin binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|lung benign neoplasm|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|arthropathy|arthritis|agnosia,ppi
11901,13929,219293,ATAD3C,ATPase family; AAA domain containing 3C,7,zinc ion binding,,ppi
11902,13931,440699,LRRC52,leucine rich repeat containing 52,1,voltage-gated potassium channel activity|potassium channel activator activity,,ppi
11903,13932,92170,MTG1,mitochondrial ribosome associated GTPase 1,15,GTPase activity,,ppi
11904,13936,2202,EFEMP1,EGF containing fibulin like extracellular matrix protein 1,59,epidermal growth factor-activated receptor activity|epidermal growth factor receptor binding|extracellular matrix structural constituent,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|large intestine cancer|colorectal cancer|lung benign neoplasm|pancreatic cancer|blindness|malignant mesothelioma|benign mesothelioma|fundus dystrophy|breast cancer|Doyne honeycomb retinal dystrophy,ppi
11905,13937,30008,EFEMP2,EGF containing fibulin like extracellular matrix protein 2,56,extracellular matrix structural constituent,aortic aneurysm|ptosis|congenital ptosis|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|enophthalmos|orbital disease|exophthalmos|inguinal hernia|prostate cancer|prostate carcinoma|pulmonary valve insufficiency|bladder diverticulum|congenital diaphragmatic hernia|urinary tract obstruction|intestinal obstruction|ileus,ppi
11906,13938,79037,PVRIG,poliovirus receptor related immunoglobulin domain containing,14,signaling receptor activity,,ppi
11907,13939,129521,NMS,neuromedin S,1,,,ppi
11908,13941,55889,GOLGA6B,golgin A6 family member B,1,,,ppi
11909,13943,389421,LIN28B,lin-28 homolog B,37,RNA binding,neuroblastoma,ppi
11910,13944,1942,EFNA1,ephrin A1,17,signaling receptor binding|ephrin receptor binding,breast cancer,ppi
11911,13945,388650,FAM69A,family with sequence similarity 69 member A,26,,,ppi
11912,13946,1943,EFNA2,ephrin A2,8,ephrin receptor binding,,ppi
11913,13948,196483,EEF2KMT,eukaryotic elongation factor 2 lysine methyltransferase,11,protein-lysine N-methyltransferase activity,,ppi
11914,13949,653333,FAM86B2,family with sequence similarity 86 member B2,15,,,ppi
11915,13950,388324,INCA1,inhibitor of CDK; cyclin A1 interacting protein 1,33,cyclin-dependent protein serine/threonine kinase inhibitor activity|cyclin binding,,ppi
11916,13951,26100,WIPI2,WD repeat domain; phosphoinositide interacting 2,46,phosphatidylinositol-3-phosphate binding|phosphatidylinositol-3;5-bisphosphate binding,,ppi
11917,13952,1944,EFNA3,ephrin A3,9,transmembrane-ephrin receptor activity|ephrin receptor binding,,ppi
11918,13954,401466,C8orf59,chromosome 8 open reading frame 59,4,,,ppi
11919,13956,1945,EFNA4,ephrin A4,10,transmembrane-ephrin receptor activity|ephrin receptor binding,,ppi
11920,13958,1946,EFNA5,ephrin A5,14,neurotrophin TRKA receptor binding|neurotrophin TRKB receptor binding|neurotrophin TRKC receptor binding|transmembrane receptor protein tyrosine kinase activator activity|ephrin receptor binding,,ppi
11921,13959,1947,EFNB1,ephrin B1,41,protein tyrosine kinase activity|ephrin receptor binding,cleft lip|isolated cleft palate|cleft palate|craniosynostosis|cryptorchidism|alternating exotropia|exotropia|monocular exotropia|sensorineural hearing loss|umbilical hernia|omphalocele|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|humeroradial synostosis|cleidocranial dysplasia,ppi
11922,13960,1948,EFNB2,ephrin B2,76,protein tyrosine kinase activity|ephrin receptor binding,liver cancer|schizophrenia,ppi
11923,13961,100129654,TCF24,transcription factor 24,2,,,ppi
11924,13962,1949,EFNB3,ephrin B3,31,protein tyrosine kinase activity|transmembrane-ephrin receptor activity|ephrin receptor binding,,ppi
11925,13965,1950,EGF,epidermal growth factor,24,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|epidermal growth factor receptor binding|growth factor activity|transmembrane receptor protein tyrosine kinase activator activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|Wnt-activated receptor activity|Wnt-protein binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|alcohol dependence|alcohol abuse|autistic disorder|isolated cleft palate|cleft palate|glioblastoma multiforme|giant cell glioblastoma|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|prostate cancer|prostate carcinoma|postinflammatory pulmonary fibrosis,ppi
11926,13966,619279,ZNF704,zinc finger protein 704,17,,,ppi
11927,13967,203076,C8orf74,chromosome 8 open reading frame 74,7,,,ppi
11928,13968,1951,CELSR3,cadherin EGF LAG seven-pass G-type receptor 3,26,,,ppi
11929,13969,388701,C1orf189,chromosome 1 open reading frame 189,2,,,ppi
11930,13972,164153,UBL4B,ubiquitin like 4B,2,,,ppi
11931,13973,1952,CELSR2,cadherin EGF LAG seven-pass G-type receptor 2,32,G-protein coupled receptor activity,,ppi
11932,13974,389677,RBM12B,RNA binding motif protein 12B,17,RNA binding,,ppi
11933,13976,139562,OTUD6A,OTU deubiquitinase 6A,8,thiol-dependent ubiquitin-specific protease activity,,ppi
11934,13977,343521,TCTEX1D4,Tctex1 domain containing 4,6,protein phosphatase 1 binding,,ppi
11935,13978,1953,MEGF6,multiple EGF like domains 6,7,,,ppi
11936,13983,541468,LURAP1,leucine rich adaptor protein 1,19,,,ppi
11937,13984,1954,MEGF8,multiple EGF like domains 8,15,,clubfoot|craniosynostosis|cryptorchidism|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|patent ductus arteriosus|intellectual disability|learning disability|obesity|Carpenter syndrome,ppi
11938,13989,25975,EGFL6,EGF like domain multiple 6,15,integrin binding,,ppi
11939,13991,1956,EGFR,epidermal growth factor receptor,1295,chromatin binding|double-stranded DNA binding|MAP kinase kinase kinase activity|protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity|epidermal growth factor-activated receptor activity|Ras guanyl-nucleotide exchange factor activity|cadherin binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|protein heterodimerization activity|actin filament binding|nitric-oxide synthase regulator activity|epidermal growth factor binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|alcohol dependence|alcohol abuse|bile duct cancer|bile duct carcinoma|urinary bladder cancer|lung cancer|bronchiolo-alveolar adenocarcinoma|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA,ppi
11940,13992,494143,CHAC2,ChaC cation transport regulator homolog 2,6,gamma-glutamylcyclotransferase activity,,ppi
11941,13995,440955,TMEM89,transmembrane protein 89,1,,,ppi
11942,13996,1958,EGR1,early growth response 1,45,transcription regulatory region sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|zinc ion binding|double-stranded methylated DNA binding|sequence-specific DNA binding|hemi-methylated DNA-binding|promoter-specific chromatin binding,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|brain ischemia|primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis|cholestasis|intrahepatic cholestasis|hydronephrosis|ischemia|malignant mesothelioma|benign mesothelioma|prostate cancer|prostate carcinoma|schizophrenia|cocaine abuse|cocaine dependence,ppi
11943,13999,56898,BDH2,3-hydroxybutyrate dehydrogenase 2,10,3-hydroxybutyrate dehydrogenase activity|oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor|NAD binding,,ppi
11944,14000,1959,EGR2,early growth response 2,19,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II activating transcription factor binding|chromatin binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding,autistic disorder|bipolar disorder|hereditary motor and sensory neuropathy with agenesis of the corpus callosum|hereditary neuropathy with liability to pressure palsies|Charcot-Marie-Tooth disease type 1A|Charcot-Marie-Tooth disease type 1F|Charcot-Marie-Tooth disease type 1D|Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease type 1B|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease type 2A1|Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2B1|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2B|Charcot-Marie-Tooth disease axonal type 2T|Charcot-Marie-Tooth disease type 2R|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease type 2D,ppi
11945,14001,338661,TMEM225,transmembrane protein 225,1,,,ppi
11946,14003,219537,SMTNL1,smoothelin like 1,1,,,ppi
11947,14006,10554,AGPAT1,1-acylglycerol-3-phosphate O-acyltransferase 1,15,1-acylglycerol-3-phosphate O-acyltransferase activity,,ppi
11948,14012,1961,EGR4,early growth response 4,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,schizophrenia,ppi
11949,14013,400966,RGPD1,RANBP2-like and GRIP domain containing 1,12,Ran GTPase binding|GTPase activator activity,,ppi
11950,14015,653489,RGPD3,RANBP2-like and GRIP domain containing 3,12,Ran GTPase binding|GTPase activator activity,,ppi
11951,14016,285190,RGPD4,RANBP2-like and GRIP domain containing 4,5,GTPase activator activity|Ran GTPase binding,,ppi
11952,14018,729540,RGPD6,RANBP2-like and GRIP domain containing 6,43,,,ppi
11953,14019,10938,EHD1,EH domain containing 1,71,cadherin binding,,ppi
11954,14023,374768,SPEM1,spermatid maturation 1,2,,,ppi
11955,14024,30846,EHD2,EH domain containing 2,28,nucleic acid binding,,ppi
11956,14025,388364,TMIGD1,transmembrane and immunoglobulin domain containing 1,1,,,ppi
11957,14027,30845,EHD3,EH domain containing 3,10,nucleic acid binding,acute myeloid leukemia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
11958,14029,399823,FOXI2,forkhead box I2,51,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11959,14030,30844,EHD4,EH domain containing 4,54,nucleic acid binding|cadherin binding,,ppi
11960,14031,440138,ALG11,ALG11; alpha-1;2-mannosyltransferase,9,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1;2-mannosyltransferase activity,congenital disorder of glycosylation type I,ppi
11961,14033,644353,ZCCHC18,zinc finger CCHC-type containing 18,1,,,ppi
11962,14034,26298,EHF,ETS homologous factor,8,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,prostate cancer|prostate carcinoma,ppi
11963,14041,1962,EHHADH,enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase,32,3-hydroxyacyl-CoA dehydrogenase activity|enoyl-CoA hydratase activity|long-chain-enoyl-CoA hydratase activity,bipolar disorder|proteinuria|osteomalacia|rickets|lactic acidosis|substance abuse|substance-related disorder|Fanconi syndrome|osteogenesis imperfecta|Ehlers-Danlos syndrome,ppi
11964,14044,389119,FAM212A,family with sequence similarity 212 member A,2,protein serine/threonine kinase inhibitor activity,,ppi
11965,14045,100128731,OST4,oligosaccharyltransferase complex subunit 4; non-catalytic,5,,,ppi
11966,14046,344892,RTP2,receptor transporter protein 2,1,olfactory receptor binding,,ppi
11967,14047,121642,ALKBH2,alkB homolog 2; alpha-ketoglutarate dependent dioxygenase,10,ferrous iron binding|DNA-N1-methyladenine dioxygenase activity|cytosine C-5 DNA demethylase activity,,ppi
11968,14049,10209,EIF1,eukaryotic translation initiation factor 1,10,RNA binding|translation initiation factor activity|translation factor activity; RNA binding|ribosomal small subunit binding,,ppi
11969,14050,10555,AGPAT2,1-acylglycerol-3-phosphate O-acyltransferase 2,11,1-acylglycerol-3-phosphate O-acyltransferase activity,acanthosis nigricans|hyperpituitarism|acromegaly|acute pancreatitis|pancreatitis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|diabetic ketoacidosis|diabetes mellitus|lipoatrophic diabetes|lipodystrophy|umbilical hernia|omphalocele|hypertrichosis|Zollinger-Ellison syndrome|hyperinsulinism|bulimia nervosa|liver cirrhosis|intellectual disability,ppi
11970,14051,1964,EIF1AX,eukaryotic translation initiation factor 1A; X-linked,48,RNA binding|translation factor activity; RNA binding,uveal melanoma|papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma,ppi
11971,14052,9086,EIF1AY,eukaryotic translation initiation factor 1A; Y-linked,10,,,ppi
11972,14053,340075,ARSI,arylsulfatase family member I,4,arylsulfatase activity,,ppi
11973,14056,83939,EIF2A,eukaryotic translation initiation factor 2A,62,tRNA binding|translation initiation factor activity|ribosome binding|cadherin binding,coronary artery disease,ppi
11974,14057,643382,TMEM253,transmembrane protein 253,2,,,ppi
11975,14058,9451,EIF2AK3,eukaryotic translation initiation factor 2 alpha kinase 3,41,protein kinase activity|protein serine/threonine kinase activity|eukaryotic translation initiation factor 2alpha kinase activity|protein homodimerization activity,diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21|type 1 diabetes mellitus 22,ppi
11976,14059,100128927,ZBTB42,zinc finger and BTB domain containing 42,10,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
11977,14060,752014,CEMP1,cementum protein 1,1,hydroxyapatite binding,,ppi
11978,14061,644815,FAM83G,family with sequence similarity 83 member G,10,,,ppi
11979,14063,1967,EIF2B1,eukaryotic translation initiation factor 2B subunit alpha,60,translation initiation factor activity|guanyl-nucleotide exchange factor activity,epilepsy|premature menopause|androgen insensitivity syndrome|optic atrophy|visual epilepsy|amnestic disorder|retrograde amnesia|leukoencephalopathy with vanishing white matter,ppi
11980,14064,149069,DCDC2B,doublecortin domain containing 2B,12,,,ppi
11981,14065,8892,EIF2B2,eukaryotic translation initiation factor 2B subunit beta,70,ATP binding|GTP binding|translation initiation factor activity|guanyl-nucleotide exchange factor activity,epilepsy|premature menopause|androgen insensitivity syndrome|optic atrophy|visual epilepsy|amnestic disorder|retrograde amnesia|leukoencephalopathy with vanishing white matter,ppi
11982,14066,254042,METAP1D,methionyl aminopeptidase type 1D; mitochondrial,7,aminopeptidase activity|metalloexopeptidase activity,,ppi
11983,14067,8891,EIF2B3,eukaryotic translation initiation factor 2B subunit gamma,59,translation initiation factor activity|guanyl-nucleotide exchange factor activity|translation factor activity; RNA binding,epilepsy|premature menopause|androgen insensitivity syndrome|optic atrophy|visual epilepsy|amnestic disorder|retrograde amnesia|leukoencephalopathy with vanishing white matter,ppi
11984,14068,57580,PREX1,phosphatidylinositol-3;4;5-trisphosphate dependent Rac exchange factor 1,8,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|GTPase activator activity|phospholipid binding|enzyme binding|Rac guanyl-nucleotide exchange factor activity,,ppi
11985,14069,56894,AGPAT3,1-acylglycerol-3-phosphate O-acyltransferase 3,18,1-acylglycerol-3-phosphate O-acyltransferase activity|transferase activity; transferring acyl groups,neurodegenerative disease,ppi
11986,14070,8890,EIF2B4,eukaryotic translation initiation factor 2B subunit delta,45,translation initiation factor binding|translation initiation factor activity|guanyl-nucleotide exchange factor activity,epilepsy|premature menopause|androgen insensitivity syndrome|optic atrophy|visual epilepsy|lung cancer|lung adenocarcinoma|amnestic disorder|retrograde amnesia|leukoencephalopathy with vanishing white matter,ppi
11987,14071,8893,EIF2B5,eukaryotic translation initiation factor 2B subunit epsilon,45,translation initiation factor activity|guanyl-nucleotide exchange factor activity|translation initiation factor binding,epilepsy|premature menopause|androgen insensitivity syndrome|optic atrophy|visual epilepsy|lung cancer|lung adenocarcinoma|amnestic disorder|retrograde amnesia|leukoencephalopathy with vanishing white matter,ppi
11988,14072,26523,AGO1,argonaute 1; RISC catalytic component,200,RNA polymerase II complex binding|core promoter binding|RNA binding|double-stranded RNA binding|single-stranded RNA binding|miRNA binding|endoribonuclease activity,alcohol dependence|alcohol abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|malignant mesothelioma|benign mesothelioma,ppi
11989,14073,27161,AGO2,argonaute 2; RISC catalytic component,220,RNA 7-methylguanosine cap binding|RNA polymerase II complex binding|core promoter binding|RNA binding|double-stranded RNA binding|single-stranded RNA binding|translation initiation factor activity|endoribonuclease activity|siRNA binding|miRNA binding|endoribonuclease activity; cleaving siRNA-paired mRNA|endoribonuclease activity; cleaving miRNA-paired mRNA,alcohol dependence|alcohol abuse|lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia|cocaine abuse|cocaine dependence|malignant mesothelioma|benign mesothelioma,ppi
11990,14074,1965,EIF2S1,eukaryotic translation initiation factor 2 subunit alpha,88,RNA binding|translation initiation factor activity|ribosome binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|osteosarcoma|bone osteosarcoma|schizophrenia|status epilepticus,ppi
11991,14075,8894,EIF2S2,eukaryotic translation initiation factor 2 subunit beta,90,RNA binding|translation initiation factor activity|translation factor activity; RNA binding,breast cancer,ppi
11992,14076,131405,TRIM71,tripartite motif containing 71,17,ubiquitin-protein transferase activity|translation repressor activity|miRNA binding|ubiquitin protein ligase activity,,ppi
11993,14077,1968,EIF2S3,eukaryotic translation initiation factor 2 subunit gamma,56,translation initiation factor activity|translation factor activity; RNA binding|cadherin binding,,ppi
11994,14078,147166,TRIM16L,tripartite motif containing 16-like,10,,,ppi
11995,14079,493829,TRIM72,tripartite motif containing 72,9,phosphatidylserine binding,,ppi
11996,14080,84292,WDR83,WD repeat domain 83,135,,,ppi
11997,14083,400569,MED11,mediator complex subunit 11,32,,,ppi
11998,14085,414918,DENND6B,DENN domain containing 6B,5,Rab guanyl-nucleotide exchange factor activity,,ppi
11999,14086,652991,SKOR2,SKI family transcriptional corepressor 2,2,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|SMAD binding,,ppi
12000,14088,387640,SKIDA1,SKI/DACH domain containing 1,3,,,ppi
12001,14090,8540,AGPS,alkylglycerone phosphate synthase,28,alkylglycerone-phosphate synthase activity|FAD binding,rhizomelic chondrodysplasia punctata type 3|chondrodysplasia punctata,ppi
12002,14091,8669,EIF3J,eukaryotic translation initiation factor 3 subunit J,41,translation initiation factor activity,,ppi
12003,14092,388389,CCDC103,coiled-coil domain containing 103,21,protein homodimerization activity,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1|primary ciliary dyskinesia 17,ppi
12004,14093,100130086,HSFX2,heat shock transcription factor family; X-linked 2,7,,,ppi
12005,14095,8661,EIF3A,eukaryotic translation initiation factor 3 subunit A,140,RNA binding|structural molecule activity|translation initiation factor activity|mRNA binding,prostate cancer|prostate carcinoma,ppi
12006,14096,8668,EIF3I,eukaryotic translation initiation factor 3 subunit I,137,translation initiation factor activity,colon cancer|colonic benign neoplasm,ppi
12007,14097,8667,EIF3H,eukaryotic translation initiation factor 3 subunit H,95,RNA binding|translation initiation factor activity|metallopeptidase activity,large intestine cancer|colorectal cancer|prostate cancer|prostate carcinoma|liver cancer|hepatocellular carcinoma,ppi
12008,14098,8666,EIF3G,eukaryotic translation initiation factor 3 subunit G,59,RNA binding|translation initiation factor activity,,ppi
12009,14099,8665,EIF3F,eukaryotic translation initiation factor 3 subunit F,101,translation initiation factor activity|thiol-dependent ubiquitin-specific protease activity|translation initiation factor binding,,ppi
12010,14100,3646,EIF3E,eukaryotic translation initiation factor 3 subunit E,121,RNA binding|translation initiation factor activity|cadherin binding,,ppi
12011,14101,8664,EIF3D,eukaryotic translation initiation factor 3 subunit D,80,RNA binding|mRNA cap binding|translation initiation factor activity,,ppi
12012,14104,8663,EIF3C,eukaryotic translation initiation factor 3 subunit C,100,RNA binding|translation initiation factor activity|translation initiation factor binding,,ppi
12013,14105,56902,PNO1,partner of NOB1 homolog,59,RNA binding,,ppi
12014,14106,10551,AGR2,anterior gradient 2; protein disulphide isomerase family member,22,dystroglycan binding|protein homodimerization activity,prostate cancer|prostate carcinoma|breast cancer,ppi
12015,14107,8662,EIF3B,eukaryotic translation initiation factor 3 subunit B,86,RNA binding|translation initiation factor activity|protein-containing complex scaffold activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
12016,14108,1973,EIF4A1,eukaryotic translation initiation factor 4A1,119,RNA cap binding|RNA binding|double-stranded RNA binding|mRNA binding|helicase activity|translation factor activity; RNA binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
12017,14109,1974,EIF4A2,eukaryotic translation initiation factor 4A2,80,RNA binding|helicase activity|ATPase activity,,ppi
12018,14110,1975,EIF4B,eukaryotic translation initiation factor 4B,96,RNA binding|helicase activity|RNA strand-exchange activity|translation initiation factor activity|ribosomal small subunit binding|RNA strand annealing activity,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
12019,14111,1977,EIF4E,eukaryotic translation initiation factor 4E,77,RNA cap binding|RNA 7-methylguanosine cap binding|RNA binding|translation initiation factor activity|enzyme binding|eukaryotic initiation factor 4G binding|repressing transcription factor binding,lymphosarcoma|B-cell lymphoma,ppi
12020,14112,1978,EIF4EBP1,eukaryotic translation initiation factor 4E binding protein 1,50,eukaryotic initiation factor 4E binding|translation repressor activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|kidney cancer|acute myeloid leukemia|lymphosarcoma|B-cell lymphoma,ppi
12021,14113,1979,EIF4EBP2,eukaryotic translation initiation factor 4E binding protein 2,12,eukaryotic initiation factor 4E binding|translation repressor activity,,ppi
12022,14114,375790,AGRN,agrin,20,dystroglycan binding|structural constituent of cytoskeleton|extracellular matrix structural constituent|calcium ion binding|sialic acid binding|chondroitin sulfate binding|laminin binding|heparan sulfate proteoglycan binding,acute myeloid leukemia|congenital myasthenic syndrome,ppi
12023,14115,8637,EIF4EBP3,eukaryotic translation initiation factor 4E binding protein 3,9,translation repressor activity|eukaryotic initiation factor 4E binding,,ppi
12024,14117,100049587,SIGLEC14,sialic acid binding Ig like lectin 14,1,,,ppi
12025,14119,9470,EIF4E2,eukaryotic translation initiation factor 4E family member 2,79,RNA cap binding|RNA binding|translation factor activity; RNA binding,,ppi
12026,14122,401541,CENPP,centromere protein P,18,,,ppi
12027,14127,400986,ANKRD36C,ankyrin repeat domain 36C,1,,,ppi
12028,14128,388591,RNF207,ring finger protein 207,4,,,ppi
12029,14129,55627,SMPD4,sphingomyelin phosphodiesterase 4,25,sphingomyelin phosphodiesterase activity|sphingomyelin phosphodiesterase D activity,,ppi
12030,14130,340578,DCAF12L2,DDB1 and CUL4 associated factor 12 like 2,11,,,ppi
12031,14132,130502,TTC32,tetratricopeptide repeat domain 32,10,,,ppi
12032,14134,1981,EIF4G1,eukaryotic translation initiation factor 4 gamma 1,122,RNA binding|mRNA binding|translation initiation factor activity|ATP binding|translation factor activity; RNA binding|eukaryotic initiation factor 4E binding|translation initiation factor binding|protein-containing complex scaffold activity,Parkinson's disease,ppi
12033,14136,493861,EID3,EP300 interacting inhibitor of differentiation 3,30,,,ppi
12034,14139,1982,EIF4G2,eukaryotic translation initiation factor 4 gamma 2,55,RNA binding|translation initiation factor activity|translation factor activity; RNA binding|cadherin binding|mRNA binding,,ppi
12035,14141,55559,HAUS7,HAUS augmin like complex subunit 7,73,thioesterase binding,,ppi
12036,14142,8672,EIF4G3,eukaryotic translation initiation factor 4 gamma 3,43,RNA binding|translation factor activity; RNA binding|mRNA binding|translation initiation factor activity,,ppi
12037,14143,1983,EIF5,eukaryotic translation initiation factor 5,66,RNA binding|translation initiation factor activity|GTPase activity|translation factor activity; RNA binding|cadherin binding,schizophrenia,ppi
12038,14144,21,ABCA3,ATP binding cassette subfamily A member 3,26,transporter activity|lipid transporter activity|ATPase activity; coupled to transmembrane movement of substances,large intestine cancer|colorectal cancer|pulmonary alveolar proteinosis|desquamative interstitial pneumonia,ppi
12039,14145,181,AGRP,agouti related neuropeptide,12,signaling receptor binding|neuropeptide hormone activity,obesity,ppi
12040,14146,1984,EIF5A,eukaryotic translation initiation factor 5A,68,RNA binding|translation elongation factor activity|U6 snRNA binding,,ppi
12041,14147,56648,EIF5A2,eukaryotic translation initiation factor 5A2,28,,,ppi
12042,14148,1990,CELA1,chymotrypsin like elastase family member 1,22,serine-type endopeptidase activity,,ppi
12043,14149,1991,ELANE,elastase; neutrophil expressed,32,transcription corepressor activity|endopeptidase activity|serine-type endopeptidase activity|heparin binding|peptidase activity,anemia|macrocytic anemia|hypereosinophilic syndrome|gingival disease|epulis|primary polycythemia|acute monocytic leukemia|neutropenia|agranulocytosis|severe congenital neutropenia|periodontal disease|periodontitis|aphthous stomatitis|cyclic hematopoiesis|thrombocytosis,ppi
12044,14150,493869,GPX8,glutathione peroxidase 8 (putative),8,peroxidase activity,,ppi
12045,14151,284307,ZIK1,zinc finger protein interacting with K protein 1,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12046,14152,90333,ZNF468,zinc finger protein 468,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12047,14153,400720,ZNF772,zinc finger protein 772,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12048,14154,388569,ZNF324B,zinc finger protein 324B,78,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12049,14155,342132,ZNF774,zinc finger protein 774,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12050,14157,1992,SERPINB1,serpin family B member 1,20,serine-type endopeptidase inhibitor activity,,ppi
12051,14159,147808,ZNF784,zinc finger protein 784,3,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding|DNA-binding transcription factor activity,,ppi
12052,14162,388536,ZNF790,zinc finger protein 790,4,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12053,14163,390927,ZNF793,zinc finger protein 793,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12054,14164,387755,INSC,inscuteable homolog (Drosophila),5,,,ppi
12055,14165,1994,ELAVL1,ELAV like RNA binding protein 1,1762,RNA binding|double-stranded RNA binding|mRNA binding|mRNA 3'-UTR binding|AU-rich element binding|miRNA binding|mRNA 3'-UTR AU-rich region binding,endometriosis of uterus|endometriosis,ppi
12056,14166,389524,GTF2IRD2B,GTF2I repeat domain containing 2B,4,protein binding,,ppi
12057,14167,641371,ACOT1,acyl-CoA thioesterase 1,9,acyl-CoA hydrolase activity,liver cancer,ppi
12058,14168,1993,ELAVL2,ELAV like RNA binding protein 2,117,RNA binding|mRNA 3'-UTR binding,schizophrenia|lung small cell carcinoma,ppi
12059,14170,1995,ELAVL3,ELAV like RNA binding protein 3,13,AU-rich element binding,polycystic ovary syndrome,ppi
12060,14171,474343,SPIN2B,spindlin family member 2B,24,methylated histone binding,,ppi
12061,14172,1996,ELAVL4,ELAV like RNA binding protein 4,14,RNA binding|mRNA 3'-UTR binding|AU-rich element binding,,ppi
12062,14175,441518,FAM127C,family with sequence similarity 127 member C,8,,,ppi
12063,14176,641372,ACOT6,acyl-CoA thioesterase 6,2,acyl-CoA hydrolase activity,schizophrenia,ppi
12064,14177,1997,ELF1,E74 like ETS transcription factor 1,13,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
12065,14179,440093,H3F3C,H3 histone family member 3C,22,nucleosomal DNA binding,,ppi
12066,14181,1998,ELF2,E74 like ETS transcription factor 2,20,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12067,14184,139067,SPANXN3,SPANX family member N3,11,,,ppi
12068,14185,441525,SPANXN4,SPANX family member N4,1,,,ppi
12069,14188,1999,ELF3,E74 like ETS transcription factor 3,53,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity,biliary tract cancer,ppi
12070,14191,653784,MZT2A,mitotic spindle organizing protein 2A,19,,,ppi
12071,14192,401138,AMTN,amelotin,11,,,ppi
12072,14193,2000,ELF4,E74 like ETS transcription factor 4,10,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,isolated growth hormone deficiency type III,ppi
12073,14196,440503,PLIN5,perilipin 5,6,,,ppi
12074,14197,2001,ELF5,E74 like ETS transcription factor 5,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12075,14201,2002,ELK1,ELK1; ETS transcription factor,42,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
12076,14203,388558,ZNF808,zinc finger protein 808,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12077,14204,55957,LIN37,lin-37 DREAM MuvB core complex component,41,,,ppi
12078,14205,285193,DUSP28,dual specificity phosphatase 28,28,phosphatase activity,,ppi
12079,14206,56267,KYAT3,kynurenine aminotransferase 3,19,RNA binding|kynurenine-oxoglutarate transaminase activity|kynurenine-glyoxylate transaminase activity,major depressive disorder|mental depression|endogenous depression|neurotic disorder|melancholia,ppi
12080,14208,2004,ELK3,ELK3; ETS transcription factor,13,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity|purine-rich negative regulatory element binding,breast cancer,ppi
12081,14209,126017,ZNF813,zinc finger protein 813,3,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12082,14211,2005,ELK4,ELK4; ETS transcription factor,12,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|core promoter binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|chromatin binding|DNA-binding transcription factor activity|transcription coregulator activity,,ppi
12083,14212,442247,RFPL4B,ret finger protein like 4B,43,,,ppi
12084,14213,541466,CT45A1,cancer/testis antigen family 45 member A1,3,,,ppi
12085,14214,441519,CT45A3,cancer/testis antigen family 45 member A3,4,,,ppi
12086,14215,2006,ELN,elastin,27,extracellular matrix structural constituent|extracellular matrix constituent conferring elasticity,generalized anxiety disorder|anxiety disorder|supravalvular aortic stenosis|aortic valve insufficiency|sick sinus syndrome|autistic disorder|blepharophimosis|brain ischemia|constipation|pseudosarcomatous fibromatosis|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia,ppi
12087,14216,441521,CT45A5,cancer/testis antigen family 45 member A5,5,,,ppi
12088,14218,100381270,ZBED6,zinc finger BED-type containing 6,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12089,14219,342979,PALM3,paralemmin 3,5,,,ppi
12090,14220,388698,FLG2,filaggrin family member 2,25,structural constituent of epidermis,,ppi
12091,14221,642968,FAM163B,family with sequence similarity 163 member B,1,,,ppi
12092,14223,342371,ATXN1L,ataxin 1 like,66,,autosomal dominant cerebellar ataxia,ppi
12093,14224,346288,SEPT14,septin 14,9,GTPase activity|protein-containing complex scaffold activity,glioblastoma multiforme|giant cell glioblastoma|malignant glioma|gliosarcoma,ppi
12094,14237,183,AGT,angiotensinogen,27,serine-type endopeptidase inhibitor activity|hormone activity|growth factor activity,proteinuria|anemia|macrocytic anemia|anuria|aortic aneurysm|sick sinus syndrome|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|bipolar disorder|alcoholic cardiomyopathy|heart disease|cardiovascular system disease|carotid artery disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression,ppi
12095,14238,2009,EML1,echinoderm microtubule associated protein like 1,14,calcium ion binding|microtubule binding|tubulin binding,epilepsy|visual epilepsy|lissencephaly|chromosome 17p13.1 deletion syndrome,ppi
12096,14239,2010,EMD,emerin,186,actin binding|cadherin binding|beta-tubulin binding,atrioventricular block|Emery-Dreifuss muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y|autosomal recessive limb-girdle muscular dystrophy type 2O,ppi
12097,14240,2011,MARK2,microtubule affinity regulating kinase 2,103,magnesium ion binding|RNA binding|protein serine/threonine kinase activity|ATP binding|protein kinase activator activity|cadherin binding|tau protein binding|tau-protein kinase activity,salivary gland adenoid cystic carcinoma|schizophrenia,ppi
12098,14241,2012,EMP1,epithelial membrane protein 1,3,,prostate cancer|prostate carcinoma|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
12099,14242,2013,EMP2,epithelial membrane protein 2,3,protein kinase binding,nephrotic syndrome,ppi
12100,14243,642273,FAM110C,family with sequence similarity 110 member C,6,alpha-tubulin binding,,ppi
12101,14245,2014,EMP3,epithelial membrane protein 3,3,,prostate cancer|prostate carcinoma,ppi
12102,14246,392465,GLOD5,glyoxalase domain containing 5,1,,,ppi
12103,14248,30817,ADGRE2,adhesion G protein-coupled receptor E2,1,chondroitin sulfate binding|G-protein coupled receptor activity,rosacea|angioedema,ppi
12104,14249,2017,CTTN,cortactin,139,cadherin binding,tongue squamous cell carcinoma|squamous cell carcinoma,ppi
12105,14250,727936,GXYLT2,glucoside xylosyltransferase 2,9,UDP-xylosyltransferase activity,,ppi
12106,14252,2016,EMX1,empty spiracles homeobox 1,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12107,14253,2018,EMX2,empty spiracles homeobox 2,4,DNA-binding transcription factor activity; RNA polymerase II-specific,epilepsy|lung benign neoplasm|intellectual disability|learning disability|schizophrenia|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|porencephaly|locked-in syndrome|quadriplegia,ppi
12108,14254,2019,EN1,engrailed homeobox 1,3,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,salivary gland adenoid cystic carcinoma|central nervous system disease|nervous system disease|autonomic neuropathy|schizophrenia,ppi
12109,14255,2020,EN2,engrailed homeobox 2,2,DNA-binding transcription factor activity; RNA polymerase II-specific,autistic disorder|schizophrenia,ppi
12110,14257,200312,RNF215,ring finger protein 215,1,ubiquitin protein ligase activity,,ppi
12111,14259,10117,ENAM,enamelin,2,structural constituent of tooth enamel,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia,ppi
12112,14260,100037417,DDTL,D-dopachrome tautomerase-like,4,,,ppi
12113,14261,8507,ENC1,ectodermal-neural cortex 1,16,,,ppi
12114,14262,339230,CCDC137,coiled-coil domain containing 137,26,RNA binding,schizophrenia,ppi
12115,14263,343990,KIAA1211L,KIAA1211 like,1,,,ppi
12116,14264,729025,SLC15A5,solute carrier family 15 member 5,1,peptide:proton symporter activity|oligopeptide transmembrane transporter activity|peptide transmembrane transporter activity,,ppi
12117,14265,2021,ENDOG,endonuclease G,23,,,ppi
12118,14266,389289,ANXA2R,annexin A2 receptor,1,,urinary bladder cancer,ppi
12119,14267,9941,EXOG,exo/endonuclease G,13,endonuclease activity|5'-3' exonuclease activity,,ppi
12120,14268,339761,CYP27C1,cytochrome P450 family 27 subfamily C member 1,2,retinoic acid binding|11-cis retinal binding|all-trans retinal binding|all-trans retinol 3;4-desaturase activity|all-trans retinal 3;4-desaturase activity|all-trans retinoic acid 3;4-desaturase activity|11-cis-retinal 3;4-desaturase activity|all-trans-retinol binding,,ppi
12121,14269,92312,MEX3A,mex-3 RNA binding family member A,3,RNA binding,,ppi
12122,14270,388115,C15orf52,chromosome 15 open reading frame 52,4,RNA binding,,ppi
12123,14271,2022,ENG,endoglin,20,transmembrane signaling receptor activity|transforming growth factor beta receptor; cytoplasmic mediator activity|type II transforming growth factor beta receptor binding|galactose binding|glycosaminoglycan binding|type I transforming growth factor beta receptor binding|activin binding,anemia|macrocytic anemia|intracranial abscess|cholecystitis|epilepsy|hemangioma|cavernous hemangioma|capillary hemangioma|portal hypertension|liver cirrhosis|polycythemia vera|Chuvash polycythemia|acquired polycythemia|stress polycythemia|erythropoietin polycythemia|polycythemia|visual epilepsy|hereditary hemorrhagic telangiectasia|capillary disease|telangiectasis,ppi
12124,14273,414899,BLID,BH3-like motif containing; cell death inducer,12,,,ppi
12125,14274,84126,ATRIP,ATR interacting protein,50,K63-linked polyubiquitin modification-dependent protein binding,Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome|Cockayne syndrome|Noonan syndrome|Aarskog syndrome,ppi
12126,14275,2023,ENO1,enolase 1,334,RNA polymerase II regulatory region sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA binding|phosphopyruvate hydratase activity|protein homodimerization activity|cadherin binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
12127,14276,388325,SCIMP,SLP adaptor and CSK interacting membrane protein,1,,,ppi
12128,14278,152138,PYDC2,pyrin domain containing 2,5,,,ppi
12129,14279,100101467,ZSCAN30,zinc finger and SCAN domain containing 30,7,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12130,14283,727910,TLCD2,TLC domain containing 2,3,,,ppi
12131,14284,2026,ENO2,enolase 2,95,phosphopyruvate hydratase activity,urinary bladder cancer|lung cancer|non-small cell lung carcinoma|acute myeloid leukemia|schizophrenia,ppi
12132,14285,2027,ENO3,enolase 3,59,phosphopyruvate hydratase activity,gallbladder disease|liver disease|fibromyalgia|myositis,ppi
12133,14286,442038,SULT1C3,sulfotransferase family 1C member 3,5,alcohol sulfotransferase activity,,ppi
12134,14288,2028,ENPEP,glutamyl aminopeptidase,4,aminopeptidase activity|metallopeptidase activity|metalloaminopeptidase activity|zinc ion binding|peptide binding,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
12135,14290,284184,NDUFAF8,NADH:ubiquinone oxidoreductase complex assembly factor 8,38,,,ppi
12136,14291,5167,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,15,exonuclease activity|phosphodiesterase I activity|nucleotide diphosphatase activity|insulin receptor binding|calcium ion binding|ATP binding|zinc ion binding|protein homodimerization activity|nucleoside-triphosphate diphosphatase activity|3'-phosphoadenosine 5'-phosphosulfate binding|protein binding,angioid streaks|craniosynostosis|diabetes mellitus|type 2 diabetes mellitus|endometriosis of uterus|endometriosis|exanthem|sensorineural hearing loss|congestive heart failure|hypertension|essential hypertension|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|myopia|obesity|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV,ppi
12137,14292,5168,ENPP2,ectonucleotide pyrophosphatase/phosphodiesterase 2,4,lysophospholipase activity|calcium ion binding|transcription factor binding|zinc ion binding|hydrolase activity|alkylglycerophosphoethanolamine phosphodiesterase activity|phosphodiesterase I activity,thyroid cancer|thyroid adenoma|thyroid carcinoma,ppi
12138,14293,5169,ENPP3,ectonucleotide pyrophosphatase/phosphodiesterase 3,2,phosphodiesterase I activity|calcium ion binding|zinc ion binding|nucleoside-triphosphate diphosphatase activity,,ppi
12139,14294,146439,BICDL2,BICD family like cargo adaptor 2,1,Rab GTPase binding,,ppi
12140,14295,22875,ENPP4,ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative),8,bis(5'-adenosyl)-triphosphatase activity,,ppi
12141,14296,728833,FAM72D,family with sequence similarity 72 member D,1,,,ppi
12142,14299,185,AGTR1,angiotensin II receptor type 1,43,angiotensin type I receptor activity|angiotensin type II receptor activity,anuria|diabetic cataract|diabetic retinopathy|patent ductus arteriosus|congestive heart failure|hypertension|essential hypertension|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|pituitary adenoma|pituitary cancer|pituitary carcinoma|proteinuria|oligohydramnios|abdominal aortic aneurysm|pancreatic ductal carcinoma,ppi
12143,14300,2029,ENSA,endosulfine alpha,35,signaling receptor binding|ion channel inhibitor activity|phosphatase inhibitor activity|potassium channel inhibitor activity|protein phosphatase regulator activity|protein phosphatase 2A binding|protein phosphatase inhibitor activity,coronary artery disease,ppi
12144,14304,440603,BCL2L15,BCL2 like 15,5,,,ppi
12145,14308,729440,CCDC61,coiled-coil domain containing 61,17,,,ppi
12146,14309,953,ENTPD1,ectonucleoside triphosphate diphosphohydrolase 1,1,nucleoside-diphosphatase activity|nucleoside-triphosphatase activity,intellectual disability|learning disability|muscular atrophy|hereditary spastic paraplegia 64,ppi
12147,14311,375033,PEAR1,platelet endothelial aggregation receptor 1,2,,,ppi
12148,14312,642843,CPSF4L,cleavage and polyadenylation specific factor 4 like,7,,,ppi
12149,14313,954,ENTPD2,ectonucleoside triphosphate diphosphohydrolase 2,2,nucleoside-triphosphatase activity,primary biliary cirrhosis,ppi
12150,14314,956,ENTPD3,ectonucleoside triphosphate diphosphohydrolase 3,1,nucleoside-diphosphatase activity|nucleoside-triphosphatase activity,,ppi
12151,14315,957,ENTPD5,ectonucleoside triphosphate diphosphohydrolase 5,6,guanosine-diphosphatase activity|nucleoside-diphosphatase activity|uridine-diphosphatase activity,,ppi
12152,14316,955,ENTPD6,ectonucleoside triphosphate diphosphohydrolase 6 (putative),12,nucleoside-diphosphatase activity,testicular cancer|seminoma|testicular germ cell cancer|testis seminoma,ppi
12153,14318,100131211,NEMP2,nuclear envelope integral membrane protein 2,1,,,ppi
12154,14319,114769,CARD16,caspase recruitment domain family member 16,5,cysteine-type endopeptidase inhibitor activity|identical protein binding|caspase binding,,ppi
12155,14320,125988,C19orf70,chromosome 19 open reading frame 70,24,,,ppi
12156,14321,130106,CIB4,calcium and integrin binding family member 4,2,magnesium ion binding|calcium ion binding,,ppi
12157,14322,130612,TMEM198,transmembrane protein 198,1,,,ppi
12158,14323,131920,TMEM207,transmembrane protein 207,2,,,ppi
12159,14327,150383,CDPF1,cysteine rich DPF motif domain containing 1,3,,,ppi
12160,14328,153364,MBLAC2,metallo-beta-lactamase domain containing 2,38,,,ppi
12161,14330,161247,FITM1,fat storage inducing transmembrane protein 1,1,,,ppi
12162,14332,167555,FAM151B,family with sequence similarity 151 member B,1,,,ppi
12163,14333,196541,METTL21C,methyltransferase like 21C,16,protein-lysine N-methyltransferase activity,,ppi
12164,14335,199953,TMEM201,transmembrane protein 201,11,actin filament binding|lamin binding,,ppi
12165,14336,8320,EOMES,eomesodermin,1,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II activating transcription factor binding|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|DNA binding|sequence-specific DNA binding,anxiety disorder|phobic disorder|urinary bladder cancer,ppi
12166,14339,201181,ZNF385C,zinc finger protein 385C,7,,,ppi
12167,14340,221091,LRRN4CL,LRRN4 C-terminal like,1,,,ppi
12168,14343,284338,PRR19,proline rich 19,2,,,ppi
12169,14344,2033,EP300,E1A binding protein p300,521,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA binding|chromatin binding|damaged DNA binding|transcription coactivator activity|histone acetyltransferase activity|lysine N-acetyltransferase activity; acting on acetyl phosphate as donor|protein C-terminus binding|acetyltransferase activity|transferase activity; transferring acyl groups|peptide N-acetyltransferase activity|peptide-lysine-N-acetyltransferase activity|protein propionyltransferase activity|peptide butyryltransferase activity|histone crotonyltransferase activity,agoraphobia|alcohol dependence|alcohol abuse|sick sinus syndrome|autistic disorder|urinary bladder cancer|ptosis|congenital ptosis|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|transitional cell carcinoma|coloboma|large intestine cancer,ppi
12170,14345,285382,C3orf70,chromosome 3 open reading frame 70,1,,,ppi
12171,14349,339184,CCDC144NL,coiled-coil domain containing 144 family; N-terminal like,1,,,ppi
12172,14351,340527,NHSL2,NHS like 2,18,,,ppi
12173,14353,342897,NCCRP1,non-specific cytotoxic cell receptor protein 1 homolog (zebrafish),23,,,ppi
12174,14354,2034,EPAS1,endothelial PAS domain protein 1,116,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|protein heterodimerization activity|sequence-specific DNA binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|polycythemia,ppi
12175,14356,347273,MURC,muscle related coiled-coil protein,1,,,ppi
12176,14358,374395,TMEM179B,transmembrane protein 179B,15,,,ppi
12177,14359,374739,TEPP,testis; prostate and placenta expressed,1,,,ppi
12178,14362,387856,CCDC184,coiled-coil domain containing 184,9,,,ppi
12179,14363,387921,NHLRC3,NHL repeat containing 3,11,ubiquitin protein ligase activity,,ppi
12180,14364,387990,TOMM20L,translocase of outer mitochondrial membrane 20 like,2,protein transmembrane transporter activity|P-P-bond-hydrolysis-driven protein transmembrane transporter activity|mitochondrion targeting sequence binding,,ppi
12181,14365,388135,C15orf59,chromosome 15 open reading frame 59,1,,,ppi
12182,14366,388272,C16orf87,chromosome 16 open reading frame 87,22,,,ppi
12183,14368,388323,GLTPD2,glycolipid transfer protein domain containing 2,1,,,ppi
12184,14369,388335,TMEM220,transmembrane protein 220,5,,,ppi
12185,14371,388818,KRTAP26-1,keratin associated protein 26-1,27,,,ppi
12186,14375,389170,LEKR1,leucine; glutamate and lysine rich 1,1,,,ppi
12187,14376,389197,C4orf50,chromosome 4 open reading frame 50,1,,,ppi
12188,14378,389336,C5orf46,chromosome 5 open reading frame 46,2,,,ppi
12189,14380,2035,EPB41,erythrocyte membrane protein band 4.1,143,structural constituent of cytoskeleton|1-phosphatidylinositol binding|protein C-terminus binding|spectrin binding|protein N-terminus binding|phosphoprotein binding,hemolytic anemia|favism|hereditary elliptocytosis|congenital hemolytic anemia|melanoma|skin melanoma,ppi
12190,14381,389541,LAMTOR4,late endosomal/lysosomal adaptor; MAPK and MTOR activator 4,18,guanyl-nucleotide exchange factor activity|protein-containing complex scaffold activity,,ppi
12191,14384,389658,FAM150A,family with sequence similarity 150 member A,2,receptor signaling protein tyrosine kinase activator activity|receptor tyrosine kinase binding,,ppi
12192,14385,389799,CFAP77,cilia and flagella associated protein 77,2,,,ppi
12193,14386,389812,LCN15,lipocalin 15,9,,,ppi
12194,14388,2036,EPB41L1,erythrocyte membrane protein band 4.1 like 1,58,,autosomal dominant non-syndromic intellectual disability,ppi
12195,14389,390928,ACP7,acid phosphatase 7; tartrate resistant (putative),5,,,ppi
12196,14390,391356,PTRHD1,peptidyl-tRNA hydrolase domain containing 1,6,,,ppi
12197,14391,391723,HELT,helt bHLH transcription factor,1,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|RNA polymerase II regulatory region sequence-specific DNA binding|transcription factor binding|sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|microsatellite binding|sequence-specific double-stranded DNA binding,,ppi
12198,14395,399947,C11orf87,chromosome 11 open reading frame 87,9,,,ppi
12199,14396,2037,EPB41L2,erythrocyte membrane protein band 4.1 like 2,63,,,ppi
12200,14397,400073,C12orf76,chromosome 12 open reading frame 76,2,,,ppi
12201,14398,400120,SERTM1,serine rich and transmembrane domain containing 1,1,,,ppi
12202,14401,186,AGTR2,angiotensin II receptor type 2,12,receptor antagonist activity,hypertension|essential hypertension|intellectual disability|learning disability|stomach cancer|invasive lobular carcinoma|autistic disorder,ppi
12203,14402,23136,EPB41L3,erythrocyte membrane protein band 4.1 like 3,114,structural constituent of cytoskeleton,breast cancer,ppi
12204,14403,400566,C17orf97,chromosome 17 open reading frame 97,3,,,ppi
12205,14405,400673,VMAC,vimentin-type intermediate filament associated coiled-coil protein,4,,,ppi
12206,14409,2038,EPB42,erythrocyte membrane protein band 4.2,17,structural constituent of cytoskeleton|ATP binding,hemolytic anemia|hereditary spherocytosis,ppi
12207,14410,221264,AK9,adenylate kinase 9,11,nucleoside diphosphate kinase activity|nucleoside kinase activity|nucleoside monophosphate kinase activity,,ppi
12208,14414,2039,DMTN,dematin actin binding protein,25,actin binding|signaling receptor binding|spectrin binding|actin filament binding,,ppi
12209,14417,414919,C8orf82,chromosome 8 open reading frame 82,3,,,ppi
12210,14418,440068,CARD17,caspase recruitment domain family member 17,3,identical protein binding|caspase binding,,ppi
12211,14420,2040,STOM,stomatin,124,,hemolytic anemia,ppi
12212,14421,440145,MZT1,mitotic spindle organizing protein 1,35,gamma-tubulin binding,,ppi
12213,14423,441273,SPDYE2,speedy/RINGO cell cycle regulator family member E2,1,protein kinase binding,,ppi
12214,14425,441478,NRARP,NOTCH-regulated ankyrin repeat protein,1,,brain cancer,ppi
12215,14427,445328,ARHGEF35,Rho guanine nucleotide exchange factor 35,6,,,ppi
12216,14428,492311,IGIP,IgA inducing protein,2,,,ppi
12217,14429,493753,COA5,cytochrome c oxidase assembly factor 5,3,,,ppi
12218,14431,2041,EPHA1,EPH receptor A1,81,protein kinase activity|transmembrane-ephrin receptor activity|transmembrane receptor protein tyrosine kinase activity|protein tyrosine kinase activity|transmembrane signaling receptor activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|large intestine cancer|colorectal cancer,ppi
12219,14433,550631,CCDC157,coiled-coil domain containing 157,1,,,ppi
12220,14434,554235,ASPDH,aspartate dehydrogenase domain containing,10,,,ppi
12221,14437,642938,FAM196A,family with sequence similarity 196 member A,30,,,ppi
12222,14438,1969,EPHA2,EPH receptor A2,91,transmembrane receptor protein tyrosine kinase activity|cadherin binding|transmembrane-ephrin receptor activity|protein tyrosine kinase activity|transmembrane signaling receptor activity,choroideremia|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types,ppi
12223,14442,643853,TMPPE,transmembrane protein with metallophosphoesterase domain,26,,,ppi
12224,14444,644096,SDHAF1,succinate dehydrogenase complex assembly factor 1,4,,vascular dementia|mitochondrial complex II deficiency,ppi
12225,14445,645121,CCNI2,cyclin I family member 2,6,protein kinase binding|protein kinase activity|cyclin-dependent protein serine/threonine kinase regulator activity,,ppi
12226,14446,2042,EPHA3,EPH receptor A3,33,GPI-linked ephrin receptor activity|protein tyrosine kinase activity|transmembrane signaling receptor activity|transmembrane-ephrin receptor activity|transmembrane receptor protein tyrosine kinase activity,,ppi
12227,14449,654346,LGALS9C,galectin 9C,27,,,ppi
12228,14452,728489,DNLZ,DNL-type zinc finger,19,chaperone binding,,ppi
12229,14453,2043,EPHA4,EPH receptor A4,48,protein kinase activity|GPI-linked ephrin receptor activity|transmembrane-ephrin receptor activity|kinase activity|DH domain binding|transmembrane signaling receptor activity|protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|muscular atrophy|neurodegenerative disease,ppi
12230,14454,51763,INPP5K,inositol polyphosphate-5-phosphatase K,41,phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity|vasopressin receptor activity|inositol bisphosphate phosphatase activity|phosphatidylinositol-3;4;5-trisphosphate 5-phosphatase activity|phosphatidylinositol trisphosphate phosphatase activity|phosphatidylinositol phosphate 5-phosphatase activity|lipid phosphatase activity|inositol trisphosphate phosphatase activity,,ppi
12231,14455,390616,ANKRD34C,ankyrin repeat domain 34C,1,,,ppi
12232,14456,2044,EPHA5,EPH receptor A5,12,ephrin receptor activity|GPI-linked ephrin receptor activity|transmembrane-ephrin receptor activity|protein tyrosine kinase activity|transmembrane signaling receptor activity|transmembrane receptor protein tyrosine kinase activity,,ppi
12233,14458,150221,RIMBP3C,RIMS binding protein 3C,1,benzodiazepine receptor binding,,ppi
12234,14459,388468,POTEC,POTE ankyrin domain family member C,8,,,ppi
12235,14460,445582,POTEE,POTE ankyrin domain family member E,33,,,ppi
12236,14463,187,APLNR,apelin receptor,97,signaling receptor activity,,ppi
12237,14464,2045,EPHA7,EPH receptor A7,48,protein tyrosine kinase activity|GPI-linked ephrin receptor activity|axon guidance receptor activity|chemorepellent activity|transmembrane-ephrin receptor activity|transmembrane signaling receptor activity|transmembrane receptor protein tyrosine kinase activity,lung small cell carcinoma,ppi
12238,14467,728378,POTEF,POTE ankyrin domain family member F,62,,,ppi
12239,14469,441250,TYW1B,tRNA-yW synthesizing protein 1 homolog B,11,,,ppi
12240,14470,2046,EPHA8,EPH receptor A8,17,GPI-linked ephrin receptor activity|transmembrane receptor protein tyrosine kinase activity|protein tyrosine kinase activity|transmembrane signaling receptor activity|transmembrane-ephrin receptor activity,alcohol dependence|alcohol abuse,ppi
12241,14471,402055,SRRD,SRR1 domain containing,3,,,ppi
12242,14474,2047,EPHB1,EPH receptor B1,19,protein tyrosine kinase activity|transmembrane-ephrin receptor activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,,ppi
12243,14476,2048,EPHB2,EPH receptor B2,45,amyloid-beta binding|protein tyrosine kinase activity|transmembrane-ephrin receptor activity|protein-containing complex binding|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,malignant glioma|benign ependymoma|myxopapillary ependymoma|cellular ependymoma|tanycytic ependymoma|papillary ependymoma|prostate cancer|prostate carcinoma,ppi
12244,14478,2049,EPHB3,EPH receptor B3,13,protein tyrosine kinase activity|ephrin receptor activity|transmembrane signaling receptor activity|transmembrane receptor protein tyrosine kinase activity|transmembrane-ephrin receptor activity,,ppi
12245,14480,728661,SLC35E2B,solute carrier family 35 member E2B,1,,,ppi
12246,14481,2050,EPHB4,EPH receptor B4,29,protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|ephrin receptor activity|transmembrane signaling receptor activity|transmembrane-ephrin receptor activity,breast cancer,ppi
12247,14483,2051,EPHB6,EPH receptor B6,22,protein tyrosine kinase activity|signaling receptor activity|transmembrane-ephrin receptor activity|transmembrane signaling receptor activity|transmembrane receptor protein tyrosine kinase activity,,ppi
12248,14485,644943,RASSF10,Ras association domain family member 10,37,,,ppi
12249,14487,644591,PPIAL4G,peptidylprolyl isomerase A like 4G,17,cyclosporin A binding|peptidyl-prolyl cis-trans isomerase activity|unfolded protein binding,,ppi
12250,14488,730262,PPIAL4E,peptidylprolyl isomerase A like 4E,1,cyclosporin A binding|unfolded protein binding|peptidyl-prolyl cis-trans isomerase activity,,ppi
12251,14491,24,ABCA4,ATP binding cassette subfamily A member 4,1,transporter activity|eye pigment precursor transporter activity|ATPase activity|ATPase activity; coupled to transmembrane movement of substances|phosphatidylethanolamine-translocating ATPase activity,choroid disease|cleft lip|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|large intestine cancer|colorectal cancer|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|retinitis pigmentosa 30|age related macular degeneration|macular degeneration,ppi
12252,14495,100101267,POM121C,POM121 transmembrane nucleoporin C,13,,,ppi
12253,14497,2052,EPHX1,epoxide hydrolase 1,27,epoxide hydrolase activity|cis-stilbene-oxide hydrolase activity,alcohol dependence|alcohol abuse|chronic obstructive pulmonary disease|lung benign neoplasm|lymphosarcoma|lymphoma|central nervous system lymphoma|Langerhans-cell histiocytosis|reticulosarcoma|non-Hodgkin lymphoma|B-cell lymphoma|multiple myeloma|pre-eclampsia|prostate cancer|prostate carcinoma|osteomalacia|rickets|skin benign neoplasm|skin cancer|steatorrhea,ppi
12254,14498,2053,EPHX2,epoxide hydrolase 2,5,magnesium ion binding|epoxide hydrolase activity|toxic substance binding|phosphatase activity|lipid phosphatase activity|protein homodimerization activity,congestive heart failure|familial hypercholesterolemia,ppi
12255,14499,497189,TIFAB,TIFA inhibitor,1,,,ppi
12256,14500,2054,STX2,syntaxin 2,19,protein dimerization activity|calcium-dependent protein binding|SNARE binding|SNAP receptor activity,male infertility,ppi
12257,14501,374899,ZNF829,zinc finger protein 829,8,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12258,14504,387911,C1QTNF9B,C1q and tumor necrosis factor related protein 9B,2,,,ppi
12259,14506,256223,CDRT15L2,CMT1A duplicated region transcript 15-like 2,1,,,ppi
12260,14507,189,AGXT,alanine-glyoxylate aminotransferase,5,alanine-glyoxylate transaminase activity|transaminase activity|amino acid binding|pyridoxal phosphate binding|protein homodimerization activity|protein self-association|serine-pyruvate transaminase activity,atrioventricular block|primary hyperoxaluria|intermittent claudication|calcium metabolism disease|nephrocalcinosis|calcinosis|hypercalcemia|phosphorus metabolism disease|optic atrophy|osteopetrosis|osteosclerosis|polyneuropathy|peripheral nervous system disease|neuropathy|kidney failure|uremia|retinitis|retinal disease|lactic acidosis|nephrolithiasis,ppi
12261,14508,7957,EPM2A,EPM2A; laforin glucan phosphatase,27,,agnosia|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|childhood absence epilepsy|focal hand dystonia|blepharospasm|schizophreniform disorder|schizoaffective disorder|photosensitivity disease|photosensitive epilepsy|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy|Lafora disease,ppi
12262,14509,2056,EPO,erythropoietin,4,cytokine activity|erythropoietin receptor binding|protein kinase activator activity,anemia|macrocytic anemia|hemolytic anemia|beta thalassemia|calcium metabolism disease|nephrocalcinosis|calcinosis|Balo concentric sclerosis|adrenoleukodystrophy|narcolepsy|central nervous system disease|nervous system disease|heart disease|cardiovascular system disease|ventricular septal defect|hemolytic-uremic syndrome|hypertension|essential hypertension|nephritis|glomerulonephritis,ppi
12263,14510,2057,EPOR,erythropoietin receptor,50,erythropoietin receptor activity,melanoma|skin melanoma|polycythemia vera|Chuvash polycythemia|acquired polycythemia|stress polycythemia|erythropoietin polycythemia|polycythemia|thyroid cancer|thyroid adenoma|thyroid carcinoma|thrombophilia|central nervous system origin vertigo|primary polycythemia|familial erythrocytosis 1|breast cancer,ppi
12264,14511,2058,EPRS,glutamyl-prolyl-tRNA synthetase,138,glutamate-tRNA ligase activity|proline-tRNA ligase activity|zinc ion binding|RNA stem-loop binding,,ppi
12265,14513,2060,EPS15,epidermal growth factor receptor pathway substrate 15,156,polyubiquitin modification-dependent protein binding|cadherin binding,,ppi
12266,14514,2059,EPS8,epidermal growth factor receptor pathway substrate 8,70,actin binding|SH3/SH2 adaptor activity|Rac GTPase binding|Rac guanyl-nucleotide exchange factor activity,,ppi
12267,14519,8288,EPX,eosinophil peroxidase,5,peroxidase activity,,ppi
12268,14521,729830,FAM160A1,family with sequence similarity 160 member A1,2,,,ppi
12269,14522,26284,ERAL1,Era like 12S mitochondrial rRNA chaperone 1,35,RNA binding|rRNA binding|ribosomal small subunit binding,,ppi
12270,14528,100287898,TTC34,tetratricopeptide repeat domain 34,3,,,ppi
12271,14529,344657,LRRIQ4,leucine rich repeats and IQ motif containing 4,2,,,ppi
12272,14531,191,AHCY,adenosylhomocysteinase,86,adenosylhomocysteinase activity,amino acid metabolic disorder|iron metabolism disease|hemochromatosis|Wilson disease|intellectual disability|learning disability|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|hypermethioninemia,ppi
12273,14532,2064,ERBB2,erb-b2 receptor tyrosine kinase 2,302,RNA polymerase I core binding|protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity|Ras guanyl-nucleotide exchange factor activity|ErbB-3 class receptor binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|protein heterodimerization activity|protein dimerization activity|growth factor binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|lung cancer|bronchiolo-alveolar adenocarcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|colon cancer|colonic benign neoplasm,ppi
12274,14536,2065,ERBB3,erb-b2 receptor tyrosine kinase 3,190,protein tyrosine kinase activity|transmembrane signaling receptor activity|Ras guanyl-nucleotide exchange factor activity|growth factor binding|protein tyrosine kinase activator activity|neuregulin binding|protein homodimerization activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|protein heterodimerization activity|transmembrane receptor protein tyrosine kinase activity|neuregulin receptor activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|congestive heart failure|gallbladder cancer|polyhydramnios|hydronephrosis|lung benign neoplasm|prostate cancer|prostate carcinoma|schizophrenia|endogenous depression|melancholia|muscular atrophy|breast cancer|lethal congenital contracture syndrome 2|nasopharynx carcinoma,ppi
12275,14537,2066,ERBB4,erb-b2 receptor tyrosine kinase 4,88,protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|transcription regulatory region DNA binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|epidermal growth factor receptor binding|transmembrane signaling receptor activity,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|gallbladder cancer|melanoma|skin melanoma|schizophrenia|skin benign neoplasm|skin cancer|muscular atrophy|neurodegenerative disease|amyotrophic lateral sclerosis type 19,ppi
12276,14538,2067,ERCC1,ERCC excision repair 1; endonuclease non-catalytic subunit,32,damaged DNA binding|single-stranded DNA binding|single-stranded DNA endodeoxyribonuclease activity|DNA binding|3' overhang single-stranded DNA endodeoxyribonuclease activity,blepharophimosis|lung cancer|non-small cell lung carcinoma|cervical cancer|craniosynostosis|enophthalmos|orbital disease|exophthalmos|epilepsy|placental insufficiency|sensorineural hearing loss|hypogonadism|melanoma|skin melanoma|microphthalmia|germ cell cancer|germ cell and embryonal cancer|embryonal cancer|spontaneous ocular nystagmus|dissociated nystagmus,ppi
12277,14539,90485,ZNF835,zinc finger protein 835,1,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region DNA binding|DNA-binding transcription factor activity,,ppi
12278,14542,2068,ERCC2,ERCC excision repair 2; TFIIH core complex helicase subunit,42,DNA-dependent ATPase activity|5'-3' DNA helicase activity|protein kinase activity|RNA polymerase II CTD heptapeptide repeat kinase activity|ATP-dependent 5'-3' DNA helicase activity|damaged DNA binding|ATP-dependent DNA helicase activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|asthma|intrinsic asthma|allergic asthma|urinary bladder cancer|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|cerebellar disease|large intestine cancer|colorectal cancer|conjunctivitis|pseudosarcomatous fibromatosis|cryptorchidism|sensorineural hearing loss,ppi
12279,14544,339541,C1orf228,chromosome 1 open reading frame 228,1,,,ppi
12280,14549,2071,ERCC3,ERCC excision repair 3; TFIIH core complex helicase subunit,57,DNA binding|damaged DNA binding|helicase activity|transcription factor binding|ATPase activity|3'-5' DNA helicase activity|protein kinase activity|DNA-dependent ATPase activity|RNA polymerase II CTD heptapeptide repeat kinase activity|ATP-dependent DNA helicase activity|DNA translocase activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|cerebellar disease|cryptorchidism|sensorineural hearing loss|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|hypogonadism|keratitis|keratoconjunctivitis|melanoma|skin melanoma|intellectual disability,ppi
12281,14551,400793,C1orf226,chromosome 1 open reading frame 226,9,,,ppi
12282,14553,388969,C2orf68,chromosome 2 open reading frame 68,10,,,ppi
12283,14555,2072,ERCC4,ERCC excision repair 4; endonuclease catalytic subunit,34,damaged DNA binding|single-stranded DNA binding|endodeoxyribonuclease activity|telomerase inhibitor activity|DNA binding|3' overhang single-stranded DNA endodeoxyribonuclease activity|single-stranded DNA endodeoxyribonuclease activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|biliary atresia|urinary bladder cancer|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|cerebellar disease|cryptorchidism|sensorineural hearing loss|dental enamel hypoplasia|achondroplasia|Laron syndrome|enophthalmos|orbital disease|exophthalmos|esophageal atresia|Fanconi anemia,ppi
12284,14556,390637,GDPGP1,GDP-D-glucose phosphorylase 1,11,GDP-D-glucose phosphorylase activity,,ppi
12285,14558,2073,ERCC5,ERCC excision repair 5; endonuclease,25,bubble DNA binding|double-stranded DNA binding|single-stranded DNA binding|endodeoxyribonuclease activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|cerebellar disease|clubfoot|cryptorchidism|sensorineural hearing loss|congestive heart failure|epilepsy|placental insufficiency|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|hypogonadism|keratitis,ppi
12286,14559,2074,ERCC6,ERCC excision repair 6; chromatin remodeling factor,51,DNA binding|chromatin binding|ATP binding|DNA-dependent ATPase activity|protein tyrosine kinase activator activity|protein-containing complex binding|DNA helicase activity,hypohidrosis|anhidrosis|sick sinus syndrome|blepharophimosis|cerebellar disease|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome|Cockayne syndrome|Noonan syndrome,ppi
12287,14560,388939,C2orf71,chromosome 2 open reading frame 71,5,,cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|retinitis pigmentosa 54,ppi
12288,14563,1161,ERCC8,ERCC excision repair 8; CSA ubiquitin ligase complex subunit,41,protein-containing complex binding|DNA helicase activity|DNA-dependent ATPase activity|ubiquitin-protein transferase activity,hypohidrosis|anhidrosis|sick sinus syndrome|cerebellar disease|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome|Cockayne syndrome|Noonan syndrome|Aarskog syndrome,ppi
12289,14564,643246,MAP1LC3B2,microtubule associated protein 1 light chain 3 beta 2,10,microtubule binding,,ppi
12290,14567,4951,OCM2,oncomodulin 2,4,calcium ion binding,,ppi
12291,14568,100137047,JMJD7,jumonji domain containing 7,2,,,ppi
12292,14569,790955,UQCC3,ubiquinol-cytochrome c reductase complex assembly factor 3,7,phosphatidic acid binding|cardiolipin binding,mitochondrial complex III deficiency nuclear type 9,ppi
12293,14570,10768,AHCYL1,adenosylhomocysteinase like 1,155,adenosylhomocysteinase activity,,ppi
12294,14572,440087,SMCO3,single-pass membrane protein with coiled-coil domains 3,5,,,ppi
12295,14573,123688,HYKK,hydroxylysine kinase,3,hydroxylysine kinase activity|protein binding,,ppi
12296,14574,400506,KNOP1,lysine rich nucleolar protein 1,61,RNA binding,,ppi
12297,14578,84461,NEURL4,neuralized E3 ubiquitin protein ligase 4,56,,,ppi
12298,14581,729475,RAD51AP2,RAD51 associated protein 2,1,,,ppi
12299,14582,653140,FAM228A,family with sequence similarity 228 member A,1,,,ppi
12300,14583,652968,GATSL3,GATS protein like 3,5,arginine binding|identical protein binding,,ppi
12301,14584,646450,ARIH2OS,ariadne homolog 2 opposite strand,1,,,ppi
12302,14585,131544,CRYBG3,crystallin beta-gamma domain containing 3,7,,,ppi
12303,14587,2069,EREG,epiregulin,5,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|epidermal growth factor receptor binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|growth factor activity,erythropoietic protoporphyria|cutaneous porphyria|ovarian cancer,ppi
12304,14588,389337,ARHGEF37,Rho guanine nucleotide exchange factor 37,1,Rho guanyl-nucleotide exchange factor activity,,ppi
12305,14589,441150,C6orf226,chromosome 6 open reading frame 226,8,,,ppi
12306,14591,377630,USP17L2,ubiquitin specific peptidase 17-like family member 2,13,thiol-dependent ubiquitin-specific protease activity|thiol-dependent ubiquitinyl hydrolase activity|cysteine-type endopeptidase activity,,ppi
12307,14592,340359,KLHL38,kelch like family member 38,32,,,ppi
12308,14594,401115,C4orf48,chromosome 4 open reading frame 48,3,,,ppi
12309,14596,339804,C2orf74,chromosome 2 open reading frame 74,1,,,ppi
12310,14597,2077,ERF,ETS2 repressor factor,27,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription corepressor activity|sequence-specific DNA binding,congenital heart disease|ptosis|congenital ptosis|conjunctivitis|craniosynostosis|enophthalmos|orbital disease|exophthalmos|communication disorder|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|ophthalmoplegia|mechanical strabismus|hypertropia|pseudotumor cerebri|intracranial hypertension|Crouzon syndrome,ppi
12311,14604,728568,C12orf73,chromosome 12 open reading frame 73,1,,,ppi
12312,14607,145853,C15orf61,chromosome 15 open reading frame 61,1,,,ppi
12313,14610,2078,ERG,ERG; ETS transcription factor,85,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding,leukemia|acute myeloid leukemia|prostate cancer|prostate carcinoma|extraosseous Ewings sarcoma-primitive neuroepithelial tumor|Ewing sarcoma|neuroectodermal tumor|acute lymphocytic leukemia,ppi
12314,14611,2079,ERH,enhancer of rudimentary homolog (Drosophila),51,RNA binding|methyl-CpG binding,,ppi
12315,14613,2081,ERN1,endoplasmic reticulum to nucleus signaling 1,34,magnesium ion binding|endoribonuclease activity|protein serine/threonine kinase activity|ATP binding|protein homodimerization activity|ADP binding|Hsp90 protein binding,epilepsy,ppi
12316,14615,388336,SHISA6,shisa family member 6,1,ionotropic glutamate receptor binding,,ppi
12317,14617,100170841,EPOP,elongin BC and polycomb repressive complex 2 associated protein,21,chromatin binding,,ppi
12318,14619,374920,C19orf68,chromosome 19 open reading frame 68,6,,polycystic ovary syndrome,ppi
12319,14625,344787,ZNF860,zinc finger protein 860,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12320,14626,643904,RNF222,ring finger protein 222,1,,,ppi
12321,14627,81552,VOPP1,vesicular; overexpressed in cancer; prosurvival protein 1,15,,acute myeloid leukemia,ppi
12322,14628,643641,ZNF862,zinc finger protein 862,3,,,ppi
12323,14629,388512,CLEC17A,C-type lectin domain family 17 member A,1,mannose binding|fucose binding,,ppi
12324,14633,100188893,TOMM6,translocase of outer mitochondrial membrane 6,2,,,ppi
12325,14638,402665,IGLON5,IgLON family member 5,13,,,ppi
12326,14639,57491,AHRR,aryl-hydrocarbon receptor repressor,5,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12327,14640,2098,ESD,esterase D,37,hydrolase activity; acting on ester bonds|S-formylglutathione hydrolase activity|carboxylic ester hydrolase activity,arthropathy|arthritis,ppi
12328,14641,11082,ESM1,endothelial cell specific molecule 1,2,hepatocyte growth factor receptor binding|integrin binding,,ppi
12329,14642,2099,ESR1,estrogen receptor 1,1057,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|chromatin binding|DNA-binding transcription factor activity|steroid hormone receptor activity|steroid binding|nitric-oxide synthase regulator activity|estrogen receptor activity|estrogen response element binding|RNA polymerase II transcription factor activity; estrogen-activated sequence-specific DNA binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|ATPase binding,acanthosis nigricans|adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration,ppi
12330,14643,2100,ESR2,estrogen receptor 2,492,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|steroid hormone receptor activity|transcription coactivator activity|nuclear receptor activity|steroid binding|estrogen receptor activity|estrogen response element binding|RNA polymerase II transcription factor activity; estrogen-activated sequence-specific DNA binding|receptor antagonist activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|sick sinus syndrome|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|urinary bladder cancer|transitional cell carcinoma|large intestine cancer|colorectal cancer,ppi
12331,14644,79026,AHNAK,AHNAK nucleoprotein,99,RNA binding|cadherin binding|structural molecule activity conferring elasticity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
12332,14645,2101,ESRRA,estrogen related receptor alpha,49,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|nuclear receptor activity|sequence-specific DNA binding,disease of metabolism|osteosarcoma|bone osteosarcoma|breast cancer,ppi
12333,14646,2103,ESRRB,estrogen related receptor beta,93,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II complex binding|enhancer sequence-specific DNA binding|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription coactivator activity|nuclear receptor activity|transcription factor binding|sequence-specific DNA binding,sensorineural hearing loss|autosomal recessive nonsyndromic deafness 35,ppi
12334,14647,2104,ESRRG,estrogen related receptor gamma,34,DNA-binding transcription factor activity; RNA polymerase II-specific|AF-2 domain binding,,ppi
12335,14648,2107,ETF1,eukaryotic translation termination factor 1,63,RNA binding|translation release factor activity|translation termination factor activity|ribosome binding|sequence-specific mRNA binding|translation release factor activity; codon specific,,ppi
12336,14649,196,AHR,aryl hydrocarbon receptor,48,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|nuclear receptor activity|enhancer binding|protein homodimerization activity|transcription regulatory region DNA binding|protein heterodimerization activity|protein dimerization activity|Hsp90 protein binding|E-box binding|sequence-specific double-stranded DNA binding,rheumatoid arthritis|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|stone in bladder diverticulum|bladder calculus|contact dermatitis|occupational dermatitis|congenital heart disease|hypertension|essential hypertension|male infertility|gallbladder disease|liver disease|liver cancer|disease of metabolism|obesity|pancreatic cancer,ppi
12337,14650,2108,ETFA,electron transfer flavoprotein alpha subunit,94,electron transfer activity|oxidoreductase activity|flavin adenine dinucleotide binding,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
12338,14651,2109,ETFB,electron transfer flavoprotein beta subunit,39,electron transfer activity,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
12339,14652,2110,ETFDH,electron transfer flavoprotein dehydrogenase,5,electron-transferring-flavoprotein dehydrogenase activity|electron transfer activity|oxidoreductase activity|oxidoreductase activity; oxidizing metal ions with flavin as acceptor|quinone binding|ubiquinone binding|flavin adenine dinucleotide binding|4 iron; 4 sulfur cluster binding,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
12340,14653,2113,ETS1,ETS proto-oncogene 1; transcription factor,114,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription factor binding,celiac disease|systemic lupus erythematosus,ppi
12341,14654,2114,ETS2,ETS proto-oncogene 2; transcription factor,36,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,allergic contact dermatitis|breast cancer,ppi
12342,14655,197,AHSG,alpha 2-HS glycoprotein,24,kinase inhibitor activity,calcium metabolism disease|nephrocalcinosis|calcinosis,ppi
12343,14656,2115,ETV1,ETS variant 1,27,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,prostate cancer|prostate carcinoma|Ewing sarcoma,ppi
12344,14657,2116,ETV2,ETS variant 2,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12345,14658,2117,ETV3,ETS variant 3,13,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12346,14659,2118,ETV4,ETS variant 4,17,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,prostate cancer|prostate carcinoma|Ewing sarcoma|breast cancer,ppi
12347,14660,2119,ETV5,ETS variant 5,22,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding,,ppi
12348,14661,2120,ETV6,ETS variant 6,41,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,fibrosarcoma|acute myeloid leukemia|chronic monocytic leukemia|juvenile myelomonocytic leukemia|purpura|thrombocytopenia|substance abuse|substance-related disorder|papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma|hematologic cancer|mesoblastic nephroma|congenital mesoblastic nephroma|acute lymphocytic leukemia,ppi
12349,14662,10205,MPZL2,myelin protein zero like 2,8,,,ppi
12350,14663,2121,EVC,EvC ciliary complex subunit 1,2,,cleft lip|clubfoot|cryptorchidism|Dandy-Walker syndrome|Clouston syndrome|Ellis-Van Creveld syndrome|atrioventricular septal defect|placental insufficiency|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect,ppi
12351,14664,2122,MECOM,MDS1 and EVI1 complex locus,30,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|histone-lysine N-methyltransferase activity,colon cancer|colonic benign neoplasm|lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia|nasopharynx carcinoma|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|ovarian cancer|breast cancer,ppi
12352,14665,2123,EVI2A,ecotropic viral integration site 2A,9,transmembrane signaling receptor activity,,ppi
12353,14666,23461,ABCA5,ATP binding cassette subfamily A member 5,2,lipid transporter activity|ATPase activity; coupled to transmembrane movement of substances,large intestine cancer|colorectal cancer|gingival overgrowth|gingival hypertrophy|gingival fibromatosis,ppi
12354,14668,7813,EVI5,ecotropic viral integration site 5,14,GTPase activator activity|Rab GTPase binding,,ppi
12355,14669,2125,EVPL,envoplakin,37,structural molecule activity|protein binding; bridging|cadherin binding,,ppi
12356,14670,2128,EVX1,even-skipped homeobox 1,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
12357,14672,2130,EWSR1,EWS RNA binding protein 1,639,RNA binding,medulloblastoma|medulloepithelioma|supratentorial primitive neuroectodermal tumor|ependymoblastoma|cerebral primitive neuroectodermal tumor|extraosseous Ewings sarcoma-primitive neuroepithelial tumor|Ewing sarcoma|intestinal obstruction|ileus|spindle cell sarcoma|epithelioid sarcoma|sarcoma|cancer|extraskeletal myxoid chondrosarcoma,ppi
12358,14673,9156,EXO1,exonuclease 1,31,DNA binding|RNA-DNA hybrid ribonuclease activity|exonuclease activity|5'-3' exonuclease activity|5'-3' exodeoxyribonuclease activity|single-stranded DNA 5'-3' exodeoxyribonuclease activity|flap endonuclease activity|double-stranded DNA 5'-3' exodeoxyribonuclease activity|double-stranded DNA binding|5'-flap endonuclease activity|chromatin binding,large intestine cancer|colorectal cancer|breast cancer,ppi
12359,14675,2131,EXT1,exostosin glycosyltransferase 1,22,acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity; transferring glycosyl groups|heparan sulfate N-acetylglucosaminyltransferase activity|protein homodimerization activity|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,autistic disorder|chondrosarcoma|hereditary multiple exostoses|trichorhinophalangeal syndrome type II|intellectual disability|learning disability|osteonecrosis|cranial nerve palsy|cranial nerve disease|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|Leri-Weill dyschondrosteosis,ppi
12360,14679,2132,EXT2,exostosin glycosyltransferase 2,30,glucuronosyltransferase activity|transferase activity; transferring glycosyl groups|heparan sulfate N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|protein homodimerization activity|acetylglucosaminyltransferase activity,chondrosarcoma|constipation|cryptorchidism|epilepsy|hereditary multiple exostoses|esophagitis|peptic esophagitis|gastroesophageal reflux disease|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|osteonecrosis|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|cranial nerve palsy|cranial nerve disease|humeroradial synostosis,ppi
12361,14680,2134,EXTL1,exostosin like glycosyltransferase 1,2,,,ppi
12362,14685,2135,EXTL2,exostosin like glycosyltransferase 2,16,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|alpha-1;4-N-acetylgalactosaminyltransferase activity,,ppi
12363,14686,387882,C12orf75,chromosome 12 open reading frame 75,10,,,ppi
12364,14689,2137,EXTL3,exostosin like glycosyltransferase 3,28,transferase activity; transferring glycosyl groups,,ppi
12365,14690,2138,EYA1,EYA transcriptional coactivator and phosphatase 1,23,protein tyrosine phosphatase activity,tuberous sclerosis|Marfan syndrome|situs inversus|polyp of middle ear|cholesteatoma|isolated cleft palate|cleft palate|sensorineural hearing loss|congenital heart disease|Meckel syndrome|autosomal dominant polycystic kidney disease|intellectual disability|learning disability|speech disorder|vesicoureteral reflux|branchiootorenal syndrome|multinodular goiter|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda,ppi
12366,14691,199,AIF1,allograft inflammatory factor 1,4,calcium ion binding|actin filament binding,Parkinson's disease|trigeminal neuralgia|Lewy body dementia,ppi
12367,14692,2139,EYA2,EYA transcriptional coactivator and phosphatase 2,84,magnesium ion binding|protein tyrosine phosphatase activity,,ppi
12368,14693,100271927,RASA4B,RAS p21 protein activator 4B,1,,,ppi
12369,14694,2140,EYA3,EYA transcriptional coactivator and phosphatase 3,29,protein tyrosine phosphatase activity,,ppi
12370,14695,2070,EYA4,EYA transcriptional coactivator and phosphatase 4,24,protein tyrosine phosphatase activity,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
12371,14698,651746,ANKRD33B,ankyrin repeat domain 33B,1,,,ppi
12372,14700,644186,SYCE3,synaptonemal complex central element protein 3,43,,,ppi
12373,14701,2145,EZH1,enhancer of zeste 1 polycomb repressive complex 2 subunit,17,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12374,14702,2146,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,287,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|chromatin binding|protein-lysine N-methyltransferase activity|histone-lysine N-methyltransferase activity|chromatin DNA binding|histone methyltransferase activity|histone methyltransferase activity (H3-K27 specific)|promoter-specific chromatin binding,myelofibrosis|clubfoot|craniosynostosis|cryptorchidism|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|endometrial cancer|endometrial carcinoma|epilepsy|inguinal hernia|umbilical hernia|omphalocele|intellectual disability|learning disability|osteosarcoma|bone osteosarcoma|prostate cancer,ppi
12375,14703,2159,F10,coagulation factor X,19,serine-type endopeptidase activity|phospholipid binding,blood coagulation disease|factor X deficiency|hemarthrosis,ppi
12376,14704,2160,F11,coagulation factor XI,11,serine-type endopeptidase activity,factor XI deficiency|hypertension|essential hypertension|blood coagulation disease,ppi
12377,14705,2161,F12,coagulation factor XII,24,serine-type endopeptidase activity|misfolded protein binding,hereditary angioedema|angioedema|factor XII deficiency|hypertension|essential hypertension,ppi
12378,14706,2162,F13A1,coagulation factor XIII A chain,16,protein-glutamine gamma-glutamyltransferase activity,factor XIII deficiency|hemarthrosis|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|thrombophilia|allergic contact dermatitis,ppi
12379,14707,2165,F13B,coagulation factor XIII B chain,2,,factor XIII deficiency|thrombophilia,ppi
12380,14708,2147,F2,coagulation factor II; thrombin,44,lipopolysaccharide binding|serine-type endopeptidase activity|growth factor activity|heparin binding|thrombospondin receptor activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|rheumatoid arthritis|blood coagulation disease|cerebral artery occlusion|brain stem infarction|cerebral infarction,ppi
12381,14709,2149,F2R,coagulation factor II thrombin receptor,32,G-protein alpha-subunit binding|G-protein coupled receptor activity|thrombin-activated receptor activity|G-protein beta-subunit binding,fatty liver disease|liver cirrhosis|stomach cancer,ppi
12382,14710,2150,F2RL1,F2R like trypsin receptor 1,25,G-protein alpha-subunit binding|G-protein coupled receptor activity|signaling receptor binding|G-protein beta-subunit binding|signaling receptor activity,colitis|ileitis|ileocolitis|gastroenteritis|melanoma|skin melanoma|coronary artery disease,ppi
12383,14711,2151,F2RL2,coagulation factor II thrombin receptor like 2,16,phosphatidylinositol phospholipase C activity|G-protein coupled receptor activity,,ppi
12384,14712,9002,F2RL3,F2R like thrombin/trypsin receptor 3,2,G-protein coupled receptor activity,cholestasis|peliosis hepatis,ppi
12385,14714,2152,F3,coagulation factor III; tissue factor,10,phospholipid binding|serine-type endopeptidase activity,purpura fulminans|disseminated intravascular coagulation|acute promyelocytic leukemia|liver cirrhosis|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|thrombotic thrombocytopenic purpura|thrombophilia|coronary artery disease|breast cancer,ppi
12386,14716,400954,EML6,echinoderm microtubule associated protein like 6,3,microtubule binding,,ppi
12387,14719,2153,F5,coagulation factor V,18,,blood coagulation disease|cerebral artery occlusion|brain stem infarction|cerebral infarction|cerebrovascular disease|brain ischemia|colon cancer|colonic benign neoplasm|factor VII deficiency|factor V deficiency|congenital afibrinogenemia|portal hypertension|liver cirrhosis|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|familial adenomatous polyposis|islet cell tumor|pre-eclampsia,ppi
12388,14721,100169851,PATE3,prostate and testis expressed 3,1,,,ppi
12389,14723,100272147,CMC4,C-X9-C motif containing 4,1,,,ppi
12390,14724,2155,F7,coagulation factor VII,22,serine-type peptidase activity|serine-type endopeptidase activity,purpura fulminans|disseminated intravascular coagulation|factor VII deficiency|factor V deficiency|congenital afibrinogenemia|hemarthrosis|hemorrhagic disease|thrombophilia,ppi
12391,14726,641700,ECSCR,endothelial cell surface expressed chemotaxis and apoptosis regulator,2,,,ppi
12392,14727,317762,CCDC85C,coiled-coil domain containing 85C,49,,,ppi
12393,14728,2157,F8,coagulation factor VIII,20,,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|hemarthrosis|factor VIII deficiency|arthropathy|arthritis|thrombophilia|protein S deficiency|antithrombin III deficiency|protein C deficiency,ppi
12394,14734,2158,F9,coagulation factor IX,35,endopeptidase activity|serine-type endopeptidase activity|calcium ion binding,bipolar disorder|hemophilia B|hemarthrosis|factor VIII deficiency|arthropathy|arthritis|malignant mesothelioma|benign mesothelioma|thrombophilia|protein S deficiency|antithrombin III deficiency|protein C deficiency|blood coagulation disease,ppi
12395,14735,2166,FAAH,fatty acid amide hydrolase,2,fatty acid amide hydrolase activity,cannabis dependence|cannabis abuse|Huntington's disease|obesity|placenta disease|schizophreniform disorder|schizoaffective disorder|schizophrenia|epilepsy|visual epilepsy|neurotic disorder|endogenous depression|melancholia|substance abuse|substance-related disorder|mood disorder|major depressive disorder|mental depression,ppi
12396,14736,7923,HSD17B8,hydroxysteroid 17-beta dehydrogenase 8,18,3-hydroxyacyl-CoA dehydrogenase activity|estradiol 17-beta-dehydrogenase activity|3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity|NADH binding,,ppi
12397,14737,2168,FABP1,fatty acid binding protein 1,7,antioxidant activity,chronic kidney disease|acute kidney tubular necrosis|chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease,ppi
12398,14738,2169,FABP2,fatty acid binding protein 2,3,fatty acid binding|long-chain fatty acid binding,alcohol dependence|alcohol abuse,ppi
12399,14739,2170,FABP3,fatty acid binding protein 3,19,long-chain fatty acid binding|oleic acid binding,familial periodic paralysis|myopathy|schizophrenia,ppi
12400,14740,2167,FABP4,fatty acid binding protein 4,24,long-chain fatty acid transporter activity|fatty acid binding|long-chain fatty acid binding,contact dermatitis|occupational dermatitis,ppi
12401,14741,202,AIM1,absent in melanoma 1,14,,,ppi
12402,14742,2171,FABP5,fatty acid binding protein 5,75,fatty acid binding|lipid binding|identical protein binding,schizophrenia|coronary artery disease|liver cancer|hepatocellular carcinoma,ppi
12403,14743,2172,FABP6,fatty acid binding protein 6,1,,,ppi
12404,14744,2173,FABP7,fatty acid binding protein 7,10,,bipolar disorder|schizophrenia|breast cancer,ppi
12405,14745,646480,FABP9,fatty acid binding protein 9,1,,,ppi
12406,14746,2180,ACSL1,acyl-CoA synthetase long-chain family member 1,10,long-chain fatty acid-CoA ligase activity,obesity,ppi
12407,14747,9447,AIM2,absent in melanoma 2,108,double-stranded DNA binding,,ppi
12408,14748,2181,ACSL3,acyl-CoA synthetase long-chain family member 3,45,long-chain fatty acid-CoA ligase activity,,ppi
12409,14749,2182,ACSL4,acyl-CoA synthetase long-chain family member 4,46,long-chain fatty acid-CoA ligase activity|very long-chain fatty acid-CoA ligase activity|arachidonate-CoA ligase activity,sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|favism|hereditary elliptocytosis|congenital hemolytic anemia|intellectual disability|learning disability|prostate cancer|prostate carcinoma|proteinuria|kidney failure|uremia|schizophrenia|syndromic X-linked intellectual disability 94|granuloma annulare,ppi
12410,14750,8772,FADD,Fas associated via death domain,77,,epilepsy|sensorineural hearing loss|ventricular septal defect|visual epilepsy|brain disease|liver disease|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
12411,14751,3992,FADS1,fatty acid desaturase 1,18,C-5 sterol desaturase activity|oxidoreductase activity|omega-6 fatty acid desaturase activity,large intestine cancer|colorectal cancer|schizophrenia|stomach cancer,ppi
12412,14752,9415,FADS2,fatty acid desaturase 2,9,linoleoyl-CoA desaturase activity,bipolar disorder|large intestine cancer|colorectal cancer|chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease|schizophrenia,ppi
12413,14753,3995,FADS3,fatty acid desaturase 3,17,,,ppi
12414,14754,11124,FAF1,Fas associated factor 1,135,protein kinase regulator activity|protein kinase binding|heat shock protein binding|ubiquitin protein ligase binding|ubiquitin binding,,ppi
12415,14755,2184,FAH,fumarylacetoacetate hydrolase,11,fumarylacetoacetase activity,blood coagulation disease|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|hemorrhagic disease|hypoglycemia|liver cirrhosis|calcium metabolism disease|nephrocalcinosis|calcinosis|hypercalcemia|phosphorus metabolism disease|intestinal pseudo-obstruction|paralytic ileus|kidney failure|uremia|liver disease|hepatitis|renal osteodystrophy|tyrosinemia,ppi
12416,14756,9049,AIP,aryl hydrocarbon receptor interacting protein,57,transcription coactivator activity|transcription factor binding|GAF domain binding|unfolded protein binding,hyperpituitarism|acromegaly|adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|generalized anxiety disorder|anxiety disorder|spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
12417,14757,2186,BPTF,bromodomain PHD finger transcription factor,44,transcription factor binding|sequence-specific DNA binding|DNA-dependent ATPase activity,urinary bladder cancer,ppi
12418,14758,2175,FANCA,Fanconi anemia complementation group A,86,,anemia|macrocytic anemia|urinary bladder cancer|cryptorchidism|salivary gland adenoid cystic carcinoma|sensorineural hearing loss|esophageal atresia|Fanconi anemia|congenital heart disease|leukemia|leukopenia|intellectual disability|learning disability|microphthalmia|pancytopenia|ophthalmoplegia|mechanical strabismus|hypertropia|thrombocytopenia|placental insufficiency,ppi
12419,14759,2187,FANCB,Fanconi anemia complementation group B,15,,anemia|macrocytic anemia|imperforate anus|atrioventricular septal defect|esophageal atresia|Fanconi anemia|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|hydronephrosis|leukopenia|intellectual disability|learning disability|thrombocytopenia|Klippel-Feil syndrome|spondylolisthesis|Potter's syndrome|VACTERL association|dextro-looped transposition of the great arteries 1,ppi
12420,14760,2176,FANCC,Fanconi anemia complementation group C,60,,anemia|macrocytic anemia|cryptorchidism|sensorineural hearing loss|esophageal atresia|Fanconi anemia|congenital heart disease|leukemia|leukopenia|intellectual disability|learning disability|microphthalmia|pancytopenia|ophthalmoplegia|mechanical strabismus|hypertropia|thrombocytopenia|placental insufficiency|capillary hemangioma|hematologic cancer,ppi
12421,14761,2177,FANCD2,Fanconi anemia complementation group D2,74,DNA polymerase binding,anemia|macrocytic anemia|cryptorchidism|sensorineural hearing loss|esophageal atresia|Fanconi anemia|congenital heart disease|leukemia|leukopenia|intellectual disability|learning disability|microphthalmia|pancytopenia|ophthalmoplegia|mechanical strabismus|hypertropia|thrombocytopenia|placental insufficiency|capillary hemangioma|hematologic cancer,ppi
12422,14762,2178,FANCE,Fanconi anemia complementation group E,22,,anemia|macrocytic anemia|cryptorchidism|sensorineural hearing loss|esophageal atresia|Fanconi anemia|congenital heart disease|leukemia|leukopenia|intellectual disability|learning disability|microphthalmia|pancytopenia|ophthalmoplegia|mechanical strabismus|hypertropia|thrombocytopenia|placental insufficiency|capillary hemangioma|hematologic cancer,ppi
12423,14763,2188,FANCF,Fanconi anemia complementation group F,16,protein binding|ubiquitin protein ligase activity,esophageal atresia|Fanconi anemia|leukopenia|intellectual disability|learning disability|thrombocytopenia,ppi
12424,14764,2189,FANCG,Fanconi anemia complementation group G,53,damaged DNA binding,anemia|macrocytic anemia|esophageal atresia|Fanconi anemia|leukemia|leukopenia|intellectual disability|learning disability|mouth disease|thrombocytopenia|hematologic cancer|essential thrombocythemia|myelodysplastic syndrome,ppi
12425,14765,23746,AIPL1,aryl hydrocarbon receptor interacting protein like 1,21,farnesylated protein binding|unfolded protein binding,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|epilepsy|corneal disease|keratoconus|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|visual epilepsy|asthenopia,ppi
12426,14766,2191,FAP,fibroblast activation protein alpha,25,endopeptidase activity|metalloendopeptidase activity|serine-type endopeptidase activity|peptidase activity|serine-type peptidase activity|dipeptidyl-peptidase activity|protein homodimerization activity|protein dimerization activity,,ppi
12427,14767,10160,FARP1,FERM; ARH/RhoGEF and pleckstrin domain protein 1,17,Rho guanyl-nucleotide exchange factor activity|Rac guanyl-nucleotide exchange factor activity,substance abuse|substance-related disorder,ppi
12428,14768,2193,FARSA,phenylalanyl-tRNA synthetase alpha subunit,55,RNA binding|phenylalanine-tRNA ligase activity,,ppi
12429,14769,2194,FASN,fatty acid synthase,123,RNA binding|fatty acid synthase activity|cadherin binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
12430,14770,2195,FAT1,FAT atypical cadherin 1,42,,large intestine cancer|colorectal cancer|salivary gland adenoid cystic carcinoma|glioblastoma multiforme|giant cell glioblastoma|head and neck cancer|esophagus squamous cell carcinoma,ppi
12431,14772,2197,FAU,FAU; ubiquitin like and ribosomal protein S30 fusion,98,RNA binding,,ppi
12432,14773,2091,FBL,fibrillarin,277,RNA binding|histone-glutamine methyltransferase activity|rRNA methyltransferase activity,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|breast cancer,ppi
12433,14774,23460,ABCA6,ATP binding cassette subfamily A member 6,1,ATPase activity; coupled to transmembrane movement of substances,large intestine cancer|colorectal cancer|allergic contact dermatitis,ppi
12434,14775,326,AIRE,autoimmune regulator,102,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|chromatin binding|zinc ion binding|histone binding|transcription regulatory region DNA binding,alopecia|anemia|macrocytic anemia|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|oral candidiasis|candidiasis|chronic mucocutaneous candidiasis|cholecystolithiasis|choledocholithiasis|dental enamel hypoplasia|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9,ppi
12435,14776,2192,FBLN1,fibulin 1,67,extracellular matrix structural constituent|calcium ion binding|identical protein binding,endometriosis of uterus|endometriosis|prostate cancer|prostate carcinoma|polydactyly|synpolydactyly,ppi
12436,14777,2199,FBLN2,fibulin 2,24,extracellular matrix structural constituent|extracellular matrix constituent conferring elasticity|extracellular matrix binding,large intestine cancer|colorectal cancer,ppi
12437,14778,10516,FBLN5,fibulin 5,26,integrin binding|extracellular matrix constituent conferring elasticity|protein homodimerization activity,aortic aneurysm|supravalvular aortic stenosis|ptosis|congenital ptosis|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|congestive heart failure|inguinal hernia|umbilical hernia|omphalocele|primary pulmonary hypertension|pulmonary hypertension|mitral valve insufficiency|mitral valve prolapse|prostate cancer|prostate carcinoma|adult respiratory distress syndrome,ppi
12438,14779,2200,FBN1,fibrillin 1,25,extracellular matrix structural constituent|calcium ion binding|heparin binding|extracellular matrix constituent conferring elasticity,aortic aneurysm|aortic valve insufficiency|aortic valve stenosis|pseudosarcomatous fibromatosis|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|patent ductus arteriosus|achondroplasia|Laron syndrome|endometriosis of uterus|endometriosis|enophthalmos|orbital disease|exophthalmos|clubfoot|glaucoma|congestive heart failure,ppi
12439,14780,2201,FBN2,fibrillin 2,26,extracellular matrix constituent conferring elasticity|extracellular matrix structural constituent,large intestine cancer|colorectal cancer|patent ductus arteriosus|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|retinitis pigmentosa 30|age related macular degeneration|macular degeneration|mitral valve insufficiency|mitral valve prolapse,ppi
12440,14781,2203,FBP1,fructose-bisphosphatase 1,46,obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|AMP binding|fructose 1;6-bisphosphate 1-phosphatase activity|metal ion binding|monosaccharide binding,colon cancer|colonic benign neoplasm|epilepsy|fructose-1;6-bisphosphatase deficiency|hypoglycemia|Parkinson's disease|schizophrenia|visual epilepsy|stomach cancer|lactic acidosis|liver cancer|hepatocellular carcinoma,ppi
12441,14782,8789,FBP2,fructose-bisphosphatase 2,20,fructose 1;6-bisphosphate 1-phosphatase activity,,ppi
12442,14783,2204,FCAR,Fc fragment of IgA receptor,10,,,ppi
12443,14784,2205,FCER1A,Fc fragment of IgE receptor Ia,7,,angioedema,ppi
12444,14785,203,AK1,adenylate kinase 1,26,adenylate kinase activity|nucleoside diphosphate kinase activity,hemolytic anemia|coronary artery disease|lymphosarcoma|B-cell lymphoma,ppi
12445,14786,2207,FCER1G,Fc fragment of IgE receptor Ig,11,protein homodimerization activity|IgE binding|IgE receptor activity|IgG binding,,ppi
12446,14787,2208,FCER2,Fc fragment of IgE receptor II,7,integrin binding,myelitis|encephalomyelitis|encephalitis|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
12447,14788,2209,FCGR1A,Fc fragment of IgG receptor Ia,25,,calcium metabolism disease|nephrocalcinosis|calcinosis|heart valve disease,ppi
12448,14790,2212,FCGR2A,Fc fragment of IgG receptor IIa,34,,rheumatoid arthritis|inflammatory bowel disease|ulcerative colitis|systemic lupus erythematosus|Kawasaki disease|schizophrenia|thrombocytopenia|Sjogren's syndrome|keratoconjunctivitis sicca,ppi
12449,14791,2213,FCGR2B,Fc fragment of IgG receptor IIb,23,low-affinity IgG receptor activity|IgG binding,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|systemic lupus erythematosus|malaria|neutropenia|agranulocytosis|severe congenital neutropenia,ppi
12450,14792,2214,FCGR3A,Fc fragment of IgG receptor IIIa,19,,primary immunodeficiency disease|systemic lupus erythematosus|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|sinusitis,ppi
12451,14793,204,AK2,adenylate kinase 2,49,adenylate kinase activity,anemia|macrocytic anemia|sensorineural hearing loss|leukopenia|lymphopenia|adenosine deaminase deficiency|MHC class II deficiency|severe combined immunodeficiency|agammaglobulinemia|otitis media|reticular dysgenesis|neutropenia|agranulocytosis|severe congenital neutropenia,ppi
12452,14794,2215,FCGR3B,Fc fragment of IgG receptor IIIb,21,,lupus nephritis|allergic contact dermatitis|Wegener's granulomatosis|Takayasu's arteritis|Goodpasture syndrome|polyarteritis nodosa,ppi
12453,14795,2217,FCGRT,Fc fragment of IgG receptor and transporter,58,IgG binding|peptide antigen binding|beta-2-microglobulin binding,,ppi
12454,14796,2218,FKTN,fukutin,4,,imperforate anus|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
12455,14797,2219,FCN1,ficolin 1,17,serine-type endopeptidase activity|signaling pattern recognition receptor activity|sialic acid binding,,ppi
12456,14798,2220,FCN2,ficolin 2,7,antigen binding|serine-type endopeptidase activity|proteoglycan binding|mannan binding,malignant mesothelioma|benign mesothelioma,ppi
12457,14799,8547,FCN3,ficolin 3,1,antigen binding|serine-type endopeptidase activity,primary immunodeficiency disease|common wart,ppi
12458,14800,2222,FDFT1,farnesyl-diphosphate farnesyltransferase 1,38,farnesyl-diphosphate farnesyltransferase activity|squalene synthase activity,cannabis dependence|cannabis abuse|phencyclidine abuse|cocaine abuse|cocaine dependence|liver cancer|hepatocellular carcinoma,ppi
12459,14801,205,AK4,adenylate kinase 4,15,adenylate kinase activity|nucleoside diphosphate kinase activity|nucleoside triphosphate adenylate kinase activity|nucleoside monophosphate kinase activity,arthropathy|arthritis,ppi
12460,14802,2224,FDPS,farnesyl diphosphate synthase,54,RNA binding|dimethylallyltranstransferase activity|geranyltranstransferase activity,porokeratosis,ppi
12461,14803,2230,FDX1,ferredoxin 1,15,iron ion binding|electron transfer activity|2 iron; 2 sulfur cluster binding,,ppi
12462,14804,2232,FDXR,ferredoxin reductase,27,ferredoxin-NADP+ reductase activity|NADPH-adrenodoxin reductase activity|oxidoreductase activity,,ppi
12463,14805,2235,FECH,ferrochelatase,45,ferrochelatase activity|ferrous iron binding,hemolytic anemia|bile duct disease|cholecystolithiasis|choledocholithiasis|dermatitis|congestive heart failure|granuloma annulare|erythropoietic protoporphyria|cutaneous porphyria|photosensitivity disease|photosensitive epilepsy,ppi
12464,14806,10116,FEM1B,fem-1 homolog B,49,ubiquitin-protein transferase activity|death receptor binding,,ppi
12465,14807,26289,AK5,adenylate kinase 5,10,nucleoside diphosphate kinase activity|nucleoside kinase activity,,ppi
12466,14808,2237,FEN1,flap structure-specific endonuclease 1,79,DNA binding|damaged DNA binding|double-stranded DNA binding|endonuclease activity|RNA-DNA hybrid ribonuclease activity|exonuclease activity|double-stranded DNA exodeoxyribonuclease activity|5'-3' exonuclease activity|5'-flap endonuclease activity|flap endonuclease activity|single-stranded DNA 5'-3' exodeoxyribonuclease activity|magnesium ion binding|manganese ion binding|double-stranded DNA 5'-3' exodeoxyribonuclease activity,large intestine cancer|colorectal cancer,ppi
12467,14809,2241,FER,FER tyrosine kinase,33,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|epidermal growth factor receptor binding|lipid binding,,ppi
12468,14810,26509,MYOF,myoferlin,24,phospholipid binding,,ppi
12469,14811,2242,FES,FES proto-oncogene; tyrosine kinase,44,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|immunoglobulin receptor binding|phosphatidylinositol binding,,ppi
12470,14813,9638,FEZ1,fasciculation and elongation protein zeta 1,126,,bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
12471,14814,9637,FEZ2,fasciculation and elongation protein zeta 2,29,,coronary artery disease,ppi
12472,14815,2243,FGA,fibrinogen alpha chain,36,structural molecule activity|signaling receptor binding|cell adhesion molecule binding,factor VII deficiency|factor V deficiency|congenital afibrinogenemia|cholestasis|congestive heart failure|exanthem|hypertension|essential hypertension|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|osteoporosis|proteinuria|pulmonary embolism|thrombophilia,ppi
12473,14816,2244,FGB,fibrinogen beta chain,113,structural molecule activity|signaling receptor binding|cell adhesion molecule binding,factor VII deficiency|factor V deficiency|congenital afibrinogenemia|osteoporosis|Parkinson's disease|thrombophilia|blood coagulation disease,ppi
12474,14817,2245,FGD1,FYVE; RhoGEF and PH domain containing 1,16,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|small GTPase binding,ptosis|congenital ptosis|cleft lip|isolated cleft palate|cleft palate|cryptorchidism|inguinal hernia|umbilical hernia|omphalocele|hyperopia|tooth agenesis|anodontia|intellectual disability|learning disability|ophthalmoplegia|mechanical strabismus|hypertropia|syndactyly|Seckel syndrome|Robinow syndrome,ppi
12475,14818,221472,FGD2,FYVE; RhoGEF and PH domain containing 2,3,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|small GTPase binding,,ppi
12476,14819,2246,FGF1,fibroblast growth factor 1,29,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|fibroblast growth factor receptor binding|integrin binding|growth factor activity|heparin binding|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,leukemia|malignant mesothelioma|benign mesothelioma|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|coronary artery disease|ovarian cancer,ppi
12477,14820,2255,FGF10,fibroblast growth factor 10,8,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|fibroblast growth factor receptor binding|growth factor activity|heparin binding|1-phosphatidylinositol-3-kinase activity|chemoattractant activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,cleft lip|isolated cleft palate|cleft palate|corneal ulcer|dacryoadenitis|dacryocystitis|dental caries|dental enamel hypoplasia|tooth agenesis|anodontia|lacrimal duct obstruction|nephrosclerosis|prostate cancer|prostate carcinoma|recurrent corneal erosion|LADD syndrome|Potter's syndrome|breast cancer,ppi
12478,14822,2257,FGF12,fibroblast growth factor 12,16,sodium channel regulator activity|ion channel binding,,ppi
12479,14823,8165,AKAP1,A-kinase anchoring protein 1,37,RNA binding,obesity,ppi
12480,14824,2258,FGF13,fibroblast growth factor 13,6,microtubule binding|sodium channel regulator activity|protein kinase activator activity|ion channel binding|beta-tubulin binding,pancreatic cancer,ppi
12481,14825,2259,FGF14,fibroblast growth factor 14,2,,bone disease|cartilage disease|connective tissue disease|chondromalacia|articular cartilage disease|ophthalmoplegia|mechanical strabismus|hypertropia|amnestic disorder|retrograde amnesia|spinocerebellar ataxia type 27,ppi
12482,14826,8823,FGF16,fibroblast growth factor 16,1,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,salivary gland adenoid cystic carcinoma,ppi
12483,14827,8822,FGF17,fibroblast growth factor 17,4,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|type 1 fibroblast growth factor receptor binding|type 2 fibroblast growth factor receptor binding|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,generalized anxiety disorder|anxiety disorder|bipolar disorder|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertrophy of breast|infant gynecomastia|gynecomastia|hypogonadism|osteoporosis|premature menopause|androgen insensitivity syndrome|eunuchism|isolated growth hormone deficiency|isolated growth hormone deficiency type II,ppi
12484,14828,8817,FGF18,fibroblast growth factor 18,5,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|type 1 fibroblast growth factor receptor binding|type 2 fibroblast growth factor receptor binding|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,hiatus hernia|congenital diaphragmatic hernia|polycystic ovary syndrome|malignant mesothelioma|benign mesothelioma,ppi
12485,14829,9965,FGF19,fibroblast growth factor 19,1,Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,liver cancer|hepatocellular carcinoma,ppi
12486,14830,2247,FGF2,fibroblast growth factor 2,39,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|cytokine activity|integrin binding|growth factor activity|1-phosphatidylinositol-3-kinase activity|nuclear receptor transcription coactivator activity|chemoattractant activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|receptor-receptor interaction,cleft lip|isolated cleft palate|cleft palate|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy with generalized tonic-clonic seizures|malignant glioma|gliosarcoma|mixed glioma|hiatus hernia|congenital diaphragmatic hernia|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
12487,14831,26281,FGF20,fibroblast growth factor 20,1,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|signaling receptor binding|growth factor activity|1-phosphatidylinositol-3-kinase activity|heparan sulfate proteoglycan binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|receptor-receptor interaction,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|intestinal disease|gastrointestinal system disease|oligohydramnios|Potter's syndrome|Parkinson's disease,ppi
12488,14832,26291,FGF21,fibroblast growth factor 21,7,,diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21|type 1 diabetes mellitus 22,ppi
12489,14834,11216,AKAP10,A-kinase anchoring protein 10,9,,bipolar disorder,ppi
12490,14835,8074,FGF23,fibroblast growth factor 23,4,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,calcium metabolism disease|nephrocalcinosis|calcinosis|osteomalacia|rickets|hyperphosphatemia|autosomal dominant hypophosphatemic rickets,ppi
12491,14836,2248,FGF3,fibroblast growth factor 3,58,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,cleft lip|isolated cleft palate|cleft palate|sensorineural hearing loss|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag|breast cancer|liver cancer|hepatocellular carcinoma,ppi
12492,14837,2249,FGF4,fibroblast growth factor 4,5,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,breast cancer|liver cancer|hepatocellular carcinoma,ppi
12493,14838,2250,FGF5,fibroblast growth factor 5,6,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|fibroblast growth factor receptor binding|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,cataract,ppi
12494,14839,2251,FGF6,fibroblast growth factor 6,4,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,amyotrophic lateral sclerosis type 1,ppi
12495,14840,2252,FGF7,fibroblast growth factor 7,13,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|chemoattractant activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,cleft lip|isolated cleft palate|cleft palate|gingival overgrowth|gingival hypertrophy|liver cirrhosis|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|prostatic adenoma,ppi
12496,14841,2253,FGF8,fibroblast growth factor 8,98,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,generalized anxiety disorder|anxiety disorder|cleft lip|isolated cleft palate|cleft palate|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|DiGeorge syndrome|velocardiofacial syndrome|hypertrophy of breast|infant gynecomastia|gynecomastia|osteoporosis|hypogonadism|premature menopause,ppi
12497,14842,2254,FGF9,fibroblast growth factor 9,13,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|lung cancer|non-small cell lung carcinoma|cleft lip|isolated cleft palate|cleft palate|lung benign neoplasm|calcaneonavicular coalition|multiple synostoses syndrome|malignant mesothelioma|benign mesothelioma|humeroradial synostosis,ppi
12498,14843,2260,FGFR1,fibroblast growth factor receptor 1,107,protein tyrosine kinase activity|fibroblast growth factor-activated receptor activity|Ras guanyl-nucleotide exchange factor activity|heparin binding|1-phosphatidylinositol-3-kinase activity|fibroblast growth factor binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|receptor-receptor interaction|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,alopecia|generalized anxiety disorder|anxiety disorder|congenital heart disease|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|bipolar disorder|ptosis|congenital ptosis|lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma,ppi
12499,14844,2263,FGFR2,fibroblast growth factor receptor 2,97,protein tyrosine kinase activity|fibroblast growth factor-activated receptor activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|fibroblast growth factor binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|transmembrane signaling receptor activity|transmembrane receptor protein tyrosine kinase activity,acanthosis nigricans|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X|Nance-Horan syndrome|Muenke Syndrome|Warburg micro syndrome 1|Warburg micro syndrome 2|Warburg micro syndrome 3|Warburg micro syndrome 4|acrocephalosyndactylia|Mobius syndrome|Pfeiffer syndrome|Saethre-Chotzen syndrome|Goldenhar syndrome|Weissenbacher-Zweymuller syndrome|ankylosis|congenital heart disease,ppi
12500,14845,11215,AKAP11,A-kinase anchoring protein 11,38,protein phosphatase 1 binding|protein kinase A binding,,ppi
12501,14846,2261,FGFR3,fibroblast growth factor receptor 3,57,protein tyrosine kinase activity|fibroblast growth factor-activated receptor activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|fibroblast growth factor binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|transmembrane signaling receptor activity|transmembrane receptor protein tyrosine kinase activity,acanthosis nigricans|achondroplasia|osteochondrodysplasia|congenital heart disease|urinary bladder cancer|bladder carcinoma|ptosis|congenital ptosis|focal hand dystonia|blepharospasm|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|transitional cell carcinoma|cervical cancer|choanal atresia,ppi
12502,14847,2264,FGFR4,fibroblast growth factor receptor 4,50,protein tyrosine kinase activity|fibroblast growth factor-activated receptor activity|Ras guanyl-nucleotide exchange factor activity|heparin binding|1-phosphatidylinositol-3-kinase activity|fibroblast growth factor binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,salivary gland adenoid cystic carcinoma|prostate cancer|prostate carcinoma|adult respiratory distress syndrome|newborn respiratory distress syndrome,ppi
12503,14848,53834,FGFRL1,fibroblast growth factor receptor-like 1,23,fibroblast growth factor-activated receptor activity|heparin binding|fibroblast growth factor binding,ptosis|congenital ptosis|cleft lip|isolated cleft palate|cleft palate|clubfoot|epilepsy|enophthalmos|orbital disease|exophthalmos|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|ventricular septal defect|glomus tumor|hemangioma|lymphangioma|chorioangioma|intramuscular hemangioma,ppi
12504,14849,2266,FGG,fibrinogen gamma chain,28,structural molecule activity,stomach cancer|thrombophilia|factor VII deficiency|factor V deficiency|congenital afibrinogenemia|blood coagulation disease,ppi
12505,14850,2267,FGL1,fibrinogen like 1,69,,,ppi
12506,14851,10875,FGL2,fibrinogen like 2,11,,allergic contact dermatitis,ppi
12507,14852,2268,FGR,FGR proto-oncogene; Src family tyrosine kinase,39,phosphotyrosine residue binding|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|protein kinase binding|immunoglobulin receptor binding|Fc-gamma receptor I complex binding|signaling receptor binding,,ppi
12508,14853,10347,ABCA7,ATP binding cassette subfamily A member 7,7,transporter activity|ATPase activity|apolipoprotein A-I receptor activity|phosphatidylcholine-translocating ATPase activity|phosphatidylserine-translocating ATPase activity|ATPase activity; coupled to transmembrane movement of substances,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
12509,14854,9590,AKAP12,A-kinase anchoring protein 12,29,,breast cancer,ppi
12510,14855,2271,FH,fumarate hydratase,82,fumarate hydratase activity,lactic acidosis|cholestasis|optic atrophy|polycythemia vera|Chuvash polycythemia|acquired polycythemia|stress polycythemia|erythropoietin polycythemia|polycythemia|speech disorder|status epilepticus|blindness|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|leiomyoma cutis,ppi
12511,14856,2272,FHIT,fragile histidine triad,18,catalytic activity|hydrolase activity|bis(5'-adenosyl)-triphosphatase activity,lung cancer|non-small cell lung carcinoma|liver cancer|lung benign neoplasm|malignant mesothelioma|benign mesothelioma|prostate cancer|prostate carcinoma|schizophrenia|stomach cancer|urinary system benign neoplasm|substance abuse|substance-related disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
12512,14857,2273,FHL1,four and a half LIM domains 1,55,,sick sinus syndrome|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|pseudosarcomatous fibromatosis|muscular atrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q,ppi
12513,14858,2274,FHL2,four and a half LIM domains 2,150,transcription coactivator activity|androgen receptor binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
12514,14859,2275,FHL3,four and a half LIM domains 3,125,actin binding,,ppi
12515,14860,9158,FIBP,FGF1 intracellular binding protein,22,,,ppi
12516,14861,728116,ZBTB8B,zinc finger and BTB domain containing 8B,22,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12517,14862,5205,ATP8B1,ATPase phospholipid transporting 8B1,4,phospholipid-translocating ATPase activity,intrahepatic cholestasis|sensorineural hearing loss|achondroplasia|Laron syndrome|liver cirrhosis|acute pancreatitis|pancreatitis,ppi
12518,14863,729438,GATSL2,GATS protein like 2,4,identical protein binding|arginine binding,,ppi
12519,14864,2277,VEGFD,vascular endothelial growth factor D,11,platelet-derived growth factor receptor binding|chemoattractant activity|growth factor activity|vascular endothelial growth factor receptor 3 binding,,ppi
12520,14866,653269,POTEI,POTE ankyrin domain family member I,33,,,ppi
12521,14867,653781,POTEJ,POTE ankyrin domain family member J,5,,,ppi
12522,14871,11214,AKAP13,A-kinase anchoring protein 13,33,MAP-kinase scaffold activity|guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|protein-containing complex scaffold activity|protein kinase A binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|esophageal cancer,ppi
12523,14872,387885,CFAP73,cilia and flagella associated protein 73,1,dynein complex binding,,ppi
12524,14873,2280,FKBP1A,FK506 binding protein 1A,69,peptidyl-prolyl cis-trans isomerase activity|transforming growth factor beta receptor binding|macrolide binding|FK506 binding|type I transforming growth factor beta receptor binding|ion channel binding|calcium channel inhibitor activity,bipolar disorder|esophagus squamous cell carcinoma,ppi
12525,14875,2281,FKBP1B,FK506 binding protein 1B,28,peptidyl-prolyl cis-trans isomerase activity|FK506 binding|calcium channel inhibitor activity|ion channel binding|ryanodine-sensitive calcium-release channel activity,,ppi
12526,14878,654254,ZNF732,zinc finger protein 732,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12527,14879,100293516,ZNF587B,zinc finger protein 587B,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
12528,14882,646754,TRIM64C,tripartite motif containing 64C,1,,,ppi
12529,14883,100462977,MTRNR2L1,MT-RNR2-like 1,9,receptor antagonist activity,,ppi
12530,14897,728386,USP17L5,ubiquitin specific peptidase 17-like family member 5,1,thiol-dependent ubiquitin-specific protease activity|cysteine-type endopeptidase activity,,ppi
12531,14898,2286,FKBP2,FK506 binding protein 2,49,FK506 binding,stomach cancer,ppi
12532,14899,392197,USP17L7,ubiquitin specific peptidase 17-like family member 7,3,thiol-dependent ubiquitin-specific protease activity|cysteine-type endopeptidase activity,,ppi
12533,14901,401447,USP17L1,ubiquitin specific peptidase 17-like family member 1,2,cysteine-type endopeptidase activity|thiol-dependent ubiquitin-specific protease activity,,ppi
12534,14902,2287,FKBP3,FK506 binding protein 3,50,RNA binding|FK506 binding|signaling receptor activity,,ppi
12535,14903,11217,AKAP2,A-kinase anchoring protein 2,39,,,ppi
12536,14904,2288,FKBP4,FK506 binding protein 4,95,RNA binding|peptidyl-prolyl cis-trans isomerase activity|FK506 binding|protein binding; bridging,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
12537,14906,729355,TP53TG3B,TP53 target 3B,1,,,ppi
12538,14913,2289,FKBP5,FK506 binding protein 5,143,peptidyl-prolyl cis-trans isomerase activity|FK506 binding,alcohol dependence|alcohol abuse|rheumatoid arthritis|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometriosis of uterus|endometriosis|schizophreniform disorder|schizoaffective disorder|mood disorder,ppi
12539,14917,643376,BTBD18,BTB domain containing 18,1,,,ppi
12540,14923,8468,FKBP6,FK506 binding protein 6,46,Hsp90 protein binding|peptidyl-prolyl cis-trans isomerase activity,,ppi
12541,14927,729250,PRR20E,proline rich 20E,20,,,ppi
12542,14930,390594,KBTBD13,kelch repeat and BTB domain containing 13,1,,nemaline myopathy,ppi
12543,14931,647042,GOLGA6L10,golgin A6 family-like 10,1,,,ppi
12544,14932,440295,GOLGA6L9,golgin A6 family-like 9,4,,,ppi
12545,14933,51661,FKBP7,FK506 binding protein 7,26,,,ppi
12546,14937,79583,TMEM231,transmembrane protein 231,37,,Joubert syndrome|Meckel syndrome,ppi
12547,14942,23770,FKBP8,FK506 binding protein 8,108,,,ppi
12548,14944,284067,C17orf105,chromosome 17 open reading frame 105,5,,,ppi
12549,14945,100134934,TEN1,TEN1; CST complex subunit,2,telomeric DNA binding|telomerase inhibitor activity,,ppi
12550,14946,440498,HSBP1L1,heat shock factor binding protein 1 like 1,1,,,ppi
12551,14950,729991,BORCS8,BLOC-1 related complex subunit 8,3,,,ppi
12552,14953,11328,FKBP9,FK506 binding protein 9,36,calcium ion binding,,ppi
12553,14955,100271715,ARHGEF33,Rho guanine nucleotide exchange factor 33,1,,,ppi
12554,14958,440957,SMIM4,small integral membrane protein 4,1,,,ppi
12555,14960,389203,SMIM20,small integral membrane protein 20,6,,,ppi
12556,14965,134111,UBE2QL1,ubiquitin conjugating enzyme E2 Q family like 1,1,ubiquitin conjugating enzyme activity,,ppi
12557,14966,642987,TMEM232,transmembrane protein 232,1,,,ppi
12558,14973,100134938,UPK3BL,uroplakin 3B-like,24,,,ppi
12559,14975,401399,PRRT4,proline rich transmembrane protein 4,1,,,ppi
12560,14976,441282,AKR1B15,aldo-keto reductase family 1 member B15,11,estradiol 17-beta-dehydrogenase activity|oxidoreductase activity|alditol:NADP+ 1-oxidoreductase activity|alcohol dehydrogenase (NADP+) activity,,ppi
12561,14977,653857,ACTR3C,ARP3 actin-related protein 3 homolog C,4,,,ppi
12562,14980,441476,STPG3,sperm-tail PG-rich repeat containing 3,3,,,ppi
12563,14983,100142659,CTAGE8,CTAGE family member 8,1,lipoprotein transporter activity,,ppi
12564,14985,10566,AKAP3,A-kinase anchoring protein 3,10,protein kinase A binding,,ppi
12565,14986,100287362,PRSS46,protease; serine 46,1,,,ppi
12566,14987,2307,FOXS1,forkhead box S1,77,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
12567,14988,8852,AKAP4,A-kinase anchoring protein 4,7,protein kinase A binding,,ppi
12568,14994,100289087,TSPY10,testis specific protein; Y-linked 10,1,,,ppi
12569,14995,2312,FLG,filaggrin,28,structural molecule activity|structural constituent of epidermis,asthma|intrinsic asthma|allergic asthma|atopic dermatitis|contact dermatitis|occupational dermatitis|dermatitis|ichthyosis|ichthyosis vulgaris|epidermolytic hyperkeratosis|atopic dermatitis 2,ppi
12570,14996,2313,FLI1,Fli-1 proto-oncogene; ETS transcription factor,22,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,ptosis|congenital ptosis|heart disease|cardiovascular system disease|constipation|cryptorchidism|clubfoot|ventricular septal defect|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|intellectual disability|learning disability|ophthalmoplegia|mechanical strabismus|hypertropia|thrombocytopenia|cornea plana,ppi
12571,14998,9495,AKAP5,A-kinase anchoring protein 5,44,protein phosphatase 2B binding|glutamate receptor binding|protein kinase A binding|GABA receptor binding|beta-2 adrenergic receptor binding|adenylate cyclase binding|protein-containing complex scaffold activity|protein kinase A regulatory subunit binding,developmental coordination disorder|schizophrenia,ppi
12572,14999,2314,FLII,FLII; actin remodeling protein,75,actin binding,generalized anxiety disorder|anxiety disorder|constipation|enophthalmos|orbital disease|exophthalmos|clubfoot|esophagitis|peptic esophagitis|gastroesophageal reflux disease|intellectual disability|learning disability|myopia|obesity|speech disorder|stereotypic movement disorder|ophthalmoplegia|mechanical strabismus|hypertropia|craniosynostosis,ppi
12573,15000,2316,FLNA,filamin A,334,RNA binding|protein binding|potassium channel regulator activity|Rho GTPase binding|Ral GTPase binding|small GTPase binding|Fc-gamma receptor I complex binding|protein homodimerization activity|cadherin binding|Rac GTPase binding|actin filament binding,aortic valve insufficiency|ptosis|congenital ptosis|blood coagulation disease|isolated cleft palate|cleft palate|clubfoot|constipation|cryptorchidism|benign breast phyllodes tumor|breast malignant phyllodes tumor|sensorineural hearing loss|patent ductus arteriosus|epilepsy|enophthalmos|orbital disease|exophthalmos|esophagitis|peptic esophagitis|gastroesophageal reflux disease,ppi
12574,15001,2317,FLNB,filamin B,324,RNA binding|actin binding|cadherin binding,cleft lip|isolated cleft palate|cleft palate|clubfoot|recurrent corneal erosion|cryptorchidism|dental enamel hypoplasia|achondroplasia|Laron syndrome|enophthalmos|orbital disease|exophthalmos|placental insufficiency|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7,ppi
12575,15002,2318,FLNC,filamin C,271,,large intestine cancer|colorectal cancer|familial periodic paralysis|myopathy|polyneuropathy|peripheral nervous system disease|neuropathy|restrictive cardiomyopathy|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|myofibrillar myopathy 5|distal muscular dystrophy,ppi
12576,15003,10211,FLOT1,flotillin 1,108,protein heterodimerization activity,trypanosomiasis|Q fever|typhus,ppi
12577,15004,2319,FLOT2,flotillin 2,78,protein heterodimerization activity,,ppi
12578,15005,9472,AKAP6,A-kinase anchoring protein 6,18,adenylate cyclase binding|protein-containing complex scaffold activity|protein kinase A regulatory subunit binding|protein membrane anchor|protein kinase A binding|ion channel binding,,ppi
12579,15006,23769,FLRT1,fibronectin leucine rich transmembrane protein 1,16,protein binding; bridging,,ppi
12580,15007,23768,FLRT2,fibronectin leucine rich transmembrane protein 2,1,protein binding; bridging,,ppi
12581,15008,23767,FLRT3,fibronectin leucine rich transmembrane protein 3,4,protein binding; bridging|protein homodimerization activity,cryptorchidism|hypertrophy of breast|infant gynecomastia|gynecomastia|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|eunuchism|hypogonadism,ppi
12582,15009,2321,FLT1,fms related tyrosine kinase 1,46,transmembrane receptor protein tyrosine kinase activity|vascular endothelial growth factor-activated receptor activity|VEGF-A-activated receptor activity|VEGF-B-activated receptor activity|placental growth factor-activated receptor activity|transmembrane signaling receptor activity|protein tyrosine kinase activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|angiosarcoma|liver cirrhosis|melanoma|skin melanoma|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|pre-eclampsia|skin benign neoplasm|skin cancer|kidney failure|uremia|breast cancer,ppi
12583,15012,2322,FLT3,fms related tyrosine kinase 3,21,transmembrane receptor protein tyrosine kinase activity|cytokine receptor activity|vascular endothelial growth factor-activated receptor activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|protein homodimerization activity|protein self-association|protein tyrosine kinase activity|transmembrane signaling receptor activity,acute lymphocytic leukemia|acute leukemia|B- and T-cell mixed leukemia|acute myeloid leukemia|acute promyelocytic leukemia,ppi
12584,15013,2323,FLT3LG,fms related tyrosine kinase 3 ligand,3,Ras guanyl-nucleotide exchange factor activity|signaling receptor binding|1-phosphatidylinositol-3-kinase activity|receptor tyrosine kinase binding,,ppi
12585,15014,2324,FLT4,fms related tyrosine kinase 4,31,transmembrane receptor protein tyrosine kinase activity|vascular endothelial growth factor-activated receptor activity|VEGF-C-activated receptor activity|protein homodimerization activity|protein tyrosine kinase activity|transmembrane signaling receptor activity,glomus tumor|hemangioma|lymphangioma|chorioangioma|intramuscular hemangioma|histiocytoid hemangioma|cavernous hemangioma|elephantiasis|lymphedema|nail disease|polycystic ovary syndrome|capillary hemangioma|angioma serpiginosum|keratosis follicularis|pseudoxanthoma elasticum|mongolian spot|hereditary lymphedema,ppi
12586,15015,342184,FMN1,formin 1,7,,,ppi
12587,15016,2326,FMO1,flavin containing monooxygenase 1,1,monooxygenase activity|N;N-dimethylaniline monooxygenase activity,amyotrophic lateral sclerosis type 1,ppi
12588,15017,9465,AKAP7,A-kinase anchoring protein 7,18,protein kinase A binding|protein kinase A regulatory subunit binding,substance abuse|substance-related disorder,ppi
12589,15018,2327,FMO2,flavin containing monooxygenase 2,1,monooxygenase activity|N;N-dimethylaniline monooxygenase activity,endometriosis of uterus|endometriosis,ppi
12590,15019,2328,FMO3,flavin containing monooxygenase 3,1,N;N-dimethylaniline monooxygenase activity|monooxygenase activity,anemia|macrocytic anemia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertension|essential hypertension|familial adenomatous polyposis|islet cell tumor,ppi
12591,15021,2330,FMO5,flavin containing monooxygenase 5,5,N;N-dimethylaniline monooxygenase activity|monooxygenase activity,,ppi
12592,15022,2331,FMOD,fibromodulin,7,extracellular matrix structural constituent conferring compression resistance,,ppi
12593,15023,2332,FMR1,fragile X mental retardation 1,58,G-quadruplex RNA binding|chromatin binding|RNA binding|mRNA binding|mRNA 3'-UTR binding|microtubule binding|poly(U) RNA binding|translation repressor activity|RNA strand annealing activity|poly(G) binding|methylated histone binding|siRNA binding|miRNA binding|RNA stem-loop binding|identical protein binding|protein homodimerization activity|protein heterodimerization activity|mRNA 5'-UTR binding|dynein complex binding|sequence-specific mRNA binding,tuberous sclerosis|Marfan syndrome|situs inversus|generalized anxiety disorder|anxiety disorder|autistic disorder|bipolar disorder|cryptorchidism|sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|enophthalmos|orbital disease|exophthalmos|epilepsy|placental insufficiency,ppi
12594,15024,2334,AFF2,AF4/FMR2 family member 2,5,G-quadruplex RNA binding|DNA-binding transcription factor activity|double-stranded DNA binding,fragile X syndrome|intellectual disability|learning disability|obsessive-compulsive disorder,ppi
12595,15025,2335,FN1,fibronectin 1,778,integrin binding|extracellular matrix structural constituent|collagen binding|heparin binding,aortic valve insufficiency|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|diabetic ketoacidosis|diabetes mellitus|glioblastoma multiforme|giant cell glioblastoma|focal segmental glomerulosclerosis|hypertension|essential hypertension|lipoid nephrosis,ppi
12596,15026,10270,AKAP8,A-kinase anchoring protein 8,70,RNA binding|histone deacetylase binding|protein kinase A regulatory subunit binding,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
12597,15027,2339,FNTA,farnesyltransferase; CAAX box; alpha,33,protein farnesyltransferase activity|protein geranylgeranyltransferase activity|microtubule binding|alpha-tubulin binding|CAAX-protein geranylgeranyltransferase activity,,ppi
12598,15028,2342,FNTB,farnesyltransferase; CAAX box; beta,54,protein farnesyltransferase activity|zinc ion binding,,ppi
12599,15029,2346,FOLH1,folate hydrolase 1,4,metallocarboxypeptidase activity|peptidase activity|dipeptidase activity|Ac-Asp-Glu binding|tetrahydrofolyl-poly(glutamate) polymer binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|prostate cancer|prostate carcinoma|schizophrenia,ppi
12600,15030,10142,AKAP9,A-kinase anchoring protein 9,84,Ras guanyl-nucleotide exchange factor activity|signaling receptor binding|potassium channel regulator activity|protein-containing complex scaffold activity|protein kinase A regulatory subunit binding,long QT syndrome|long QT syndrome 1|seborrheic keratosis|skin disease|actinic keratosis|long QT syndrome 11,ppi
12601,15031,2348,FOLR1,folate receptor 1,8,folic acid binding|signaling receptor activity|methotrexate binding|folic acid receptor activity,tuberous sclerosis|Marfan syndrome|situs inversus|alcohol dependence|alcohol abuse|colon cancer|colonic benign neoplasm|epilepsy|congenital heart disease|intellectual disability|learning disability|movement disease|lingual-facial-buccal dyskinesia|osteosarcoma|bone osteosarcoma|visual epilepsy|neurodegenerative disease|ovarian cancer,ppi
12602,15032,2350,FOLR2,folate receptor beta,1,folic acid binding|methotrexate binding|folic acid receptor activity|signaling receptor activity,,ppi
12603,15033,552889,ATXN7L3B,ataxin 7 like 3B,5,protein binding,,ppi
12604,15034,2352,FOLR3,folate receptor 3,1,signaling receptor activity,,ppi
12605,15035,2353,FOS,Fos proto-oncogene; AP-1 transcription factor subunit,216,RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|obsolete transcriptional activator activity; RNA polymerase II transcription factor binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding|protein heterodimerization activity|RNA polymerase II proximal promoter sequence-specific DNA binding,acanthosis nigricans|hyperpituitarism|acromegaly|anxiety disorder|phobic disorder|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetic ketoacidosis|diabetes mellitus|lipoatrophic diabetes|lipodystrophy|endometriosis of uterus|endometriosis,ppi
12606,15036,2354,FOSB,FosB proto-oncogene; AP-1 transcription factor subunit,10,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription factor binding|RNA polymerase II proximal promoter sequence-specific DNA binding,epilepsy|intermittent explosive disorder|impulse control disorder|kleptomania|liver cancer|movement disease|lingual-facial-buccal dyskinesia|cocaine abuse|cocaine dependence|mood disorder,ppi
12607,15037,2355,FOSL2,FOS like 2; AP-1 transcription factor subunit,64,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding,glioblastoma multiforme|giant cell glioblastoma,ppi
12608,15038,27023,FOXB1,forkhead box B1,132,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
12609,15040,10327,AKR1A1,aldo-keto reductase family 1 member A1,28,aldo-keto reductase (NADP) activity|electron transfer activity|L-glucuronate reductase activity|oxidoreductase activity|alcohol dehydrogenase (NADP+) activity|alditol:NADP+ 1-oxidoreductase activity,alcohol dependence|alcohol abuse|schizophrenia|perinatal necrotizing enterocolitis,ppi
12610,15041,2296,FOXC1,forkhead box C1,54,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator binding|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|DNA binding; bending|sequence-specific DNA binding|transcription regulatory region DNA binding|promoter-specific chromatin binding,aniridia|Dandy-Walker syndrome|sensorineural hearing loss|patent ductus arteriosus|enophthalmos|orbital disease|exophthalmos|glaucoma|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|tooth agenesis,ppi
12611,15042,2303,FOXC2,forkhead box C2,37,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|chromatin DNA binding|sequence-specific DNA binding|transcription regulatory region DNA binding|promoter-specific chromatin binding,sick sinus syndrome|ptosis|congenital ptosis|conjunctivitis|corneal ulcer|patent ductus arteriosus|ectropion|ventricular septal defect|elephantiasis|lymphedema|tetralogy of Fallot|varicose veins|asthenopia|cataract|osteogenesis imperfecta|Ehlers-Danlos syndrome|recurrent corneal erosion|yellow nail syndrome|keratosis follicularis|pseudoxanthoma elasticum,ppi
12612,15043,2297,FOXD1,forkhead box D1,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|DNA binding; bending|sequence-specific DNA binding,,ppi
12613,15044,2306,FOXD2,forkhead box D2,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
12614,15045,27022,FOXD3,forkhead box D3,19,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
12615,15047,2298,FOXD4,forkhead box D4,40,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding; bending|sequence-specific DNA binding,,ppi
12616,15048,2304,FOXE1,forkhead box E1,77,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,choanal atresia|isolated cleft palate|cleft palate|congenital hypothyroidism|myxedema|hypothyroidism|nodular goiter|head and neck cancer|polyhydramnios|intellectual disability|learning disability|follicular thyroid carcinoma|papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma|Bamforth-Lazarus syndrome,ppi
12617,15050,2294,FOXF1,forkhead box F1,17,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|sequence-specific DNA binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding,patent ductus arteriosus|polyhydramnios|hydronephrosis|hypertension|essential hypertension|primary pulmonary hypertension|pulmonary hypertension|urticaria pigmentosa|mastocytosis|Meckel's diverticulum|persistent fetal circulation syndrome|pulmonary valve insufficiency|annular pancreas|hypoplastic left heart syndrome|obstructive lung disease,ppi
12618,15051,231,AKR1B1,aldo-keto reductase family 1 member B,53,alditol:NADP+ 1-oxidoreductase activity|electron transfer activity|glyceraldehyde oxidoreductase activity|alcohol dehydrogenase (NADP+) activity|oxidoreductase activity,endometrial cancer|endometrial carcinoma|endometriosis of uterus|endometriosis|adult respiratory distress syndrome|newborn respiratory distress syndrome|cataract,ppi
12619,15052,2295,FOXF2,forkhead box F2,16,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|sequence-specific DNA binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding,,ppi
12620,15053,2290,FOXG1,forkhead box G1,85,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,agnosia|blepharophimosis|bruxism|syndromic X-linked intellectual disability type 10|choreatic disease|clubfoot|constipation|sensorineural hearing loss|dystonia|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|intellectual disability|learning disability|microcephaly|movement disease|lingual-facial-buccal dyskinesia|central nervous system disease|nervous system disease,ppi
12621,15054,8928,FOXH1,forkhead box H1,46,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|enhancer binding|sequence-specific DNA binding|transcription regulatory region DNA binding|co-SMAD binding|R-SMAD binding|DNA binding,tetralogy of Fallot|holoprosencephaly,ppi
12622,15055,2299,FOXI1,forkhead box I1,12,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding; bending|sequence-specific DNA binding|transcription regulatory region DNA binding,goiter|nontoxic goiter|thyroid gland disease|sensorineural hearing loss|congenital hypothyroidism|myxedema|hypothyroidism|intellectual disability|learning disability|Pendred Syndrome|dyshormonogenic goiter|thyroid cancer|thyroid adenoma|thyroid carcinoma|autosomal recessive nonsyndromic deafness 4|enlarged vestibular aqueduct,ppi
12623,15056,2302,FOXJ1,forkhead box J1,23,transcription regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,vasomotor rhinitis|allergic rhinitis,ppi
12624,15057,2300,FOXL1,forkhead box L1,126,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|DNA binding; bending|sequence-specific DNA binding,,ppi
12625,15058,2305,FOXM1,forkhead box M1,80,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific,lung cancer|non-small cell lung carcinoma|IgA glomerulonephritis|leukemia|lung benign neoplasm|breast cancer|liver cancer|hepatocellular carcinoma,ppi
12626,15059,2308,FOXO1,forkhead box O1,70,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|beta-catenin binding|sequence-specific DNA binding|protein phosphatase 2A binding|DNA-binding transcription factor activity|transcription factor binding,corneal disease|keratoconus|acute myeloid leukemia|alveolar rhabdomyosarcoma,ppi
12627,15060,57016,AKR1B10,aldo-keto reductase family 1 member B10,15,retinal dehydrogenase activity|aldo-keto reductase (NADP) activity|geranylgeranyl reductase activity|indanol dehydrogenase activity|alcohol dehydrogenase (NADP+) activity|alditol:NADP+ 1-oxidoreductase activity|oxidoreductase activity,large intestine cancer|colorectal cancer|contact dermatitis|occupational dermatitis|endometrial cancer|endometrial carcinoma|melanoma|skin melanoma|liver cancer|hepatocellular carcinoma,ppi
12628,15061,2309,FOXO3,forkhead box O3,72,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|chromatin DNA binding|mitochondrial sequence-specific DNA-binding transcription factor activity|sequence-specific DNA binding|transcription factor binding,bipolar disorder|lung cancer|non-small cell lung carcinoma|salivary gland adenoid cystic carcinoma|chronic obstructive pulmonary disease|obesity|lung adenocarcinoma,ppi
12629,15062,27086,FOXP1,forkhead box P1,43,DNA-binding transcription factor activity; RNA polymerase II-specific|protein self-association|androgen receptor binding,anemia|macrocytic anemia|constipation|intellectual disability|learning disability|pancreatic cancer|stereotypic movement disorder|vitiligo|lymphosarcoma|B-cell lymphoma|Barrett's esophagus|esophagus adenocarcinoma|autistic disorder|gastric lymphoma,ppi
12630,15063,2356,FPGS,folylpolyglutamate synthase,8,tetrahydrofolylpolyglutamate synthase activity|dihydrofolate synthase activity,rheumatoid arthritis|large intestine cancer|colorectal cancer|Langerhans-cell histiocytosis|lymphosarcoma|lymphoma|reticulosarcoma|non-Hodgkin lymphoma|B-cell lymphoma|acute lymphocytic leukemia,ppi
12631,15064,8790,FPGT,fucose-1-phosphate guanylyltransferase,1,catalytic activity|fucose-1-phosphate guanylyltransferase activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
12632,15065,2357,FPR1,formyl peptide receptor 1,7,N-formyl peptide receptor activity|G-protein coupled receptor activity,,ppi
12633,15066,2358,FPR2,formyl peptide receptor 2,72,G-protein coupled receptor activity|cargo receptor activity|N-formyl peptide receptor activity,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease,ppi
12634,15068,1645,AKR1C1,aldo-keto reductase family 1 member C1,8,alditol:NADP+ 1-oxidoreductase activity|aldo-keto reductase (NADP) activity|oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor|phenanthrene 9;10-monooxygenase activity|carboxylic acid binding|bile acid binding|androsterone dehydrogenase (B-specific) activity|ketosteroid monooxygenase activity|trans-1;2-dihydrobenzene-1;2-diol dehydrogenase activity|oxidoreductase activity|steroid dehydrogenase activity|alcohol dehydrogenase (NADP+) activity,lung cancer|non-small cell lung carcinoma|endometrial cancer|endometrial carcinoma|endometriosis of uterus|endometriosis|arthropathy|arthritis|polycystic ovary syndrome|sex differentiation disease|hermaphroditism|pseudohermaphroditism,ppi
12635,15069,100423062,IGLL5,immunoglobulin lambda like polypeptide 5,22,immunoglobulin receptor binding|antigen binding,,ppi
12636,15070,1646,AKR1C2,aldo-keto reductase family 1 member C2,13,alditol:NADP+ 1-oxidoreductase activity|oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor|phenanthrene 9;10-monooxygenase activity|carboxylic acid binding|bile acid binding|ketosteroid monooxygenase activity|trans-1;2-dihydrobenzene-1;2-diol dehydrogenase activity|oxidoreductase activity|steroid dehydrogenase activity|alcohol dehydrogenase (NADP+) activity,cryptorchidism|contact dermatitis|occupational dermatitis|endometriosis of uterus|endometriosis|arthropathy|arthritis|polycystic ovary syndrome|sex differentiation disease|hermaphroditism|pseudohermaphroditism|46 XY gonadal dysgenesis|liver cancer|hepatocellular carcinoma,ppi
12637,15071,8644,AKR1C3,aldo-keto reductase family 1 member C3,11,retinal dehydrogenase activity|alditol:NADP+ 1-oxidoreductase activity|aldo-keto reductase (NADP) activity|retinol dehydrogenase activity|oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor|phenanthrene 9;10-monooxygenase activity|dihydrotestosterone 17-beta-dehydrogenase activity|prostaglandin H2 endoperoxidase reductase activity|prostaglandin D2 11-ketoreductase activity|geranylgeranyl reductase activity|ketoreductase activity|15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity|androsterone dehydrogenase activity|ketosteroid monooxygenase activity|delta4-3-oxosteroid 5beta-reductase activity|NADP-retinol dehydrogenase activity|alcohol dehydrogenase (NADP+) activity|steroid dehydrogenase activity|oxidoreductase activity,alcohol dependence|alcohol abuse|bipolar disorder|endometrial cancer|endometrial carcinoma|endometriosis of uterus|endometriosis|obesity|polycystic ovary syndrome|prostate cancer|prostate carcinoma|sex differentiation disease|hermaphroditism|pseudohermaphroditism|stomach cancer,ppi
12638,15078,388559,ZNF888,zinc finger protein 888,2,,,ppi
12639,15079,1109,AKR1C4,aldo-keto reductase family 1 member C4,4,retinal dehydrogenase activity|aldo-keto reductase (NADP) activity|electron transfer activity|bile acid transmembrane transporter activity|oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor|androsterone dehydrogenase activity|oxidoreductase activity|alcohol dehydrogenase (NADP+) activity|steroid dehydrogenase activity|alditol:NADP+ 1-oxidoreductase activity|ketosteroid monooxygenase activity,alcohol dependence|alcohol abuse|bipolar disorder|paranoid schizophrenia|delusional disorder|46 XY gonadal dysgenesis,ppi
12640,15080,100507290,ZNF865,zinc finger protein 865,13,,,ppi
12641,15085,6718,AKR1D1,aldo-keto reductase family 1 member D1,8,aldo-keto reductase (NADP) activity|steroid binding|alditol:NADP+ 1-oxidoreductase activity|ketosteroid monooxygenase activity|steroid dehydrogenase activity|alcohol dehydrogenase (NADP+) activity|oxidoreductase activity,obstructive jaundice|biliary tract disease|blood coagulation disease|intrahepatic cholestasis|iron metabolism disease|hemochromatosis|Wilson disease|liver cirrhosis|steatorrhea|liver disease|congenital bile acid synthesis defect,ppi
12642,15087,8574,AKR7A2,aldo-keto reductase family 7 member A2,29,alditol:NADP+ 1-oxidoreductase activity|aldo-keto reductase (NADP) activity|electron transfer activity|phenanthrene-9;10-epoxide hydrolase activity,,ppi
12643,15088,10350,ABCA9,ATP binding cassette subfamily A member 9,2,ATPase activity; coupled to transmembrane movement of substances,large intestine cancer|colorectal cancer,ppi
12644,15089,22977,AKR7A3,aldo-keto reductase family 7 member A3,9,aldo-keto reductase (NADP) activity|electron transfer activity,,ppi
12645,15091,207,AKT1,AKT serine/threonine kinase 1,365,protein kinase activity|protein serine/threonine kinase activity|protein serine/threonine/tyrosine kinase activity|ATP binding|phosphatidylinositol-3;4;5-trisphosphate binding|kinase activity|enzyme binding|nitric-oxide synthase regulator activity|protein homodimerization activity|phosphatidylinositol-3;4-bisphosphate binding,angioid streaks|arteriovenous malformation|bipolar disorder|ptosis|congenital ptosis|breast cancer|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|heart disease|cardiovascular system disease|cerebellar disease|large intestine cancer|colorectal cancer,ppi
12646,15093,208,AKT2,AKT serine/threonine kinase 2,115,protein serine/threonine kinase activity|ATP binding,acanthosis nigricans|bipolar disorder|diabetes mellitus|type 2 diabetes mellitus|epilepsy|hypertrophy of breast|infant gynecomastia|gynecomastia|lipoatrophic diabetes|lipodystrophy|polycystic ovary syndrome|visual epilepsy|familial partial lipodystrophy|breast cancer|fatty liver disease|nasopharynx carcinoma,ppi
12647,15094,10000,AKT3,AKT serine/threonine kinase 3,41,protein kinase activity|protein serine/threonine kinase activity|ATP binding,epilepsy|ventricular septal defect|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|intellectual disability|learning disability|mitral valve insufficiency|mitral valve prolapse|visual epilepsy,ppi
12648,15095,2475,MTOR,mechanistic target of rapamycin,160,RNA polymerase III type 1 promoter DNA binding|RNA polymerase III type 2 promoter DNA binding|RNA polymerase III type 3 promoter DNA binding|TFIIIC-class transcription factor complex binding|protein kinase activity|protein serine/threonine kinase activity|kinase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|cervical cancer|hypertension|essential hypertension|malignant mesothelioma|benign mesothelioma|schizophrenia|neurotic disorder|endogenous depression,ppi
12649,15097,646960,PRSS56,protease; serine 56,1,serine-type endopeptidase activity,angle-closure glaucoma|primary angle-closure glaucoma|chronic closed-angle glaucoma|microphthalmia|myopia|isolated microphthalmia 6,ppi
12650,15098,10023,FRAT1,FRAT1; WNT signaling pathway regulator,19,,,ppi
12651,15099,210,ALAD,aminolevulinate dehydratase,23,catalytic activity|porphobilinogen synthase activity|zinc ion binding,hemolytic anemia|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|constipation|hematopoietic system disease|hypertension|essential hypertension|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|liver cirrhosis|gallbladder disease|liver disease,ppi
12652,15100,2395,FXN,frataxin,8,ferroxidase activity|ferrous iron binding|ferric iron binding|iron chaperone activity|2 iron; 2 sulfur cluster binding,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|diabetic ketoacidosis|diabetes mellitus|Friedreich ataxia|congestive heart failure|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|sensory peripheral neuropathy,ppi
12653,15101,23413,NCS1,neuronal calcium sensor 1,31,voltage-gated calcium channel activity|calcium ion binding,bipolar disorder|schizophrenia|cocaine abuse|cocaine dependence|morphine dependence,ppi
12654,15102,2483,FRG1,FSHD region gene 1,13,RNA binding|actin filament binding,epilepsy|sensorineural hearing loss|intellectual disability|learning disability|visual epilepsy|retinal detachment|retinal telangiectasia|ophthalmoplegia|chronic progressive external ophthalmoplegia|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H,ppi
12655,15103,2444,FRK,fyn related Src family tyrosine kinase,14,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|signaling receptor binding,glucose intolerance|prediabetes syndrome,ppi
12656,15104,2487,FRZB,frizzled-related protein,7,Wnt-protein binding|Wnt-activated receptor activity,arthropathy|arthritis|osteoarthritis,ppi
12657,15105,211,ALAS1,5'-aminolevulinate synthase 1,57,5-aminolevulinate synthase activity,porphyria,ppi
12658,15106,25794,FSCN2,fascin actin-bundling protein 2; retinal,3,actin binding|actin filament binding,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
12659,15108,29999,FSCN3,fascin actin-bundling protein 3,3,actin filament binding,,ppi
12660,15109,2488,FSHB,follicle stimulating hormone beta subunit,3,follicle-stimulating hormone activity|hormone activity,alcohol dependence|alcohol abuse|amenorrhea|azoospermia|hypogonadism|infertility|male infertility|Sertoli cell-only syndrome|oligospermia|lateral medullary syndrome|premature menopause|androgen insensitivity syndrome|eunuchism|atrophy of testis|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome,ppi
12661,15110,2491,CENPI,centromere protein I,16,,,ppi
12662,15111,2492,FSHR,follicle stimulating hormone receptor,36,follicle-stimulating hormone receptor activity|G-protein coupled peptide receptor activity,gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|hypertrichosis|premature menopause|androgen insensitivity syndrome|osteoporosis|polycystic ovary syndrome|kidney disease|ovarian hyperstimulation syndrome|capillary leak syndrome|46 XX gonadal dysgenesis|hermaphroditism,ppi
12663,15112,212,ALAS2,5'-aminolevulinate synthase 2,4,5-aminolevulinate synthase activity|glycine binding|coenzyme binding,anemia|macrocytic anemia|sideroblastic anemia|X-linked sideroblastic anemia|photosensitivity disease|photosensitive epilepsy|erythropoietic protoporphyria,ppi
12664,15113,10468,FST,follistatin,16,,liver cancer|polycystic ovary syndrome|stomach cancer|hepatitis|breast cancer|hepatocellular carcinoma,ppi
12665,15114,11167,FSTL1,follistatin like 1,39,,aortic valve insufficiency|schizophrenia,ppi
12666,15115,10272,FSTL3,follistatin like 3,6,,,ppi
12667,15116,10841,FTCD,formimidoyltransferase cyclodeaminase,4,microtubule binding|formimidoyltransferase activity|formimidoyltetrahydrofolate cyclodeaminase activity,megaloblastic anemia|Burkitt lymphoma|intellectual disability|learning disability,ppi
12668,15118,2495,FTH1,ferritin heavy chain 1,104,iron ion binding|ferric iron binding|ferrous iron binding|identical protein binding|ferroxidase activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|contact dermatitis|occupational dermatitis|malignant glioma|gliosarcoma|mixed glioma|malignant mesothelioma|benign mesothelioma|neurodegenerative disease,ppi
12669,15119,10840,ALDH1L1,aldehyde dehydrogenase 1 family member L1,4,catalytic activity|aldehyde dehydrogenase (NAD) activity,obesity,ppi
12670,15121,213,ALB,albumin,215,DNA binding|fatty acid binding|copper ion binding|drug binding|toxic substance binding|antioxidant activity|pyridoxal phosphate binding|oxygen binding,hereditary angioedema|angioedema|anuria|azoospermia|brain disease|heart disease|cardiovascular system disease|brain ischemia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetic angiopathy|echinococcosis|epilepsy|nephritis|glomerulonephritis|kidney disease,ppi
12671,15123,2512,FTL,ferritin light chain,53,iron ion binding|ferric iron binding|ferroxidase activity|identical protein binding|ferrous iron binding,focal hand dystonia|blepharospasm|cerebellar disease|syndromic X-linked intellectual disability type 10|choreatic disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|iron metabolism disease|hemochromatosis|Wilson disease|dystonia|spastic diplegia|spastic monoplegia|spastic quadriplegia|cerebral palsy|mutism,ppi
12672,15124,5243,ABCB1,ATP binding cassette subfamily B member 1,20,transporter activity|xenobiotic transmembrane transporting ATPase activity|ATPase activity; coupled to transmembrane movement of substances|phosphatidylcholine-translocating ATPase activity|phosphatidylethanolamine-translocating ATPase activity|ceramide-translocating ATPase activity,rheumatoid arthritis|disease of mental health|bipolar disorder|lung cancer|non-small cell lung carcinoma|large intestine cancer|colorectal cancer|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|esophageal cancer|congenital heart disease|multiple system atrophy|kidney cancer|cannabis dependence|cannabis abuse,ppi
12673,15125,214,ALCAM,activated leukocyte cell adhesion molecule,12,signaling receptor binding,,ppi
12674,15127,100506144,TMEM35B,transmembrane protein 35B,3,,,ppi
12675,15134,643008,SMIM5,small integral membrane protein 5,1,,,ppi
12676,15135,342346,C16orf96,chromosome 16 open reading frame 96,2,,,ppi
12677,15139,644041,C18orf63,chromosome 18 open reading frame 63,1,,,ppi
12678,15142,8880,FUBP1,far upstream element binding protein 1,103,single-stranded DNA binding|DNA-binding transcription factor activity|RNA binding,,ppi
12679,15146,100288797,TMEM239,transmembrane protein 239,11,,,ppi
12680,15151,8939,FUBP3,far upstream element binding protein 3,67,RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA binding,,ppi
12681,15152,345643,MCIDAS,multiciliate differentiation and DNA synthesis associated cell cycle protein,2,,,ppi
12682,15154,2517,FUCA1,fucosidase; alpha-L- 1; tissue,13,alpha-L-fucosidase activity,angiokeratoma|hypohidrosis|anhidrosis|pseudosarcomatous fibromatosis|recurrent corneal erosion|sensorineural hearing loss|epilepsy|aspartylglucosaminuria|fucosidosis|enterocele|congenital hypothyroidism|myxedema|hypothyroidism|intellectual disability|learning disability|polyneuropathy|peripheral nervous system disease|neuropathy|visual epilepsy|syndromic X-linked intellectual disability 94,ppi
12683,15155,2519,FUCA2,fucosidase; alpha-L- 2; plasma,13,alpha-L-fucosidase activity,,ppi
12684,15156,2521,FUS,FUS RNA binding protein,366,transcription coactivator activity|RNA binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|myxoid liposarcoma|muscular atrophy|neurodegenerative disease|amyotrophic lateral sclerosis type 6|essential tremor,ppi
12685,15157,2523,FUT1,fucosyltransferase 1 (H blood group),17,galactoside 2-alpha-L-fucosyltransferase activity|fucosyltransferase activity,,ppi
12686,15158,2524,FUT2,fucosyltransferase 2,1,galactoside 2-alpha-L-fucosyltransferase activity|fucosyltransferase activity,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease,ppi
12687,15159,2525,FUT3,fucosyltransferase 3 (Lewis blood group),15,fucosyltransferase activity|3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity|alpha-(1->3)-fucosyltransferase activity,,ppi
12688,15160,2526,FUT4,fucosyltransferase 4,5,fucosyltransferase activity|alpha-(1->3)-fucosyltransferase activity,,ppi
12689,15163,2529,FUT7,fucosyltransferase 7,1,fucosyltransferase activity|alpha-(1->3)-fucosyltransferase activity,polycystic ovary syndrome,ppi
12690,15164,2530,FUT8,fucosyltransferase 8,28,glycoprotein 6-alpha-L-fucosyltransferase activity|alpha-(1->6)-fucosyltransferase activity,schizophrenia,ppi
12691,15165,216,ALDH1A1,aldehyde dehydrogenase 1 family member A1,7,retinal dehydrogenase activity|aldehyde dehydrogenase (NAD) activity|GTPase activator activity|androgen binding|NAD binding|benzaldehyde dehydrogenase (NAD+) activity,alcohol dependence|alcohol abuse|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|Creutzfeldt-Jakob disease|schizophrenia|secondary Parkinson disease,ppi
12692,15166,10690,FUT9,fucosyltransferase 9,8,fucosyltransferase activity|alpha-(1->3)-fucosyltransferase activity,,ppi
12693,15167,2531,KDSR,3-ketodihydrosphingosine reductase,19,3-dehydrosphinganine reductase activity,,ppi
12694,15168,26515,TIMM10B,translocase of inner mitochondrial membrane 10B,9,,,ppi
12695,15169,8087,FXR1,FMR1 autosomal homolog 1,73,RNA binding|RNA strand annealing activity|protein homodimerization activity|protein heterodimerization activity|mRNA binding|mRNA 3'-UTR binding|translation regulator activity,,ppi
12696,15170,9513,FXR2,FMR1 autosomal homolog 2,136,RNA binding|protein homodimerization activity|protein heterodimerization activity|mRNA binding|mRNA 3'-UTR binding|translation regulator activity,,ppi
12697,15171,5348,FXYD1,FXYD domain containing ion transport regulator 1,17,chloride channel activity|sodium channel regulator activity|ion channel binding,schizophrenia,ppi
12698,15172,486,FXYD2,FXYD domain containing ion transport regulator 2,1,transporter activity|sodium channel regulator activity,epilepsy|hypertension|essential hypertension|visual epilepsy|renal hypomagnesemia 3|renal hypomagnesemia 2,ppi
12699,15173,5349,FXYD3,FXYD domain containing ion transport regulator 3,7,chloride channel activity|sodium channel regulator activity,pancreatic cancer,ppi
12700,15176,224,ALDH3A2,aldehyde dehydrogenase 3 family member A2,73,aldehyde dehydrogenase (NAD) activity|long-chain-alcohol oxidase activity|long-chain-aldehyde dehydrogenase activity|medium-chain-aldehyde dehydrogenase activity|3-chloroallyl aldehyde dehydrogenase activity,dental enamel hypoplasia|epilepsy|ichthyosis|spastic diplegia|spastic monoplegia|spastic quadriplegia|cerebral palsy|retinitis pigmentosa 30|age related macular degeneration|macular degeneration|intellectual disability|learning disability|myopia|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|retinitis|retinal disease|visual epilepsy|congenital ichthyosiform erythroderma,ppi
12701,15177,53826,FXYD6,FXYD domain containing ion transport regulator 6,18,sodium channel regulator activity,acute myeloid leukemia|schizophrenia,ppi
12702,15178,53822,FXYD7,FXYD domain containing ion transport regulator 7,5,sodium channel regulator activity,,ppi
12703,15179,2532,ACKR1,atypical chemokine receptor 1 (Duffy blood group),8,transmembrane signaling receptor activity|signaling receptor activity|C-C chemokine binding,malaria,ppi
12704,15180,2533,FYB,FYN binding protein,33,signaling receptor binding,allergic contact dermatitis,ppi
12705,15181,2534,FYN,FYN proto-oncogene; Src family tyrosine kinase,378,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|type 5 metabotropic glutamate receptor binding|alpha-tubulin binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|tau protein binding|signaling receptor binding,alcohol dependence|alcohol abuse|bipolar disorder|adult T-cell leukemia|acute T cell leukemia|schizophrenia|stomach cancer,ppi
12706,15183,8321,FZD1,frizzled class receptor 1,13,Wnt-protein binding|Wnt-activated receptor activity,,ppi
12707,15184,11211,FZD10,frizzled class receptor 10,49,Wnt-activated receptor activity|Wnt-protein binding,,ppi
12708,15185,217,ALDH2,aldehyde dehydrogenase 2 family (mitochondrial),49,aldehyde dehydrogenase (NAD) activity|aldehyde dehydrogenase [NAD(P)+] activity|electron transfer activity|NAD binding,alcohol dependence|alcohol abuse|asthma|intrinsic asthma|allergic asthma|bipolar disorder|large intestine cancer|colorectal cancer|esophageal cancer|male infertility|contact dermatitis|occupational dermatitis|vascular disease|esophagus squamous cell carcinoma|Wernicke-Korsakoff syndrome|perinatal necrotizing enterocolitis,ppi
12709,15186,2535,FZD2,frizzled class receptor 2,22,Wnt-protein binding|Wnt-activated receptor activity,colon cancer|colonic benign neoplasm|cryptorchidism|omodysplasia,ppi
12710,15187,7976,FZD3,frizzled class receptor 3,10,Wnt-protein binding|Wnt-activated receptor activity,schizophreniform disorder|schizoaffective disorder|schizophrenia|mood disorder,ppi
12711,15188,8322,FZD4,frizzled class receptor 4,12,Wnt-protein binding|PDZ domain binding|signaling receptor activity|Wnt-activated receptor activity,bipolar disorder|isolated cleft palate|cleft palate|retinal detachment|retinitis|retinal disease|proliferative vitreoretinopathy|exudative vitreoretinopathy|retinopathy of prematurity|syndactyly|persistent hyperplastic primary vitreous|vitreous detachment,ppi
12712,15189,7855,FZD5,frizzled class receptor 5,18,amyloid-beta binding|Wnt-protein binding|Wnt-activated receptor activity,coloboma,ppi
12713,15190,8323,FZD6,frizzled class receptor 6,12,Wnt-protein binding|Wnt-activated receptor activity|amyloid-beta binding,nonsyndromic congenital nail disorder 10,ppi
12714,15191,8324,FZD7,frizzled class receptor 7,15,phosphatidylinositol-4;5-bisphosphate binding|Wnt-protein binding|Wnt-activated receptor activity,,ppi
12715,15192,8325,FZD8,frizzled class receptor 8,11,Wnt-activated receptor activity|Wnt-protein binding,,ppi
12716,15193,8326,FZD9,frizzled class receptor 9,6,Wnt-activated receptor activity|Wnt-protein binding,,ppi
12717,15194,218,ALDH3A1,aldehyde dehydrogenase 3 family member A1,19,aldehyde dehydrogenase (NAD) activity|aldehyde dehydrogenase [NAD(P)+] activity|alcohol dehydrogenase (NADP+) activity|benzaldehyde dehydrogenase (NAD+) activity|3-chloroallyl aldehyde dehydrogenase activity,schizophrenia,ppi
12718,15195,9636,ISG15,ISG15 ubiquitin-like modifier,199,,primary immunodeficiency disease|influenza,ppi
12719,15196,2537,IFI6,interferon alpha inducible protein 6,3,,influenza,ppi
12720,15197,2547,XRCC6,X-ray repair cross complementing 6,314,DNA binding|double-stranded DNA binding|RNA binding|transcription regulatory region DNA binding|5'-deoxyribose-5-phosphate lyase activity|double-stranded telomeric DNA binding|telomeric DNA binding,,ppi
12721,15198,2538,G6PC,glucose-6-phosphatase catalytic subunit,4,glucose-6-phosphatase activity|phosphate ion binding,lactic acidosis|gout|focal segmental glomerulosclerosis|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|familial hyperlipidemia|hypertension|essential hypertension|hypoglycemia|osteoporosis|acute pancreatitis|pancreatitis|proteinuria|xanthomatosis|liver disease|acute urate nephropathy|blood coagulation disease,ppi
12722,15199,2539,G6PD,glucose-6-phosphate dehydrogenase,70,glucose-6-phosphate dehydrogenase activity|glucose binding|NADP binding,hemolytic anemia|congenital nonspherocytic hemolytic anemia|bipolar disorder|contact dermatitis|occupational dermatitis|favism|hereditary elliptocytosis|congenital hemolytic anemia|chronic granulomatous disease|neonatal jaundice|phagocyte bactericidal dysfunction|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia,ppi
12723,15200,8659,ALDH4A1,aldehyde dehydrogenase 4 family member A1,24,1-pyrroline-5-carboxylate dehydrogenase activity|aldehyde dehydrogenase (NAD) activity|electron transfer activity|identical protein binding,epilepsy|intellectual disability|learning disability|visual epilepsy,ppi
12724,15201,2542,SLC37A4,solute carrier family 37 member 4,2,transporter activity|glucose-6-phosphate transmembrane transporter activity|glucose 6-phosphate:inorganic phosphate antiporter activity,lactic acidosis|gout|focal segmental glomerulosclerosis|familial hyperlipidemia|hypertension|essential hypertension|primary pulmonary hypertension|pulmonary hypertension|hypoglycemia|osteoporosis|acute pancreatitis|pancreatitis|proteinuria|kidney failure|uremia|xanthomatosis|liver disease|aphthous stomatitis|hepatocellular carcinoma|hepatoblastoma,ppi
12725,15202,2548,GAA,glucosidase alpha; acid,45,alpha-1;4-glucosidase activity|alpha-glucosidase activity,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|sensorineural hearing loss|membranous glomerulonephritis|glycogen storage disease II|diaphragm disease|Lown-Ganong-Levine syndrome|Wolff-Parkinson-White syndrome|intracranial aneurysm,ppi
12726,15203,2549,GAB1,GRB2 associated binding protein 1,91,SH3/SH2 adaptor activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,polycystic ovary syndrome,ppi
12727,15204,11337,GABARAP,GABA type A receptor-associated protein,496,beta-tubulin binding|GABA receptor binding,schizophrenia,ppi
12728,15205,23710,GABARAPL1,GABA type A receptor associated protein like 1,523,beta-tubulin binding|GABA receptor binding,,ppi
12729,15206,219,ALDH1B1,aldehyde dehydrogenase 1 family member B1,49,aldehyde dehydrogenase (NAD) activity|NAD binding,colon cancer|colonic benign neoplasm,ppi
12730,15207,2550,GABBR1,gamma-aminobutyric acid type B receptor subunit 1,20,G-protein coupled GABA receptor activity,alcohol dependence|alcohol abuse|autistic disorder|schizophrenia|cocaine abuse|cocaine dependence,ppi
12731,15208,2551,GABPA,GA binding protein transcription factor alpha subunit,29,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|transcription regulatory region DNA binding|protein heterodimerization activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
12732,15209,2553,GABPB1,GA binding protein transcription factor beta subunit 1,28,DNA-binding transcription factor activity|transcription regulatory region DNA binding|protein heterodimerization activity,,ppi
12733,15210,2554,GABRA1,gamma-aminobutyric acid type A receptor alpha1 subunit,11,drug binding|GABA-gated chloride ion channel activity|GABA receptor activity|benzodiazepine receptor activity|GABA-A receptor activity|transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential|extracellular ligand-gated ion channel activity|inhibitory extracellular ligand-gated ion channel activity|chloride channel activity,alcohol dependence|alcohol abuse|autistic disorder|bipolar disorder|cerebellar disease|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|childhood absence epilepsy|hepatic coma|hepatic encephalopathy|intellectual disability|learning disability|schizophrenia|status epilepticus|essential tremor|juvenile myoclonic epilepsy|photosensitivity disease|photosensitive epilepsy|mood disorder|infantile epileptic encephalopathy,ppi
12734,15211,2555,GABRA2,gamma-aminobutyric acid type A receptor alpha2 subunit,2,benzodiazepine receptor activity|GABA-gated chloride ion channel activity|inhibitory extracellular ligand-gated ion channel activity|transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential|chloride channel activity|extracellular ligand-gated ion channel activity|GABA-A receptor activity,alcohol dependence|alcohol abuse|anxiety disorder|phobic disorder|autistic disorder|cannabis dependence|cannabis abuse|opiate dependence|morphine dependence|heroin dependence|cocaine abuse|cocaine dependence,ppi
12735,15212,2556,GABRA3,gamma-aminobutyric acid type A receptor alpha3 subunit,22,benzodiazepine receptor activity|chloride channel activity|GABA-A receptor activity|inhibitory extracellular ligand-gated ion channel activity|transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential|GABA-gated chloride ion channel activity|extracellular ligand-gated ion channel activity,autistic disorder|bipolar disorder|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|Graves' disease|thyrotoxicosis|hyperthyroidism|obesity|locked-in syndrome|quadriplegia|pseudosarcomatous fibromatosis|Plummer's disease|hyperglycemia,ppi
12736,15213,2557,GABRA4,gamma-aminobutyric acid type A receptor alpha4 subunit,3,benzodiazepine receptor activity|extracellular ligand-gated ion channel activity|chloride channel activity|transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential|GABA-gated chloride ion channel activity|inhibitory extracellular ligand-gated ion channel activity|GABA-A receptor activity,autistic disorder|schizophrenia,ppi
12737,15214,2558,GABRA5,gamma-aminobutyric acid type A receptor alpha5 subunit,1,transporter activity|signaling receptor activity|inhibitory extracellular ligand-gated ion channel activity|extracellular ligand-gated ion channel activity|GABA-A receptor activity|benzodiazepine receptor activity|chloride channel activity|GABA-gated chloride ion channel activity|transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,alcohol dependence|alcohol abuse|autistic disorder|bipolar disorder|schizophrenia|epilepsy|visual epilepsy|mood disorder,ppi
12738,15215,7915,ALDH5A1,aldehyde dehydrogenase 5 family member A1,27,succinate-semialdehyde dehydrogenase (NAD+) activity|protein homodimerization activity|succinate-semialdehyde dehydrogenase [NAD(P)+] activity,generalized anxiety disorder|anxiety disorder|autistic disorder|cerebellar disease|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|childhood absence epilepsy|intellectual disability|learning disability|schizophreniform disorder|schizoaffective disorder|status epilepticus|focal hand dystonia|dystonia|generalized dystonia|visual epilepsy|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy,ppi
12739,15216,2559,GABRA6,gamma-aminobutyric acid type A receptor alpha6 subunit,11,benzodiazepine receptor activity|GABA-gated chloride ion channel activity|chloride channel activity|GABA-A receptor activity|extracellular ligand-gated ion channel activity|transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential|inhibitory extracellular ligand-gated ion channel activity,alcohol dependence|alcohol abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|mood disorder|middle cerebral artery infarction,ppi
12740,15217,2560,GABRB1,gamma-aminobutyric acid type A receptor beta1 subunit,10,GABA-A receptor activity|ligand-gated ion channel activity|GABA-gated chloride ion channel activity|extracellular ligand-gated ion channel activity,alcohol dependence|alcohol abuse|autistic disorder|bipolar disorder|hepatic coma|hepatic encephalopathy|adult respiratory distress syndrome|newborn respiratory distress syndrome|schizophrenia,ppi
12741,15218,2561,GABRB2,gamma-aminobutyric acid type A receptor beta2 subunit,7,GABA-A receptor activity|chloride channel activity|extracellular ligand-gated ion channel activity,alcohol dependence|alcohol abuse|bipolar disorder|schizophrenia|mood disorder,ppi
12742,15219,2562,GABRB3,gamma-aminobutyric acid type A receptor beta3 subunit,12,GABA-A receptor activity|GABA-gated chloride ion channel activity|extracellular ligand-gated ion channel activity,alcohol dependence|alcohol abuse|autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|childhood absence epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|antisocial personality disorder|avoidant personality disorder,ppi
12743,15220,2563,GABRD,gamma-aminobutyric acid type A receptor delta subunit,17,GABA-A receptor activity|extracellular ligand-gated ion channel activity,autistic disorder|constipation|enophthalmos|orbital disease|exophthalmos|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|intellectual disability|learning disability|schizophrenia|visual epilepsy|stereotypic movement disorder|ophthalmoplegia|mechanical strabismus|hypertropia|craniosynostosis|cerebral degeneration|idiopathic generalized epilepsy,ppi
12744,15221,2564,GABRE,gamma-aminobutyric acid type A receptor epsilon subunit,42,GABA-gated chloride ion channel activity|transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential|inhibitory extracellular ligand-gated ion channel activity|extracellular ligand-gated ion channel activity|chloride channel activity|GABA-A receptor activity|benzodiazepine receptor activity,,ppi
12745,15222,2565,GABRG1,gamma-aminobutyric acid type A receptor gamma1 subunit,2,inhibitory extracellular ligand-gated ion channel activity|benzodiazepine receptor activity|GABA-gated chloride ion channel activity|chloride channel activity|extracellular ligand-gated ion channel activity|transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential|GABA-A receptor activity,alcohol dependence|alcohol abuse|bipolar disorder,ppi
12746,15223,2566,GABRG2,gamma-aminobutyric acid type A receptor gamma2 subunit,16,GABA-A receptor activity|chloride channel activity|benzodiazepine receptor activity|extracellular ligand-gated ion channel activity|GABA-gated chloride ion channel activity|inhibitory extracellular ligand-gated ion channel activity|transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,alcohol dependence|alcohol abuse|cerebellar disease|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|childhood absence epilepsy|hepatic coma|hepatic encephalopathy|schizophrenia|cocaine abuse|cocaine dependence|photosensitivity disease|photosensitive epilepsy|visual epilepsy|infantile epileptic encephalopathy|Dravet syndrome|focal epilepsy|partial motor epilepsy|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy,ppi
12747,15224,2567,GABRG3,gamma-aminobutyric acid type A receptor gamma3 subunit,1,GABA-gated chloride ion channel activity|GABA-A receptor activity|chloride channel activity|benzodiazepine receptor activity|extracellular ligand-gated ion channel activity|transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential|inhibitory extracellular ligand-gated ion channel activity,alcohol dependence|alcohol abuse,ppi
12748,15226,220,ALDH1A3,aldehyde dehydrogenase 1 family member A3,9,retinal dehydrogenase activity|aldehyde dehydrogenase [NAD(P)+] activity|protein homodimerization activity|aldehyde dehydrogenase (NAD) activity,microphthalmia|stomach cancer|isolated microphthalmia 1|isolated microphthalmia 8,ppi
12749,15227,2569,GABRR1,gamma-aminobutyric acid type A receptor rho1 subunit,15,GABA-A receptor activity|extracellular ligand-gated ion channel activity,alcohol dependence|alcohol abuse|bipolar disorder|schizophrenia,ppi
12750,15228,2570,GABRR2,gamma-aminobutyric acid type A receptor rho2 subunit,5,GABA-A receptor activity|extracellular ligand-gated ion channel activity,alcohol dependence|alcohol abuse|bipolar disorder|gallbladder disease|liver disease|toxic encephalopathy,ppi
12751,15230,647286,RD3L,retinal degeneration 3-like,1,,,ppi
12752,15231,2571,GAD1,glutamate decarboxylase 1,16,glutamate decarboxylase activity,alcohol dependence|alcohol abuse|autistic disorder|bipolar disorder|spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|pseudosarcomatous fibromatosis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|hyperprolactinemia|intellectual disability|learning disability,ppi
12753,15232,2572,GAD2,glutamate decarboxylase 2,9,glutamate decarboxylase activity,alcohol dependence|alcohol abuse|bipolar disorder|diabetic cataract|diabetic retinopathy|schizophrenia|epilepsy|visual epilepsy|Wernicke-Korsakoff syndrome|cocaine abuse|cocaine dependence|mood disorder|major depressive disorder|mental depression|endogenous depression|melancholia,ppi
12754,15233,1647,GADD45A,growth arrest and DNA damage inducible alpha,85,protein homodimerization activity|protein N-terminus binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|pancreatic cancer|prostate cancer|prostate carcinoma|stomach cancer|ovarian cancer,ppi
12755,15234,4616,GADD45B,growth arrest and DNA damage inducible beta,31,,schizophreniform disorder|schizoaffective disorder|seborrheic keratosis|skin disease|actinic keratosis,ppi
12756,15235,10912,GADD45G,growth arrest and DNA damage inducible gamma,59,,,ppi
12757,15236,2543,GAGE1,G antigen 1,3,,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|pancreatic cancer,ppi
12758,15238,23456,ABCB10,ATP binding cassette subfamily B member 10,25,transporter activity|ATPase activity; coupled to transmembrane movement of substances,large intestine cancer|colorectal cancer,ppi
12759,15239,221,ALDH3B1,aldehyde dehydrogenase 3 family member B1,41,3-chloroallyl aldehyde dehydrogenase activity|aldehyde dehydrogenase [NAD(P)+] activity,schizophrenia|paranoid schizophrenia|delusional disorder,ppi
12760,15240,26748,GAGE12I,G antigen 12I,1,,,ppi
12761,15241,8712,PAGE1,PAGE family member 1,1,,,ppi
12762,15243,222,ALDH3B2,aldehyde dehydrogenase 3 family member B2,6,,alcohol dependence|alcohol abuse,ppi
12763,15244,139793,PAGE3,PAGE family member 3,3,,,ppi
12764,15246,2580,GAK,cyclin G associated kinase,95,cyclin binding|chaperone binding|clathrin binding,Parkinson's disease,ppi
12765,15247,51083,GAL,galanin and GMAP prepropeptide,10,galanin receptor activity|neuropeptide hormone activity|type 1 galanin receptor binding|type 2 galanin receptor binding|type 3 galanin receptor binding,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertension|essential hypertension|cannabis dependence|cannabis abuse|mood disorder|familial temporal lobe epilepsy 8,ppi
12766,15248,2581,GALC,galactosylceramidase,12,galactosylceramidase activity,sensorineural hearing loss|epilepsy|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|Krabbe disease|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|visual epilepsy|thrombocytopenia|thrombocytopenia due to platelet alloimmunization|autoimmune thrombocytopenic purpura|Evans' syndrome|neurodegenerative disease,ppi
12767,15249,2582,GALE,UDP-galactose-4-epimerase,29,UDP-glucose 4-epimerase activity,glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|galactokinase deficiency|sensorineural hearing loss|intellectual disability|learning disability,ppi
12768,15250,2583,B4GALNT1,beta-1;4-N-acetyl-galactosaminyltransferase 1,5,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,hereditary spastic paraplegia 26,ppi
12769,15251,2584,GALK1,galactokinase 1,23,galactokinase activity|ATP binding|galactose binding,glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|galactokinase deficiency|neonatal jaundice|cataract,ppi
12770,15252,2585,GALK2,galactokinase 2,15,galactokinase activity,,ppi
12771,15253,223,ALDH9A1,aldehyde dehydrogenase 9 family member A1,18,3-chloroallyl aldehyde dehydrogenase activity|aldehyde dehydrogenase (NAD) activity|aminobutyraldehyde dehydrogenase activity|4-trimethylammoniobutyraldehyde dehydrogenase activity,,ppi
12772,15254,2588,GALNS,galactosamine (N-acetyl)-6-sulfatase,30,N-acetylgalactosamine-4-sulfatase activity|sulfuric ester hydrolase activity|N-acetylgalactosamine-6-sulfatase activity,sensorineural hearing loss|dental caries|heart valve disease|inguinal hernia|osteochondrodysplasia|mucopolysaccharidosis|mucopolysaccharidosis II|mucopolysaccharidosis VI|mucopolysaccharidosis III|mucopolysaccharidosis IV|osteoporosis,ppi
12773,15255,2589,GALNT1,polypeptide N-acetylgalactosaminyltransferase 1,11,polypeptide N-acetylgalactosaminyltransferase activity|manganese ion binding,,ppi
12774,15256,2590,GALNT2,polypeptide N-acetylgalactosaminyltransferase 2,18,polypeptide N-acetylgalactosaminyltransferase activity|manganese ion binding,,ppi
12775,15257,2591,GALNT3,polypeptide N-acetylgalactosaminyltransferase 3,3,polypeptide N-acetylgalactosaminyltransferase activity|calcium ion binding|manganese ion binding,calcium metabolism disease|nephrocalcinosis|calcinosis|prostate cancer|prostate carcinoma|hyperphosphatemia,ppi
12776,15258,8693,GALNT4,polypeptide N-acetylgalactosaminyltransferase 4,10,polypeptide N-acetylgalactosaminyltransferase activity,,ppi
12777,15259,11227,GALNT5,polypeptide N-acetylgalactosaminyltransferase 5,3,polypeptide N-acetylgalactosaminyltransferase activity,,ppi
12778,15260,11226,GALNT6,polypeptide N-acetylgalactosaminyltransferase 6,24,polypeptide N-acetylgalactosaminyltransferase activity,,ppi
12779,15261,51809,GALNT7,polypeptide N-acetylgalactosaminyltransferase 7,27,polypeptide N-acetylgalactosaminyltransferase activity,,ppi
12780,15262,26290,GALNT8,polypeptide N-acetylgalactosaminyltransferase 8,1,polypeptide N-acetylgalactosaminyltransferase activity,,ppi
12781,15263,50614,GALNT9,polypeptide N-acetylgalactosaminyltransferase 9,1,polypeptide N-acetylgalactosaminyltransferase activity,,ppi
12782,15264,2587,GALR1,galanin receptor 1,1,galanin receptor activity|peptide hormone binding|G-protein coupled peptide receptor activity,alcohol dependence|alcohol abuse|cocaine abuse|cocaine dependence|morphine dependence,ppi
12783,15265,8811,GALR2,galanin receptor 2,3,galanin receptor activity|peptide hormone binding|G-protein coupled peptide receptor activity,alcohol dependence|alcohol abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
12784,15266,8484,GALR3,galanin receptor 3,1,galanin receptor activity|peptide hormone binding|G-protein coupled peptide receptor activity,alcohol dependence|alcohol abuse,ppi
12785,15267,2592,GALT,galactose-1-phosphate uridylyltransferase,7,UDP-glucose:hexose-1-phosphate uridylyltransferase activity|zinc ion binding,hemolytic anemia|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|galactokinase deficiency|hypoglycemia|liver cirrhosis|premature menopause|androgen insensitivity syndrome|intellectual disability|learning disability|osteoporosis|ovarian disease|cataract|liver disease|lactic acidosis|agnosia|hypogonadism,ppi
12786,15268,2593,GAMT,guanidinoacetate N-methyltransferase,8,methyltransferase activity|guanidinoacetate N-methyltransferase activity|S-adenosylmethionine-dependent methyltransferase activity,amino acid metabolic disorder|cerebellar disease|epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|visual epilepsy|guanidinoacetate methyltransferase deficiency,ppi
12787,15269,8139,GAN,gigaxonin,206,,clubfoot|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|polyneuropathy|peripheral nervous system disease|neuropathy|paraplegia|Bell's palsy|facial paralysis,ppi
12788,15270,23193,GANAB,glucosidase II alpha subunit,115,RNA binding|glucan 1;3-alpha-glucosidase activity,Meckel syndrome|autosomal dominant polycystic kidney disease|polycystic kidney disease 3,ppi
12789,15271,2595,GANC,glucosidase alpha; neutral C,2,alpha-1;4-glucosidase activity,,ppi
12790,15272,226,ALDOA,aldolase; fructose-bisphosphate A,125,RNA binding|actin binding|fructose-bisphosphate aldolase activity|cytoskeletal protein binding|tubulin binding|identical protein binding|cadherin binding|fructose binding,ptosis|congenital ptosis|cholecystitis|cholecystolithiasis|choledocholithiasis|normocytic anemia|coronary artery disease|lung cancer|lung adenocarcinoma|breast cancer,ppi
12791,15273,2596,GAP43,growth associated protein 43,24,calmodulin binding,alcohol dependence|alcohol abuse|bipolar disorder|colon cancer|colonic benign neoplasm|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|status epilepticus|mood disorder,ppi
12792,15274,2597,GAPDH,glyceraldehyde-3-phosphate dehydrogenase,267,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity|microtubule binding|aspartic-type endopeptidase inhibitor activity|peptidyl-cysteine S-nitrosylase activity,alcohol dependence|alcohol abuse|tongue squamous cell carcinoma|squamous cell carcinoma|esophageal cancer|arthropathy|arthritis|osteoporosis|liver cancer|hepatocellular carcinoma,ppi
12793,15275,2615,LRRC32,leucine rich repeat containing 32,10,,,ppi
12794,15276,2617,GARS,glycyl-tRNA synthetase,102,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity|glycine-tRNA ligase activity|protein dimerization activity,Charcot-Marie-Tooth disease type 2D,ppi
12795,15277,2618,GART,phosphoribosylglycinamide formyltransferase; phosphoribosylglycinamide synthetase; phosphoribosylaminoimidazole synthetase,73,phosphoribosylamine-glycine ligase activity|phosphoribosylformylglycinamidine cyclo-ligase activity|phosphoribosylglycinamide formyltransferase activity,rheumatoid arthritis,ppi
12796,15278,2520,GAST,gastrin,13,hormone activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|Barrett's esophagus|colon cancer|colonic benign neoplasm|gastroenteritis|intestinal disease|gastrointestinal system disease|proctitis|lung benign neoplasm|peptic ulcer disease|stomach cancer,ppi
12797,15279,2619,GAS1,growth arrest specific 1,5,,holoprosencephaly,ppi
12798,15280,2622,GAS8,growth arrest specific 8,6,microtubule binding|Rab GTPase binding,Kartagener syndrome|primary ciliary dyskinesia|primary ciliary dyskinesia 1,ppi
12799,15281,2620,GAS2,growth arrest specific 2,4,,salivary gland adenoid cystic carcinoma,ppi
12800,15282,2621,GAS6,growth arrest specific 6,21,phosphatidylserine binding|signaling receptor binding|voltage-gated calcium channel activity|protein tyrosine kinase activator activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|receptor ligand activity|molecular adaptor activity,salivary gland adenoid cystic carcinoma,ppi
12801,15283,8522,GAS7,growth arrest specific 7,30,DNA-binding transcription factor activity|cytoskeletal protein binding|actin filament binding,obesity,ppi
12802,15284,229,ALDOB,aldolase; fructose-bisphosphate B,31,fructose-bisphosphate aldolase activity|cytoskeletal protein binding|ATPase binding|fructose-1-phosphate aldolase activity|fructose binding,lactic acidosis|epilepsy|hereditary fructose intolerance syndrome|hypoglycemia|liver cirrhosis|intellectual disability|learning disability|visual epilepsy|stomach cancer|liver disease|marasmus|kwashiorkor|protein-energy malnutrition|nutrition disease|autoimmune hepatitis|renal tubular acidosis|hyperuricemia|fatty liver disease,ppi
12803,15285,2623,GATA1,GATA binding protein 1,70,transcription regulatory region sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|chromatin DNA binding|sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|obsolete transcription factor activity; RNA polymerase II transcription factor binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|anemia|macrocytic anemia|hemolytic anemia|imperforate anus|sick sinus syndrome,ppi
12804,15286,2624,GATA2,GATA binding protein 2,51,DNA-binding transcription factor activity; RNA polymerase II-specific|enhancer sequence-specific DNA binding|chromatin binding|DNA-binding transcription factor activity|obsolete transcription factor activity; RNA polymerase II transcription factor binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding,bone disease|cartilage disease|connective tissue disease|chondromalacia|articular cartilage disease|cellulitis|primary immunodeficiency disease|acute myeloid leukemia|elephantiasis|lymphedema|pancytopenia|juvenile myelomonocytic leukemia|essential thrombocythemia|myelodysplastic syndrome,ppi
12805,15287,2625,GATA3,GATA binding protein 3,55,transcription regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|transcription regulatory region DNA binding|E-box binding|obsolete transcription factor activity; RNA polymerase II transcription factor binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,rheumatoid arthritis|sensorineural hearing loss|Hodgkin's lymphoma; lymphocytic-histiocytic predominance|Hodgkin's lymphoma|Hodgkin's lymphoma; lymphocytic depletion|Hodgkin's granuloma|Hodgkin's lymphoma; mixed cellularity|hypoparathyroidism|pseudohypoparathyroidism|adult T-cell leukemia|acute T cell leukemia|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|chronic kidney disease|renal agenesis|hypoparathyroidism-deafness-renal disease syndrome,ppi
12806,15288,2626,GATA4,GATA binding protein 4,31,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|transcription coactivator activity|activating transcription factor binding|sequence-specific DNA binding|transcription regulatory region DNA binding|DNA-binding transcription factor activity|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding|obsolete transcription factor activity; RNA polymerase II transcription factor binding,alcohol dependence|alcohol abuse|azoospermia|large intestine cancer|colorectal cancer|cryptorchidism|atrioventricular septal defect|epilepsy|enophthalmos|orbital disease|exophthalmos|placental insufficiency|gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|hypertrophy of breast|infant gynecomastia|gynecomastia|atrial heart septal defect 1|atrial heart septal defect 2,ppi
12807,15289,2627,GATA6,GATA binding protein 6,12,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding|obsolete transcription factor activity; RNA polymerase II transcription factor binding,cryptorchidism|diabetic ketoacidosis|diabetes mellitus|double outlet right ventricle|patent ductus arteriosus|atrioventricular septal defect|enophthalmos|orbital disease|exophthalmos|placental insufficiency|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale,ppi
12808,15290,2628,GATM,glycine amidinotransferase,4,glycine amidinotransferase activity|amidinotransferase activity,autistic disorder|congestive heart failure|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|intellectual disability|learning disability|coronary artery disease|AGAT deficiency,ppi
12809,15291,2629,GBA,glucosylceramidase beta,44,glucosylceramidase activity|signaling receptor binding|hydrolase activity,anemia|macrocytic anemia|cerebellar disease|pseudosarcomatous fibromatosis|sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|ectropion|epilepsy|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|monocular esotropia|esotropia|placental insufficiency|Gaucher's disease,ppi
12810,15292,2631,GBAS,glioblastoma amplified sequence,58,,,ppi
12811,15293,230,ALDOC,aldolase; fructose-bisphosphate C,72,fructose-bisphosphate aldolase activity|cytoskeletal protein binding,,ppi
12812,15294,2632,GBE1,1;4-alpha-glucan branching enzyme 1,31,1;4-alpha-glucan branching enzyme activity,Cauda equina syndrome|neurogenic bladder|congestive heart failure|glycogen storage disease III|glycogen storage disease VII|glycogen storage disease IV|glycogen storage disease VI|polyhydramnios|portal hypertension|liver cirrhosis|intellectual disability|learning disability|chronic ulcer of skin|locked-in syndrome|quadriplegia|muscular atrophy|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
12813,15295,8729,GBF1,golgi brefeldin A resistant guanine nucleotide exchange factor 1,50,guanyl-nucleotide exchange factor activity|ARF guanyl-nucleotide exchange factor activity|phosphatidylinositol-3;4;5-trisphosphate binding|phosphatidylinositol-3;5-bisphosphate binding,,ppi
12814,15296,2633,GBP1,guanylate binding protein 1,21,actin binding|GTPase activity|GTP binding|GDP binding|protein homodimerization activity,influenza,ppi
12815,15297,2634,GBP2,guanylate binding protein 2,43,protein homodimerization activity,coronary artery disease,ppi
12816,15298,2635,GBP3,guanylate binding protein 3,3,protein homodimerization activity,,ppi
12817,15301,2638,GC,GC; vitamin D binding protein,22,vitamin D binding|calcidiol binding,rheumatoid arthritis|Graves' disease|thyrotoxicosis|hyperthyroidism|hepatic coma|hepatic encephalopathy|liver cirrhosis|lung benign neoplasm|toxic shock syndrome|hepatitis,ppi
12818,15302,23464,GCAT,glycine C-acetyltransferase,13,glycine C-acetyltransferase activity,,ppi
12819,15303,2639,GCDH,glutaryl-CoA dehydrogenase,23,glutaryl-CoA dehydrogenase activity,dystonia|basal ganglia disease|focal hand dystonia|blepharospasm|hypoglycemia|spastic diplegia|spastic monoplegia|spastic quadriplegia|cerebral palsy|brain disease|lactic acidosis|hyperlysinemia,ppi
12820,15306,100316904,SAP25,Sin3A associated protein 25,28,,,ppi
12821,15308,2641,GCG,glucagon,13,signaling receptor binding|hormone activity|glucagon receptor binding,colitis|ileitis|ileocolitis|gastroenteritis|colon cancer|colonic benign neoplasm|constipation|diabetes mellitus|type 2 diabetes mellitus|heart disease|cardiovascular system disease|congestive heart failure|hyperglycemia|Zollinger-Ellison syndrome|hyperinsulinism|familial hyperlipidemia|hypertension|essential hypertension|obesity|duodenal disease,ppi
12822,15314,2642,GCGR,glucagon receptor,6,glucagon receptor activity|guanyl-nucleotide exchange factor activity|G-protein coupled peptide receptor activity|peptide hormone binding,diabetes mellitus|type 2 diabetes mellitus,ppi
12823,15315,2643,GCH1,GTP cyclohydrolase 1,29,GTPase activity|GTP cyclohydrolase I activity|GTP binding|zinc ion binding,bipolar disorder|clubfoot|dystonia|epilepsy|hypertension|essential hypertension|schizophreniform disorder|schizoaffective disorder|schizophrenia|visual epilepsy|neurotic disorder|endogenous depression|melancholia|basal ganglia disease|focal hand dystonia|blepharospasm|coronary artery disease|generalized dystonia|secondary Parkinson disease|mood disorder,ppi
12824,15316,2644,GCHFR,GTP cyclohydrolase I feedback regulator,14,GTP cyclohydrolase binding,,ppi
12825,15317,2645,GCK,glucokinase,9,glucokinase activity|ATP binding|glucose binding|fructokinase activity|mannokinase activity,ptosis|congenital ptosis|diabetic ketoacidosis|diabetes mellitus|type 2 diabetes mellitus|epilepsy|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|placental insufficiency|congenital heart disease|hyperglycemia|hypoglycemic coma|intellectual disability|learning disability|polyneuropathy|peripheral nervous system disease|neuropathy|retinitis|retinal disease|visual epilepsy,ppi
12826,15318,2646,GCKR,glucokinase regulator,5,fructose-6-phosphate binding|carbohydrate binding|enzyme binding|enzyme inhibitor activity,diabetes mellitus|type 2 diabetes mellitus,ppi
12827,15319,8521,GCM1,glial cells missing homolog 1,13,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
12828,15322,9247,GCM2,glial cells missing homolog 2,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,epilepsy|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hypoparathyroidism|pseudohypoparathyroidism|male infertility|visual epilepsy|hyperphosphatemia|cataract,ppi
12829,15328,613037,NPIPB13,nuclear pore complex interacting protein family; member B13,3,,,ppi
12830,15329,10985,GCN1,GCN1; eIF2 alpha kinase activator homolog,128,RNA binding|translation factor activity; RNA binding|cadherin binding,,ppi
12831,15330,8647,ABCB11,ATP binding cassette subfamily B member 11,4,transporter activity|sodium-exporting ATPase activity; phosphorylative mechanism|bile acid-exporting ATPase activity|canalicular bile acid transmembrane transporter activity,factor VII deficiency|factor V deficiency|congenital afibrinogenemia|cholecystolithiasis|choledocholithiasis|cholestasis|intrahepatic cholestasis|large intestine cancer|colorectal cancer|liver cirrhosis|liver cancer|hepatocellular carcinoma,ppi
12832,15331,2647,BLOC1S1,biogenesis of lysosomal organelles complex 1 subunit 1,26,,schizophrenia,ppi
12833,15332,2648,KAT2A,lysine acetyltransferase 2A,126,chromatin binding|transcription coactivator activity|histone acetyltransferase activity|H3 histone acetyltransferase activity|thiol-dependent ubiquitinyl hydrolase activity|peptide-lysine-N-acetyltransferase activity|histone succinyltransferase activity,,ppi
12834,15333,2650,GCNT1,glucosaminyl (N-acetyl) transferase 1; core 2,20,beta-1;3-galactosyl-O-glycosyl-glycoprotein beta-1;6-N-acetylglucosaminyltransferase activity,prostate cancer|prostate carcinoma,ppi
12835,15334,2651,GCNT2,glucosaminyl (N-acetyl) transferase 2; I-branching enzyme (I blood group),9,N-acetyllactosaminide beta-1;6-N-acetylglucosaminyltransferase activity,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
12836,15335,9245,GCNT3,glucosaminyl (N-acetyl) transferase 3; mucin type,10,beta-1;3-galactosyl-O-glycosyl-glycoprotein beta-1;6-N-acetylglucosaminyltransferase activity,,ppi
12837,15336,2652,OPN1MW,opsin 1 (cone pigments); medium-wave-sensitive,2,,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|myopia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|blindness|asthenopia|blue cone monochromacy,ppi
12838,15337,2653,GCSH,glycine cleavage system protein H,9,aminomethyltransferase activity,epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|visual epilepsy|brain disease|glycine encephalopathy,ppi
12839,15338,9615,GDA,guanine deaminase,38,guanine deaminase activity|zinc ion binding,,ppi
12840,15341,2662,GDF10,growth differentiation factor 10,8,cytokine activity|transforming growth factor beta receptor binding,malignant mesothelioma|benign mesothelioma|breast cancer,ppi
12841,15342,10220,GDF11,growth differentiation factor 11,16,cytokine activity|transforming growth factor beta receptor binding,,ppi
12842,15343,2658,GDF2,growth differentiation factor 2,3,cytokine activity|transforming growth factor beta receptor binding,cholecystitis|hemangioma|cavernous hemangioma|capillary hemangioma|portal hypertension|hereditary hemorrhagic telangiectasia|capillary disease|telangiectasis|microcytic anemia|migraine|liver cancer|hepatocellular carcinoma,ppi
12843,15344,9573,GDF3,growth differentiation factor 3,3,cytokine activity|transforming growth factor beta receptor binding,coloboma|sensorineural hearing loss|Klippel-Feil syndrome|spondylolisthesis|microphthalmia|germ cell cancer|germ cell and embryonal cancer|embryonal cancer|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|blindness|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|isolated microphthalmia 1|isolated microphthalmia 7,ppi
12844,15345,8200,GDF5,growth differentiation factor 5,31,cytokine activity|transforming growth factor beta receptor binding,rheumatoid arthritis|pseudosarcomatous fibromatosis|clubfoot|sensorineural hearing loss|tooth agenesis|anodontia|arthropathy|arthritis|osteoarthritis|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|speech disorder|polydactyly|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|Leri-Weill dyschondrosteosis|calcaneonavicular coalition|acromesomelic dysplasia; Grebe type,ppi
12845,15346,392255,GDF6,growth differentiation factor 6,5,cytokine activity|transforming growth factor beta receptor binding,coloboma|Klippel-Feil syndrome|spondylolisthesis|Leber congenital amaurosis|microphthalmia|isolated microphthalmia 4|Leber congenital amaurosis 17|spondylocostal dysostosis,ppi
12846,15347,151449,GDF7,growth differentiation factor 7,1,cytokine activity|transforming growth factor beta receptor binding,,ppi
12847,15348,2660,MSTN,myostatin,8,identical protein binding|transforming growth factor beta receptor binding|cytokine activity,congestive heart failure,ppi
12848,15349,2661,GDF9,growth differentiation factor 9,54,transforming growth factor beta receptor binding|cytokine activity,polycystic ovary syndrome,ppi
12849,15350,2664,GDI1,GDP dissociation inhibitor 1,93,GDP-dissociation inhibitor activity|Rab GDP-dissociation inhibitor activity,intellectual disability|learning disability|autistic disorder|amyotrophic lateral sclerosis type 1|non-syndromic X-linked intellectual disability,ppi
12850,15351,2665,GDI2,GDP dissociation inhibitor 2,66,RNA binding,esophagus squamous cell carcinoma,ppi
12851,15352,2668,GDNF,glial cell derived neurotrophic factor,17,Ras guanyl-nucleotide exchange factor activity|signaling receptor binding|protein homodimerization activity|chemoattractant activity involved in axon guidance,bipolar disorder|heart disease|cardiovascular system disease|constipation|malignant glioma|benign ependymoma|myxopapillary ependymoma|cellular ependymoma|tanycytic ependymoma|papillary ependymoma|gangliocytoma|glioblastoma multiforme|giant cell glioblastoma|gliosarcoma|mixed glioma|Hirschsprung's disease|Huntington's disease|intestinal obstruction|ileus|megacolon,ppi
12852,15353,2669,GEM,GTP binding protein overexpressed in skeletal muscle,43,magnesium ion binding|GTPase activity|GTP binding|GDP binding,,ppi
12853,15354,2670,GFAP,glial fibrillary acidic protein,124,,alcohol dependence|alcohol abuse|progressive muscular atrophy|amyotrophic lateral sclerosis|bipolar disorder|cerebellar disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|central nervous system disease|nervous system disease|autonomic neuropathy,ppi
12854,15355,2671,GFER,growth factor; augmenter of liver regeneration,34,protein disulfide oxidoreductase activity|flavin adenine dinucleotide binding|flavin-linked sulfhydryl oxidase activity,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
12855,15356,2672,GFI1,growth factor independent 1 transcriptional repressor,20,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription regulatory region DNA binding|DNA-binding transcription factor activity,acute myeloid leukemia|autosomal dominant cerebellar ataxia|neutropenia|agranulocytosis|severe congenital neutropenia,ppi
12856,15357,8328,GFI1B,growth factor independent 1B transcriptional repressor,77,DNA-binding transcription factor activity; RNA polymerase II-specific,myelofibrosis|qualitative platelet defect|Glanzmann's thrombasthenia|thrombocytopenia,ppi
12857,15359,374383,NCR3LG1,natural killer cell cytotoxicity receptor 3 ligand 1,36,,,ppi
12858,15360,2673,GFPT1,glutamine--fructose-6-phosphate transaminase 1,67,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,ptosis|congenital ptosis|obesity|ophthalmoplegia|mechanical strabismus|hypertropia|muscular atrophy|Bell's palsy|facial paralysis|congenital myasthenic syndrome,ppi
12859,15361,9945,GFPT2,glutamine-fructose-6-phosphate transaminase 2,29,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,,ppi
12860,15362,2674,GFRA1,GDNF family receptor alpha 1,7,Ras guanyl-nucleotide exchange factor activity|signaling receptor binding|glial cell-derived neurotrophic factor receptor activity,schizophrenia,ppi
12861,15363,2675,GFRA2,GDNF family receptor alpha 2,3,Ras guanyl-nucleotide exchange factor activity|glial cell-derived neurotrophic factor receptor activity,schizophrenia,ppi
12862,15365,2677,GGCX,gamma-glutamyl carboxylase,15,gamma-glutamyl carboxylase activity,angioid streaks|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|blood coagulation disease|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|factor VII deficiency|factor V deficiency|congenital afibrinogenemia|factor X deficiency|hemarthrosis|night blindness|congenital stationary night blindness|cone-rod dystrophy,ppi
12863,15366,8836,GGH,gamma-glutamyl hydrolase,26,exopeptidase activity|omega peptidase activity|gamma-glutamyl-peptidase activity,alcohol dependence|alcohol abuse|rheumatoid arthritis|urinary bladder cancer|transitional cell carcinoma|large intestine cancer|colorectal cancer,ppi
12864,15367,9453,GGPS1,geranylgeranyl diphosphate synthase 1,29,dimethylallyltranstransferase activity|farnesyltranstransferase activity|geranyltranstransferase activity,,ppi
12865,15368,2678,GGT1,gamma-glutamyltransferase 1,8,peptidyltransferase activity|leukotriene-C(4) hydrolase|glutathione hydrolase activity,alcohol dependence|alcohol abuse|gallbladder disease|liver disease|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|periodontitis|prostate cancer|prostate carcinoma,ppi
12866,15369,728441,GGT2,gamma-glutamyltransferase 2,1,,,ppi
12867,15370,2686,GGT7,gamma-glutamyltransferase 7,30,glutathione hydrolase activity|peptidyltransferase activity,,ppi
12868,15371,2687,GGT5,gamma-glutamyltransferase 5,4,peptidyltransferase activity|leukotriene-C(4) hydrolase|glutathione hydrolase activity,,ppi
12869,15372,2688,GH1,growth hormone 1,82,growth hormone receptor binding|prolactin receptor binding|growth factor activity|hormone activity,hyperpituitarism|acromegaly|alcohol dependence|alcohol abuse|heart disease|cardiovascular system disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|achondroplasia|Laron syndrome|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome,ppi
12870,15373,2689,GH2,growth hormone 2,3,hormone activity|growth factor activity|growth hormone receptor binding,Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome|Cockayne syndrome|Noonan syndrome|Aarskog syndrome,ppi
12871,15374,2690,GHR,growth hormone receptor,55,protein kinase binding|protein homodimerization activity|proline-rich region binding|cytokine receptor activity|cytokine binding|growth hormone receptor activity|growth factor binding|peptide hormone binding,autistic disorder|achondroplasia|Laron syndrome|hypoglycemia|arthropathy|arthritis|neurogenic arthropathy|prostate cancer|prostate carcinoma|coronary artery disease|familial hypercholesterolemia,ppi
12872,15375,2691,GHRH,growth hormone releasing hormone,3,growth hormone-releasing hormone activity|growth hormone-releasing hormone receptor binding|neuropeptide hormone activity|peptide hormone receptor binding,bipolar disorder|pulmonary edema,ppi
12873,15376,2692,GHRHR,growth hormone releasing hormone receptor,3,G-protein coupled receptor activity|growth hormone-releasing hormone receptor activity|G-protein coupled peptide receptor activity|growth factor binding|peptide hormone binding,isolated growth hormone deficiency type IB,ppi
12874,15377,2693,GHSR,growth hormone secretagogue receptor,2,growth hormone secretagogue receptor activity|G-protein coupled receptor activity|growth hormone-releasing hormone receptor activity,alcohol dependence|alcohol abuse|gastrointestinal system cancer|hypoglycemia,ppi
12875,15379,2694,GIF,gastric intrinsic factor,5,cobalamin binding,megaloblastic anemia|bipolar disorder|schizophrenia|pernicious anemia|congenital intrinsic factor deficiency,ppi
12876,15380,238,ALK,anaplastic lymphoma receptor tyrosine kinase,82,NF-kappaB-inducing kinase activity|protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,alcohol dependence|alcohol abuse|brain cancer|lung cancer|non-small cell lung carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|neuroblastoma|schizophrenia,ppi
12877,15381,2695,GIP,gastric inhibitory polypeptide,11,,,ppi
12878,15382,2696,GIPR,gastric inhibitory polypeptide receptor,3,transmembrane signaling receptor activity|peptide hormone binding|gastric inhibitory peptide receptor activity|G-protein coupled peptide receptor activity,lung cancer|non-small cell lung carcinoma,ppi
12879,15383,28964,GIT1,GIT ArfGAP 1,88,,attention deficit hyperactivity disorder,ppi
12880,15384,9815,GIT2,GIT ArfGAP 2,62,,,ppi
12881,15385,2697,GJA1,gap junction protein alpha 1,157,gap junction channel activity|ion transmembrane transporter activity|gap junction channel activity involved in cardiac conduction electrical coupling|gap junction channel activity involved in cell communication by electrical coupling,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|alopecia|sick sinus syndrome|autistic disorder|Cauda equina syndrome|neurogenic bladder|blepharophimosis|cerebellar disease|cleft lip|isolated cleft palate|cleft palate|coronary aneurysm|dental caries|dental enamel hypoplasia|diabetic ketoacidosis|diabetes mellitus,ppi
12882,15386,2700,GJA3,gap junction protein alpha 3,6,,cataract 5 multiple types|cataract 14 multiple types|cataract 16 multiple types,ppi
12883,15387,2701,GJA4,gap junction protein alpha 4,3,,angiosarcoma|hypertension|essential hypertension,ppi
12884,15388,2702,GJA5,gap junction protein alpha 5,7,gap junction hemi-channel activity|gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling|gap junction channel activity involved in cardiac conduction electrical coupling|gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling|gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling|gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling|gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,atrial fibrillation|autistic disorder|cryptorchidism|patent ductus arteriosus|endocardial fibroelastosis|enophthalmos|orbital disease|exophthalmos|placental insufficiency|hypertension|essential hypertension|intellectual disability|learning disability|schizophrenia|tetralogy of Fallot|familial atrial fibrillation|dextro-looped transposition of the great arteries 1|dextro-looped transposition of the great arteries 3|dextro-looped transposition of the great arteries,ppi
12885,15389,7840,ALMS1,ALMS1; centrosome and basal body associated protein,45,alpha-actinin binding,acanthosis nigricans|alopecia|asthma|intrinsic asthma|allergic asthma|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E,ppi
12886,15390,10052,GJC1,gap junction protein gamma 1,17,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling|gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,hypertension|essential hypertension,ppi
12887,15391,2703,GJA8,gap junction protein alpha 8,2,channel activity,autistic disorder|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types,ppi
12888,15392,2705,GJB1,gap junction protein beta 1,11,gap junction channel activity,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|hereditary motor and sensory neuropathy with agenesis of the corpus callosum|hereditary neuropathy with liability to pressure palsies|Charcot-Marie-Tooth disease type 1A|Charcot-Marie-Tooth disease type 1F|Charcot-Marie-Tooth disease type 1D|Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease type 1B|Charcot-Marie-Tooth disease type 1E,ppi
12889,15393,2706,GJB2,gap junction protein beta 2,21,,alopecia|tongue squamous cell carcinoma|squamous cell carcinoma|cellulitis|corneal ulcer|sensorineural hearing loss|xerophthalmia|dry eye syndrome|hypohidrosis|anhidrosis|ichthyosis|keratitis|keratoconjunctivitis|Sjogren's syndrome|keratoconjunctivitis sicca|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|pustulosis of palm and sole,ppi
12890,15394,2707,GJB3,gap junction protein beta 3,3,gap junction channel activity,alopecia|sensorineural hearing loss|diabetic ketoacidosis|diabetes mellitus|exanthem|glaucoma|polyneuropathy|peripheral nervous system disease|neuropathy|seborrheic keratosis|skin disease|actinic keratosis|granuloma annulare|ichthyosis vulgaris|epidermolytic hyperkeratosis|cataract|erythrokeratodermia variabilis|photosensitivity disease|photosensitive epilepsy|autosomal recessive nonsyndromic deafness 1A,ppi
12891,15395,127534,GJB4,gap junction protein beta 4,1,,ichthyosis vulgaris|epidermolytic hyperkeratosis|erythrokeratodermia variabilis,ppi
12892,15396,2709,GJB5,gap junction protein beta 5,6,,skin benign neoplasm|skin cancer,ppi
12893,15397,10804,GJB6,gap junction protein beta 6,2,,alopecia|blepharitis|conjunctivitis|sensorineural hearing loss|Clouston syndrome|hypohidrosis|anhidrosis|hypotrichosis|ichthyosis|keratitis|keratoconjunctivitis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|chronic ulcer of skin|ophthalmoplegia|mechanical strabismus|hypertropia|geographic tongue,ppi
12894,15398,2710,GK,glycerol kinase,48,glycerol kinase activity,adrenal cortical hypofunction|Addison's disease|epilepsy|hypoglycemia|intellectual disability|learning disability|familial periodic paralysis|myopathy|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H,ppi
12895,15399,239,ALOX12,arachidonate 12-lipoxygenase; 12S type,9,arachidonate 12-lipoxygenase activity|linoleate 13S-lipoxygenase activity|oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen|hepoxilin-epoxide hydrolase activity|hepoxilin A3 synthase activity,bipolar disorder|polyneuropathy|peripheral nervous system disease|neuropathy|schizophrenia|seborrheic keratosis|skin disease|actinic keratosis,ppi
12896,15400,2712,GK2,glycerol kinase 2,4,glycerol kinase activity,,ppi
12897,15401,646817,SETSIP,SET-like protein,7,chromatin binding,,ppi
12898,15402,441869,ANKRD65,ankyrin repeat domain 65,1,,,ppi
12899,15405,2717,GLA,galactosidase alpha,17,catalytic activity|alpha-galactosidase activity|signaling receptor binding|hydrolase activity|protein homodimerization activity,anemia|macrocytic anemia|angiokeratoma|chylomicron retention disease|Fabry disease|lipid storage disease|sick sinus syndrome|arthropathy|arthritis|atrioventricular block|corneal dystrophy|recurrent corneal erosion|epilepsy|congestive heart failure|familial hyperlipidemia|hypertension|essential hypertension|hypohidrosis|anhidrosis|nephritis,ppi
12900,15411,389690,MROH5,maestro heat like repeat family member 5,1,,,ppi
12901,15412,2720,GLB1,galactosidase beta 1,46,exo-alpha-sialidase activity|beta-galactosidase activity,chylomicron retention disease|Fabry disease|lipid storage disease|aortic valve stenosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P,ppi
12902,15413,6890,TAP1,transporter 1; ATP binding cassette subfamily B member,43,ATP binding|peptide antigen binding|protein homodimerization activity|ADP binding|TAP1 binding|peptide transmembrane transporter activity|ATPase activity; coupled to transmembrane movement of substances,bronchiectasis|bronchiolitis|schizophrenia|chronic ulcer of skin|chronic sphenoidal sinusitis|chronic ethmoiditis|coronary artery disease|otitis media|MHC class II deficiency|MHC class I deficiency,ppi
12903,15414,242,ALOX12B,arachidonate 12-lipoxygenase; 12R type,21,arachidonate 12-lipoxygenase activity|oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen|linoleate 9S-lipoxygenase activity,alopecia|sensorineural hearing loss|ectropion|hypohidrosis|anhidrosis|hypotrichosis|ichthyosis|autosomal recessive congenital ichthyosis 1|congenital ichthyosiform erythroderma|keratosis follicularis|pseudoxanthoma elasticum|mongolian spot|keratitis|keratoconjunctivitis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|intellectual disability|learning disability|nail disease|autosomal recessive congenital ichthyosis 2,ppi
12904,15415,2729,GCLC,glutamate-cysteine ligase catalytic subunit,10,magnesium ion binding|glutamate-cysteine ligase activity|glutamate binding|ADP binding,amino acid metabolic disorder|anemia|macrocytic anemia|hemolytic anemia|lung cancer|non-small cell lung carcinoma|contact dermatitis|occupational dermatitis|hypertension|essential hypertension|familial periodic paralysis|myopathy|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|polyneuropathy|peripheral nervous system disease|neuropathy|schizophrenia,ppi
12905,15416,2730,GCLM,glutamate-cysteine ligase modifier subunit,25,glutamate-cysteine ligase activity|enzyme regulator activity,berylliosis|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|drug psychosis|schizophrenia|childhood disintegrative disease,ppi
12906,15417,2731,GLDC,glycine decarboxylase,21,glycine dehydrogenase (decarboxylating) activity|electron transfer activity|protein homodimerization activity|pyridoxal binding|glycine binding,epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|visual epilepsy|brain disease|glycine encephalopathy,ppi
12907,15418,2733,GLE1,GLE1; RNA export mediator,23,phospholipid binding|translation initiation factor binding|inositol hexakisphosphate binding,congestive heart failure|polyhydramnios|anterior horn cell disease|muscular atrophy|lateral sclerosis|motor neuron disease|lethal congenital contracture syndrome 1,ppi
12908,15419,2734,GLG1,golgi glycoprotein 1,23,signaling receptor binding|fibroblast growth factor binding,,ppi
12909,15420,2735,GLI1,GLI family zinc finger 1,65,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription regulatory region DNA binding,urinary bladder cancer|acute promyelocytic leukemia|polyneuropathy|peripheral nervous system disease|neuropathy|liver cancer|hepatocellular carcinoma,ppi
12910,15421,2736,GLI2,GLI family zinc finger 2,18,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|zinc ion binding|sequence-specific DNA binding|promoter-specific chromatin binding,alcohol dependence|alcohol abuse|nevoid basal cell carcinoma syndrome|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|cryptorchidism|epilepsy|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|hypoglycemia|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome,ppi
12911,15422,2737,GLI3,GLI family zinc finger 3,28,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|histone deacetylase binding,imperforate anus|cleft lip|cryptorchidism|Dandy-Walker syndrome|patent ductus arteriosus|epilepsy|esophageal atresia|placental insufficiency|ventricular septal defect|cystic kidney disease|tongue disease|microphthalmia|visual epilepsy|syndromic X-linked intellectual disability 94|stomach cancer|holoprosencephaly|polydactyly|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis,ppi
12912,15423,2738,GLI4,GLI family zinc finger 4,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
12913,15424,2739,GLO1,glyoxalase I,42,lactoylglutathione lyase activity|zinc ion binding,anxiety disorder|phobic disorder|autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|melanoma|skin melanoma|schizophrenia|esophagus squamous cell carcinoma,ppi
12914,15425,2740,GLP1R,glucagon like peptide 1 receptor,77,transmembrane signaling receptor activity|glucagon-like peptide 1 receptor activity|peptide hormone binding|G-protein coupled peptide receptor activity,hypertension|essential hypertension,ppi
12915,15426,9340,GLP2R,glucagon like peptide 2 receptor,2,G-protein coupled receptor activity|glucagon receptor activity|peptide hormone binding|G-protein coupled peptide receptor activity,,ppi
12916,15428,2742,GLRA2,glycine receptor alpha 2,30,glycine binding|extracellularly glycine-gated chloride channel activity|glycine-gated chloride ion channel activity|extracellular ligand-gated ion channel activity|chloride channel activity,schizophrenia,ppi
12917,15429,8001,GLRA3,glycine receptor alpha 3,1,extracellularly glycine-gated chloride channel activity|glycine-gated chloride ion channel activity|chloride channel activity|glycine binding|extracellular ligand-gated ion channel activity,,ppi
12918,15430,2743,GLRB,glycine receptor beta,12,extracellularly glycine-gated ion channel activity|glycine binding|extracellularly glycine-gated chloride channel activity|extracellular ligand-gated ion channel activity|chloride channel activity,hyperekplexia 1|hyperekplexia 2,ppi
12919,15431,246,ALOX15,arachidonate 15-lipoxygenase,5,arachidonate 12-lipoxygenase activity|iron ion binding|phosphatidylinositol-4;5-bisphosphate binding|arachidonate 15-lipoxygenase activity|eoxin A4 synthase activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|esophageal cancer|hypertension|essential hypertension,ppi
12920,15432,2745,GLRX,glutaredoxin,22,glutathione disulfide oxidoreductase activity|glutathione oxidoreductase activity,,ppi
12921,15433,2744,GLS,glutaminase,48,glutaminase activity,arthropathy|arthritis|schizophrenia,ppi
12922,15434,29998,GLTSCR1,glioma tumor suppressor candidate region gene 1,16,,,ppi
12923,15435,29997,GLTSCR2,glioma tumor suppressor candidate region gene 2,109,RNA binding|5S rRNA binding|identical protein binding,polycystic ovary syndrome,ppi
12924,15436,2746,GLUD1,glutamate dehydrogenase 1,53,glutamate dehydrogenase (NAD+) activity|glutamate dehydrogenase [NAD(P)+] activity|GTP binding|identical protein binding|ADP binding|NAD+ binding|leucine binding,placental insufficiency|Zollinger-Ellison syndrome|hyperinsulinism|hypoglycemic coma|intellectual disability|learning disability|urea cycle disorder|hyperinsulinemic hypoglycemia,ppi
12925,15437,2747,GLUD2,glutamate dehydrogenase 2,17,glutamate dehydrogenase (NAD+) activity|glutamate dehydrogenase [NAD(P)+] activity|GTP binding|ADP binding|leucine binding,,ppi
12926,15438,247,ALOX15B,arachidonate 15-lipoxygenase; type B,8,iron ion binding|calcium ion binding|linoleate 13S-lipoxygenase activity|arachidonate 15-lipoxygenase activity,,ppi
12927,15439,2752,GLUL,glutamate-ammonia ligase,42,glutamate-ammonia ligase activity,alcohol dependence|alcohol abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|exanthem|hepatic coma|hepatic encephalopathy|obesity|schizophreniform disorder|schizoaffective disorder|schizophrenia|visual epilepsy|brain disease|Alzheimer's disease|Pick's disease,ppi
12928,15441,240,ALOX5,arachidonate 5-lipoxygenase,62,arachidonate 5-lipoxygenase activity|iron ion binding,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|rheumatoid arthritis|asthma|intrinsic asthma|allergic asthma|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|colitis|ileitis|ileocolitis|gastroenteritis|colon cancer|colonic benign neoplasm,ppi
12929,15443,241,ALOX5AP,arachidonate 5-lipoxygenase activating protein,4,arachidonic acid binding|glutathione transferase activity|leukotriene-C4 synthase activity|glutathione peroxidase activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|cerebral artery occlusion|brain stem infarction|cerebral infarction|cerebrovascular disease|gallbladder disease|liver disease|proteinuria|toxic encephalopathy,ppi
12930,15447,2760,GM2A,GM2 ganglioside activator,27,sphingolipid activator protein activity,epilepsy|visual epilepsy|hyperekplexia 1|Tay-Sachs disease AB variant,ppi
12931,15448,2762,GMDS,GDP-mannose 4;6-dehydratase,25,GDP-mannose 4;6-dehydratase activity|NADP+ binding,,ppi
12932,15449,248,ALPI,alkaline phosphatase; intestinal,20,magnesium ion binding|alkaline phosphatase activity|zinc ion binding,,ppi
12933,15450,10691,GMEB1,glucocorticoid modulatory element binding protein 1,24,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
12934,15451,26205,GMEB2,glucocorticoid modulatory element binding protein 2,13,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
12935,15452,2764,GMFB,glia maturation factor beta,17,protein kinase inhibitor activity|enzyme activator activity,,ppi
12936,15453,9535,GMFG,glia maturation factor gamma,7,protein kinase inhibitor activity|enzyme activator activity,,ppi
12937,15454,2765,GML,glycosylphosphatidylinositol anchored molecule like,24,,,ppi
12938,15455,2766,GMPR,guanosine monophosphate reductase,1,GMP reductase activity,,ppi
12939,15456,51292,GMPR2,guanosine monophosphate reductase 2,7,GMP reductase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|stomach cancer,ppi
12940,15458,8833,GMPS,guanine monophosphate synthase,58,GMP synthase activity|GMP synthase (glutamine-hydrolyzing) activity,acute myeloid leukemia,ppi
12941,15459,2767,GNA11,G protein subunit alpha 11,47,GTPase activity|type 2A serotonin receptor binding|G-protein beta/gamma-subunit complex binding|G-protein coupled receptor binding,alopecia|generalized anxiety disorder|anxiety disorder|sick sinus syndrome|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|congenital heart disease|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|melanoma|skin melanoma|calcium metabolism disease|calcinosis|retinal detachment|hyperphosphatemia,ppi
12942,15460,249,ALPL,alkaline phosphatase; liver/bone/kidney,13,pyrophosphatase activity,anemia|macrocytic anemia|calcium metabolism disease|nephrocalcinosis|calcinosis|constipation|craniosynostosis|dental caries|epilepsy|enophthalmos|orbital disease|exophthalmos|polyhydramnios|hypercalcemia|phosphorus metabolism disease|secondary hyperparathyroidism|gallbladder disease|liver disease|familial periodic paralysis|myopathy,ppi
12943,15461,2768,GNA12,G protein subunit alpha 12,40,GTPase activity|D5 dopamine receptor binding|G-protein coupled receptor binding|G-protein beta/gamma-subunit complex binding,inflammatory bowel disease|ulcerative colitis|schizophreniform disorder|schizoaffective disorder|coronary artery disease,ppi
12944,15462,10672,GNA13,G protein subunit alpha 13,66,GTPase activity|guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|G-protein coupled receptor binding|G-protein beta/gamma-subunit complex binding|D5 dopamine receptor binding|type 1 angiotensin receptor binding,Burkitt lymphoma,ppi
12945,15463,9630,GNA14,G protein subunit alpha 14,10,G-protein coupled receptor binding|G-protein beta/gamma-subunit complex binding|GTPase activity,,ppi
12946,15464,2769,GNA15,G protein subunit alpha 15,28,G-protein coupled receptor binding|GTPase activity|G-protein beta/gamma-subunit complex binding,,ppi
12947,15465,2770,GNAI1,G protein subunit alpha i1,100,magnesium ion binding|G-protein coupled receptor binding|GTPase activity|GTP binding|GDP binding|G-protein coupled serotonin receptor binding|G-protein beta/gamma-subunit complex binding,amnestic disorder|dissociative amnesia,ppi
12948,15466,2771,GNAI2,G protein subunit alpha i2,136,GTPase activity|GTP binding|G-protein coupled receptor binding|G-protein beta/gamma-subunit complex binding,atrioventricular block|breast cancer,ppi
12949,15467,2773,GNAI3,G protein subunit alpha i3,105,GTPase activity|GTP binding|GDP binding|G-protein beta/gamma-subunit complex binding|G-protein coupled receptor binding,amnestic disorder|dissociative amnesia|isolated cleft palate|cleft palate,ppi
12950,15468,2774,GNAL,G protein subunit alpha L,9,G-protein beta/gamma-subunit complex binding|GTPase activity|G-protein coupled receptor binding,bipolar disorder|dystonia|schizophrenia|focal hand dystonia|blepharospasm|generalized dystonia,ppi
12951,15469,2775,GNAO1,G protein subunit alpha o1,106,GTPase activity|GTP binding|G-protein beta/gamma-subunit complex binding|G-protein coupled receptor binding|G-protein coupled serotonin receptor binding|corticotropin-releasing hormone receptor 1 binding|mu-type opioid receptor binding,schizophrenia|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|infantile epileptic encephalopathy|Ohtahara syndrome,ppi
12952,15470,250,ALPP,alkaline phosphatase; placental,29,magnesium ion binding|alkaline phosphatase activity|zinc ion binding,,ppi
12953,15471,2776,GNAQ,G protein subunit alpha q,101,GTPase activator activity|G-protein coupled receptor binding|GTPase activity|type 2A serotonin receptor binding|G-protein beta/gamma-subunit complex binding,proteinuria|arteriovenous malformation|blood coagulation disease|epilepsy|glaucoma|focal segmental glomerulosclerosis|congenital heart disease|buphthalmos|hydrophthalmos|melanoma|skin melanoma|intellectual disability|learning disability|optic atrophy|retinal detachment|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|cerebral infarction,ppi
12954,15472,2778,GNAS,GNAS complex locus,96,mu-type opioid receptor binding|D1 dopamine receptor binding|G-protein beta/gamma-subunit complex binding|corticotropin-releasing hormone receptor 1 binding|G-protein coupled receptor binding|insulin-like growth factor receptor binding|beta-2 adrenergic receptor binding|ionotropic glutamate receptor binding|GTPase activity,hyperpituitarism|acromegaly|adrenal gland cancer|generalized anxiety disorder|anxiety disorder|sensorineural hearing loss|dental enamel hypoplasia|neurotic disorder|major depressive disorder|endogenous depression|melancholia|mental depression|dysthymic disorder|diabetic ketoacidosis|diabetes mellitus|endocrine system disease|epilepsy|McCune Albright syndrome|hemorrhagic disease|hyperparathyroidism,ppi
12955,15473,2779,GNAT1,G protein subunit alpha transducin 1,7,acyl binding|GTPase activity|GTP binding|GDP binding|protein kinase binding|G-protein beta/gamma-subunit complex binding|G-protein coupled receptor binding,night blindness|congenital stationary night blindness|hereditary night blindness,ppi
12956,15474,2780,GNAT2,G protein subunit alpha transducin 2,16,GTPase activity|GTP binding|G-protein coupled photoreceptor activity|G-protein coupled receptor binding|G-protein beta/gamma-subunit complex binding,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|alternating exotropia|exotropia|monocular exotropia|hyperopia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|blindness|asthenopia,ppi
12957,15476,2781,GNAZ,G protein subunit alpha z,57,GTPase activity|GTP binding|G-protein beta/gamma-subunit complex binding|G-protein coupled receptor binding,,ppi
12958,15477,2782,GNB1,G protein subunit beta 1,104,GTPase activity|protein-containing complex binding,anxiety disorder|phobic disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|acute lymphocytic leukemia,ppi
12959,15478,54584,GNB1L,G protein subunit beta 1 like,16,,bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
12960,15480,2783,GNB2,G protein subunit beta 2,155,GTPase activity|protein-containing complex binding,,ppi
12961,15481,10399,RACK1,receptor for activated C kinase 1,248,RNA binding|protein kinase C binding|signaling receptor binding|ion channel inhibitor activity|cysteine-type endopeptidase activator activity involved in apoptotic process|protein tyrosine kinase inhibitor activity|receptor tyrosine kinase binding|protein-containing complex scaffold activity|signaling adaptor activity|SH2 domain binding|protein homodimerization activity|ribosome binding|cadherin binding|enzyme binding,alcohol dependence|alcohol abuse|bipolar disorder|tongue squamous cell carcinoma|squamous cell carcinoma,ppi
12962,15482,6891,TAP2,transporter 2; ATP binding cassette subfamily B member,26,transporter activity|ATP binding|peptide antigen-transporting ATPase activity|tapasin binding|peptide transmembrane transporter activity|ATPase activity; coupled to transmembrane movement of substances,bipolar disorder|bronchiectasis|bronchiolitis|schizophrenia|chronic ulcer of skin|chronic sphenoidal sinusitis|chronic ethmoiditis|otitis media|MHC class II deficiency|MHC class I deficiency,ppi
12963,15483,2784,GNB3,G protein subunit beta 3,31,GTPase activity,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetes mellitus|type 2 diabetes mellitus|hypertension|essential hypertension|obesity|schizophrenia|epilepsy|visual epilepsy|mood disorder|coronary artery disease,ppi
12964,15484,10681,GNB5,G protein subunit beta 5,50,GTPase activity|GTPase activator activity,,ppi
12965,15485,2790,GNG10,G protein subunit gamma 10,15,protein binding,,ppi
12966,15486,2791,GNG11,G protein subunit gamma 11,11,protein binding,lung cancer|lung adenocarcinoma,ppi
12967,15487,54331,GNG2,G protein subunit gamma 2,35,GTPase activity|G-protein beta-subunit binding,,ppi
12968,15488,2785,GNG3,G protein subunit gamma 3,17,type 1 angiotensin receptor binding,,ppi
12969,15489,2786,GNG4,G protein subunit gamma 4,17,G-protein beta-subunit binding,,ppi
12970,15490,2787,GNG5,G protein subunit gamma 5,29,GTPase activity|PDZ domain binding|protein binding,prostate cancer|prostate carcinoma,ppi
12971,15491,251,ALPPL2,alkaline phosphatase; placental like 2,7,alkaline phosphatase activity,,ppi
12972,15492,2788,GNG7,G protein subunit gamma 7,13,,esophageal cancer,ppi
12973,15493,2792,GNGT1,G protein subunit gamma transducin 1,12,protein binding,,ppi
12974,15495,2793,GNGT2,G protein subunit gamma transducin 2,6,GTPase activity,,ppi
12975,15497,2794,GNL1,G protein nucleolar 1 (putative),32,structural molecule activity|GTP binding,,ppi
12976,15498,10578,GNLY,granulysin,1,,,ppi
12977,15500,27232,GNMT,glycine N-methyltransferase,21,glycine binding|glycine N-methyltransferase activity,hepatitis|liver cancer|prostate cancer|prostate carcinoma|liver disease|hyperhomocysteinemia|hepatocellular carcinoma,ppi
12978,15504,8443,GNPAT,glyceronephosphate O-acyltransferase,35,glycerone-phosphate O-acyltransferase activity|palmitoyl-CoA hydrolase activity|glycerol-3-phosphate O-acyltransferase activity,pseudosarcomatous fibromatosis|intellectual disability|learning disability|schizophrenia|cataract|rhizomelic chondrodysplasia punctata type 2,ppi
12979,15507,10007,GNPDA1,glucosamine-6-phosphate deaminase 1,40,glucosamine-6-phosphate deaminase activity|identical protein binding,,ppi
12980,15508,2796,GNRH1,gonadotropin releasing hormone 1,9,hormone activity|gonadotropin-releasing hormone receptor binding|gonadotropin hormone-releasing hormone activity,adrenal gland cancer|generalized anxiety disorder|anxiety disorder|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertrophy of breast|infant gynecomastia|gynecomastia|hyperprolactinemia|hypertension|essential hypertension|hypogonadism|male infertility|osteoporosis|adult respiratory distress syndrome,ppi
12981,15511,2797,GNRH2,gonadotropin releasing hormone 2,1,gonadotropin hormone-releasing hormone activity|gonadotropin-releasing hormone receptor binding,,ppi
12982,15519,2798,GNRHR,gonadotropin releasing hormone receptor,3,,adrenal gland cancer|generalized anxiety disorder|anxiety disorder|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertrophy of breast|infant gynecomastia|gynecomastia|hypogonadism|osteoporosis|premature menopause|androgen insensitivity syndrome|eunuchism|psychologic dyspareunia|premature ejaculation,ppi
12983,15520,2799,GNS,glucosamine (N-acetyl)-6-sulfatase,36,N-acetylglucosamine-6-sulfatase activity|sulfuric ester hydrolase activity|glycosaminoglycan binding,pseudosarcomatous fibromatosis|sensorineural hearing loss|epilepsy|hypertrichosis|intellectual disability|learning disability|mucopolysaccharidosis|mucopolysaccharidosis II|mucopolysaccharidosis VI|mucopolysaccharidosis III|mucopolysaccharidosis IV|visual epilepsy|mucopolysaccharidosis I|hypertrophic cardiomyopathy 1,ppi
12984,15521,2800,GOLGA1,golgin A1,14,,,ppi
12985,15522,2801,GOLGA2,golgin A2,334,microtubule binding|cadherin binding|importin-alpha family protein binding,,ppi
12986,15523,2802,GOLGA3,golgin A3,44,transporter activity|cadherin binding,,ppi
12987,15524,2803,GOLGA4,golgin A4,36,,prostate cancer|prostate carcinoma|seborrheic keratosis|skin disease|actinic keratosis,ppi
12988,15525,9950,GOLGA5,golgin A5,43,Rab GTPase binding,papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma,ppi
12989,15526,2804,GOLGB1,golgin B1,47,RNA binding,,ppi
12990,15527,57679,ALS2,ALS2; alsin Rho guanine nucleotide exchange factor,12,Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding|Rac guanyl-nucleotide exchange factor activity|protein serine/threonine kinase activator activity|guanyl-nucleotide exchange factor activity,amyotrophic lateral sclerosis type 2,ppi
12991,15528,9527,GOSR1,golgi SNAP receptor complex member 1,38,SNAP receptor activity,,ppi
12992,15529,9570,GOSR2,golgi SNAP receptor complex member 2,21,SNARE binding|SNAP receptor activity,cerebellar disease|childhood absence epilepsy|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|progressive myoclonus epilepsy,ppi
12993,15532,2805,GOT1,glutamic-oxaloacetic transaminase 1,61,L-aspartate:2-oxoglutarate aminotransferase activity|L-cysteine:2-oxoglutarate aminotransferase activity,,ppi
12994,15533,2806,GOT2,glutamic-oxaloacetic transaminase 2,46,RNA binding|L-aspartate:2-oxoglutarate aminotransferase activity|4-hydroxyglutamate transaminase activity,,ppi
12995,15535,2811,GP1BA,glycoprotein Ib platelet alpha subunit,22,thrombin-activated receptor activity,hemolytic anemia|qualitative platelet defect|Bernard-Soulier syndrome|hypertension|essential hypertension|purpura|thrombocytopenia|von Willebrand's disease|blood coagulation disease,ppi
12996,15536,285141,ERICH2,glutamate rich 2,3,,,ppi
12997,15537,2812,GP1BB,glycoprotein Ib platelet beta subunit,36,transmembrane signaling receptor activity,qualitative platelet defect|Bernard-Soulier syndrome|ptosis|congenital ptosis|isolated cleft palate|cleft palate|constipation|dental caries|DiGeorge syndrome|velocardiofacial syndrome|congenital heart disease|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9,ppi
12998,15542,2813,GP2,glycoprotein 2,5,,,ppi
12999,15543,2814,GP5,glycoprotein V platelet,5,,,ppi
13000,15546,2815,GP9,glycoprotein IX platelet,7,,qualitative platelet defect|Bernard-Soulier syndrome|purpura|thrombocytopenia|blood coagulation disease,ppi
13001,15555,10223,GPA33,glycoprotein A33,1,signaling receptor activity,,ppi
13002,15559,728369,USP17L24,ubiquitin specific peptidase 17-like family member 24,5,,,ppi
13003,15565,8733,GPAA1,glycosylphosphatidylinositol anchor attachment 1,31,tubulin binding|GPI-anchor transamidase activity|GPI anchor binding,,ppi
13004,15567,2817,GPC1,glypican 1,24,copper ion binding|fibroblast growth factor binding|laminin binding,biliary atresia,ppi
13005,15568,23064,SETX,senataxin,49,transcription termination site sequence-specific DNA binding|DNA binding|DNA helicase activity,progressive muscular atrophy|amyotrophic lateral sclerosis|primary polycythemia|polyneuropathy|peripheral nervous system disease|neuropathy|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy|amyotrophic lateral sclerosis type 4,ppi
13006,15569,221914,GPC2,glypican 2,1,,,ppi
13007,15570,2719,GPC3,glypican 3,22,peptidyl-dipeptidase inhibitor activity,sick sinus syndrome|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|sensorineural hearing loss|patent ductus arteriosus|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|inguinal hernia,ppi
13008,15571,2239,GPC4,glypican 4,25,coreceptor activity involved in Wnt signaling pathway; planar cell polarity pathway,sick sinus syndrome|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|sensorineural hearing loss|patent ductus arteriosus|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|inguinal hernia,ppi
13009,15572,2262,GPC5,glypican 5,1,,proteinuria|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome,ppi
13010,15573,10082,GPC6,glypican 6,15,coreceptor activity involved in Wnt signaling pathway; planar cell polarity pathway,blepharophimosis|cryptorchidism|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|glomus tumor|hemangioma|lymphangioma|chorioangioma|intramuscular hemangioma|histiocytoid hemangioma,ppi
13011,15574,2819,GPD1,glycerol-3-phosphate dehydrogenase 1,10,glycerol-3-phosphate dehydrogenase [NAD+] activity|glycerol-3-phosphate dehydrogenase (quinone) activity|glycerol-3-phosphate dehydrogenase [NAD(P)+] activity|NAD binding,liver disease|liver cirrhosis|fatty liver disease,ppi
13012,15575,2820,GPD2,glycerol-3-phosphate dehydrogenase 2,26,glycerol-3-phosphate dehydrogenase (quinone) activity|glycerol-3-phosphate dehydrogenase [NAD+] activity,diabetes mellitus|type 2 diabetes mellitus|osteoporosis,ppi
13013,15576,2821,GPI,glucose-6-phosphate isomerase,57,glucose-6-phosphate isomerase activity|intramolecular transferase activity|monosaccharide binding,hemolytic anemia|cerebellar disease|cholecystitis|intellectual disability|learning disability|breast cancer|congenital nonspherocytic hemolytic anemia,ppi
13014,15577,2822,GPLD1,glycosylphosphatidylinositol specific phospholipase D1,9,glycosylphosphatidylinositol phospholipase D activity|phospholipase D activity|sodium channel regulator activity,,ppi
13015,15578,2823,GPM6A,glycoprotein M6A,33,,schizophrenia,ppi
13016,15579,2824,GPM6B,glycoprotein M6B,13,,,ppi
13017,15580,10457,GPNMB,glycoprotein nmb,5,heparin binding|chemoattractant activity|receptor ligand activity|integrin binding,large intestine cancer|colorectal cancer|hepatitis|breast cancer,ppi
13018,15581,2825,GPR1,G protein-coupled receptor 1,3,G-protein coupled receptor activity|neuropeptide binding,,ppi
13019,15582,2834,PRLHR,prolactin releasing hormone receptor,5,G-protein coupled receptor activity|neuropeptide receptor activity,,ppi
13020,15590,2835,GPR12,G protein-coupled receptor 12,2,,,ppi
13021,15598,2837,UTS2R,urotensin 2 receptor,2,G-protein coupled receptor activity|urotensin II receptor activity|G-protein coupled peptide receptor activity,,ppi
13022,15599,2838,GPR15,G protein-coupled receptor 15,2,virus receptor activity|G-protein coupled receptor activity|coreceptor activity,,ppi
13023,15600,9189,ZBED1,zinc finger BED-type containing 1,45,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|transposase activity|SUMO transferase activity|sequence-specific DNA binding,prostate cancer|prostate carcinoma,ppi
13024,15601,2840,GPR17,G protein-coupled receptor 17,2,chemokine receptor activity|G-protein coupled receptor activity,brain infarction,ppi
13025,15602,2841,GPR18,G protein-coupled receptor 18,12,G-protein coupled receptor activity,,ppi
13026,15604,2826,CCR10,C-C motif chemokine receptor 10,17,G-protein coupled receptor activity|C-C chemokine binding|C-C chemokine receptor activity|chemokine binding,status epilepticus,ppi
13027,15605,2843,GPR20,G protein-coupled receptor 20,3,G-protein coupled receptor activity,,ppi
13028,15606,2844,GPR21,G protein-coupled receptor 21,73,,,ppi
13029,15607,2845,GPR22,G protein-coupled receptor 22,3,G-protein coupled receptor activity,,ppi
13030,15608,2846,LPAR4,lysophosphatidic acid receptor 4,33,lysophosphatidic acid receptor activity|G-protein coupled receptor activity,papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma,ppi
13031,15609,2847,MCHR1,melanin concentrating hormone receptor 1,2,G-protein coupled receptor activity|neuropeptide receptor activity|neuropeptide binding|melanin-concentrating hormone receptor activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|mood disorder,ppi
13032,15610,2848,GPR25,G protein-coupled receptor 25,7,,,ppi
13033,15611,2849,GPR26,G protein-coupled receptor 26,1,G-protein coupled receptor activity,,ppi
13034,15613,2827,GPR3,G protein-coupled receptor 3,9,,,ppi
13035,15618,257,ALX3,ALX homeobox 3,16,DNA-binding transcription factor activity; RNA polymerase II-specific,ptosis|congenital ptosis|coloboma|intellectual disability|learning disability|microphthalmia|tetralogy of Fallot|cataract|corpus callosum lipoma|parietal foramina,ppi
13036,15620,2859,GPR35,G protein-coupled receptor 35,7,G-protein coupled receptor activity|C-X-C chemokine receptor activity,primary sclerosing cholangitis|sclerosing cholangitis,ppi
13037,15621,2861,GPR37,G protein-coupled receptor 37,25,G-protein coupled receptor activity|G-protein coupled peptide receptor activity|prosaposin receptor activity,malignant mesothelioma|benign mesothelioma,ppi
13038,15622,2862,MLNR,motilin receptor,4,,,ppi
13039,15623,2863,GPR39,G protein-coupled receptor 39,1,,,ppi
13040,15625,2864,FFAR1,free fatty acid receptor 1,2,G-protein coupled receptor activity|guanyl-nucleotide exchange factor activity|bioactive lipid receptor activity,,ppi
13041,15627,5244,ABCB4,ATP binding cassette subfamily B member 4,3,phospholipid transporter activity|phosphatidylcholine transporter activity|ATPase activity; coupled to transmembrane movement of substances|phosphatidylcholine-translocating ATPase activity|ceramide-translocating ATPase activity,bipolar disorder|primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis|cholecystitis|cholecystolithiasis|choledocholithiasis|intrahepatic cholestasis|large intestine cancer|colorectal cancer|obstructive jaundice|biliary tract disease|liver cirrhosis|primary biliary cirrhosis|acute pancreatitis|pancreatitis|liver disease|fatty liver disease,ppi
13042,15628,60529,ALX4,ALX homeobox 4,15,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,lung benign neoplasm|polydactyly|parietal foramina|craniosynostosis,ppi
13043,15630,2867,FFAR2,free fatty acid receptor 2,4,G-protein coupled receptor activity,,ppi
13044,15631,11251,PTGDR2,prostaglandin D2 receptor 2,4,G-protein coupled receptor activity|prostaglandin D receptor activity|neuropeptide binding,asthma|intrinsic asthma|allergic asthma,ppi
13045,15632,11250,GPR45,G protein-coupled receptor 45,4,G-protein coupled receptor activity,,ppi
13046,15633,100129278,TDRD15,tudor domain containing 15,3,,,ppi
13047,15634,8549,LGR5,leucine rich repeat containing G protein-coupled receptor 5,2,transmembrane signaling receptor activity|G-protein coupled receptor activity|G-protein coupled peptide receptor activity,colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer,ppi
13048,15635,9248,GPR50,G protein-coupled receptor 50,19,G-protein coupled receptor activity,bipolar disorder|schizophrenia|endogenous depression|mood disorder|autistic disorder,ppi
13049,15636,9568,GABBR2,gamma-aminobutyric acid type B receptor subunit 2,12,G-protein coupled GABA receptor activity,autistic disorder|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression|nicotine dependence,ppi
13050,15637,9293,GPR52,G protein-coupled receptor 52,31,G-protein coupled receptor activity|G-protein coupled photoreceptor activity,schizophreniform disorder|schizoaffective disorder,ppi
13051,15638,23600,AMACR,alpha-methylacyl-CoA racemase,4,alpha-methylacyl-CoA racemase activity,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|obstructive jaundice|biliary tract disease|blood coagulation disease|cholestasis|intrahepatic cholestasis|large intestine cancer|colorectal cancer|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetes mellitus|type 2 diabetes mellitus,ppi
13052,15639,84634,KISS1R,KISS1 receptor,3,neuropeptide receptor activity|G-protein coupled peptide receptor activity,stomach cancer|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|eunuchism|hypogonadism,ppi
13053,15640,9290,GPR55,G protein-coupled receptor 55,4,G-protein coupled receptor activity|cannabinoid receptor activity,,ppi
13054,15641,9289,ADGRG1,adhesion G protein-coupled receptor G1,2,G-protein coupled receptor activity|collagen binding|heparin binding|extracellular matrix binding,epilepsy|monocular esotropia|esotropia|alternating exotropia|exotropia|monocular exotropia|communication disorder|language disorder|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy,ppi
13055,15643,9287,TAAR2,trace amine associated receptor 2,1,G-protein coupled receptor activity|trace-amine receptor activity,,ppi
13056,15645,2830,GPR6,G protein-coupled receptor 6,2,G-protein coupled receptor activity,,ppi
13057,15648,10316,NMUR1,neuromedin U receptor 1,2,neuromedin U receptor activity|G-protein coupled receptor activity|neuropeptide receptor activity|neuromedin U binding,,ppi
13058,15650,258,AMBN,ameloblastin,4,growth factor activity,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia|dental enamel hypoplasia,ppi
13059,15651,2831,NPBWR1,neuropeptides B/W receptor 1,2,opioid receptor activity|G-protein coupled receptor activity|neuropeptide binding,,ppi
13060,15655,10886,NPFFR2,neuropeptide FF receptor 2,3,G-protein coupled receptor activity,,ppi
13061,15657,27202,C5AR2,complement component 5a receptor 2,59,G-protein coupled receptor activity|complement component C5a receptor activity,,ppi
13062,15658,27201,GPR78,G protein-coupled receptor 78,1,G-protein coupled receptor activity,bipolar disorder|schizophrenia,ppi
13063,15659,259,AMBP,alpha-1-microglobulin/bikunin precursor,14,serine-type endopeptidase inhibitor activity|calcium channel inhibitor activity|IgA binding|heme binding|calcium oxalate binding,transitional cell carcinoma,ppi
13064,15660,2832,NPBWR2,neuropeptides B/W receptor 2,12,opioid receptor activity|G-protein coupled receptor activity|neuropeptide binding,,ppi
13065,15662,27198,HCAR1,hydroxycarboxylic acid receptor 1,1,,,ppi
13066,15664,53831,GPR84,G protein-coupled receptor 84,3,G-protein coupled peptide receptor activity|urotensin II receptor activity,,ppi
13067,15665,54329,GPR85,G protein-coupled receptor 85,1,G-protein coupled receptor activity,,ppi
13068,15667,53836,GPR87,G protein-coupled receptor 87,1,G-protein coupled purinergic nucleotide receptor activity,,ppi
13069,15669,2833,CXCR3,C-X-C motif chemokine receptor 3,10,chemokine receptor activity|chemokine binding|C-C chemokine binding|C-C chemokine receptor activity,alopecia areata|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|atopic dermatitis|contact dermatitis|occupational dermatitis|nephritis|glomerulonephritis|kidney disease|allergic hypersensitivity disease|ischemia|pleural disease|pneumonia|cerebral infarction|cerebrovascular disease,ppi
13070,15670,56670,SUCNR1,succinate receptor 1,1,,,ppi
13071,15671,2868,GRK4,G protein-coupled receptor kinase 4,8,rhodopsin kinase activity,,ppi
13072,15672,2869,GRK5,G protein-coupled receptor kinase 5,177,protein serine/threonine kinase activity|protein kinase C binding|phospholipid binding|beta-adrenergic receptor kinase activity,heart disease|cardiovascular system disease|gallbladder disease|liver disease|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
13073,15673,2870,GRK6,G protein-coupled receptor kinase 6,37,beta-adrenergic receptor kinase activity,rheumatoid arthritis|schizophrenia,ppi
13074,15674,2873,GPS1,G protein pathway suppressor 1,67,GTPase inhibitor activity,schizophrenia,ppi
13075,15675,2874,GPS2,G protein pathway suppressor 2,66,transcription coactivator activity|transcription corepressor activity|GTPase inhibitor activity,,ppi
13076,15676,9524,TECR,trans-2;3-enoyl-CoA reductase,65,very-long-chain-acyl-CoA dehydrogenase activity|oxidoreductase activity,intellectual disability|learning disability|autosomal recessive non-syndromic intellectual disability,ppi
13077,15677,2875,GPT,glutamic--pyruvic transaminase,5,L-alanine:2-oxoglutarate aminotransferase activity,fatty liver disease|gallbladder disease|liver disease,ppi
13078,15678,2876,GPX1,glutathione peroxidase 1,18,glutathione peroxidase activity,autistic disorder|urinary bladder cancer|tongue squamous cell carcinoma|squamous cell carcinoma|transitional cell carcinoma|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ,ppi
13079,15679,2877,GPX2,glutathione peroxidase 2,3,glutathione peroxidase activity|electron transfer activity,breast cancer,ppi
13080,15680,2878,GPX3,glutathione peroxidase 3,3,glutathione peroxidase activity|transcription factor binding|selenium binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|endometriosis of uterus|endometriosis|Fanconi syndrome|liver cancer|lung benign neoplasm|obesity|prostate cancer|prostate carcinoma|neurodegenerative disease,ppi
13081,15681,2879,GPX4,glutathione peroxidase 4,41,glutathione peroxidase activity|identical protein binding|phospholipid-hydroperoxide glutathione peroxidase activity,sick sinus syndrome|atrioventricular block|clubfoot|large intestine cancer|colorectal cancer|cryptorchidism|fatty liver disease|congestive heart failure|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|male infertility,ppi
13082,15684,2882,GPX7,glutathione peroxidase 7,38,catalase activity|peroxidase activity,,ppi
13083,15685,10750,GRAP,GRB2-related adaptor protein,15,SH3/SH2 adaptor activity,,ppi
13084,15686,9402,GRAP2,GRB2-related adaptor protein 2,55,SH3/SH2 adaptor activity,,ppi
13085,15687,2887,GRB10,growth factor receptor bound protein 10,46,insulin receptor binding,schizophrenia,ppi
13086,15688,2888,GRB14,growth factor receptor bound protein 14,23,identical protein binding|protein homodimerization activity,diabetes mellitus|type 2 diabetes mellitus,ppi
13087,15689,2885,GRB2,growth factor receptor bound protein 2,949,RNA binding|SH3/SH2 adaptor activity|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|SH3 domain binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,schizophrenia,ppi
13088,15690,2886,GRB7,growth factor receptor bound protein 7,47,protein kinase binding|phosphatidylinositol binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|lung benign neoplasm|prostate cancer|prostate carcinoma|breast cancer,ppi
13089,15691,2889,RAPGEF1,Rap guanine nucleotide exchange factor 1,26,guanyl-nucleotide exchange factor activity|Rap guanyl-nucleotide exchange factor activity,,ppi
13090,15692,262,AMD1,adenosylmethionine decarboxylase 1,29,adenosylmethionine decarboxylase activity|putrescine binding,,ppi
13091,15693,9380,GRHPR,glyoxylate and hydroxypyruvate reductase,32,glycerate dehydrogenase activity|hydroxypyruvate reductase activity|glyoxylate reductase (NADP) activity|protein homodimerization activity|NAD binding|NADPH binding|oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor,primary hyperoxaluria|calcium metabolism disease|nephrocalcinosis|calcinosis|hypercalcemia|phosphorus metabolism disease|prostate cancer|prostate carcinoma|nephrolithiasis,ppi
13092,15694,2890,GRIA1,glutamate ionotropic receptor AMPA type subunit 1,30,amyloid-beta binding|AMPA glutamate receptor activity|excitatory extracellular ligand-gated ion channel activity|glutamate receptor activity|PDZ domain binding|neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|intellectual disability|learning disability|cocaine dependence|opiate dependence|morphine dependence|heroin dependence|hypoactive sexual desire disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia|cocaine abuse,ppi
13093,15695,2891,GRIA2,glutamate ionotropic receptor AMPA type subunit 2,37,amyloid-beta binding|ionotropic glutamate receptor activity|AMPA glutamate receptor activity|excitatory extracellular ligand-gated ion channel activity,bipolar disorder|schizophrenia|status epilepticus|neurotic disorder|endogenous depression|melancholia|cocaine abuse|cocaine dependence|major depressive disorder|mental depression,ppi
13094,15696,2892,GRIA3,glutamate ionotropic receptor AMPA type subunit 3,26,amyloid-beta binding|AMPA glutamate receptor activity|excitatory extracellular ligand-gated ion channel activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|enophthalmos|orbital disease|exophthalmos|intellectual disability|learning disability|hypoactive sexual desire disorder|schizophrenia|syndromic X-linked intellectual disability 94|craniosynostosis|amyotrophic lateral sclerosis type 1,ppi
13095,15697,2893,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,15,ionotropic glutamate receptor activity|AMPA glutamate receptor activity|excitatory extracellular ligand-gated ion channel activity,bipolar disorder|myopia|schizophrenia|neurotic disorder|endogenous depression|melancholia|substance abuse|substance-related disorder|major depressive disorder|mental depression,ppi
13096,15698,2894,GRID1,glutamate ionotropic receptor delta type subunit 1,8,glutamate receptor activity,bipolar disorder|large intestine cancer|colorectal cancer|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia,ppi
13097,15699,2895,GRID2,glutamate ionotropic receptor delta type subunit 2,11,glutamate receptor activity|PDZ domain binding|scaffold protein binding,monocular esotropia|esotropia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|agnosia|autosomal recessive spinocerebellar ataxia 18,ppi
13098,15701,2897,GRIK1,glutamate ionotropic receptor kainate type subunit 1,6,ligand-gated ion channel activity|kainate selective glutamate receptor activity|glutamate receptor activity,alcohol dependence|alcohol abuse|bipolar disorder|schizophrenia|epilepsy|visual epilepsy,ppi
13099,15702,2898,GRIK2,glutamate ionotropic receptor kainate type subunit 2,20,extracellularly glutamate-gated ion channel activity|ligand-gated ion channel activity|kainate selective glutamate receptor activity|glutamate receptor activity,autistic disorder|bipolar disorder|intellectual disability|learning disability|hypoactive sexual desire disorder|schizophrenia|substance abuse|substance-related disorder|mood disorder|autosomal recessive non-syndromic intellectual disability,ppi
13100,15703,2899,GRIK3,glutamate ionotropic receptor kainate type subunit 3,5,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity|G-protein coupled receptor binding|ionotropic glutamate receptor activity|glutamate receptor activity|ligand-gated ion channel activity|kainate selective glutamate receptor activity,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia|lung small cell carcinoma,ppi
13101,15704,2900,GRIK4,glutamate ionotropic receptor kainate type subunit 4,4,ligand-gated ion channel activity|kainate selective glutamate receptor activity|glutamate receptor activity,bipolar disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
13102,15705,2901,GRIK5,glutamate ionotropic receptor kainate type subunit 5,11,ligand-gated ion channel activity|kainate selective glutamate receptor activity|glutamate receptor activity,bipolar disorder|schizophrenia,ppi
13103,15706,2902,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,59,NMDA glutamate receptor activity|Ras guanyl-nucleotide exchange factor activity|calcium ion binding|calmodulin binding|glycine binding|glutamate binding|glutamate-gated calcium ion channel activity|neurotransmitter binding|protein-containing complex binding|calcium channel activity,alcohol dependence|alcohol abuse|bipolar disorder|intellectual disability|learning disability|schizophreniform disorder|schizoaffective disorder|trigeminal neuralgia|cocaine abuse|cocaine dependence|autosomal dominant non-syndromic intellectual disability,ppi
13104,15707,2903,GRIN2A,glutamate ionotropic receptor NMDA type subunit 2A,27,NMDA glutamate receptor activity|Ras guanyl-nucleotide exchange factor activity|zinc ion binding|glutamate-gated calcium ion channel activity,agnosia|alcohol dependence|alcohol abuse|autistic disorder|bipolar disorder|large intestine cancer|colorectal cancer|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|communication disorder|melanoma|skin melanoma|cocaine dependence|opiate dependence|morphine dependence,ppi
13105,15708,2904,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B,47,NMDA glutamate receptor activity|Ras guanyl-nucleotide exchange factor activity|zinc ion binding|glycine binding|glutamate binding|glutamate-gated calcium ion channel activity,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|intellectual disability|learning disability|schizophrenia|visual epilepsy|infantile epileptic encephalopathy|autistic disorder|autosomal dominant non-syndromic intellectual disability,ppi
13106,15709,2905,GRIN2C,glutamate ionotropic receptor NMDA type subunit 2C,6,NMDA glutamate receptor activity|Ras guanyl-nucleotide exchange factor activity|glutamate-gated calcium ion channel activity,schizophrenia,ppi
13107,15710,2906,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,36,ionotropic glutamate receptor activity|NMDA glutamate receptor activity|Ras guanyl-nucleotide exchange factor activity|glutamate-gated calcium ion channel activity,schizophrenia,ppi
13108,15712,2909,ARHGAP35,Rho GTPase activating protein 35,14,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|transcription corepressor activity|GTPase activator activity|phospholipid binding,lung cancer|lung adenocarcinoma,ppi
13109,15713,2911,GRM1,glutamate metabotropic receptor 1,16,G-protein coupled receptor activity|glutamate receptor activity|G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential|neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,alcohol dependence|alcohol abuse|ptosis|congenital ptosis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|complex partial epilepsy|temporal lobe epilepsy|monocular esotropia|esotropia|clubfoot|intellectual disability|learning disability|schizophrenia|status epilepticus,ppi
13110,15714,2912,GRM2,glutamate metabotropic receptor 2,8,G-protein coupled receptor activity|glutamate receptor activity|calcium channel regulator activity,alcohol dependence|alcohol abuse|complex partial epilepsy|temporal lobe epilepsy|drug psychosis|schizophrenia|mood disorder,ppi
13111,15715,2913,GRM3,glutamate metabotropic receptor 3,6,G-protein coupled receptor activity|glutamate receptor activity,alcohol dependence|alcohol abuse|bipolar disorder|complex partial epilepsy|temporal lobe epilepsy|melanoma|skin melanoma|schizophrenia|mood disorder,ppi
13112,15716,2914,GRM4,glutamate metabotropic receptor 4,5,G-protein coupled receptor activity|glutamate receptor activity|group III metabotropic glutamate receptor activity,alcohol dependence|alcohol abuse|bipolar disorder|complex partial epilepsy|temporal lobe epilepsy|osteosarcoma|bone osteosarcoma|schizophrenia,ppi
13113,15717,2915,GRM5,glutamate metabotropic receptor 5,19,G-protein coupled receptor activity|glutamate receptor activity|protein tyrosine kinase activator activity|protein tyrosine kinase binding|neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration|G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,bipolar disorder|diabetic autonomic neuropathy|diabetic polyneuropathy|diabetic neuropathy|complex partial epilepsy|temporal lobe epilepsy|schizophrenia|status epilepticus|neurotic disorder|endogenous depression|melancholia|cocaine abuse|cocaine dependence|substance abuse|substance-related disorder|attention deficit hyperactivity disorder|major depressive disorder|mental depression,ppi
13114,15718,2916,GRM6,glutamate metabotropic receptor 6,2,G-protein coupled receptor activity|glutamate receptor activity|group III metabotropic glutamate receptor activity,night blindness|myopia|congenital stationary night blindness|hereditary night blindness,ppi
13115,15719,2917,GRM7,glutamate metabotropic receptor 7,13,group III metabotropic glutamate receptor activity|glutamate receptor activity|adenylate cyclase inhibitor activity|serine binding|calcium channel regulator activity,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|substance abuse|substance-related disorder|attention deficit hyperactivity disorder,ppi
13116,15720,340273,ABCB5,ATP binding cassette subfamily B member 5,3,xenobiotic transmembrane transporting ATPase activity|efflux transmembrane transporter activity,large intestine cancer|colorectal cancer|melanoma|skin melanoma,ppi
13117,15721,2918,GRM8,glutamate metabotropic receptor 8,4,G-protein coupled receptor activity|glutamate receptor activity|group III metabotropic glutamate receptor activity,alcohol dependence|alcohol abuse|anxiety disorder|phobic disorder|autistic disorder|schizophrenia|lung small cell carcinoma|attention deficit hyperactivity disorder,ppi
13118,15722,2896,GRN,granulin precursor,102,RNA binding|growth factor activity,alexia|dyslexia|generalized anxiety disorder|anxiety disorder|agnosia|bipolar disorder|cerebellar disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|echolalia|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|bulimia nervosa|mutism|optic atrophy|schizophrenia,ppi
13119,15723,2919,CXCL1,C-X-C motif chemokine ligand 1,10,signaling receptor binding|enzyme activator activity|chemokine activity,allergic hypersensitivity disease|chronic obstructive pulmonary disease|pneumonia|asthma|autoimmune hepatitis,ppi
13120,15724,2920,CXCL2,C-X-C motif chemokine ligand 2,9,chemokine activity,rheumatoid arthritis|cholestasis|esophageal cancer|congestive heart failure|hypertension|essential hypertension|chronic obstructive pulmonary disease|arthropathy|arthritis|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|seborrheic keratosis|skin disease|actinic keratosis|coronary artery disease|allergic contact dermatitis|middle cerebral artery infarction|breast cancer,ppi
13121,15725,2921,CXCL3,C-X-C motif chemokine ligand 3,2,chemokine activity,seborrheic keratosis|skin disease|actinic keratosis|breast cancer,ppi
13122,15726,2922,GRP,gastrin releasing peptide,4,signaling receptor binding|neuropeptide hormone activity,amnestic disorder|dissociative amnesia|head and neck cancer,ppi
13123,15727,2923,PDIA3,protein disulfide isomerase family A member 3,141,RNA binding|cysteine-type endopeptidase activity|phospholipase C activity|disulfide oxidoreductase activity|peptide disulfide oxidoreductase activity|protein disulfide isomerase activity,prostate cancer|prostate carcinoma|spinocerebellar ataxia type 17|liver cancer|hepatocellular carcinoma,ppi
13124,15728,2925,GRPR,gastrin releasing peptide receptor,53,neuropeptide receptor activity|G-protein coupled peptide receptor activity|G-protein coupled receptor activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|prostate cancer|prostate carcinoma,ppi
13125,15729,265,AMELX,amelogenin; X-linked,1,growth factor activity|structural constituent of tooth enamel|identical protein binding|hydroxyapatite binding,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia|dental enamel hypoplasia,ppi
13126,15730,2926,GRSF1,G-rich RNA sequence binding factor 1,64,RNA binding|mRNA binding,,ppi
13127,15731,145258,GSC,goosecoid homeobox,6,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II transcription factor binding|RNA polymerase II repressing transcription factor binding,,ppi
13128,15732,2928,GSC2,goosecoid homeobox 2,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
13129,15733,2931,GSK3A,glycogen synthase kinase 3 alpha,72,protein serine/threonine kinase activity|tau-protein kinase activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia,ppi
13130,15734,2932,GSK3B,glycogen synthase kinase 3 beta,381,p53 binding|protein kinase activity|protein serine/threonine kinase activity|kinase activity|tau-protein kinase activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression,ppi
13131,15736,2934,GSN,gelsolin,86,actin binding|calcium ion binding,Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|malignant mesothelioma|benign mesothelioma|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|osteoporosis|polyneuropathy|peripheral nervous system disease|neuropathy|kidney failure|uremia|schizophrenia|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy,ppi
13132,15737,2935,GSPT1,G1 to S phase transition 1,56,RNA binding|translation release factor activity|GTPase activity,,ppi
13133,15738,23708,GSPT2,G1 to S phase transition 2,46,RNA binding|translation release factor activity|GTPase activity,,ppi
13134,15739,2936,GSR,glutathione-disulfide reductase,35,glutathione-disulfide reductase activity|electron transfer activity|flavin adenine dinucleotide binding,progressive muscular atrophy|amyotrophic lateral sclerosis|anemia|macrocytic anemia|hemolytic anemia|contact dermatitis|occupational dermatitis|congestive heart failure|Graves' disease|thyrotoxicosis|hyperthyroidism|hypoglycemia|secondary Parkinson disease|neurodegenerative disease,ppi
13135,15740,2937,GSS,glutathione synthetase,29,magnesium ion binding|glutathione synthase activity|ATP binding|protein homodimerization activity|glutathione binding,hemolytic anemia|cerebellar disease|contact dermatitis|occupational dermatitis|epilepsy|intellectual disability|learning disability|mouth disease|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|schizophrenia|visual epilepsy,ppi
13136,15741,2938,GSTA1,glutathione S-transferase alpha 1,15,glutathione transferase activity|glutathione peroxidase activity,prostate cancer|prostate carcinoma|schizophreniform disorder|schizoaffective disorder|schizophrenia|coronary artery disease|fatty liver disease,ppi
13137,15742,2939,GSTA2,glutathione S-transferase alpha 2,6,glutathione transferase activity,,ppi
13138,15743,2940,GSTA3,glutathione S-transferase alpha 3,4,glutathione transferase activity,,ppi
13139,15744,2941,GSTA4,glutathione S-transferase alpha 4,6,glutathione transferase activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|Parkinson's disease,ppi
13140,15745,267,AMFR,autocrine motility factor receptor,125,ubiquitin-protein transferase activity|protein binding; bridging|ubiquitin-ubiquitin ligase activity|ubiquitin protein ligase activity|BAT3 complex binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|urinary bladder cancer,ppi
13141,15746,2944,GSTM1,glutathione S-transferase mu 1,9,glutathione transferase activity|glutathione binding,alcohol dependence|alcohol abuse|asthma|intrinsic asthma|allergic asthma|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|autistic disorder|bipolar disorder|urinary bladder cancer|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
13142,15747,2946,GSTM2,glutathione S-transferase mu 2,6,glutathione transferase activity|glutathione peroxidase activity|glutathione binding,lung cancer|non-small cell lung carcinoma|Down syndrome|schizophrenia|coronary artery disease|neurodegenerative disease,ppi
13143,15748,2947,GSTM3,glutathione S-transferase mu 3,32,glutathione transferase activity|protein homodimerization activity|glutathione binding,large intestine cancer|colorectal cancer|prostate cancer|prostate carcinoma,ppi
13144,15749,2948,GSTM4,glutathione S-transferase mu 4,14,glutathione transferase activity|glutathione binding,neurodegenerative disease,ppi
13145,15750,2949,GSTM5,glutathione S-transferase mu 5,7,glutathione transferase activity,colon cancer|colonic benign neoplasm|neurodegenerative disease,ppi
13146,15751,2950,GSTP1,glutathione S-transferase pi 1,63,glutathione transferase activity|glutathione peroxidase activity|JUN kinase binding|kinase regulator activity|S-nitrosoglutathione binding|dinitrosyl-iron complex binding|nitric oxide binding,progressive muscular atrophy|amyotrophic lateral sclerosis|asthma|intrinsic asthma|allergic asthma|autistic disorder|urinary bladder cancer|lung cancer|non-small cell lung carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|carotid artery disease|contact dermatitis|occupational dermatitis|malignant glioma,ppi
13147,15752,268,AMH,anti-Mullerian hormone,8,hormone activity,cryptorchidism|inguinal hernia|male infertility|persistent Mullerian duct syndrome,ppi
13148,15753,2952,GSTT1,glutathione S-transferase theta 1,17,glutathione transferase activity|glutathione peroxidase activity,asbestosis|anthracosilicosis|byssinosis|bipolar disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|glioblastoma multiforme|giant cell glioblastoma|hypertension,ppi
13149,15754,2953,GSTT2,glutathione S-transferase theta 2 (gene/pseudogene),6,glutathione transferase activity,hypertension|essential hypertension|schizophrenia|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y,ppi
13150,15755,2954,GSTZ1,glutathione S-transferase zeta 1,11,glutathione transferase activity|glutathione peroxidase activity|maleylacetoacetate isomerase activity|hydrolase activity; acting on acid halide bonds; in C-halide compounds,bipolar disorder|urinary bladder cancer|central nervous system origin vertigo|inner ear disease|vestibular disease,ppi
13151,15756,2957,GTF2A1,general transcription factor IIA subunit 1,61,DNA binding|transcription coactivator activity,,ppi
13152,15757,2958,GTF2A2,general transcription factor IIA subunit 2,10,transcription coactivator activity|TBP-class protein binding,,ppi
13153,15758,2959,GTF2B,general transcription factor IIB,100,RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II complex binding|core promoter binding|zinc ion binding|acetyltransferase activity|promoter-specific chromatin binding,,ppi
13154,15759,269,AMHR2,anti-Mullerian hormone receptor type 2,7,anti-Mullerian hormone receptor activity|SMAD binding|growth factor binding|BMP receptor activity|transforming growth factor beta receptor activity; type II|transforming growth factor beta-activated receptor activity,cryptorchidism|inguinal hernia|male infertility|persistent Mullerian duct syndrome,ppi
13155,15760,2960,GTF2E1,general transcription factor IIE subunit 1,54,obsolete transcription factor activity; RNA polymerase II transcription factor binding|RNA polymerase II complex binding|TFIIH-class transcription factor complex binding,,ppi
13156,15761,2961,GTF2E2,general transcription factor IIE subunit 2,116,RNA binding|obsolete transcription factor activity; RNA polymerase II transcription factor binding|TFIIH-class transcription factor complex binding,photosensitive trichothiodystrophy,ppi
13157,15762,2962,GTF2F1,general transcription factor IIF subunit 1,102,transcription coactivator activity|RNA binding|phosphatase activator activity|promoter-specific chromatin binding,,ppi
13158,15763,2963,GTF2F2,general transcription factor IIF subunit 2,74,obsolete transcription factor activity; core RNA polymerase II binding,,ppi
13159,15764,2965,GTF2H1,general transcription factor IIH subunit 1,60,protein kinase activity|DNA-dependent ATPase activity|RNA polymerase II CTD heptapeptide repeat kinase activity,,ppi
13160,15765,2966,GTF2H2,general transcription factor IIH subunit 2,23,nucleic acid binding|DNA-binding transcription factor activity|translation factor activity; RNA binding|protein kinase activity|DNA-dependent ATPase activity|RNA polymerase II CTD heptapeptide repeat kinase activity,,ppi
13161,15766,2967,GTF2H3,general transcription factor IIH subunit 3,16,damaged DNA binding|DNA-binding transcription factor activity|translation factor activity; RNA binding|protein kinase activity|DNA-dependent ATPase activity|RNA polymerase II CTD heptapeptide repeat kinase activity,,ppi
13162,15767,2968,GTF2H4,general transcription factor IIH subunit 4,20,DNA-binding transcription factor activity|protein kinase activity|DNA-dependent ATPase activity|RNA polymerase II CTD heptapeptide repeat kinase activity|double-stranded DNA binding,,ppi
13163,15768,2969,GTF2I,general transcription factor IIi,136,DNA-binding transcription factor activity,generalized anxiety disorder|anxiety disorder|supravalvular aortic stenosis|autistic disorder|blepharophimosis|brain ischemia|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|basal ganglia disease|focal hand dystonia|blepharospasm|clubfoot|sensorineural hearing loss|inguinal hernia|nephrocalcinosis,ppi
13164,15769,9569,GTF2IRD1,GTF2I repeat domain containing 1,45,DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding,generalized anxiety disorder|anxiety disorder|supravalvular aortic stenosis|autistic disorder|blepharophimosis|brain ischemia|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|basal ganglia disease|focal hand dystonia|blepharospasm|clubfoot|sensorineural hearing loss|inguinal hernia|nephrocalcinosis,ppi
13165,15770,2971,GTF3A,general transcription factor IIIA,10,DNA-binding transcription factor activity; RNA polymerase II-specific|5S rRNA binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
13166,15771,2975,GTF3C1,general transcription factor IIIC subunit 1,94,DNA binding|RNA polymerase III general transcription initiation factor activity|RNA polymerase III type 1 promoter sequence-specific DNA binding|RNA polymerase III type 2 promoter sequence-specific DNA binding,,ppi
13167,15772,2976,GTF3C2,general transcription factor IIIC subunit 2,61,DNA binding|RNA polymerase III general transcription initiation factor activity,,ppi
13168,15773,9330,GTF3C3,general transcription factor IIIC subunit 3,68,DNA binding|RNA polymerase III general transcription initiation factor activity,,ppi
13169,15774,9329,GTF3C4,general transcription factor IIIC subunit 4,67,enzyme activator activity|DNA binding,,ppi
13170,15775,9328,GTF3C5,general transcription factor IIIC subunit 5,49,DNA binding|RNA polymerase III type 1 promoter sequence-specific DNA binding|RNA polymerase III type 2 promoter sequence-specific DNA binding|RNA polymerase III transcription regulator recruiting activity|RNA polymerase III general transcription initiation factor activity,,ppi
13171,15776,9567,GTPBP1,GTP binding protein 1,29,RNA binding|GTPase activity|translation elongation factor activity,,ppi
13172,15777,9949,AMMECR1,Alport syndrome; mental retardation; midface hypoplasia and elliptocytosis chromosomal region gene 1,21,,sensorineural hearing loss|favism|hereditary elliptocytosis|congenital hemolytic anemia|proteinuria|kidney failure|uremia|syndromic X-linked intellectual disability 94,ppi
13173,15778,54676,GTPBP2,GTP binding protein 2,21,translation elongation factor activity,,ppi
13174,15779,2978,GUCA1A,guanylate cyclase activator 1A,2,calcium ion binding|calcium sensitive guanylate cyclase activator activity|guanylate cyclase regulator activity,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|night blindness|congenital stationary night blindness|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|blindness|asthenopia,ppi
13175,15780,2979,GUCA1B,guanylate cyclase activator 1B,2,,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|blindness,ppi
13176,15781,270,AMPD1,adenosine monophosphate deaminase 1,11,AMP deaminase activity,anterior horn cell disease|muscular atrophy|familial periodic paralysis|myopathy,ppi
13177,15783,2980,GUCA2A,guanylate cyclase activator 2A,1,hormone activity|guanylate cyclase activator activity,,ppi
13178,15784,2981,GUCA2B,guanylate cyclase activator 2B,1,calcium sensitive guanylate cyclase activator activity|guanylate cyclase activator activity,chronic kidney disease|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome,ppi
13179,15785,2977,GUCY1A2,guanylate cyclase 1 soluble subunit alpha 2,12,,large intestine cancer|colorectal cancer|breast cancer,ppi
13180,15786,2982,GUCY1A3,guanylate cyclase 1 soluble subunit alpha,10,guanylate cyclase activity|signaling receptor activity,colon cancer|colonic benign neoplasm|salivary gland adenoid cystic carcinoma|megaesophagus|achalasia|hypertension|essential hypertension|cerebral infarction|cerebrovascular disease|psychologic dyspareunia|premature ejaculation|coronary artery disease|Moyamoya disease,ppi
13181,15787,2983,GUCY1B3,guanylate cyclase 1 soluble subunit beta,16,guanylate cyclase activity|heme binding|signaling receptor activity,,ppi
13182,15788,2984,GUCY2C,guanylate cyclase 2C,4,guanylate cyclase activity|peptide receptor activity,large intestine cancer|colorectal cancer|megacystis-microcolon-intestinal hypoperistalsis syndrome|congenital diarrhea 6,ppi
13183,15789,3000,GUCY2D,guanylate cyclase 2D; retinal,7,guanylate cyclase activity|signaling receptor activity|peptide receptor activity,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|epilepsy|sensorineural hearing loss|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cone-rod dystrophy|retinitis pigmentosa,ppi
13184,15790,271,AMPD2,adenosine monophosphate deaminase 2,27,AMP deaminase activity,epilepsy|optic atrophy|visual epilepsy|paraplegia|cortical blindness|cerebral degeneration|hereditary spastic paraplegia 63|pontocerebellar hypoplasia type 9,ppi
13185,15791,2986,GUCY2F,guanylate cyclase 2F; retinal,2,guanylate cyclase activity|signaling receptor activity|peptide receptor activity,,ppi
13186,15792,2987,GUK1,guanylate kinase 1,10,guanylate kinase activity,,ppi
13187,15793,2990,GUSB,glucuronidase beta,15,beta-glucuronidase activity|carbohydrate binding,pseudosarcomatous fibromatosis|recurrent corneal erosion|sensorineural hearing loss|heart valve disease|inguinal hernia|umbilical hernia|omphalocele|hypertrichosis|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|elephantiasis|lymphedema|intellectual disability|learning disability|central nervous system disease|nervous system disease|autonomic neuropathy|proteinuria,ppi
13188,15794,2992,GYG1,glycogenin 1,24,glycogenin glucosyltransferase activity,sick sinus syndrome|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|coronary artery disease|muscular atrophy|glycogen storage disease XV,ppi
13189,15795,10058,ABCB6,ATP binding cassette subfamily B member 6 (Langereis blood group),19,ATP binding|heme transporter activity|heme-transporting ATPase activity|efflux transmembrane transporter activity|heme binding,coloboma|large intestine cancer|colorectal cancer|sensorineural hearing loss|hypertension|essential hypertension|polycystic ovary syndrome|photosensitivity disease|photosensitive epilepsy|dyschromatosis universalis hereditaria,ppi
13190,15796,272,AMPD3,adenosine monophosphate deaminase 3,4,AMP deaminase activity,,ppi
13191,15797,8908,GYG2,glycogenin 2,16,glycogenin glucosyltransferase activity,,ppi
13192,15798,2993,GYPA,glycophorin A (MNS blood group),13,,malaria|skin benign neoplasm|skin cancer,ppi
13193,15799,2994,GYPB,glycophorin B (MNS blood group),49,,,ppi
13194,15800,2995,GYPC,glycophorin C (Gerbich blood group),3,protein binding,favism|hereditary elliptocytosis|congenital hemolytic anemia|malaria,ppi
13195,15802,2997,GYS1,glycogen synthase 1,47,glycogen (starch) synthase activity|glycogen synthase activity; transferring glucose-1-phosphate|glucose binding|protein kinase binding,visual epilepsy|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
13196,15803,2998,GYS2,glycogen synthase 2,8,glycogen (starch) synthase activity|protein homodimerization activity|glycogen synthase activity; transferring glucose-1-phosphate|protein kinase binding|glucose binding,epilepsy|visual epilepsy|hypoglycemia|hyperglycemia,ppi
13197,15804,3001,GZMA,granzyme A,18,serine-type endopeptidase activity|protein homodimerization activity,,ppi
13198,15805,3002,GZMB,granzyme B,30,serine-type endopeptidase activity|serine-type peptidase activity,autistic disorder|breast cancer,ppi
13199,15806,273,AMPH,amphiphysin,52,phospholipid binding,,ppi
13200,15807,2999,GZMH,granzyme H,1,serine-type endopeptidase activity,,ppi
13201,15808,3003,GZMK,granzyme K,12,serine-type peptidase activity,,ppi
13202,15809,3004,GZMM,granzyme M,5,serine-type endopeptidase activity|serine-type peptidase activity,,ppi
13203,15810,3005,H1F0,H1 histone family member 0,45,RNA binding|chromatin DNA binding|nucleosomal DNA binding|double-stranded DNA binding|protein binding,acute myeloid leukemia,ppi
13204,15811,3024,HIST1H1A,histone cluster 1 H1 family member a,183,chromatin DNA binding|nucleosomal DNA binding|protein binding|double-stranded DNA binding,,ppi
13205,15812,3006,HIST1H1C,histone cluster 1 H1 family member c,140,RNA binding|chromatin DNA binding|nucleosomal DNA binding|protein binding|double-stranded DNA binding,acute myeloid leukemia|breast cancer,ppi
13206,15813,3007,HIST1H1D,histone cluster 1 H1 family member d,55,RNA binding|chromatin DNA binding|protein binding|nucleosomal DNA binding|double-stranded DNA binding,,ppi
13207,15814,3008,HIST1H1E,histone cluster 1 H1 family member e,140,RNA binding|chromatin DNA binding|AMP binding|GTP binding|calcium ion binding|double-stranded DNA binding|nucleosomal DNA binding|ATP binding|ADP binding|protein binding,salivary gland adenoid cystic carcinoma|schizophrenia,ppi
13208,15815,3009,HIST1H1B,histone cluster 1 H1 family member b,74,RNA binding|chromatin DNA binding|nucleosomal DNA binding|double-stranded DNA binding|protein binding|histone deacetylase binding,schizophrenia,ppi
13209,15816,3010,HIST1H1T,histone cluster 1 H1 family member t,89,double-stranded DNA binding|protein binding|nucleosomal DNA binding,,ppi
13210,15817,8971,H1FX,H1 histone family member X,73,RNA binding|cadherin binding|double-stranded DNA binding|protein binding|nucleosomal DNA binding,,ppi
13211,15818,3012,HIST1H2AE,histone cluster 1 H2A family member e,73,,,ppi
13212,15819,8329,HIST1H2AI,histone cluster 1 H2A family member i,55,,,ppi
13213,15821,8331,HIST1H2AJ,histone cluster 1 H2A family member j,14,DNA binding,,ppi
13214,15822,3013,HIST1H2AD,histone cluster 1 H2A family member d,30,DNA binding,,ppi
13215,15823,275,AMT,aminomethyltransferase,5,aminomethyltransferase activity,epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|visual epilepsy|brain disease|glycine encephalopathy,ppi
13216,15825,8334,HIST1H2AC,histone cluster 1 H2A family member c,8,DNA binding,,ppi
13217,15830,8338,HIST2H2AC,histone cluster 2 H2A family member c,117,DNA binding,,ppi
13218,15831,3014,H2AFX,H2A histone family member X,314,DNA binding,glioblastoma multiforme|giant cell glioblastoma|schizophrenia|breast cancer,ppi
13219,15832,276,AMY1A,amylase; alpha 1A (salivary),37,,,ppi
13220,15833,9555,H2AFY,H2A histone family member Y,89,rDNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|DNA binding|double-stranded methylated DNA binding|protein serine/threonine kinase inhibitor activity|chromatin DNA binding|nucleosomal DNA binding|transcription regulatory region DNA binding|promoter-specific chromatin binding,,ppi
13221,15834,3015,H2AFZ,H2A histone family member Z,56,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|chromatin DNA binding|nucleosomal DNA binding|DNA binding,,ppi
13222,15835,8339,HIST1H2BG,histone cluster 1 H2B family member g,261,,prostate cancer|prostate carcinoma,ppi
13223,15836,3017,HIST1H2BD,histone cluster 1 H2B family member d,20,DNA binding,,ppi
13224,15837,8340,HIST1H2BL,histone cluster 1 H2B family member l,35,DNA binding,,ppi
13225,15838,8341,HIST1H2BN,histone cluster 1 H2B family member n,16,DNA binding,,ppi
13226,15840,8342,HIST1H2BM,histone cluster 1 H2B family member m,14,DNA binding,esophagus squamous cell carcinoma,ppi
13227,15841,3018,HIST1H2BB,histone cluster 1 H2B family member b,59,DNA binding,,ppi
13228,15844,8345,HIST1H2BH,histone cluster 1 H2B family member h,12,DNA binding,,ppi
13229,15847,8348,HIST1H2BO,histone cluster 1 H2B family member o,20,DNA binding,,ppi
13230,15849,8349,HIST2H2BE,histone cluster 2 H2B family member e,141,DNA binding,,ppi
13231,15850,8970,HIST1H2BJ,histone cluster 1 H2B family member j,31,lipopolysaccharide binding|DNA binding,schizophrenia,ppi
13232,15851,3020,H3F3A,H3 histone family member 3A,135,,glioblastoma multiforme|giant cell glioblastoma|malignant glioma|gliosarcoma|mixed glioma|bone giant cell tumor,ppi
13233,15853,8350,HIST1H3A,histone cluster 1 H3 family member a,447,,,ppi
13234,15857,279,AMY2A,amylase; alpha 2A (pancreatic),6,alpha-amylase activity|calcium ion binding|chloride ion binding,,ppi
13235,15864,8290,HIST3H3,histone cluster 3 H3,252,nucleosomal DNA binding,asbestosis|anthracosilicosis|pneumoconiosis|siderosis|bagassosis|intellectual disability|learning disability,ppi
13236,15865,280,AMY2B,amylase; alpha 2B (pancreatic),2,alpha-amylase activity,,ppi
13237,15876,8369,HIST1H4G,histone cluster 1 H4 family member g,3,DNA binding,,ppi
13238,15879,9563,H6PD,hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase,5,,hypertrichosis|infertility|obesity|acne,ppi
13239,15880,23498,HAAO,3-hydroxyanthranilate 3;4-dioxygenase,5,3-hydroxyanthranilate 3;4-dioxygenase activity|ferrous iron binding|electron transfer activity,,ppi
13240,15881,3026,HABP2,hyaluronan binding protein 2,8,glycosaminoglycan binding|serine-type endopeptidase activity,nodular goiter|head and neck cancer|follicular thyroid carcinoma|papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma|thrombophilia|protein S deficiency|antithrombin III deficiency|protein C deficiency,ppi
13241,15882,3033,HADH,hydroxyacyl-CoA dehydrogenase,27,3-hydroxyacyl-CoA dehydrogenase activity,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
13242,15883,22,ABCB7,ATP binding cassette subfamily B member 7,29,heme transporter activity,sideroblastic anemia|X-linked sideroblastic anemia with ataxia,ppi
13243,15884,3028,HSD17B10,hydroxysteroid 17-beta dehydrogenase 10,138,tRNA binding|RNA binding|3-hydroxyacyl-CoA dehydrogenase activity|cholate 7-alpha-dehydrogenase activity|testosterone dehydrogenase [NAD(P)] activity,lactic acidosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|epilepsy|sensorineural hearing loss|hypoglycemia|intellectual disability|learning disability|movement disease|lingual-facial-buccal dyskinesia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|schizophreniform disorder|schizoaffective disorder|retinal degeneration|visual epilepsy|basal ganglia disease,ppi
13244,15885,3030,HADHA,hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein); alpha subunit,103,3-hydroxyacyl-CoA dehydrogenase activity|acetyl-CoA C-acetyltransferase activity|long-chain-3-hydroxyacyl-CoA dehydrogenase activity|enoyl-CoA hydratase activity,lactic acidosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
13245,15886,3032,HADHB,hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein); beta subunit,93,RNA binding|3-hydroxyacyl-CoA dehydrogenase activity|enoyl-CoA hydratase activity|acetyl-CoA C-acyltransferase activity|acetyl-CoA C-acetyltransferase activity,lactic acidosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
13246,15887,3029,HAGH,hydroxyacylglutathione hydrolase,9,hydroxyacylglutathione hydrolase activity,schizophrenia,ppi
13247,15888,3034,HAL,histidine ammonia-lyase,35,histidine ammonia-lyase activity,,ppi
13248,15889,9421,HAND1,heart and neural crest derivatives expressed 1,15,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription coactivator activity|transcription corepressor activity|identical protein binding|protein homodimerization activity|transcription regulatory region DNA binding,,ppi
13249,15890,9464,HAND2,heart and neural crest derivatives expressed 2,16,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|AT DNA binding|transcription coactivator activity|transcription factor binding|activating transcription factor binding|protein homodimerization activity|E-box binding|transcription regulatory region DNA binding,congenital heart disease|tetralogy of Fallot,ppi
13250,15891,54363,HAO1,hydroxyacid oxidase 1,4,(S)-2-hydroxy-acid oxidase activity|glycolate oxidase activity|FMN binding|glyoxylate oxidase activity,prostate cancer|prostate carcinoma,ppi
13251,15892,51179,HAO2,hydroxyacid oxidase 2,25,(S)-2-hydroxy-acid oxidase activity|long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity|FMN binding,,ppi
13252,15893,9001,HAP1,huntingtin associated protein 1,74,ion channel binding|brain-derived neurotrophic factor binding|myosin binding|signaling receptor binding,,ppi
13253,15894,8997,KALRN,kalirin; RhoGEF kinase,25,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|GTPase activator activity,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
13254,15895,3035,HARS,histidyl-tRNA synthetase,60,histidine-tRNA ligase activity|identical protein binding,astigmatism|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|cerebellar disease|sensorineural hearing loss|lung disease|night blindness|congenital stationary night blindness|scotoma|blindness|asthenopia|cataract|spontaneous ocular nystagmus,ppi
13255,15896,23438,HARS2,histidyl-tRNA synthetase 2; mitochondrial,35,RNA binding|histidine-tRNA ligase activity|protein homodimerization activity|identical protein binding,sensorineural hearing loss|Perrault syndrome,ppi
13256,15897,3036,HAS1,hyaluronan synthase 1,5,hyaluronan synthase activity,,ppi
13257,15898,3037,HAS2,hyaluronan synthase 2,1,hyaluronan synthase activity,,ppi
13258,15899,3038,HAS3,hyaluronan synthase 3,2,hyaluronan synthase activity,,ppi
13259,15900,8520,HAT1,histone acetyltransferase 1,52,histone acetyltransferase activity|H4 histone acetyltransferase activity|histone binding,,ppi
13260,15901,3039,HBA1,hemoglobin subunit alpha 1,91,,alpha thalassemia-intellectual disability syndrome type 1|alpha thalassemia-X-linked intellectual disability syndrome|hemoglobin H disease|thalassemia|alpha thalassemia|anemia|macrocytic anemia|hemolytic anemia|cerebral artery occlusion|brain stem infarction|cerebral infarction|cerebrovascular disease|clubfoot|cryptorchidism|diabetes mellitus|type 2 diabetes mellitus|congestive heart failure|polyhydramnios|hydrocephalus|obstructive hydrocephalus,ppi
13261,15903,3042,HBM,hemoglobin subunit mu,20,oxygen binding|organic acid binding|oxygen carrier activity|heme binding|protein binding|haptoglobin binding|peroxidase activity,,ppi
13262,15904,3043,HBB,hemoglobin subunit beta,63,oxygen carrier activity|oxygen binding|hemoglobin binding|peroxidase activity|haptoglobin binding|heme binding|protein binding|hemoglobin alpha binding|organic acid binding,alpha thalassemia-intellectual disability syndrome type 1|alpha thalassemia-X-linked intellectual disability syndrome|hemoglobin H disease|thalassemia|alpha thalassemia|anemia|macrocytic anemia|beta thalassemia|hemolytic anemia|sickle cell anemia|generalized anxiety disorder|anxiety disorder|cholecystolithiasis|choledocholithiasis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
13263,15905,3045,HBD,hemoglobin subunit delta,24,protein binding|peroxidase activity|hemoglobin alpha binding|organic acid binding|haptoglobin binding|heme binding|oxygen binding|oxygen carrier activity,microcytic anemia,ppi
13264,15906,283,ANG,angiogenin,15,DNA binding|actin binding|endonuclease activity|ribonuclease activity|signaling receptor binding|copper ion binding|heparin binding|rRNA binding|peptide binding|protein homodimerization activity,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|muscular atrophy|neurodegenerative disease|amyotrophic lateral sclerosis type 1|amyotrophic lateral sclerosis type 9,ppi
13265,15907,3046,HBE1,hemoglobin subunit epsilon 1,7,heme binding|protein binding|organic acid binding|peroxidase activity|hemoglobin alpha binding|oxygen carrier activity|haptoglobin binding|oxygen binding,,ppi
13266,15908,3047,HBG1,hemoglobin subunit gamma 1,12,heme binding|peroxidase activity|haptoglobin binding|oxygen binding|oxygen carrier activity|protein binding|organic acid binding,anemia|macrocytic anemia|beta thalassemia|prostate cancer|prostate carcinoma|microcytic anemia,ppi
13267,15909,3048,HBG2,hemoglobin subunit gamma 2,13,heme binding|oxygen carrier activity|protein binding|oxygen binding|peroxidase activity|organic acid binding|haptoglobin binding,anemia|macrocytic anemia|beta thalassemia|methemoglobinemia|sulfhemoglobinemia|prostate cancer|prostate carcinoma,ppi
13268,15910,100287399,POTEB2,POTE ankyrin domain family member B2,3,,,ppi
13269,15912,3049,HBQ1,hemoglobin subunit theta 1,2,haptoglobin binding|protein binding|oxygen binding|peroxidase activity|oxygen carrier activity|organic acid binding|heme binding,,ppi
13270,15915,10767,HBS1L,HBS1 like translational GTPase,43,GTPase activity,,ppi
13271,15916,3050,HBZ,hemoglobin subunit zeta,27,protein binding|organic acid binding|oxygen carrier activity|oxygen binding|peroxidase activity|heme binding|haptoglobin binding,,ppi
13272,15918,3052,HCCS,holocytochrome c synthase,33,holocytochrome-c synthase activity,imperforate anus|sick sinus syndrome|sensorineural hearing loss|epilepsy|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain,ppi
13273,15919,3053,SERPIND1,serpin family D member 1,8,endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity,carotid stenosis|carotid artery thrombosis|purpura fulminans|disseminated intravascular coagulation|mesenteric vascular occlusion|thrombophilia|protein S deficiency|antithrombin III deficiency|protein C deficiency,ppi
13274,15920,3054,HCFC1,host cell factor C1,120,chromatin binding|DNA-binding transcription factor activity|transcription coactivator activity|cadherin binding|histone acetyltransferase activity (H4-K5 specific)|histone acetyltransferase activity (H4-K8 specific)|histone acetyltransferase activity (H4-K16 specific),liver cancer|intellectual disability|learning disability|craniosynostosis|infantile epileptic encephalopathy,ppi
13275,15921,284,ANGPT1,angiopoietin 1,4,Ras guanyl-nucleotide exchange factor activity,,ppi
13276,15922,3055,HCK,HCK proto-oncogene; Src family tyrosine kinase,95,protein tyrosine kinase activity|signaling receptor binding|non-membrane spanning protein tyrosine kinase activity,acute lymphocytic leukemia,ppi
13277,15923,3059,HCLS1,hematopoietic cell-specific Lyn substrate 1,32,,rheumatoid arthritis,ppi
13278,15924,348980,HCN1,hyperpolarization activated cyclic nucleotide gated potassium channel 1,4,intracellular cAMP-activated cation channel activity|voltage-gated sodium channel activity|voltage-gated potassium channel activity|potassium channel activity|voltage-gated cation channel activity|cAMP binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|visual epilepsy|Ohtahara syndrome,ppi
13279,15925,610,HCN2,hyperpolarization activated cyclic nucleotide gated potassium channel 2,6,intracellular cAMP-activated cation channel activity|voltage-gated sodium channel activity|voltage-gated potassium channel activity,,ppi
13280,15926,3060,HCRT,hypocretin neuropeptide precursor,3,,cannabis dependence|cannabis abuse|narcolepsy|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|Balo concentric sclerosis|adrenoleukodystrophy|central nervous system disease|cocaine abuse|cocaine dependence|transient global amnesia|neurodegenerative disease,ppi
13281,15927,3061,HCRTR1,hypocretin receptor 1,4,G-protein coupled receptor activity|orexin receptor activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|cocaine abuse|cocaine dependence|mood disorder,ppi
13282,15928,3062,HCRTR2,hypocretin receptor 2,2,neuropeptide receptor activity|orexin receptor activity|G-protein coupled receptor activity,Balo concentric sclerosis|adrenoleukodystrophy|narcolepsy|central nervous system disease,ppi
13283,15929,285,ANGPT2,angiopoietin 2,14,signaling receptor binding,angiosarcoma,ppi
13284,15930,3064,HTT,huntingtin,390,ion channel binding|dynein intermediate chain binding|beta-tubulin binding,syndromic X-linked intellectual disability type 10|choreatic disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|Huntington's disease|movement disease|lingual-facial-buccal dyskinesia|visual epilepsy|cerebral degeneration|mood disorder,ppi
13285,15931,3065,HDAC1,histone deacetylase 1,594,transcription regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|core promoter sequence-specific DNA binding|transcription corepressor activity|histone deacetylase activity|transcription factor binding|deacetylase activity|protein deacetylase activity|transcription regulatory region DNA binding|protein N-terminus binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,tongue squamous cell carcinoma|squamous cell carcinoma|endometriosis of uterus|endometriosis|heart disease|cardiovascular system disease|schizophrenia|mood disorder,ppi
13286,15932,3066,HDAC2,histone deacetylase 2,371,chromatin binding|RNA binding|histone deacetylase activity|deacetylase activity|protein deacetylase activity|sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,alcohol dependence|alcohol abuse|tongue squamous cell carcinoma|squamous cell carcinoma|neurotic disorder|major depressive disorder|mental depression|endometriosis of uterus|endometriosis|lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia|chronic obstructive pulmonary disease|melanoma|skin melanoma|schizophreniform disorder|schizoaffective disorder|schizophrenia|mood disorder,ppi
13287,15933,8841,HDAC3,histone deacetylase 3,242,chromatin binding|transcription corepressor activity|histone deacetylase activity|transcription factor binding|protein deacetylase activity,heart disease|cardiovascular system disease|schizophrenia,ppi
13288,15934,3067,HDC,histidine decarboxylase,2,histidine decarboxylase activity,,ppi
13289,15935,3068,HDGF,hepatoma-derived growth factor,191,transcription corepressor activity|RNA binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
13290,15936,3069,HDLBP,high density lipoprotein binding protein,95,RNA binding|lipid binding|cadherin binding,autistic disorder,ppi
13291,15937,3070,HELLS,helicase; lymphoid-specific,49,,anemia|macrocytic anemia|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|lymphopenia|intellectual disability|learning disability|polycystic ovary syndrome|agammaglobulinemia,ppi
13292,15938,3071,NCKAP1L,NCK associated protein 1 like,8,GTPase activator activity|protein kinase activator activity|protein-containing complex binding,,ppi
13293,15940,9843,HEPH,hephaestin,1,ferroxidase activity|copper ion binding|ferrous iron binding|oxidoreductase activity; oxidizing metal ions,malignant mesothelioma|benign mesothelioma,ppi
13294,15941,8925,HERC1,HECT and RLD domain containing E3 ubiquitin protein ligase family member 1,58,ARF guanyl-nucleotide exchange factor activity,,ppi
13295,15942,8924,HERC2,HECT and RLD domain containing E3 ubiquitin protein ligase 2,232,ubiquitin-protein transferase activity|guanyl-nucleotide exchange factor activity|SUMO binding,inflammatory bowel disease|ulcerative colitis|Zollinger-Ellison syndrome|hyperinsulinism|hyperopia|bulimia nervosa|infertility|intellectual disability|learning disability|obesity|schizophrenia|obstructive sleep apnea|congenital central hypoventilation syndrome|ophthalmoplegia|mechanical strabismus|hypertropia|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB,ppi
13296,15943,51378,ANGPT4,angiopoietin 4,3,transmembrane receptor protein tyrosine kinase activator activity|receptor tyrosine kinase binding,,ppi
13297,15944,8916,HERC3,HECT and RLD domain containing E3 ubiquitin protein ligase 3,44,,liver cancer,ppi
13298,15945,8820,HESX1,HESX homeobox 1,8,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,isolated cleft palate|cleft palate|constipation|cryptorchidism|neurohypophyseal diabetes insipidus|diabetes insipidus|epilepsy|umbilical hernia|omphalocele|hypoglycemia|congenital hypothyroidism|myxedema|hypothyroidism|infertility|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus,ppi
13299,15946,3073,HEXA,hexosaminidase subunit alpha,37,beta-N-acetylhexosaminidase activity|acetylglucosaminyltransferase activity|protein heterodimerization activity,epilepsy|visual epilepsy|Tay-Sachs disease|hyperekplexia 1|intellectual disability|learning disability,ppi
13300,15947,3074,HEXB,hexosaminidase subunit beta,26,beta-N-acetylhexosaminidase activity|acetylglucosaminyltransferase activity|protein homodimerization activity|protein heterodimerization activity,cerebellar disease|hypohidrosis|anhidrosis|multiple system atrophy|Sandhoff disease|psychologic dyspareunia|premature ejaculation|muscular atrophy,ppi
13301,15948,23462,HEY1,hes related family bHLH transcription factor with YRPW motif 1,20,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity|transcription factor binding|microsatellite binding|transcription corepressor activity|sequence-specific DNA binding|sequence-specific double-stranded DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|glioblastoma multiforme|giant cell glioblastoma|lung benign neoplasm|oligodendroglioma|childhood oligodendroglioma|adult oligodendroglioma|mixed oligodendroglioma-astrocytoma|medulloblastoma|medulloepithelioma|supratentorial primitive neuroectodermal tumor,ppi
13302,15949,23493,HEY2,hes related family bHLH transcription factor with YRPW motif 2,26,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity|transcription factor binding|microsatellite binding|sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding|sequence-specific double-stranded DNA binding|transcription corepressor activity|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|pancreatic ductal carcinoma|Brugada syndrome|Brugada syndrome 1|breast cancer,ppi
13303,15950,440563,HNRNPCL2,heterogeneous nuclear ribonucleoprotein C-like 2,1,RNA binding,,ppi
13304,15951,26508,HEYL,hes related family bHLH transcription factor with YRPW motif-like,22,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity|transcription corepressor activity|transcription factor binding|microsatellite binding|protein heterodimerization activity|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding|sequence-specific double-stranded DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,breast cancer,ppi
13305,15952,3075,CFH,complement factor H,22,heparin binding|heparan sulfate proteoglycan binding,membranoproliferative glomerulonephritis|primary immunodeficiency disease|pre-eclampsia|HELLP syndrome|age related macular degeneration|macular degeneration|degeneration of macula and posterior pole|basal laminar drusen|chronic kidney disease|Doyne honeycomb retinal dystrophy|age related macular degeneration 4|hemolytic-uremic syndrome,ppi
13306,15953,3077,HFE,hemochromatosis,6,peptide antigen binding|natural killer cell lectin-like receptor binding,alopecia|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|sick sinus syndrome|azoospermia|diabetic ketoacidosis|diabetes mellitus,ppi
13307,15954,148738,HFE2,hemochromatosis type 2 (juvenile),3,coreceptor activity|BMP receptor activity,iron metabolism disease|hemochromatosis|Wilson disease,ppi
13308,15956,9068,ANGPTL1,angiopoietin like 1,2,,,ppi
13309,15957,3080,CFHR2,complement factor H related 2,1,protein homodimerization activity|protein heterodimerization activity,,ppi
13310,15958,3081,HGD,homogentisate 1;2-dioxygenase,5,homogentisate 1;2-dioxygenase activity,ochronosis|alkaptonuria|arthropathy|arthritis|neurogenic arthropathy|nail disease|prostatitis|aortic aneurysm|acute urate nephropathy|aortic valve stenosis,ppi
13311,15960,3082,HGF,hepatocyte growth factor,20,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|growth factor activity|chemoattractant activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|serine-type endopeptidase activity,astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|Barrett's esophagus|tongue squamous cell carcinoma|squamous cell carcinoma|diabetic autonomic neuropathy|diabetic polyneuropathy|diabetic neuropathy|hepatitis|acute myeloid leukemia|liver cirrhosis|liver cancer,ppi
13312,15961,3083,HGFAC,HGF activator,10,serine-type endopeptidase activity|serine-type peptidase activity,liver cancer|hepatocellular carcinoma,ppi
13313,15962,729852,UMAD1,UBAP1-MVB12-associated (UMA) domain containing 1,1,,,ppi
13314,15963,9146,HGS,hepatocyte growth factor-regulated tyrosine kinase substrate,217,,,ppi
13315,15964,11194,ABCB8,ATP binding cassette subfamily B member 8,26,transporter activity|ATPase activity; coupled to transmembrane movement of substances,,ppi
13316,15965,23452,ANGPTL2,angiopoietin like 2,2,signaling receptor binding,,ppi
13317,15966,3087,HHEX,hematopoietically expressed homeobox,16,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|eukaryotic initiation factor 4E binding|DNA binding; bending|TBP-class protein binding|sequence-specific DNA binding|transcription regulatory region DNA binding|repressing transcription factor binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,diabetes mellitus|type 2 diabetes mellitus|fatty liver disease|breast cancer,ppi
13318,15969,11147,HHLA3,HERV-H LTR-associating 3,1,,,ppi
13319,15970,11112,HIBADH,3-hydroxyisobutyrate dehydrogenase,11,3-hydroxyisobutyrate dehydrogenase activity|oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor,,ppi
13320,15971,26275,HIBCH,3-hydroxyisobutyryl-CoA hydrolase,36,3-hydroxyisobutyryl-CoA hydrolase activity,dystonia|epilepsy|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|arthropathy|arthritis|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|tetralogy of Fallot|Klippel-Feil syndrome|spondylolisthesis,ppi
13321,15972,3090,HIC1,HIC ZBTB transcriptional repressor 1,30,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|histone deacetylase binding|sequence-specific DNA binding,heart disease|cardiovascular system disease|epilepsy|gastrointestinal system cancer|polyhydramnios|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|visual epilepsy|cerebral degeneration|lissencephaly|Miller-Dieker lissencephaly syndrome|chromosome 17p13.1 deletion syndrome|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|syndromic X-linked intellectual disability Najm type,ppi
13322,15973,27329,ANGPTL3,angiopoietin like 3,9,enzyme inhibitor activity|phospholipase inhibitor activity|growth factor activity,hypobetalipoproteinemia,ppi
13323,15974,3091,HIF1A,hypoxia inducible factor 1 alpha subunit,176,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|protein heterodimerization activity|Hsp90 protein binding|sequence-specific DNA binding,astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|bipolar disorder|carcinoma|brain ischemia|primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis|neurotic disorder|major depressive disorder,ppi
13324,15975,3094,HINT1,histidine triad nucleotide binding protein 1,76,protein kinase C binding|hydrolase activity,bipolar disorder|familial periodic paralysis|myopathy|schizophrenia|myotonic dystrophy type 2|Gamstorp-Wohlfart syndrome|episodic ataxia type 1|muscular atrophy|nicotine dependence,ppi
13325,15976,3092,HIP1,huntingtin interacting protein 1,37,epidermal growth factor receptor binding|structural constituent of cytoskeleton|clathrin binding|phosphatidylinositol-3-phosphate binding|phosphatidylinositol binding|glutamate receptor binding|clathrin adaptor activity|protein homodimerization activity|phosphatidylinositol-3;4-bisphosphate binding|actin filament binding|phosphatidylinositol-3;5-bisphosphate binding|phosphatidylinositol-4;5-bisphosphate binding|clathrin light chain binding,prostate cancer|prostate carcinoma,ppi
13326,15977,3093,UBE2K,ubiquitin conjugating enzyme E2 K,97,ubiquitin-protein transferase activity|ubiquitin-ubiquitin ligase activity|ubiquitin conjugating enzyme activity,,ppi
13327,15978,10114,HIPK3,homeodomain interacting protein kinase 3,40,protein kinase activity|protein serine/threonine kinase activity,,ppi
13328,15980,7290,HIRA,histone cell cycle regulator,44,DNA-binding transcription factor activity|transcription corepressor activity|nucleosome binding|DNA binding,ptosis|congenital ptosis|isolated cleft palate|cleft palate|constipation|dental caries|DiGeorge syndrome|velocardiofacial syndrome|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect,ppi
13329,15981,8479,HIRIP3,HIRA interacting protein 3,37,,,ppi
13330,15984,286,ANK1,ankyrin 1,32,structural molecule activity|structural constituent of cytoskeleton|cytoskeletal adaptor activity|enzyme binding|spectrin binding|ion channel binding,hemolytic anemia|azoospermia|cholecystolithiasis|choledocholithiasis|cryptorchidism|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|hereditary spherocytosis|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism,ppi
13331,15985,3096,HIVEP1,human immunodeficiency virus type I enhancer binding protein 1,53,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|distal enhancer DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
13332,15986,3097,HIVEP2,human immunodeficiency virus type I enhancer binding protein 2,14,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,coronary artery disease,ppi
13333,15987,3098,HK1,hexokinase 1,78,glucokinase activity|hexokinase activity|peptidoglycan binding|fructokinase activity|mannokinase activity,cholecystitis|cholecystolithiasis|choledocholithiasis|diabetes mellitus|type 2 diabetes mellitus|polyneuropathy|peripheral nervous system disease|neuropathy|schizophrenia|normocytic anemia|coronary artery disease|Charcot-Marie-Tooth disease type 4G,ppi
13334,15988,3099,HK2,hexokinase 2,62,glucokinase activity|hexokinase activity|mannokinase activity|fructokinase activity,obesity|coronary artery disease,ppi
13335,15989,3101,HK3,hexokinase 3,20,glucokinase activity|hexokinase activity|mannokinase activity|fructokinase activity,gallbladder disease|liver disease,ppi
13336,15990,10471,PFDN6,prefoldin subunit 6,47,unfolded protein binding|chaperone binding,,ppi
13337,15991,7922,SLC39A7,solute carrier family 39 member 7,23,zinc ion transmembrane transporter activity,,ppi
13338,15992,284459,HKR1,HKR1; GLI-Kruppel zinc finger family member,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
13339,15994,342945,ZSCAN22,zinc finger and SCAN domain containing 22,7,DNA-binding transcription factor activity; RNA polymerase II-specific,liver cancer,ppi
13340,15995,287,ANK2,ankyrin 2,42,protein binding; bridging|ion channel binding|ATPase binding,atrial fibrillation|long QT syndrome|long QT syndrome 1,ppi
13341,15996,3104,ZBTB48,zinc finger and BTB domain containing 48,90,DNA-binding transcription factor activity; RNA polymerase II-specific|double-stranded telomeric DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding,,ppi
13342,15997,3105,HLA-A,major histocompatibility complex; class I; A,103,,autistic disorder|vitreous disease|vitreous detachment|malignant glioma|gliosarcoma|mixed glioma|cystoid macular edema|macular retinal edema|retinal perforation|hole retinal cyst|macular holes|multiple myeloma|psoriasis|parapsoriasis|schizophrenia|paranoid schizophrenia|delusional disorder|ankylosing spondylitis|Stevens-Johnson syndrome|thrombocytopenia,ppi
13343,15998,3106,HLA-B,major histocompatibility complex; class I; B,347,,anemia|macrocytic anemia|vascular disease|arthropathy|arthritis|Behcet's disease|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|acrodermatitis|dermatitis|dermatomyositis|childhood type dermatomyositis|epilepsy|exanthem|malignant glioma|gliosarcoma|mixed glioma|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
13344,15999,3107,HLA-C,major histocompatibility complex; class I; C,120,,psoriatic arthritis|malignant glioma|gliosarcoma|mixed glioma|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|pustulosis of palm and sole|psoriasis|parapsoriasis|schizophrenia|Stevens-Johnson syndrome,ppi
13345,16001,3109,HLA-DMB,major histocompatibility complex; class II; DM beta,11,MHC class II protein complex binding,,ppi
13346,16002,3111,HLA-DOA,major histocompatibility complex; class II; DO alpha,3,MHC class II protein complex binding|MHC class II receptor activity,,ppi
13347,16003,3112,HLA-DOB,major histocompatibility complex; class II; DO beta,2,MHC class II protein complex binding|MHC class II receptor activity,,ppi
13348,16004,3113,HLA-DPA1,major histocompatibility complex; class II; DP alpha 1,94,MHC class II receptor activity|peptide antigen binding,,ppi
13349,16009,288,ANK3,ankyrin 3,42,structural constituent of cytoskeleton|cytoskeletal protein binding|spectrin binding|protein binding; bridging|ion channel binding|cadherin binding,bipolar disorder|intellectual disability|learning disability|progeria|Werner syndrome|schizophreniform disorder|schizoaffective disorder|schizophrenia|status epilepticus|mood disorder|autosomal recessive non-syndromic intellectual disability,ppi
13350,16010,3115,HLA-DPB1,major histocompatibility complex; class II; DP beta 1,37,peptide antigen binding,hereditary angioedema|angioedema|rheumatoid arthritis|asthma|intrinsic asthma|allergic asthma|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|berylliosis|celiac disease|brain ischemia|cervical cancer|endometriosis of uterus|endometriosis|exanthem|chronic obstructive pulmonary disease|multiple sclerosis|myasthenia gravis|lower respiratory tract disease|paranasal sinus disease,ppi
13351,16012,3117,HLA-DQA1,major histocompatibility complex; class II; DQ alpha 1,30,MHC class II receptor activity|peptide antigen binding,asthma|intrinsic asthma|allergic asthma|celiac disease|acrodermatitis|dermatitis|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15,ppi
13352,16017,3120,HLA-DQB2,major histocompatibility complex; class II; DQ beta 2,8,MHC class II receptor activity,,ppi
13353,16018,3122,HLA-DRA,major histocompatibility complex; class II; DR alpha,45,MHC class II protein complex binding|MHC class II receptor activity|peptide antigen binding,alcohol dependence|alcohol abuse|alopecia|multiple sclerosis|Parkinson's disease,ppi
13354,16019,3123,HLA-DRB1,major histocompatibility complex; class II; DR beta 1,41,MHC class II protein complex binding|peptide antigen binding,hereditary angioedema|angioedema|arthropathy|arthritis|rheumatoid arthritis|asthma|intrinsic asthma|allergic asthma|autistic disorder|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|berylliosis|bipolar disorder|narcolepsy|inflammatory bowel disease|ulcerative colitis|pseudosarcomatous fibromatosis|Crohn's colitis|Crohn's disease|dental caries,ppi
13355,16020,26287,ANKRD2,ankyrin repeat domain 2,8,structural constituent of muscle|RNA polymerase II sequence-specific DNA-binding transcription factor binding|titin binding,,ppi
13356,16024,3125,HLA-DRB3,major histocompatibility complex; class II; DR beta 3,15,MHC class II receptor activity|peptide antigen binding,,ppi
13357,16025,3126,HLA-DRB4,major histocompatibility complex; class II; DR beta 4,11,,bipolar disorder|allergic hypersensitivity disease|schizophrenia|paranoid schizophrenia|delusional disorder,ppi
13358,16026,3127,HLA-DRB5,major histocompatibility complex; class II; DR beta 5,16,peptide antigen binding,allergic hypersensitivity disease,ppi
13359,16029,54101,RIPK4,receptor interacting serine/threonine kinase 4,294,,cleft lip|isolated cleft palate|cleft palate|recurrent corneal erosion|placental insufficiency|intellectual disability|learning disability|syndactyly|sex differentiation disease|hermaphroditism|pseudohermaphroditism|blepharophimosis|clubfoot|popliteal pterygium syndrome,ppi
13360,16033,3133,HLA-E,major histocompatibility complex; class I; E,57,beta-2-microglobulin binding|MHC class I protein binding|peptide antigen binding|T cell receptor binding|signaling receptor binding,bipolar disorder|psoriasis|parapsoriasis|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
13361,16034,3134,HLA-F,major histocompatibility complex; class I; F,18,peptide antigen binding|signaling receptor binding,,ppi
13362,16035,3135,HLA-G,major histocompatibility complex; class I; G,19,protein homodimerization activity|signaling receptor binding|peptide antigen binding,asthma|intrinsic asthma|allergic asthma|bipolar disorder,ppi
13363,16036,8989,TRPA1,transient receptor potential cation channel subfamily A member 1,2,calcium channel activity|channel activity|calcium-release channel activity|temperature-gated cation channel activity,asthma|intrinsic asthma|allergic asthma|low compliance bladder,ppi
13364,16037,3140,MR1,major histocompatibility complex; class I-related,15,MHC class I receptor activity,,ppi
13365,16038,3141,HLCS,holocarboxylase synthetase,11,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity|biotin binding|biotin-protein ligase activity,alopecia|epilepsy|exanthem|keratitis|keratoconjunctivitis|visual epilepsy|thrombocytopenia|lactic acidosis|urea cycle disorder|holocarboxylase synthetase deficiency,ppi
13366,16039,3131,HLF,HLF; PAR bZIP transcription factor,13,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|double-stranded DNA binding|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression|acute lymphocytic leukemia,ppi
13367,16040,3142,HLX,H2.0 like homeobox,19,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
13368,16041,3110,MNX1,motor neuron and pancreas homeobox 1,1,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,imperforate anus|Cauda equina syndrome|neurogenic bladder|vesicoureteral reflux|anal fistula|urinary tract obstruction,ppi
13369,16042,3145,HMBS,hydroxymethylbilane synthase,12,hydroxymethylbilane synthase activity,generalized anxiety disorder|anxiety disorder|sick sinus syndrome|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|hypertension|essential hypertension|hypertensive encephalopathy|intestinal pseudo-obstruction|paralytic ileus|diaphragm disease|visual epilepsy|acute intermittent porphyria|fibromyalgia,ppi
13370,16043,3146,HMGB1,high mobility group box 1,127,four-way junction DNA binding|bubble DNA binding|lipopolysaccharide binding|phosphatidylserine binding|damaged DNA binding|double-stranded DNA binding|single-stranded DNA binding|DNA-binding transcription factor activity|RNA binding|cytokine activity|integrin binding|DNA binding; bending|lyase activity|C-X-C chemokine binding|chemoattractant activity|RAGE receptor binding|DNA polymerase binding|supercoiled DNA binding,alcohol dependence|alcohol abuse|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|coronary artery disease|esophagus squamous cell carcinoma,ppi
13371,16044,3150,HMGN1,high mobility group nucleosome binding domain 1,31,DNA binding,,ppi
13372,16046,3151,HMGN2,high mobility group nucleosomal binding domain 2,29,RNA binding,,ppi
13373,16047,10473,HMGN4,high mobility group nucleosomal binding domain 4,7,,,ppi
13374,16048,1,A1BG,alpha-1-B glycoprotein,22,,,ppi
13375,16049,23457,ABCB9,ATP binding cassette subfamily B member 9,7,ATP binding|oligopeptide-transporting ATPase activity|peptide-transporting ATPase activity|transmembrane transporter activity|protein homodimerization activity|ATPase activity; coupled to transmembrane movement of substances,,ppi
13376,16050,290,ANPEP,alanyl aminopeptidase; membrane,2,aminopeptidase activity|metallopeptidase activity|signaling receptor activity|zinc ion binding|peptide binding|metalloaminopeptidase activity,urinary bladder cancer|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
13377,16051,3148,HMGB2,high mobility group box 2,55,four-way junction DNA binding|enhancer sequence-specific DNA binding|DNA binding|damaged DNA binding|double-stranded DNA binding|single-stranded DNA binding|DNA-binding transcription factor activity|RNA binding|transcription factor binding|drug binding|DNA binding; bending|chemoattractant activity|transcription regulatory region DNA binding|non-sequence-specific DNA binding; bending|RAGE receptor binding|supercoiled DNA binding,obesity|lung cancer|lung adenocarcinoma|liver cancer|hepatocellular carcinoma,ppi
13378,16052,10363,HMG20A,high mobility group 20A,65,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,diabetes mellitus|type 2 diabetes mellitus,ppi
13379,16053,10362,HMG20B,high mobility group 20B,33,DNA-binding transcription factor activity; RNA polymerase II-specific|histone deacetylase activity,,ppi
13380,16054,10042,HMGXB4,HMG-box containing 4,29,,bipolar disorder,ppi
13381,16055,3149,HMGB3,high mobility group box 3,26,four-way junction DNA binding|double-stranded DNA binding|RNA binding|DNA binding; bending,ptosis|congenital ptosis|coloboma|monocular esotropia|esotropia|intellectual disability|learning disability|microphthalmia|cornea plana|Peters anomaly|spontaneous ocular nystagmus|dissociated nystagmus|pathologic nystagmus,ppi
13382,16056,3155,HMGCL,3-hydroxymethyl-3-methylglutaryl-CoA lyase,24,magnesium ion binding|hydroxymethylglutaryl-CoA lyase activity|manganese ion binding|protein homodimerization activity|metal ion binding,hypoglycemia|lactic acidosis|urea cycle disorder|hyperlysinemia,ppi
13383,16057,3156,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,35,hydroxymethylglutaryl-CoA reductase activity|coenzyme binding|NADPH binding|hydroxymethylglutaryl-CoA reductase (NADPH) activity,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|chronic kidney disease|familial periodic paralysis|myopathy|trypanosomiasis|Q fever|typhus|liver cancer|hepatocellular carcinoma,ppi
13384,16058,3157,HMGCS1,3-hydroxy-3-methylglutaryl-CoA synthase 1,33,hydroxymethylglutaryl-CoA synthase activity|protein homodimerization activity,,ppi
13385,16059,3158,HMGCS2,3-hydroxy-3-methylglutaryl-CoA synthase 2,6,hydroxymethylglutaryl-CoA synthase activity,colon cancer|colonic benign neoplasm|epilepsy|hypoglycemia|visual epilepsy|coronary artery disease,ppi
13386,16060,8091,HMGA2,high mobility group AT-hook 2,31,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|AT DNA binding|transcription coregulator activity|DNA-(apurinic or apyrimidinic site) endonuclease activity|DNA-dependent protein kinase activity|DNA binding; bending|nucleosomal DNA binding|cAMP response element binding|MH2 domain binding|MH1 domain binding|transcription regulatory region DNA binding|5'-deoxyribose-5-phosphate lyase activity|C2H2 zinc finger domain binding,placental insufficiency|osteopoikilosis|leiomyoma|uterine fibroid|myofibroma|liposarcoma|pleomorphic liposarcoma|atypical lipomatous tumor|sclerosing liposarcoma|inflammatory liposarcoma|pleomorphic adenoma|pleomorphic lipoma|lipoma,ppi
13387,16061,3159,HMGA1,high mobility group AT-hook 1,98,DNA-binding transcription factor activity; RNA polymerase II-specific|enhancer sequence-specific DNA binding|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|AT DNA binding|chromatin binding|transcription factor binding|nuclear receptor transcription coactivator activity|retinoic acid receptor binding|peroxisome proliferator activated receptor binding|retinoid X receptor binding|DNA-(apurinic or apyrimidinic site) endonuclease activity,diabetes mellitus|type 2 diabetes mellitus|hyperglycemia|leiomyosarcoma|epithelioid leiomyosarcoma|myxoid leiomyosarcoma|schizophrenia|uterine cancer|metabolic syndrome X,ppi
13388,16062,3161,HMMR,hyaluronan mediated motility receptor,46,,chronic myeloid leukemia|polycystic ovary syndrome|breast cancer,ppi
13389,16063,3162,HMOX1,heme oxygenase 1,33,heme oxygenase (decyclizing) activity|enzyme binding|heme binding|protein homodimerization activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|hemolytic anemia|asthma|intrinsic asthma|allergic asthma|blood coagulation disease,ppi
13390,16064,3163,HMOX2,heme oxygenase 2,63,heme oxygenase (decyclizing) activity|heme binding,,ppi
13391,16066,3167,HMX2,H6 family homeobox 2,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
13392,16067,340784,HMX3,H6 family homeobox 3,2,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
13393,16068,3169,FOXA1,forkhead box A1,47,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding,fatty liver disease|prostate cancer|prostate carcinoma|breast cancer,ppi
13394,16069,3170,FOXA2,forkhead box A2,21,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding,hiatus hernia|congenital diaphragmatic hernia|lung disease,ppi
13395,16070,3171,FOXA3,forkhead box A3,51,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription regulatory region DNA binding,prostate cancer|prostate carcinoma,ppi
13396,16071,3172,HNF4A,hepatocyte nuclear factor 4 alpha,89,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II activating transcription factor binding|DNA binding|DNA-binding transcription factor activity|signaling receptor binding|fatty acid binding|protein homodimerization activity|transcription regulatory region DNA binding,inflammatory bowel disease|ulcerative colitis|diabetic ketoacidosis|diabetes mellitus|type 2 diabetes mellitus|epilepsy|hypoglycemia|intellectual disability|learning disability|calcium metabolism disease|nephrocalcinosis|calcinosis|hypercalcemia|phosphorus metabolism disease|proteinuria|osteomalacia|rickets|visual epilepsy|liver disease|Fanconi syndrome,ppi
13397,16072,3174,HNF4G,hepatocyte nuclear factor 4 gamma,16,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
13398,16073,3176,HNMT,histamine N-methyltransferase,6,histamine N-methyltransferase activity,alcohol dependence|alcohol abuse|asthma|intrinsic asthma|allergic asthma|rhinitis|angioedema,ppi
13399,16075,10949,HNRNPA0,heterogeneous nuclear ribonucleoprotein A0,111,RNA binding|AU-rich element binding|mRNA binding,,ppi
13400,16076,3178,HNRNPA1,heterogeneous nuclear ribonucleoprotein A1,557,single-stranded DNA binding|RNA binding|single-stranded RNA binding|miRNA binding|pre-mRNA binding|telomeric repeat-containing RNA binding|G-rich strand telomeric DNA binding|mRNA binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|familial periodic paralysis|myopathy|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D,ppi
13401,16079,3181,HNRNPA2B1,heterogeneous nuclear ribonucleoprotein A2/B1,228,RNA binding|mRNA 3'-UTR binding|miRNA binding|single-stranded telomeric DNA binding|G-rich strand telomeric DNA binding|N6-methyladenosine-containing RNA binding|mRNA binding,adult T-cell leukemia|acute T cell leukemia|familial periodic paralysis|myopathy|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R,ppi
13402,16080,3182,HNRNPAB,heterogeneous nuclear ribonucleoprotein A/B,114,RNA binding|mRNA binding|DNA-binding transcription factor activity|sequence-specific DNA binding|sequence-specific double-stranded DNA binding,,ppi
13403,16081,3183,HNRNPC,heterogeneous nuclear ribonucleoprotein C (C1/C2),205,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|RNA binding|mRNA 3'-UTR binding|poly(U) RNA binding|nucleosomal DNA binding|N6-methyladenosine-containing RNA binding,,ppi
13404,16082,3184,HNRNPD,heterogeneous nuclear ribonucleoprotein D,300,RNA binding|telomeric DNA binding|mRNA binding|sequence-specific double-stranded DNA binding|mRNA 3'-UTR AU-rich region binding|sequence-specific DNA binding|AT DNA binding,,ppi
13405,16083,9987,HNRNPDL,heterogeneous nuclear ribonucleoprotein D like,129,RNA binding|poly(G) binding|sequence-specific double-stranded DNA binding|poly(A) binding|sequence-specific DNA binding,familial periodic paralysis|myopathy|cataract|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y,ppi
13406,16084,3185,HNRNPF,heterogeneous nuclear ribonucleoprotein F,210,RNA binding|single-stranded RNA binding,,ppi
13407,16085,3187,HNRNPH1,heterogeneous nuclear ribonucleoprotein H1 (H),219,RNA binding|poly(U) RNA binding,prostate cancer|prostate carcinoma,ppi
13408,16086,3188,HNRNPH2,heterogeneous nuclear ribonucleoprotein H2 (H'),126,RNA binding,,ppi
13409,16087,3189,HNRNPH3,heterogeneous nuclear ribonucleoprotein H3,121,RNA binding,,ppi
13410,16088,3190,HNRNPK,heterogeneous nuclear ribonucleoprotein K,303,RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|single-stranded DNA binding|RNA binding|cadherin binding,ptosis|congenital ptosis|constipation|craniosynostosis|cryptorchidism|intellectual disability|learning disability|polydactyly|breast cancer,ppi
13411,16089,3191,HNRNPL,heterogeneous nuclear ribonucleoprotein L,144,RNA binding|transcription regulatory region DNA binding|pre-mRNA intronic binding,stomach cancer|breast cancer,ppi
13412,16090,4670,HNRNPM,heterogeneous nuclear ribonucleoprotein M,279,RNA binding|mRNA binding,,ppi
13413,16091,10236,HNRNPR,heterogeneous nuclear ribonucleoprotein R,233,RNA binding,breast cancer,ppi
13414,16092,3192,HNRNPU,heterogeneous nuclear ribonucleoprotein U,569,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II complex binding|TFIIH-class transcription factor complex binding|DNA binding|chromatin binding|double-stranded DNA binding|single-stranded DNA binding|transcription corepressor activity|RNA binding|double-stranded RNA binding|single-stranded RNA binding|mRNA 3'-UTR binding|actin binding|ATP binding|poly(A) binding|snRNA binding|poly(C) RNA binding|chromatin DNA binding|poly(G) binding|pre-mRNA binding,,ppi
13415,16093,3195,TLX1,T-cell leukemia homeobox 1,14,DNA-binding transcription factor activity; RNA polymerase II-specific,adult T-cell leukemia|acute T cell leukemia|splenic disease|splenic infarction|hypersplenism,ppi
13416,16094,3196,TLX2,T-cell leukemia homeobox 2,9,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding,,ppi
13417,16097,3198,HOXA1,homeobox A1,90,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding,autistic disorder|sensorineural hearing loss|congenital heart disease|Athabaskan brainstem dysgenesis syndrome,ppi
13418,16098,4363,ABCC1,ATP binding cassette subfamily C member 1,53,phospholipid-translocating ATPase activity|transporter activity|cobalamin-transporting ATPase activity|ATPase activity|ATPase activity; coupled to transmembrane movement of substances|ATPase-coupled anion transmembrane transporter activity|sphingolipid-translocating ATPase activity|glutathione S-conjugate-exporting ATPase activity|xenobiotic transmembrane transporting ATPase activity|glutathione transmembrane transporter activity,large intestine cancer|colorectal cancer|heart disease|cardiovascular system disease|hypertension|essential hypertension|polyneuropathy|peripheral nervous system disease|neuropathy|head and neck squamous cell carcinoma|breast cancer,ppi
13419,16099,3206,HOXA10,homeobox A10,22,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|endometrial cancer|endometrial carcinoma,ppi
13420,16100,3207,HOXA11,homeobox A11,8,DNA-binding transcription factor activity; RNA polymerase II-specific,aplastic anemia|endometrial cancer|endometrial carcinoma|sensorineural hearing loss|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|purpura|syndactyly|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis,ppi
13421,16101,3209,HOXA13,homeobox A13,8,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|sequence-specific DNA binding,kidney failure|uremia|vesicoureteral reflux|hand-foot-genital syndrome|priapism|urinary tract obstruction|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa,ppi
13422,16102,3199,HOXA2,homeobox A2,6,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding,isolated cleft palate|cleft palate|stomach cancer,ppi
13423,16103,3200,HOXA3,homeobox A3,11,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding,congenital heart disease,ppi
13424,16105,3202,HOXA5,homeobox A5,21,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|RNA polymerase II distal enhancer sequence-specific DNA binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding,hiatus hernia|congenital diaphragmatic hernia|head and neck squamous cell carcinoma,ppi
13425,16107,3204,HOXA7,homeobox A7,5,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|RNA polymerase II distal enhancer sequence-specific DNA binding,,ppi
13426,16108,3205,HOXA9,homeobox A9,18,DNA-binding transcription factor activity; RNA polymerase II-specific,urinary bladder cancer|acute myeloid leukemia|melanoma|skin melanoma,ppi
13427,16109,3211,HOXB1,homeobox B1,10,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding,Bell's palsy|facial paralysis,ppi
13428,16110,10481,HOXB13,homeobox B13,16,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|methyl-CpG binding|sequence-specific DNA binding,melanoma|skin melanoma|prostate cancer|prostate carcinoma|breast cancer,ppi
13429,16111,3212,HOXB2,homeobox B2,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
13430,16112,3213,HOXB3,homeobox B3,3,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,hiatus hernia|congenital diaphragmatic hernia,ppi
13431,16113,3214,HOXB4,homeobox B4,5,DNA-binding transcription factor activity; RNA polymerase II-specific|activating transcription factor binding|DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
13432,16114,3215,HOXB5,homeobox B5,51,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|RNA polymerase II distal enhancer sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,obesity,ppi
13433,16115,3216,HOXB6,homeobox B6,15,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II distal enhancer sequence-specific DNA binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding,,ppi
13434,16116,3217,HOXB7,homeobox B7,17,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|RNA polymerase II distal enhancer sequence-specific DNA binding,,ppi
13435,16118,3218,HOXB8,homeobox B8,4,DNA-binding transcription factor activity; RNA polymerase II-specific,obsessive-compulsive disorder|trichotillomania,ppi
13436,16119,3219,HOXB9,homeobox B9,49,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
13437,16120,3226,HOXC10,homeobox C10,12,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
13438,16121,3227,HOXC11,homeobox C11,14,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
13439,16123,649330,HNRNPCL3,heterogeneous nuclear ribonucleoprotein C-like 3,1,RNA binding,,ppi
13440,16134,3229,HOXC13,homeobox C13,25,DNA-binding transcription factor activity; RNA polymerase II-specific,Clouston syndrome|hypotrichosis,ppi
13441,16141,3221,HOXC4,homeobox C4,22,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding|activating transcription factor binding|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
13442,16147,3223,HOXC6,homeobox C6,9,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|RNA polymerase II distal enhancer sequence-specific DNA binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
13443,16148,3224,HOXC8,homeobox C8,20,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
13444,16149,3225,HOXC9,homeobox C9,25,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
13445,16150,3231,HOXD1,homeobox D1,1,DNA-binding transcription factor activity; RNA polymerase II-specific,large intestine cancer|colorectal cancer|ovarian cancer,ppi
13446,16151,3236,HOXD10,homeobox D10,7,DNA-binding transcription factor activity; RNA polymerase II-specific,arthropathy|arthritis|rheumatoid arthritis|Charcot-Marie-Tooth disease type 2|hereditary motor and sensory neuropathy with agenesis of the corpus callosum|hereditary neuropathy with liability to pressure palsies|Charcot-Marie-Tooth disease type 1A|Charcot-Marie-Tooth disease type 1F|Charcot-Marie-Tooth disease type 1D|Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease type 1B|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease type 2A1|Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2B1|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2B|Charcot-Marie-Tooth disease axonal type 2T|Charcot-Marie-Tooth disease type 2R,ppi
13447,16153,3237,HOXD11,homeobox D11,2,DNA-binding transcription factor activity; RNA polymerase II-specific,rheumatoid arthritis|autistic disorder|male infertility|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|ovarian cancer|head and neck squamous cell carcinoma|breast cancer,ppi
13448,16154,3238,HOXD12,homeobox D12,8,DNA-binding transcription factor activity; RNA polymerase II-specific,melanoma|skin melanoma,ppi
13449,16155,3239,HOXD13,homeobox D13,42,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,imperforate anus|rheumatoid arthritis|choanal atresia|patent ductus arteriosus|esophageal atresia|placental insufficiency|heart septal defect|ventricular septal defect|polyhydramnios|hydronephrosis|laryngostenosis|syndactyly|tetralogy of Fallot|tracheal stenosis|vesicoureteral reflux|myelomeningocele|tethered spinal cord syndrome|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis,ppi
13450,16156,3232,HOXD3,homeobox D3,3,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding,prostate cancer|prostate carcinoma,ppi
13451,16158,3233,HOXD4,homeobox D4,21,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|activating transcription factor binding,acute lymphocytic leukemia,ppi
13452,16159,3234,HOXD8,homeobox D8,5,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
13453,16160,3235,HOXD9,homeobox D9,10,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific,mucinous adenocarcinoma|large intestine cancer|colorectal cancer|ovarian cancer,ppi
13454,16161,3240,HP,haptoglobin,47,hemoglobin binding|serine-type endopeptidase activity,bipolar disorder|mood disorder|anemia|macrocytic anemia|sickle cell anemia|arthropathy|arthritis|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|heart disease|cardiovascular system disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression,ppi
13455,16162,3208,HPCA,hippocalcin,8,actin binding|calcium ion binding|identical protein binding,focal hand dystonia|blepharospasm|generalized dystonia|torsion dystonia 1,ppi
13456,16163,3241,HPCAL1,hippocalcin like 1,29,,,ppi
13457,16164,3242,HPD,4-hydroxyphenylpyruvate dioxygenase,6,4-hydroxyphenylpyruvate dioxygenase activity,epilepsy|gallbladder disease|liver disease|visual epilepsy|lactic acidosis|tyrosinemia|tyrosinemia type III,ppi
13458,16166,3248,HPGD,hydroxyprostaglandin dehydrogenase 15-(NAD),1,catalytic activity|prostaglandin E receptor activity|15-hydroxyprostaglandin dehydrogenase (NAD+) activity|protein homodimerization activity|NAD binding|NAD+ binding,arthropathy|arthritis|ptosis|congenital ptosis|clubfoot|patent ductus arteriosus|dermatitis|neurogenic arthropathy|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|secondary hypertrophic osteoarthropathy|primary hypertrophic osteoarthropathy|osteoporosis|prostate cancer|prostate carcinoma|acrodermatitis|seborrheic keratosis|seborrheic infantile dermatitis|seborrheic dermatitis|thyroid cancer,ppi
13459,16167,3249,HPN,hepsin,3,serine-type endopeptidase activity|peptidase activity|serine-type peptidase activity|calcium-activated potassium channel activity,chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease|prostate cancer|prostate carcinoma,ppi
13460,16168,3250,HPR,haptoglobin-related protein,4,hemoglobin binding|serine-type endopeptidase activity,,ppi
13461,16169,3251,HPRT1,hypoxanthine phosphoribosyltransferase 1,46,magnesium ion binding|hypoxanthine phosphoribosyltransferase activity|guanine phosphoribosyltransferase activity,anemia|macrocytic anemia|megaloblastic anemia|gout|dystonia|basal ganglia disease|focal hand dystonia|blepharospasm|Lesch-Nyhan syndrome|purine-pyrimidine metabolic disorder|intellectual disability|learning disability|movement disease|lingual-facial-buccal dyskinesia|kidney failure|uremia|atrophy of testis|acute urate nephropathy|hyperuricemia,ppi
13462,16171,3257,HPS1,HPS1; biogenesis of lysosomal organelles complex 3 subunit 1,9,guanyl-nucleotide exchange factor activity,oculocutaneous albinism|Griscelli syndrome|Griscelli syndrome type 1|Griscelli syndrome type 2|Griscelli syndrome type 3|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|inflammatory bowel disease|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus,ppi
13463,16172,10855,HPSE,heparanase,7,beta-glucuronidase activity|heparanase activity|syndecan binding|protein dimerization activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|IgA glomerulonephritis|melanoma|skin melanoma|kidney disease|nephrosis|breast cancer,ppi
13464,16174,3263,HPX,hemopexin,10,protein binding|metallopeptidase activity,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|anterior compartment syndrome|nerve compression syndrome|compartment syndrome|diabetes mellitus|type 2 diabetes mellitus,ppi
13465,16177,55806,HR,HR; lysine demethylase and nuclear receptor corepressor,15,DNA binding|DNA-binding transcription factor activity|transcription regulatory region sequence-specific DNA binding|chromatin DNA binding|histone demethylase activity (H3-K9 specific),alopecia|alopecia areata|atrichia with papular lesions|alopecia universalis,ppi
13466,16178,3265,HRAS,HRas proto-oncogene; GTPase,149,GTPase activity|GTP binding|GDP binding,acanthosis nigricans|alopecia|sick sinus syndrome|autistic disorder|urinary bladder cancer|ptosis|congenital ptosis|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|transitional cell carcinoma|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|clubfoot|coloboma|cryptorchidism,ppi
13467,16179,3266,ERAS,ES cell expressed Ras,4,,,ppi
13468,16180,3267,AGFG1,ArfGAP with FG repeats 1,38,RNA binding,,ppi
13469,16181,11103,KRR1,KRR1; small subunit processome component homolog,83,RNA binding,,ppi
13470,16182,3268,AGFG2,ArfGAP with FG repeats 2,8,,,ppi
13471,16183,3270,HRC,histidine rich calcium binding protein,6,calcium ion binding,,ppi
13472,16184,3273,HRG,histidine rich glycoprotein,16,signaling receptor binding|heparin binding|zinc ion binding|immunoglobulin binding|heme binding|heparan sulfate proteoglycan binding|metal ion binding|serine-type endopeptidase inhibitor activity,thrombophilia|protein S deficiency|antithrombin III deficiency|protein C deficiency|breast cancer,ppi
13473,16187,3269,HRH1,histamine receptor H1,1,G-protein coupled receptor activity|histamine receptor activity|G-protein coupled serotonin receptor activity|neurotransmitter receptor activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|rhinitis|schizophrenia|vasomotor rhinitis|allergic rhinitis,ppi
13474,16190,3274,HRH2,histamine receptor H2,1,G-protein coupled serotonin receptor activity|G-protein coupled receptor activity|histamine receptor activity|neurotransmitter receptor activity,transitional cell carcinoma|schizophrenia|coronary stenosis,ppi
13475,16193,11255,HRH3,histamine receptor H3,1,G-protein coupled acetylcholine receptor activity|G-protein coupled serotonin receptor activity|neurotransmitter receptor activity|G-protein coupled receptor activity,amnestic disorder|dissociative amnesia|hypertension|essential hypertension,ppi
13476,16195,8739,HRK,harakiri; BCL2 interacting protein,8,,,ppi
13477,16196,3275,PRMT2,protein arginine methyltransferase 2,60,transcription coactivator activity|histone-arginine N-methyltransferase activity|protein-arginine N-methyltransferase activity|estrogen receptor binding|histone methyltransferase activity|protein-arginine omega-N asymmetric methyltransferase activity,,ppi
13478,16197,3276,PRMT1,protein arginine methyltransferase 1,180,RNA binding|methyltransferase activity|N-methyltransferase activity|protein methyltransferase activity|methyl-CpG binding|protein-arginine N-methyltransferase activity|protein-arginine omega-N monomethyltransferase activity|protein-arginine omega-N asymmetric methyltransferase activity|histone methyltransferase activity|identical protein binding|histone methyltransferase activity (H4-R3 specific)|S-adenosyl-L-methionine binding|histone-arginine N-methyltransferase activity,,ppi
13479,16198,56341,PRMT8,protein arginine methyltransferase 8,37,histone-arginine N-methyltransferase activity|S-adenosylmethionine-dependent methyltransferase activity|protein-arginine omega-N monomethyltransferase activity|protein-arginine omega-N asymmetric methyltransferase activity|identical protein binding|protein homodimerization activity|protein heterodimerization activity|S-adenosyl-L-methionine binding,,ppi
13480,16200,3280,HES1,hes family bHLH transcription factor 1,42,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription factor binding|protein homodimerization activity|sequence-specific DNA binding|N-box binding|E-box binding|sequence-specific double-stranded DNA binding|transcription corepressor activity|RNA polymerase II regulatory region sequence-specific DNA binding,lung cancer|non-small cell lung carcinoma|cervical cancer|colon cancer|colonic benign neoplasm|glioblastoma multiforme|giant cell glioblastoma|lung benign neoplasm|meningioma|spinal meningioma|acoustic neuroma|intraventricular meningioma|pituitary adenoma|intraorbital meningioma|clear cell meningioma|benign meningioma|secretory meningioma|microcystic meningioma|cerebral convexity meningioma|angiomatous meningioma,ppi
13481,16201,9653,HS2ST1,heparan sulfate 2-O-sulfotransferase 1,21,heparan sulfate 2-O-sulfotransferase activity|sulfotransferase activity,,ppi
13482,16202,9957,HS3ST1,heparan sulfate-glucosamine 3-sulfotransferase 1,2,sulfotransferase activity|[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,,ppi
13483,16203,9956,HS3ST2,heparan sulfate-glucosamine 3-sulfotransferase 2,11,sulfotransferase activity|[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,,ppi
13484,16204,9955,HS3ST3A1,heparan sulfate-glucosamine 3-sulfotransferase 3A1,1,sulfotransferase activity|[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,,ppi
13485,16205,9953,HS3ST3B1,heparan sulfate-glucosamine 3-sulfotransferase 3B1,1,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,endometriosis of uterus|endometriosis,ppi
13486,16206,89845,ABCC10,ATP binding cassette subfamily C member 10,8,ATPase-coupled anion transmembrane transporter activity|ATPase activity; coupled to transmembrane movement of substances,,ppi
13487,16208,9394,HS6ST1,heparan sulfate 6-O-sulfotransferase 1,9,sulfotransferase activity|heparan sulfate 6-O-sulfotransferase activity,generalized anxiety disorder|anxiety disorder|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertrophy of breast|infant gynecomastia|gynecomastia|osteoporosis|hypogonadism|premature menopause|androgen insensitivity syndrome|eunuchism|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA,ppi
13488,16209,3281,HSBP1,heat shock factor binding protein 1,24,,,ppi
13489,16210,3290,HSD11B1,hydroxysteroid 11-beta dehydrogenase 1,16,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity|steroid binding,rheumatoid arthritis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hyperglycemia|hypertension|essential hypertension|obesity|allergic contact dermatitis,ppi
13490,16211,3291,HSD11B2,hydroxysteroid 11-beta dehydrogenase 2,4,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,asthma|intrinsic asthma|allergic asthma|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19,ppi
13491,16212,3292,HSD17B1,hydroxysteroid 17-beta dehydrogenase 1,2,catalytic activity|estradiol 17-beta-dehydrogenase activity|steroid binding|NADP+ binding|estradiol binding,endometriosis of uterus|endometriosis|prostate cancer|prostate carcinoma,ppi
13492,16213,3294,HSD17B2,hydroxysteroid 17-beta dehydrogenase 2,2,estradiol 17-beta-dehydrogenase activity|17-alpha;20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity|testosterone dehydrogenase (NAD+) activity,endometrial cancer|endometrial carcinoma|endometriosis of uterus|endometriosis,ppi
13493,16214,3293,HSD17B3,hydroxysteroid 17-beta dehydrogenase 3,21,testosterone dehydrogenase (NAD+) activity|testosterone 17-beta-dehydrogenase (NADP+) activity,cryptorchidism|hypertrophy of breast|infant gynecomastia|gynecomastia|congenital hypothyroidism|myxedema|hypothyroidism|infertility|prostate cancer|prostate carcinoma|sex differentiation disease|hermaphroditism|pseudohermaphroditism|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism,ppi
13494,16215,3295,HSD17B4,hydroxysteroid 17-beta dehydrogenase 4,52,3-hydroxyacyl-CoA dehydrogenase activity|long-chain-enoyl-CoA hydratase activity|3alpha;7alpha;12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity|protein homodimerization activity|17-beta-hydroxysteroid dehydrogenase (NAD+) activity,adrenal cortical hypofunction|Addison's disease|cholestasis|clubfoot|epilepsy|gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|sensorineural hearing loss|polyhydramnios|cystic kidney disease|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|osteoporosis|visual epilepsy|infantile epileptic encephalopathy|ophthalmoplegia|mechanical strabismus,ppi
13495,16216,51478,HSD17B7,hydroxysteroid 17-beta dehydrogenase 7,14,3-keto sterol reductase activity,,ppi
13496,16217,3283,HSD3B1,hydroxy-delta-5-steroid dehydrogenase; 3 beta- and steroid delta-isomerase 1,1,3-beta-hydroxy-delta5-steroid dehydrogenase activity|steroid delta-isomerase activity|oxidoreductase activity|oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor,polycystic ovary syndrome|prostate cancer|prostate carcinoma,ppi
13497,16218,3284,HSD3B2,hydroxy-delta-5-steroid dehydrogenase; 3 beta- and steroid delta-isomerase 2,18,3-beta-hydroxy-delta5-steroid dehydrogenase activity|steroid delta-isomerase activity|oxidoreductase activity|oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor,lactic acidosis|cryptorchidism|hypertrophy of breast|infant gynecomastia|gynecomastia|osteoporosis|polycystic ovary syndrome|prostate cancer|prostate carcinoma|glucose intolerance|prediabetes syndrome|congenital adrenal hyperplasia|hypospadias|paranoid schizophrenia|delusional disorder|liver cancer|hepatocellular carcinoma,ppi
13498,16219,3297,HSF1,heat shock transcription factor 1,115,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding|DNA binding|DNA-binding transcription factor activity|heat shock protein binding|chromatin DNA binding|identical protein binding|sequence-specific DNA binding|protein self-association|protein heterodimerization activity|Hsp90 protein binding|translation elongation factor binding|promoter-specific chromatin binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|amyotrophic lateral sclerosis type 1,ppi
13499,16220,3298,HSF2,heat shock transcription factor 2,72,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|RNA polymerase II proximal promoter sequence-specific DNA binding|sequence-specific DNA binding,,ppi
13500,16221,11077,HSF2BP,heat shock transcription factor 2 binding protein,5,,,ppi
13501,16222,3299,HSF4,heat shock transcription factor 4,22,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity|sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding,cataract 16 multiple types|cataract 32 multiple types|cataract 5 multiple types,ppi
13502,16224,3300,DNAJB2,DnaJ heat shock protein family (Hsp40) member B2,44,ATPase activator activity|ubiquitin binding|unfolded protein binding|ubiquitin-dependent protein binding|Hsp70 protein binding|chaperone binding,progressive muscular atrophy|spinal muscular atrophy,ppi
13503,16227,3301,DNAJA1,DnaJ heat shock protein family (Hsp40) member A1,210,ATPase activator activity|Hsp70 protein binding|low-density lipoprotein particle receptor binding|chaperone binding,mouth disease,ppi
13504,16228,3303,HSPA1A,heat shock protein family A (Hsp70) member 1A,407,,gallbladder disease|liver disease|major depressive disorder|mental depression|endogenous depression|melanoma|skin melanoma|Parkinson's disease|prostate cancer|prostate carcinoma|schizophrenia|paranoid schizophrenia|delusional disorder|neurotic disorder|melancholia|coronary artery disease|pancreatic ductal carcinoma,ppi
13505,16230,3305,HSPA1L,heat shock protein family A (Hsp70) member 1 like,181,unfolded protein binding|ATP binding|misfolded protein binding|ATPase activity|heat shock protein binding|ATPase activity; coupled|protein binding involved in protein folding,major depressive disorder|mental depression|endogenous depression|schizophrenia|paranoid schizophrenia|delusional disorder|neurotic disorder|melancholia,ppi
13506,16231,3306,HSPA2,heat shock protein family A (Hsp70) member 2,101,unfolded protein binding|misfolded protein binding|heat shock protein binding|ATPase activity|ATPase activity; coupled|protein binding involved in protein folding|ATP binding,colon cancer|colonic benign neoplasm|coronary artery disease,ppi
13507,16232,3308,HSPA4,heat shock protein family A (Hsp70) member 4,359,ATP binding,bipolar disorder|neurotic disorder|endogenous depression|melancholia|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S,ppi
13508,16233,3309,HSPA5,heat shock protein family A (Hsp70) member 5,561,calcium ion binding|ATPase activity|cadherin binding|unfolded protein binding|chaperone binding|misfolded protein binding|ATPase activity; coupled|ATP binding|protein binding involved in protein folding|heat shock protein binding,asbestosis|anthracosilicosis|byssinosis|bipolar disorder|chronic myeloid leukemia|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|obesity|esophagus squamous cell carcinoma|hematologic cancer|spinocerebellar ataxia type 17|liver cancer|hepatocellular carcinoma,ppi
13509,16235,3310,HSPA6,heat shock protein family A (Hsp70) member 6,101,ATPase activity; coupled|unfolded protein binding|heat shock protein binding|ubiquitin protein ligase binding|ATP binding|ATPase activity|misfolded protein binding|protein binding involved in protein folding,,ppi
13510,16236,3312,HSPA8,heat shock protein family A (Hsp70) member 8,626,RNA binding|ATP binding|ATPase activity|MHC class II protein complex binding|ATPase activity; coupled|cadherin binding|unfolded protein binding|clathrin-uncoating ATPase activity|protein binding involved in protein folding|misfolded protein binding|heat shock protein binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|tongue squamous cell carcinoma|squamous cell carcinoma|stomach cancer|spinocerebellar ataxia type 17,ppi
13511,16238,3313,HSPA9,heat shock protein family A (Hsp70) member 9,425,RNA binding|unfolded protein binding|ATP binding|misfolded protein binding|protein binding involved in protein folding|ATPase activity|ATPase activity; coupled|heat shock protein binding,sideroblastic anemia|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|Parkinson's disease|schizophrenia|uveitis|ciliary body disease|iris disease|panuveitis|coronary artery disease|perinatal necrotizing enterocolitis,ppi
13512,16239,3315,HSPB1,heat shock protein family B (small) member 1,438,RNA binding|protein kinase C binding|protein kinase C inhibitor activity|identical protein binding|protein homodimerization activity|ubiquitin binding|protein binding involved in protein folding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|colon cancer|colonic benign neoplasm|contact dermatitis|occupational dermatitis|congestive heart failure|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|acute myeloid leukemia,ppi
13513,16240,3316,HSPB2,heat shock protein family B (small) member 2,98,enzyme activator activity,,ppi
13514,16241,8988,HSPB3,heat shock protein family B (small) member 3,21,,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|polyneuropathy|peripheral nervous system disease|neuropathy|muscular atrophy,ppi
13515,16242,27129,HSPB7,heat shock protein family B (small) member 7,14,protein C-terminus binding,,ppi
13516,16243,3320,HSP90AA1,heat shock protein 90 alpha family class A member 1,852,nucleotide binding|RNA binding|protein tyrosine kinase activity|ATP binding|ATPase activity|MHC class II protein complex binding|nitric-oxide synthase regulator activity|TPR domain binding|ATPase activity; coupled|identical protein binding|protein homodimerization activity,contact dermatitis|occupational dermatitis|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|neurotic disorder|endogenous depression|melancholia|mood disorder|major depressive disorder|mental depression|breast cancer,ppi
13517,16244,3326,HSP90AB1,heat shock protein 90 alpha family class B member 1,702,RNA binding|double-stranded RNA binding|ATP binding|MHC class II protein complex binding|nitric-oxide synthase regulator activity|TPR domain binding|ATPase activity; coupled|protein homodimerization activity|cadherin binding|protein dimerization activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|prostate cancer|prostate carcinoma,ppi
13518,16245,3329,HSPD1,heat shock protein family D (Hsp60) member 1,342,lipopolysaccharide binding|DNA replication origin binding|single-stranded DNA binding|RNA binding|double-stranded RNA binding|high-density lipoprotein particle binding|ATPase activity|unfolded protein binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|pseudosarcomatous fibromatosis|epilepsy|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|leukodystrophy,ppi
13519,16246,3336,HSPE1,heat shock protein family E (Hsp10) member 1,141,RNA binding|unfolded protein binding|chaperone binding|metal ion binding,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
13520,16247,3337,DNAJB1,DnaJ heat shock protein family (Hsp40) member B1,112,ATPase activator activity|transcription corepressor activity|cadherin binding|unfolded protein binding|chaperone binding|Hsp70 protein binding,bipolar disorder|fibrolamellar carcinoma,ppi
13521,16248,3338,DNAJC4,DnaJ heat shock protein family (Hsp40) member C4,4,unfolded protein binding,,ppi
13522,16249,3339,HSPG2,heparan sulfate proteoglycan 2,53,extracellular matrix structural constituent conferring compression resistance|low-density lipoprotein particle receptor binding,blepharophimosis|ptosis|congenital ptosis|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|inguinal hernia|umbilical hernia,ppi
13523,16250,10524,KAT5,lysine acetyltransferase 5,228,transcription coactivator activity|histone acetyltransferase activity|acetyltransferase activity|androgen receptor binding|H4 histone acetyltransferase activity|histone binding,,ppi
13524,16251,27336,HTATSF1,HIV-1 Tat specific factor 1,56,RNA binding,,ppi
13525,16252,3344,FOXN2,forkhead box N2,10,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
13526,16253,3346,HTN1,histatin 1,3,,autistic disorder,ppi
13527,16254,3347,HTN3,histatin 3,2,,,ppi
13528,16255,3350,HTR1A,5-hydroxytryptamine receptor 1A,9,G-protein coupled serotonin receptor activity|receptor-receptor interaction|serotonin binding|neurotransmitter receptor activity|G-protein coupled receptor activity,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|intellectual disability|learning disability|drug psychosis|schizophrenia|epilepsy|visual epilepsy|stomach cancer|migraine|postpartum depression|cocaine abuse|cocaine dependence,ppi
13529,16256,3351,HTR1B,5-hydroxytryptamine receptor 1B,6,G-protein coupled serotonin receptor activity|G-protein coupled receptor activity|neurotransmitter receptor activity,alcohol dependence|alcohol abuse|autistic disorder|bipolar disorder|cocaine abuse|cocaine dependence|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophreniform disorder|schizoaffective disorder|epilepsy|visual epilepsy|mood disorder|morphine dependence,ppi
13530,16257,3352,HTR1D,5-hydroxytryptamine receptor 1D,3,G-protein coupled serotonin receptor activity|neurotransmitter receptor activity|G-protein coupled receptor activity,autistic disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|obsessive-compulsive disorder|schizophrenia,ppi
13531,16258,3354,HTR1E,5-hydroxytryptamine receptor 1E,8,G-protein coupled receptor activity|G-protein coupled serotonin receptor activity|serotonin binding|neurotransmitter receptor activity,,ppi
13532,16259,3355,HTR1F,5-hydroxytryptamine receptor 1F,1,G-protein coupled serotonin receptor activity|serotonin binding|G-protein coupled receptor activity|neurotransmitter receptor activity,schizophrenia,ppi
13533,16260,3356,HTR2A,5-hydroxytryptamine receptor 2A,19,G-protein coupled serotonin receptor activity|drug binding|serotonin binding|1-(4-iodo-2;5-dimethoxyphenyl)propan-2-amine binding|neurotransmitter receptor activity|G-protein coupled receptor activity,alcohol dependence|alcohol abuse|anorexia nervosa|autistic disorder|basal ganglia disease|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|chronic obstructive pulmonary disease|disease of metabolism|obesity|obsessive-compulsive disorder|drug psychosis|schizophreniform disorder|schizoaffective disorder,ppi
13534,16261,3357,HTR2B,5-hydroxytryptamine receptor 2B,6,G-protein alpha-subunit binding|G-protein coupled serotonin receptor activity|GTPase activator activity|drug binding|serotonin binding|neurotransmitter receptor activity|G-protein coupled receptor activity,congestive heart failure|heart valve disease|hypertension|essential hypertension|primary pulmonary hypertension|pulmonary hypertension,ppi
13535,16262,3358,HTR2C,5-hydroxytryptamine receptor 2C,91,Gq/11-coupled serotonin receptor activity|G-protein coupled serotonin receptor activity|drug binding|serotonin binding|1-(4-iodo-2;5-dimethoxyphenyl)propan-2-amine binding|G-protein coupled receptor activity|neurotransmitter receptor activity,alcohol dependence|alcohol abuse|bipolar disorder|cocaine abuse|cocaine dependence|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|obesity|schizophrenia|metabolic syndrome X|mood disorder,ppi
13536,16263,3359,HTR3A,5-hydroxytryptamine receptor 3A,103,serotonin-gated cation-selective channel activity|serotonin binding|extracellular ligand-gated ion channel activity,alcohol dependence|alcohol abuse|autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|mood disorder,ppi
13537,16264,9177,HTR3B,5-hydroxytryptamine receptor 3B,1,serotonin-gated cation-selective channel activity|extracellular ligand-gated ion channel activity,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|familial periodic paralysis|myopathy|schizophrenia,ppi
13538,16265,3360,HTR4,5-hydroxytryptamine receptor 4,1,G-protein coupled serotonin receptor activity|neurotransmitter receptor activity|G-protein coupled receptor activity,sick sinus syndrome|atrial fibrillation|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|cerebral infarction|cerebrovascular disease|mood disorder,ppi
13539,16266,1244,ABCC2,ATP binding cassette subfamily C member 2,48,organic anion transmembrane transporter activity|bilirubin transmembrane transporter activity|ATPase activity; coupled to transmembrane movement of substances|ATPase-coupled anion transmembrane transporter activity,alopecia|rheumatoid arthritis|obstructive jaundice|biliary tract disease|cholestasis|large intestine cancer|colorectal cancer|gastroenteritis|intestinal disease|gastrointestinal system disease|proctitis|heart disease|cardiovascular system disease|Gilbert syndrome|bilirubin metabolic disorder|Dubin-Johnson syndrome|primary biliary cirrhosis|central nervous system disease|nervous system disease|autonomic neuropathy,ppi
13540,16268,3362,HTR6,5-hydroxytryptamine receptor 6,29,histamine receptor activity|G-protein coupled serotonin receptor activity|G-protein coupled receptor activity|neurotransmitter receptor activity,drug psychosis|schizophrenia|mood disorder,ppi
13541,16269,3363,HTR7,5-hydroxytryptamine receptor 7,79,G-protein coupled serotonin receptor activity|G-protein coupled receptor activity|neurotransmitter receptor activity,alcohol dependence|alcohol abuse|anxiety disorder|phobic disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|intellectual disability|learning disability|familial periodic paralysis|myopathy|schizophrenia|mood disorder,ppi
13542,16270,3364,HUS1,HUS1 checkpoint clamp component,37,,,ppi
13543,16271,3371,TNC,tenascin C,8,extracellular matrix structural constituent|syndecan binding,asthma|intrinsic asthma|allergic asthma|sensorineural hearing loss|endometriosis of uterus|endometriosis|melanoma|skin melanoma|pleural disease|varicose veins|autosomal dominant nonsyndromic deafness 56,ppi
13544,16272,3373,HYAL1,hyaluronoglucosaminidase 1,7,hyalurononglucosaminidase activity|transcription factor binding|hyaluronan synthase activity|virus receptor activity,skin disease|seborrheic keratosis|actinic keratosis|isolated cleft palate|mucopolysaccharidosis IX,ppi
13545,16273,8692,HYAL2,hyaluronoglucosaminidase 2,16,virus receptor activity|hyalurononglucosaminidase activity|hyaluronic acid binding|receptor signaling protein tyrosine kinase inhibitor activity|hyaluronoglucuronidase activity|transforming growth factor beta binding,,ppi
13546,16274,8372,HYAL3,hyaluronoglucosaminidase 3,5,hyalurononglucosaminidase activity|hyaluronoglucuronidase activity|virus receptor activity,,ppi
13547,16275,23553,HYAL4,hyaluronoglucosaminidase 4,2,,,ppi
13548,16276,3375,IAPP,islet amyloid polypeptide,7,amyloid-beta binding|signaling receptor binding,diabetes mellitus|type 2 diabetes mellitus|gastric ulcer,ppi
13549,16277,301,ANXA1,annexin A1,127,signaling receptor binding|structural molecule activity|calcium ion binding|phospholipid binding|calcium-dependent phospholipid binding|phospholipase A2 inhibitor activity|protein binding; bridging|cadherin binding involved in cell-cell adhesion|protein homodimerization activity|double-stranded DNA-dependent ATPase activity|single-stranded RNA binding|DNA/DNA annealing activity|calcium-dependent protein binding|single-stranded DNA binding,tongue squamous cell carcinoma|squamous cell carcinoma|hypertension|essential hypertension|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|prostate cancer|prostate carcinoma|duodenal disease|stomach disease|esophageal disease|lung cancer|lung adenocarcinoma|esophagus squamous cell carcinoma,ppi
13550,16278,3376,IARS,isoleucyl-tRNA synthetase,116,isoleucine-tRNA ligase activity,,ppi
13551,16279,64127,NOD2,nucleotide binding oligomerization domain containing 2,36,actin binding|muramyl dipeptide binding|peptidoglycan binding|Hsp90 protein binding,psoriatic arthritis|bipolar disorder|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|sarcoidosis|uveoparotid fever|Blau syndrome,ppi
13552,16280,11199,ANXA10,annexin A10,3,protein binding,,ppi
13553,16282,3382,ICA1,islet cell autoantigen 1,13,,,ppi
13554,16283,3383,ICAM1,intercellular adhesion molecule 1,170,transmembrane signaling receptor activity|integrin binding|signaling receptor activity,asthma|intrinsic asthma|allergic asthma|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|Behcet's disease|bronchiectasis|heart disease|cardiovascular system disease|brain ischemia|cholestasis|inflammatory bowel disease|ulcerative colitis|colon cancer|colonic benign neoplasm|diabetes mellitus|type 2 diabetes mellitus,ppi
13555,16284,3384,ICAM2,intercellular adhesion molecule 2,20,integrin binding,stomach cancer|malignant mesothelioma|benign mesothelioma,ppi
13556,16285,3385,ICAM3,intercellular adhesion molecule 3,14,signaling receptor binding|integrin binding,primary biliary cirrhosis,ppi
13557,16286,3386,ICAM4,intercellular adhesion molecule 4 (Landsteiner-Wiener blood group),12,integrin binding,,ppi
13558,16287,7087,ICAM5,intercellular adhesion molecule 5,18,integrin binding,large intestine cancer|colorectal cancer|breast cancer,ppi
13559,16288,311,ANXA11,annexin A11,48,RNA binding|MHC class II protein complex binding|protein binding|calcium-dependent phospholipid binding|S100 protein binding|calcium-dependent protein binding|phosphatidylethanolamine binding|calcium ion binding,sarcoidosis|uveoparotid fever,ppi
13560,16289,23463,ICMT,isoprenylcysteine carboxyl methyltransferase,13,protein C-terminal carboxyl O-methyltransferase activity|protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,,ppi
13561,16290,29851,ICOS,inducible T-cell costimulator,5,phosphatidylinositol-4;5-bisphosphate 3-kinase activity,hemolytic anemia|imperforate anus|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|bronchiectasis|common variable immunodeficiency|conjunctivitis|primary immunodeficiency disease|adult T-cell leukemia|acute T cell leukemia|lymphosarcoma|lymphoma|central nervous system lymphoma|lymphopenia|meningitis|pneumonia|purpura|agammaglobulinemia|liver disease|immunoglobulin alpha deficiency,ppi
13562,16291,3394,IRF8,interferon regulatory factor 8,22,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding,rheumatoid arthritis|multiple sclerosis,ppi
13563,16292,3396,MRPL58,mitochondrial ribosomal protein L58,266,aminoacyl-tRNA hydrolase activity|translation release factor activity; codon nonspecific,,ppi
13564,16293,312,ANXA13,annexin A13,9,phosphatidylglycerol binding|phosphatidylserine binding,,ppi
13565,16294,3397,ID1,inhibitor of DNA binding 1; HLH protein,47,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II transcription factor binding|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|transcription factor binding|DNA-binding transcription factor activity,diabetes mellitus|type 2 diabetes mellitus|coronary artery disease,ppi
13566,16295,3398,ID2,inhibitor of DNA binding 2; HLH protein,84,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II transcription factor binding|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|transcription factor binding|DNA-binding transcription factor activity,acute myeloid leukemia|seborrheic keratosis|skin disease|actinic keratosis|goiter|thyroid gland disease|lung small cell carcinoma,ppi
13567,16296,3399,ID3,inhibitor of DNA binding 3; HLH protein,42,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|transcription factor binding|RNA polymerase II transcription factor binding|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|DNA-binding transcription factor activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|Burkitt lymphoma|colon cancer|colonic benign neoplasm|lung benign neoplasm|central nervous system disease|nervous system disease|autonomic neuropathy|prostate cancer|prostate carcinoma|goiter|thyroid gland disease|coronary artery disease,ppi
13568,16297,3400,ID4,inhibitor of DNA binding 4; HLH protein,16,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|obsolete transcriptional repressor activity; RNA polymerase II transcription factor binding|RNA polymerase II transcription factor binding|DNA-binding transcription factor activity|transcription factor binding,stomach cancer,ppi
13569,16298,302,ANXA2,annexin A2,152,RNA binding|calcium-dependent phospholipid binding|phosphatidylinositol-4;5-bisphosphate binding|phospholipase A2 inhibitor activity|cadherin binding involved in cell-cell adhesion|molecular function regulator|S100 protein binding|bone sialoprotein binding|calcium channel activity|Rab GTPase binding|protease binding|phosphatidylserine binding|protein binding|voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels|identical protein binding|virion binding,tongue squamous cell carcinoma|squamous cell carcinoma|acute myeloid leukemia|liver cancer|lung benign neoplasm|osteoporosis|malignant mesothelioma|benign mesothelioma,ppi
13570,16299,3416,IDE,insulin degrading enzyme,89,metalloendopeptidase activity|ATP binding|zinc ion binding|insulin binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|schizophrenia,ppi
13571,16300,3417,IDH1,isocitrate dehydrogenase (NADP(+)) 1; cytosolic,58,magnesium ion binding|isocitrate dehydrogenase (NADP+) activity|cadherin binding|(R)-2-hydroxyglutarate dehydrogenase activity|protein homodimerization activity,Maffucci syndrome|hereditary multiple exostoses|Ollier disease|malignant glioma|gliosarcoma|mixed glioma|glomus tumor|hemangioma|lymphangioma|chorioangioma|intramuscular hemangioma|histiocytoid hemangioma|cavernous hemangioma|acute myeloid leukemia|acute promyelocytic leukemia|oligodendroglioma|childhood oligodendroglioma|adult oligodendroglioma|mixed oligodendroglioma-astrocytoma|thrombophilia,ppi
13572,16301,3418,IDH2,isocitrate dehydrogenase (NADP(+)) 2; mitochondrial,28,magnesium ion binding|isocitrate dehydrogenase (NADP+) activity|protein homodimerization activity,Maffucci syndrome|hereditary multiple exostoses|Ollier disease|epilepsy|glomus tumor|hemangioma|lymphangioma|chorioangioma|intramuscular hemangioma|histiocytoid hemangioma|cavernous hemangioma|acute myeloid leukemia|acute promyelocytic leukemia|oligodendroglioma|childhood oligodendroglioma|adult oligodendroglioma|mixed oligodendroglioma-astrocytoma|arthropathy|arthritis|osteoporosis,ppi
13573,16302,3419,IDH3A,isocitrate dehydrogenase 3 (NAD(+)) alpha,55,magnesium ion binding|isocitrate dehydrogenase (NAD+) activity,arthropathy|arthritis,ppi
13574,16303,3420,IDH3B,isocitrate dehydrogenase 3 (NAD(+)) beta,36,electron transfer activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|stomach cancer,ppi
13575,16304,3421,IDH3G,isocitrate dehydrogenase 3 (NAD(+)) gamma,26,magnesium ion binding|isocitrate dehydrogenase (NAD+) activity,,ppi
13576,16305,3422,IDI1,isopentenyl-diphosphate delta isomerase 1,6,isopentenyl-diphosphate delta-isomerase activity,,ppi
13577,16306,3423,IDS,iduronate 2-sulfatase,42,iduronate-2-sulfatase activity|sulfuric ester hydrolase activity,asthma|intrinsic asthma|allergic asthma|ptosis|congenital ptosis|pseudosarcomatous fibromatosis|sensorineural hearing loss|achondroplasia|Laron syndrome|epilepsy|congestive heart failure|heart valve disease|inguinal hernia|umbilical hernia|omphalocele|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|hypertrichosis,ppi
13578,16307,3425,IDUA,iduronidase; alpha-L-,2,L-iduronidase activity,aortic valve insufficiency|aortic valve stenosis|spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|pseudosarcomatous fibromatosis|recurrent corneal erosion|sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|gingival overgrowth|gingival hypertrophy|glaucoma|heart valve disease,ppi
13579,16308,8870,IER3,immediate early response 3,16,,hypertension|essential hypertension|seborrheic keratosis|skin disease|actinic keratosis,ppi
13580,16309,51278,IER5,immediate early response 5,12,identical protein binding,,ppi
13581,16310,3426,CFI,complement factor I,4,serine-type endopeptidase activity,arthropathy|arthritis|nephritis|glomerulonephritis|kidney disease|interstitial nephritis|pyelonephritis|pyelitis|kidney failure|uremia|vasculitis|pre-eclampsia|HELLP syndrome|age related macular degeneration|macular degeneration|degeneration of macula and posterior pole|urinary tract obstruction|Doyne honeycomb retinal dystrophy|hemolytic-uremic syndrome|complement factor I deficiency,ppi
13582,16311,3428,IFI16,interferon gamma inducible protein 16,435,RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|double-stranded DNA binding|RNA binding|transcription factor binding,,ppi
13583,16312,3429,IFI27,interferon alpha inducible protein 27,5,lamin binding,influenza,ppi
13584,16313,10437,IFI30,IFI30; lysosomal thiol reductase,40,oxidoreductase activity; acting on a sulfur group of donors,acute myeloid leukemia|allergic contact dermatitis,ppi
13585,16314,3430,IFI35,interferon induced protein 35,8,,influenza,ppi
13586,16315,8714,ABCC3,ATP binding cassette subfamily C member 3,9,organic anion transmembrane transporter activity|bile acid-exporting ATPase activity|ATPase activity; coupled to transmembrane movement of substances|ATPase-coupled anion transmembrane transporter activity,rheumatoid arthritis|cholestasis|large intestine cancer|colorectal cancer,ppi
13587,16316,3431,SP110,SP110 nuclear body protein,18,DNA-binding transcription factor activity; RNA polymerase II-specific,primary immunodeficiency disease|gallbladder disease|liver disease|selective IgG deficiency disease|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
13588,16317,3434,IFIT1,interferon induced protein with tetratricopeptide repeats 1,47,RNA binding,endometriosis of uterus|endometriosis|influenza,ppi
13589,16318,3433,IFIT2,interferon induced protein with tetratricopeptide repeats 2,44,RNA binding,influenza,ppi
13590,16319,306,ANXA3,annexin A3,15,calcium-dependent phospholipid binding|calcium-dependent protein binding|phospholipase A2 inhibitor activity,rheumatoid arthritis|systemic lupus erythematosus|prostate cancer|prostate carcinoma|ovarian cancer,ppi
13591,16320,3437,IFIT3,interferon induced protein with tetratricopeptide repeats 3,71,RNA binding,influenza,ppi
13592,16321,8519,IFITM1,interferon induced transmembrane protein 1,4,,,ppi
13593,16322,10581,IFITM2,interferon induced transmembrane protein 2,3,,,ppi
13594,16323,10410,IFITM3,interferon induced transmembrane protein 3,5,,influenza,ppi
13595,16324,3439,IFNA1,interferon alpha 1,16,,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|bipolar disorder|large intestine cancer|colorectal cancer|VIPoma|pancreatic cholera|hepatitis B|adult T-cell leukemia|acute T cell leukemia|liver cirrhosis|liver cancer|melanoma|skin melanoma|pancreatic cancer,ppi
13596,16325,3446,IFNA10,interferon alpha 10,3,type I interferon receptor binding|cytokine activity,,ppi
13597,16327,307,ANXA4,annexin A4,21,phospholipase inhibitor activity|calcium ion binding|calcium-dependent phospholipid binding|calcium-dependent protein binding|identical protein binding|heparin binding|protein binding|chondroitin sulfate binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|acute myeloid leukemia|liver cancer|prostate cancer|prostate carcinoma|hepatocellular carcinoma,ppi
13598,16328,3448,IFNA14,interferon alpha 14,9,cytokine receptor binding|type I interferon receptor binding|cytokine activity,,ppi
13599,16329,3449,IFNA16,interferon alpha 16,2,type I interferon receptor binding|cytokine activity,,ppi
13600,16330,3451,IFNA17,interferon alpha 17,6,type I interferon receptor binding|cytokine activity,,ppi
13601,16331,3440,IFNA2,interferon alpha 2,9,type I interferon receptor binding|cytokine activity,anemia|macrocytic anemia|hemolytic anemia|anxiety disorder|phobic disorder|disease of mental health|urinary bladder cancer|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|transitional cell carcinoma|large intestine cancer|colorectal cancer|neurotic disorder,ppi
13602,16332,3452,IFNA21,interferon alpha 21,25,cytokine receptor binding|cytokine activity|type I interferon receptor binding,,ppi
13603,16333,3441,IFNA4,interferon alpha 4,10,type I interferon receptor binding|cytokine activity,,ppi
13604,16334,3442,IFNA5,interferon alpha 5,16,cytokine receptor binding|type I interferon receptor binding|cytokine activity,melanoma|skin melanoma|pancreatic cancer,ppi
13605,16335,3443,IFNA6,interferon alpha 6,4,type I interferon receptor binding|cytokine activity,,ppi
13606,16336,3444,IFNA7,interferon alpha 7,1,type I interferon receptor binding|cytokine activity,,ppi
13607,16337,3445,IFNA8,interferon alpha 8,12,cytokine receptor binding|type I interferon receptor binding|cytokine activity,,ppi
13608,16338,308,ANXA5,annexin A5,46,phospholipase inhibitor activity|phospholipid binding|calcium-dependent phospholipid binding|calcium-transporting ATPase activity|molecular adaptor activity|protein binding|heparin binding|receptor tyrosine kinase binding|peptide hormone binding,tongue squamous cell carcinoma|squamous cell carcinoma|iron metabolism disease|hemochromatosis|Wilson disease|acute myeloid leukemia|pre-eclampsia|stomach cancer|lung cancer|lung adenocarcinoma,ppi
13609,16339,3454,IFNAR1,interferon alpha and beta receptor subunit 1,28,type I interferon receptor activity|type I interferon binding,viral infectious disease|mental depression,ppi
13610,16340,3455,IFNAR2,interferon alpha and beta receptor subunit 2,20,type I interferon receptor activity,hepatitis B,ppi
13611,16341,3456,IFNB1,interferon beta 1,2,cytokine activity|type I interferon receptor binding|chloramphenicol O-acetyltransferase activity,anus neoplasm|anal carcinoma|urinary bladder cancer|brain disease|transitional cell carcinoma|hepatitis B|melanoma|skin melanoma|multiple sclerosis|neuroblastoma|epilepsy|visual epilepsy|amelanotic melanoma|breast cancer,ppi
13612,16342,3458,IFNG,interferon gamma,6,cytokine activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|aplastic anemia|appendicitis|arthropathy|septic arthritis|rheumatoid arthritis|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|autistic disorder|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|bipolar disorder|brain disease|bronchiolitis obliterans|colitis|ileitis,ppi
13613,16343,3459,IFNGR1,interferon gamma receptor 1,33,interferon-gamma receptor activity,endometriosis of uterus|endometriosis|hematopoietic system disease|hepatitis B|peripheral vascular disease|coronary artery disease,ppi
13614,16344,309,ANXA6,annexin A6,45,GTP binding|calcium-dependent phospholipid binding|lipid binding|ligand-gated ion channel activity|cholesterol binding|protein homodimerization activity|chondroitin sulfate binding|phosphatidylserine binding|actin filament binding|calcium channel activity|protein-containing complex binding|heparin binding|signaling receptor activity|enzyme binding|calcium-dependent protein binding,acute myeloid leukemia,ppi
13615,16345,3460,IFNGR2,interferon gamma receptor 2 (interferon gamma transducer 1),9,interferon-gamma receptor activity,primary immunodeficiency disease,ppi
13616,16346,3467,IFNW1,interferon omega 1,4,cytokine receptor binding|cytokine activity|type I interferon receptor binding,,ppi
13617,16347,310,ANXA7,annexin A7,140,RNA binding|integrin binding|calcium-dependent protein binding|calcium-dependent phospholipid binding|identical protein binding,liver cancer,ppi
13618,16348,3475,IFRD1,interferon related developmental regulator 1,16,,adult respiratory distress syndrome|newborn respiratory distress syndrome|spinocerebellar ataxia type 18,ppi
13619,16349,7866,IFRD2,interferon related developmental regulator 2,20,,,ppi
13620,16351,3476,IGBP1,immunoglobulin (CD79A) binding protein 1,125,protein phosphatase regulator activity|protein phosphatase 2A binding,choanal atresia|isolated cleft palate|cleft palate|patent ductus arteriosus|sensorineural hearing loss|ventricular septal defect|lung benign neoplasm|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|blindness|visual pathway disease|coloboma of optic nerve|breast cancer|corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome|liver cancer|hepatocellular carcinoma,ppi
13621,16352,3479,IGF1,insulin like growth factor 1,14,insulin-like growth factor receptor binding|integrin binding|hormone activity,hyperpituitarism|acromegaly|adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease,ppi
13622,16353,3480,IGF1R,insulin like growth factor 1 receptor,123,protein tyrosine kinase activity|insulin-like growth factor-activated receptor activity|insulin receptor binding|insulin-like growth factor binding|insulin-like growth factor I binding|insulin receptor substrate binding|insulin-activated receptor activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|generalized anxiety disorder|anxiety disorder|endometrial cancer|endometrial carcinoma|placental insufficiency,ppi
13623,16354,3481,IGF2,insulin like growth factor 2,23,insulin-like growth factor receptor binding|integrin binding|growth factor activity|protein serine/threonine kinase activator activity|receptor ligand activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|anemia|macrocytic anemia|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis,ppi
13624,16355,3482,IGF2R,insulin like growth factor 2 receptor,42,insulin-like growth factor-activated receptor activity|protein binding|signaling receptor activity|phosphoprotein binding|mannose binding|retinoic acid binding|insulin-like growth factor II binding|insulin-like growth factor binding|kringle domain binding|G-protein alpha-subunit binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|lung disease|Parkinson's disease|congenital diaphragmatic hernia|Lewy body dementia|liver cancer,ppi
13625,16356,3483,IGFALS,insulin like growth factor binding protein acid labile subunit,5,insulin-like growth factor binding,,ppi
13626,16357,3484,IGFBP1,insulin like growth factor binding protein 1,23,signaling receptor binding|insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding,colon cancer|colonic benign neoplasm|endometriosis of uterus|endometriosis|liver cirrhosis|primary biliary cirrhosis,ppi
13627,16358,8416,ANXA9,annexin A9,6,phosphatidylserine binding|phospholipid binding|acetylcholine receptor activity|protein homodimerization activity|protein binding,,ppi
13628,16359,3485,IGFBP2,insulin like growth factor binding protein 2,8,signaling receptor binding|insulin-like growth factor I binding|insulin-like growth factor II binding,bipolar disorder|salivary gland adenoid cystic carcinoma|contact dermatitis|occupational dermatitis|liver cirrhosis|obesity,ppi
13629,16360,3486,IGFBP3,insulin like growth factor binding protein 3,41,insulin-like growth factor binding|protein tyrosine phosphatase activator activity|metal ion binding|insulin-like growth factor II binding|fibronectin binding|insulin-like growth factor I binding,rheumatoid arthritis|autistic disorder|urinary bladder cancer|transitional cell carcinoma|large intestine cancer|colorectal cancer|prostate cancer|prostate carcinoma|stomach cancer|coronary artery disease,ppi
13630,16361,3487,IGFBP4,insulin like growth factor binding protein 4,8,signaling receptor binding|insulin-like growth factor I binding|insulin-like growth factor II binding,,ppi
13631,16362,3488,IGFBP5,insulin like growth factor binding protein 5,23,insulin-like growth factor II binding|fibronectin binding|insulin-like growth factor I binding,urinary bladder cancer|breast cancer,ppi
13632,16363,3489,IGFBP6,insulin like growth factor binding protein 6,8,signaling receptor binding|insulin-like growth factor II binding|fibronectin binding|insulin-like growth factor I binding,contact dermatitis|occupational dermatitis|endometriosis of uterus|endometriosis|prostate cancer|prostate carcinoma|adult respiratory distress syndrome|newborn respiratory distress syndrome,ppi
13633,16364,3490,IGFBP7,insulin like growth factor binding protein 7,15,extracellular matrix structural constituent,alcohol dependence|alcohol abuse|prostate cancer|prostate carcinoma|stomach cancer|retinal detachment|breast cancer|pulmonary valve stenosis,ppi
13634,16365,3492,IGH,immunoglobulin heavy locus,1,,anemia|macrocytic anemia|bone marrow disease|constipation|lymphosarcoma|lymphoma|central nervous system lymphoma|Langerhans-cell histiocytosis|reticulosarcoma|non-Hodgkin lymphoma|B-cell lymphoma|gastric lymphoma,ppi
13635,16366,3493,IGHA1,immunoglobulin heavy constant alpha 1,89,,,ppi
13636,16367,3494,IGHA2,immunoglobulin heavy constant alpha 2 (A2m marker),27,,,ppi
13637,16368,313,AOAH,acyloxyacyl hydrolase,1,calcium ion binding|acyloxyacyl hydrolase activity,,ppi
13638,16369,3495,IGHD,immunoglobulin heavy constant delta,4,,,ppi
13639,16378,314,AOC2,amine oxidase; copper containing 2,5,primary amine oxidase activity|electron transfer activity|copper ion binding,,ppi
13640,16389,10257,ABCC4,ATP binding cassette subfamily C member 4,17,ATPase activity; coupled to transmembrane movement of ions; phosphorylative mechanism|15-hydroxyprostaglandin dehydrogenase (NAD+) activity|ATPase-coupled anion transmembrane transporter activity|ATPase activity; coupled to transmembrane movement of substances,rheumatoid arthritis|large intestine cancer|colorectal cancer|endometriosis of uterus|endometriosis|prostate cancer|prostate carcinoma|substance abuse|substance-related disorder,ppi
13641,16390,8639,AOC3,amine oxidase; copper containing 3,11,copper ion binding|calcium ion binding|primary amine oxidase activity|protein homodimerization activity|quinone binding,diabetic ketoacidosis|diabetes mellitus|hypertension|essential hypertension|chronic kidney disease,ppi
13642,16410,3497,IGHE,immunoglobulin heavy constant epsilon,3,,,ppi
13643,16411,3500,IGHG1,immunoglobulin heavy constant gamma 1 (G1m marker),92,,chronic lymphocytic leukemia|Richter's syndrome|myositis|polycystic ovary syndrome,ppi
13644,16412,3501,IGHG2,immunoglobulin heavy constant gamma 2 (G2m marker),37,,myositis,ppi
13645,16413,3502,IGHG3,immunoglobulin heavy constant gamma 3 (G3m marker),12,,,ppi
13646,16414,3503,IGHG4,immunoglobulin heavy constant gamma 4 (G4m marker),5,,,ppi
13647,16416,316,AOX1,aldehyde oxidase 1,11,aldehyde oxidase activity|iron ion binding|protein homodimerization activity|molybdopterin cofactor binding|flavin adenine dinucleotide binding|2 iron; 2 sulfur cluster binding|xanthine dehydrogenase activity,prostate cancer|prostate carcinoma,ppi
13648,16422,162,AP1B1,adaptor related protein complex 1 beta 1 subunit,89,transporter activity|protein kinase binding,,ppi
13649,16424,3507,IGHM,immunoglobulin heavy constant mu,47,,agammaglobulinemia|arthropathy|arthritis|bronchiectasis|conjunctivitis|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|exanthem|primary immunodeficiency disease|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|sinusitis|otitis media,ppi
13650,16425,3508,IGHMBP2,immunoglobulin mu binding protein 2,13,tRNA binding|DNA binding|DNA helicase activity|single-stranded DNA binding|RNA binding|ATP binding|DNA-dependent ATPase activity|RNA-dependent ATPase activity|ATP-dependent 5'-3' RNA helicase activity|ribosome binding|ATP-dependent 5'-3' DNA helicase activity,clubfoot|constipation|diaphragmatic eventration|placental insufficiency|progressive muscular atrophy|spinal muscular atrophy|diaphragm disease|Charcot-Marie-Tooth disease axonal type 2S,ppi
13651,16427,164,AP1G1,adaptor related protein complex 1 gamma 1 subunit,59,transporter activity,,ppi
13652,16428,28474,IGHV1-2,immunoglobulin heavy variable 1-2,1,,,ppi
13653,16436,8906,AP1G2,adaptor related protein complex 1 gamma 2 subunit,29,,,ppi
13654,16442,11276,SYNRG,synergin gamma,18,,,ppi
13655,16447,10053,AP1M2,adaptor related protein complex 1 mu 2 subunit,37,,,ppi
13656,16454,28442,IGHV3-23,immunoglobulin heavy variable 3-23,1,,,ppi
13657,16455,1174,AP1S1,adaptor related protein complex 1 sigma 1 subunit,22,,cholestasis|intrahepatic cholestasis|sensorineural hearing loss|ichthyosis|intestinal disease|gastrointestinal system disease|chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease|liver cirrhosis|intellectual disability|learning disability|polyneuropathy|peripheral nervous system disease|neuropathy|granuloma annulare|acquired hyperkeratosis|MEDNIK syndrome,ppi
13658,16461,10057,ABCC5,ATP binding cassette subfamily C member 5,14,organic anion transmembrane transporter activity|ATPase-coupled anion transmembrane transporter activity|ATPase activity; coupled to transmembrane movement of substances,rheumatoid arthritis|large intestine cancer|colorectal cancer,ppi
13659,16462,8905,AP1S2,adaptor related protein complex 1 sigma 2 subunit,37,,cryptorchidism|inguinal hernia|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|spastic diplegia|spastic monoplegia|spastic quadriplegia|cerebral palsy|ophthalmoplegia|mechanical strabismus|hypertropia|cerebral degeneration|syndromic X-linked intellectual disability 5|autistic disorder,ppi
13660,16465,28424,IGHV3-48,immunoglobulin heavy variable 3-48,1,,,ppi
13661,16467,160,AP2A1,adaptor related protein complex 2 alpha 1 subunit,122,protein kinase binding|clathrin adaptor activity,,ppi
13662,16471,161,AP2A2,adaptor related protein complex 2 alpha 2 subunit,77,protein kinase binding|clathrin adaptor activity,,ppi
13663,16478,163,AP2B1,adaptor related protein complex 2 beta 1 subunit,118,signal sequence binding|clathrin binding|clathrin adaptor activity,mental depression,ppi
13664,16482,1173,AP2M1,adaptor related protein complex 2 mu 1 subunit,222,signal sequence binding|transporter activity|low-density lipoprotein particle receptor binding|clathrin adaptor activity,,ppi
13665,16489,28396,IGHV4-31,immunoglobulin heavy variable 4-31,1,,,ppi
13666,16490,1175,AP2S1,adaptor related protein complex 2 sigma 1 subunit,46,transporter activity|protein transporter activity|clathrin adaptor activity,nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|pleomorphic lipoma|lipoma|acute pancreatitis|pancreatitis|primary hyperparathyroidism|chondrocalcinosis|musculoskeletal system disease|familial hypocalciuric hypercalcemia 3,ppi
13667,16499,8546,AP3B1,adaptor related protein complex 3 beta 1 subunit,59,,oculocutaneous albinism|Griscelli syndrome|Griscelli syndrome type 1|Griscelli syndrome type 2|Griscelli syndrome type 3|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|dental caries|gingival disease|epulis|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|periodontal disease|periodontitis|postinflammatory pulmonary fibrosis,ppi
13668,16504,8120,AP3B2,adaptor related protein complex 3 beta 2 subunit,13,transporter activity,,ppi
13669,16505,8943,AP3D1,adaptor related protein complex 3 delta 1 subunit,56,transporter activity,,ppi
13670,16506,26985,AP3M1,adaptor related protein complex 3 mu 1 subunit,63,,schizophrenia,ppi
13671,16507,368,ABCC6,ATP binding cassette subfamily C member 6,5,transporter activity|ATPase activity; coupled to transmembrane movement of substances|ATPase-coupled anion transmembrane transporter activity,angioid streaks|restrictive cardiomyopathy|large intestine cancer|colorectal cancer|exanthem|congestive heart failure|intermittent claudication|retinitis pigmentosa 30|age related macular degeneration|macular degeneration|mitral valve insufficiency|mitral valve prolapse|mitral valve stenosis|myopia|keratosis follicularis|pseudoxanthoma elasticum|mongolian spot|kidney failure|uremia|retinitis,ppi
13672,16508,10947,AP3M2,adaptor related protein complex 3 mu 2 subunit,11,,,ppi
13673,16509,10239,AP3S2,adaptor related protein complex 3 sigma 2 subunit,13,,diabetes mellitus|type 2 diabetes mellitus,ppi
13674,16510,3512,JCHAIN,joining chain of multimeric IgA and IgM,24,antigen binding|IgA binding|protein homodimerization activity|single-stranded DNA binding|phosphatidylcholine binding|immunoglobulin receptor binding|peptidoglycan binding,,ppi
13675,16512,3514,IGKC,immunoglobulin kappa constant,45,,dysgammaglobulinemia|myositis,ppi
13676,16514,10717,AP4B1,adaptor related protein complex 4 beta 1 subunit,12,,dystonia|epilepsy|visual epilepsy|syndromic X-linked intellectual disability 94|paraplegia,ppi
13677,16519,3516,RBPJ,recombination signal binding protein for immunoglobulin kappa J region,133,recombinase activity|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription factor binding|sequence-specific DNA binding|RNA polymerase II repressing transcription factor binding|repressing transcription factor binding,rheumatoid arthritis|endometriosis of uterus|endometriosis|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|microphthalmia|ophthalmoplegia|mechanical strabismus|hypertropia|tetralogy of Fallot|cataract|Adams-Oliver syndrome|Clouston syndrome|clubfoot,ppi
13678,16520,23431,AP4E1,adaptor related protein complex 4 epsilon 1 subunit,18,,clubfoot|pseudosarcomatous fibromatosis|epilepsy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|syndromic X-linked intellectual disability 94|paraplegia|cerebral degeneration|locked-in syndrome|quadriplegia|stuttering|intellectual disability|learning disability,ppi
13679,16521,28940,IGKV1-12,immunoglobulin kappa variable 1-12,1,,,ppi
13680,16528,9179,AP4M1,adaptor related protein complex 4 mu 1 subunit,40,protein domain specific binding,spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|clubfoot|epilepsy|visual epilepsy|syndromic X-linked intellectual disability 94|paraplegia|ophthalmoplegia|mechanical strabismus|hypertropia|locked-in syndrome|quadriplegia|hereditary spastic paraplegia 50|intellectual disability|learning disability,ppi
13681,16530,28299,IGKV1-5,immunoglobulin kappa variable 1-5,6,,,ppi
13682,16538,11154,AP4S1,adaptor related protein complex 4 sigma 1 subunit,22,,spastic diplegia|spastic monoplegia|hemiplegia|spastic quadriplegia|cerebral palsy|clubfoot|pseudosarcomatous fibromatosis|syndromic X-linked intellectual disability 94|paraplegia,ppi
13683,16545,317,APAF1,apoptotic peptidase activating factor 1,33,nucleotide binding|cysteine-type endopeptidase activator activity involved in apoptotic process,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|transitional cell carcinoma|microphthalmia|retinal detachment|skin disease|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
13684,16548,320,APBA1,amyloid beta precursor protein binding family A member 1,22,amyloid-beta binding,,ppi
13685,16552,28919,IGKV2-30,immunoglobulin kappa variable 2-30,1,,,ppi
13686,16553,28916,IGKV2-40,immunoglobulin kappa variable 2-40,4,,,ppi
13687,16554,321,APBA2,amyloid beta precursor protein binding family A member 2,31,amyloid-beta binding,schizophrenia,ppi
13688,16558,9546,APBA3,amyloid beta precursor protein binding family A member 3,45,enzyme inhibitor activity|amyloid-beta binding,,ppi
13689,16559,28882,IGKV2D-29,immunoglobulin kappa variable 2D-29,1,,,ppi
13690,16562,322,APBB1,amyloid beta precursor protein binding family B member 1,94,amyloid-beta binding|chromatin binding|transcription factor binding,,ppi
13691,16565,28912,IGKV3-20,immunoglobulin kappa variable 3-20,1,,,ppi
13692,16566,323,APBB2,amyloid beta precursor protein binding family B member 2,34,amyloid-beta binding|transcription factor binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
13693,16572,324,APC,APC; WNT signaling pathway regulator,216,beta-catenin binding|microtubule binding|protein kinase regulator activity|ubiquitin protein ligase binding|identical protein binding|microtubule plus-end binding|cadherin binding|gamma-catenin binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|autistic disorder|colon cancer,ppi
13694,16574,28908,IGKV4-1,immunoglobulin kappa variable 4-1,3,,,ppi
13695,16579,325,APCS,amyloid P component; serum,17,complement component C1q binding|calcium ion binding|virion binding|unfolded protein binding|low-density lipoprotein particle binding,congestive heart failure|liver cancer|coronary artery disease|hepatocellular carcinoma,ppi
13696,16580,3535,IGL,immunoglobulin lambda locus,4,,,ppi
13697,16581,3537,IGLC1,immunoglobulin lambda constant 1,4,,,ppi
13698,16582,3538,IGLC2,immunoglobulin lambda constant 2,4,,,ppi
13699,16584,327,APEH,acylaminoacyl-peptide hydrolase,41,RNA binding|serine-type endopeptidase activity|omega peptidase activity,,ppi
13700,16586,28834,IGLC7,immunoglobulin lambda constant 7,2,,,ppi
13701,16594,328,APEX1,apurinic/apyrimidinic endodeoxyribonuclease 1,124,DNA binding|damaged DNA binding|double-stranded telomeric DNA binding|transcription coactivator activity|transcription corepressor activity|RNA binding|DNA-(apurinic or apyrimidinic site) endonuclease activity|endonuclease activity|endodeoxyribonuclease activity|RNA-DNA hybrid ribonuclease activity|phosphodiesterase I activity|uracil DNA N-glycosylase activity|phosphoric diester hydrolase activity|double-stranded DNA exodeoxyribonuclease activity|3'-5' exonuclease activity|oxidoreductase activity|site-specific endodeoxyribonuclease activity; specific for altered base|chromatin DNA binding|metal ion binding|double-stranded DNA 3'-5' exodeoxyribonuclease activity,heart disease|cardiovascular system disease|melanoma|skin melanoma|prostate cancer|prostate carcinoma|epilepsy|visual epilepsy|stomach cancer|liver cancer|hepatocellular carcinoma,ppi
13702,16595,3543,IGLL1,immunoglobulin lambda like polypeptide 1,4,immunoglobulin receptor binding|antigen binding,agammaglobulinemia|arthropathy|arthritis|conjunctivitis|exanthem|primary immunodeficiency disease|meningitis|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|sinusitis|otitis media,ppi
13703,16599,9140,ATG12,autophagy related 12,66,Atg8 ligase activity,,ppi
13704,16606,28815,IGLV2-14,immunoglobulin lambda variable 2-14,1,,,ppi
13705,16608,9474,ATG5,autophagy related 5,108,Atg8 ligase activity,anemia|macrocytic anemia|lymphopenia,ppi
13706,16615,6833,ABCC8,ATP binding cassette subfamily C member 8,5,potassium channel activity|ATP-activated inward rectifier potassium channel activity|ATPase activity; coupled to transmembrane movement of substances,ptosis|congenital ptosis|cerebellar disease|large intestine cancer|colorectal cancer|diabetic ketoacidosis|diabetes mellitus|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15,ppi
13707,16616,329,BIRC2,baculoviral IAP repeat containing 2,143,transcription coactivator activity|ubiquitin-protein transferase activity|zinc ion binding|transferase activity|ubiquitin binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|ubiquitin protein ligase activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|leukemia|stomach cancer|breast cancer,ppi
13708,16619,28796,IGLV3-21,immunoglobulin lambda variable 3-21,1,,,ppi
13709,16621,28793,IGLV3-25,immunoglobulin lambda variable 3-25,1,,,ppi
13710,16622,330,BIRC3,baculoviral IAP repeat containing 3,85,ubiquitin-protein transferase activity|transferase activity|ubiquitin protein ligase activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process,anemia|macrocytic anemia|urinary bladder cancer|constipation|fatty liver disease|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|leukemia|lymphosarcoma|B-cell lymphoma|gastric lymphoma,ppi
13711,16627,331,XIAP,X-linked inhibitor of apoptosis,144,ubiquitin-protein transferase activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|ubiquitin protein ligase activity,anemia|macrocytic anemia|myelitis|encephalomyelitis|encephalitis|esophageal cancer|hepatic coma|hepatic encephalopathy|primary immunodeficiency disease|lymphosarcoma|lymphoma|central nervous system lymphoma|meningitis|pancytopenia|thrombocytopenia|agammaglobulinemia|selective IgG deficiency disease|X-linked lymphoproliferative syndrome 1|X-linked lymphoproliferative syndrome 2|ovarian cancer,ppi
13712,16628,28785,IGLV4-60,immunoglobulin lambda variable 4-60,1,,,ppi
13713,16637,332,BIRC5,baculoviral IAP repeat containing 5,60,microtubule binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|lung cancer|non-small cell lung carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|cervical cancer|colon cancer|colonic benign neoplasm|large intestine cancer,ppi
13714,16641,8539,API5,apoptosis inhibitor 5,47,RNA binding,,ppi
13715,16642,3547,IGSF1,immunoglobulin superfamily member 1,12,inhibin binding|activin receptor antagonist activity,congenital hypothyroidism|myxedema|hypothyroidism|testicular disease,ppi
13716,16643,9398,CD101,CD101 molecule,4,,,ppi
13717,16644,3321,IGSF3,immunoglobulin superfamily member 3,8,,excessive tearing|lacrimal apparatus disease,ppi
13718,16645,23705,CADM1,cell adhesion molecule 1,15,signaling receptor binding|PDZ domain binding|protein homodimerization activity,autistic disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|breast cancer,ppi
13719,16646,150084,IGSF5,immunoglobulin superfamily member 5,4,,prostate cancer|prostate carcinoma,ppi
13720,16647,10261,IGSF6,immunoglobulin superfamily member 6,7,transmembrane signaling receptor activity,allergic contact dermatitis,ppi
13721,16648,3549,IHH,indian hedgehog,4,calcium ion binding,endometriosis of uterus|endometriosis|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|osteogenesis imperfecta|Ehlers-Danlos syndrome|acrocapitofemoral dysplasia|brachydactyly,ppi
13722,16649,3550,IK,IK cytokine; down-regulator of HLA II,89,,,ppi
13723,16650,8518,IKBKAP,inhibitor of kappa light polypeptide gene enhancer in B-cells; kinase complex-associated protein,82,phosphorylase kinase regulator activity|RNA polymerase II complex binding,arthropathy|neurogenic arthropathy|cerebellar disease|constipation|corneal ulcer|Riley-Day syndrome|esophagitis|peptic esophagitis|gastroesophageal reflux disease|hypertension|essential hypertension|hypohidrosis|anhidrosis|multiple system atrophy|malignant hyperthermia|recurrent corneal erosion|renal osteodystrophy|agnosia,ppi
13724,16651,3551,IKBKB,inhibitor of kappa light polypeptide gene enhancer in B-cells; kinase beta,180,protein kinase activity|protein serine/threonine kinase activity|IkappaB kinase activity|protein homodimerization activity|protein heterodimerization activity|scaffold protein binding,agammaglobulinemia|primary immunodeficiency disease,ppi
13725,16652,8517,IKBKG,inhibitor of kappa light polypeptide gene enhancer in B-cells; kinase gamma,429,protein homodimerization activity|protein heterodimerization activity|linear polyubiquitin binding|K63-linked polyubiquitin modification-dependent protein binding,alopecia|recurrent corneal erosion|dysgammaglobulinemia|Clouston syndrome|hypereosinophilic syndrome|epilepsy|exanthem|tooth agenesis|anodontia|primary immunodeficiency disease|Bloch-Sulzberger syndrome|incontinentia pigmenti achromians|keratitis|keratoconjunctivitis|lung benign neoplasm|elephantiasis|lymphedema|intellectual disability|learning disability|microphthalmia,ppi
13726,16653,3586,IL10,interleukin 10,3,cytokine activity|interleukin-10 receptor binding|growth factor activity,alcohol dependence|alcohol abuse|appendicitis|arthropathy|arthritis|rheumatoid arthritis|autistic disorder|Behcet's disease|lung cancer|non-small cell lung carcinoma|colitis|ileitis|ileocolitis|gastroenteritis|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|atopic dermatitis|diabetic ketoacidosis,ppi
13727,16654,3587,IL10RA,interleukin 10 receptor subunit alpha,4,signaling receptor activity|interleukin-10 receptor activity,gastroenteritis|visceral leishmaniasis|pyoderma|schizophrenia|inflammatory bowel disease,ppi
13728,16655,3588,IL10RB,interleukin 10 receptor subunit beta,9,signaling receptor activity|interleukin-10 receptor activity,brain ischemia|gastroenteritis|hepatitis B|inflammatory bowel disease,ppi
13729,16656,3589,IL11,interleukin 11,4,interleukin-11 receptor binding|growth factor activity|cytokine activity,trigonitis|cystitis|congestive heart failure|gallbladder disease|liver disease|neurotic disorder|endogenous depression|melancholia|middle cerebral artery infarction|major depressive disorder|mental depression,ppi
13730,16657,3590,IL11RA,interleukin 11 receptor subunit alpha,1,transmembrane signaling receptor activity|cytokine binding|interleukin-11 receptor activity|interleukin-11 binding|cytokine receptor activity,optic papillitis|papilledema|retinal edema|ovarian cancer,ppi
13731,16658,3592,IL12A,interleukin 12A,12,interleukin-12 receptor binding|cytokine activity|growth factor activity,arthropathy|arthritis|Behcet's disease|primary biliary cirrhosis|malignant glioma|gliosarcoma|mixed glioma|portal hypertension|multiple system atrophy|liver cirrhosis|liver cancer|meningitis|multiple sclerosis|orchitis|aphthous stomatitis|goiter|thyroid gland disease|vasculitis|thrombophilia|asthenopia,ppi
13732,16659,333,APLP1,amyloid beta precursor like protein 1,56,,,ppi
13733,16660,3593,IL12B,interleukin 12B,6,interleukin-12 receptor binding|cytokine activity|growth factor activity|interleukin-23 receptor binding|interleukin-12 alpha subunit binding|cytokine receptor activity|cytokine binding,anemia|macrocytic anemia|vascular disease|arthropathy|arthritis|psoriatic arthritis|asthma|intrinsic asthma|allergic asthma|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|epilepsy|malignant glioma|gliosarcoma|mixed glioma,ppi
13734,16661,3594,IL12RB1,interleukin 12 receptor subunit beta 1,21,cytokine receptor activity|interleukin-12 receptor activity|interleukin-23 receptor activity|interleukin-23 binding|interleukin-12 receptor binding|cytokine binding,brain ischemia|primary biliary cirrhosis|portal hypertension|multiple system atrophy|primary immunodeficiency disease|liver cirrhosis|goiter|thyroid gland disease|dermatographia|liver cancer|hepatocellular carcinoma,ppi
13735,16662,3595,IL12RB2,interleukin 12 receptor subunit beta 2,6,cytokine receptor activity|cytokine binding,,ppi
13736,16663,3596,IL13,interleukin 13,6,,asthma|intrinsic asthma|allergic asthma|autistic disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|atopic dermatitis|allergic hypersensitivity disease|lung disease|pneumonia|pustulosis of palm and sole|psoriasis|parapsoriasis|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia,ppi
13737,16664,3597,IL13RA1,interleukin 13 receptor subunit alpha 1,13,interleukin-13 receptor activity|cytokine receptor activity|cytokine binding,,ppi
13738,16665,3598,IL13RA2,interleukin 13 receptor subunit alpha 2,106,cytokine receptor activity|cytokine binding,,ppi
13739,16666,3600,IL15,interleukin 15,7,,autistic disorder|celiac disease|endometriosis of uterus|endometriosis,ppi
13740,16667,3601,IL15RA,interleukin 15 receptor subunit alpha,13,cytokine receptor activity,,ppi
13741,16668,334,APLP2,amyloid beta precursor like protein 2,41,DNA binding,coronary artery disease,ppi
13742,16669,3603,IL16,interleukin 16,39,,allergic hypersensitivity disease|prostate cancer|prostate carcinoma,ppi
13743,16670,3605,IL17A,interleukin 17A,9,,alcohol dependence|alcohol abuse|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|Balo concentric sclerosis|adrenoleukodystrophy|narcolepsy|central nervous system disease|nervous system disease|brain ischemia|colitis|ileitis|ileocolitis|gastroenteritis|allergic hypersensitivity disease|acute promyelocytic leukemia|lymphoproliferative syndrome 1|lymphoproliferative syndrome 2|autoimmune lymphoproliferative syndrome type 2A|autoimmune lymphoproliferative syndrome type 2B,ppi
13744,16671,27190,IL17B,interleukin 17B,2,,,ppi
13745,16674,23765,IL17RA,interleukin 17 receptor A,68,interleukin-17 receptor activity,chronic mucocutaneous candidiasis|brain ischemia|angular cheilitis|cheilitis|lip disease|exanthem|chronic ulcer of skin|granuloma annulare|acquired hyperkeratosis,ppi
13746,16675,3606,IL18,interleukin 18,14,cytokine activity|interleukin-18 receptor binding,rheumatoid arthritis|calcium metabolism disease|nephrocalcinosis|calcinosis|brain ischemia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|contact dermatitis|occupational dermatitis|nephritis|glomerulonephritis|kidney disease|heart valve disease|allergic hypersensitivity disease|leishmaniasis|pneumonia,ppi
13747,16676,10068,IL18BP,interleukin 18 binding protein,1,interleukin-18 binding|receptor antagonist activity,,ppi
13748,16677,8809,IL18R1,interleukin 18 receptor 1,4,signaling receptor activity|interleukin-18 binding,schizophrenia,ppi
13749,16678,8807,IL18RAP,interleukin 18 receptor accessory protein,5,interleukin-18 receptor activity,inflammatory bowel disease|ulcerative colitis,ppi
13750,16679,29949,IL19,interleukin 19,2,cytokine activity,diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21|type 1 diabetes mellitus 22,ppi
13751,16680,3552,IL1A,interleukin 1 alpha,12,cytokine activity|copper ion binding,alcohol dependence|alcohol abuse|amnestic disorder|dissociative amnesia|asbestosis|anthracosilicosis|anthracosis|brain ischemia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dermatomyositis|childhood type dermatomyositis|hemolytic-uremic syndrome|Kearns-Sayre syndrome|schizophrenia|seborrheic keratosis,ppi
13752,16681,3553,IL1B,interleukin 1 beta,21,cytokine activity|interleukin-1 receptor binding|integrin binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|alcohol dependence|alcohol abuse|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease,ppi
13753,16682,3554,IL1R1,interleukin 1 receptor type 1,25,transmembrane signaling receptor activity|interleukin-1 receptor activity,alcohol dependence|alcohol abuse|endometriosis of uterus|endometriosis|allergic hypersensitivity disease|pneumonia|seborrheic keratosis|skin disease|actinic keratosis,ppi
13754,16683,7850,IL1R2,interleukin 1 receptor type 2,41,interleukin-1 receptor activity,inflammatory bowel disease|ulcerative colitis|allergic hypersensitivity disease|gallbladder disease|liver disease|pneumonia|ankylosing spondylitis,ppi
13755,16684,3556,IL1RAP,interleukin 1 receptor accessory protein,20,,gallbladder disease|liver disease,ppi
13756,16685,11141,IL1RAPL1,interleukin 1 receptor accessory protein like 1,2,signaling receptor binding|voltage-gated calcium channel activity|interleukin-1 binding,autistic disorder|melanoma|skin melanoma|intellectual disability|learning disability|non-syndromic X-linked intellectual disability,ppi
13757,16686,26280,IL1RAPL2,interleukin 1 receptor accessory protein like 2,1,interleukin-1 receptor activity,,ppi
13758,16687,9173,IL1RL1,interleukin 1 receptor like 1,9,cytokine receptor activity,asthma|intrinsic asthma|allergic asthma,ppi
13759,16688,8808,IL1RL2,interleukin 1 receptor like 2,8,interleukin-1 receptor activity,,ppi
13760,16689,10060,ABCC9,ATP binding cassette subfamily C member 9,6,transporter activity|sulfonylurea receptor activity|potassium channel regulator activity|ATPase-coupled anion transmembrane transporter activity|potassium channel activity|ATPase activity; coupled to transmembrane movement of substances,blepharophimosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
13761,16690,335,APOA1,apolipoprotein A1,92,amyloid-beta binding|phospholipid binding|cholesterol binding|cholesterol transporter activity|chemorepellent activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|anemia|macrocytic anemia|Behcet's disease|cholestasis|recurrent corneal erosion|congestive heart failure|exanthem|membranous glomerulonephritis|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|hypertension|essential hypertension|nephritis|glomerulonephritis|kidney disease,ppi
13762,16691,3557,IL1RN,interleukin 1 receptor antagonist,11,interleukin-1 receptor antagonist activity|interleukin-1 type I receptor antagonist activity|interleukin-1 type II receptor antagonist activity|interleukin-1 receptor binding|interleukin-1; type I receptor binding|interleukin-1; type II receptor binding|cytokine activity,bipolar disorder|mood disorder|alcohol dependence|alcohol abuse|asbestosis|anthracosilicosis|anthracosis|rheumatoid arthritis|asthma|intrinsic asthma|allergic asthma|autistic disorder|brain ischemia|colon cancer|colonic benign neoplasm|subacute delirium|neurotic disorder|dysthymic disorder|gout|nephritis,ppi
13763,16692,3558,IL2,interleukin 2,11,Ras guanyl-nucleotide exchange factor activity|cytokine activity|interleukin-2 receptor binding|growth factor activity|kinase activator activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|amnestic disorder|dissociative amnesia|anemia|macrocytic anemia|autistic disorder|urinary bladder cancer|brain cancer|glioblastoma multiforme|giant cell glioblastoma|nephritis|glomerulonephritis|kidney disease|kidney cancer|leukemia|adult T-cell leukemia|acute T cell leukemia|leukopenia|liver cancer,ppi
13764,16693,50604,IL20,interleukin 20,3,interleukin-20 receptor binding,diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21|type 1 diabetes mellitus 22,ppi
13765,16694,53832,IL20RA,interleukin 20 receptor subunit alpha,35,interleukin-20 binding,,ppi
13766,16695,53833,IL20RB,interleukin 20 receptor subunit beta,21,,,ppi
13767,16696,59067,IL21,interleukin 21,6,cytokine receptor binding,celiac disease|systemic lupus erythematosus|common variable immunodeficiency,ppi
13768,16697,50615,IL21R,interleukin 21 receptor,4,interleukin-21 receptor activity,bronchiectasis|primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis|primary immunodeficiency disease|liver cirrhosis|systemic lupus erythematosus|pneumonia,ppi
13769,16698,3559,IL2RA,interleukin 2 receptor subunit alpha,10,Ras guanyl-nucleotide exchange factor activity|interleukin-2 binding|interleukin-2 receptor activity,alopecia|alopecia areata|fetal erythroblastosis|autoimmune hemolytic anemia|agnosia|rheumatoid arthritis|berylliosis|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9,ppi
13770,16699,3560,IL2RB,interleukin 2 receptor subunit beta,31,interleukin-2 receptor activity|Ras guanyl-nucleotide exchange factor activity|interleukin-2 binding,agnosia|rheumatoid arthritis|bipolar disorder|allergic hypersensitivity disease|uveitis|anterior uveitis|ciliary body disease|pneumonia|juvenile rheumatoid arthritis|arthropathy|arthritis|neurogenic arthropathy,ppi
13771,16700,336,APOA2,apolipoprotein A2,20,lipid transporter activity|phospholipid binding|lipid binding|cholesterol binding|phosphatidylcholine binding|protein homodimerization activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|cholesterol transporter activity|apolipoprotein receptor binding|high-density lipoprotein particle receptor binding|high-density lipoprotein particle binding,familial hypercholesterolemia,ppi
13772,16701,3561,IL2RG,interleukin 2 receptor subunit gamma,35,Ras guanyl-nucleotide exchange factor activity|interleukin-2 binding|interleukin-2 receptor activity|interleukin-4 receptor activity|interleukin-7 receptor activity|cytokine receptor activity|cytokine binding,agammaglobulinemia|alopecia|congestive heart failure|hypereosinophilic syndrome|exanthem|otitis media|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|pneumonia|schizophrenia|Sezary's disease|sinusitis|adenosine deaminase deficiency|MHC class II deficiency|severe combined immunodeficiency|selective IgG deficiency disease|combined T cell and B cell immunodeficiency|gamma chain deficiency,ppi
13773,16702,3562,IL3,interleukin 3,6,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|interleukin-3 receptor binding,anemia|macrocytic anemia|leukopenia|schizophrenia|thrombocytopenia|malignant mesothelioma|benign mesothelioma|fatty liver disease,ppi
13774,16703,3563,IL3RA,interleukin 3 receptor subunit alpha,19,protein tyrosine kinase activity|interleukin-3 receptor activity|Ras guanyl-nucleotide exchange factor activity|cytokine receptor activity|cytokine binding,schizophrenia,ppi
13775,16704,3565,IL4,interleukin 4,8,interleukin-4 receptor binding|growth factor activity,asthma|intrinsic asthma|allergic asthma|autistic disorder|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|colitis|ileitis|ileocolitis|gastroenteritis|atopic dermatitis|allergic hypersensitivity disease|cutaneous leishmaniasis|adult T-cell leukemia|acute T cell leukemia|systemic lupus erythematosus|pleural disease|asbestosis|anthracosilicosis|pneumoconiosis,ppi
13776,16705,3566,IL4R,interleukin 4 receptor,48,interleukin-4 receptor activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
13777,16706,3567,IL5,interleukin 5,3,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity,asthma|intrinsic asthma|allergic asthma|autistic disorder|atopic dermatitis|hypereosinophilic syndrome|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|allergic contact dermatitis|autoimmune hepatitis,ppi
13778,16707,3568,IL5RA,interleukin 5 receptor subunit alpha,7,protein tyrosine kinase activity|interleukin-5 receptor activity|Ras guanyl-nucleotide exchange factor activity|cytokine binding|cytokine receptor activity,allergic hypersensitivity disease|pneumonia,ppi
13779,16708,3569,IL6,interleukin 6,8,cytokine activity|interleukin-6 receptor binding|growth factor activity,proteinuria|alcohol dependence|alcohol abuse|amnestic disorder|dissociative amnesia|rheumatoid arthritis|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|autistic disorder|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|berylliosis|bipolar disorder|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma,ppi
13780,16709,3570,IL6R,interleukin 6 receptor,21,ciliary neurotrophic factor receptor activity|interleukin-6 receptor activity|interleukin-12 receptor binding|interleukin-6 binding|interleukin-12 alpha subunit binding|interleukin-23 receptor binding|cytokine receptor activity|cytokine binding|growth factor activity,rheumatoid arthritis|lung cancer|non-small cell lung carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|osteoporosis|schizophrenia|stomach cancer,ppi
13781,16710,337,APOA4,apolipoprotein A4,5,,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|familial hypercholesterolemia,ppi
13782,16711,3572,IL6ST,interleukin 6 signal transducer,39,ciliary neurotrophic factor receptor activity|protein homodimerization activity|interleukin-27 receptor activity|interleukin-6 receptor activity|leukemia inhibitory factor receptor activity|oncostatin-M receptor activity|interleukin-6 binding|ciliary neurotrophic factor receptor binding|interleukin-6 receptor binding|cytokine receptor activity|cytokine binding,rheumatoid arthritis|large intestine cancer|colorectal cancer|allergic hypersensitivity disease|pneumonia|coronary artery disease|middle cerebral artery infarction|ovarian cancer,ppi
13783,16712,3574,IL7,interleukin 7,4,cytokine activity|growth factor activity,lymphopenia|multiple sclerosis,ppi
13784,16713,3575,IL7R,interleukin 7 receptor,104,antigen binding|cytokine receptor activity|interleukin-7 receptor activity,alopecia|inflammatory bowel disease|ulcerative colitis|dermatitis|congestive heart failure|endometriosis of uterus|endometriosis|hypereosinophilic syndrome|primary biliary cirrhosis|multiple sclerosis|otitis media|pneumonia|adenosine deaminase deficiency|MHC class II deficiency|severe combined immunodeficiency|acute T cell leukemia|Omenn syndrome,ppi
13785,16714,3576,CXCL8,C-X-C motif chemokine ligand 8,22,chemokine activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|alcohol dependence|alcohol abuse|intermediate coronary syndrome|psoriatic arthritis|rheumatoid arthritis|Barrett's esophagus|Behcet's disease|bipolar disorder|urinary bladder cancer|lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|cholestasis|inflammatory bowel disease,ppi
13786,16715,3577,CXCR1,C-X-C motif chemokine receptor 1,16,interleukin-8 receptor activity|G-protein coupled receptor activity|chemokine receptor activity|C-C chemokine receptor activity|chemokine binding|C-C chemokine binding,inflammatory bowel disease|ulcerative colitis|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
13787,16716,3579,CXCR2,C-X-C motif chemokine receptor 2,22,interleukin-8 receptor activity|G-protein coupled receptor activity|C-X-C chemokine receptor activity|C-C chemokine receptor activity|C-C chemokine binding|chemokine binding,inflammatory bowel disease|ulcerative colitis|allergic hypersensitivity disease|mastitis|pneumonia|middle cerebral artery infarction,ppi
13788,16717,3578,IL9,interleukin 9,2,cytokine activity|interleukin-9 receptor binding,autoimmune hepatitis,ppi
13789,16718,338,APOB,apolipoprotein B,68,phospholipid binding|heparin binding|cholesterol transporter activity|low-density lipoprotein particle receptor binding,arcus senilis|Behcet's disease|heart disease|cardiovascular system disease|cerebellar disease|atherosclerosis|arteriosclerotic cardiovascular disease|coronary artery disease|nutmeg liver|fatty liver disease|familial hypercholesterolemia|familial hyperlipidemia|hypertension|essential hypertension|hypobetalipoproteinemia|congestive heart failure|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction,ppi
13790,16719,3581,IL9R,interleukin 9 receptor,24,interleukin-9 receptor activity,gallbladder disease|liver disease|mood disorder,ppi
13791,16720,3607,FOXK2,forkhead box K2,130,magnesium ion binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription regulatory region sequence-specific DNA binding,,ppi
13792,16721,3608,ILF2,interleukin enhancer binding factor 2,307,DNA binding|RNA binding|double-stranded RNA binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
13793,16722,3609,ILF3,interleukin enhancer binding factor 3,347,DNA binding|RNA binding|double-stranded RNA binding|single-stranded RNA binding,,ppi
13794,16723,339,APOBEC1,apolipoprotein B mRNA editing enzyme catalytic subunit 1,8,RNA binding|cytidine deaminase activity,,ppi
13795,16724,3611,ILK,integrin linked kinase,461,protein serine/threonine kinase activity,vertebrobasilar insufficiency|transient cerebral ischemia|familial adenomatous polyposis|epilepsy|cocaine abuse|cocaine dependence|malignant mesothelioma|benign mesothelioma,ppi
13796,16725,10994,ILVBL,ilvB acetolactate synthase like,61,,,ppi
13797,16726,10989,IMMT,inner membrane mitochondrial protein,153,RNA binding,arthropathy|arthritis,ppi
13798,16727,10930,APOBEC2,apolipoprotein B mRNA editing enzyme catalytic subunit 2,1,RNA binding|cytidine deaminase activity,,ppi
13799,16728,3612,IMPA1,inositol monophosphatase 1,18,magnesium ion binding|inositol monophosphate 1-phosphatase activity|manganese ion binding|lithium ion binding|protein homodimerization activity|inositol monophosphate 3-phosphatase activity|inositol monophosphate 4-phosphatase activity|inositol monophosphate phosphatase activity,bipolar disorder|epilepsy|visual epilepsy,ppi
13800,16729,3613,IMPA2,inositol monophosphatase 2,36,inositol monophosphate 1-phosphatase activity|protein homodimerization activity|inositol monophosphate 3-phosphatase activity|inositol monophosphate 4-phosphatase activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometriosis of uterus|endometriosis|schizophrenia|mood disorder,ppi
13801,16730,3614,IMPDH1,inosine monophosphate dehydrogenase 1,77,nucleic acid binding|DNA binding|IMP dehydrogenase activity,epilepsy|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy,ppi
13802,16731,3615,IMPDH2,inosine monophosphate dehydrogenase 2,100,nucleotide binding|IMP dehydrogenase activity,,ppi
13803,16732,3617,IMPG1,interphotoreceptor matrix proteoglycan 1,1,extracellular matrix structural constituent,choroideremia|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|blindness|vitelliform macular dystrophy,ppi
13804,16733,9118,INA,internexin neuronal intermediate filament protein alpha,45,structural constituent of cytoskeleton,neurodegenerative disease|amyotrophic lateral sclerosis type 1,ppi
13805,16734,3619,INCENP,inner centromere protein,26,,melanoma|skin melanoma,ppi
13806,16735,3620,IDO1,indoleamine 2;3-dioxygenase 1,4,tryptophan 2;3-dioxygenase activity|electron transfer activity|indoleamine 2;3-dioxygenase activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometriosis of uterus|endometriosis|obesity|neurodegenerative disease|breast cancer,ppi
13807,16736,3621,ING1,inhibitor of growth family member 1,51,methylated histone binding,tongue squamous cell carcinoma|squamous cell carcinoma|contact dermatitis|occupational dermatitis|stomach cancer|squamous cell neoplasm|head and neck squamous cell carcinoma,ppi
13808,16737,3622,ING2,inhibitor of growth family member 2,46,DNA binding|methylated histone binding|phosphatidylinositol binding|protein-containing complex binding,,ppi
13809,16738,3623,INHA,inhibin alpha subunit,10,cytokine activity|hormone activity|growth factor activity|transforming growth factor beta receptor binding,,ppi
13810,16739,3624,INHBA,inhibin beta A subunit,15,cytokine activity|hormone activity|growth factor activity|transforming growth factor beta receptor binding,leiomyoma|uterine fibroid|pre-eclampsia|uterine cancer|hepatitis|ovary adenocarcinoma,ppi
13811,16740,3625,INHBB,inhibin beta B subunit,10,cytokine activity|hormone activity|host cell surface receptor binding|transforming growth factor beta receptor binding,,ppi
13812,16741,3626,INHBC,inhibin beta C subunit,6,transforming growth factor beta receptor binding|cytokine activity,,ppi
13813,16742,11185,INMT,indolethylamine N-methyltransferase,1,amine N-methyltransferase activity,,ppi
13814,16743,341,APOC1,apolipoprotein C1,6,phospholipase inhibitor activity|fatty acid binding|phosphatidylcholine binding|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity,congestive heart failure,ppi
13815,16744,3628,INPP1,inositol polyphosphate-1-phosphatase,13,inositol-1;4-bisphosphate 1-phosphatase activity|inositol-1;3;4-trisphosphate 1-phosphatase activity,autistic disorder|bipolar disorder,ppi
13816,16745,3631,INPP4A,inositol polyphosphate-4-phosphatase type I A,8,phosphatidylinositol-3;4-bisphosphate 4-phosphatase activity|inositol-1;3;4-trisphosphate 4-phosphatase activity|inositol-3;4-bisphosphate 4-phosphatase activity,intellectual disability|learning disability,ppi
13817,16746,8821,INPP4B,inositol polyphosphate-4-phosphatase type II B,4,phosphatidylinositol-3;4-bisphosphate 4-phosphatase activity|inositol-1;3;4-trisphosphate 4-phosphatase activity|inositol-3;4-bisphosphate 4-phosphatase activity,,ppi
13818,16747,3632,INPP5A,inositol polyphosphate-5-phosphatase A,12,inositol-polyphosphate 5-phosphatase activity|inositol-1;4;5-trisphosphate 5-phosphatase activity,tongue squamous cell carcinoma|squamous cell carcinoma|schizophrenia|seborrheic keratosis|skin disease|actinic keratosis,ppi
13819,16748,3633,INPP5B,inositol polyphosphate-5-phosphatase B,14,phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity|GTPase activator activity|inositol-1;4;5-trisphosphate 5-phosphatase activity|inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity|inositol phosphate phosphatase activity,,ppi
13820,16749,3635,INPP5D,inositol polyphosphate-5-phosphatase D,60,phosphatidylinositol-3;4;5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3;4;5-trisphosphate 5-phosphatase activity|inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity,,ppi
13821,16750,3636,INPPL1,inositol polyphosphate phosphatase like 1,113,phosphatidylinositol-3;4;5-trisphosphate 5-phosphatase activity|inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity,cryptorchidism|diabetes mellitus|type 2 diabetes mellitus|achondroplasia|Laron syndrome|congestive heart failure|polyhydramnios|hypertension|essential hypertension|elephantiasis|lymphedema|schneckenbecken dysplasia|metabolic syndrome X,ppi
13822,16751,3630,INS,insulin,26,insulin receptor binding|hormone activity,proteinuria|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|bipolar disorder|bladder disease|ptosis|congenital ptosis,ppi
13823,16752,3638,INSIG1,insulin induced gene 1,19,,,ppi
13824,16753,3640,INSL3,insulin like 3,9,signaling receptor binding|insulin receptor binding|G-protein coupled receptor binding,cryptorchidism|Potter's syndrome,ppi
13825,16755,10022,INSL5,insulin like 5,51,G-protein coupled receptor binding,,ppi
13826,16756,11172,INSL6,insulin like 6,18,hormone activity,,ppi
13827,16757,344,APOC2,apolipoprotein C2,6,lipid binding|phospholipase activator activity|protein homodimerization activity|lipase inhibitor activity|lipoprotein lipase activator activity|phospholipase binding,chylomicron retention disease|hyperlipoproteinemia type V|familial lipoprotein lipase deficiency|acute pancreatitis|pancreatitis,ppi
13828,16758,3642,INSM1,INSM transcriptional repressor 1,9,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|chromatin DNA binding,lung small cell carcinoma,ppi
13829,16759,3643,INSR,insulin receptor,135,protein tyrosine kinase activity|insulin-activated receptor activity|insulin-like growth factor receptor binding|ATP binding|GTP binding|insulin binding|insulin receptor substrate binding|transmembrane signaling receptor activity|transmembrane receptor protein tyrosine kinase activity,acanthosis nigricans|hyperpituitarism|acromegaly|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|cholestasis|diabetic ketoacidosis,ppi
13830,16760,3645,INSRR,insulin receptor related receptor,6,transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity|protein tyrosine kinase activity|insulin-activated receptor activity|insulin receptor substrate binding,salivary gland adenoid cystic carcinoma,ppi
13831,16762,215,ABCD1,ATP binding cassette subfamily D member 1,28,transporter activity|long-chain fatty acid transporter activity|ATP binding|fatty-acyl-CoA transmembrane transporter activity|ATPase activity|ATPase activity; coupled to transmembrane movement of substances|protein homodimerization activity|ADP binding,adrenal cortical hypofunction|Addison's disease|sensorineural hearing loss|epilepsy|hypogonadism|polyneuropathy|peripheral nervous system disease|neuropathy|schizophreniform disorder|schizoaffective disorder|visual epilepsy|paraplegia|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy|adrenoleukodystrophy|psychologic dyspareunia|premature ejaculation|agnosia|neurodegenerative disease,ppi
13832,16763,345,APOC3,apolipoprotein C3,5,phospholipid binding|cholesterol binding|enzyme regulator activity|lipase inhibitor activity|high-density lipoprotein particle receptor binding,heart disease|cardiovascular system disease|familial hypercholesterolemia|familial hyperlipidemia|hypobetalipoproteinemia|lung benign neoplasm|coronary artery disease,ppi
13833,16764,50943,FOXP3,forkhead box P3,80,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|protein homodimerization activity|sequence-specific DNA binding|NF-kappaB binding,fetal erythroblastosis|autoimmune hemolytic anemia|rheumatoid arthritis|bipolar disorder|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18,ppi
13834,16765,3651,PDX1,pancreatic and duodenal homeobox 1,16,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding,ptosis|congenital ptosis|diabetic ketoacidosis|diabetes mellitus|type 2 diabetes mellitus|epilepsy|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|placental insufficiency|congenital heart disease|hyperglycemia|pancreatic cancer|polyneuropathy|peripheral nervous system disease|neuropathy|retinitis|retinal disease|visual epilepsy|exocrine pancreatic insufficiency|maturity-onset diabetes of the young,ppi
13835,16766,3652,IPP,intracisternal A particle-promoted polypeptide,12,,,ppi
13836,16767,346,APOC4,apolipoprotein C4,1,lipid transporter activity,,ppi
13837,16768,8826,IQGAP1,IQ motif containing GTPase activating protein 1,292,GTPase inhibitor activity|GTPase activator activity|calcium ion binding|calmodulin binding|phosphatidylinositol-3;4;5-trisphosphate binding|protein serine/threonine kinase activator activity|cadherin binding,liver cancer|hepatocellular carcinoma,ppi
13838,16769,10788,IQGAP2,IQ motif containing GTPase activating protein 2,24,actin binding|GTPase inhibitor activity|phosphatidylinositol-3;4;5-trisphosphate binding|Rho GTPase binding|Rac GTPase binding|actin filament binding|Arp2/3 complex binding,liver cancer|hepatocellular carcinoma,ppi
13839,16770,3654,IRAK1,interleukin 1 receptor associated kinase 1,134,protein kinase activity|protein serine/threonine kinase activity|NF-kappaB-inducing kinase activity|kinase activity|protein homodimerization activity,rheumatoid arthritis|coronary artery disease,ppi
13840,16771,3656,IRAK2,interleukin 1 receptor associated kinase 2,42,protein serine/threonine kinase activity,,ppi
13841,16772,3658,IREB2,iron responsive element binding protein 2,23,RNA binding|iron-responsive element binding|aconitate hydratase activity|regulatory region RNA binding|4 iron; 4 sulfur cluster binding,,ppi
13842,16773,3659,IRF1,interferon regulatory factor 1,37,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding,lung cancer|bronchiolo-alveolar adenocarcinoma|lung benign neoplasm|stomach cancer|cerebral infarction|cerebrovascular disease|coronary artery disease|stomach carcinoma,ppi
13843,16774,3660,IRF2,interferon regulatory factor 2,35,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,liver cancer|hepatocellular carcinoma,ppi
13844,16775,3661,IRF3,interferon regulatory factor 3,95,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|transcription coregulator activity|sequence-specific DNA binding,,ppi
13845,16776,3662,IRF4,interferon regulatory factor 4,25,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription factor binding|sequence-specific DNA binding,chronic lymphocytic leukemia|Richter's syndrome|adult T-cell leukemia|acute T cell leukemia|multiple myeloma|cutaneous T cell lymphoma,ppi
13846,16777,347,APOD,apolipoprotein D,47,lipid transporter activity|cholesterol binding,bipolar disorder|malignant glioma|gliosarcoma|mixed glioma|intellectual disability|learning disability|schizophrenia|neurodegenerative disease,ppi
13847,16778,3663,IRF5,interferon regulatory factor 5,37,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding,arthropathy|arthritis|rheumatoid arthritis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|primary biliary cirrhosis|inflammatory bowel disease|ulcerative colitis|pseudosarcomatous fibromatosis|dental caries|esophagitis|peptic esophagitis|gastroesophageal reflux disease|portal hypertension|multiple system atrophy|liver cirrhosis|systemic lupus erythematosus|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis,ppi
13848,16779,3664,IRF6,interferon regulatory factor 6,7,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|sequence-specific DNA binding,cleft lip|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|tooth agenesis|anodontia|nail disease|skin disease|Klippel-Feil syndrome|spondylolisthesis|Van der Woude syndrome|popliteal pterygium syndrome|blepharophimosis|glycine encephalopathy|orofacial cleft,ppi
13849,16780,3665,IRF7,interferon regulatory factor 7,46,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|DNA binding,primary immunodeficiency disease|influenza|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
13850,16781,3667,IRS1,insulin receptor substrate 1,95,transmembrane receptor protein tyrosine kinase adaptor activity|protein kinase C binding|Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|SH2 domain binding|phosphatidylinositol 3-kinase binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|insulin receptor binding,diabetic ketoacidosis|diabetes mellitus|type 2 diabetes mellitus|Zollinger-Ellison syndrome|hyperinsulinism|familial hyperlipidemia|obesity|prostate cancer|prostate carcinoma|coronary artery disease|liver cancer|hepatocellular carcinoma,ppi
13851,16782,8660,IRS2,insulin receptor substrate 2,60,Ras guanyl-nucleotide exchange factor activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|phosphatidylinositol 3-kinase binding|insulin receptor binding,diabetes mellitus|type 2 diabetes mellitus|hyperglycemia|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|stomach cancer|liver cancer|hepatocellular carcinoma,ppi
13852,16783,8471,IRS4,insulin receptor substrate 4,145,SH3/SH2 adaptor activity|phosphatidylinositol 3-kinase binding|insulin receptor binding,,ppi
13853,16784,50805,IRX4,iroquois homeobox 4,1,DNA-binding transcription factor activity; RNA polymerase II-specific,salivary gland adenoid cystic carcinoma,ppi
13854,16785,348,APOE,apolipoprotein E,74,amyloid-beta binding|structural molecule activity|lipid transporter activity|phospholipid binding|heparin binding|lipid binding|antioxidant activity|identical protein binding|protein homodimerization activity|protein-containing complex binding|metal chelating activity|protein dimerization activity|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|very-low-density lipoprotein particle receptor binding|cholesterol transporter activity|cholesterol binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|alcohol dependence|alcohol abuse|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease,ppi
13855,16786,3669,ISG20,interferon stimulated exonuclease gene 20,10,3'-5'-exoribonuclease activity|exonuclease activity|single-stranded DNA 3'-5' exodeoxyribonuclease activity|U1 snRNA binding|U2 snRNA binding|U3 snoRNA binding,,ppi
13856,16787,10379,IRF9,interferon regulatory factor 9,32,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
13857,16788,3670,ISL1,ISL LIM homeobox 1,29,DNA-binding transcription factor activity; RNA polymerase II-specific|enhancer sequence-specific DNA binding|transcription coactivator activity|nuclear receptor binding|estrogen receptor binding|promoter-specific chromatin binding,bipolar disorder|bladder diverticulum|urinary bladder cancer|inguinal hernia|umbilical hernia|omphalocele|vesicoureteral reflux|urinary tract obstruction,ppi
13858,16789,3671,ISLR,immunoglobulin superfamily containing leucine rich repeat,57,,,ppi
13859,16790,3672,ITGA1,integrin subunit alpha 1,18,collagen binding|collagen binding involved in cell-matrix adhesion,,ppi
13860,16791,8515,ITGA10,integrin subunit alpha 10,1,collagen binding|collagen binding involved in cell-matrix adhesion,,ppi
13861,16792,22801,ITGA11,integrin subunit alpha 11,2,collagen binding|collagen receptor activity|collagen binding involved in cell-matrix adhesion,,ppi
13862,16793,3673,ITGA2,integrin subunit alpha 2,35,amyloid-beta binding|collagen binding|collagen receptor activity|heparan sulfate proteoglycan binding|collagen binding involved in cell-matrix adhesion,endometriosis of uterus|endometriosis|retinal vein occlusion|thrombocytopenia,ppi
13863,16794,3674,ITGA2B,integrin subunit alpha 2b,18,,anemia|macrocytic anemia|carotid stenosis|carotid artery thrombosis|purpura|cerebral infarction|cerebrovascular disease|qualitative platelet defect|Glanzmann's thrombasthenia|thrombocytopenia|platelet-type bleeding disorder 16,ppi
13864,16795,3675,ITGA3,integrin subunit alpha 3,21,protein heterodimerization activity,lactic acidosis|hypertrophy of breast|infant gynecomastia|gynecomastia|proteinuria|kidney failure|uremia,ppi
13865,16796,3676,ITGA4,integrin subunit alpha 4,483,coreceptor activity|cell adhesion molecule binding|C-X3-C chemokine binding,autistic disorder|chronic lymphocytic leukemia|Richter's syndrome,ppi
13866,16797,3678,ITGA5,integrin subunit alpha 5,54,platelet-derived growth factor receptor binding|vascular endothelial growth factor receptor 2 binding,tongue squamous cell carcinoma|squamous cell carcinoma|stomach cancer,ppi
13867,16798,3655,ITGA6,integrin subunit alpha 6,45,insulin-like growth factor I binding|neuregulin binding|cadherin binding,rheumatoid arthritis|dental enamel hypoplasia|ectropion|esophageal atresia|polyhydramnios|hydronephrosis|intestinal atresia|ureterocele|kidney disease|Clouston syndrome|renal agenesis|junctional epidermolysis bullosa with pyloric atresia,ppi
13868,16799,3679,ITGA7,integrin subunit alpha 7,27,,colon cancer|colonic benign neoplasm|intellectual disability|learning disability|familial periodic paralysis|myopathy|muscular atrophy|centronuclear myopathy|congenital structural myopathy|muscular dystrophy-dystroglycanopathy|megaconial type congenital muscular dystrophy|rigid spine muscular dystrophy 1|congenital muscular dystrophy 1B|muscular dystrophy-dystroglycanopathy type B5|congenital merosin-deficient muscular dystrophy 1A|muscular dystrophy-dystroglycanopathy type B6|congenital muscular dystrophy due to integrin alpha-7 deficiency|congenital muscular dystrophy due to LMNA mutation|nemaline myopathy|central core myopathy,ppi
13869,16800,8516,ITGA8,integrin subunit alpha 8,19,,clubfoot|hypertension|essential hypertension|intestinal disease|gastrointestinal system disease|proteinuria|schizophrenia|stomach cancer|oligohydramnios|Potter's syndrome|ovarian cancer|renal agenesis,ppi
13870,16801,3680,ITGA9,integrin subunit alpha 9,20,,bipolar disorder,ppi
13871,16802,3681,ITGAD,integrin subunit alpha D,4,,,ppi
13872,16803,3682,ITGAE,integrin subunit alpha E,5,,,ppi
13873,16804,3683,ITGAL,integrin subunit alpha L,13,ICAM-3 receptor activity|cell adhesion molecule binding,Behcet's disease|acute promyelocytic leukemia,ppi
13874,16805,3684,ITGAM,integrin subunit alpha M,21,complement component C3b binding|protein heterodimerization activity,bipolar disorder|colitis|ileitis|ileocolitis|gastroenteritis|acute promyelocytic leukemia|systemic lupus erythematosus|schizophrenia|allergic contact dermatitis,ppi
13875,16806,319,APOF,apolipoprotein F,3,signaling receptor binding|lipid transporter activity|cholesterol binding,,ppi
13876,16807,3685,ITGAV,integrin subunit alpha V,76,fibronectin binding|protease binding|voltage-gated calcium channel activity|coreceptor activity|transforming growth factor beta binding|extracellular matrix binding|extracellular matrix protein binding|opsonin binding|protein kinase C binding|fibroblast growth factor binding|C-X3-C chemokine binding|insulin-like growth factor I binding|neuregulin binding,cerebral infarction|cerebrovascular disease,ppi
13877,16808,3687,ITGAX,integrin subunit alpha X,4,signaling receptor activity,acute promyelocytic leukemia|systemic lupus erythematosus,ppi
13878,16809,3688,ITGB1,integrin subunit beta 1,138,actin binding|coreceptor activity|cadherin binding|protein heterodimerization activity|collagen binding involved in cell-matrix adhesion|C-X3-C chemokine binding|integrin binding|laminin binding|fibronectin binding,calcium metabolism disease|nephrocalcinosis|calcinosis|lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L,ppi
13879,16810,26548,ITGB1BP2,integrin subunit beta 1 binding protein 2,22,,,ppi
13880,16811,3689,ITGB2,integrin subunit beta 2,59,amyloid-beta binding|complement component C3b binding|ICAM-3 receptor activity|protein heterodimerization activity|cell adhesion molecule binding|integrin binding,Behcet's disease|calcium metabolism disease|nephrocalcinosis|calcinosis|acrodermatitis|dermatitis|gingival disease|epulis|gingivitis|heart valve disease|allergic hypersensitivity disease|acute promyelocytic leukemia|leukocyte disease|kidney disease|nephrosis|periodontal disease|periodontitis|pneumonia|chronic ulcer of skin|leukocyte-adhesion deficiency syndrome,ppi
13881,16812,3690,ITGB3,integrin subunit beta 3,63,fibronectin binding|protease binding|protein disulfide isomerase activity|platelet-derived growth factor receptor binding|coreceptor activity|vascular endothelial growth factor receptor 2 binding|extracellular matrix binding|fibroblast growth factor binding|C-X3-C chemokine binding|insulin-like growth factor I binding|neuregulin binding|integrin binding|fibrinogen binding,anemia|macrocytic anemia|autistic disorder|carotid stenosis|carotid artery thrombosis|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|purpura|prostate cancer|prostate carcinoma|schizophrenia|cerebral infarction|cerebrovascular disease|qualitative platelet defect|Glanzmann's thrombasthenia|thrombocytopenia|platelet-type bleeding disorder 16,ppi
13882,16813,23421,ITGB3BP,integrin subunit beta 3 binding protein,68,protein C-terminus binding,endometriosis of uterus|endometriosis,ppi
13883,16814,3691,ITGB4,integrin subunit beta 4,54,insulin-like growth factor I binding|neuregulin binding|integrin binding,anemia|macrocytic anemia|salivary gland adenoid cystic carcinoma|dental caries|dental enamel hypoplasia|Clouston syndrome|ectropion|epidermolysis bullosa|esophageal atresia|polyhydramnios|hydronephrosis|tooth agenesis|anodontia|intestinal atresia|ureterocele|epidermolysis bullosa simplex Dowling-Meara type|epidermolysis bullosa simplex|epidermolysis bullosa simplex Ogna type|junctional epidermolysis bullosa non-Herlitz type|junctional epidermolysis bullosa,ppi
13884,16815,3692,EIF6,eukaryotic translation initiation factor 6,206,ribosome binding|ribosomal large subunit binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|breast cancer,ppi
13885,16816,350,APOH,apolipoprotein H,18,phospholipid binding|lipid binding|lipoprotein lipase activator activity,schizophrenia,ppi
13886,16817,3693,ITGB5,integrin subunit beta 5,64,integrin binding,goiter|thyroid gland disease,ppi
13887,16818,3694,ITGB6,integrin subunit beta 6,8,integrin binding,alopecia|amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia|hypersensitivity reaction type II disease,ppi
13888,16819,3695,ITGB7,integrin subunit beta 7,22,cell adhesion molecule binding|integrin binding,,ppi
13889,16820,3696,ITGB8,integrin subunit beta 8,16,extracellular matrix protein binding|integrin binding,endometriosis of uterus|endometriosis,ppi
13890,16822,3697,ITIH1,inter-alpha-trypsin inhibitor heavy chain 1,6,calcium ion binding,bipolar disorder|liver cancer|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
13891,16823,3698,ITIH2,inter-alpha-trypsin inhibitor heavy chain 2,18,endopeptidase inhibitor activity,,ppi
13892,16824,3699,ITIH3,inter-alpha-trypsin inhibitor heavy chain 3,8,endopeptidase inhibitor activity,bipolar disorder|schizophrenia|liver cancer|hepatocellular carcinoma,ppi
13893,16825,3700,ITIH4,inter-alpha-trypsin inhibitor heavy chain family member 4,5,endopeptidase inhibitor activity,bipolar disorder|colon cancer|colonic benign neoplasm|familial adenomatous polyposis|islet cell tumor|familial hypercholesterolemia,ppi
13894,16826,3702,ITK,IL2 inducible T-cell kinase,45,non-membrane spanning protein tyrosine kinase activity,anemia|macrocytic anemia|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|lymphosarcoma|lymphoma|central nervous system lymphoma|pancytopenia|aphthous stomatitis|thrombocytopenia|selective IgG deficiency disease|lymphoproliferative syndrome 1,ppi
13895,16827,3703,STT3A,STT3A; catalytic subunit of the oligosaccharyltransferase complex,22,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,cryptorchidism|epilepsy|intellectual disability|learning disability|visual epilepsy|congenital disorder of glycosylation type I,ppi
13896,16828,9452,ITM2A,integral membrane protein 2A,15,amyloid-beta binding,,ppi
13897,16829,9445,ITM2B,integral membrane protein 2B,34,amyloid-beta binding,cerebellar disease|sensorineural hearing loss|hypertension|essential hypertension|schizophreniform disorder|schizoaffective disorder|asthenopia|fundus dystrophy|cerebral amyloid angiopathy,ppi
13898,16830,81618,ITM2C,integral membrane protein 2C,10,amyloid-beta binding,,ppi
13899,16831,3704,ITPA,inosine triphosphatase,51,dITP diphosphatase activity|ITP diphosphatase activity|XTP diphosphatase activity|nucleoside-triphosphate diphosphatase activity,hemolytic anemia|inherited metabolic disorder|thrombocytopenia,ppi
13900,16832,3705,ITPK1,inositol-tetrakisphosphate 1-kinase,14,catalytic activity|inositol tetrakisphosphate 1-kinase activity|inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity|inositol-1;3;4-trisphosphate 6-kinase activity|inositol-1;3;4-trisphosphate 5-kinase activity|inositol-1;3;4;5;6-pentakisphosphate 1-phosphatase activity|inositol-1;3;4;6-tetrakisphosphate 6-phosphatase activity|inositol-1;3;4;6-tetrakisphosphate 1-phosphatase activity|inositol-3;4;6-trisphosphate 1-kinase activity,,ppi
13901,16833,3706,ITPKA,inositol-trisphosphate 3-kinase A,8,inositol-1;4;5-trisphosphate 3-kinase activity,,ppi
13902,16834,3707,ITPKB,inositol-trisphosphate 3-kinase B,13,inositol-1;4;5-trisphosphate 3-kinase activity,,ppi
13903,16835,8542,APOL1,apolipoprotein L1,5,chloride channel activity|lipid binding,schizophrenia|focal segmental glomerulosclerosis,ppi
13904,16836,3708,ITPR1,inositol 1;4;5-trisphosphate receptor type 1,55,inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity|calcium ion transmembrane transporter activity|calcium-release channel activity|calcium channel inhibitor activity|phosphatidylinositol binding|inositol 1;4;5 trisphosphate binding|calcium ion binding,aniridia|bipolar disorder|cerebellar disease|intellectual disability|learning disability|movement disease|lingual-facial-buccal dyskinesia|prostate cancer|prostate carcinoma|spinocerebellar ataxia type 15|spinocerebellar ataxia type 29,ppi
13905,16837,3709,ITPR2,inositol 1;4;5-trisphosphate receptor type 2,24,inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity|calcium ion transmembrane transporter activity|calcium ion binding|phosphatidylinositol binding|inositol 1;4;5 trisphosphate binding,hypohidrosis|anhidrosis|isolated anhidrosis with normal sweat glands,ppi
13906,16838,3710,ITPR3,inositol 1;4;5-trisphosphate receptor type 3,47,inositol hexakisphosphate binding|inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity|calcium-release channel activity|inositol 1;3;4;5 tetrakisphosphate binding|inositol 1;4;5 trisphosphate binding|calcium ion binding|phosphatidylinositol binding,diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21|type 1 diabetes mellitus 22,ppi
13907,16839,6453,ITSN1,intersectin 1,119,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|calcium ion binding|protein-containing complex scaffold activity,,ppi
13908,16840,50618,ITSN2,intersectin 2,93,SH3/SH2 adaptor activity,breast cancer|Sjogren's syndrome|keratoconjunctivitis sicca,ppi
13909,16841,3712,IVD,isovaleryl-CoA dehydrogenase,14,isovaleryl-CoA dehydrogenase activity,epilepsy|leukopenia|pancytopenia|visual epilepsy|thrombocytopenia|lactic acidosis|isovaleric acidemia,ppi
13910,16842,3713,IVL,involucrin,36,structural molecule activity|protein binding; bridging,tongue squamous cell carcinoma|squamous cell carcinoma|skin benign neoplasm|skin cancer,ppi
13911,16843,182,JAG1,jagged 1,17,Notch binding|structural molecule activity|phospholipid binding|growth factor activity,renal tubular acidosis|bone disease|cartilage disease|connective tissue disease|recurrent corneal erosion|cryptorchidism|salivary gland adenoid cystic carcinoma|sensorineural hearing loss|enophthalmos|orbital disease|exophthalmos|microphthalmia|placental insufficiency|glioblastoma multiforme|giant cell glioblastoma|congenital heart disease|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4,ppi
13912,16844,3714,JAG2,jagged 2,18,growth factor activity,glioblastoma multiforme|giant cell glioblastoma|schizophrenia|syndactyly|pancreatic ductal carcinoma|breast cancer,ppi
13913,16845,23780,APOL2,apolipoprotein L2,29,signaling receptor binding|high-density lipoprotein particle binding|lipid binding,cannabis dependence|cannabis abuse|phencyclidine abuse|schizophrenia|cocaine abuse|cocaine dependence,ppi
13914,16846,3716,JAK1,Janus kinase 1,116,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|growth hormone receptor binding,,ppi
13915,16847,3717,JAK2,Janus kinase 2,123,protein kinase activity|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|growth hormone receptor binding|interleukin-12 receptor binding|protein kinase binding|heme binding|histone kinase activity (H3-Y41 specific)|histone binding,myelofibrosis|calcium metabolism disease|nephrocalcinosis|calcinosis|brain ischemia|inflammatory bowel disease|ulcerative colitis|heart valve disease|hypertension|essential hypertension|portal hypertension|leukemia|acute myeloid leukemia|liver cirrhosis|mesenteric vascular occlusion|myeloproliferative neoplasm|bone marrow cancer|coronary thrombosis|myocardial infarction|silent myocardial infarction,ppi
13916,16848,3718,JAK3,Janus kinase 3,88,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity,intestinal obstruction|ileus|meningitis|pneumonia|adenosine deaminase deficiency|MHC class II deficiency|severe combined immunodeficiency|juvenile myelomonocytic leukemia|amyotrophic lateral sclerosis type 1,ppi
13917,16849,3720,JARID2,jumonji and AT-rich interaction domain containing 2,23,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|histone demethylase activity|DNA-binding transcription repressor activity; RNA polymerase II-specific|methylated histone binding|histone demethylase activity (H3-trimethyl-K4 specific),schizophrenia|autistic disorder,ppi
13918,16850,8629,JRK,Jrk helix-turn-helix protein,5,,idiopathic generalized epilepsy|childhood absence epilepsy|juvenile myoclonic epilepsy,ppi
13919,16851,351,APP,amyloid beta precursor protein,2123,DNA binding|serine-type endopeptidase inhibitor activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|amnestic disorder|dissociative amnesia|amyloidosis|anxiety disorder|phobic disorder,ppi
13920,16852,8690,JRKL,JRK-like,5,,,ppi
13921,16853,10899,JTB,jumping translocation breakpoint,7,protein kinase binding,,ppi
13922,16854,3725,JUN,Jun proto-oncogene; AP-1 transcription factor subunit,1482,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|obsolete transcriptional activator activity; RNA polymerase II transcription factor binding|DNA binding|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription coactivator activity|RNA binding|GTPase activator activity|cAMP response element binding|protein homodimerization activity|transcription regulatory region DNA binding|protein heterodimerization activity|transcription factor binding|RNA polymerase II proximal promoter sequence-specific DNA binding,brain ischemia|colon cancer|colonic benign neoplasm|angiosarcoma|hypertension|essential hypertension|liver cancer|lung benign neoplasm|osteosarcoma|bone osteosarcoma|polyneuropathy|peripheral nervous system disease|neuropathy|schizophrenia|status epilepticus|stomach cancer|breast cancer|hepatocellular carcinoma,ppi
13923,16855,3726,JUNB,JunB proto-oncogene; AP-1 transcription factor subunit,71,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription coactivator activity|transcription corepressor activity|RNA polymerase II proximal promoter sequence-specific DNA binding|transcription factor binding,lung benign neoplasm|status epilepticus|coronary artery disease|lung cancer|lung adenocarcinoma|middle cerebral artery infarction,ppi
13924,16856,3727,JUND,JunD proto-oncogene; AP-1 transcription factor subunit,55,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription regulatory region DNA binding|transcription coactivator activity|RNA polymerase II proximal promoter sequence-specific DNA binding|transcription factor binding,nephritis|glomerulonephritis|kidney disease|liver cirrhosis|status epilepticus|cocaine abuse|cocaine dependence|amyotrophic lateral sclerosis type 1,ppi
13925,16857,3728,JUP,junction plakoglobin,151,transcription coactivator activity|structural molecule activity|structural constituent of cell wall|protein homodimerization activity|cadherin binding|cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication|alpha-catenin binding|protein phosphatase binding|nuclear hormone receptor binding,alopecia|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
13926,16858,8883,NAE1,NEDD8 activating enzyme E1 subunit 1,40,NEDD8 activating enzyme activity,,ppi
13927,16859,3732,CD82,CD82 molecule,32,,prostate cancer|prostate carcinoma,ppi
13928,16860,3730,ANOS1,anosmin 1,5,extracellular matrix structural constituent,generalized anxiety disorder|anxiety disorder|cerebellar disease|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertrophy of breast|infant gynecomastia|gynecomastia|osteoporosis|hypogonadism|premature menopause|androgen insensitivity syndrome|eunuchism|atrophy of testis|isolated growth hormone deficiency,ppi
13929,16861,3735,KARS,lysyl-tRNA synthetase,97,tRNA binding|ATP adenylyltransferase activity|lysine-tRNA ligase activity,sensorineural hearing loss|meningioma|acoustic neuroma|pituitary adenoma|neurilemmoma|cellular schwannoma|melanotic neurilemmoma|plexiform schwannoma|Charcot-Marie-Tooth disease recessive intermediate B|autosomal recessive nonsyndromic deafness 89,ppi
13930,16862,11104,KATNA1,katanin catalytic subunit A1,49,microtubule binding|microtubule-severing ATPase activity|ATPase activity,,ppi
13931,16863,10300,KATNB1,katanin regulatory subunit B1,18,microtubule binding|microtubule-severing ATPase activity,lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|septooptic dysplasia|microcephaly,ppi
13932,16864,3736,KCNA1,potassium voltage-gated channel subfamily A member 1,9,voltage-gated potassium channel activity|delayed rectifier potassium channel activity|potassium channel activity|potassium ion transmembrane transporter activity,cerebellar disease|movement disease|lingual-facial-buccal dyskinesia|central nervous system origin vertigo|amblyopia|episodic ataxia type 1|episodic ataxia,ppi
13933,16865,3744,KCNA10,potassium voltage-gated channel subfamily A member 10,17,intracellular cyclic nucleotide activated cation channel activity|outward rectifier potassium channel activity|delayed rectifier potassium channel activity|voltage-gated potassium channel activity,,ppi
13934,16866,10513,APPBP2,amyloid beta precursor protein binding protein 2,111,microtubule motor activity,,ppi
13935,16867,3737,KCNA2,potassium voltage-gated channel subfamily A member 2,19,voltage-gated potassium channel activity|delayed rectifier potassium channel activity|potassium channel activity,cerebellar disease|epilepsy|hiatus hernia|congenital diaphragmatic hernia|communication disorder|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|visual epilepsy|intellectual disability|learning disability,ppi
13936,16868,3738,KCNA3,potassium voltage-gated channel subfamily A member 3,17,voltage-gated ion channel activity|delayed rectifier potassium channel activity|voltage-gated potassium channel activity|outward rectifier potassium channel activity,,ppi
13937,16869,3739,KCNA4,potassium voltage-gated channel subfamily A member 4,24,voltage-gated potassium channel activity|delayed rectifier potassium channel activity,,ppi
13938,16870,3741,KCNA5,potassium voltage-gated channel subfamily A member 5,57,delayed rectifier potassium channel activity|outward rectifier potassium channel activity|voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization|voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization|voltage-gated potassium channel activity involved in SA node cell action potential repolarization|voltage-gated potassium channel activity,atrial fibrillation|familial atrial fibrillation,ppi
13939,16871,3742,KCNA6,potassium voltage-gated channel subfamily A member 6,12,voltage-gated potassium channel activity|delayed rectifier potassium channel activity,,ppi
13940,16873,7881,KCNAB1,potassium voltage-gated channel subfamily A member regulatory beta subunit 1,14,aldo-keto reductase (NADP) activity|potassium channel regulator activity|NADPH binding,,ppi
13941,16874,8514,KCNAB2,potassium voltage-gated channel subfamily A regulatory beta subunit 2,33,aldo-keto reductase (NADP) activity|potassium channel regulator activity,autistic disorder|constipation|enophthalmos|orbital disease|exophthalmos|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|intellectual disability|learning disability|visual epilepsy|stereotypic movement disorder|ophthalmoplegia|mechanical strabismus|hypertropia|craniosynostosis|cerebral degeneration|chromosome 1p36 deletion syndrome,ppi
13942,16875,9196,KCNAB3,potassium voltage-gated channel subfamily A regulatory beta subunit 3,7,potassium channel regulator activity,,ppi
13943,16876,3745,KCNB1,potassium voltage-gated channel subfamily B member 1,17,delayed rectifier potassium channel activity|protein heterodimerization activity|voltage-gated potassium channel activity,hiatus hernia|congenital diaphragmatic hernia|infantile epileptic encephalopathy,ppi
13944,16877,9312,KCNB2,potassium voltage-gated channel subfamily B member 2,7,delayed rectifier potassium channel activity|protein heterodimerization activity|voltage-gated potassium channel activity,,ppi
13945,16878,3746,KCNC1,potassium voltage-gated channel subfamily C member 1,8,voltage-gated potassium channel activity|delayed rectifier potassium channel activity,epilepsy|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|visual epilepsy|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy,ppi
13946,16879,3747,KCNC2,potassium voltage-gated channel subfamily C member 2,1,voltage-gated potassium channel activity|delayed rectifier potassium channel activity,,ppi
13947,16880,3748,KCNC3,potassium voltage-gated channel subfamily C member 3,2,voltage-gated potassium channel activity|delayed rectifier potassium channel activity,intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|spinocerebellar ataxia type 13,ppi
13948,16881,3749,KCNC4,potassium voltage-gated channel subfamily C member 4,27,potassium channel activity|voltage-gated potassium channel activity|delayed rectifier potassium channel activity,complex partial epilepsy|temporal lobe epilepsy,ppi
13949,16882,3750,KCND1,potassium voltage-gated channel subfamily D member 1,2,voltage-gated potassium channel activity,,ppi
13950,16883,3751,KCND2,potassium voltage-gated channel subfamily D member 2,20,voltage-gated potassium channel activity|A-type (transient outward) potassium channel activity|voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,,ppi
13951,16884,3752,KCND3,potassium voltage-gated channel subfamily D member 3,29,A-type (transient outward) potassium channel activity|voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization|voltage-gated potassium channel activity,focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|Brugada syndrome|Brugada syndrome 1|spinocerebellar ataxia type 19/22|Brugada syndrome 9,ppi
13952,16885,3753,KCNE1,potassium voltage-gated channel subfamily E regulatory subunit 1,7,delayed rectifier potassium channel activity|potassium channel regulator activity|voltage-gated potassium channel activity|voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,sensorineural hearing loss|Jervell-Lange Nielsen syndrome|long QT syndrome|long QT syndrome 1|familial atrial fibrillation|long QT syndrome 5,ppi
13953,16886,23630,KCNE5,potassium voltage-gated channel subfamily E regulatory subunit 5,3,potassium channel regulator activity|voltage-gated potassium channel activity|voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,sensorineural hearing loss|favism|hereditary elliptocytosis|congenital hemolytic anemia|proteinuria|kidney failure|uremia|syndromic X-linked intellectual disability 94,ppi
13954,16887,9992,KCNE2,potassium voltage-gated channel subfamily E regulatory subunit 2,3,potassium channel regulator activity|ion channel binding|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization|inward rectifier potassium channel activity|delayed rectifier potassium channel activity,atrial fibrillation|long QT syndrome|long QT syndrome 1|familial atrial fibrillation|long QT syndrome 6,ppi
13955,16888,10008,KCNE3,potassium voltage-gated channel subfamily E regulatory subunit 3,10,potassium channel regulator activity,cardiac arrest|familial periodic paralysis|obsolete Timothy syndrome|hyperkalemic periodic paralysis|hypokalemic periodic paralysis|Brugada syndrome|Brugada syndrome 1|hyperglycemia|Brugada syndrome 6,ppi
13956,16889,23704,KCNE4,potassium voltage-gated channel subfamily E regulatory subunit 4,8,,,ppi
13957,16890,3754,KCNF1,potassium voltage-gated channel modifier subfamily F member 1,5,potassium channel activity|voltage-gated potassium channel activity,,ppi
13958,16891,3755,KCNG1,potassium voltage-gated channel modifier subfamily G member 1,5,delayed rectifier potassium channel activity|potassium channel activity|voltage-gated potassium channel activity,,ppi
13959,16892,26251,KCNG2,potassium voltage-gated channel modifier subfamily G member 2,1,delayed rectifier potassium channel activity|voltage-gated potassium channel activity,,ppi
13960,16893,3756,KCNH1,potassium voltage-gated channel subfamily H member 1,10,delayed rectifier potassium channel activity|phosphatidylinositol bisphosphate binding|cyclic nucleotide binding|voltage-gated potassium channel activity,patent ductus arteriosus|epilepsy|gingival overgrowth|gingival hypertrophy|umbilical hernia|omphalocele|hypertrichosis|myopia|osteosarcoma|bone osteosarcoma|schizophrenia|visual epilepsy|syndromic X-linked intellectual disability 94|Klippel-Feil syndrome|spondylolisthesis|cataract|gingival fibromatosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
13961,16894,3757,KCNH2,potassium voltage-gated channel subfamily H member 2,32,inward rectifier potassium channel activity|voltage-gated potassium channel activity|delayed rectifier potassium channel activity|voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,sick sinus syndrome|colon cancer|colonic benign neoplasm|cardiac arrest|long QT syndrome|anterior horn cell disease|muscular atrophy|schizophreniform disorder|schizoaffective disorder|long QT syndrome 1|schizophrenia|short QT syndrome|long QT syndrome 2,ppi
13962,16897,27133,KCNH5,potassium voltage-gated channel subfamily H member 5,1,voltage-gated potassium channel activity,,ppi
13963,16898,3758,KCNJ1,potassium voltage-gated channel subfamily J member 1,8,inward rectifier potassium channel activity|phosphatidylinositol-4;5-bisphosphate binding|ATP-activated inward rectifier potassium channel activity,Liddle syndrome|Conn's syndrome|Bartter disease|primary hyperaldosteronism|constipation|epilepsy|polyhydramnios|Waterhouse-Friderichsen syndrome|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hypertension|essential hypertension|hypokalemia|intellectual disability|learning disability|calcium metabolism disease|calcinosis|visual epilepsy|hypoparathyroidism,ppi
13964,16899,3766,KCNJ10,potassium voltage-gated channel subfamily J member 10,23,inward rectifier potassium channel activity|ATP-activated inward rectifier potassium channel activity|G-protein activated inward rectifier potassium channel activity,cerebellar disease|epilepsy|goiter|nontoxic goiter|thyroid gland disease|sensorineural hearing loss|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypokalemia|congenital hypothyroidism|myxedema|hypothyroidism|intellectual disability|learning disability|multiple sclerosis|schizophrenia|visual epilepsy|Pendred Syndrome,ppi
13965,16900,3767,KCNJ11,potassium voltage-gated channel subfamily J member 11,13,voltage-gated potassium channel activity|ATP binding|ATP-activated inward rectifier potassium channel activity|potassium ion binding|inward rectifier potassium channel activity,ptosis|congenital ptosis|diabetic ketoacidosis|diabetes mellitus|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19,ppi
13966,16903,353,APRT,adenine phosphoribosyltransferase,35,adenine phosphoribosyltransferase activity|AMP binding|adenine binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|kidney failure|uremia|adenine phosphoribosyltransferase deficiency|acute urate nephropathy|breast cancer,ppi
13967,16905,3772,KCNJ15,potassium voltage-gated channel subfamily J member 15,5,inward rectifier potassium channel activity|G-protein activated inward rectifier potassium channel activity,,ppi
13968,16906,3773,KCNJ16,potassium voltage-gated channel subfamily J member 16,4,inward rectifier potassium channel activity|G-protein activated inward rectifier potassium channel activity,,ppi
13969,16907,3759,KCNJ2,potassium voltage-gated channel subfamily J member 2,14,inward rectifier potassium channel activity|phosphatidylinositol-4;5-bisphosphate binding|G-protein activated inward rectifier potassium channel activity|voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,sick sinus syndrome|blepharophimosis|isolated cleft palate|cleft palate|dental enamel hypoplasia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|seborrheic keratosis|skin disease|actinic keratosis|catecholaminergic polymorphic ventricular tachycardia|catecholaminergic polymorphic ventricular tachycardia 1|catecholaminergic polymorphic ventricular tachycardia 2|catecholaminergic polymorphic ventricular tachycardia 3|catecholaminergic polymorphic ventricular tachycardia 4|catecholaminergic polymorphic ventricular tachycardia 5,ppi
13970,16908,3760,KCNJ3,potassium voltage-gated channel subfamily J member 3,10,G-protein activated inward rectifier potassium channel activity|voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization|inward rectifier potassium channel activity,schizophrenia,ppi
13971,16909,3761,KCNJ4,potassium voltage-gated channel subfamily J member 4,14,inward rectifier potassium channel activity|G-protein activated inward rectifier potassium channel activity,Parkinson's disease,ppi
13972,16910,3762,KCNJ5,potassium voltage-gated channel subfamily J member 5,16,G-protein activated inward rectifier potassium channel activity|voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization|inward rectifier potassium channel activity,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|atrioventricular block|cardiac arrest|congestive heart failure|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypertension|essential hypertension|hypokalemia|pulmonary embolism|long QT syndrome|long QT syndrome 1|atrial fibrillation|Andersen-Tawil syndrome,ppi
13973,16911,3763,KCNJ6,potassium voltage-gated channel subfamily J member 6,15,inward rectifier potassium channel activity|G-protein activated inward rectifier potassium channel activity,alcohol dependence|alcohol abuse|pseudosarcomatous fibromatosis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|enophthalmos|orbital disease|exophthalmos|gingival overgrowth|gingival hypertrophy|polyhydramnios|syndromic X-linked intellectual disability 94,ppi
13974,16912,3764,KCNJ8,potassium voltage-gated channel subfamily J member 8,22,inward rectifier potassium channel activity|ATP-activated inward rectifier potassium channel activity|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,patent ductus arteriosus|umbilical hernia|omphalocele|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|osteoporosis|sudden infant death syndrome|coronary artery disease|hypertrichotic osteochondrodysplasia Cantu type|Brugada syndrome|Brugada syndrome 1,ppi
13975,16913,3765,KCNJ9,potassium voltage-gated channel subfamily J member 9,5,G-protein activated inward rectifier potassium channel activity|inward rectifier potassium channel activity,,ppi
13976,16914,3775,KCNK1,potassium two pore domain channel subfamily K member 1,6,inward rectifier potassium channel activity|potassium channel activity|sodium channel activity|potassium ion leak channel activity|voltage-gated potassium channel activity,,ppi
13977,16915,54207,KCNK10,potassium two pore domain channel subfamily K member 10,1,potassium channel activity|potassium ion leak channel activity,,ppi
13978,16916,56660,KCNK12,potassium two pore domain channel subfamily K member 12,1,potassium ion leak channel activity,,ppi
13979,16919,3777,KCNK3,potassium two pore domain channel subfamily K member 3,10,ion channel activity|potassium channel activity|potassium ion leak channel activity,primary pulmonary hypertension|pulmonary hypertension,ppi
13980,16920,50801,KCNK4,potassium two pore domain channel subfamily K member 4,2,potassium channel activity|temperature-gated cation channel activity|mechanosensitived potassium channel activity|potassium ion leak channel activity,,ppi
13981,16921,8645,KCNK5,potassium two pore domain channel subfamily K member 5,2,potassium channel activity|potassium ion leak channel activity,status epilepticus,ppi
13982,16924,51305,KCNK9,potassium two pore domain channel subfamily K member 9,8,potassium channel activity|potassium ion leak channel activity,childhood absence epilepsy|intellectual disability|learning disability|mood disorder|Birk-Barel syndrome,ppi
13983,16925,3778,KCNMA1,potassium calcium-activated channel subfamily M alpha 1,15,actin binding|voltage-gated potassium channel activity|calcium-activated potassium channel activity|large conductance calcium-activated potassium channel activity|outward rectifier potassium channel activity,autistic disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|childhood absence epilepsy|hiatus hernia|congenital diaphragmatic hernia|morbid obesity|status epilepticus|visual epilepsy,ppi
13984,16926,3779,KCNMB1,potassium calcium-activated channel subfamily M regulatory beta subunit 1,5,calcium-activated potassium channel activity|potassium channel regulator activity,hypertension|essential hypertension,ppi
13985,16927,10242,KCNMB2,potassium calcium-activated channel subfamily M regulatory beta subunit 2,1,ion channel inhibitor activity|calcium-activated potassium channel activity|potassium channel regulator activity,,ppi
13986,16930,3780,KCNN1,potassium calcium-activated channel subfamily N member 1,1,calcium-activated potassium channel activity|calmodulin binding|small conductance calcium-activated potassium channel activity,,ppi
13987,16931,3781,KCNN2,potassium calcium-activated channel subfamily N member 2,4,calcium-activated potassium channel activity|small conductance calcium-activated potassium channel activity|calmodulin binding,,ppi
13988,16932,3782,KCNN3,potassium calcium-activated channel subfamily N member 3,5,small conductance calcium-activated potassium channel activity|calmodulin binding,atrial fibrillation|bipolar disorder|schizophrenia,ppi
13989,16933,3783,KCNN4,potassium calcium-activated channel subfamily N member 4,7,potassium channel activity|calcium-activated potassium channel activity|Intermediate conductance calcium-activated potassium channel activity|calmodulin binding|small conductance calcium-activated potassium channel activity,hemolytic anemia|abetalipoproteinemia,ppi
13990,16934,3784,KCNQ1,potassium voltage-gated channel subfamily Q member 1,18,voltage-gated potassium channel activity|delayed rectifier potassium channel activity|calmodulin binding|phosphatidylinositol-4;5-bisphosphate binding|protein phosphatase 1 binding|outward rectifier potassium channel activity|protein kinase A catalytic subunit binding|protein kinase A regulatory subunit binding|voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization|voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization|voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|atrial fibrillation|cryptorchidism|diabetes mellitus|type 2 diabetes mellitus|enophthalmos|orbital disease|exophthalmos|intestinal cancer|intestinal benign neoplasm|Jervell-Lange Nielsen syndrome|long QT syndrome|adenosarcoma|nephroblastoma|long QT syndrome 1|hepatocellular carcinoma,ppi
13991,16935,3785,KCNQ2,potassium voltage-gated channel subfamily Q member 2,6,voltage-gated potassium channel activity|calmodulin binding|delayed rectifier potassium channel activity,bipolar disorder|dystonia|enophthalmos|orbital disease|exophthalmos|epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|central nervous system disease|nervous system disease|autonomic neuropathy|schizophrenia|visual epilepsy|basal ganglia disease|benign familial infantile epilepsy|benign neonatal seizures,ppi
13992,16936,3786,KCNQ3,potassium voltage-gated channel subfamily Q member 3,4,voltage-gated potassium channel activity|calmodulin binding|delayed rectifier potassium channel activity,bipolar disorder|dystonia|enophthalmos|orbital disease|exophthalmos|epilepsy|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|schizophrenia|visual epilepsy|basal ganglia disease|benign familial infantile epilepsy|benign neonatal seizures|benign familial neonatal epilepsy|juvenile myoclonic epilepsy|partial motor epilepsy,ppi
13993,16937,9132,KCNQ4,potassium voltage-gated channel subfamily Q member 4,7,potassium channel activity|delayed rectifier potassium channel activity|voltage-gated potassium channel activity|calmodulin binding,sensorineural hearing loss|autosomal dominant nonsyndromic deafness 2A,ppi
13994,16938,56479,KCNQ5,potassium voltage-gated channel subfamily Q member 5,8,voltage-gated potassium channel activity|delayed rectifier potassium channel activity|calmodulin binding,myopia,ppi
13995,16939,357,SHROOM2,shroom family member 2,10,actin binding|beta-catenin binding|ligand-gated sodium channel activity|actin filament binding,,ppi
13996,16941,3788,KCNS2,potassium voltage-gated channel modifier subfamily S member 2,1,voltage-gated potassium channel activity,,ppi
13997,16942,3790,KCNS3,potassium voltage-gated channel modifier subfamily S member 3,35,delayed rectifier potassium channel activity|potassium channel regulator activity|voltage-gated potassium channel activity,schizophrenia,ppi
13998,16943,10945,KDELR1,KDEL endoplasmic reticulum protein retention receptor 1,28,KDEL sequence binding,prostate cancer|prostate carcinoma,ppi
13999,16944,11014,KDELR2,KDEL endoplasmic reticulum protein retention receptor 2,12,KDEL sequence binding,,ppi
14000,16945,11015,KDELR3,KDEL endoplasmic reticulum protein retention receptor 3,18,,,ppi
14001,16946,3791,KDR,kinase insert domain receptor,80,protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|vascular endothelial growth factor-activated receptor activity|Hsp90 protein binding|vascular endothelial growth factor binding|transmembrane signaling receptor activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|large intestine cancer|colorectal cancer|complex partial epilepsy|temporal lobe epilepsy|esophageal cancer|angiosarcoma|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|pancreatic cancer|schizophrenia|neurotic disorder|endogenous depression|melancholia|kidney failure,ppi
14002,16947,3792,KEL,Kell blood group; metallo-endopeptidase,7,metalloendopeptidase activity,,ppi
14003,16948,11081,KERA,keratocan,14,,arcus senilis|hyperopia|microphthalmia|cornea plana,ppi
14004,16949,3795,KHK,ketohexokinase,20,ketohexokinase activity|carbohydrate kinase activity,,ppi
14005,16950,8570,KHSRP,KH-type splicing regulatory protein,100,RNA binding|mRNA 3'-UTR AU-rich region binding,lung small cell carcinoma,ppi
14006,16951,10749,KIF1C,kinesin family member 1C,37,RNA binding|motor activity|ATPase activity|microtubule binding|microtubule motor activity|ATP-dependent microtubule motor activity; plus-end-directed,spontaneous ocular nystagmus|dissociated nystagmus|pathologic nystagmus|spastic ataxia 2,ppi
14007,16952,3796,KIF2A,kinesin family member 2A,70,motor activity|microtubule binding|microtubule motor activity|ATPase activity,epilepsy|microcephaly|schizophrenia|visual epilepsy|lissencephaly|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|Miller-Dieker lissencephaly syndrome|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|septooptic dysplasia|locked-in syndrome|quadriplegia,ppi
14008,16953,11127,KIF3A,kinesin family member 3A,73,ATP-dependent microtubule motor activity; plus-end-directed|spectrin binding|ATPase activity|microtubule binding|microtubule motor activity,asthma|intrinsic asthma|allergic asthma|polydactyly,ppi
14009,16954,9371,KIF3B,kinesin family member 3B,23,microtubule motor activity|ATP-dependent microtubule motor activity; plus-end-directed|microtubule binding|ATPase activity,,ppi
14010,16955,3797,KIF3C,kinesin family member 3C,7,motor activity|microtubule binding|microtubule motor activity|ATPase activity,amyotrophic lateral sclerosis type 1,ppi
14011,16956,285643,KIF4B,kinesin family member 4B,2,ATPase activity|microtubule binding|microtubule motor activity,,ppi
14012,16957,3798,KIF5A,kinesin family member 5A,43,motor activity|microtubule binding|ATP-dependent microtubule motor activity; plus-end-directed|microtubule motor activity|ATPase activity,rheumatoid arthritis|paraplegia|hereditary spastic paraplegia 10,ppi
14013,16958,3799,KIF5B,kinesin family member 5B,123,microtubule motor activity|microtubule binding|cadherin binding|ATPase activity,lung cancer|non-small cell lung carcinoma|diabetic ketoacidosis|diabetes mellitus,ppi
14014,16959,3800,KIF5C,kinesin family member 5C,33,microtubule motor activity|ATP-dependent microtubule motor activity; plus-end-directed|microtubule binding|ATPase activity,epilepsy|placental insufficiency|microcephaly|visual epilepsy|locked-in syndrome|quadriplegia,ppi
14015,16960,3801,KIFC3,kinesin family member C3,116,microtubule motor activity|ATPase activity|microtubule binding,,ppi
14016,16961,22944,KIN,Kin17 DNA and RNA binding protein,9,DNA binding|double-stranded DNA binding|RNA binding,,ppi
14017,16962,3802,KIR2DL1,killer cell immunoglobulin like receptor; two Ig domains and long cytoplasmic tail 1,4,signaling receptor activity,,ppi
14018,16963,358,AQP1,aquaporin 1 (Colton blood group),43,intracellular cGMP-activated cation channel activity|potassium channel activity|water transmembrane transporter activity|ammonium transmembrane transporter activity|potassium ion transmembrane transporter activity|glycerol transmembrane transporter activity|water channel activity|transmembrane transporter activity|nitric oxide transmembrane transporter activity|carbon dioxide transmembrane transporter activity,choledochal cyst|salivary gland adenoid cystic carcinoma|hypertension|essential hypertension|Graves' disease|thyrotoxicosis|hyperthyroidism|toxic shock syndrome|autosomal recessive polycystic kidney disease,ppi
14019,16964,3803,KIR2DL2,killer cell immunoglobulin like receptor; two Ig domains and long cytoplasmic tail 2,5,,,ppi
14020,16965,3804,KIR2DL3,killer cell immunoglobulin like receptor; two Ig domains and long cytoplasmic tail 3,7,antigen binding|signaling receptor activity,,ppi
14021,16966,3805,KIR2DL4,killer cell immunoglobulin like receptor; two Ig domains and long cytoplasmic tail 4,6,transmembrane signaling receptor activity,,ppi
14022,16967,3806,KIR2DS1,killer cell immunoglobulin like receptor; two Ig domains and short cytoplasmic tail 1,3,transmembrane signaling receptor activity,,ppi
14023,16968,100132285,KIR2DS2,killer cell immunoglobulin like receptor; two Ig domains and short cytoplasmic tail 2,33,transmembrane signaling receptor activity,,ppi
14024,16969,3808,KIR2DS3,killer cell immunoglobulin like receptor; two Ig domains and short cytoplasmic tail 3,1,,,ppi
14025,16970,3809,KIR2DS4,killer cell immunoglobulin like receptor; two Ig domains and short cytoplasmic tail 4,3,,,ppi
14026,16971,3810,KIR2DS5,killer cell immunoglobulin like receptor; two Ig domains and short cytoplasmic tail 5,2,HLA-C specific inhibitory MHC class I receptor activity,,ppi
14027,16972,3811,KIR3DL1,killer cell immunoglobulin like receptor; three Ig domains and long cytoplasmic tail 1,7,HLA-B specific inhibitory MHC class I receptor activity|amyloid-beta binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
14028,16973,3812,KIR3DL2,killer cell immunoglobulin like receptor; three Ig domains and long cytoplasmic tail 2,20,,,ppi
14029,16974,359,AQP2,aquaporin 2,1,water transmembrane transporter activity|glycerol transmembrane transporter activity|water channel activity,constipation|epilepsy|intellectual disability|learning disability|visual epilepsy|nephrogenic diabetes insipidus|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
14030,16975,3813,KIR3DS1,killer cell immunoglobulin like receptor; three Ig domains and short cytoplasmic tail 1,24,MHC class I receptor activity,,ppi
14031,16976,3814,KISS1,KiSS-1 metastasis-suppressor,7,kisspeptin receptor binding,generalized anxiety disorder|anxiety disorder|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|hypertrophy of breast|infant gynecomastia|gynecomastia|osteoporosis|stomach cancer|hypogonadism|premature menopause|androgen insensitivity syndrome|eunuchism|psychologic dyspareunia|premature ejaculation,ppi
14032,16977,3815,KIT,KIT proto-oncogene receptor tyrosine kinase,100,protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|cytokine binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|transmembrane signaling receptor activity,lung cancer|non-small cell lung carcinoma|constipation|cryptorchidism|hypereosinophilic syndrome|gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|Hirschsprung's disease|intestinal obstruction|ileus|acute myeloid leukemia|chronic myeloid leukemia|chronic monocytic leukemia|juvenile myelomonocytic leukemia|acute promyelocytic leukemia|lung disease|urticaria pigmentosa|mastocytosis|megacolon,ppi
14033,16978,4254,KITLG,KIT ligand,11,Ras guanyl-nucleotide exchange factor activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,sensorineural hearing loss|germ cell cancer|germ cell and embryonal cancer|embryonal cancer|testicular cancer|coronary artery disease|capillary hemangioma|acquired hyperkeratosis|seminoma|testicular germ cell cancer,ppi
14034,16979,9365,KL,klotho,1,Ras guanyl-nucleotide exchange factor activity|beta-glucosidase activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|fibroblast growth factor receptor binding|fibroblast growth factor binding,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|calcium metabolism disease|nephrocalcinosis|calcinosis|hypercalcemia|phosphorus metabolism disease|infertility|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|intellectual disability|learning disability|osteoporosis|seborrheic keratosis|skin disease|actinic keratosis,ppi
14035,16980,10661,KLF1,Kruppel like factor 1,16,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding,anemia|macrocytic anemia|congenital dyserythropoietic anemia|hematopoietic system disease|beta thalassemia,ppi
14036,16981,11278,KLF12,Kruppel like factor 12,8,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription corepressor activity,schizophrenia|substance abuse|substance-related disorder,ppi
14037,16982,10365,KLF2,Kruppel like factor 2,11,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,lung disease,ppi
14038,16983,9314,KLF4,Kruppel like factor 4,30,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II transcription factor binding|obsolete transcriptional activator activity; RNA polymerase II transcription factor binding|DNA-binding transcription factor activity|zinc ion binding|transcription regulatory region DNA binding|promoter-specific chromatin binding,tuberous sclerosis|Marfan syndrome|situs inversus|congenital heart disease|coronary artery disease,ppi
14039,16984,688,KLF5,Kruppel like factor 5,51,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,tongue squamous cell carcinoma|squamous cell carcinoma|pancreatic cancer|schizophrenia|lung cancer|lung adenocarcinoma,ppi
14040,16985,8609,KLF7,Kruppel like factor 7,3,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|zinc ion binding,,ppi
14041,16986,11279,KLF8,Kruppel like factor 8,14,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,,ppi
14042,16987,57626,KLHL1,kelch like family member 1,10,actin binding,,ppi
14043,16988,11275,KLHL2,kelch like family member 2,67,actin binding,,ppi
14044,16989,26249,KLHL3,kelch like family member 3,22,structural molecule activity,hypertension|essential hypertension|autosomal recessive pseudohypoaldosteronism type 1|autosomal dominant pseudohypoaldosteronism type 1|pseudohypoaldosteronism,ppi
14045,16990,56062,KLHL4,kelch like family member 4,3,,,ppi
14046,16991,51088,KLHL5,kelch like family member 5,7,,cocaine abuse|cocaine dependence,ppi
14047,16992,3816,KLK1,kallikrein 1,3,serine-type endopeptidase activity,hypertension|essential hypertension|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction,ppi
14048,16993,5655,KLK10,kallikrein related peptidase 10,16,serine-type peptidase activity,stomach cancer|ovarian cancer|breast cancer,ppi
14049,16994,11012,KLK11,kallikrein related peptidase 11,27,serine-type peptidase activity,,ppi
14050,16995,360,AQP3,aquaporin 3 (Gill blood group),3,transporter activity|water channel activity|glycerol channel activity,urinary bladder cancer|tongue squamous cell carcinoma|squamous cell carcinoma|esophageal cancer|skin benign neoplasm|skin cancer|tongue cancer|ovarian cancer,ppi
14051,16997,26085,KLK13,kallikrein related peptidase 13,6,serine-type endopeptidase activity|hydrolase activity,,ppi
14052,16999,3817,KLK2,kallikrein related peptidase 2,20,serine-type endopeptidase activity,prostate cancer|prostate carcinoma,ppi
14053,17000,354,KLK3,kallikrein related peptidase 3,19,endopeptidase activity|serine-type endopeptidase activity|serine-type peptidase activity|hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds; in linear amides,prostate cancer|prostate carcinoma|prostate malignant phyllodes tumor|prostatic adenoma,ppi
14054,17001,9622,KLK4,kallikrein related peptidase 4,4,serine-type peptidase activity,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia|dental caries,ppi
14055,17002,25818,KLK5,kallikrein related peptidase 5,52,endopeptidase activity|serine-type endopeptidase activity|peptidase activity|serine-type peptidase activity,prostate cancer|prostate carcinoma,ppi
14056,17003,5653,KLK6,kallikrein related peptidase 6,24,serine-type endopeptidase activity,,ppi
14057,17004,5650,KLK7,kallikrein related peptidase 7,26,metalloendopeptidase activity|peptidase activity|serine-type peptidase activity,,ppi
14058,17005,11202,KLK8,kallikrein related peptidase 8,15,serine-type endopeptidase activity,bipolar disorder|schizophrenia,ppi
14059,17006,361,AQP4,aquaporin 4,6,water transmembrane transporter activity|water channel activity,autistic disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|neuromyelitis optica|schizophrenia|status epilepticus,ppi
14060,17007,284366,KLK9,kallikrein related peptidase 9,11,serine-type endopeptidase activity,,ppi
14061,17008,3818,KLKB1,kallikrein B1,12,serine-type endopeptidase activity,carotid stenosis|carotid artery thrombosis|pulmonary embolism,ppi
14062,17009,3820,KLRB1,killer cell lectin like receptor B1,2,transmembrane signaling receptor activity,melanoma|skin melanoma,ppi
14063,17010,3821,KLRC1,killer cell lectin like receptor C1,8,transmembrane signaling receptor activity|protein antigen binding,,ppi
14064,17011,3822,KLRC2,killer cell lectin like receptor C2,6,transmembrane signaling receptor activity|protein antigen binding,Creutzfeldt-Jakob disease,ppi
14065,17012,3823,KLRC3,killer cell lectin like receptor C3,3,transmembrane signaling receptor activity,,ppi
14066,17013,8302,KLRC4,killer cell lectin like receptor C4,4,,arthropathy|arthritis|Behcet's disease|chronic lymphocytic leukemia|Richter's syndrome|meningitis|orchitis|aphthous stomatitis|vasculitis|thrombophilia|asthenopia|migraine|fibromyalgia|myositis|acne,ppi
14067,17014,3824,KLRD1,killer cell lectin like receptor D1,6,transmembrane signaling receptor activity|protein antigen binding,,ppi
14068,17015,362,AQP5,aquaporin 5,8,water channel activity,hiatus hernia|congenital diaphragmatic hernia|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|chronic ulcer of skin|granuloma annulare,ppi
14069,17016,10219,KLRG1,killer cell lectin like receptor G1,2,signaling receptor activity|carbohydrate binding|protein binding,,ppi
14070,17017,8564,KMO,kynurenine 3-monooxygenase,1,kynurenine 3-monooxygenase activity|NAD(P)H oxidase activity|flavin adenine dinucleotide binding|FAD binding,bipolar disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|allergic contact dermatitis|major depressive disorder|mental depression,ppi
14071,17018,3827,KNG1,kininogen 1,51,cysteine-type endopeptidase inhibitor activity|heparin binding|zinc ion binding,sick sinus syndrome|congestive heart failure|hereditary angioedema|angioedema|allergic hypersensitivity disease|hypertension|essential hypertension,ppi
14072,17019,3831,KLC1,kinesin light chain 1,83,motor activity,,ppi
14073,17020,3832,KIF11,kinesin family member 11,130,microtubule motor activity|protein-containing complex binding|ATPase activity|ATP-dependent microtubule motor activity; plus-end-directed|microtubule binding,elephantiasis|lymphedema|microcephaly with or without chorioretinopathy; lymphedema; or mental retardation,ppi
14074,17021,3833,KIFC1,kinesin family member C1,20,microtubule motor activity|ATP binding|microtubule binding|ATPase activity,,ppi
14075,17023,3834,KIF25,kinesin family member 25,1,ATP-dependent microtubule motor activity; minus-end-directed|ATPase activity|microtubule motor activity|microtubule binding,,ppi
14076,17024,3835,KIF22,kinesin family member 22,62,microtubule motor activity|ATPase activity|microtubule binding,laryngostenosis|arthropathy|arthritis|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV,ppi
14077,17025,9493,KIF23,kinesin family member 23,62,microtubule binding|ATPase activity|microtubule motor activity,congenital dyserythropoietic anemia,ppi
14078,17026,11004,KIF2C,kinesin family member 2C,75,centromeric DNA binding|microtubule plus-end binding|ATPase activity|microtubule motor activity|microtubule binding,contact dermatitis|occupational dermatitis,ppi
14079,17027,3836,KPNA1,karyopherin subunit alpha 1,131,nuclear localization sequence binding|protein transporter activity,schizophrenia,ppi
14080,17028,3838,KPNA2,karyopherin subunit alpha 2,208,RNA binding|nuclear localization sequence binding,,ppi
14081,17029,3839,KPNA3,karyopherin subunit alpha 3,87,nuclear localization sequence binding,alcohol dependence|alcohol abuse|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
14082,17030,3840,KPNA4,karyopherin subunit alpha 4,85,,,ppi
14083,17031,3841,KPNA5,karyopherin subunit alpha 5,31,nuclear localization sequence binding|protein transporter activity,,ppi
14084,17032,23633,KPNA6,karyopherin subunit alpha 6,75,protein transporter activity|nuclear localization sequence binding,,ppi
14085,17034,3837,KPNB1,karyopherin subunit beta 1,267,RNA binding|nuclear localization sequence binding|zinc ion binding|protein transporter activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
14086,17035,3842,TNPO1,transportin 1,83,RNA binding|nuclear localization sequence binding|protein transporter activity,,ppi
14087,17036,3843,IPO5,importin 5,122,RNA binding|GTPase inhibitor activity|protein transporter activity|nuclear localization sequence binding,schizophrenia,ppi
14088,17037,11133,KPTN,kaptin; actin binding protein,40,actin filament binding,generalized anxiety disorder|anxiety disorder|intellectual disability|learning disability|stereotypic movement disorder|autosomal recessive non-syndromic intellectual disability,ppi
14089,17038,3845,KRAS,KRAS proto-oncogene; GTPase,87,protein-containing complex binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|alopecia|generalized anxiety disorder|anxiety disorder|sick sinus syndrome|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma,ppi
14090,17039,9935,MAFB,MAF bZIP transcription factor B,23,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor binding|sequence-specific DNA binding|DNA-binding transcription factor activity|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding,blepharophimosis|cleft lip|Duane retraction syndrome|enophthalmos|orbital disease|exophthalmos|sensorineural hearing loss|hypertension|essential hypertension|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|partial third-nerve palsy|total third-nerve palsy|oculomotor nerve paralysis|proteinuria|kidney failure|uremia,ppi
14091,17040,3848,KRT1,keratin 1,88,structural constituent of epidermis|signaling receptor activity|protein heterodimerization activity,tongue squamous cell carcinoma|squamous cell carcinoma|pseudosarcomatous fibromatosis|dermatitis|ichthyosis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|nail disease|skin benign neoplasm|skin cancer|granuloma annulare|ichthyosis vulgaris|epidermolytic hyperkeratosis|common wart,ppi
14092,17041,3858,KRT10,keratin 10,71,structural constituent of epidermis|protein heterodimerization activity,tongue squamous cell carcinoma|squamous cell carcinoma|contact dermatitis|occupational dermatitis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|skin benign neoplasm|skin cancer|granuloma annulare|ichthyosis vulgaris|epidermolytic hyperkeratosis,ppi
14093,17042,3859,KRT12,keratin 12,3,,corneal dystrophy|Meesmann corneal dystrophy,ppi
14094,17043,3860,KRT13,keratin 13,61,,esophagus squamous cell carcinoma|hereditary mucosal leukokeratosis,ppi
14095,17044,3861,KRT14,keratin 14,53,structural constituent of cytoskeleton,alopecia|anemia|macrocytic anemia|ptosis|congenital ptosis|tongue squamous cell carcinoma|squamous cell carcinoma|dental caries|dental enamel hypoplasia|Clouston syndrome|hypohidrosis|anhidrosis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|nail disease|tongue cancer|epidermolysis bullosa simplex Dowling-Meara type|epidermolysis bullosa simplex,ppi
14096,17046,3866,KRT15,keratin 15,125,structural constituent of cytoskeleton,salivary gland adenoid cystic carcinoma,ppi
14097,17047,3868,KRT16,keratin 16,45,structural constituent of cytoskeleton,urinary bladder cancer|dental caries|dermatitis|ichthyosis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|granuloma annulare|pachyonychia congenita|epidermolytic hyperkeratosis|common wart,ppi
14098,17048,3872,KRT17,keratin 17,41,structural constituent of cytoskeleton|MHC class II receptor activity,basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|dental caries|dermoid cyst|ichthyosis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|skin benign neoplasm|skin cancer|tuberous sclerosis|pachyonychia congenita|esophagus squamous cell carcinoma|sebaceous adenoma,ppi
14099,17049,366,AQP9,aquaporin 9,2,amine transmembrane transporter activity|purine nucleobase transmembrane transporter activity|pyrimidine nucleobase transmembrane transporter activity|water transmembrane transporter activity|polyol transmembrane transporter activity|water channel activity|glycerol channel activity|urea channel activity|porin activity|carboxylic acid transmembrane transporter activity,leukemia|acute myeloid leukemia|acute promyelocytic leukemia,ppi
14100,17050,3875,KRT18,keratin 18,129,RNA binding|cadherin binding involved in cell-cell adhesion,liver cirrhosis|liver cancer|hepatitis|breast cancer,ppi
14101,17051,3880,KRT19,keratin 19,58,structural constituent of cytoskeleton|structural constituent of muscle,asthma|intrinsic asthma|allergic asthma|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis|hepatitis|esophagus squamous cell carcinoma,ppi
14102,17052,25984,KRT23,keratin 23,1,,,ppi
14103,17053,3849,KRT2,keratin 2,65,structural constituent of cytoskeleton|structural constituent of epidermis,contact dermatitis|occupational dermatitis|ichthyosis vulgaris|epidermolytic hyperkeratosis|ichthyosis bullosa of Siemens,ppi
14104,17054,367,AR,androgen receptor,357,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|chromatin binding|DNA-binding transcription factor activity|nuclear receptor activity|androgen receptor activity|androgen binding|beta-catenin binding|transcription regulatory region DNA binding|protein dimerization activity|ATPase binding,alcohol dependence|alcohol abuse|alopecia|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|autistic disorder|azoospermia|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression,ppi
14105,17055,3850,KRT3,keratin 3,20,structural molecule activity,corneal dystrophy|polycystic ovary syndrome|Meesmann corneal dystrophy,ppi
14106,17056,3851,KRT4,keratin 4,27,,contact dermatitis|occupational dermatitis|hereditary mucosal leukokeratosis|oral mucosa leukoplakia,ppi
14107,17057,3852,KRT5,keratin 5,72,structural constituent of cytoskeleton,ptosis|congenital ptosis|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|salivary gland adenoid cystic carcinoma|exanthem|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|nail disease|granuloma annulare|epidermolysis bullosa simplex Dowling-Meara type|epidermolysis bullosa simplex|epidermolysis bullosa simplex Ogna type|epidermolysis bullosa|skin atrophy|ophthalmoplegia,ppi
14108,17058,3853,KRT6A,keratin 6A,47,structural constituent of cytoskeleton,dental caries|dermoid cyst|gingivitis|ichthyosis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|geographic tongue|fissured tongue|acrodermatitis|pachyonychia congenita,ppi
14109,17059,3854,KRT6B,keratin 6B,34,structural constituent of cytoskeleton,tongue squamous cell carcinoma|squamous cell carcinoma|dental caries|ichthyosis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|pachyonychia congenita,ppi
14110,17060,3855,KRT7,keratin 7,20,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|hepatitis|primary biliary cirrhosis|renal oncocytoma|oxyphilic adenoma,ppi
14111,17061,3856,KRT8,keratin 8,82,,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|liver cirrhosis|liver cancer|stomach cancer|hepatitis|breast cancer,ppi
14112,17062,3857,KRT9,keratin 9,57,structural constituent of cytoskeleton,dermatitis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|granuloma annulare|epidermolytic hyperkeratosis|common wart,ppi
14113,17063,3881,KRT31,keratin 31,197,structural constituent of cytoskeleton,,ppi
14114,17064,3882,KRT32,keratin 32,6,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma,ppi
14115,17065,3883,KRT33A,keratin 33A,5,,,ppi
14116,17066,3884,KRT33B,keratin 33B,23,,,ppi
14117,17067,3885,KRT34,keratin 34,8,,,ppi
14118,17068,3886,KRT35,keratin 35,9,,,ppi
14119,17069,8689,KRT36,keratin 36,16,structural constituent of epidermis,,ppi
14120,17070,8688,KRT37,keratin 37,5,,,ppi
14121,17071,8687,KRT38,keratin 38,45,,,ppi
14122,17072,3887,KRT81,keratin 81,13,,alopecia|hypotrichosis|nail disease|monilethrix|diffuse alopecia areata,ppi
14123,17073,3888,KRT82,keratin 82,16,structural constituent of epidermis,,ppi
14124,17074,369,ARAF,A-Raf proto-oncogene; serine/threonine kinase,94,protein kinase activity|protein serine/threonine kinase activity,breast cancer,ppi
14125,17075,3889,KRT83,keratin 83,11,,alopecia|hypotrichosis|nail disease|monilethrix|diffuse alopecia areata,ppi
14126,17076,3890,KRT84,keratin 84,6,structural constituent of cytoskeleton,,ppi
14127,17077,3891,KRT85,keratin 85,25,,alopecia,ppi
14128,17079,8844,KSR1,kinase suppressor of ras 1,361,MAP-kinase scaffold activity|protein C-terminus binding,,ppi
14129,17080,3895,KTN1,kinectin 1,68,RNA binding|cadherin binding,,ppi
14130,17081,8942,KYNU,kynureninase,46,kynureninase activity|protein homodimerization activity|3-hydroxykynureninase activity,sensorineural hearing loss|intellectual disability|learning disability|neurotic disorder|endogenous depression|melancholia|lactic acidosis|mental depression|neurodegenerative disease|major depressive disorder,ppi
14131,17082,3897,L1CAM,L1 cell adhesion molecule,32,protein domain specific binding|axon guidance receptor activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|clubfoot|epilepsy|Hirschsprung's disease|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|megacolon|toxic megacolon|intellectual disability|learning disability|visual epilepsy|syndromic X-linked intellectual disability 94,ppi
14132,17083,3898,LAD1,ladinin 1,8,cadherin binding,,ppi
14133,17084,3899,AFF3,AF4/FMR2 family member 3,3,double-stranded DNA binding|DNA-binding transcription factor activity,rheumatoid arthritis|substance abuse|substance-related disorder,ppi
14134,17085,3902,LAG3,lymphocyte activating 3,2,antigen binding|MHC class II protein binding,,ppi
14135,17086,3903,LAIR1,leukocyte associated immunoglobulin like receptor 1,6,,IgA glomerulonephritis,ppi
14136,17087,3904,LAIR2,leukocyte associated immunoglobulin like receptor 2,2,,,ppi
14137,17088,23237,ARC,activity regulated cytoskeleton associated protein,8,mRNA binding,alcohol dependence|alcohol abuse|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|movement disease|lingual-facial-buccal dyskinesia|schizophrenia,ppi
14138,17089,3906,LALBA,lactalbumin alpha,6,,,ppi
14139,17090,284217,LAMA1,laminin subunit alpha 1,40,extracellular matrix structural constituent,large intestine cancer|colorectal cancer|schizophrenia|fatty liver disease|intellectual disability|learning disability,ppi
14140,17091,3908,LAMA2,laminin subunit alpha 2,10,structural molecule activity|extracellular matrix structural constituent,urinary bladder cancer|brain edema|pseudosarcomatous fibromatosis|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|intellectual disability|learning disability|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G,ppi
14141,17092,3909,LAMA3,laminin subunit alpha 3,25,structural molecule activity|extracellular matrix structural constituent,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia|anemia|macrocytic anemia,ppi
14142,17093,3910,LAMA4,laminin subunit alpha 4,33,extracellular matrix structural constituent,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
14143,17094,3911,LAMA5,laminin subunit alpha 5,34,integrin binding|extracellular matrix structural constituent,,ppi
14144,17095,3912,LAMB1,laminin subunit beta 1,52,structural molecule activity|extracellular matrix structural constituent,autistic disorder|inflammatory bowel disease|ulcerative colitis|coloboma|endometriosis of uterus|endometriosis|epilepsy|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|visual epilepsy|lissencephaly,ppi
14145,17096,3913,LAMB2,laminin subunit beta 2,37,structural molecule activity|extracellular matrix structural constituent,congestive heart failure|lymphoplasmacytic lymphoma|macroglobulinemia|myopia|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|prostate cancer|prostate carcinoma|proteinuria|ophthalmoplegia|mechanical strabismus|hypertropia|Pierson syndrome,ppi
14146,17097,372,ARCN1,archain 1,46,RNA binding,,ppi
14147,17098,3914,LAMB3,laminin subunit beta 3,24,structural molecule activity,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia|anemia|macrocytic anemia,ppi
14148,17099,22798,LAMB4,laminin subunit beta 4,2,,,ppi
14149,17100,3915,LAMC1,laminin subunit gamma 1,42,extracellular matrix structural constituent,aortic disease|tuberous sclerosis|Marfan syndrome|situs inversus|prostate cancer|prostate carcinoma,ppi
14150,17101,3918,LAMC2,laminin subunit gamma 2,13,,anemia|macrocytic anemia|dental caries|dental enamel hypoplasia|tooth agenesis|anodontia|laryngostenosis|liver cirrhosis|paronychia|pyloric stenosis|junctional epidermolysis bullosa non-Herlitz type|junctional epidermolysis bullosa|junctional epidermolysis bullosa Herlitz type|Clouston syndrome,ppi
14151,17102,10319,LAMC3,laminin subunit gamma 3,23,structural molecule activity,brain disease|autistic disorder,ppi
14152,17103,3916,LAMP1,lysosomal associated membrane protein 1,51,,,ppi
14153,17104,3920,LAMP2,lysosomal associated membrane protein 2,93,,sick sinus syndrome|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
14154,17105,3921,RPSA,ribosomal protein SA,229,RNA binding|structural constituent of ribosome,,ppi
14155,17106,10314,LANCL1,LanC like 1,28,G-protein coupled receptor activity|zinc ion binding|glutathione binding|low-density lipoprotein particle receptor binding,,ppi
14156,17107,55915,LANCL2,LanC like 2,23,ATP binding|GTP binding|phosphatidylinositol-5-phosphate binding|phosphatidylinositol-3-phosphate binding|phosphatidylinositol-4-phosphate binding,,ppi
14157,17108,374,AREG,amphiregulin,15,epidermal growth factor receptor binding|growth factor activity,asthma|intrinsic asthma|allergic asthma|lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|endometriosis of uterus|endometriosis|head and neck cancer|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|stomach cancer|coronary artery disease|erythropoietic protoporphyria|cutaneous porphyria|ovarian cancer|breast cancer,ppi
14158,17109,3925,STMN1,stathmin 1,64,tubulin binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|malignant glioma|gliosarcoma|mixed glioma|prostate cancer|prostate carcinoma|breast cancer,ppi
14159,17110,9215,LARGE1,LARGE xylosyl- and glucuronyltransferase 1,6,acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity; transferring glycosyl groups|manganese ion binding|UDP-xylosyltransferase activity|xylosyltransferase activity,imperforate anus|cleft lip|isolated cleft palate|cleft palate|coloboma|pseudosarcomatous fibromatosis|recurrent corneal erosion|Dandy-Walker syndrome|epilepsy|glaucoma|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|buphthalmos|hydrophthalmos|liver cancer|intellectual disability|learning disability|microphthalmia,ppi
14160,17111,51520,LARS,leucyl-tRNA synthetase,81,glutamine-tRNA ligase activity|leucine-tRNA ligase activity|GTPase activator activity,lactic acidosis|anemia|macrocytic anemia|blood coagulation disease|epilepsy|visual epilepsy|liver disease|hepatitis|fatty liver disease,ppi
14161,17112,3927,LASP1,LIM and SH3 protein 1,74,SH3/SH2 adaptor activity|ion transmembrane transporter activity|cadherin binding,autistic disorder|schizophrenia,ppi
14162,17113,9113,LATS1,large tumor suppressor kinase 1,103,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma,ppi
14163,17114,26524,LATS2,large tumor suppressor kinase 2,160,protein serine/threonine kinase activity|ATP binding,astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma,ppi
14164,17115,3929,LBP,lipopolysaccharide binding protein,17,lipopolysaccharide binding|signaling receptor binding|lipoteichoic acid binding|lipopeptide binding,obesity|metabolic syndrome X,ppi
14165,17116,3930,LBR,lamin B receptor,53,RNA binding|lamin binding|delta14-sterol reductase activity,arthropathy|arthritis|calcium metabolism disease|nephrocalcinosis|calcinosis|primary biliary cirrhosis|systemic scleroderma|scleroderma|localized scleroderma|xerophthalmia|dry eye syndrome|exanthem|esophagitis|peptic esophagitis|gastroesophageal reflux disease|polyhydramnios|neurogenic arthropathy|Sjogren's syndrome|keratoconjunctivitis sicca|elephantiasis,ppi
14166,17117,375,ARF1,ADP ribosylation factor 1,103,RNA binding|GTPase activity|protein heterodimerization activity|GTP binding,,ppi
14167,17118,3931,LCAT,lecithin-cholesterol acyltransferase,6,phosphatidylcholine-sterol O-acyltransferase activity,hemolytic anemia|recurrent corneal erosion|familial hypercholesterolemia|chorea-acanthocytosis|abetalipoproteinemia|hypolipoproteinemia|Tangier disease|Norum disease|proteinuria|kidney failure|uremia,ppi
14168,17119,3932,LCK,LCK proto-oncogene; Src family tyrosine kinase,152,protein tyrosine kinase activity|protein serine/threonine phosphatase activity|kinase activity|SH2 domain binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|non-membrane spanning protein tyrosine kinase activity|signaling receptor binding,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|primary immunodeficiency disease|nodular nonsuppurative panniculitis|panniculitis,ppi
14169,17120,3933,LCN1,lipocalin 1,13,cysteine-type endopeptidase inhibitor activity|zinc ion binding|chloride ion binding,,ppi
14170,17121,3934,LCN2,lipocalin 2,18,iron ion binding,rheumatoid arthritis|beta thalassemia|calcium metabolism disease|nephrocalcinosis|calcinosis|contact dermatitis|occupational dermatitis|heart valve disease|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|adult respiratory distress syndrome|newborn respiratory distress syndrome|schizophrenia|chronic kidney disease,ppi
14171,17122,3936,LCP1,lymphocyte cytosolic protein 1,24,actin binding|calcium ion binding|actin filament binding,nicotine dependence,ppi
14172,17123,3937,LCP2,lymphocyte cytosolic protein 2,49,,,ppi
14173,17124,3938,LCT,lactase,3,lactase activity|beta-glucosidase activity,lactose intolerance|adult respiratory distress syndrome|newborn respiratory distress syndrome|lactic acidosis,ppi
14174,17125,8861,LDB1,LIM domain binding 1,43,transcription corepressor activity|LIM domain binding|protein homodimerization activity|obsolete transcription factor activity; transcription factor binding|RNA polymerase II activating transcription factor binding,,ppi
14175,17126,9079,LDB2,LIM domain binding 2,15,LIM domain binding|obsolete transcription factor activity; transcription factor binding|RNA polymerase II activating transcription factor binding,,ppi
14176,17127,3939,LDHA,lactate dehydrogenase A,162,L-lactate dehydrogenase activity|cadherin binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|kidney failure|uremia|pseudosarcomatous fibromatosis|endogenous depression|melancholia|fibromyalgia|myositis|mood disorder|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
14177,17128,377,ARF3,ADP ribosylation factor 3,21,GTPase activity|GTP binding,,ppi
14178,17129,3945,LDHB,lactate dehydrogenase B,147,L-lactate dehydrogenase activity,carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|inherited metabolic disorder|prostate cancer|prostate carcinoma|breast cancer,ppi
14179,17130,3948,LDHC,lactate dehydrogenase C,24,L-lactate dehydrogenase activity,male infertility|lung disease,ppi
14180,17131,9382,COG1,component of oligomeric golgi complex 1,23,,clubfoot|congenital disorder of glycosylation type II,ppi
14181,17132,22796,COG2,component of oligomeric golgi complex 2,27,protein transporter activity,liver disease|locked-in syndrome|quadriplegia,ppi
14182,17133,3949,LDLR,low density lipoprotein receptor,39,low-density lipoprotein particle receptor activity|low-density lipoprotein particle binding|very-low-density lipoprotein particle receptor activity|clathrin heavy chain binding,arcus senilis|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|nutmeg liver|fatty liver disease|familial hypercholesterolemia|familial hyperlipidemia|hypertension|essential hypertension|congestive heart failure|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|obesity|trypanosomiasis|Q fever,ppi
14183,17134,23641,LDOC1,leucine zipper down-regulated in cancer 1,63,,,ppi
14184,17135,378,ARF4,ADP ribosylation factor 4,56,GTPase activity|ARF guanyl-nucleotide exchange factor activity|epidermal growth factor receptor binding|GTP binding,,ppi
14185,17137,51176,LEF1,lymphoid enhancer binding factor 1,55,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|beta-catenin binding|DNA binding; bending|estrogen receptor activity|estrogen receptor binding|enhancer binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|sequence-specific DNA binding|transcription regulatory region DNA binding|gamma-catenin binding|armadillo repeat domain binding|chromatin binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding,colon cancer|colonic benign neoplasm|chronic lymphocytic leukemia|Richter's syndrome|sebaceous gland neoplasm,ppi
14186,17138,10637,LEFTY1,left-right determination factor 1,2,cytokine activity|transforming growth factor beta receptor binding,,ppi
14187,17139,3952,LEP,leptin,10,peptide hormone receptor binding|hormone activity,alcohol dependence|alcohol abuse|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|autistic disorder|colon cancer|colonic benign neoplasm,ppi
14188,17140,3953,LEPR,leptin receptor,27,transmembrane signaling receptor activity|leptin receptor activity|peptide hormone binding|cytokine binding|cytokine receptor activity,proteinuria|diabetic ketoacidosis|diabetes mellitus|type 2 diabetes mellitus|diabetic autonomic neuropathy|diabetic polyneuropathy|diabetic neuropathy|fatty liver disease|hypertrophy of breast|infant gynecomastia|gynecomastia|hyperglycemia|Zollinger-Ellison syndrome|hyperinsulinism|familial hyperlipidemia|bulimia nervosa|hypertension|essential hypertension|hypogonadism|primary immunodeficiency disease,ppi
14189,17141,23484,LEPROTL1,leptin receptor overlapping transcript-like 1,5,,,ppi
14190,17142,3954,LETM1,leucine zipper and EF-hand containing transmembrane protein 1,28,calcium:proton antiporter activity,ptosis|congenital ptosis|cerebellar disease|cleft lip|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|sensorineural hearing loss|epilepsy|enophthalmos|orbital disease|exophthalmos|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3,ppi
14191,17143,379,ARL4D,ADP ribosylation factor like GTPase 4D,26,GTPase activity|GTP binding,,ppi
14192,17144,3955,LFNG,LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase,6,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity|acetylglucosaminyltransferase activity,placental insufficiency|spondylocostal dysostosis,ppi
14193,17145,3956,LGALS1,galectin 1,106,RNA binding,lung cancer|non-small cell lung carcinoma|liver cirrhosis|nephritis|glomerulonephritis|kidney disease,ppi
14194,17146,3957,LGALS2,galectin 2,9,,coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|perinatal necrotizing enterocolitis,ppi
14195,17147,3958,LGALS3,galectin 3,187,RNA binding|IgE binding|chemoattractant activity|laminin binding,esophageal cancer|melanoma|skin melanoma|nephritis|glomerulonephritis|kidney disease|stomach cancer,ppi
14196,17148,3959,LGALS3BP,galectin 3 binding protein,185,,liver cirrhosis,ppi
14197,17149,3960,LGALS4,galectin 4,7,,,ppi
14198,17150,3963,LGALS7,galectin 7,55,,tongue squamous cell carcinoma|squamous cell carcinoma,ppi
14199,17151,3964,LGALS8,galectin 8,109,carbohydrate binding,,ppi
14200,17152,3965,LGALS9,galectin 9,78,galactose binding|carbohydrate binding|disaccharide binding,nephritis|glomerulonephritis|kidney disease,ppi
14201,17153,9211,LGI1,leucine rich glioma inactivated 1,2,,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|malignant glioma|gliosarcoma|mixed glioma|focal epilepsy|familial temporal lobe epilepsy 1,ppi
14202,17154,381,ARF5,ADP ribosylation factor 5,67,GTPase activity|GTP binding,,ppi
14203,17155,1939,EIF2D,eukaryotic translation initiation factor 2D,23,translation initiation factor activity|signaling receptor activity,,ppi
14204,17156,3972,LHB,luteinizing hormone beta polypeptide,4,signaling receptor binding|hormone activity,alcohol dependence|alcohol abuse|hypertrophy of breast|infant gynecomastia|gynecomastia|hyperprolactinemia|hypertension|essential hypertension|hypogonadism|male infertility|Leydig cell tumor|polycystic ovary syndrome|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism,ppi
14205,17157,3973,LHCGR,luteinizing hormone/choriogonadotropin receptor,12,luteinizing hormone receptor activity|choriogonadotropin hormone receptor activity|choriogonadotropin hormone binding|G-protein coupled peptide receptor activity,male infertility|Leydig cell tumor|sex differentiation disease|hermaphroditism|pseudohermaphroditism|acne|hypogonadism,ppi
14206,17162,382,ARF6,ADP ribosylation factor 6,168,GTPase activity|GTP binding,,ppi
14207,17163,3975,LHX1,LIM homeobox 1,6,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity,diabetic ketoacidosis|diabetes mellitus|chromosome 17q12 deletion syndrome|Meckel syndrome|autosomal dominant polycystic kidney disease,ppi
14208,17164,9355,LHX2,LIM homeobox 2,5,DNA-binding transcription factor activity; RNA polymerase II-specific,rheumatoid arthritis,ppi
14209,17165,8022,LHX3,LIM homeobox 3,8,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding,constipation|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|sensorineural hearing loss|umbilical hernia|omphalocele|intellectual disability|learning disability|hypogonadism|septooptic dysplasia|pituitary hypoplasia,ppi
14210,17166,3976,LIF,leukemia inhibitory factor,2,cytokine activity|leukemia inhibitory factor receptor binding|growth factor activity,subacute delirium|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|polycystic ovary syndrome|fatty liver disease,ppi
14211,17167,3977,LIFR,leukemia inhibitory factor receptor alpha,20,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|cytokine binding|ciliary neurotrophic factor receptor binding|cytokine receptor activity,asthma|intrinsic asthma|allergic asthma|clubfoot|placental insufficiency|primary pulmonary hypertension|pulmonary hypertension|hypohidrosis|anhidrosis|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|osteoporosis|polycystic ovary syndrome|prostate cancer|prostate carcinoma|schizophrenia|oligohydramnios|atrophic glossitis|Horner's syndrome,ppi
14212,17168,3978,LIG1,DNA ligase 1,22,DNA ligase activity|DNA ligase (ATP) activity,urinary bladder cancer,ppi
14213,17169,225,ABCD2,ATP binding cassette subfamily D member 2,4,long-chain fatty acid transporter activity|protein homodimerization activity,large intestine cancer|colorectal cancer,ppi
14214,17170,373,TRIM23,tripartite motif containing 23,145,GTPase activity|ubiquitin-protein transferase activity|GTP binding|enzyme activator activity|GDP binding,,ppi
14215,17171,3980,LIG3,DNA ligase 3,70,DNA ligase activity|DNA ligase (ATP) activity,,ppi
14216,17172,3981,LIG4,DNA ligase 4,126,DNA binding|DNA ligase activity|DNA ligase (ATP) activity|ligase activity,alopecia|blepharophimosis|ptosis|congenital ptosis|cryptorchidism|sensorineural hearing loss|dermatitis|congestive heart failure|hypereosinophilic syndrome|placental insufficiency|lymphosarcoma|lymphoma|central nervous system lymphoma|intellectual disability|learning disability|multiple myeloma|pancytopenia|pneumonia|granuloma annulare|adenosine deaminase deficiency,ppi
14217,17173,11024,LILRA1,leukocyte immunoglobulin like receptor A1,1,antigen binding|transmembrane signaling receptor activity,alcohol dependence|alcohol abuse,ppi
14218,17175,11026,LILRA3,leukocyte immunoglobulin like receptor A3,7,antigen binding|signaling receptor activity,,ppi
14219,17176,10859,LILRB1,leukocyte immunoglobulin like receptor B1,9,HLA-A specific inhibitory MHC class I receptor activity|HLA-B specific inhibitory MHC class I receptor activity|MHC class I receptor activity|SH2 domain binding|MHC class I protein binding|amyloid-beta binding,schizophrenia,ppi
14220,17177,10288,LILRB2,leukocyte immunoglobulin like receptor B2,10,,,ppi
14221,17178,11025,LILRB3,leukocyte immunoglobulin like receptor B3,7,,,ppi
14222,17179,11006,LILRB4,leukocyte immunoglobulin like receptor B4,15,antigen binding|signaling receptor activity,,ppi
14223,17180,10990,LILRB5,leukocyte immunoglobulin like receptor B5,1,transmembrane signaling receptor activity,,ppi
14224,17181,26286,ARFGAP3,ADP ribosylation factor GTPase activating protein 3,24,GTPase activator activity|protein transporter activity,,ppi
14225,17182,3982,LIM2,lens intrinsic membrane protein 2,2,,adult respiratory distress syndrome|newborn respiratory distress syndrome|cataract|cataract 19 multiple types,ppi
14226,17183,8994,LIMD1,LIM domains containing 1,52,transcription corepressor activity|zinc ion binding,,ppi
14227,17184,3984,LIMK1,LIM domain kinase 1,49,protein kinase activity|protein serine/threonine kinase activity|heat shock protein binding,generalized anxiety disorder|anxiety disorder|supravalvular aortic stenosis|autistic disorder|blepharophimosis|brain ischemia|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|basal ganglia disease|focal hand dystonia|blepharospasm|clubfoot|sensorineural hearing loss|inguinal hernia|nephrocalcinosis,ppi
14228,17185,3985,LIMK2,LIM domain kinase 2,39,protein serine/threonine kinase activity,,ppi
14229,17186,3987,LIMS1,LIM zinc finger domain containing 1,55,zinc ion binding,,ppi
14230,17187,3988,LIPA,lipase A; lysosomal acid type,1,sterol esterase activity|lipase activity,anemia|macrocytic anemia|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|cholesterol ester storage disease|primary pulmonary hypertension|pulmonary hypertension|steatorrhea|lipid storage disease|Wolman disease|marasmus|kwashiorkor|protein-energy malnutrition|nutrition disease|Niemann-Pick disease|liver cirrhosis|coronary artery disease,ppi
14231,17188,3990,LIPC,lipase C; hepatic type,6,phospholipase activity|triglyceride lipase activity|low-density lipoprotein particle binding|apolipoprotein binding,diabetes mellitus|type 2 diabetes mellitus|familial hypercholesterolemia|familial hyperlipidemia|lipid metabolism disorder,ppi
14232,17189,10139,ARFRP1,ADP ribosylation factor related protein 1,3,GTPase activity,,ppi
14233,17190,3991,LIPE,lipase E; hormone sensitive type,14,,acanthosis nigricans|lipoatrophic diabetes|lipodystrophy|polycystic ovary syndrome|fatty liver disease,ppi
14234,17191,8513,LIPF,lipase F; gastric type,10,triglyceride lipase activity|lipid binding|lipase activity,,ppi
14235,17192,9388,LIPG,lipase G; endothelial type,21,lipoprotein lipase activity|phospholipase activity|phospholipase A1 activity,,ppi
14236,17193,3996,LLGL1,LLGL1; scribble cell polarity complex component,42,GTPase activator activity|structural molecule activity|protein kinase binding|Rab GTPase binding|syntaxin binding,breast cancer,ppi
14237,17194,3993,LLGL2,LLGL2; scribble cell polarity complex component,93,syntaxin binding|Rab GTPase binding|GTPase activator activity,,ppi
14238,17195,383,ARG1,arginase 1,37,arginase activity|manganese ion binding,amino acid metabolic disorder|asthma|intrinsic asthma|allergic asthma|epilepsy|hair disease|immune system disease|leishmaniasis|intellectual disability|learning disability|familial periodic paralysis|myopathy|visual epilepsy|syndromic X-linked intellectual disability 94|asbestosis|anthracosilicosis|silicosis|speech disorder|urea cycle disorder|hyperargininemia,ppi
14239,17196,3998,LMAN1,lectin; mannose binding 1,78,unfolded protein binding|mannose binding,factor VII deficiency|factor V deficiency|congenital afibrinogenemia|blood coagulation disease|factor VIII deficiency,ppi
14240,17197,79748,LMAN1L,lectin; mannose binding 1 like,1,mannose binding,,ppi
14241,17198,29995,LMCD1,LIM and cysteine rich domains 1,9,transcription corepressor activity,mitral valve insufficiency|mitral valve prolapse,ppi
14242,17199,4000,LMNA,lamin A/C,266,,acanthosis nigricans|acute pancreatitis|pancreatitis|alopecia|aortic valve stenosis|sick sinus syndrome|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|atrial fibrillation|blepharophimosis|ptosis|congenital ptosis|calcium metabolism disease|nephrocalcinosis|calcinosis|skin benign neoplasm|skin cancer,ppi
14243,17200,4001,LMNB1,lamin B1,107,,cerebellar disease|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|pseudobulbar palsy|Pelizaeus-Merzbacher disease|psychologic dyspareunia|premature ejaculation|locked-in syndrome|quadriplegia,ppi
14244,17201,84823,LMNB2,lamin B2,43,,lipodystrophy,ppi
14245,17202,384,ARG2,arginase 2,5,arginase activity|manganese ion binding,asthma|intrinsic asthma|allergic asthma|primary pulmonary hypertension|pulmonary hypertension|prostate cancer|prostate carcinoma|pancreatic ductal carcinoma,ppi
14246,17203,4004,LMO1,LIM domain only 1,37,,T-cell leukemia|neuroblastoma|acute T cell leukemia,ppi
14247,17204,4005,LMO2,LIM domain only 2,153,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|obsolete transcriptional activator activity; RNA polymerase II transcription factor binding|DNA-binding transcription activator activity; RNA polymerase II-specific|E-box binding,T-cell leukemia|acute T cell leukemia,ppi
14248,17205,55885,LMO3,LIM domain only 3,32,,,ppi
14249,17206,8543,LMO4,LIM domain only 4,62,DNA-binding transcription factor activity|transcription factor binding,,ppi
14250,17207,4007,PRICKLE3,prickle planar cell polarity protein 3,64,,,ppi
14251,17208,4008,LMO7,LIM domain 7,49,DNA-binding transcription factor activity|ubiquitin-protein transferase activity,,ppi
14252,17209,25802,LMOD1,leiomodin 1,1,tropomyosin binding,endometriosis of uterus|endometriosis,ppi
14253,17211,56203,LMOD3,leiomodin 3,1,actin monomer binding|tropomyosin binding,nemaline myopathy,ppi
14254,17212,4009,LMX1A,LIM homeobox transcription factor 1 alpha,6,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific,schizophrenia,ppi
14255,17213,4010,LMX1B,LIM homeobox transcription factor 1 beta,20,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity,disease of mental health|ptosis|congenital ptosis|cleft lip|isolated cleft palate|cleft palate|clubfoot|glaucoma|nephritis|glomerulonephritis|kidney disease|sensorineural hearing loss|familial hyperlipidemia|corneal disease|keratoconus|Holt-Oram syndrome|VACTERL association|thrombocytopenia-absent radius syndrome|Rubinstein-Taybi syndrome|Klippel-Trenaunay syndrome,ppi
14256,17214,4012,LNPEP,leucyl and cystinyl aminopeptidase,42,aminopeptidase activity|metallopeptidase activity|peptide binding|metalloaminopeptidase activity|zinc ion binding,,ppi
14257,17215,84708,LNX1,ligand of numb-protein X 1,246,,,ppi
14258,17216,4013,VWA5A,von Willebrand factor A domain containing 5A,31,,,ppi
14259,17217,4014,LOR,loricrin,12,structural molecule activity|structural constituent of cytoskeleton|structural constituent of epidermis|protein binding; bridging,tongue squamous cell carcinoma|squamous cell carcinoma|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|skin benign neoplasm|skin cancer|granuloma annulare|autosomal recessive congenital ichthyosis 1|congenital ichthyosiform erythroderma|autosomal recessive congenital ichthyosis 2|autosomal recessive congenital ichthyosis 3|autosomal recessive congenital ichthyosis 4A|autosomal recessive congenital ichthyosis 5|autosomal recessive congenital ichthyosis 6|autosomal recessive congenital ichthyosis 7|autosomal recessive congenital ichthyosis 8|autosomal recessive congenital ichthyosis 9|autosomal recessive congenital ichthyosis 10|erythrokeratodermia variabilis|acquired hyperkeratosis,ppi
14260,17218,4015,LOX,lysyl oxidase,30,protein-lysine 6-oxidase activity,aortic valve insufficiency|hepatitis B|hepatitis C|iron metabolism disease|hemochromatosis|Wilson disease|hypertension|essential hypertension|primary pulmonary hypertension|pulmonary hypertension|congestive heart failure|liver cirrhosis|primary biliary cirrhosis|oral submucous fibrosis|osteosarcoma|bone osteosarcoma|cutis laxa|thoracic aortic aneurysm|Loeys-Dietz syndrome|coronary artery disease,ppi
14261,17219,4016,LOXL1,lysyl oxidase like 1,9,protein-lysine 6-oxidase activity,urinary bladder cancer|exfoliation syndrome,ppi
14262,17220,4017,LOXL2,lysyl oxidase like 2,33,protein-lysine 6-oxidase activity|copper ion binding|calcium ion binding|electron transfer activity|oligosaccharide binding,hepatitis B|hepatitis C|iron metabolism disease|hemochromatosis|Wilson disease|primary biliary cirrhosis|esophagus squamous cell carcinoma|breast cancer,ppi
14263,17221,4018,LPA,lipoprotein(a),9,,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|heart disease|cardiovascular system disease|chorea-acanthocytosis|abetalipoproteinemia|hypolipoproteinemia|Tangier disease|Norum disease|cerebral infarction|cerebrovascular disease|thrombophilia,ppi
14264,17222,387,RHOA,ras homolog family member A,182,GTPase activity|GTP binding|protein kinase binding,urinary bladder cancer|proteinuria|stomach cancer|cutaneous T cell lymphoma|congenital diaphragmatic hernia,ppi
14265,17223,4023,LPL,lipoprotein lipase,25,lipoprotein lipase activity|phospholipase activity|triglyceride lipase activity|heparin binding,heart disease|cardiovascular system disease|colon cancer|colonic benign neoplasm|hepatitis C|familial hypercholesterolemia|familial hyperlipidemia|familial combined hyperlipidemia|hyperlipoproteinemia type V|familial lipoprotein lipase deficiency|hypertension|essential hypertension|chylomicron retention disease|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|obesity|acute pancreatitis|pancreatitis,ppi
14266,17224,4025,LPO,lactoperoxidase,1,thiocyanate peroxidase activity|peroxidase activity,,ppi
14267,17225,4026,LPP,LIM domain containing preferred translocation partner in lipoma,64,,acute myeloid leukemia,ppi
14268,17226,388,RHOB,ras homolog family member B,41,GTPase activity|GTP binding|protein kinase binding,systemic scleroderma|scleroderma,ppi
14269,17227,9227,LRAT,lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase),2,O-palmitoyltransferase activity|transferase activity; transferring acyl groups|phosphatidylcholine-retinol O-acyltransferase activity,epilepsy|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy,ppi
14270,17228,389,RHOC,ras homolog family member C,37,protein kinase binding|GTPase activity|GTP binding,coronary artery disease,ppi
14271,17229,4033,LRMP,lymphoid restricted membrane protein,4,,,ppi
14272,17230,4034,LRCH4,leucine rich repeats and calponin homology domain containing 4,15,,,ppi
14273,17231,4035,LRP1,LDL receptor related protein 1,141,RNA binding|low-density lipoprotein particle receptor activity|scavenger receptor activity|calcium ion binding|alpha-2 macroglobulin receptor activity|apolipoprotein receptor activity|apolipoprotein binding|signaling receptor activity|lipoprotein transporter activity|heparan sulfate proteoglycan binding|protein-containing complex binding|lipoprotein particle receptor binding,schizophrenia|neurotic disorder|endogenous depression|melancholia|migraine|migraine without aura|major depressive disorder|mental depression,ppi
14274,17232,53353,LRP1B,LDL receptor related protein 1B,29,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|melanoma|skin melanoma,ppi
14275,17233,4036,LRP2,LDL receptor related protein 2,80,low-density lipoprotein particle receptor activity|calcium ion binding|drug binding|steroid hormone receptor binding|lipoprotein transporter activity|chaperone binding,enophthalmos|orbital disease|exophthalmos|sensorineural hearing loss|hiatus hernia|congenital diaphragmatic hernia|umbilical hernia|omphalocele|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|intellectual disability|learning disability|myopia|prostate cancer|prostate carcinoma|proteinuria|retinal detachment,ppi
14276,17234,4037,LRP3,LDL receptor related protein 3,3,,,ppi
14277,17235,4038,LRP4,LDL receptor related protein 4,28,receptor tyrosine kinase binding|scaffold protein binding,ptosis|congenital ptosis|sensorineural hearing loss|osteopetrosis|osteosclerosis|syndactyly|sclerosteosis|sclerosteosis 1|Bell's palsy|facial paralysis|Potter's syndrome|congenital myasthenic syndrome|sclerosteosis 2,ppi
14278,17236,4041,LRP5,LDL receptor related protein 5,39,Wnt-protein binding|Wnt-activated receptor activity|coreceptor activity involved in canonical Wnt signaling pathway|toxin transmembrane transporter activity,craniosynostosis|malignant glioma|gliosarcoma|mixed glioma|sensorineural hearing loss|ventricular septal defect|microphthalmia|osteopetrosis|osteosclerosis|osteoporosis|retinal detachment|proliferative vitreoretinopathy|exudative vitreoretinopathy|retinopathy of prematurity|cataract|polycystic liver disease|idiopathic juvenile osteoporosis|blind hypotensive eye|Bell's palsy|facial paralysis,ppi
14279,17237,4040,LRP6,LDL receptor related protein 6,52,low-density lipoprotein particle receptor activity|Wnt-protein binding|kinase inhibitor activity|toxin transmembrane transporter activity|coreceptor activity involved in Wnt signaling pathway|coreceptor activity involved in canonical Wnt signaling pathway|apolipoprotein binding,tooth agenesis|anodontia|coronary artery disease,ppi
14280,17238,5825,ABCD3,ATP binding cassette subfamily D member 3,75,long-chain fatty acid transporter activity|ATP binding|ATPase activity|protein homodimerization activity,large intestine cancer|colorectal cancer|Zellweger syndrome|liver disease|hypochromic anemia|deficiency anemia|microcytic anemia,ppi
14281,17239,29984,RHOD,ras homolog family member D,26,GTP binding|GTPase activity|protein kinase binding,,ppi
14282,17240,7804,LRP8,LDL receptor related protein 8,38,transmembrane signaling receptor activity|low-density lipoprotein particle receptor activity|very-low-density lipoprotein particle receptor activity|apolipoprotein binding|reelin receptor activity,alcohol dependence|alcohol abuse|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
14283,17241,4043,LRPAP1,LDL receptor related protein associated protein 1,31,amyloid-beta binding|signaling receptor binding|receptor antagonist activity|low-density lipoprotein particle receptor binding,blindness,ppi
14284,17242,9208,LRRFIP1,LRR binding FLII interacting protein 1,37,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|double-stranded RNA binding|protein homodimerization activity|cadherin binding,,ppi
14285,17243,9209,LRRFIP2,LRR binding FLII interacting protein 2,31,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
14286,17244,4045,LSAMP,limbic system-associated membrane protein,5,,schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
14287,17245,4046,LSP1,lymphocyte-specific protein 1,32,,calcium metabolism disease|nephrocalcinosis|calcinosis|inflammatory bowel disease|ulcerative colitis|heart valve disease|breast cancer,ppi
14288,17246,4047,LSS,lanosterol synthase (2;3-oxidosqualene-lanosterol cyclase),15,lanosterol synthase activity,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
14289,17247,4049,LTA,lymphotoxin alpha,13,signaling receptor binding,psoriatic arthritis|hepatic coma|hepatic encephalopathy|leprosy|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|schizophrenia|neurotic disorder|endogenous depression|melancholia|malignant mesothelioma|benign mesothelioma|major depressive disorder|mental depression|coronary artery disease,ppi
14290,17248,390,RND3,Rho family GTPase 3,17,protein kinase binding|GTPase activity|GTP binding,,ppi
14291,17249,4048,LTA4H,leukotriene A4 hydrolase,27,RNA binding|aminopeptidase activity|epoxide hydrolase activity|leukotriene-A4 hydrolase activity|peptidase activity|zinc ion binding|metalloaminopeptidase activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
14292,17250,4050,LTB,lymphotoxin beta,4,signaling receptor binding,,ppi
14293,17251,1241,LTB4R,leukotriene B4 receptor,5,nucleotide binding|leukotriene receptor activity|leukotriene B4 receptor activity|galanin receptor activity|G-protein coupled peptide receptor activity,gallbladder disease|liver disease,ppi
14294,17252,4052,LTBP1,latent transforming growth factor beta binding protein 1,38,transforming growth factor beta-activated receptor activity|extracellular matrix structural constituent|microfibril binding,,ppi
14295,17253,4053,LTBP2,latent transforming growth factor beta binding protein 2,3,extracellular matrix structural constituent,aortic valve stenosis|recurrent corneal erosion|glaucoma|buphthalmos|hydrophthalmos|myopia|asthenopia|ocular hypertension|Weill-Marchesani syndrome|megalocornea|pulmonary valve stenosis|primary congenital glaucoma,ppi
14296,17254,4054,LTBP3,latent transforming growth factor beta binding protein 3,15,,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia|bone disease|cartilage disease,ppi
14297,17255,8425,LTBP4,latent transforming growth factor beta binding protein 4,35,transforming growth factor beta-activated receptor activity|integrin binding|extracellular matrix structural constituent|calcium ion binding|glycosaminoglycan binding|transforming growth factor beta binding,Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|Duchenne muscular dystrophy|muscular dystrophy|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|esophagitis|peptic esophagitis,ppi
14298,17256,4055,LTBR,lymphotoxin beta receptor,77,ubiquitin protein ligase binding|identical protein binding,malaria,ppi
14299,17257,4056,LTC4S,leukotriene C4 synthase,3,glutathione transferase activity|leukotriene-C4 synthase activity|lipid binding|glutathione peroxidase activity,,ppi
14300,17258,391,RHOG,ras homolog family member G,25,GTPase activity|GTP binding|protein kinase binding,,ppi
14301,17259,4057,LTF,lactotransferrin,42,lipopolysaccharide binding|cysteine-type endopeptidase inhibitor activity|iron ion binding|heparin binding|protein serine/threonine kinase activator activity,oral candidiasis|candidiasis|inflammatory bowel disease|ulcerative colitis|colon cancer|colonic benign neoplasm|endometriosis of uterus|endometriosis|hypertension|essential hypertension|arthropathy|arthritis|neurogenic arthropathy|liver cancer|osteoporosis|perinatal necrotizing enterocolitis|vulvovaginal candidiasis,ppi
14302,17260,4058,LTK,leukocyte receptor tyrosine kinase,16,protein kinase activity|protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,polycystic ovary syndrome,ppi
14303,17261,4059,BCAM,basal cell adhesion molecule (Lutheran blood group),21,transmembrane signaling receptor activity|laminin receptor activity|protein C-terminus binding|laminin binding,,ppi
14304,17262,55692,LUC7L,LUC7 like,117,mRNA binding,,ppi
14305,17263,4060,LUM,lumican,11,extracellular matrix structural constituent|collagen binding|extracellular matrix structural constituent conferring compression resistance,liver cirrhosis|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L|autosomal recessive limb-girdle muscular dystrophy type 2Q|autosomal recessive limb-girdle muscular dystrophy type 2R|autosomal recessive limb-girdle muscular dystrophy type 2S|autosomal recessive limb-girdle muscular dystrophy type 2Y|autosomal recessive limb-girdle muscular dystrophy type 2O|autosomal recessive limb-girdle muscular dystrophy type 2P,ppi
14306,17264,4064,CD180,CD180 molecule,1,,,ppi
14307,17265,4061,LY6E,lymphocyte antigen 6 complex; locus E,3,acetylcholine receptor inhibitor activity,influenza|pancreatic cancer,ppi
14308,17266,4062,LY6H,lymphocyte antigen 6 complex; locus H,3,acetylcholine receptor binding|acetylcholine receptor inhibitor activity,,ppi
14309,17267,4065,LY75,lymphocyte antigen 75,1,signaling receptor activity|transmembrane signaling receptor activity,,ppi
14310,17268,392,ARHGAP1,Rho GTPase activating protein 1,53,SH3/SH2 adaptor activity|GTPase activator activity|cadherin binding,schizophrenia,ppi
14311,17269,4063,LY9,lymphocyte antigen 9,5,,,ppi
14312,17270,9437,NCR1,natural cytotoxicity triggering receptor 1,7,,,ppi
14313,17271,9436,NCR2,natural cytotoxicity triggering receptor 2,4,transmembrane signaling receptor activity,,ppi
14314,17272,4066,LYL1,LYL1; basic helix-loop-helix family member,10,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,lymphoblastic leukemia|myeloid leukemia|acute myeloid leukemia|essential thrombocythemia|myelodysplastic syndrome,ppi
14315,17273,4067,LYN,LYN proto-oncogene; Src family tyrosine kinase,235,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|kinase activity|signaling receptor binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
14316,17274,10434,LYPLA1,lysophospholipase I,25,lysophospholipase activity|palmitoyl-(protein) hydrolase activity|lipase activity|carboxylic ester hydrolase activity,,ppi
14317,17275,11313,LYPLA2,lysophospholipase II,23,palmitoyl-(protein) hydrolase activity|cadherin binding|carboxylic ester hydrolase activity,,ppi
14318,17276,393,ARHGAP4,Rho GTPase activating protein 4,6,SH3/SH2 adaptor activity|GTPase activator activity|Rac GTPase binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
14319,17277,4069,LYZ,lysozyme,46,lysozyme activity,cholestasis|congestive heart failure|exanthem|hypertension|essential hypertension|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|proteinuria|familial visceral amyloidosis,ppi
14320,17278,54585,LZTFL1,leucine zipper transcription factor like 1,22,protein-containing complex binding,hypertension|essential hypertension|hypogonadism|cystic kidney disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|retinal degeneration|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|Laurence-Moon syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 3,ppi
14321,17279,8216,LZTR1,leucine zipper like transcription regulator 1,62,DNA-binding transcription factor activity,sick sinus syndrome|autistic disorder|ptosis|congenital ptosis|blood coagulation disease|cryptorchidism|enophthalmos|orbital disease|exophthalmos|glioblastoma multiforme|giant cell glioblastoma|heart septal defect|hemorrhagic disease|mitral valve stenosis|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome,ppi
14322,17280,4076,CAPRIN1,cell cycle associated protein 1,48,RNA binding,,ppi
14323,17281,4077,NBR1,NBR1; autophagy cargo receptor,40,ubiquitin binding|mitogen-activated protein kinase binding,,ppi
14324,17282,394,ARHGAP5,Rho GTPase activating protein 5,20,GTPase activator activity|SH2 domain binding,,ppi
14325,17283,4074,M6PR,mannose-6-phosphate receptor; cation dependent,26,transmembrane signaling receptor activity|retromer complex binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|prostate cancer|prostate carcinoma|stomach cancer,ppi
14326,17284,4081,MAB21L1,mab-21 like 1,11,,,ppi
14327,17285,10586,MAB21L2,mab-21 like 2,15,,rheumatoid arthritis|coloboma|microphthalmia|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
14328,17286,4082,MARCKS,myristoylated alanine rich protein kinase C substrate,37,,rheumatoid arthritis|salivary gland adenoid cystic carcinoma,ppi
14329,17287,395,ARHGAP6,Rho GTPase activating protein 6,1,SH3/SH2 adaptor activity|GTPase activator activity,,ppi
14330,17288,4084,MXD1,MAX dimerization protein 1,28,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coregulator activity|transcription corepressor activity,allergic contact dermatitis,ppi
14331,17289,8379,MAD1L1,MAD1 mitotic arrest deficient like 1,69,kinetochore binding,prostate cancer|prostate carcinoma|schizophrenia|testicular cancer|seminoma|testicular germ cell cancer,ppi
14332,17290,4085,MAD2L1,MAD2 mitotic arrest deficient-like 1 (yeast),83,,polycystic ovary syndrome|esophagus squamous cell carcinoma,ppi
14333,17291,10459,MAD2L2,MAD2 mitotic arrest deficient-like 2 (yeast),60,JUN kinase binding,Fanconi anemia|leukopenia|intellectual disability|learning disability|thrombocytopenia,ppi
14334,17292,8174,MADCAM1,mucosal vascular addressin cell adhesion molecule 1,6,integrin binding involved in cell-matrix adhesion,colitis|ileitis|ileocolitis|gastroenteritis,ppi
14335,17293,8567,MADD,MAP kinase activating death domain,32,death receptor binding|Rab guanyl-nucleotide exchange factor activity|protein kinase activator activity,,ppi
14336,17294,4086,SMAD1,SMAD family member 1,193,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transforming growth factor beta receptor; pathway-specific cytoplasmic mediator activity,,ppi
14337,17295,4087,SMAD2,SMAD family member 2,372,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|double-stranded DNA binding|DNA-binding transcription factor activity|transforming growth factor beta receptor; pathway-specific cytoplasmic mediator activity|enhancer binding|tau protein binding|DNA binding,hepatitis,ppi
14338,17296,4088,SMAD3,SMAD family member 3,385,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II core promoter sequence-specific DNA binding|proximal promoter sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coregulator activity|zinc ion binding|transforming growth factor beta receptor; pathway-specific cytoplasmic mediator activity|enhancer binding|ubiquitin binding|sequence-specific DNA binding|transcription regulatory region DNA binding,aortic aneurysm|aortic valve insufficiency|atrial fibrillation|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|clubfoot|inguinal hernia|umbilical hernia|omphalocele|hypertension|essential hypertension|congestive heart failure|leiomyoma|uterine fibroid|liver cirrhosis|alcoholic liver cirrhosis|mitral valve insufficiency|mitral valve prolapse,ppi
14339,17297,23779,ARHGAP8,Rho GTPase activating protein 8,10,GTPase activator activity,,ppi
14340,17298,4089,SMAD4,SMAD family member 4,262,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|transcription coregulator activity|transforming growth factor beta receptor; common-partner cytoplasmic mediator activity|identical protein binding|sulfate binding|transcription regulatory region DNA binding|DNA binding|DNA-binding transcription factor activity|sequence-specific DNA binding,anemia|macrocytic anemia|aortic valve stenosis|autistic disorder|blepharophimosis|cholecystitis|large intestine cancer|colorectal cancer|cryptorchidism|sensorineural hearing loss|patent ductus arteriosus|enophthalmos|orbital disease|exophthalmos|epilepsy|placental insufficiency|heart septal defect|hemangioma|cavernous hemangioma|capillary hemangioma,ppi
14341,17299,4090,SMAD5,SMAD family member 5,70,DNA-binding transcription factor activity; RNA polymerase II-specific|transforming growth factor beta receptor; pathway-specific cytoplasmic mediator activity,diabetes mellitus|type 2 diabetes mellitus|schizophrenia,ppi
14342,17300,4091,SMAD6,SMAD family member 6,51,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|transforming growth factor beta receptor; inhibitory cytoplasmic mediator activity|type I transforming growth factor beta receptor binding|transcription regulatory region DNA binding|type I activin receptor binding,aortic valve stenosis|aortic valve disease,ppi
14343,17301,4092,SMAD7,SMAD family member 7,96,DNA-binding transcription factor activity; RNA polymerase II-specific|transforming growth factor beta receptor; inhibitory cytoplasmic mediator activity|transcription regulatory region DNA binding,large intestine cancer|colorectal cancer|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis,ppi
14344,17302,4093,SMAD9,SMAD family member 9,128,DNA-binding transcription factor activity; RNA polymerase II-specific|transforming growth factor beta receptor; pathway-specific cytoplasmic mediator activity,primary pulmonary hypertension|pulmonary hypertension,ppi
14345,17303,9372,ZFYVE9,zinc finger FYVE-type containing 9,51,1-phosphatidylinositol binding|serine-type peptidase activity,,ppi
14346,17304,4094,MAF,MAF bZIP transcription factor,25,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding|sequence-specific DNA binding|DNA-binding transcription factor activity|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,ptosis|congenital ptosis|intrahepatic cholestasis|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset,ppi
14347,17305,396,ARHGDIA,Rho GDP dissociation inhibitor alpha,103,Rac GTPase binding|Rho GDP-dissociation inhibitor activity,congestive heart failure|sensorineural hearing loss|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|intellectual disability|learning disability|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|proteinuria|cortical blindness|breast cancer|chronic kidney disease,ppi
14348,17306,23764,MAFF,MAF bZIP transcription factor F,35,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
14349,17307,4097,MAFG,MAF bZIP transcription factor G,35,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding,intrahepatic cholestasis,ppi
14350,17308,7975,MAFK,MAF bZIP transcription factor K,21,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
14351,17309,4099,MAG,myelin associated glycoprotein,19,sialic acid binding|ganglioside GT1b binding,astigmatism|hyperopia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|Parkinson's disease|schizophrenia|Lewy body dementia|hereditary spastic paraplegia 75,ppi
14352,17310,397,ARHGDIB,Rho GDP dissociation inhibitor beta,22,GTPase activity|Rho GDP-dissociation inhibitor activity|Rac GTPase binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
14353,17311,4100,MAGEA1,MAGE family member A1,77,histone deacetylase binding,melanoma|skin melanoma,ppi
14354,17312,4109,MAGEA10,MAGE family member A10,42,,,ppi
14355,17313,4110,MAGEA11,MAGE family member A11,97,,,ppi
14356,17314,4111,MAGEA12,MAGE family member A12,16,,,ppi
14357,17315,5826,ABCD4,ATP binding cassette subfamily D member 4,12,ATP binding|ATPase activity; coupled to transmembrane movement of substances,anemia|macrocytic anemia|large intestine cancer|colorectal cancer|inguinal hernia|homocystinuria|inherited metabolic disorder|thrombocytopenia,ppi
14358,17316,398,ARHGDIG,Rho GDP dissociation inhibitor gamma,11,Rac GTPase binding|Rho GDP-dissociation inhibitor activity,,ppi
14359,17318,4102,MAGEA3,MAGE family member A3,5,caspase binding,,ppi
14360,17319,4103,MAGEA4,MAGE family member A4,32,,,ppi
14361,17320,4105,MAGEA6,MAGE family member A6,76,,,ppi
14362,17321,4107,MAGEA8,MAGE family member A8,10,,,ppi
14363,17322,4108,MAGEA9,MAGE family member A9,6,,urinary bladder cancer,ppi
14364,17323,4112,MAGEB1,MAGE family member B1,7,,,ppi
14365,17324,4113,MAGEB2,MAGE family member B2,46,,,ppi
14366,17325,9138,ARHGEF1,Rho guanine nucleotide exchange factor 1,35,RNA binding|guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
14367,17326,4114,MAGEB3,MAGE family member B3,2,,,ppi
14368,17327,4115,MAGEB4,MAGE family member B4,22,,,ppi
14369,17328,9947,MAGEC1,MAGE family member C1,10,,melanoma|skin melanoma|schizophrenia,ppi
14370,17329,9500,MAGED1,MAGE family member D1,130,,,ppi
14371,17330,54551,MAGEL2,MAGE family member L2,5,ubiquitin-protein transferase activity,autistic disorder|constipation|pseudosarcomatous fibromatosis|cryptorchidism|monocular esotropia|esotropia|Zollinger-Ellison syndrome|hyperinsulinism|hyperopia|bulimia nervosa|hypogonadism|infertility|intellectual disability|learning disability|myopia|obesity|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II,ppi
14372,17331,4116,MAGOH,mago homolog; exon junction complex core component,209,RNA binding,,ppi
14373,17332,4117,MAK,male germ cell associated kinase,14,transcription coactivator activity|protein kinase activity|protein serine/threonine kinase activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
14374,17333,4118,MAL,mal; T-cell differentiation protein,15,lipid binding|peptidase activator activity involved in apoptotic process|structural constituent of myelin sheath,tongue squamous cell carcinoma|squamous cell carcinoma|head and neck cancer|breast cancer,ppi
14375,17334,7851,MALL,mal; T-cell differentiation protein like,9,structural constituent of myelin sheath,,ppi
14376,17335,10892,MALT1,MALT1 paracaspase,41,cysteine-type endopeptidase activity|ubiquitin-protein transferase activity|peptidase activity|kinase activator activity,anemia|macrocytic anemia|constipation|primary immunodeficiency disease|lymphosarcoma|B-cell lymphoma|gastric lymphoma,ppi
14377,17336,9181,ARHGEF2,Rho/Rac guanine nucleotide exchange factor 2,67,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|microtubule binding|transcription factor binding|zinc ion binding|Rho GTPase binding|Rac guanyl-nucleotide exchange factor activity|Rac GTPase binding,,ppi
14378,17337,4121,MAN1A1,mannosidase alpha class 1A member 1,10,mannosyl-oligosaccharide 1;2-alpha-mannosidase activity|mannosidase activity,,ppi
14379,17338,10905,MAN1A2,mannosidase alpha class 1A member 2,19,mannosyl-oligosaccharide 1;2-alpha-mannosidase activity,,ppi
14380,17339,11253,MAN1B1,mannosidase alpha class 1B member 1,7,mannosyl-oligosaccharide 1;2-alpha-mannosidase activity|calcium ion binding,epilepsy|visual epilepsy|non-syndromic intellectual disability|intellectual disability|learning disability,ppi
14381,17340,4124,MAN2A1,mannosidase alpha class 2A member 1,14,mannosyl-oligosaccharide 1;3-1;6-alpha-mannosidase activity|alpha-mannosidase activity,,ppi
14382,17341,4122,MAN2A2,mannosidase alpha class 2A member 2,27,mannosyl-oligosaccharide 1;3-1;6-alpha-mannosidase activity|alpha-mannosidase activity,,ppi
14383,17342,4125,MAN2B1,mannosidase alpha class 2B member 1,17,alpha-mannosidase activity,gingival overgrowth|gingival hypertrophy|IgA glomerulonephritis|sensorineural hearing loss|inguinal hernia|hypertrichosis|alpha-mannosidosis|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|Klippel-Feil syndrome|spondylolisthesis|agammaglobulinemia|mucopolysaccharidosis I|mucopolysaccharidosis|mucopolysaccharidosis II|mucopolysaccharidosis VI,ppi
14384,17343,4123,MAN2C1,mannosidase alpha class 2C member 1,12,alpha-mannosidase activity,,ppi
14385,17344,50650,ARHGEF3,Rho guanine nucleotide exchange factor 3,12,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
14386,17345,4126,MANBA,mannosidase beta,18,beta-mannosidase activity,angiokeratoma|sensorineural hearing loss|epilepsy|intellectual disability|learning disability|visual epilepsy|speech disorder|beta-mannosidosis,ppi
14387,17346,4128,MAOA,monoamine oxidase A,7,primary amine oxidase activity,alcohol dependence|alcohol abuse|antisocial personality disorder|personality disorder|autistic disorder|disease of mental health|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometriosis of uterus|endometriosis|hepatic coma|hepatic encephalopathy|Huntington's disease|familial periodic paralysis|myopathy,ppi
14388,17347,4129,MAOB,monoamine oxidase B,4,primary amine oxidase activity|electron transfer activity,alcohol dependence|alcohol abuse|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|megaloblastic anemia|autistic disorder|bipolar disorder,ppi
14389,17348,4130,MAP1A,microtubule associated protein 1A,42,actin binding|structural molecule activity|microtubule binding|cytoskeletal adaptor activity|tubulin binding,,ppi
14390,17349,4131,MAP1B,microtubule associated protein 1B,88,structural molecule activity|microtubule binding|actin binding|tubulin binding,,ppi
14391,17350,84557,MAP1LC3A,microtubule associated protein 1 light chain 3 alpha,436,phospholipid binding|phosphatidylethanolamine binding|microtubule binding,,ppi
14392,17351,4133,MAP2,microtubule associated protein 2,54,structural molecule activity|microtubule binding,bipolar disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|mood disorder|major depressive disorder|mental depression,ppi
14393,17352,50649,ARHGEF4,Rho guanine nucleotide exchange factor 4,10,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|Rac guanyl-nucleotide exchange factor activity,,ppi
14394,17353,5604,MAP2K1,mitogen-activated protein kinase kinase 1,106,protein kinase activity|protein serine/threonine kinase activity|MAP kinase kinase activity|protein serine/threonine/tyrosine kinase activity|protein C-terminus binding|protein serine/threonine kinase activator activity|protein N-terminus binding,ptosis|congenital ptosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|brain ischemia|cryptorchidism|patent ductus arteriosus|epilepsy|factor XII deficiency|sensorineural hearing loss|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9,ppi
14395,17354,5605,MAP2K2,mitogen-activated protein kinase kinase 2,46,protein serine/threonine kinase activity|MAP kinase kinase activity|protein serine/threonine/tyrosine kinase activity|PDZ domain binding|protein serine/threonine kinase activator activity,ptosis|congenital ptosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41,ppi
14396,17355,5606,MAP2K3,mitogen-activated protein kinase kinase 3,37,protein serine/threonine kinase activity|MAP kinase kinase activity,,ppi
14397,17356,6416,MAP2K4,mitogen-activated protein kinase kinase 4,53,protein kinase activity|MAP kinase kinase activity|protein serine/threonine kinase activity|JUN kinase kinase activity,,ppi
14398,17357,5607,MAP2K5,mitogen-activated protein kinase kinase 5,27,protein kinase activity|protein serine/threonine kinase activity|MAP kinase kinase activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
14399,17358,5608,MAP2K6,mitogen-activated protein kinase kinase 6,31,protein serine/threonine kinase activity|MAP kinase kinase activity,colon cancer|colonic benign neoplasm|congestive heart failure|allergic hypersensitivity disease,ppi
14400,17359,5609,MAP2K7,mitogen-activated protein kinase kinase 7,71,magnesium ion binding|MAP kinase kinase activity|protein phosphatase binding|JUN kinase kinase activity|protein serine/threonine kinase activity,congestive heart failure|lung benign neoplasm|schizophrenia|breast cancer,ppi
14401,17360,4214,MAP3K1,mitogen-activated protein kinase kinase kinase 1,216,protein kinase activity|protein serine/threonine kinase activity|MAP kinase kinase kinase activity,azoospermia|cryptorchidism|dysgerminoma|gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|hypertrophy of breast|infant gynecomastia|gynecomastia|male infertility|osteoporosis|polycystic ovary syndrome|gonadoblastoma|priapism|sex differentiation disease|hermaphroditism|pseudohermaphroditism|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA,ppi
14402,17361,4294,MAP3K10,mitogen-activated protein kinase kinase kinase 10,32,transcription corepressor activity|protein kinase activity|protein serine/threonine kinase activity|JUN kinase kinase kinase activity|protein homodimerization activity,,ppi
14403,17362,9459,ARHGEF6,Rac/Cdc42 guanine nucleotide exchange factor 6,43,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|GTPase activator activity,intellectual disability|learning disability|non-syndromic X-linked intellectual disability,ppi
14404,17363,4296,MAP3K11,mitogen-activated protein kinase kinase kinase 11,40,protein kinase activity|protein serine/threonine kinase activity|JUN kinase kinase kinase activity,,ppi
14405,17364,7786,MAP3K12,mitogen-activated protein kinase kinase kinase 12,18,protein kinase activity|protein serine/threonine kinase activity|protein homodimerization activity|JUN kinase kinase kinase activity,,ppi
14406,17365,9175,MAP3K13,mitogen-activated protein kinase kinase kinase 13,10,protein serine/threonine kinase activity|MAP kinase kinase kinase activity|protein kinase binding|protein homodimerization activity|JUN kinase kinase kinase activity,,ppi
14407,17366,9020,MAP3K14,mitogen-activated protein kinase kinase kinase 14,136,protein kinase activity|protein serine/threonine kinase activity|NF-kappaB-inducing kinase activity|kinase activity,,ppi
14408,17367,10746,MAP3K2,mitogen-activated protein kinase kinase kinase 2,40,protein kinase activity|protein serine/threonine kinase activity,,ppi
14409,17368,4215,MAP3K3,mitogen-activated protein kinase kinase kinase 3,196,protein kinase activity|protein serine/threonine kinase activity,esophageal cancer,ppi
14410,17369,4216,MAP3K4,mitogen-activated protein kinase kinase kinase 4,53,MAP kinase kinase kinase activity|protein serine/threonine kinase activity,endometrial cancer|endometrial carcinoma,ppi
14411,17370,4217,MAP3K5,mitogen-activated protein kinase kinase kinase 5,94,magnesium ion binding|protein kinase activity|protein serine/threonine kinase activity|MAP kinase kinase kinase activity|ATP binding|protein homodimerization activity,diabetic ketoacidosis|diabetes mellitus|melanoma|skin melanoma|Parkinson's disease|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
14412,17371,9064,MAP3K6,mitogen-activated protein kinase kinase kinase 6,18,magnesium ion binding|MAP kinase kinase kinase activity|ATP binding|protein kinase activity,stomach cancer,ppi
14413,17372,6885,MAP3K7,mitogen-activated protein kinase kinase kinase 7,184,protein kinase activity|protein serine/threonine kinase activity|MAP kinase kinase kinase activity|scaffold protein binding,microphthalmia|eye disease|sensorineural hearing loss|mitral valve insufficiency|mitral valve prolapse|prostate cancer|prostate carcinoma,ppi
14414,17373,399,RHOH,ras homolog family member H,11,GTPase inhibitor activity|GTP binding|Rho GTPase binding|kinase inhibitor activity|protein kinase binding|GTPase activity,,ppi
14415,17374,1326,MAP3K8,mitogen-activated protein kinase kinase kinase 8,41,protein serine/threonine kinase activity|MAP kinase kinase kinase activity,lung cancer|bronchiolo-alveolar adenocarcinoma|lung benign neoplasm|coronary artery disease,ppi
14416,17375,4293,MAP3K9,mitogen-activated protein kinase kinase kinase 9,4,protein serine/threonine kinase activity|JUN kinase kinase kinase activity|MAP kinase kinase activity|protein homodimerization activity,melanoma|skin melanoma,ppi
14417,17376,4134,MAP4,microtubule associated protein 4,75,RNA binding|structural molecule activity|microtubule binding,,ppi
14418,17377,11184,MAP4K1,mitogen-activated protein kinase kinase kinase kinase 1,37,protein kinase activity|protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity,,ppi
14419,17378,5871,MAP4K2,mitogen-activated protein kinase kinase kinase kinase 2,17,protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity,,ppi
14420,17379,8491,MAP4K3,mitogen-activated protein kinase kinase kinase kinase 3,17,protein kinase activity|protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity,,ppi
14421,17380,9448,MAP4K4,mitogen-activated protein kinase kinase kinase kinase 4,57,creatine kinase activity|protein serine/threonine kinase activity|ATP binding,,ppi
14422,17381,11183,MAP4K5,mitogen-activated protein kinase kinase kinase kinase 5,21,protein kinase activity|protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity,,ppi
14423,17382,4135,MAP6,microtubule associated protein 6,6,microtubule binding,schizophrenia,ppi
14424,17383,9053,MAP7,microtubule associated protein 7,37,signaling receptor binding|structural molecule activity,,ppi
14425,17384,9077,DIRAS3,DIRAS family GTPase 3,21,,,ppi
14426,17385,5594,MAPK1,mitogen-activated protein kinase 1,319,protein serine/threonine kinase activity|MAP kinase activity|RNA polymerase II CTD heptapeptide repeat kinase activity|kinase activity,bipolar disorder|tongue squamous cell carcinoma|squamous cell carcinoma|brain ischemia|enophthalmos|orbital disease|exophthalmos|placental insufficiency|clubfoot|head and neck cancer|kidney cancer|communication disorder|language disorder|lung benign neoplasm|intellectual disability|learning disability|schizophrenia|Sezary's disease|stomach cancer|trigeminal neuralgia,ppi
14427,17386,5602,MAPK10,mitogen-activated protein kinase 10,48,JUN kinase activity|MAP kinase kinase activity|MAP kinase activity,intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|antisocial personality disorder|avoidant personality disorder|narcissistic personality disorder|brain disease|visual epilepsy|autistic disorder,ppi
14428,17387,5600,MAPK11,mitogen-activated protein kinase 11,48,protein serine/threonine kinase activity|MAP kinase activity,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
14429,17388,6300,MAPK12,mitogen-activated protein kinase 12,41,magnesium ion binding|protein serine/threonine kinase activity|MAP kinase activity,,ppi
14430,17389,5603,MAPK13,mitogen-activated protein kinase 13,102,protein serine/threonine kinase activity|MAP kinase activity,cholestasis,ppi
14431,17390,1432,MAPK14,mitogen-activated protein kinase 14,310,protein serine/threonine kinase activity|MAP kinase activity|MAP kinase kinase activity|NFAT protein binding,cholestasis|chronic myeloid leukemia|liver cancer|lung benign neoplasm|cannabis dependence|cannabis abuse|schizophrenia|mental depression|coronary artery disease|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
14432,17391,5595,MAPK3,mitogen-activated protein kinase 3,270,protein serine/threonine kinase activity|MAP kinase activity|kinase activity,tongue squamous cell carcinoma|squamous cell carcinoma|brain ischemia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|head and neck cancer|kidney cancer|lung benign neoplasm|prostate cancer|prostate carcinoma|schizophrenia|stomach cancer|trigeminal neuralgia|cocaine abuse|cocaine dependence|cardiomyopathy,ppi
14433,17392,5596,MAPK4,mitogen-activated protein kinase 4,18,protein serine/threonine kinase activity|protein kinase binding|protein homodimerization activity|MAP kinase activity,,ppi
14434,17393,5597,MAPK6,mitogen-activated protein kinase 6,386,protein serine/threonine kinase activity|MAP kinase activity,,ppi
14435,17394,57381,RHOJ,ras homolog family member J,28,GTPase activity|protein kinase binding|GTP binding,colon cancer|colonic benign neoplasm|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
14436,17395,5598,MAPK7,mitogen-activated protein kinase 7,64,protein serine/threonine kinase activity|MAP kinase activity,,ppi
14437,17396,5599,MAPK8,mitogen-activated protein kinase 8,205,protein serine/threonine kinase activity|JUN kinase activity|kinase activity|histone deacetylase regulator activity|MAP kinase activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|atopic dermatitis|schizophrenia|stomach cancer|trigeminal neuralgia|hepatitis,ppi
14438,17397,9479,MAPK8IP1,mitogen-activated protein kinase 8 interacting protein 1,41,protein kinase inhibitor activity,diabetes mellitus|type 2 diabetes mellitus,ppi
14439,17398,23542,MAPK8IP2,mitogen-activated protein kinase 8 interacting protein 2,95,amyloid-beta binding|MAP-kinase scaffold activity|structural molecule activity|kinesin binding,,ppi
14440,17399,23162,MAPK8IP3,mitogen-activated protein kinase 8 interacting protein 3,39,MAP-kinase scaffold activity|kinesin binding|receptor signaling complex scaffold activity|JUN kinase binding,polycystic ovary syndrome,ppi
14441,17400,5601,MAPK9,mitogen-activated protein kinase 9,126,JUN kinase activity|transcription factor binding|MAP kinase activity,ischemia|trigeminal neuralgia,ppi
14442,17401,9261,MAPKAPK2,mitogen-activated protein kinase-activated protein kinase 2,60,protein kinase activity|protein serine/threonine kinase activity|mitogen-activated protein kinase binding|calcium-dependent protein serine/threonine kinase activity|calmodulin binding|calmodulin-dependent protein kinase activity,,ppi
14443,17402,7867,MAPKAPK3,mitogen-activated protein kinase-activated protein kinase 3,45,protein serine/threonine kinase activity|MAP kinase kinase activity|calmodulin-dependent protein kinase activity|calcium-dependent protein serine/threonine kinase activity|calmodulin binding|mitogen-activated protein kinase binding,,ppi
14444,17403,8550,MAPKAPK5,mitogen-activated protein kinase-activated protein kinase 5,31,p53 binding|protein serine/threonine kinase activity|MAP kinase kinase activity|calmodulin-dependent protein kinase activity|calmodulin binding|calcium-dependent protein serine/threonine kinase activity|mitogen-activated protein kinase binding,,ppi
14445,17404,25820,ARIH1,ariadne RBR E3 ubiquitin protein ligase 1,103,ubiquitin-protein transferase activity|zinc ion binding|ubiquitin-like protein transferase activity|ubiquitin protein ligase activity|ubiquitin conjugating enzyme binding,,ppi
14446,17405,22919,MAPRE1,microtubule associated protein RP/EB family member 1,174,RNA binding|protein C-terminus binding|cadherin binding|microtubule plus-end binding|microtubule binding,coronary artery disease,ppi
14447,17406,10982,MAPRE2,microtubule associated protein RP/EB family member 2,40,microtubule plus-end binding|microtubule binding,isolated cleft palate|cleft palate|cryptorchidism|congestive heart failure|microphthalmia|cornea plana|Peters anomaly,ppi
14448,17407,22924,MAPRE3,microtubule associated protein RP/EB family member 3,30,microtubule binding|microtubule plus-end binding,polycystic ovary syndrome,ppi
14449,17408,4137,MAPT,microtubule associated protein tau,121,DNA binding|AT DNA binding|double-stranded DNA binding|single-stranded DNA binding|RNA binding|actin binding|microtubule binding|enzyme binding|protein kinase binding|protein binding; bridging|dynactin binding|phosphatidylinositol binding|identical protein binding|protein homodimerization activity|sequence-specific DNA binding|receptor ligand activity|protein phosphatase 2A binding|histone-dependent DNA binding|microtubule lateral binding|phosphatidylinositol bisphosphate binding,alexia|dyslexia|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder,ppi
14450,17409,8685,MARCO,macrophage receptor with collagenous structure,3,amyloid-beta binding|G-protein coupled receptor binding|transmembrane signaling receptor activity|signaling pattern recognition receptor activity|extracellular matrix structural constituent,,ppi
14451,17410,4139,MARK1,microtubule affinity regulating kinase 1,19,magnesium ion binding|phosphatidylserine binding|protein serine/threonine kinase activity|ATP binding|phosphatidylinositol-4;5-bisphosphate binding|tau-protein kinase activity|phosphatidic acid binding,autistic disorder|stomach cancer,ppi
14452,17411,4140,MARK3,microtubule affinity regulating kinase 3,64,protein serine/threonine kinase activity|tau-protein kinase activity,,ppi
14453,17412,4141,MARS,methionyl-tRNA synthetase,90,methionine-tRNA ligase activity,anemia|macrocytic anemia|congenital hypothyroidism|myxedema|hypothyroidism|pulmonary alveolar proteinosis|liver disease|interstitial lung disease|axonal neuropathy|fatty liver disease|Charcot-Marie-Tooth disease axonal type 2U,ppi
14454,17413,4142,MAS1,MAS1 proto-oncogene; G protein-coupled receptor,68,angiotensin receptor activity|G-protein coupled receptor activity|angiotensin type II receptor activity|peptide binding,,ppi
14455,17414,6059,ABCE1,ATP binding cassette subfamily E member 1,242,endoribonuclease inhibitor activity|ribosomal small subunit binding|ATP binding|iron ion binding,large intestine cancer|colorectal cancer,ppi
14456,17415,10425,ARIH2,ariadne RBR E3 ubiquitin protein ligase 2,67,ubiquitin-protein transferase activity|zinc ion binding|ubiquitin conjugating enzyme binding|ubiquitin protein ligase activity,,ppi
14457,17416,5648,MASP1,mannan binding lectin serine peptidase 1,29,serine-type endopeptidase activity|calcium ion binding|peptidase activity,blepharophimosis|ptosis|congenital ptosis|cleft lip|isolated cleft palate|cleft palate|craniosynostosis|sensorineural hearing loss|glaucoma|hydronephrosis|intellectual disability|learning disability|Klippel-Feil syndrome|spondylolisthesis|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|cryptorchidism|incontinentia pigmenti achromians|umbilical hernia,ppi
14458,17417,10747,MASP2,mannan binding lectin serine peptidase 2,4,complement component C4b binding|serine-type endopeptidase activity|peptidase activity,inflammatory bowel disease|ulcerative colitis|Stevens-Johnson syndrome|hypersensitivity reaction type III disease,ppi
14459,17418,4143,MAT1A,methionine adenosyltransferase 1A,11,methionine adenosyltransferase activity|selenomethionine adenosyltransferase activity,amino acid metabolic disorder|brain disease|demyelinating disease|diabetes mellitus|type 2 diabetes mellitus|dystonia|fatty liver disease|liver cancer|hepatocellular carcinoma,ppi
14460,17419,4144,MAT2A,methionine adenosyltransferase 2A,45,methionine adenosyltransferase activity,,ppi
14461,17420,27430,MAT2B,methionine adenosyltransferase 2B,42,methionine adenosyltransferase regulator activity,,ppi
14462,17421,4145,MATK,megakaryocyte-associated tyrosine kinase,21,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity,,ppi
14463,17422,4146,MATN1,matrilin 1; cartilage matrix protein,5,,,ppi
14464,17423,4147,MATN2,matrilin 2,21,extracellular matrix structural constituent,,ppi
14465,17424,4148,MATN3,matrilin 3,10,extracellular matrix structural constituent,osteochondrodysplasia|multiple epiphyseal dysplasia|arthropathy|arthritis|chondrodysplasia punctata|osteogenesis imperfecta|Ehlers-Danlos syndrome,ppi
14466,17425,401,PHOX2A,paired like homeobox 2a,7,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,suppression amblyopia|amblyopia|alternating exotropia|exotropia|monocular exotropia|blindness|congenital fibrosis of the extraocular muscles,ppi
14467,17426,8785,MATN4,matrilin 4,13,,,ppi
14468,17427,9782,MATR3,matrin 3,220,RNA binding|structural molecule activity|miRNA binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|muscular atrophy|neurodegenerative disease|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E,ppi
14469,17428,4149,MAX,MYC associated factor X,134,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coregulator activity|transcription coactivator activity|protein homodimerization activity|E-box binding|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II core promoter sequence-specific DNA binding,adrenal gland cancer|duodenum cancer|heart cancer|phaeochromocytoma|small intestine cancer,ppi
14470,17429,4150,MAZ,MYC associated zinc finger protein,18,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|RNA binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
14471,17430,4151,MB,myoglobin,5,,,ppi
14472,17431,4152,MBD1,methyl-CpG binding domain protein 1,44,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|methyl-CpG binding|double-stranded methylated DNA binding,,ppi
14473,17432,8932,MBD2,methyl-CpG binding domain protein 2,43,satellite DNA binding|methyl-CpG binding|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,prostate cancer|prostate carcinoma|schizophrenia,ppi
14474,17433,53615,MBD3,methyl-CpG binding domain protein 3,95,DNA binding|histone deacetylase activity|methyl-CpG binding|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding,autistic disorder,ppi
14475,17434,8930,MBD4,methyl-CpG binding domain 4; DNA glycosylase,20,satellite DNA binding|endodeoxyribonuclease activity|pyrimidine-specific mismatch base pair DNA N-glycosylase activity|DNA N-glycosylase activity|DNA binding,autistic disorder,ppi
14476,17435,400,ARL1,ADP ribosylation factor like GTPase 1,36,GTPase activity|GTP binding|enzyme activator activity,,ppi
14477,17436,4153,MBL2,mannose binding lectin 2,12,serine-type endopeptidase activity|mannose binding|calcium ion binding,bipolar disorder|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|polyneuropathy|peripheral nervous system disease|neuropathy|gestational diabetes,ppi
14478,17437,4154,MBNL1,muscleblind like splicing regulator 1,33,RNA binding|double-stranded RNA binding,schizophrenia,ppi
14479,17438,9741,LAPTM4A,lysosomal protein transmembrane 4 alpha,13,,,ppi
14480,17439,4155,MBP,myelin basic protein,87,structural constituent of myelin sheath,alcohol dependence|alcohol abuse|demyelinating disease|neuromyelitis optica|schizophrenia,ppi
14481,17440,4157,MC1R,melanocortin 1 receptor,30,melanocortin receptor activity|G-protein coupled peptide receptor activity,oculocutaneous albinism|Griscelli syndrome|Griscelli syndrome type 1|Griscelli syndrome type 2|Griscelli syndrome type 3|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
14482,17441,402,ARL2,ADP ribosylation factor like GTPase 2,28,GTPase activity|GTPase inhibitor activity|GTP binding,melanoma|skin melanoma,ppi
14483,17442,4158,MC2R,melanocortin 2 receptor,5,melanocortin receptor activity,bipolar disorder|epilepsy|hypertension|essential hypertension|prostate cancer|prostate carcinoma|visual epilepsy,ppi
14484,17443,4159,MC3R,melanocortin 3 receptor,5,melanocortin receptor activity|neuropeptide binding,obesity,ppi
14485,17444,4160,MC4R,melanocortin 4 receptor,13,melanocortin receptor activity|melanocyte-stimulating hormone receptor activity|neuropeptide binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|Zollinger-Ellison syndrome|hyperinsulinism|bulimia nervosa|obesity|cocaine abuse|cocaine dependence|morphine dependence,ppi
14486,17445,4161,MC5R,melanocortin 5 receptor,5,,bipolar disorder|schizophrenia,ppi
14487,17446,4162,MCAM,melanoma cell adhesion molecule,18,,multiple sclerosis|malignant mesothelioma|benign mesothelioma|autoimmune lymphoproliferative syndrome|basal ganglia disease|autonomic neuropathy|autoimmune disease of the nervous system,ppi
14488,17447,4163,MCC,mutated in colorectal cancers,258,signaling receptor activity,autistic disorder|familial adenomatous polyposis|islet cell tumor|rectal neoplasm|rectum cancer|intellectual disability|learning disability,ppi
14489,17448,56922,MCCC1,methylcrotonoyl-CoA carboxylase 1,52,biotin carboxylase activity|biotin binding|methylcrotonoyl-CoA carboxylase activity,3-Methylcrotonyl-CoA carboxylase deficiency,ppi
14490,17449,64087,MCCC2,methylcrotonoyl-CoA carboxylase 2,58,methylcrotonoyl-CoA carboxylase activity,3-Methylcrotonyl-CoA carboxylase deficiency,ppi
14491,17450,4166,CHST6,carbohydrate sulfotransferase 6,13,N-acetylglucosamine 6-O-sulfotransferase activity,corneal dystrophy|corneal ulcer|corneal granular dystrophy|macular corneal dystrophy|asthenopia|recurrent corneal erosion,ppi
14492,17451,403,ARL3,ADP ribosylation factor like GTPase 3,20,GTP binding|microtubule binding|GDP binding,,ppi
14493,17452,4168,MCF2,MCF.2 cell line derived transforming sequence,13,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
14494,17453,4170,MCL1,BCL2 family apoptosis regulator,72,protein transmembrane transporter activity|protein homodimerization activity|protein heterodimerization activity,Barrett's esophagus|leishmaniasis|lung benign neoplasm|multiple myeloma|cutaneous T cell lymphoma|spindle cell sarcoma|epithelioid sarcoma|sarcoma|cancer,ppi
14495,17454,4171,MCM2,minichromosome maintenance complex component 2,868,DNA binding,colon cancer|colonic benign neoplasm,ppi
14496,17455,4172,MCM3,minichromosome maintenance complex component 3,156,,,ppi
14497,17456,8888,MCM3AP,minichromosome maintenance complex component 3 associated protein,34,,,ppi
14498,17457,4173,MCM4,minichromosome maintenance complex component 4,108,ATP-dependent DNA helicase activity,adrenal cortical hypofunction|Addison's disease|placental insufficiency|autoimmune lymphoproliferative syndrome|lymphoproliferative syndrome 1|lymphoproliferative syndrome 2|autoimmune lymphoproliferative syndrome type 2A|autoimmune lymphoproliferative syndrome type 2B|autoimmune lymphoproliferative syndrome type 3,ppi
14499,17458,4174,MCM5,minichromosome maintenance complex component 5,247,,,ppi
14500,17459,4175,MCM6,minichromosome maintenance complex component 6,100,ATP binding|ATP-dependent DNA helicase activity,lactose intolerance,ppi
14501,17460,10124,ARL4A,ADP ribosylation factor like GTPase 4A,10,GTP binding,,ppi
14502,17461,4176,MCM7,minichromosome maintenance complex component 7,279,DNA binding|ATP-dependent DNA helicase activity,,ppi
14503,17462,4179,CD46,CD46 molecule,17,signaling receptor activity,measles|pre-eclampsia|HELLP syndrome|hemolytic-uremic syndrome,ppi
14504,17463,79648,MCPH1,microcephalin 1,28,,microcephaly,ppi
14505,17464,26225,ARL5A,ADP ribosylation factor like GTPase 5A,7,GTP binding,,ppi
14506,17465,10445,MCRS1,microspherule protein 1,83,G-quadruplex RNA binding|poly(U) RNA binding|poly(G) binding|histone acetyltransferase activity (H4-K5 specific)|histone acetyltransferase activity (H4-K8 specific)|histone acetyltransferase activity (H4-K16 specific),,ppi
14507,17466,4184,SMCP,sperm mitochondria associated cysteine rich protein,20,,,ppi
14508,17467,4188,MDFI,MyoD family inhibitor,228,transcription factor binding,,ppi
14509,17468,4189,DNAJB9,DnaJ heat shock protein family (Hsp40) member B9,45,chaperone binding|misfolded protein binding,cholestasis,ppi
14510,17469,23204,ARL6IP1,ADP ribosylation factor like GTPase 6 interacting protein 1,48,,prostate cancer|prostate carcinoma|paraplegia|sensory peripheral neuropathy|hereditary spastic paraplegia 61,ppi
14511,17470,4190,MDH1,malate dehydrogenase 1,42,malic enzyme activity|L-malate dehydrogenase activity,hypertension|essential hypertension|adult respiratory distress syndrome|newborn respiratory distress syndrome|schizophrenia,ppi
14512,17471,4191,MDH2,malate dehydrogenase 2,65,RNA binding|L-malate dehydrogenase activity,,ppi
14513,17472,4192,MDK,midkine (neurite growth-promoting factor 2),53,growth factor activity|heparin binding,anxiety disorder|phobic disorder|malignant glioma|gliosarcoma|mixed glioma|schizophrenia|malignant mesothelioma|benign mesothelioma,ppi
14514,17473,4193,MDM2,MDM2 proto-oncogene,843,ubiquitin-protein transferase activity|5S rRNA binding|zinc ion binding|ligase activity|SUMO transferase activity|ribonucleoprotein complex binding|ubiquitin binding|ubiquitin protein ligase activity|NEDD8 ligase activity,adrenal cortex cancer|skin benign neoplasm|skin cancer|lung cancer|non-small cell lung carcinoma|colon cancer|colonic benign neoplasm|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|male infertility|lymphosarcoma|lymphoma|central nervous system lymphoma|melanoma|skin melanoma|osteosarcoma|bone osteosarcoma|pancreatic cancer|prostate cancer|prostate carcinoma,ppi
14515,17474,4194,MDM4,MDM4; p53 regulator,74,zinc ion binding|ubiquitin protein ligase activity,glioblastoma multiforme|giant cell glioblastoma|asbestosis|anthracosilicosis|pneumoconiosis|siderosis|bagassosis|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression|breast cancer,ppi
14516,17475,10123,ARL4C,ADP ribosylation factor like GTPase 4C,21,GTPase activity|alpha-tubulin binding|GTP binding,,ppi
14517,17476,4199,ME1,malic enzyme 1,30,malic enzyme activity|malate dehydrogenase (decarboxylating) (NADP+) activity|electron transfer activity|manganese ion binding|ADP binding|NADP binding|NAD binding,obesity|liver cancer|hepatocellular carcinoma,ppi
14518,17477,4200,ME2,malic enzyme 2,13,malic enzyme activity|malate dehydrogenase (decarboxylating) (NAD+) activity|electron transfer activity|malate dehydrogenase (decarboxylating) (NADP+) activity,bipolar disorder|opiate dependence|schizophreniform disorder|schizoaffective disorder|schizophrenia|idiopathic generalized epilepsy|generalized epilepsy with febrile seizures plus,ppi
14519,17478,10873,ME3,malic enzyme 3,1,malic enzyme activity|malate dehydrogenase (decarboxylating) (NADP+) activity|cofactor binding,,ppi
14520,17479,4201,MEA1,male-enhanced antigen 1,11,,,ppi
14521,17480,4204,MECP2,methyl-CpG binding protein 2,154,DNA binding|transcription corepressor activity|RNA binding|double-stranded methylated DNA binding|methyl-CpG binding,generalized anxiety disorder|anxiety disorder|phobic disorder|agnosia|autistic disorder|blepharophimosis|ptosis|congenital ptosis|bruxism|cerebellar disease|syndromic X-linked intellectual disability type 10|choreatic disease|constipation|cryptorchidism|sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia,ppi
14522,17481,4205,MEF2A,myocyte enhancer factor 2A,62,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|chromatin binding|DNA-binding transcription factor activity|transcription coactivator activity|sequence-specific DNA binding|histone deacetylase binding|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific,schizophreniform disorder|schizoaffective disorder|coronary artery disease,ppi
14523,17482,100271849,MEF2B,myocyte enhancer factor 2B,8,,,ppi
14524,17483,4208,MEF2C,myocyte enhancer factor 2C,38,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II core promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|AT DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding|histone deacetylase binding,autistic disorder|epilepsy|visual epilepsy|syndromic X-linked intellectual disability 94|status epilepticus|stereotypic movement disorder|autosomal dominant non-syndromic intellectual disability|intellectual disability|learning disability,ppi
14525,17484,4209,MEF2D,myocyte enhancer factor 2D,42,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|histone deacetylase binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,migraine without aura,ppi
14526,17485,4210,MEFV,MEFV; pyrin innate immunity regulator,14,actin binding|zinc ion binding,arthropathy|arthritis|psoriatic arthritis|Behcet's disease|constipation|epilepsy|erysipelas|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|meningitis|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|orchitis|pericarditis|familial Mediterranean fever|proteinuria|kidney failure|uremia|visual epilepsy,ppi
14527,17486,2,A2M,alpha-2-macroglobulin,153,serine-type endopeptidase inhibitor activity|GTPase activator activity|signaling receptor binding|growth factor binding|interleukin-1 binding|tumor necrosis factor binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|colon cancer|colonic benign neoplasm|neurotic disorder|major depressive disorder|mental depression,ppi
14528,17487,23,ABCF1,ATP binding cassette subfamily F member 1,71,RNA binding|translation factor activity; RNA binding,allergic hypersensitivity disease|pneumonia,ppi
14529,17488,405,ARNT,aryl hydrocarbon receptor nuclear translocator,62,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|enhancer binding|protein homodimerization activity|protein heterodimerization activity|sequence-specific double-stranded DNA binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|sequence-specific DNA binding,large intestine cancer|colorectal cancer|endometriosis of uterus|endometriosis|liver cirrhosis|melanoma|skin melanoma|acute lymphocytic leukemia,ppi
14530,17489,4211,MEIS1,Meis homeobox 1,45,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,restless legs syndrome|breast cancer,ppi
14531,17490,4212,MEIS2,Meis homeobox 2,32,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coregulator activity|transcription corepressor activity|transcription factor binding,isolated cleft palate|cleft palate|enophthalmos|orbital disease|exophthalmos|intellectual disability|learning disability,ppi
14532,17491,4218,RAB8A,RAB8A; member RAS oncogene family,111,GTPase activity|GTP binding|Rab GTPase binding|GDP binding,rheumatoid arthritis,ppi
14533,17492,406,ARNTL,aryl hydrocarbon receptor nuclear translocator like,32,transcription regulatory region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II proximal promoter sequence-specific DNA binding|DNA binding|sequence-specific DNA binding|Hsp90 protein binding|E-box binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|chronic myeloid leukemia|coronary artery disease|mood disorder,ppi
14534,17493,4221,MEN1,menin 1,70,four-way junction DNA binding|Y-form DNA binding|double-stranded DNA binding|protein binding; bridging|transcription regulatory region DNA binding|histone-lysine N-methyltransferase activity|chromatin binding,hyperpituitarism|acromegaly|VIPoma|pancreatic cholera|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|gastrinoma|hypertrophy of breast|infant gynecomastia|gynecomastia|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hyperparathyroidism|osteitis fibrosa|bulimia nervosa|hypoglycemia|insulinoma,ppi
14535,17494,4222,MEOX1,mesenchyme homeobox 1,34,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,cleft lip|isolated cleft palate|cleft palate|sensorineural hearing loss|ventricular septal defect|Klippel-Feil syndrome|spondylolisthesis|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|allergic contact dermatitis,ppi
14536,17495,4223,MEOX2,mesenchyme homeobox 2,211,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,coronary artery disease,ppi
14537,17496,4224,MEP1A,meprin A subunit alpha,21,metalloendopeptidase activity,colon cancer|colonic benign neoplasm,ppi
14538,17497,4225,MEP1B,meprin A subunit beta,14,metalloendopeptidase activity,,ppi
14539,17498,10461,MERTK,MER proto-oncogene; tyrosine kinase,12,transmembrane signaling receptor activity|transmembrane receptor protein tyrosine kinase activity|protein tyrosine kinase activity|Wnt-protein binding,glaucoma|IgA glomerulonephritis|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|pulmonary embolism,ppi
14540,17499,4232,MEST,mesoderm specific transcript,19,,,ppi
14541,17500,4233,MET,MET proto-oncogene; receptor tyrosine kinase,129,protein tyrosine kinase activity|hepatocyte growth factor-activated receptor activity|Ras guanyl-nucleotide exchange factor activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|Wnt-protein binding|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|autistic disorder|lung cancer|non-small cell lung carcinoma|papillary renal cell carcinoma|renal cell carcinoma,ppi
14542,17501,10552,ARPC1A,actin related protein 2/3 complex subunit 1A,35,actin binding|actin filament binding,,ppi
14543,17502,4234,METTL1,methyltransferase like 1,37,tRNA (guanine-N7-)-methyltransferase activity,,ppi
14544,17503,4236,MFAP1,microfibrillar associated protein 1,69,RNA binding,,ppi
14545,17504,4237,MFAP2,microfibrillar associated protein 2,6,,,ppi
14546,17505,4238,MFAP3,microfibrillar associated protein 3,33,,,ppi
14547,17506,4239,MFAP4,microfibrillar associated protein 4,7,extracellular matrix structural constituent,,ppi
14548,17507,4240,MFGE8,milk fat globule-EGF factor 8 protein,6,extracellular matrix structural constituent,bipolar disorder|breast cancer,ppi
14549,17508,4241,MELTF,melanotransferrin,8,iron ion binding,,ppi
14550,17509,4242,MFNG,MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase,4,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity|acetylglucosaminyltransferase activity,,ppi
14551,17510,10095,ARPC1B,actin related protein 2/3 complex subunit 1B,62,structural constituent of cytoskeleton|actin filament binding,,ppi
14552,17511,8972,MGAM,maltase-glucoamylase,1,catalytic activity|alpha-1;4-glucosidase activity,,ppi
14553,17512,4245,MGAT1,mannosyl (alpha-1;3-)-glycoprotein beta-1;2-N-acetylglucosaminyltransferase,11,alpha-1;3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity|acetylglucosaminyltransferase activity,,ppi
14554,17513,4247,MGAT2,mannosyl (alpha-1;6-)-glycoprotein beta-1;2-N-acetylglucosaminyltransferase,3,alpha-1;6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,epilepsy|factor XI deficiency|factor XII deficiency|clubfoot|gingival overgrowth|gingival hypertrophy|sensorineural hearing loss|ventricular septal defect|visual epilepsy|syndromic X-linked intellectual disability 94|stereotypic movement disorder|craniosynostosis|thrombophilia|protein S deficiency|antithrombin III deficiency|protein C deficiency|congenital disorder of glycosylation|congenital disorder of glycosylation type II,ppi
14555,17514,4248,MGAT3,mannosyl (beta-1;4-)-glycoprotein beta-1;4-N-acetylglucosaminyltransferase,1,beta-1;4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity|transferase activity; transferring glycosyl groups,,ppi
14556,17515,11320,MGAT4A,mannosyl (alpha-1;3-)-glycoprotein beta-1;4-N-acetylglucosaminyltransferase; isozyme A,1,alpha-1;3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,,ppi
14557,17516,11282,MGAT4B,mannosyl (alpha-1;3-)-glycoprotein beta-1;4-N-acetylglucosaminyltransferase; isozyme B,11,alpha-1;3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,,ppi
14558,17517,4249,MGAT5,mannosyl (alpha-1;6-)-glycoprotein beta-1;6-N-acetyl-glucosaminyltransferase,16,alpha-1;6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,,ppi
14559,17518,10109,ARPC2,actin related protein 2/3 complex subunit 2,74,structural constituent of cytoskeleton|actin filament binding,inflammatory bowel disease|ulcerative colitis,ppi
14560,17519,4250,SCGB2A2,secretoglobin family 2A member 2,78,,,ppi
14561,17520,4246,SCGB2A1,secretoglobin family 2A member 1,22,protein heterodimerization activity,,ppi
14562,17521,10724,MGEA5,meningioma expressed antigen 5 (hyaluronidase),41,hyalurononglucosaminidase activity|beta-N-acetylglucosaminidase activity,,ppi
14563,17522,4255,MGMT,O-6-methylguanine-DNA methyltransferase,74,methyltransferase activity|DNA-methyltransferase activity,brain cancer|glioblastoma multiforme|giant cell glioblastoma|malignant glioma|gliosarcoma|mixed glioma|leukemia|lymphatic system disease|melanoma|skin melanoma|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag|esophagus squamous cell carcinoma|head and neck squamous cell carcinoma|familial melanoma|dysplastic nevus syndrome,ppi
14564,17523,10094,ARPC3,actin related protein 2/3 complex subunit 3,76,structural constituent of cytoskeleton|actin filament binding,,ppi
14565,17524,4256,MGP,matrix Gla protein,1,extracellular matrix structural constituent|structural constituent of bone,sensorineural hearing loss|epilepsy|ventricular septal defect|primary pulmonary hypertension|pulmonary hypertension|visual epilepsy|kidney failure|uremia|varicose veins|chronic sphenoidal sinusitis|chronic ethmoiditis|chondrodysplasia punctata|pulmonary valve stenosis,ppi
14566,17525,4257,MGST1,microsomal glutathione S-transferase 1,7,glutathione transferase activity|glutathione peroxidase activity|prostaglandin-E synthase activity,neurodegenerative disease,ppi
14567,17526,4258,MGST2,microsomal glutathione S-transferase 2,4,glutathione transferase activity|leukotriene-C4 synthase activity|glutathione peroxidase activity,,ppi
14568,17527,4259,MGST3,microsomal glutathione S-transferase 3,27,glutathione transferase activity|leukotriene-C4 synthase activity|glutathione peroxidase activity,,ppi
14569,17528,4261,CIITA,class II major histocompatibility complex transactivator,31,transcription coactivator activity|transcription regulatory region DNA binding|protein-containing complex binding|DNA binding,adrenal cortical hypofunction|Addison's disease|agammaglobulinemia|rheumatoid arthritis|obstructive jaundice|biliary tract disease|chronic mucocutaneous candidiasis|colitis|ileitis|ileocolitis|gastroenteritis|myelitis|encephalomyelitis|encephalitis|multiple sclerosis|urinary tract obstruction|celiac disease|MHC class II deficiency,ppi
14570,17529,10093,ARPC4,actin related protein 2/3 complex subunit 4,71,structural constituent of cytoskeleton|actin filament binding,,ppi
14571,17530,8190,MIA,melanoma inhibitory activity,3,,stomach cancer,ppi
14572,17531,10092,ARPC5,actin related protein 2/3 complex subunit 5,52,structural constituent of cytoskeleton|actin filament binding,,ppi
14573,17532,4267,CD99,CD99 molecule,15,,schizophrenia|mesenchymal chondrosarcoma,ppi
14574,17534,4277,MICB,MHC class I polypeptide-related sequence B,5,natural killer cell lectin-like receptor binding,dengue hemorrhagic fever|schizophrenia,ppi
14575,17535,4281,MID1,midline 1,71,microtubule binding|protein homodimerization activity|protein heterodimerization activity,imperforate anus|cleft lip|isolated cleft palate|cleft palate|cryptorchidism|esophageal atresia|esophagitis|peptic esophagitis|gastroesophageal reflux disease|congenital heart disease|Opitz-GBBB syndrome,ppi
14576,17536,11043,MID2,midline 2,133,microtubule binding|protein homodimerization activity|protein heterodimerization activity,intellectual disability|learning disability|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
14577,17537,4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor),82,dopachrome isomerase activity|cytokine activity|cytokine receptor binding|chemoattractant activity|phenylpyruvate tautomerase activity,anxiety disorder|phobic disorder|rheumatoid arthritis|autistic disorder|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|colitis|ileitis|ileocolitis|gastroenteritis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|exanthem|prostate cancer|prostate carcinoma|schizophrenia,ppi
14578,17538,4283,CXCL9,C-X-C motif chemokine ligand 9,9,cytokine activity|chemokine activity|CXCR3 chemokine receptor binding,alopecia areata|allergic hypersensitivity disease|primary biliary cirrhosis|pneumonia|interstitial cystitis|chronic interstitial cystitis|malignant mesothelioma|benign mesothelioma|breast cancer,ppi
14579,17539,10061,ABCF2,ATP binding cassette subfamily F member 2,58,transporter activity,,ppi
14580,17540,407,ARR3,arrestin 3,32,,,ppi
14581,17541,9562,MINPP1,multiple inositol-polyphosphate phosphatase 1,19,inositol-1;3;4;5;6-pentakisphosphate 3-phosphatase activity|bisphosphoglycerate 3-phosphatase activity|inositol-1;3;4;5-tetrakisphosphate 3-phosphatase activity|inositol phosphate phosphatase activity|inositol hexakisphosphate 2-phosphatase activity|protein histidine phosphatase activity|acid phosphatase activity,seborrheic keratosis|skin disease|actinic keratosis|follicular thyroid carcinoma|papillary thyroid carcinoma,ppi
14582,17542,4284,MIP,major intrinsic protein of lens fiber,9,calmodulin binding|water channel activity,cataract|cataract 7|cataract 9 multiple types|cataract 16 multiple types|cataract 15 multiple types,ppi
14583,17543,4285,MIPEP,mitochondrial intermediate peptidase,26,metalloendopeptidase activity,,ppi
14584,17544,4286,MITF,melanogenesis associated transcription factor,36,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|E-box binding,oculocutaneous albinism|Griscelli syndrome|Griscelli syndrome type 1|Griscelli syndrome type 2|Griscelli syndrome type 3|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|sensorineural hearing loss|hyperopia|lymphatic system disease,ppi
14585,17545,4287,ATXN3,ataxin 3,95,thiol-dependent ubiquitin-specific protease activity|ubiquitin protein ligase binding|thiol-dependent ubiquitinyl hydrolase activity|Lys63-specific deubiquitinase activity|Lys48-specific deubiquitinase activity,ptosis|congenital ptosis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|enophthalmos|orbital disease|exophthalmos|Machado-Joseph disease,ppi
14586,17546,4288,MKI67,marker of proliferation Ki-67,61,RNA binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|hepatitis|polyneuropathy|peripheral nervous system disease|neuropathy|pustulosis of palm and sole|psoriasis|parapsoriasis|mesenchymal chondrosarcoma|ovarian cancer|breast cancer,ppi
14587,17547,8195,MKKS,McKusick-Kaufman syndrome,20,,imperforate anus|asthma|intrinsic asthma|allergic asthma|obstructive jaundice|biliary tract disease|cerebellar disease|cryptorchidism|diabetic ketoacidosis|diabetes mellitus|congestive heart failure|Hirschsprung's disease|hypertrichosis|hydronephrosis|hypertension|essential hypertension|tooth agenesis|anodontia|hypogonadism|cystic kidney disease,ppi
14588,17548,4289,MKLN1,muskelin 1,53,,,ppi
14589,17549,408,ARRB1,arrestin beta 1,272,enzyme inhibitor activity|GTPase activator activity|transcription regulatory region DNA binding|histone acetyltransferase activity,liver cirrhosis|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
14590,17550,8569,MKNK1,MAP kinase interacting serine/threonine kinase 1,40,protein serine/threonine kinase activity|ATP binding|calmodulin-dependent protein kinase activity|calcium-dependent protein serine/threonine kinase activity|calmodulin binding,substance abuse|substance-related disorder,ppi
14591,17551,2872,MKNK2,MAP kinase interacting serine/threonine kinase 2,42,protein serine/threonine kinase activity|ATP binding|calmodulin binding|calmodulin-dependent protein kinase activity|calcium-dependent protein serine/threonine kinase activity,,ppi
14592,17552,23608,MKRN1,makorin ring finger protein 1,24,RNA binding|ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
14593,17553,23609,MKRN2,makorin ring finger protein 2,29,RNA binding,,ppi
14594,17554,7681,MKRN3,makorin ring finger protein 3,73,,Zollinger-Ellison syndrome|hyperinsulinism|hyperopia|bulimia nervosa|infertility|obesity|obstructive sleep apnea|congenital central hypoventilation syndrome|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|hypogonadism|photosensitivity disease|photosensitive epilepsy,ppi
14595,17555,409,ARRB2,arrestin beta 2,389,protein-containing complex scaffold activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|mood disorder|cocaine abuse|cocaine dependence|morphine dependence,ppi
14596,17556,54903,MKS1,Meckel syndrome; type 1,84,,anencephaly|imperforate anus|congenital heart disease|cerebellar disease|cleft lip|isolated cleft palate|cleft palate|autosomal recessive polycystic kidney disease|cryptorchidism|Dandy-Walker syndrome|patent ductus arteriosus|placental insufficiency|heart septal defect|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|hypertension|essential hypertension|hypogonadism,ppi
14597,17557,2315,MLANA,melan-A,3,,contact dermatitis|occupational dermatitis|melanoma|skin melanoma|malignant mesothelioma|benign mesothelioma,ppi
14598,17558,4291,MLF1,myeloid leukemia factor 1,111,DNA binding|protein domain specific binding,acute myeloid leukemia|stomach cancer,ppi
14599,17559,8079,MLF2,myeloid leukemia factor 2,49,DNA binding,,ppi
14600,17560,4292,MLH1,mutL homolog 1,174,single-stranded DNA binding|MutSalpha complex binding|ATPase activity,generalized anxiety disorder|anxiety disorder|colon cancer|colonic benign neoplasm|large intestine cancer|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|colorectal cancer|Lynch syndrome|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|malignant glioma|benign ependymoma,ppi
14601,17561,27030,MLH3,mutL homolog 3,46,satellite DNA binding|single-stranded DNA binding|ATPase activity,generalized anxiety disorder|anxiety disorder|colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|Lynch syndrome|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometrial cancer|endometrial carcinoma|epilepsy|esophageal cancer|glioblastoma multiforme|giant cell glioblastoma,ppi
14602,17562,410,ARSA,arylsulfatase A,25,arylsulfatase activity|cerebroside-sulfatase activity|calcium ion binding|sulfuric ester hydrolase activity,alcohol dependence|alcohol abuse|cerebellar disease|cholecystitis|syndromic X-linked intellectual disability type 10|choreatic disease|dystonia|epilepsy|metachromatic leukodystrophy|intellectual disability|learning disability|optic atrophy|locked-in syndrome|quadriplegia|visual epilepsy|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
14603,17563,4297,KMT2A,lysine methyltransferase 2A,103,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|AT DNA binding|DNA-binding transcription factor activity|zinc ion binding|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K4 specific)|protein homodimerization activity|transcription regulatory region DNA binding|unmethylated CpG binding|lysine-acetylated histone binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|urinary bladder cancer|blepharophimosis|transitional cell carcinoma|leukemia|lymphoblastic leukemia|myeloid leukemia|acute leukemia|B- and T-cell mixed leukemia|acute monocytic leukemia|acute myeloid leukemia|chronic monocytic leukemia|intellectual disability|learning disability|schizophrenia|stomach cancer,ppi
14604,17564,8085,KMT2D,lysine methyltransferase 2D,41,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|histone-lysine N-methyltransferase activity|histone methyltransferase activity (H3-K4 specific)|transcription regulatory region DNA binding|histone binding|transcription coactivator activity,hemolytic anemia|imperforate anus|urinary bladder cancer|ptosis|congenital ptosis|isolated cleft palate|cleft palate|congenital hypothyroidism|myxedema|hypothyroidism|cryptorchidism|benign breast phyllodes tumor|breast malignant phyllodes tumor|sensorineural hearing loss|epilepsy|heart septal defect|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4,ppi
14605,17565,4298,MLLT1,MLLT1; super elongation complex subunit,50,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,,ppi
14606,17566,4299,AFF1,AF4/FMR2 family member 1,34,DNA-binding transcription factor activity|double-stranded DNA binding,,ppi
14607,17567,4300,MLLT3,MLLT3; super elongation complex subunit,57,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|histone binding|lysine-acetylated histone binding|modification-dependent protein binding,bipolar disorder,ppi
14608,17568,4301,AFDN,afadin; adherens junction formation factor,85,protein C-terminus binding|Ras GTPase binding|cadherin binding|cell adhesion molecule binding,,ppi
14609,17569,4302,MLLT6,MLLT6; PHD finger domain containing,48,nucleosome binding,,ppi
14610,17570,4303,FOXO4,forkhead box O4,23,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|beta-catenin binding|sequence-specific DNA binding|transcription factor binding,,ppi
14611,17571,411,ARSB,arylsulfatase B,12,N-acetylgalactosamine-4-sulfatase activity|arylsulfatase activity,sensorineural hearing loss|glaucoma|heart valve disease|inguinal hernia|umbilical hernia|omphalocele|hypertrichosis|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|mucopolysaccharidosis|mucopolysaccharidosis II|mucopolysaccharidosis VI|mucopolysaccharidosis III|mucopolysaccharidosis IV|mucopolysaccharidosis I|chondrodysplasia punctata|cardiomyopathy|hypertrophic cardiomyopathy,ppi
14612,17572,4295,MLN,motilin,1,,,ppi
14613,17573,65108,MARCKSL1,MARCKS like 1,45,,,ppi
14614,17574,4308,TRPM1,transient receptor potential cation channel subfamily M member 1,4,calcium channel activity,dermatitis|myopia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|schizophrenia|hereditary night blindness,ppi
14615,17575,23417,MLYCD,malonyl-CoA decarboxylase,7,malonyl-CoA decarboxylase activity,lactic acidosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|epilepsy|hypoglycemia|visual epilepsy,ppi
14616,17577,23531,MMD,monocyte to macrophage differentiation associated,1,protein kinase activity|signaling receptor activity,,ppi
14617,17578,4311,MME,membrane metalloendopeptidase,107,endopeptidase activity|metalloendopeptidase activity|metallopeptidase activity|exopeptidase activity|zinc ion binding|peptide binding,diabetic autonomic neuropathy|diabetic polyneuropathy|diabetic neuropathy|prostate cancer|prostate carcinoma|breast cancer|kidney failure,ppi
14618,17579,4312,MMP1,matrix metallopeptidase 1,20,endopeptidase activity|metalloendopeptidase activity|serine-type endopeptidase activity,vascular disease|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|blepharitis|lung cancer|non-small cell lung carcinoma|large intestine cancer|colorectal cancer|constipation|pseudosarcomatous fibromatosis|dental caries|ectropion|chronic obstructive pulmonary disease|lung benign neoplasm|ocular hypertension|oral submucous fibrosis|osteoporosis,ppi
14619,17580,4319,MMP10,matrix metallopeptidase 10,16,metalloendopeptidase activity|serine-type endopeptidase activity,rheumatoid arthritis|asthma|intrinsic asthma|allergic asthma|bipolar disorder|contact dermatitis|occupational dermatitis|lung benign neoplasm|stomach cancer,ppi
14620,17581,4320,MMP11,matrix metallopeptidase 11,2,metalloendopeptidase activity|serine-type endopeptidase activity,lung cancer|non-small cell lung carcinoma,ppi
14621,17582,4321,MMP12,matrix metallopeptidase 12,6,core promoter binding|endopeptidase activity|metalloendopeptidase activity|serine-type endopeptidase activity|calcium ion binding|zinc ion binding|sequence-specific DNA binding,rheumatoid arthritis|colon cancer|colonic benign neoplasm,ppi
14622,17583,4322,MMP13,matrix metallopeptidase 13,8,metalloendopeptidase activity|serine-type endopeptidase activity|calcium ion binding|collagen binding|zinc ion binding,dental caries|arthropathy|arthritis|prostate cancer|prostate carcinoma|osteogenesis imperfecta|Ehlers-Danlos syndrome|spondyloepimetaphyseal dysplasia; Missouri type,ppi
14623,17584,4323,MMP14,matrix metallopeptidase 14,31,endopeptidase activity|metalloendopeptidase activity|serine-type endopeptidase activity|metalloaminopeptidase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|recurrent corneal erosion|esophageal cancer|gingival overgrowth|gingival hypertrophy|arthropathy|arthritis|neurogenic arthropathy|chronic obstructive pulmonary disease|osteoporosis|abdominal aortic aneurysm|breast cancer,ppi
14624,17585,4324,MMP15,matrix metallopeptidase 15,3,metalloendopeptidase activity|enzyme activator activity|metalloaminopeptidase activity,,ppi
14625,17586,4325,MMP16,matrix metallopeptidase 16,2,metalloendopeptidase activity|enzyme activator activity|zinc ion binding|metalloaminopeptidase activity,,ppi
14626,17587,4326,MMP17,matrix metallopeptidase 17,3,enzyme activator activity|metalloaminopeptidase activity,,ppi
14627,17588,4327,MMP19,matrix metallopeptidase 19,1,metalloendopeptidase activity|serine-type endopeptidase activity,,ppi
14628,17589,4313,MMP2,matrix metallopeptidase 2,63,metalloendopeptidase activity|serine-type endopeptidase activity|metallopeptidase activity,alcohol dependence|alcohol abuse|aortic disease|aortic aneurysm|rheumatoid arthritis|bone disease|cartilage disease|connective tissue disease|bone cancer|calcium metabolism disease|nephrocalcinosis|calcinosis|large intestine cancer|colorectal cancer|diabetic autonomic neuropathy|diabetic polyneuropathy|diabetic neuropathy|enophthalmos|orbital disease|exophthalmos,ppi
14629,17590,9313,MMP20,matrix metallopeptidase 20,1,metalloendopeptidase activity|serine-type endopeptidase activity,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia,ppi
14630,17592,8510,MMP23B,matrix metallopeptidase 23B,2,metalloendopeptidase activity|metallopeptidase activity|zinc ion binding,,ppi
14631,17593,10893,MMP24,matrix metallopeptidase 24,1,metalloendopeptidase activity|enzyme activator activity,,ppi
14632,17594,4314,MMP3,matrix metallopeptidase 3,27,endopeptidase activity|metalloendopeptidase activity|serine-type endopeptidase activity|metallopeptidase activity,astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|bipolar disorder|polyneuropathy|peripheral nervous system disease|neuropathy|schizophrenia|coronary restenosis|breast cancer|coronary artery disease,ppi
14633,17595,4316,MMP7,matrix metallopeptidase 7,37,metalloendopeptidase activity|serine-type endopeptidase activity|metallopeptidase activity,colon cancer|colonic benign neoplasm|stomach cancer,ppi
14634,17596,4317,MMP8,matrix metallopeptidase 8,9,metalloendopeptidase activity|serine-type endopeptidase activity|zinc ion binding,contact dermatitis|occupational dermatitis|lung disease|melanoma|skin melanoma|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
14635,17597,4318,MMP9,matrix metallopeptidase 9,48,endopeptidase activity|metalloendopeptidase activity|serine-type endopeptidase activity|collagen binding|metallopeptidase activity|zinc ion binding,alcohol dependence|alcohol abuse|aortic aneurysm|aortic disease|asthma|intrinsic asthma|allergic asthma|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|bipolar disorder|bone cancer|calcium metabolism disease,ppi
14636,17598,22915,MMRN1,multimerin 1,16,extracellular matrix structural constituent,,ppi
14637,17599,4329,ALDH6A1,aldehyde dehydrogenase 6 family member A1,21,fatty-acyl-CoA binding|RNA binding|methylmalonate-semialdehyde dehydrogenase (acylating) activity|malonate-semialdehyde dehydrogenase (acetylating) activity,amino acid metabolic disorder|dystonia|microphthalmia|obesity|cataract|coronary artery disease|lactic acidosis,ppi
14638,17600,4330,MN1,MN1 proto-oncogene; transcriptional regulator,3,,acute myeloid leukemia|meningioma|spinal meningioma|acoustic neuroma|intraventricular meningioma|pituitary adenoma|intraorbital meningioma|clear cell meningioma|benign meningioma|secretory meningioma|microcystic meningioma|cerebral convexity meningioma|angiomatous meningioma|parasagittal meningioma|psammomatous meningioma|fibrous meningioma|meningothelial meningioma|transitional meningioma|olfactory groove meningioma|familial meningioma,ppi
14639,17601,4331,MNAT1,MNAT1; CDK activating kinase assembly factor,87,zinc ion binding|DNA-dependent ATPase activity|RNA polymerase II CTD heptapeptide repeat kinase activity,,ppi
14640,17602,4332,MNDA,myeloid cell nuclear differentiation antigen,165,,,ppi
14641,17603,4335,MNT,MAX network transcriptional repressor,13,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|transcription corepressor activity,isolated cleft palate|cleft palate|chromosome 17p13.1 deletion syndrome,ppi
14642,17604,4336,MOBP,myelin-associated oligodendrocyte basic protein,6,myosin binding|actin binding|Rab GTPase binding,alcohol dependence|alcohol abuse|progressive muscular atrophy|amyotrophic lateral sclerosis|schizophrenia|progressive supranuclear palsy,ppi
14643,17605,415,ARSE,arylsulfatase E (chondrodysplasia punctata 1),4,arylsulfatase activity,sensorineural hearing loss|hypogonadism|ichthyosis|cataract|X-linked chondrodysplasia punctata|autosomal dominant chondrodysplasia punctata|chondrodysplasia punctata,ppi
14644,17606,4337,MOCS1,molybdenum cofactor synthesis 1,10,,epilepsy|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|purine-pyrimidine metabolic disorder|Arts syndrome|xanthinuria|locked-in syndrome|quadriplegia,ppi
14645,17607,4338,MOCS2,molybdenum cofactor synthesis 2,8,molybdopterin synthase activity,spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|purine-pyrimidine metabolic disorder|Arts syndrome|locked-in syndrome|quadriplegia,ppi
14646,17608,4340,MOG,myelin oligodendrocyte glycoprotein,4,signaling receptor binding,alcohol dependence|alcohol abuse|narcolepsy|demyelinating disease|Balo concentric sclerosis|adrenoleukodystrophy|central nervous system disease|obesity|schizophrenia|transient global amnesia,ppi
14647,17609,27136,MORC1,MORC family CW-type zinc finger 1,5,,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
14648,17610,4342,MOS,MOS proto-oncogene; serine/threonine kinase,56,protein serine/threonine kinase activity|MAP kinase kinase kinase activity,,ppi
14649,17611,55324,ABCF3,ATP binding cassette subfamily F member 3,33,cadherin binding,,ppi
14650,17612,4343,MOV10,Mov10 RISC complex RNA helicase,993,RNA binding,,ppi
14651,17613,54456,MOV10L1,Mov10 RISC complex RNA helicase like 1,1,magnesium ion binding|RNA binding|ATP-dependent RNA helicase activity|ATP binding,,ppi
14652,17614,4345,CD200,CD200 molecule,3,,,ppi
14653,17615,9526,MPDU1,mannose-P-dolichol utilization defect 1,11,,cerebellar disease|pseudosarcomatous fibromatosis|epilepsy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|acquired hyperkeratosis|congenital disorder of glycosylation type I,ppi
14654,17616,8777,MPDZ,multiple PDZ domain crumbs cell polarity complex component,43,,alcohol dependence|alcohol abuse|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|epilepsy|intellectual disability|learning disability|visual epilepsy|Wernicke-Korsakoff syndrome,ppi
14655,17617,416,ARSF,arylsulfatase F,3,arylsulfatase activity,,ppi
14656,17618,4350,MPG,N-methylpurine DNA glycosylase,93,damaged DNA binding|DNA N-glycosylase activity|alkylbase DNA N-glycosylase activity,,ppi
14657,17619,9585,KIF20B,kinesin family member 20B,29,microtubule binding|ATP-dependent microtubule motor activity; plus-end-directed|ATPase activity|protein homodimerization activity|microtubule motor activity,,ppi
14658,17620,10199,MPHOSPH10,M-phase phosphoprotein 10,50,RNA binding,,ppi
14659,17621,10200,MPHOSPH6,M-phase phosphoprotein 6,41,,,ppi
14660,17622,10198,MPHOSPH9,M-phase phosphoprotein 9,33,,,ppi
14661,17623,4351,MPI,mannose phosphate isomerase,21,mannose-6-phosphate isomerase activity,autosomal recessive polycystic kidney disease|factor XI deficiency|hypoglycemia|liver cirrhosis|elephantiasis|lymphedema|protein-losing enteropathy|thrombophilia|protein S deficiency|antithrombin III deficiency|protein C deficiency|celiac disease|blood coagulation disease|congenital disorder of glycosylation type I,ppi
14662,17624,4352,MPL,MPL proto-oncogene; thrombopoietin receptor,10,transmembrane signaling receptor activity|thrombopoietin receptor activity,anemia|macrocytic anemia|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|myelofibrosis|myeloproliferative neoplasm|bone marrow cancer|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag|pancytopenia,ppi
14663,17625,4353,MPO,myeloperoxidase,9,chromatin binding|peroxidase activity|heparin binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|rheumatoid arthritis|urinary bladder cancer|brain disease|heart disease|cardiovascular system disease,ppi
14664,17626,4354,MPP1,membrane palmitoylated protein 1,48,guanylate kinase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|lung benign neoplasm,ppi
14665,17627,4355,MPP2,membrane palmitoylated protein 2,24,,,ppi
14666,17628,4356,MPP3,membrane palmitoylated protein 3,37,,,ppi
14667,17629,4357,MPST,mercaptopyruvate sulfurtransferase,20,3-mercaptopyruvate sulfurtransferase activity,,ppi
14668,17630,4358,MPV17,MPV17; mitochondrial inner membrane protein,50,,lactic acidosis|cerebellar disease|cochlear disease|corneal ulcer|dystonia|focal segmental glomerulosclerosis|hypoglycemia|neonatal jaundice|liver cirrhosis|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|proteinuria|liver disease|recurrent corneal erosion|hepatitis|incontinentia pigmenti achromians|mitochondrial myopathy|mitochondrial metabolism disease,ppi
14669,17631,4359,MPZ,myelin protein zero,4,structural molecule activity,Charcot-Marie-Tooth disease type 2|hereditary motor and sensory neuropathy with agenesis of the corpus callosum|hereditary neuropathy with liability to pressure palsies|Charcot-Marie-Tooth disease type 1A|Charcot-Marie-Tooth disease type 1F|Charcot-Marie-Tooth disease type 1D|Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease type 1B|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease type 2A1|Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2B1|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2B|Charcot-Marie-Tooth disease axonal type 2T|Charcot-Marie-Tooth disease type 2R|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease type 2E,ppi
14670,17632,9019,MPZL1,myelin protein zero like 1,48,structural molecule activity,schizophrenia,ppi
14671,17633,22808,MRAS,muscle RAS oncogene homolog,16,,carotid artery disease|coronary artery disease,ppi
14672,17634,4360,MRC1,mannose receptor C-type 1,2,cargo receptor activity|transmembrane signaling receptor activity,allergic contact dermatitis,ppi
14673,17635,417,ART1,ADP-ribosyltransferase 1,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity|NAD+ ADP-ribosyltransferase activity,,ppi
14674,17636,4361,MRE11,MRE11 homolog; double strand break repair nuclease,123,single-stranded DNA endodeoxyribonuclease activity|double-stranded DNA binding|nuclease activity|endodeoxyribonuclease activity|3'-5' exonuclease activity|cadherin binding|DNA binding|ATP-dependent DNA helicase activity|double-stranded telomeric DNA binding|manganese ion binding|single-stranded telomeric DNA binding|endonuclease activity,syndromic X-linked intellectual disability type 10|choreatic disease|dystonia|hereditary hemorrhagic telangiectasia|capillary disease|telangiectasis|hereditary breast ovarian cancer syndrome|ataxia with oculomotor apraxia type 1,ppi
14675,17637,92399,MRRF,mitochondrial ribosome recycling factor,31,ribosomal large subunit binding,,ppi
14676,17638,10335,MRVI1,murine retrovirus integration site 1 homolog,3,,,ppi
14677,17639,419,ART3,ADP-ribosyltransferase 3,24,NAD+ ADP-ribosyltransferase activity,,ppi
14678,17640,420,ART4,ADP-ribosyltransferase 4 (Dombrock blood group),2,NAD(P)+-protein-arginine ADP-ribosyltransferase activity|NAD+ ADP-ribosyltransferase activity,,ppi
14679,17642,421,ARVCF,armadillo repeat gene deleted in velocardiofacial syndrome,19,cadherin binding,ptosis|congenital ptosis|isolated cleft palate|cleft palate|constipation|dental caries|DiGeorge syndrome|velocardiofacial syndrome|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect,ppi
14680,17643,9619,ABCG1,ATP binding cassette subfamily G member 1,6,ATP binding|phospholipid binding|phospholipid transporter activity|cholesterol binding|cholesterol transporter activity|toxin transmembrane transporter activity|sterol-transporting ATPase activity|glycoprotein transporter activity|protein homodimerization activity|ADP binding|protein dimerization activity|ATPase activity; coupled to transmembrane movement of substances,large intestine cancer|colorectal cancer|chronic kidney disease|mood disorder,ppi
14681,17644,931,MS4A1,membrane spanning 4-domains A1,18,MHC class II protein complex binding,hemolytic anemia|imperforate anus|bronchiectasis|lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|common variable immunodeficiency|primary immunodeficiency disease|lymphopenia|pneumonia|purpura|agammaglobulinemia|liver disease|lung adenocarcinoma|craniosynostosis|thrombocytopenia|thrombocytopenia due to platelet alloimmunization|autoimmune thrombocytopenic purpura|otitis media,ppi
14682,17645,2206,MS4A2,membrane spanning 4-domains A2,12,,,ppi
14683,17646,932,MS4A3,membrane spanning 4-domains A3,2,,,ppi
14684,17647,9242,MSC,musculin,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity,,ppi
14685,17648,10801,SEPT9,septin 9,62,GTPase activity|cadherin binding|protein-containing complex scaffold activity,blepharophimosis|ptosis|congenital ptosis|isolated cleft palate|cleft palate|enophthalmos|orbital disease|exophthalmos|acute myeloid leukemia|polyneuropathy|peripheral nervous system disease|neuropathy|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|amyotrophic neuralgia|brachial plexus neuritis,ppi
14686,17649,4436,MSH2,mutS homolog 2,146,DNA binding|guanine/thymine mispair binding|protein homodimerization activity|magnesium ion binding|four-way junction DNA binding|double-stranded DNA binding|single-stranded DNA binding|ATP binding|ATPase activity|mismatched DNA binding|dinucleotide insertion or deletion binding|single guanine insertion binding|single thymine insertion binding|dinucleotide repeat insertion binding|oxidized purine DNA binding|MutLalpha complex binding|ADP binding|DNA-dependent ATPase activity|Y-form DNA binding|protein kinase binding,generalized anxiety disorder|anxiety disorder|colon cancer|colonic benign neoplasm|large intestine cancer|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|colorectal cancer|Lynch syndrome|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|malignant glioma|benign ependymoma,ppi
14687,17650,4437,MSH3,mutS homolog 3,35,guanine/thymine mispair binding|protein homodimerization activity|oxidized purine DNA binding|single-stranded DNA binding|mismatched DNA binding|dinucleotide insertion or deletion binding|single guanine insertion binding|dinucleotide repeat insertion binding|centromeric DNA binding|Y-form DNA binding|single thymine insertion binding|double-strand/single-strand DNA junction binding|damaged DNA binding|DNA-dependent ATPase activity|heteroduplex DNA loop binding|ATP binding,prostate cancer|prostate carcinoma|lung cancer|lung adenocarcinoma|endometrial cancer|endometrial carcinoma|uterine corpus cancer,ppi
14688,17651,4438,MSH4,mutS homolog 4,11,DNA binding|DNA-dependent ATPase activity|single thymine insertion binding|ATP binding|guanine/thymine mispair binding|damaged DNA binding,,ppi
14689,17652,4439,MSH5,mutS homolog 5,7,single thymine insertion binding|DNA-dependent ATPase activity|guanine/thymine mispair binding|ATP binding|damaged DNA binding,,ppi
14690,17653,2956,MSH6,mutS homolog 6,101,mismatched DNA binding|methylated histone binding|magnesium ion binding|four-way junction DNA binding|double-stranded DNA binding|ATP binding|ATPase activity|guanine/thymine mispair binding|single guanine insertion binding|single thymine insertion binding|oxidized purine DNA binding|MutLalpha complex binding|ADP binding|damaged DNA binding|DNA-dependent ATPase activity,generalized anxiety disorder|anxiety disorder|colon cancer|colonic benign neoplasm|large intestine cancer|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|Lynch syndrome|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometrial cancer|endometrial carcinoma|malignant glioma,ppi
14691,17654,4440,MSI1,musashi RNA binding protein 1,8,RNA binding,,ppi
14692,17655,427,ASAH1,N-acylsphingosine amidohydrolase 1,34,catalytic activity|N-acylsphingosine amidohydrolase activity|hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds,arthropathy|arthritis|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease|intellectual disability|learning disability|progressive muscular atrophy|spinal muscular atrophy|focal hand dystonia|blepharospasm|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|osteoporosis|schizophrenia,ppi
14693,17656,27163,NAAA,N-acylethanolamine acid amidase,54,hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds,,ppi
14694,17657,10943,MSL3,male-specific lethal 3 homolog (Drosophila),16,DNA binding|methylated histone binding,,ppi
14695,17658,10232,MSLN,mesothelin,14,,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|malignant mesothelioma|benign mesothelioma|pancreatic cancer|pleural disease|stomach cancer|endometrial carcinoma|bile duct carcinoma|bile duct adenocarcinoma|intrahepatic cholangiocarcinoma|cholangiocarcinoma|pancreatic ductal carcinoma|ovarian cancer,ppi
14696,17659,4477,MSMB,microseminoprotein beta,2,,prostate cancer|prostate carcinoma,ppi
14697,17660,4478,MSN,moesin,141,double-stranded RNA binding|structural constituent of cytoskeleton,arthropathy|arthritis|coronary artery disease,ppi
14698,17661,4481,MSR1,macrophage scavenger receptor 1,12,amyloid-beta binding|scavenger receptor activity|low-density lipoprotein particle binding,Barrett's esophagus|chronic kidney disease|prostate cancer|prostate carcinoma|esophageal cancer|esophageal carcinoma,ppi
14699,17662,4482,MSRA,methionine sulfoxide reductase A,5,peptide-methionine (S)-S-oxide reductase activity,schizophrenia|substance abuse|substance-related disorder,ppi
14700,17663,429,ASCL1,achaete-scute family bHLH transcription factor 1,10,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|E-box binding|RNA polymerase II regulatory region sequence-specific DNA binding,heart disease|cardiovascular system disease|constipation|epilepsy|gangliocytoma|esophagitis|peptic esophagitis|gastroesophageal reflux disease|Hirschsprung's disease|megacolon|toxic megacolon|intellectual disability|learning disability|central nervous system disease|nervous system disease|autonomic neuropathy|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
14701,17664,4485,MST1,macrophage stimulating 1,10,receptor tyrosine kinase binding|serine-type endopeptidase activity,primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease,ppi
14702,17665,4486,MST1R,macrophage stimulating 1 receptor,33,macrophage colony-stimulating factor receptor activity|protein tyrosine kinase activity|transmembrane signaling receptor activity|Wnt-protein binding|transmembrane receptor protein tyrosine kinase activity,osteosarcoma|bone osteosarcoma,ppi
14703,17666,430,ASCL2,achaete-scute family bHLH transcription factor 2,10,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|E-box binding|RNA polymerase II regulatory region sequence-specific DNA binding,colon cancer|colonic benign neoplasm,ppi
14704,17667,4487,MSX1,msh homeobox 1,25,DNA-binding transcription factor activity; RNA polymerase II-specific,cleft lip|isolated cleft palate|cleft palate|tooth agenesis|anodontia|stomach cancer|tooth and nail syndrome|orofacial cleft|Wolf-Hirschhorn syndrome,ppi
14705,17668,4488,MSX2,msh homeobox 2,24,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coregulator activity|sequence-specific DNA binding|transcription regulatory region DNA binding,cleft lip|isolated cleft palate|cleft palate|epilepsy|visual epilepsy|craniosynostosis|parietal foramina,ppi
14706,17669,4489,MT1A,metallothionein 1A,5,zinc ion binding|metal ion binding,urinary bladder cancer|tongue squamous cell carcinoma|squamous cell carcinoma|hepatitis|liver cancer|hepatocellular carcinoma,ppi
14707,17671,4493,MT1E,metallothionein 1E,1,zinc ion binding|metal ion binding,,ppi
14708,17672,4494,MT1F,metallothionein 1F,2,zinc ion binding|metal ion binding,,ppi
14709,17673,4495,MT1G,metallothionein 1G,2,zinc ion binding|metal ion binding,esophageal cancer,ppi
14710,17674,9429,ABCG2,ATP binding cassette subfamily G member 2 (Junior blood group),8,transporter activity|xenobiotic transmembrane transporting ATPase activity|heme transporter activity|ATPase activity; coupled to transmembrane movement of substances|protein homodimerization activity|drug transmembrane transporter activity|cholesterol transporter activity,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|rheumatoid arthritis|large intestine cancer|colorectal cancer|primary biliary cirrhosis|central nervous system disease|nervous system disease|autonomic neuropathy|head and neck squamous cell carcinoma|breast cancer|acute T cell leukemia,ppi
14711,17675,56676,ASCL3,achaete-scute family bHLH transcription factor 3,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
14712,17676,4496,MT1H,metallothionein 1H,3,zinc ion binding|metal ion binding,,ppi
14713,17678,4501,MT1X,metallothionein 1X,5,zinc ion binding|metal ion binding,,ppi
14714,17679,4502,MT2A,metallothionein 2A,25,drug binding|zinc ion binding|metal ion binding,urinary bladder cancer|diabetic ketoacidosis|diabetes mellitus|heart disease|cardiovascular system disease|prostate cancer|prostate carcinoma|adult respiratory distress syndrome|newborn respiratory distress syndrome|stomach cancer|chronic kidney disease|liver cancer|hepatocellular carcinoma,ppi
14715,17680,4504,MT3,metallothionein 3,3,copper ion binding|drug binding|zinc ion binding|antioxidant activity|protein kinase activator activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|cadmium ion binding|metal ion binding,urinary bladder cancer|lung cancer|non-small cell lung carcinoma|adult respiratory distress syndrome|newborn respiratory distress syndrome|epilepsy|visual epilepsy|breast cancer,ppi
14716,17681,9112,MTA1,metastasis associated 1,113,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator activity|transcription corepressor activity|histone deacetylase activity|obsolete transcription factor activity; transcription factor binding|histone deacetylase binding|RNA polymerase II repressing transcription factor binding,endometriosis of uterus|endometriosis,ppi
14717,17682,9219,MTA2,metastasis associated 1 family member 2,131,DNA-binding transcription factor activity; RNA polymerase II-specific|histone deacetylase activity|transcription regulatory region sequence-specific DNA binding|nucleosomal DNA binding|obsolete transcription factor activity; transcription factor binding|RNA polymerase II repressing transcription factor binding|transcription corepressor activity|transcription coactivator activity|histone deacetylase binding,endometriosis of uterus|endometriosis,ppi
14718,17683,4507,MTAP,methylthioadenosine phosphorylase,51,phosphorylase activity|S-methyl-5-thioadenosine phosphorylase activity,melanoma|skin melanoma|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag|prostate cancer|prostate carcinoma,ppi
14719,17684,4508,MT-ATP6,mitochondrially encoded ATP synthase 6,6,transmembrane transporter activity|ATPase activity,sick sinus syndrome|cerebellar disease|diabetic ketoacidosis|diabetes mellitus|dystonia|epilepsy|Leigh disease|familial periodic paralysis|myopathy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|polyneuropathy|peripheral nervous system disease|neuropathy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
14720,17685,4509,MT-ATP8,mitochondrially encoded ATP synthase 8,20,transmembrane transporter activity|ATPase activity,cerebellar disease|sensorineural hearing loss|Kearns-Sayre syndrome|chronic progressive external ophthalmoplegia|muscular atrophy,ppi
14721,17686,27085,MTBP,MDM2 binding protein,7,,,ppi
14722,17687,4512,MT-CO1,mitochondrially encoded cytochrome c oxidase I,42,cytochrome-c oxidase activity,lactic acidosis|generalized anxiety disorder|anxiety disorder|ptosis|congenital ptosis|cerebellar disease|brain ischemia|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types,ppi
14723,17688,432,ASGR1,asialoglycoprotein receptor 1,21,,,ppi
14724,17689,4513,MT-CO2,mitochondrially encoded cytochrome c oxidase II,68,cytochrome-c oxidase activity,lactic acidosis|generalized anxiety disorder|anxiety disorder|ptosis|congenital ptosis|cerebellar disease|brain ischemia|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types,ppi
14725,17690,4514,MT-CO3,mitochondrially encoded cytochrome c oxidase III,10,oxidoreduction-driven active transmembrane transporter activity|electron transfer activity|cytochrome-c oxidase activity,lactic acidosis|generalized anxiety disorder|anxiety disorder|sick sinus syndrome|ptosis|congenital ptosis|cerebellar disease|brain ischemia|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18,ppi
14726,17691,4515,MTCP1,mature T-cell proliferation 1,5,protein serine/threonine kinase activator activity,,ppi
14727,17692,4519,MT-CYB,mitochondrially encoded cytochrome b,10,ubiquinol-cytochrome-c reductase activity,lactic acidosis|sick sinus syndrome|cerebellar disease|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset,ppi
14728,17693,4520,MTF1,metal regulatory transcription factor 1,4,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|RNA polymerase II regulatory region sequence-specific DNA binding,autistic disorder,ppi
14729,17694,433,ASGR2,asialoglycoprotein receptor 2,44,asialoglycoprotein receptor activity,,ppi
14730,17695,4522,MTHFD1,methylenetetrahydrofolate dehydrogenase; cyclohydrolase and formyltetrahydrofolate synthetase 1,94,formate-tetrahydrofolate ligase activity|methenyltetrahydrofolate cyclohydrolase activity|methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity|methylenetetrahydrofolate dehydrogenase (NAD+) activity|methylenetetrahydrofolate dehydrogenase (NADP+) activity,bipolar disorder|schizophrenia|neural tube defect,ppi
14731,17696,10797,MTHFD2,methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2; methenyltetrahydrofolate cyclohydrolase,25,magnesium ion binding|methenyltetrahydrofolate cyclohydrolase activity|methylenetetrahydrofolate dehydrogenase (NAD+) activity|methylenetetrahydrofolate dehydrogenase (NADP+) activity|phosphate ion binding,Hodgkin's lymphoma; lymphocytic-histiocytic predominance|Hodgkin's lymphoma|Hodgkin's lymphoma; lymphocytic depletion|Hodgkin's granuloma|Hodgkin's lymphoma; mixed cellularity,ppi
14732,17697,4524,MTHFR,methylenetetrahydrofolate reductase,21,methylenetetrahydrofolate reductase (NAD(P)H) activity|flavin adenine dinucleotide binding|modified amino acid binding|FAD binding,adrenal cortical hypofunction|Addison's disease|bipolar disorder|mood disorder|alcohol dependence|alcohol abuse|alopecia|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease,ppi
14733,17698,10588,MTHFS,5;10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase),3,ATP binding|folic acid binding|5-formyltetrahydrofolate cyclo-ligase activity,cleft lip|isolated cleft palate|cleft palate,ppi
14734,17699,9070,ASH2L,ASH2 like histone lysine methyltransferase complex subunit,85,beta-catenin binding|histone-lysine N-methyltransferase activity|transcription regulatory region DNA binding|histone methyltransferase activity (H3-K4 specific),,ppi
14735,17700,4528,MTIF2,mitochondrial translational initiation factor 2,40,RNA binding|translation factor activity; RNA binding|ribosomal small subunit binding,,ppi
14736,17702,4534,MTM1,myotubularin 1,32,phosphatidylinositol-3-phosphatase activity|phosphoprotein phosphatase activity|intermediate filament binding|phosphatidylinositol binding|phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity,atrioventricular block|ptosis|congenital ptosis|pseudosarcomatous fibromatosis|cryptorchidism|diaphragmatic eventration|epilepsy|hemangioma|cavernous hemangioma|capillary hemangioma|polyhydramnios|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|pyloric stenosis|visual epilepsy|liver disease|ophthalmoplegia|chronic progressive external ophthalmoplegia,ppi
14737,17703,8776,MTMR1,myotubularin related protein 1,26,phosphatidylinositol-3-phosphatase activity|phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity,,ppi
14738,17704,434,ASIP,agouti signaling protein,6,signaling receptor binding,basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|melanoma|skin melanoma|skin benign neoplasm|skin cancer,ppi
14739,17705,8898,MTMR2,myotubularin related protein 2,33,phosphatidylinositol-3-phosphatase activity|protein tyrosine/serine/threonine phosphatase activity|phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity,clubfoot|Bell's palsy|facial paralysis|Charcot-Marie-Tooth disease type 4B1,ppi
14740,17706,8897,MTMR3,myotubularin related protein 3,33,phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity,,ppi
14741,17707,9110,MTMR4,myotubularin related protein 4,46,phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity,malignant mesothelioma|benign mesothelioma,ppi
14742,17708,9107,MTMR6,myotubularin related protein 6,36,phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|calcium-activated potassium channel activity|phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity|phosphatidylinositol-3;5-bisphosphate phosphatase activity,,ppi
14743,17709,9108,MTMR7,myotubularin related protein 7,38,phosphatidylinositol-3-phosphatase activity|phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity,,ppi
14744,17710,4535,MT-ND1,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1,45,NADH dehydrogenase (ubiquinone) activity|NADH dehydrogenase activity,lactic acidosis|generalized anxiety disorder|anxiety disorder|sick sinus syndrome|bipolar disorder|ptosis|congenital ptosis|cerebellar disease|brain ischemia|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42,ppi
14745,17711,4536,MT-ND2,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2,12,NADH dehydrogenase (ubiquinone) activity,sick sinus syndrome|cerebellar disease|dystonia|familial periodic paralysis|myopathy|optic atrophy|polyneuropathy|peripheral nervous system disease|neuropathy|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy|retinal telangiectasia|amblyopia|Leber hereditary optic neuropathy|Alzheimer's disease|mitochondrial complex I deficiency|nutritional optic neuropathy,ppi
14746,17712,4537,MT-ND3,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3,2,NADH dehydrogenase (ubiquinone) activity,Leigh disease|mitochondrial complex I deficiency,ppi
14747,17713,4538,MT-ND4,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4,31,NADH dehydrogenase (ubiquinone) activity|NADH dehydrogenase activity|ubiquinone binding,lactic acidosis|generalized anxiety disorder|anxiety disorder|sick sinus syndrome|ptosis|congenital ptosis|cerebellar disease|brain ischemia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetes mellitus|type 2 diabetes mellitus|dystonia|sensorineural hearing loss|familial periodic paralysis|myopathy,ppi
14748,17714,435,ASL,argininosuccinate lyase,16,argininosuccinate lyase activity,brain edema|cerebellar disease|epilepsy|intellectual disability|learning disability|visual epilepsy|urea cycle disorder|liver cirrhosis|argininosuccinic aciduria,ppi
14749,17715,4539,MT-ND4L,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L,3,NADH dehydrogenase (ubiquinone) activity,sick sinus syndrome|cerebellar disease|dystonia|familial periodic paralysis|myopathy|optic atrophy|polyneuropathy|peripheral nervous system disease|neuropathy|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy|retinal telangiectasia|amblyopia|Leber hereditary optic neuropathy|nutritional optic neuropathy,ppi
14750,17716,4540,MT-ND5,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5,30,NADH dehydrogenase (ubiquinone) activity,lactic acidosis|generalized anxiety disorder|anxiety disorder|sick sinus syndrome|ptosis|congenital ptosis|cerebellar disease|brain ischemia|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18,ppi
14751,17717,4541,MT-ND6,mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6,6,,lactic acidosis|generalized anxiety disorder|anxiety disorder|sick sinus syndrome|ptosis|congenital ptosis|cerebellar disease|brain ischemia|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18,ppi
14752,17718,4543,MTNR1A,melatonin receptor 1A,153,melatonin receptor activity,retinitis|retinal disease|schizophrenia|autistic disorder,ppi
14753,17719,4544,MTNR1B,melatonin receptor 1B,131,G-protein coupled receptor activity,diabetes mellitus|type 2 diabetes mellitus|polycystic ovary syndrome|schizophrenia|autistic disorder,ppi
14754,17720,4547,MTTP,microsomal triglyceride transfer protein,5,lipid transporter activity|phospholipid transporter activity|protein heterodimerization activity,chorea-acanthocytosis|abetalipoproteinemia|hypolipoproteinemia|Tangier disease|Norum disease|cerebellar disease|fatty liver disease|movement disease|lingual-facial-buccal dyskinesia|retinitis|retinal disease|metabolic syndrome X,ppi
14755,17721,4548,MTR,5-methyltetrahydrofolate-homocysteine methyltransferase,33,methionine synthase activity,megaloblastic anemia|bipolar disorder|cleft lip|isolated cleft palate|cleft palate|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|Down syndrome|epilepsy|gastroenteritis|intestinal disease|gastrointestinal system disease|proctitis|hematopoietic system disease|homocystinuria|male infertility,ppi
14756,17722,9617,MTRF1,mitochondrial translation release factor 1,5,,,ppi
14757,17723,4552,MTRR,5-methyltetrahydrofolate-homocysteine methyltransferase reductase,11,NADPH-hemoprotein reductase activity|FMN binding|oxidoreductase activity; oxidizing metal ions; NAD or NADP as acceptor|[methionine synthase] reductase activity|aquacobalamin reductase (NADPH) activity|flavin adenine dinucleotide binding|NADP binding|NADPH binding|FAD binding|oxidoreductase activity,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|anemia|macrocytic anemia|megaloblastic anemia|large intestine cancer|colorectal cancer|epilepsy|homocystinuria|male infertility|central nervous system disease|nervous system disease|autonomic neuropathy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus,ppi
14758,17725,4580,MTX1,metaxin 1,36,,,ppi
14759,17726,10651,MTX2,metaxin 2,29,,,ppi
14760,17727,4582,MUC1,mucin 1; cell surface associated,54,RNA polymerase II proximal promoter sequence-specific DNA binding|transcription coregulator activity,anemia|macrocytic anemia|gout|hypertension|essential hypertension|malignant mesothelioma|benign mesothelioma|multiple myeloma|stomach cancer|renal infectious disease|interstitial nephritis|pyelonephritis|renal osteodystrophy|cerebral degeneration,ppi
14761,17728,8623,ASMTL,acetylserotonin O-methyltransferase-like,14,,acute myeloid leukemia,ppi
14762,17729,10071,MUC12,mucin 12; cell surface associated,2,,,ppi
14763,17730,56667,MUC13,mucin 13; cell surface associated,12,protein homodimerization activity,,ppi
14764,17731,4583,MUC2,mucin 2; oligomeric mucus/gel-forming,8,,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|intestinal cancer|intestinal benign neoplasm|rectal neoplasm|rectum cancer,ppi
14765,17732,4584,MUC3A,mucin 3A; cell surface associated,2,extracellular matrix structural constituent|extracellular matrix constituent; lubricant activity,inflammatory bowel disease|ulcerative colitis,ppi
14766,17733,4585,MUC4,mucin 4; cell surface associated,5,ErbB-2 class receptor binding|extracellular matrix constituent; lubricant activity,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|prostate cancer|prostate carcinoma,ppi
14767,17734,4586,MUC5AC,mucin 5AC; oligomeric mucus/gel-forming,5,extracellular matrix structural constituent,,ppi
14768,17735,727897,MUC5B,mucin 5B; oligomeric mucus/gel-forming,15,,idiopathic interstitial pneumonia|idiopathic pulmonary fibrosis,ppi
14769,17736,4588,MUC6,mucin 6; oligomeric mucus/gel-forming,1,extracellular matrix structural constituent,stomach cancer,ppi
14770,17737,4589,MUC7,mucin 7; secreted,24,,asthma|intrinsic asthma|allergic asthma,ppi
14771,17738,439,ASNA1,arsA arsenite transporter; ATP-binding; homolog 1 (bacterial),46,transporter activity|arsenite transmembrane transporter activity|ATPase activity,,ppi
14772,17739,53841,CDHR5,cadherin related family member 5,13,calcium ion binding|cell adhesion molecule binding,,ppi
14773,17740,4591,TRIM37,tripartite motif containing 37,92,ubiquitin-protein transferase activity|protein homodimerization activity|ubiquitin protein ligase activity,astigmatism|placental insufficiency|McCune Albright syndrome|congestive heart failure|tooth agenesis|anodontia|tongue disease|adenosarcoma|nephroblastoma|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
14774,17741,4593,MUSK,muscle associated receptor tyrosine kinase,14,protein tyrosine kinase activity|Wnt-protein binding|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,blepharophimosis|ptosis|congenital ptosis|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|enophthalmos|orbital disease|exophthalmos|placental insufficiency|polyhydramnios|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|myasthenia gravis|ophthalmoplegia|cystic lymphangioma|Bell's palsy,ppi
14775,17742,4594,MUT,methylmalonyl-CoA mutase,13,GTPase activity|methylmalonyl-CoA mutase activity|cobalamin binding|identical protein binding|protein homodimerization activity|modified amino acid binding,dystonia|primary immunodeficiency disease|leukopenia|intellectual disability|learning disability|inherited metabolic disorder|obesity|acute pancreatitis|pancreatitis|thrombocytopenia|renal infectious disease|interstitial nephritis|pyelonephritis|urea cycle disorder|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency,ppi
14776,17743,4595,MUTYH,mutY DNA glycosylase,21,purine-specific mismatch base pair DNA N-glycosylase activity|DNA N-glycosylase activity|MutSalpha complex binding|MutLalpha complex binding|MutLbeta complex binding|MutSbeta complex binding|8-oxo-7;8-dihydroguanine DNA N-glycosylase activity|oxidized purine DNA binding|adenine/guanine mispair binding,colon cancer|colonic benign neoplasm|familial adenomatous polyposis|islet cell tumor|stomach cancer|pilomatrixoma|hair follicle neoplasm|stomach carcinoma,ppi
14777,17744,4597,MVD,mevalonate diphosphate decarboxylase,33,diphosphomevalonate decarboxylase activity|protein homodimerization activity,porokeratosis,ppi
14778,17745,440,ASNS,asparagine synthetase (glutamine-hydrolyzing),85,asparagine synthase (glutamine-hydrolyzing) activity|protein homodimerization activity,epilepsy|chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease|visual epilepsy|brain disease|cortical blindness|hyperekplexia 1|locked-in syndrome|quadriplegia|infantile epileptic encephalopathy,ppi
14779,17746,4598,MVK,mevalonate kinase,15,magnesium ion binding|mevalonate kinase activity|ATP binding|identical protein binding,arthropathy|arthritis|cerebellar disease|congestive heart failure|epilepsy|exanthem|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|aphthous stomatitis|thrombocytopenia|angioedema|vasculitis|central nervous system origin vertigo,ppi
14780,17747,9961,MVP,major vault protein,86,protein phosphatase binding,arthropathy|arthritis,ppi
14781,17748,4599,MX1,MX dynamin like GTPase 1,45,GTPase activity|microtubule binding,Fanconi anemia|influenza|acute myeloid leukemia|stomach cancer|coronary artery disease,ppi
14782,17749,4600,MX2,MX dynamin like GTPase 2,3,GTP binding|microtubule binding|GTPase activity,influenza|melanoma|skin melanoma,ppi
14783,17750,4601,MXI1,MAX interactor 1; dimerization protein,20,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription corepressor activity|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription repressor activity; RNA polymerase II-specific,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|prostate cancer|prostate carcinoma,ppi
14784,17751,25878,MXRA5,matrix remodeling associated 5,4,,lung cancer|non-small cell lung carcinoma|bronchus carcinoma|lung carcinoma|bronchus cancer,ppi
14785,17752,439921,MXRA7,matrix remodeling associated 7,6,,,ppi
14786,17753,54587,MXRA8,matrix remodeling associated 8,1,,,ppi
14787,17754,91663,MYADM,myeloid associated differentiation marker,25,,,ppi
14788,17755,4602,MYB,MYB proto-oncogene; transcription factor,75,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,asthma|intrinsic asthma|allergic asthma|salivary gland adenoid cystic carcinoma|malignant glioma|gliosarcoma|mixed glioma|natural killer cell leukemia|acute T cell leukemia,ppi
14789,17756,10514,MYBBP1A,MYB binding protein 1a,146,transcription corepressor activity|RNA binding|transcription factor binding|sequence-specific DNA binding,,ppi
14790,17757,4603,MYBL1,MYB proto-oncogene like 1,8,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,salivary gland adenoid cystic carcinoma|malignant glioma|gliosarcoma|mixed glioma|polycystic ovary syndrome,ppi
14791,17758,4605,MYBL2,MYB proto-oncogene like 2,52,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
14792,17759,4604,MYBPC1,myosin binding protein C; slow type,25,structural constituent of muscle|titin binding|actin filament binding|muscle alpha-actinin binding,distal arthrogryposis|clubfoot,ppi
14793,17760,4606,MYBPC2,myosin binding protein C; fast type,34,structural constituent of muscle|actin filament binding|muscle alpha-actinin binding,,ppi
14794,17761,4607,MYBPC3,myosin binding protein C; cardiac,22,ATPase activator activity|structural constituent of muscle|myosin binding|titin binding|muscle alpha-actinin binding|actin filament binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
14795,17762,4608,MYBPH,myosin binding protein H,10,structural constituent of muscle,,ppi
14796,17763,4609,MYC,v-myc avian myelocytomatosis viral oncogene homolog,889,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|protein-containing complex binding|E-box binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|urinary bladder cancer|bone marrow disease|Burkitt lymphoma|lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cervical cancer|cleft lip|isolated cleft palate|cleft palate|colon cancer,ppi
14797,17764,26292,MYCBP,MYC binding protein,44,transcription coactivator activity,salivary gland adenoid cystic carcinoma,ppi
14798,17765,4610,MYCL,v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog,41,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|prostate cancer|prostate carcinoma|lung small cell carcinoma,ppi
14799,17766,4613,MYCN,v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog,30,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,blepharophimosis|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|salivary gland adenoid cystic carcinoma|sensorineural hearing loss|patent ductus arteriosus|esophageal atresia|polyhydramnios|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|intellectual disability|learning disability|neuroblastoma|annular pancreas|familial retinoblastoma,ppi
14800,17767,443,ASPA,aspartoacylase,5,aminoacylase activity|aspartoacylase activity,sensorineural hearing loss|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|Canavan disease,ppi
14801,17768,4615,MYD88,myeloid differentiation primary response 88,63,death receptor binding|protein self-association,hypereosinophilic syndrome|hypertension|essential hypertension|primary immunodeficiency disease|leukemia|lymphosarcoma|lymphoma|central nervous system lymphoma|lymphoplasmacytic lymphoma|macroglobulinemia|polyneuropathy|peripheral nervous system disease|neuropathy|pneumonia|central nervous system origin vertigo|normocytic anemia|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy|mental depression,ppi
14802,17769,26579,MYEOV,myeloma overexpressed,2,,,ppi
14803,17770,4617,MYF5,myogenic factor 5,9,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|protein heterodimerization activity|E-box binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
14804,17771,4618,MYF6,myogenic factor 6,18,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|protein heterodimerization activity|E-box binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific,Duchenne muscular dystrophy|muscular dystrophy|centronuclear myopathy|congenital structural myopathy,ppi
14805,17772,4619,MYH1,myosin heavy chain 1,28,,,ppi
14806,17773,4628,MYH10,myosin heavy chain 10,97,microfilament motor activity|actin binding|ATP binding|ATPase activity|actin-dependent ATPase activity|RNA stem-loop binding|ADP binding|mRNA 5'-UTR binding|actin filament binding,focal segmental glomerulosclerosis,ppi
14807,17774,4629,MYH11,myosin heavy chain 11,58,structural constituent of muscle,aortic valve insufficiency|patent ductus arteriosus|polyhydramnios|hypertension|essential hypertension|congestive heart failure|acute myeloid leukemia|aortic valve stenosis|megacystis-microcolon-intestinal hypoperistalsis syndrome|thoracic aortic aneurysm|Loeys-Dietz syndrome|coronary artery disease|Meckel syndrome|autosomal dominant polycystic kidney disease,ppi
14808,17775,444,ASPH,aspartate beta-hydroxylase,45,structural molecule activity|calcium ion binding|structural constituent of muscle|electron transfer activity,,ppi
14809,17776,8735,MYH13,myosin heavy chain 13,28,microfilament motor activity,arthropathy|arthritis,ppi
14810,17777,4620,MYH2,myosin heavy chain 2,25,microfilament motor activity,familial periodic paralysis|myopathy|inclusion body myositis,ppi
14811,17778,4621,MYH3,myosin heavy chain 3,21,microfilament motor activity|calmodulin binding|myosin phosphatase activity|ATPase activity; coupled|actin filament binding,blepharophimosis|ptosis|congenital ptosis|clubfoot|cryptorchidism|sensorineural hearing loss|enophthalmos|orbital disease|exophthalmos|epilepsy|inguinal hernia|malignant hyperthermia|visual epilepsy|skin disease|seborrheic keratosis|actinic keratosis|speech disorder|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
14812,17779,4622,MYH4,myosin heavy chain 4,21,microfilament motor activity|double-stranded RNA binding|ATPase activity,,ppi
14813,17780,4624,MYH6,myosin heavy chain 6,34,microfilament motor activity|ATPase activity|myosin phosphatase activity|actin-dependent ATPase activity,sick sinus syndrome|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
14814,17781,4625,MYH7,myosin heavy chain 7,46,microfilament motor activity|ATPase activity|actin-dependent ATPase activity,sick sinus syndrome|atrial fibrillation|ptosis|congenital ptosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P,ppi
14815,17782,4626,MYH8,myosin heavy chain 8,13,microfilament motor activity|ATP binding|structural constituent of muscle|ATPase activity|myosin phosphatase activity|myosin light chain binding|actin filament binding,ptosis|congenital ptosis|clubfoot|distal arthrogryposis|Carney complex,ppi
14816,17783,4627,MYH9,myosin heavy chain 9,368,microfilament motor activity|RNA binding|motor activity|actin binding|ATP binding|ATPase activity|actin-dependent ATPase activity|protein homodimerization activity|protein membrane anchor|ADP binding|cadherin binding|actin filament binding,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
14817,17784,445,ASS1,argininosuccinate synthase 1,85,RNA binding|argininosuccinate synthase activity|amino acid binding,brain edema|cerebellar disease|diabetic angiopathy|epilepsy|liver cirrhosis|intellectual disability|learning disability|visual epilepsy|citrullinemia|urea cycle disorder,ppi
14818,17785,4632,MYL1,myosin light chain 1,12,structural constituent of muscle,,ppi
14819,17786,4633,MYL2,myosin light chain 2,17,actin monomer binding|calcium ion binding|structural constituent of muscle|myosin heavy chain binding,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|familial periodic paralysis|myopathy|catecholaminergic polymorphic ventricular tachycardia|catecholaminergic polymorphic ventricular tachycardia 1|catecholaminergic polymorphic ventricular tachycardia 2|catecholaminergic polymorphic ventricular tachycardia 3|catecholaminergic polymorphic ventricular tachycardia 4|catecholaminergic polymorphic ventricular tachycardia 5|centronuclear myopathy|congenital structural myopathy|muscular dystrophy-dystroglycanopathy|megaconial type congenital muscular dystrophy|rigid spine muscular dystrophy 1|congenital muscular dystrophy 1B|muscular dystrophy-dystroglycanopathy type B5|congenital merosin-deficient muscular dystrophy 1A|muscular dystrophy-dystroglycanopathy type B6,ppi
14820,17787,4634,MYL3,myosin light chain 3,11,actin monomer binding|structural constituent of muscle|myosin II heavy chain binding,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|restrictive cardiomyopathy|hypertrophic cardiomyopathy 8,ppi
14821,17788,4635,MYL4,myosin light chain 4,5,actin monomer binding|myosin II heavy chain binding|actin filament binding,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|familial atrial fibrillation,ppi
14822,17789,4636,MYL5,myosin light chain 5,3,structural constituent of muscle,,ppi
14823,17790,4637,MYL6,myosin light chain 6,95,motor activity|structural constituent of muscle|actin-dependent ATPase activity,,ppi
14824,17791,4638,MYLK,myosin light chain kinase,27,myosin light chain kinase activity|protein kinase activity,aortic aneurysm|aortic valve insufficiency|gastroenteritis|intestinal disease|gastrointestinal system disease|proctitis|glaucoma|malignant glioma|gliosarcoma|mixed glioma|allergic hypersensitivity disease|hypertension|essential hypertension|congestive heart failure|pneumonia|vascular disease|thoracic aortic aneurysm|brain edema|Loeys-Dietz syndrome|coronary artery disease,ppi
14825,17792,4651,MYO10,myosin X,27,motor activity|phosphatidylinositol-3;4;5-trisphosphate binding|spectrin binding|actin-dependent ATPase activity|actin filament binding|plus-end directed microfilament motor activity,,ppi
14826,17793,51168,MYO15A,myosin XVA,5,,autosomal recessive nonsyndromic deafness 3,ppi
14827,17794,4640,MYO1A,myosin IA,16,,sensorineural hearing loss|autosomal dominant nonsyndromic deafness 48,ppi
14828,17795,4430,MYO1B,myosin IB,68,microfilament motor activity|ATP binding|phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3;4;5-trisphosphate binding|cadherin binding|actin filament binding,,ppi
14829,17796,4641,MYO1C,myosin IC,204,,,ppi
14830,17797,4642,MYO1D,myosin ID,60,microfilament motor activity|calmodulin binding|actin-dependent ATPase activity|calcium-dependent protein binding|actin filament binding,autistic disorder,ppi
14831,17798,4643,MYO1E,myosin IE,64,microfilament motor activity|motor activity|calmodulin binding|phosphatidylinositol binding|ATPase activity; coupled|actin filament binding,congestive heart failure|focal segmental glomerulosclerosis|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|proteinuria|chronic kidney disease,ppi
14832,17799,25,ABL1,ABL proto-oncogene 1; non-receptor tyrosine kinase,353,magnesium ion binding|DNA binding|actin monomer binding|nicotinate-nucleotide adenylyltransferase activity|protein kinase activity|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|ATP binding|kinase activity|manganese ion binding|ephrin receptor binding|proline-rich region binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|esophageal cancer|chronic myeloid leukemia|liver cancer|myeloproliferative neoplasm|bone marrow cancer|thrombocytopenia|thrombocytosis|breast cancer|acute lymphocytic leukemia,ppi
14833,17800,4542,MYO1F,myosin IF,12,actin binding|ATP binding,,ppi
14834,17801,53904,MYO3A,myosin IIIA,5,microfilament motor activity|protein kinase activity|calmodulin binding|actin-dependent ATPase activity|ADP binding|plus-end directed microfilament motor activity,autosomal recessive nonsyndromic deafness 30,ppi
14835,17802,4644,MYO5A,myosin VA,64,microfilament motor activity|RNA binding,cerebellar disease|epilepsy|familial hyperlipidemia|intellectual disability|learning disability|movement disease|lingual-facial-buccal dyskinesia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|polyneuropathy|peripheral nervous system disease|neuropathy|retinitis|retinal disease|visual epilepsy|piebaldism|Griscelli syndrome type 3|Griscelli syndrome type 1,ppi
14836,17803,4645,MYO5B,myosin VB,43,microfilament motor activity,intestinal disease|gastrointestinal system disease|liver cancer|inherited metabolic disorder|schizophrenia|marasmus|kwashiorkor|protein-energy malnutrition|nutrition disease|microvillus inclusion disease|mood disorder|celiac disease,ppi
14837,17804,55930,MYO5C,myosin VC,98,,substance abuse|substance-related disorder,ppi
14838,17805,4646,MYO6,myosin VI,102,motor activity|actin binding|calmodulin binding|ADP binding|actin filament binding|minus-end directed microfilament motor activity,substance abuse|substance-related disorder|autosomal dominant nonsyndromic deafness|autosomal recessive nonsyndromic deafness|X-linked nonsyndromic deafness|autosomal dominant auditory neuropathy 1|autosomal recessive nonsyndromic deafness 101|autosomal recessive nonsyndromic deafness 102|autosomal recessive nonsyndromic deafness 103|autosomal recessive nonsyndromic deafness 104|autosomal recessive nonsyndromic deafness 105|autosomal recessive nonsyndromic deafness 12|autosomal recessive nonsyndromic deafness 13|autosomal recessive nonsyndromic deafness 14|autosomal recessive nonsyndromic deafness 15|autosomal recessive nonsyndromic deafness 16|autosomal recessive nonsyndromic deafness 17|autosomal recessive nonsyndromic deafness 18A|autosomal recessive nonsyndromic deafness 18B|autosomal recessive nonsyndromic deafness 1A,ppi
14839,17806,4647,MYO7A,myosin VIIA,17,microfilament motor activity|calmodulin binding|spectrin binding|actin filament binding,cerebellar disease|sensorineural hearing loss|melanoma|skin melanoma|intellectual disability|learning disability|myopia|night blindness|congenital stationary night blindness|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|schizophrenia|scotoma|central nervous system origin vertigo|cataract|Usher syndrome|retinitis pigmentosa-deafness syndrome|autosomal dominant nonsyndromic deafness|autosomal recessive nonsyndromic deafness,ppi
14840,17807,4648,MYO7B,myosin VIIB,3,,,ppi
14841,17808,4649,MYO9A,myosin IXA,24,GTPase activator activity,,ppi
14842,17809,4650,MYO9B,myosin IXB,31,microfilament motor activity|actin binding|GTPase activator activity|calmodulin binding|ATP binding|ATPase activity|ADP binding|protein homodimerization activity,celiac disease|schizophrenia,ppi
14843,17810,4653,MYOC,myocilin,45,,glaucoma|buphthalmos|hydrophthalmos|myopia|open-angle glaucoma,ppi
14844,17811,4654,MYOD1,myogenic differentiation 1,84,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|chromatin binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|chromatin DNA binding|protein heterodimerization activity|E-box binding|promoter-specific chromatin binding|RNA polymerase II proximal promoter sequence-specific DNA binding,isolated cleft palate|cleft palate|cryptorchidism|placental insufficiency|polyhydramnios|cystic lymphangioma|embryonal rhabdomyosarcoma|botryoid rhabdomyosarcoma|congenital diaphragmatic hernia,ppi
14845,17812,4656,MYOG,myogenin,42,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|chromatin DNA binding|sequence-specific DNA binding|protein heterodimerization activity|E-box binding|RNA polymerase II proximal promoter sequence-specific DNA binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding,,ppi
14846,17813,8736,MYOM1,myomesin 1,8,structural constituent of muscle|protein homodimerization activity|muscle alpha-actinin binding|actin filament binding,,ppi
14847,17814,9172,MYOM2,myomesin 2,17,structural constituent of muscle|actin filament binding|muscle alpha-actinin binding,,ppi
14848,17815,4659,PPP1R12A,protein phosphatase 1 regulatory subunit 12A,101,enzyme inhibitor activity|phosphatase regulator activity|14-3-3 protein binding,,ppi
14849,17816,4660,PPP1R12B,protein phosphatase 1 regulatory subunit 12B,20,enzyme activator activity|phosphatase regulator activity|enzyme inhibitor activity,,ppi
14850,17817,4661,MYT1,myelin transcription factor 1,7,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|zinc ion binding|RNA polymerase II regulatory region sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
14851,17818,23040,MYT1L,myelin transcription factor 1 like,7,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific,intellectual disability|learning disability|obesity|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
14852,17819,4664,NAB1,NGFI-A binding protein 1,12,,,ppi
14853,17820,4665,NAB2,NGFI-A binding protein 2,44,transcription corepressor activity,hemangiopericytoma,ppi
14854,17821,4666,NACA,nascent polypeptide-associated complex alpha subunit,62,,,ppi
14855,17822,4668,NAGA,alpha-N-acetylgalactosaminidase,6,alpha-N-acetylgalactosaminidase activity|alpha-galactosidase activity,chylomicron retention disease|Fabry disease|lipid storage disease|autistic disorder|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|sensorineural hearing loss|epilepsy|basal ganglia disease|focal hand dystonia|blepharospasm|microphthalmia|eye disease|elephantiasis|lymphedema|intellectual disability|learning disability|early myoclonic encephalopathy|Unverricht-Lundborg syndrome,ppi
14856,17823,4669,NAGLU,N-acetyl-alpha-glucosaminidase,24,alpha-N-acetylglucosaminidase activity,sensorineural hearing loss|epilepsy|hypertrichosis|intellectual disability|learning disability|mucopolysaccharidosis|mucopolysaccharidosis II|mucopolysaccharidosis VI|mucopolysaccharidosis III|mucopolysaccharidosis IV|prostate cancer|prostate carcinoma|visual epilepsy|mucopolysaccharidosis I|hypertrophic cardiomyopathy 1|Charcot-Marie-Tooth disease axonal type 2V,ppi
14857,17824,4671,NAIP,NLR family apoptosis inhibitory protein,11,ATP binding,survival motor neuron spinal muscular atrophy|juvenile spinal muscular atrophy|Werdnig-Hoffmann disease|intermediate spinal muscular atrophy,ppi
14858,17825,4673,NAP1L1,nucleosome assembly protein 1 like 1,159,RNA binding,,ppi
14859,17826,4674,NAP1L2,nucleosome assembly protein 1 like 2,4,,,ppi
14860,17827,4675,NAP1L3,nucleosome assembly protein 1 like 3,6,,,ppi
14861,17828,4676,NAP1L4,nucleosome assembly protein 1 like 4,74,RNA binding|nucleosome binding|unfolded protein binding,alcohol dependence|alcohol abuse,ppi
14862,17829,8775,NAPA,NSF attachment protein alpha,58,SNARE binding|protein-containing complex binding|syntaxin binding|soluble NSF attachment protein activity,,ppi
14863,17830,8774,NAPG,NSF attachment protein gamma,30,syntaxin binding|soluble NSF attachment protein activity,bipolar disorder,ppi
14864,17831,4677,NARS,asparaginyl-tRNA synthetase,68,asparagine-tRNA ligase activity,,ppi
14865,17832,4678,NASP,nuclear autoantigenic sperm protein,64,histone binding,,ppi
14866,17833,9,NAT1,N-acetyltransferase 1,3,arylamine N-acetyltransferase activity,alcohol dependence|alcohol abuse|urinary bladder cancer|contact dermatitis|occupational dermatitis|prostate cancer|prostate carcinoma,ppi
14867,17834,10,NAT2,N-acetyltransferase 2,21,arylamine N-acetyltransferase activity,urinary bladder cancer|leukopenia|liver cancer|contact dermatitis|occupational dermatitis|prostate cancer|prostate carcinoma|malignant mesothelioma|benign mesothelioma|breast cancer|coronary artery disease|acute lymphocytic leukemia,ppi
14868,17835,26960,NBEA,neurobeachin,19,,autistic disorder,ppi
14869,17836,4681,NBL1,neuroblastoma 1; DAN family BMP antagonist,4,morphogen activity|BMP binding|protein homodimerization activity,,ppi
14870,17837,4683,NBN,nibrin,92,damaged DNA binding|ATP-dependent DNA helicase activity,aplastic anemia|fetal erythroblastosis|autoimmune hemolytic anemia|imperforate anus|breast cancer|bronchiectasis|choanal atresia|cleft lip|isolated cleft palate|cleft palate|dysgammaglobulinemia|placental insufficiency|malignant glioma|gliosarcoma|mixed glioma|hydronephrosis|acute lymphocytic leukemia|lymphosarcoma|lymphoma|central nervous system lymphoma,ppi
14871,17838,83988,NCALD,neurocalcin delta,21,actin binding|ligand-gated ion channel activity|tubulin binding|clathrin binding,,ppi
14872,17839,4684,NCAM1,neural cell adhesion molecule 1,40,Ras guanyl-nucleotide exchange factor activity,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|cannabis dependence|cannabis abuse|schizophrenia|mood disorder,ppi
14873,17840,4685,NCAM2,neural cell adhesion molecule 2,6,,,ppi
14874,17841,4686,NCBP1,nuclear cap binding protein subunit 1,147,RNA cap binding|RNA 7-methylguanosine cap binding|RNA binding|mRNA binding,,ppi
14875,17842,22916,NCBP2,nuclear cap binding protein subunit 2,48,RNA cap binding|RNA 7-methylguanosine cap binding|RNA binding|mRNA binding|snRNA binding,,ppi
14876,17843,653361,NCF1,neutrophil cytosolic factor 1,54,electron transfer activity|superoxide-generating NADPH oxidase activity|phosphatidylinositol binding|phosphatidylinositol-3;4-bisphosphate binding|superoxide-generating NADPH oxidase activator activity,rheumatoid arthritis|intracranial aneurysm|diabetic ketoacidosis|diabetes mellitus|chronic granulomatous disease|hypertension|essential hypertension|chronic kidney disease|abdominal aortic aneurysm,ppi
14877,17844,4688,NCF2,neutrophil cytosolic factor 2,30,electron transfer activity,rheumatoid arthritis|dermatitis|chronic granulomatous disease|chronic obstructive pulmonary disease|lupus erythematosus|lymphadenitis|otitis media|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|pyloric stenosis|sinusitis|photosensitivity disease|photosensitive epilepsy,ppi
14878,17845,4689,NCF4,neutrophil cytosolic factor 4,11,superoxide-generating NADPH oxidase activator activity|phosphatidylinositol-3-phosphate binding|protein dimerization activity|phosphatidylinositol binding,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|chronic granulomatous disease|heart disease|cardiovascular system disease|chronic obstructive pulmonary disease|otitis media|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|pyloric stenosis|sinusitis|aphthous stomatitis|photosensitivity disease|photosensitive epilepsy,ppi
14879,17846,4690,NCK1,NCK adaptor protein 1,263,protein kinase inhibitor activity|SH3/SH2 adaptor activity|cytoskeletal adaptor activity|receptor signaling complex scaffold activity|protein binding; bridging|cadherin binding,proteinuria|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome,ppi
14880,17847,8440,NCK2,NCK adaptor protein 2,148,SH3/SH2 adaptor activity|cytoskeletal adaptor activity|receptor signaling complex scaffold activity,proteinuria|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome,ppi
14881,17848,10787,NCKAP1,NCK associated protein 1,57,protein-containing complex binding|Rac GTPase binding,,ppi
14882,17849,4691,NCL,nucleolin,303,RNA binding|telomeric DNA binding|mRNA 5'-UTR binding,coronary artery disease,ppi
14883,17850,8648,NCOA1,nuclear receptor coactivator 1,115,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator activity|nuclear receptor transcription coactivator activity|nuclear hormone receptor binding|androgen receptor binding|nuclear receptor binding,endometriosis of uterus|endometriosis|prostate cancer|prostate carcinoma|breast cancer,ppi
14884,17851,10499,NCOA2,nuclear receptor coactivator 2,91,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription coactivator activity|nuclear receptor transcription coactivator activity|nuclear hormone receptor binding|nuclear receptor binding,prostate cancer|prostate carcinoma|breast cancer,ppi
14885,17852,8202,NCOA3,nuclear receptor coactivator 3,123,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II complex binding|transcription coactivator activity|histone acetyltransferase activity|nuclear hormone receptor binding|thyroid hormone receptor binding|protein heterodimerization activity|androgen receptor binding|nuclear receptor binding|nuclear receptor transcription coactivator activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|bone cancer|lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma,ppi
14886,17853,8031,NCOA4,nuclear receptor coactivator 4,29,transcription coactivator activity|androgen receptor binding,thyroid cancer|thyroid adenoma|thyroid carcinoma|papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma,ppi
14887,17854,9611,NCOR1,nuclear receptor corepressor 1,190,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|transcription regulatory region DNA binding|nuclear receptor binding|thyroid hormone receptor binding,urinary bladder cancer|transitional cell carcinoma|endometriosis of uterus|endometriosis|glioblastoma multiforme|giant cell glioblastoma|liver cancer|breast cancer,ppi
14888,17855,9612,NCOR2,nuclear receptor corepressor 2,128,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|nuclear receptor binding,bipolar disorder,ppi
14889,17856,4692,NDN,necdin; MAGE family member,60,,Zollinger-Ellison syndrome|hyperinsulinism|hyperopia|bulimia nervosa|infertility|obesity|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome|Cockayne syndrome,ppi
14890,17857,56160,NSMCE3,NSE3 homolog; SMC5-SMC6 complex component,12,protein dimerization activity,,ppi
14891,17858,4693,NDP,NDP; norrin cystine knot growth factor,7,growth factor activity|cytokine activity,generalized anxiety disorder|anxiety disorder|enophthalmos|orbital disease|exophthalmos|epilepsy|ocular cancer|glaucoma|sensorineural hearing loss|microphthalmia|angiokeratoma|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|schizophreniform disorder|schizoaffective disorder|retinal detachment|exudative vitreoretinopathy,ppi
14892,17859,10397,NDRG1,N-myc downstream regulated 1,115,microtubule binding|Rab GTPase binding|gamma-tubulin binding|cadherin binding,astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|lung cancer|non-small cell lung carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|sensorineural hearing loss,ppi
14893,17860,3340,NDST1,N-deacetylase and N-sulfotransferase 1,11,[heparan sulfate]-glucosamine N-sulfotransferase activity|heparan sulfate N-acetylglucosaminyltransferase activity|N-acetylglucosamine deacetylase activity,microphthalmia|intellectual disability|learning disability,ppi
14894,17861,8509,NDST2,N-deacetylase and N-sulfotransferase 2,16,[heparan sulfate]-glucosamine N-sulfotransferase activity|N-acetylglucosamine deacetylase activity,,ppi
14895,17863,4694,NDUFA1,NADH:ubiquinone oxidoreductase subunit A1,8,NADH dehydrogenase (ubiquinone) activity,lactic acidosis|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|hypoglycemia|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
14896,17864,4705,NDUFA10,NADH:ubiquinone oxidoreductase subunit A10,58,NADH dehydrogenase (ubiquinone) activity|deoxynucleoside kinase activity,lactic acidosis|ptosis|congenital ptosis|cerebellar disease|dystonia|epilepsy|sensorineural hearing loss|hypertrichosis|Leigh disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
14897,17865,4695,NDUFA2,NADH:ubiquinone oxidoreductase subunit A2,91,NADH dehydrogenase (ubiquinone) activity,lactic acidosis|ptosis|congenital ptosis|cerebellar disease|dystonia|epilepsy|sensorineural hearing loss|hypertrichosis|Leigh disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
14898,17866,4696,NDUFA3,NADH:ubiquinone oxidoreductase subunit A3,17,NADH dehydrogenase (ubiquinone) activity,,ppi
14899,17867,4697,NDUFA4,NDUFA4; mitochondrial complex associated,173,NADH dehydrogenase (ubiquinone) activity|protein-containing complex binding|cytochrome-c oxidase activity,Leigh disease,ppi
14900,17868,4698,NDUFA5,NADH:ubiquinone oxidoreductase subunit A5,47,NADH dehydrogenase (ubiquinone) activity,,ppi
14901,17869,4700,NDUFA6,NADH:ubiquinone oxidoreductase subunit A6,56,NADH dehydrogenase (ubiquinone) activity,,ppi
14902,17870,4701,NDUFA7,NADH:ubiquinone oxidoreductase subunit A7,79,structural constituent of ribosome|NADH dehydrogenase (ubiquinone) activity,,ppi
14903,17871,4702,NDUFA8,NADH:ubiquinone oxidoreductase subunit A8,69,NADH dehydrogenase (ubiquinone) activity|protein-containing complex binding,,ppi
14904,17872,4704,NDUFA9,NADH:ubiquinone oxidoreductase subunit A9,95,NADH dehydrogenase activity|NADH dehydrogenase (ubiquinone) activity|protein-containing complex binding,lactic acidosis|ptosis|congenital ptosis|cerebellar disease|dystonia|epilepsy|sensorineural hearing loss|hypertrichosis|Leigh disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus,ppi
14905,17873,4706,NDUFAB1,NADH:ubiquinone oxidoreductase subunit AB1,29,acyl carrier activity|fatty acid binding|calcium ion binding|NADH dehydrogenase (ubiquinone) activity|phosphopantetheine binding|acyl binding,,ppi
14906,17874,4707,NDUFB1,NADH:ubiquinone oxidoreductase subunit B1,19,NADH dehydrogenase (ubiquinone) activity,,ppi
14907,17875,4716,NDUFB10,NADH:ubiquinone oxidoreductase subunit B10,46,NADH dehydrogenase (ubiquinone) activity,,ppi
14908,17876,4708,NDUFB2,NADH:ubiquinone oxidoreductase subunit B2,2,NADH dehydrogenase (ubiquinone) activity,,ppi
14909,17877,4709,NDUFB3,NADH:ubiquinone oxidoreductase subunit B3,28,NADH dehydrogenase (ubiquinone) activity,lactic acidosis|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|hypoglycemia|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
14910,17878,4710,NDUFB4,NADH:ubiquinone oxidoreductase subunit B4,38,NADH dehydrogenase (ubiquinone) activity,,ppi
14911,17879,27,ABL2,ABL proto-oncogene 2; non-receptor tyrosine kinase,57,magnesium ion binding|actin monomer binding|protein kinase activity|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|manganese ion binding|actin filament binding,,ppi
14912,17880,4711,NDUFB5,NADH:ubiquinone oxidoreductase subunit B5,60,NADH dehydrogenase (ubiquinone) activity,,ppi
14913,17881,4712,NDUFB6,NADH:ubiquinone oxidoreductase subunit B6,29,NADH dehydrogenase (ubiquinone) activity,,ppi
14914,17882,4713,NDUFB7,NADH:ubiquinone oxidoreductase subunit B7,41,NADH dehydrogenase (ubiquinone) activity,iron metabolism disease|hemochromatosis|Wilson disease,ppi
14915,17883,4714,NDUFB8,NADH:ubiquinone oxidoreductase subunit B8,65,NADH dehydrogenase (ubiquinone) activity,seborrheic keratosis|skin disease|actinic keratosis,ppi
14916,17884,4715,NDUFB9,NADH:ubiquinone oxidoreductase subunit B9,63,NADH dehydrogenase (ubiquinone) activity,lactic acidosis|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|hypoglycemia|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
14917,17886,4718,NDUFC2,NADH:ubiquinone oxidoreductase subunit C2,24,NADH dehydrogenase (ubiquinone) activity,,ppi
14918,17887,4719,NDUFS1,NADH:ubiquinone oxidoreductase core subunit S1,102,NADH dehydrogenase (ubiquinone) activity|electron transfer activity|4 iron; 4 sulfur cluster binding|NADH dehydrogenase activity,lactic acidosis|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|hypoglycemia|Leigh disease|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|schizophrenia|visual epilepsy|stomach cancer,ppi
14919,17888,4720,NDUFS2,NADH:ubiquinone oxidoreductase core subunit S2,71,NADH dehydrogenase (ubiquinone) activity|electron transfer activity|NADH dehydrogenase activity,lactic acidosis|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|hypoglycemia|Leigh disease|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus,ppi
14920,17889,4722,NDUFS3,NADH:ubiquinone oxidoreductase core subunit S3,157,NADH dehydrogenase activity|NADH dehydrogenase (ubiquinone) activity|electron transfer activity,lactic acidosis|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|dystonia|epilepsy|sensorineural hearing loss|hypertrichosis|hypoglycemia|Leigh disease|leukodystrophy|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus,ppi
14921,17890,4724,NDUFS4,NADH:ubiquinone oxidoreductase subunit S4,82,NADH dehydrogenase (ubiquinone) activity,lactic acidosis|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|dystonia|epilepsy|sensorineural hearing loss|hypertrichosis|hypoglycemia|Leigh disease|leukodystrophy|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus,ppi
14922,17891,4725,NDUFS5,NADH:ubiquinone oxidoreductase subunit S5,55,NADH dehydrogenase (ubiquinone) activity,,ppi
14923,17892,4726,NDUFS6,NADH:ubiquinone oxidoreductase subunit S6,94,NADH dehydrogenase (ubiquinone) activity|electron transfer activity,lactic acidosis|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|hypoglycemia|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
14924,17893,374291,NDUFS7,NADH:ubiquinone oxidoreductase core subunit S7,94,NADH dehydrogenase (ubiquinone) activity|oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor|NADH dehydrogenase activity,Leigh disease|schizophrenia|mitochondrial complex I deficiency,ppi
14925,17894,4728,NDUFS8,NADH:ubiquinone oxidoreductase core subunit S8,66,NADH dehydrogenase (ubiquinone) activity|NADH dehydrogenase activity,lactic acidosis|ptosis|congenital ptosis|cerebellar disease|dystonia|epilepsy|sensorineural hearing loss|hypertrichosis|Leigh disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|optic atrophy|arthropathy|arthritis|cone-rod dystrophy,ppi
14926,17895,4723,NDUFV1,NADH:ubiquinone oxidoreductase core subunit V1,91,NADH dehydrogenase (ubiquinone) activity,lactic acidosis|bipolar disorder|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|hypoglycemia|Leigh disease|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|arthropathy|arthritis,ppi
14927,17896,4729,NDUFV2,NADH:ubiquinone oxidoreductase core subunit V2,58,NADH dehydrogenase (ubiquinone) activity|electron transfer activity,lactic acidosis|bipolar disorder|ptosis|congenital ptosis|brain edema|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|epilepsy|sensorineural hearing loss|hypoglycemia|Leigh disease|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|schizophrenia|visual epilepsy,ppi
14928,17897,4731,NDUFV3,NADH:ubiquinone oxidoreductase subunit V3,39,RNA binding|NADH dehydrogenase (ubiquinone) activity,bipolar disorder,ppi
14929,17898,4703,NEB,nebulin,44,structural constituent of muscle|actin filament binding,isolated cleft palate|cleft palate|microphthalmia|eye disease|polyhydramnios|Bell's palsy|facial paralysis|nemaline myopathy|progressive bulbar palsy,ppi
14930,17899,121441,NEDD1,neural precursor cell expressed; developmentally down-regulated 1,137,,,ppi
14931,17900,4734,NEDD4,neural precursor cell expressed; developmentally down-regulated 4; E3 ubiquitin protein ligase,303,sodium channel inhibitor activity|beta-2 adrenergic receptor binding|ubiquitin binding|phosphoserine residue binding|phosphothreonine residue binding|ubiquitin protein ligase activity|proline-rich region binding,bipolar disorder|Stevens-Johnson syndrome|coronary artery disease,ppi
14932,17901,23327,NEDD4L,neural precursor cell expressed; developmentally down-regulated 4-like; E3 ubiquitin protein ligase,186,ubiquitin-protein transferase activity|potassium channel regulator activity|sodium channel regulator activity|potassium channel inhibitor activity|sodium channel inhibitor activity|ubiquitin protein ligase activity,isolated cleft palate|cleft palate|endometriosis of uterus|endometriosis|hypertension|essential hypertension|syndactyly|periventricular nodular heterotopia,ppi
14933,17902,4735,SEPT2,septin 2,101,cadherin binding|GTPase activity|protein-containing complex scaffold activity,schizophreniform disorder|schizoaffective disorder,ppi
14934,17904,4738,NEDD8,neural precursor cell expressed; developmentally down-regulated 8,759,ubiquitin protein ligase binding|protein tag,,ppi
14935,17905,4739,NEDD9,neural precursor cell expressed; developmentally down-regulated 9,51,,,ppi
14936,17906,4741,NEFM,neurofilament medium,58,structural constituent of cytoskeleton|microtubule binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometriosis of uterus|endometriosis,ppi
14937,17907,4744,NEFH,neurofilament heavy,48,structural molecule activity|structural constituent of cytoskeleton|microtubule binding|kinesin binding|protein binding; bridging|dynein complex binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|polyneuropathy|peripheral nervous system disease|neuropathy|muscular atrophy|neurodegenerative disease|amyotrophic lateral sclerosis type 1,ppi
14938,17908,4747,NEFL,neurofilament light,63,Ras guanyl-nucleotide exchange factor activity|structural constituent of cytoskeleton|protein binding; bridging,bipolar disorder|pseudosarcomatous fibromatosis|schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression|Charcot-Marie-Tooth disease type 1F|Charcot-Marie-Tooth disease type 2E,ppi
14939,17909,4750,NEK1,NIMA related kinase 1,35,protein kinase activity|kinase activity|14-3-3 protein binding|protein serine/threonine kinase activity,progressive muscular atrophy|amyotrophic lateral sclerosis|isolated cleft palate|cleft palate|Meckel syndrome|autosomal dominant polycystic kidney disease|short-rib thoracic dysplasia 6 with or without polydactyly|sex differentiation disease|hermaphroditism|pseudohermaphroditism,ppi
14940,17910,4751,NEK2,NIMA related kinase 2,50,protein kinase activity|protein serine/threonine kinase activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|asthenopia,ppi
14941,17911,4752,NEK3,NIMA related kinase 3,11,protein serine/threonine kinase activity,,ppi
14942,17912,341676,NEK5,NIMA related kinase 5,1,,,ppi
14943,17913,10783,NEK6,NIMA related kinase 6,89,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,,ppi
14944,17914,462,SERPINC1,serpin family C member 1,19,serine-type endopeptidase inhibitor activity,blood coagulation disease|purpura fulminans|disseminated intravascular coagulation|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|pulmonary embolism|adult respiratory distress syndrome|newborn respiratory distress syndrome|thrombophilia|hepatitis|protein S deficiency|antithrombin III deficiency|protein C deficiency|intracranial thrombosis,ppi
14945,17915,4745,NELL1,neural EGFL like 1,38,,craniosynostosis|neurotic disorder|endogenous depression|melancholia|Barrett's esophagus|esophagus adenocarcinoma|major depressive disorder|mental depression,ppi
14946,17916,4753,NELL2,neural EGFL like 2,36,,,ppi
14947,17917,4756,NEO1,neogenin 1,11,,,ppi
14948,17918,10763,NES,nestin,63,intermediate filament binding,epilepsy with generalized tonic-clonic seizures|kidney disease|nephrosis,ppi
14949,17919,4758,NEU1,neuraminidase 1,13,exo-alpha-sialidase activity|alpha-sialidase activity,cerebellar disease|recurrent corneal erosion|epilepsy|sensorineural hearing loss|enterocele|inguinal hernia|glycoproteinosis|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV,ppi
14950,17920,4759,NEU2,neuraminidase 2,21,exo-alpha-sialidase activity|exo-alpha-(2->3)-sialidase activity,,ppi
14951,17921,10825,NEU3,neuraminidase 3,6,exo-alpha-sialidase activity|alpha-sialidase activity|exo-alpha-(2->3)-sialidase activity|exo-alpha-(2->8)-sialidase activity,,ppi
14952,17922,9148,NEURL1,neuralized E3 ubiquitin protein ligase 1,7,ubiquitin-protein transferase activity|translation factor activity; non-nucleic acid binding,large intestine cancer|colorectal cancer,ppi
14953,17923,4760,NEUROD1,neuronal differentiation 1,19,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|DNA-binding transcription factor activity|transcription coactivator activity|protein heterodimerization activity|E-box binding|sequence-specific DNA binding,diabetes mellitus|type 2 diabetes mellitus|central nervous system disease|nervous system disease|autonomic neuropathy|maturity-onset diabetes of the young,ppi
14954,17924,4761,NEUROD2,neuronal differentiation 2,2,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity|protein heterodimerization activity|E-box binding,alcohol dependence|alcohol abuse,ppi
14955,17925,4762,NEUROG1,neurogenin 1,6,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|DNA-binding transcription factor activity|protein homodimerization activity|E-box binding|sequence-specific double-stranded DNA binding,schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
14956,17926,4763,NF1,neurofibromin 1,49,GTPase activator activity|phosphatidylethanolamine binding|phosphatidylcholine binding,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|autistic disorder|ptosis|congenital ptosis|cardiomyopathy|hypertrophic cardiomyopathy,ppi
14957,17927,463,ZFHX3,zinc finger homeobox 3,14,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription regulatory region DNA binding,atrial fibrillation|prostate cancer|prostate carcinoma,ppi
14958,17928,4771,NF2,neurofibromin 2,217,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|cerebellar disease|sensorineural hearing loss|meningioma|spinal meningioma|acoustic neuroma|intraventricular meningioma|pituitary adenoma|intraorbital meningioma|clear cell meningioma|benign meningioma|secretory meningioma|microcystic meningioma|cerebral convexity meningioma,ppi
14959,17929,10725,NFAT5,nuclear factor of activated T-cells 5,8,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|chromatin binding|transcription factor binding,,ppi
14960,17930,4772,NFATC1,nuclear factor of activated T-cells 1,149,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II transcription factor binding|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|FK506 binding|mitogen-activated protein kinase p38 binding|RNA polymerase II proximal promoter sequence-specific DNA binding|transcription factor binding|chromatin binding,,ppi
14961,17931,4773,NFATC2,nuclear factor of activated T-cells 2,187,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding|transcription factor binding|chromatin binding,central nervous system disease|nervous system disease|autonomic neuropathy,ppi
14962,17932,4775,NFATC3,nuclear factor of activated T-cells 3,18,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|chromatin binding|transcription factor binding|DNA-binding transcription factor activity,,ppi
14963,17933,4776,NFATC4,nuclear factor of activated T-cells 4,19,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription coactivator activity|chromatin binding|RNA polymerase II proximal promoter sequence-specific DNA binding|transcription factor binding|DNA-binding transcription factor activity,,ppi
14964,17934,4778,NFE2,nuclear factor; erythroid 2,25,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|DNA binding|transcription coactivator activity|sequence-specific DNA binding|WW domain binding|DNA-binding transcription factor activity|transcription regulatory region sequence-specific DNA binding,,ppi
14965,17935,4779,NFE2L1,nuclear factor; erythroid 2 like 1,34,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coregulator activity|transcription regulatory region sequence-specific DNA binding,,ppi
14966,17936,4780,NFE2L2,nuclear factor; erythroid 2 like 2,72,transcription regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding,lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|cholestasis|endometrial cancer|endometrial carcinoma|gastroenteritis|intestinal disease|gastrointestinal system disease|proctitis|hyperglycemia|keratosis|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|liver cirrhosis|liver cancer,ppi
14967,17937,9603,NFE2L3,nuclear factor; erythroid 2 like 3,15,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|transcription regulatory region sequence-specific DNA binding,,ppi
14968,17938,4774,NFIA,nuclear factor I A,44,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,chromosome 1p32-p31 deletion syndrome,ppi
14969,17939,4781,NFIB,nuclear factor I B,12,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding,salivary gland adenoid cystic carcinoma,ppi
14970,17940,4782,NFIC,nuclear factor I C,28,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,prostate cancer|prostate carcinoma,ppi
14971,17941,4783,NFIL3,nuclear factor; interleukin 3 regulated,23,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription corepressor activity,,ppi
14972,17942,4784,NFIX,nuclear factor I X,21,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding,generalized anxiety disorder|anxiety disorder|bipolar disorder|choanal atresia|sensorineural hearing loss|patent ductus arteriosus|gingival overgrowth|gingival hypertrophy|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|umbilical hernia,ppi
14973,17943,85300,ATCAY,ATCAY; caytaxin,3,exopolyphosphatase activity,Cayman type cerebellar ataxia,ppi
14974,17944,4790,NFKB1,nuclear factor kappa B subunit 1,425,transcription regulatory region sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription factor binding|transcription regulatory region DNA binding|protein heterodimerization activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|alcohol dependence|alcohol abuse|hemolytic anemia|imperforate anus|bronchiectasis|brain ischemia|colon cancer|colonic benign neoplasm|common variable immunodeficiency|diabetes mellitus|type 2 diabetes mellitus|primary hyperoxaluria|primary immunodeficiency disease|chronic kidney disease|primary biliary cirrhosis,ppi
14975,17945,4791,NFKB2,nuclear factor kappa B subunit 2,175,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity,hemolytic anemia|imperforate anus|asthma|intrinsic asthma|allergic asthma|bronchiectasis|common variable immunodeficiency|hypoglycemic coma|primary immunodeficiency disease|lymphopenia|pneumonia|purpura|cutaneous T cell lymphoma|agammaglobulinemia|liver disease|craniosynostosis|thrombocytopenia|thrombocytopenia due to platelet alloimmunization|autoimmune thrombocytopenic purpura|otitis media,ppi
14976,17946,4792,NFKBIA,NFKB inhibitor alpha,188,transcription factor binding|NF-kappaB binding,hypohidrosis|anhidrosis|brain ischemia|Hodgkin's lymphoma; lymphocytic-histiocytic predominance|Hodgkin's lymphoma|Hodgkin's lymphoma; lymphocytic depletion|Hodgkin's granuloma|Hodgkin's lymphoma; mixed cellularity|tooth agenesis|anodontia|pancreatic cancer|pustulosis of palm and sole|psoriasis|parapsoriasis|coronary artery disease|malignant glioma|gliosarcoma|glioblastoma multiforme|giant cell glioblastoma|breast cancer,ppi
14977,17947,4793,NFKBIB,NFKB inhibitor beta,89,transcription coactivator activity,,ppi
14978,17948,4794,NFKBIE,NFKB inhibitor epsilon,57,,rheumatoid arthritis|melanoma|skin melanoma,ppi
14979,17949,3983,ABLIM1,actin binding LIM protein 1,68,actin filament binding,substance abuse|substance-related disorder,ppi
14980,17950,4795,NFKBIL1,NFKB inhibitor like 1,27,,rheumatoid arthritis,ppi
14981,17951,4796,TONSL,tonsoku-like; DNA repair protein,33,transcription corepressor activity|histone binding,polycystic ovary syndrome,ppi
14982,17952,4798,NFRKB,nuclear factor related to kappaB binding protein,46,protease binding,,ppi
14983,17953,4799,NFX1,nuclear transcription factor; X-box binding 1,50,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA binding,,ppi
14984,17954,4800,NFYA,nuclear transcription factor Y subunit alpha,65,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|RNA polymerase II distal enhancer sequence-specific DNA binding|transcription regulatory region DNA binding,lung benign neoplasm,ppi
14985,17955,4801,NFYB,nuclear transcription factor Y subunit beta,37,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|RNA polymerase II distal enhancer sequence-specific DNA binding|transcription regulatory region DNA binding,,ppi
14986,17956,4802,NFYC,nuclear transcription factor Y subunit gamma,46,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|RNA polymerase II distal enhancer sequence-specific DNA binding|transcription regulatory region DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|transcription factor binding|sequence-specific DNA binding,,ppi
14987,17957,25791,NGEF,neuronal guanine nucleotide exchange factor,21,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,,ppi
14988,17958,4803,NGF,nerve growth factor,10,metalloendopeptidase inhibitor activity|nerve growth factor receptor binding|growth factor activity,amnestic disorder|dissociative amnesia|corneal ulcer|trigonitis|cystitis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy with generalized tonic-clonic seizures|nephritis|glomerulonephritis|kidney disease|opiate dependence|morphine dependence|heroin dependence|hereditary sensory neuropathy|sensory peripheral neuropathy,ppi
14989,17959,4804,NGFR,nerve growth factor receptor,62,transmembrane signaling receptor activity|death receptor activity|calmodulin binding|coreceptor activity|Rab GTPase binding|signaling receptor activity|neurotrophin binding|nerve growth factor binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|prostate cancer|prostate carcinoma|schizophrenia|epilepsy|visual epilepsy|neurodegenerative disease,ppi
14990,17960,4807,NHLH1,nescient helix-loop-helix 1,11,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
14991,17961,4808,NHLH2,nescient helix-loop-helix 2,3,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,obesity,ppi
14992,17962,4809,SNU13,SNU13 homolog; small nuclear ribonucleoprotein (U4/U6.U5),169,RNA binding|U4 snRNA binding|U4atac snRNA binding|U3 snoRNA binding|box C/D snoRNA binding|snoRNA binding,,ppi
14993,17963,11101,ATE1,arginyltransferase 1,30,arginyltransferase activity,,ppi
14994,17964,4810,NHS,NHS actin remodeling regulator,15,,autistic disorder|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types,ppi
14995,17965,4811,NID1,nidogen 1,29,extracellular matrix structural constituent|collagen binding|laminin binding,,ppi
14996,17966,4814,NINJ1,ninjurin 1,2,,allergic contact dermatitis,ppi
14997,17967,4815,NINJ2,ninjurin 2,2,,,ppi
14998,17968,8508,NIPSNAP1,nipsnap homolog 1 (C. elegans),76,,,ppi
14999,17969,4817,NIT1,nitrilase 1,53,nitrilase activity,,ppi
15000,17970,466,ATF1,activating transcription factor 1,43,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,polycystic ovary syndrome,ppi
15001,17971,4818,NKG7,natural killer cell granule protein 7,4,,,ppi
15002,17972,4820,NKTR,natural killer cell triggering receptor,24,peptidyl-prolyl cis-trans isomerase activity|cyclosporin A binding|unfolded protein binding,,ppi
15003,17973,4821,NKX2-2,NK2 homeobox 2,3,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|chromatin binding|transcription coactivator activity,,ppi
15004,17974,159296,NKX2-3,NK2 homeobox 3,3,DNA-binding transcription factor activity; RNA polymerase II-specific,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease,ppi
15005,17975,644524,NKX2-4,NK2 homeobox 4,1,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
15006,17976,4824,NKX3-1,NK3 homeobox 1,36,transcription regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|androgen receptor activity|estrogen receptor activity|protein kinase activator activity|estrogen receptor binding|sequence-specific DNA binding|protein self-association|transcription regulatory region DNA binding|cysteine-type endopeptidase activator activity involved in apoptotic process,prostate cancer|prostate carcinoma,ppi
15007,17977,4825,NKX6-1,NK6 homeobox 1,1,DNA-binding transcription factor activity; RNA polymerase II-specific,diabetes mellitus|type 2 diabetes mellitus,ppi
15008,17978,1386,ATF2,activating transcription factor 2,241,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|enhancer sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription coactivator activity|histone acetyltransferase activity|cAMP response element binding protein binding|cAMP response element binding,,ppi
15009,17979,4828,NMB,neuromedin B,3,hormone activity,,ppi
15010,17980,4829,NMBR,neuromedin B receptor,1,G-protein coupled receptor activity,breast cancer,ppi
15011,17981,4830,NME1,NME/NM23 nucleoside diphosphate kinase 1,71,magnesium ion binding|RNA binding|deoxyribonuclease activity|nucleoside diphosphate kinase activity|ATP binding|GTP binding,anemia|macrocytic anemia|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|cerebellar disease|large intestine cancer|colorectal cancer|gangliocytoma|Horner's syndrome|hypertension|essential hypertension|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|neuroblastoma|spinal cord disease|ganglioneuroblastoma|Brown's tendon sheath syndrome,ppi
15012,17982,467,ATF3,activating transcription factor 3,68,transcription regulatory region sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity|protein homodimerization activity|transcription regulatory region DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding,lung cancer|non-small cell lung carcinoma|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetes mellitus|type 2 diabetes mellitus|influenza|liver cancer|central nervous system disease|nervous system disease|autonomic neuropathy|polyneuropathy|peripheral nervous system disease|neuropathy|prostate cancer|prostate carcinoma,ppi
15013,17983,4831,NME2,NME/NM23 nucleoside diphosphate kinase 2,135,,large intestine cancer|colorectal cancer|malignant mesothelioma|benign mesothelioma|arthropathy|arthritis|ovarian cancer,ppi
15014,17984,4832,NME3,NME/NM23 nucleoside diphosphate kinase 3,26,nucleoside diphosphate kinase activity,,ppi
15015,17985,4833,NME4,NME/NM23 nucleoside diphosphate kinase 4,58,nucleoside diphosphate kinase activity|cardiolipin binding,,ppi
15016,17986,8382,NME5,NME/NM23 family member 5,3,,,ppi
15017,17987,9111,NMI,N-myc and STAT interactor,74,,,ppi
15018,17988,4835,NQO2,NAD(P)H quinone dehydrogenase 2,15,dihydronicotinamide riboside quinone reductase activity|zinc ion binding|electron transfer activity|oxidoreductase activity|oxidoreductase activity; acting on other nitrogenous compounds as donors|chloride ion binding|FAD binding|melatonin binding|resveratrol binding|NAD(P)H dehydrogenase (quinone) activity,neutropenia|agranulocytosis|alcohol dependence|alcohol abuse|bone marrow disease|contact dermatitis|occupational dermatitis|schizophreniform disorder|schizoaffective disorder|schizophrenia|breast cancer,ppi
15019,17989,4836,NMT1,N-myristoyltransferase 1,83,glycylpeptide N-tetradecanoyltransferase activity|myristoyltransferase activity,,ppi
15020,17990,9397,NMT2,N-myristoyltransferase 2,32,glycylpeptide N-tetradecanoyltransferase activity,,ppi
15021,17991,10874,NMU,neuromedin U,15,signaling receptor binding|type 1 neuromedin U receptor binding|type 2 neuromedin U receptor binding|neuromedin U receptor binding,,ppi
15022,17992,468,ATF4,activating transcription factor 4,83,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|obsolete transcription factor activity; RNA polymerase II transcription factor binding|DNA binding|DNA-binding transcription factor activity|leucine zipper domain binding|sequence-specific DNA binding|transcription regulatory region DNA binding|protein heterodimerization activity|RNA polymerase II regulatory region sequence-specific DNA binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|invasive ductal carcinoma,ppi
15023,17993,4826,NNAT,neuronatin,2,,lung cancer|non-small cell lung carcinoma|neuroblastoma,ppi
15024,17994,4837,NNMT,nicotinamide N-methyltransferase,7,nicotinamide N-methyltransferase activity|pyridine N-methyltransferase activity,bipolar disorder|schizophrenia,ppi
15025,17995,23530,NNT,nicotinamide nucleotide transhydrogenase,45,NAD(P)+ transhydrogenase (B-specific) activity|NAD(P)+ transhydrogenase activity|NADP binding|NAD binding|NAD(P)+ transhydrogenase (AB-specific) activity,hypoglycemia,ppi
15026,17996,10328,EMC8,ER membrane protein complex subunit 8,32,,,ppi
15027,17997,4838,NODAL,nodal growth differentiation factor,1,morphogen activity|type I activin receptor binding|transforming growth factor beta receptor binding|cytokine activity,placental insufficiency|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|tuberous sclerosis|Marfan syndrome|situs inversus|holoprosencephaly|dextro-looped transposition of the great arteries 1|dextro-looped transposition of the great arteries 3|dextro-looped transposition of the great arteries,ppi
15028,17998,9241,NOG,noggin,5,protein homodimerization activity,sensorineural hearing loss|hyperopia|ophthalmoplegia|mechanical strabismus|hypertropia|Klippel-Feil syndrome|spondylolisthesis|calcaneonavicular coalition|multiple synostoses syndrome|tarsal-carpal coalition syndrome|brachydactyly|proximal symphalangism,ppi
15029,17999,4839,NOP2,NOP2 nucleolar protein,160,RNA binding|rRNA (cytosine-C5-)-methyltransferase activity,,ppi
15030,18000,8996,NOL3,nucleolar protein 3,33,RNA binding|calcium ion binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process,focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|mitochondrial myopathy|mitochondrial metabolism disease,ppi
15031,18001,8715,NOL4,nucleolar protein 4,11,RNA binding,,ppi
15032,18002,4841,NONO,non-POU domain containing; octamer-binding,188,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin binding|RNA binding|E-box binding|transcription regulatory region sequence-specific DNA binding,syndromic X-linked intellectual disability 34,ppi
15033,18003,4842,NOS1,nitric oxide synthase 1,37,nitric-oxide synthase activity|FMN binding|sodium channel regulator activity|heme binding|tetrahydrobiopterin binding|arginine binding|ion channel binding|cadmium ion binding|flavin adenine dinucleotide binding|NADP binding|scaffold protein binding|oxidoreductase activity|NADPH-hemoprotein reductase activity,disease of mental health|cerebellar disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12,ppi
15034,18004,4843,NOS2,nitric oxide synthase 2,153,nitric-oxide synthase activity|FMN binding|heme binding|tetrahydrobiopterin binding|arginine binding|protein homodimerization activity|flavin adenine dinucleotide binding|NADP binding|oxidoreductase activity|NADPH-hemoprotein reductase activity,psoriatic arthritis|asbestosis|anthracosilicosis|byssinosis|asthma|intrinsic asthma|allergic asthma|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|autistic disorder|bronchial disease|brain ischemia|primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis,ppi
15035,18005,4846,NOS3,nitric oxide synthase 3,53,nitric-oxide synthase activity|FMN binding|heme binding|tetrahydrobiopterin binding|arginine binding|cadmium ion binding|flavin adenine dinucleotide binding|NADP binding|oxidoreductase activity|NADPH-hemoprotein reductase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
15036,18006,23019,CNOT1,CCR4-NOT transcription complex subunit 1,94,RNA binding|estrogen receptor binding|protein-containing complex scaffold activity|retinoic acid receptor binding|poly(A)-specific ribonuclease activity,,ppi
15037,18007,4848,CNOT2,CCR4-NOT transcription complex subunit 2,58,RNA polymerase II transcription corepressor binding|transcription coregulator activity|poly(A)-specific ribonuclease activity,,ppi
15038,18008,4849,CNOT3,CCR4-NOT transcription complex subunit 3,42,,acute T cell leukemia,ppi
15039,18009,4850,CNOT4,CCR4-NOT transcription complex subunit 4,19,RNA binding|ubiquitin-protein transferase activity,,ppi
15040,18010,4851,NOTCH1,notch 1,214,RNA polymerase II proximal promoter sequence-specific DNA binding|obsolete transcriptional activator activity; RNA polymerase II transcription factor binding|enzyme inhibitor activity|enzyme binding,tuberous sclerosis|Marfan syndrome|situs inversus|aortic valve stenosis|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|calcium metabolism disease|nephrocalcinosis|calcinosis|cervical cancer|colon cancer|colonic benign neoplasm,ppi
15041,18011,4853,NOTCH2,notch 2,65,signaling receptor activity,renal tubular acidosis|congenital heart disease|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|cervical cancer|cholestasis|cryptorchidism|sensorineural hearing loss|diabetes mellitus|type 2 diabetes mellitus|patent ductus arteriosus|gingival disease,ppi
15042,18012,4854,NOTCH3,notch 3,74,signaling receptor activity|cadherin binding,ptosis|congenital ptosis|skin benign neoplasm|skin cancer|lung cancer|non-small cell lung carcinoma|brain ischemia|cryptorchidism|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|patent ductus arteriosus|epilepsy|gingival overgrowth|glioblastoma multiforme|giant cell glioblastoma|hemiplegia,ppi
15043,18013,4855,NOTCH4,notch 4,15,calcium ion binding|signaling receptor activity|protein heterodimerization activity,bipolar disorder|schizophrenia|pancreatic ductal carcinoma|breast cancer,ppi
15044,18014,4856,NOV,nephroblastoma overexpressed,18,heparin binding|integrin binding,,ppi
15045,18015,4857,NOVA1,NOVA alternative splicing regulator 1,11,RNA binding,,ppi
15046,18016,4858,NOVA2,NOVA alternative splicing regulator 2,3,RNA binding,,ppi
15047,18017,27035,NOX1,NADPH oxidase 1,4,superoxide-generating NADPH oxidase activity|NADP binding,colon cancer|colonic benign neoplasm|congestive heart failure,ppi
15048,18019,50507,NOX4,NADPH oxidase 4,3,nucleotide binding|electron transfer activity|NAD(P)H oxidase activity|superoxide-generating NADPH oxidase activity|oxygen sensor activity|heme binding|flavin adenine dinucleotide binding|modified amino acid binding|protein tyrosine kinase binding,colon cancer|colonic benign neoplasm|congestive heart failure|chronic kidney disease|kidney failure,ppi
15049,18020,4860,PNP,purine nucleoside phosphorylase,50,nucleoside binding|purine nucleobase binding|purine-nucleoside phosphorylase activity|drug binding|phosphate ion binding,fetal erythroblastosis|autoimmune hemolytic anemia|cerebellar disease|spastic diplegia|spastic monoplegia|spastic quadriplegia|cerebral palsy|lymphosarcoma|lymphoma|central nervous system lymphoma|lymphopenia|intellectual disability|learning disability|osteoporosis|otitis media|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|pneumonia,ppi
15050,18021,4861,NPAS1,neuronal PAS domain protein 1,15,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|protein heterodimerization activity,schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
15051,18022,4862,NPAS2,neuronal PAS domain protein 2,27,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|Hsp90 protein binding,autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
15052,18023,4863,NPAT,nuclear protein; coactivator of histone transcription,29,transcription coactivator activity|transcription corepressor activity,,ppi
15053,18024,4864,NPC1,NPC intracellular cholesterol transporter 1,16,transmembrane signaling receptor activity|sterol transporter activity|cholesterol binding|signaling receptor activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|brucellosis|narcolepsy|cerebellar disease|dystonia|epilepsy|neonatal jaundice|liver cirrhosis|gallbladder disease|liver disease|intellectual disability|learning disability|obesity|ophthalmoplegia|schizophreniform disorder|schizoaffective disorder,ppi
15054,18025,29881,NPC1L1,NPC1 like intracellular cholesterol transporter 1,2,,,ppi
15055,18026,56654,NPDC1,neural proliferation; differentiation and control 1,30,,,ppi
15056,18027,28,ABO,ABO; alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase,3,nucleotide binding|antigen binding|manganese ion binding|transferase activity; transferring glycosyl groups|glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,alcohol dependence|alcohol abuse|duodenal ulcer|pancreatic cancer|prostate cancer|prostate carcinoma|mood disorder|ovarian cancer|ovarian carcinoma|coronary artery disease,ppi
15057,18028,22809,ATF5,activating transcription factor 5,14,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|chromatin binding|DNA-binding transcription factor activity|transcription corepressor activity|tubulin binding|sequence-specific DNA binding|transcription regulatory region DNA binding,bipolar disorder,ppi
15058,18029,9520,NPEPPS,aminopeptidase puromycin sensitive,62,aminopeptidase activity|zinc ion binding|metalloaminopeptidase activity|peptide binding,,ppi
15059,18030,8620,NPFF,neuropeptide FF-amide peptide precursor,4,signaling receptor binding|G-protein coupled receptor binding|neuropeptide hormone activity,,ppi
15060,18031,4867,NPHP1,nephrocystin 1,90,structural molecule activity,anemia|macrocytic anemia|cerebellar disease|hypertension|essential hypertension|hypogonadism|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|premature menopause|androgen insensitivity syndrome|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity,ppi
15061,18032,27031,NPHP3,nephrocystin 3,18,,aortic valve stenosis|primary biliary cirrhosis|cholestasis|Dandy-Walker syndrome|patent ductus arteriosus|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|hypertension|essential hypertension|Meckel syndrome|autosomal dominant polycystic kidney disease,ppi
15062,18033,4868,NPHS1,NPHS1; nephrin,17,,proteinuria|congestive heart failure|esophagitis|peptic esophagitis|gastroesophageal reflux disease|nephritis|glomerulonephritis|kidney disease|focal segmental glomerulosclerosis|familial hyperlipidemia|lymphoplasmacytic lymphoma|macroglobulinemia|congenital hypothyroidism|myxedema|hypothyroidism|pyoureter|nephrosis|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome,ppi
15063,18034,9284,NPIPA1,nuclear pore complex interacting protein family member A1,1,,,ppi
15064,18035,22926,ATF6,activating transcription factor 6,38,transcription regulatory region sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|sequence-specific DNA binding,asbestosis|anthracosilicosis|byssinosis|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|alternating exotropia|exotropia|monocular exotropia|hyperopia|Creutzfeldt-Jakob disease|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|scrapie|blindness|asthenopia,ppi
15065,18036,4869,NPM1,nucleophosmin,635,core promoter binding|transcription coactivator activity|RNA binding|protein kinase inhibitor activity|Tat protein binding|histone binding|protein homodimerization activity|ribosomal large subunit binding|ribosomal small subunit binding|protein heterodimerization activity|NF-kappaB binding|unfolded protein binding|chromatin binding,acute myeloid leukemia|acute promyelocytic leukemia|stomach cancer,ppi
15066,18037,11016,ATF7,activating transcription factor 7,45,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription factor binding|mitogen-activated protein kinase binding,,ppi
15067,18038,10361,NPM2,nucleophosmin/nucleoplasmin 2,9,histone binding|chromatin binding,,ppi
15068,18039,10360,NPM3,nucleophosmin/nucleoplasmin 3,27,RNA binding|histone binding|chromatin binding,,ppi
15069,18040,4878,NPPA,natriuretic peptide A,46,signaling receptor binding|neuropeptide hormone activity|neuropeptide receptor binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|aortic valve insufficiency|atrial fibrillation|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L,ppi
15070,18041,471,ATIC,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase,82,IMP cyclohydrolase activity|phosphoribosylaminoimidazolecarboxamide formyltransferase activity|cadherin binding,rheumatoid arthritis|epilepsy|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|optic atrophy|osteoporosis|visual epilepsy|syndromic X-linked intellectual disability 94|skin disease|seborrheic keratosis|actinic keratosis,ppi
15071,18042,4879,NPPB,natriuretic peptide B,13,signaling receptor binding|hormone activity|diuretic hormone activity,sickle cell anemia|aortic valve insufficiency|atrial fibrillation|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B,ppi
15072,18043,4880,NPPC,natriuretic peptide C,10,,bone disease|cartilage disease|connective tissue disease|chondromalacia|articular cartilage disease,ppi
15073,18044,4881,NPR1,natriuretic peptide receptor 1,8,guanylate cyclase activity|G-protein coupled peptide receptor activity|natriuretic peptide receptor activity|peptide hormone binding|peptide receptor activity,congestive heart failure|hypertension|essential hypertension|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
15074,18045,4882,NPR2,natriuretic peptide receptor 2,6,guanylate cyclase activity|natriuretic peptide receptor activity|peptide receptor activity|peptide hormone binding,humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|acromesomelic dysplasia; Maroteaux type,ppi
15075,18046,4883,NPR3,natriuretic peptide receptor 3,3,G-protein coupled peptide receptor activity|natriuretic peptide receptor activity|peptide hormone binding|chloride ion binding|protein homodimerization activity,prostate cancer|prostate carcinoma,ppi
15076,18047,472,ATM,ATM serine/threonine kinase,191,protein serine/threonine kinase activity|DNA-dependent protein kinase activity|1-phosphatidylinositol-3-kinase activity|protein-containing complex binding|protein dimerization activity|protein N-terminus binding,ataxia telangiectasia|urinary bladder cancer|bone marrow disease|bronchiectasis|tongue squamous cell carcinoma|squamous cell carcinoma|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K,ppi
15077,18048,4884,NPTX1,neuronal pentraxin 1,41,,,ppi
15078,18049,4885,NPTX2,neuronal pentraxin 2,5,,,ppi
15079,18050,23467,NPTXR,neuronal pentraxin receptor,5,,,ppi
15080,18051,4852,NPY,neuropeptide Y,18,G-protein coupled receptor activity|signaling receptor binding|neuropeptide hormone activity|calcium channel regulator activity|G-protein coupled receptor binding|neuropeptide Y receptor binding,alcohol dependence|alcohol abuse|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|anxiety disorder|phobic disorder|asthma,ppi
15081,18052,4886,NPY1R,neuropeptide Y receptor Y1,5,neuropeptide Y receptor activity|pancreatic polypeptide receptor activity,anxiety disorder|phobic disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|obesity|drug psychosis|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
15082,18053,4887,NPY2R,neuropeptide Y receptor Y2,55,neuropeptide Y receptor activity|calcium channel regulator activity|signaling receptor activity,alcohol dependence|alcohol abuse|epilepsy|complex partial epilepsy|temporal lobe epilepsy|cocaine abuse|cocaine dependence|mood disorder,ppi
15083,18054,4889,NPY5R,neuropeptide Y receptor Y5,5,neuropeptide Y receptor activity|peptide YY receptor activity|pancreatic polypeptide receptor activity,alcohol dependence|alcohol abuse|obesity,ppi
15084,18055,190,NR0B1,nuclear receptor subfamily 0 group B member 1,17,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription corepressor activity|RNA binding|nuclear receptor activity|DNA hairpin binding|sequence-specific DNA binding|transcription factor binding,azoospermia|cryptorchidism|gonadal dysgenesis|Turner syndrome|mixed gonadal dysgenesis|hypertrophy of breast|infant gynecomastia|gynecomastia|male infertility|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G,ppi
15085,18056,8431,NR0B2,nuclear receptor subfamily 0 group B member 2,63,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription corepressor activity|transcription factor binding,chylomicron retention disease|Fabry disease|lipid storage disease|Wolman disease|obesity|liver cancer|hepatocellular carcinoma,ppi
15086,18057,9572,NR1D1,nuclear receptor subfamily 1 group D member 1,13,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription corepressor binding|transcription corepressor activity|nuclear receptor activity|heme binding|transcription regulatory region DNA binding|signaling receptor activity|nuclear receptor transcription coactivator activity|DNA-binding transcription factor activity|transcription factor binding|transcription regulatory region sequence-specific DNA binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
15087,18058,9975,NR1D2,nuclear receptor subfamily 1 group D member 2,31,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|nuclear receptor activity|transcription factor binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|signaling receptor activity|RNA polymerase II regulatory region sequence-specific DNA binding|transcription regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity|nuclear receptor transcription coactivator activity,endometriosis of uterus|endometriosis,ppi
15088,18059,7376,NR1H2,nuclear receptor subfamily 1 group H member 2,64,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|transcription regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity|nuclear receptor transcription coactivator activity|signaling receptor activity|transcription factor binding|nuclear receptor activity|RNA polymerase II regulatory region sequence-specific DNA binding,cholestasis|liver cancer|hepatocellular carcinoma,ppi
15089,18060,10062,NR1H3,nuclear receptor subfamily 1 group H member 3,50,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription coactivator activity|nuclear receptor activity|cholesterol binding|sterol response element binding|transcription regulatory region DNA binding|transcription regulatory region sequence-specific DNA binding|signaling receptor activity|nuclear receptor transcription coactivator activity|transcription factor binding|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity,cholestasis|fatty liver disease,ppi
15090,18061,9971,NR1H4,nuclear receptor subfamily 1 group H member 4,31,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|obsolete transcriptional activator activity; RNA polymerase II transcription factor binding|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription coactivator activity|transcription corepressor activity|nuclear receptor activity|nuclear receptor binding|bile acid binding|bile acid receptor activity|sequence-specific DNA binding|chenodeoxycholic acid binding|transcription regulatory region sequence-specific DNA binding|nuclear receptor transcription coactivator activity|signaling receptor activity|transcription factor binding,cholestasis|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|intestinal cancer|intestinal benign neoplasm|gallbladder disease|liver disease|liver cancer|hepatocellular carcinoma,ppi
15091,18062,8856,NR1I2,nuclear receptor subfamily 1 group I member 2,42,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|transcription coactivator activity|nuclear receptor activity|drug binding|signaling receptor activity|transcription regulatory region sequence-specific DNA binding|nuclear receptor transcription coactivator activity|DNA-binding transcription factor activity|transcription factor binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|Barrett's esophagus|diabetic ketoacidosis|diabetes mellitus|esophageal cancer|fatty liver disease|neonatal jaundice|obesity|osteosarcoma|bone osteosarcoma|metabolic syndrome X,ppi
15092,18063,9970,NR1I3,nuclear receptor subfamily 1 group I member 3,36,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|nuclear receptor activity|androgen receptor activity|signaling receptor activity|transcription factor binding|nuclear receptor transcription coactivator activity|transcription regulatory region sequence-specific DNA binding,diabetic ketoacidosis|diabetes mellitus|liver cancer|obesity|metabolic syndrome X,ppi
15093,18064,474,ATOH1,atonal bHLH transcription factor 1,76,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
15094,18065,7181,NR2C1,nuclear receptor subfamily 2 group C member 1,31,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|signaling receptor activity,endometriosis of uterus|endometriosis,ppi
15095,18066,7182,NR2C2,nuclear receptor subfamily 2 group C member 2,51,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|signaling receptor activity|sequence-specific DNA binding|protein heterodimerization activity,endometriosis of uterus|endometriosis,ppi
15096,18067,7101,NR2E1,nuclear receptor subfamily 2 group E member 1,32,DNA-binding transcription factor activity; RNA polymerase II-specific,bipolar disorder|schizophrenia,ppi
15097,18068,10002,NR2E3,nuclear receptor subfamily 2 group E member 3,29,RNA polymerase II proximal promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|nuclear receptor activity|sequence-specific DNA binding,glaucoma|sensorineural hearing loss|night blindness|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
15098,18069,7025,NR2F1,nuclear receptor subfamily 2 group F member 1,36,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|sequence-specific DNA binding,intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|ophthalmoplegia|mechanical strabismus|hypertropia|blindness|breast cancer,ppi
15099,18070,7026,NR2F2,nuclear receptor subfamily 2 group F member 2,62,DNA-binding transcription factor activity; RNA polymerase II-specific|retinoic acid binding|DNA-binding transcription factor activity|transcription corepressor activity|nuclear receptor activity|sequence-specific DNA binding,aortic valve stenosis|atrioventricular septal defect|endometriosis of uterus|endometriosis|heart septal defect|ventricular septal defect|hiatus hernia|congenital diaphragmatic hernia|tetralogy of Fallot|hypoplastic left heart syndrome|atrial heart septal defect 1,ppi
15100,18071,2063,NR2F6,nuclear receptor subfamily 2 group F member 6,35,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|nuclear receptor activity|thyroid hormone receptor activity|sequence-specific DNA binding,endometriosis of uterus|endometriosis|breast cancer,ppi
15101,18072,2908,NR3C1,nuclear receptor subfamily 3 group C member 1,272,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|core promoter binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|nuclear receptor activity|glucocorticoid receptor activity|steroid binding|RNA polymerase II transcription factor activity; glucocorticoid-activated sequence-specific DNA binding|steroid hormone binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometriosis of uterus|endometriosis|hypertrichosis|hypertension|essential hypertension|hypoglycemia|hypokalemia|ocular hypertension|prostate cancer|prostate carcinoma|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
15102,18073,4306,NR3C2,nuclear receptor subfamily 3 group C member 2,35,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|steroid hormone receptor activity,alcohol dependence|alcohol abuse|bipolar disorder|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B,ppi
15103,18074,475,ATOX1,antioxidant 1 copper chaperone,14,copper ion binding|metallochaperone activity|copper chaperone activity,hepatitis|hypertension|essential hypertension|lung benign neoplasm,ppi
15104,18075,3164,NR4A1,nuclear receptor subfamily 4 group A member 1,124,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|protein heterodimerization activity|glucocorticoid receptor binding|RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|sequence-specific DNA binding,endometriosis of uterus|endometriosis|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|proteinuria|coronary artery disease,ppi
15105,18076,4929,NR4A2,nuclear receptor subfamily 4 group A member 2,33,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|nuclear receptor activity|beta-catenin binding|protein homodimerization activity|retinoid X receptor binding|protein heterodimerization activity|RNA polymerase II proximal promoter sequence-specific DNA binding|sequence-specific DNA binding|glucocorticoid receptor binding|RNA polymerase II regulatory region sequence-specific DNA binding,alcohol dependence|alcohol abuse|psoriatic arthritis|bipolar disorder|cocaine abuse|cocaine dependence|large intestine cancer|colorectal cancer|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|schizophrenia|seborrheic keratosis|skin disease|actinic keratosis,ppi
15106,18077,8013,NR4A3,nuclear receptor subfamily 4 group A member 3,5,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|thyroid hormone receptor activity|cAMP response element binding|protein homodimerization activity|glucocorticoid receptor binding|RNA polymerase II proximal promoter sequence-specific DNA binding|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,rheumatoid arthritis|chondrosarcoma|extraskeletal myxoid chondrosarcoma,ppi
15107,18078,2516,NR5A1,nuclear receptor subfamily 5 group A member 1,61,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|chromatin binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription coactivator activity|nuclear receptor activity|phospholipid binding|sequence-specific DNA binding|transcription regulatory region sequence-specific DNA binding,adrenal cortical hypofunction|Addison's disease|azoospermia|cryptorchidism|endometriosis of uterus|endometriosis|gonadal dysgenesis|Turner syndrome|46 XY gonadal dysgenesis|mixed gonadal dysgenesis|hypertrophy of breast|infant gynecomastia|gynecomastia|male infertility|premature menopause|androgen insensitivity syndrome|osteoporosis|polycystic ovary syndrome|premature ovarian failure|sex differentiation disease,ppi
15108,18079,2494,NR5A2,nuclear receptor subfamily 5 group A member 2,26,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|chromatin binding|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|nuclear receptor activity|phospholipid binding|sequence-specific DNA binding|transcription regulatory region DNA binding|transcription regulatory region sequence-specific DNA binding,anovulation|pancreatic cancer,ppi
15109,18080,2649,NR6A1,nuclear receptor subfamily 6 group A member 1,6,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|nuclear receptor activity|protein homodimerization activity|sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
15110,18081,4892,NRAP,nebulin related anchoring protein,11,actin binding|muscle alpha-actinin binding|actin filament binding,,ppi
15111,18082,4893,NRAS,neuroblastoma RAS viral oncogene homolog,63,protein-containing complex binding,alopecia|hemolytic anemia|sick sinus syndrome|ptosis|congenital ptosis|blood coagulation disease|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|coloboma|large intestine cancer|colorectal cancer,ppi
15112,18083,476,ATP1A1,ATPase Na+/K+ transporting subunit alpha 1,233,sodium:potassium-exchanging ATPase activity|ATP binding|potassium ion binding|sodium ion binding|steroid hormone binding,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|bipolar disorder|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypertension|essential hypertension|central nervous system origin vertigo|inner ear disease|vestibular disease|coronary artery disease,ppi
15113,18084,29959,NRBP1,nuclear receptor binding protein 1,29,protein homodimerization activity|protein serine/threonine kinase activity,,ppi
15114,18085,4897,NRCAM,neuronal cell adhesion molecule,11,ankyrin binding,autistic disorder|large intestine cancer|colorectal cancer|substance abuse|substance-related disorder|breast cancer,ppi
15115,18086,4898,NRDC,nardilysin convertase,83,metalloendopeptidase activity|epidermal growth factor binding,alcohol dependence|alcohol abuse,ppi
15116,18087,4899,NRF1,nuclear respiratory factor 1,18,RNA polymerase II proximal promoter sequence-specific DNA binding|core promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|protein homodimerization activity,basal cell carcinoma|in situ carcinoma|penis carcinoma in situ,ppi
15117,18088,3084,NRG1,neuregulin 1,68,transcription coregulator activity|protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|cytokine activity|integrin binding|growth factor activity|transmembrane receptor protein tyrosine kinase activator activity|receptor tyrosine kinase binding|ErbB-3 class receptor binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|protein tyrosine kinase activator activity|signaling receptor binding,bipolar disorder|cannabis dependence|cannabis abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|contact dermatitis|occupational dermatitis|congestive heart failure|Hirschsprung's disease|movement disease|lingual-facial-buccal dyskinesia|polycystic ovary syndrome|drug psychosis|schizophrenia|gastric ulcer|breast cancer,ppi
15118,18089,9542,NRG2,neuregulin 2,2,protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|signaling receptor binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,,ppi
15119,18090,10718,NRG3,neuregulin 3,1,growth factor activity|transmembrane receptor protein tyrosine kinase activator activity|receptor tyrosine kinase binding|signaling receptor binding,bipolar disorder|schizophrenia,ppi
15120,18091,26,AOC1,amine oxidase; copper containing 1,4,copper ion binding|calcium ion binding|primary amine oxidase activity|drug binding|heparin binding|zinc ion binding|protein-containing complex binding|quinone binding|diamine oxidase activity|histamine oxidase activity,hypertension|essential hypertension,ppi
15121,18092,477,ATP1A2,ATPase Na+/K+ transporting subunit alpha 2,39,sodium:potassium-exchanging ATPase activity|steroid hormone binding|ATP binding|ATPase activity|potassium ion binding|sodium ion binding,agnosia|bipolar disorder|cerebellar disease|dystonia|epilepsy|hemiplegia|hypertension|essential hypertension|intellectual disability|learning disability|movement disease|lingual-facial-buccal dyskinesia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|central nervous system origin vertigo|basal ganglia disease|focal hand dystonia,ppi
15122,18093,4900,NRGN,neurogranin,13,calmodulin binding,bipolar disorder|cocaine abuse|cocaine dependence|schizophrenia,ppi
15123,18094,8204,NRIP1,nuclear receptor interacting protein 1,67,RNA polymerase II proximal promoter sequence-specific DNA binding|transcription coactivator activity|transcription corepressor activity|androgen receptor binding|estrogen receptor binding|retinoid X receptor binding|glucocorticoid receptor binding,endometrial cancer|endometrial carcinoma|congestive heart failure|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|schizophrenia|breast cancer,ppi
15124,18095,4901,NRL,neural retina leucine zipper,4,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|transcription coactivator activity|sequence-specific DNA binding|DNA-binding transcription factor activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|retinal degeneration|cone-rod dystrophy,ppi
15125,18096,11270,NRM,nurim (nuclear envelope membrane protein),9,,,ppi
15126,18097,8829,NRP1,neuropilin 1,56,vascular endothelial growth factor-activated receptor activity|GTPase activator activity|coreceptor activity|semaphorin receptor activity|growth factor binding|cytokine binding,endometriosis of uterus|endometriosis|gallbladder disease|liver disease|pancreatic cancer|prostate cancer|prostate carcinoma,ppi
15127,18098,8828,NRP2,neuropilin 2,23,vascular endothelial growth factor-activated receptor activity|semaphorin receptor activity|growth factor binding|cytokine binding|signaling receptor activity,autistic disorder|epilepsy|visual epilepsy,ppi
15128,18099,4902,NRTN,neurturin,3,Ras guanyl-nucleotide exchange factor activity|signaling receptor binding,bipolar disorder|constipation|Hirschsprung's disease|intestinal obstruction|ileus|megacolon|toxic megacolon,ppi
15129,18100,9378,NRXN1,neurexin 1,31,calcium channel regulator activity|calcium ion binding|acetylcholine receptor binding|signaling receptor activity|cell adhesion molecule binding|neuroligin family protein binding,autistic disorder|bipolar disorder|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|esophagitis|peptic esophagitis|gastroesophageal reflux disease|communication disorder|schizophrenia|syndromic X-linked intellectual disability 94|ophthalmoplegia|mechanical strabismus|hypertropia|pulmonary valve stenosis|Pitt-Hopkins syndrome,ppi
15130,18101,9379,NRXN2,neurexin 2,11,transmembrane signaling receptor activity|calcium channel regulator activity|cell adhesion molecule binding|neuroligin family protein binding,schizophrenia|autistic disorder,ppi
15131,18102,478,ATP1A3,ATPase Na+/K+ transporting subunit alpha 3,101,amyloid-beta binding|sodium:potassium-exchanging ATPase activity|ATP binding|steroid hormone binding,generalized anxiety disorder|anxiety disorder|bipolar disorder|cerebellar disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|congestive heart failure|hemiplegia|mutism|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|arthropathy,ppi
15132,18103,9369,NRXN3,neurexin 3,12,signaling receptor activity|cell adhesion molecule binding|neuroligin family protein binding,alcohol dependence|alcohol abuse|schizophrenia|substance abuse|substance-related disorder,ppi
15133,18104,8506,CNTNAP1,contactin associated protein 1,22,SH3/SH2 adaptor activity|SH3 domain binding|signaling receptor activity,polyhydramnios,ppi
15134,18105,79366,HMGN5,high mobility group nucleosome binding domain 5,11,chromatin binding|RNA binding,,ppi
15135,18106,4904,YBX1,Y-box binding protein 1,395,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|double-stranded DNA binding|DNA-binding transcription factor activity|RNA binding,breast cancer,ppi
15136,18107,4905,NSF,N-ethylmaleimide sensitive factor; vesicle fusing ATPase,93,SNARE binding|ATPase activity|syntaxin-1 binding|Rab GTPase binding|protein kinase binding|protein-containing complex binding,schizophrenia|cocaine abuse|cocaine dependence|morphine dependence,ppi
15137,18108,8439,NSMAF,neutral sphingomyelinase activation associated factor,40,,,ppi
15138,18109,4907,NT5E,5'-nucleotidase ecto,51,5'-nucleotidase activity,arthropathy|arthritis|neurogenic arthropathy|stomach cancer,ppi
15139,18110,22978,NT5C2,5'-nucleotidase; cytosolic II,30,5'-nucleotidase activity|nucleoside phosphotransferase activity,pseudosarcomatous fibromatosis|intellectual disability|learning disability|myopia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|paraplegia|acute lymphocytic leukemia|hereditary spastic paraplegia 45,ppi
15140,18111,4908,NTF3,neurotrophin 3,11,signaling receptor binding|growth factor activity|chemoattractant activity,autistic disorder|bipolar disorder|diabetic autonomic neuropathy|diabetic polyneuropathy|diabetic neuropathy|Down syndrome|epilepsy with generalized tonic-clonic seizures|schizophrenia|status epilepticus|neurotic disorder|endogenous depression|melancholia|mood disorder|major depressive disorder|mental depression|sensorineural hearing loss,ppi
15141,18112,4909,NTF4,neurotrophin 4,6,growth factor activity,autistic disorder|bipolar disorder|primary open angle glaucoma|open-angle glaucoma|intellectual disability|learning disability,ppi
15142,18113,4913,NTHL1,nth like DNA glycosylase 1,21,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity|double-stranded DNA binding|DNA-(apurinic or apyrimidinic site) endonuclease activity|endonuclease activity|oxidized purine nucleobase lesion DNA N-glycosylase activity|DNA N-glycosylase activity|class I DNA-(apurinic or apyrimidinic site) endonuclease activity,skin benign neoplasm|skin cancer|meningioma|spinal meningioma|acoustic neuroma|intraventricular meningioma|pituitary adenoma|intraorbital meningioma|clear cell meningioma|benign meningioma|secretory meningioma|microcystic meningioma|cerebral convexity meningioma|angiomatous meningioma|parasagittal meningioma|psammomatous meningioma|fibrous meningioma|meningothelial meningioma|transitional meningioma|olfactory groove meningioma,ppi
15143,18114,9423,NTN1,netrin 1,8,,,ppi
15144,18115,4917,NTN3,netrin 3,2,,,ppi
15145,18116,4914,NTRK1,neurotrophic receptor tyrosine kinase 1,1954,protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|nerve growth factor receptor activity|protein homodimerization activity|neurotrophin binding|nerve growth factor binding|neurotrophin receptor activity|transmembrane signaling receptor activity,hypohidrosis|anhidrosis|arthropathy|neurogenic arthropathy|bipolar disorder|corneal ulcer|malignant glioma|gliosarcoma|mixed glioma|hereditary sensory neuropathy|sensory peripheral neuropathy|keratitis|keratoconjunctivitis|intellectual disability|learning disability|neuroblastoma|schizophreniform disorder|schizoaffective disorder|schizophrenia|chronic ulcer of skin,ppi
15146,18117,4915,NTRK2,neurotrophic receptor tyrosine kinase 2,35,protein homodimerization activity|neurotrophin binding|brain-derived neurotrophic factor binding|brain-derived neurotrophic factor-activated receptor activity|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity|protein tyrosine kinase activity|neurotrophin receptor activity,alcohol dependence|alcohol abuse|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
15147,18118,4916,NTRK3,neurotrophic receptor tyrosine kinase 3,54,neurotrophin receptor activity|neurotrophin binding|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity|protein tyrosine kinase activity,endometriosis of uterus|endometriosis|fibrosarcoma|malignant glioma|gliosarcoma|mixed glioma|schizophrenia|status epilepticus|neurotic disorder|endogenous depression|melancholia|papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma|mood disorder|major depressive disorder|mental depression|mesoblastic nephroma|congenital mesoblastic nephroma,ppi
15148,18119,4922,NTS,neurotensin,9,,alcohol dependence|alcohol abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|mood disorder,ppi
15149,18120,4923,NTSR1,neurotensin receptor 1,2,G-protein coupled receptor activity|G-protein coupled neurotensin receptor activity,alcohol dependence|alcohol abuse|schizophrenia|mood disorder|autistic disorder,ppi
15150,18121,481,ATP1B1,ATPase Na+/K+ transporting subunit beta 1,82,ATPase activator activity|MHC class II protein complex binding|sodium:potassium-exchanging ATPase activity|ATP binding|ATPase activity|potassium ion binding|sodium ion binding,acute myeloid leukemia|hypertension|essential hypertension|substance abuse|substance-related disorder,ppi
15151,18122,23620,NTSR2,neurotensin receptor 2,1,G-protein coupled receptor activity,,ppi
15152,18123,4682,NUBP1,nucleotide binding protein 1,19,nucleotide binding|iron-sulfur cluster binding,,ppi
15153,18124,10101,NUBP2,nucleotide binding protein 2,56,nucleotide binding|iron-sulfur cluster binding,,ppi
15154,18125,4924,NUCB1,nucleobindin 1,43,,Stevens-Johnson syndrome,ppi
15155,18126,4925,NUCB2,nucleobindin 2,31,,prostate cancer|prostate carcinoma,ppi
15156,18127,10726,NUDC,nuclear distribution C; dynein complex regulator,165,cadherin binding|unfolded protein binding,,ppi
15157,18128,4521,NUDT1,nudix hydrolase 1,19,GTPase activity|8-oxo-7;8-dihydroguanosine triphosphate pyrophosphatase activity|snoRNA binding|8-oxo-7;8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity|GTP diphosphatase activity|2-hydroxy-adenosine triphosphate pyrophosphatase activity|2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity|ATP diphosphatase activity|m7G(5')pppN diphosphatase activity,,ppi
15158,18129,318,NUDT2,nudix hydrolase 2,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity|bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,breast cancer,ppi
15159,18130,482,ATP1B2,ATPase Na+/K+ transporting subunit beta 2,11,ATPase activator activity|sodium:potassium-exchanging ATPase activity,malignant glioma|gliosarcoma|mixed glioma|esophagus squamous cell carcinoma,ppi
15160,18131,11165,NUDT3,nudix hydrolase 3,41,magnesium ion binding|diphosphoinositol-polyphosphate diphosphatase activity|inositol bisdiphosphate tetrakisphosphate diphosphatase activity|inositol diphosphate pentakisphosphate diphosphatase activity|bis(5'-adenosyl)-hexaphosphatase activity|bis(5'-adenosyl)-pentaphosphatase activity|m7G(5')pppN diphosphatase activity|endopolyphosphatase activity,,ppi
15161,18132,11163,NUDT4,nudix hydrolase 4,1,diphosphoinositol-polyphosphate diphosphatase activity|snoRNA binding|inositol diphosphate tetrakisphosphate diphosphatase activity|inositol bisdiphosphate tetrakisphosphate diphosphatase activity|inositol diphosphate pentakisphosphate diphosphatase activity|m7G(5')pppN diphosphatase activity|bis(5'-adenosyl)-pentaphosphatase activity|bis(5'-adenosyl)-hexaphosphatase activity|endopolyphosphatase activity,,ppi
15162,18133,11164,NUDT5,nudix hydrolase 5,30,magnesium ion binding|nucleotidyltransferase activity|ADP-sugar diphosphatase activity|snoRNA binding|protein homodimerization activity|8-oxo-dGDP phosphatase activity|ADP-ribose diphosphatase activity|m7G(5')pppN diphosphatase activity,,ppi
15163,18134,11162,NUDT6,nudix hydrolase 6,14,growth factor activity|NAD binding|NADH pyrophosphatase activity|ADP-ribose diphosphatase activity,,ppi
15164,18135,283927,NUDT7,nudix hydrolase 7,2,acetyl-CoA hydrolase activity|CoA hydrolase activity|snoRNA binding|m7G(5')pppN diphosphatase activity,liver cancer,ppi
15165,18136,254552,NUDT8,nudix hydrolase 8,8,,,ppi
15166,18137,53343,NUDT9,nudix hydrolase 9,16,ADP-sugar diphosphatase activity|ADP-ribose diphosphatase activity|adenosine-diphosphatase activity,,ppi
15167,18138,26747,NUFIP1,NUFIP1; FMR1 interacting protein 1,110,DNA binding|RNA binding|snoRNA binding,,ppi
15168,18139,4926,NUMA1,nuclear mitotic apparatus protein 1,109,structural molecule activity|microtubule binding|protein C-terminus binding|tubulin binding|phosphatidylinositol binding|protein-containing complex binding|microtubule plus-end binding|microtubule minus-end binding|dynein complex binding|disordered domain specific binding,acute promyelocytic leukemia|allergic contact dermatitis,ppi
15169,18140,483,ATP1B3,ATPase Na+/K+ transporting subunit beta 3,105,ATPase activator activity|sodium:potassium-exchanging ATPase activity,,ppi
15170,18141,8650,NUMB,NUMB; endocytic adaptor protein,61,cadherin binding,,ppi
15171,18142,9253,NUMBL,NUMB like; endocytic adaptor protein,33,,schizophrenia,ppi
15172,18143,9972,NUP153,nucleoporin 153,118,structural constituent of nuclear pore|protein membrane anchor|nuclear localization sequence binding,,ppi
15173,18144,9631,NUP155,nucleoporin 155,65,transporter activity|structural constituent of nuclear pore,atrial fibrillation|familial atrial fibrillation,ppi
15174,18145,8021,NUP214,nucleoporin 214,79,nuclear export signal receptor activity|structural constituent of nuclear pore|nuclear localization sequence binding,acute lymphocytic leukemia|acute myeloid leukemia,ppi
15175,18146,10762,NUP50,nucleoporin 50,94,Ran GTPase binding|GTPase activator activity,,ppi
15176,18147,23636,NUP62,nucleoporin 62,110,chromatin binding|receptor signaling complex scaffold activity|SH2 domain binding|ubiquitin binding|thyroid hormone receptor binding|structural constituent of nuclear pore|phospholipid binding,dystonia|intellectual disability|learning disability|optic atrophy|basal ganglia disease|focal hand dystonia|blepharospasm|spontaneous ocular nystagmus|dissociated nystagmus|pathologic nystagmus|striatonigral degeneration,ppi
15177,18148,4927,NUP88,nucleoporin 88,44,transporter activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
15178,18149,4928,NUP98,nucleoporin 98,197,transcription coactivator activity|mRNA binding|transporter activity|structural constituent of nuclear pore|promoter-specific chromatin binding|RNA binding|nuclear localization sequence binding,acute myeloid leukemia,ppi
15179,18150,4931,NVL,nuclear VCP-like,37,RNA binding|ATP binding|preribosome binding|ATPase activity,,ppi
15180,18151,10482,NXF1,nuclear RNA export factor 1,1122,RNA binding,,ppi
15181,18152,56001,NXF2,nuclear RNA export factor 2,63,,,ppi
15182,18153,56000,NXF3,nuclear RNA export factor 3,7,RNA binding,,ppi
15183,18154,55998,NXF5,nuclear RNA export factor 5,8,RNA binding,,ppi
15184,18155,11249,NXPH2,neurexophilin 2,21,signaling receptor binding,,ppi
15185,18156,11248,NXPH3,neurexophilin 3,14,signaling receptor binding,,ppi
15186,18157,11247,NXPH4,neurexophilin 4,4,signaling receptor binding,,ppi
15187,18159,23439,ATP1B4,ATPase Na+/K+ transporting family member beta 4,38,monovalent inorganic cation transmembrane transporter activity|sodium:potassium-exchanging ATPase activity|ATPase activator activity,,ppi
15188,18160,60506,NYX,nyctalopin,13,,congenital stationary night blindness,ppi
15189,18161,4938,OAS1,2'-5'-oligoadenylate synthetase 1,6,2'-5'-oligoadenylate synthetase activity|double-stranded RNA binding|ATP binding,diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21|type 1 diabetes mellitus 22,ppi
15190,18162,4939,OAS2,2'-5'-oligoadenylate synthetase 2,5,2'-5'-oligoadenylate synthetase activity|double-stranded RNA binding|ATP binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|influenza,ppi
15191,18163,4940,OAS3,2'-5'-oligoadenylate synthetase 3,17,2'-5'-oligoadenylate synthetase activity|double-stranded RNA binding|ATP binding,influenza,ppi
15192,18164,8638,OASL,2'-5'-oligoadenylate synthetase like,8,DNA binding|RNA binding|double-stranded RNA binding|thyroid hormone receptor binding|2'-5'-oligoadenylate synthetase activity,influenza,ppi
15193,18165,4942,OAT,ornithine aminotransferase,55,ornithine-oxo-acid transaminase activity|pyridoxal phosphate binding,gyrate atrophy|myopia|night blindness|congenital stationary night blindness|perinatal necrotizing enterocolitis,ppi
15194,18166,4943,TBC1D25,TBC1 domain family member 25,10,GTPase activator activity|Rab GTPase binding,mood disorder,ppi
15195,18167,4946,OAZ1,ornithine decarboxylase antizyme 1,27,ornithine decarboxylase inhibitor activity,,ppi
15196,18168,4947,OAZ2,ornithine decarboxylase antizyme 2,7,ornithine decarboxylase inhibitor activity,,ppi
15197,18169,51686,OAZ3,ornithine decarboxylase antizyme 3,32,ornithine decarboxylase inhibitor activity|putrescine transmembrane transporter activity,,ppi
15198,18170,29,ABR,active BCR-related,16,guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity|GTPase activator activity,medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|prostate cancer|prostate carcinoma,ppi
15199,18171,729330,OC90,otoconin 90,1,structural molecule activity,central nervous system origin vertigo|inner ear disease|vestibular disease,ppi
15200,18172,4948,OCA2,OCA2 melanosomal transmembrane protein,3,transporter activity|L-tyrosine transmembrane transporter activity,oculocutaneous albinism|Griscelli syndrome|Griscelli syndrome type 1|Griscelli syndrome type 2|Griscelli syndrome type 3|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|mechanical strabismus|hypertropia|blindness|asthenopia,ppi
15201,18176,4952,OCRL,OCRL; inositol polyphosphate-5-phosphatase,55,phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity|GTPase activator activity|phosphatidylinositol phosphate 4-phosphatase activity|phosphatidylinositol-3;5-bisphosphate 5-phosphatase activity|inositol-1;4;5-trisphosphate 5-phosphatase activity|inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity|inositol phosphate phosphatase activity|Rac GTPase binding,suppression amblyopia|amblyopia|generalized anxiety disorder|anxiety disorder|arthropathy|arthritis|skin benign neoplasm|skin cancer|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18,ppi
15202,18177,4953,ODC1,ornithine decarboxylase 1,20,ornithine decarboxylase activity|protein homodimerization activity,colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|squamous cell papilloma|papilloma|skin benign neoplasm|skin cancer,ppi
15203,18178,487,ATP2A1,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1,25,calcium-transporting ATPase activity|calcium ion binding|proton-exporting ATPase activity; phosphorylative mechanism,congestive heart failure|Brody myopathy,ppi
15204,18179,130497,OSR1,odd-skipped related transciption factor 1,4,DNA-binding transcription factor activity; RNA polymerase II-specific|protein serine/threonine kinase activity|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
15205,18180,4956,ODF1,outer dense fiber of sperm tails 1,23,,,ppi
15206,18181,4957,ODF2,outer dense fiber of sperm tails 2,129,structural molecule activity,,ppi
15207,18182,10178,TENM1,teneurin transmembrane protein 1,3,heparin binding|protein homodimerization activity|protein heterodimerization activity|cell adhesion molecule binding,,ppi
15208,18183,488,ATP2A2,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2,106,calcium-transporting ATPase activity|calcium ion binding|calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential|proton-exporting ATPase activity; phosphorylative mechanism,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetes mellitus|type 2 diabetes mellitus|epilepsy|heart disease|cardiovascular system disease|congestive heart failure|keratosis follicularis|pseudoxanthoma elasticum|mongolian spot|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|schizophrenia|visual epilepsy,ppi
15209,18184,4967,OGDH,oxoglutarate dehydrogenase,45,oxoglutarate dehydrogenase (succinyl-transferring) activity|thiamine pyrophosphate binding,cerebellar disease|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|movement disease|lingual-facial-buccal dyskinesia|lactic acidosis|muscular atrophy,ppi
15210,18185,4968,OGG1,8-oxoguanine DNA glycosylase,8,damaged DNA binding|endonuclease activity|oxidized purine nucleobase lesion DNA N-glycosylase activity|oxidized purine DNA binding|DNA N-glycosylase activity|8-oxo-7;8-dihydroguanine DNA N-glycosylase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|brain disease|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|diabetes mellitus|type 2 diabetes mellitus|heart disease|cardiovascular system disease|Huntington's disease|male infertility|lung benign neoplasm,ppi
15211,18186,4969,OGN,osteoglycin,10,extracellular matrix structural constituent conferring compression resistance,,ppi
15212,18187,8473,OGT,O-linked N-acetylglucosamine (GlcNAc) transferase,132,phosphatidylinositol-3;4;5-trisphosphate binding|acetylglucosaminyltransferase activity|protein N-acetylglucosaminyltransferase activity|protein O-GlcNAc transferase activity|histone acetyltransferase activity (H4-K5 specific)|histone acetyltransferase activity (H4-K8 specific)|histone acetyltransferase activity (H4-K16 specific),,ppi
15213,18188,489,ATP2A3,ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3,47,calcium-transporting ATPase activity|proton-exporting ATPase activity; phosphorylative mechanism,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|diabetes mellitus|type 2 diabetes mellitus,ppi
15214,18189,4973,OLR1,oxidized low density lipoprotein receptor 1,12,,congestive heart failure|hypertension|essential hypertension|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
15215,18190,4958,OMD,osteomodulin,4,,,ppi
15216,18191,4974,OMG,oligodendrocyte myelin glycoprotein,2,,,ppi
15217,18192,4975,OMP,olfactory marker protein,2,,,ppi
15218,18193,3175,ONECUT1,one cut homeobox 1,7,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding,,ppi
15219,18194,9480,ONECUT2,one cut homeobox 2,1,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding,,ppi
15220,18195,490,ATP2B1,ATPase plasma membrane Ca2+ transporting 1,41,calcium-transporting ATPase activity|calcium ion transmembrane transporter activity|PDZ domain binding,hypertension|essential hypertension|cataract|coronary artery disease,ppi
15221,18196,4976,OPA1,OPA1; mitochondrial dynamin like GTPase,73,magnesium ion binding|GTPase activity|phosphatidic acid binding|cardiolipin binding|microtubule binding,ptosis|congenital ptosis|cerebellar disease|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|sensorineural hearing loss|intellectual disability|learning disability|familial periodic paralysis|myopathy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|optic atrophy,ppi
15222,18197,80207,OPA3,OPA3; outer mitochondrial membrane lipid metabolism regulator,27,,3-methylglutaconic aciduria type 3|optic atrophy,ppi
15223,18198,4978,OPCML,opioid binding protein/cell adhesion molecule like,12,,schizophrenia|ovarian cancer|hereditary breast ovarian cancer syndrome,ppi
15224,18199,4983,OPHN1,oligophrenin 1,6,GTPase activator activity|phospholipid binding,autistic disorder|cryptorchidism|enophthalmos|orbital disease|exophthalmos|epilepsy|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|speech disorder|ophthalmoplegia|mechanical strabismus|hypertropia|attention deficit hyperactivity disorder|syndromic intellectual disability,ppi
15225,18200,26873,OPLAH,5-oxoprolinase (ATP-hydrolysing),2,5-oxoprolinase (ATP-hydrolyzing) activity,gastroenteritis|nephrolithiasis,ppi
15226,18201,491,ATP2B2,ATPase plasma membrane Ca2+ transporting 2,122,calcium-transporting ATPase activity|PDZ domain binding,autosomal recessive nonsyndromic deafness 12,ppi
15227,18202,4985,OPRD1,opioid receptor delta 1,27,opioid receptor activity|enkephalin receptor activity|neuropeptide binding|G-protein coupled receptor activity,alcohol dependence|alcohol abuse|epilepsy|multiple system atrophy|schizophreniform disorder|schizoaffective disorder|substance abuse|substance-related disorder|cocaine abuse|cocaine dependence|morphine dependence,ppi
15228,18203,4986,OPRK1,opioid receptor kappa 1,13,opioid receptor activity|dynorphin receptor activity|G-protein coupled receptor activity|neuropeptide binding,alcohol dependence|alcohol abuse|sick sinus syndrome|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|epilepsy|visual epilepsy|cocaine abuse|cocaine dependence|mood disorder|morphine dependence,ppi
15229,18204,4987,OPRL1,opioid related nociceptin receptor 1,4,nociceptin receptor activity|G-protein coupled receptor activity|neuropeptide binding,alcohol dependence|alcohol abuse|sick sinus syndrome|cocaine dependence|opiate dependence|morphine dependence|heroin dependence,ppi
15230,18205,4988,OPRM1,opioid receptor mu 1,80,G-protein alpha-subunit binding|G-protein coupled receptor activity|beta-endorphin receptor activity|voltage-gated calcium channel activity|morphine receptor activity|neuropeptide binding|G-protein beta-subunit binding,alcohol dependence|alcohol abuse|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|epilepsy|hepatic coma|hepatic encephalopathy|hepatitis C|opiate dependence|morphine dependence|heroin dependence|multiple system atrophy|cocaine dependence|movement disease,ppi
15231,18206,10280,SIGMAR1,sigma non-opioid intracellular receptor 1,14,drug binding,alcohol dependence|alcohol abuse|amnestic disorder|dissociative amnesia|progressive muscular atrophy|amyotrophic lateral sclerosis|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|intellectual disability|learning disability|spinal muscular atrophy|schizophrenia|epilepsy|visual epilepsy|cocaine abuse|cocaine dependence|mood disorder|amyotrophic lateral sclerosis type 16,ppi
15232,18207,26254,OPTC,opticin,2,extracellular matrix structural constituent,,ppi
15233,18208,492,ATP2B3,ATPase plasma membrane Ca2+ transporting 3,35,calcium-transporting ATPase activity|calcium ion transmembrane transporter activity|PDZ domain binding,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|Conn's syndrome|Bartter disease|primary hyperaldosteronism|Waterhouse-Friderichsen syndrome|hypertension|essential hypertension,ppi
15234,18212,493,ATP2B4,ATPase plasma membrane Ca2+ transporting 4,56,calcium-transporting ATPase activity|calmodulin binding|protein phosphatase 2B binding|nitric-oxide synthase inhibitor activity|scaffold protein binding|sodium channel regulator activity|PDZ domain binding,,ppi
15235,18214,26533,OR10G3,olfactory receptor family 10 subfamily G member 3,1,olfactory receptor activity,,ppi
15236,18217,26532,OR10H3,olfactory receptor family 10 subfamily H member 3,7,G-protein coupled receptor activity|G-protein coupled serotonin receptor activity|neurotransmitter receptor activity,,ppi
15237,18218,26476,OR10J1,olfactory receptor family 10 subfamily J member 1,1,,,ppi
15238,18226,4991,OR1D2,olfactory receptor family 1 subfamily D member 2,1,olfactory receptor activity,,ppi
15239,18230,495,ATP4A,ATPase H+/K+ transporting alpha subunit,88,potassium:proton exchanging ATPase activity|sodium:potassium-exchanging ATPase activity,,ppi
15240,18231,8388,OR1E2,olfactory receptor family 1 subfamily E member 2,1,signaling receptor activity,,ppi
15241,18234,30,ACAA1,acetyl-CoA acyltransferase 1,30,acetyl-CoA C-acyltransferase activity|acetate CoA-transferase activity|palmitoyl-CoA oxidase activity,,ppi
15242,18235,496,ATP4B,ATPase H+/K+ transporting beta subunit,5,potassium:proton exchanging ATPase activity|sodium:potassium-exchanging ATPase activity|ATPase activator activity,,ppi
15243,18236,8390,OR1G1,olfactory receptor family 1 subfamily G member 1,1,,,ppi
15244,18252,498,ATP5A1,ATP synthase; H+ transporting; mitochondrial F1 complex; alpha subunit 1; cardiac muscle,209,RNA binding|ATP binding|transmembrane transporter activity|MHC class I protein binding|proton-transporting ATP synthase activity; rotational mechanism|ATPase activity|ADP binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|epilepsy|placental insufficiency|congestive heart failure|primary pulmonary hypertension|pulmonary hypertension,ppi
15245,18261,135948,OR2F2,olfactory receptor family 2 subfamily F member 2,1,olfactory receptor activity,,ppi
15246,18262,26716,OR2H1,olfactory receptor family 2 subfamily H member 1,1,olfactory receptor activity,,ppi
15247,18267,26248,OR2K2,olfactory receptor family 2 subfamily K member 2,1,olfactory receptor activity,,ppi
15248,18272,56656,OR2S2,olfactory receptor family 2 subfamily S member 2 (gene/pseudogene),2,olfactory receptor activity,,ppi
15249,18275,26692,OR2W1,olfactory receptor family 2 subfamily W member 1,1,olfactory receptor activity,,ppi
15250,18276,4994,OR3A1,olfactory receptor family 3 subfamily A member 1,1,,,ppi
15251,18277,4995,OR3A2,olfactory receptor family 3 subfamily A member 2,1,signaling receptor activity,,ppi
15252,18284,10449,ACAA2,acetyl-CoA acyltransferase 2,60,RNA binding|acetyl-CoA C-acyltransferase activity,arthropathy|arthritis|adult respiratory distress syndrome|newborn respiratory distress syndrome,ppi
15253,18285,506,ATP5B,ATP synthase; H+ transporting; mitochondrial F1 complex; beta polypeptide,205,transporter activity|transmembrane transporter activity|MHC class I protein binding|proton-transporting ATP synthase activity; rotational mechanism|proton-transporting ATPase activity; rotational mechanism|ATPase activity,fatty liver disease|spinocerebellar ataxia type 17,ppi
15254,18289,219982,OR5A1,olfactory receptor family 5 subfamily A member 1,1,olfactory receptor activity|odorant binding,,ppi
15255,18292,509,ATP5C1,ATP synthase; H+ transporting; mitochondrial F1 complex; gamma polypeptide 1,134,RNA binding|transmembrane transporter activity|ATPase activity|proton-transporting ATPase activity; rotational mechanism,,ppi
15256,18294,338674,OR5F1,olfactory receptor family 5 subfamily F member 1,9,olfactory receptor activity|odorant binding,,ppi
15257,18305,26659,OR7A5,olfactory receptor family 7 subfamily A member 5,1,olfactory receptor activity,,ppi
15258,18306,513,ATP5D,ATP synthase; H+ transporting; mitochondrial F1 complex; delta subunit,55,transporter activity|ATPase activity|transmembrane transporter activity|ATP binding|ADP binding|proton-transporting ATP synthase activity; rotational mechanism,urinary bladder cancer,ppi
15259,18307,26664,OR7C1,olfactory receptor family 7 subfamily C member 1,1,olfactory receptor activity,,ppi
15260,18310,514,ATP5E,ATP synthase; H+ transporting; mitochondrial F1 complex; epsilon subunit,35,transmembrane transporter activity|ATPase activity,lactic acidosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|intellectual disability|learning disability|polyneuropathy|peripheral nervous system disease|neuropathy|mitochondrial complex V (ATP synthase) deficiency nuclear type 3|3-methylglutaconic aciduria,ppi
15261,18313,31,ACACA,acetyl-CoA carboxylase alpha,101,acetyl-CoA carboxylase activity,congestive heart failure|familial periodic paralysis|myopathy|liver cancer|hepatocellular carcinoma,ppi
15262,18314,515,ATP5F1,ATP synthase; H+ transporting; mitochondrial Fo complex subunit B1,152,transmembrane transporter activity|ATPase activity|proton-transporting ATP synthase activity; rotational mechanism,,ppi
15263,18315,516,ATP5G1,ATP synthase; H+ transporting; mitochondrial Fo complex subunit C1 (subunit 9),9,transporter activity|proton-transporting ATP synthase activity; rotational mechanism,,ppi
15264,18316,517,ATP5G2,ATP synthase; H+ transporting; mitochondrial Fo complex subunit C2 (subunit 9),3,transporter activity|proton-transporting ATP synthase activity; rotational mechanism,,ppi
15265,18317,518,ATP5G3,ATP synthase; H+ transporting; mitochondrial Fo complex subunit C3 (subunit 9),9,transporter activity|proton-transporting ATP synthase activity; rotational mechanism,,ppi
15266,18318,10476,ATP5H,ATP synthase; H+ transporting; mitochondrial Fo complex subunit D,64,transmembrane transporter activity|ATPase activity|proton-transporting ATP synthase activity; rotational mechanism,lung cancer|lung adenocarcinoma|liver cancer|hepatocellular carcinoma,ppi
15267,18319,521,ATP5I,ATP synthase; H+ transporting; mitochondrial Fo complex subunit E,42,transmembrane transporter activity|ATPase activity,,ppi
15268,18324,522,ATP5J,ATP synthase; H+ transporting; mitochondrial Fo complex subunit F6,49,transporter activity|transmembrane transporter activity|ATPase activity,heart disease|cardiovascular system disease,ppi
15269,18325,26595,OR8B2,olfactory receptor family 8 subfamily B member 2,1,odorant binding|olfactory receptor activity,,ppi
15270,18329,9551,ATP5J2,ATP synthase; H+ transporting; mitochondrial Fo complex subunit F2,44,transmembrane transporter activity|ATPase activity,,ppi
15271,18331,283160,OR8D2,olfactory receptor family 8 subfamily D member 2 (gene/pseudogene),2,olfactory receptor activity|odorant binding,,ppi
15272,18334,4998,ORC1,origin recognition complex subunit 1,56,DNA replication origin binding,blepharophimosis|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|sensorineural hearing loss|achondroplasia|Laron syndrome|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|intellectual disability|learning disability|microcephaly|ophthalmoplegia|mechanical strabismus|hypertropia|Klippel-Feil syndrome|spondylolisthesis,ppi
15273,18335,4999,ORC2,origin recognition complex subunit 2,66,DNA replication origin binding,,ppi
15274,18336,23595,ORC3,origin recognition complex subunit 3,43,DNA replication origin binding,,ppi
15275,18337,5000,ORC4,origin recognition complex subunit 4,50,nucleotide binding|DNA replication origin binding,placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|adult respiratory distress syndrome|Meier-Gorlin syndrome,ppi
15276,18338,5001,ORC5,origin recognition complex subunit 5,49,nucleotide binding|DNA replication origin binding,,ppi
15277,18339,9390,SLC22A13,solute carrier family 22 member 13,3,organic cation transmembrane transporter activity|nicotinate transmembrane transporter activity,,ppi
15278,18341,5004,ORM1,orosomucoid 1,17,,mental depression|melancholia,ppi
15279,18342,5005,ORM2,orosomucoid 2,5,,,ppi
15280,18343,32,ACACB,acetyl-CoA carboxylase beta,22,acetyl-CoA carboxylase activity,obesity,ppi
15281,18344,539,ATP5O,ATP synthase; H+ transporting; mitochondrial F1 complex; O subunit,118,transporter activity|drug binding|ATPase activity|transmembrane transporter activity,,ppi
15282,18345,5007,OSBP,oxysterol binding protein,45,oxysterol binding|sterol transporter activity|phosphatidylinositol-4-phosphate binding|lipid binding|sterol binding,,ppi
15283,18346,23762,OSBP2,oxysterol binding protein 2,10,cholesterol binding|sterol binding|sterol transporter activity|lipid binding,,ppi
15284,18347,5008,OSM,oncostatin M,17,cytokine activity|growth factor activity,contact dermatitis|occupational dermatitis,ppi
15285,18348,9180,OSMR,oncostatin M receptor,10,oncostatin-M receptor activity|cytokine binding|cytokine receptor activity,amyloidosis|lung cancer|non-small cell lung carcinoma|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|primary cutaneous amyloidosis|malignant mesothelioma|benign mesothelioma,ppi
15286,18349,9943,OXSR1,oxidative stress responsive 1,171,magnesium ion binding|protein serine/threonine kinase activity|ATP binding,hypertension|essential hypertension|schizophrenia,ppi
15287,18350,523,ATP6V1A,ATPase H+ transporting V1 subunit A,143,proton-transporting ATPase activity; rotational mechanism,,ppi
15288,18351,26578,OSTF1,osteoclast stimulating factor 1,34,,,ppi
15289,18352,5009,OTC,ornithine carbamoyltransferase,12,ornithine carbamoyltransferase activity,brain disease|brain edema|epilepsy|hypoglycemia|intellectual disability|learning disability|pyloric stenosis|visual epilepsy|urea cycle disorder|ornithine carbamoyltransferase deficiency|episodic ataxia,ppi
15290,18353,5010,CLDN11,claudin 11,2,identical protein binding,multiple sclerosis|schizophrenia,ppi
15291,18354,9381,OTOF,otoferlin,2,calcium ion binding,sensorineural hearing loss|autosomal recessive nonsyndromic deafness 9,ppi
15292,18358,5013,OTX1,orthodenticle homeobox 1,43,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
15293,18359,5015,OTX2,orthodenticle homeobox 2,11,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|eukaryotic initiation factor 4E binding,bipolar disorder|isolated cleft palate|cleft palate|coloboma|cryptorchidism|epilepsy|polyhydramnios|hypoglycemia|infertility|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|tongue disease|microphthalmia|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus,ppi
15294,18360,5016,OVGP1,oviductal glycoprotein 1,4,chitin binding|chitinase activity,asbestosis|anthracosilicosis|pneumoconiosis|siderosis|bagassosis,ppi
15295,18361,5017,OVOL1,ovo like transcriptional repressor 1,5,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,atopic dermatitis|pilomatrixoma|hair follicle neoplasm,ppi
15296,18362,5018,OXA1L,OXA1L; mitochondrial inner membrane protein,31,protein homodimerization activity|mitochondrial ribosome binding,,ppi
15297,18363,5019,OXCT1,3-oxoacid CoA-transferase 1,67,3-oxoacid CoA-transferase activity|protein homodimerization activity,osteoporosis,ppi
15298,18364,5020,OXT,oxytocin/neurophysin I prepropeptide,11,,alcohol dependence|alcohol abuse|anxiety disorder|phobic disorder|autistic disorder|colon cancer|colonic benign neoplasm|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|purpura fulminans|disseminated intravascular coagulation|congestive heart failure|epilepsy with generalized tonic-clonic seizures|asphyxia neonatorum|hypertension|essential hypertension,ppi
15299,18365,5021,OXTR,oxytocin receptor,5,oxytocin receptor activity|vasopressin receptor activity,autistic disorder|lung cancer|non-small cell lung carcinoma|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia,ppi
15300,18366,525,ATP6V1B1,ATPase H+ transporting V1 subunit B1,96,proton transmembrane transporter activity,renal tubular acidosis|sensorineural hearing loss|acute urate nephropathy,ppi
15301,18367,5023,P2RX1,purinergic receptor P2X 1,15,purinergic nucleotide receptor activity|cation channel activity|ATP-gated ion channel activity|extracellularly ATP-gated cation channel activity,toxic encephalopathy,ppi
15302,18368,5024,P2RX3,purinergic receptor P2X 3,1,purinergic nucleotide receptor activity|extracellularly ATP-gated cation channel activity|ATP binding|ATP-gated ion channel activity,,ppi
15303,18369,5025,P2RX4,purinergic receptor P2X 4,32,purinergic nucleotide receptor activity|extracellularly ATP-gated cation channel activity|signaling receptor binding|copper ion binding|ATP binding|zinc ion binding|protein homodimerization activity|ligand-gated calcium channel activity|ATP-gated ion channel activity,epilepsy|complex partial epilepsy|temporal lobe epilepsy,ppi
15304,18370,5026,P2RX5,purinergic receptor P2X 5,22,purinergic nucleotide receptor activity|transmembrane signaling receptor activity|extracellularly ATP-gated cation channel activity|ion channel activity|ATP binding|ATP-gated ion channel activity,,ppi
15305,18371,5027,P2RX7,purinergic receptor P2X 7,12,lipopolysaccharide binding|purinergic nucleotide receptor activity|extracellularly ATP-gated cation channel activity|signaling receptor binding|ATP binding|protein homodimerization activity|ATP-gated ion channel activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|complex partial epilepsy|temporal lobe epilepsy|chronic lymphocytic leukemia|Richter's syndrome|multiple sclerosis|mood disorder,ppi
15306,18372,9127,P2RX6,purinergic receptor P2X 6,6,purinergic nucleotide receptor activity|transmembrane signaling receptor activity|extracellularly ATP-gated cation channel activity|ATP binding|channel activity|ATP-gated ion channel activity,,ppi
15307,18373,5028,P2RY1,purinergic receptor P2Y1,10,ATP binding|signaling receptor activity|G-protein coupled purinergic nucleotide receptor activity|ATP-activated adenosine receptor activity|ADP-activated adenosine receptor activity|scaffold protein binding,,ppi
15308,18374,526,ATP6V1B2,ATPase H+ transporting V1 subunit B2,132,proton transmembrane transporter activity|proton-transporting ATPase activity; rotational mechanism,gingival overgrowth|gingival hypertrophy|sensorineural hearing loss|arthropathy|arthritis|Clouston syndrome,ppi
15309,18375,5032,P2RY11,purinergic receptor P2Y11,1,neurotransmitter receptor activity|signaling receptor activity|ATP-activated adenosine receptor activity,narcolepsy|Balo concentric sclerosis|adrenoleukodystrophy|central nervous system disease|transient global amnesia,ppi
15310,18376,5029,P2RY2,purinergic receptor P2Y2,9,signaling receptor activity,,ppi
15311,18377,5030,P2RY4,pyrimidinergic receptor P2Y4,2,uridine nucleotide receptor activity,,ppi
15312,18378,5031,P2RY6,pyrimidinergic receptor P2Y6,3,ADP receptor activity|G-protein coupled receptor activity|UDP-activated nucleotide receptor activity|UTP-activated nucleotide receptor activity,,ppi
15313,18379,5033,P4HA1,prolyl 4-hydroxylase subunit alpha 1,44,procollagen-proline 4-dioxygenase activity,,ppi
15314,18380,8974,P4HA2,prolyl 4-hydroxylase subunit alpha 2,80,electron transfer activity|procollagen-proline 4-dioxygenase activity,,ppi
15315,18381,5034,P4HB,prolyl 4-hydroxylase subunit beta,162,RNA binding|protein disulfide isomerase activity|peptide disulfide oxidoreductase activity|protein heterodimerization activity|procollagen-proline 4-dioxygenase activity|peptidyl-proline 4-dioxygenase activity,hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|enophthalmos|orbital disease|exophthalmos|placental insufficiency|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|osteoporosis|craniosynostosis|prostate cancer|prostate carcinoma|coronary artery disease|spinocerebellar ataxia type 17|Cole-Carpenter syndrome,ppi
15316,18382,26258,BLOC1S6,biogenesis of lysosomal organelles complex 1 subunit 6,42,syntaxin binding|protein homodimerization activity|actin filament binding,spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|Hermansky-Pudlak syndrome 9,ppi
15317,18383,527,ATP6V0C,ATPase H+ transporting V0 subunit c,27,proton-transporting ATP synthase activity; rotational mechanism|proton-transporting ATPase activity; rotational mechanism,,ppi
15318,18384,5036,PA2G4,proliferation-associated 2G4,127,DNA binding|DNA-binding transcription factor activity|RNA binding,stomach cancer,ppi
15319,18385,26986,PABPC1,poly(A) binding protein cytoplasmic 1,271,RNA binding|mRNA 3'-UTR binding|poly(A) binding|poly(U) RNA binding|translation activator activity,urinary bladder cancer|transitional cell carcinoma|breast cancer,ppi
15320,18386,5042,PABPC3,poly(A) binding protein cytoplasmic 3,29,poly(A) binding|poly(U) RNA binding|RNA binding|mRNA 3'-UTR binding,,ppi
15321,18387,8761,PABPC4,poly(A) binding protein cytoplasmic 4,159,RNA binding|poly(A) binding|poly(U) RNA binding|poly(C) RNA binding|mRNA 3'-UTR binding,,ppi
15322,18388,528,ATP6V1C1,ATPase H+ transporting V1 subunit C1,63,transporter activity|proton-transporting ATPase activity; rotational mechanism|proton-exporting ATPase activity; phosphorylative mechanism,,ppi
15323,18389,8106,PABPN1,poly(A) binding protein nuclear 1,58,RNA binding|RNA polymerase binding,ptosis|congenital ptosis|familial periodic paralysis|myopathy|ophthalmoplegia|Klippel-Feil syndrome|spondylolisthesis|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy type 2A|autosomal recessive limb-girdle muscular dystrophy type 2B|autosomal recessive limb-girdle muscular dystrophy type 2C|autosomal recessive limb-girdle muscular dystrophy type 2D|autosomal recessive limb-girdle muscular dystrophy type 2E|autosomal recessive limb-girdle muscular dystrophy type 2F|autosomal recessive limb-girdle muscular dystrophy type 2G|autosomal recessive limb-girdle muscular dystrophy type 2H|autosomal recessive limb-girdle muscular dystrophy type 2J|autosomal recessive limb-girdle muscular dystrophy type 2L,ppi
15324,18390,5045,FURIN,furin; paired basic amino acid cleaving enzyme,41,endopeptidase activity|serine-type endopeptidase activity|serine-type endopeptidase inhibitor activity|peptidase activity|peptide binding|nerve growth factor binding,,ppi
15325,18391,5046,PCSK6,proprotein convertase subtilisin/kexin type 6,6,endopeptidase activity|serine-type endopeptidase activity|heparin binding|nerve growth factor binding,,ppi
15326,18392,529,ATP6V1E1,ATPase H+ transporting V1 subunit E1,70,,,ppi
15327,18393,29993,PACSIN1,protein kinase C and casein kinase substrate in neurons 1,47,phospholipid binding|cytoskeletal protein binding,,ppi
15328,18394,11252,PACSIN2,protein kinase C and casein kinase substrate in neurons 2,50,transporter activity|cadherin binding|phosphatidic acid binding|cytoskeletal protein binding|phospholipid binding,,ppi
15329,18395,29763,PACSIN3,protein kinase C and casein kinase substrate in neurons 3,68,cytoskeletal protein binding|lipid binding|calcium channel inhibitor activity|phospholipid binding,,ppi
15330,18396,5047,PAEP,progestagen associated endometrial protein,21,,breast cancer,ppi
15331,18397,5048,PAFAH1B1,platelet activating factor acetylhydrolase 1b regulatory subunit 1,74,phospholipase A2 activity|microtubule binding|heparin binding|dynactin binding|protein homodimerization activity|phospholipase binding|phosphoprotein binding|dynein complex binding|microtubule plus-end binding,heart disease|cardiovascular system disease|epilepsy|polyhydramnios|intellectual disability|learning disability|schizophrenia|visual epilepsy|cerebral degeneration|lissencephaly|Miller-Dieker lissencephaly syndrome|chromosome 17p13.1 deletion syndrome|pontocerebellar hypoplasia type 2D|pontocerebellar hypoplasia type 7|pontocerebellar hypoplasia type 8|pontocerebellar hypoplasia type 9|syndromic X-linked intellectual disability Najm type|short-rib thoracic dysplasia 14 with polydactyly|hydranencephaly|septooptic dysplasia,ppi
15332,18398,5049,PAFAH1B2,platelet activating factor acetylhydrolase 1b catalytic subunit 2,61,phospholipase A2 activity|platelet-activating factor acetyltransferase activity,,ppi
15333,18399,5050,PAFAH1B3,platelet activating factor acetylhydrolase 1b catalytic subunit 3,47,phospholipase A2 activity|platelet-activating factor acetyltransferase activity,,ppi
15334,18401,5053,PAH,phenylalanine hydroxylase,3,phenylalanine 4-monooxygenase activity,generalized anxiety disorder|anxiety disorder|autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|systemic scleroderma|scleroderma|localized scleroderma|dermatitis|epilepsy|intellectual disability|learning disability|obsessive-compulsive disorder|phenylketonuria|schizophreniform disorder,ppi
15335,18402,5054,SERPINE1,serpin family E member 1,24,serine-type endopeptidase inhibitor activity,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|autistic disorder|Behcet's disease|cholestasis|fatty liver disease|focal segmental glomerulosclerosis|congestive heart failure|hypertension|essential hypertension|chronic kidney disease|liver cancer|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|central nervous system disease|nervous system disease,ppi
15336,18403,5055,SERPINB2,serpin family B member 2,55,serine-type endopeptidase inhibitor activity,polyneuropathy|peripheral nervous system disease|neuropathy|stomach cancer|fatty liver disease|breast cancer,ppi
15337,18404,10606,PAICS,phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase,98,phosphoribosylaminoimidazole carboxylase activity|phosphoribosylaminoimidazolesuccinocarboxamide synthase activity|cadherin binding,,ppi
15338,18405,5058,PAK1,p21 (RAC1) activated kinase 1,155,protein kinase activity|protein serine/threonine kinase activity|Rac GTPase binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|proteinuria|breast cancer,ppi
15339,18406,5062,PAK2,p21 (RAC1) activated kinase 2,147,protein kinase activity|protein serine/threonine kinase activity|protein tyrosine kinase activator activity|cadherin binding|Rac GTPase binding,proteinuria|schizophrenia,ppi
15340,18407,5063,PAK3,p21 (RAC1) activated kinase 3,18,protein serine/threonine kinase activity|MAP kinase kinase activity|Rac GTPase binding,generalized anxiety disorder|anxiety disorder|epilepsy|intellectual disability|learning disability|schizophreniform disorder|schizoaffective disorder|visual epilepsy|non-syndromic X-linked intellectual disability,ppi
15341,18408,5064,PALM,paralemmin,15,,,ppi
15342,18409,5066,PAM,peptidylglycine alpha-amidating monooxygenase,23,peptidylglycine monooxygenase activity|peptidylamidoglycolate lyase activity|zinc ion binding,anxiety disorder|phobic disorder|diabetes mellitus|type 2 diabetes mellitus|epilepsy|visual epilepsy,ppi
15343,18410,53354,PANK1,pantothenate kinase 1,3,pantothenate kinase activity|protein homodimerization activity|acetyl-CoA binding,,ppi
15344,18411,24145,PANX1,pannexin 1,11,calcium channel activity|leak channel activity|gap junction hemi-channel activity,,ppi
15345,18412,56666,PANX2,pannexin 2,2,gap junction hemi-channel activity,schizophrenia,ppi
15346,18413,5068,REG3A,regenerating family member 3 alpha,9,oligosaccharide binding|transmembrane signaling receptor activity|peptidoglycan binding,,ppi
15347,18414,5069,PAPPA,pappalysin 1,17,metalloendopeptidase activity|metallopeptidase activity|zinc ion binding,intermediate coronary syndrome|endometriosis of uterus|endometriosis|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|coronary artery disease,ppi
15348,18415,9061,PAPSS1,3'-phosphoadenosine 5'-phosphosulfate synthase 1,51,adenylylsulfate kinase activity|sulfate adenylyltransferase (ATP) activity|nucleotidyltransferase activity,,ppi
15349,18416,9060,PAPSS2,3'-phosphoadenosine 5'-phosphosulfate synthase 2,15,adenylylsulfate kinase activity|sulfate adenylyltransferase (ATP) activity|nucleotidyltransferase activity,hypertrichosis|osteogenesis imperfecta|Ehlers-Danlos syndrome|acne|spondyloepimetaphyseal dysplasia; Pakistani type,ppi
15350,18417,8505,PARG,poly(ADP-ribose) glycohydrolase,7,poly(ADP-ribose) glycohydrolase activity,,ppi
15351,18418,5071,PARK2,parkin RBR E3 ubiquitin protein ligase,419,transcription regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity|ubiquitin-protein transferase activity|beta-catenin binding|zinc ion binding|SH3 domain binding|ubiquitin conjugating enzyme binding|ubiquitin binding|ubiquitin protein ligase activity|cullin family protein binding,autistic disorder|lung cancer|bronchiolo-alveolar adenocarcinoma|colon cancer|colonic benign neoplasm|dysgerminoma|dystonia|glioblastoma multiforme|giant cell glioblastoma|intellectual disability|learning disability|leprosy|lung benign neoplasm|Parkinson's disease|secondary Parkinson disease|breast cancer|breast carcinoma|autosomal recessive juvenile Parkinson disease 2|hereditary breast ovarian cancer syndrome,ppi
15352,18419,5073,PARN,poly(A)-specific ribonuclease,22,RNA binding|mRNA 3'-UTR binding|nuclease activity|poly(A)-specific ribonuclease activity|cation binding|telomerase RNA binding|3'-5'-exoribonuclease activity,alopecia|anemia|macrocytic anemia|blood coagulation disease|dental caries|placental insufficiency|gingival disease|epulis|hemorrhagic disease|tooth agenesis|anodontia|primary immunodeficiency disease|hereditary mucosal leukokeratosis|oral mucosa leukoplakia|intellectual disability|learning disability|periodontal disease|periodontitis|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia,ppi
15353,18420,533,ATP6V0B,ATPase H+ transporting V0 subunit b,9,transporter activity|proton-transporting ATPase activity; rotational mechanism,,ppi
15354,18421,5074,PAWR,pro-apoptotic WT1 regulator,48,transcription corepressor activity|actin binding|enzyme binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|bipolar disorder|endometrial cancer|endometrial carcinoma|prostate cancer|prostate carcinoma|schizophreniform disorder|schizoaffective disorder|schizophrenia|neurotic disorder|endogenous depression|melancholia|mood disorder|cocaine abuse|cocaine dependence|morphine dependence,ppi
15355,18422,5075,PAX1,paired box 1,2,DNA-binding transcription factor activity; RNA polymerase II-specific,dental caries|intellectual disability|learning disability|speech disorder|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa,ppi
15356,18423,5076,PAX2,paired box 2,26,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter sequence-specific DNA binding|DNA binding|superoxide-generating NADPH oxidase activity|transcription regulatory region DNA binding,clubfoot|endometriosis of uterus|endometriosis|epilepsy|focal segmental glomerulosclerosis|sensorineural hearing loss|hypertension|essential hypertension|chronic kidney disease|intellectual disability|learning disability|microphthalmia|myopia|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|proteinuria|kidney failure|uremia|visual epilepsy,ppi
15357,18424,5077,PAX3,paired box 3,29,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,blepharophimosis|sensorineural hearing loss|Hirschsprung's disease|megacolon|toxic megacolon|intellectual disability|learning disability|paraplegia|Waardenburg's syndrome|piebaldism|myelomeningocele|tethered spinal cord syndrome|humeroradial synostosis|cleidocranial dysplasia|radioulnar synostosis|alveolar rhabdomyosarcoma|spindle cell sarcoma|epithelioid sarcoma|sarcoma|cancer,ppi
15358,18425,5078,PAX4,paired box 4,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding,diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21|type 1 diabetes mellitus 22,ppi
15359,18426,5079,PAX5,paired box 5,16,DNA-binding transcription factor activity; RNA polymerase II-specific,acute lymphocytic leukemia,ppi
15360,18427,534,ATP6V1G2,ATPase H+ transporting V1 subunit G2,6,,,ppi
15361,18428,5080,PAX6,paired box 6,55,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|ubiquitin-protein transferase activity|transcription factor binding|protein kinase binding|histone acetyltransferase binding,suppression amblyopia|amblyopia|aniridia|autistic disorder|ptosis|congenital ptosis|cerebellar disease|coloboma|recurrent corneal erosion|cryptorchidism|diabetes mellitus|type 2 diabetes mellitus|glaucoma|buphthalmos|hydrophthalmos|keratitis|keratoconjunctivitis|melanoma|skin melanoma|intellectual disability,ppi
15362,18429,5081,PAX7,paired box 7,14,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,alveolar rhabdomyosarcoma,ppi
15363,18430,7849,PAX8,paired box 8,19,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|thyroid-stimulating hormone receptor activity|transcription regulatory region DNA binding,large intestine cancer|colorectal cancer|constipation|congenital hypothyroidism|myxedema|hypothyroidism|goiter|nontoxic goiter|thyroid gland disease|umbilical hernia|omphalocele|syndromic X-linked intellectual disability 94|papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma|recurrent hypersomnia,ppi
15364,18431,5083,PAX9,paired box 9,12,DNA-binding transcription factor activity; RNA polymerase II-specific,tooth agenesis|anodontia,ppi
15365,18432,22976,PAXIP1,PAX interacting protein 1,260,,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
15366,18433,8992,ATP6V0E1,ATPase H+ transporting V0 subunit e1,11,transporter activity|ATPase coupled ion transmembrane transporter activity|proton-transporting ATPase activity; rotational mechanism,,ppi
15367,18434,5037,PEBP1,phosphatidylethanolamine binding protein 1,65,RNA binding|phosphatidylethanolamine binding|mitogen-activated protein kinase binding|ATP binding|signaling receptor binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|congestive heart failure|coronary artery disease,ppi
15368,18435,5087,PBX1,PBX homeobox 1,48,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|RNA polymerase II regulatory region sequence-specific DNA binding,Burkitt lymphoma|substance abuse|substance-related disorder,ppi
15369,18436,5089,PBX2,PBX homeobox 2,51,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
15370,18437,5090,PBX3,PBX homeobox 3,27,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
15371,18438,5091,PC,pyruvate carboxylase,75,pyruvate carboxylase activity,lactic acidosis|Burkitt lymphoma|epilepsy|hypoglycemia|periventricular leukomalacia|intellectual disability|learning disability|pyruvate decarboxylase deficiency|pyruvate carboxylase deficiency disease|visual epilepsy|renal tubular acidosis,ppi
15372,18439,8850,KAT2B,lysine acetyltransferase 2B,199,chromatin binding|transcription coactivator activity|histone acetyltransferase activity|lysine N-acetyltransferase activity; acting on acetyl phosphate as donor|cyclin-dependent protein serine/threonine kinase inhibitor activity|acetyltransferase activity|protein kinase binding|protein-containing complex binding|peptide-lysine-N-acetyltransferase activity,mood disorder,ppi
15373,18440,9550,ATP6V1G1,ATPase H+ transporting V1 subunit G1,24,,,ppi
15374,18442,5092,PCBD1,pterin-4 alpha-carbinolamine dehydratase 1,92,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,phenylketonuria,ppi
15375,18443,5093,PCBP1,poly(rC) binding protein 1,203,single-stranded DNA binding|RNA binding|mRNA binding|cadherin binding,,ppi
15376,18444,5094,PCBP2,poly(rC) binding protein 2,120,RNA binding,,ppi
15377,18445,535,ATP6V0A1,ATPase H+ transporting V0 subunit a1,96,ATPase binding|proton-transporting ATPase activity; rotational mechanism,,ppi
15378,18446,54039,PCBP3,poly(rC) binding protein 3,37,RNA binding,,ppi
15379,18447,57060,PCBP4,poly(rC) binding protein 4,11,RNA binding|mRNA 3'-UTR binding,,ppi
15380,18448,5095,PCCA,propionyl-CoA carboxylase alpha subunit,27,biotin binding,lactic acidosis|anemia|macrocytic anemia|sick sinus syndrome|constipation|dystonia|dermatitis|epilepsy|hypoglycemia|intellectual disability|learning disability|osteoporosis|acute pancreatitis|pancreatitis|pancytopenia|visual epilepsy|thrombocytopenia|Alzheimer's disease|Pick's disease|cerebral degeneration,ppi
15381,18449,5096,PCCB,propionyl-CoA carboxylase beta subunit,22,,lactic acidosis|anemia|macrocytic anemia|sick sinus syndrome|constipation|dystonia|dermatitis|epilepsy|hypoglycemia|intellectual disability|learning disability|osteoporosis|acute pancreatitis|pancreatitis|pancytopenia|visual epilepsy|thrombocytopenia|Alzheimer's disease|Pick's disease|cerebral degeneration,ppi
15382,18450,5097,PCDH1,protocadherin 1,13,,,ppi
15383,18451,27328,PCDH11X,protocadherin 11 X-linked,1,,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
15384,18452,51294,PCDH12,protocadherin 12,16,,alcohol dependence|alcohol abuse,ppi
15385,18453,5099,PCDH7,protocadherin 7,36,,,ppi
15386,18454,50617,ATP6V0A4,ATPase H+ transporting V0 subunit a4,8,ATPase binding|proton-transporting ATPase activity; rotational mechanism,calcium metabolism disease|nephrocalcinosis|calcinosis|hypercalcemia|phosphorus metabolism disease|autosomal dominant nonsyndromic deafness|autosomal recessive nonsyndromic deafness|X-linked nonsyndromic deafness|autosomal dominant auditory neuropathy 1|autosomal recessive nonsyndromic deafness 101|autosomal recessive nonsyndromic deafness 102|autosomal recessive nonsyndromic deafness 103|autosomal recessive nonsyndromic deafness 104|autosomal recessive nonsyndromic deafness 105|autosomal recessive nonsyndromic deafness 12|autosomal recessive nonsyndromic deafness 13|autosomal recessive nonsyndromic deafness 14|autosomal recessive nonsyndromic deafness 15|autosomal recessive nonsyndromic deafness 16|autosomal recessive nonsyndromic deafness 17,ppi
15387,18455,5100,PCDH8,protocadherin 8,3,,prostate cancer|prostate carcinoma|schizophrenia,ppi
15388,18456,5101,PCDH9,protocadherin 9,12,,autistic disorder,ppi
15389,18459,537,ATP6AP1,ATPase H+ transporting accessory protein 1,29,transporter activity|Rab GTPase binding,,ppi
15390,18460,538,ATP7A,ATPase copper transporting alpha,23,copper-exporting ATPase activity|copper ion transmembrane transporter activity|copper ion binding|ATP binding|superoxide dismutase copper chaperone activity|cuprous ion binding|copper-transporting ATPase activity,anemia|macrocytic anemia|vascular disease|aortic aneurysm|colon cancer|colonic benign neoplasm|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|epilepsy|placental insufficiency|clubfoot|hepatitis|inguinal hernia|umbilical hernia|omphalocele|hydronephrosis|primary pulmonary hypertension,ppi
15391,18462,27034,ACAD8,acyl-CoA dehydrogenase family member 8,24,acyl-CoA dehydrogenase activity,anemia|macrocytic anemia|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q,ppi
15392,18463,540,ATP7B,ATPase copper transporting beta,16,copper-exporting ATPase activity|copper ion transmembrane transporter activity|copper ion binding|ATP binding|copper-transporting ATPase activity,anemia|macrocytic anemia|hemolytic anemia|arthropathy|arthritis|large intestine cancer|colorectal cancer|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|fatty liver disease|iron metabolism disease|hemochromatosis|Wilson disease|nephrocalcinosis|hypercalcemia,ppi
15393,18464,93974,ATPIF1,ATPase inhibitory factor 1,22,enzyme inhibitor activity|calmodulin binding|ATPase inhibitor activity|protein homodimerization activity|angiostatin binding|ATPase binding|5-formyltetrahydrofolate cyclo-ligase activity,fatty liver disease,ppi
15394,18465,5104,SERPINA5,serpin family A member 5,33,retinoic acid binding|serine-type endopeptidase inhibitor activity|glycosaminoglycan binding|heparin binding|phosphatidylcholine binding,,ppi
15395,18466,5105,PCK1,phosphoenolpyruvate carboxykinase 1,72,magnesium ion binding|phosphoenolpyruvate carboxykinase (GTP) activity|GTP binding|manganese ion binding|carboxylic acid binding,epilepsy|congestive heart failure|hypoglycemia|obesity|optic atrophy|schizophrenia|visual epilepsy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|pyruvate decarboxylase deficiency|pyruvate carboxylase deficiency disease|liver cancer|hepatocellular carcinoma|fatty liver disease,ppi
15396,18467,5106,PCK2,phosphoenolpyruvate carboxykinase 2; mitochondrial,42,phosphoenolpyruvate carboxykinase activity|phosphoenolpyruvate carboxykinase (GTP) activity|manganese ion binding,hypoglycemia|pyruvate decarboxylase deficiency|pyruvate carboxylase deficiency disease|fatty liver disease,ppi
15397,18468,5108,PCM1,pericentriolar material 1,247,identical protein binding,schizophrenia|papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma,ppi
15398,18469,5110,PCMT1,protein-L-isoaspartate (D-aspartate) O-methyltransferase,138,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity|cadherin binding,myelomeningocele|tethered spinal cord syndrome,ppi
15399,18470,5111,PCNA,proliferating cell nuclear antigen,323,purine-specific mismatch base pair DNA N-glycosylase activity|chromatin binding|damaged DNA binding|dinucleotide insertion or deletion binding|MutLalpha complex binding|DNA polymerase processivity factor activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|brain cancer|cerebellar disease|colon cancer|colonic benign neoplasm|focal segmental glomerulosclerosis|ischemia|lung benign neoplasm|pustulosis of palm and sole|psoriasis|parapsoriasis|asthenopia|hepatocellular carcinoma|hepatoblastoma|photosensitivity disease|photosensitive epilepsy,ppi
15400,18471,79902,NUP85,nucleoporin 85,59,structural constituent of nuclear pore,,ppi
15401,18473,5118,PCOLCE,procollagen C-endopeptidase enhancer,17,extracellular matrix structural constituent|collagen binding|heparin binding|peptidase activator activity,liver cirrhosis,ppi
15402,18474,26577,PCOLCE2,procollagen C-endopeptidase enhancer 2,10,collagen binding|heparin binding|peptidase activator activity,,ppi
15403,18475,5119,CHMP1A,charged multivesicular body protein 1A,38,metallopeptidase activity|zinc ion binding,astigmatism|syndromic X-linked intellectual disability type 10|choreatic disease|clubfoot|monocular esotropia|esotropia|hyperopia|intellectual disability|learning disability|myopia|pontocerebellar hypoplasia type 8,ppi
15404,18476,5121,PCP4,Purkinje cell protein 4,5,calcium ion binding|calmodulin binding,colon cancer|colonic benign neoplasm,ppi
15405,18477,5122,PCSK1,proprotein convertase subtilisin/kexin type 1,8,serine-type endopeptidase activity,cholestasis|bulimia nervosa|obesity|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|hypogonadism|hypoglycemia|celiac disease,ppi
15406,18478,5126,PCSK2,proprotein convertase subtilisin/kexin type 2,4,serine-type endopeptidase activity,diabetes mellitus|type 2 diabetes mellitus,ppi
15407,18479,54760,PCSK4,proprotein convertase subtilisin/kexin type 4,1,,,ppi
15408,18480,5125,PCSK5,proprotein convertase subtilisin/kexin type 5,32,endopeptidase activity|serine-type endopeptidase activity|peptidase activity|peptide binding,imperforate anus|heart septal defect|ventricular septal defect|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|lung disease|Holt-Oram syndrome|VACTERL association|thrombocytopenia-absent radius syndrome|Rubinstein-Taybi syndrome|Klippel-Trenaunay syndrome|nail-patella syndrome|umbilical hernia|omphalocele,ppi
15409,18481,9159,PCSK7,proprotein convertase subtilisin/kexin type 7,7,peptidase activity,,ppi
15410,18482,5127,CDK16,cyclin dependent kinase 16,49,protein serine/threonine kinase activity|cyclin-dependent protein serine/threonine kinase activity,schizophrenia,ppi
15411,18483,5128,CDK17,cyclin dependent kinase 17,31,protein kinase activity|cyclin-dependent protein serine/threonine kinase activity|protein serine/threonine kinase activity,,ppi
15412,18484,5129,CDK18,cyclin dependent kinase 18,60,cyclin-dependent protein serine/threonine kinase activity|protein serine/threonine kinase activity,,ppi
15413,18485,58488,PCTP,phosphatidylcholine transfer protein,4,phosphatidylcholine transporter activity|phosphatidylcholine binding,,ppi
15414,18486,5130,PCYT1A,phosphate cytidylyltransferase 1; choline; alpha,81,choline-phosphate cytidylyltransferase activity|phosphatidylcholine binding,astigmatism|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|achondroplasia|Laron syndrome|myopia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|myelomeningocele,ppi
15415,18487,9468,PCYT1B,phosphate cytidylyltransferase 1; choline; beta,14,choline-phosphate cytidylyltransferase activity|phosphatidylcholine binding,,ppi
15416,18488,5833,PCYT2,phosphate cytidylyltransferase 2; ethanolamine,21,ethanolamine-phosphate cytidylyltransferase activity,,ppi
15417,18489,5132,PDC,phosducin,7,phospholipase inhibitor activity,,ppi
15418,18490,5133,PDCD1,programmed cell death 1,52,,systemic lupus erythematosus|melanoma|skin melanoma|multiple sclerosis,ppi
15419,18491,11235,PDCD10,programmed cell death 10,60,,epilepsy|visual epilepsy,ppi
15420,18492,5134,PDCD2,programmed cell death 2,12,,neurotic disorder|major depressive disorder|endogenous depression|melancholia,ppi
15421,18493,27250,PDCD4,programmed cell death 4,59,,,ppi
15422,18494,9141,PDCD5,programmed cell death 5,29,heparin binding|acetyltransferase activator activity,,ppi
15423,18495,10016,PDCD6,programmed cell death 6,112,magnesium ion binding|calcium ion binding|protein homodimerization activity|protein membrane anchor|molecular adaptor activity,neurotic disorder|major depressive disorder|endogenous depression|melancholia,ppi
15424,18496,10015,PDCD6IP,programmed cell death 6 interacting protein,125,,arthropathy|arthritis,ppi
15425,18497,10081,PDCD7,programmed cell death 7,23,,,ppi
15426,18498,9131,AIFM1,apoptosis inducing factor; mitochondria associated 1,146,NAD(P)H oxidase activity|oxidoreductase activity; acting on NAD(P)H,sensorineural hearing loss|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21,ppi
15427,18499,10884,MRPS30,mitochondrial ribosomal protein S30,77,RNA binding,,ppi
15428,18500,501,ALDH7A1,aldehyde dehydrogenase 7 family member A1,41,aldehyde dehydrogenase (NAD) activity|L-aminoadipate-semialdehyde dehydrogenase activity|betaine-aldehyde dehydrogenase activity,bone disease|cartilage disease|connective tissue disease|coloboma|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|intellectual disability|learning disability|movement disease|lingual-facial-buccal dyskinesia|speech disorder|status epilepticus|stomach cancer|visual epilepsy|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy,ppi
15429,18501,5082,PDCL,phosducin like,45,,,ppi
15430,18502,10846,PDE10A,phosphodiesterase 10A,4,3';5'-cyclic-nucleotide phosphodiesterase activity|3';5'-cyclic-AMP phosphodiesterase activity|cGMP-stimulated cyclic-nucleotide phosphodiesterase activity|cAMP binding|cGMP binding|3';5'-cyclic-GMP phosphodiesterase activity,alcohol dependence|alcohol abuse|bipolar disorder|schizophreniform disorder|schizoaffective disorder,ppi
15431,18504,5136,PDE1A,phosphodiesterase 1A,6,3';5'-cyclic-AMP phosphodiesterase activity|calmodulin-dependent cyclic-nucleotide phosphodiesterase activity|3';5'-cyclic-GMP phosphodiesterase activity,,ppi
15432,18505,5153,PDE1B,phosphodiesterase 1B,3,3';5'-cyclic-AMP phosphodiesterase activity|calmodulin-dependent cyclic-nucleotide phosphodiesterase activity|3';5'-cyclic-GMP phosphodiesterase activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|intellectual disability|learning disability,ppi
15433,18506,5137,PDE1C,phosphodiesterase 1C,4,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,substance abuse|substance-related disorder,ppi
15434,18507,5138,PDE2A,phosphodiesterase 2A,4,3';5'-cyclic-AMP phosphodiesterase activity|cGMP-stimulated cyclic-nucleotide phosphodiesterase activity|calcium channel activity|drug binding|cAMP binding|cGMP binding|3';5'-cyclic-GMP phosphodiesterase activity,breast cancer,ppi
15435,18508,5139,PDE3A,phosphodiesterase 3A,21,3';5'-cyclic-AMP phosphodiesterase activity|cGMP-inhibited cyclic-nucleotide phosphodiesterase activity|3';5'-cyclic-GMP phosphodiesterase activity,hypertension|essential hypertension|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction,ppi
15436,18509,5140,PDE3B,phosphodiesterase 3B,32,3';5'-cyclic-nucleotide phosphodiesterase activity|3';5'-cyclic-AMP phosphodiesterase activity|cGMP-inhibited cyclic-nucleotide phosphodiesterase activity|protein kinase B binding|3';5'-cyclic-GMP phosphodiesterase activity,polycystic ovary syndrome,ppi
15437,18510,5141,PDE4A,phosphodiesterase 4A,8,3';5'-cyclic-AMP phosphodiesterase activity|cAMP binding,autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia,ppi
15438,18511,5142,PDE4B,phosphodiesterase 4B,13,3';5'-cyclic-AMP phosphodiesterase activity|cAMP binding|ion channel binding,alcohol dependence|alcohol abuse|asthma|intrinsic asthma|allergic asthma|autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|acute myeloid leukemia|schizophrenia|seborrheic keratosis|skin disease|actinic keratosis|coronary artery disease,ppi
15439,18512,5143,PDE4C,phosphodiesterase 4C,2,3';5'-cyclic-AMP phosphodiesterase activity,,ppi
15440,18513,5144,PDE4D,phosphodiesterase 4D,44,3';5'-cyclic-nucleotide phosphodiesterase activity|3';5'-cyclic-AMP phosphodiesterase activity|enzyme binding|cAMP binding|beta-2 adrenergic receptor binding|ion channel binding,asthma|intrinsic asthma|allergic asthma|autistic disorder|congenital hypothyroidism|myxedema|hypothyroidism|cryptorchidism|sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetic ketoacidosis|diabetes mellitus|placental insufficiency|nephrocalcinosis|hypercalcemia,ppi
15441,18514,8654,PDE5A,phosphodiesterase 5A,3,3';5'-cyclic-nucleotide phosphodiesterase activity|cGMP binding|3';5'-cyclic-GMP phosphodiesterase activity,,ppi
15442,18515,5145,PDE6A,phosphodiesterase 6A,3,3';5'-cyclic-GMP phosphodiesterase activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa,ppi
15443,18516,5158,PDE6B,phosphodiesterase 6B,1,3';5'-cyclic-GMP phosphodiesterase activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|retinal degeneration|cone-rod dystrophy,ppi
15444,18518,5147,PDE6D,phosphodiesterase 6D,31,GTPase inhibitor activity,coloboma|placental insufficiency|microphthalmia|syndactyly|Joubert syndrome with orofaciodigital defect,ppi
15445,18519,5148,PDE6G,phosphodiesterase 6G,10,enzyme inhibitor activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|cystoid macular edema|macular retinal edema|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy,ppi
15446,18520,5149,PDE6H,phosphodiesterase 6H,4,enzyme inhibitor activity,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|alternating exotropia|exotropia|monocular exotropia|hyperopia|night blindness|congenital stationary night blindness|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|blindness|asthenopia|spontaneous ocular nystagmus|dissociated nystagmus|pathologic nystagmus,ppi
15447,18521,5150,PDE7A,phosphodiesterase 7A,4,3';5'-cyclic-AMP phosphodiesterase activity,,ppi
15448,18522,27115,PDE7B,phosphodiesterase 7B,2,3';5'-cyclic-AMP phosphodiesterase activity,schizophrenia,ppi
15449,18523,5151,PDE8A,phosphodiesterase 8A,2,3';5'-cyclic-AMP phosphodiesterase activity|3';5'-cyclic-GMP phosphodiesterase activity,,ppi
15450,18524,8622,PDE8B,phosphodiesterase 8B,2,3';5'-cyclic-AMP phosphodiesterase activity,basal ganglia disease|diabetic ketoacidosis|diabetes mellitus|hypertension|essential hypertension|hypogonadism|osteoporosis|muscular atrophy|neurodegenerative disease|striatonigral degeneration|primary pigmented nodular adrenocortical disease,ppi
15451,18525,5152,PDE9A,phosphodiesterase 9A,19,3';5'-cyclic-nucleotide phosphodiesterase activity|3';5'-cyclic-GMP phosphodiesterase activity,bipolar disorder,ppi
15452,18526,5154,PDGFA,platelet derived growth factor subunit A,17,Ras guanyl-nucleotide exchange factor activity|platelet-derived growth factor receptor binding|collagen binding|growth factor activity|protein homodimerization activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,lung disease|malignant mesothelioma|benign mesothelioma|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|essential thrombocythemia|thyroid cancer|thyroid adenoma|thyroid carcinoma|breast cancer|amyotrophic lateral sclerosis type 1,ppi
15453,18527,33,ACADL,acyl-CoA dehydrogenase; long chain,6,acyl-CoA dehydrogenase activity|long-chain-acyl-CoA dehydrogenase activity|palmitoyl-CoA oxidase activity|flavin adenine dinucleotide binding,,ppi
15454,18528,5155,PDGFB,platelet derived growth factor subunit B,81,Ras guanyl-nucleotide exchange factor activity|platelet-derived growth factor receptor binding|collagen binding|growth factor activity|superoxide-generating NADPH oxidase activator activity|chemoattractant activity|protein homodimerization activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,generalized anxiety disorder|anxiety disorder|basal ganglia disease|calcium metabolism disease|nephrocalcinosis|calcinosis|skin benign neoplasm|skin cancer|syndromic X-linked intellectual disability type 10|choreatic disease|recurrent corneal erosion|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|epilepsy|placental insufficiency,ppi
15455,18529,56034,PDGFC,platelet derived growth factor C,8,platelet-derived growth factor receptor binding,malignant mesothelioma|benign mesothelioma,ppi
15456,18530,5156,PDGFRA,platelet derived growth factor receptor alpha,59,protein kinase activity|transmembrane receptor protein tyrosine kinase activity|platelet-derived growth factor alpha-receptor activity|vascular endothelial growth factor-activated receptor activity|Ras guanyl-nucleotide exchange factor activity|protein homodimerization activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|platelet-derived growth factor binding|transmembrane signaling receptor activity|protein tyrosine kinase activity,restrictive cardiomyopathy|isolated cleft palate|cleft palate|constipation|hypereosinophilic syndrome|intestinal obstruction|ileus|lung disease|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|myeloproliferative neoplasm|bone marrow cancer|stomach cancer|angioedema|thrombophilia|myelomeningocele|tethered spinal cord syndrome,ppi
15457,18531,5159,PDGFRB,platelet derived growth factor receptor beta,116,protein tyrosine kinase activity|platelet activating factor receptor activity|platelet-derived growth factor-activated receptor activity|platelet-derived growth factor beta-receptor activity|Ras guanyl-nucleotide exchange factor activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|platelet-derived growth factor binding|transmembrane receptor protein tyrosine kinase activity|transmembrane signaling receptor activity,basal ganglia disease|ptosis|congenital ptosis|calcium metabolism disease|nephrocalcinosis|calcinosis|skin benign neoplasm|skin cancer|syndromic X-linked intellectual disability type 10|choreatic disease|recurrent corneal erosion|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|hypereosinophilic syndrome|epilepsy,ppi
15458,18532,5157,PDGFRL,platelet derived growth factor receptor like,24,platelet activating factor receptor activity|platelet-derived growth factor beta-receptor activity,large intestine cancer|colorectal cancer|colon carcinoma|liver cancer|hepatocellular carcinoma,ppi
15459,18533,5160,PDHA1,pyruvate dehydrogenase (lipoamide) alpha 1,63,pyruvate dehydrogenase activity,lactic acidosis|ptosis|congenital ptosis|dystonia|epilepsy|Leigh disease|intellectual disability|learning disability|arthropathy|arthritis|prostate cancer|prostate carcinoma|pyruvate decarboxylase deficiency|pyruvate carboxylase deficiency disease|visual epilepsy|stomach cancer|basal ganglia disease|focal hand dystonia|blepharospasm|coronary artery disease,ppi
15460,18534,5161,PDHA2,pyruvate dehydrogenase (lipoamide) alpha 2,13,pyruvate dehydrogenase (acetyl-transferring) activity,,ppi
15461,18535,5162,PDHB,pyruvate dehydrogenase (lipoamide) beta,77,pyruvate dehydrogenase activity|pyruvate dehydrogenase (NAD+) activity,lactic acidosis|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|pyruvate decarboxylase deficiency|pyruvate carboxylase deficiency disease,ppi
15462,18536,5163,PDK1,pyruvate dehydrogenase kinase 1,62,protein kinase activity|pyruvate dehydrogenase (acetyl-transferring) kinase activity,,ppi
15463,18537,5164,PDK2,pyruvate dehydrogenase kinase 2,20,protein kinase activity|pyruvate dehydrogenase (acetyl-transferring) kinase activity|ATP binding,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
15464,18538,5165,PDK3,pyruvate dehydrogenase kinase 3,39,protein kinase activity|protein serine/threonine kinase activity|pyruvate dehydrogenase (acetyl-transferring) kinase activity|ATP binding,Charcot-Marie-Tooth disease X-linked dominant 6,ppi
15465,18539,5166,PDK4,pyruvate dehydrogenase kinase 4,7,protein kinase activity|pyruvate dehydrogenase (acetyl-transferring) kinase activity|ATP binding,coronary artery disease,ppi
15466,18540,5170,PDPK1,3-phosphoinositide dependent protein kinase 1,90,protein serine/threonine kinase activity|3-phosphoinositide-dependent protein kinase activity|phospholipase activator activity|kinase activity,congestive heart failure|breast cancer,ppi
15467,18542,8566,PDXK,pyridoxal (pyridoxine; vitamin B6) kinase,34,magnesium ion binding|ATP binding|zinc ion binding|pyridoxal kinase activity|pyridoxal phosphate binding|potassium ion binding|sodium ion binding|lithium ion binding|protein homodimerization activity,status epilepticus,ppi
15468,18543,545,ATR,ATR serine/threonine kinase,121,protein kinase activity|protein serine/threonine kinase activity|MutLalpha complex binding|MutSalpha complex binding,alopecia|blepharophimosis|isolated cleft palate|cleft palate|craniosynostosis|cryptorchidism|dental caries|dental enamel hypoplasia|epilepsy|placental insufficiency|clubfoot|glaucoma|intellectual disability|learning disability|pancytopenia|asbestosis|anthracosilicosis|pneumoconiosis|siderosis|bagassosis,ppi
15469,18544,5173,PDYN,prodynorphin,10,,alcohol dependence|alcohol abuse|amnestic disorder|dissociative amnesia|bipolar disorder|cholestasis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|cannabis dependence|cannabis abuse|movement disease|lingual-facial-buccal dyskinesia|adult respiratory distress syndrome|lung disease|schizophrenia,ppi
15470,18545,5174,PDZK1,PDZ domain containing 1,59,transporter activity,salivary gland adenoid cystic carcinoma|prostate cancer|prostate carcinoma|schizophrenia|breast cancer,ppi
15471,18546,8682,PEA15,phosphoprotein enriched in astrocytes 15,24,,schizophrenia|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
15472,18547,5175,PECAM1,platelet and endothelial cell adhesion molecule 1,34,protein homodimerization activity,autistic disorder|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|thrombocytopenia,ppi
15473,18548,5176,SERPINF1,serpin family F member 1,13,serine-type endopeptidase inhibitor activity,corneal ulcer|salivary gland adenoid cystic carcinoma|diabetic angiopathy|prostate cancer|prostate carcinoma|uveitis|ciliary body disease|iris disease|panuveitis|osteogenesis imperfecta type 3|osteogenesis imperfecta type 4,ppi
15474,18549,5178,PEG3,paternally expressed 3,8,DNA-binding transcription factor activity; RNA polymerase II-specific,bile duct carcinoma|bile duct adenocarcinoma|intrahepatic cholangiocarcinoma|cholangiocarcinoma,ppi
15475,18550,57162,PELI1,pellino E3 ubiquitin protein ligase 1,26,protein serine/threonine kinase activity|ubiquitin-ubiquitin ligase activity|ubiquitin protein ligase activity,seborrheic keratosis|skin disease|actinic keratosis,ppi
15476,18551,57161,PELI2,pellino E3 ubiquitin protein ligase family member 2,22,protein serine/threonine kinase activity|ubiquitin-ubiquitin ligase activity|ubiquitin protein ligase activity,,ppi
15477,18552,53918,PELO,pelota homolog (Drosophila),37,ribosome binding,,ppi
15478,18553,10400,PEMT,phosphatidylethanolamine N-methyltransferase,1,phosphatidylethanolamine N-methyltransferase activity,schizophrenia,ppi
15479,18554,5179,PENK,proenkephalin,10,neuropeptide hormone activity,alcohol dependence|alcohol abuse|cannabis dependence|cannabis abuse|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|Balo concentric sclerosis|adrenoleukodystrophy|narcolepsy|central nervous system disease|opiate dependence|nervous system disease|autonomic neuropathy|prostate cancer|prostate carcinoma|amyotrophic lateral sclerosis type 1,ppi
15480,18555,5184,PEPD,peptidase D,43,metallocarboxypeptidase activity,anemia|macrocytic anemia|asthma|intrinsic asthma|allergic asthma|ptosis|congenital ptosis|sensorineural hearing loss|dental caries|diabetes mellitus|type 2 diabetes mellitus|enophthalmos|orbital disease|exophthalmos|neonatal jaundice|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|systemic lupus erythematosus|purpura|chronic ulcer of skin,ppi
15481,18556,5187,PER1,period circadian clock 1,43,RNA polymerase II proximal promoter sequence-specific DNA binding|chromatin DNA binding|E-box binding|transcription corepressor binding|obsolete transcription factor activity; transcription factor binding|transcription regulatory region sequence-specific DNA binding|transcription factor binding,autistic disorder|chronic myeloid leukemia|cocaine abuse|cocaine dependence|morphine dependence,ppi
15482,18557,8864,PER2,period circadian clock 2,20,transcription regulatory region sequence-specific DNA binding|transcription coactivator activity|transcription corepressor binding|obsolete transcription factor activity; transcription factor binding|transcription factor binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|chronic myeloid leukemia|postpartum depression|cocaine abuse|cocaine dependence|morphine dependence|advanced sleep phase syndrome 1,ppi
15483,18558,8863,PER3,period circadian clock 3,16,transcription factor binding|obsolete transcription factor activity; transcription factor binding|transcription regulatory region sequence-specific DNA binding|transcription corepressor binding,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|chronic myeloid leukemia|schizophrenia|breast cancer|advanced sleep phase syndrome 1,ppi
15484,18559,23481,PES1,pescadillo ribosomal biogenesis factor 1,125,RNA binding,,ppi
15485,18560,5188,GATB,glutamyl-tRNA amidotransferase subunit B,8,translation factor activity; RNA binding|glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,,ppi
15486,18561,8455,ATRN,attractin,8,,,ppi
15487,18562,5189,PEX1,peroxisomal biogenesis factor 1,16,ATP binding|ATPase activity; coupled|protein-containing complex binding|ATPase activity,adrenal cortical hypofunction|Addison's disease|proteinuria|amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta,ppi
15488,18563,5192,PEX10,peroxisomal biogenesis factor 10,20,,adrenal cortical hypofunction|Addison's disease|ptosis|congenital ptosis|cerebellar disease|recurrent corneal erosion|cryptorchidism|epilepsy|sensorineural hearing loss|hydronephrosis|gallbladder disease|liver disease|movement disease|lingual-facial-buccal dyskinesia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus,ppi
15489,18564,8800,PEX11A,peroxisomal biogenesis factor 11 alpha,5,protein homodimerization activity,,ppi
15490,18565,8799,PEX11B,peroxisomal biogenesis factor 11 beta,12,protein homodimerization activity,adrenal cortical hypofunction|Addison's disease|ptosis|congenital ptosis|cerebellar disease|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41,ppi
15491,18566,5193,PEX12,peroxisomal biogenesis factor 12,4,zinc ion binding|ubiquitin-protein transferase activity,adrenal cortical hypofunction|Addison's disease|ptosis|congenital ptosis|cerebellar disease|recurrent corneal erosion|cryptorchidism|epilepsy|sensorineural hearing loss|hydronephrosis|gallbladder disease|liver disease|intellectual disability|learning disability|movement disease|lingual-facial-buccal dyskinesia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus,ppi
15492,18567,5194,PEX13,peroxisomal biogenesis factor 13,10,,adrenal cortical hypofunction|Addison's disease|ptosis|congenital ptosis|cerebellar disease|recurrent corneal erosion|cryptorchidism|epilepsy|sensorineural hearing loss|hydronephrosis|cystic kidney disease|gallbladder disease|liver disease|movement disease|lingual-facial-buccal dyskinesia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus,ppi
15493,18568,5195,PEX14,peroxisomal biogenesis factor 14,86,transcription corepressor activity|microtubule binding|signaling receptor binding,adrenal cortical hypofunction|Addison's disease|ptosis|congenital ptosis|cerebellar disease|recurrent corneal erosion|cryptorchidism|epilepsy|microphthalmia|eye disease|sensorineural hearing loss|hydronephrosis|gallbladder disease|liver disease|movement disease|lingual-facial-buccal dyskinesia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus,ppi
15494,18569,9409,PEX16,peroxisomal biogenesis factor 16,12,,adrenal cortical hypofunction|Addison's disease|ptosis|congenital ptosis|cerebellar disease|recurrent corneal erosion|cryptorchidism|epilepsy|sensorineural hearing loss|ventricular septal defect|hydronephrosis|gallbladder disease|liver disease|movement disease|lingual-facial-buccal dyskinesia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus,ppi
15495,18570,8504,PEX3,peroxisomal biogenesis factor 3,11,lipid binding|protein dimerization activity,adrenal cortical hypofunction|Addison's disease|ptosis|congenital ptosis|cerebellar disease|recurrent corneal erosion|cryptorchidism|epilepsy|sensorineural hearing loss|hydronephrosis|gallbladder disease|liver disease|movement disease|lingual-facial-buccal dyskinesia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus,ppi
15496,18571,5190,PEX6,peroxisomal biogenesis factor 6,17,ATP binding|ATPase activity|ATPase activity; coupled|protein-containing complex binding,adrenal cortical hypofunction|Addison's disease|ptosis|congenital ptosis|cerebellar disease|recurrent corneal erosion|cryptorchidism|epilepsy|clubfoot|sensorineural hearing loss|hydronephrosis|cystic kidney disease|gallbladder disease|liver disease|movement disease|lingual-facial-buccal dyskinesia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus,ppi
15497,18572,546,ATRX,ATRX; chromatin remodeler,60,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA helicase activity|chromatin binding|helicase activity|DNA translocase activity|methylated histone binding|histone binding,autistic disorder|ptosis|congenital ptosis|clubfoot|constipation|cryptorchidism|salivary gland adenoid cystic carcinoma|epilepsy|alternating exotropia|exotropia|monocular exotropia|esophagitis|peptic esophagitis|gastroesophageal reflux disease|malignant glioma|gliosarcoma|mixed glioma|sensorineural hearing loss|hematopoietic system disease|umbilical hernia,ppi
15498,18573,5191,PEX7,peroxisomal biogenesis factor 7,28,peroxisome matrix targeting signal-2 binding|protein homodimerization activity,alopecia|sick sinus syndrome|ptosis|congenital ptosis|cerebellar disease|isolated cleft palate|cleft palate|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types,ppi
15499,18574,5196,PF4,platelet factor 4,14,chemokine activity|heparin binding|CXCR3 chemokine receptor binding,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|allergic hypersensitivity disease|pneumonia|thrombocytopenia,ppi
15500,18575,5197,PF4V1,platelet factor 4 variant 1,1,chemokine activity,,ppi
15501,18576,5198,PFAS,phosphoribosylformylglycinamidine synthase,80,phosphoribosylformylglycinamidine synthase activity,,ppi
15502,18577,5199,CFP,complement factor properdin,9,serine-type endopeptidase activity,,ppi
15503,18578,5201,PFDN1,prefoldin subunit 1,100,DNA-binding transcription factor activity,,ppi
15504,18579,5202,PFDN2,prefoldin subunit 2,101,unfolded protein binding|protein binding involved in protein folding,,ppi
15505,18580,5203,PFDN4,prefoldin subunit 4,70,chaperone binding,,ppi
15506,18581,5204,PFDN5,prefoldin subunit 5,93,transcription corepressor activity,,ppi
15507,18582,5207,PFKFB1,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase 1,7,6-phosphofructo-2-kinase activity|fructose-2;6-bisphosphate 2-phosphatase activity,,ppi
15508,18583,5208,PFKFB2,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase 2,29,6-phosphofructo-2-kinase activity|fructose-2;6-bisphosphate 2-phosphatase activity,,ppi
15509,18584,5209,PFKFB3,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase 3,13,6-phosphofructo-2-kinase activity|fructose-2;6-bisphosphate 2-phosphatase activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|obesity|seborrheic keratosis|skin disease|actinic keratosis|endogenous depression|melancholia|coronary artery disease|mood disorder,ppi
15510,18585,5210,PFKFB4,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase 4,5,6-phosphofructo-2-kinase activity|fructose-2;6-bisphosphate 2-phosphatase activity,,ppi
15511,18586,5211,PFKL,phosphofructokinase; liver type,66,6-phosphofructokinase activity|ATP binding|fructose binding|fructose-6-phosphate binding|monosaccharide binding|identical protein binding|AMP binding,bipolar disorder|mood disorder,ppi
15512,18587,5213,PFKM,phosphofructokinase; muscle,68,6-phosphofructokinase activity|ATP binding|fructose binding|AMP binding|monosaccharide binding|identical protein binding|fructose-6-phosphate binding|protein homodimerization activity,anemia|macrocytic anemia|hemolytic anemia|gout|cholecystolithiasis|choledocholithiasis|glycogen storage disease VII|glycogen storage disease IV|glycogen storage disease VI|coronary artery disease|muscular atrophy|hyperuricemia,ppi
15513,18588,5214,PFKP,phosphofructokinase; platelet,93,6-phosphofructokinase activity|protein-containing complex binding|cadherin binding|ATP binding|fructose-6-phosphate binding|identical protein binding|monosaccharide binding|AMP binding,,ppi
15514,18589,547,KIF1A,kinesin family member 1A,47,motor activity|microtubule motor activity|microtubule binding|ATP-dependent microtubule motor activity; plus-end-directed|ATPase activity,hypohidrosis|anhidrosis|diabetic ketoacidosis|diabetes mellitus|microphthalmia|eye disease|esophagitis|peptic esophagitis|gastroesophageal reflux disease|gingival overgrowth|gingival hypertrophy|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|movement disease|lingual-facial-buccal dyskinesia|optic atrophy|paronychia|polyneuropathy,ppi
15515,18590,5216,PFN1,profilin 1,82,adenyl-nucleotide exchange factor activity|RNA binding|actin monomer binding|phosphatidylinositol-4;5-bisphosphate binding|cadherin binding|actin binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|muscular atrophy|esophagus squamous cell carcinoma|neurodegenerative disease|amyotrophic lateral sclerosis type 18,ppi
15516,18591,5217,PFN2,profilin 2,58,phosphatidylinositol-4;5-bisphosphate binding|ATPase activity|actin binding,,ppi
15517,18592,5218,CDK14,cyclin dependent kinase 14,23,cyclin-dependent protein serine/threonine kinase activity|cyclin binding,liver cancer|hepatocellular carcinoma,ppi
15518,18596,5223,PGAM1,phosphoglycerate mutase 1,48,phosphoglycerate mutase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|bipolar disorder|lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|stomach cancer,ppi
15519,18597,5224,PGAM2,phosphoglycerate mutase 2,16,phosphoglycerate mutase activity,familial periodic paralysis|myopathy|prostate cancer|prostate carcinoma|kidney failure|uremia|pseudosarcomatous fibromatosis,ppi
15520,18598,5225,PGC,progastricsin,4,aspartic-type endopeptidase activity,,ppi
15521,18599,5226,PGD,phosphogluconate dehydrogenase,66,phosphogluconate dehydrogenase (decarboxylating) activity,liver cancer|hepatocellular carcinoma,ppi
15522,18600,5228,PGF,placental growth factor,4,growth factor activity|chemoattractant activity|vascular endothelial growth factor receptor 3 binding,,ppi
15523,18601,5229,PGGT1B,protein geranylgeranyltransferase type I subunit beta,14,protein geranylgeranyltransferase activity|CAAX-protein geranylgeranyltransferase activity|zinc ion binding,,ppi
15524,18602,5230,PGK1,phosphoglycerate kinase 1,109,phosphoglycerate kinase activity|ATP binding|protein-disulfide reductase activity|ADP binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|cerebellar disease|epilepsy|intellectual disability|learning disability|pseudosarcomatous fibromatosis|visual epilepsy|migraine|liver cancer|hepatocellular carcinoma,ppi
15525,18603,5232,PGK2,phosphoglycerate kinase 2,32,phosphoglycerate kinase activity|ATP binding|ADP binding,,ppi
15526,18604,34,ACADM,acyl-CoA dehydrogenase; C-4 to C-12 straight chain,58,acyl-CoA dehydrogenase activity|identical protein binding|medium-chain-acyl-CoA dehydrogenase activity,brain edema|epilepsy|hypoglycemia|obesity|visual epilepsy|liver disease|Reye syndrome|medium chain acyl-CoA dehydrogenase deficiency|lactic acidosis|perinatal necrotizing enterocolitis|fatty liver disease,ppi
15527,18605,549,AUH,AU RNA binding methylglutaconyl-CoA hydratase,5,mRNA 3'-UTR binding|enoyl-CoA hydratase activity|methylglutaconyl-CoA hydratase activity,cerebellar disease|dystonia|optic atrophy|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|lactic acidosis|3-methylglutaconic aciduria type 1|locked-in syndrome|quadriplegia|3-methylglutaconic aciduria,ppi
15528,18606,25796,PGLS,6-phosphogluconolactonase,24,6-phosphogluconolactonase activity,osteoporosis,ppi
15529,18607,8993,PGLYRP1,peptidoglycan recognition protein 1,4,peptidoglycan receptor activity|peptidoglycan binding|N-acetylmuramoyl-L-alanine amidase activity,,ppi
15530,18608,5236,PGM1,phosphoglucomutase 1,48,magnesium ion binding|phosphoglucomutase activity,coronary artery disease|congenital disorder of glycosylation type I,ppi
15531,18609,55276,PGM2,phosphoglucomutase 2,15,phosphoglucomutase activity|phosphopentomutase activity,,ppi
15532,18610,5238,PGM3,phosphoglucomutase 3,17,phosphoacetylglucosamine mutase activity,asthma|intrinsic asthma|allergic asthma|bronchiectasis|cerebellar disease|dermatitis|sensorineural hearing loss|primary immunodeficiency disease|lymphopenia|intellectual disability|learning disability|vasomotor rhinitis|allergic rhinitis,ppi
15533,18611,5239,PGM5,phosphoglucomutase 5,11,structural molecule activity|phosphoglucomutase activity,,ppi
15534,18612,283871,PGP,phosphoglycolate phosphatase,7,magnesium ion binding|protein tyrosine phosphatase activity|phosphoglycolate phosphatase activity|glycerol-3-phosphatase activity|nucleotide phosphatase activity; acting on free nucleotides|phosphatase activity|phosphoprotein phosphatase activity,bipolar disorder,ppi
15535,18613,550,AUP1,ancient ubiquitous protein 1,62,ubiquitin-protein transferase activator activity|ubiquitin binding,,ppi
15536,18614,5241,PGR,progesterone receptor,76,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|ATPase binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|endometrial cancer|endometrial carcinoma|endometriosis of uterus|endometriosis|meningioma|spinal meningioma|acoustic neuroma|intraventricular meningioma|pituitary adenoma|intraorbital meningioma|clear cell meningioma|benign meningioma|secretory meningioma|microcystic meningioma|cerebral convexity meningioma,ppi
15537,18615,5245,PHB,prohibitin,182,complement component C3a binding|complement component C3b binding|transcription regulatory region DNA binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|esophageal cancer|drug psychosis|schizophrenia|stomach cancer|breast cancer|liver cancer|hepatocellular carcinoma,ppi
15538,18616,5251,PHEX,phosphate regulating endopeptidase homolog; X-linked,2,zinc ion binding,craniosynostosis|calcium metabolism disease|nephrocalcinosis|calcinosis|hypercalcemia|phosphorus metabolism disease|arthropathy|arthritis|osteomalacia|rickets|spinal cord disease|osteogenesis imperfecta|Ehlers-Danlos syndrome|X-linked hypophosphatemic rickets,ppi
15539,18617,5252,PHF1,PHD finger protein 1,42,DNA-binding transcription factor activity|methylated histone binding|sequence-specific DNA binding|nucleosome binding,,ppi
15540,18618,5253,PHF2,PHD finger protein 2,6,iron ion binding|zinc ion binding|histone demethylase activity|histone demethylase activity (H3-K9 specific)|methylated histone binding|transcription coactivator activity,,ppi
15541,18619,23469,PHF3,PHD finger protein 3,13,,alcohol dependence|alcohol abuse,ppi
15542,18620,26227,PHGDH,phosphoglycerate dehydrogenase,132,phosphoglycerate dehydrogenase activity|electron transfer activity,megaloblastic anemia|lung cancer|non-small cell lung carcinoma|cleft lip|isolated cleft palate|cleft palate|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types,ppi
15543,18621,5255,PHKA1,phosphorylase kinase regulatory subunit alpha 1,17,phosphorylase kinase activity,muscular atrophy,ppi
15544,18622,5256,PHKA2,phosphorylase kinase regulatory subunit alpha 2,20,phosphorylase kinase activity,glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|hypoglycemia|liver disease|glycogen storage disease IX,ppi
15545,18623,5257,PHKB,phosphorylase kinase regulatory subunit beta,25,phosphorylase kinase activity,glycogen storage disease IX,ppi
15546,18624,5260,PHKG1,phosphorylase kinase catalytic subunit gamma 1,6,calmodulin binding|calmodulin-dependent protein kinase activity,,ppi
15547,18625,5261,PHKG2,phosphorylase kinase catalytic subunit gamma 2,282,protein serine/threonine kinase activity|phosphorylase kinase activity|tau-protein kinase activity|calmodulin-dependent protein kinase activity|calmodulin binding,lactic acidosis|liver cirrhosis|liver disease|hypoglycemia|glycogen storage disease IX,ppi
15548,18626,22822,PHLDA1,pleckstrin homology like domain family A member 1,15,,allergic contact dermatitis,ppi
15549,18627,23612,PHLDA3,pleckstrin homology like domain family A member 3,95,phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3;4;5-trisphosphate binding|phosphatidylinositol-5-phosphate binding|phosphatidylinositol-3-phosphate binding|phosphatidylinositol-3;4-bisphosphate binding|phosphatidylinositol-3;5-bisphosphate binding,,ppi
15550,18628,10745,PHTF1,putative homeodomain transcription factor 1,4,DNA-binding transcription factor activity,,ppi
15551,18629,551,AVP,arginine vasopressin,26,protein kinase activity|signaling receptor binding|neuropeptide hormone activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process,amnestic disorder|dissociative amnesia|sick sinus syndrome|autistic disorder|bipolar disorder|neurohypophyseal diabetes insipidus|diabetes insipidus|congestive heart failure|hypertension|essential hypertension|portal hypertension|inappropriate ADH syndrome|ischemia|schizophreniform disorder|schizoaffective disorder|schizophrenia|multiple system atrophy|neurotic disorder|endogenous depression|melancholia,ppi
15552,18630,5264,PHYH,phytanoyl-CoA 2-hydroxylase,16,ferrous iron binding|carboxylic acid binding|cofactor binding|phytanoyl-CoA dioxygenase activity,sick sinus syndrome|ptosis|congenital ptosis|cerebellar disease|sensorineural hearing loss|congestive heart failure|ichthyosis|osteochondrodysplasia|multiple epiphyseal dysplasia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|mucopolysaccharidosis IV|polyneuropathy|peripheral nervous system disease|neuropathy|infantile Refsum disease,ppi
15553,18631,5265,SERPINA1,serpin family A member 1,55,serine-type endopeptidase inhibitor activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|anxiety disorder|phobic disorder|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|asbestosis|anthracosilicosis|byssinosis|bipolar disorder|bronchiectasis|cholestasis|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|hypoglycemia|liver cirrhosis,ppi
15554,18632,5273,SERPINB10,serpin family B member 10,1,serine-type endopeptidase inhibitor activity,prostate cancer|prostate carcinoma,ppi
15555,18633,5274,SERPINI1,serpin family I member 1,4,serine-type endopeptidase inhibitor activity,epilepsy|basal ganglia disease|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|schizophrenia|visual epilepsy|brain disease|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|dentatorubral-pallidoluysian atrophy|progressive myoclonus epilepsy|familial encephalopathy with neuroserpin inclusion bodies,ppi
15556,18634,5275,SERPINB13,serpin family B member 13,32,serine-type endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity,,ppi
15557,18635,5276,SERPINI2,serpin family I member 2,6,serine-type endopeptidase inhibitor activity,,ppi
15558,18637,5266,PI3,peptidase inhibitor 3,5,endopeptidase inhibitor activity|structural constituent of epidermis,contact dermatitis|occupational dermatitis,ppi
15559,18638,5267,SERPINA4,serpin family A member 4,17,serine-type endopeptidase inhibitor activity,malignant mesothelioma|benign mesothelioma|liver cancer|hepatocellular carcinoma,ppi
15560,18639,5268,SERPINB5,serpin family B member 5,73,serine-type endopeptidase inhibitor activity,colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|invasive ductal carcinoma|breast cancer,ppi
15561,18640,552,AVPR1A,arginine vasopressin receptor 1A,4,protein kinase C binding|vasopressin receptor activity,autistic disorder|schizophrenia,ppi
15562,18641,5269,SERPINB6,serpin family B member 6,19,serine-type endopeptidase inhibitor activity,autosomal recessive nonsyndromic deafness 91,ppi
15563,18642,5270,SERPINE2,serpin family E member 2,27,serine-type endopeptidase inhibitor activity|glycosaminoglycan binding|heparin binding,,ppi
15564,18643,5271,SERPINB8,serpin family B member 8,27,serine-type endopeptidase inhibitor activity,pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
15565,18644,5272,SERPINB9,serpin family B member 9,36,serine-type endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process,,ppi
15566,18645,27124,INPP5J,inositol polyphosphate-5-phosphatase J,6,phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity|phosphatidylinositol-3;4;5-trisphosphate 5-phosphatase activity|inositol-1;4;5-trisphosphate 5-phosphatase activity|inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity|inositol-polyphosphate 5-phosphatase activity,,ppi
15567,18646,5277,PIGA,phosphatidylinositol glycan anchor biosynthesis class A,26,UDP-glycosyltransferase activity|phosphatidylinositol N-acetylglucosaminyltransferase activity,hemolytic anemia|pseudosarcomatous fibromatosis|sensorineural hearing loss|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|gingival overgrowth|gingival hypertrophy|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|paroxysmal nocturnal hemoglobinuria|infantile epileptic encephalopathy,ppi
15568,18647,9488,PIGB,phosphatidylinositol glycan anchor biosynthesis class B,6,mannosyltransferase activity|glycolipid mannosyltransferase activity,,ppi
15569,18648,553,AVPR1B,arginine vasopressin receptor 1B,3,protein kinase C binding|vasopressin receptor activity,bipolar disorder|mood disorder,ppi
15570,18649,5279,PIGC,phosphatidylinositol glycan anchor biosynthesis class C,6,catalytic activity,,ppi
15571,18650,5281,PIGF,phosphatidylinositol glycan anchor biosynthesis class F,2,ethanolaminephosphotransferase activity,,ppi
15572,18651,5283,PIGH,phosphatidylinositol glycan anchor biosynthesis class H,7,catalytic activity,,ppi
15573,18652,10026,PIGK,phosphatidylinositol glycan anchor biosynthesis class K,12,protein disulfide isomerase activity|GPI-anchor transamidase activity|GPI anchor binding,,ppi
15574,18653,9487,PIGL,phosphatidylinositol glycan anchor biosynthesis class L,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,isolated cleft palate|cleft palate|epilepsy|ventricular septal defect|hydronephrosis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|acute lymphocytic leukemia|intellectual disability|learning disability|visual epilepsy|tetralogy of Fallot|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|craniosynostosis|dextro-looped transposition of the great arteries 1|dextro-looped transposition of the great arteries 3|dextro-looped transposition of the great arteries,ppi
15575,18654,23556,PIGN,phosphatidylinositol glycan anchor biosynthesis class N,15,mannose-ethanolamine phosphotransferase activity,suppression amblyopia|amblyopia|imperforate anus|isolated cleft palate|cleft palate|recurrent corneal erosion|cryptorchidism|patent ductus arteriosus|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|heart septal defect|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7,ppi
15576,18655,5284,PIGR,polymeric immunoglobulin receptor,34,polymeric immunoglobulin receptor activity,IgA glomerulonephritis,ppi
15577,18656,554,AVPR2,arginine vasopressin receptor 2,16,vasopressin receptor activity,constipation|neurohypophyseal diabetes insipidus|diabetes insipidus|epilepsy|congestive heart failure|intellectual disability|learning disability|visual epilepsy|nephrogenic diabetes insipidus|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
15578,18657,5286,PIK3C2A,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha,60,1-phosphatidylinositol-3-kinase activity|phosphatidylinositol 3-kinase activity|1-phosphatidylinositol-4-phosphate 3-kinase activity,,ppi
15579,18658,5287,PIK3C2B,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta,24,1-phosphatidylinositol-4-phosphate 3-kinase activity|1-phosphatidylinositol-3-kinase activity,,ppi
15580,18660,5289,PIK3C3,phosphatidylinositol 3-kinase catalytic subunit type 3,44,kinase activity|1-phosphatidylinositol-3-kinase activity,bipolar disorder|schizophrenia,ppi
15581,18661,5290,PIK3CA,phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit alpha,96,kinase activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol 3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|1-phosphatidylinositol-4-phosphate 3-kinase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|angioid streaks|generalized anxiety disorder|anxiety disorder|arteriovenous malformation|breast cancer|colon cancer|colonic benign neoplasm|large intestine cancer|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|lung cancer|bronchiolo-alveolar adenocarcinoma|papillary renal cell carcinoma,ppi
15582,18662,5291,PIK3CB,phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit beta,52,kinase activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol 3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|1-phosphatidylinositol-4-phosphate 3-kinase activity,schizophrenia,ppi
15583,18663,5293,PIK3CD,phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit delta,20,kinase activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol 3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|1-phosphatidylinositol-4-phosphate 3-kinase activity,bronchiectasis|cellulitis|primary immunodeficiency disease|prostate cancer|prostate carcinoma|agammaglobulinemia|lymphosarcoma|B-cell lymphoma,ppi
15584,18664,5294,PIK3CG,phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit gamma,33,protein kinase activity|kinase activity|phosphatidylinositol 3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|1-phosphatidylinositol-3-kinase activity|1-phosphatidylinositol-4-phosphate 3-kinase activity,autistic disorder|congestive heart failure|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
15585,18665,5295,PIK3R1,phosphoinositide-3-kinase regulatory subunit 1,327,transmembrane receptor protein tyrosine kinase adaptor activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol 3-kinase regulator activity|ErbB-3 class receptor binding|phosphatidylinositol 3-kinase binding|insulin binding|insulin receptor substrate binding|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|1-phosphatidylinositol-3-kinase regulator activity,agammaglobulinemia|alcohol dependence|alcohol abuse|arthropathy|arthritis|Burkitt lymphoma|conjunctivitis|enophthalmos|orbital disease|exophthalmos|exanthem|placental insufficiency|glaucoma|sensorineural hearing loss|inguinal hernia|hyperglycemia|tooth agenesis|anodontia|primary immunodeficiency disease|lipoatrophic diabetes,ppi
15586,18666,5296,PIK3R2,phosphoinositide-3-kinase regulatory subunit 2,136,GTPase activator activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity|protein heterodimerization activity|1-phosphatidylinositol-3-kinase regulator activity,ptosis|congenital ptosis|epilepsy|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|mitral valve insufficiency,ppi
15587,18667,8503,PIK3R3,phosphoinositide-3-kinase regulatory subunit 3,130,1-phosphatidylinositol-3-kinase activity|1-phosphatidylinositol-3-kinase regulator activity,,ppi
15588,18668,30849,PIK3R4,phosphoinositide-3-kinase regulatory subunit 4,25,protein kinase activity|1-phosphatidylinositol-3-kinase activity|protein serine/threonine kinase activity,,ppi
15589,18669,5297,PI4KA,phosphatidylinositol 4-kinase alpha,77,1-phosphatidylinositol 4-kinase activity|kinase activity|cadherin binding,clubfoot|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
15590,18670,5298,PI4KB,phosphatidylinositol 4-kinase beta,25,1-phosphatidylinositol 4-kinase activity|14-3-3 protein binding,,ppi
15591,18671,390502,SERPINA2,serpin family A member 2 (gene/pseudogene),1,,,ppi
15592,18672,5292,PIM1,Pim-1 proto-oncogene; serine/threonine kinase,54,protein serine/threonine kinase activity|ATP binding|manganese ion binding,glioblastoma multiforme|giant cell glioblastoma|interstitial nephritis|pyelonephritis|pyelitis|allergic contact dermatitis|congenital diaphragmatic hernia|breast cancer,ppi
15593,18673,11040,PIM2,Pim-2 proto-oncogene; serine/threonine kinase,22,protein serine/threonine kinase activity,acute myeloid leukemia,ppi
15594,18674,5300,PIN1,peptidylprolyl cis/trans isomerase; NIMA-interacting 1,261,peptidyl-prolyl cis-trans isomerase activity|motor activity|beta-catenin binding|phosphoserine residue binding|phosphothreonine residue binding|phosphoprotein binding,breast cancer,ppi
15595,18675,5303,PIN4,peptidylprolyl cis/trans isomerase; NIMA-interacting 4,38,RNA binding,,ppi
15596,18676,5304,PIP,prolactin induced protein,22,actin binding|aspartic-type endopeptidase activity|IgG binding|protein dimerization activity,sinusitis,ppi
15597,18677,8394,PIP5K1A,phosphatidylinositol-4-phosphate 5-kinase type 1 alpha,55,1-phosphatidylinositol-3-phosphate 5-kinase activity|1-phosphatidylinositol-4-phosphate 5-kinase activity|kinase binding|1-phosphatidylinositol-5-kinase activity|1-phosphatidylinositol-3-phosphate 4-kinase activity|phosphatidylinositol-3;4-bisphosphate 5-kinase activity,,ppi
15598,18678,8395,PIP5K1B,phosphatidylinositol-4-phosphate 5-kinase type 1 beta,4,1-phosphatidylinositol-3-phosphate 5-kinase activity|1-phosphatidylinositol-4-phosphate 5-kinase activity|1-phosphatidylinositol-5-kinase activity|1-phosphatidylinositol-3-phosphate 4-kinase activity|phosphatidylinositol-3;4-bisphosphate 5-kinase activity,,ppi
15599,18679,23396,PIP5K1C,phosphatidylinositol-4-phosphate 5-kinase type 1 gamma,18,1-phosphatidylinositol-4-phosphate 5-kinase activity|1-phosphatidylinositol-3-phosphate 4-kinase activity|phosphatidylinositol-3;4-bisphosphate 5-kinase activity,muscular atrophy,ppi
15600,18680,5305,PIP4K2A,phosphatidylinositol-5-phosphate 4-kinase type 2 alpha,103,1-phosphatidylinositol-4-phosphate 5-kinase activity|1-phosphatidylinositol-5-phosphate 4-kinase activity|1-phosphatidylinositol-3-phosphate 4-kinase activity,bipolar disorder|melanoma|skin melanoma|schizophrenia,ppi
15601,18681,8396,PIP4K2B,phosphatidylinositol-5-phosphate 4-kinase type 2 beta,32,1-phosphatidylinositol-4-phosphate 5-kinase activity|1-phosphatidylinositol-5-phosphate 4-kinase activity|protein homodimerization activity|1-phosphatidylinositol-3-phosphate 4-kinase activity,,ppi
15602,18682,23761,PISD,phosphatidylserine decarboxylase,10,phosphatidylserine decarboxylase activity,,ppi
15603,18683,35,ACADS,acyl-CoA dehydrogenase; C-2 to C-3 short chain,12,acyl-CoA dehydrogenase activity|butyryl-CoA dehydrogenase activity,bipolar disorder|pseudosarcomatous fibromatosis|epilepsy|familial periodic paralysis|myopathy|schizophreniform disorder|schizoaffective disorder|visual epilepsy|short chain acyl-CoA dehydrogenase deficiency|Bell's palsy|facial paralysis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
15604,18684,5306,PITPNA,phosphatidylinositol transfer protein alpha,24,phosphatidylcholine transporter activity|phosphatidylinositol transporter activity|phosphatidylcholine binding|phosphatidylinositol binding|phosphatidylglycerol binding,,ppi
15605,18685,23760,PITPNB,phosphatidylinositol transfer protein beta,26,phosphatidylcholine transporter activity|phosphatidylinositol transporter activity|phosphatidylcholine binding|phosphatidylinositol binding,,ppi
15606,18686,9600,PITPNM1,phosphatidylinositol transfer protein membrane associated 1,8,calcium ion binding|phosphatidylinositol transporter activity|receptor tyrosine kinase binding|phosphatidylcholine binding|phosphatidylinositol binding|phosphatidic acid binding|phosphatidylcholine transporter activity,schizophrenia,ppi
15607,18687,5307,PITX1,paired like homeodomain 1,31,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II transcription factor binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|sequence-specific DNA binding,autistic disorder|clubfoot|testicular cancer|seminoma|testicular germ cell cancer,ppi
15608,18688,5308,PITX2,paired like homeodomain 2,31,transcription regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding,aniridia|imperforate anus|recurrent corneal erosion|sensorineural hearing loss|glaucoma|congenital heart disease|buphthalmos|hydrophthalmos|tooth agenesis|anodontia|ophthalmoplegia|mechanical strabismus|hypertropia|Axenfeld-Rieger syndrome|cornea plana|Peters anomaly|megalocornea|iridogoniodysgenesis syndrome|familial atrial fibrillation|Axenfeld-Rieger syndrome type 1,ppi
15609,18689,5309,PITX3,paired like homeodomain 3,4,DNA-binding transcription factor activity; RNA polymerase II-specific|sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II transcription factor binding|RNA polymerase II proximal promoter sequence-specific DNA binding,cocaine abuse|cocaine dependence|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|microphthalmia|schizophrenia|cataract|anterior segment mesenchymal dysgenesis|cataract 11 multiple types|cataract 16 multiple types,ppi
15610,18690,9271,PIWIL1,piwi like RNA-mediated gene silencing 1,14,mRNA binding|endoribonuclease activity|piRNA binding,substance abuse|substance-related disorder,ppi
15611,18691,5310,PKD1,polycystin 1; transient receptor potential channel interacting,32,calcium channel activity,Meckel syndrome|autosomal dominant polycystic kidney disease|kidney failure|uremia|polycystic kidney disease 1|intracranial aneurysm,ppi
15612,18692,5311,PKD2,polycystin 2; transient receptor potential cation channel,39,voltage-gated ion channel activity|voltage-gated calcium channel activity|voltage-gated sodium channel activity|voltage-gated potassium channel activity|potassium channel activity|calcium ion binding|cytoskeletal protein binding|outward rectifier potassium channel activity|voltage-gated cation channel activity|identical protein binding|protein homodimerization activity|actinin binding|calcium-induced calcium release activity|ATPase binding|calcium channel activity,Meckel syndrome|autosomal dominant polycystic kidney disease|kidney failure|uremia|retinitis|retinal disease|vascular disease|polycystic kidney disease 1|neurodegenerative disease|polycystic kidney disease 2,ppi
15613,18693,9033,PKD2L1,polycystin 2 like 1; transient receptor potential cation channel,5,calcium activated cation channel activity|cation channel activity|calcium channel activity|sodium channel activity|calcium ion binding|calcium-activated potassium channel activity|identical protein binding|cation transmembrane transporter activity|sour taste receptor activity,,ppi
15614,18694,27039,PKD2L2,polycystin 2 like 2; transient receptor potential cation channel,4,calcium channel activity,,ppi
15615,18695,10343,PKDREJ,polycystin (PKD) family receptor for egg jelly,4,calcium channel activity,,ppi
15616,18696,5314,PKHD1,polycystic kidney and hepatic disease 1 (autosomal recessive),3,signaling receptor activity,obstructive jaundice|biliary tract disease|choledochal cyst|autosomal recessive polycystic kidney disease|portal hypertension|cystic kidney disease|Meckel syndrome|autosomal dominant polycystic kidney disease|kidney failure|uremia|oligohydramnios|Caroli disease|non-congenital cyst of kidney,ppi
15617,18697,5569,PKIA,protein kinase (cAMP-dependent; catalytic) inhibitor alpha,9,cAMP-dependent protein kinase inhibitor activity,,ppi
15618,18698,5570,PKIB,protein kinase (cAMP-dependent; catalytic) inhibitor beta,7,cAMP-dependent protein kinase inhibitor activity,,ppi
15619,18699,11142,PKIG,protein kinase (cAMP-dependent; catalytic) inhibitor gamma,9,cAMP-dependent protein kinase inhibitor activity,,ppi
15620,18700,5313,PKLR,pyruvate kinase; liver and RBC,20,pyruvate kinase activity,cholecystitis|cholecystolithiasis|choledocholithiasis|polycythemia vera|Chuvash polycythemia|acquired polycythemia|stress polycythemia|erythropoietin polycythemia|polycythemia|thalassemia,ppi
15621,18701,5315,PKM,pyruvate kinase; muscle,348,RNA binding|pyruvate kinase activity|MHC class II protein complex binding|cadherin binding,osteoporosis|liver cancer|hepatocellular carcinoma,ppi
15622,18702,5316,PKNOX1,PBX/knotted 1 homeobox 1,28,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,,ppi
15623,18703,5317,PKP1,plakophilin 1,41,lamin binding|intermediate filament binding|structural constituent of epidermis|cadherin binding,alopecia|blepharitis|Clouston syndrome|hypotrichosis|primary immunodeficiency disease|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|nail disease|chronic ulcer of skin|geographic tongue|fissured tongue|granuloma annulare|meibomian cyst|hordeolum|liver cancer|hepatocellular carcinoma,ppi
15624,18704,5318,PKP2,plakophilin 2,66,sodium channel regulator activity|intermediate filament binding|protein-containing complex scaffold activity|ion channel binding|cadherin binding|cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication|protein kinase C binding|alpha-catenin binding,vascular disease|heart aneurysm|arrhythmogenic right ventricular dysplasia 9,ppi
15625,18705,11187,PKP3,plakophilin 3,56,cadherin binding involved in cell-cell adhesion|RNA binding|translation regulator activity|cadherin binding,prostate cancer|prostate carcinoma,ppi
15626,18706,8502,PKP4,plakophilin 4,55,cadherin binding,,ppi
15627,18707,8399,PLA2G10,phospholipase A2 group X,54,phospholipase activity|phospholipase A2 activity|phospholipid binding|calcium-dependent phospholipase A2 activity|calcium ion binding,,ppi
15628,18708,8312,AXIN1,axin 1,100,beta-catenin binding|protein kinase binding|protein-containing complex scaffold activity|signaling adaptor activity|identical protein binding|protein homodimerization activity|armadillo repeat domain binding,hand-foot-genital syndrome|liver cancer|hepatocellular carcinoma,ppi
15629,18709,5319,PLA2G1B,phospholipase A2 group IB,5,phospholipase A2 activity|signaling receptor binding|calcium ion binding|bile acid binding|calcium-dependent phospholipase A2 activity|phospholipid binding,bipolar disorder|schizophrenia|mood disorder,ppi
15630,18710,5320,PLA2G2A,phospholipase A2 group IIA,28,phospholipase A2 activity|phospholipid binding|calcium-dependent phospholipase A2 activity|calcium ion binding,atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|bipolar disorder|large intestine cancer|colorectal cancer|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|endometriosis of uterus|endometriosis,ppi
15631,18712,26279,PLA2G2D,phospholipase A2 group IID,1,phospholipase A2 activity|phospholipid binding|calcium-dependent phospholipase A2 activity|calcium ion binding,,ppi
15632,18713,5321,PLA2G4A,phospholipase A2 group IVA,42,lysophospholipase activity|phospholipase A2 activity|calcium ion binding|calcium-dependent phospholipid binding|phospholipase A1 activity|calcium-dependent phospholipase A2 activity,progressive muscular atrophy|amyotrophic lateral sclerosis|autistic disorder|bipolar disorder|blood platelet disease|acrodermatitis|dermatitis|duodenal ulcer|inherited metabolic disorder|adult respiratory distress syndrome|newborn respiratory distress syndrome|schizophreniform disorder|schizoaffective disorder|schizophrenia|breast cancer,ppi
15633,18714,100137049,PLA2G4B,phospholipase A2 group IVB,4,,schizophrenia,ppi
15634,18715,8605,PLA2G4C,phospholipase A2 group IVC,2,lysophospholipase activity|phospholipase A2 activity|phospholipid binding|phospholipase A1 activity|calcium-independent phospholipase A2 activity|calcium ion binding|calcium-dependent phospholipase A2 activity|calcium-dependent phospholipid binding,schizophrenia,ppi
15635,18716,5322,PLA2G5,phospholipase A2 group V,1,phospholipase A2 activity|calcium ion binding|calcium-dependent phospholipase A2 activity|phospholipid binding,,ppi
15636,18717,8398,PLA2G6,phospholipase A2 group VI,3,phospholipase A2 activity|hydrolase activity,bipolar disorder|cerebellar disease|syndromic X-linked intellectual disability type 10|choreatic disease|sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|epilepsy|intellectual disability|learning disability|syringoma|skin papilloma|hidradenoma|cutaneous fibrous histiocytoma|skin tag,ppi
15637,18718,8313,AXIN2,axin 2,30,beta-catenin binding,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|colon cancer|colonic benign neoplasm|large intestine cancer|colorectal cancer|tooth agenesis|anodontia|stomach cancer|bladder urothelial carcinoma|uterus leiomyosarcoma,ppi
15638,18719,7941,PLA2G7,phospholipase A2 group VII,3,1-alkyl-2-acetylglycerophosphocholine esterase activity|phospholipid binding|hydrolase activity; acting on ester bonds|calcium-independent phospholipase A2 activity,asthma|intrinsic asthma|allergic asthma|atherosclerosis|arteriosclerotic cardiovascular disease|coronary artery disease|inherited metabolic disorder|schizophrenia|cerebral infarction|cerebrovascular disease,ppi
15639,18720,22925,PLA2R1,phospholipase A2 receptor 1,3,transmembrane signaling receptor activity,substance abuse|substance-related disorder,ppi
15640,18721,9373,PLAA,phospholipase A2 activating protein,41,ubiquitin binding,schizophrenia,ppi
15641,18722,10761,PLAC1,placenta specific 1,20,,,ppi
15642,18723,5324,PLAG1,PLAG1 zinc finger,7,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|DNA binding,pleomorphic adenoma,ppi
15643,18724,5325,PLAGL1,PLAG1 like zinc finger 1,12,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding,placental insufficiency|hyperglycemia|intellectual disability|learning disability|stomach cancer|transient neonatal diabetes mellitus,ppi
15644,18725,5326,PLAGL2,PLAG1 like zinc finger 2,6,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
15645,18726,558,AXL,AXL receptor tyrosine kinase,30,phosphatidylserine binding|protein tyrosine kinase activity|Wnt-protein binding|transmembrane signaling receptor activity|transmembrane receptor protein tyrosine kinase activity,lung cancer|non-small cell lung carcinoma|cryptorchidism|hypertrophy of breast|infant gynecomastia|gynecomastia|kidney cancer|acoustic neuroma|neurilemmoma|cellular schwannoma|melanotic neurilemmoma|plexiform schwannoma|malignant peripheral nerve sheath tumor|plexiform neurofibroma|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome,ppi
15646,18727,5327,PLAT,plasminogen activator; tissue type,40,serine-type endopeptidase activity|protein binding,lactic acidosis|hereditary angioedema|angioedema|peripheral vascular disease|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|cardiac tamponade|cerebral artery occlusion|brain stem infarction|cerebral infarction|cerebrovascular disease|brain ischemia|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|congestive heart failure,ppi
15647,18728,5328,PLAU,plasminogen activator; urokinase,31,serine-type endopeptidase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
15648,18729,5329,PLAUR,plasminogen activator; urokinase receptor,116,urokinase plasminogen activator receptor activity|signaling receptor activity,autistic disorder|prostate cancer|prostate carcinoma,ppi
15649,18730,5330,PLCB2,phospholipase C beta 2,14,phosphatidylinositol phospholipase C activity|phospholipase C activity,,ppi
15650,18731,5331,PLCB3,phospholipase C beta 3,27,phosphatidylinositol phospholipase C activity|phospholipase C activity|calmodulin binding|cadherin binding,,ppi
15651,18733,5332,PLCB4,phospholipase C beta 4,3,phosphatidylinositol phospholipase C activity|phospholipase C activity,isolated cleft palate|cleft palate|melanoma|skin melanoma|uveal melanoma,ppi
15652,18734,5333,PLCD1,phospholipase C delta 1,19,phosphatidylinositol phospholipase C activity|phosphatidylinositol-4;5-bisphosphate binding,blepharitis|arthropathy|arthritis|asthenopia|tuberous sclerosis|meibomian cyst|hordeolum|acute urate nephropathy|nonsyndromic congenital nail disorder 3|sebaceous adenoma,ppi
15653,18735,113026,PLCD3,phospholipase C delta 3,13,phosphatidylinositol phospholipase C activity,,ppi
15654,18736,84812,PLCD4,phospholipase C delta 4,3,phosphatidylinositol phospholipase C activity,,ppi
15655,18738,23228,PLCL2,phospholipase C like 2,8,GABA receptor binding,schizophrenia,ppi
15656,18739,5335,PLCG1,phospholipase C gamma 1,237,phosphatidylinositol phospholipase C activity|phospholipase C activity,bipolar disorder|angiosarcoma|adult T-cell leukemia|acute T cell leukemia|Sezary's disease|cutaneous T cell lymphoma,ppi
15657,18740,5336,PLCG2,phospholipase C gamma 2,67,phosphatidylinositol phospholipase C activity|phospholipase C activity,bronchiolitis|cellulitis|granuloma annulare|angioedema|vitiligo|immunoglobulin alpha deficiency|selective IgA deficiency disease|interstitial lung disease|autoimmune thyroiditis|vasomotor rhinitis|allergic rhinitis,ppi
15658,18741,5337,PLD1,phospholipase D1,50,phospholipase D activity,middle cerebral artery infarction,ppi
15659,18742,5338,PLD2,phospholipase D2,58,phospholipase D activity,,ppi
15660,18743,5339,PLEC,plectin,117,RNA binding|structural constituent of muscle|cadherin binding|ankyrin binding|structural constituent of cytoskeleton|structural molecule activity,anemia|macrocytic anemia|pseudosarcomatous fibromatosis|dental caries|dental enamel hypoplasia|ectropion|enophthalmos|orbital disease|exophthalmos|esophageal atresia|polyhydramnios|hydronephrosis|keratitis|keratoconjunctivitis|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|Duchenne muscular dystrophy|muscular dystrophy|autosomal dominant limb-girdle muscular dystrophy|autosomal recessive limb-girdle muscular dystrophy,ppi
15661,18744,5341,PLEK,pleckstrin,13,DNA-binding transcription factor activity; RNA polymerase II-specific|protein kinase C binding|protein homodimerization activity|phosphatidylinositol-3;4-bisphosphate binding,rheumatoid arthritis|osteoporosis,ppi
15662,18745,5340,PLG,plasminogen,67,endopeptidase activity|serine-type endopeptidase activity|serine-type peptidase activity,conjunctivitis|Dandy-Walker syndrome|duodenal ulcer|gingival disease|epulis|gingival overgrowth|gingival hypertrophy|gingivitis|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|hypertension|essential hypertension|keratitis|keratoconjunctivitis|periodontal disease|periodontitis|schizophrenia|skin disease,ppi
15663,18748,5345,SERPINF2,serpin family F member 2,19,endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity,hemarthrosis|hemopneumothorax|alpha-2-plasmin inhibitor deficiency,ppi
15664,18749,5346,PLIN1,perilipin 1,4,lipid binding,acanthosis nigricans|diabetic ketoacidosis|diabetes mellitus|Zollinger-Ellison syndrome|hyperinsulinism|hypertension|essential hypertension|infertility|obesity|polycystic ovary syndrome|liver cirrhosis|fatty liver disease|familial partial lipodystrophy,ppi
15665,18750,5347,PLK1,polo like kinase 1,286,magnesium ion binding|protein kinase activity|protein serine/threonine kinase activity|ATP binding|microtubule binding|kinase activity,malignant glioma|gliosarcoma|mixed glioma|leukemia,ppi
15666,18751,5350,PLN,phospholamban,14,enzyme inhibitor activity|ATPase inhibitor activity|identical protein binding|ATPase binding,atrial fibrillation|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B,ppi
15667,18752,5351,PLOD1,procollagen-lysine;2-oxoglutarate 5-dioxygenase 1,77,procollagen-lysine 5-dioxygenase activity|protein homodimerization activity|procollagen glucosyltransferase activity,clubfoot|glaucoma|congestive heart failure|inguinal hernia|corneal disease|keratoconus|mitral valve insufficiency|mitral valve prolapse|myopia|osteoporosis|retinal detachment|retinitis|retinal disease|blindness|bladder diverticulum|cornea plana|Peters anomaly|Ehlers-Danlos syndrome|brittle cornea syndrome,ppi
15668,18753,5352,PLOD2,procollagen-lysine;2-oxoglutarate 5-dioxygenase 2,47,procollagen-lysine 5-dioxygenase activity|procollagen glucosyltransferase activity,bone cancer|clubfoot|pseudosarcomatous fibromatosis|inguinal hernia|liver cirrhosis|arthropathy|arthritis|osteoporosis|pterygium|Bruck syndrome,ppi
15669,18754,8985,PLOD3,procollagen-lysine;2-oxoglutarate 5-dioxygenase 3,43,procollagen-lysine 5-dioxygenase activity|procollagen glucosyltransferase activity|procollagen galactosyltransferase activity,clubfoot|sensorineural hearing loss|diaphragmatic eventration|placental insufficiency|myopia|cataract|intracranial aneurysm,ppi
15670,18755,5354,PLP1,proteolipid protein 1,26,structural molecule activity|structural constituent of myelin sheath,cerebellar disease|cocaine abuse|cocaine dependence|pseudosarcomatous fibromatosis|dystonia|basal ganglia disease|focal hand dystonia|blepharospasm|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|schizophrenia|paraplegia|Pelizaeus-Merzbacher disease|muscular atrophy|hereditary spastic paraplegia 2,ppi
15671,18756,5355,PLP2,proteolipid protein 2,31,ion transmembrane transporter activity,,ppi
15672,18757,5356,PLRG1,pleiotropic regulator 1,69,,,ppi
15673,18758,5357,PLS1,plastin 1,46,structural constituent of cytoskeleton|actin filament binding,liver cancer,ppi
15674,18759,5358,PLS3,plastin 3,58,actin filament binding,arthropathy|arthritis|osteoporosis,ppi
15675,18760,5359,PLSCR1,phospholipid scramblase 1,134,proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|calcium ion binding|SH3 domain binding|phospholipid scramblase activity,influenza,ppi
15676,18761,5360,PLTP,phospholipid transfer protein,34,lipid transporter activity|phospholipid transporter activity|phosphatidylethanolamine binding|phosphatidylcholine transporter activity|diacylglycerol binding|phosphatidylcholine binding|ceramide transporter activity|phosphatidic acid binding|ceramide binding|phosphatidylglycerol binding|phosphatidylethanolamine transporter activity|phosphatidic acid transporter activity,,ppi
15677,18762,5361,PLXNA1,plexin A1,27,semaphorin receptor activity|signaling receptor activity,,ppi
15678,18763,36,ACADSB,acyl-CoA dehydrogenase; short/branched chain,18,acyl-CoA dehydrogenase activity,autistic disorder|epilepsy|alternating exotropia|exotropia|monocular exotropia|hypoglycemia|visual epilepsy,ppi
15679,18764,563,AZGP1,alpha-2-glycoprotein 1; zinc-binding,25,ribonuclease activity|protein transmembrane transporter activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|lung benign neoplasm|polycystic ovary syndrome|prostate cancer|prostate carcinoma|sinusitis,ppi
15680,18765,5362,PLXNA2,plexin A2,34,semaphorin receptor activity,schizophrenia,ppi
15681,18766,55558,PLXNA3,plexin A3,30,transmembrane signaling receptor activity|semaphorin receptor activity,endometrial cancer|endometrial carcinoma,ppi
15682,18767,91584,PLXNA4,plexin A4,4,semaphorin receptor activity,,ppi
15683,18768,5364,PLXNB1,plexin B1,32,transmembrane signaling receptor activity|GTPase activator activity|semaphorin receptor activity|semaphorin receptor binding|GTPase activating protein binding|signaling receptor activity,,ppi
15684,18769,23654,PLXNB2,plexin B2,39,semaphorin receptor activity,,ppi
15685,18770,5365,PLXNB3,plexin B3,13,semaphorin receptor activity,,ppi
15686,18771,10154,PLXNC1,plexin C1,1,signaling receptor binding|semaphorin receptor activity,endometriosis of uterus|endometriosis,ppi
15687,18772,23129,PLXND1,plexin D1,4,semaphorin receptor activity,ptosis|congenital ptosis|clubfoot|recurrent corneal erosion|ophthalmoplegia|mechanical strabismus|hypertropia|double outlet right ventricle|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X|Nance-Horan syndrome|Muenke Syndrome|Warburg micro syndrome 1|Warburg micro syndrome 2|Warburg micro syndrome 3|Warburg micro syndrome 4|Mobius syndrome,ppi
15688,18773,5366,PMAIP1,phorbol-12-myristate-13-acetate-induced protein 1,14,,chronic lymphocytic leukemia|Richter's syndrome|substance abuse|substance-related disorder,ppi
15689,18774,5367,PMCH,pro-melanin concentrating hormone,10,,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|obesity|mood disorder,ppi
15690,18775,11243,PMF1,polyamine modulated factor 1,59,transcription coactivator activity,,ppi
15691,18776,5371,PML,promyelocytic leukemia,252,SUMO transferase activity|SMAD binding|SUMO binding|transcription coactivator activity,glioblastoma multiforme|giant cell glioblastoma|acute promyelocytic leukemia|Paget's disease of bone|schizophrenia|Stevens-Johnson syndrome,ppi
15692,18777,5372,PMM1,phosphomannomutase 1,13,phosphomannomutase activity,,ppi
15693,18778,5373,PMM2,phosphomannomutase 2,7,phosphomannomutase activity,cerebellar disease|pseudosarcomatous fibromatosis|epilepsy|monocular esotropia|esotropia|factor XI deficiency|congenital hypothyroidism|myxedema|hypothyroidism|cystic kidney disease|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|hemopericardium|pericardial effusion|polyneuropathy,ppi
15694,18779,5375,PMP2,peripheral myelin protein 2,9,fatty acid binding|cholesterol binding,schizophrenia,ppi
15695,18780,5376,PMP22,peripheral myelin protein 22,14,,Charcot-Marie-Tooth disease type 2|hereditary motor and sensory neuropathy with agenesis of the corpus callosum|hereditary neuropathy with liability to pressure palsies|Charcot-Marie-Tooth disease type 1A|Charcot-Marie-Tooth disease type 1F|Charcot-Marie-Tooth disease type 1D|Charcot-Marie-Tooth disease type 1C|Charcot-Marie-Tooth disease type 1B|Charcot-Marie-Tooth disease type 1E|Charcot-Marie-Tooth disease type 2A1|Charcot-Marie-Tooth disease type 2A2|Charcot-Marie-Tooth disease type 2B1|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2B|Charcot-Marie-Tooth disease axonal type 2T|Charcot-Marie-Tooth disease type 2R|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease type 2D|Charcot-Marie-Tooth disease type 2E,ppi
15696,18781,9512,PMPCB,peptidase; mitochondrial processing beta subunit,82,metalloendopeptidase activity,,ppi
15697,18782,5378,PMS1,PMS1 homolog 1; mismatch repair system component,62,DNA binding|single-stranded DNA binding|ATPase activity,generalized anxiety disorder|anxiety disorder|colon cancer|colonic benign neoplasm|large intestine cancer|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|glioblastoma multiforme|giant cell glioblastoma|rectal neoplasm|rectum cancer|visual epilepsy|migraine|pseudotumor cerebri,ppi
15698,18783,5395,PMS2,PMS1 homolog 2; mismatch repair system component,63,DNA binding|endonuclease activity|single base insertion or deletion binding|single-stranded DNA binding|MutSalpha complex binding|ATPase activity,generalized anxiety disorder|anxiety disorder|colon cancer|colonic benign neoplasm|large intestine cancer|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|Lynch syndrome|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|malignant glioma|benign ependymoma|myxopapillary ependymoma,ppi
15699,18784,64599,GIGYF1,GRB10 interacting GYF protein 1,19,,,ppi
15700,18785,566,AZU1,azurocidin 1,18,heparin binding|peptidase activity|toxic substance binding|heparan sulfate proteoglycan binding,,ppi
15701,18786,5393,EXOSC9,exosome component 9,57,3'-5'-exoribonuclease activity|RNA binding|AU-rich element binding|exoribonuclease activity,,ppi
15702,18787,5394,EXOSC10,exosome component 10,84,3'-5'-exoribonuclease activity|RNA binding|exoribonuclease activity|telomerase RNA binding,,ppi
15703,18788,567,B2M,beta-2-microglobulin,55,,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|cholestasis|xerophthalmia|dry eye syndrome|congestive heart failure|exanthem|heart disease|cardiovascular system disease|primary polycythemia|hypertension|essential hypertension|lymphoplasmacytic lymphoma|macroglobulinemia|Sjogren's syndrome|keratoconjunctivitis sicca|nephritis|glomerulonephritis|kidney disease|pyoureter,ppi
15704,18789,10654,PMVK,phosphomevalonate kinase,26,phosphomevalonate kinase activity|ATP binding,skin benign neoplasm|skin cancer|photosensitivity disease|photosensitive epilepsy|acquired hyperkeratosis|porokeratosis,ppi
15705,18790,5396,PRRX1,paired related homeobox 1,5,DNA-binding transcription factor activity; RNA polymerase II-specific,atrial fibrillation|isolated cleft palate|cleft palate|microphthalmia|eye disease|polyhydramnios|tongue disease|prostate cancer|prostate carcinoma|tuberous sclerosis|Marfan syndrome|situs inversus|holoprosencephaly|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X|Nance-Horan syndrome|Muenke Syndrome,ppi
15706,18791,8929,PHOX2B,paired like homeobox 2b,1,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific,heart disease|cardiovascular system disease|constipation|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|epilepsy|gangliocytoma|esophagitis|peptic esophagitis|gastroesophageal reflux disease|Hirschsprung's disease|megacolon|toxic megacolon|intellectual disability|learning disability|neuroblastoma|schizophrenia|visual epilepsy,ppi
15707,18792,25953,PNKD,paroxysmal nonkinesigenic dyskinesia,97,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|focal hand dystonia|blepharospasm|dystonia,ppi
15708,18793,11284,PNKP,polynucleotide kinase 3'-phosphatase,63,damaged DNA binding|double-stranded DNA binding|endonuclease activity|ATP binding|purine nucleotide binding|polynucleotide 3'-phosphatase activity|ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity|nucleoside monophosphate kinase activity,cerebellar disease|dystonia|epilepsy|microcephaly|polyneuropathy|peripheral nervous system disease|neuropathy|locked-in syndrome|quadriplegia|visual epilepsy|syndromic X-linked intellectual disability 94|muscular atrophy|infantile epileptic encephalopathy|Ohtahara syndrome,ppi
15709,18794,5406,PNLIP,pancreatic lipase,12,triglyceride lipase activity|lipase activity,megaloblastic anemia|steatorrhea|exocrine pancreatic insufficiency,ppi
15710,18795,5407,PNLIPRP1,pancreatic lipase related protein 1,9,triglyceride lipase activity|calcium ion binding|lipase activity,,ppi
15711,18796,5408,PNLIPRP2,pancreatic lipase related protein 2 (gene/pseudogene),4,phospholipase activity|triglyceride lipase activity|calcium ion binding|acylglycerol lipase activity|galactolipase activity,,ppi
15712,18797,9240,PNMA1,paraneoplastic Ma antigen 1,129,,,ppi
15713,18798,10687,PNMA2,paraneoplastic Ma antigen 2,48,,,ppi
15714,18799,8708,B3GALT1,beta-1;3-galactosyltransferase 1,1,UDP-galactose:beta-N-acetylglucosamine beta-1;3-galactosyltransferase activity|acetylgalactosaminyltransferase activity,,ppi
15715,18800,5409,PNMT,phenylethanolamine N-methyltransferase,3,phenylethanolamine N-methyltransferase activity,,ppi
15716,18801,5411,PNN,pinin; desmosome associated protein,113,RNA binding|structural molecule activity,,ppi
15717,18802,5368,PNOC,prepronociceptin,1,neuropeptide hormone activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|intellectual disability|learning disability|schizophrenia|mood disorder,ppi
15718,18803,5413,SEPT5,septin 5,25,GTPase activity|structural molecule activity|protein-containing complex scaffold activity,adult respiratory distress syndrome|newborn respiratory distress syndrome|neurodegenerative disease,ppi
15719,18804,5414,SEPT4,septin 4,26,magnesium ion binding|GTPase activity|structural molecule activity|GTP binding|protein homodimerization activity|protein-containing complex scaffold activity,,ppi
15720,18805,8707,B3GALT2,beta-1;3-galactosyltransferase 2,10,UDP-galactose:beta-N-acetylglucosamine beta-1;3-galactosyltransferase activity|acetylgalactosaminyltransferase activity,,ppi
15721,18806,5420,PODXL,podocalyxin like,18,,carotid artery disease|prostate cancer|prostate carcinoma|Parkinson's disease,ppi
15722,18807,5422,POLA1,DNA polymerase alpha 1; catalytic subunit,54,nucleotide binding|DNA binding|chromatin binding|DNA-directed DNA polymerase activity|purine nucleotide binding|protein heterodimerization activity|DNA replication origin binding,amyloidosis|cryptorchidism|sensorineural hearing loss|epilepsy|hemiplegia|inguinal hernia|leukemia|intellectual disability|learning disability|visual epilepsy|blindness|hematologic cancer,ppi
15723,18808,5423,POLB,DNA polymerase beta,38,DNA-directed DNA polymerase activity|DNA-(apurinic or apyrimidinic site) endonuclease activity|microtubule binding|lyase activity|DNA binding,urinary bladder cancer|colon cancer|colonic benign neoplasm|chronic lymphocytic leukemia|Richter's syndrome,ppi
15724,18809,5424,POLD1,DNA polymerase delta 1; catalytic subunit,79,DNA binding|chromatin binding|damaged DNA binding|DNA-directed DNA polymerase activity|3'-5'-exodeoxyribonuclease activity,large intestine cancer|colorectal cancer|pseudosarcomatous fibromatosis|cryptorchidism|sensorineural hearing loss|diabetic ketoacidosis|diabetes mellitus|endometrial cancer|endometrial carcinoma|enophthalmos|orbital disease|exophthalmos|hypogonadism|lipoatrophic diabetes|lipodystrophy|osteoporosis|hereditary hemorrhagic telangiectasia|capillary disease|telangiectasis|liver disease,ppi
15725,18810,5425,POLD2,DNA polymerase delta 2; accessory subunit,38,DNA-directed DNA polymerase activity,,ppi
15726,18811,5426,POLE,DNA polymerase epsilon; catalytic subunit,51,DNA binding|chromatin binding|DNA-directed DNA polymerase activity|single-stranded DNA 3'-5' exodeoxyribonuclease activity,large intestine cancer|colorectal cancer|primary immunodeficiency disease,ppi
15727,18812,5427,POLE2,DNA polymerase epsilon 2; accessory subunit,35,DNA-directed DNA polymerase activity,,ppi
15728,18813,5428,POLG,DNA polymerase gamma; catalytic subunit,17,chromatin binding|DNA-directed DNA polymerase activity|3'-5' exonuclease activity,lactic acidosis|bipolar disorder|ptosis|congenital ptosis|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P,ppi
15729,18814,8706,B3GALNT1,beta-1;3-N-acetylgalactosaminyltransferase 1 (globoside blood group),26,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity|UDP-galactose:beta-N-acetylglucosamine beta-1;3-galactosyltransferase activity|acetylgalactosaminyltransferase activity,,ppi
15730,18815,11232,POLG2,DNA polymerase gamma 2; accessory subunit,16,DNA-directed DNA polymerase activity|glycine-tRNA ligase activity,sick sinus syndrome|ptosis|congenital ptosis|chronic progressive external ophthalmoplegia|fibromyalgia|myositis|glucose intolerance|prediabetes syndrome|Bell's palsy|facial paralysis,ppi
15731,18816,5429,POLH,DNA polymerase eta,42,DNA-directed DNA polymerase activity,basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|conjunctivitis|ectropion|entropion|keratitis|keratoconjunctivitis|melanoma|skin melanoma|hereditary hemorrhagic telangiectasia|capillary disease|telangiectasis|xeroderma pigmentosum|xeroderma pigmentosum group A|xeroderma pigmentosum group C|xeroderma pigmentosum group D,ppi
15732,18817,11201,POLI,DNA polymerase iota,20,DNA-directed DNA polymerase activity,,ppi
15733,18818,51426,POLK,DNA polymerase kappa,40,DNA-directed DNA polymerase activity|protein binding,glioblastoma multiforme|giant cell glioblastoma,ppi
15734,18819,27343,POLL,DNA polymerase lambda,47,DNA binding|DNA-directed DNA polymerase activity|5'-deoxyribose-5-phosphate lyase activity,,ppi
15735,18820,27434,POLM,DNA polymerase mu,12,DNA-directed DNA polymerase activity,,ppi
15736,18821,10721,POLQ,DNA polymerase theta,1,chromatin binding|damaged DNA binding|DNA-directed DNA polymerase activity|single-stranded DNA-dependent ATPase activity|5'-deoxyribose-5-phosphate lyase activity|5'-3' exonuclease activity,,ppi
15737,18822,5430,POLR2A,RNA polymerase II subunit A,295,DNA binding|RNA binding|DNA-directed 5'-3' RNA polymerase activity|promoter-specific chromatin binding|RNA polymerase II activity,,ppi
15738,18823,5431,POLR2B,RNA polymerase II subunit B,110,RNA binding|RNA polymerase II activity|DNA-directed 5'-3' RNA polymerase activity,,ppi
15739,18824,5432,POLR2C,RNA polymerase II subunit C,110,RNA polymerase II activity,,ppi
15740,18825,8705,B3GALT4,beta-1;3-galactosyltransferase 4,4,UDP-galactose:beta-N-acetylglucosamine beta-1;3-galactosyltransferase activity|acetylgalactosaminyltransferase activity,,ppi
15741,18826,5433,POLR2D,RNA polymerase II subunit D,68,DNA-directed 5'-3' RNA polymerase activity|single-stranded RNA binding|single-stranded DNA binding|translation initiation factor binding,,ppi
15742,18827,5434,POLR2E,RNA polymerase II subunit E,129,DNA-directed 5'-3' RNA polymerase activity|RNA polymerase II activity|RNA polymerase III activity|RNA polymerase I activity,,ppi
15743,18828,5435,POLR2F,RNA polymerase II subunit F,72,DNA-directed 5'-3' RNA polymerase activity|RNA polymerase II activity|RNA polymerase I activity|RNA polymerase III activity,,ppi
15744,18829,5436,POLR2G,RNA polymerase II subunit G,90,DNA-directed 5'-3' RNA polymerase activity|translation initiation factor binding|single-stranded DNA binding|single-stranded RNA binding,,ppi
15745,18830,5437,POLR2H,RNA polymerase II subunit H,68,single-stranded DNA binding|RNA polymerase II activity|RNA polymerase I activity|RNA polymerase III activity,,ppi
15746,18831,5438,POLR2I,RNA polymerase II subunit I,42,DNA-directed 5'-3' RNA polymerase activity,,ppi
15747,18832,5439,POLR2J,RNA polymerase II subunit J,58,DNA-directed 5'-3' RNA polymerase activity|RNA polymerase II activity,,ppi
15748,18833,5440,POLR2K,RNA polymerase II subunit K,25,zinc ion binding|RNA polymerase III activity|RNA polymerase I activity|RNA polymerase II activity,,ppi
15749,18834,5441,POLR2L,RNA polymerase II subunit L,57,DNA-directed 5'-3' RNA polymerase activity|RNA polymerase II activity|RNA polymerase I activity|RNA polymerase III activity|zinc ion binding,,ppi
15750,18835,37,ACADVL,acyl-CoA dehydrogenase; very long chain,45,acyl-CoA dehydrogenase activity|long-chain-acyl-CoA dehydrogenase activity|very-long-chain-acyl-CoA dehydrogenase activity|fatty-acyl-CoA binding,cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|fatty liver disease|Pearson syndrome|very long chain acyl-CoA dehydrogenase deficiency,ppi
15751,18837,5442,POLRMT,RNA polymerase mitochondrial,37,RNA binding|DNA-directed 5'-3' RNA polymerase activity|sequence-specific DNA binding|mitochondrial promoter sequence-specific DNA binding,,ppi
15752,18838,5443,POMC,proopiomelanocortin,17,G-protein coupled receptor binding|signaling receptor binding|hormone activity|type 1 melanocortin receptor binding,adrenal cortex disease|adrenal cortical hypofunction|Addison's disease|alcohol dependence|alcohol abuse|amnestic disorder|dissociative amnesia|gout|autistic disorder|disease of mental health|bipolar disorder|calcium metabolism disease|nephrocalcinosis|calcinosis|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma,ppi
15753,18839,10585,POMT1,protein O-mannosyltransferase 1,30,mannosyltransferase activity,imperforate anus|cleft lip|isolated cleft palate|cleft palate|coloboma|pseudosarcomatous fibromatosis|recurrent corneal erosion|Dandy-Walker syndrome|epilepsy|glaucoma|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|buphthalmos|hydrophthalmos|intellectual disability|learning disability|microphthalmia|familial periodic paralysis,ppi
15754,18840,22932,POMZP3,POM121 and ZP3 fusion,3,acrosin binding,,ppi
15755,18841,5444,PON1,paraoxonase 1,10,aryldialkylphosphatase activity|arylesterase activity|calcium ion binding|phospholipid binding|protein homodimerization activity|acyl-L-homoserine-lactone lactonohydrolase activity,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|aortitis|vasculitis|rheumatoid arthritis|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|autistic disorder|bipolar disorder|brain cancer|heart disease|cardiovascular system disease|constipation|coronary artery vasospasm|neurotic disorder,ppi
15756,18842,5445,PON2,paraoxonase 2,82,identical protein binding|acyl-L-homoserine-lactone lactonohydrolase activity|arylesterase activity,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|heart disease|cardiovascular system disease|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|familial hypercholesterolemia|muscular atrophy|neurodegenerative disease,ppi
15757,18843,5446,PON3,paraoxonase 3,2,arylesterase activity|protein homodimerization activity|acyl-L-homoserine-lactone lactonohydrolase activity,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|muscular atrophy|neurodegenerative disease,ppi
15758,18844,9337,CNOT8,CCR4-NOT transcription complex subunit 8,43,3'-5'-exoribonuclease activity|DNA-binding transcription factor activity|poly(A)-specific ribonuclease activity,,ppi
15759,18845,5447,POR,cytochrome p450 oxidoreductase,43,NADPH-hemoprotein reductase activity|FMN binding|flavin adenine dinucleotide binding|oxidoreductase activity,amenorrhea|congenital heart disease|urinary bladder cancer|choanal atresia|pseudosarcomatous fibromatosis|craniosynostosis|cryptorchidism|endocrine system disease|enophthalmos|orbital disease|exophthalmos|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9,ppi
15760,18846,27087,B3GAT1,beta-1;3-glucuronyltransferase 1,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,schizophrenia|fatty liver disease,ppi
15761,18847,5449,POU1F1,POU class 1 homeobox 1,16,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription coactivator activity,constipation|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism|panhypopituitarism|Sheehan syndrome|enophthalmos|orbital disease|exophthalmos|umbilical hernia|omphalocele|hypoglycemia|congenital hypothyroidism|myxedema|hypothyroidism|infertility,ppi
15762,18848,5450,POU2AF1,POU class 2 associating factor 1,17,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|transcription coregulator activity|transcription coactivator activity,primary biliary cirrhosis|portal hypertension|multiple system atrophy|liver cirrhosis|goiter|thyroid gland disease|dermatographia|liver cancer|hepatocellular carcinoma,ppi
15763,18849,5451,POU2F1,POU class 2 homeobox 1,72,RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II core promoter sequence-specific DNA binding|DNA binding|sequence-specific DNA binding,,ppi
15764,18850,5452,POU2F2,POU class 2 homeobox 2,20,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,,ppi
15765,18851,5453,POU3F1,POU class 3 homeobox 1,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,rheumatoid arthritis|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
15766,18852,5454,POU3F2,POU class 3 homeobox 2,9,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,bipolar disorder,ppi
15767,18853,5455,POU3F3,POU class 3 homeobox 3,6,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding,arthropathy|arthritis,ppi
15768,18854,5456,POU3F4,POU class 3 homeobox 4,4,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity,sensorineural hearing loss|X-linked nonsyndromic deafness,ppi
15769,18855,5457,POU4F1,POU class 4 homeobox 1,3,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|single-stranded DNA binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription coactivator activity|transcription corepressor activity|sequence-specific DNA binding,cervical cancer|acute myeloid leukemia|cervix uteri carcinoma in situ,ppi
15770,18856,5458,POU4F2,POU class 4 homeobox 2,1,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription coactivator activity|transcription corepressor activity|promoter-specific chromatin binding,,ppi
15771,18858,5459,POU4F3,POU class 4 homeobox 3,1,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,sensorineural hearing loss|autosomal dominant nonsyndromic deafness 15,ppi
15772,18859,5460,POU5F1,POU class 5 homeobox 1,318,transcription regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|RNA binding|miRNA binding|sequence-specific DNA binding,congenital heart disease|germ cell cancer|germ cell and embryonal cancer|embryonal cancer|gestational trophoblastic neoplasm,ppi
15773,18862,8501,SLC43A1,solute carrier family 43 member 1,3,amino acid transmembrane transporter activity|neutral amino acid transmembrane transporter activity|L-amino acid transmembrane transporter activity,,ppi
15774,18863,5464,PPA1,pyrophosphatase (inorganic) 1,44,inorganic diphosphatase activity,,ppi
15775,18864,56342,PPAN,peter pan homolog (Drosophila),123,,,ppi
15776,18865,8611,PLPP1,phospholipid phosphatase 1,8,phosphatidate phosphatase activity|sphingosine-1-phosphate phosphatase activity|lipid phosphatase activity|phosphatase activity,stomach cancer,ppi
15777,18866,8613,PLPP3,phospholipid phosphatase 3,11,phosphoprotein phosphatase activity|sphingosine-1-phosphate phosphatase activity|phosphatidate phosphatase activity|lipid phosphatase activity|phosphatase activity,coronary artery disease,ppi
15778,18867,26229,B3GAT3,beta-1;3-glucuronyltransferase 3,25,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity|glucuronosyltransferase activity|protein phosphatase activator activity,suppression amblyopia|amblyopia|isolated cleft palate|cleft palate|clubfoot|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|monocular esotropia|esotropia|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8,ppi
15779,18868,8612,PLPP2,phospholipid phosphatase 2,9,phosphoprotein phosphatase activity|sphingosine-1-phosphate phosphatase activity|phosphatidate phosphatase activity|lipid phosphatase activity|phosphatase activity,,ppi
15780,18869,5465,PPARA,peroxisome proliferator activated receptor alpha,55,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|steroid hormone receptor activity|nuclear receptor activity|drug binding|lipid binding|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|nuclear receptor transcription coactivator activity|RNA polymerase II repressing transcription factor binding|transcription regulatory region sequence-specific DNA binding|fatty acid binding|signaling receptor activity|DNA-binding transcription repressor activity; RNA polymerase II-specific|transcription factor binding,inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|atopic dermatitis|diabetes mellitus|type 2 diabetes mellitus|fatty liver disease|familial hyperlipidemia|hypertension|essential hypertension|hypoglycemia|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|chronic kidney disease|acute kidney tubular necrosis|liver cancer,ppi
15781,18870,5469,MED1,mediator complex subunit 1,111,RNA polymerase II core promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|core promoter binding|chromatin binding|transcription coregulator activity|transcription coactivator activity|nuclear receptor binding|nuclear receptor transcription coactivator activity|thyroid hormone receptor coactivator activity|mediator complex binding|signaling receptor activity|vitamin D receptor binding|thyroid hormone receptor binding|retinoic acid receptor binding,endometriosis of uterus|endometriosis|liver cancer|hepatocellular carcinoma,ppi
15782,18871,5467,PPARD,peroxisome proliferator activated receptor delta,57,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|nuclear receptor activity|drug binding|lipid binding|linoleic acid binding|fatty acid binding|signaling receptor activity|RNA polymerase II regulatory region sequence-specific DNA binding|transcription regulatory region sequence-specific DNA binding|nuclear receptor transcription coactivator activity|transcription factor binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II repressing transcription factor binding,bipolar disorder|fatty liver disease|obesity|polyneuropathy|peripheral nervous system disease|neuropathy|skin benign neoplasm|skin cancer|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
15783,18872,5468,PPARG,peroxisome proliferator activated receptor gamma,162,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|chromatin binding|double-stranded DNA binding|DNA-binding transcription factor activity|nuclear receptor activity|prostaglandin receptor activity|protein C-terminus binding|drug binding|zinc ion binding|nuclear receptor transcription coactivator activity|activating transcription factor binding|peptide binding|protein self-association|transcription regulatory region DNA binding|retinoid X receptor binding|protein heterodimerization activity|arachidonic acid binding|DBD domain binding|LBD domain binding,acanthosis nigricans|hyperpituitarism|acromegaly|adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease,ppi
15784,18873,10891,PPARGC1A,PPARG coactivator 1 alpha,68,DNA binding|transcription coregulator activity|transcription coactivator activity|RNA binding|transcription factor binding|nuclear receptor transcription coactivator activity|chromatin DNA binding|sequence-specific DNA binding|androgen receptor binding,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|basal cell carcinoma|in situ carcinoma|penis carcinoma in situ|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetes mellitus|type 2 diabetes mellitus|congestive heart failure|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction,ppi
15785,18874,5471,PPAT,phosphoribosyl pyrophosphate amidotransferase,39,amidophosphoribosyltransferase activity,coronary artery disease,ppi
15786,18875,2683,B4GALT1,beta-1;4-galactosyltransferase 1,24,beta-N-acetylglucosaminylglycopeptide beta-1;4-galactosyltransferase activity|N-acetyllactosamine synthase activity|lactose synthase activity|galactosyltransferase activity|manganese ion binding|UDP-galactosyltransferase activity,blood coagulation disease|Dandy-Walker syndrome|hemorrhagic disease|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|familial periodic paralysis|myopathy|congenital disorder of glycosylation type II,ppi
15787,18876,5473,PPBP,pro-platelet basic protein,23,glucose transmembrane transporter activity|chemokine activity,allergic hypersensitivity disease|hypertension|essential hypertension,ppi
15788,18877,5475,PPEF1,protein phosphatase with EF-hand domain 1,47,protein serine/threonine phosphatase activity,,ppi
15789,18878,5470,PPEF2,protein phosphatase with EF-hand domain 2,23,protein serine/threonine phosphatase activity|Hsp70 protein binding|Hsp90 protein binding,,ppi
15790,18879,8500,PPFIA1,PTPRF interacting protein alpha 1,63,,,ppi
15791,18880,8499,PPFIA2,PTPRF interacting protein alpha 2,16,,,ppi
15792,18881,8541,PPFIA3,PTPRF interacting protein alpha 3,19,,,ppi
15793,18882,8497,PPFIA4,PTPRF interacting protein alpha 4,7,,,ppi
15794,18883,8496,PPFIBP1,PPFIA binding protein 1,33,cadherin binding,pulmonary plasma cell granuloma,ppi
15795,18884,8704,B4GALT2,beta-1;4-galactosyltransferase 2,1,beta-N-acetylglucosaminylglycopeptide beta-1;4-galactosyltransferase activity|galactosyltransferase activity,,ppi
15796,18885,8495,PPFIBP2,PPFIA binding protein 2,11,identical protein binding,prostate cancer|prostate carcinoma,ppi
15797,18886,5476,CTSA,cathepsin A,41,carboxypeptidase activity|serine-type carboxypeptidase activity|exo-alpha-sialidase activity|enzyme activator activity,recurrent corneal erosion|sensorineural hearing loss|achondroplasia|Laron syndrome|epilepsy|glomus tumor|hemangioma|lymphangioma|chorioangioma|intramuscular hemangioma|histiocytoid hemangioma|cavernous hemangioma|intellectual disability|learning disability|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|visual epilepsy|gangliosidosis GM1|mucopolysaccharidosis I,ppi
15798,18887,5478,PPIA,peptidylprolyl isomerase A,122,RNA binding|peptidyl-prolyl cis-trans isomerase activity|cyclosporin A binding|virion binding|unfolded protein binding,lung cancer|non-small cell lung carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|schizophrenia|stomach cancer,ppi
15799,18888,5479,PPIB,peptidylprolyl isomerase B,112,RNA binding|peptidyl-prolyl cis-trans isomerase activity|cyclosporin A binding|protein-containing complex binding|unfolded protein binding|collagen binding,amelogenesis imperfecta type 1B|amelogenesis imperfecta type 4|amelogenesis imperfecta type 1A|amelogenesis imperfecta type 3|amelogenesis imperfecta type 1C|amelogenesis imperfecta type 2A1|amelogenesis imperfecta type 1E|X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2|amelogenesis imperfecta hypomaturation type 2A2|amelogenesis imperfecta hypomaturation type 2A3|amelogenesis imperfecta hypomaturation type 2A4|amelogenesis imperfecta hypomaturation type 2A5|amelogenesis imperfecta type 1H|amelogenesis imperfecta type 1F|amelogenesis imperfecta type 1G|amelogenesis imperfecta|dentinogenesis imperfecta|dentin dysplasia|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
15800,18889,5480,PPIC,peptidylprolyl isomerase C,10,peptidyl-prolyl cis-trans isomerase activity|cyclosporin A binding|unfolded protein binding,stomach cancer,ppi
15801,18890,5481,PPID,peptidylprolyl isomerase D,61,peptidyl-prolyl cis-trans isomerase activity|transcription factor binding|cyclosporin A binding|estrogen receptor binding|Hsp70 protein binding|Hsp90 protein binding|unfolded protein binding,bipolar disorder,ppi
15802,18891,10450,PPIE,peptidylprolyl isomerase E,51,RNA binding|mRNA binding|peptidyl-prolyl cis-trans isomerase activity|poly(A) binding|cyclosporin A binding|unfolded protein binding,,ppi
15803,18892,10105,PPIF,peptidylprolyl isomerase F,41,peptidyl-prolyl cis-trans isomerase activity|cyclosporin A binding|unfolded protein binding,intestinal disease|gastrointestinal system disease,ppi
15804,18893,8703,B4GALT3,beta-1;4-galactosyltransferase 3,32,beta-N-acetylglucosaminylglycopeptide beta-1;4-galactosyltransferase activity|galactosyltransferase activity,,ppi
15805,18894,51645,PPIL1,peptidylprolyl isomerase like 1,29,peptidyl-prolyl cis-trans isomerase activity|cyclosporin A binding,,ppi
15806,18895,23759,PPIL2,peptidylprolyl isomerase like 2,21,ubiquitin-ubiquitin ligase activity|ubiquitin protein ligase activity|peptidyl-prolyl cis-trans isomerase activity|cyclosporin A binding,,ppi
15807,18896,53938,PPIL3,peptidylprolyl isomerase like 3,39,peptidyl-prolyl cis-trans isomerase activity,,ppi
15808,18897,8702,B4GALT4,beta-1;4-galactosyltransferase 4,11,beta-N-acetylglucosaminylglycopeptide beta-1;4-galactosyltransferase activity|galactosyltransferase activity,prostate cancer|prostate carcinoma,ppi
15809,18898,5493,PPL,periplakin,57,structural constituent of cytoskeleton|cadherin binding|structural molecule activity,,ppi
15810,18899,5494,PPM1A,protein phosphatase; Mg2+/Mn2+ dependent 1A,93,protein serine/threonine phosphatase activity|calmodulin-dependent protein phosphatase activity,,ppi
15811,18900,5495,PPM1B,protein phosphatase; Mg2+/Mn2+ dependent 1B,93,protein serine/threonine phosphatase activity,lactic acidosis|glycogen storage disease|glycogen storage disease I|glucosephosphate dehydrogenase deficiency|cystinuria|galactosemia|epilepsy|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hypogonadism|visual epilepsy|coronary artery disease|acute urate nephropathy|hypotonia-cystinuria syndrome,ppi
15812,18901,8493,PPM1D,protein phosphatase; Mg2+/Mn2+ dependent 1D,49,protein serine/threonine kinase activity|protein serine/threonine phosphatase activity,breast cancer|malignant glioma|gliosarcoma|mixed glioma|brain stem cancer|breast carcinoma|hereditary breast ovarian cancer syndrome,ppi
15813,18902,5496,PPM1G,protein phosphatase; Mg2+/Mn2+ dependent 1G,144,protein serine/threonine phosphatase activity,,ppi
15814,18903,54704,PDP1,pyruvate dehyrogenase phosphatase catalytic subunit 1,28,protein serine/threonine phosphatase activity|[pyruvate dehydrogenase (lipoamide)] phosphatase activity,lactic acidosis|epilepsy|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|pyruvate decarboxylase deficiency,ppi
15815,18904,9334,B4GALT5,beta-1;4-galactosyltransferase 5,20,beta-N-acetylglucosaminylglycopeptide beta-1;4-galactosyltransferase activity|galactosyltransferase activity,,ppi
15816,18905,5498,PPOX,protoporphyrinogen oxidase,18,oxygen-dependent protoporphyrinogen oxidase activity|flavin adenine dinucleotide binding,constipation|polyneuropathy|peripheral nervous system disease|neuropathy|schizophreniform disorder|schizoaffective disorder|variegate porphyria|photosensitivity disease|photosensitive epilepsy,ppi
15817,18906,5499,PPP1CA,protein phosphatase 1 catalytic subunit alpha,401,phosphoprotein phosphatase activity|protein serine/threonine phosphatase activity|phosphatase activity|cadherin binding involved in cell-cell adhesion,,ppi
15818,18907,5500,PPP1CB,protein phosphatase 1 catalytic subunit beta,269,phosphatase activity|myosin phosphatase activity|myosin-light-chain-phosphatase activity,,ppi
15819,18908,5501,PPP1CC,protein phosphatase 1 catalytic subunit gamma,342,RNA binding|phosphoprotein phosphatase activity|protein serine/threonine phosphatase activity|phosphatase activity|protein N-terminus binding,ovarian cancer,ppi
15820,18909,5514,PPP1R10,protein phosphatase 1 regulatory subunit 10,41,RNA binding,,ppi
15821,18910,6992,PPP1R11,protein phosphatase 1 regulatory inhibitor subunit 11,12,ubiquitin protein ligase activity|protein phosphatase 1 binding|protein serine/threonine phosphatase inhibitor activity,,ppi
15822,18911,5502,PPP1R1A,protein phosphatase 1 regulatory inhibitor subunit 1A,11,protein serine/threonine phosphatase inhibitor activity,sick sinus syndrome|congestive heart failure|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|liver cancer|hepatocellular carcinoma,ppi
15823,18912,84152,PPP1R1B,protein phosphatase 1 regulatory inhibitor subunit 1B,11,protein kinase inhibitor activity|cAMP-dependent protein kinase inhibitor activity|protein phosphatase inhibitor activity|protein phosphatase regulator activity,alcohol dependence|alcohol abuse|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|dystonia|schizophrenia,ppi
15824,18913,5504,PPP1R2,protein phosphatase 1 regulatory inhibitor subunit 2,50,protein serine/threonine phosphatase inhibitor activity|protein phosphatase inhibitor activity,,ppi
15825,18914,9331,B4GALT6,beta-1;4-galactosyltransferase 6,4,beta-N-acetylglucosaminylglycopeptide beta-1;4-galactosyltransferase activity|galactosyltransferase activity,,ppi
15826,18915,5506,PPP1R3A,protein phosphatase 1 regulatory subunit 3A,48,,acanthosis nigricans|diabetes mellitus|type 2 diabetes mellitus|hypertrichosis|hyperglycemia|Zollinger-Ellison syndrome|hyperinsulinism|hypertension|essential hypertension|lipoatrophic diabetes|lipodystrophy|liver cirrhosis|pre-eclampsia|gestational diabetes|familial partial lipodystrophy|chorea-acanthocytosis|abetalipoproteinemia|hypolipoproteinemia|Tangier disease|Norum disease,ppi
15827,18916,5507,PPP1R3C,protein phosphatase 1 regulatory subunit 3C,27,protein serine/threonine phosphatase activity|protein phosphatase binding,,ppi
15828,18917,5509,PPP1R3D,protein phosphatase 1 regulatory subunit 3D,10,protein serine/threonine phosphatase activity,,ppi
15829,18918,5510,PPP1R7,protein phosphatase 1 regulatory subunit 7,62,protein phosphatase regulator activity|enzyme regulator activity,,ppi
15830,18919,5511,PPP1R8,protein phosphatase 1 regulatory subunit 8,47,RNA binding|protein serine/threonine phosphatase inhibitor activity|ribonuclease E activity|mRNA binding,,ppi
15831,18920,84687,PPP1R9B,protein phosphatase 1 regulatory subunit 9B,50,protein phosphatase inhibitor activity|protein phosphatase 1 binding|actin filament binding,schizophrenia|sinusitis,ppi
15832,18921,5515,PPP2CA,protein phosphatase 2 catalytic subunit alpha,298,phosphoprotein phosphatase activity|protein serine/threonine phosphatase activity,asthma|intrinsic asthma|allergic asthma|heart disease|cardiovascular system disease|coronary artery disease,ppi
15833,18922,38,ACAT1,acetyl-CoA acetyltransferase 1,74,acetyl-CoA C-acetyltransferase activity|carbon-carbon lyase activity|ligase activity; forming carbon-carbon bonds|acetyl-CoA C-acyltransferase activity,chronic kidney disease|intellectual disability|learning disability|epilepsy|visual epilepsy|beta-ketothiolase deficiency,ppi
15834,18923,11285,B4GALT7,beta-1;4-galactosyltransferase 7,24,beta-N-acetylglucosaminylglycopeptide beta-1;4-galactosyltransferase activity|galactosyltransferase activity|manganese ion binding|xylosylprotein 4-beta-galactosyltransferase activity,aortic valve stenosis|pseudosarcomatous fibromatosis|cryptorchidism|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|enophthalmos|orbital disease|exophthalmos|clubfoot|gingivitis|lipoatrophic diabetes|lipodystrophy|osteochondrodysplasia|multiple epiphyseal dysplasia|mucopolysaccharidosis IV|spermatic cord torsion|humeroradial synostosis,ppi
15835,18924,5516,PPP2CB,protein phosphatase 2 catalytic subunit beta,188,protein serine/threonine phosphatase activity,,ppi
15836,18925,5518,PPP2R1A,protein phosphatase 2 scaffold subunit Aalpha,317,protein phosphatase regulator activity|protein serine/threonine phosphatase activity,epilepsy|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|intellectual disability|learning disability|arthropathy|arthritis|visual epilepsy|stomach cancer,ppi
15837,18926,5519,PPP2R1B,protein phosphatase 2 scaffold subunit Abeta,117,protein phosphatase regulator activity|protein serine/threonine phosphatase activity,lung cancer|bronchiolo-alveolar adenocarcinoma|lung benign neoplasm,ppi
15838,18927,5520,PPP2R2A,protein phosphatase 2 regulatory subunit Balpha,116,protein serine/threonine phosphatase activity|protein phosphatase regulator activity,,ppi
15839,18928,5521,PPP2R2B,protein phosphatase 2 regulatory subunit Bbeta,197,protein serine/threonine phosphatase activity,generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|autosomal dominant cerebellar ataxia|cerebral degeneration|secondary Parkinson disease|facial nerve disease|geniculate ganglionitis|spinocerebellar ataxia type 12,ppi
15840,18929,5522,PPP2R2C,protein phosphatase 2 regulatory subunit Bgamma,51,protein phosphatase regulator activity|protein serine/threonine phosphatase activity,bipolar disorder,ppi
15841,18930,5523,PPP2R3A,protein phosphatase 2 regulatory subunit B''alpha,30,protein phosphatase regulator activity,,ppi
15842,18931,5524,PTPA,protein phosphatase 2 phosphatase activator,67,ATP binding|protein tyrosine phosphatase activator activity|protein phosphatase regulator activity|protein homodimerization activity|protein heterodimerization activity|protein phosphatase 2A binding|ATPase activity|peptidyl-prolyl cis-trans isomerase activity,bipolar disorder|stomach cancer,ppi
15843,18932,5525,PPP2R5A,protein phosphatase 2 regulatory subunit B'alpha,43,phosphoprotein phosphatase activity|protein phosphatase activator activity,,ppi
15844,18933,5526,PPP2R5B,protein phosphatase 2 regulatory subunit B'beta,14,protein phosphatase activator activity,,ppi
15845,18934,5527,PPP2R5C,protein phosphatase 2 regulatory subunit B'gamma,43,protein phosphatase regulator activity|protein phosphatase activator activity,chronic lymphocytic leukemia|Richter's syndrome,ppi
15846,18935,5528,PPP2R5D,protein phosphatase 2 regulatory subunit B'delta,78,phosphoprotein phosphatase activity|protein serine/threonine phosphatase activity|protein phosphatase activator activity,enophthalmos|orbital disease|exophthalmos|epilepsy|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|hypoglycemia|intellectual disability|learning disability|myopia|pyloric stenosis|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
15847,18936,5529,PPP2R5E,protein phosphatase 2 regulatory subunit B'epsilon,67,protein phosphatase activator activity,,ppi
15848,18937,5530,PPP3CA,protein phosphatase 3 catalytic subunit alpha,81,protein serine/threonine phosphatase activity|calcium ion binding|calmodulin binding|drug binding|cyclosporin A binding|enzyme binding|calmodulin-dependent protein phosphatase activity,iron metabolism disease|hemochromatosis|Wilson disease|acute pancreatitis|pancreatitis|prostate cancer|prostate carcinoma|testicular disease|lung cancer|lung adenocarcinoma,ppi
15849,18938,5532,PPP3CB,protein phosphatase 3 catalytic subunit beta,58,protein serine/threonine phosphatase activity|calcium ion binding|calmodulin binding|drug binding|enzyme binding|protein phosphatase 2B binding|calmodulin-dependent protein phosphatase activity,iron metabolism disease|hemochromatosis|Wilson disease,ppi
15850,18939,5533,PPP3CC,protein phosphatase 3 catalytic subunit gamma,40,calmodulin-dependent protein phosphatase activity|calmodulin binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
15851,18940,5534,PPP3R1,protein phosphatase 3 regulatory subunit B; alpha,41,calcium-dependent protein serine/threonine phosphatase activity|calcium ion binding|calmodulin binding|cyclosporin A binding,schizophrenia|coronary artery disease,ppi
15852,18941,5535,PPP3R2,protein phosphatase 3 regulatory subunit B; beta,15,,,ppi
15853,18942,5531,PPP4C,protein phosphatase 4 catalytic subunit,78,NF-kappaB-inducing kinase activity|protein serine/threonine phosphatase activity,,ppi
15854,18943,570,BAAT,bile acid-CoA:amino acid N-acyltransferase,23,N-acyltransferase activity|transferase activity; transferring acyl groups|glycine N-choloyltransferase activity|medium-chain acyl-CoA hydrolase activity|long-chain acyl-CoA hydrolase activity|very long chain acyl-CoA hydrolase activity|acyl-CoA hydrolase activity,osteomalacia|rickets|steatorrhea|vitamin K deficiency hemorrhagic disease,ppi
15855,18944,9989,PPP4R1,protein phosphatase 4 regulatory subunit 1,35,protein phosphatase regulator activity|phosphoprotein phosphatase activity|protein serine/threonine phosphatase activity,,ppi
15856,18945,5536,PPP5C,protein phosphatase 5 catalytic subunit,114,phosphoprotein phosphatase activity|protein serine/threonine phosphatase activity|ATP binding|phosphatase activity|ADP binding,,ppi
15857,18946,5537,PPP6C,protein phosphatase 6 catalytic subunit,61,protein serine/threonine phosphatase activity,basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|melanoma|skin melanoma,ppi
15858,18947,5538,PPT1,palmitoyl-protein thioesterase 1,41,palmitoyl-(protein) hydrolase activity|palmitoyl-CoA hydrolase activity,cerebellar disease|pseudosarcomatous fibromatosis|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|epilepsy|retinitis pigmentosa 30|age related macular degeneration|macular degeneration|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|optic atrophy|retinal degeneration,ppi
15859,18948,9374,PPT2,palmitoyl-protein thioesterase 2,34,thiolester hydrolase activity|palmitoyl hydrolase activity,,ppi
15860,18949,5539,PPY,pancreatic polypeptide,1,hormone activity|neuropeptide hormone activity|G-protein coupled receptor binding,,ppi
15861,18950,5540,NPY4R,neuropeptide Y receptor Y4,4,pancreatic polypeptide receptor activity|G-protein coupled receptor activity,,ppi
15862,18951,23621,BACE1,beta-secretase 1,30,aspartic-type endopeptidase activity|peptidase activity|beta-aspartyl-peptidase activity|amyloid-beta binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|schizophrenia,ppi
15863,18952,10084,PQBP1,polyglutamine binding protein 1,55,DNA binding|double-stranded DNA binding|transcription coactivator activity|ribonucleoprotein complex binding,imperforate anus|generalized anxiety disorder|anxiety disorder|isolated cleft palate|cleft palate|coloboma|sensorineural hearing loss|epilepsy|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect,ppi
15864,18953,23532,PRAME,preferentially expressed antigen in melanoma,51,retinoic acid receptor binding,lung cancer|non-small cell lung carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|head and neck cancer|leukemia|chronic myeloid leukemia|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|melanoma|skin melanoma|multiple myeloma,ppi
15865,18954,5542,PRB1,proline rich protein BstNI subfamily 1,4,,,ppi
15866,18955,653247,PRB2,proline rich protein BstNI subfamily 2,1,,,ppi
15867,18956,5544,PRB3,proline rich protein BstNI subfamily 3,1,,,ppi
15868,18957,25825,BACE2,beta-site APP-cleaving enzyme 2,16,aspartic-type endopeptidase activity|amyloid-beta binding,,ppi
15869,18958,5545,PRB4,proline rich protein BstNI subfamily 4,1,,,ppi
15870,18959,9055,PRC1,protein regulator of cytokinesis 1,28,,IgA glomerulonephritis|breast cancer,ppi
15871,18960,5546,PRCC,papillary renal cell carcinoma (translocation-associated),33,,papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|papillary adenocarcinoma|papillary thyroid carcinoma,ppi
15872,18961,5547,PRCP,prolylcarboxypeptidase,26,serine-type carboxypeptidase activity|dipeptidyl-peptidase activity,,ppi
15873,18962,639,PRDM1,PR/SET domain 1,36,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|promoter-specific chromatin binding|sequence-specific DNA binding|histone deacetylase binding|RNA polymerase II regulatory region sequence-specific DNA binding|chromatin DNA binding,rheumatoid arthritis|inflammatory bowel disease|ulcerative colitis|systemic lupus erythematosus|Sjogren's syndrome|keratoconjunctivitis sicca,ppi
15874,18963,7799,PRDM2,PR/SET domain 2,14,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|zinc ion binding|chromatin DNA binding|sequence-specific DNA binding,urinary bladder cancer|thyroid cancer|thyroid adenoma|thyroid carcinoma,ppi
15875,18964,11108,PRDM4,PR/SET domain 4,9,DNA-binding transcription factor activity; RNA polymerase II-specific|zinc ion binding|histone methyltransferase binding|sequence-specific DNA binding|chromatin DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
15876,18965,11107,PRDM5,PR/SET domain 5,40,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|sequence-specific DNA binding|transcription regulatory region DNA binding|repressing transcription factor binding|RNA polymerase II regulatory region sequence-specific DNA binding|chromatin DNA binding,corneal dystrophy|sensorineural hearing loss|corneal disease|keratoconus|myopia|osteoporosis|fibromyalgia|myositis|brittle cornea syndrome,ppi
15877,18966,571,BACH1,BTB domain and CNC homolog 1,63,DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|heme binding,,ppi
15878,18967,93166,PRDM6,PR/SET domain 6,11,DNA-binding transcription factor activity; RNA polymerase II-specific|chromatin DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|sequence-specific DNA binding,,ppi
15879,18968,11105,PRDM7,PR/SET domain 7,1,DNA-binding transcription factor activity; RNA polymerase II-specific|histone methyltransferase activity (H3-K4 specific)|chromatin DNA binding|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
15880,18969,5052,PRDX1,peroxiredoxin 1,164,RNA binding|peroxidase activity|thioredoxin peroxidase activity|cadherin binding,asbestosis|anthracosilicosis|byssinosis|lung cancer|non-small cell lung carcinoma|lung benign neoplasm|enterobiasis|trichinosis|esophagus squamous cell carcinoma,ppi
15881,18970,7001,PRDX2,peroxiredoxin 2,115,thioredoxin peroxidase activity|antioxidant activity,asbestosis|anthracosilicosis|byssinosis|Down syndrome|esophageal cancer|lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia|melanoma|skin melanoma|osteosarcoma|bone osteosarcoma|prostate cancer|prostate carcinoma|liver cancer|hepatocellular carcinoma,ppi
15882,18971,10935,PRDX3,peroxiredoxin 3,82,thioredoxin peroxidase activity|alkyl hydroperoxide reductase activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process,osteoporosis|anterior horn cell disease|amyotrophic lateral sclerosis type 1|amyotrophic lateral sclerosis type 2|amyotrophic lateral sclerosis type 4|lateral sclerosis|motor neuron disease,ppi
15883,18972,25824,PRDX5,peroxiredoxin 5,77,RNA polymerase III regulatory region DNA binding|peroxidase activity|thioredoxin peroxidase activity|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|protein dimerization activity,alopecia areata|stomach cancer,ppi
15884,18973,10113,PREB,prolactin regulatory element binding,18,guanyl-nucleotide exchange factor activity|Sar guanyl-nucleotide exchange factor activity|GTPase activator activity|GTPase binding,,ppi
15885,18974,5549,PRELP,proline and arginine rich end leucine rich repeat protein,16,extracellular matrix structural constituent|extracellular matrix structural constituent conferring compression resistance|heparin binding,,ppi
15886,18975,5550,PREP,prolyl endopeptidase,38,serine-type peptidase activity|endopeptidase activity|oligopeptidase activity,amnestic disorder|dissociative amnesia|retrograde amnesia|bipolar disorder|stomach cancer,ppi
15887,18977,572,BAD,BCL2 associated agonist of cell death,61,phospholipid binding|lipid binding|cysteine-type endopeptidase activator activity involved in apoptotic process|protein kinase binding|protein phosphatase binding,vertebrobasilar insufficiency|transient cerebral ischemia|leukemia|prostate cancer|prostate carcinoma,ppi
15888,18978,5551,PRF1,perforin 1,7,calcium ion binding|wide pore channel activity,anemia|macrocytic anemia|aplastic anemia|autistic disorder|cerebellar disease|myelitis|encephalomyelitis|encephalitis|epilepsy|hemiplegia|lymphoplasmacytic lymphoma|macroglobulinemia|leukopenia|lymphosarcoma|lymphoma|central nervous system lymphoma|Langerhans-cell histiocytosis|reticulosarcoma|non-Hodgkin lymphoma|B-cell lymphoma,ppi
15889,18979,5552,SRGN,serglycin,18,,,ppi
15890,18980,5553,PRG2,proteoglycan 2; pro eosinophil major basic protein,66,,,ppi
15891,18981,10394,PRG3,proteoglycan 3; pro eosinophil major basic protein 2,31,,,ppi
15892,18982,10216,PRG4,proteoglycan 4,2,extracellular matrix structural constituent conferring compression resistance,arthropathy|arthritis|pseudosarcomatous fibromatosis|neurogenic arthropathy|pericarditis|constrictive pericarditis|synovitis,ppi
15893,18983,5554,PRH1,proline rich protein HaeIII subfamily 1,4,,,ppi
15894,18985,5557,PRIM1,primase (DNA) subunit 1,31,single-stranded DNA binding|DNA primase activity,,ppi
15895,18986,573,BAG1,BCL2 associated athanogene 1,94,adenyl-nucleotide exchange factor activity,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|schizophrenia|invasive ductal carcinoma|breast cancer,ppi
15896,18987,5558,PRIM2,primase (DNA) subunit 2,32,DNA primase activity|single-stranded DNA binding,,ppi
15897,18988,5562,PRKAA1,protein kinase AMP-activated catalytic subunit alpha 1,287,chromatin binding|protein kinase activity|AMP-activated protein kinase activity|cAMP-dependent protein kinase activity|histone serine kinase activity|protein serine/threonine kinase activity,stomach cancer|glucose intolerance|prediabetes syndrome,ppi
15898,18989,5563,PRKAA2,protein kinase AMP-activated catalytic subunit alpha 2,92,chromatin binding|protein kinase activity|protein serine/threonine kinase activity|AMP-activated protein kinase activity|protein serine/threonine/tyrosine kinase activity|histone serine kinase activity,cerebral infarction|cerebrovascular disease|glucose intolerance|prediabetes syndrome|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
15899,18990,5564,PRKAB1,protein kinase AMP-activated non-catalytic subunit beta 1,188,protein kinase activity|protein kinase binding|AMP-activated protein kinase activity,stomach cancer,ppi
15900,18991,5565,PRKAB2,protein kinase AMP-activated non-catalytic subunit beta 2,99,AMP-activated protein kinase activity|protein kinase binding,,ppi
15901,18992,9532,BAG2,BCL2 associated athanogene 2,188,adenyl-nucleotide exchange factor activity,,ppi
15902,18993,5566,PRKACA,protein kinase cAMP-activated catalytic subunit alpha,332,protein kinase activity|protein serine/threonine kinase activity|cAMP-dependent protein kinase activity|protein serine/threonine/tyrosine kinase activity|ubiquitin protein ligase binding,adrenal gland cancer|alopecia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetic ketoacidosis|diabetes mellitus|hypertrichosis|hypertension|essential hypertension|hypogonadism|osteoporosis|bile duct carcinoma|bile duct adenocarcinoma|intrahepatic cholangiocarcinoma|cholangiocarcinoma|muscular atrophy,ppi
15903,18994,5567,PRKACB,protein kinase cAMP-activated catalytic subunit beta,161,magnesium ion binding|protein serine/threonine kinase activity|cAMP-dependent protein kinase activity|ATP binding|kinase activity|ubiquitin protein ligase binding,biliary tract cancer|prostate cancer|prostate carcinoma|bile duct carcinoma|bile duct adenocarcinoma|intrahepatic cholangiocarcinoma|cholangiocarcinoma,ppi
15904,18995,5568,PRKACG,protein kinase cAMP-activated catalytic subunit gamma,25,protein serine/threonine kinase activity|cAMP-dependent protein kinase activity,anemia|macrocytic anemia,ppi
15905,18996,5571,PRKAG1,protein kinase AMP-activated non-catalytic subunit gamma 1,66,protein kinase activity|cAMP-dependent protein kinase activity|ATP binding|cAMP-dependent protein kinase regulator activity|AMP binding|protein kinase binding|ADP binding|AMP-activated protein kinase activity,,ppi
15906,18997,51422,PRKAG2,protein kinase AMP-activated non-catalytic subunit gamma 2,30,cAMP-dependent protein kinase inhibitor activity|ATP binding|cAMP-dependent protein kinase regulator activity|phosphorylase kinase regulator activity|protein kinase binding|protein kinase activator activity|ADP binding,atrial fibrillation|atrioventricular block|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|congestive heart failure|left bundle branch hemiblock|pulmonary edema|cerebral infarction|cerebrovascular disease|Lown-Ganong-Levine syndrome|Wolff-Parkinson-White syndrome|hypertrophic cardiomyopathy 1|hypertrophic cardiomyopathy 6,ppi
15907,18998,53632,PRKAG3,protein kinase AMP-activated non-catalytic subunit gamma 3,12,protein kinase binding,carbohydrate metabolic disorder|lipid metabolism disorder,ppi
15908,18999,5573,PRKAR1A,protein kinase cAMP-dependent type I regulatory subunit alpha,121,cAMP-dependent protein kinase inhibitor activity|cAMP-dependent protein kinase regulator activity|ubiquitin protein ligase binding|3';5'-cyclic-GMP phosphodiesterase activity,hyperpituitarism|acromegaly|generalized anxiety disorder|anxiety disorder|autistic disorder|congenital hypothyroidism|myxedema|hypothyroidism|cryptorchidism|Cushing's syndrome|adrenal gland hyperfunction|sensorineural hearing loss|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetic ketoacidosis|diabetes mellitus,ppi
15909,19000,9531,BAG3,BCL2 associated athanogene 3,467,adenyl-nucleotide exchange factor activity|cadherin binding,alcohol dependence|alcohol abuse|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q,ppi
15910,19001,5575,PRKAR1B,protein kinase cAMP-dependent type I regulatory subunit beta,38,cAMP-dependent protein kinase inhibitor activity|cAMP-dependent protein kinase regulator activity|3';5'-cyclic-GMP phosphodiesterase activity,,ppi
15911,19002,5576,PRKAR2A,protein kinase cAMP-dependent type II regulatory subunit alpha,72,cAMP-dependent protein kinase inhibitor activity|cAMP-dependent protein kinase regulator activity|ubiquitin protein ligase binding|3';5'-cyclic-GMP phosphodiesterase activity,,ppi
15912,19003,5577,PRKAR2B,protein kinase cAMP-dependent type II regulatory subunit beta,65,cAMP-dependent protein kinase inhibitor activity|cAMP-dependent protein kinase regulator activity|ubiquitin protein ligase binding|3';5'-cyclic-GMP phosphodiesterase activity,congestive heart failure|obesity,ppi
15913,19004,5578,PRKCA,protein kinase C alpha,274,protein kinase activity|protein serine/threonine kinase activity|protein kinase C activity|calcium-dependent protein kinase C activity|integrin binding|enzyme binding|histone kinase activity (H3-T6 specific),intestinal cancer|intestinal benign neoplasm|schizophreniform disorder|schizoaffective disorder|schizophrenia|nephrogenic diabetes insipidus,ppi
15914,19005,9463,PICK1,protein interacting with PRKCA 1,86,G-protein coupled receptor binding|protein kinase C binding|signaling receptor binding|protein domain specific binding|identical protein binding|actin filament binding|Arp2/3 complex binding|phospholipid binding,drug psychosis|schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
15915,19006,5579,PRKCB,protein kinase C beta,102,chromatin binding|protein serine/threonine kinase activity|protein kinase C activity|calcium-dependent protein kinase C activity|nuclear receptor transcription coactivator activity|histone kinase activity (H3-T6 specific)|histone binding|androgen receptor binding,autistic disorder|large intestine cancer|colorectal cancer|diabetes mellitus|type 2 diabetes mellitus|hyperglycemia|adult T-cell leukemia|acute T cell leukemia|stomach cancer|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
15916,19007,23613,ZMYND8,zinc finger MYND-type containing 8,59,transcription corepressor activity|methylated histone binding|repressing transcription factor binding|lysine-acetylated histone binding,,ppi
15917,19008,10215,OLIG2,oligodendrocyte lineage transcription factor 2,7,DNA-binding transcription factor activity; RNA polymerase II-specific,schizophreniform disorder|schizoaffective disorder|schizophrenia,ppi
15918,19009,5580,PRKCD,protein kinase C delta,221,protein kinase activity|protein serine/threonine kinase activity|protein kinase C activity|calcium-independent protein kinase C activity|enzyme activator activity|enzyme binding|insulin receptor substrate binding,hemolytic anemia|imperforate anus|bronchiectasis|common variable immunodeficiency|membranous glomerulonephritis|hypertension|essential hypertension|primary immunodeficiency disease|intestinal cancer|intestinal benign neoplasm|lymphopenia|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|pneumonia|purpura|epilepsy|visual epilepsy|agammaglobulinemia|liver disease,ppi
15919,19010,39,ACAT2,acetyl-CoA acetyltransferase 2,53,acetyl-CoA C-acetyltransferase activity|3-hydroxyacyl-CoA dehydrogenase activity|enoyl-CoA hydratase activity|acetyl-CoA C-acyltransferase activity,syndromic X-linked intellectual disability type 10|choreatic disease,ppi
15920,19011,9530,BAG4,BCL2 associated athanogene 4,92,adenyl-nucleotide exchange factor activity|RNA binding,,ppi
15921,19012,112464,PRKCDBP,protein kinase C delta binding protein,42,protein kinase C binding,,ppi
15922,19013,5581,PRKCE,protein kinase C epsilon,74,actin monomer binding|protein serine/threonine kinase activity|protein kinase C activity|enzyme activator activity|enzyme binding,large intestine cancer|colorectal cancer|liver cancer|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|polyneuropathy|peripheral nervous system disease|neuropathy|coronary artery disease|substance abuse|substance-related disorder|coronary stenosis|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis,ppi
15923,19014,5582,PRKCG,protein kinase C gamma,67,protein kinase activity|protein kinase C activity|calcium-dependent protein kinase C activity|protein serine/threonine/tyrosine kinase activity|protein serine/threonine kinase activity,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|trigeminal neuralgia|autosomal dominant cerebellar ataxia|amnestic disorder|retrograde amnesia|facial nerve disease|geniculate ganglionitis|focal hand dystonia|dystonia|generalized dystonia|attention deficit hyperactivity disorder,ppi
15924,19015,5583,PRKCH,protein kinase C eta,20,protein kinase C activity|protein serine/threonine kinase activity,cerebral artery occlusion|brain stem infarction|cerebral infarction|cerebrovascular disease|obesity|substance abuse|substance-related disorder,ppi
15925,19016,5584,PRKCI,protein kinase C iota,103,protein kinase activity|protein serine/threonine kinase activity|protein kinase C activity|ATP binding|phospholipid binding,bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder,ppi
15926,19017,5585,PKN1,protein kinase N1,69,chromatin binding|protein kinase activity|protein serine/threonine kinase activity|GTP-Rho binding|nuclear receptor transcription coactivator activity|histone kinase activity (H3-T11 specific)|histone binding|histone deacetylase binding|Rac GTPase binding|androgen receptor binding,,ppi
15927,19018,5586,PKN2,protein kinase N2,89,RNA binding|protein kinase activity|protein serine/threonine kinase activity|kinase activity|histone deacetylase binding|cadherin binding,,ppi
15928,19019,5587,PRKD1,protein kinase D1,45,protein serine/threonine kinase activity|protein kinase C activity|kinase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|large intestine cancer|colorectal cancer,ppi
15929,19020,23683,PRKD3,protein kinase D3,16,protein serine/threonine kinase activity|kinase activity,,ppi
15930,19021,9529,BAG5,BCL2 associated athanogene 5,60,adenyl-nucleotide exchange factor activity|ubiquitin protein ligase binding,,ppi
15931,19022,5588,PRKCQ,protein kinase C theta,49,protein kinase activity|protein serine/threonine kinase activity,rheumatoid arthritis|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21,ppi
15932,19023,5589,PRKCSH,protein kinase C substrate 80K-H,67,,heart disease|cardiovascular system disease|cystic kidney disease|Meckel syndrome|autosomal dominant polycystic kidney disease|polycystic liver disease|non-congenital cyst of kidney,ppi
15933,19024,5590,PRKCZ,protein kinase C zeta,121,protein kinase activity|protein serine/threonine kinase activity|protein kinase C activity|insulin receptor substrate binding,bipolar disorder|leukemia|prostate cancer|prostate carcinoma,ppi
15934,19025,5591,PRKDC,protein kinase; DNA-activated; catalytic polypeptide,327,double-stranded DNA binding|RNA binding|protein kinase activity|protein serine/threonine kinase activity|DNA-dependent protein kinase activity,tongue squamous cell carcinoma|squamous cell carcinoma|salivary gland adenoid cystic carcinoma|hepatic coma|hepatic encephalopathy|lung disease|prostate cancer|prostate carcinoma|aphthous stomatitis|adenosine deaminase deficiency|MHC class II deficiency|severe combined immunodeficiency,ppi
15935,19026,5592,PRKG1,protein kinase; cGMP-dependent; type I,28,protein kinase activity|protein serine/threonine kinase activity|cGMP-dependent protein kinase activity|calcium channel regulator activity,aortic valve insufficiency|hypertension|essential hypertension|primary pulmonary hypertension|pulmonary hypertension|congestive heart failure|Sezary's disease|thoracic aortic aneurysm|Loeys-Dietz syndrome|coronary artery disease,ppi
15936,19027,5593,PRKG2,protein kinase; cGMP-dependent; type II,12,protein kinase activity|cGMP-dependent protein kinase activity,,ppi
15937,19029,575,ADGRB1,adhesion G protein-coupled receptor B1,20,lipopolysaccharide binding|phosphatidylserine binding|G-protein coupled receptor activity,,ppi
15938,19030,5610,EIF2AK2,eukaryotic translation initiation factor 2 alpha kinase 2,242,RNA binding|double-stranded RNA binding|protein kinase activity|protein serine/threonine kinase activity|eukaryotic translation initiation factor 2alpha kinase activity|protein phosphatase regulator activity,influenza|prostate cancer|prostate carcinoma|status epilepticus,ppi
15939,19031,8575,PRKRA,protein activator of interferon induced protein kinase EIF2AK2,64,RNA binding|double-stranded RNA binding|pre-miRNA binding,dystonia|secondary Parkinson disease|focal hand dystonia|generalized dystonia|intellectual disability|learning disability,ppi
15940,19032,5611,DNAJC3,DnaJ heat shock protein family (Hsp40) member C3,20,protein kinase inhibitor activity|protein kinase binding|misfolded protein binding|unfolded protein binding|chaperone binding,diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6|type 1 diabetes mellitus 7|type 1 diabetes mellitus 8|obsolete obsolete type 1 diabetes mellitus 9|type 1 diabetes mellitus 10|type 1 diabetes mellitus 11|type 1 diabetes mellitus 12|type 1 diabetes mellitus 13|type 1 diabetes mellitus 15|type 1 diabetes mellitus 17|type 1 diabetes mellitus 18|type 1 diabetes mellitus 19|type 1 diabetes mellitus 20|type 1 diabetes mellitus 21|type 1 diabetes mellitus 22,ppi
15941,19033,576,ADGRB2,adhesion G protein-coupled receptor B2,9,G-protein coupled receptor activity,,ppi
15942,19034,5612,THAP12,THAP domain containing 12,25,DNA-binding transcription factor activity; RNA polymerase II-specific,,ppi
15943,19035,5613,PRKX,protein kinase; X-linked,12,cAMP-dependent protein kinase activity,,ppi
15944,19036,5617,PRL,prolactin,4,prolactin receptor binding|hormone activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|amenorrhea|anemia|macrocytic anemia|autistic disorder|basal ganglia disease|endometriosis of uterus|endometriosis|hypertrophy of breast|infant gynecomastia|gynecomastia|congestive heart failure|hyperprolactinemia,ppi
15945,19037,5618,PRLR,prolactin receptor,21,prolactin receptor activity|protein homodimerization activity|ornithine decarboxylase activator activity|peptide hormone binding|cytokine binding|cytokine receptor activity,autistic disorder|endometriosis of uterus|endometriosis|hyperprolactinemia|infertility,ppi
15946,19038,5619,PRM1,protamine 1,2,,,ppi
15947,19039,5620,PRM2,protamine 2,4,zinc ion binding|cadmium ion binding,,ppi
15948,19040,5621,PRNP,prion protein,88,amyloid-beta binding|protease binding|copper ion binding|glycosaminoglycan binding|microtubule binding|tubulin binding|type 5 metabotropic glutamate receptor binding|signaling receptor activity|identical protein binding|protein-containing complex binding|cuprous ion binding|type 8 metabotropic glutamate receptor binding|cupric ion binding|ion channel binding|lamin binding|chaperone binding|protein binding|ATP-dependent protein binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|generalized anxiety disorder|anxiety disorder|agnosia|cerebellar disease|syndromic X-linked intellectual disability type 10,ppi
15949,19041,577,ADGRB3,adhesion G protein-coupled receptor B3,4,GTPase activator activity|G-protein coupled receptor activity,,ppi
15950,19042,5624,PROC,protein C; inactivator of coagulation factors Va and VIIIa,19,serine-type endopeptidase activity,aortitis|vasculitis|purpura fulminans|disseminated intravascular coagulation|epilepsy|microphthalmia|eye disease|hypertension|essential hypertension|pulmonary embolism|purpura|visual epilepsy|thrombophilia|protein S deficiency|antithrombin III deficiency|protein C deficiency,ppi
15951,19043,10544,PROCR,protein C receptor,23,,,ppi
15952,19044,5625,PRODH,proline dehydrogenase 1,7,proline dehydrogenase activity|FAD binding,amino acid metabolic disorder|bipolar disorder|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|intellectual disability|learning disability|central nervous system disease|nervous system disease|autonomic neuropathy|proteinuria|schizophrenia|status epilepticus|stereotypic movement disorder,ppi
15953,19045,8842,PROM1,prominin 1,5,actinin binding|cholesterol binding,choroid disease|colon cancer|colonic benign neoplasm|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|large intestine cancer|colorectal cancer|glaucoma|glioblastoma multiforme|giant cell glioblastoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus,ppi
15954,19046,5626,PROP1,PROP paired-like homeobox 1,13,DNA-binding transcription factor activity; RNA polymerase II-specific,adrenal cortical hypofunction|Addison's disease|constipation|umbilical hernia|omphalocele|hypoglycemia|hypogonadism|congenital hypothyroidism|myxedema|hypothyroidism|infertility|intellectual disability|learning disability|isolated growth hormone deficiency|isolated growth hormone deficiency type II|isolated growth hormone deficiency type IA|isolated growth hormone deficiency type IB|isolated growth hormone deficiency type III|Kallmann syndrome|hypopituitarism,ppi
15955,19047,5627,PROS1,protein S (alpha),16,endopeptidase inhibitor activity,purpura fulminans|disseminated intravascular coagulation|pulmonary embolism|purpura|adult respiratory distress syndrome|newborn respiratory distress syndrome|retinitis|retinal disease|thrombophlebitis|thrombophilia|protein S deficiency|antithrombin III deficiency|protein C deficiency|sagittal sinus thrombosis,ppi
15956,19048,11212,PROSC,proline synthetase cotranscribed homolog (bacterial),59,pyridoxal phosphate binding,,ppi
15957,19049,5629,PROX1,prospero homeobox 1,21,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription corepressor activity|transcription regulatory region DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific,diabetes mellitus|type 2 diabetes mellitus,ppi
15958,19050,9223,MAGI1,membrane associated guanylate kinase; WW and PDZ domain containing 1,42,protein C-terminus binding,bipolar disorder|salivary gland adenoid cystic carcinoma|schizophrenia,ppi
15959,19051,8858,PROZ,protein Z; vitamin K dependent plasma glycoprotein,32,,,ppi
15960,19052,5630,PRPH,peripherin,26,,progressive muscular atrophy|amyotrophic lateral sclerosis|generalized anxiety disorder|anxiety disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|muscular atrophy|neurodegenerative disease|amyotrophic lateral sclerosis type 1,ppi
15961,19053,5631,PRPS1,phosphoribosyl pyrophosphate synthetase 1,54,ribose phosphate diphosphokinase activity|ATP binding,gout|cerebellar disease|sensorineural hearing loss|epilepsy|primary immunodeficiency disease|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|optic atrophy|polyneuropathy|peripheral nervous system disease|neuropathy|locked-in syndrome|quadriplegia|kidney failure|uremia|visual epilepsy,ppi
15962,19054,221823,PRPS1L1,phosphoribosyl pyrophosphate synthetase 1-like 1,8,ribose phosphate diphosphokinase activity|ATP binding|protein homodimerization activity,,ppi
15963,19055,5634,PRPS2,phosphoribosyl pyrophosphate synthetase 2,25,ribose phosphate diphosphokinase activity|ATP binding|protein homodimerization activity,,ppi
15964,19056,5635,PRPSAP1,phosphoribosyl pyrophosphate synthetase associated protein 1,32,enzyme inhibitor activity|enzyme regulator activity,,ppi
15965,19057,5636,PRPSAP2,phosphoribosyl pyrophosphate synthetase associated protein 2,32,enzyme inhibitor activity|enzyme regulator activity,,ppi
15966,19058,5638,PRRG1,proline rich and Gla domain 1,4,,,ppi
15967,19059,10458,BAIAP2,BAI1 associated protein 2,72,protein C-terminus binding|proline-rich region binding|cadherin binding involved in cell-cell adhesion,,ppi
15968,19060,5639,PRRG2,proline rich and Gla domain 2,5,,,ppi
15969,19061,5641,LGMN,legumain,22,cysteine-type endopeptidase activity|peptidase activity,,ppi
15970,19062,5644,PRSS1,protease; serine 1,28,serine-type endopeptidase activity|serine-type peptidase activity,diabetic ketoacidosis|diabetes mellitus|lymphoplasmacytic lymphoma|macroglobulinemia|acute pancreatitis|pancreatitis|steatorrhea|exocrine pancreatic insufficiency,ppi
15971,19063,5654,HTRA1,HtrA serine peptidase 1,31,serine-type endopeptidase activity|serine-type peptidase activity,alopecia|cerebellar disease|basal ganglia disease|focal hand dystonia|blepharospasm|vertebrobasilar insufficiency|transient cerebral ischemia|age related macular degeneration 7,ppi
15972,19064,8492,PRSS12,protease; serine 12,4,serine-type peptidase activity,intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|ophthalmoplegia|mechanical strabismus|hypertropia|autosomal recessive non-syndromic intellectual disability,ppi
15973,19065,9361,LONP1,lon peptidase 1; mitochondrial,69,mitochondrial promoter sequence-specific DNA binding|single-stranded RNA binding|ATP-dependent peptidase activity|ATP binding|ADP binding|sequence-specific DNA binding|G-quadruplex DNA binding|single-stranded DNA binding,ptosis|congenital ptosis|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38,ppi
15974,19066,8938,BAIAP3,BAI1 associated protein 3,2,SNARE binding|calcium ion binding|phospholipid binding,,ppi
15975,19067,10279,PRSS16,protease; serine 16,2,serine-type peptidase activity|dipeptidyl-peptidase activity,schizophrenia,ppi
15976,19068,5645,PRSS2,protease; serine 2,17,metalloendopeptidase activity|serine-type endopeptidase activity|calcium ion binding|serine-type peptidase activity,,ppi
15977,19069,10942,PRSS21,protease; serine 21,8,serine-type peptidase activity|serine-type endopeptidase activity,,ppi
15978,19070,5646,PRSS3,protease; serine 3,33,serine-type endopeptidase activity|calcium ion binding|serine-type peptidase activity,urinary bladder cancer,ppi
15979,19071,578,BAK1,BCL2 antagonist/killer 1,37,protein homodimerization activity|protein heterodimerization activity,colon cancer|colonic benign neoplasm,ppi
15980,19072,5651,TMPRSS15,transmembrane protease; serine 15,3,,lymphoplasmacytic lymphoma|macroglobulinemia,ppi
15981,19073,5652,PRSS8,protease; serine 8,1,endopeptidase activity|serine-type peptidase activity|sodium channel regulator activity,placenta disease|prostate cancer|prostate carcinoma|seborrheic keratosis|skin disease|actinic keratosis,ppi
15982,19074,5657,PRTN3,proteinase 3,17,serine-type endopeptidase activity|serine-type peptidase activity,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|brain ischemia|exanthem|chronic myeloid leukemia|chronic obstructive pulmonary disease|lower respiratory tract disease|paranasal sinus disease|nasal cavity disease|upper respiratory tract disease|proteinuria|postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|sinusitis|vasculitis|transient cerebral ischemia|Wegener's granulomatosis|Takayasu's arteritis|Goodpasture syndrome,ppi
15983,19075,5660,PSAP,prosaposin,49,beta-galactosidase activity|phospholipid binding|enzyme activator activity|lipid binding|protein homodimerization activity|ganglioside GM1 binding|ganglioside GM2 binding|ganglioside GM3 binding|ganglioside GT1b binding|ganglioside GP1c binding,anemia|macrocytic anemia|dystonia|epilepsy|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|polyneuropathy|peripheral nervous system disease|neuropathy|visual epilepsy|thrombocytopenia|meningoencephalitis|critical illness polyneuropathy|inflammatory and toxic neuropathy|metachromatic leukodystrophy|central sleep apnea|Krabbe disease|Gaucher's disease,ppi
15984,19076,9197,SLC33A1,solute carrier family 33 member 1,62,acetyl-CoA transmembrane transporter activity|solute:proton symporter activity,cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38|cataract 26 multiple types|cataract 30,ppi
15985,19077,8314,BAP1,BRCA1 associated protein 1,79,chromatin binding|thiol-dependent ubiquitin-specific protease activity|peptidase activity|thiol-dependent ubiquitinyl hydrolase activity,urinary bladder cancer|bone cancer|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|colon cancer|colonic benign neoplasm|head and neck cancer|kidney cancer|leukemia|pleomorphic lipoma|lipoma,ppi
15986,19078,8000,PSCA,prostate stem cell antigen,2,,urinary bladder cancer|duodenal ulcer|linitis plastica|prostate cancer|prostate carcinoma|stomach cancer,ppi
15987,19079,9267,CYTH1,cytohesin 1,20,ARF guanyl-nucleotide exchange factor activity,,ppi
15988,19080,9266,CYTH2,cytohesin 2,29,ARF guanyl-nucleotide exchange factor activity|inositol 1;4;5 trisphosphate binding,,ppi
15989,19081,9265,CYTH3,cytohesin 3,16,ARF guanyl-nucleotide exchange factor activity|phosphatidylinositol-3;4;5-trisphosphate binding,,ppi
15990,19082,27128,CYTH4,cytohesin 4,9,ARF guanyl-nucleotide exchange factor activity,,ppi
15991,19083,9595,CYTIP,cytohesin 1 interacting protein,8,,,ppi
15992,19084,5662,PSD,pleckstrin and Sec7 domain containing,10,ARF guanyl-nucleotide exchange factor activity,schizophrenia,ppi
15993,19085,5663,PSEN1,presenilin 1,117,endopeptidase activity|aspartic-type endopeptidase activity|calcium channel activity|aspartic endopeptidase activity; intramembrane cleaving|cadherin binding|beta-catenin binding,alexia|dyslexia|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|amyloidosis|progressive muscular atrophy|amyotrophic lateral sclerosis,ppi
15994,19086,5664,PSEN2,presenilin 2,74,aspartic-type endopeptidase activity|endopeptidase activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|asphyxia neonatorum|bipolar disorder|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D,ppi
15995,19087,579,NKX3-2,NK3 homeobox 2,6,DNA-binding transcription factor activity; RNA polymerase II-specific,pseudosarcomatous fibromatosis|osteogenesis imperfecta|Ehlers-Danlos syndrome,ppi
15996,19088,5669,PSG1,pregnancy specific beta-1-glycoprotein 1,47,,,ppi
15997,19089,5680,PSG11,pregnancy specific beta-1-glycoprotein 11,4,,,ppi
15998,19090,5670,PSG2,pregnancy specific beta-1-glycoprotein 2,2,,,ppi
15999,19091,580,BARD1,BRCA1 associated RING domain 1,274,RNA binding|ubiquitin-protein transferase activity|kinase binding,neuroblastoma|hereditary breast ovarian cancer syndrome|breast cancer,ppi
16000,19092,5671,PSG3,pregnancy specific beta-1-glycoprotein 3,11,,,ppi
16001,19093,5672,PSG4,pregnancy specific beta-1-glycoprotein 4,7,,,ppi
16002,19094,5673,PSG5,pregnancy specific beta-1-glycoprotein 5,4,,rheumatoid arthritis,ppi
16003,19095,5675,PSG6,pregnancy specific beta-1-glycoprotein 6,1,,,ppi
16004,19097,440533,PSG8,pregnancy specific beta-1-glycoprotein 8,37,,,ppi
16005,19098,5678,PSG9,pregnancy specific beta-1-glycoprotein 9,20,,,ppi
16006,19099,11168,PSIP1,PC4 and SFRS1 interacting protein 1,54,RNA binding|supercoiled DNA binding,acute myeloid leukemia,ppi
16007,19100,5681,PSKH1,protein serine kinase H1,7,,,ppi
16008,19101,56751,BARHL1,BarH like homeobox 1,3,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding,,ppi
16009,19102,5682,PSMA1,proteasome subunit alpha 1,208,RNA binding|endopeptidase activity,,ppi
16010,19103,5683,PSMA2,proteasome subunit alpha 2,145,endopeptidase activity,heart disease|cardiovascular system disease|osteoporosis,ppi
16011,19104,5684,PSMA3,proteasome subunit alpha 3,285,endopeptidase activity,,ppi
16012,19105,5685,PSMA4,proteasome subunit alpha 4,113,endopeptidase activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|liver cancer|adult respiratory distress syndrome|newborn respiratory distress syndrome,ppi
16013,19106,5686,PSMA5,proteasome subunit alpha 5,142,endopeptidase activity,fatty liver disease|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|osteoporosis,ppi
16014,19107,5687,PSMA6,proteasome subunit alpha 6,165,RNA binding|endopeptidase activity|purine ribonucleoside triphosphate binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction,ppi
16015,19108,5688,PSMA7,proteasome subunit alpha 7,132,endopeptidase activity,,ppi
16016,19109,5689,PSMB1,proteasome subunit beta 1,147,endopeptidase activity,arthropathy|arthritis|polyneuropathy|peripheral nervous system disease|neuropathy,ppi
16017,19110,5699,PSMB10,proteasome subunit beta 10,23,endopeptidase activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
16018,19111,5690,PSMB2,proteasome subunit beta 2,106,endopeptidase activity,urinary bladder cancer,ppi
16019,19112,343472,BARHL2,BarH like homeobox 2,1,DNA-binding transcription factor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific,,ppi
16020,19113,5691,PSMB3,proteasome subunit beta 3,110,endopeptidase activity,,ppi
16021,19114,5692,PSMB4,proteasome subunit beta 4,105,endopeptidase activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
16022,19115,5693,PSMB5,proteasome subunit beta 5,124,peptidase activity|endopeptidase activity,coronary artery disease,ppi
16023,19116,5694,PSMB6,proteasome subunit beta 6,94,endopeptidase activity|cadherin binding,,ppi
16024,19117,5695,PSMB7,proteasome subunit beta 7,89,endopeptidase activity,,ppi
16025,19118,5696,PSMB8,proteasome subunit beta 8,58,endopeptidase activity,secondary hypertrophic osteoarthropathy|clubfoot|conjunctivitis|scleritis|exanthem|congestive heart failure|primary polycythemia|hyperostosis|lipoatrophic diabetes|lipodystrophy|nodular nonsuppurative panniculitis|panniculitis|granuloma annulare|microcytic anemia|liver disease|muscular atrophy,ppi
16026,19119,5698,PSMB9,proteasome subunit beta 9,76,endopeptidase activity,,ppi
16027,19120,5700,PSMC1,proteasome 26S subunit; ATPase 1,152,RNA binding|ATPase activity|TBP-class protein binding|proteasome-activating ATPase activity,,ppi
16028,19121,5701,PSMC2,proteasome 26S subunit; ATPase 2,180,ATPase activity|TBP-class protein binding,,ppi
16029,19122,5702,PSMC3,proteasome 26S subunit; ATPase 3,200,ATPase activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
16030,19123,56033,BARX1,BARX homeobox 1,6,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription activator activity; RNA polymerase II-specific,Barrett's esophagus|esophagus adenocarcinoma,ppi
16031,19124,5704,PSMC4,proteasome 26S subunit; ATPase 4,147,ATPase activity,,ppi
16032,19125,5705,PSMC5,proteasome 26S subunit; ATPase 5,239,transcription factor binding|ATPase activity|TBP-class protein binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|Stevens-Johnson syndrome,ppi
16033,19126,5706,PSMC6,proteasome 26S subunit; ATPase 6,138,ATPase activity|protein binding; bridging,,ppi
16034,19127,5707,PSMD1,proteasome 26S subunit; non-ATPase 1,145,endopeptidase activity,,ppi
16035,19128,5716,PSMD10,proteasome 26S subunit; non-ATPase 10,73,,,ppi
16036,19129,5717,PSMD11,proteasome 26S subunit; non-ATPase 11,160,structural molecule activity,,ppi
16037,19130,5718,PSMD12,proteasome 26S subunit; non-ATPase 12,117,,contact dermatitis|occupational dermatitis,ppi
16038,19131,5719,PSMD13,proteasome 26S subunit; non-ATPase 13,112,structural molecule activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
16039,19132,5708,PSMD2,proteasome 26S subunit; non-ATPase 2,261,endopeptidase activity,,ppi
16040,19133,8538,BARX2,BARX homeobox 2,1,RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding,,ppi
16041,19134,5709,PSMD3,proteasome 26S subunit; non-ATPase 3,155,,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
16042,19135,5710,PSMD4,proteasome 26S subunit; non-ATPase 4,197,RNA binding|polyubiquitin modification-dependent protein binding,,ppi
16043,19136,5711,PSMD5,proteasome 26S subunit; non-ATPase 5,76,,,ppi
16044,19137,9861,PSMD6,proteasome 26S subunit; non-ATPase 6,129,ATPase activity,diabetes mellitus|type 2 diabetes mellitus|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
16045,19138,5713,PSMD7,proteasome 26S subunit; non-ATPase 7,129,protein homodimerization activity,,ppi
16046,19139,5714,PSMD8,proteasome 26S subunit; non-ATPase 8,96,,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
16047,19140,5715,PSMD9,proteasome 26S subunit; non-ATPase 9,68,transcription coactivator activity|bHLH transcription factor binding,,ppi
16048,19141,5720,PSME1,proteasome activator subunit 1,80,endopeptidase activator activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|esophagus squamous cell carcinoma,ppi
16049,19142,5721,PSME2,proteasome activator subunit 2,55,endopeptidase activator activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|esophagus squamous cell carcinoma,ppi
16050,19143,10409,BASP1,brain abundant membrane attached signal protein 1,46,transcription corepressor activity|transcription regulatory region DNA binding,,ppi
16051,19144,10197,PSME3,proteasome activator subunit 3,186,p53 binding|endopeptidase activator activity|MDM2/MDM4 family protein binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
16052,19145,9491,PSMF1,proteasome inhibitor subunit 1,42,endopeptidase inhibitor activity|protein homodimerization activity|proteasome binding,,ppi
16053,19146,5723,PSPH,phosphoserine phosphatase,20,magnesium ion binding|phosphoserine phosphatase activity|calcium ion binding|phosphatase activity,amino acid metabolic disorder|epilepsy|placental insufficiency|intellectual disability|learning disability|visual epilepsy|PSPH deficiency,ppi
16054,19148,10538,BATF,basic leucine zipper ATF-like transcription factor,27,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
16055,19149,9051,PSTPIP1,proline-serine-threonine phosphatase interacting protein 1,70,cytoskeletal protein binding|actin filament binding,arthropathy|arthritis|primary polycythemia|pyoderma|chronic ulcer of skin|skin disease|acne,ppi
16056,19150,9050,PSTPIP2,proline-serine-threonine phosphatase interacting protein 2,9,cytoskeletal protein binding|actin filament binding,,ppi
16057,19151,5724,PTAFR,platelet activating factor receptor,12,G-protein coupled receptor activity|platelet activating factor receptor activity|phospholipid binding|G-protein coupled purinergic nucleotide receptor activity,polycystic ovary syndrome,ppi
16058,19152,5725,PTBP1,polypyrimidine tract binding protein 1,154,RNA binding|poly-pyrimidine tract binding|pre-mRNA binding,,ppi
16059,19154,5727,PTCH1,patched 1,101,cholesterol binding|hedgehog receptor activity|smoothened binding|hedgehog family protein binding,congenital heart disease|nevoid basal cell carcinoma syndrome|brain cancer|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|cleft lip|isolated cleft palate|cleft palate|epilepsy|glaucoma|umbilical hernia|omphalocele|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain,ppi
16060,19155,8643,PTCH2,patched 2,5,hedgehog receptor activity|hedgehog family protein binding|smoothened binding,nevoid basal cell carcinoma syndrome|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|cleft lip|isolated cleft palate|cleft palate|glaucoma|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma|microphthalmia|syringoma,ppi
16061,19156,9791,PTDSS1,phosphatidylserine synthase 1,11,transferase activity,choanal atresia|cryptorchidism|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|placental insufficiency|sensorineural hearing loss|inguinal hernia|intellectual disability|learning disability|tongue disease|syndactyly|priapism|humeroradial synostosis,ppi
16062,19157,5728,PTEN,phosphatase and tensin homolog,246,phosphatidylinositol-3-phosphatase activity|phosphoprotein phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|phosphatidylinositol-3;4;5-trisphosphate 3-phosphatase activity|inositol-1;3;4;5-tetrakisphosphate 3-phosphatase activity|phosphatidylinositol-3;4-bisphosphate 3-phosphatase activity,acanthosis nigricans|adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|suppression amblyopia|amblyopia|angioid streaks|angiokeratoma|anisometropia|imperforate anus|arteriovenous malformation|asthma|intrinsic asthma|allergic asthma|autistic disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma,ppi
16063,19158,581,BAX,BCL2 associated X; apoptosis regulator,91,lipid binding|channel activity|protein homodimerization activity|BH3 domain binding|protein heterodimerization activity,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|colon cancer|colonic benign neoplasm|esophageal cancer|human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
16064,19159,9317,PTER,phosphotriesterase related,14,,liver cancer|melanoma|skin melanoma,ppi
16065,19160,5729,PTGDR,prostaglandin D2 receptor,8,prostaglandin D receptor activity,,ppi
16066,19161,5730,PTGDS,prostaglandin D2 synthase,22,prostaglandin-D synthase activity|retinoid binding|fatty acid binding,bipolar disorder|schizophrenia,ppi
16067,19162,5731,PTGER1,prostaglandin E receptor 1,6,prostaglandin E receptor activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|tongue squamous cell carcinoma|squamous cell carcinoma|invasive ductal carcinoma,ppi
16068,19163,5732,PTGER2,prostaglandin E receptor 2,7,prostaglandin E receptor activity,endometriosis of uterus|endometriosis|infertility,ppi
16069,19164,5733,PTGER3,prostaglandin E receptor 3,113,prostaglandin E receptor activity,cicatricial pemphigoid|polycystic ovary syndrome|schizophrenia|Stevens-Johnson syndrome,ppi
16070,19165,5734,PTGER4,prostaglandin E receptor 4,5,prostaglandin E receptor activity,endometriosis of uterus|endometriosis|lymphosarcoma|lymphoma|central nervous system lymphoma|ankylosing spondylitis,ppi
16071,19166,9536,PTGES,prostaglandin E synthase,3,glutathione binding|prostaglandin-E synthase activity|glutathione transferase activity,hydronephrosis,ppi
16072,19167,11177,BAZ1A,bromodomain adjacent to zinc finger domain 1A,39,histone acetyltransferase activity,,ppi
16073,19168,5737,PTGFR,prostaglandin F receptor,16,prostaglandin F receptor activity,endometriosis of uterus|endometriosis,ppi
16074,19169,5738,PTGFRN,prostaglandin F2 receptor inhibitor,17,,,ppi
16075,19170,5739,PTGIR,prostaglandin I2 (prostacyclin) receptor (IP),68,guanyl-nucleotide exchange factor activity,heart disease|cardiovascular system disease,ppi
16076,19171,5740,PTGIS,prostaglandin I2 synthase,4,prostaglandin-I synthase activity|heme binding,patent ductus arteriosus|lung benign neoplasm|Stevens-Johnson syndrome|hypertension|essential hypertension,ppi
16077,19172,5742,PTGS1,prostaglandin-endoperoxide synthase 1,7,peroxidase activity|prostaglandin-endoperoxide synthase activity,esophageal cancer|congestive heart failure|chronic kidney disease|schizophrenia|gastric ulcer|asthma|breast cancer,ppi
16078,19173,5743,PTGS2,prostaglandin-endoperoxide synthase 2,33,peroxidase activity|prostaglandin-endoperoxide synthase activity|oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen|heme binding|arachidonate 15-lipoxygenase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|adrenal gland cancer|proteinuria|progressive muscular atrophy|amyotrophic lateral sclerosis|sick sinus syndrome|rheumatoid arthritis|asphyxia neonatorum|atherosclerosis|arteriosclerotic cardiovascular disease|arteriosclerosis|coronary artery disease|arteriolosclerosis|autistic disorder|Barrett's esophagus|bladder neck obstruction,ppi
16079,19174,5741,PTH,parathyroid hormone,6,transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|hormone activity|type 1 parathyroid hormone receptor binding|protein N-terminus binding|receptor ligand activity|peptide hormone receptor binding|parathyroid hormone receptor binding,anemia|macrocytic anemia|epilepsy|congestive heart failure|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hyperostosis|secondary hyperparathyroidism|hypertension|essential hypertension|hypoparathyroidism|pseudohypoparathyroidism|osteoporosis|osteomalacia|rickets|visual epilepsy|kidney failure|uremia|hyperphosphatemia,ppi
16080,19175,5744,PTHLH,parathyroid hormone like hormone,8,peptide hormone receptor binding|hormone activity,lung cancer|non-small cell lung carcinoma|congestive heart failure|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|lung disease|multiple myeloma|pancreatic cancer|prostate cancer|prostate carcinoma|neuroendocrine tumor|alcoholic pancreatitis|breast cancer|brachydactyly,ppi
16081,19176,5745,PTH1R,parathyroid hormone 1 receptor,53,parathyroid hormone receptor activity|peptide hormone binding|protein homodimerization activity|protein self-association|G-protein coupled peptide receptor activity,choanal atresia|secondary hypertrophic osteoarthropathy|sensorineural hearing loss|achondroplasia|Laron syndrome|Maffucci syndrome|hereditary multiple exostoses|Ollier disease|enophthalmos|orbital disease|exophthalmos|polyhydramnios|nephrocalcinosis|hypercalcemia|phosphorus metabolism disease|hyperparathyroidism|osteitis fibrosa|tooth agenesis|anodontia|hypoparathyroidism,ppi
16082,19177,5746,PTH2R,parathyroid hormone 2 receptor,6,parathyroid hormone receptor activity|G-protein coupled peptide receptor activity|peptide hormone binding,,ppi
16083,19178,9031,BAZ1B,bromodomain adjacent to zinc finger domain 1B,72,protein tyrosine kinase activity|zinc ion binding|histone kinase activity,generalized anxiety disorder|anxiety disorder|supravalvular aortic stenosis|autistic disorder|blepharophimosis|brain ischemia|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|basal ganglia disease|focal hand dystonia|blepharospasm|clubfoot|sensorineural hearing loss|inguinal hernia|nephrocalcinosis,ppi
16084,19179,5747,PTK2,protein tyrosine kinase 2,168,actin binding|protein kinase activity|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|JUN kinase binding,rheumatoid arthritis|tongue squamous cell carcinoma|squamous cell carcinoma|glioblastoma multiforme|giant cell glioblastoma|liver cancer|hepatocellular carcinoma,ppi
16085,19180,2185,PTK2B,protein tyrosine kinase 2 beta,93,calmodulin-dependent protein kinase activity|protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|protein C-terminus binding|NMDA glutamate receptor activity,alcohol dependence|alcohol abuse|melanoma|skin melanoma|skin benign neoplasm|skin cancer|status epilepticus,ppi
16086,19181,5753,PTK6,protein tyrosine kinase 6,29,protein tyrosine kinase activity|non-membrane spanning protein tyrosine kinase activity|signaling receptor binding,,ppi
16087,19182,5754,PTK7,protein tyrosine kinase 7 (inactive),42,coreceptor activity involved in Wnt signaling pathway; planar cell polarity pathway,,ppi
16088,19183,11176,BAZ2A,bromodomain adjacent to zinc finger domain 2A,25,RNA polymerase I CORE element sequence-specific DNA binding|RNA binding|nuclear receptor binding|lysine-acetylated histone binding,prostate cancer|prostate carcinoma,ppi
16089,19184,5756,TWF1,twinfilin actin binding protein 1,54,actin binding|actin monomer binding|ATP binding|phosphatidylinositol-4;5-bisphosphate binding|cadherin binding|protein tyrosine kinase activity|actin filament binding,lymphosarcoma|lymphoma|central nervous system lymphoma,ppi
16090,19185,11344,TWF2,twinfilin actin binding protein 2,64,RNA binding|actin monomer binding|ATP binding|phosphatidylinositol-4;5-bisphosphate binding|cadherin binding|actin filament binding,,ppi
16091,19186,5757,PTMA,prothymosin; alpha,91,,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|fatty liver disease|lung benign neoplasm|rhabdomyosarcoma,ppi
16092,19187,5763,PTMS,parathymosin,32,,,ppi
16093,19188,29994,BAZ2B,bromodomain adjacent to zinc finger domain 2B,12,,,ppi
16094,19189,5764,PTN,pleiotrophin,101,protein phosphatase inhibitor activity|growth factor activity|heparin binding|chondroitin sulfate binding,,ppi
16095,19190,53635,PTOV1,prostate tumor overexpressed 1,21,,stomach cancer,ppi
16096,19191,7803,PTP4A1,protein tyrosine phosphatase type IVA; member 1,52,protein tyrosine phosphatase activity,alcohol dependence|alcohol abuse,ppi
16097,19192,8073,PTP4A2,protein tyrosine phosphatase type IVA; member 2,35,prenylated protein tyrosine phosphatase activity|protein tyrosine phosphatase activity,,ppi
16098,19193,11156,PTP4A3,protein tyrosine phosphatase type IVA; member 3,109,prenylated protein tyrosine phosphatase activity|protein tyrosine phosphatase activity,colon cancer|colonic benign neoplasm,ppi
16099,19194,9200,HACD1,3-hydroxyacyl-CoA dehydratase 1,16,3R-hydroxyacyl-CoA dehydratase activity|3-hydroxyacyl-CoA dehydratase activity,familial periodic paralysis|myopathy|polycystic ovary syndrome|centronuclear myopathy|congenital structural myopathy|muscular dystrophy-dystroglycanopathy|megaconial type congenital muscular dystrophy|rigid spine muscular dystrophy 1|congenital muscular dystrophy 1B|muscular dystrophy-dystroglycanopathy type B5|congenital merosin-deficient muscular dystrophy 1A|muscular dystrophy-dystroglycanopathy type B6|congenital muscular dystrophy due to integrin alpha-7 deficiency|congenital muscular dystrophy due to LMNA mutation|nemaline myopathy|central core myopathy|congenital fiber-type disproportion,ppi
16100,19195,8424,BBOX1,gamma-butyrobetaine hydroxylase 1,17,zinc ion binding|gamma-butyrobetaine dioxygenase activity|oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen,,ppi
16101,19196,201562,HACD2,3-hydroxyacyl-CoA dehydratase 2,26,3-hydroxyacyl-CoA dehydratase activity|enzyme binding|3R-hydroxyacyl-CoA dehydratase activity|protein tyrosine phosphatase activity,,ppi
16102,19197,5770,PTPN1,protein tyrosine phosphatase; non-receptor type 1,176,RNA binding|protein tyrosine phosphatase activity|zinc ion binding|cadherin binding,diabetes mellitus|type 2 diabetes mellitus|Hodgkin's lymphoma; lymphocytic-histiocytic predominance|Hodgkin's lymphoma|Hodgkin's lymphoma; lymphocytic depletion|Hodgkin's granuloma|Hodgkin's lymphoma; mixed cellularity|mediastinal cancer|obesity|Rett syndrome|schizophrenia|lymphosarcoma|B-cell lymphoma,ppi
16103,19198,5781,PTPN11,protein tyrosine phosphatase; non-receptor type 11,197,phosphotyrosine residue binding|phosphoprotein phosphatase activity|protein tyrosine phosphatase activity|non-membrane spanning protein tyrosine phosphatase activity|1-phosphatidylinositol-3-kinase activity|phosphatidylinositol-4;5-bisphosphate 3-kinase activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|sick sinus syndrome|astrocytoma|malignant glioma|grade III astrocytoma|pilocytic astrocytoma|subependymal giant cell astrocytoma|fibrillary astrocytoma|juvenile pilocytic astrocytoma|gemistocytic astrocytoma|childhood cerebral astrocytoma|protoplasmic astrocytoma|ptosis|congenital ptosis|blood coagulation disease|tongue squamous cell carcinoma,ppi
16104,19199,5782,PTPN12,protein tyrosine phosphatase; non-receptor type 12,94,phosphoprotein phosphatase activity|protein tyrosine phosphatase activity|non-membrane spanning protein tyrosine phosphatase activity,,ppi
16105,19200,5783,PTPN13,protein tyrosine phosphatase; non-receptor type 13,50,protein tyrosine phosphatase activity,,ppi
16106,19201,5784,PTPN14,protein tyrosine phosphatase; non-receptor type 14,63,transcription coregulator activity|protein tyrosine phosphatase activity,basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|choanal atresia|elephantiasis|lymphedema|neuroblastoma|hemopericardium|pericardial effusion,ppi
16107,19202,26469,PTPN18,protein tyrosine phosphatase; non-receptor type 18,48,protein tyrosine phosphatase activity,,ppi
16108,19203,5771,PTPN2,protein tyrosine phosphatase; non-receptor type 2,109,protein tyrosine phosphatase activity,agnosia|rheumatoid arthritis|inflammatory bowel disease|ulcerative colitis|Crohn's colitis|Crohn's disease|uveitis|anterior uveitis|ciliary body disease|T-cell leukemia|juvenile rheumatoid arthritis|arthropathy|arthritis|neurogenic arthropathy|acute T cell leukemia,ppi
16109,19204,11099,PTPN21,protein tyrosine phosphatase; non-receptor type 21,46,,schizophrenia,ppi
16110,19205,26191,PTPN22,protein tyrosine phosphatase; non-receptor type 22,55,protein tyrosine phosphatase activity|phosphatase activity|SH3 domain binding|kinase binding,alopecia|agnosia|arthropathy|arthritis|rheumatoid arthritis|hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|brain ischemia|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|diabetic ketoacidosis|type 1 diabetes mellitus 2|type 1 diabetes mellitus 3|type 1 diabetes mellitus 4|type 1 diabetes mellitus 5|type 1 diabetes mellitus 6,ppi
16111,19206,5774,PTPN3,protein tyrosine phosphatase; non-receptor type 3,46,protein tyrosine phosphatase activity|sodium channel regulator activity,biliary tract cancer|bile duct carcinoma|bile duct adenocarcinoma|intrahepatic cholangiocarcinoma|cholangiocarcinoma|bile duct cancer,ppi
16112,19207,5775,PTPN4,protein tyrosine phosphatase; non-receptor type 4,45,,,ppi
16113,19208,84867,PTPN5,protein tyrosine phosphatase; non-receptor type 5,55,phosphotyrosine residue binding|protein tyrosine phosphatase activity,schizophrenia,ppi
16114,19209,5777,PTPN6,protein tyrosine phosphatase; non-receptor type 6,169,phosphotyrosine residue binding|protein tyrosine phosphatase activity|transmembrane receptor protein tyrosine phosphatase activity,calcium metabolism disease|nephrocalcinosis|calcinosis|heart valve disease|schizophrenia,ppi
16115,19210,5778,PTPN7,protein tyrosine phosphatase; non-receptor type 7,38,,,ppi
16116,19211,582,BBS1,Bardet-Biedl syndrome 1,52,smoothened binding|patched binding,asthma|intrinsic asthma|allergic asthma|obstructive jaundice|biliary tract disease|cerebellar disease|diabetic ketoacidosis|diabetes mellitus|hypertrichosis|hypertension|essential hypertension|tooth agenesis|anodontia|hypogonadism|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus,ppi
16117,19212,5780,PTPN9,protein tyrosine phosphatase; non-receptor type 9,35,protein tyrosine phosphatase activity|non-membrane spanning protein tyrosine phosphatase activity,,ppi
16118,19213,140885,SIRPA,signal regulatory protein alpha,18,,,ppi
16119,19214,5786,PTPRA,protein tyrosine phosphatase; receptor type A,60,protein tyrosine phosphatase activity|transmembrane receptor protein tyrosine phosphatase activity|Ras guanyl-nucleotide exchange factor activity,schizophrenia|coronary artery disease,ppi
16120,19215,5787,PTPRB,protein tyrosine phosphatase; receptor type B,44,transmembrane receptor protein tyrosine phosphatase activity,angiosarcoma,ppi
16121,19216,5788,PTPRC,protein tyrosine phosphatase; receptor type C,51,protein tyrosine phosphatase activity|transmembrane receptor protein tyrosine phosphatase activity,rheumatoid arthritis|dermatitis|hepatitis C|multiple sclerosis|otitis media|schizophreniform disorder|schizoaffective disorder|retinitis|retinal disease|adenosine deaminase deficiency|MHC class II deficiency|severe combined immunodeficiency,ppi
16122,19217,5790,PTPRCAP,protein tyrosine phosphatase; receptor type C associated protein,5,,,ppi
16123,19218,5789,PTPRD,protein tyrosine phosphatase; receptor type D,46,transmembrane receptor protein tyrosine phosphatase activity|signaling receptor binding|cell adhesion molecule binding,large intestine cancer|colorectal cancer|restless legs syndrome|attention deficit hyperactivity disorder|breast cancer,ppi
16124,19219,5791,PTPRE,protein tyrosine phosphatase; receptor type E,46,transmembrane receptor protein tyrosine phosphatase activity,,ppi
16125,19220,583,BBS2,Bardet-Biedl syndrome 2,43,,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypertension|essential hypertension|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|retinal degeneration|cone-rod dystrophy,ppi
16126,19221,5792,PTPRF,protein tyrosine phosphatase; receptor type F,68,protein tyrosine phosphatase activity|transmembrane receptor protein tyrosine phosphatase activity,stomach cancer|malignant mesothelioma|benign mesothelioma,ppi
16127,19222,5793,PTPRG,protein tyrosine phosphatase; receptor type G,65,protein tyrosine phosphatase activity|transmembrane receptor protein tyrosine phosphatase activity,stomach cancer,ppi
16128,19223,5794,PTPRH,protein tyrosine phosphatase; receptor type H,31,,,ppi
16129,19224,5795,PTPRJ,protein tyrosine phosphatase; receptor type J,79,protein tyrosine phosphatase activity|phosphatase activity,large intestine cancer|colorectal cancer,ppi
16130,19225,5796,PTPRK,protein tyrosine phosphatase; receptor type K,127,protein tyrosine phosphatase activity|transmembrane receptor protein tyrosine phosphatase activity,melanoma|skin melanoma|prostate cancer|prostate carcinoma,ppi
16131,19226,5797,PTPRM,protein tyrosine phosphatase; receptor type M,15,protein tyrosine phosphatase activity|transmembrane receptor protein tyrosine phosphatase activity|cadherin binding,,ppi
16132,19227,5798,PTPRN,protein tyrosine phosphatase; receptor type N,92,transcription factor binding|ubiquitin-like protein ligase binding|protein tyrosine phosphatase activity,,ppi
16133,19228,5799,PTPRN2,protein tyrosine phosphatase; receptor type N2,28,transmembrane receptor protein tyrosine phosphatase activity,,ppi
16134,19229,5800,PTPRO,protein tyrosine phosphatase; receptor type O,100,protein tyrosine phosphatase activity|transmembrane receptor protein tyrosine phosphatase activity|phosphatase activity|Wnt-protein binding|protein homodimerization activity,congestive heart failure|focal segmental glomerulosclerosis|liver cancer|melanoma|skin melanoma|lipoid nephrosis|nephrotic syndrome|familial nephrotic syndrome|proteinuria,ppi
16135,19231,5801,PTPRR,protein tyrosine phosphatase; receptor type R,42,protein tyrosine phosphatase activity|transmembrane receptor protein tyrosine phosphatase activity|protein kinase binding,neurotic disorder|endogenous depression|melancholia|major depressive disorder|mental depression,ppi
16136,19232,5802,PTPRS,protein tyrosine phosphatase; receptor type S,59,phosphoprotein phosphatase activity|protein tyrosine phosphatase activity|heparin binding|chondroitin sulfate binding|heparan sulfate proteoglycan binding,,ppi
16137,19233,11122,PTPRT,protein tyrosine phosphatase; receptor type T,9,protein tyrosine phosphatase activity|alpha-catenin binding|gamma-catenin binding,,ppi
16138,19234,10076,PTPRU,protein tyrosine phosphatase; receptor type U,26,protein tyrosine phosphatase activity|transmembrane receptor protein tyrosine phosphatase activity,,ppi
16139,19235,5803,PTPRZ1,protein tyrosine phosphatase; receptor type Z1,22,protein tyrosine phosphatase activity|transmembrane receptor protein tyrosine phosphatase activity,asbestosis|anthracosilicosis|pneumoconiosis|siderosis|bagassosis|schizophrenia|peripheral vascular disease,ppi
16140,19236,284119,PTRF,polymerase I and transcript release factor,74,RNA binding|rRNA primary transcript binding,congenital generalized lipodystrophy,ppi
16141,19237,5805,PTS,6-pyruvoyltetrahydropterin synthase,23,6-pyruvoyltetrahydropterin synthase activity,cerebellar disease|dystonia|epilepsy|visual epilepsy|basal ganglia disease|focal hand dystonia|blepharospasm|placental insufficiency|secondary Parkinson disease|phenylketonuria,ppi
16142,19238,585,BBS4,Bardet-Biedl syndrome 4,40,microtubule motor activity|dynactin binding|alpha-tubulin binding|beta-tubulin binding,asthma|intrinsic asthma|allergic asthma|obstructive jaundice|biliary tract disease|cerebellar disease|cryptorchidism|diabetic ketoacidosis|diabetes mellitus|hypertrichosis|hypertension|essential hypertension|tooth agenesis|anodontia|hypogonadism|cystic kidney disease|intellectual disability|learning disability|night blindness|congenital stationary night blindness,ppi
16143,19239,9232,PTTG1,pituitary tumor-transforming 1,50,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|cysteine-type endopeptidase inhibitor activity,pustulosis of palm and sole|psoriasis|parapsoriasis|Sjogren's syndrome|keratoconjunctivitis sicca,ppi
16144,19240,10744,PTTG2,pituitary tumor-transforming 2,1,,,ppi
16145,19241,5806,PTX3,pentraxin 3,17,complement component C1q binding|virion binding,postinflammatory pulmonary fibrosis|idiopathic interstitial pneumonia|pulmonary fibrosis|seborrheic keratosis|skin disease|actinic keratosis|neurotic disorder|endogenous depression|melancholia|mental depression|major depressive disorder,ppi
16146,19242,129880,BBS5,Bardet-Biedl syndrome 5,16,phosphatidylinositol-3-phosphate binding,Laurence-Moon syndrome|Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 3|Bardet-Biedl syndrome 4|Bardet-Biedl syndrome 5|Bardet-Biedl syndrome 6|Bardet-Biedl syndrome 7|Bardet-Biedl syndrome 8|Bardet-Biedl syndrome 9|Bardet-Biedl syndrome 10|Bardet-Biedl syndrome 11|Bardet-Biedl syndrome 12|Bardet-Biedl syndrome 13|Bardet-Biedl syndrome 14|Bardet-Biedl syndrome 15|Bardet-Biedl syndrome 16|Bardet-Biedl syndrome 17|Bardet-Biedl syndrome 18,ppi
16147,19243,9543,IGDCC3,immunoglobulin superfamily DCC subclass member 3,1,,,ppi
16148,19244,5813,PURA,purine rich element binding protein A,44,DNA-binding transcription factor activity; RNA polymerase II-specific|double-stranded telomeric DNA binding|single-stranded DNA binding|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|RNA binding|transcription factor binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|double-stranded DNA binding|purine-rich negative regulatory element binding|sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding,epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|visual epilepsy|ophthalmoplegia|mechanical strabismus|hypertropia,ppi
16149,19245,5814,PURB,purine rich element binding protein B,27,DNA-binding transcription factor activity; RNA polymerase II-specific|single-stranded DNA binding|RNA binding|mRNA binding|transcription factor binding|DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II regulatory region sequence-specific DNA binding|double-stranded DNA binding|sequence-specific DNA binding|purine-rich negative regulatory element binding,,ppi
16150,19246,5816,PVALB,parvalbumin,1,calcium ion binding,bipolar disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|schizophreniform disorder|schizoaffective disorder|schizophrenia|epilepsy|visual epilepsy|renal oncocytoma|oxyphilic adenoma,ppi
16151,19247,5817,PVR,poliovirus receptor,56,signaling receptor activity|cell adhesion molecule binding|protein homodimerization activity,poliomyelitis|bulbar polio,ppi
16152,19248,5818,NECTIN1,nectin cell adhesion molecule 1,14,coreceptor activity|protein homodimerization activity|cell adhesion molecule binding|signaling receptor activity,alopecia|cleft lip|isolated cleft palate|cleft palate|dental caries|Clouston syndrome|tooth agenesis|anodontia|hypogonadism|nonepidermolytic palmoplantar keratoderma|palmoplantar keratosis|intellectual disability|learning disability|speech disorder|cleft lip-palate-ectodermal dysplasia syndrome,ppi
16153,19249,5819,NECTIN2,nectin cell adhesion molecule 2,36,coreceptor activity,,ppi
16154,19250,9564,BCAR1,BCAR1; Cas family scaffolding protein,288,,pancreatic cancer,ppi
16155,19251,5822,PWP2,PWP2 periodic tryptophan protein homolog (yeast),46,RNA binding|snoRNA binding,,ppi
16156,19252,5824,PEX19,peroxisomal biogenesis factor 19,122,peroxisome membrane class-1 targeting sequence binding,adrenal cortical hypofunction|Addison's disease|ptosis|congenital ptosis|cerebellar disease|cholecystolithiasis|choledocholithiasis|recurrent corneal erosion|cryptorchidism|epilepsy|sensorineural hearing loss|hydronephrosis|gallbladder disease|liver disease|movement disease|lingual-facial-buccal dyskinesia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus,ppi
16157,19253,5827,PXMP2,peroxisomal membrane protein 2,19,,,ppi
16158,19254,5828,PEX2,peroxisomal biogenesis factor 2,14,,adrenal cortical hypofunction|Addison's disease|ptosis|congenital ptosis|cerebellar disease|isolated cleft palate|cleft palate|clubfoot|recurrent corneal erosion|cryptorchidism|epilepsy|placental insufficiency|sensorineural hearing loss|congenital heart disease|hydronephrosis|cystic kidney disease|gallbladder disease|liver disease|intellectual disability|learning disability,ppi
16159,19255,5829,PXN,paxillin,134,,lung cancer|non-small cell lung carcinoma,ppi
16160,19256,5830,PEX5,peroxisomal biogenesis factor 5,92,peroxisome targeting sequence binding|peroxisome matrix targeting signal-1 binding,adrenal cortical hypofunction|Addison's disease|asthma|intrinsic asthma|allergic asthma|ptosis|congenital ptosis|cerebellar disease|isolated cleft palate|cleft palate|clubfoot|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types,ppi
16161,19257,5831,PYCR1,pyrroline-5-carboxylate reductase 1,36,pyrroline-5-carboxylate reductase activity,blepharophimosis|cryptorchidism|Hailey-Hailey disease|lethal restrictive dermopathy|mal de Meleda|Rothmund-Thomson syndrome|cutis laxa|achondroplasia|Laron syndrome|enophthalmos|orbital disease|exophthalmos|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|inguinal hernia|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus,ppi
16162,19258,5832,ALDH18A1,aldehyde dehydrogenase 18 family member A1,44,RNA binding|glutamate 5-kinase activity|glutamate-5-semialdehyde dehydrogenase activity|delta1-pyrroline-5-carboxylate synthetase activity|identical protein binding,arcus senilis|clubfoot|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types|cataract 41|cataract 13 with adult i phenotype|cataract 46 juvenile-onset|cataract 38,ppi
16163,19259,5834,PYGB,glycogen phosphorylase B,51,glycogen phosphorylase activity|pyridoxal phosphate binding,salivary gland adenoid cystic carcinoma|coronary artery disease,ppi
16164,19260,5836,PYGL,glycogen phosphorylase L,46,purine nucleobase binding|ATP binding|glucose binding|drug binding|glycogen phosphorylase activity|AMP binding|vitamin binding|bile acid binding|protein homodimerization activity|pyridoxal phosphate binding,glycogen storage disease VII|glycogen storage disease IV|glycogen storage disease VI|familial hyperlipidemia|hypoglycemia|liver cancer|hepatocellular carcinoma,ppi
16165,19261,5837,PYGM,glycogen phosphorylase; muscle associated,34,glycogen phosphorylase activity|pyridoxal phosphate binding,glycogen storage disease V|familial periodic paralysis|myopathy|pseudosarcomatous fibromatosis,ppi
16166,19262,8412,BCAR3,breast cancer anti-estrogen resistance 3,77,,substance abuse|substance-related disorder|breast cancer,ppi
16167,19263,8537,BCAS1,breast carcinoma amplified sequence 1,4,,prostate cancer|prostate carcinoma,ppi
16168,19264,5697,PYY,peptide YY,7,hormone activity|neuropeptide hormone activity|G-protein coupled receptor binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia,ppi
16169,19265,10286,BCAS2,BCAS2; pre-mRNA processing factor,81,,,ppi
16170,19266,5858,PZP,PZP; alpha-2-macroglobulin like,10,,,ppi
16171,19267,5859,QARS,glutaminyl-tRNA synthetase,139,glutamine-tRNA ligase activity|protein kinase inhibitor activity|protein kinase binding,prostate cancer|prostate carcinoma|status epilepticus|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome,ppi
16172,19268,5860,QDPR,quinoid dihydropteridine reductase,25,6;7-dihydropteridine reductase activity|electron transfer activity|NADH binding|NADPH binding,dystonia|epilepsy|intellectual disability|learning disability|focal hand dystonia|blepharospasm|early myoclonic encephalopathy|Unverricht-Lundborg syndrome|phenylketonuria|visual epilepsy|basal ganglia disease,ppi
16173,19269,25797,QPCT,glutaminyl-peptide cyclotransferase,21,zinc ion binding|glutaminyl-peptide cyclotransferase activity,chronic lymphocytic leukemia|Richter's syndrome|melanoma|skin melanoma|allergic contact dermatitis,ppi
16174,19270,23475,QPRT,quinolinate phosphoribosyltransferase,47,nicotinate-nucleotide diphosphorylase (carboxylating) activity|protein homodimerization activity,,ppi
16175,19271,5768,QSOX1,quiescin sulfhydryl oxidase 1,15,protein disulfide isomerase activity|flavin-linked sulfhydryl oxidase activity,substance abuse|substance-related disorder,ppi
16176,19272,23518,R3HDM1,R3H domain containing 1,9,RNA binding,,ppi
16177,19273,5861,RAB1A,RAB1A; member RAS oncogene family,156,GTPase activity|cadherin binding,,ppi
16178,19274,10890,RAB10,RAB10; member RAS oncogene family,80,GTP binding|GDP binding|cadherin binding involved in cell-cell adhesion|GTPase activity,,ppi
16179,19275,586,BCAT1,branched chain amino acid transaminase 1,37,branched-chain-amino-acid transaminase activity,,ppi
16180,19276,8766,RAB11A,RAB11A; member RAS oncogene family,104,GTPase activity|microtubule binding|syntaxin binding,,ppi
16181,19277,9230,RAB11B,RAB11B; member RAS oncogene family,87,GTPase activity|GTP binding|GDP binding|cadherin binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
16182,19278,5872,RAB13,RAB13; member RAS oncogene family,21,GTP binding|GTPase activity,,ppi
16183,19279,5862,RAB2A,RAB2A; member RAS oncogene family,115,GTPase activity|GTP binding|GDP binding,polycystic ovary syndrome,ppi
16184,19280,57403,RAB22A,RAB22A; member RAS oncogene family,17,GTPase activity|GTP binding|GDP binding,,ppi
16185,19281,53917,RAB24,RAB24; member RAS oncogene family,12,GTPase activity,,ppi
16186,19282,5873,RAB27A,RAB27A; member RAS oncogene family,31,GTPase activity|GTP binding|GDP binding,epilepsy|familial hyperlipidemia|primary immunodeficiency disease|pancytopenia|visual epilepsy|piebaldism|Griscelli syndrome type 2,ppi
16187,19283,5874,RAB27B,RAB27B; member RAS oncogene family,16,GTPase activity|GTP binding|GDP binding,,ppi
16188,19284,9364,RAB28,RAB28; member RAS oncogene family,8,GTP binding|GDP binding|GTPase activity,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|night blindness|congenital stationary night blindness|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|asthenopia,ppi
16189,19285,5863,RGL2,ral guanine nucleotide dissociation stimulator like 2,16,Ras guanyl-nucleotide exchange factor activity,,ppi
16190,19286,587,BCAT2,branched chain amino acid transaminase 2,13,branched-chain-amino-acid transaminase activity,maple syrup urine disease,ppi
16191,19287,27314,RAB30,RAB30; member RAS oncogene family,26,GTPase activity,,ppi
16192,19288,11031,RAB31,RAB31; member RAS oncogene family,32,GTP binding|GDP binding|GTPase activity,,ppi
16193,19289,10981,RAB32,RAB32; member RAS oncogene family,27,GTPase activity|GTP binding|AP-2 adaptor complex binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|leprosy|allergic contact dermatitis,ppi
16194,19290,9363,RAB33A,RAB33A; member RAS oncogene family,8,GTPase activity,,ppi
16195,19291,11021,RAB35,RAB35; member RAS oncogene family,42,GTPase activity|GTP binding|phosphatidylinositol-4;5-bisphosphate binding|GDP binding,,ppi
16196,19292,9609,RAB36,RAB36; member RAS oncogene family,2,GTPase activity,,ppi
16197,19293,23682,RAB38,RAB38; member RAS oncogene family,8,GTPase activity|GTP binding|AP-2 adaptor complex binding,,ppi
16198,19294,5864,RAB3A,RAB3A; member RAS oncogene family,47,GTPase activity,malignant glioma|benign ependymoma|myxopapillary ependymoma|cellular ependymoma|tanycytic ependymoma|papillary ependymoma,ppi
16199,19295,5865,RAB3B,RAB3B; member RAS oncogene family,32,GTPase activity|GDP binding,,ppi
16200,19296,9545,RAB3D,RAB3D; member RAS oncogene family,16,GTPase activity,,ppi
16201,19297,56647,BCCIP,BRCA2 and CDKN1A interacting protein,59,RNA binding|kinase regulator activity|tubulin binding,,ppi
16202,19298,5866,RAB3IL1,RAB3A interacting protein like 1,28,Rab guanyl-nucleotide exchange factor activity,,ppi
16203,19299,5867,RAB4A,RAB4A; member RAS oncogene family,45,GTPase activity|GTP binding|GDP binding,,ppi
16204,19300,53916,RAB4B,RAB4B; member RAS oncogene family,20,GTPase activity,prostate cancer|prostate carcinoma,ppi
16205,19301,5868,RAB5A,RAB5A; member RAS oncogene family,124,GTPase activity|GTP binding|GDP binding,coronary artery disease,ppi
16206,19302,5869,RAB5B,RAB5B; member RAS oncogene family,61,GTPase activity|GDP binding|GTP-dependent protein binding,,ppi
16207,19303,5878,RAB5C,RAB5C; member RAS oncogene family,157,GTPase activity|GDP binding,,ppi
16208,19304,5870,RAB6A,RAB6A; member RAS oncogene family,49,GTPase activity|GTP binding,,ppi
16209,19305,10112,KIF20A,kinesin family member 20A,38,transporter activity|ATPase activity|microtubule binding|microtubule motor activity,,ppi
16210,19306,7879,RAB7A,RAB7A; member RAS oncogene family,186,GTPase activity|GTP binding|GDP binding|retromer complex binding,clubfoot|coronary artery disease|Charcot-Marie-Tooth disease type 2B,ppi
16211,19307,8934,RAB29,RAB29; member RAS oncogene family,19,GTP binding|Rab GTPase binding|GDP binding|dynein complex binding|GTPase activity,,ppi
16212,19308,9367,RAB9A,RAB9A; member RAS oncogene family,29,GTPase activity|GTP binding|GDP binding,,ppi
16213,19309,10567,RABAC1,Rab acceptor 1,69,,,ppi
16214,19310,5875,RABGGTA,Rab geranylgeranyltransferase alpha subunit,29,Rab geranylgeranyltransferase activity|Rab GTPase binding,,ppi
16215,19311,5876,RABGGTB,Rab geranylgeranyltransferase beta subunit,73,Rab geranylgeranyltransferase activity|zinc ion binding|Rab GTPase binding,,ppi
16216,19312,5877,RABIF,RAB interacting factor,31,guanyl-nucleotide exchange factor activity|zinc ion binding,,ppi
16217,19313,11159,RABL2A,RAB; member of RAS oncogene family-like 2A,20,GTPase activity,,ppi
16218,19314,11158,RABL2B,RAB; member of RAS oncogene family-like 2B,4,GTPase activity,,ppi
16219,19315,5879,RAC1,ras-related C3 botulinum toxin substrate 1 (rho family; small GTP binding protein Rac1),232,GTPase activity|protein serine/threonine kinase activity|GTP binding|Rho GDP-dissociation inhibitor binding,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
16220,19316,5880,RAC2,ras-related C3 botulinum toxin substrate 2 (rho family; small GTP binding protein Rac2),34,GTP binding|GTPase activity,heart disease|cardiovascular system disease|primary immunodeficiency disease|lymphosarcoma|lymphoma|central nervous system lymphoma|melanoma|skin melanoma|juvenile myelomonocytic leukemia,ppi
16221,19317,5881,RAC3,ras-related C3 botulinum toxin substrate 3 (rho family; small GTP binding protein Rac3),35,GTPase activity|GTP binding|protein kinase binding,,ppi
16222,19318,29127,RACGAP1,Rac GTPase activating protein 1,95,GTPase activator activity|phosphatidylinositol-3;4;5-trisphosphate binding|microtubule binding|alpha-tubulin binding|gamma-tubulin binding|beta-tubulin binding,polycystic ovary syndrome,ppi
16223,19319,5810,RAD1,RAD1 checkpoint DNA exonuclease,21,damaged DNA binding|3'-5' exonuclease activity,,ppi
16224,19320,5884,RAD17,RAD17 checkpoint clamp loader component,33,DNA clamp loader activity|chromatin binding,,ppi
16225,19321,5885,RAD21,RAD21 cohesin complex component,249,chromatin binding,generalized anxiety disorder|anxiety disorder|blepharitis|ptosis|congenital ptosis|cryptorchidism|placental insufficiency|esophagitis|peptic esophagitis|gastroesophageal reflux disease|sensorineural hearing loss|lymphoblastic leukemia|myeloid leukemia|chronic monocytic leukemia|myopia|obsessive-compulsive disorder|syndromic X-linked intellectual disability 94|speech disorder|vesicoureteral reflux|humeroradial synostosis,ppi
16226,19322,5886,RAD23A,RAD23 homolog A; nucleotide excision repair protein,157,single-stranded DNA binding|polyubiquitin modification-dependent protein binding|ubiquitin binding|proteasome binding,stomach cancer,ppi
16227,19323,5887,RAD23B,RAD23 homolog B; nucleotide excision repair protein,126,single-stranded DNA binding|polyubiquitin modification-dependent protein binding|proteasome binding|ubiquitin binding,male infertility|prostate cancer|prostate carcinoma,ppi
16228,19324,10111,RAD50,RAD50 double strand break repair protein,114,DNA binding|protein binding; bridging|single-stranded DNA endodeoxyribonuclease activity|ATP-dependent DNA helicase activity|3'-5' exonuclease activity|double-stranded telomeric DNA binding|adenylate kinase activity|G-quadruplex DNA binding|single-stranded telomeric DNA binding,asthma|intrinsic asthma|allergic asthma|cerebellar disease|hyperopia|intellectual disability|learning disability|hereditary breast ovarian cancer syndrome,ppi
16229,19325,5888,RAD51,RAD51 recombinase,124,double-stranded DNA binding|single-stranded DNA binding|ATP binding|single-stranded DNA-dependent ATPase activity|DNA-dependent ATPase activity|recombinase activity,breast cancer|Fanconi anemia|head and neck cancer|leukopenia|intellectual disability|learning disability|thrombocytopenia|hereditary breast ovarian cancer syndrome,ppi
16230,19326,5889,RAD51C,RAD51 paralog C,28,DNA binding|four-way junction DNA binding|crossover junction endodeoxyribonuclease activity,imperforate anus|cryptorchidism|esophageal atresia|Fanconi anemia|congenital heart disease|hydronephrosis|cystic kidney disease|leukopenia|intellectual disability|learning disability|thrombocytopenia|hereditary breast ovarian cancer syndrome|ovarian cancer|breast cancer|non-congenital cyst of kidney,ppi
16231,19327,5890,RAD51B,RAD51 paralog B,14,DNA binding|double-stranded DNA binding|single-stranded DNA binding|DNA-dependent ATPase activity|four-way junction DNA binding,substance abuse|substance-related disorder|male breast cancer|breast cancer,ppi
16232,19328,5892,RAD51D,RAD51 paralog D,38,DNA binding|single-stranded DNA binding|DNA-dependent ATPase activity|gamma-tubulin binding|four-way junction DNA binding,hereditary breast ovarian cancer syndrome|ovarian cancer,ppi
16233,19329,5893,RAD52,RAD52 homolog; DNA repair protein,45,DNA binding|single-stranded DNA binding|identical protein binding,,ppi
16234,19330,8438,RAD54L,RAD54-like (S. cerevisiae),9,annealing helicase activity,breast cancer|lymphosarcoma|lymphoma|central nervous system lymphoma|Langerhans-cell histiocytosis|reticulosarcoma|non-Hodgkin lymphoma|B-cell lymphoma|hereditary breast ovarian cancer syndrome,ppi
16235,19331,5883,RAD9A,RAD9 checkpoint clamp component A,35,3'-5' exonuclease activity,,ppi
16236,19332,8480,RAE1,ribonucleic acid export 1,128,RNA binding|microtubule binding|ubiquitin binding,,ppi
16237,19333,5894,RAF1,Raf-1 proto-oncogene; serine/threonine kinase,191,protein kinase activity|protein serine/threonine kinase activity|kinase activity,sick sinus syndrome|ptosis|congenital ptosis|blood coagulation disease|lung cancer|non-small cell lung carcinoma|dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K,ppi
16238,19334,590,BCHE,butyrylcholinesterase,28,amyloid-beta binding|catalytic activity|acetylcholinesterase activity|cholinesterase activity|hydrolase activity; acting on ester bonds|enzyme binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|bipolar disorder|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma,ppi
16239,19335,5896,RAG1,recombination activating 1,31,DNA binding|endonuclease activity|ubiquitin-protein transferase activity|zinc ion binding|histone binding|protein homodimerization activity|sequence-specific DNA binding|metal ion binding,alopecia|anemia|macrocytic anemia|fetal erythroblastosis|autoimmune hemolytic anemia|arthropathy|arthritis|conjunctivitis|congestive heart failure|hypereosinophilic syndrome|lymphoplasmacytic lymphoma|macroglobulinemia|mastoiditis|meningitis|otitis media|pneumonia|thrombocytopenia|adenosine deaminase deficiency|MHC class II deficiency|severe combined immunodeficiency,ppi
16240,19336,5897,RAG2,recombination activating 2,5,chromatin binding|phosphatidylinositol-4;5-bisphosphate binding|phosphatidylinositol-3;4;5-trisphosphate binding|zinc ion binding|methylated histone binding|phosphatidylinositol binding|phosphatidylinositol-3;4-bisphosphate binding|phosphatidylinositol-3;5-bisphosphate binding,alopecia|anemia|macrocytic anemia|arthropathy|arthritis|conjunctivitis|congestive heart failure|hypereosinophilic syndrome|lymphoplasmacytic lymphoma|macroglobulinemia|mastoiditis|meningitis|otitis media|pneumonia|thrombocytopenia|adenosine deaminase deficiency|MHC class II deficiency|severe combined immunodeficiency|selective IgG deficiency disease|fatty liver disease,ppi
16241,19337,5891,MOK,MOK protein kinase,16,protein kinase activity|protein serine/threonine kinase activity,diabetes mellitus|type 2 diabetes mellitus,ppi
16242,19338,10743,RAI1,retinoic acid induced 1,27,enhancer binding|DNA-binding transcription factor activity|transcription regulatory region DNA binding,generalized anxiety disorder|anxiety disorder|phobic disorder|autistic disorder|constipation|sensorineural hearing loss|echolalia|enophthalmos|orbital disease|exophthalmos|epilepsy|clubfoot|esophagitis|peptic esophagitis|gastroesophageal reflux disease|stereotypic movement disorder|congenital heart disease|melanoma|skin melanoma|intellectual disability,ppi
16243,19339,10742,RAI2,retinoic acid induced 2,9,,,ppi
16244,19340,9052,GPRC5A,G protein-coupled receptor class C group 5 member A,18,cadherin binding|protein kinase activator activity,rheumatoid arthritis,ppi
16245,19341,5898,RALA,RAS like proto-oncogene A,76,GTP binding|GDP binding|Edg-2 lysophosphatidic acid receptor binding,,ppi
16246,19342,5899,RALB,RAS like proto-oncogene B,31,GTPase activity|GTP binding|GDP binding,,ppi
16247,19343,10928,RALBP1,ralA binding protein 1,86,GTPase activator activity|drug transmembrane transporter activity|transmembrane transporter activity|ATPase activity; coupled to transmembrane movement of substances|Ral GTPase binding,hypertension|essential hypertension|prostate cancer|prostate carcinoma|coronary artery disease,ppi
16248,19344,5900,RALGDS,ral guanine nucleotide dissociation stimulator,32,GTPase regulator activity,intellectual disability|learning disability,ppi
16249,19345,10267,RAMP1,receptor activity modifying protein 1,6,protein transporter activity|amylin receptor activity|coreceptor activity,,ppi
16250,19346,10266,RAMP2,receptor activity modifying protein 2,5,protein transporter activity|coreceptor activity|amylin receptor activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|lung benign neoplasm|adult respiratory distress syndrome|newborn respiratory distress syndrome,ppi
16251,19347,10268,RAMP3,receptor activity modifying protein 3,10,protein transporter activity|amylin receptor activity|coreceptor activity,,ppi
16252,19348,5901,RAN,RAN; member RAS oncogene family,184,magnesium ion binding|chromatin binding|transcription coactivator activity|RNA binding|GTPase activity|GTP binding|GDP binding|cadherin binding|androgen receptor binding|nuclear export signal receptor activity|pre-miRNA binding,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|arthropathy|arthritis,ppi
16253,19349,5902,RANBP1,RAN binding protein 1,53,GDP-dissociation inhibitor activity|Ran GTPase binding|cadherin binding|GTPase activator activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome|schizophrenia,ppi
16254,19350,5903,RANBP2,RAN binding protein 2,152,SUMO transferase activity|peptidyl-prolyl cis-trans isomerase activity|cyclosporin A binding|GTPase activator activity|Ran GTPase binding,,ppi
16255,19351,727851,RGPD8,RANBP2-like and GRIP domain containing 8,24,Ran GTPase binding|GTPase activator activity,,ppi
16256,19352,8498,RANBP3,RAN binding protein 3,49,Ran GTPase binding|GTPase activator activity,,ppi
16257,19353,26953,RANBP6,RAN binding protein 6,68,protein transporter activity|nuclear localization sequence binding,,ppi
16258,19354,10527,IPO7,importin 7,107,transporter activity|GTPase regulator activity|protein transporter activity,human immunodeficiency virus infectious disease|acquired immunodeficiency syndrome,ppi
16259,19355,10526,IPO8,importin 8,61,protein transporter activity,,ppi
16260,19356,5905,RANGAP1,Ran GTPase activating protein 1,130,RNA binding|GTPase activator activity|cadherin binding,,ppi
16261,19357,5906,RAP1A,RAP1A; member of RAS oncogene family,88,protein transporter activity|Rap guanyl-nucleotide exchange factor activity|protein-containing complex binding,ptosis|congenital ptosis|isolated cleft palate|cleft palate|sensorineural hearing loss|heart septal defect|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|tooth agenesis|anodontia|ophthalmoplegia|mechanical strabismus|hypertropia|cerebral degeneration|Klippel-Feil syndrome|spondylolisthesis|Hailey-Hailey disease|lethal restrictive dermopathy,ppi
16262,19358,5908,RAP1B,RAP1B; member of RAS oncogene family,76,GTPase activity|GTP binding|GDP binding|protein-containing complex binding,ptosis|congenital ptosis|isolated cleft palate|cleft palate|sensorineural hearing loss|heart septal defect|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|tooth agenesis|anodontia|ophthalmoplegia|mechanical strabismus|hypertropia|cerebral degeneration|Klippel-Feil syndrome|spondylolisthesis|Hailey-Hailey disease|lethal restrictive dermopathy,ppi
16263,19359,5909,RAP1GAP,RAP1 GTPase activating protein,23,GTPase activity|GTPase activator activity,acute promyelocytic leukemia|melanoma|skin melanoma|pancreatic cancer|thyroid cancer|thyroid adenoma|thyroid carcinoma,ppi
16264,19360,5910,RAP1GDS1,Rap1 GTPase-GDP dissociation stimulator 1,82,GTPase activator activity,,ppi
16265,19361,593,BCKDHA,branched chain keto acid dehydrogenase E1; alpha polypeptide,29,alpha-ketoacid dehydrogenase activity|carboxy-lyase activity,lactic acidosis|brain edema|cerebellar disease|epilepsy|hypoglycemia|maple syrup urine disease|intellectual disability|learning disability|acute pancreatitis|pancreatitis|visual epilepsy,ppi
16266,19362,5911,RAP2A,RAP2A; member of RAS oncogene family,58,magnesium ion binding|GTPase activity|GTP binding|GDP binding,rheumatoid arthritis,ppi
16267,19363,5912,RAP2B,RAP2B; member of RAS oncogene family,15,GTP binding|GDP binding,,ppi
16268,19364,5913,RAPSN,receptor associated protein of the synapse,11,acetylcholine receptor binding,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|blepharophimosis|ptosis|congenital ptosis|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|enophthalmos|orbital disease|exophthalmos|placental insufficiency|polyhydramnios|hydrocephalus|obstructive hydrocephalus|communicating hydrocephalus|senile degeneration of brain|familial periodic paralysis|myopathy,ppi
16269,19365,5914,RARA,retinoic acid receptor alpha,188,DNA-binding transcription factor activity; RNA polymerase II-specific|retinoic acid binding|DNA-binding transcription factor activity|retinoic acid receptor activity|transcription coactivator activity|transcription corepressor activity|signaling receptor binding|chromatin DNA binding|retinoic acid-responsive element binding|protein heterodimerization activity|protein kinase A binding|RNA polymerase II regulatory region sequence-specific DNA binding|transcription regulatory region sequence-specific DNA binding|nuclear receptor transcription coactivator activity|signaling receptor activity|nuclear receptor activity|transcription factor binding,bipolar disorder|benign breast phyllodes tumor|breast malignant phyllodes tumor|acute promyelocytic leukemia|schizophrenia|sciatic neuropathy|lesion of sciatic nerve|breast fibroadenoma|mood disorder|breast cancer|liver cancer|hepatocellular carcinoma,ppi
16270,19366,5915,RARB,retinoic acid receptor beta,30,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|transcription regulatory region sequence-specific DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|DNA-binding transcription factor activity|retinoic acid receptor activity|transcription factor binding|signaling receptor activity|nuclear receptor activity|nuclear receptor transcription coactivator activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|tongue squamous cell carcinoma|squamous cell carcinoma|cervical cancer|endometriosis of uterus|endometriosis|head and neck cancer|lung benign neoplasm|microphthalmia|stomach cancer|sciatic neuropathy|lesion of sciatic nerve|congenital diaphragmatic hernia|breast cancer|Matthew-Wood syndrome,ppi
16271,19367,5916,RARG,retinoic acid receptor gamma,45,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|retinoid X receptor binding|nuclear receptor activity|retinoic acid receptor activity|RNA polymerase II regulatory region sequence-specific DNA binding|transcription factor binding|nuclear receptor transcription coactivator activity|transcription regulatory region sequence-specific DNA binding|signaling receptor activity,isolated cleft palate|cleft palate|heart disease|cardiovascular system disease|osteogenesis imperfecta|Ehlers-Danlos syndrome,ppi
16272,19370,5920,RARRES3,retinoic acid receptor responder 3,15,phospholipase A2 activity|transferase activity; transferring acyl groups,,ppi
16273,19371,594,BCKDHB,branched chain keto acid dehydrogenase E1 subunit beta,14,alpha-ketoacid dehydrogenase activity,lactic acidosis|brain edema|cerebellar disease|epilepsy|hypoglycemia|maple syrup urine disease|intellectual disability|learning disability|acute pancreatitis|pancreatitis|visual epilepsy,ppi
16274,19372,5917,RARS,arginyl-tRNA synthetase,76,arginine-tRNA ligase activity|cadherin binding,basal ganglia disease|focal hand dystonia|blepharospasm|leukodystrophy|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|hypomyelinating leukodystrophy 9,ppi
16275,19373,5921,RASA1,RAS p21 protein activator 1,105,GTPase activity|GTPase activator activity|potassium channel inhibitor activity,arteriovenous malformation|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|von Hippel-Lindau disease|Peutz-Jeghers syndrome|varicose veins|lung cancer|lung adenocarcinoma|cavernous hemangioma|capillary hemangioma|angioma serpiginosum|blood coagulation disease,ppi
16276,19374,5922,RASA2,RAS p21 protein activator 2,2,,sick sinus syndrome|ptosis|congenital ptosis|blood coagulation disease|cryptorchidism|enophthalmos|orbital disease|exophthalmos|hemorrhagic disease|melanoma|skin melanoma|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3,ppi
16277,19375,8437,RASAL1,RAS protein activator like 1,4,,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis,ppi
16278,19376,9462,RASAL2,RAS protein activator like 2,14,,,ppi
16279,19377,5923,RASGRF1,Ras protein specific guanine nucleotide releasing factor 1,24,guanyl-nucleotide exchange factor activity|Ras guanyl-nucleotide exchange factor activity,bipolar disorder|myopia|refractive error,ppi
16280,19378,5924,RASGRF2,Ras protein specific guanine nucleotide releasing factor 2,5,guanyl-nucleotide exchange factor activity|Ras guanyl-nucleotide exchange factor activity|Rho guanyl-nucleotide exchange factor activity,alcohol dependence|alcohol abuse,ppi
16281,19379,10125,RASGRP1,RAS guanyl releasing protein 1,5,phosphatidylserine binding|guanyl-nucleotide exchange factor activity|Ras guanyl-nucleotide exchange factor activity|calcium ion binding|zinc ion binding|lipid binding|diacylglycerol binding|phosphatidylcholine binding|protein homodimerization activity,rheumatoid arthritis|bipolar disorder|endometriosis of uterus|endometriosis|acute myeloid leukemia|systemic lupus erythematosus,ppi
16282,19380,10235,RASGRP2,RAS guanyl releasing protein 2,7,guanyl-nucleotide exchange factor activity|calcium ion binding|lipid binding|diacylglycerol binding,,ppi
16283,19381,11186,RASSF1,Ras association domain family member 1,76,zinc ion binding,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|bladder disease|urinary bladder cancer|lung cancer|bronchiolo-alveolar adenocarcinoma|non-small cell lung carcinoma|cardiomyopathy|hypertrophic cardiomyopathy|endomyocardial fibrosis|inflammatory bowel disease|lung benign neoplasm|medulloblastoma|medullomyoblastoma|adult medulloblastoma|melanotic medulloblastoma|childhood medulloblastoma,ppi
16284,19382,9770,RASSF2,Ras association domain family member 2,31,protein kinase activity,nasopharynx carcinoma,ppi
16285,19383,5925,RB1,RB transcriptional corepressor 1,273,proximal promoter sequence-specific DNA binding|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|kinase binding|androgen receptor binding|RNA polymerase II regulatory region DNA binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II activating transcription factor binding,adrenal gland cancer|urinary bladder cancer|ptosis|congenital ptosis|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|lung cancer|non-small cell lung carcinoma|brain ischemia|isolated cleft palate|cleft palate|placental insufficiency|leukemia|lung benign neoplasm|lymphosarcoma|lymphoma|central nervous system lymphoma|intellectual disability,ppi
16286,19384,5926,ARID4A,AT-rich interaction domain 4A,33,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|histone deacetylase activity|transcription regulatory region DNA binding,,ppi
16287,19385,5927,KDM5A,lysine demethylase 5A,30,DNA-binding transcription factor activity; RNA polymerase II-specific|core promoter sequence-specific DNA binding|DNA binding|DNA-binding transcription factor activity|transcription coactivator activity|zinc ion binding|histone demethylase activity|histone demethylase activity (H3-trimethyl-K4 specific)|histone demethylase activity (H3-dimethyl-K4 specific)|methylated histone binding|histone binding|histone demethylase activity (H3-K9 specific)|chromatin binding|DNA-binding transcription repressor activity; RNA polymerase II-specific,intellectual disability|learning disability,ppi
16288,19386,5928,RBBP4,RB binding protein 4; chromatin remodeling factor,218,histone deacetylase activity|histone binding|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-dependent ATPase activity|nucleosomal DNA binding,,ppi
16289,19387,5929,RBBP5,RB binding protein 5; histone lysine methyltransferase complex subunit,82,histone-lysine N-methyltransferase activity|methylated histone binding|transcription regulatory region DNA binding|histone methyltransferase activity (H3-K4 specific),,ppi
16290,19388,5930,RBBP6,RB binding protein 6; ubiquitin ligase,85,RNA binding|ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
16291,19389,8915,BCL10,B-cell CLL/lymphoma 10,78,transcription coactivator activity|protein kinase binding|NF-kappaB binding|kinase activator activity|protein kinase B binding|transcription factor binding,anemia|macrocytic anemia|constipation|myelitis|encephalomyelitis|encephalitis|epilepsy|primary immunodeficiency disease|visual epilepsy|lymphosarcoma|B-cell lymphoma|agammaglobulinemia|gastric lymphoma,ppi
16292,19390,5931,RBBP7,RB binding protein 7; chromatin remodeling factor,182,histone deacetylase activity,,ppi
16293,19391,5932,RBBP8,RB binding protein 8; endonuclease,54,single-stranded DNA endodeoxyribonuclease activity|damaged DNA binding|transcription corepressor activity|double-stranded DNA binding|double-strand/single-strand DNA junction binding|Y-form DNA binding|flap-structured DNA binding|single-stranded DNA binding,craniosynostosis|placental insufficiency|glaucoma|intellectual disability|learning disability|tongue disease|microphthalmia|Seckel syndrome|Robinow syndrome|microcephalic osteodysplastic primordial dwarfism type I|microcephalic osteodysplastic primordial dwarfism type II|chondrodysplasia-pseudohermaphroditism syndrome|autosomal recessive Robinow syndrome|autosomal dominant Robinow syndrome 2|autosomal dominant Robinow syndrome 1|autosomal dominant Robinow syndrome 3|Cornelia de Lange syndrome|Prader-Willi syndrome|Silver-Russell syndrome|Dubowitz syndrome,ppi
16294,19392,10741,RBBP9,RB binding protein 9; serine hydrolase,5,,,ppi
16295,19393,5933,RBL1,RB transcriptional corepressor like 1,92,promoter-specific chromatin binding|RNA polymerase II activating transcription factor binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II regulatory region DNA binding,,ppi
16296,19394,5934,RBL2,RB transcriptional corepressor like 2,71,promoter-specific chromatin binding|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|RNA polymerase II activating transcription factor binding|RNA polymerase II regulatory region DNA binding,chronic lymphocytic leukemia|Richter's syndrome|ovarian cancer,ppi
16297,19395,8241,RBM10,RNA binding motif protein 10,82,RNA binding|miRNA binding|protein-containing complex binding,isolated cleft palate|cleft palate|clubfoot|placental insufficiency|hydronephrosis,ppi
16298,19396,54033,RBM11,RNA binding motif protein 11,16,poly(U) RNA binding|protein homodimerization activity|single-stranded RNA binding,,ppi
16299,19397,10137,RBM12,RNA binding motif protein 12,44,RNA binding,,ppi
16300,19398,40,ASIC2,acid sensing ion channel subunit 2,5,ligand-gated sodium channel activity|acid-sensing ion channel activity,autistic disorder,ppi
16301,19399,596,BCL2,BCL2; apoptosis regulator,124,protease binding|channel activity|channel inhibitor activity|sequence-specific DNA binding|protein heterodimerization activity|protein homodimerization activity,adenocarcinoma|granular cell carcinoma|tubular adenocarcinoma|cribriform carcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease,ppi
16302,19400,5935,RBM3,RNA binding motif (RNP1; RRM) protein 3,102,RNA binding|translation repressor activity|poly(U) RNA binding|ribosomal large subunit binding|mRNA 3'-UTR binding|small ribosomal subunit rRNA binding,breast cancer,ppi
16303,19401,5936,RBM4,RNA binding motif protein 4,164,RNA binding|mRNA binding|mRNA 3'-UTR binding|miRNA binding|pre-mRNA intronic binding|pre-mRNA intronic pyrimidine-rich binding,,ppi
16304,19402,10181,RBM5,RNA binding motif protein 5,41,DNA binding|RNA binding|mRNA binding,,ppi
16305,19403,10180,RBM6,RNA binding motif protein 6,23,DNA binding|RNA binding,,ppi
16306,19404,10179,RBM7,RNA binding motif protein 7,58,RNA binding|single-stranded RNA binding,lung cancer|non-small cell lung carcinoma,ppi
16307,19405,9939,RBM8A,RNA binding motif protein 8A,115,RNA binding|mRNA binding,anemia|macrocytic anemia|blood coagulation disease|hypereosinophilic syndrome|epilepsy|atrial heart septal defect 1|atrial heart septal defect 2|atrial heart septal defect 3|atrial heart septal defect 4|atrial heart septal defect 5|atrial heart septal defect 6|atrial heart septal defect 7|atrial heart septal defect 8|atrial heart septal defect 9|patent foramen ovale|atrial heart septal defect|ventricular septal defect|hemorrhagic disease|Meckel's diverticulum|intellectual disability,ppi
16308,19406,23543,RBFOX2,RNA binding protein; fox-1 homolog 2,103,transcription corepressor activity|RNA binding|transcription factor binding|mRNA binding,salivary gland adenoid cystic carcinoma,ppi
16309,19407,5937,RBMS1,RNA binding motif single stranded interacting protein 1,41,double-stranded DNA binding|single-stranded DNA binding|RNA binding|poly(U) RNA binding|poly(A) binding|mRNA 3'-UTR binding,,ppi
16310,19408,5939,RBMS2,RNA binding motif single stranded interacting protein 2,18,RNA binding|mRNA 3'-UTR binding|poly(A) binding|poly(U) RNA binding,,ppi
16311,19409,597,BCL2A1,BCL2 related protein A1,17,protein homodimerization activity|protein heterodimerization activity,rheumatoid arthritis|esophageal cancer|breast cancer,ppi
16312,19410,27316,RBMX,RNA binding motif protein; X-linked,161,RNA polymerase II proximal promoter sequence-specific DNA binding|chromatin binding|RNA binding|mRNA binding|identical protein binding,blepharophimosis|obesity,ppi
16313,19411,5940,RBMY1A1,RNA binding motif protein; Y-linked; family 1; member A1,18,mRNA binding|RNA binding,azoospermia|male infertility|Sertoli cell-only syndrome|oligospermia,ppi
16314,19412,5947,RBP1,retinol binding protein 1,18,retinoid binding|all-trans-retinol binding,schizophrenia|stomach cancer,ppi
16315,19413,598,BCL2L1,BCL2 like 1,105,protein heterodimerization activity|protein homodimerization activity,adenocarcinoma|adenoma|papillary adenoma|microcystic adenoma|follicular adenoma|cryptorchidism|diabetes mellitus|type 2 diabetes mellitus|head and neck cancer|gallbladder disease|liver disease|lung benign neoplasm|multiple myeloma|coronary thrombosis|myocardial infarction|silent myocardial infarction|acute myocardial infarction|pancreatic cancer|stomach cancer|toxic encephalopathy,ppi
16316,19414,5948,RBP2,retinol binding protein 2,7,retinoid binding,,ppi
16317,19415,5949,RBP3,retinol binding protein 3,2,retinoid binding|retinol binding,hypersensitivity reaction type II disease|autoimmune lymphoproliferative syndrome|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy,ppi
16318,19416,5950,RBP4,retinol binding protein 4,17,retinol binding|retinol transmembrane transporter activity,patent ductus arteriosus|congestive heart failure|nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|alcoholic hepatitis|liver cirrhosis|alcoholic liver cirrhosis|microphthalmia|polycystic ovary syndrome|stomach cancer|blindness|keratomalacia|fundus dystrophy,ppi
16319,19417,9978,RBX1,ring-box 1,176,ubiquitin-protein transferase activity|NEDD8 transferase activity|ubiquitin protein ligase binding|ubiquitin-ubiquitin ligase activity|ubiquitin protein ligase activity|cullin family protein binding,Stevens-Johnson syndrome,ppi
16320,19418,10017,BCL2L10,BCL2 like 10,11,protein heterodimerization activity|protein homodimerization activity,,ppi
16321,19419,5954,RCN1,reticulocalbin 1,105,calcium ion binding,,ppi
16322,19420,5955,RCN2,reticulocalbin 2,85,calcium ion binding,,ppi
16323,19421,5956,OPN1LW,opsin 1 (cone pigments); long-wave-sensitive,3,,blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|myopia|night blindness|congenital stationary night blindness|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|blindness|asthenopia|blue cone monochromacy,ppi
16324,19422,5957,RCVRN,recoverin,15,calcium sensitive guanylate cyclase activator activity,,ppi
16325,19423,10018,BCL2L11,BCL2 like 11,67,microtubule binding,primary sclerosing cholangitis|sclerosing cholangitis|suppurative cholangitis|ascending cholangitis|cholangitis,ppi
16326,19424,5959,RDH5,retinol dehydrogenase 5,7,retinol dehydrogenase activity,myopia|night blindness|congenital stationary night blindness|retinitis pigmentosa|fundus albipunctatus,ppi
16327,19425,5961,PRPH2,peripherin 2,4,,choroid disease|choroideremia|blue color blindness|color blindness|red-green color blindness|red color blindness|achromatopsia|acquired color blindness|glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|retinitis pigmentosa 30|age related macular degeneration|macular degeneration|intellectual disability|learning disability,ppi
16328,19426,5962,RDX,radixin,90,RNA binding|actin binding|protein homodimerization activity|cadherin binding|protein kinase A binding,cholestasis|autosomal recessive nonsyndromic deafness 24,ppi
16329,19427,5965,RECQL,RecQ like helicase,33,DNA helicase activity|ATP-dependent DNA helicase activity|annealing helicase activity|four-way junction helicase activity|ATP-dependent 3'-5' DNA helicase activity|DNA binding|protein binding,breast cancer,ppi
16330,19428,9401,RECQL4,RecQ like helicase 4,26,bubble DNA binding|helicase activity|ATP binding|oxidized purine DNA binding|annealing helicase activity|ATP-dependent 3'-5' DNA helicase activity|telomeric D-loop binding|four-way junction helicase activity|DNA binding|single-stranded DNA binding|protein binding,alopecia|imperforate anus|blepharophimosis|basal cell carcinoma|sweat gland cancer|carcinoma|sebaceous carcinoma|tongue squamous cell carcinoma|squamous cell carcinoma|isolated cleft palate|cleft palate|clubfoot|cryptorchidism|sensorineural hearing loss|epilepsy|enophthalmos|orbital disease|exophthalmos|placental insufficiency|glaucoma,ppi
16331,19429,599,BCL2L2,BCL2 like 2,26,protein heterodimerization activity|protein homodimerization activity,,ppi
16332,19430,9400,RECQL5,RecQ like helicase 5,52,RNA polymerase II complex binding|DNA helicase activity|ATP-dependent 3'-5' DNA helicase activity|DNA binding|four-way junction helicase activity|identical protein binding,,ppi
16333,19431,5967,REG1A,regenerating family member 1 alpha,4,growth factor activity|peptidoglycan binding|oligosaccharide binding|transmembrane signaling receptor activity,,ppi
16334,19432,5968,REG1B,regenerating family member 1 beta,4,oligosaccharide binding|transmembrane signaling receptor activity|peptidoglycan binding,,ppi
16335,19433,5966,REL,REL proto-oncogene; NF-kB subunit,235,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity|chromatin binding|RNA polymerase II regulatory region sequence-specific DNA binding,rheumatoid arthritis|Hodgkin's lymphoma; lymphocytic-histiocytic predominance|Hodgkin's lymphoma|Hodgkin's lymphoma; lymphocytic depletion|Hodgkin's granuloma|Hodgkin's lymphoma; mixed cellularity|pustulosis of palm and sole|psoriasis|parapsoriasis,ppi
16336,19434,5970,RELA,RELA proto-oncogene; NF-kB subunit,378,RNA polymerase II regulatory region sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II core promoter sequence-specific DNA binding|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|distal enhancer DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|chromatin binding|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|chromatin DNA binding|phosphate ion binding|identical protein binding|protein homodimerization activity|transcription regulatory region DNA binding|protein heterodimerization activity,Barrett's esophagus|brain cancer|papillary renal cell carcinoma|renal cell carcinoma|renal carcinoma|collecting duct carcinoma|renal clear cell carcinoma|chromophobe renal cell carcinoma|sarcomatoid renal cell carcinoma|brain ischemia|cholestasis|colitis|ileitis|ileocolitis|gastroenteritis|inflammatory bowel disease|ulcerative colitis|colon cancer|colonic benign neoplasm|trigonitis,ppi
16337,19435,5971,RELB,RELB proto-oncogene; NF-kB subunit,98,RNA polymerase II distal enhancer sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription factor activity|transcription corepressor activity|RNA polymerase II regulatory region sequence-specific DNA binding|chromatin binding,,ppi
16338,19436,5649,RELN,reelin,5,lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding,Alzheimer's disease 2|Alzheimer's disease 5|Alzheimer's disease 6|Alzheimer's disease 7|Alzheimer's disease 8|Alzheimer's disease 10|Alzheimer's disease 11|Alzheimer's disease 12|Alzheimer's disease 13|Alzheimer's disease 14|Alzheimer's disease 15|Alzheimer's disease|Pick's disease|cerebral degeneration|Reye syndrome|autistic disorder|bipolar disorder|neurotic disorder|major depressive disorder|mental depression,ppi
16339,19437,5972,REN,renin,10,aspartic-type endopeptidase activity|peptidase activity,proteinuria|alcohol dependence|alcohol abuse|anemia|macrocytic anemia|anuria|Liddle syndrome|Conn's syndrome|Bartter disease|primary hyperaldosteronism|bipolar disorder|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|placental insufficiency|focal segmental glomerulosclerosis|congestive heart failure,ppi
16340,19438,5973,RENBP,renin binding protein,3,endopeptidase inhibitor activity|N-acylglucosamine 2-epimerase activity,dilated cardiomyopathy 1C|dilated cardiomyopathy 1CC|dilated cardiomyopathy 1D|dilated cardiomyopathy 1V|dilated cardiomyopathy 1AA|dilated cardiomyopathy 1H|dilated cardiomyopathy 1G|dilated cardiomyopathy 1I|dilated cardiomyopathy 1NN|dilated cardiomyopathy 1E|dilated cardiomyopathy 1Z|dilated cardiomyopathy 1GG|dilated cardiomyopathy 1L|dilated cardiomyopathy 1K|dilated cardiomyopathy 1JJ|dilated cardiomyopathy 1P|dilated cardiomyopathy 2B|dilated cardiomyopathy 1Q|dilated cardiomyopathy 1B|dilated cardiomyopathy 1X,ppi
16341,19439,5976,UPF1,UPF1; RNA helicase and ATPase,187,chromatin binding|RNA binding|ATP-dependent RNA helicase activity|helicase activity|telomeric DNA binding,,ppi
16342,19440,9185,REPS2,RALBP1 associated Eps domain containing 2,28,,breast cancer,ppi
16343,19441,5977,DPF2,double PHD fingers 2,58,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|histone binding|histone acetyltransferase activity,,ppi
16344,19442,473,RERE,arginine-glutamic acid dipeptide repeats,32,DNA-binding transcription factor activity; RNA polymerase II-specific|poly-glutamine tract binding|transcription corepressor activity|RNA polymerase II transcription factor binding|DNA binding,autistic disorder|constipation|enophthalmos|orbital disease|exophthalmos|epilepsy|esophagitis|peptic esophagitis|gastroesophageal reflux disease|intellectual disability|learning disability|visual epilepsy|stereotypic movement disorder|ophthalmoplegia|mechanical strabismus|hypertropia|craniosynostosis|cerebral degeneration|chromosome 1p36 deletion syndrome,ppi
16345,19443,5978,REST,RE1 silencing transcription factor,39,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription repressor activity; RNA polymerase II-specific|chromatin binding|DNA-binding transcription factor activity|histone deacetylase activity|outward rectifier potassium channel activity|transcription regulatory region DNA binding,adenosarcoma|nephroblastoma|schizophrenia|epilepsy|visual epilepsy|major depressive disorder|mental depression|endogenous depression|melancholia,ppi
16346,19444,5979,RET,ret proto-oncogene,61,protein tyrosine kinase activity|transmembrane receptor protein tyrosine kinase activity|Ras guanyl-nucleotide exchange factor activity|calcium ion binding|signaling receptor activity|transmembrane signaling receptor activity,Burkitt lymphoma|heart disease|cardiovascular system disease|clubfoot|large intestine cancer|colorectal cancer|cataract 32 multiple types|cataract 8 multiple types|cataract 6 multiple types|cataract 34 multiple types|cataract 1 multiple types|cataract 29|cataract 27|cataract 4 multiple types|cataract 2 multiple types|cataract 39 multiple types|cataract 42|cataract 18|cataract 12 multiple types|cataract 20 multiple types,ppi
16347,19445,5980,REV3L,REV3 like; DNA directed polymerase zeta catalytic subunit,14,3'-5' exonuclease activity,ptosis|congenital ptosis|clubfoot|recurrent corneal erosion|ophthalmoplegia|mechanical strabismus|hypertropia|Baraitser-Winter syndrome|branchiootic syndrome|orofaciodigital syndrome I|Sakati-Nyhan syndrome|orofaciodigital syndrome X|Nance-Horan syndrome|Muenke Syndrome|Warburg micro syndrome 1|Warburg micro syndrome 2|Warburg micro syndrome 3|Warburg micro syndrome 4|Mobius syndrome|Goldenhar syndrome,ppi
16348,19446,5981,RFC1,replication factor C subunit 1,77,enzyme activator activity|DNA binding,alcohol dependence|alcohol abuse|colon cancer|colonic benign neoplasm|osteosarcoma|bone osteosarcoma,ppi
16349,19447,5982,RFC2,replication factor C subunit 2,68,DNA clamp loader activity|single-stranded DNA-dependent ATPase activity,generalized anxiety disorder|anxiety disorder|supravalvular aortic stenosis|autistic disorder|blepharophimosis|brain ischemia|constipation|neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|basal ganglia disease|focal hand dystonia|blepharospasm|clubfoot|sensorineural hearing loss|inguinal hernia|nephrocalcinosis,ppi
16350,19448,5983,RFC3,replication factor C subunit 3,48,DNA clamp loader activity|DNA binding|ATPase activity|single-stranded DNA-dependent ATPase activity,,ppi
16351,19449,5984,RFC4,replication factor C subunit 4,99,DNA clamp loader activity|single-stranded DNA-dependent ATPase activity,,ppi
16352,19450,5985,RFC5,replication factor C subunit 5,70,enzyme binding|DNA clamp loader activity|single-stranded DNA-dependent ATPase activity,,ppi
16353,19452,5987,TRIM27,tripartite motif containing 27,317,nucleic acid binding|ubiquitin-protein transferase activity|SUMO transferase activity|metal ion binding|ubiquitin protein ligase activity,papillary adenocarcinoma|papillary thyroid carcinoma|papillary renal cell carcinoma,ppi
16354,19453,10206,TRIM13,tripartite motif containing 13,36,ubiquitin-protein transferase activity|ubiquitin protein ligase activity,,ppi
16355,19454,5988,RFPL1,ret finger protein like 1,1,,,ppi
16356,19455,10739,RFPL2,ret finger protein like 2,14,,,ppi
16357,19456,602,BCL3,B-cell CLL/lymphoma 3,49,protein binding; bridging,,ppi
16358,19457,10738,RFPL3,ret finger protein like 3,8,,,ppi
16359,19458,5989,RFX1,regulatory factor X1,33,DNA-binding transcription factor activity; RNA polymerase II-specific|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|DNA-binding transcription factor activity|RNA polymerase II proximal promoter sequence-specific DNA binding,,ppi
16360,19459,5990,RFX2,regulatory factor X2,13,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity,,ppi
16361,19460,5991,RFX3,regulatory factor X3,24,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA binding|DNA-binding transcription factor activity|transcription factor activity; RNA polymerase II distal enhancer sequence-specific binding|transcription regulatory region DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding,seborrheic keratosis|skin disease|actinic keratosis,ppi
16362,19461,5992,RFX4,regulatory factor X4,3,RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity; RNA polymerase II-specific|proximal promoter DNA-binding transcription activator activity; RNA polymerase II-specific|DNA-binding transcription factor activity,alcohol dependence|alcohol abuse|bipolar disorder,ppi
16363,19462,5993,RFX5,regulatory factor X5,29,DNA-binding transcription factor activity; RNA polymerase II-specific|DNA-binding transcription activator activity; RNA polymerase II-specific|DNA binding|sequence-specific DNA binding|RNA polymerase II proximal promoter sequence-specific DNA binding|DNA-binding transcription factor activity,agammaglobulinemia|obstructive jaundice|biliary tract disease|chronic mucocutaneous candidiasis|colitis|ileitis|ileocolitis|gastroenteritis|myelitis|encephalomyelitis|encephalitis|urinary tract obstruction|celiac disease|MHC class II deficiency,ppi
16364,19463,8625,RFXANK,regulatory factor X associated ankyrin containing protein,39,DNA-binding transcription factor activity|transcription coregulator activity,agammaglobulinemia|obstructive jaundice|biliary tract disease|chronic mucocutaneous candidiasis|colitis|ileitis|ileocolitis|gastroenteritis|myelitis|encephalomyelitis|encephalitis|urinary tract obstruction|celiac disease|MHC class II deficiency,ppi
16365,19464,5994,RFXAP,regulatory factor X associated protein,9,DNA-binding transcription factor activity|transcription coactivator activity|DNA binding,agammaglobulinemia|obstructive jaundice|biliary tract disease|chronic mucocutaneous candidiasis|colitis|ileitis|ileocolitis|gastroenteritis|myelitis|encephalomyelitis|encephalitis|urinary tract obstruction|celiac disease|MHC class II deficiency,ppi
16366,19465,9104,RGN,regucalcin,8,gluconolactonase activity|calcium ion binding|zinc ion binding,nephritis|glomerulonephritis|kidney disease|pyoureter|nephrosis|liver cirrhosis,ppi
16367,19466,5995,RGR,retinal G protein coupled receptor,2,G-protein coupled receptor activity|G-protein coupled photoreceptor activity,glaucoma|sensorineural hearing loss|Zollinger-Ellison syndrome|hyperinsulinism|hypogonadism|corneal disease|keratoconus|intellectual disability|learning disability|spontaneous ocular nystagmus|dissociated nystagmus|congenital nystagmus|pathologic nystagmus|obesity|ophthalmoplegia|optic atrophy|cone-rod dystrophy|retinitis pigmentosa|fundus albipunctatus|blindness,ppi
16368,19467,5996,RGS1,regulator of G-protein signaling 1,11,GTPase activator activity|calmodulin binding,neurotic disorder|major depressive disorder|mental depression|endogenous depression|melancholia|dysthymic disorder|osteosarcoma|bone osteosarcoma|seborrheic keratosis|skin disease|actinic keratosis|allergic contact dermatitis,ppi
16369,19468,6001,RGS10,regulator of G-protein signaling 10,13,GTPase activator activity,schizophrenia,ppi
16370,19469,8786,RGS11,regulator of G-protein signaling 11,6,GTPase activator activity,,ppi
16371,19470,6002,RGS12,regulator of G-protein signaling 12,22,GTPase regulator activity,schizophrenia,ppi
16372,19471,6003,RGS13,regulator of G-protein signaling 13,10,,,ppi
16373,19472,10636,RGS14,regulator of G-protein signaling 14,18,GDP-dissociation inhibitor activity|GTPase activator activity|microtubule binding|receptor signaling complex scaffold activity,,ppi
16374,19473,6004,RGS16,regulator of G-protein signaling 16,15,GTPase activator activity|calmodulin binding,,ppi
16375,19474,5997,RGS2,regulator of G-protein signaling 2,70,GTPase activator activity|calmodulin binding,hypertension|essential hypertension|acute myeloid leukemia|secondary Parkinson disease|schizophrenia|stomach cancer|breast cancer,ppi
16376,19475,5998,RGS3,regulator of G-protein signaling 3,58,GTPase activator activity,,ppi
